PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hoang, VT; Nyswaner, K; Torres-Ayuso, P; Brognard, J				Hoang, Van T.; Nyswaner, Katherine; Torres-Ayuso, Pedro; Brognard, John			The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase; extracellular-signal-regulated kinase (ERK); c-Jun N-terminal kinase (JNK); oncogene; GTPase Kras (KRAS); lung cancer; cell proliferation; kinase signaling; kinome; YSK4	BRAF(V600E) INHIBITION; RESISTANCE; REVEALS	Identifying additional mitogen-activated protein kinase (MAPK) pathway regulators is invaluable in aiding our understanding of the complex signaling networks that regulate cellular processes, including cell proliferation and survival. Here, usingin vitrokinase assays and by expressing WT or kinase-dead MAPK kinase kinase 19 (MAP3K19) in the HEK293T cell line and assessing activation of the extracellular signal?regulated kinase (ERK) and JUN N-terminal kinase (JNK) signaling pathways, we defined MAP3K19 as a novel regulator of MAPK signaling. We also observed that overexpression of WT MAP3K19 activates both the ERK and JNK pathways in a panel of cancer cell lines. Furthermore, MAP3K19 sustained ERK pathway activation in the presence of inhibitors targeting the RAF proto-oncogene Ser/Thr protein kinase (RAF) and MAPK/ERK kinase, indicating that MAP3K19 activates ERK via a RAF-independent mechanism. Findings fromin vitroand in-cell kinase assays demonstrate that MAP3K19 is a kinase that directly phosphorylates both MAPK/ERK kinase (MEK) and MAPK kinase 7 (MKK7). Results from an short-hairpin RNA screen indicated that MAP3K19 is essential for maintaining survival in KRAS-mutant cancers; therefore, we depleted or inhibited MAP3K19 in KRAS-mutant cancer cell lines and observed that this reduces viability and decreases ERK and JNK pathway activation. In summary, our results reveal that MAP3K19 directly activates the ERK and JNK cascades and highlight a role for this kinase in maintaining survival of KRAS-mutant lung cancer cells.	[Hoang, Van T.; Nyswaner, Katherine; Torres-Ayuso, Pedro; Brognard, John] NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brognard, J (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA.	john.brognard@nih.gov	Torres-Ayuso, Pedro/AAE-6014-2021; Brognard, John/T-5099-2019	Torres-Ayuso, Pedro/0000-0003-2213-9014; Brognard, John/0000-0002-9243-6615	Intramural Research Program of NCI, National Institutes of Health [1ZIABC011691]	Intramural Research Program of NCI, National Institutes of Health	This research was supported by the Intramural Research Program of NCI, National Institutes of Health Grant 1ZIABC011691. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arozarena I, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.09; Atay O, 2017, J CELL BIOL, V216, P317, DOI 10.1083/jcb.201609124; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bhullar KS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0804-2; Boehme SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167169; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Durham AL, 2015, LUNG CANCER, V90, P121, DOI 10.1016/j.lungcan.2015.08.017; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Hoang VT, 2017, CANCER LETT, V392, P51, DOI 10.1016/j.canlet.2017.01.034; Knapp S, 2018, BRIT J CANCER, V118, P936, DOI 10.1038/s41416-018-0045-6; Marusiak AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4901; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Thumar J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-45; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	25	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8470	8479		10.1074/jbc.RA119.012365	http://dx.doi.org/10.1074/jbc.RA119.012365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358059	hybrid, Green Published			2022-12-26	WOS:000546986500011
J	Balasuriya, N; Davey, NE; Johnson, JL; Liu, HD; Biggar, KK; Cantley, LC; Li, SSC; O'Donoghue, P				Balasuriya, Nileeka; Davey, Norman E.; Johnson, Jared L.; Liu, Huadong; Biggar, Kyle K.; Cantley, Lewis C.; Li, Shawn Shun-Cheng; O'Donoghue, Patrick			Phosphorylation-dependent substrate selectivity of protein kinase B (AKT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide array; Akt PKB; RNA metabolism; substrate specificity; protein phosphorylation; cell signaling; post-translational modification (PTM); serine; threonine protein kinase; genetic code expansion; oriented peptide array library; phosphoinositide-dependent kinase 1; phosphoseryl-tRNA synthetase; tRNASep	NF-KAPPA-B; SIGNALING PATHWAY; AKT/PKB; IDENTIFICATION; SPECIFICITY; ACTIVATION; SURVIVAL; CANCER; PREDICTION; MECHANISM	Protein kinase B (AKT1) is a central node in a signaling pathway that regulates cell survival. The diverse pathways regulated by AKT1 are communicated in the cell via the phosphorylation of perhaps more than 100 cellular substrates. AKT1 is itself activated by phosphorylation at Thr-308 and Ser-473. Despite the fact that these phosphorylation sites are biomarkers for cancers and tumor biology, their individual roles in shaping AKT1 substrate selectivity are unknown. We recently developed a method to produce AKT1 with programmed phosphorylation at either or both of its key regulatory sites. Here, we used both defined and randomized peptide libraries to map the substrate selectivity of site-specific, singly and doubly phosphorylated AKT1 variants. To globally quantitate AKT1 substrate preferences, we synthesized three AKT1 substrate peptide libraries: one based on 84 ?known? substrates and two independent and larger oriented peptide array libraries (OPALs) of ?10(11)peptides each. We found that each phospho-form of AKT1 has common and distinct substrate requirements. Compared with pAKT1(T308), the addition of Ser-473 phosphorylation increased AKT1 activities on some, but not all of its substrates. This is the first report that Ser-473 phosphorylation can positively or negatively regulate kinase activity in a substrate-dependent fashion. Bioinformatics analysis indicated that the OPAL-activity data effectively discriminate known AKT1 substrates from closely related kinase substrates. Our results also enabled predictions of novel AKT1 substrates that suggest new and expanded roles for AKT1 signaling in regulating cellular processes.	[Balasuriya, Nileeka; Liu, Huadong; Li, Shawn Shun-Cheng; O'Donoghue, Patrick] Univ Western Ontario, Dept Biochem, London, ON, Canada; [O'Donoghue, Patrick] Univ Western Ontario, Dept Chem, London, ON, Canada; [Davey, Norman E.] Inst Canc Res, Div Canc Biol, London, England; [Johnson, Jared L.; Cantley, Lewis C.] Weill Cornell Med Coll, Meyer Canc Ctr, Dept Med, New York, NY USA; [Liu, Huadong] Xi An Jiao Tong Univ, Ctr Mitochondria Biol & Med, Xian, Shanxi, Peoples R China; [Biggar, Kyle K.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cornell University; Xi'an Jiaotong University; Carleton University	O'Donoghue, P (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.; O'Donoghue, P (corresponding author), Univ Western Ontario, Dept Chem, London, ON, Canada.	patrick.odonoghue@uwo.ca		O'Donoghue, Patrick/0000-0002-9500-8640; Johnson, Jared/0000-0003-1802-6527; Davey, Norman/0000-0001-6988-4850	Canadian Institutes of Health Research [165985]; Natural Sciences and Engineering Research Council of Canada [04282]; Canadian Cancer Society Research Institute innovation Grant [704324]; Canada Foundation for Innovation Grant [229917]; Ontario Research Fund [229917]; Canadian Breast Cancer Foundation; Canada Research Chairs [229917, 232341]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Cancer Society Research Institute innovation Grant; Canada Foundation for Innovation Grant(Canada Foundation for Innovation); Ontario Research Fund; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by the Canadian Institutes of Health Research Grant 165985 (to P. O.), Natural Sciences and Engineering Research Council of Canada Grant 04282 (to P. O.), Canadian Cancer Society Research Institute innovation Grant 704324 (to P. O. and S. S.-C. L.), Canada Foundation for Innovation Grant 229917 (to P. O.), Ontario Research Fund Grant 229917 (to P. O.), Canada Research Chairs 229917 and 232341 (to P. O.), and the Canadian Breast Cancer Foundation (to S. S.-C. L.).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balasuriya N, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090450; Balasuriya N, 2018, J BIOL CHEM, V293, P10744, DOI 10.1074/jbc.RA118.002357; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bradley D, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000341; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; Cheng J, 2014, MOL IMMUNOL, V59, P110, DOI 10.1016/j.molimm.2014.01.011; Chung CZ, 2019, RNA BIOL, V16, P1022, DOI 10.1080/15476286.2019.1608754; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dumble M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100880; Ehrenberger T, 2015, METHODS MOL BIOL, V1278, P57, DOI 10.1007/978-1-4939-2425-7_4; Fabbro D, 1999, PROTEIN EXPRES PURIF, V17, P83, DOI 10.1006/prep.1999.1102; Freudlsperger C, 2015, INT J CANCER, V136, P2775, DOI 10.1002/ijc.29328; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guan KL, 2000, J BIOL CHEM, V275, P27354; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Iacovides DC, 2013, MOL CELL PROTEOMICS, V12, P3210, DOI 10.1074/mcp.M112.023119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jin Y, 2019, BIOCHEM BIOPHYS REP, V18, DOI 10.1016/j.bbrep.2019.100625; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim HA, 2017, ANTICANCER RES, V37, P1409, DOI 10.21873/anticanres.11463; Krystkowiak I, 2018, NUCLEIC ACIDS RES, V46, pW235, DOI 10.1093/nar/gky426; Lee Rachel S, 2011, Enzyme Res, V2011, P720985, DOI 10.4061/2011/720985; Ma CX, 2016, CLIN CANCER RES, V22, P2650, DOI 10.1158/1078-0432.CCR-15-2160; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Soares CD, 2017, MELANOMA RES, V27, P448, DOI 10.1097/CMR.0000000000000368; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; Wang R, 2018, BIOCHEMISTRY-US, V57, P5257, DOI 10.1021/acs.biochem.8b00677; Wei R, 2018, MOL CELL PROTEOMICS, V17, P2216, DOI 10.1074/mcp.RA117.000114; Yeh PY, 2006, J BIOL CHEM, V281, P167, DOI 10.1074/jbc.M511014200; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	59	22	24	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8120	8134		10.1074/jbc.RA119.012425	http://dx.doi.org/10.1074/jbc.RA119.012425			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350110	Green Published, hybrid			2022-12-26	WOS:000542965700001
J	Yang, J; Zhang, H; Gong, WB; Liu, ZY; Wu, HW; Hu, WH; Chen, XX; Wang, L; Wu, S; Chen, C; Perrett, S				Yang, Jie; Zhang, Hong; Gong, Weibin; Liu, Zhenyan; Wu, Huiwen; Hu, Wanhui; Chen, Xinxin; Wang, Lei; Wu, Si; Chen, Chang; Perrett, Sarah			S-Glutathionylation of human inducible Hsp70 reveals a regulatory mechanism involving the C-terminal ?-helical lid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; oxidative stress; glutathionylation; 70-kilodalton heat shock protein (Hsp70); protein structure; cysteine modification; disulfide bond; HspA1A; protein homeostasis	SUBSTRATE-BINDING DOMAIN; OXIDATIVE STRESS; ALLOSTERIC REGULATION; CYSTEINE OXIDATION; NMR STRUCTURE; CELL BIOLOGY; DNAK; IDENTIFICATION; HEAT-SHOCK-PROTEIN-70; DYNAMICS	Heat shock protein 70 (Hsp70) proteins are a family of ancient and conserved chaperones. Cysteine modifications have been widely detected among different Hsp70 family membersin vivo, but their effects on Hsp70 structure and function are unclear. Here, we treated HeLa cells with diamide, which typically induces disulfide bond formation except in the presence of excess GSH, when glutathionylated cysteines predominate. We show that in these cells, HspA1A (hHsp70) undergoes reversible cysteine modifications, including glutathionylation, potentially at all five cysteine residues.In vitroexperiments revealed that modification of cysteines in the nucleotide-binding domain of hHsp70 is prevented by nucleotide binding but that Cys-574 and Cys-603, located in the C-terminal ?-helical lid of the substrate-binding domain, can undergo glutathionylation in both the presence and absence of nucleotide. We found that glutathionylation of these cysteine residues results in unfolding of the ?-helical lid structure. The unfolded region mimics substrate by binding to and blocking the substrate-binding site, thereby promoting intrinsic ATPase activity and competing with binding of external substrates, including heat shock transcription factor 1 (Hsf1). Thus, post-translational modification can alter the structure and regulate the function of hHsp70.	[Yang, Jie; Zhang, Hong; Gong, Weibin; Liu, Zhenyan; Wu, Huiwen; Hu, Wanhui; Chen, Xinxin; Wang, Lei; Wu, Si; Chen, Chang; Perrett, Sarah] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Yang, Jie; Zhang, Hong; Wu, Huiwen; Hu, Wanhui; Chen, Xinxin; Wang, Lei; Wu, Si; Chen, Chang; Perrett, Sarah] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Chang] Beijing Inst Brain Disorders, Beijing, Peoples R China; [Wu, Huiwen] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA USA; [Hu, Wanhui] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute; ShanghaiTech University	Zhang, H; Chen, C; Perrett, S (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Zhang, H; Chen, C; Perrett, S (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Chen, C (corresponding author), Beijing Inst Brain Disorders, Beijing, Peoples R China.	zhangh@moon.ibp.ac.cn; changchen@moon.ibp.ac.cn; sarah.perrett@cantab.net		Zhang, Hong/0000-0001-9204-2547; Wang, Lei/0000-0002-5071-5800; Gong, Weibin/0000-0001-7130-4093	Chinese Ministry of Science and Technology Grant [2017YFA-0504000]; National Natural Science Foundation of China [31570780, 31770829, 21673278, 31920103011, 31470747, 91849203, 31570857]; Beijing Natural Science Foundation [5172026]; Youth Innovation Promotion Association; Chinese Academy of Sciences (CAS); National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	Chinese Ministry of Science and Technology Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Youth Innovation Promotion Association; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	This work was supported by Chinese Ministry of Science and Technology Grant 2017YFA-0504000; National Natural Science Foundation of China Grants 31570780, 31770829, 21673278, 31920103011, 31470747, 91849203, and 31570857; Beijing Natural Science Foundation Grant 5172026; the Youth Innovation Promotion Association; the Chinese Academy of Sciences (CAS) (to L. W.); the National Laboratory of Biomacromolecules; and the CAS Center of Excellence in Biomacromolecules.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ansong C, 2013, P NATL ACAD SCI USA, V110, P10153, DOI 10.1073/pnas.1221210110; Azoulay I, 2013, INT J MOL SCI, V14, P12675, DOI 10.3390/ijms140612675; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callahan MK, 2002, J BIOL CHEM, V277, P33604, DOI 10.1074/jbc.M202890200; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Duan JC, 2016, ACS NANO, V10, P524, DOI 10.1021/acsnano.5b05524; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; Fratelli M, 2004, EXPERT REV PROTEOMIC, V1, P365, DOI 10.1586/14789450.1.3.365; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Guo J, 2014, NAT PROTOC, V9, P64, DOI 10.1038/nprot.2013.161; Hassan AQ, 2015, CHEM BIOL, V22, P87, DOI 10.1016/j.chembiol.2014.11.007; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Je JH, 2013, SCAND J IMMUNOL, V78, P238, DOI 10.1111/sji.12078; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Konstantinidis D, 2009, CELL STRESS CHAPERON, V14, P591, DOI 10.1007/s12192-009-0110-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Li R, 2017, METHOD ENZYMOL, V585, P269, DOI 10.1016/bs.mie.2016.10.006; Li R, 2015, J PROTEOME RES, V14, P2026, DOI 10.1021/acs.jproteome.5b00133; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Noguchi A, 2014, J BACTERIOL, V196, P1694, DOI 10.1128/JB.01197-13; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Penna C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00216; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Soss SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128240; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Tao LM, 2004, BIOCHEMISTRY-US, V43, P4028, DOI 10.1021/bi035924o; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Tutturen AEV, 2013, ANAL BIOANAL CHEM, V405, P9321, DOI 10.1007/s00216-013-7376-1; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855; Wang J, 2016, J BIOL CHEM, V291, P7541, DOI 10.1074/jbc.M115.694810; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Wani R, 2017, METHODS MOL BIOL, V1558, P191, DOI 10.1007/978-1-4939-6783-4_9; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang J, 2016, MOL CELL PROTEOMICS, V15, P1, DOI 10.1074/mcp.O115.056051; Yap LP, 2010, BIOCHEM J, V428, P85, DOI 10.1042/BJ20100164; Zhang H, 2016, J BIOL CHEM, V291, P6967, DOI 10.1074/jbc.M115.673608; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x; Zhang J, 2018, FREE RADICAL BIO MED, V120, P204, DOI 10.1016/j.freeradbiomed.2018.03.038; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108; Zylicz M, 2001, IUBMB LIFE, V51, P283	85	11	12	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8302	8324		10.1074/jbc.RA119.012372	http://dx.doi.org/10.1074/jbc.RA119.012372			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32332101	Green Published, hybrid			2022-12-26	WOS:000542965700017
J	Garcia-Gomez, JC; Gonzalez, AR; Maestre, MJ; Espinosa, F				Garcia-Gomez, Jose C.; Gonzalez, Alexandre R.; Maestre, Manuel J.; Espinosa, Free			Detect coastal disturbances and climate change effects in coralligenous community through sentinel stations	PLOS ONE			English	Article							ROCKY BENTHIC COMMUNITIES; LIFE-HISTORY TRAITS; MASS MORTALITY; ECOLOGICAL STATUS; ASTROIDES-CALYCULARIS; SECONDARY PRODUCTION; MARINE COMMUNITIES; ECOSYSTEM SHIFT; BIOTIC INDEXES; HARD-SUBSTRATA	This study was implemented to assess the Sessile Bioindicators in Permanent Quadrats (SBPQ) underwater environmental alert method. The SBPQ is a non-invasive and low-cost protocol; it uses sessile target species (indicators) to detect environmental alterations (natural or anthropic) at either the local or global (i.e., climate change) scale and the intrusion of invasive species. The SBPQ focuses on the monitoring of preselected sessile and sensitive benthic species associated with rocky coralligenous habitats using permanent quadrats in underwater sentinel stations. The selected target species have been well documented as bioindicators that disappear in the absence of environmental stability. However, whether these species are good indicators of stability or, in contrast, suffer variations in long-term coverage has not been verified. The purpose of this study was to assess the part of the method based on the hypothesis that, over a long temporal series in a highly structured and biodiverse coralligenous assemblage, the cover of sensitive sessile species does not change over time if the environmental stability characterising the habitat is not altered. Over a ten-year period (2005-2014), the sublittoral sessile biota in the Straits of Gibraltar Natural Park on the southern Iberian Peninsula was monitored at a 28 m-deep underwater sentinel stations. Analyses of the coverages of target indicator species (i.e., Paramuricea clavata and Astroides calycularis) together with other accompanying sessile organisms based on the periodic superimposition of gridded images from horizontal and vertical rocky surfaces allowed us to assess the effectiveness of the method. We conclude that no alterations occurred during the study period; only minimal fluctuations in cover were detected, and the method is reliable for detecting biological changes in ecosystems found in other geographical areas containing the chosen indicator species at similar dominance levels.	[Garcia-Gomez, Jose C.; Gonzalez, Alexandre R.; Maestre, Manuel J.; Espinosa, Free] Lab Biol Marina Univ Sevilla LBMUS, Area Invest I D I Acuario Sevilla, Estn Biol Marina Estrecho Ceuta, Seville, Spain		Garcia-Gomez, JC (corresponding author), Lab Biol Marina Univ Sevilla LBMUS, Area Invest I D I Acuario Sevilla, Estn Biol Marina Estrecho Ceuta, Seville, Spain.	jcgarcia@us.es			Regional Activity Centre for Special Protected Areas (RAC/SPA); Mediterranean Protected Areas Network (MedPAN) projects; Consejeria de Medio Ambiente de la Junta de Andalucia; Autoridad Portuaria de Sevilla; Compania Espanola de Petroleos S.A.U. (CEPSA) Foundation; Red Electrica de Espana (REE)	Regional Activity Centre for Special Protected Areas (RAC/SPA); Mediterranean Protected Areas Network (MedPAN) projects; Consejeria de Medio Ambiente de la Junta de Andalucia(Junta de Andalucia); Autoridad Portuaria de Sevilla; Compania Espanola de Petroleos S.A.U. (CEPSA) Foundation; Red Electrica de Espana (REE)	This research supported by the Regional Activity Centre for Special Protected Areas (RAC/SPA) and the Mediterranean Protected Areas Network (MedPAN) projects, Consejeria de Medio Ambiente de la Junta de Andalucia, and cofinanced by Autoridad Portuaria de Sevilla, Compania Espanola de Petroleos S.A.U. (CEPSA) Foundation and Red Electrica de Espana (REE). Also, research was partially supported by the University of Seville providing salaries to the authors JCG-G and, FE, and Research Foundation of University of Seville (different projects) providing salaries to ARG and MJM. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany J., 2005, ENTRE MARES CONTINEN; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Balduzzi A., 1989, J EXPT MARINE BIOL E, V53, P387; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V138, P93, DOI 10.3354/meps138093; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bertolino M, 2016, J MAR BIOL ASSOC UK, V96, P341, DOI 10.1017/S0025315415001186; Betti F, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12439; Bevilacqua S, 2006, J ANIM ECOL, V75, P908, DOI 10.1111/j.1365-2656.2006.01108.x; Bianchi CN, 2019, EUR ZOOL J, V86, P458, DOI 10.1080/24750263.2019.1687765; Bianchi C N, 2004, HARD BOTTOMS BIOL MA, V11, P85; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi CN, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11110215; Bianchi CN, 2018, AQUAT CONSERV, V28, P1209, DOI 10.1002/aqc.2918; BOHNSACK JA, 1979, B MAR SCI, V29, P242; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Bussotti S, 2006, MAR ECOL PROG SER, V325, P109, DOI 10.3354/meps325109; Cabaitan PC, 2007, SCI DILIMAN, V19, P7; Canovas-Molina A, 2016, CONT SHELF RES, V121, P13, DOI 10.1016/j.csr.2016.01.008; Carballo JL, 1996, MAR ECOL PROG SER, V135, P109, DOI 10.3354/meps135109; Garcia-Gomez JC, 2020, SCI TOTAL ENVIRON, V704, DOI 10.1016/j.scitotenv.2019.135408; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Casas-Guell E, 2015, MAR BIOL, V162, P901, DOI 10.1007/s00227-015-2635-7; Cattaneo-Vietti R, 2002, MAR ECOL-P S Z N I, V23, P65, DOI 10.1111/j.1439-0485.2002.tb00008.x; Clarke KR, 2006, J EXP MAR BIOL ECOL, V338, P179, DOI 10.1016/j.jembe.2006.06.019; Coma R, 1998, ESTUAR COAST SHELF S, V47, P459, DOI 10.1006/ecss.1998.0375; Coma R, 2012, ASSESSMENT ECOLOGICA, P67; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Consejeria de Medio Ambiente de la Junta de Andalucia, 2009, AC ESP ENTR CONS MED; Cupido R, 2009, MAR ECOL PROG SER, V394, P195, DOI 10.3354/meps08260; DAUER DM, 1993, MAR POLLUT BULL, V26, P249, DOI 10.1016/0025-326X(93)90063-P; De Biasi A.M., 2004, J CHEM ECOL, V20, P89; de Juan S, 2012, ECOL INDIC, V18, P183, DOI 10.1016/j.ecolind.2011.11.020; Deter J, 2012, J EXP MAR BIOL ECOL, V418, P75, DOI 10.1016/j.jembe.2012.03.006; Deter J, 2012, ECOL INDIC, V20, P345, DOI 10.1016/j.ecolind.2012.03.001; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Di Franco A, 2009, ENVIRON CONSERV, V36, P32, DOI 10.1017/S0376892909005426; Dietz H, 1996, J VEG SCI, V7, P131, DOI 10.2307/3236426; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; EC, 2000, OFFICIAL J EUROPEA L, V327, P1, DOI DOI 10.1039/AP9842100196; Enrichetti F, 2019, ECOL INDIC, V102, P218, DOI 10.1016/j.ecolind.2019.02.028; Estacio FJ, 1999, J COASTAL RES, V15, P155; Estacio FJ, 1997, MAR POLLUT BULL, V34, P780, DOI 10.1016/S0025-326X(97)00046-5; Ferrigno F, 2017, ECOL INDIC, V82, P271, DOI 10.1016/j.ecolind.2017.07.020; Foden J, 2007, MAR POLLUT BULL, V55, P181, DOI 10.1016/j.marpolbul.2006.08.021; Foden J, 2007, HYDROBIOLOGIA, V579, P187, DOI 10.1007/s10750-006-0402-y; FOSTER MS, 1991, J EXP MAR BIOL ECOL, V146, P193, DOI 10.1016/0022-0981(91)90025-R; Fraschetti S, 2001, MAR ECOL PROG SER, V212, P1, DOI 10.3354/meps212001; Garcia-Gomez J C., 2015, RAC SPA MEDMPANET PR; Garcia-Gomez J C., 2007, BIOTA LITORAL VIGILA; Garrabou J, 1999, MAR ECOL PROG SER, V178, P193, DOI 10.3354/meps178193; Garrabou J, 2000, EUR J PHYCOL, V35, P1; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gaspar R, 2012, ECOL INDIC, V19, P24, DOI 10.1016/j.ecolind.2011.08.022; Gatti G, 2015, ECOL INDIC, V52, P567, DOI 10.1016/j.ecolind.2014.12.026; Gatti Giulia, 2012, Advances in Oceanography and Limnology, V3, P51, DOI 10.1080/19475721.2012.671190; Gatti G, 2017, MAR POLLUT BULL, V114, P528, DOI 10.1016/j.marpolbul.2016.10.022; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; Gerovasileiou V, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e8692; Gili Josep-Maria, 1992, Oecologia Aquatica, V10, P243; GLYNN PW, 1991, TRENDS ECOL EVOL, V6, P175, DOI 10.1016/0169-5347(91)90208-F; Gobert S, 2009, MAR POLLUT BULL, V58, P1727, DOI 10.1016/j.marpolbul.2009.06.012; Gorley C.K., 2006, GETTING STARTED PRIM; Grall J, 1997, ESTUAR COAST SHELF S, V44, P43, DOI 10.1016/S0272-7714(97)80006-6; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guerra-Garcia JM, 2004, CRUSTACEANA, V77, P353, DOI 10.1163/1568540041181538; Guidetti P, 2004, MAR ECOL PROG SER, V274, P57, DOI 10.3354/meps274057; Guinda X, 2012, J SEA RES, V67, P34, DOI 10.1016/j.seares.2011.09.006; Hawkins SJ, 2012, AQUAT CONSERV, V22, P281, DOI 10.1002/aqc.2239; Hill JJ, 2004, METHODS ECOLOGICAL M; JACKSON JBC, 1991, BIOSCIENCE, V41, P475, DOI 10.2307/1311805; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Juanes JA, 2008, ECOL INDIC, V8, P351, DOI 10.1016/j.ecolind.2007.04.005; Kipson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027103; Krause-Jensen D, 2005, WATER RESOUR MANAG, V19, P63, DOI 10.1007/s11269-005-0293-0; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA; Laborel J., 2005, ENCYCL COAST SCI, P833; LANYON JM, 1995, AQUAT BOT, V49, P217, DOI 10.1016/0304-3770(94)00435-O; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; LEONARD GH, 1993, MAR ECOL PROG SER, V101, P203, DOI 10.3354/meps101203; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Linares C, 2010, MAR ECOL PROG SER, V402, P59, DOI 10.3354/meps08437; LUNDALV T, 1986, HYDROBIOLOGIA, V142, P81, DOI 10.1007/BF00026749; Magorrian BH, 1998, MAR POLLUT BULL, V36, P354, DOI 10.1016/S0025-326X(97)00192-6; MAJEED SA, 1987, MAR POLLUT BULL, V18, P490, DOI 10.1016/0025-326X(87)90360-2; Marti R, 2005, ESTUAR COAST SHELF S, V64, P613, DOI 10.1016/j.ecss.2005.04.009; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; MISTRI M, 1994, MAR ECOL PROG SER, V103, P291, DOI 10.3354/meps103291; Molloy PP, 2013, AQUAT CONSERV, V23, P820, DOI 10.1002/aqc.2372; Montefalcone M, 2017, MAR POLLUT BULL, V117, P229, DOI 10.1016/j.marpolbul.2017.01.072; Morales C., 2007, THESIS; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Neto JM, 2012, ECOL INDIC, V19, P39, DOI 10.1016/j.ecolind.2011.09.006; Occhipinti-Ambrogi A, 2007, MAR POLLUT BULL, V55, P342, DOI 10.1016/j.marpolbul.2006.11.014; Orejas C, 1970, B I OCEANOGRAPHIQUE, V1410, P1; Orfanidis S., 2001, MEDITERRANEAN MARINE, V2, P45, DOI [DOI 10.12681/MMS.266, 10.12681/mms.266]; Panayotidis P, 2004, J APPL PHYCOL, V16, P49, DOI 10.1023/B:JAPH.0000019114.47824.42; Pardo A, 2005, ANALISIS DATOS CON S, P395; Parravicini V, 2009, ESTUAR COAST SHELF S, V81, P359, DOI 10.1016/j.ecss.2008.11.007; Parravicini V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075767; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PECKOL P, 1984, ESTUAR COAST SHELF S, V18, P133, DOI 10.1016/0272-7714(84)90101-X; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Piazzi L, 2019, AQUAT CONSERV, V29, P189, DOI 10.1002/aqc.2983; Piazzi L, 2017, AQUAT CONSERV, V27, P1091, DOI 10.1002/aqc.2773; Piazzi L, 2017, SCI MAR, V81, P283, DOI 10.3989/scimar.04565.01B; Piazzi L, 2014, SCI MAR, V78, P319, DOI 10.3989/scimar.03989.28A; Puente A, 2008, ESTUAR COAST SHELF S, V78, P327, DOI 10.1016/j.ecss.2007.12.006; ROBERTS DE, 1994, J EXP MAR BIOL ECOL, V177, P157, DOI 10.1016/0022-0981(94)90234-8; Romano JC, 2000, CR ACAD SCI III-VIE, V323, P415, DOI 10.1016/S0764-4469(00)00141-4; ROS JD, 1991, TOXICOL ENVIRON CHEM, V31-2, P441, DOI 10.1080/02772249109357719; Rosenberg R, 2004, MAR POLLUT BULL, V49, P728, DOI 10.1016/j.marpolbul.2004.05.013; Rovere A, 2015, HANDBOOK OF SEA-LEVEL RESEARCH, P268; RYGG B, 1985, MAR POLLUT BULL, V16, P469, DOI 10.1016/0025-326X(85)90378-9; Sanchez-Moyano JE, 2002, HYDROBIOLOGIA, V470, P133, DOI 10.1023/A:1015680106097; Sant N, 2017, SCI MAR, V81, P129, DOI 10.3989/scimar.04463.04A; Sartoretto S, 2017, MAR POLLUT BULL, V120, P222, DOI 10.1016/j.marpolbul.2017.05.020; Sebens K.P., 1991, P211; SIMBOURA N., 2002, MEDITERRANEAN MARINE, V3, P77, DOI DOI 10.12681/MMS.249; Soto CG, 2001, REV FISH BIOL FISHER, V11, P181, DOI 10.1023/A:1020364409616; Terron-Sigler A, 2016, OCEAN COAST MANAGE, V122, P1, DOI 10.1016/j.ocecoaman.2016.01.002; Terron-Sigler A, 2014, AQUAT BIOL, V21, P143, DOI 10.3354/ab00577; Urkiaga-Alberdi J, 1999, ACTA OECOL, V20, P489, DOI 10.1016/S1146-609X(99)00119-8; van Rein H, 2012, J MAR BIOL ASSOC UK, V92, P49, DOI 10.1017/S0025315411000233; Van Rein H, 2011, AQUAT CONSERV, V21, P690, DOI 10.1002/aqc.1230; Van Rein H, 2011, AQUAT CONSERV, V21, P676, DOI 10.1002/aqc.1224; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARWICK RM, 1993, AUST J ECOL, V18, P63, DOI 10.1111/j.1442-9993.1993.tb00435.x; WEINBAUER MG, 1995, MAR ECOL PROG SER, V121, P211, DOI 10.3354/meps121211; WEINBERG S, 1978, MAR BIOL, V49, P33, DOI 10.1007/BF00390728; Wells E, 2007, MAR POLLUT BULL, V55, P151, DOI 10.1016/j.marpolbul.2006.08.031; WHORFF JS, 1992, J EXP MAR BIOL ECOL, V160, P1, DOI 10.1016/0022-0981(92)90106-K; Witman JD, 1998, ECOLOGY, V79, P2429, DOI 10.1890/0012-9658(1998)079[2429:LBRSAP]2.0.CO;2; ZIBROUWIUS H, 1995, GEOBIOS-LYON, V28, P9, DOI 10.1016/S0016-6995(95)80201-0	141	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0231641	10.1371/journal.pone.0231641	http://dx.doi.org/10.1371/journal.pone.0231641			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369490	gold, Green Published			2022-12-26	WOS:000537280000007
J	Zhang, YQ; Zhang, Z; Wu, YF; Ga, LT; Xu, DC; Li, WB				Zhang, Yuqi; Zhang, Zhe; Wu, Yafeng; Ga, Latai; Xu, Daochun; Li, Wenbin			Research on a floating thermoelectric power generator for use in wetland monitoring	PLOS ONE			English	Article							FRESNEL LENS; HYBRID SYSTEM; TEMPERATURE; PERFORMANCE; MODULE	A floating power generation device is designed and fabricated to overcome the power supply limitations of wireless sensor networks for environmental monitoring. Once there is a temperature difference between the upper surface exposed to sunlight and the lower surface in the water, the device is capable of generating power while floating in the wetland environment. Fresnel lenses were applied to concentrate solar irradiation on a selective absorbing coat. Meanwhile two vertical axis rotors were used to cool the cold side of the thermoelectric power generator by catching the breeze. The effects of solar irradiation, temperature distribution, load resistance, wind speed, the maximum power and the electrical efficiency of the thermoelectric power generator were analyzed. When subjected to solar irradiation of 896.38 W/m(2), the device generated a potential difference of 381.03 mV and a power output of 8.86 mW via thermoelectric generation. In addition, compared with the system without wind, the output power was increased by approximately 10.96% in our system. The low power wireless networks, used in wetland environments, could be operated by the thermoelectric power generated by the floating device. Besides, this system offers powering solution for self-power miniature devices that are applied in aqueous environment.	[Zhang, Yuqi; Zhang, Zhe; Wu, Yafeng; Ga, Latai; Xu, Daochun; Li, Wenbin] Beijing Forestry Univ, Sch Technol, Beijing, Peoples R China; [Xu, Daochun; Li, Wenbin] Key Lab State Forestry Adm Forestry Equipment & A, Beijing, Peoples R China	Beijing Forestry University	Xu, DC; Li, WB (corresponding author), Beijing Forestry Univ, Sch Technol, Beijing, Peoples R China.; Xu, DC; Li, WB (corresponding author), Key Lab State Forestry Adm Forestry Equipment & A, Beijing, Peoples R China.	xudaochun@bjfu.edu.cn; leewb@bjfu.edu.cn		Zhang, Yuqi/0000-0002-3426-4544	National Science Foundation of China [31670716]; China Postdoctoral Science Special Foundation [2016T90044]; China Postdoctoral Science Foundation [2015M570945]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Science Foundation of China (31670716) China Postdoctoral Science Special Foundation (2016T90044) China Postdoctoral Science Foundation (2015M570945) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri M, 2017, J RENEWABLE ENERGY E, V4, P39; Brantut JP, 2013, SCIENCE, V342, P713, DOI 10.1126/science.1242308; Elghool A, 2017, ENERG CONVERS MANAGE, V134, P260, DOI 10.1016/j.enconman.2016.12.046; Carneiro JF, 2018, ENERG CONVERS MANAGE, V163, P38, DOI 10.1016/j.enconman.2018.02.031; Guan MJ, 2017, ENERG CONVERS MANAGE, V138, P30, DOI 10.1016/j.enconman.2017.01.049; Hornung T, 2012, SOL ENERG MAT SOL C, V99, P333, DOI 10.1016/j.solmat.2011.12.024; Hu MK, 2018, APPL ENERG, V231, P288, DOI 10.1016/j.apenergy.2018.09.137; Koysal Y, 2018, J SOL ENERG-T ASME, V140, DOI 10.1115/1.4039777; Lee G, 2019, ENERGY, V179, P12, DOI 10.1016/j.energy.2019.05.018; Lee W-K, 2016, 2016 IEEE IND EL APP; Lee WK, 2018, IEEE T IND APPL, V54, P2606, DOI 10.1109/TIA.2018.2799158; Li GQ, 2018, ENERGY, V158, P41, DOI 10.1016/j.energy.2018.06.021; Li GQ, 2016, ENERG CONVERS MANAGE, V112, P191, DOI 10.1016/j.enconman.2016.01.025; Li XW, 2012, ENERG CONVERS MANAGE, V53, P189, DOI 10.1016/j.enconman.2011.08.001; Lv S, 2018, ENERG CONVERS MANAGE, V156, P167, DOI 10.1016/j.enconman.2017.11.011; Mahmoudinezhad S, 2018, ENERGY, V159, P1123, DOI 10.1016/j.energy.2018.06.181; Marandi OF, 2018, SOL ENERGY, V161, P38, DOI 10.1016/j.solener.2017.12.039; Meng X, 2014, J ELECTRON MATER, V43, P1509, DOI 10.1007/s11664-013-2768-8; Nia MH, 2014, ENERG CONVERS MANAGE, V84, P305, DOI 10.1016/j.enconman.2014.04.041; Shakouri A, 2011, ANNU REV MATER RES, V41, P399, DOI 10.1146/annurev-matsci-062910-100445; Shen ZG, 2017, ENERGY, V141, P215, DOI 10.1016/j.energy.2017.09.051; Verma G, 2019, IEEE T IND ELECTRON, V66, P3530, DOI 10.1109/TIE.2018.2863190; Willars-Rodriguez FJ, 2017, INT J ENERG RES, V41, P377, DOI 10.1002/er.3614; Zhang Z, 2016, ENERG CONVERS MANAGE, V127, P301, DOI 10.1016/j.enconman.2016.09.023; Zhang Z, 2015, ENERG CONVERS MANAGE, V97, P178, DOI 10.1016/j.enconman.2015.03.060; Zheng XF, 2014, RENEW SUST ENERG REV, V32, P486, DOI 10.1016/j.rser.2013.12.053	26	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232331	10.1371/journal.pone.0232331	http://dx.doi.org/10.1371/journal.pone.0232331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369524	Green Published, gold			2022-12-26	WOS:000537280000025
J	Charantimath, U; Belled, R; Majantashetti, N; Washio, Y; Derman, R; Kelly, PJ; Short, V; Chung, E; Goudar, S				Charantimath, Umesh; Belled, Roopa; Majantashetti, Niranjana; Washio, Yukiko; Derman, Richard; Kelly, Patricia J.; Short, Vanessa; Chung, Esther; Goudar, Shivaprasad			Facilitators and challenges to exclusive breastfeeding in Belagavi District, Karnataka, India	PLOS ONE			English	Article								Objective A primary objective of this study was to identify specific facilitators and challenges around exclusive breastfeeding (EBF) in our community in India, from the perspective of breastfeeding mothers and their support networks. Methods We conducted eight focus groups incorporating 75 women and their support networks in the Belagavi District, Karnataka State, India. We used a directed content analysis to guide the analysis. Results The specific facilitator that emerged as a theme, broad support for and knowledge about breastfeeding on the individual, family and community levels, was a seeming contraction to the identified specific challenge, the paradox of the common practice of supplemental feeds. Conclusions Despite voicing strong support for and knowledge about EBF, participants were familiar with a variety of supplemental feeding practices in their communities. In place of universal condemnation of all supplemental feeding, policy makers might consider strategies to address the most potentially dangerous of these practices.	[Charantimath, Umesh; Belled, Roopa; Majantashetti, Niranjana; Goudar, Shivaprasad] Jawaharlal Nehru Med Coll, Belagavi, Karnataka, India; [Washio, Yukiko] RTI Int, Durham, NC USA; [Derman, Richard; Short, Vanessa; Chung, Esther] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Kelly, Patricia J.] Univ Missouri, Kansas City, MO 64110 USA	K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; Research Triangle Institute; Jefferson University; University of Missouri System; University of Missouri Kansas City	Kelly, PJ (corresponding author), Univ Missouri, Kansas City, MO 64110 USA.	Kellypj@umkc.edu	Bellad, Roopa M/AAT-4060-2020; GOUDAR, SHIVAPRASAD S/S-1217-2019	Bellad, Roopa M/0000-0003-4383-1704; GOUDAR, SHIVAPRASAD S/0000-0002-8680-7053; Chung, Esther/0000-0002-1906-9863; CHARANTIMATH, UMESH/0000-0003-1726-2798; Washio, Yukiko/0000-0002-3882-2953	U.S. National Institute of Health, National Institute of Child Health and Development [R21TW010609]	U.S. National Institute of Health, National Institute of Child Health and Development	The study was funded by the U.S. National Institute of Health, National Institute of Child Health and Development, R21TW010609, recipient Richard Derman, MD, MPH Website: https://www.nichd.nih.gov The sponsors played no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Al Ketbi MI, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0165-x; Alamirew MW, 2017, NURS RES PRACT, V2017, DOI 10.1155/2017/6561028; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; Dallazen C, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00202816; Desai A, 2014, J NUTR, V144, P1113, DOI 10.3945/jn.113.188714; Global Breastfeeding Investment Case, 2017, INVESTMENT CASE BREA; Grant Kathie A, 2013, Community Pract, V86, P44; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huberman A. M., 2014, QUALITATIVE DATA ANA; Ip S, 2007, BREASTFEEDING MATERN; Kavle JA, 2017, PUBLIC HEALTH NUTR, V20, P3120, DOI 10.1017/S1368980017002531; Legesse M, 2015, J TROP PEDIATRICS, V61, P357, DOI 10.1093/tropej/fmv039; Mulol H, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0159-8; Nishimura H, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0178-5; Patel Dipen V, 2015, Adv Prev Med, V2015, P892825, DOI 10.1155/2015/892825; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Radwan H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-171; WHO, BREASTFEEDING; World Health Organization (WHO-c), EN WOM BREASTF BETT; Zhang ZH, 2018, MIDWIFERY, V62, P177, DOI 10.1016/j.midw.2018.04.006	20	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0231755	10.1371/journal.pone.0231755	http://dx.doi.org/10.1371/journal.pone.0231755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365108	gold, Green Published			2022-12-26	WOS:000536959700011
J	Ghazi, S; Bourgeois, S; Gomariz, A; Bugarski, M; Haenni, D; Martins, JR; Nombela-Arrieta, C; Unwin, RJ; Wagner, CA; Hall, AM; Craigie, E				Ghazi, Susan; Bourgeois, Soline; Gomariz, Alvaro; Bugarski, Milica; Haenni, Dominik; Martins, Joana R.; Nombela-Arrieta, Cesar; Unwin, Robert J.; Wagner, Carsten A.; Hall, Andrew M.; Craigie, Eilidh			Multiparametric imaging reveals that mitochondria-rich intercalated cells in the kidney collecting duct have a very high glycolytic capacity	FASEB JOURNAL			English	Article						calcium; epididymis; mitochondria; multiphoton microscopy	RENAL TUBULAR-ACIDOSIS; VACUOLAR H+-ATPASE; V-ATPASE; MOUSE; PROTON; PH; LOCALIZATION; METABOLISM; MICE; IDENTIFICATION	Alpha intercalated cells (alpha ICs) in the kidney collecting duct (CD) belong to a family of mitochondria rich cells (MRCs) and have a crucial role in acidifying the urine via apical V-ATPase pumps. The nature of metabolism in alpha ICs and its relationship to transport was not well-understood. Here, using multiphoton live cell imaging in mouse kidney tissue, FIB-SEM, and other complementary techniques, we provide new insights into mitochondrial structure and function in alpha ICs. We show that alpha IC mitochondria have a rounded structure and are not located in close proximity to V-ATPase containing vesicles. They display a bright NAD(P)H fluorescence signal and low uptake of voltage-dependent dyes, but are energized by a pH gradient. However, expression of complex V (ATP synthase) is relatively low in alpha ICs, even when stimulated by metabolic acidosis. In contrast, anaerobic glycolytic capacity is surprisingly high, and sufficient to maintain intracellular calcium homeostasis in the presence of complete aerobic inhibition. Moreover, glycolysis is essential for V-ATPase-mediated proton pumping. Key findings were replicated in narrow/clear cells in the epididymis, also part of the MRC family. In summary, using a range of cutting-edge techniques to investigate alpha IC metabolism in situ, we have discovered that these mitochondria dense cells have a high glycolytic capacity.	[Ghazi, Susan; Bugarski, Milica; Haenni, Dominik; Hall, Andrew M.; Craigie, Eilidh] Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Gomariz, Alvaro; Nombela-Arrieta, Cesar] Univ Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland; [Gomariz, Alvaro] Swiss Fed Inst Technol, Comp Vis Lab, Zurich, Switzerland; [Haenni, Dominik; Martins, Joana R.] Univ Zurich, Ctr Microscopy & Image Anal, Zurich, Switzerland; [Unwin, Robert J.] UCL, Dept Renal Med, London, England; [Unwin, Robert J.] AstraZeneca Biopharmaceut R&D, Gothenburg, Sweden; [Hall, Andrew M.] Univ Hosp Zurich, Dept Nephrol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of London; University College London; University of Zurich; University Zurich Hospital	Hall, AM (corresponding author), Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	andrew.hall@uzh.ch	Hall, Andrew/GWV-2838-2022; Gomariz, Alvaro/AAY-7529-2020	Gomariz, Alvaro/0000-0002-6172-5190; Hall, Andrew/0000-0002-6328-7892; Bugarski, Milica/0000-0001-9845-1368; Haenni, Dominik/0000-0002-2166-7109	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation	BAGNASCO S, 1985, AM J PHYSIOL, V248, pF522, DOI 10.1152/ajprenal.1985.248.4.F522; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; BASSNETT S, 1990, AM J PHYSIOL, V258, pC171, DOI 10.1152/ajpcell.1990.258.1.C171; Battistone MA, 2018, J AM SOC NEPHROL, V29, P545, DOI 10.1681/ASN.2017060643; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; BERGERON M, 1980, KIDNEY INT, V17, P175, DOI 10.1038/ki.1980.21; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bourgeois S, 2018, KIDNEY INT, V93, P390, DOI 10.1016/j.kint.2017.07.027; Brown D, 1996, J EXP BIOL, V199, P2345; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; Chambrey R, 2013, P NATL ACAD SCI USA, V110, P7928, DOI 10.1073/pnas.1221496110; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Da Silva N, 2010, AM J PHYSIOL-CELL PH, V298, pC1326, DOI 10.1152/ajpcell.00552.2009; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Dunn Kenneth W, 2018, Curr Protoc Cytom, V83, DOI 10.1002/cpcy.32; ERECINSKA M, 1995, J NEUROCHEM, V65, P2765; Fry AC, 2007, PHYSIOLOGY, V22, P202, DOI 10.1152/physiol.00044.2006; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gomariz A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04770-z; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Helmuth JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-372; Hering-Smith KS, 1998, KIDNEY INT, V53, P408, DOI 10.1046/j.1523-1755.1998.00754.x; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Luisier F, 2010, SIGNAL PROCESS, V90, P415, DOI 10.1016/j.sigpro.2009.07.009; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; McKenzie M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154371; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; MUTO S, 1990, J CLIN INVEST, V86, P1829, DOI 10.1172/JCI114913; Nakamura S, 2004, AM J PHYSIOL-CELL PH, V287, pC97, DOI 10.1152/ajpcell.00469.2003; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Nowik M, 2010, CELL PHYSIOL BIOCHEM, V26, P1059, DOI 10.1159/000323984; OWEN CS, 1992, ANAL BIOCHEM, V204, P65, DOI 10.1016/0003-2697(92)90140-3; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Peppiatt-Wildman CM, 2012, NEPHRON EXP NEPHROL, V121, pE49, DOI 10.1159/000342812; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Peti-Peterdi J, 2012, AM J PHYSIOL-RENAL, V302, pF227, DOI 10.1152/ajprenal.00561.2011; Ramshesh VK, 2018, METHODS MOL BIOL, V1782, P351, DOI 10.1007/978-1-4939-7831-1_21; Ransick A, 2019, DEV CELL, V51, P399, DOI 10.1016/j.devcel.2019.10.005; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sieber MH, 2016, CELL, V164, P420, DOI 10.1016/j.cell.2015.12.020; Smolkova Katarina, 2012, Int J Cell Biol, V2012, P273947, DOI 10.1155/2012/273947; SOLTOFF SP, 1986, ANNU REV PHYSIOL, V48, P9; SPICER SS, 1958, J HISTOCHEM CYTOCHEM, V6, P52, DOI 10.1177/6.1.52; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; STEINMETZ PR, 1981, J MEMBRANE BIOL, V59, P27, DOI 10.1007/BF01870818; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; TengUmnuay P, 1996, J AM SOC NEPHROL, V7, P260; THORENS B, 1990, AM J PHYSIOL, V259, pC286; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Weiner ID, 2016, CURR OPIN NEPHROL HY, V25, P436, DOI 10.1097/MNH.0000000000000255; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011; WIRTHENSOHN G, 1986, PHYSIOL REV, V66, P469, DOI 10.1152/physrev.1986.66.2.469; Wu J, 2016, CELL, V166, P1371, DOI 10.1016/j.cell.2016.08.008; YAMADA E, 1995, J ELECTRON MICROSC, V44, P148	70	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8510	8525		10.1096/fj.202000273R	http://dx.doi.org/10.1096/fj.202000273R		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367531				2022-12-26	WOS:000530925000001
J	Nobles, AL; Leas, EC; Noar, S; Dredze, M; Latkin, CA; Strathdee, SA; Ayers, JW				Nobles, Alicia L.; Leas, Eric C.; Noar, Seth; Dredze, Mark; Latkin, Carl A.; Strathdee, Steffanie A.; Ayers, John W.			Automated image analysis of instagram posts: Implications for risk perception and communication in public health using a case study of #HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOCIAL MEDIA; NORMS; INTERVENTION; DISPARITIES; INFORMATION; PREVENTION; ENGAGEMENT	People's perceptions about health risks, including their risk of acquiring HIV, are impacted in part by who they see portrayed as at risk in the media. Viewers in these cases are asking themselves "do those portrayed as at risk look like me?" An accurate perception of risk is critical for high-risk populations, who already suffer from a range of health disparities. Yet, to date no study has evaluated the demographic representation of health-related content from social media. The objective of this case study was to apply automated image recognition software to examine the demographic profile of faces in Instagram posts containing the hashtag #HIV (obtained from January 2017 through July 2018) and compare this to the demographic breakdown of those most at risk of a new HIV diagnosis (estimates of incidence of new HIV diagnoses from the 2017 US Centers for Disease Control HIV Surveillance Report). We discovered 26,766 Instagram posts containing #HIV authored in American English with 10,036 (37.5%) containing a detectable human face with a total of 18,227 faces (mean = 1.8, standard deviation [SD] = 1.7). Faces skewed older (47% vs. 11% were 35-39 years old), more female (41% vs. 19%), more white (43% vs. 26%), less black (31% vs 44%), and less Hispanic (13% vs 25%) on Instagram than for new HIV diagnoses. The results were similarly skewed among the subset of #HIV posts mentioning pre-exposure prophylaxis (PrEP). This disparity might lead Instagram users to potentially misjudge their own HIV risk and delay prophylactic behaviors. Social media managers and organic advocates should be encouraged to share images that better reflect at-risk populations so as not to further marginalize these populations and to reduce disparity in risk perception. Replication of our methods for additional diseases, such as cancer, is warranted to discover and address other misrepresentations.	[Nobles, Alicia L.; Strathdee, Steffanie A.; Ayers, John W.] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA; [Leas, Eric C.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Hlth Policy, La Jolla, CA 92093 USA; [Noar, Seth] Univ N Carolina, Sch Media & Journalism, Chapel Hill, NC 27515 USA; [Dredze, Mark] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ayers, JW (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA.	ayers.john.w@gmail.com	Noar, Seth/AAT-9402-2021; Nobles, Alicia/AAG-7841-2021	Dredze, Mark/0000-0002-0422-2474	California HIV/AIDS Research Program, Office of the University of California [OS17-SD-001]; NIDA [T32 T32DA023356]	California HIV/AIDS Research Program, Office of the University of California; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	JWA, California HIV/AIDS Research Program, Office of the University of California (OS17-SD-001); http://californiaaidsresearch.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ALN was supported by NIDA T32 T32DA023356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allem JP, 2017, PREV SCI, V18, P541, DOI 10.1007/s11121-017-0792-2; Ayers JW, 2016, JAMA INTERN MED, V176, P552, DOI 10.1001/jamainternmed.2016.0003; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers J, 2019, JAMA INTERN MED, V179, P441, DOI 10.1001/jamainternmed.2018.6562; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bakhshi S, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P965, DOI 10.1145/2556288.2557403; Boczkowski P., 2017, P 50 HAW INT C SYST; Bull SS, 2012, AM J PREV MED, V43, P467, DOI 10.1016/j.amepre.2012.07.022; Buolamwini J., 2018, C FAIRNESS ACCOUNTAB, P77; Byrne E, 2017, P NUTR SOC, V76, pE103, DOI 10.1017/S0029665117001768; Caputi TL, 2019, JAMA INTERN MED, V179, P258, DOI 10.1001/jamainternmed.2018.5094; Centers for Disease Control and Prevention, 2018, HIV SURV REP 2017; Chakraborty Abhijnan, 2017, P 11 INT C ONWEB SOC, V11, P22; Chen T, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8221; Cherian R, 2018, JMIR PUBLIC HLTH SUR, V4, P97, DOI 10.2196/publichealth.8144; Chu KH, 2017, TOB CONTROL, V26, P575, DOI 10.1136/tobaccocontrol-2016-053052; Chu SC, 2011, INT J ADVERT, V30, P47, DOI 10.2501/IJA-30-1-047-075; Chung A, 2016, REV COMMUN RES, V4, P1, DOI 10.12840/issn.2255-4165.2016.04.01.008; Cialdini R. B., 1991, ADV EXPT SOCIAL PSYC, V21, P201, DOI [DOI 10.1016/S0065-2601(08)60330-5, 10.1016/S0065-2601(08)60330-5]; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; Earnshaw VA, 2013, AM PSYCHOL, V68, P225, DOI 10.1037/a0032705; Fraze J L, 2009, Public Health, V123 Suppl 1, pe23, DOI 10.1016/j.puhe.2009.08.006; Kallgren CA, 2000, PERS SOC PSYCHOL B, V26, P1002, DOI 10.1177/01461672002610009; Kamel Boulos Maged N., 2016, Future Internet, V8, DOI 10.3390/fi8030037; Lama Y, 2018, J MED INTERNET RES, V20, DOI 10.2196/10244; Larralde M, INSTALOOTER; Liu ZW, 2015, IEEE I CONF COMP VIS, P3730, DOI 10.1109/ICCV.2015.425; Lui M, LANGUAGE IDENTIFICAT; McDonald L, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1247-8; McIntosh S, 2019, BBC NEWS; McLaughlin ML, 2016, HEALTH COMMUN, V31, P998, DOI 10.1080/10410236.2015.1027033; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Morgan M, 2010, J BROADCAST ELECTRON, V54, P337, DOI 10.1080/08838151003735018; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Noar SM, 2018, PREV MED, V111, P280, DOI 10.1016/j.ypmed.2017.10.038; Noar SM., 2009, ANN INT COMMUN ASS, V33, P73, DOI [10.1080/23808985.2009.11679085, DOI 10.1080/23808985.2009.11679085]; Nobles AL, 2019, JAMA, V2019; Nobles AL, 2020, AIDS BEHAV, V24, P2045, DOI 10.1007/s10461-019-02765-5; O'Donnell NH, 2017, J VIS COMMUN MED, V40, P149, DOI 10.1080/17453054.2017.1384995; Paul Michael, 2017, SOCIAL MONITORING PU; Perez S, 2018, INSTAGRAM NOW ALLOWS; Perrin A., 2019, SHARE US ADULTS USIN; Perrin M., 2019, SHARE US ADULTS USIN; Reid AE, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P263, DOI 10.1007/978-0-387-09488-5_19; Rivis A, 2003, CURR PSYCHOL, V22, P218, DOI 10.1007/s12144-003-1018-2; Saha K, 2019, TRANSL BEHAV MED, V9, P1197, DOI 10.1093/tbm/ibz028; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015; Smith A., 2018, SOCIAL MEDIA USE 201, DOI [DOI 10.1007/S12529-008-9004-6, 14/2018/03/01105133/PI_2018.03.01_Social-Media_FINAL.pdf]; Strathdee SA, 2019, CURR OPIN HIV AIDS, V14, P481, DOI 10.1097/COH.0000000000000584; Young SD, 2014, PREV MED, V63, P112, DOI 10.1016/j.ypmed.2014.01.024; Young SD, 2013, J CONS HLTH INTERNET, V17, P353, DOI 10.1080/15398285.2013.833445; Zeng F., 2009, J INTERACT ADVERT, V10, P1, DOI [10.1080/15252019.2009.10722159, DOI 10.1080/15252019.2009.10722159]	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0231155	10.1371/journal.pone.0231155	http://dx.doi.org/10.1371/journal.pone.0231155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365124	Green Published, gold			2022-12-26	WOS:000536959700008
J	Sari, I; Gumus, E; Taskiran, AS; Sokmensuer, LK				Sari, Ismail; Gumus, Erkan; Taskiran, Ahmet Sevki; Sokmensuer, Lale Karakoc			Effect of ovarian stimulation on the expression of piRNA pathway proteins	PLOS ONE			English	Article							PIWI PROTEINS; ESTRADIOL CONCENTRATIONS; NUAGE FORMATION; SMALL RNAS; BIOGENESIS; GERMLINE; GENE; MIWI; MAELSTROM; REVEALS	PIWI-interacting RNAs (piRNAs) play an important role in gametogenesis, fertility and embryonic development. The current study investigated the effect of different doses of pregnant mare serum gonadotrophin/human chorionic gonadotrophin (PMSG/hCG) and repeated ovarian stimulation (OS) on the expression of the Mili, Miwi, Mael, Tdrd1, Tdrd9, qnd Mitopld genes, which have crucial roles in the biogenesis and function of piRNAs. Here, we found that after treatment with 7.5 I.U. PMSG/hCG and two repeated rounds of OS, both the mRNA and protein levels of Tdrd9, Tdrd1 and Mael showed the greatest decrease in the ovarian tissue, but the plasma E-2 levels showed the strongest increases (p< 0.05). However, we found that the Mitopld, Miwi and Mili gene levels were decreased significantly after treatment with 12.5 I.U. PMSG/hCG. Our results suggested that exogenous gonadotropin administration leads to a significant decrease in the expression of the Mili, Miwi, Mael, Tdrd1, Tdrd9 and Mitopld genes, which are critically important in the piRNA pathway, and the changes in the expression levels of Tdrd9, Tdrd1 and Mael may be associated with plasma E-2 levels. New comprehensive studies are needed to reduce the potential effects of OS on the piRNA pathway, which silences transposable elements and maintains genome integrity, and to contribute to the safety of OS.	[Sari, Ismail] Nigde Omer Halis Demir Univ, Fac Med, Dept Med Biochem, Nigde, Turkey; [Gumus, Erkan] Adnan Menderes Univ, Fac Med, Dept Histol & Embryol, Aydin, Turkey; [Taskiran, Ahmet Sevki] Sivas Cumhuriyet Univ, Fac Med, Dept Physiol, Sivas, Turkey; [Sokmensuer, Lale Karakoc] Hacettepe Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey	Adnan Menderes University; Cumhuriyet University; Hacettepe University	Sari, I (corresponding author), Nigde Omer Halis Demir Univ, Fac Med, Dept Med Biochem, Nigde, Turkey.	smlsr@hotmail.com	Taskiran, Ahmet Sevki/GLV-1676-2022	Taskiran, Ahmet Sevki/0000-0002-5810-8415; Sari, Ismail/0000-0003-3732-2102	TUBITAK (The Scientific and Technological Research Council of Turkey) [116s674]	TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by TUBITAK (The Scientific and Technological Research Council of Turkey) under grand number 116s674.	Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Bagavandoss P, 2012, ANAT REC, V295, P1717, DOI 10.1002/ar.22550; Barckmann B, 2018, NUCLEIC ACIDS RES, V46, P9524, DOI 10.1093/nar/gky761; Barckmann B, 2015, CELL REP, V12, P1205, DOI 10.1016/j.celrep.2015.07.030; Basir GS, 2001, HUM REPROD, V16, P435, DOI 10.1093/humrep/16.3.435; Castaneda J, 2014, EMBO J, V33, P1999, DOI 10.15252/embj.201386855; Chuma S, 2003, MECH DEVELOP, V120, P979, DOI 10.1016/S0925-4773(03)00181-3; Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Drakopoulos P, 2019, REPROD BIOL, V19, P1, DOI 10.1016/j.repbio.2019.02.003; FORMAN R, 1988, FERTIL STERIL, V49, P118; Gainetdinov I, 2018, MOL CELL, V71, P775, DOI 10.1016/j.molcel.2018.08.007; Goldman B, 2007, NATURE, V445, P479, DOI 10.1038/445479a; Gou LT, 2017, CELL, V169, P1090, DOI 10.1016/j.cell.2017.04.034; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; HOFKER MH, 2003, TRANSGENIC MOUSE MET; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kabayama Y, 2017, NUCLEIC ACIDS RES, V45, P5387, DOI 10.1093/nar/gkx027; Kinjo ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109149; Ku HY, 2014, NATL SCI REV, V1, P205, DOI 10.1093/nsr/nwu014; Lim EA, 2004, J REPROD DEVELOP, V50, P179, DOI 10.1262/jrd.50.179; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moyano M, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0133-5; Ni FF, 2019, GENE, V701, P104, DOI 10.1016/j.gene.2019.03.045; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Oner C., 2019, AGODRIVEN NONCODING, P3; Pan Y, 2012, CELL TISSUE RES, V350, P177, DOI 10.1007/s00441-012-1447-z; Pandey RR, 2014, EMBO J, V33, P1979, DOI 10.15252/embj.201489670; Pereira N, 2016, GYNECOL ENDOCRINOL, V32, P823, DOI 10.1080/09513590.2016.1177013; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Roy J, 2019, MOL GENET GENOMICS, P1; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Sato A, 2007, HUM REPROD, V22, P26, DOI 10.1093/humrep/del316; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Tarumi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099423; Timofeeva AV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122912; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Valbuena D, 2001, FERTIL STERIL, V76, P962, DOI 10.1016/S0015-0282(01)02018-0; Venegas B, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-019-0539-y; Wang HZ, 2018, GENE, V658, P86, DOI 10.1016/j.gene.2018.03.016; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Wenda JM, 2017, DEV CELL, V41, P623, DOI 10.1016/j.devcel.2017.05.021; Xie YF, 2019, INSECT MOL BIOL, V28, P136, DOI 10.1111/imb.12533; Yang XG, 2020, FISHERIES SCI, V86, P307, DOI 10.1007/s12562-019-01396-y; Yoshimura T, 2018, EMBO REP, V19, DOI 10.15252/embr.201642054; Zhao C, 2018, GENE, V647, P181, DOI 10.1016/j.gene.2018.01.038	47	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232629	10.1371/journal.pone.0232629	http://dx.doi.org/10.1371/journal.pone.0232629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365144	Green Published, gold			2022-12-26	WOS:000536959700048
J	Ohlmeier, C; Gothe, H; Haas, J; Osowski, U; Weinhold, C; Blauwitz, S; Schmedt, N; Galetzka, W; Berkemeier, F; Tackenberg, B; Stangel, M				Ohlmeier, Christoph; Gothe, Holger; Haas, Judith; Osowski, Ulrike; Weinhold, Carina; Blauwitz, Sarah; Schmedt, Niklas; Galetzka, Wolfgang; Berkemeier, Fabian; Tackenberg, Bjoern; Stangel, Martin			Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data	PLOS ONE			English	Article							GUIDELINE; INSIGHTS	Background Multiple Sclerosis (MS) is a chronic inflammatory, immune mediated disease of the central nervous system, with Relapsing Remitting MS (RRMS) being the most common type. Within the last years, the status of high disease activity (HDA) has become increasingly important for clinical decisions. Nevertheless, little is known about the incidence, the characteristics, and the current treatment of patients with RRMS and HDA in Germany. Therefore, this study aims to estimate the incidence of HDA in a German RRMS patient population, to characterize this population and to describe current drug treatment routines and further healthcare utilization of these patients. Methods A claims data analyses has been conducted, using a sample of the InGef Research Database that comprises data of approximately four million insured persons from around 70 German statutory health insurances (SHI). The study was conducted in a retrospective cohort design, including the years 2012-2016. Identification of RRMS population based on ICD-10 code (ICD-10-GM: G35.1). For identification of HDA, criteria from other studies as well as expert opinions have been used. Information on incidence, characteristics and current treatment of patients with RRMS and HDA was considered. Results The overall HDA incidence within the RRMS population was 8.5% for 2016. It was highest for the age group of 0-19 years (29.4% women, 33.3% men) and lowest for the age group of. 50 years (4.3% women, 5.6% men). Mean age of patients with RRMS and incident HDA was 38.4 years (SD: 11.8) and women accounted for 67.8%. Analyses of drug utilization showed that 82.4% received at least one disease-modifying drug (DMD) in 2016. A percentage of 49.8% of patients received drugs for relapse therapy. A share of 55% of RRMS patients with HDA had at least one hospitalization with a mean length of stay of 13.9 days (SD: 18.3 days) in 2016. The average number of outpatient physician contacts was 28.1 (SD: 14.0). Conclusions This study based on representative Germany-wide claims data from the SHI showed a high incidence of HDA especially within the young RRMS population. Future research should consider HDA as an important criterion for the quality of care for MS patients.	[Ohlmeier, Christoph; Gothe, Holger; Blauwitz, Sarah; Berkemeier, Fabian] IGES Inst GmbH, Dept Hlth Serv Res, Berlin, Germany; [Gothe, Holger] Tech Univ Dresden, Med Fac Carl Gustav Carus, Chair Hlth Sci Publ Hlth, Dresden, Germany; [Gothe, Holger] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria; [Haas, Judith] Jewish Hosp Berlin, Ctr Multiple Sclerosis, Berlin, Germany; [Osowski, Ulrike; Weinhold, Carina] Merck Serono GmbH, Darmstadt, Germany; [Schmedt, Niklas; Galetzka, Wolfgang] InGef Inst Appl Hlth Res Berlin GmbH, Berlin, Germany; [Tackenberg, Bjoern] Philipps Univ, Ctr Neuroimmunol, Marburg, Germany; [Stangel, Martin] Hannover Med Sch, Dept Neurol, Clin Neuroimmunol & Neurochem, Hannover, Germany; [Tackenberg, Bjoern] F Hoffmann La Roche & Cie AG, Basel, Switzerland	IGES Institut GmbH; Technische Universitat Dresden; Carl Gustav Carus University Hospital; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; Merck KGaA; EMD Serono Inc.; Philipps University Marburg; Hannover Medical School; Roche Holding	Ohlmeier, C (corresponding author), IGES Inst GmbH, Dept Hlth Serv Res, Berlin, Germany.	christoph.ohlmeier@iges.com	Gothe, Holger/AAD-5613-2022	Gothe, Holger/0000-0003-0425-3788	Merck Serono GmbH, an affiliate of Merck KGaA, Darmstadt, Germany	Merck Serono GmbH, an affiliate of Merck KGaA, Darmstadt, Germany	The study was funded by Merck Serono GmbH, an affiliate of Merck KGaA, Darmstadt, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; Chastek Benjamin J, 2010, J Med Econ, V13, P618, DOI 10.3111/13696998.2010.523670; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Deutsche Gesellschaft fur Neurologie, 2014, DIAGN THER MULT SKLE; Fernandez O, 2017, MULT SCLER RELAT DIS, V17, P75, DOI 10.1016/j.msard.2017.07.003; Flachenecker P, 2008, DTSCH ARZTEBL INT, V105, P113, DOI 10.3238/arztebl.2008.0113; Flachenecker P, 2017, MULT SCLER J, V23, P78, DOI 10.1177/1352458517708141; Fox RJ, 2014, NEUROLOGY, V82, P1491, DOI 10.1212/WNL.0000000000000355; Goodin DS, 2014, HAND CLINIC, V122, P231, DOI 10.1016/B978-0-444-52001-2.00010-8; Hoer A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-381; Holstiege J, 2017, EPIDEMIOLOGY MULTIPL; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Montalban X, 2018, EUR J NEUROL, V25, P215, DOI 10.1111/ene.13536; Multiple Sclerosis International Federation, 2013, ATL MS 2013 MAPP MUL; Ollendorf Daniel A, 2002, J Manag Care Pharm, V8, P469; Petersen G, 2014, NERVENARZT, V85, P990, DOI 10.1007/s00115-014-4097-4; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rae-Grant A, 2018, NEUROLOGY, V90, P777, DOI 10.1212/WNL.0000000000005347; Raimundo K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-131; Rommer PS, 2018, MULT SCLER; Rovira A, 2013, THER ADV NEUROL DISO, V6, P298, DOI 10.1177/1756285613484079; Schmidt S, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756285617749802; Scott TF, 2014, CLIN NEUROL NEUROSUR, V127, P86, DOI 10.1016/j.clineuro.2014.09.008; Stahmann A, 2016, GERMAN MS REGISTER U; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; von Bismarck O, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000446; Windt R, 2013, INT J CLIN PHARM-NET, V35, P1229, DOI 10.1007/s11096-013-9857-x; Zettl U, 2018, NEUROTRANSMITTER, V29, P42	28	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0231846	10.1371/journal.pone.0231846	http://dx.doi.org/10.1371/journal.pone.0231846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357176	Green Published, gold			2022-12-26	WOS:000536957700010
J	Islam, MZ; Johannesen, TB; Lilje, B; Urth, TR; Larsen, AR; Angen, O; Larsen, J				Islam, Md Zohorul; Johannesen, Thor Bech; Lilje, Berit; Urth, Tinna Ravnholt; Larsen, Anders Rhod; Angen, Oystein; Larsen, Jesper			Investigation of the human nasal microbiome in persons with long- and short-term exposure to methicillin-resistant Staphylococcus aureus and other bacteria from the pig farm environment	PLOS ONE			English	Article							CARRIAGE; COLONIZATION; CC398	Since its emergence in the early 2000s, livestock-associated methicillin-resistant Staphylococcus aureus clonal complex 398 (LA-MRSA CC398) has led to an increasing number of human infections in Denmark and other European countries with industrial pig production. LA-MRSA CC398 is primarily associated with skin infections among pig farm workers but is also increasingly recognized as a cause of life-threatening disease among elderly and immunocompromised people. Pig farm workers may serve as vehicles for the spread of LA-MRSA CC398 and other farm-origin bacteria between farms and into the general population. Yet, little is known about the bacterial community dynamics in pig farm workers and other persons with long- and short-term exposure to the pig farm environment. To gain insight into this, we investigated the nasal microbiomes in pig farm workers during a workweek on four LA-MRSA CC398-positive pig farms, as well as in short-term visitors two hours before, immediately after, and 48 hours after a 1-hour visit to another LA-MRSA CC398-positive pig farm. S. aureus and LA-MRSA CC398 carriage was quantified by means of culture, and the composition of the bacterial communities was investigated through sequencing of the 16S rRNA gene. Pig farm workers often carried LA-MRSA CC398 and other bacteria from the pig farm environment, both at work and at home, although at lower levels at home. In contrast, short-term visitors were subject to a less dramatic and rapidly reversible change in the nasal bacterial community composition. These results suggest that pig farm workers may be an important source of LA-MRSA CC398 and perhaps other pathogens of human and veterinary relevance.	[Islam, Md Zohorul; Johannesen, Thor Bech; Lilje, Berit; Larsen, Anders Rhod; Angen, Oystein; Larsen, Jesper] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark; [Islam, Md Zohorul] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark; [Urth, Tinna Ravnholt] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Copenhagen, Denmark; [Islam, Md Zohorul] Chattogram Vet & Anim Sci Univ, Dept Microbiol & Vet Publ Hlth, Chattogram, Bangladesh	Statens Serum Institut; University of Copenhagen; Statens Serum Institut	Larsen, J (corresponding author), Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark.	JRL@ssi.dk	Islam, Zohorul/T-4023-2019; Larsen, Jesper/AAJ-3161-2021	Islam, Zohorul/0000-0002-2015-5195; Larsen, Jesper/0000-0003-0582-0457	Ministry of Environment and Food of Denmark through The Danish Agrifish Agency [33010-NIFA-14-612]	Ministry of Environment and Food of Denmark through The Danish Agrifish Agency	This study was supported by a grant from the Ministry of Environment and Food of Denmark through The Danish Agrifish Agency (J. no. 33010-NIFA-14-612 to ARL and JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angen O, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01489-17, 10.1128/aem.01489-17]; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; [Anonymous], 2019, GPLOTS STAT PACKAGE; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bassis CM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-27; Becker K, 2017, INT J MED MICROBIOL, V307, P21, DOI 10.1016/j.ijmm.2016.11.007; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Correa-Fiz F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2700-8; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dall'Antonia M, 2005, J HOSP INFECT, V61, P62, DOI 10.1016/j.jhin.2005.01.008; Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2015, DANMAP 2014 USE ANTI; Datta R, 2014, INFECT CONT HOSP EP, V35, P1257, DOI 10.1086/678062; De Boeck I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02372; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Espinosa-Gongora C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160331; Garcia-Graells C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065512; Ghasemzadeh-Moghaddam H, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.006; Goerge T, 2017, VET MICROBIOL, V200, P6, DOI 10.1016/j.vetmic.2015.10.027; Huang SS, 2011, CRIT CARE, V15, DOI 10.1186/cc10445; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Islam MZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00543; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Johnson JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13036-1; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kraemer JG, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.03038-18; Kraemer JG, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02470-17; Larsen J, 2015, EUROSURVEILLANCE, V20, P5, DOI 10.2807/1560-7917.ES.2015.20.37.30021; Larsen J, 2017, CLIN INFECT DIS, V65, P1072, DOI 10.1093/cid/cix504; Liu CM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400216; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mercier C, 2013, SUMATRA SUMACLUSTFAS; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Slifierz MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0512-7; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Weese JS, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-69; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232456	10.1371/journal.pone.0232456	http://dx.doi.org/10.1371/journal.pone.0232456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353071	Green Published, gold			2022-12-26	WOS:000536673200096
J	Omar, SM; Taha, Z; Hassan, AA; Al-Wutayd, O; Adam, I				Omar, Saeed M.; Taha, Zainab; Hassan, Ahmed Ali; Al-Wutayd, Osama; Adam, Ishag			Prevalence and factors associated with overweight and central obesity among adults in the Eastern Sudan	PLOS ONE			English	Article							BODY-MASS INDEX; POPULATION; HYPERTENSION; RISK	Background A global epidemic of obesity has been documented, particularly among African countries. While central obesity and overweight have been reported for many countries, very limited information exists about the prevalence of these health problems in Sudan, and these data are nonexistent for Eastern Sudan. The present study aimed to determine the prevalence of obesity and central obesity, as well as the factors associated with both, among adults in Gadarif, Eastern Sudan. Methods A cross-sectional study was conducted in Gadarif, Eastern Sudan, during the period of January through May 2018. Sociodemographic and health characteristics data were collected through a questionnaire. Body mass index (BMI) and waist circumference (WC) were measured using the standard methods. Both descriptive and inferential statics were applied to analyze the data. Results A total of 594 adults participated in the study; 70.4% of them were female. The mean (standard deviation) age was 44.98 (16.64) years. Of the 594 enrolled participants, 33.7%, 7.4%, 26.8%, and 32.2% were normal weight, underweight, overweight, and obese, respectively. The prevalence of central obesity was (67.8%). Approximately, one-third of the participants (29.29%) were obese and had central obesity. In the multinomial regression, being married was the main risk factor associated with overweight, and older age, female sex, being married and hypertension were significantly associated with obesity. In the binary regression, the main risk factors associated with central obesity were female sex and being married. Conclusion The prevalence rates of both obesity and central obesity among the study participants were high. Older age and hypertension were only associated with obesity. Obesity and central obesity were significantly associated with female sex and being married. This study provided valuable baseline information to develop appropriate strategies for the prevention and control of obesity in Eastern Sudan.	[Omar, Saeed M.] Gadarif Univ, Fac Med, Gadarif, Sudan; [Taha, Zainab] Zayed Univ, Coll Nat & Hlth Sci, Dubai, U Arab Emirates; [Hassan, Ahmed Ali] Univ Khartoum, Fac Med, Khartoum, Sudan; [Al-Wutayd, Osama] Qassim Univ, Unaizah Coll Med & Med Sci, Dept Family & Community Med, Unaizah, Saudi Arabia; [Adam, Ishag] Qassim Univ, Unaizah Coll Med & Med Sci, Dept Obstet & Gynecol, Unaizah, Saudi Arabia	Zayed University; University of Khartoum; Qassim University; Qassim University	Al-Wutayd, O (corresponding author), Qassim Univ, Unaizah Coll Med & Med Sci, Dept Family & Community Med, Unaizah, Saudi Arabia.	Osama.alwutayd@gmail.com	Al-Wutayd, Osama/AAU-7492-2020	Al-Wutayd, Osama/0000-0001-6029-9663; Taha, Zainab/0000-0002-3915-3755; Adam, Ishag/0000-0001-5031-7741				Ahmed MH, 2017, DIABETES METAB SYND, V11, pS963, DOI 10.1016/j.dsx.2017.07.023; Al-Kandari YY, 2006, OBES REV, V7, P147, DOI 10.1111/j.1467-789X.2006.00231.x; Ali YA, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.05.11; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bushara SO, 2015, RENAL FAILURE, V37, P1022, DOI 10.3109/0886022X.2015.1052951; Coll JL, 2015, OBESITY FACTS, V8, P220, DOI 10.1159/000435826; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; EVERS S, 1987, NUTR RES, V7, P3, DOI 10.1016/S0271-5317(87)80186-0; Feinkohl I, 2018, CLIN EPIDEMIOL, V10, P853, DOI 10.2147/CLEP.S164793; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; International Diabetes Federation (IDF), IDF CONS WORLDW DEF; Janghorbani M, 2008, ARCH IRAN MED, V11, P274, DOI 08113/AIM.008; Kabwama Steven Ndugwa, 2018, BMC Obes, V5, P40, DOI 10.1186/s40608-018-0217-1; Kirunda BE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2506-7; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Meshram II, 2016, BRIT J NUTR, V115, P1265, DOI 10.1017/S0007114516000039; Mohieldin A., 2015, INT J HEALTHC SCI, V3, P185; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; National Institutes of Health, 1998, CLIN GUID ID EV TREA; Nonterah EA, 2018, GLOBAL HEALTH ACTION, V11, P68, DOI 10.1080/16549716.2018.1467588; Owolabi EO, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0133-x; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Rayis Duria A, 2010, BMC Res Notes, V3, P327, DOI 10.1186/1756-0500-3-327; Shafer EF, 2010, J FAM ISSUES, V31, P1166, DOI 10.1177/0192513X10366006; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2017, OTH COMM MENT DIS GL, P1; Zhang P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160402	28	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232624	10.1371/journal.pone.0232624	http://dx.doi.org/10.1371/journal.pone.0232624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353069	Green Published, gold			2022-12-26	WOS:000536673200111
J	Rabassa, M; Alonso-Coello, P; Casino, G				Rabassa, Montserrat; Alonso-Coello, Pablo; Casino, Gonzalo			Nutrimedia: A novel web-based resource for the general public that evaluates the veracity of nutrition claims using the GRADE approach	PLOS ONE			English	Article							FINDINGS TABLES; QUALITY; STRENGTH; DIETARY; MEDIA	The objective of Nutrimedia is to evaluate, based on the scientific evidence, the veracity of nutrition claims disseminated to the public by the media. In this article, we describe the methodology, characteristics and contents of this web-based resource, as well as its web traffic and media impact since it was launched. Nutrimedia uses a systematic process to evaluate common beliefs, claims from newspapers and advertising identified and selected by its research team, as well as questions from the public. After formulating a structured question for each claim, we conduct a pragmatic search, prioritizing guidelines and/or systematic reviews. We evaluate the certainty of the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and classify the veracity of each claim into seven categories (true, probably true, possibly true, possibly false, probably false, false, and uncertain). For each evaluation, we develop a scientific report, a plain language summary, a summary of findings table, and, in some cases, a video. From November 2017 to May 2019, we published 30 evaluations (21 were related to foods, six to diets, and three to supplements), most of which were triggered by questions from the public (40%; 12/30). Overall, nearly half of the claims were classified as uncertain (47%; 14/30). Nutrimedia received 47,265 visitors, with a total of 181,360 pages viewed. The project and its results were reported in 84 written media and 386 websites from Spain and 14 other countries, mostly from Latin America. To our knowledge, Nutrimedia is the first web-based resource for the public that evaluates the certainty of evidence and the veracity of nutrition claims using the GRADE approach. The scientific rigor combined with the use of friendly presentation formats are distinctive features of this resource, developed to help the public to make informed choices about nutrition.	[Rabassa, Montserrat; Alonso-Coello, Pablo; Casino, Gonzalo] Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Alonso-Coello, Pablo] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Casino, Gonzalo] Pompeu Fabra Univ, Dept Commun, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University	Alonso-Coello, P; Casino, G (corresponding author), Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain.; Alonso-Coello, P (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.; Casino, G (corresponding author), Pompeu Fabra Univ, Dept Commun, Barcelona, Spain.	palonso@santpau.cat; gonzalo.casino@upf.edu	Casino, Gonzalo/K-3254-2016	Casino, Gonzalo/0000-0003-1872-4130; Rabassa Bonet, Montserrat/0000-0002-0276-6726	Spanish Foundation for Science and Technology (FECYT) from the Spanish Ministry of Science, Innovation and Universities [FCT-16-11294, FCT-17-12460]	Spanish Foundation for Science and Technology (FECYT) from the Spanish Ministry of Science, Innovation and Universities	Nutrimedia has been partially supported by the Spanish Foundation for Science and Technology (FECYT) grants from the Spanish Ministry of Science, Innovation and Universities (FCT-16-11294 and FCT-17-12460). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Alonso-Coello P, 2018, GAC SANIT, V32; Alonso-Coello P, 2013, ARCH BRONCONEUMOL, V49, P261, DOI 10.1016/j.arbres.2012.12.001; Cochrane Iberoamerica, 2019, BLOGSH; Cochrane Nutrition, 2019, EV COCHR NUTR REV; Cochrane UK, 2019, BLOGSH INF ARCH; Cooper BEJ, 2012, PUBLIC UNDERST SCI, V21, P664, DOI 10.1177/0963662511401782; Gholizadeh Zahra, 2017, J Educ Health Promot, V6, P48, DOI 10.4103/jehp.jehp_83_14; GRADE working group, 2015, WIND BAS GRAD 3 0 SO; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Helm J, 2016, J ACAD NUTR DIET, V116, P1825, DOI 10.1016/j.jand.2016.09.003; Higgins JPT, 2019, COCHRANE HDB SYSTEMA, V2nd, DOI 10.1002/9781119536604; Kininmonth AR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014633; Garcia LM, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0058-2; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Nagler RH, 2014, J HEALTH COMMUN, V19, P24, DOI 10.1080/10810730.2013.798384; National Health Service (NHS), 2019, HEADL FOOD DIET; Nutrimedia. Mensajes Evaluados, 2019, MENS EV REAL CANC CA; Nutrimedia. Para saber mas, 2019, SAB MAS VID PENS CRI; Ostry A, 2008, HEALTH EDUC RES, V23, P648, DOI 10.1093/her/cym050; Practice-Based Evidence in Nutrition (PEN), 2019, GLOB RES NUTR PRACT; Public Health Agency of Catalonia, 2018, SMALL CHANG EAT BETT; Quaidoo EY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6159-1; ROSENBAUM SE, 2010, J CLIN EPIDEMIOL, V63, P620, DOI DOI 10.1016/j.jclinepi.2009.12.014; Viswanath K, 2007, J NUTR EDUC BEHAV, V39, pS20, DOI 10.1016/j.jneb.2006.07.008; Williams G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003926; World Health Organization (WHO), 2018, NON DIS KEY FACTS; Yuen Eva Y N, 2018, Health Lit Res Pract, V2, pe134, DOI 10.3928/24748307-20180625-01	29	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232393	10.1371/journal.pone.0232393	http://dx.doi.org/10.1371/journal.pone.0232393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353048	Green Published, gold			2022-12-26	WOS:000536673200087
J	Tung, CH; Chien, CH; Chen, CW; Huang, LY; Liu, YN; Chu, YW				Tung, Chi-Hua; Chien, Ching-Hsuan; Chen, Chi-Wei; Huang, Lan-Ying; Liu, Yu-Nan; Chu, Yen-Wei			QUATgo: Protein quaternary structural attributes predicted by two-stage machine learning approaches with heterogeneous feature encoding	PLOS ONE			English	Article							FEATURE-SELECTION; WEB SERVER; AAINDEX; CLASSIFICATION; EVOLUTION; DATABASE; DOMAIN	Many proteins exist in natures as oligomers with various quaternary structural attributes rather than as single chains. Predicting these attributes is an essential task in computational biology for the advancement of proteomics. However, the existing methods do not consider the integration of heterogeneous coding and the accuracy of subunit categories with limited data. To this end, we proposed a tool that can predict more than 12 subunit protein oligomers, QUATgo. Meanwhile, three kinds of sequence coding were used, including dipeptide composition, which was used for the first time to predict protein quaternary structural attributes, and protein half-life characteristics, and we modified the coding method of the functional domain composition proposed by predecessors to solve the problem of large feature vectors. QUATgo solves the problem of insufficient data for a single subunit using a two-stage architecture and uses 10-fold cross-validation to test the predictive accuracy of the classifier. QUATgo has 49.0% cross-validation accuracy and 31.1% independent test accuracy. In the case study, the accuracy of QUATgo can reach 61.5% for predicting the quaternary structure of influenza virus hemagglutinin proteins. Finally, QUATgo is freely accessible to the public as a web server via the site http://predictor.nchu.edu.tw/QUATgo.	[Tung, Chi-Hua] Chung Hua Univ, Dept Bioinformat, Hsinchu, Taiwan; [Chien, Ching-Hsuan] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung, Taiwan; [Chien, Ching-Hsuan; Chen, Chi-Wei; Huang, Lan-Ying; Liu, Yu-Nan; Chu, Yen-Wei] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung, Taiwan; [Chen, Chi-Wei] Natl Chung Hsing Univ, Dept Comp Sci & Engn, Taichung, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, Inst Mol Biol, Taichung, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan; [Chu, Yen-Wei] Rong Hsing Res Ctr Translat Med, Taichung, Taiwan	Chung Hua University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chu, YW (corresponding author), Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung, Taiwan.; Chu, YW (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung, Taiwan.; Chu, YW (corresponding author), Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan.; Chu, YW (corresponding author), Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan.; Chu, YW (corresponding author), Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan.; Chu, YW (corresponding author), Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.	ywchu@nchu.edu.tw		Tung, Chi-Hua/0000-0002-7232-312X; Chu, Yen-Wei/0000-0002-5525-4011; Chen, Chi-Wei/0000-0002-3026-634X; Chen, Chi-Wei/0000-0002-5799-9017	Ministry of Science and Technology, Taiwan, R.O. C. [106-2221-E-005-077-MY2, 107-2634-F-005-002, 107-2321-B-005 -013]; National Chung Hsing University; Chung-Shan Medical University [NCHU-CSMU-10705]	Ministry of Science and Technology, Taiwan, R.O. C.(Ministry of Science and Technology, Taiwan); National Chung Hsing University; Chung-Shan Medical University	This research was supported by the Ministry of Science and Technology, Taiwan, R.O. C. [grant numbers 106-2221-E-005-077-MY2, 107-2634-F-005-002, and 107-2321-B-005 -013], and the National Chung Hsing University and Chung-Shan Medical University [grant number NCHU-CSMU-10705]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumel J, 2009, TRANSFUS MED HEMOTH, V36, P32, DOI 10.1159/000197314; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chen ZH, 2002, J BIOL CHEM, V277, P24653, DOI 10.1074/jbc.M111862200; Chou KC, 2003, PROTEINS, V53, P282, DOI 10.1002/prot.10500; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Garian R, 2001, BIOINFORMATICS, V17, P551, DOI 10.1093/bioinformatics/17.6.551; Gorris HH, 2009, ANAL CHEM, V81, P1580, DOI 10.1021/ac802324f; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kirkpatrick E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28706-1; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin H, 2007, J COMPUT CHEM, V28, P1463, DOI 10.1002/jcc.20554; Liu B., 2017, NAT SCI, V09, P67, DOI [10.4236/ns.2017.94007, DOI 10.4236/NS.2017.94007]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu WM, 1999, PROTEIN ENG, V12, P1041, DOI 10.1093/protein/12.12.1041; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng Y, 2012, STUD INFORM CONTROL, V21, P241; Sharma A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-282; Shen HB, 2009, J PROTEOME RES, V8, P1577, DOI 10.1021/pr800957q; Sheng YJ, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/715494; [施建宇 SHI Jianyu], 2006, [生物物理学报, Acta Biophysica Sinica], V22, P49; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; Tung CH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9480276; Xiao XA, 2011, MOL DIVERS, V15, P149, DOI 10.1007/s11030-010-9227-8; Zhang SW, 2003, BIOINFORMATICS, V19, P2390, DOI 10.1093/bioinformatics/btg331	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232087	10.1371/journal.pone.0232087	http://dx.doi.org/10.1371/journal.pone.0232087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348325	gold, Green Published			2022-12-26	WOS:000536668200038
J	Asgedom, SW; Amanuel, K; Gidey, MT; Niriayo, YL; Gidey, K; Atey, TM				Asgedom, Solomon Weldegebreal; Amanuel, Kidus; Gidey, Meles Tekie; Niriayo, Yirga Legesse; Gidey, Kidu; Atey, Tesfay Mehari			Treatment resistant hypertension among ambulatory hypertensive patients: A cross sectional study	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; UNITED-STATES; FOLLOW-UP; PREVALENCE; PREDICTORS; UNIVERSITY; OUTCOMES; DISEASE	Background Treatment resistant hypertension(TRH) is detrimental risk of cardiovascular and premature deaths. Globally, the prevalence of resistant hypertension is inclining from time to time and it is yet to be determined in Ethiopia. Objective To assess the prevalence of apparent TRH and its predictors among ambulatory hypertensive patients on follow up in hypertension clinic of Mekelle Hospital, Northern Ethiopia. Method A hospital based cross sectional study was conducted from Nov 25, 2018 to July 20, 2019, among 338 adult ambulatory hypertensive patients on follow up in Mekelle Hospital hypertension clinic. Hypertensive patient aged >= 18 years who were on regular follow up and taking antihypertensive medications for at least 6 months were included in the study. A simple random sampling technique was used to recruit the study patients. Results A total of 338 adult ambulatory hypertensive patients were analysed. More than half, 182 (53.8%) patients were females and the average age of the patients was 58.9 +/- 11.5. Three hundred thirty-three (98.5%) patients had no family history of hypertension. Majority, 66.8% of the patients were on monotherapy. The prevalence of apparent TRH was calculated to be 8.6% [Confidence Interval = 0.056-0.116]. Patients with Body Mass Index(BMI) greater than 30[Adjusted Odds Ratio(AOR) = 12.1, 95%CI:2.00-73.19, p = 0.007] and longer duration of hypertension were the predictors of resistant hypertension. Conclusion Even if escalation of antihypertensive medications was not aggressive, apparent TRH was common in the study setting. Obesity (BMI greater than 30) and longer duration of hypertension since diagnosis were the predictors of TRH. Meticulous emphasis should be placed on to detect the prevalence of true hypertension resistance and future studies should discover the impact of aggressive antihypertensive medications scale up on the risks of TRH.	[Asgedom, Solomon Weldegebreal; Amanuel, Kidus; Niriayo, Yirga Legesse; Gidey, Kidu; Atey, Tesfay Mehari] Mekelle Univ, Sch Pharm, Coll Hlth Sci, Clin Pharm Unit, Mekelle, Tigray, Ethiopia; [Gidey, Meles Tekie] Mekelle Univ, Sch Pharm, Coll Hlth Sci, Social Pharm & Pharmacoepidemiol Unit, Mekelle, Ethiopia	Mekelle University; Mekelle University	Asgedom, SW (corresponding author), Mekelle Univ, Sch Pharm, Coll Hlth Sci, Clin Pharm Unit, Mekelle, Tigray, Ethiopia.	s.weldegebreal@gmail.com		Atey, Tesfay Mehari/0000-0002-6483-2258				Abdu O., 2017, HYPERTENSION, V140, P6; Animu Y, 2018, INTEGR BLOOD PRESS C, V11, P37, DOI 10.2147/IBPC.S150628; Asgedom SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166432; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Carey RM, 2019, HYPERTENSION, V73, P424, DOI 10.1161/HYPERTENSIONAHA.118.12191; Chen GF, 2016, TROP J PHARM RES, V15, P2261, DOI 10.4314/tjpr.v15i10.27; Cherif AB, 2015, J HYPERTENS, V33, pE498, DOI 10.1097/01.hjh.0000468959.33385.5e; Chia YC, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-131; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Epstein Murray, 2007, J Clin Hypertens (Greenwich), V9, P2, DOI 10.1111/j.1524-6175.2007.06171.x; FERGUSON RK, 1980, AM HEART J, V99, P579, DOI 10.1016/0002-8703(80)90730-9; Hernandez-Vila E, 2015, TEX HEART I J, V42, P226, DOI 10.14503/THIJ-15-5067; Hoffmann J C, 2008, Z Gastroenterol, V46, P1094, DOI 10.1055/s-2008-1027796; Kumara W A Nuwan, 2013, BMC Res Notes, V6, P373, DOI 10.1186/1756-0500-6-373; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; Ma WJ, 2013, J HYPERTENS, V31, P2386, DOI 10.1097/HJH.0b013e32836586a1; Mendis S., 2011, GLOBAL ATLAS CARDIOV, P1, DOI [10.1016/S0022-3476(51)80275-0., DOI 10.1016/S0022-3476(51)80275-0.]; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Nansseu JRN, 2016, BMJ OPEN, V6, DOI [10.1055/s-2008-1027796, DOI 10.1055/S-2008-1027796]; Noubiap JJ, 2019, HEART, V105, P98, DOI 10.1136/heartjnl-2018-313599; Park Jeanie, 2007, J Clin Hypertens (Greenwich), V9, P7, DOI 10.1111/j.1524-6175.2007.6106.x; Paulo C, 2010, J HYPERTENS, V28, pE323, DOI 10.1097/01.hjh.0000379173.96487.64; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Pierdomenico SD, 2005, AM J HYPERTENS, V18, P1422, DOI 10.1016/j.amjhyper.2005.05.014; Prejbisz A, 2015, POL ARCH MED WEWN, V125, P249, DOI 10.20452/pamw.2782; Smith SM, 2014, J HYPERTENS, V32, P635, DOI 10.1097/HJH.0000000000000051; Tesfaye B, 2017, RES REP CLIN CARDIOL, V8, P21, DOI 10.2147/RRCC.S132126; Teshome DF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196535; Thinyane KH, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.424.5040; Tsioufis C, 2014, J HYPERTENS, V32, P415, DOI 10.1097/HJH.0000000000000023; Ventura HO, 2019, CURR OPIN CARDIOL, V34, P329, DOI 10.1097/HCO.0000000000000631; Weitzman D, 2014, HYPERTENSION, V64, P501, DOI 10.1161/HYPERTENSIONAHA.114.03718; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yameogo N, 2014, ANN CARDIOLOGIE ANGE; Yazzie D., 2018, J BIOANAL BIOMED, V10, P80, DOI [10.4172/1948-593X.1000210, DOI 10.4172/1948-593X.1000210]; Youmbissi T J, 1994, West Afr J Med, V13, P175	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232254	10.1371/journal.pone.0232254	http://dx.doi.org/10.1371/journal.pone.0232254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343723	gold, Green Accepted, Green Published			2022-12-26	WOS:000536661300045
J	Christley, S; Shogan, B; Levine, Z; Koo, H; Guyton, K; Owens, S; Gilbert, J; Zaborina, O; Alverdy, JC				Christley, Scott; Shogan, Benjamin; Levine, Zoe; Koo, Hyun; Guyton, Kristina; Owens, Sarah; Gilbert, Jack; Zaborina, Olga; Alverdy, John C.			Comparative genetics of Enterococcus faecalis intestinal tissue isolates before and after surgery in a rat model of colon anastomosis	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; BACTERIAL DIVERSITY; GELATINASE; FSR; GENOME; COLONIZATION; PATHOGENESIS; CONTRIBUTES; VIRULENCE; SYSTEM	We have recently demonstrated that collagenolytic Enterococcus faecalis plays a key and causative role in the pathogenesis of anastomotic leak, an uncommon but potentially lethal complication characterized by disruption of the intestinal wound following segmental removal of the colon (resection) and its reconnection (anastomosis). Here we hypothesized that comparative genetic analysis of E. faecalis isolates present at the anastomotic wound site before and after surgery would shed insight into the mechanisms by which collagenolytic strains are selected for and predominate at sites of anastomotic disruption. Whole genome optical mapping of four pairs of isolates from rat colonic tissue obtained following surgical resection (herein named "pre-op" isolates) and then 6 days later from the anastomotic site (herein named "post-op" isolates) demonstrated that the isolates with higher collagenolytic activity formed a distinct cluster. In order to perform analysis at a deeper level, a single pair of E. faecalis isolates (16A pre-op and 16A post-op) was selected for whole genome sequencing and assembled using a hybrid assembly algorithm. Comparative genomics demonstrated absence of multiple gene clusters, notably a pathogenicity island in the post-op isolate. No differences were found in the fsr-gelE-sprE genes (EF1817-1822) responsible for regulation and production of collagenolytic activity. Analysis of unique genes among the 16A pre-op and post-op isolates revealed the predominance of transporter systems-related genes in the pre-op isolate and phage-related and hydrolytic enzyme-encoding genes in the post-op isolate. Despite genetic differences observed between pre-op and post-op isolates, the precise genetic determinants responsible for their differential expression of collagenolytic activity remains unknown.	[Christley, Scott; Shogan, Benjamin; Levine, Zoe; Koo, Hyun; Guyton, Kristina; Gilbert, Jack; Zaborina, Olga; Alverdy, John C.] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Owens, Sarah; Gilbert, Jack] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA; [Christley, Scott] UT Southwestern Med Ctr, Dallas, TX USA; [Guyton, Kristina] Cleveland Clin Ohio, Cleveland, OH USA; [Gilbert, Jack] Univ Calif San Diego, La Jolla, CA 92093 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cleveland Clinic Foundation; University of California System; University of California San Diego	Alverdy, JC (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jalverdy@surgery.bsd.uchicago.edu	Zaborina, Olga/AAQ-6977-2021; Guyton, Kristina/AAC-4734-2021	Guyton, Kristina/0000-0003-2008-5577	NIH [R01-GM062344-18]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been supported by NIH grant R01-GM062344-18 (JCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Belmouhand M, 2017, SCAND J SURG; Del Papa MF, 2007, J BACTERIOL, V189, P8835, DOI 10.1128/JB.01311-07; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Flores-Mireles AL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009384; Gaines S, 2019, GASTROENTEROLOGY; Galloway-Pena JR, 2011, APPL ENVIRON MICROB, V77, P442, DOI 10.1128/AEM.00756-10; Gilmore MS, 2015, P NATL ACAD SCI USA, V112, P7273, DOI 10.1073/pnas.1500553112; Gomez JAL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016720; Guyton K, 2017, NAT REV GASTRO HEPAT, V14, P43, DOI 10.1038/nrgastro.2016.139; Guyton KL, 2019, DIS COLON RECTUM, V62, P972, DOI 10.1097/DCR.0000000000001417; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Hyoju SK, 2020, BRIT J SURG, V107, P743, DOI 10.1002/bjs.11388; Hyoju SK, 2017, ANN SURG; Kirby A, 2015, J HOSP INFECT, V89, P259, DOI 10.1016/j.jhin.2014.11.016; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lebreton F., 2014, ENTEROCOCCI COMMENSA; Lee DS, 2015, INT J COLORECTAL DIS, V30, P497, DOI 10.1007/s00384-015-2161-6; Macfarlane S, 2005, APPL ENVIRON MICROB, V71, P7483, DOI 10.1128/AEM.71.11.7483-7492.2005; Macfarlane S, 2004, ADV APPL MICROBIOL, V54, P261, DOI 10.1016/S0065-2164(04)54010-8; Nakayama J, 2002, APPL ENVIRON MICROB, V68, P3152, DOI 10.1128/AEM.68.6.3152-3155.2002; Nallapareddy SR, 2008, J INFECT DIS, V197, P1728, DOI 10.1086/588143; Olivas AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044326; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shakhsheer BA, 2016, J GASTROINTEST SURG, V20, P1744, DOI 10.1007/s11605-016-3237-5; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; SHOCKMAN GD, 1969, J BACTERIOL, V98, P1199, DOI 10.1128/JB.98.3.1199-1207.1969; Shogan BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010658; Shogan BD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-35; Singh KV, 2015, INFECT IMMUN, V83, P4487, DOI 10.1128/IAI.00884-15; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Thurlow LR, 2010, INFECT IMMUN, V78, P4936, DOI 10.1128/IAI.01118-09; Torelli R, 2012, J INFECT DIS, V206, P952, DOI 10.1093/infdis/jis440; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Waters CM, 2003, J BACTERIOL, V185, P3613, DOI 10.1128/JB.185.12.3613-3623.2003; Zaborin A, 2014, MBIO, V5, DOI 10.1128/mBio.01361-14	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232165	10.1371/journal.pone.0232165	http://dx.doi.org/10.1371/journal.pone.0232165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343730	gold, Green Published, Green Submitted			2022-12-26	WOS:000536661300036
J	Wilkinson, BP; Haynes-Sutton, AM; Meggs, L; Jodice, PGR				Wilkinson, Bradley P.; Haynes-Sutton, Ann M.; Meggs, Llewelyn; Jodice, Patrick G. R.			High spatial fidelity among foraging trips of Masked Boobies from Pedro Cays, Jamaica	PLOS ONE			English	Article							SEABIRD; BEHAVIOR; COLONY; WORLD; SIZE	In marine environments, tropical and subtropical habitats are considered to be inherently less productive than more temperate systems. As such, foraging site fidelity among vertebrate predators occupying low-latitude marine systems is generally low as a response to an increased unpredictability of resources. We investigated the foraging movements of Masked Boobies breeding on Middle Cay, Jamaica using GPS loggers to examine if the presence of a nearby bathymetric feature influenced foraging site fidelity in a tropical system, the Caribbean Sea. According to the movements of tracked individuals, this population of boobies shows a high degree of spatial fidelity in foraging site selection, concentrated on the northern edge of Pedro Bank. We suggest this feature as an important location for marine conservation in the region and demonstrate its utility to foraging boobies via habitat modeling using a maximum entropy approach of relevant habitat variables. Finally, we place this study into the global context of Masked Booby foraging by examining the published literature of relevant tracking studies for population-level similarity in foraging metrics. According to hierarchical clustering of foraging effort, Masked Boobies demonstrate a density-dependent response to foraging effort regardless of colony origin or oceanic basin consistent with the principles of Ashmole's Halo.	[Wilkinson, Bradley P.] Clemson Univ, Dept Forestry & Environm Conservat, South Carolina Cooperat Fish & Wildlife Res Unit, Clemson, SC USA; [Haynes-Sutton, Ann M.] Marshalls Pen, Mandeville, Jamaica; [Meggs, Llewelyn] Yardie Environm Conservationists Ltd, Kingston, Jamaica; [Jodice, Patrick G. R.] Clemson Univ, Dept Forestry & Environm Conservat, US Geol Survey, South Carolina Cooperat Fish & Wildlife Res Unit, Clemson, SC USA	Clemson University; Clemson University; United States Department of the Interior; United States Geological Survey	Wilkinson, BP (corresponding author), Clemson Univ, Dept Forestry & Environm Conservat, South Carolina Cooperat Fish & Wildlife Res Unit, Clemson, SC USA.	bpwilki@g.clemson.edu			National Fish and Wildlife Foundation; Nature Conservancy; South Carolina Cooperative Fish and Wildlife Research Unit; U.S. Geological Survey; South Carolina DNR; Clemson University	National Fish and Wildlife Foundation; Nature Conservancy; South Carolina Cooperative Fish and Wildlife Research Unit; U.S. Geological Survey(United States Geological Survey); South Carolina DNR; Clemson University	Funding and support for data collection, field logistics, and analysis was provided by The National Fish and Wildlife Foundation, The Nature Conservancy, and the South Carolina Cooperative Fish and Wildlife Research Unit. Yardie Environmental Conservationists Limited currently provided support in the form of salary for author LM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The Jamaica Defence Force provided transportation to and from Pedro Cays. The tagging was conducted as part of a National Fish and Wildlife Foundation capacity building workshop with BirdsCaribbean and assistance in the field with tagging and handling was provided by the workshop trainees; Damany Calder, Martha-Ines Garcia-Escobar, Jaedon Lawe, Adriana Vallarino Moncada, Maureen Milbourn, Carine Precheur, Fernando Simal, Hugh Small, Camillo Trench, and Susan Zaluski. We are grateful to Esther Figueroa, Vagabond Media/Juniroa Productions, Inc., who diligently filmed all aspects of the research and training effort. The South Carolina Cooperative Fish and Wildlife Research Unit is jointly supported by the U.S. Geological Survey, South Carolina DNR, and Clemson University. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Baldwin K., 2014, P 67 GULF CAR FISH I, P27; Ballance L. T., 1999, P INT ORN C, P2057; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Burke CM, 2009, J ZOOL, V278, P354, DOI 10.1111/j.1469-7998.2009.00584.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Chambault P, 2016, PROG OCEANOGR, V142, P58, DOI 10.1016/j.pocean.2016.01.006; Conners MG, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0060-7; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Fleishman A.B., 2019, TRAKR BASIC ANIMAL T; Harding A, 2013, DEEP-SEA RES PT II, V94, P178, DOI 10.1016/j.dsr2.2013.03.013; Hazen EL, 2017, J APPL ECOL, V54, P1415, DOI 10.1111/1365-2664.12820; Hebshi AJ, 2008, AQUAT BIOL, V4, P89, DOI 10.3354/ab00098; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jodice P.G.R., 2012, UNPUB; Jodice PGR, 2015, ENDANGER SPECIES RES, V29, P23, DOI 10.3354/esr00697; Jovani R, 2016, OIKOS, V125, P968, DOI 10.1111/oik.02781; Kappes MA, 2011, MAR ECOL PROG SER, V441, P281, DOI 10.3354/meps09376; Kennish MJ, 2001, PRACTICAL HDB MARINE; Kitson-Walters KA, 2018, FISH RES, V199, P53, DOI 10.1016/j.fishres.2017.11.010; Lamb J. S., 2017, ECOL EVOL, P1; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Monnereau I, 2012, SOC INDIC RES, V109, P95, DOI 10.1007/s11205-012-0058-0; Oppel S, 2015, BEHAV ECOL SOCIOBIOL, V69, P915, DOI 10.1007/s00265-015-1903-3; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poli CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178318; Potier M., 2007, MAR ECOL PROG SER, V275, P297; Santora JA, 2014, ECOL APPL, V24, P1730, DOI 10.1890/13-1605.1; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Shaffer SA, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0118-9; Soanes LM, 2016, MAR POLICY, V70, P85, DOI 10.1016/j.marpol.2016.04.019; Soldatini C., 2019, POPUL ECOL, P1; Sommerfeld J, 2015, J EXP MAR BIOL ECOL, V463, P79, DOI 10.1016/j.jembe.2014.11.005; Sommerfeld J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063742; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478	42	5	5	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231654	10.1371/journal.pone.0231654	http://dx.doi.org/10.1371/journal.pone.0231654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32340024	Green Published, gold			2022-12-26	WOS:000536657400010
J	Chen, X; Gao, YQ; Zheng, YY; Wang, W; Wang, P; Liang, J; Zhao, W; Tao, T; Sun, J; Wei, LS; Li, YQ; Zhou, YW; Gan, ZJ; Zhang, XN; Chen, HQ; Zhu, MS				Chen, Xin; Gao, Yun-Qian; Zheng, Yan-Yan; Wang, Wei; Wang, Pei; Liang, Juan; Zhao, Wei; Tao, Tao; Sun, Jie; Wei, Lisha; Li, Yeqiong; Zhou, Yuwei; Gan, Zhenji; Zhang, Xuena; Chen, Hua-Qun; Zhu, Min-Sheng			The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						skeletal muscle; microRNA (miRNA); muscle physiology; cell differentiation; STAT3; dynamin 2 (Dnm2); epigenetic regulation; miR-199a-1; myotubularin 1 (Mtm1); X-linked centronuclear myopathy (XLCNM)	SKELETAL-MUSCLE; CONGENITAL MYOPATHIES; AMPHIPHYSIN-2 BIN1; PROLONGS SURVIVAL; MUTATIONS; MYOTUBULARIN; INHIBITION; EXPRESSION; IDENTIFICATION; PROLIFERATION	Mutations in the myotubularin 1 (MTM1) gene can cause the fatal disease X-linked centronuclear myopathy (XLCNM), but the underlying mechanism is incompletely understood. In this report, using anMtm1(?/y)disease model, we found that expression of the intragenic microRNA miR-199a-1 is up-regulated along with that of its host gene, dynamin 2 (Dnm2), in XLCNM skeletal muscle. To assess the role of miR-199a-1 in XLCNM, we crossedmiR-199a-1(?/?)withMtm1(?/y)mice and found that the resultantmiR-199a-1-Mtm1double-knockout mice display markers of improved health, as evidenced by lifespans prolonged by 30% and improved muscle strength and histology. Mechanistic analyses showed that miR-199a-1 directly targets nonmuscle myosin IIA (NM IIA) expression and, hence, inhibits muscle postnatal development as well as muscle maturation. Further analysis revealed that increased expression and phosphorylation of signal transducer and activator of transcription 3 (STAT3) up-regulatesDnm2/miR-199a-1expression in XLCNM muscle. Our results suggest that miR-199a-1 has a critical role in XLCNM pathology and imply that this microRNA could be targeted in therapies to manage XLCNM.	[Chen, Xin; Zheng, Yan-Yan; Wang, Wei; Wang, Pei; Liang, Juan; Zhao, Wei; Tao, Tao; Sun, Jie; Wei, Lisha; Li, Yeqiong; Zhou, Yuwei; Gan, Zhenji; Zhang, Xuena; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Minist Educ MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Chen, Xin; Zheng, Yan-Yan; Wang, Wei; Wang, Pei; Liang, Juan; Zhao, Wei; Tao, Tao; Sun, Jie; Wei, Lisha; Li, Yeqiong; Zhou, Yuwei; Gan, Zhenji; Zhang, Xuena; Zhu, Min-Sheng] Nanjing Univ, Sch Med, Nanjing, Peoples R China; [Gao, Yun-Qian] Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn, Sch Life Sci, Shanghai, Peoples R China; [Gao, Yun-Qian] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai, Peoples R China; [Gao, Yun-Qian] Fudan Univ, Inst BioMed Sci, Shanghai Med Coll, Shanghai, Peoples R China; [Chen, Hua-Qun] Nanjing Normal Univ, Coll Life Sci, Nanjing, Peoples R China	Nanjing University; Nanjing University; Fudan University; Fudan University; Fudan University; Nanjing Normal University	Zhang, XN; Zhu, MS (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Minist Educ MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China.; Zhang, XN; Zhu, MS (corresponding author), Nanjing Univ, Sch Med, Nanjing, Peoples R China.; Chen, HQ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Peoples R China.	zhums@nju.edu.cn; chenhuaqun@njnu.edu.cn; zhangxn@nicemice.cn		Chen, Xin/0000-0003-3304-8943; Gao, Yun-Qian/0000-0003-1229-3130; Gan, Zhenji/0000-0001-5940-207X	National Natural Science Foundation of China [31330034, 31671548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China Grants 31330034 and 31671548.	Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Amburgey K, 2017, NEUROLOGY, V89, P1355, DOI 10.1212/WNL.0000000000004415; Bachmann C, 2017, HUM MOL GENET, V26, P320, DOI 10.1093/hmg/ddw388; Biancalana V, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2012.91; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Childers MK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007523; Chin YH, 2015, HUM MOL GENET, V24, P5542, DOI 10.1093/hmg/ddv285; Cowling BS, 2017, J CLIN INVEST, V127, P4477, DOI 10.1172/JCI90542; Cowling BS, 2014, J CLIN INVEST, V124, P1350, DOI 10.1172/JCI71206; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Joshi HP, 2014, P NATL ACAD SCI USA, V111, P5331, DOI 10.1073/pnas.1317242111; Jungbluth H, 2018, NAT REV NEUROL, V14, P151, DOI 10.1038/nrneurol.2017.191; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kutchukian C, 2017, J PHYSIOL-LONDON, V595, P7369, DOI 10.1113/JP274990; Kutchukian C, 2016, P NATL ACAD SCI USA, V113, P14432, DOI 10.1073/pnas.1604099113; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Sabha N, 2016, J CLIN INVEST, V126, P3613, DOI 10.1172/JCI86841; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Shin JY, 2017, HUM MOL GENET, V26, P65, DOI 10.1093/hmg/ddw368; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tasfaout Hichem, 2018, J Neuromuscul Dis, V5, P387, DOI 10.3233/JND-180309; Tasfaout H, 2018, MOL THER, V26, P1082, DOI 10.1016/j.ymthe.2018.02.008; Tasfaout H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15661; Tay Y, 2014, CELL REP, V8, P714, DOI 10.1016/j.celrep.2014.06.064; Verver EJJ, 2016, EAR HEARING, V37, P112, DOI 10.1097/AUD.0000000000000198; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119	48	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8656	8667		10.1074/jbc.RA119.010839	http://dx.doi.org/10.1074/jbc.RA119.010839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32354746	Green Published, hybrid			2022-12-26	WOS:000546296800003
J	Metcalfe, RD; Aizel, K; Zlatic, CO; Nguyen, PM; Morton, CJ; Lio, DSS; Cheng, HC; Dobson, RCJ; Parker, MW; Gooley, PR; Putoczki, TL; Griffin, MDW				Metcalfe, Riley D.; Aizel, Kaheina; Zlatic, Courtney O.; Nguyen, Paul M.; Morton, Craig J.; Lio, Daisy Sio-Seng; Cheng, Heung-Chin; Dobson, Renwick C. J.; Parker, Michael W.; Gooley, Paul R.; Putoczki, Tracy L.; Griffin, Michael D. W.			The structure of the extracellular domains of human interleukin 11? receptor reveals mechanisms of cytokine engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; receptor structure-function; interleukin; signaling; structural biology; inflammation; cancer; fibrosis; gp130; IL6 family cytokine	BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; MOLECULAR-CLONING; BINDING SITES; IDENTIFICATION; DYNAMICS; GP130; CRANIOSYNOSTOSIS; INTEGRATION; RECOGNITION	Interleukin (IL) 11 activates multiple intracellular signaling pathways by forming a complex with its cell surface ?-receptor, IL-11R?, and the ?-subunit receptor, gp130. Dysregulated IL-11 signaling has been implicated in several diseases, including some cancers and fibrosis. Mutations in IL-11R? that reduce signaling are also associated with hereditary cranial malformations. Here we present the first crystal structure of the extracellular domains of human IL-11R? and a structure of human IL-11 that reveals previously unresolved detail. Disease-associated mutations in IL-11R? are generally distal to putative ligand-binding sites. Molecular dynamics simulations showed that specific mutations destabilize IL-11R? and may have indirect effects on the cytokine-binding region. We show that IL-11 and IL-11R? form a 1:1 complex with nanomolar affinity and present a model of the complex. Our results suggest that the thermodynamic and structural mechanisms of complex formation between IL-11 and IL-11R? differ substantially from those previously reported for similar cytokines. This work reveals key determinants of the engagement of IL-11 by IL-11R? that may be exploited in the development of strategies to modulate formation of the IL-11?IL-11R? complex.	[Metcalfe, Riley D.; Aizel, Kaheina; Zlatic, Courtney O.; Morton, Craig J.; Lio, Daisy Sio-Seng; Cheng, Heung-Chin; Dobson, Renwick C. J.; Parker, Michael W.; Gooley, Paul R.; Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Putoczki, Tracy L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Putoczki, Tracy L.] Univ Melbourne, Dept Surg, Parkville, Vic, Australia; [Aizel, Kaheina; Nguyen, Paul M.; Putoczki, Tracy L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [Nguyen, Paul M.; Putoczki, Tracy L.] Walter & Eliza Hall Inst Med Res, Personalised Oncol Div, Parkville, Vic, Australia; [Lio, Daisy Sio-Seng] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia; [Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch, New Zealand; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Parker, Michael W.] Australian Canc Res Fdn, St Vincents Inst Med Res, Rat Drug Discovery Ctr, Fitzroy, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Canterbury; University of Canterbury; St. Vincent's Institute of Medical Research	Griffin, MDW (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia.	mgriffin@unimelb.edu.au	Parker, Michael W/F-9069-2013; Morton, Craig/GON-8638-2022; Dobson, Renwick/AAZ-7020-2021	Parker, Michael W/0000-0002-3101-1138; Morton, Craig/0000-0001-5452-5193; Dobson, Renwick/0000-0002-5506-4939; Gooley, Paul/0000-0002-0323-449X; Nguyen, Paul/0000-0003-1490-5401; Cheng, Heung-Chin/0000-0002-4965-7148; Metcalfe, Riley/0000-0002-7154-780X	National Health & Medical Research Council of Australia [APP1147621, APP1080498]; Australian Research Council [FT140100544]; Victorian Cancer Agency Fellowship [MCRF16009]; Victorian Government Operational Infrastructure Support Scheme [UOC1506]; New Zealand Royal Society Marsden Fund; National Health & Medical Research Council of Australia Research Fellowship [APP1117183]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Cancer Agency Fellowship; Victorian Government Operational Infrastructure Support Scheme; New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); National Health & Medical Research Council of Australia Research Fellowship	This work was supported by National Health & Medical Research Council of Australia Grants APP1147621 and APP1080498), Australian Research Council Future Fellowship Project FT140100544 (to M. D. W. G), Victorian Cancer Agency Fellowship MCRF16009 (to T. L. P.), National Health & Medical Research Council of Australia Research Fellowship APP1117183 (to M. W. P.), and Contract UOC1506 from the Victorian Government Operational Infrastructure Support Scheme to St. Vincent's Institute and the New Zealand Royal Society Marsden Fund (to R. C. J. D.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agthe M, 2018, CELL REP, V25, P10, DOI 10.1016/j.celrep.2018.09.005; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Bobby R, 2014, FEBS J, V281, P2471, DOI 10.1111/febs.12800; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Brischoux-Boucher E, 2018, CLIN GENET, V94, P373, DOI 10.1111/cge.13409; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Czupryn M, 1995, ANN NY ACAD SCI, V762, P152; Dagil R, 2012, STRUCTURE, V20, P270, DOI 10.1016/j.str.2011.12.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giese B, 2005, J CELL SCI, V118, P5129, DOI 10.1242/jcs.02628; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung Y, 2011, BIOCHEM BIOPH RES CO, V405, P399, DOI 10.1016/j.bbrc.2011.01.041; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Keupp K, 2013, MOL GENET GENOM MED, V1, P223, DOI 10.1002/mgg3.28; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lee CG, 2008, AM J RESP CELL MOL, V39, P739, DOI 10.1165/rcmb.2008-0053OC; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Luft JR, 1999, ACTA CRYSTALLOGR D, V55, P988, DOI 10.1107/S0907444999002085; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Morris R, 2018, PROTEIN SCI, V27, P1984, DOI 10.1002/pro.3519; MURPHY KP, 1993, PROTEINS, V15, P113, DOI 10.1002/prot.340150203; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Putoczki TL, 2014, ACTA CRYSTALLOGR D, V70, P2277, DOI 10.1107/S1399004714012267; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Ryan TM, 2018, J APPL CRYSTALLOGR, V51, P97, DOI 10.1107/S1600576717017101; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott DJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18045-y; Seabrook SA, 2013, ACS COMB SCI, V15, P387, DOI 10.1021/co400013v; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tacken I, 1999, EUR J BIOCHEM, V265, P645, DOI 10.1046/j.1432-1327.1999.00755.x; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; Wang XM, 2002, EUR J BIOCHEM, V269, P61, DOI 10.1046/j.0014-2956.2002.02622.x; Widjaja AA, 2019, GASTROENTEROLOGY, V157, P777, DOI 10.1053/j.gastro.2019.05.002; Yao SG, 2000, PROTEIN SCI, V9, P671; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao HY, 2015, ACTA CRYSTALLOGR D, V71, P3, DOI 10.1107/S1399004714010372; Zhao HY, 2014, ANAL CHEM, V86, P3181, DOI 10.1021/ac500093m; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083439	79	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8285	8301		10.1074/jbc.RA119.012351	http://dx.doi.org/10.1074/jbc.RA119.012351			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32332100	hybrid, Green Published			2022-12-26	WOS:000542965700016
J	Hills, SP; Barrett, S; Hobbs, M; Barwood, MJ; Radcliffe, JN; Cooke, CB; Russell, M				Hills, Samuel P.; Barrett, Stephen; Hobbs, Matthew; Barwood, Martin J.; Radcliffe, Jon N.; Cooke, Carlton B.; Russell, Mark			Modifying the pre-pitch entry practices of professional soccer substitutes may contribute towards improved movement-related performance indicators on match-day: A case study	PLOS ONE			English	Article							UP RECOVERY-TIME; RE-WARM-UP; MUSCLE TEMPERATURE; SPRINT PERFORMANCE; HEAT MAINTENANCE; POWER OUTPUT; PLAYERS; RELIABILITY; STRATEGIES; MECHANISMS	Modifying a soccer substitute's pre-pitch-entry activities may represent an opportunity to maximise physical performance and minimise injury-risk following match-introduction. Using a professional team that has previously participated in substitute profiling research, this follow-up case study investigated the effects of a modified match-day protocol that included substitutes; 1) performing a new pre-match warm-up alongside members of the starting team (as opposed to a separate substitute-only warm-up), 2) participating in a staff-led half-time rewarm-up (as opposed to player-led half-time activities), and 3) receiving ongoing education focusing on the efficacy of (re)warm-up activities. English Championship substitutes (n = 15) were monitored using Micro-electromechanical Systems during 13 matches incorporating the modified practices (35 observations). On an individual player basis, data were organised into bouts of warm-up activity (pre-pitch-entry) and five min epochs of match-play (post-pitch-entry). Linear mixed modelling assessed the influence of 'bout' and 'epoch', position, and scoreline. Substitutes performed 3 +/- 1 rewarm-up bouts.-player(-1).match(-1) between kick-off and pitch-entry, which were shorter (-17.2 to -27.1 min) and elicited less distance (-696 to -1257 m) than the pre-match warm-up (p <= 0.001). Compared with previous data, heightened absolute movement responses were observed during the pre-match and staff-led half-time (re)warm-ups, alongside greater relative distances covered during player-led activities performed between kick-off and pitch-entry. Whilst less distance (-10%) was covered during the second versus first five min period following match-introduction, values remained higher than previously reported. Between pitch-entry and the end of the match, the scoreline improved and worsened following 26% and 11% of substitutions, respectively; a favourable record compared with existing observations. Acknowledging the likely contribution from external factors, this case study reports heightened movement profiles and improved match scorelines when pre-pitch-entry practices were modified. Practitioners should note the potential influence of match-day activities on the physical responses of soccer substitutes and, if deemed necessary, consider adapting their pre-pitch-entry routines accordingly.	[Hills, Samuel P.; Barwood, Martin J.; Radcliffe, Jon N.; Cooke, Carlton B.; Russell, Mark] Leeds Trinity Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England; [Barrett, Stephen] PlayerMaker, London, England; [Hobbs, Matthew] Univ Canterbury, Geospatial Res Inst, GeoHlth Lab, Christchurch, New Zealand	University of Canterbury	Russell, M (corresponding author), Leeds Trinity Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England.	m.russell@leedstrinity.ac.uk		/0000-0001-8398-7485; Hills, Samuel/0000-0002-8622-4333; Russell, Mark/0000-0002-7305-1090; Radcliffe, Jon/0000-0001-5409-4338				Anderson P, 2014, RES SPORTS MED, V22, P88, DOI 10.1080/15438627.2013.852091; BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bishop D, 2003, SPORTS MED, V33, P439, DOI 10.2165/00007256-200333060-00005; Bixler B, 1992, Fam Pract Res J, V12, P131; Boyd LJ, 2011, INT J SPORT PHYSIOL, V6, P311, DOI 10.1123/ijspp.6.3.311; Bradley PS, 2018, INT J SPORT PHYSIOL, V13, P656, DOI 10.1123/ijspp.2017-0433; Bradley PS, 2014, INT J SPORT PHYSIOL, V9, P415, DOI [10.1123/ijspp.2013-0304, 10.1123/IJSPP.2013-0304]; Bradley PS, 2013, J SPORT SCI, V31, P1261, DOI 10.1080/02640414.2013.786185; Carling C, 2010, J SCI MED SPORT, V13, P253, DOI 10.1016/j.jsams.2009.02.012; Del Corral J, 2008, J SPORT ECON, V9, P160, DOI 10.1177/1527002507308309; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Federation Internationale de Football Association, 2018, 2018 FIFA WORLD CUP; Ferraz R, 2018, J SPORT SCI, V36, P116, DOI 10.1080/24733938.2017.1283433; Gabbett TJ, 2015, INT J SPORT PHYSIOL, V10, P298, DOI 10.1123/ijspp.2013-0543; Galazoulas C, 2012, EUR J APPL PHYSIOL, V112, P3327, DOI 10.1007/s00421-012-2320-1; Hammami A, 2018, J SPORT MED PHYS FIT, V58, P135, DOI 10.23736/S0022-4707.16.06806-7; Hills SP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228790; Hills SP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211563; Hills SP, 2018, SPORTS MED, V48, P2255, DOI 10.1007/s40279-018-0962-9; Holt NL, 2002, SPORT PSYCHOL, V16, P251, DOI 10.1123/tsp.16.3.251; Ingham SA, 2013, INT J SPORT PHYSIOL, V8, P77, DOI 10.1123/ijspp.8.1.77; Kilduff LP, 2013, J SCI MED SPORT, V16, P482, DOI 10.1016/j.jsams.2012.11.889; Lovell R, 2013, SCAND J MED SCI SPOR, V23, P105, DOI 10.1111/j.1600-0838.2011.01353.x; McGowan CJ, 2015, SPORTS MED, V45, P1523, DOI 10.1007/s40279-015-0376-x; Mohr M, 2004, SCAND J MED SCI SPOR, V14, P156, DOI 10.1111/j.1600-0838.2004.00349.x; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Myers BR, 2012, J QUANT ANAL SPORTS, V8, DOI 10.1515/1559-0410.1349; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Roe G, 2017, INT J SPORT PHYSIOL, V12, P836, DOI 10.1123/ijspp.2016-0256; Russell M, 2018, J SCI MED SPORT, V21, P327, DOI 10.1016/j.jsams.2017.06.005; Russell M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119374; SARGEANT AJ, 1987, EUR J APPL PHYSIOL, V56, P693, DOI 10.1007/BF00424812; Silva LM, 2018, SPORTS MED, V48, P2285, DOI 10.1007/s40279-018-0958-5; The Football Association, HDB STAND RUL 2019 2; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; West DJ, 2013, J SCI MED SPORT, V16, P172, DOI 10.1016/j.jsams.2012.06.002; Zochowski T, 2007, INTJ SPORT PHYSIOL, V2, P201, DOI 10.1123/ijspp.2.2.201	39	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232611	10.1371/journal.pone.0232611	http://dx.doi.org/10.1371/journal.pone.0232611			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369507	Green Accepted, Green Published, gold			2022-12-26	WOS:000537280000036
J	Randall, TE; Fernandez-Bayo, JD; Harrold, DR; Achmon, Y; Hestmark, KV; Gordon, TR; Stapleton, JJ; Simmons, CW; VanderGheynst, JS				Randall, Tara E.; Fernandez-Bayo, Jesus D.; Harrold, Duff R.; Achmon, Yigal; Hestmark, Kelley, V; Gordon, Thomas R.; Stapleton, James J.; Simmons, Christopher W.; VanderGheynst, Jean S.			Changes of Fusarium oxysporum f.sp. lactucae levels and soil microbial community during soil biosolarization using chitin as soil amendment	PLOS ONE			English	Article							ORGANIC-ACIDS; WILT; LETTUCE; WASTE; DISINFESTATION; INACTIVATION; AGRICULTURE; MANAGEMENT; DISEASES; COMPOST	Regulatory pressure along with environmental and human health concerns drive the development of soil fumigation alternatives such as soil biosolarization (SBS). SBS involves tarping soil that is at field capacity with a transparent film following amendment with certain organic materials. Heating via the greenhouse effect results in an increase of the soil temperature. The organic amendments can promote microbial activity that can enhance pest inactivation by depleting oxygen, producing biopesticidal fermentation products, and competing with pests. The properties of the organic amendments can heavily influence the type and magnitude of these effects. This study evaluated the viability of chitin as a novel SBS soil amendment to influence soil fungal and bacterial microbial communities, including control of the plant pathogen Fusarium oxysporum f.sp. lactucae (FOL). Changes to FOL and the broader soil microbiota were monitored in response to biosolarization using 0.1% (by dry weight) amendment with chitin (Rootguard). FOL suppression was only observed in chitin amended soils that were incubated at room temperature, not under solarized conditions. Conversely, it decreased solarization efficacy in the upper (0-10 cm) soil layer. The presence of chitin also showed increase in FOL under anaerobic and fluctuating temperature regime conditions. Biosolarization with chitin amendment did exhibit an impact on the overall soil microbial community. The fungal genus Mortierella and the bacterial family Chitinophagaceae were consistently enriched in biosolarized soils with chitin amendment. This study showed low potential FOL suppression due chitin amendment at the studied levels. However, chitin amendment showed a higher impact on the fungal community than the bacterial community. The impact of these microbial changes on crop protection and yields need to be studied in the long-term.	[Randall, Tara E.; Fernandez-Bayo, Jesus D.; Harrold, Duff R.; Achmon, Yigal; Hestmark, Kelley, V; VanderGheynst, Jean S.] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA; [Fernandez-Bayo, Jesus D.; Achmon, Yigal; Simmons, Christopher W.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Gordon, Thomas R.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Stapleton, James J.] Univ Calif Kearney Agr Res & Extens Ctr, Statewide Integrated Pest Management Program, Parlier, CA USA; [VanderGheynst, Jean S.] Univ Massachusetts, Dept Bioengn, Dartmouth, MA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Massachusetts System; University Massachusetts Dartmouth	Fernandez-Bayo, JD (corresponding author), Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA.; Fernandez-Bayo, JD (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.	jdfbayo@ucdavis.edu	Stapleton, James J./AAV-4337-2020; Bayo, Jesus Dionisio Fernandez/L-2380-2014	Bayo, Jesus Dionisio Fernandez/0000-0002-7641-0036	California Department of Pesticide Regulation [14-PML-R004]; National Science Foundation [CBET-1438694]	California Department of Pesticide Regulation; National Science Foundation(National Science Foundation (NSF))	JJS,14-PML-R004, California Department of Pesticide Regulation. https://www.cdpr.ca.gov/JSV, CBET-1438694, National Science Foundation. https://www.nsf.gov/div/index.jsp? div=CBET The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achmon Y, 2017, PEST MANAG SCI, V73, P862, DOI 10.1002/ps.4354; Agricultural Marketing Resource Center, 2018, LETT; [Anonymous], 2018, METH BROM CHLOR SAF; [Anonymous], 2014, RES REV J AGR ALLIED; Beier S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00149; Brzezinska MS, 2014, CURR MICROBIOL, V68, P71, DOI 10.1007/s00284-013-0440-4; Cretoiu MS, 2013, APPL ENVIRON MICROB, V79, P5291, DOI 10.1128/AEM.01361-13; Deacon J., 2013, FUNGAL BIOL, P213; Debode J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00565; Fernandez-Bayo JD, 2017, APPL SOIL ECOL, V119, P183, DOI 10.1016/j.apsoil.2017.06.016; Fernandez-Bayo JD, 2018, PEST MANAG SCI, V74, P1892, DOI 10.1002/ps.4891; Gao XY, 2016, ACS SUSTAIN CHEM ENG, V4, P3912, DOI 10.1021/acssuschemeng.6b00767; Garibaldi A, 2002, PLANT DIS, V86, P1052, DOI 10.1094/PDIS.2002.86.9.1052B; Gelsomino A, 2006, SOIL BIOL BIOCHEM, V38, P91, DOI 10.1016/j.soilbio.2005.04.021; Hestmark KV, 2019, RESOUR CONSERV RECY, V143, P27, DOI 10.1016/j.resconrec.2018.12.009; Hewavitharana SS, 2016, PHYTOPATHOLOGY, V106, P1015, DOI 10.1094/PHYTO-12-15-0329-R; Hewavitharana SS, 2014, EUR J PLANT PATHOL, V140, P39, DOI 10.1007/s10658-014-0442-5; Huang J. H., 1998, Plant Pathology Bulletin, V7, P150; Huang XQ, 2015, MICROBIOL RES, V181, P33, DOI 10.1016/j.micres.2015.08.004; Jari Oksanen FGB, 2013, COMMUNITY ECOLOGY PA, V2; KATAN J, 1976, PHYTOPATHOLOGY, V66, P683, DOI 10.1094/Phyto-66-683; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Komirenko Z., 2018, FARM LEVEL REGIONAL; Kopecny J, 1996, LETT APPL MICROBIOL, V23, P195, DOI 10.1111/j.1472-765X.1996.tb00063.x; Korthals GW, 2014, APPL SOIL ECOL, V76, P112, DOI 10.1016/j.apsoil.2013.12.016; Lamers JG, 2010, ACTA HORTIC, V883, P277, DOI 10.17660/ActaHortic.2010.883.34; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Levels CoAEG, 2012, DIV EARTH LIF STUD; Li F, 2018, LAND DEGRAD DEV, V29, P1642, DOI 10.1002/ldr.2965; Matheron ME, 2010, PLANT DIS, V94, P1323, DOI 10.1094/PDIS-04-10-0296; MATUO T., 1967, Trans, mycol. Soc, Japan, V8, P13; Momma Noriaki, 2006, Journal of General Plant Pathology, V72, P247, DOI 10.1007/s10327-006-0274-z; Momma N, 2013, APPL MICROBIOL BIOT, V97, P3801, DOI 10.1007/s00253-013-4826-9; Paugh KR, 2019, PLANT DIS, V103, P1498, DOI 10.1094/PDIS-09-18-1614-RE; Pepper A, 2015, ECONOMIC PSYCHOLOGY OF INCENTIVES: NEW DESIGN PRINCIPLES FOR EXECUTIVE PAY, P59; Rosenberg E., 2014, PROKARYOTES, DOI DOI 10.1007/978-3-642-38954-2_137; Savary S, 2012, FOOD SECUR, V4, P519, DOI 10.1007/s12571-012-0200-5; Scott JC, 2010, PLANT PATHOL, V59, P139, DOI 10.1111/j.1365-3059.2009.02179.x; Scott JC, 2010, PLANT DIS, V94, P13, DOI 10.1094/PDIS-94-1-0013; Sharp RG, 2013, AGRONOMY-BASEL, V3, P757, DOI 10.3390/agronomy3040757; Shen ZZ, 2018, BIOL FERT SOILS, V54, P793, DOI 10.1007/s00374-018-1303-8; Siegel-Hertz K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00568; Simmons CW, 2014, APPL SOIL ECOL, V73, P97, DOI 10.1016/j.apsoil.2013.08.014; van Agtmaal M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00701; Ventura JA, 2008, PLANT DIS, V92, P976, DOI 10.1094/PDIS-92-6-0976C; Visioli G, 2018, MOLECULES, V23, DOI 10.3390/molecules23061461; Wang SL, 1997, APPL ENVIRON MICROB, V63, P380, DOI 10.1128/AEM.63.2.380-386.1997; Winkler AJ, 2017, MAR DRUGS, V15, DOI 10.3390/md15020040; Yan N, 2015, NATURE, V524, P155, DOI 10.1038/524155a	49	12	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232662	10.1371/journal.pone.0232662	http://dx.doi.org/10.1371/journal.pone.0232662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369503	Green Published, gold			2022-12-26	WOS:000537280000038
J	Rast, W; Kimmig, SE; Giese, L; Berger, A				Rast, Wanja; Kimmig, Sophia Elisabeth; Giese, Lisa; Berger, Anne			Machine learning goes wild: Using data from captive individuals to infer wildlife behaviours	PLOS ONE			English	Article							FOXES VULPES-VULPES; ARTIFICIAL NEURAL-NETWORKS; ACCELERATION DATA; CLASSIFICATION; ACCELEROMETER; AVAILABILITY; ANIMALS; ECOLOGY; CITY	1. Remotely tracking distinct behaviours of animals using acceleration data and machine learning has been carried out successfully in several species in captive settings. In order to study the ecology of animals in natural habitats, such behaviour classification models need to be transferred to wild individuals. However, at present, the development of those models usually requires direct observation of the target animals. 2. The goal of this study was to infer the behaviour of wild, free-roaming animals from acceleration data by training behaviour classification models on captive individuals, without the necessity to observe their wild conspecifics. We further sought to develop methods to validate the credibility of the resulting behaviour extrapolations. 3. We trained two machine learning algorithms proposed by the literature, Random Forest (RF) and Support Vector Machine (SVM), on data from captive red foxes (Vulpes vulpes) and later applied them to data from wild foxes. We also tested a new advance for behaviour classification, by applying a moving window to an Artificial Neural Network (ANN). Finally, we investigated four strategies to validate our classification output. 4. While all three machine learning algorithms performed well under training conditions (Kappa values: RF (0.82), SVM (0.78), ANN (0.85)), the established methods, RF and SVM, failed in classifying distinct behaviours when transferred from captive to wild foxes. Behaviour classification with the ANN and a moving window, in contrast, inferred distinct behaviours and showed consistent results for most individuals. 5. Our approach is a substantial improvement over the methods previously proposed in the literature as it generated plausible results for wild fox behaviour. We were able to infer the behaviour of wild animals that have never been observed in the wild and to further illustrate the credibility of the output. This framework is not restricted to foxes but can be applied to infer the behaviour of many other species and thus empowers new advances in behavioural ecology.	[Rast, Wanja; Giese, Lisa; Berger, Anne] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany; [Kimmig, Sophia Elisabeth] Leibniz Inst Zoo & Wildlife Res, Dept Ecol Dynam, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Leibniz Institut fur Zoo und Wildtierforschung	Berger, A (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany.	BERGER@izw-berlin.de	Rast, Wanja/AAN-3472-2020; Berger, Anne/ABB-8335-2021	Rast, Wanja/0000-0003-3465-3117; Berger, Anne/0000-0001-5765-8039; Kimmig, Sophia Elisabeth/0000-0002-4140-6002	Open Access Fund of the Leibniz Association; Stiftung Naturschutz Berlin	Open Access Fund of the Leibniz Association; Stiftung Naturschutz Berlin	The publication of this article was funded by the Open Access Fund of the Leibniz Association. Stiftung Naturschutz Berlin provided funding for telemetry devices and fox traps in the project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins CA, 1998, J ZOOL, V244, P335, DOI 10.1111/j.1469-7998.1998.tb00038.x; Allaire J.J., KERAS R INTERFACE KE; Allaire J.J., 2018, DEEP LEARNING WITH R; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Burla JB, 2014, COMPUT ELECTRON AGR, V102, P127, DOI 10.1016/j.compag.2014.01.001; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins PM, 2015, ECOL EVOL, V5, P4642, DOI 10.1002/ece3.1660; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; CRAIGHEAD F C JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P84; Diaz-Ruiz F, 2016, J ZOOL, V298, P128, DOI 10.1111/jzo.12294; Dietterich T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114; DONCASTER CP, 1990, J MAMMAL, V71, P188, DOI 10.2307/1382166; Fehlmann G., 2017, ANIMAL BIOTELEMETRY, V5, DOI 10.1186/s40317-017-0121-3; Ferreira J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174959; Giese L, 2016, THESIS; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hokkanen AH, 2011, APPL ANIM BEHAV SCI, V134, P10, DOI 10.1016/j.applanim.2011.06.016; Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891; Kroschel M., 2017, ANIMAL BIOTELEMETRY, V5, DOI 10.1186/s40317-017-0125-z; le Roux S.P., 2017, ANIMAL BIOTELEMETRY, V5, DOI 10.1186/s40317-017-0140-0; Lush L, 2016, J ZOOL, V298, P257, DOI 10.1111/jzo.12308; Meyer D, 2017, E1071 MISC FUNCTIONS; Moreau M, 2009, APPL ANIM BEHAV SCI, V119, P158, DOI 10.1016/j.applanim.2009.04.008; NAM K, 1995, LOGIST TRANSPORT REV, V31, P239; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Painter MS., 2016, ANIM BIOTELEM, V4, P1, DOI [10.1186/s40317-016-0113-8, DOI 10.1186/S40317-016-0113-8]; R Core Team, 2021, R LANGUAGE ENV STAT; R Studio Team, 2016, RSTUDIO INT DEV ENV; Ricci S, 1998, J ARID ENVIRON, V38, P335, DOI 10.1006/jare.1997.0347; Srivastava N., 2014, DROPOUT SIMPLE WAY P; Studd EK, 2019, ECOL EVOL, V9, P619, DOI 10.1002/ece3.4786; Tatler J, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.184085; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yoda K, 1999, J EXP BIOL, V202, P3121; Yoda K, 2001, J EXP BIOL, V204, P685; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zimmer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016098	47	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0227317	10.1371/journal.pone.0227317	http://dx.doi.org/10.1371/journal.pone.0227317			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS6OE	32369485	Green Submitted, Green Published, gold			2022-12-26	WOS:000536500100001
J	Banchi, P; Quaranta, G; Ricci, A; von Degerfeld, MM				Banchi, Penelope; Quaranta, Giuseppe; Ricci, Alessandro; von Degerfeld, Mitzy Mauthe			Reliability and construct validity of a composite pain scale for rabbit (CANCRS) in a clinical environment	PLOS ONE			English	Article							BUPRENORPHINE; ANALGESIA	A composite pain scale for assessing and quantifying pain in rabbits (CANCRS) has been designed merging the Rabbit Grimace Scale (RbtGS) and a scale including clinical parameters (CPS). Construct validity and inter-rater reliability were assessed for CANCRS, for RbtGS and for CPS, in order to test their potential to detect pain in a clinical setting. Rabbits (n = 116) were either hybrids or purebreds and they were independently evaluated by two raters, who could be veterinarians (V) or veterinary medicine students (S). Score intervals determined four pain classes (No pain, Discomfort, Moderate pain and Severe pain) that matched presumptive pain classes associated with some pathological conditions. A chi-square test was used to assess the construct validity of the scales by checking how frequently scale results and presumptive pain classes matched. Sixty-nine patients were evaluated by one V and one S, whereas forty-seven rabbits were assessed by two V, in order to test inter-rater reliability. An intra-class correlation coefficient (ICC) was used to test reliability of the scales, whereas Cohen's kappa tested inter-rater agreement for each parameter of the CANCRS. Construct validity results show that CANCRS and RbtGS efficiently reveal pain (P <= 0.05), while CPS does not (p > 0.05). Inter-rater reliability was very good for both CANCRS and CPS (ICC 0.88 V-V, 0.94 between V-S; ICC 0.97 V-V, 0.91 V-S) and good for RbtGS (ICC 0.77 V-V, 0.88 V-S); therefore, CPS reproducibility was better between veterinarians and students than between veterinarians. Inter-rater agreement between veterinarians and veterinary medicine students was moderate to very good for all the parameters included in the CANCRS (Cohen's kappa > 0,60). In conclusion, it is possible to state that the CANCRS has construct validity and it is a reliable tool for use in clinical practice, when coping with many rabbits with morphological differences. It is easy and fast to use and enriches the RbtGS with some clinical parameters that should be monitored during any clinical examination, allowing for capture of the multidimensional aspect of pain.	[Banchi, Penelope; Quaranta, Giuseppe; von Degerfeld, Mitzy Mauthe] Univ Torino, Dip Sci Vet, CANC Ctr Anim Non Convenz, Turin, Italy; [Ricci, Alessandro] Univ Torino, Dip Sci Vet, Turin, Italy	University of Turin; University of Turin	von Degerfeld, MM (corresponding author), Univ Torino, Dip Sci Vet, CANC Ctr Anim Non Convenz, Turin, Italy.	mitzy.mauthe@unito.it	/ABC-3544-2020; von Degerfeld, Mitzy Mauthe/AAO-2838-2020	von Degerfeld, Mitzy Mauthe/0000-0003-2884-3360; RICCI, ALESSANDRO/0000-0003-4131-2900; Banchi, Penelope/0000-0001-6061-4889				Altman DG, 1991, PRATICAL STAT MED RE; Belshaw Z, 2018, VET J, V239, P59, DOI 10.1016/j.tvjl.2018.07.010; Benato L, 2019, VET ANAESTH ANALG, V46, P151, DOI 10.1016/j.vaa.2018.10.007; Clark Nathan, 2014, Ann Am Thorac Soc, V11, P890, DOI 10.1513/AnnalsATS.201310-369OC; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; DiVincenti L, 2016, JAVMA-J AM VET MED A, V248, P795, DOI 10.2460/javma.248.7.795; Firth AM, 1999, J AM VET MED ASSOC, V214, P651; Goldschlager GB, 2013, J AM ASSOC LAB ANIM, V52, P571; Hageri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175839; Harcourt-Brown F., 2002, TXB RABBIT MED BIOL; Holopherne-Doran D., 2010, VET ANAESTH ANALG, V37, P1; Holton LL, 1998, J SMALL ANIM PRACT, V39, P469, DOI 10.1111/j.1748-5827.1998.tb03681.x; Johnston MS, 2005, SEMIN AVIAN EXOT PET, V14, P229, DOI 10.1053/j.saep.2005.09.003; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; Mathews K, 2014, J SMALL ANIM PRACT, V55, pE10, DOI 10.1111/jsap.12200; Mayer J, 2007, LAB ANIMAL, V36, P43, DOI 10.1038/laban0607-43; McLennan KM, 2019, APPL ANIM BEHAV SCI, V217, P1, DOI 10.1016/j.applanim.2019.06.001; Mich P.M., 2009, VET PAIN MANAGEMENT; Miller-Keane, 2003, ENCY DICT MED NURSIN, P2344; Morgan CA, 2007, VET CLIN N AM-SMALL, V37, P165, DOI 10.1016/j.cvsm.2006.09.008; Oliver V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097882; Reid J, 2007, ANIM WELFARE, V16, P97; Reid J, 2017, VET REC, V180, P449, DOI 10.1136/vr.104208; Reijgwart ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187986; Rocca G. della, 2015, American Journal of Animal and Veterinary Sciences, V10, P57; Tindall SC, 1990, CLIN METHODS HIST PH; Varga M., 2014, TXB RABBIT MED; Vedpathak HS, 2009, VET WORLD, V2, P360; Wenger S, 2012, J EXOT PET MED, V21, P7, DOI 10.1053/j.jepm.2011.11.010; Wildemeersch D, 2018, ACTA ANAESTHESIOL SC	32	12	16	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0221377	10.1371/journal.pone.0221377	http://dx.doi.org/10.1371/journal.pone.0221377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352960	gold, Green Published, Green Submitted			2022-12-26	WOS:000536673200001
J	Brand, CM; Johnson, MB; Parker, LD; Maldonado, JE; Korte, L; Vanthomme, H; Alonso, A; Ruiz-Lopez, MJ; Wells, CP; Ting, N				Brand, Colin M.; Johnson, Mireille B.; Parker, Lillian D.; Maldonado, Jesus E.; Korte, Lisa; Vanthomme, Hadrien; Alonso, Alfonso; Jose Ruiz-Lopez, Maria; Wells, Caitlin P.; Ting, Nelson			Abundance, density, and social structure of African forest elephants (Loxodonta cyclotis) in a human-modified landscape in southwestern Gabon	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC RELATEDNESS; FEEDING-BEHAVIOR; COMPUTER-PROGRAM; FISSION-FUSION; CONSERVATION; SAVANNA; RESERVE; DIET; DEMOGRAPHY	Population monitoring is critical to effective conservation, but forest living taxa can be difficult to directly observe. This has been true of African forest elephants (Loxodonta cyclotis), for which we have limited information regarding population size and social behavior despite their threatened conservation status. In this study, we estimated demographic parameters using genetic capture-recapture of forest elephants in the southern Industrial Corridor of the Gamba Complex of Protected Areas in southwestern Gabon, which is considered a global stronghold for forest elephants. Additionally, we examined social networks, predicting that we would find matrilineal structure seen in both savanna and forest elephants. Given 95% confidence intervals, we estimate population size in the sampled area to be between 754 and 1,502 individuals and our best density estimate ranges from 0.47 to 0.80 elephants per km(2). When extrapolated across the entire Industrial Corridor, this estimate suggests an elephant population size of 3,033 to 6,043 based on abundance or 1,684 to 2,832 based on density, approximately 40-80% smaller than previously suggested. Our social network analysis revealed approximately half of network components included females with different mitochondrial haplotypes suggesting a wider range of variation in forest elephant sociality than previously thought. This study emphasizes the threatened status of forest elephants and demonstrates the need to further refine baseline estimates of population size and knowledge on social behavior in this taxon, both of which will aid in determining how population dynamics in this keystone species may be changing through time in relation to increasing conservation threats.	[Brand, Colin M.; Ting, Nelson] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Johnson, Mireille B.; Korte, Lisa] Smithsonian Conservat Biol Inst, Gabon Biodivers Program, Gamba, Gabon; [Parker, Lillian D.; Maldonado, Jesus E.] George Mason Univ, Dept Biosci, Sch Syst Biol, Fairfax, VA 22030 USA; [Parker, Lillian D.; Maldonado, Jesus E.] Smithsonian Conservat Biol Inst, Natl Zool Pk, Ctr Conservat Genom, Washington, DC USA; [Vanthomme, Hadrien; Alonso, Alfonso] Smithsonian Conservat Biol Inst, Ctr Conservat & Sustainabil, Natl Zool Pk, Washington, DC USA; [Jose Ruiz-Lopez, Maria] Estn Biol Donana, Seville, Spain; [Wells, Caitlin P.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Wells, Caitlin P.; Ting, Nelson] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon; George Mason University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Colorado State University; University of Oregon	Ting, N (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.; Ting, N (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	nting@uoregon.edu	Parker, Lillian/ADQ-4350-2022; Wells, Caitlin P/AAH-7057-2021; Ruiz-Lopez, Maria Jose/AAA-8693-2020; Maldonado, Jesus/AIE-8664-2022	Parker, Lillian/0000-0003-3370-9473; Wells, Caitlin P/0000-0002-8840-3095; Ruiz-Lopez, Maria Jose/0000-0002-6849-644X; Maldonado, Jesus/0000-0002-4282-1072	GabonOregon Center; Shell Gabon; National Zoo Center for Conservation Genomics	GabonOregon Center; Shell Gabon; National Zoo Center for Conservation Genomics	Funding was provided by the GabonOregon Center to NT, Shell Gabon to the Smithsonian Conservation Biology Institute, and the National Zoo Center for Conservation Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Rob Fleischer and Nancy McInerney for all their help and support for this project at the Center for Conservation Genomics at the National Zoological Park. Many thanks to our collaborators who contributed to field work: L. Tchignoumba, M. Onbenotori, G. R. Mihindou, A. Litona-Boubeya, and N. Simons. We also thank Murray Efford who graciously helped with the SECR analyses. This is contribution #192 of the Gabon Biodiversity Program.	Ahlering MA, 2013, CONSERV BIOL, V27, P569, DOI 10.1111/cobi.12061; Ahlering MA, 2012, DIVERS DISTRIB, V18, P952, DOI 10.1111/j.1472-4642.2012.00896.x; Ahlering MA, 2011, MOL ECOL RESOUR, V11, P831, DOI 10.1111/j.1755-0998.2011.03030.x; Alonso A., 2014, Africa Today, V61, P3, DOI 10.2979/africatoday.61.1.3; Arandjelovic M, 2010, BIOL CONSERV, V143, P1780, DOI 10.1016/j.biocon.2010.04.030; Arandjelovic M, 2018, AM J PRIMATOL, V80, DOI 10.1002/ajp.22743; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Archie EA, 2012, MOL ECOL, V21, P765, DOI 10.1111/j.1365-294X.2011.05237.x; Arrendal J, 2007, CONSERV GENET, V8, P1097, DOI 10.1007/s10592-006-9266-y; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brand Colin M., 2016, Primate Conservation, V30, P103; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Eggert LS, 2014, CONSERV BIOL, V28, P107, DOI 10.1111/cobi.12161; Fernando P, 2000, HEREDITY, V84, P362, DOI 10.1046/j.1365-2540.2000.00674.x; Fishlock V, 2013, ANIM BEHAV, V85, P357, DOI 10.1016/j.anbehav.2012.11.004; Fishlock V, 2008, PACHYDERM, P17; Gobush K, 2009, MOL ECOL, V18, P722, DOI 10.1111/j.1365-294X.2008.04043.x; Goswami VR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44795-y; Granjon AC, 2017, J WILDLIFE MANAGE, V81, P279, DOI 10.1002/jwmg.21190; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Johnson MB, 2019, CONSERV SCI PRACT, V1, DOI 10.1111/csp2.76; Johnson MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-244; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kolowski JM, 2010, AFR J ECOL, V48, P1134, DOI 10.1111/j.1365-2028.2009.01204.x; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; McCarthy MS, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0052-x; Meyer M, 2017, ELIFE, V6, DOI 10.7554/eLife.25413; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Moore DL, 2014, AM J PRIMATOL, V76, P335, DOI 10.1002/ajp.22237; Morgan BJ, 2007, AFR J ECOL, V45, P519, DOI 10.1111/j.1365-2028.2007.00762.x; Mormont L, 2007, THESIS; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Munshi-South J, 2008, DIVERS DISTRIB, V14, P995, DOI 10.1111/j.1472-4642.2008.00509.x; Munshi-South J, 2011, J HERED, V102, P391, DOI 10.1093/jhered/esr030; Nyakaana S, 2001, ANIM CONSERV, V4, P231, DOI 10.1017/S1367943001001275; Palkopoulou E, 2018, P NATL ACAD SCI USA, V115, pE2566, DOI 10.1073/pnas.1720554115; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pennell MW, 2013, MOL ECOL RESOUR, V13, P154, DOI 10.1111/1755-0998.12019; Poulsen JR, 2017, CURR BIOL, V27, pR134, DOI 10.1016/j.cub.2017.01.023; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Querouil S, 1999, AFR J ECOL, V37, P161, DOI 10.1046/j.1365-2028.1999.00157.x; R Core Team, 2021, R LANGUAGE ENV STAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Schuttler SG, 2014, ENDANGER SPECIES RES, V25, P165, DOI 10.3354/esr00618; Schuttler SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088074; SHORT J, 1981, MAMMALIA, V45, P177, DOI 10.1515/mamm.1981.45.2.177; TCHAMBA MN, 1993, AFR J ECOL, V31, P165, DOI 10.1111/j.1365-2028.1993.tb00529.x; Thibault M, 2001, PRELIMINARY REPORT; Turkalo Andrea, 1995, Pachyderm, V20, P45; Turkalo AK, 2017, J APPL ECOL, V54, P153, DOI 10.1111/1365-2664.12764; Turkalo AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085154; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanthomme H, 2013, CONSERV BIOL, V27, P281, DOI 10.1111/cobi.12017; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WHITE LJT, 1993, AFR J ECOL, V31, P181, DOI 10.1111/j.1365-2028.1993.tb00532.x; Wikberg EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048740; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018	64	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231832	10.1371/journal.pone.0231832	http://dx.doi.org/10.1371/journal.pone.0231832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9ZW	32348354	Green Submitted, gold, Green Published			2022-12-26	WOS:000533983300001
J	Nakano, D; Kawaguchi, T; Iwamoto, H; Hayakawa, M; Koga, H; Torimura, T				Nakano, Dan; Kawaguchi, Takumi; Iwamoto, Hideki; Hayakawa, Masako; Koga, Hironori; Torimura, Takuji			Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)	PLOS ONE			English	Article							BIOMARKER DISCOVERY; CANCER; INHIBITOR; PROLIFERATION; EXPRESSION; GENES; CYCLE	Aim Metabolic reprograming is crucial in the proliferation of hepatocellular carcinoma (HCC). Canagliflozin (CANA), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, affects various metabolisms. We investigated the effects of CANA on proliferation and metabolic reprograming of HCC cell lines using multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT). Methods The cells were counted 72 hours after treatment with CANA (10 mu M; n = 5) or dimethyl sulfoxide (control [CON]; n = 5) in Hep3B and Huh7 cells. In Hep3B cells, metabolomics and iMPAQT were used to evaluate the levels of metabolites and metabolic enzymes in the CANA and CON groups (each n = 5) 48 hours after treatment. Results Seventy-two hours after treatment, the number of cells in the CANA group was significantly decreased compared to that in the CON group in Hep3B and Huh7 cells. On multi-omics analysis, there was a significant difference in the levels of 85 metabolites and 68 metabolic enzymes between the CANA and CON groups. For instance, CANA significantly downregulated ATP synthase F1 subunit alpha, a mitochondrial electron transport system protein (CON 297.28 +/- 20.63 vs. CANA 251.83 +/- 22.83 fmol/10 mu g protein; P = 0.0183). CANA also significantly upregulated 3-hydroxybutyrate, a beta-oxidation metabolite (CON 530 +/- 14 vs. CANA 854 +/- 68 arbitrary units; P < 0.001). Moreover, CANA significantly downregulated nucleoside diphosphate kinase 1 (CON 110.30 +/- 11.37 vs. CANA 89.14 +/- 8.39 fmol/10 mu g protein; P = 0.0172). Conclusions We found that CANA suppressed the proliferation of HCC cells through alterations in mitochondrial oxidative phosphorylation metabolism, fatty acid metabolism, and purine and pyrimidine metabolism. Thus, CANA may suppress the proliferation of HCC by regulating metabolic reprograming.	[Nakano, Dan; Kawaguchi, Takumi; Iwamoto, Hideki; Koga, Hironori; Torimura, Takuji] Kurume Univ, Div Gastroenterol, Dept Med, Sch Med, Kurume, Fukuoka, Japan; [Iwamoto, Hideki; Hayakawa, Masako; Koga, Hironori; Torimura, Takuji] Kurume Univ, Liver Canc Div, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka, Japan	Kurume University; Kurume University	Kawaguchi, T (corresponding author), Kurume Univ, Div Gastroenterol, Dept Med, Sch Med, Kurume, Fukuoka, Japan.	takumi@med.kurume-u.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP19fk0210040]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This research was supported by Japan Agency for Medical Research and Development (AMED) under Grant Number JP19fk0210040.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Devineni D, 2015, CLIN PHARM DRUG DEV, V4, P295, DOI 10.1002/cpdd.162; Fine EJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-14; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Guo W, 2018, CANCER MANAG RES, V10, P715, DOI 10.2147/CMAR.S156837; Hindupur SK, 2018, NATURE, V555, P678, DOI 10.1038/nature26140; Hnasko TS, 2015, METHODS MOL BIOL, V1318, P87, DOI 10.1007/978-1-4939-2742-5_9; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hung MH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1646-6; Kaji K, 2018, INT J CANCER, V142, P1712, DOI 10.1002/ijc.31193; Kawaguchi T, 2015, INT J ONCOL, V46, P2216, DOI 10.3892/ijo.2015.2928; Kuang HY, 2017, MED SCI MONITOR, V23, P3737, DOI 10.12659/MSM.902530; Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Liu FF, 2015, TUMORI, V101, P206, DOI 10.5301/tj.5000241; Liu RQ, 2019, CANCER LETT, V443, P34, DOI 10.1016/j.canlet.2018.11.030; Liu Y, 2014, INT J CANCER, V135, P658, DOI 10.1002/ijc.28706; Lopez-Mejia IC, 2017, MOL CELL, V68, P336, DOI 10.1016/j.molcel.2017.09.034; Ma F, 2019, HEPATOLOGY, V70, P1785, DOI 10.1002/hep.30703; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Matsumoto M, 2017, NAT METHODS, V14, P251, DOI [10.1038/NMETH.4116, 10.1038/nmeth.4116]; Obara K, 2017, ONCOTARGET, V8, P58353, DOI 10.18632/oncotarget.16874; Odell ID, 2013, J INVEST DERMATOL, V133, pE1, DOI 10.1038/jid.2012.455; Okamoto S, 2019, METABOLISM, V90, P52, DOI 10.1016/j.metabol.2018.10.003; Osataphan S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123130; Poff AM, 2014, INT J CANCER, V135, P1711, DOI 10.1002/ijc.28809; Puts GS, 2018, LAB INVEST, V98, P211, DOI 10.1038/labinvest.2017.109; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; Scafoglio C, 2015, P NATL ACAD SCI USA, V112, pE4111, DOI 10.1073/pnas.1511698112; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Secker PF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0273-y; Selvendiran K, 2006, CANCER RES, V66, P4826, DOI 10.1158/0008-5472.CAN-05-4062; Shiba K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19658-7; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Sugita S, 2018, INT J ONCOL, V53, P725, DOI 10.3892/ijo.2018.4435; Tahrani AA, 2013, LANCET DIABETES ENDO, V1, P140, DOI 10.1016/S2213-8587(13)70050-0; Takahashi R, 2001, LEUKEMIA RES, V25, P77, DOI 10.1016/S0145-2126(00)00087-4; Tang HL, 2017, DIABETOLOGIA, V60, P1862, DOI 10.1007/s00125-017-4370-8; Tian Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11274-x; Villani LA, 2016, MOL METAB, V5, P1048, DOI 10.1016/j.molmet.2016.08.014; Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130; Wani NA, 2018, MOL CANCER RES, V16, P256, DOI 10.1158/1541-7786.MCR-17-0304; Xie Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41089; Yamamura S, 2020, HEPATOL RES, V50, P199, DOI 10.1111/hepr.13436; Yan HX, 2017, PATHOL RES PRACT, V213, P316, DOI 10.1016/j.prp.2017.01.019; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhong XY, 2018, CELL REP, V24, P3207, DOI 10.1016/j.celrep.2018.08.066	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232283	10.1371/journal.pone.0232283	http://dx.doi.org/10.1371/journal.pone.0232283			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343721	Green Published, gold			2022-12-26	WOS:000536661300049
J	Well, L; Jaeger, A; Kehrer-Sawatzki, H; Farschtschi, S; Avanesov, M; Sauer, M; de Sousa, MT; Bannas, P; Derlin, T; Adam, G; Mautner, VF; Salamon, JM				Well, Lennart; Jaeger, Anna; Kehrer-Sawatzki, Hildegard; Farschtschi, Said; Avanesov, Maxim; Sauer, Markus; de Sousa, Manuela Tavares; Bannas, Peter; Derlin, Thorsten; Adam, Gerhard; Mautner, Victor F.; Salamon, Johannes M.			The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1	PLOS ONE			English	Article							NERVE SHEATH TUMORS; PLEXIFORM NEUROFIBROMAS; STEROID-HORMONES; VOLUME	Introduction Patients with Neurofibromatosis type 1 (NF1) develop plexiform neurofibromas (PNF) and cutaneous neurofibromas. These tumors are a major cause of the patient's morbidity and mortality. An influence of estrogen and progesterone on tumor growth has been suggested but reports on growth or malignant transformation of tumors during pregnancy remain anecdotal. The purpose of this study was to quantify growth of cutaneous and plexiform neurofibromas in NF1 patients during pregnancy, and to assess the onset of NF1 related symptoms. Material and methods Retrospectively, 13 mothers with NF1 were included and compared to nullipara, nulligravida, age-matched women with NF1. All women received whole-body magnetic resonance imaging (MRI) before and after pregnancy or after a matched time period. Presence of plexiform and cutaneous neurofibromas was evaluated. PNF were subjected to semi-automated volumetry (MedX). The sum of the longest diameters (SLD) of representative cutaneous neurofibromas was determined for both groups. Clinical symptoms and subjective tumor growth were assessed. Results PNF were identified in 12/26 women (46.2%). Follow up showed neither new PNF nor a significant difference in growth rate (median tumor-growth/year: pregnant group-0.38% (IQR -1.1-5.4%) vs control group 3.59% (IQR -2.1-5.5%; P = 0.69). Malignant transformation of PNF was not observed. There was a significant growth of cutaneous neurofibromas in both groups (median SLD increase: pregnant group 17mm; P = 0.0026 / control group 12mm; P = 0.0004) The difference in increase of SLD was not significant (P = 0.48). Singular cutaneous neurofibromas in the pregnant group displayed high levels of tumor growth (>20%/year). NF1-associated symptoms and subjective tumor growth were not significantly increased in pregnant patients. Conclusions Growth of plexiform and cutaneous neurofibromas in pregnant patients is not significantly different compared to non-pregnant patients. Cutaneous neurofibromas show a significant increase in growth over time in both, pregnant and non-pregnant patients and NF1 related clinical symptoms do not significantly aggravate during the course of pregnancy.	[Well, Lennart; Avanesov, Maxim; Sauer, Markus; Bannas, Peter; Adam, Gerhard; Salamon, Johannes M.] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany; [Jaeger, Anna] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany; [Kehrer-Sawatzki, Hildegard] Univ Ulm, Inst Human Genet, Ulm, Germany; [Farschtschi, Said; Mautner, Victor F.] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [de Sousa, Manuela Tavares] Univ Med Ctr Hamburg Eppendorf, Dept Obstet & Fetal Med, Hamburg, Germany; [Derlin, Thorsten] Hannover Med Sch, Dept Nucl Med, Hannover, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Well, L (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.	l.well@uke.de		Bannas, Peter/0000-0002-7102-534X	Bundesverband Neurofibromatose e.V.	Bundesverband Neurofibromatose e.V.	This study has been supported by a grant of the "Bundesverband Neurofibromatose e.V." to Johannes M. Salamon (https://bv-nf.de/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NEUROFIBROMATOSIS, V1, P172; Cai WL, 2009, RADIOLOGY, V250, P665, DOI 10.1148/radiol.2503080700; Dombi E, 2007, NEUROLOGY, V68, P643, DOI 10.1212/01.wnl.0000250332.89420.e6; Dugoff L, 1996, AM J MED GENET, V66, P7, DOI 10.1002/(SICI)1096-8628(19961202)66:1<7::AID-AJMG2>3.0.CO;2-R; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0607-y; Fishbein L, 2007, MOL CARCINOGEN, V46, P512, DOI 10.1002/mc.20236; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; Friedman JM, 1999, NEUROFIBROMATOSIS PH, P29; Friedrich RE, 2003, ANTICANCER RES, V23, P949; Granstrom S, 2012, DERMATOLOGY, V224, P160, DOI 10.1159/000337548; HUSON SM, 1989, J MED GENET, V26, P712, DOI 10.1136/jmg.26.11.712; Isikoglu M., 2002, Archives of Gynecology and Obstetrics, V267, P41, DOI 10.1007/s004040100239; Jett K, 2015, AM J MED GENET A, V167, P1518, DOI 10.1002/ajmg.a.37068; Korf BR, 2002, J CHILD NEUROL, V17, P573, DOI 10.1177/088307380201700806; Lammert M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-16; Li H, 2010, CANCER BIOL THER, V10, P758, DOI 10.4161/cbt.10.8.12878; Mautner VF, 2007, ANTICANCER RES, V27, P1819; McLaughlin ME, 2003, CANCER RES, V63, P752; Nguyen R, 2014, J NEURO-ONCOL, V116, P307, DOI 10.1007/s11060-013-1293-1; Nguyen R, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-75; Plotkin SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035711; Posma E, 2003, BJOG-INT J OBSTET GY, V110, P530, DOI 10.1016/S1470-0328(02)02649-6; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Roth TM, 2008, AM J MED GENET A, V146A, P1624, DOI 10.1002/ajmg.a.32301; Salamon J, 2015, ROFO-FORTSCHR RONTG, V187, P1084, DOI 10.1055/s-0035-1553505; SHARMA JB, 1991, INT J GYNECOL OBSTET, V34, P221, DOI 10.1016/0020-7292(91)90353-7; Solomon J, 2004, COMPUT MED IMAG GRAP, V28, P257, DOI 10.1016/j.compmedimag.2004.03.002; Terry AR, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.029; WEISSMAN A, 1993, J REPROD MED, V38, P890	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232031	10.1371/journal.pone.0232031	http://dx.doi.org/10.1371/journal.pone.0232031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343738	gold, Green Published			2022-12-26	WOS:000536661300028
J	Balakrishnan, M; Geetha, TV				Balakrishnan, Mathiarasi; Geetha, T. V.			A neural network framework for predicting dynamic variations in heterogeneous social networks	PLOS ONE			English	Article							LINK-PREDICTION; TIME-SERIES; RECOMMENDATION	Forecasting possible future relationships between people in a network requires a study of the evolution of their links. To capture network dynamics and temporal variations in link strengths between various types of nodes in a network, a dynamic weighted heterogeneous network is to be considered. Link strength prediction in such networks is still an open problem. Moreover, a study of variations in link strengths with respect to time has not yet been explored. The time granularity at which the weights of various links change remains to be delved into. To tackle these problems, we propose a neural network framework to predict dynamic variations in weighted heterogeneous social networks. Our link strength prediction model predicts future relationships between people, along with a measure of the strength of those relationships. The experimental results highlight the fact that link weights and dynamism greatly impact the performance of link strength prediction.	[Balakrishnan, Mathiarasi; Geetha, T. V.] Anna Univ, Dept Comp Sci & Engn, Chennai, Tamil Nadu, India	Anna University; Anna University Chennai	Balakrishnan, M (corresponding author), Anna Univ, Dept Comp Sci & Engn, Chennai, Tamil Nadu, India.	b.mathi.rajesh@gmail.com		Balakrishnan, Mathiarasi/0000-0001-9752-318X				Aggarwal Cham, 2012, P SIAM INT C DAT MIN, P415; Ahmed C, 2016, SOC NETW ANAL MIN, V6, DOI 10.1007/s13278-016-0333-1; Ahmed NM, 2016, INFORM SCIENCES, V331, P120, DOI 10.1016/j.ins.2015.10.036; Al Hasan M, 2011, SOCIAL NETWORK DATA ANALYTICS, P243; Berg Rv d, 2017, ARXIV170602263; Bhatia M., 2018, J INTELL FUZZY SYST, P1; Box G. E. P., 2015, TIME SERIES ANAL FOR; Cui YW, 2016, PROCEDIA COMPUT SCI, V91, P953, DOI 10.1016/j.procs.2016.07.119; Davis D, 2013, SOC NETW ANAL MIN, V3, P127, DOI 10.1007/s13278-012-0068-6; Gilbert E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P211; Gunes I, 2016, DATA MIN KNOWL DISC, V30, P147, DOI 10.1007/s10618-015-0407-0; Kahanda I., 2009, P 3 INT AAAI C WEBL; Khosravi H, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P191, DOI 10.1109/CIDM.2013.6597236; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Kipf TN, 2016, NIPS WORKSH BAYES DE; Leskovec J., 2014, SNAP DATASETS STANFO; Li N, 2012, INT CONF COMP SCI ED, P1115, DOI 10.1109/ICCSE.2012.6295261; Li XT, 2014, LECT NOTES COMPUT SC, V8351, P289, DOI 10.1007/978-3-319-09265-2_30; Liang WX, 2018, APPL INTELL, V48, P1111, DOI 10.1007/s10489-017-1044-7; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Nair Vinod, 2010, P 27 INT C INT C MAC, P807; Ozcan A, 2019, INT J INF TECH DECIS, V18, P241, DOI 10.1142/S0219622018500530; Papadimitriou A, 2012, J SYST SOFTWARE, V85, P2119, DOI 10.1016/j.jss.2012.04.019; Shakibian H, 2016, J COMPUT SCI-NETH, V17, P73, DOI 10.1016/j.jocs.2016.10.001; Shi C, 2017, IEEE T KNOWL DATA EN, V29, P17, DOI 10.1109/TKDE.2016.2598561; Soares PRS, 2013, EXPERT SYST APPL, V40, P6652, DOI 10.1016/j.eswa.2013.06.016; Sun Y., 2012, P 5 ACM INT C WEB SE, P663, DOI DOI 10.1145/2124295.2124373; Sun YZ, 2011, 2011 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2011), P121, DOI 10.1109/ASONAM.2011.112; Symeonidis P, 2013, SOC NETW ANAL MIN, V3, P1433, DOI 10.1007/s13278-013-0128-6; Tang J., 2008, PROC ACM SIGKDD INT, P990, DOI DOI 10.1145/1401890.1402008; Tsugawa S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170279; WANG P, 2015, SCI CHINA INFORM SCI, V58, P1, DOI DOI 10.1007/S11432-014-5237-Y; Wu BX, 2015, LECT NOTES ARTIF INT, V9227, P375, DOI 10.1007/978-3-319-22053-6_41; Xiang Rongjing, 2010, P 19 INT C WORLD WID; Xu ZQ, 2016, PHYSICA A, V456, P294, DOI 10.1016/j.physa.2016.03.091; Yang HD, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P196, DOI 10.1109/ICDMW.2015.73; Zhang M., 2018, ARXIV180209691CSSTAT; Zhang Muhan, 2019, ARXIV190412058; Zhang W, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1415-9; [No title captured], DOI DOI 10.1016/J.KN0SYS.2016.01.034	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231842	10.1371/journal.pone.0231842	http://dx.doi.org/10.1371/journal.pone.0231842			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339174	gold, Green Published			2022-12-26	WOS:000536657400014
J	Jiang, FY; Huang, H; Yang, N; Feng, HM; Li, Y; Han, BB				Jiang, Fangyan; Huang, Hai; Yang, Ning; Feng, Huimin; Li, Yu; Han, Bingbing			Isolation, identification, and biological control in vitro of tail rot pathogen strain from Hippocampus kuda	PLOS ONE			English	Article							LINED SEAHORSE; STOCKING DENSITY; LIGHT-INTENSITY; ERECTUS PERRY; SP NOV.; INFECTION; GROWTH; GUTTULATUS; MECHANISM; BACTERIUM	Tail rot disease is associated with major economic losses in the seahorse aquaculture in China. This study aimed to isolate and identify the pathogen causing tail rot disease in seahorses. Three culturable intestinal bacteria strains were isolated from Hippocampus kuda specimens with tail rot disease. Strain HL11, HL12, and HL13 were identified as Pseudoalteromonas spongiae, Bacillus subtilis and Photobacterium ganghwense based on its morphological characteristics, physiological and biochemical properties, through 16S rRNA and gyrB sequencing, respectively. Challenge experiments using these strains on healthy H. kuda and bacterial re-isolation from challenged diseased seahorses showed that the bacteria strain named HL11 induced identical pathological symptoms, indicating that it is the causative pathogen of the disease. Antibiotic-resistance tests against of 32 antibiotics revealed that HL11 was highly sensitive to 13 kinds, while exhibited intermediate susceptibility to 6, and resistance to 13 kinds. Antibacterial tests of the bioactive agents showed that HL11 was susceptible to five kinds, including tea polyphenols, lactic acid, gallic acid, allicin, and polylysine; however, it was not susceptible to the other 13 kinds of bioactive agents. The results demonstrate the potential of using bioactive agents to replace antibiotics to generate an environmentally friendly mode of culturing seahorses.	[Jiang, Fangyan; Huang, Hai; Feng, Huimin] Hainan Trop Ocean Univ, Key Lab Utilizat & Conservat Trop Marine Bioresou, Minist Educ, Sanya, Peoples R China; [Jiang, Fangyan; Huang, Hai] Hainan Trop Ocean Univ, Key Lab Trop Marine Fishery Resources Protect & U, Sanya, Peoples R China; [Yang, Ning; Li, Yu; Han, Bingbing] Sanya Sci & Technol Acad Hainan Natl Breeding & M, Sanya, Peoples R China	Hainan Tropical Ocean University; Hainan Tropical Ocean University	Yang, N (corresponding author), Sanya Sci & Technol Acad Hainan Natl Breeding & M, Sanya, Peoples R China.	dayangning@163.com			Applied Technology Research, Demonstration and Extension Program of Hainan Province [ZDXM2015006]; Marine Science and Technology Program of Hainan Province [XH201403]; Major Scientific and Technological Program of Hainan Province [ZDKJ2016009]; Scientific Research and Trial Manufacture Program of Sanya [2014CZ09]; Institutional Science and Technology Cooperation Program of Sanya [2015YD07]	Applied Technology Research, Demonstration and Extension Program of Hainan Province; Marine Science and Technology Program of Hainan Province; Major Scientific and Technological Program of Hainan Province; Scientific Research and Trial Manufacture Program of Sanya; Institutional Science and Technology Cooperation Program of Sanya	This work was financially supported by the Applied Technology Research, Demonstration and Extension Program of Hainan Province (No. ZDXM2015006), the Marine Science and Technology Program of Hainan Province (No. XH201403), Major Scientific and Technological Program of Hainan Province (No. ZDKJ2016009), the Scientific Research and Trial Manufacture Program of Sanya (No. 2014CZ09), the Institutional Science and Technology Cooperation Program of Sanya (No. 2015YD07).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aurelio M, 2013, MAR BIOL, V160, P2663, DOI 10.1007/s00227-013-2259-8; Balcazar JL, 2010, ANTON LEEUW INT J G, V97, P207, DOI 10.1007/s10482-009-9398-4; Bansal S, 2013, FOOD RES INT, V53, P568, DOI 10.1016/j.foodres.2013.01.032; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beurmann S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188319; Brenner DJ, 2008, BERGEYS MANUAL SYSTE, V2; Dai XM, 2015, RSC ADV, V5, P69325, DOI 10.1039/c5ra10393b; Dang T.B., 2016, INT J INNOVATIVE STU, V2, P43; Declercq AM, 2014, J FISH DIS, V37, P501, DOI 10.1111/jfd.12138; Egan S, 2001, INT J SYST EVOL MICR, V51, P1499, DOI 10.1099/00207713-51-4-1499; Faleiro F, 2013, AQUAC RES, V44, P618, DOI 10.1111/j.1365-2109.2011.03067.x; Pujalte MJ, 2007, AQUACULTURE, V271, P47, DOI 10.1016/j.aquaculture.2007.06.015; Ko J, 2016, FISH SHELLFISH IMMUN, V58, P622, DOI 10.1016/j.fsi.2016.10.014; Koldewey H., 2005, SEAHORSE HUSBANDRY P; Koldewey HJ, 2010, AQUACULTURE, V302, P131, DOI 10.1016/j.aquaculture.2009.11.010; Leary S, 2013, AVMA GUIDELINES EUTH; Lin Q, 2008, AQUACULTURE, V277, P287, DOI 10.1016/j.aquaculture.2008.02.030; Lin QA, 2010, AQUAC RES, V42, P91, DOI 10.1111/j.1365-2109.2010.02573.x; Lin Q, 2009, AQUACULTURE, V292, P111, DOI 10.1016/j.aquaculture.2009.03.028; Lin TT, 2016, FISH SHELLFISH IMMUN, V50, P247, DOI 10.1016/j.fsi.2016.01.039; Lourie S.A., 1999, PROJ SEAHORSE LONDON, P214; Balcazar JL, 2014, CURR MICROBIOL, V69, P329, DOI 10.1007/s00284-014-0588-6; Luo W, 2016, FISH SHELLFISH IMMUN, V58, P521, DOI 10.1016/j.fsi.2016.09.057; Mundell NA, 2015, J COMP NEUROL, V523, P1639, DOI 10.1002/cne.23761; Nikolaj GV, 2011, MAR BIOTECHNOL, V13, P1062, DOI [10.1007/s10126-011-9369-4, DOI 10.1007/S10126-011-9369-4]; Planas M, 2008, AQUACULTURE, V283, P19, DOI 10.1016/j.aquaculture.2008.06.023; Qin G, 2017, J FISH DIS, V40, P601, DOI 10.1111/jfd.12533; Raj ST, 2010, INDIAN J MAR SCI, V39, P151; Rezk A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0596-5; Rob J, HUMANE EUTHANASIA TE; Salin K. R., 2006, Aquaculture Asia Magazine, V11, P3; Sanaye S., 2013, FISHING CHIMES, V32, P65; Shin SP, 2011, AFR J MICROBIOL RES, V5, P738; Sun X, 2016, CLEAN-SOIL AIR WATER, V44, P304, DOI 10.1002/clen.201200478; Tendencia EA, 2004, AQUAC RES, V35, P1292, DOI 10.1111/j.1365-2109.2004.01109.x; VINCENT ACJ, 1989, J WILDLIFE DIS, V25, P404, DOI 10.7589/0090-3558-25.3.404; Wang CJ, 2015, FOOD CONTROL, V47, P231, DOI 10.1016/j.foodcont.2014.06.034; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; YANG Q, 2017, J FISHERY SCI CHINA, V24, P21311, DOI DOI 10.3724/SP.J.1118; Zeng YinXin, 2011, Advances in Polar Science, V22, P25, DOI 10.3724/SP.J.1085.2011.00025; Zhang D, 2011, AQUACULTURE, V322, P255, DOI 10.1016/j.aquaculture.2011.10.008; Zhang Z, 1997, Zhong Yao Cai, V20, P140; Zheng YF, 2016, AQUACULTURE, V451, P163, DOI 10.1016/j.aquaculture.2015.09.020; Zou ZH, 1958, REARING SEAHORSE, P13	45	2	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232162	10.1371/journal.pone.0232162	http://dx.doi.org/10.1371/journal.pone.0232162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330196	gold, Green Published			2022-12-26	WOS:000536647300057
J	Hewitt, SC; Grimm, SA; Wu, SP; DeMayo, FJ; Korach, KS				Hewitt, Sylvia C.; Grimm, Sara A.; Wu, San-Pin; DeMayo, Francesco J.; Korach, Kenneth S.			Estrogen receptor ? (ER?)-binding super-enhancers drive key mediators that control uterine estrogen responses in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; gene expression; chromatin modification; transcription; reproduction; chromatin conformation capture; chromatin looping; epigenetic regulation; female reproduction; super-enhancer	RETINOIC ACID; ER-ALPHA; MOUSE; DECIDUALIZATION; CONSEQUENCES; IMPLANTATION; COACTIVATOR; DISRUPTION; PUBERTY; UTERUS	Estrogen receptor ? (ER?) modulates gene expression by interacting with chromatin regions that are frequently distal from the promoters of estrogen-regulated genes. Active chromatin-enriched ?super-enhancer? (SE) regions, mainly observed inin vitroculture systems, often control production of key cell type?determining transcription factors. Here, we defined super-enhancers that bind to ER?in vivowithin hormone-responsive uterine tissue in mice. We found that SEs are already formed prior to estrogen exposure at the onset of puberty. The genes at SEs encoded critical developmental factors, including retinoic acid receptor ? (RARA) and homeobox D (HOXD). Using high-throughput chromosome conformation capture (Hi-C) along with DNA sequence analysis, we demonstrate that most SEs are located at a chromatin loop end and that most uterine genes in loop ends associated with these SEs are regulated by estrogen. Although the SEs were formed before puberty, SE-associated genes acquired optimal ER?-dependent expression after reproductive maturity, indicating that pubertal processes that occur after SE assembly and ER? binding are needed for gene responses. Genes associated with these SEs affected key estrogen-mediated uterine functions, including transforming growth factor ? (TGF?) and LIF interleukin-6 family cytokine (LIF) signaling pathways. To the best of our knowledge, this is the first identification of SE interactions that underlie hormonal regulation of genes in uterine tissue and optimal development of estrogen responses in this tissue.	[Hewitt, Sylvia C.; Wu, San-Pin; DeMayo, Francesco J.; Korach, Kenneth S.] NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Grimm, Sara A.] NIEHS, Integrat Bioinformat Support Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hewitt, SC (corresponding author), NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Sylvia.Hewitt@nih.gov	, San Pin Wu/AAF-8371-2020	, San Pin Wu/0000-0001-9626-784X; Hewitt, Sylvia/0000-0001-7713-0805	Intramural Research Program of NIEHS, National Institutes of Health [1ZIAES070065, 1ZIAES103311]	Intramural Research Program of NIEHS, National Institutes of Health	This work was supported in part by the Intramural Research Program of NIEHS, National Institutes of Health, Grants 1ZIAES070065 (to K. S. K.) and 1ZIAES103311 (to F. J. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Beliakoff Jason, 2006, Nucl Recept Signal, V4, pe017; Bernard V, 2017, J CLIN ENDOCR METAB, V102, P93, DOI 10.1210/jc.2016-2749; Binder AK., 2015, KNOBIL NEILLS PHYSL, P1099, DOI [10.1016/b978-0-12-397175-3.00025-9, DOI 10.1016/B978-0-12-397175-3.00025-9]; Blackmore JK, 2014, ENDOCRINOLOGY, V155, P3251, DOI 10.1210/en.2014-1002; Bojcsuk D, 2017, NUCLEIC ACIDS RES, V45, P3693, DOI 10.1093/nar/gkw1283; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Clementi C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003863; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; Du HL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a023002; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gao Y, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125146; Gassler J, 2017, EMBO J, V36, P3600, DOI 10.15252/embj.201798083; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Herndon CN, 2016, REPROD SCI, V23, P1289, DOI 10.1177/1933719116650758; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2019, J BIOL CHEM, V294, P9746, DOI 10.1074/jbc.RA119.008759; Hewitt SC, 2019, FASEB J, V33, P3010, DOI 10.1096/fj.201801752; Hewitt SC, 2018, ENDOCR REV, V39, P664, DOI 10.1210/er.2018-00087; Hewitt SC, 2017, ENDOCRINOLOGY, V158, P2427, DOI 10.1210/en.2017-00349; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong SH, 2018, P NATL ACAD SCI USA, V115, P10381, DOI 10.1073/pnas.1809480115; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; KATZENELLENBOGEN BS, 1974, MOL CELL ENDOCRINOL, V2, P31, DOI 10.1016/0303-7207(74)90010-0; Kelleher AM, 2019, ENDOCR REV, V40, P1424, DOI 10.1210/er.2018-00281; Kriseman M, 2019, P NATL ACAD SCI USA, V116, P3873, DOI 10.1073/pnas.1806862116; Le Dily F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020306; Li QL, 2019, P NATL ACAD SCI USA, V116, P3367, DOI 10.1073/pnas.1821606116; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin L, 2007, J CLIN ENDOCR METAB, V92, P982, DOI 10.1210/jc.2006-1181; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miano V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020593; Monsivais D, 2019, P NATL ACAD SCI USA, V116, P3883, DOI 10.1073/pnas.1806838116; Monsivais D, 2016, P NATL ACAD SCI USA, V113, pE387, DOI 10.1073/pnas.1523758113; Mucenski ML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40923-w; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; Nakajima T, 2019, REPROD TOXICOL, V86, P56, DOI 10.1016/j.reprotox.2019.03.006; Nakajima T, 2019, BIOCHEM BIOPHYS REP, V17, P44, DOI 10.1016/j.bbrep.2018.10.013; Nakajima T, 2016, P NATL ACAD SCI USA, V113, P14354, DOI 10.1073/pnas.1608808113; Nanjappa MK, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125724; Panigrahi AK, 2018, MOL CELL, V70, P679, DOI 10.1016/j.molcel.2018.04.014; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; QUARMBY VE, 1984, ENDOCRINOLOGY, V114, P694, DOI 10.1210/endo-114-3-694; Quaynor SD, 2013, NEW ENGL J MED, V369, P164, DOI 10.1056/NEJMoa1303611; Raines AM, 2013, DEVELOPMENT, V140, P2942, DOI 10.1242/dev.092569; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Santen RJ, 2019, ENDOCRINOLOGY, V160, P605, DOI 10.1210/en.2018-00529; Sengupta S, 2017, TRENDS CANCER, V3, P269, DOI 10.1016/j.trecan.2017.03.006; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Stewart CA, 2011, BIOL REPROD, V85, P954, DOI 10.1095/biolreprod.111.091470; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Tasaki Hirotaka, 2013, Front Endocrinol (Lausanne), V4, P82, DOI 10.3389/fendo.2013.00082; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Walters KA, 2009, ENDOCRINOLOGY, V150, P3274, DOI 10.1210/en.2008-1750; Wang JJ, 2016, BRIEF FUNCT GENOMICS, V15, P385, DOI 10.1093/bfgp/elv062; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303	68	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8387	8400		10.1074/jbc.RA120.013666	http://dx.doi.org/10.1074/jbc.RA120.013666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32354741	hybrid, Green Published			2022-12-26	WOS:000546986500004
J	Wang, D; Chen, YP; Liu, MW; Cao, QQ; Wang, QH; Zhou, SS; Wang, YX; Mao, SS; Gu, XS; Luo, ZG; Yu, B				Wang, Dong; Chen, Yanping; Liu, Mingwen; Cao, Qianqian; Wang, Qihui; Zhou, Shuoshuo; Wang, Yaxian; Mao, Susu; Gu, Xiaosong; Luo, Zhenge; Yu, Bin			The long noncoding RNA Arrl1 inhibits neurite outgrowth by functioning as a competing endogenous RNA during neuronal regeneration in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuron; neurite outgrowth; neurite growth; long noncoding RNA (long ncRNA; lncRNA); regeneration; microRNA (miRNA); Arrl1; axon regeneration; competing endogenous RNA (ceRNA); long noncoding RNA; peripheral nerve injury; miR-761; cyclin-dependent kinase inhibitor 2B (Cdkn2b); RNA sponge; transcriptomics	AXON REGENERATION; INTRINSIC CONTROL; NERVOUS-SYSTEM; OVEREXPRESSION; MECHANISMS; EVOLUTION; INJURY; STAT3; PTEN; ATF3	The intrinsic regeneration ability of neurons is a pivotal factor in the repair of peripheral nerve injury. Therefore, identifying the key modulators of nerve regeneration may help improve axon regeneration and functional recovery after injury. Unlike for classical transcription factors and regeneration-associated genes, the function of long noncoding RNAs (lncRNAs) in the regulation of neuronal regeneration remains mostly unknown. In this study, we used RNA-Seq?based transcriptome profiling to analyze the expression patterns of lncRNAs and mRNAs in rat dorsal root ganglion (DRG) following sciatic nerve injury. Analyses using the lncRNA-mRNA co-expression network, gene ontology enrichment, and Kyoto Encyclopedia of Genes and Genomes pathway databases indicated that the lncRNA Arrl1 decreases neurite outgrowth after neuronal injury. shRNA-mediated Arrl1 silencing increased axon regeneration bothin vitroandin vivoand improved functional recovery of the sciatic nerve. Moreover, inhibiting an identified target gene of Arrl1, cyclin-dependent kinase inhibitor 2B (Cdkn2b), markedly promoted neurite outgrowth of DRG neurons. We also found that Arrl1 acts as a competing endogenous RNA that sponges a Cdkn2b repressor, microRNA-761 (miR-761), and thereby up-regulates Cdkn2b expression during neuron regeneration. We conclude that the lncRNA Arrl1 affects the intrinsic regeneration of DRG neurons by derepressing Cdkn2b expression. Our findings indicate a role for an lncRNA-microRNA-kinase pathway in the regulation of axon regeneration and functional recovery following peripheral nerve injury in rats.	[Wang, Dong; Chen, Yanping; Liu, Mingwen; Cao, Qianqian; Wang, Qihui; Zhou, Shuoshuo; Wang, Yaxian; Mao, Susu; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Wang, Dong; Chen, Yanping; Liu, Mingwen; Cao, Qianqian; Wang, Qihui; Zhou, Shuoshuo; Wang, Yaxian; Mao, Susu; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong, Peoples R China; [Luo, Zhenge] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Nantong University; Nantong University; Nantong University; ShanghaiTech University	Yu, B (corresponding author), Nantong Univ, Affiliated Hosp, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.; Yu, B (corresponding author), Nantong Univ, Affiliated Hosp, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.; Yu, B (corresponding author), Nantong Univ, Affiliated Hosp, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong, Peoples R China.	yubin@ntu.edu.cn		Wang, Dong/0000-0001-9921-8058	National Major Project of Research and Development Grant [2017YFA0104701]; National Natural Science Foundation of China [81771326, 81901257]; Natural Science Foundation of Jiangsu Province [BK20180951]; Natural Science Fund for Colleges and Universities in Jiangsu Province [19KJB180025, 18KJB180022]; Jiangsu Provincial Key Medical Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Major Project of Research and Development Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Fund for Colleges and Universities in Jiangsu Province; Jiangsu Provincial Key Medical Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Major Project of Research and Development Grant 2017YFA0104701, National Natural Science Foundation of China Grants 81771326 and 81901257, Natural Science Foundation of Jiangsu Province Grant BK20180951, Natural Science Fund for Colleges and Universities in Jiangsu Province Grants 19KJB180025 and 18KJB180022, and the Jiangsu Provincial Key Medical Center and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Afshari FT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001288; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Bareyre FM, 2011, P NATL ACAD SCI USA, V108, P6282, DOI 10.1073/pnas.1015239108; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bunch H, 2018, MOL GENET GENOMICS, V293, P1, DOI 10.1007/s00438-017-1370-9; Chen ZQ, 2019, CANCER SCI, V110, P568, DOI 10.1111/cas.13901; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Cohen JE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0509; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fagoe ND, 2015, HUM MOL GENET, V24, P6788, DOI 10.1093/hmg/ddv383; Gong LL, 2016, BIOCHEM BIOPH RES CO, V478, P206, DOI 10.1016/j.bbrc.2016.07.067; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Jankowski MP, 2009, BRAIN RES, V1256, P43, DOI 10.1016/j.brainres.2008.12.032; Kleaveland B, 2018, CELL, V174, P350, DOI 10.1016/j.cell.2018.05.022; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Long B, 2013, FREE RADICAL BIO MED, V65, P371, DOI 10.1016/j.freeradbiomed.2013.07.009; Luo Q, 2016, CLIN INTERV AGING, V11, P867, DOI 10.2147/CIA.S107037; Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8; Mar FM, 2014, EMBO REP, V15, P254, DOI 10.1002/embr.201337723; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Perry RB, 2018, MOL CELL, V72, P553, DOI 10.1016/j.molcel.2018.09.021; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Reitz MC, 2016, PAIN, V157, P1248, DOI 10.1097/j.pain.0000000000000515; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Teotia P, 2017, STEM CELLS, V35, P2239, DOI 10.1002/stem.2675; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Wu SG, 2016, MOL PAIN, V12, DOI 10.1177/1744806916629048; Yao C, 2018, J NEUROSCI, V38, P6574, DOI 10.1523/JNEUROSCI.3790-16.2018; Yao C, 2015, EUR J NEUROSCI, V42, P1718, DOI 10.1111/ejn.12966; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Zhao XL, 2013, NAT NEUROSCI, V16, P1024, DOI 10.1038/nn.3438	44	18	19	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8374	8386		10.1074/jbc.RA119.011917	http://dx.doi.org/10.1074/jbc.RA119.011917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32336677	Green Published, hybrid			2022-12-26	WOS:000546986500003
J	Liu, LY; Yudin, Y; Rohacs, T				Liu, Luyu; Yudin, Yevgen; Rohacs, Tibor			Diacylglycerol kinases regulate TRPV1 channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential channels (TRP channels); dorsal root ganglia; diacylglycerol; calcium; phosphoinositide; PKC; DAGK; TRPV1	ACTIVATED ION-CHANNEL; CAPSAICIN RECEPTOR; PKC-EPSILON; PHOSPHOINOSITIDES; PHOSPHORYLATION; INHIBITION; PAIN; DESENSITIZATION; SENSITIZATION; MECHANISM	The transient receptor potential vanilloid 1 (TRPV1) channel is activated by heat and by capsaicin, the pungent compound in chili peppers. Calcium influx through TRPV1 has been shown to activate a calcium-sensitive phospholipase C (PLC) enzyme and to lead to a robust decrease in phosphatidylinositol 4,5-bisphosphate [PI(4,5)P-2] levels, which is a major contributor to channel desensitization. Diacylglycerol (DAG), the product of the PLC-catalyzed PI(4,5)P(2)hydrolysis, activates protein kinase C (PKC). PKC is known to potentiate TRPV1 activity during activation of G protein?coupled receptors, but it is not known whether DAG modulates TRPV1 during desensitization. We found here that inhibition of diacylglycerol kinase (DAGK) enzymes reduces desensitization of native TRPV1 in dorsal root ganglion neurons as well as of recombinant TRPV1 expressed in HEK293 cells. The effect of DAGK inhibition was eliminated by mutating two PKC-targeted phosphorylation sites, Ser-502 and Ser-800, indicating involvement of PKC. TRPV1 activation induced only a small and transient increase in DAG levels, unlike the robust and more sustained increase induced by muscarinic receptor activation. DAGK inhibition substantially increased the DAG signal evoked by TRPV1 activation but not that evoked by M1 muscarinic receptor activation. Our results show that Ca(2+)influx through TRPV1 activates PLC and DAGK enzymes and that the latter limits formation of DAG and negatively regulates TRPV1 channel activity. Our findings uncover a role of DAGK in ion channel regulation.	[Liu, Luyu; Yudin, Yevgen; Rohacs, Tibor] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rohacs, T (corresponding author), Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA.	tibor.rohacs@rutgers.edu		Rohacs, Tibor/0000-0003-3580-2575	NINDS, National Institutes of Health [NS055159]; NIGMS, National Institutes of Health [GM131048, GM093290]	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NINDS, National Institutes of Health Grants NS055159 and NIGMS, National Institutes of Health Grants GM131048 and GM093290 (to T. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldanzi G, 2010, CELL DEATH DIFFER, V17, P1059, DOI 10.1038/cdd.2009.210; Borbiro I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005667; Boroda S, 2017, BIOCHEM PHARMACOL, V123, P29, DOI 10.1016/j.bcp.2016.10.011; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Epand RM, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00112; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Joseph J, 2019, J NEUROSCI, V39, P9954, DOI 10.1523/JNEUROSCI.1064-19.2019; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Koplas PA, 1997, J NEUROSCI, V17, P3525; LEE MW, 1994, AM J PHYSIOL, V267, pC659, DOI 10.1152/ajpcell.1994.267.3.C659; Liu LY, 2019, J NEUROSCI, V39, P6067, DOI 10.1523/JNEUROSCI.2304-18.2019; Liu XL, 2017, BRIT J PHARMACOL, V174, P4464, DOI 10.1111/bph.14049; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J NEUROSCI, V33, P11451, DOI 10.1523/JNEUROSCI.5637-12.2013; Lung M, 2009, J BIOL CHEM, V284, P31062, DOI 10.1074/jbc.M109.050617; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Ogasawara D, 2016, P NATL ACAD SCI USA, V113, P26, DOI 10.1073/pnas.1522364112; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Sato M, 2013, PHARMACOLOGY, V92, P99, DOI 10.1159/000351849; Shirai Y, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-28; Suh BC, 2006, PFLUG ARCH EUR J PHY, V453, P293, DOI 10.1007/s00424-006-0092-3; Tewson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042791; Tewson PH, 2013, J BIOMOL SCREEN, V18, P797, DOI 10.1177/1087057113485427; Thams P, 1997, BIOCHEM PHARMACOL, V53, P1077, DOI 10.1016/S0006-2952(96)00813-1; Thirugnanam S, 2001, BIOCHEMISTRY-US, V40, P10607, DOI 10.1021/bi010609s; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Tu-Sekine Becky, 2015, Adv Biol Regul, V57, P147, DOI 10.1016/j.jbior.2014.09.010; Tu-Sekine Becky, 2013, Advances in Biological Regulation, V53, P118, DOI 10.1016/j.jbior.2012.09.007; WALSH JP, 1995, J BIOL CHEM, V270, P28647, DOI 10.1074/jbc.270.48.28647; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	36	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8174	8185		10.1074/jbc.RA119.012505	http://dx.doi.org/10.1074/jbc.RA119.012505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32345612	Green Published, hybrid			2022-12-26	WOS:000542965700006
J	Altegoer, F; Weiland, P; Giammarinaro, PI; Freibert, SA; Binnebesel, L; Han, XW; Lepak, A; Kahmann, R; Lechner, M; Bange, G				Altegoer, Florian; Weiland, Paul; Giammarinaro, Pietro Ivan; Freibert, Sven-Andreas; Binnebesel, Lynn; Han, Xiaowei; Lepak, Alexander; Kahmann, Regine; Lechner, Marcus; Bange, Gert			The two paralogous kiwellin proteins KWL1 and KWL1-b from maize are structurally related and have overlapping functions in plant defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; structure-function; plant defense; fungi; carbohydrate-binding protein; chorismate mutase; KWL1-b; salicylic acid pathway; Ustilago maydis; Zea mays	PSI-BETA-BARREL; USTILAGO-MAYDIS; HUMICOLA INSOLENS; ENDOGLUCANASE V; EFFECTORS; HOST	Many plant-pathogenic bacteria and fungi deploy effector proteins that down-regulate plant defense responses and reprogram plant metabolism for colonization and survival in planta. Kiwellin (KWL) proteins are a widespread family of plant-defense proteins that target these microbial effectors. The KWL1 protein from maize (corn, Zea mays) specifically inhibits the enzymatic activity of the secreted chorismate mutase Cmu1, a virulence-promoting effector of the smut fungus Ustilago maydis. In addition to KWL1, 19 additional KWL paralogs have been identified in maize. Here, we investigated the structure and mechanism of the closest KWL1 homolog, KWL1-b (ZEAMA_GRMZM2G305329). We solved the Cmu1?KWL1-b complex to 2.75 ? resolution, revealing a highly symmetric Cmu1?KWL1-b heterotetramer in which each KWL1-b monomer interacts with a monomer of the Cmu1 homodimer. The structure also revealed that the overall architecture of the heterotetramer is highly similar to that of the previously reported Cmu1?KWL1 complex. We found that upon U. maydis infection of Z. mays, KWL1-b is expressed at significantly lower levels than KWL1 and exhibits differential tissue-specific expression patterns. We also show that KWL1-b inhibits Cmu1 activity similarly to KWL1. We conclude that KWL1 and KWL1-b are part of a redundant defense system that tissue-specifically targets Cmu1. This notion was supported by the observation that both KWL proteins are carbohydrate-binding proteins with distinct and likely tissue-related specificities. Moreover, binding by Cmu1 modulated the carbohydrate-binding properties of both KWLs. These findings indicate that KWL proteins are part of a spatiotemporally coordinated, plant-wide defense response comprising proteins with overlapping activities.	[Altegoer, Florian; Weiland, Paul; Giammarinaro, Pietro Ivan; Binnebesel, Lynn; Lepak, Alexander; Lechner, Marcus; Bange, Gert] Philipps Univ Marburg, SYNMIKRO Res Ctr, Marburg, Germany; [Altegoer, Florian; Weiland, Paul; Giammarinaro, Pietro Ivan; Binnebesel, Lynn; Lepak, Alexander; Lechner, Marcus; Bange, Gert] Philipps Univ Marburg, Dept Chem, Marburg, Germany; [Freibert, Sven-Andreas] Philipps Univ Marburg, Inst Cytobiol & Cytopathol, Marburg, Germany; [Han, Xiaowei; Kahmann, Regine] Max Planck Inst Terr Microbiol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Max Planck Society	Altegoer, F; Bange, G (corresponding author), Philipps Univ Marburg, SYNMIKRO Res Ctr, Marburg, Germany.; Altegoer, F; Bange, G (corresponding author), Philipps Univ Marburg, Dept Chem, Marburg, Germany.	florian.altegoer@synmikro.uni-marburg.de; gert.bange@synmikro.uni-marburg.de	Bange, Gert/AAB-3734-2021; Han, Xiaowei/AAB-7913-2022; Kahmann, Regine/AAS-1230-2021	Han, Xiaowei/0000-0002-1333-4312; Lepak, Alexander/0000-0001-8230-0004; Bange, Gert/0000-0002-7826-0932; Giammarinaro, Pietro Ivan/0000-0002-0356-8481; Weiland, Paul/0000-0003-3175-8271; Altegoer, Florian/0000-0002-6012-9047	Peter und Traudl Engelhorn Foundation; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 987]	Peter und Traudl Engelhorn Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Peter und Traudl Engelhorn Foundation (to F. A.) and the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 987 (to G. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bange Gert, 2019, Commun Integr Biol, V12, P31, DOI 10.1080/19420889.2019.1586049; Bowler MW, 2015, J SYNCHROTRON RADIAT, V22, P1540, DOI 10.1107/S1600577515016604; Castillo RM, 1999, STRUCTURE, V7, P227, DOI 10.1016/S0969-2126(99)80028-8; Davies GJ, 1996, ACTA CRYSTALLOGR D, V52, P7, DOI 10.1107/S0907444995009280; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Hamiaux C, 2014, J STRUCT BIOL, V187, P276, DOI 10.1016/j.jsb.2014.07.005; Han XW, 2019, NATURE, V565, P650, DOI 10.1038/s41586-018-0857-9; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lanver D, 2017, NAT REV MICROBIOL, V15, P409, DOI 10.1038/nrmicro.2017.33; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matei A, 2018, NEW PHYTOL, V217, P1681, DOI 10.1111/nph.14960; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Pazzagli L, 2014, PLANT SCI, V228, P79, DOI 10.1016/j.plantsci.2014.02.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schilling L, 2014, MOL PLANT PATHOL, V15, P780, DOI 10.1111/mpp.12133; Schrodinger L. L. C., 2015, JYMOL MOL GRAPHICS D; Schuhmacher JS, 2015, P NATL ACAD SCI USA, V112, P3092, DOI 10.1073/pnas.1419388112; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; Tamburrini M, 2005, PROTEIN J, V24, P423, DOI 10.1007/s10930-005-7638-7; Villajuana-Bonequi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46734-3; Walbot V, 2010, SEX PLANT REPROD, V23, P1, DOI 10.1007/s00497-009-0109-0; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6	34	2	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7816	7825		10.1074/jbc.RA119.012207	http://dx.doi.org/10.1074/jbc.RA119.012207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350112	Green Published, hybrid			2022-12-26	WOS:000540935400001
J	Melo, DCM; Lira, SMA; Moreira, APB; Freitas, L; Lima, CAD; Thompson, F; Bertrand, A; Silva, AC; Neumann-Leitao, S				Melo, Danielle C. M.; Lira, Simone M. A.; Moreira, Ana Paula B.; Freitas, Lucas; Lima, Camilla A. D.; Thompson, Fabiano; Bertrand, Arnaud; Silva, Alex C.; Neumann-Leitao, Sigrid			Y Genetic diversity and connectivity of Flaccisagitta enflata (Chaetognatha: Sagittidae) in the tropical Atlantic ocean (northeastern Brazil)	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; PELAGIC CHAETOGNATH; GLOBAL PHYLOGEOGRAPHY; ACARTIA-TONSA; COPEPOD; MARINE; MESOZOOPLANKTON; DIFFERENTIATION; HETEROGENEITY	The phylogeography of the holoplanktonic chaetognath Flaccisagitta enflata was investigated in the Tropical Western Atlantic (TWA). Considering the cosmopolitan range of this species and the fact that its entire life cycle is planktonic, the central hypothesis of this study is that F. enflata exhibits connectivity due to its high dispersal capacity, forming a panmictic population among the study sites. The evaluated areas included neritic (Port of Recife-PR, and Tamandare - TA) and oceanic (Fernando de Noronha Archipelago-FN, Rocas Atoll-RA, Guara seamount-GS and Saint Peter and Saint Paul's Archipelago-SPSPA) locations of the Brazilian Blue Amazon. We used COI gene sequences as molecular marker. Partial sequences (425 bp) were obtained for 116 specimens and employed to reconstruct the phylogeny, build an haplotype network, evaluate gene flow through a migration model, and estimate diversity indices, population structuring and demographic history. High levels of haplotype diversity (mean: 0.98) and moderate to high levels of nucleotide diversity (mean: 0.023) were observed. The phylogeny and the haplotype network topologies showed some geographic clustering, indicating local structuring in GS and PR. This finding was supported by the AMOVA high global phi st (0.033, significant) and some pairwise phi st comparisons (7 out of 15 were significantly > 0). Significant differences suggested lower levels of connectivity when GS population was compared to those of FN and SPSPA; as well as when TA was compared to FN. These results might be related to particularities of the oceanic dynamics which rules the TWA, sustaining such dissimilarities. Structuring was also observed between PR and all oceanic locations. We hypothesize that the topography of the port inlet, enclosured by a reef barrier, may constrain the water turnover ratio and thus migration rates of F. enflata in the TWA. Accordingly, Migrate-N yielded a four metapopulations model (PR (sic) TA (sic) SPSPA+FN (sic) GS+RA) as the best (highest probability; similar to 0.90) to represent the structuring of F. enflata in the TWA. Therefore, the null hypothesis of one randomly mating population cannot be accepted. The demographic evaluation demonstrated that the neutral hypothesis of stable populations may not be rejected for most of the locations. This work is the start point to broaden the knowledge on the phylogeography and population genetic structure of a numerically dominant species in the Western Atlantic, with key role in the marine trophic web.	[Melo, Danielle C. M.; Lira, Simone M. A.; Lima, Camilla A. D.; Bertrand, Arnaud; Silva, Alex C.; Neumann-Leitao, Sigrid] Univ Fed Pernambuco, Dept Oceanog, Recife, PE, Brazil; [Lira, Simone M. A.] Univ Fed Rural Pernambuco, Programa Posgrad Ecol, Recife, PE, Brazil; [Moreira, Ana Paula B.; Thompson, Fabiano] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Freitas, Lucas] Univ Estadual Campinas, Dept Genet Evolucao Microbiol & Imunol, Sao Paulo, Brazil; [Thompson, Fabiano] Ctr Gestao Tecnol CT2, SAGE COPPE, Rio De Janeiro, Brazil; [Bertrand, Arnaud] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Bertrand, Arnaud] Univ Montpellier, Inst Rech Dev IRD, MARBEC, CNRS,Ifremer,IRD, Sete, France	Universidade Federal de Pernambuco; Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal do Rio de Janeiro; Universidade Estadual de Campinas; Universidade Federal Rural de Pernambuco (UFRPE); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Melo, DCM (corresponding author), Univ Fed Pernambuco, Dept Oceanog, Recife, PE, Brazil.	melo.danielle@yahoo.com	Bertrand, Arnaud/E-4251-2010; Moreira, Ana Paula B./ABE-5912-2020; Moreira, Ana Paula B./J-8442-2013; Freitas, Lucas/S-2923-2016	Bertrand, Arnaud/0000-0003-4723-179X; Moreira, Ana Paula B./0000-0001-9757-1317; Moreira, Ana Paula B./0000-0001-9757-1317; Thompson, Fabiano/0000-0002-7562-1683; Costa da Silva, Alex/0000-0002-5828-3598; Melo, Danielle/0000-0003-2682-190X; Freitas, Lucas/0000-0002-8766-0890; Lira, Simone/0000-0003-1751-3526	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Doctoral scholarship (DCMM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Project: Plankton community in the Saint Peter and Saint Paul Archipelago and its association with physical mechanisms: vertical distribution of diversity and productivity [405499/20124]; Institution: Universidade Federal de Pernambuco; Departamento de Oceanografia; "Acoustics along the Brazilian Coast 2" (ABRACOS 2); "Acoustics along the Brazilian Coast 2" (ABRACOS 2). Institution: French Oceanographic Fleet; Departamento de Pesca e Aquicultura, Universidade Federal Rural de Pernambuco; Institut de Recherche pour le Developpement, Universite Montpellier, France	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Doctoral scholarship (DCMM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Project: Plankton community in the Saint Peter and Saint Paul Archipelago and its association with physical mechanisms: vertical distribution of diversity and productivity(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institution: Universidade Federal de Pernambuco; Departamento de Oceanografia; "Acoustics along the Brazilian Coast 2" (ABRACOS 2); "Acoustics along the Brazilian Coast 2" (ABRACOS 2). Institution: French Oceanographic Fleet; Departamento de Pesca e Aquicultura, Universidade Federal Rural de Pernambuco; Institut de Recherche pour le Developpement, Universite Montpellier, France	This study is supported by: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Doctoral scholarship (DCMM) and research grant to APBM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Project: Plankton community in the Saint Peter and Saint Paul Archipelago and its association with physical mechanisms: vertical distribution of diversity and productivity (Process 405499/20124). Institution: Universidade Federal de Pernambuco; Departamento de Oceanografia to SNL; "Acoustics along the Brazilian Coast 2" (ABRACOS 2). Institution: French Oceanographic Fleet -DOI: 10.17600/17004100 to APAB -Institut de Recherche pour le Developpement, Universite Montpellier, France; and Departamento de Pesca e Aquicultura, Universidade Federal Rural de Pernambuco; and Institut de Recherche pour le Developpement, Universite Montpellier, France; and Departamento de Pesca e Aquicultura, Universidade Federal Rural de Pernambuco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2006, POPULATION GENETICS; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Barbosa AD, 2009, GEOAMBIENTE ON-LINE, P106; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Becker H., 2001, THESIS; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bone Q, 1991, BIOL CHAETOGNATHS; Bourles B, 1999, J GEOPHYS RES-OCEANS, V104, P1361, DOI 10.1029/1998JC900025; Bucklin A, 1996, J MAR RES, V54, P285, DOI 10.1357/0022240963213385; Bucklin A, 2000, J PLANKTON RES, V22, P1237, DOI 10.1093/plankt/22.7.1237; Casanova Jean-Paul, 1999, P1353; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Cordeiro IA, 2016, TROP OCEANOGR, V42, P1; Costa KG, 2014, J PLANKTON RES, V36, P1419, DOI 10.1093/plankt/fbu080; Crandall ED, 2019, GLOBAL ECOL BIOGEOGR, V28, P943, DOI 10.1111/geb.12905; Crandall ED, 2019, EVOL APPL, V12, P255, DOI 10.1111/eva.12712; Daponte MC, 2004, ICES J MAR SCI, V61, P680, DOI 10.1016/j.icesjms.2004.03.006; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; De Souza AS, 2015, AN ACAD BRAS CIENC, V87, P121, DOI 10.1590/0001-3765201520130411; De Souza CS, 2014, AN ACAD BRAS CIENC, V86, P1151, DOI 10.1590/0001-3765201420130101; Eberl R, 2007, AQUAT BIOL, V1, P33, DOI 10.3354/ab00002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS A, 1983, J ZOOL, V200, P51; Ekau W, 1999, ARCH FISH MAR RES, V47, P113; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farhadi A, 2013, ICES J MAR SCI, V70, P1491, DOI 10.1093/icesjms/fst097; Fernandez MV, 2013, J SEA RES, V76, P146, DOI 10.1016/j.seares.2012.08.004; Ferreira BP, 2006, MONITORAMENTO RECIFE; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gasmi S, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0084-7; Giesecke R, 2008, ICES J MAR SCI, V65, P361, DOI 10.1093/icesjms/fsn030; Rudorff CAG, 2009, BRAZ J OCEANOGR, V57, P7, DOI 10.1590/S1679-87592009000100002; Goetze E, 2005, EVOLUTION, V59, P2378; Good SA, 2013, J GEOPHYS RES-OCEANS, V118, P6704, DOI 10.1002/2013JC009067; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamilton M.B., 2009, POPULATION GENETICS; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Jennings RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009949; Endo CAK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45042-0; Kirby RR, 2007, J PLANKTON RES, V29, P97, DOI 10.1093/plankt/fb1074; Kulagin DN, 2014, HYDROBIOLOGIA, V721, P197, DOI 10.1007/s10750-013-1661-z; Kulagin DN, 2017, ICES J MAR SCI; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Leite TS, 2008, J MOLLUS STUD, V74, P63, DOI 10.1093/mollus/eym050; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mabesoonde JM, 1970, TRABALHOS OCEANOGRAF, V12, P1, DOI DOI 10.5914/TROPOCEAN.V12I1.2545; Madec G, 1996, CLIM DYNAM, V12, P381, DOI 10.1007/BF00211684; Maier-Reimer E, 1990, PALEOCEANOGRAPHY, V5, P349, DOI 10.1029/PA005i003p00349; Matus DQ, 2007, INTEGR COMP BIOL, V47, P854, DOI 10.1093/icb/icm077; Miyamoto H, 2012, PROG OCEANOGR, V104, P99, DOI 10.1016/j.pocean.2012.06.003; Miyamoto H, 2010, DEEP-SEA RES PT II, V57, P2211, DOI 10.1016/j.dsr2.2010.09.023; Moreira APB, 2014, CURR MICROBIOL, V68, P38, DOI 10.1007/s00284-013-0435-1; Nei M, 2000, MOL EVOLUTION PHYLOG; Neumann-Leitao S, 1999, ARCH FISH MAR RES, V47, P153; Neumann-Leitao S, 2008, J PLANKTON RES, V30, P795, DOI 10.1093/plankt/fbn040; Noblezada MM, 2017, J MAR BIOL ASSOC UK, V97, P129, DOI 10.1017/S0025315416000163; Norris RD, 2000, NATURE, V405, P23, DOI 10.1038/35011162; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Oke PR, 2015, J OPER OCEANOGR, V8, pS49, DOI 10.1080/1755876X.2015.1022067; Otsuka AY, 2018, BRAZ J OCEANOGR, V66, P91, DOI [10.1590/S1679-87592018149106601, 10.1590/s1679-87592018149106601]; Ozawa Miho, 2007, Plankton & Benthos Research, V2, P184, DOI 10.3800/pbr.2.184; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Papetti C, 2005, MAR ECOL PROG SER, V289, P225, DOI 10.3354/meps289225; Papillon D, 2006, MOL PHYLOGENET EVOL, V38, P621, DOI 10.1016/j.ympev.2005.12.004; Paranagua MN, 1990, TROP OCEANOGR, V21; PEARRE S, 1980, MAR ECOL PROG SER, V3, P125, DOI 10.3354/meps003125; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Questel JM, 2016, J PLANKTON RES, V38, P610, DOI 10.1093/plankt/fbw025; REEVE MR, 1970, NATURE, V227, P381, DOI 10.1038/227381a0; Rodriguez-Rey GT, 2016, J EXP MAR BIOL ECOL, V474, P204, DOI 10.1016/j.jembe.2015.10.016; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Serafini TZ, 2010, J INTEG COAST ZONE M, V10; STRAMMA L, 1991, J MAR RES, V49, P281, DOI 10.1357/002224091784995864; Stramma L, 1999, DEEP-SEA RES PT II, V46, P279, DOI 10.1016/S0967-0645(98)00109-X; TAJIMA F, 1989, GENETICS, V123, P585; Terazaki M, 1996, J PLANKTON RES, V18, P673, DOI 10.1093/plankt/18.5.673; Teschima MM, 2016, MAR ECOL-EVOL PERSP, V37, P1360, DOI 10.1111/maec.12347; Vannier J, 2007, P ROY SOC B-BIOL SCI, V274, P627, DOI 10.1098/rspb.2006.3761; Vannucci M, 1952, B I OCEANOGR, V3; Vega-Perez LA, 2011, CHECKLIST FILO CHAET, V11, P1; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323	97	1	1	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0231574	10.1371/journal.pone.0231574	http://dx.doi.org/10.1371/journal.pone.0231574			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374742	Green Published, Green Submitted, gold			2022-12-26	WOS:000537283500009
J	Wood, DA; Rose, JP; Halstead, BJ; Stoelting, RE; Swaim, KE; Vandergast, AG				Wood, Dustin A.; Rose, Jonathan P.; Halstead, Brian J.; Stoelting, Ricka E.; Swaim, Karen E.; Vandergast, Amy G.			Combining genetic and demographic monitoring better informs conservation of an endangered urban snake	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SAN-FRANCISCO GARTERSNAKE; THAMNOPHIS-SIRTALIS; R-PACKAGE; SOFTWARE; RECOMMENDATIONS; EXTINCTION; EVOLUTION; INFERENCE; CLUSTERS	Conversion and fragmentation of wildlife habitat often leads to smaller and isolated populations and can reduce a species' ability to disperse across the landscape. As a consequence, genetic drift can quickly lower genetic variation and increase vulnerability to extirpation. For species of conservation concern, quantification of population size and connectivity can clarify the influence of genetic drift in local populations and provides important information for conservation management and recovery strategies. Here, we used genome-wide single nucleotide polymorphism (SNP) data and capture-mark-recapture methods to evaluate the genetic diversity and demography within seven focal sites of the endangered San Francisco gartersnake (Thamnophis sirtalis tetrataenia), a species affected by alteration and isolation of wetland habitats throughout its distribution. The primary goals were to determine the population structure and degree of genetic isolation among T. s. tetrataenia populations and estimate effective size and population abundance within sites to better understand the present and future importance of genetic drift. We also used temporally sampled datasets to examine the magnitude of genetic change over time. We found moderate population genetic structure throughout the San Francisco Peninsula that partitions sites into northern and southern regional clusters. Point estimates of both effective size and population abundance were generally small (<= 100) for a majority of the sites, and estimates were particularly low in the northern populations. Genetic analyses of temporal datasets indicated an increase in genetic differentiation, especially for the most geographically isolated sites, and decreased genetic diversity over time in at least one site (Pacifica). Our results suggest that drift-mediated processes as a functiyon of small population size and reduced connectivity from neighboring populations may decrease diversity and increase differentiation. Improving genetic diversity and connectivity among T. s. tetrataenia populations could promote persistence of this endangered snake.	[Wood, Dustin A.; Vandergast, Amy G.] US Geol Survey, San Diego Field Stn, Western Ecol Res Ctr, San Diego, CA 92101 USA; [Rose, Jonathan P.] US Geol Survey, San Diego Field Stn, Western Ecol Res Ctr, Santa Cruz, CA USA; [Halstead, Brian J.] US Geol Survey, Western Ecol Res Ctr, Dixon Field Stn, Dixon, CA USA; [Stoelting, Ricka E.; Swaim, Karen E.] Swaim Biol Inc, Livermore, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Wood, DA (corresponding author), US Geol Survey, San Diego Field Stn, Western Ecol Res Ctr, San Diego, CA 92101 USA.	dawood@usgs.gov		Wood, Dustin/0000-0002-7668-9911	U.S. Geological Survey; Western Ecological Research Center and Ecosystems Mission Area; U.S. Fish and Wildlife Service, Sacramento Fish and Wildlife Office	U.S. Geological Survey(United States Geological Survey); Western Ecological Research Center and Ecosystems Mission Area; U.S. Fish and Wildlife Service, Sacramento Fish and Wildlife Office	Funding for this project was provided by U.S. Geological Survey, Western Ecological Research Center and Ecosystems Mission Area and U.S. Fish and Wildlife Service, Sacramento Fish and Wildlife Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barry SJ, 1996, SOME ECOLOGICAL SOCI, P1; Barry SJ, 1994, THESIS; Bradke DR, 2018, J HERPETOL, V52, P387, DOI 10.1670/18-026; Brown GP, 2005, CAN J ZOOL, V83, P1134, DOI 10.1139/Z05-115; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Davies KF, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P81; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Denwood MJ, 2016, J STAT SOFTW, V71, P1, DOI 10.18637/jss.v071.i09; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Doak DF, 2015, BIOSCIENCE, V65, P189, DOI 10.1093/biosci/biu215; Elgar MA, 2001, CONSERV BIOL, V15, P284, DOI 10.1046/j.1523-1739.2001.00072.x; Ellegren H, 2016, NAT REV GENET, V17, P422, DOI 10.1038/nrg.2016.58; ESRI, 2018, ARCGIS DESKT VERS 10; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fitzpatrick SW, 2016, EVOL APPL, V9, P879, DOI 10.1111/eva.12356; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Folt B, 2020, ANIM CONSERV, V23, P273, DOI 10.1111/acv.12537; FOX W, 1951, COPEIA, P257; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Frankham R, 2017, GENETIC MANAGEMENT OF FRAGMENTED ANIMAL AND PLANT POPULATIONS, P1; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Goal Project, 1999, REPORT HABITAT RECOM; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Halstead BJ, 2019, J WILDLIFE MANAGE, V83, P231, DOI 10.1002/jwmg.21585; Halstead BJ, 2011, J FISH WILDL MANAG, V2, P41, DOI 10.3996/012011-JFWM-009; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; Jennings MR, AMPHIBIAN REPTILE SP; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones AT, 2016, HEREDITY, V117, P217, DOI 10.1038/hdy.2016.19; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2016, APPL HIERARCHICAL MO, V1; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Kim R, 20181063 US GEOL SUR, DOI [10.3133/ofr20181063, DOI 10.3133/OFR20181063]; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lim T., 2004, THESIS; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Mace Georgina M., 1992, V64, P123; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Madsen T, 2004, BIOL CONSERV, V120, P145, DOI 10.1016/j.biocon.2004.01.022; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; MANTEL N, 1967, CANCER RES, V27, P209; McGinnis SM, 1984, CURRENT DISTRIBUTION; McGinnis SM, 1987, DISTRIBUTION FEEDING; McGowan PJK, 2017, CONSERV LETT, V10, P361, DOI 10.1111/conl.12285; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Miles LS, 2019, MOL ECOL, V28, P4138, DOI 10.1111/mec.15221; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; Nunziata SO, 2018, HEREDITY, V120, P196, DOI 10.1038/s41437-017-0037-y; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Philip Williams and Associates Ltd. Laguna Salada resource enhancement plan, 1992, PREP CIT SAN FRANC S, P67; Piry S, 2006, METHODS ECOLOGY EVOL, V7, P1463; Plummer M., 2003, P 3 INT WORKSH DISTR; Pritchard JK, 2000, GENETICS, V155, P945; R Code Development Team, 2019, R LANG ENV STAT COMP; RALLS K, 1986, TRENDS ECOL EVOL, V1, P19, DOI 10.1016/0169-5347(86)90062-5; Rambaut A., TRACER V1 6 MOL EVOL; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reeder NMM, 2015, ENDANGER SPECIES RES, V28, P77, DOI 10.3354/esr00677; Rochette NC, 2017, NATURE PROTOCOLS, V12, P2460; Royle JA, 2007, J COMPUT GRAPH STAT, V16, P67, DOI 10.1198/106186007X181425; Shine R, 2001, COPEIA, P82; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Swaim Biological Inc, 2009, SHARP PARK CONC REST; Thomas JH., 1961, FLORA SANTA CRUZ MOU; Thomson R.C., 2016, CALIFORNIA AMPHIBIAN; U.S. Fish and Wildlife Service, 2006, SAN FRANC GART SNAK; U.S. Fish and Wildlife Service, 2013, REC PLAN TID MARSH E, P77; U.S. Fish and Wildlife Service, 1985, REC PLAN SAN FRANC G; USFWS (U. S. Fish and Wildlife Service), 1967, FED REGISTER, V32, P4001; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1339; Weeks AR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01182-3; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; West-Eberhard Mary Jane, 2003, pi; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Willis K, 2010, ZOO BIOL, V29, P638, DOI 10.1002/zoo.20310; Winne Christopher T., 2006, Herpetological Review, V37, P52; Wright S, 1931, GENETICS, V16, P0097; Zinke. P., 1988, TERRESTRIAL VEGETATI, P679	96	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0231744	10.1371/journal.pone.0231744	http://dx.doi.org/10.1371/journal.pone.0231744			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369486	gold, Green Published			2022-12-26	WOS:000537280000008
J	Letzer, A; Lehmann, K; Mess, C; Konig, G; Obser, T; Peine, S; Schneppenheim, S; Budde, U; Schneider, SW; Schneppenheim, R; Brehm, MA				Letzer, Anton; Lehmann, Katja; Mess, Christian; Koenig, Gesa; Obser, Tobias; Peine, Sven; Schneppenheim, Sonja; Budde, Ulrich; Schneider, Stefan W.; Schneppenheim, Reinhard; Brehm, Maria A.			Upshaw-Schulman syndrome-associated ADAMTS13 variants possess proteolytic activity at the surface of endothelial cells and in simulated circulation	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; MOLECULAR CHARACTERIZATION; UREMIC-SYNDROME; GENE-MUTATIONS; SCISSILE BOND; SPACER DOMAIN; A2 DOMAIN; CLEAVAGE	ADAMTS13 regulates the hemostatic activity of von Willebrand factor (VWF). Determined by static assays, proteolytic activity < 10IU/dL in patient plasma, in absence of ADAMTS13 autoantibodies, indicates Upshaw-Schulman syndrome (USS); the congenital form of Thrombotic Thrombocytopenic Purpura (TTP). We have recently functionally characterized sixteen USS-associated ADAMTS13 missense variants under static conditions. Here, we used two assays under shear flow conditions to analyze the activity of those seven mutants with sufficiently high residual secretion plus two newly identified variants. One assay determines cleavage of VWF strings bound to the surface of endothelial cells. The other, light transmission aggregometry-based assay, mimics degradation of VWF-platelet complexes, which are likely to be present in the circulation during TTP bouts. We found that 100 ng/ml of all variants were able to cleave about 80-90% of VWF strings even though 5 out of 9 exhibited activity <= 1% in the state-of-the-art static assay at the same concentration. These data indicate underestimation of ADAMTS13 activity by the used static assay. In simulated circulation, two variants, with missense mutations in the vicinity of the catalytic domain, exhibited only minor residual activity while all other variants were able to effectively break down VWF-platelet complexes. In both assays, significant proteolytic activity could be observed down to 100 ng/ml ADAMTS13. It is thus intriguing to postulate that most variants would have ample activity if secretion of 10% of normal plasma levels could be achieved.	[Letzer, Anton; Lehmann, Katja; Koenig, Gesa; Obser, Tobias; Schneppenheim, Reinhard; Brehm, Maria A.] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Mess, Christian; Schneider, Stefan W.] Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany; [Peine, Sven] Univ Med Ctr Hamburg Eppendorf, Inst Transfus Med, Hamburg, Germany; [Schneppenheim, Sonja; Budde, Ulrich] MEDILYS Laborgesell mbH, Haemostaseol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Brehm, MA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany.	m.brehm@uke.de		Letzer, Anton/0000-0001-7446-2687; Brehm, Maria Alexandra/0000-0003-0416-8233	German Research Foundation (DFG) [FOR1543, SCHN325/7-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was financially supported by research funding from the German Research Foundation (DFG, https://www.dfg.de) to the Research Group FOR1543: "Shear flow regulation of hemostasis -bridging the gap between nanomechanics and clinical presentation" (grant recipient: RS, grant number: SCHN325/7-2). The Medilys Laborgesellschaft (https://www.medilys.de) provided support in the form of salaries for authors SS and UB. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Assink K, 2003, KIDNEY INT, V63, P1995, DOI 10.1046/j.1523-1755.63.6s.1.x; Brehm MA, 2014, THROMB HAEMOSTASIS, V112, P96, DOI 10.1160/TH13-11-0902; Camilleri RS, 2012, J THROMB HAEMOST, V10, P1792, DOI 10.1111/j.1538-7836.2012.04852.x; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Denorme F, 2016, BLOOD, V127, P2337, DOI 10.1182/blood-2015-08-662650; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Donadelli R, 2006, THROMB HAEMOSTASIS, V96, P454, DOI 10.1160/TH06-05-0236; Federici AB, 2007, HAEMOPHILIA, V13, P15, DOI 10.1111/j.1365-2516.2007.01573.x; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Fujimura Y, 2011, J THROMB HAEMOST, V9, P283, DOI 10.1111/j.1538-7836.2011.04341.x; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Hassenpflug WA, 2018, GENETIC FUNCTIONAL C; Hassenpflug WA, 2018, THROMB HAEMOSTASIS, V118, P709, DOI 10.1055/s-0038-1637749; Hassenpflug WA, 2014, SEMIN THROMB HEMOST, V40, P487, DOI 10.1055/s-0034-1376152; Hommais A, 2007, THROMB HAEMOSTASIS, V98, P593, DOI 10.1160/TH07-01-0059; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Jin SY, 2010, BLOOD, V115, P2300, DOI 10.1182/blood-2009-07-235101; Killick R, 2014, J STAT SOFTW, V58, P1; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Kraus E, 2014, THROMB RES, V134, P1285, DOI 10.1016/j.thromres.2014.08.013; Lammle B, 2005, J THROMB HAEMOST, V3, P1663, DOI 10.1111/j.1538-7836.2005.01425.x; Lancellotti S, 2016, THROMB HAEMOSTASIS, V115, P51, DOI 10.1160/TH15-02-0119; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Licht C, 2004, KIDNEY INT, V66, P955, DOI 10.1111/j.1523-1755.2004.00841.x; Manea M, 2007, BRIT J HAEMATOL, V138, P651, DOI 10.1111/j.1365-2141.2007.06694.x; Matsumoto M, 2004, BLOOD, V103, P1305, DOI 10.1182/blood-2003-06-1796; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Moatti-Cohen M, 2012, BLOOD, V119, P5888, DOI 10.1182/blood-2012-02-408914; Morgand M, 2014, TRANSFUSION, V54, P389, DOI 10.1111/trf.12263; Pimanda JE, 2004, BLOOD, V103, P627, DOI 10.1182/blood-2003-04-1346; Plaimauer B, 2006, BLOOD, V107, P118, DOI 10.1182/blood-2005-06-2482; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneppenheim R, 2003, BLOOD, V101, P1845, DOI 10.1182/blood-2002-08-2399; Schneppenheim R, 2006, THROMB HAEMOSTASIS, V96, P3, DOI 10.1160/TH05-12-0817; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; Scully M, 2017, J THROMB HAEMOST, V15, P312, DOI 10.1111/jth.13571; Scully M, 2014, BLOOD, V124, P211, DOI 10.1182/blood-2014-02-553131; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Skipwith CG, 2010, J BIOL CHEM, V285, P28596, DOI 10.1074/jbc.M110.131227; Soejima K, 2001, J BIOCHEM-TOKYO, V130, P475, DOI 10.1093/oxfordjournals.jbchem.a003009; South K, 2018, J THROMB HAEMOST, V16, P2289, DOI 10.1111/jth.14275; South K, 2018, J THROMB HAEMOST, V16, P6, DOI 10.1111/jth.13898; Team RC, LANG ENV STAT COMP; Uchida T, 2004, BLOOD, V104, P2081, DOI 10.1182/blood-2004-02-0715; Underwood M, 2016, THROMB RES, V147, P16, DOI 10.1016/j.thromres.2016.09.014; Veyradier A, 2004, J THROMB HAEMOST, V2, P424, DOI 10.1111/j.1538-7933.2004.00623.x; von Auer C, 2015, THROMB RES, V135, pS30, DOI 10.1016/S0049-3848(15)50437-4; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Zander CB, 2015, CURR OPIN HEMATOL, V22, P452, DOI 10.1097/MOH.0000000000000169	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232637	10.1371/journal.pone.0232637	http://dx.doi.org/10.1371/journal.pone.0232637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365113	gold, Green Published			2022-12-26	WOS:000536959700050
J	Niu, QL; Sun, H; Liu, C; Li, J; Liang, CX; Zhang, RR; Ge, FR; Liu, W				Niu, Qing-lin; Sun, Hui; Liu, Chao; Li, Juan; Liang, Chang-xu; Zhang, Rui-rui; Ge, Fu-rong; Liu, Wei			Croton tiglium essential oil compounds have anti-proliferative and pro-apoptotic effects in A549 lung cancer cell lines	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; CHEMICAL-COMPOSITION; ANTIOXIDANT; ANTIBACTERIAL; MECHANISMS; HALLMARKS; PATHWAY; GROWTH; RISK; FAK	As a traditional Chinese medicine, Croton tiglium has the characteristics of laxative, analgesic, antibacterial and swelling. This study aimed to analyze the chemical composition of C. tiglium essential oil (CTEO) extracted from the seeds of C. tiglium and its cytotoxicity and antitumor effect in vitro. Supercritical CO2 fluid extraction technology was used to extract CTEO and the chemical constituents of the essential oil were identified by comparing the retention indices and mass spectra data taken from the NIST library with those calculated based on the C7-C40 n-alkanes standard. In vitro cytotoxicity of the CTEO was assessed against cancer cell lines (A549) and the human normal bronchial epithelial cells (HBE) using the CCK-8 assay. Proliferation was detected by colony formation experiments. Wound scratch and cell invasion assays were used to detect cell migration and invasion. Levels of apoptotic markers, signaling molecules, and cell cycle regulators expression were characterized by Western blot analysis. As the results, twenty-eight compounds representing 92.39% of the total oil were identified in CTEO. The CTEO has significant antitumor activity on A549 cancer cells (IC50 48.38 mu g/mL). In vitro antitumor experiments showed that CTEO treatment significantly inhibited the proliferation and migration of A549 cells, disrupted the cell cycle process, and reduced the expression levels of cyclin A, cyclin B and CDK1. CTEO can also reduce mitochondrial membrane potential, activate caspase-dependent apoptosis pathway, and finally induce apoptosis. CTEO may become an effective anti-cancer drug and will be further developed for cancer treatment.	[Niu, Qing-lin; Ge, Fu-rong; Liu, Wei] Shandong Inst Pomol, Shandong Prov Key Lab Fruit Tree Biotechnol Breed, Tai An, Shandong, Peoples R China; [Sun, Hui; Liu, Chao; Zhang, Rui-rui] Shandong Acad Agr Sci, Key Lab Agroprod Proc Technol Shandong Prov, Key Lab Novel Food Resources Proc, Minist Agr & Rural Affairs,Inst Agrofood Sci & Te, Jinan, Shandong, Peoples R China; [Li, Juan] Taian Tradit Chinese Med Hosp, Tai An, Shandong, Peoples R China; [Liang, Chang-xu] Univ Jinan, Sch Water Conservancy & Environm, Jinan, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences; University of Jinan	Niu, QL (corresponding author), Shandong Inst Pomol, Shandong Prov Key Lab Fruit Tree Biotechnol Breed, Tai An, Shandong, Peoples R China.; Sun, H (corresponding author), Shandong Acad Agr Sci, Key Lab Agroprod Proc Technol Shandong Prov, Key Lab Novel Food Resources Proc, Minist Agr & Rural Affairs,Inst Agrofood Sci & Te, Jinan, Shandong, Peoples R China.	niuqinglin_sdau@163.com; sunhuiyinghua@126.com			Provincial Key Research and Development Program of Shandong, China [2018GNC110008, 2019GNC106016]; Provincial Natural Science Foundation of Shandong of China [ZR2016CB43]; Provincial Natural Science Foundation Key Project of Shandong, China [ZR2018ZC0944]	Provincial Key Research and Development Program of Shandong, China; Provincial Natural Science Foundation of Shandong of China; Provincial Natural Science Foundation Key Project of Shandong, China	this study was supported by the Provincial Key Research and Development Program of Shandong, China (NO. 2018GNC110008) and (NO. 2019GNC106016); the Provincial Natural Science Foundation of Shandong of China (NO. ZR2016CB43);the Provincial Natural Science Foundation Key Project of Shandong, China (NO. ZR2018ZC0944).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babahmad RA, 2018, IND CROP PROD, V121, P405, DOI 10.1016/j.indcrop.2018.05.030; BAUER R, 1983, PLANTA MED, V48, P10, DOI 10.1055/s-2007-969869; Cao MM, 2019, MOL MED REP, V19, P3941, DOI 10.3892/mmr.2019.10002; COLBURN NH, 1982, CANCER RES, V42, P3093; Corbin KS, 2013, J CLIN ONCOL, V31, P1384, DOI 10.1200/JCO.2012.45.9651; Gendy A. N. E., 2015, EGYPT IND CROP PROD, V67, P201, DOI [10.1016/j.indcrop.2015.01.038, DOI 10.1016/j.indcrop.2015.01.038]; Hainaut P, 2013, CURR OPIN ONCOL, V25, P50, DOI 10.1097/CCO.0b013e32835b651e; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harkat-Madouri L, 2015, IND CROP PROD, V78, P148, DOI 10.1016/j.indcrop.2015.10.015; HECKER E, 1981, J CANCER RES CLIN, V99, P103, DOI 10.1007/BF00412447; Hoffman RM, 2017, MED CLIN N AM, V101, P769, DOI 10.1016/j.mcna.2017.03.008; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kuhn B, 2018, BIOCHEM PHARMACOL, V155, P48, DOI 10.1016/j.bcp.2018.06.014; Lan Mei, 2012, Zhong Yao Cai, V35, P1105; Lee Buyean, 1994, Archives of Pharmacal Research (Seoul), V17, P304, DOI 10.1007/BF02974166; Lee SY, 2014, FOOD CONTROL, V42, P23, DOI 10.1016/j.foodcont.2014.01.030; Lee S, 2012, ONCOTARGET, V3, P1576; Liebich HM, 1998, J CHROMATOGR A, V795, P388, DOI 10.1016/S0021-9673(97)00972-2; Lu DF, 2015, INT J CLIN EXP MED, V8, P1904; Lv XT, 2018, CANCER MANAG RES, V10, P1377, DOI 10.2147/CMAR.S160818; MARSHALL GT, 1985, J CHEM ECOL, V11, P191, DOI 10.1007/BF00988202; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Murata J, 1999, Gan To Kagaku Ryoho, V26, P715; Prabhu KS, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00720; Qiu HX, 1996, FLORA REPUBLICAE POP; Rakmai J, 2018, IND CROP PROD, V111, P219, DOI 10.1016/j.indcrop.2017.10.027; Salatino A, 2007, J BRAZIL CHEM SOC, V18, P11, DOI 10.1590/S0103-50532007000100002; Schultze A, 2010, INVEST NEW DRUG, V28, P825, DOI 10.1007/s10637-009-9326-5; Scrima M, 2017, J CANCER, V8, P227, DOI 10.7150/jca.17093; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Sorber L, 2017, LUNG CANCER, V107, P100, DOI 10.1016/j.lungcan.2016.04.026; Sylvestre M, 2006, J ETHNOPHARMACOL, V103, P99, DOI 10.1016/j.jep.2005.07.011; Tian J, 2011, INT J FOOD MICROBIOL, V145, P464, DOI 10.1016/j.ijfoodmicro.2011.01.023; Tsai JC, 2004, BIOL PHARM BULL, V27, P162, DOI 10.1248/bpb.27.162; VANDUUREN BL, 1963, NATURE, V200, P1115, DOI 10.1038/2001115a0; Wang Y, 2018, LIFE SCI, V207, P532, DOI 10.1016/j.lfs.2018.06.035; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; YANG XH, 2007, J HAINAN U NAT SCI E, V25, P262; Zhang J, 2018, IND CROP PROD, V113, P19, DOI 10.1016/j.indcrop.2017.12.071	41	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0231437	10.1371/journal.pone.0231437	http://dx.doi.org/10.1371/journal.pone.0231437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357169	gold, Green Published			2022-12-26	WOS:000536957700007
J	Chow, JPH; Cai, YJ; Chow, DTL; Chung, SHK; Chau, KC; Ng, KY; Leung, OM; Wong, RMH; Law, AWL; Leung, YO; Kwok, SY; Leung, YC				Chow, Jeremy P. H.; Cai, Yijun; Chow, Daniel T. L.; Chung, Steven H. K.; Chau, Ka-Chun; Ng, Ka-Ying; Leung, Oscar M.; Wong, Raymond M. H.; Law, Alan W. L.; Leung, Yu-On; Kwok, Sui-Yi; Leung, Yun-chung			A modified arginine-depleting enzyme NEI-01 inhibits growth of pancreatic cancer cells	PLOS ONE			English	Article							ARGININOSUCCINATE SYNTHETASE; DEIMINASE; DEPRIVATION; THERAPY; DEATH; TRIAL	Arginine deprivation cancer therapy targets certain types of malignancies with positive result in many studies and clinical trials. NEI-01 was designed as a novel arginine-depleting enzyme comprising an albumin binding domain capable of binding to human serum albumin to lengthen its half-life. In the present work, NEI-01 is shown to bind to serum albumin from various species, including mice, rat and human. Single intraperitoneal administration of NEI-01 to mice reduced plasma arginine to undetectable level for at least 9 days. Treatment of NEI-01 specifically inhibited cell viability of MIA PaCa-2 and PANC-1 cancer cell lines, which were ASS1 negative. Using a human pancreatic mouse xenograft model, NEI-01 treatment significantly reduced tumor volume and weight. Our data provides proof of principle for a cancer treatment strategy using NEI-01.	[Chow, Jeremy P. H.; Cai, Yijun; Chow, Daniel T. L.; Chung, Steven H. K.; Chau, Ka-Chun; Ng, Ka-Ying; Leung, Oscar M.; Wong, Raymond M. H.; Law, Alan W. L.; Leung, Yu-On; Kwok, Sui-Yi] New Epsilon Innovat Ltd, Hong Kong, Peoples R China; [Leung, Yun-chung] Hong Kong Polytech Univ, State Key Lab Chem Biol & Drug Discovery, Dept Appl Biol & Chem Technol, Hong Kong, Peoples R China; [Leung, Yun-chung] Hong Kong Polytech Univ, Lo Ka Chung Res Ctr Nat Anticanc Drug Dev, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Chow, JPH; Kwok, SY (corresponding author), New Epsilon Innovat Ltd, Hong Kong, Peoples R China.; Leung, YC (corresponding author), Hong Kong Polytech Univ, State Key Lab Chem Biol & Drug Discovery, Dept Appl Biol & Chem Technol, Hong Kong, Peoples R China.; Leung, YC (corresponding author), Hong Kong Polytech Univ, Lo Ka Chung Res Ctr Nat Anticanc Drug Dev, Hong Kong, Peoples R China.	jeremy.chow@newbetainnovation.com; christine.kwok@newbetainnovation.com; bctleung@polyu.edu.hk		Chau, Ka-Chun/0000-0003-3388-6955				Alexandrou C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30591-7; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Bean GR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.232; Blum R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.38; Bobak Y, 2016, INT J BIOCHEM CELL B, V70, P29, DOI 10.1016/j.biocel.2015.10.027; Bowles TL, 2008, INT J CANCER, V123, P1950, DOI 10.1002/ijc.23723; BOYDE TRC, 1980, ANAL BIOCHEM, V107, P424, DOI 10.1016/0003-2697(80)90404-2; Changou CA, 2014, P NATL ACAD SCI USA, V111, P14147, DOI 10.1073/pnas.1404171111; Chow JPH, 2013, ONCOGENE, V32, P4778, DOI 10.1038/onc.2012.504; Delage B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.83; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Ensor CM, 2002, CANCER RES, V62, P5443; Fayura LR, 2013, J BIOTECHNOL, V167, P420, DOI 10.1016/j.jbiotec.2013.06.025; Feun Lynn, 2006, Expert Opin Investig Drugs, V15, P815, DOI 10.1517/13543784.15.7.815; Han RZ, 2016, APPL MICROBIOL BIOT, V100, P4747, DOI 10.1007/s00253-016-7490-z; Harding JJ, 2018, CANCER CHEMOTH PHARM, V82, P429, DOI 10.1007/s00280-018-3635-3; Harding JJ, 2019, J CLIN ONCOL, V4; Holtsberg FW, 2002, J CONTROL RELEASE, V80, P259, DOI 10.1016/S0168-3659(02)00042-1; Izzo F, 2004, J CLIN ONCOL, V22, P1815, DOI 10.1200/JCO.2004.11.120; Lowery MA, 2017, CANCER-AM CANCER SOC, V123, P4556, DOI 10.1002/cncr.30897; McAlpine JA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-621; Melcher RLJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44115; Miraki-Moud F, 2015, BLOOD, V125, P4060, DOI 10.1182/blood-2014-10-608133; Nicholson LJ, 2009, INT J CANCER, V125, P1454, DOI 10.1002/ijc.24546; Rodriguez-Martinez JA, 2009, BIOTECHNOL LETT, V31, P883, DOI 10.1007/s10529-009-9947-y; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Shen LJ, 2006, CURR OPIN MOL THER, V8, P240; Singh PK, 2019, MOL CANCER THER, V18, P2381, DOI 10.1158/1535-7163.MCT-18-0708; Song SL, 2017, J CELL PHYSIOL, V232, P2977, DOI 10.1002/jcp.25785; Sroda K, 2005, CELL MOL BIOL LETT, V10, P37; Stone E, 2012, J CONTROL RELEASE, V158, P171, DOI 10.1016/j.jconrel.2011.09.097; TAKAKU H, 1993, JPN J CANCER RES, V84, P1195, DOI 10.1111/j.1349-7006.1993.tb02821.x; TAKAKU H, 1992, INT J CANCER, V51, P244, DOI 10.1002/ijc.2910510213; Tanaka HY, 2018, CANCER SCI, V109, P2085, DOI 10.1111/cas.13630; Tao XM, 2019, ACTA BIOCH BIOPH SIN, V51, P263, DOI 10.1093/abbs/gmz005; Tomlinson BK, 2015, CLIN CANCER RES, V21, P2480, DOI 10.1158/1078-0432.CCR-14-2610; Tsai HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10542-4; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Yau T, 2013, INVEST NEW DRUG, V31, P99, DOI 10.1007/s10637-012-9807-9	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231633	10.1371/journal.pone.0231633	http://dx.doi.org/10.1371/journal.pone.0231633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353864	Green Published, gold			2022-12-26	WOS:000536673200019
J	Hawinkel, S; Rayner, JCW; Bijnens, L; Thas, O				Hawinkel, Stijn; Rayner, J. C. W.; Bijnens, Luc; Thas, Olivier			Sequence count data are poorly fit by the negative binomial distribution	PLOS ONE			English	Article							GOODNESS-OF-FIT; RNA-SEQ DATA; MODELS	Sequence count data are commonly modelled using the negative binomial (NB) distribution. Several empirical studies, however, have demonstrated that methods based on the NB-assumption do not always succeed in controlling the false discovery rate (FDR) at its nominal level. In this paper, we propose a dedicated statistical goodness of fit test for the NB distribution in regression models and demonstrate that the NB-assumption is violated in many publicly available RNA-Seq and 16S rRNA microbiome datasets. The zero-inflated NB distribution was not found to give a substantially better fit. We also show that the NB-based tests perform worse on the features for which the NB-assumption was violated than on the features for which no significant deviation was detected. This gives an explanation for the poor behaviour of NB-based tests in many published evaluation studies. We conclude that non-parametric tests should be preferred over parametric methods.	[Hawinkel, Stijn; Thas, Olivier] Univ Ghent, Dept Data Anal & Math Modelling, Ghent, Belgium; [Rayner, J. C. W.] Univ Newcastle, Ctr Comp Assisted Res Math & Its Applicat, Sch Math & Phys Sci, Newcastle, NSW, Australia; [Bijnens, Luc] Janssen Pharmaceut Co Johnson & Johnson, Quantitat Sci, Ghent, Belgium; [Bijnens, Luc; Thas, Olivier] Hasselt Univ, I BioStat, Hasselt, Belgium; [Rayner, J. C. W.; Thas, Olivier] Univ Wollongong, Natl Inst Appl Stat Res Australia NIASRA, Wollongong, NSW, Australia	Ghent University; University of Newcastle; Johnson & Johnson; Janssen Pharmaceuticals; Hasselt University; University of Wollongong	Hawinkel, S (corresponding author), Univ Ghent, Dept Data Anal & Math Modelling, Ghent, Belgium.	stijn.hawinkel@ugent.be		Rayner, John/0000-0003-4987-0026; Thas, Olivier/0000-0001-6442-4089; Bijnens, Luc/0000-0002-4126-3152	Janssen Pharmaceutical Companies of John-son and Johnson	Janssen Pharmaceutical Companies of John-son and Johnson	Stijn Hawinkel was funded by Janssen Pharmaceutical Companies of John-son and Johnson. Luc Bijnens is currently employed by Janssen Pharmaceu-tical Companies of Johnson and Johnson. The funders supervised the work and provided suggestions, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmericanGut org, 2015, AM GUT PROJ; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Assefa AT, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1466-5; Benidt S, 2015, BIOINFORMATICS, V31, P2131, DOI 10.1093/bioinformatics/btv124; Callewaert C, 2017, EXP DERMATOL, V26, P388, DOI 10.1111/exd.13259; Carey HV, 2013, AM J PHYSIOL-REG I, V304, pR33, DOI 10.1152/ajpregu.00387.2012; Di YM, 2015, STAT INTERFACE, V8, P405, DOI 10.4310/SII.2015.v8.n4.a1; Dong K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1208-1; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Gierlinski M, 2015, BIOINFORMATICS, V31, P3625, DOI 10.1093/bioinformatics/btv425; Hawinkel S, 2019, BRIEF BIOINFORM, V20, P210, DOI 10.1093/bib/bbx104; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; LAWLESS JF, 1987, CAN J STAT, V15, P209, DOI 10.2307/3314912; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119254; Neyman J, 1937, SKAND AKTUARIETIDSKR, V20, P149; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; PRENTICE MJ, 1979, BIOMETRIKA, V66, P167, DOI 10.2307/2335259; Props R, 2018, ENVIRON MICROBIOL, V20, P521, DOI 10.1111/1462-2920.13953; Props R, 2017, ISME J, V11, P584, DOI 10.1038/ismej.2016.117; Rayner JCW, SMOOTH TESTS G UNPUB; Rayner JCW, 2009, WILEY SERIES PROBABI; Reeb Pablo D., 2013, Frontiers in Genetics, V4, P178, DOI 10.3389/fgene.2013.00178; Rippon P, 2013, APPL SMOOTH TESTS GO; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Thas O, 2009, J STAT THEORY PRACT, V3, P705, DOI 10.1080/15598608.2009.10411955; Thas O, 2010, SPRINGER SER STAT, P1; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Van De Wiel MA, 2013, BIOSTATISTICS, V14, P113, DOI 10.1093/biostatistics/kxs031; Van den Berge K, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1406-4; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Warton DI, 2005, ENVIRONMETRICS, V16, P275, DOI 10.1002/env.702; Xu LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129606; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang WQ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0694-1; Zhang X, 2016, J BIOINFORMATICS GEN; Zhang XY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1441-7; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0224909	10.1371/journal.pone.0224909	http://dx.doi.org/10.1371/journal.pone.0224909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352970	Green Published, gold			2022-12-26	WOS:000536673200005
J	Tripodi, IJ; Chowdhury, M; Gruca, M; Dowell, RD				Tripodi, Ignacio J.; Chowdhury, Murad; Gruca, Margaret; Dowell, Robin D.			Combining signal and sequence to detect RNA polymerase initiation in ATAC-seq data	PLOS ONE			English	Article							ELEMENTS	The assay for transposase-accessible chromatin followed by sequencing (ATAC-seq) is an inexpensive protocol for measuring open chromatin regions. ATAC-seq is also relatively simple and requires fewer cells than many other high-throughput sequencing protocols. Therefore, it is tractable in numerous settings where other high throughput assays are challenging to impossible. Hence it is important to understand the limits of what can be inferred from ATAC-seq data. In this work, we leverage ATAC-seq to predict the presence of nascent transcription. Nascent transcription assays are the current gold standard for identifying regions of active transcription, including markers for functional transcription factor (TF) binding. We combine mapped short reads from ATAC-seq with the underlying peak sequence, to determine regions of active transcription genome-wide. We show that a hybrid signal/sequence representation classified using recurrent neural networks (RNNs) can identify these regions across different cell types.	[Tripodi, Ignacio J.; Chowdhury, Murad; Dowell, Robin D.] Univ Colorado, Comp Sci, Boulder, CO 80309 USA; [Tripodi, Ignacio J.; Gruca, Margaret; Dowell, Robin D.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Dowell, Robin D.] Univ Colorado, Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Dowell, RD (corresponding author), Univ Colorado, Comp Sci, Boulder, CO 80309 USA.; Dowell, RD (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.; Dowell, RD (corresponding author), Univ Colorado, Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	robin.dowell@colorado.edu	Tripodi, Ignacio/L-1719-2018	Tripodi, Ignacio/0000-0003-3066-4273; DOWELL, ROBIN/0000-0001-7665-9985	Olke C. Uhlenbeck Graduate Fellowship; NSF [ABI DBI-1759949]; NIH [R01GM125871]	Olke C. Uhlenbeck Graduate Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Olke C. Uhlenbeck Graduate Fellowship (IJT) NSF ABI DBI-1759949 (RDD) NIH R01GM125871 (RDD, IJT).	[Anonymous], DEEP TOOLS2 NEXT GEN; Azofeifa J., 2014, P 5 ACM C BIOINFORMA, P174, DOI [10.1145/2649387.2649427, DOI 10.1145/2649387.2649427]; Azofeifa JG, 2018, GENOME RES, V28, P334, DOI 10.1101/gr.225755.117; Azofeifa JG, 2017, IEEE ACM T COMPUT BI, V14, P1070, DOI 10.1109/TCBB.2016.2520919; Azofeifa JG, 2017, BIOINFORMATICS, V33, P227, DOI 10.1093/bioinformatics/btw599; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Daley T, 2013, NAT METHODS, V10, P325, DOI 10.1038/nmeth.2375; Danko CG, 2015, NAT METHODS, V12, P433, DOI [10.1038/NMETH.3329, 10.1038/nmeth.3329]; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fullard JF, 2018, GENOME RES, V28, P1243, DOI 10.1101/gr.232488.117; Gruca M., 2019, CHIP FLOW V1 3; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hill ST, 2018, NUCLEIC ACIDS RES, V46, P8105, DOI 10.1093/nar/gky567; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Picard Tools, 2017, PICARD TOOLS; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rendeiro AF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11938; Setty M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004271; Thibodeau A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34420-9; Tripodi IJ, 2018, NASCENT FLOW V1 0; Tripodi IJ, 2019, BIORXIV; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356	25	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232332	10.1371/journal.pone.0232332	http://dx.doi.org/10.1371/journal.pone.0232332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353042	Green Published, gold			2022-12-26	WOS:000536673200078
J	Harakeh, S; Angelakis, E; Karamitros, T; Bachar, D; Bahijri, S; Ajabnoor, G; Alfadul, SM; Farraj, SA; Al Amri, T; Al-Hejin, A; Ahmed, A; Mirza, AA; Didier, R; Azhar, EI				Harakeh, Steve; Angelakis, Emmanouil; Karamitros, Timokratis; Bachar, Dipankar; Bahijri, Suhad; Ajabnoor, Ghada; Alfadul, Sulaiman M.; Farraj, Suha A.; Al Amri, Turki; Al-Hejin, Ahmed; Ahmed, Abdalla; Mirza, Ahmed A.; Didier, Raoult; Azhar, Esam I.			Impact of smoking cessation, coffee and bread consumption on the intestinal microbial composition among Saudis: A cross-sectional study	PLOS ONE			English	Article							GUT MICROBIOME; DIVERSITY; SAMPLES; HEALTH; RNA	The gut microbiota is often affected by the dietary and lifestyle habits of the host, resulting in a better efficacy that favors energy harvesting from the consumed food. Our objective was to characterize the composition of gut microbiota in adult Saudis and investigate possible association with lifestyle and dietary practices. Feces from 104 Saudi volunteers (48% males) were tested for microbiota by sequencing the V3-V4 region of bacterial 16S ribosomal RNA (rRNA). For all participants, data were collected related to their lifestyle habits and dietary practices. The relative abundance (RA) of Fusobacteria was significantly higher in normal weight Saudis (P = 0.005, false discovery rate-FDR = 0.014). Individuals who consumed more coffee presented marginally significant more RA of Fusobacteria (P = 0.02, FDR = 0.20) in their gut microbiota compared to those reporting low or no coffee intake, but the RA of Fusobacteria was significantly higher in smokers compared to nonsmokers (P = 0.009, FDR = 0.027). The RA of Fusobacteria was also significantly higher in those reporting daily consumption of bread (P = 0.005, FDR = 0.015). At the species level, the gut microbiota of people who consumed coffee was dominated by Bacteroides thetaiotaomicron followed by Phascolarctobacterium faecium and Eubacterium rectale. Similarly, the gut microbiota of smokers was also enriched by B. thetaiotaomicron and Lactobacillus amylovorus. Smoking cessation, bread and coffee consumption induce changes in the intestinal microbial composition of Saudis. This indicates the significance of diet and lifestyle practices in the determination of the composition of the gut microbiota, which could possibly lead later to changes in metabolic profile and weight.	[Harakeh, Steve; Farraj, Suha A.; Mirza, Ahmed A.; Azhar, Esam I.] King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Angelakis, Emmanouil; Bachar, Dipankar] Aix Marseille Univ, APHM, IRD, VITROME,IHU Mediterranee Infect, Marseille, France; [Angelakis, Emmanouil] Hellenic Pasteur Inst, Lab Med Microbiol, Athens, Greece; [Karamitros, Timokratis] Hellenic Pasteur Inst, Unit Bioinformat & Appl Genom, Athens, Greece; [Bahijri, Suhad; Ajabnoor, Ghada] King Abdulaziz Univ, Clin Biochem Dept, Coll Med, Nutr Unit,King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Alfadul, Sulaiman M.] King Abdulaziz City Sci & Technol, Riyadh, Saudi Arabia; [Al Amri, Turki] King Abdulaziz Univ, Fac Med, Rabigh Branch, Family & Community Med Dept, Jeddah, Saudi Arabia; [Al-Hejin, Ahmed] King Abdulaziz Univ, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia; [Ahmed, Abdalla] Umm Al Qura Univ, Fac Med, Dept Med Microbiol, Mecca, Saudi Arabia; [Mirza, Ahmed A.; Azhar, Esam I.] King Abdulaziz Univ, Dept Lab Med Technol, Fac Appl Med Sci, Jeddah, Saudi Arabia; [Didier, Raoult] Aix Marseille Univ, APHM, IHU Mediterranee Infect, IRD,MEPHI, Marseille, France	King Abdulaziz University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; King Abdulaziz University; King Abdulaziz City for Science & Technology; King Abdulaziz University; King Abdulaziz University; Umm Al Qura University; King Abdulaziz University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Harakeh, S (corresponding author), King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	sharakeh@gmail.com	Amri, Turki Al/B-3384-2017; RAOULT, Didier/A-8434-2008; Mirza, Ahmed A/C-7172-2019; Azhar, Esam/ABI-1044-2020; Karamitros, Timokratis/ABE-3880-2021; Bahijri, Suhad M/AAF-4141-2020; Al-Hejin, Ahmed/D-9927-2013	Amri, Turki Al/0000-0003-4382-4109; RAOULT, Didier/0000-0002-0633-5974; Karamitros, Timokratis/0000-0003-0841-9159; Bahijri, Suhad M/0000-0001-6674-5409; Mirza, Ahmed/0000-0002-5751-1667; Farraj, Suha/0000-0003-0383-9779; Al-Hejin, Ahmed/0000-0002-9391-5650	King Abdulaziz City for Science and Technology, Saudi Arabia [AR-34-191]	King Abdulaziz City for Science and Technology, Saudi Arabia	The authors express their sincere gratitude and gratefulness to King Abdulaziz City for Science and Technology, Saudi Arabia, for funding this work under Grant #AR-34-191 to SH.	Al-Hazzaa HM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-354; Al-Raddadi R, 2018, NUTRITION, V45, P108, DOI 10.1016/j.nut.2017.07.015; Aljabri MK, 2019, J TAIBAH UNIV MED SC, V14, P139, DOI 10.1016/j.jtumed.2019.01.006; Aljoudi SB, 2015, CURR RES NUTR FOOD S, V3, P98, DOI 10.12944/CRNFSJ.3.2.02; Alqarni S.M., 2016, J OBES EAT DISORD, V2, P2, DOI [10.21767/2471-8203.100025, DOI 10.21767/2471-8203.100025]; Angelakis E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32191; Angelakis E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26276; Angelakis E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137784; Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]; Bahijri SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152559; Benjamin JL, 2012, INFLAMM BOWEL DIS, V18, P1092, DOI 10.1002/ibd.21864; Biedermann L, 2014, INFLAMM BOWEL DIS, V20, P1496, DOI 10.1097/MIB.0000000000000129; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Darwish M.A., 2014, INT J FAMILY MED, V2014, P432732, DOI [10.1155/2014/432732, DOI 10.1155/2014/432732]; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Escobar JS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0311-6; Gniechwitz D, 2007, J AGR FOOD CHEM, V55, P6989, DOI 10.1021/jf070646b; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Guo Y, 2018, EUR J ENDOCRINOL, V178, P43, DOI [10.1530/EJE-17-0403, 10.1530/eje-17-0403]; Harakeh SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00095; Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Nakayama T, 2013, FEMS MICROBIOL LETT, V343, P161, DOI 10.1111/1574-6968.12142; Patin NV, 2013, MICROB ECOL, V65, P709, DOI 10.1007/s00248-012-0145-4; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Yasir M, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.3; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143	39	12	12	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0230895	10.1371/journal.pone.0230895	http://dx.doi.org/10.1371/journal.pone.0230895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348307	Green Published, Green Submitted, gold			2022-12-26	WOS:000536668200010
J	Luo, SQ; Lenon, GB; Gill, H; Hung, A; Dias, DA; Li, MD; Nguyen, LT				Luo, Shiqi; Lenon, George Binh; Gill, Harsharn; Hung, Andrew; Dias, Daniel A.; Li, Mingdi; Linh Toan Nguyen			Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic alpha-amylase activity: Enzymatic and in silico approaches	PLOS ONE			English	Article							GREEN TEA; OBESITY; PHARMACOLOGY; INGREDIENTS	Reducing carbohydrates digestion by having a low glycaemic index (GI) foods has been linked to weight loss. Inhibiting related enzymes is an alternative way to decrease carbohydrate digestion. RCM-107 (Slimming Plus), an eight-herb formula that is modified from RCM-104, indicated significant weight-loss action in clinical trials. However, no published research has studied its mechanism of action on reducing carbohydrate absorption via suppressing the activities of porcine pancreatic alpha-amylase (PPA). In this paper, we used fluorescence PPA inhibition assay to investigate the inhibitory effects of RCM-107 and the individual herbs present in this herbal mixture on amylase activity. Subsequently, molecular docking predicted the key active compounds that may be responsible for the enzyme inhibition. According to our results, both the RCM-107 formula and several individual herbs displayed alpha-amylase inhibitory effects. Also, marginal synergistic effects of RCM-107 were detected. In addition, alisol B, (-)-epigallocatechin-3-gallate (EGCG) and plantagoside have been predicted as the key active compounds that may be responsible for the alpha-amylase inhibition effect of RCM-107 according to inter-residue contact analysis. Finally, Glu233, Gln63, His305, Asp300 and Tyr151 are predicted to be markers of important areas with which potential amylase inhibitors would interact. Therefore, our data has provided new knowledge on the mechanisms of action of the RCM-107 formula and its individual herbal ingredients for weight loss, in terms of decreasing carbohydrate digestion via the inhibition of pancreatic alpha-amylase.	[Luo, Shiqi; Lenon, George Binh; Dias, Daniel A.; Li, Mingdi] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Gill, Harsharn; Hung, Andrew] RMIT Univ, Sch Sci, Melbourne, Vic, Australia; [Linh Toan Nguyen] Vietnam Mil Med Univ, Dept Endocrine, Hanoi, Vietnam	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Lenon, GB (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	george.lenon@rmit.edu.au		Hung, Andrew/0000-0003-3569-2951; Li, Mingdi/0000-0002-5329-4562	RMIT University, School of Health and Biomedical Sciences Seeding grant [341333]; Tong Lee Pty Ltd [RE-0256]	RMIT University, School of Health and Biomedical Sciences Seeding grant; Tong Lee Pty Ltd	This research project is supported by RMIT University, School of Health and Biomedical Sciences Seeding grant (341333) & Tong Lee Pty Ltd (RE-0256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ML, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-24; Bensky D, 2004, CHINESE HERBAL MED M, V3rd; Dong X, 2017, MOL MED REP, V16, P2331, DOI 10.3892/mmr.2017.6880; Geng F, 2009, PHYTOTHER RES, P1088; Gilles C, 1996, EUR J BIOCHEM, V238, P561, DOI 10.1111/j.1432-1033.1996.0561z.x; Han Y, 2015, FOOD CHEM, V188, P648, DOI 10.1016/j.foodchem.2015.05.039; Huang C, 2014, BRIEF BIOINFORM, V15, P710, DOI 10.1093/bib/bbt035; Jastreboff AM, 2019, OBESITY, V27, P7, DOI 10.1002/oby.22378; Lenon GB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/435702; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Luo SQ, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02453; Luo SQ, 2019, CURR DRUG TARGETS, V20, P399, DOI 10.2174/1389450119666180830125958; Manoj K, 2014, MED CHEM RES, V23, P810, DOI [10.1007/s00044-013-0654-9, DOI 10.1007/S00044-013-0654-9]; Marrelli M, 2013, PLANT FOOD HUM NUTR, V68, P340, DOI 10.1007/s11130-013-0390-9; Moyers SB, 2005, J AM DIET ASSOC, V105, P948, DOI 10.1016/j.jada.2005.03.010; Park J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/732126; Paudel KR, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/789124; Perva-Uzunalic A, 2006, FOOD CHEM, V96, P597, DOI 10.1016/j.foodchem.2005.03.015; Piche ME, 2018, PROG CARDIOVASC DIS, V61, P103, DOI 10.1016/j.pcad.2018.06.004; Qian MX, 2002, BIOCHEMISTRY-US, V33, P6284, DOI [10.1021/bi00186a031, DOI 10.1021/BI00186A031]; Rios JL, 2011, PLANTA MED, V77, P681, DOI 10.1055/s-0030-1270823; Sharma BR, 2017, PHYTOTHER RES, V31, P3, DOI 10.1002/ptr.5732; Sun GL, 2009, J TRADIT CHIN VET ME, V28, P24; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; Tucci SA, 2010, DIABET METAB SYND OB, V3, P125, DOI 10.2147/DMSO.S7005; Turkozu D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672; Udani J, 2007, ALTERN THER HEALTH M, V13, P32; Wagner H, 2011, CHROMATOGRAPHIC FINGERPRINT ANALYSIS OF HERBAL MEDICINES: THIN-LAYER AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY OF CHINESE DRUGS, VOLS 1 AND 2, 2ND EDITION, pXXI; Wang F, 2017, J PHARMACEUT BIOMED, V132, P7, DOI 10.1016/j.jpba.2016.09.042; Wang X, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/519031; World Health Organization (WHO), 2016, 10 FACTS OB; Wu LF, 2016, MOLECULES, V21, DOI 10.3390/molecules21020227; Xiao WP, 2017, J FOOD DRUG ANAL, V25, P43, DOI 10.1016/j.jfda.2016.11.005; Xu XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096780, 10.1371/journal.pone.0109950]; Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c; Yang WJ, 2009, BIOL PHARM BULL, V32, P1021, DOI 10.1248/bpb.32.1021; Yilmazer-Musa M, 2012, J AGR FOOD CHEM, V60, P8924, DOI 10.1021/jf301147n; Yue GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065164; Zhou X, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00201	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231815	10.1371/journal.pone.0231815	http://dx.doi.org/10.1371/journal.pone.0231815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348327	Green Published, gold			2022-12-26	WOS:000536668200027
J	Nadanaka, S; Hashiguchi, T; Kitagawa, H				Nadanaka, Satomi; Hashiguchi, Taishi; Kitagawa, Hiroshi			Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll-like 4 receptor signaling	FASEB JOURNAL			English	Article						glycosaminoglycan; inflammation; liver cancer; NF-kappaB (NF-kappa B); proteoglycans (PG)	HEPARAN-SULFATE BIOSYNTHESIS; GENE; EXPRESSION; BIGLYCAN; MEMBER; PROTEOGLYCANS; FAMILY; IDENTIFICATION; OBESITY; ROLES	Certain proteoglycans, consisting of a core protein and glycosaminoglycan (GAG) chains, are among the many types of biomolecules that can function as damage-associated molecular pattern molecules (DAMPs). We, therefore, hypothesized that the expression level and structural alteration of GAGs affect inflammation. We have previously reported that the effects on GAG biosynthesis caused by loss of the tumor suppressor gene exostosin-like 2 (Extl2) influence liver injury and regeneration processes. To examine how altered GAG biosynthesis may underscore the relationship between inflammation and tumorigenesis, we assessed its role in non-alcoholic steatohepatitis and hepatocarcinoma (HCC) induced by dietary obesity and insulin-resistance. We demonstrated that GAGs produced in the absence of EXTL2 act as DAMPs and directly input signals into cells via the Toll-like 4 receptor. In addition, the subsequent transcriptional activation of inflammatory and tumor-promoting cytokines by NF-kappa B contributes to injury- and inflammation-driven tumor promotion. Thus, dysregulated biosynthesis of GAGs is considered to increase the risk of HCC in a background of obesity and diabetes.	[Nadanaka, Satomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Lab Biochem, Kobe, Hyogo, Japan; [Hashiguchi, Taishi] SMC Labs Inc, Tokyo, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Biochem Lab, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [JP23110003];  [JP16H05088];  [JP20H03386];  [JP25460080]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas JP23110003 (to H. K.) and for Scientific Research (B) JP16H05088 and JP20H03386 (to H. K.) and (C) JP25460080 (to S. N.) and the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gordts PLSM, 2015, CYTOKINE, V72, P118, DOI 10.1016/j.cyto.2014.12.013; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; He MZ, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0030-9; HEINEGAR.D, 1972, BIOCHIM BIOPHYS ACTA, V285, P193, DOI 10.1016/0005-2795(72)90191-2; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Kali A, 2014, INDIAN J PHARMACOL, V46, P579, DOI 10.4103/0253-7613.144891; Kazankov K, 2018, J PEDIATR GASTR NUTR, V67, P635, DOI 10.1097/MPG.0000000000002111; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2018, J BIOL CHEM, V293, P444, DOI 10.1074/jbc.M117.814509; Nadanaka S, 2013, BIOCHEM J, V454, P133, DOI 10.1042/BJ20130323; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Purnomo E, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000405; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2001, FASEB J, V15, P559; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Thelin MA, 2012, CANCER RES, V72, P1943, DOI 10.1158/0008-5472.CAN-11-1351; Troegeler A, 2014, IMMUNOL CELL BIOL, V92, P699, DOI 10.1038/icb.2014.39; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796	40	10	10	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8385	8401		10.1096/fj.201902076R	http://dx.doi.org/10.1096/fj.201902076R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32347583	Bronze			2022-12-26	WOS:000529982000001
J	Battaglia, S; Scialpi, N; Berardi, E; Antonica, G; Suppressa, P; Diella, FA; Colapietro, F; Ruggieri, R; Guglielmini, G; Noia, A; Graziano, G; Sabba, C; Cariello, M				Battaglia, Stefano; Scialpi, Natasha; Berardi, Elsa; Antonica, Gianfranco; Suppressa, Patrizia; Diella, Francesco Arcangelo; Colapietro, Francesca; Ruggieri, Roberta; Guglielmini, Giuseppe; Noia, Alessia; Graziano, Giusi; Sabba, Carlo; Cariello, Marica			Gender, BMI and fasting hyperglycaemia influence Monocyte to-HDL ratio (MHR) index in metabolic subjects	PLOS ONE			English	Article							LIPOPROTEIN CHOLESTEROL RATIO; CENSORED SURVIVAL-DATA; LYMPHOCYTE RATIO; RECURSIVE PARTITION; COMPUTER-PROGRAM; SEVERITY; RISK; BIOSTATISTICS; AMALGAMATION; INFLAMMATION	Metabolic Syndrome (MS) is characterized by a low-grade inflammatory state causing an alteration of non-invasive indexes derived from blood count, namely monocyte-to-HDL ratio (MHR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR). We analyse a population of 771 subjects (394 controls and 377 MS patients) to evaluate the best predictive index of MS. The diagnosis of MS was made according to the 2006 criteria of the International Diabetes Federation (IDF). We performed ROC curve analyses to evaluate the best predictor index of MS. MHR cut-off value was used to classify the population in two different groups and to create the outcome variable of the Recursive Partitioning and Amalgamation (RECPAM) analysis. This method is a tree-structured approach that defines "risk profiles" for each group of dichotomous variables. We showed that MHR index is significantly linked to body mass index (BMI), waist circumference, creatinine, C-reactive protein (CRP), Erythrocyte Sedimentation Rate (ESR). ROC curve defined an MHR cut-off value of 6.4, which was able to identify two patient groups with significant differences in waist circumference, blood pressure, creatinine, estimated glomerular filtration rate and fasting plasma glucose. RECPAM analysis demonstrated that gender, BMI categorization and hyperglycaemia were the most important risk determinants of increased MHR index that can be considered bona fide a useful and easily obtainable tool to suggest the presence of peculiar metabolic features that predict MS.	[Battaglia, Stefano; Berardi, Elsa; Antonica, Gianfranco; Suppressa, Patrizia; Noia, Alessia; Sabba, Carlo; Cariello, Marica] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Bari, Italy; [Battaglia, Stefano] Aldo Moro Univ Bari, Dept Tissues & Organs Transplantat & Cellular The, Bari, Italy; [Scialpi, Natasha; Diella, Francesco Arcangelo; Colapietro, Francesca; Ruggieri, Roberta; Guglielmini, Giuseppe; Graziano, Giusi] Natl Inst Biostruct & Biosyst, INBB, Rome, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Cariello, M (corresponding author), Aldo Moro Univ Bari, Dept Interdisciplinary Med, Bari, Italy.	maricacariello@gmail.com	Cariello, Marica/K-4064-2018	Battaglia, Stefano/0000-0001-6258-4847; Diella, Francesco Arcangelo/0000-0001-8262-9897				Akboga MK, 2016, BIOMARK MED, V10, P375, DOI 10.2217/bmm-2015-0050; Akboga MK, 2016, PLATELETS, V27, P178, DOI 10.3109/09537104.2015.1064518; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Balta S, 2015, PLATELETS, V26, P680, DOI 10.3109/09537104.2014.979340; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Bracht JR, 2020, ANN NY ACAD SCI, V1461, P127, DOI 10.1111/nyas.14281; Buyukkaya E, 2014, CLIN APPL THROMB-HEM, V20, P159, DOI 10.1177/1076029612459675; Canpolat U, 2015, EUROPACE, V17, P1807, DOI 10.1093/europace/euu291; Cetin EHO, 2015, BIOMARK MED, V9, P967, DOI 10.2217/bmm.15.74; Cetin MS, 2016, HEART LUNG CIRC, V25, P1077, DOI 10.1016/j.hlc.2016.02.023; CIAMPI A, 1989, COMPUT METH PROG BIO, V30, P283, DOI 10.1016/0169-2607(89)90099-0; CIAMPI A, 1988, COMPUT METH PROG BIO, V26, P239, DOI 10.1016/0169-2607(88)90004-1; Dhuper S, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-4; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ganjali S, 2018, J CELL PHYSIOL, V233, P9237, DOI 10.1002/jcp.27028; Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067688; Goldenberg I, 2008, VASC HEALTH RISK MAN, V4, P131, DOI 10.2147/vhrm.2008.04.01.131; Gong S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012813; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Krysiak R, 2013, EUR J INTERN MED, V24, P255, DOI 10.1016/j.ejim.2012.10.010; Krysiak R, 2011, BASIC CLIN PHARMACOL, V109, P23, DOI 10.1111/j.1742-7843.2011.00675.x; Laxy M, 2018, INT J OBESITY, V42, P318, DOI 10.1038/ijo.2017.252; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Pucci G, 2017, PHARMACOL RES, V120, P34, DOI 10.1016/j.phrs.2017.03.008; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Uslu AU, 2018, CLIN APPL THROMB-HEM, V24, P828, DOI 10.1177/1076029617741362; Usta A, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0351-0; Vahit D, 2017, BIOMARK MED, V11, P535, DOI 10.2217/bmm-2016-0380; Wei XB, 2018, CIRC J, V82, P283, DOI 10.1253/circj.CJ-17-0427; Yayla KG, 2017, ACTA CARDIOL SIN, V33, P41, DOI 10.6515/ACS20160427A; Zakiev E, 2017, CURR PHARM DESIGN, V23, P1207, DOI 10.2174/1381612822666161027153140	35	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231927	10.1371/journal.pone.0231927	http://dx.doi.org/10.1371/journal.pone.0231927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343751	Green Published, gold			2022-12-26	WOS:000536661300019
J	Kulkarni, AS; Troyer, TW				Kulkarni, Anand S.; Troyer, Todd W.			Optimal spectral templates for triggered feedback experiments	PLOS ONE			English	Article							GANGLIA-FOREBRAIN CIRCUIT; BASAL GANGLIA; BIRDSONG; ENCODE; OUTPUT; ERROR	In the field of songbird neuroscience, researchers have used playback of aversive noise bursts to drive changes in song behavior for specific syllables within a bird's song. Typically, a short (similar to 5-10 msec) slice of the syllable is selected for targeting and the average spectrum of the slice is used as a template. Sounds that are sufficiently close to the template are considered a match. If other syllables have portions that are spectrally similar to the target, false positive errors will weaken the operant contingency. We present a gradient descent method for template optimization that increases the separation in distance between target and distractors slices, greatly improving targeting accuracy. Applied to songs from five adult Bengalese finches, the fractional reduction in errors for sub-syllabic slices was 51.54 +/- 22.92%. At the level of song syllables, we use an error metric that controls for the vastly greater number of distractors vs. target syllables. Setting 5% average error (misses + false positives) as a minimal performance criterion, the number of targetable syllables increased from 3 to 16 out of 61 syllables. At 10% error, targetable syllables increased from 11 to 26. By using simple and robust linear discriminant methods, the algorithm reaches near asymptotic performance when using 10 songs as training data, and the error increases by < 2.3% on average when using only a single song for training. Targeting is temporally precise, with average jitter of 3.33 msec for the 16 accurately targeted syllables. Because the algorithm is concerned only with the problem of template selection, it can be used as a simple and robust front end for existing hardware and software implementations for triggered feedback.	[Kulkarni, Anand S.; Troyer, Todd W.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Kulkarni, Anand S.; Troyer, Todd W.] Univ Texas San Antonio, UTSA Neurosci Inst, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Troyer, TW (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.; Troyer, TW (corresponding author), Univ Texas San Antonio, UTSA Neurosci Inst, San Antonio, TX 78249 USA.	todd.troyer@utsa.edu			National Science Foundation [DBI-1451032, IOS-0951310]	National Science Foundation(National Science Foundation (NSF))	;This work was supported by National Science Foundation (https://www.nsf.gov/) grants DBI-1451032 and IOS-0951310 to TWT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2013, NEURON, V80, P494, DOI 10.1016/j.neuron.2013.07.049; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Boyd S., 2009, CONVEX OPTIMIZATION; Canopoli A, 2014, J NEUROSCI, V34, P7018, DOI 10.1523/JNEUROSCI.0266-14.2014; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Charlesworth JD, 2011, NAT NEUROSCI, V14, P373, DOI 10.1038/nn.2748; Chen RD, 2019, NEURON, V103, P266, DOI 10.1016/j.neuron.2019.04.038; Gadagkar V, 2016, SCIENCE, V354, P1278, DOI 10.1126/science.aah6837; Hamaguchi K, 2014, ELIFE, V3, DOI 10.7554/eLife.01833; Hamaguchi K, 2012, J NEUROSCI, V32, P11671, DOI 10.1523/JNEUROSCI.1666-12.2012; Hisey E, 2018, NAT NEUROSCI, V21, P589, DOI 10.1038/s41593-018-0092-6; Hoffmann LA, 2014, J NEUROSCI, V34, P5564, DOI 10.1523/JNEUROSCI.5169-13.2014; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kearney MG, 2019, NEURON, V104, P559, DOI 10.1016/j.neuron.2019.07.025; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Mandelblat-Cerf Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02152; Nicholson D, 2016, P 15 PYTHON SCI C, P57, DOI DOI 10.25080/MAJORA-629E541A-008; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Pearre B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181992; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; Schultz W, 2015, PHYSIOL REV, V95, P853, DOI 10.1152/physrev.00023.2014; Skocik M, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00111; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Soma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124876; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tian LY, 2017, NEURON, V96, P1168, DOI 10.1016/j.neuron.2017.10.019; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Warren TL, 2012, J NEUROSCI, V32, P15414, DOI 10.1523/JNEUROSCI.1254-12.2012; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011; Xiao L, 2018, NEURON, V98, P208, DOI 10.1016/j.neuron.2018.02.020	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0228512	10.1371/journal.pone.0228512	http://dx.doi.org/10.1371/journal.pone.0228512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343694	Green Published, gold, Green Submitted			2022-12-26	WOS:000536661300006
J	Nygard, L; Ahlborn, LB; Persson, GF; Chandrananda, D; Langer, JW; Fischer, BM; Langer, SW; Gabrielaite, M; Kjaer, A; Rosenfeld, N; Mouliere, F; Ostrup, O; Vogelius, IR; Bentzen, SM				Nygard, Lotte; Ahlborn, Lise B.; Persson, Gitte F.; Chandrananda, Dineika; Langer, Jonathan W.; Fischer, Barbara M.; Langer, Seppo W.; Gabrielaite, Migle; Kjaer, Andreas; Rosenfeld, Nitzan; Mouliere, Florent; Ostrup, Olga; Vogelius, Ivan R.; Bentzen, Soren M.			Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients-Initial observations	PLOS ONE			English	Article							TUMOR DNA; BIOMARKER; ORIGIN; PLASMA; NUMBER; SURVIVAL	Background The overall aim was to investigate the change over time in circulating cell free DNA (cfDNA) in patients with locally advanced non-small cell lung cancer (NSCLC) undergoing concurrent chemo-radiotherapy. Furthermore, to assess the possibility of detecting circulating cell free tumor DNA (ctDNA) using shallow whole genome sequencing (sWGS) and size selection. Methods Ten patients were included in a two-phase study. The first four patients had blood samples taken prior to a radiation therapy (RT) dose fraction and at 30 minutes, 1 hour and 2 hours after RT to estimate the short-term dynamics of cfDNA concentration after irradiation. The remaining six patients had one blood sample taken on six treatment days 30 minutes post treatment to measure cfDNA levels. Presence of ctDNA as indicated by chromosomal aberrations was investigated using sWGS. The sensitivity of this method was further enhanced using in silico size selection. Results cfDNA concentration from baseline to 120 min after therapy was stable within 95% tolerance limits of +/- 2 ng/ml cfDNA. Changes in cfDNA were observed during therapy with an apparent qualitative difference between adenocarcinoma (average increase of 0.69 ng/ml) and squamous cell carcinoma (average increase of 4.0 ng/ml). Tumor shrinkage on daily cone beam computer tomography scans during radiotherapy did not correlate with changes in concentration of cfDNA. Conclusion Concentrations of cfDNA remain stable during the first 2 hours after an RT fraction. However, based on the sWGS profiles, ctDNA represented only a minor fraction of cfDNA in this group of patients. The detection sensitivity of genomic alterations in ctDNA strongly increases by applying size selection.	[Nygard, Lotte; Persson, Gitte F.; Langer, Seppo W.; Vogelius, Ivan R.] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark; [Ahlborn, Lise B.; Gabrielaite, Migle; Ostrup, Olga] Copenhagen Univ Hosp, Rigshosp, Ctr Genom Med, Copenhagen, Denmark; [Chandrananda, Dineika; Rosenfeld, Nitzan] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Langer, Jonathan W.; Fischer, Barbara M.; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Langer, Jonathan W.; Fischer, Barbara M.; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, Copenhagen, Denmark; [Langer, Jonathan W.; Fischer, Barbara M.; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Fischer, Barbara M.] Kings Coll London, St Thomas Hosp, Sch Biomed Engn & Imaging Sci, PET Ctr, London, England; [Mouliere, Florent] Vrije Univ Amsterdam, Dept Pathol, Canc Ctr Amsterdam, Amsterdam UMC, Amsterdam, Netherlands; [Bentzen, Soren M.] Univ Maryland, Div Biostat & Bioinformat, Dept Epidemiol & Publ Hlth, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Bentzen, Soren M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Amsterdam; Vrije Universiteit Amsterdam; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Nygard, L (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark.	lotte.nygaard@regionh.dk	Mouliere, Florent/H-7119-2019; Persson, Gitte Fredberg/AGN-3292-2022; Gabrielaite, Migle/S-7537-2019; Kjaer, Andreas/E-8932-2015	Mouliere, Florent/0000-0001-7043-0514; Persson, Gitte Fredberg/0000-0002-3363-3256; Gabrielaite, Migle/0000-0002-7959-8767; Kjaer, Andreas/0000-0002-2706-5547; Chandrananda, Dineika/0000-0002-8834-9500; Vogelius, Ivan Richter/0000-0002-8877-1218; /0000-0001-9732-9192; Fischer, Barbara Malene/0000-0002-6065-3375; Nygard, Lotte/0000-0003-0408-1007	Danish Cancer Society [R72-A4605-13-S2]; National Institutes of Health (NIH) [P30 CA 134274-04]; Kirsten and Freddy Johansen Foundation; Jubilaeums Fonden at Rigshospitalet	Danish Cancer Society(Danish Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirsten and Freddy Johansen Foundation; Jubilaeums Fonden at Rigshospitalet	SMB: This work was supported by the Danish Cancer Society grant no. R72-A4605-13-S2 and National Institutes of Health (NIH) grant no. P30 CA 134274-04. The authors further acknowledge financial support from the Kirsten and Freddy Johansen Foundation and Jubilaeums Fonden at Rigshospitalet. https://www.cancer.dk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidousty C, 2018, J PATHOL, V246, P67, DOI 10.1002/path.5110; Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b; Bortolin MT, 2015, BIOMARKERS, V5804, P1; Dehing-Oberije C, 2008, INT J RADIAT ONCOL, V70, P1039, DOI 10.1016/j.ijrobp.2007.07.2323; Fiala C, 2018, J APPL LAB MED, V3, P300, DOI 10.1373/jalm.2018.026393; Heitzer E, 2016, MOL ONCOL, V10, P494, DOI 10.1016/j.molonc.2015.12.004; Jahr S, 2001, CANCER RES, V61, P1659; Leung F, 2016, CLIN CHEM, V62, P1054, DOI 10.1373/clinchem.2016.260331; Li BT, 2016, ANN ONCOL, V27, P154, DOI 10.1093/annonc/mdv498; Merker JD, 2018, J CLIN ONCOL, V36, P1631, DOI 10.1200/JCO.2017.76.8671; Mouliere F, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat4921; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Sozzi G, 2001, CANCER RES, V61, P4675; Spindler KLG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0108247; Stroun M, 2000, ANN NY ACAD SCI, V906, P161; Tissot C, 2015, EUR RESPIR J, V46, P1773, DOI 10.1183/13993003.00676-2015; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weiss GJ, 2017, CLIN CANCER RES, V23, P5074, DOI 10.1158/1078-0432.CCR-17-0231	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231884	10.1371/journal.pone.0231884	http://dx.doi.org/10.1371/journal.pone.0231884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343749	gold, Green Published, Green Submitted			2022-12-26	WOS:000536661300017
J	Kockum, K; Virhammar, J; Riklund, K; Soderstrom, L; Larsson, EM; Laurell, K				Kockum, Karin; Virhammar, Johan; Riklund, Katrine; Soderstrom, Lars; Larsson, Elna-Marie; Laurell, Katarina			Diagnostic accuracy of the iNPH Radscale in idiopathic normal pressure hydrocephalus	PLOS ONE			English	Article							CALLOSAL ANGLE; SCALE; MRI; SPACE	Background and purpose The idiopathic normal pressure hydrocephalus (iNPH) Radscale was developed to standardize the evaluation of radiological signs in iNPH. The purpose of this study was to estimate the diagnostic accuracy of the iNPH Radscale in a sample of "true positive" and "true negative" cases. Methods Seventy-five patients with definite iNPH, i.e. who had improved at clinical follow-up one year after ventriculoperitoneal shunt surgery, were compared with 55 asymptomatic individuals from the general population. A radiologist assessed the seven radiological features of the iNPH Radscale in computed tomography of the brain in the patients (preoperatively) and controls. Results The iNPH Radscale score was significantly higher in the iNPH group (Median = 10, interquartile range 9-11) than in the control group (Median = 1, interquartile range 1-2) (p < 0.001). Receiver operated characteristics analysis yielded an area under the curve of 99.7%, and an iNPH Radscale score. 4 identified those without iNPH, with a sensitivity of 100%, specificity of 96% and overall accuracy of 98.5%. Conclusions In this study, iNPH Radscale could accurately discriminate between patients with definite iNPH and asymptomatic individuals over 65 years old. According to the results, a diagnosis of iNPH is very likely in patients with an iNPH Radscale score above 8 and corresponding clinical symptoms. On the other hand, the diagnosis should be questioned when the iNPH Radscale score is below the cut-off level of 4. We conclude that the iNPH Radscale could work as a diagnostic screening tool to detect iNPH. Whether the scale also can be used to predict shunt outcome needs further studies.	[Kockum, Karin] Umea Univ, Dept Clin Sci, Neurosci, Umea, Sweden; [Virhammar, Johan; Laurell, Katarina] Uppsala Univ Hosp, Dept Neurosci, Neurol, Uppsala, Sweden; [Riklund, Katrine] Umea Univ, Dept Radiat Sci, Diagnost Radiol, Umea, Sweden; [Soderstrom, Lars] Ostersund Hosp, Unit Res Educ & Dev, Ostersund, Sweden; [Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden	Umea University; Uppsala University; Uppsala University Hospital; Umea University; Uppsala University	Kockum, K (corresponding author), Umea Univ, Dept Clin Sci, Neurosci, Umea, Sweden.	Karin.kockum@regionjh.se	Virhammar, Johan/AAV-6160-2021	Virhammar, Johan/0000-0001-9901-2949; Laurell, Katarina/0000-0002-7504-8354	Region Jamtland Harjedalen; Syskonen Perssons donationsfond; Visare Norr	Region Jamtland Harjedalen; Syskonen Perssons donationsfond; Visare Norr	The authors would like to thank Region Jamtland Harjedalen, Syskonen Perssons donationsfond and Visare Norr for support.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Agerskov S, 2019, AM J NEURORADIOL, V40, P74, DOI 10.3174/ajnr.A5910; Andersson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217705; Andren K, 2014, J NEUROL NEUROSUR PS, V85, P806, DOI 10.1136/jnnp-2013-306117; Badagard H, 2020, ACTA NEUROL SCAND, V141, P219, DOI 10.1111/ane.13200; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Fazekas F, 2002, CEREBROVASC DIS, V13, P31, DOI 10.1159/000049147; Hellstrom P, 2012, ACTA NEUROL SCAND, V126, P229, DOI 10.1111/j.1600-0404.2012.01677.x; Holodny AI, 1998, AM J NEURORADIOL, V19, P813; Holodny AI, 1998, J NEUROSURG, V89, P742, DOI 10.3171/jns.1998.89.5.0742; Ishii K, 2008, EUR RADIOL, V18, P2678, DOI 10.1007/s00330-008-1044-4; Ishikawa M, 2016, ACTA NEUROCHIR SUPPL, V122, P287, DOI 10.1007/978-3-319-22533-3_57; Jaraj D, 2014, NEUROLOGY, V82, P1449, DOI 10.1212/WNL.0000000000000342; Kockum K, 2018, EUR J NEUROL, V25, P569, DOI 10.1111/ene.13555; Kockum K, 2019, NEURORADIOLOGY, V61, P1397, DOI 10.1007/s00234-019-02273-2; Kojoukhova M, 2015, ACTA NEUROCHIR, V157, P1709, DOI 10.1007/s00701-015-2503-8; Kubo Y, 2008, DEMENT GERIATR COGN, V25, P37, DOI 10.1159/000111149; Miskin N, 2017, RADIOLOGY, V285, P197, DOI 10.1148/radiol.2017161216; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Narita W, 2016, AM J NEURORADIOL, V37, P1831, DOI 10.3174/ajnr.A4838; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Sasaki M, 2008, NEURORADIOLOGY, V50, P117, DOI 10.1007/s00234-007-0318-x; Toma AK, 2013, ACTA NEUROCHIR, V155, P1977, DOI 10.1007/s00701-013-1835-5; Virhammar J, 2014, AM J NEURORADIOL, V35, P2311, DOI 10.3174/ajnr.A4046; Virhammar J, 2014, J NEUROSURG, V120, P178, DOI 10.3171/2013.8.JNS13575; WIKKELSO C, 1982, J NEUROL NEUROSUR PS, V45, P64, DOI 10.1136/jnnp.45.1.64; Wikkelso C, 2013, J NEUROL NEUROSUR PS, V84, P562, DOI 10.1136/jnnp-2012-303314	27	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232275	10.1371/journal.pone.0232275	http://dx.doi.org/10.1371/journal.pone.0232275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330190	Green Published, Green Submitted, gold			2022-12-26	WOS:000536647300068
J	Pederick, JL; Thompson, AP; Bell, SG; Bruning, JB				Pederick, Jordan L.; Thompson, Andrew P.; Bell, Stephen G.; Bruning, John B.			d-Alanine?d-alanine ligase as a model for the activation of ATP-grasp enzymes by monovalent cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; enzyme mechanism; enzyme structure; enzyme catalysis; X-ray crystallography; enzyme kinetics; metal ion?protein interaction; ATP-grasp; d-alanine?d-alanine ligase (Ddl); metal activation; monovalent cation	ALANYL-D-ALANINE; LIVER PYRUVATE-CARBOXYLASE; EFFECTIVE IONIC-RADII; AMINO-ACID LIGASE; GLUTATHIONE SYNTHETASE; ENZYMATIC SYNTHESIS; ESCHERICHIA-COLI; COA CARBOXYLASE; PURIFICATION; INHIBITION	The ATP-grasp superfamily of enzymes shares an atypical nucleotide-binding site known as the ATP-grasp fold. These enzymes are involved in many biological pathways in all domains of life. One ATP-grasp enzyme, d-alanine?d-alanine ligase (Ddl), catalyzes ATP-dependent formation of the d-alanyl?d-alanine dipeptide essential for bacterial cell wall biosynthesis and is therefore an important antibiotic drug target. Ddl is activated by the monovalent cation (MVC) K+, but despite its clinical relevance and decades of research, how this activation occurs has not been elucidated. We demonstrate here that activating MVCs bind adjacent to the active site of Ddl from Thermus thermophilus and used a combined biochemical and structural approach to characterize MVC activation. We found that TtDdl is a type II MVC-activated enzyme, retaining activity in the absence of MVCs. However, the efficiency of TtDdl increased ?20-fold in the presence of activating MVCs, and it was maximally activated by K+ and Rb+ ions. A strict dependence on ionic radius of the MVC was observed, with Li+ and Na+ providing little to no TtDdl activation. To understand the mechanism of MVC activation, we solved crystal structures of TtDdl representing distinct catalytic stages in complex with K+, Rb+, or Cs+. Comparison of these structures with apo TtDdl revealed no evident conformational change on MVC binding. Of note, the identified MVC binding site is structurally conserved within the ATP-grasp superfamily. We propose that MVCs activate Ddl by altering the charge distribution of its active site. These findings provide insight into the catalytic mechanism of ATP-grasp enzymes.	[Pederick, Jordan L.; Bruning, John B.] Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA, Australia; [Pederick, Jordan L.; Thompson, Andrew P.; Bruning, John B.] Univ Adelaide, Dept Mol & Cellular Biol, Sch Biol Sci, Adelaide, SA, Australia; [Bell, Stephen G.] Univ Adelaide, Dept Chem, Adelaide, SA, Australia; [Thompson, Andrew P.] Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England	University of Adelaide; University of Adelaide; University of Adelaide; University of Oxford	Bruning, JB (corresponding author), Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA, Australia.; Bruning, JB (corresponding author), Univ Adelaide, Dept Mol & Cellular Biol, Sch Biol Sci, Adelaide, SA, Australia.	john.bruning@adelaide.edu.au	Bruning, John/AAW-8567-2020	Bruning, John/0000-0002-6919-1824; Pederick, Jordan/0000-0003-4048-9771; Bell, Stephen/0000-0002-7457-9727; Thompson, Andrew/0000-0002-3910-2317	Australian Government Research Training Program	Australian Government Research Training Program(Australian Government)	J. L. P. is a recipient of an Australian Government Research Training Program stipend scholarship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; Bartolommei G, 2016, METHODS MOL BIOL, V1377, P111, DOI 10.1007/978-1-4939-3179-8_12; Batson S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02118-7; Chou CY, 2011, J BIOL CHEM, V286, P24417, DOI 10.1074/jbc.M111.220517; Cowan JA, 1998, CHEM REV, V98, P1067, DOI 10.1021/cr960436q; Dal Piaz F, 2009, J MED CHEM, V52, P3814, DOI 10.1021/jm801637f; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDWARDS JB, 1968, BIOCHIM BIOPHYS ACTA, V159, P167, DOI 10.1016/0005-2744(68)90255-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS HJ, 1971, BIOCHEMISTRY-US, V10, P721; FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684; Firestine SM, 2009, BIOORGAN MED CHEM, V17, P3317, DOI 10.1016/j.bmc.2009.03.043; Gagne OC, 2016, ACTA CRYSTALLOGR B, V72, P602, DOI 10.1107/S2052520616008507; GIORGIO AJ, 1967, BIOCHIM BIOPHYS ACTA, V139, P487, DOI 10.1016/0005-2744(67)90052-6; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; Healy VL, 2000, CHEM BIOL, V7, P505, DOI 10.1016/S1074-5521(00)00135-6; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kino H, 2016, J BIOSCI BIOENG, V122, P155, DOI 10.1016/j.jbiosc.2016.01.014; Kino K, 2008, J BIOSCI BIOENG, V106, P313, DOI 10.1263/jbb.106.313; Kino K, 2009, BIOSCI BIOTECH BIOCH, V73, P901, DOI 10.1271/bbb.80842; Kitamura Y, 2009, ACTA CRYSTALLOGR D, V65, P1098, DOI 10.1107/S0907444909029710; Lee JH, 2006, PROTEINS, V64, P1078, DOI 10.1002/prot.20927; Liu SP, 2006, P NATL ACAD SCI USA, V103, P15178, DOI 10.1073/pnas.0604905103; MCCLURE WR, 1971, J BIOL CHEM, V246, P3569; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MEISTER A, 1985, METHOD ENZYMOL, V113, P393; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; MULLINS LS, 1990, J BIOL CHEM, V265, P8993; NEUHAUS FC, 1962, J BIOL CHEM, V237, P778; NEUHAUS FC, 1962, BIOCHEM BIOPH RES CO, V8, P377, DOI 10.1016/0006-291X(62)90011-6; NEUHAUS FC, 1962, J BIOL CHEM, V237, P3128; NIELSEN NC, 1976, BIOCHEM BIOPH RES CO, V68, P205, DOI 10.1016/0006-291X(76)90030-9; Prosser GA, 2013, ACS MED CHEM LETT, V4, P1233, DOI 10.1021/ml400349n; Prosser GA, 2013, FEBS J, V280, P1150, DOI 10.1111/febs.12108; RATHBUN WB, 1977, EXP EYE RES, V24, P145, DOI 10.1016/0014-4835(77)90255-X; ROON RJ, 1972, J BIOL CHEM, V247, P4107; RUIZAMIL M, 1965, J BIOL CHEM, V240, P3485; Sato M, 2005, J BIOSCI BIOENG, V99, P623, DOI 10.1263/jbb.99.623; Sato M, 2006, BIOSCI BIOTECH BIOCH, V70, P2790, DOI 10.1271/bbb.60307; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHASHI K, 1990, BIOCHIM BIOPHYS ACTA, V1033, P23, DOI 10.1016/0304-4165(90)90189-4; SHI Y, 1995, BIOCHEMISTRY-US, V34, P2768, DOI 10.1021/bi00009a005; Shisler KA, 2017, J AM CHEM SOC, V139, P11803, DOI 10.1021/jacs.7b04883; Sidey V, 2016, ACTA CRYSTALLOGR B, V72, P626, DOI 10.1107/S2052520616008064; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SNOKE JE, 1955, J BIOL CHEM, V213, P813; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Thoden JB, 1999, ACTA CRYSTALLOGR D, V55, P8, DOI 10.1107/S0907444998006234; WARREN GB, 1974, BIOCHEM J, V139, P297, DOI 10.1042/bj1390297; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZAWADZKE LE, 1991, BIOCHEMISTRY-US, V30, P1673, DOI 10.1021/bi00220a033; Zeczycki Tonya N, 2010, Open Enzym Inhib J, V3, P8	58	8	8	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7894	7904		10.1074/jbc.RA120.012936	http://dx.doi.org/10.1074/jbc.RA120.012936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32335509	Green Published, hybrid			2022-12-26	WOS:000540935400007
J	Rinaldi, J; Sokol, ES; Hartmaier, RJ; Trabucco, SE; Frampton, GM; Goldberg, ME; Albacker, LA; Daemen, A; Manning, G				Rinaldi, Jacob; Sokol, Ethan S.; Hartmaier, Ryan J.; Trabucco, Sally E.; Frampton, Garrett M.; Goldberg, Michael E.; Albacker, Lee A.; Daemen, Anneleen; Manning, Gerard			The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors	PLOS ONE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; ACTIVATING ESR1 MUTATIONS; ADJUVANT CHEMOTHERAPY; CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; DNMT3A MUTATIONS; DNA; TRASTUZUMAB; THERAPY	Background Metastatic breast cancer is the leading cause of cancer death in women, but the genomics of metastasis in breast cancer are poorly studied. Methods We explored a set of 11,616 breast tumors, including 5,034 metastases, which had undergone targeted sequencing during standard clinical care. Results Besides the known hotspot mutations in ESR1, we observed a metastatic enrichment of previously unreported, lower-prevalence mutations in the ligand-binding domain, implying that these mutations may also be functional. Furthermore, individual ESR1 hotspots are significantly enriched in specific metastatic tissues and histologies, suggesting functional differences between these mutations. Other alterations enriched across all metastases include loss of function of the CDK4 regulator CDKN1B, and mutations in the transcription factor CTCF. Mutations enriched at specific metastatic sites generally reflect biology of the target tissue and may be adaptations to growth in the local environment. These include PTEN and ASXL1 alterations in brain metastases and NOTCH1 alterations in skin. We observed an enrichment of KRAS, KEAP1, STK11 and EGFR mutations in lung metastases. However, the patterns of other mutations in these tumors indicate that these are misdiagnosed lung primaries rather than breast metastases. Conclusions An order-of-magnitude increase in samples relative to previous studies allowed us to detect novel genomic characteristics of metastatic cancer and to expand and clarify previous findings.	[Rinaldi, Jacob; Daemen, Anneleen; Manning, Gerard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Sokol, Ethan S.; Hartmaier, Ryan J.; Trabucco, Sally E.; Frampton, Garrett M.; Goldberg, Michael E.; Albacker, Lee A.] Fdn Med, Cambridge, MA USA	Roche Holding; Genentech; Foundation Medicine	Rinaldi, J; Manning, G (corresponding author), Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA.	jacob.rinaldi@gmail.com; manning@manninglab.org	Manning, Gerard/C-8308-2009	Daemen, Anneleen/0000-0001-6287-7105; Frampton, Garrett/0000-0002-2361-2750				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; [Anonymous], FULL TEXT VIEW; [Anonymous], HER2 NEG BREAST CANC; [Anonymous], EFF SAF TREATM ALP P; [Anonymous], AZD5363 PAT ADV SOL; Bahreini A, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0851-4; Bhattacharya A, 2017, FASEB J, V31; Bhattacharya S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0075-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burstein MD, 2014, CLIN CANC RES; Chandarlapaty S, 2016, JAMA ONCOL, V2, P1310, DOI 10.1001/jamaoncol.2016.1279; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Clatot F, 2017, AGING-US, V9, P17, DOI 10.18632/aging.101165; Coombs CC, 2017, CELL STEM CELL, V21, P374, DOI 10.1016/j.stem.2017.07.010; Daemen A, 2012, TRANSL CANCER RES, V1, P279, DOI 10.3978/j.issn.2218-676X.2012.10.05; Desmedt C, 2019, NPJ BREAST CANCER, V5, DOI 10.1038/s41523-019-0104-z; Fabrice Andre, 2018, GENOMIC CHARACTERIZA; Filippova GN, 2002, CANCER RES, V62, P48; Finn RS, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0661-5; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Fulvestrant, PALBOCICLIB ERDAFITI; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartmaier R. J., 2016, CANC RES CANRES, P2479; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Jatoi I., 2016, MANAGEMENT BREAST DI; Jay JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160519; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lefebvre C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002201; Leong PP, 1998, JNCI-J NATL CANCER I, V90, P972, DOI 10.1093/jnci/90.13.972; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lindsay Angus, 2018, GENOMIC LANDSCAPE 50; Ohqaki H., 2004, CANCER RES, V64; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Pereira B., 2016, NAT COMMUN, V7; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Reichrath J, 2012, ADV EXP MED BIOL, V727, P265, DOI 10.1007/978-1-4614-0899-4_20; Robertson JFR, 2016, LANCET, V388, P2997, DOI 10.1016/S0140-6736(16)32389-3; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Severson E. A., 2018, BLOOD; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Sledge GW, 2014, J CLIN ONCOL, V32, P1979, DOI 10.1200/JCO.2014.55.4139; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Spoerke JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11579; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Sun JX, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005965; Team RC, 2015, LANG ENV STAT COMP V; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Tomlinson DC, 2012, INT J CANCER, V130, P2857, DOI 10.1002/ijc.26304; Torre L.A., 2017, GLOBAL CANC WOMEN BU; Toy W, 2017, CANCER DISCOV, V7, P277, DOI 10.1158/2159-8290.CD-15-1523; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; Zehir A, 2017, NAT MED, V23	70	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0231999	10.1371/journal.pone.0231999	http://dx.doi.org/10.1371/journal.pone.0231999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374727	Green Published, gold			2022-12-26	WOS:000537283500013
J	Baldwin, AK; Spanjer, AR; Rosen, MR; Thom, T				Baldwin, Austin K.; Spanjer, Andrew R.; Rosen, Michael R.; Thom, Theresa			Microplastics in Lake Mead National Recreation Area, USA: Occurrence and biological uptake	PLOS ONE			English	Article							MALE COMMON CARP; CYPRINUS-CARPIO; CONTAMINANT; POLLUTION; IDENTIFICATION; ACCUMULATION; BIOMARKERS; INGESTION; SEDIMENT; PLASTICS	Microplastics are an environmental contaminant of growing concern, but there is a lack of information about microplastic distribution, persistence, availability, and biological uptake in freshwater systems. This is especially true for large river systems like the Colorado River that spans multiple states through mostly rural and agricultural land use. This study characterized the quantity and morphology of microplastics in different environmental compartments in two large reservoirs along the Colorado River: Lakes Mead and Mohave, within Lake Mead National Recreation Area. To assess microplastic occurrence, surface water and surficial sediment were sampled at a total of nine locations. Sampling locations targeted different sub-basins with varying levels of anthropogenic impact. Las Vegas Wash, a tributary which delivers treated wastewater to Lake Mead, was also sampled. A sediment core (33 cm long, representing approximately 19 years) was extracted from Las Vegas Bay to assess changes in microplastic deposition over time. Striped bass (Morone saxatilis), common carp (Cyprinus carpio), quagga mussels (Dreissena bugensis), and Asian clams (Corbicula fluminea) were sampled at a subset of locations to assess biological uptake of microplastics. Microplastic concentrations were 0.44-9.7 particles/cubic meter at the water surface and 87.5-1,010 particles/kilogram dry weight (kg dw) at the sediment surface. Sediment core concentrations were 220-2,040 particles/kg dw, with no clear increasing or decreasing trend over time. Shellfish microplastic concentrations ranged from 2.7-105 particles/organism, and fish concentrations ranged from 0-19 particles/organism. Fibers were the most abundant particle type found in all sample types. Although sample numbers are small, microplastic concentrations appear to be higher in areas of greater anthropogenic impact. Results from this study improve our understanding of the occurrence and biological uptake of microplastics in Lake Mead National Recreation Area, and help fill existing knowledge gaps on microplastics in freshwater environments in the southwestern U.S.	[Baldwin, Austin K.] US Geol Survey, Idaho Water Sci Ctr, Boise, ID 83702 USA; [Spanjer, Andrew R.] US Geol Survey, Washington Water Sci Ctr, Tacoma, WA USA; [Rosen, Michael R.] US Geol Survey, Calif Water Sci Ctr, Carson City, NV USA; [Thom, Theresa] Natl Pk Serv, Lake Mead Natl Recreat Area, Boulder City, NV USA; [Thom, Theresa] US Fish & Wildlife Serv, Fisheries & Aquat Conservat, Portland, OR USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior; US Fish & Wildlife Service	Baldwin, AK (corresponding author), US Geol Survey, Idaho Water Sci Ctr, Boise, ID 83702 USA.	akbaldwi@usgs.gov		Spanjer, Andrew/0000-0002-7288-2722	Water Quality Partnership Program of the U.S. Geological Survey; U.S. National Park Service	Water Quality Partnership Program of the U.S. Geological Survey; U.S. National Park Service	Funding was provided to AKB by the Water Quality Partnership Program of the U.S. Geological Survey and the U.S. National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2019, ENVIRON TOXICOL CHEM, V38, P436, DOI 10.1002/etc.4323; ALLEN S, 2019, NAT GEOSCI, V122, P1; Baldwin AK, 2019, US GEOL SURV DATA RE, DOI [10.5066/P9V1MNHH, DOI 10.5066/P9V1MNHH]; Baldwin AK, 2016, ENVIRON SCI TECHNOL, V50, P10377, DOI 10.1021/acs.est.6b02917; Ballent A, 2016, MAR POLLUT BULL, V110, P383, DOI 10.1016/j.marpolbul.2016.06.037; Barrows APW, 2016, ANAL METHODS; Besseling E, 2015, MAR POLLUT BULL, V95, P248, DOI 10.1016/j.marpolbul.2015.04.007; Bevans HE, 1996, 964266 US DEP INT US; Browne MA, 2007, INTEGR ENVIRON ASSES, V3, P559, DOI 10.1002/ieam.5630030412; Cai LQ, 2017, ENVIRON SCI POLLUT R, V24, P24928, DOI 10.1007/s11356-017-0116-x; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Collard F, 2019, ENVIRON SCI TECHNOL, V53, P12974, DOI 10.1021/acs.est.9b03083; Corcoran PL, 2015, ENVIRON POLLUT, V204, P17, DOI 10.1016/j.envpol.2015.04.009; Desforges JPW, 2015, ARCH ENVIRON CON TOX, V69, P320, DOI 10.1007/s00244-015-0172-5; Dris R, 2016, MAR POLLUT BULL; Dris R, 2018, SCI TOTAL ENVIRON, V618, P157, DOI 10.1016/j.scitotenv.2017.11.009; Dris R, 2015, ENVIRON CHEM, V12, P592, DOI 10.1071/EN14167; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Foley CJ, 2018, SCI TOTAL ENVIRON, V631-632, P550, DOI 10.1016/j.scitotenv.2018.03.046; Goodbred SL, 2015, GEN COMP ENDOCR, V219, P125, DOI 10.1016/j.ygcen.2015.02.015; Gregory MR, 1996, MAR POLLUT BULL, V32, P867, DOI 10.1016/S0025-326X(96)00047-1; Hartline NL, 2016, ENVIRON SCI TECHNOL, V50, P11532, DOI 10.1021/acs.est.6b03045; Hoellein TJ, 2017, FRESHW SCI; Jenkins JA, 2018, ENVIRON RES, V163, P149, DOI 10.1016/j.envres.2018.01.041; Kapp KJ, 2018, ENVIRON POLLUT, V241, P1082, DOI 10.1016/j.envpol.2018.06.033; Koelmans AA, 2019, WATER RES, V155, P410, DOI 10.1016/j.watres.2019.02.054; Kole PJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101265; Kuhn S, 2017, MAR POLLUT BULL, V115, P86, DOI 10.1016/j.marpolbul.2016.11.034; Lavers JL, 2014, ENVIRON POLLUT, V187, P124, DOI 10.1016/j.envpol.2013.12.020; Leiker TJ, 2009, SCI TOTAL ENVIRON, V407, P2102, DOI 10.1016/j.scitotenv.2008.11.009; Lenaker PL, 2019, ENVIRON SCI TECHNOL, V53, P12227, DOI 10.1021/acs.est.9b03850; Lenz R, 2015, MAR POLLUT BULL, V100, P82, DOI 10.1016/j.marpolbul.2015.09.026; Li JY, 2018, WATER RES, V137, P362, DOI 10.1016/j.watres.2017.12.056; Lorimer IAJ, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B223; Mason SA, 2016, ENVIRON POLLUT, V218, P1045, DOI 10.1016/j.envpol.2016.08.056; Masura J., 2015, LAB METHODS ANAL MIC, DOI DOI 10.25607/OBP-604; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; Meng YC, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113445; Munno K, 2018, ENVIRON TOXICOL CHEM, V37, P91, DOI 10.1002/etc.3935; National Park Service,, 2019, YELL NAT PARK SUMM 2; Patino R, 2003, J AQUAT ANIM HEALTH, V15, P55, DOI 10.1577/1548-8667(2003)015&lt;0055:MAHPOG&gt;2.0.CO;2; Patino R, 2015, GEN COMP ENDOCR, V219, P112, DOI 10.1016/j.ygcen.2014.12.013; Patino R, 2012, SCI TOTAL ENVIRON, V416, P215, DOI 10.1016/j.scitotenv.2011.11.082; Peck S, 1987, BENTHIC INVERTEBRATE, P93; Peng X, 2018, GEOCHEM PERSPECT LET, V9, P1, DOI 10.7185/geochemlet.1829; Peters CA, 2016, ENVIRON POLLUT, V210, P380, DOI 10.1016/j.envpol.2016.01.018; R Core Team, 2013, R LANG ENV STAT COMP; Ribeiro F, 2019, TRAC-TREND ANAL CHEM, V111, P139, DOI 10.1016/j.trac.2018.12.010; Rochman CM, 2019, ENVIRON TOXICOL CHEM, V38, P703, DOI 10.1002/etc.4371; Rochman CM, 2016, ECOLOGY, V97, P302, DOI 10.1890/14-2070.1; Rosen M. J., 2009, Society for Neuroscience Abstract Viewer and Itinerary Planner, V39; Rosen MR, 2010, PALAEOGEOGR PALAEOCL, V294, P30, DOI 10.1016/j.palaeo.2009.03.017; Rosen MR, 2012, 1381 USGS, V1381; Silva AB, 2018, ANAL CHIM ACTA, V1017, P1, DOI 10.1016/j.aca.2018.02.043; Song YK, 2015, MAR POLLUT BULL, V93, P202, DOI 10.1016/j.marpolbul.2015.01.015; Song YK, 2014, ENVIRON SCI TECHNOL, V48, P9014, DOI 10.1021/es501757s; Su L, 2018, ENVIRON POLLUT, V234, P347, DOI 10.1016/j.envpol.2017.11.075; Turner S, 2019, J PALEOLIMNOL, V61, P449, DOI 10.1007/s10933-019-00071-7; Twiss MR, 2016, J GREAT LAKES RES, V42, P921, DOI 10.1016/j.jglr.2016.07.032; U.S. National Park Service, 2019, FACT SHEET LAK MEAD; Wetherbee G. A., 2019, IT IS RAINING PLASTI; Wetherbee G.A., 2019, 20191048 US GEOL SUR; Wittmann ME, 2010, LAKE RESERV MANAGE, V26, P316, DOI 10.1080/07438141.2010.519855; Xu S, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134699	64	42	42	22	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0228896	10.1371/journal.pone.0228896	http://dx.doi.org/10.1371/journal.pone.0228896			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365121	Green Published, gold			2022-12-26	WOS:000536959700005
J	HaCohen-Kerner, Y; Miller, D; Yigal, Y				HaCohen-Kerner, Yaakov; Miller, Daniel; Yigal, Yair			The influence of preprocessing on text classification using a bag-of-words representation	PLOS ONE			English	Article							STYLISTIC FEATURE SETS; HISTORICAL PERIOD; CLASSIFIERS; DOCUMENTS	Text classification (TC) is the task of automatically assigning documents to a fixed number of categories. TC is an important component in many text applications. Many of these applications perform preprocessing. There are different types of text preprocessing, e.g., conversion of uppercase letters into lowercase letters, HTML tag removal, stopword removal, punctuation mark removal, lemmatization, correction of common misspelled words, and reduction of replicated characters. We hypothesize that the application of different combinations of preprocessing methods can improve TC results. Therefore, we performed an extensive and systematic set of TC experiments (and this is our main research contribution) to explore the impact of all possible combinations of five/six basic preprocessing methods on four benchmark text corpora (and not samples of them) using three ML methods and training and test sets. The general conclusion (at least for the datasets verified) is that it is always advisable to perform an extensive and systematic variety of preprocessing methods combined with TC experiments because it contributes to improve TC accuracy. For all the tested datasets, there was always at least one combination of basic preprocessing methods that could be recommended to significantly improve the TC using a BOW representation. For three datasets, stopword removal was the only single preprocessing method that enabled a significant improvement compared to the baseline result using a bag of 1,000-word unigrams. For some of the datasets, there was minimal improvement when we removed HTML tags, performed spelling correction or removed punctuation marks, and reduced replicated characters. However, for the fourth dataset, the stopword removal was not beneficial. Instead, the conversion of uppercase letters into lowercase letters was the only single preprocessing method that demonstrated a significant improvement compared to the baseline result. The best result for this dataset was obtained when we performed spelling correction and conversion into lowercase letters. In general, for all the datasets processed, there was always at least one combination of basic preprocessing methods that could be recommended to improve the accuracy results when using a bag-of-words representation.	[HaCohen-Kerner, Yaakov; Miller, Daniel; Yigal, Yair] Lev Acad Ctr, Jerusalem Coll Technol, Dept Comp Sci, Jerusalem, Israel		HaCohen-Kerner, Y (corresponding author), Lev Acad Ctr, Jerusalem Coll Technol, Dept Comp Sci, Jerusalem, Israel.	kerner@jct.ac.il		HaCohen-Kerner, Yaakov/0000-0002-4834-1272				Almeida TA, 2011, DOCENG 2011: PROCEEDINGS OF THE 2011 ACM SYMPOSIUM ON DOCUMENT ENGINEERING, P259; [Anonymous], 1998, 4 U DATA SET; Argamon S, 2007, J AM SOC INF SCI TEC, V58, P802, DOI 10.1002/asi.20553; Ayedh A, 2016, ALGORITHMS, V9, DOI 10.3390/a9020027; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cardoso-Cachopo A., 2020, DAT SINGL LAB TEXT C; Christensen R., 2006, LOG LINEAR MODELS LO; Clark E, 2011, PROCD SOC BEHV, V27, P2, DOI 10.1016/j.sbspro.2011.10.577; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Craven M, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P509; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Fix E., 1951, DISCRIMINATORY ANAL; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Fox C., 1990, SIGIR Forum, V24, P19, DOI 10.1145/378881.378888; Goncalves CA, 2010, PATTERN RECOGNITION IN INFORMATION SYSTEMS, P53; Hacohen-Kerner Y, 2003, COMPUTER APPLICATIONS IN INDUSTRY AND ENGINEERING, P172; HaCohen-Kerner Y., 2019, P 19 IND C DAT MIN I, P52; Hacohen-Kerner Y, 2008, CYBERNET SYST, V39, P213, DOI 10.1080/01969720801944299; HaCohen-Kerner Y, 2018, PROCEDIA COMPUT SCI, V126, P69, DOI 10.1016/j.procs.2018.07.210; HaCohen-Kerner Y, 2015, LECT NOTES COMPUT SC, V9398, P64, DOI 10.1007/978-3-319-27932-9_6; HaCohen-Kerner Y, 2010, J AM SOC INF SCI TEC, V61, P1644, DOI 10.1002/asi.21350; HaCohen-Kerner Y, 2010, APPL ARTIF INTELL, V24, P847, DOI 10.1080/08839514.2010.514197; Haddi E, 2013, PROCEDIA COMPUT SCI, V17, P26, DOI 10.1016/j.procs.2013.05.005; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heckerman D, 1997, DATA MIN KNOWL DISC, V1, P79, DOI 10.1023/A:1009730122752; HORMANN AM, 1962, INFORM CONTROL, V5, P347, DOI 10.1016/S0019-9958(62)90649-6; JAYNES ET, 1991, FUND THEOR, V43, P1; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kessler B, 1997, 35TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 8TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P32; Knight K, 1999, COMMUN ACM, V42, P58, DOI 10.1145/319382.319394; Kohavi R, 1995, LECT NOTES ARTIF INT, V912, P174; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Kotzias D, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P597, DOI 10.1145/2783258.2783380; Krouska A, 2017, J UNIVERS COMPUT SCI, V23, P755; Mendez J. R., 2005, C SPAN ASS ART INT, P449; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Pomikalek J, 2007, PROC WRLD ACAD SCI E, V19, P430; Pourret O., 2008, BAYESIAN NETWORKS PR, V73; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; SALTON G, 1991, SCIENCE, V253, P974, DOI 10.1126/science.253.5023.974; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Song FX, 2005, PATTERN ANAL APPL, V8, P199, DOI 10.1007/s10044-005-0256-3; Srividhya V., 2010, INT J COMPUT SCI APP, V47, P49; Tagg C., 2009, THESIS; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Toman M., 2006, PROC INSCIT, V4, P354; Uysal AK, 2014, INFORM PROCESS MANAG, V50, P104, DOI 10.1016/j.ipm.2013.08.006; Virvou M., 2016, 2016 7 INT C INF INT, P1; Witten IH, 2011, MOR KAUF D, P1; Zhao JQ, 2017, IEEE ACCESS, V5, P2870, DOI 10.1109/ACCESS.2017.2672677	52	30	30	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232525	10.1371/journal.pone.0232525	http://dx.doi.org/10.1371/journal.pone.0232525			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357164	Green Published, gold			2022-12-26	WOS:000536957700036
J	Lytle, AJ; Costa, JT; Warren, RJ				Lytle, A. J.; Costa, J. T.; Warren, R. J., II			Invasion and high-elevation acclimation of the red imported fire ant, Solenopsis invicta, in the southern Blue Ridge Escarpment region of North America	PLOS ONE			English	Article							THERMAL TOLERANCE; HYMENOPTERA; FORMICIDAE; EVOLUTION	The red imported fire ant (Solenopsis invicta) is a non-native invasive species that rapidly spread northward in the United States after its introduction from South America in the 1930s. Researchers predicted that the northward spread of this invasive ant would be limited by cold temperatures with increased latitude and greater elevation in the Blue Ridge Escarpment region of the United States. The presence of S. invicta at relatively high elevations north of their projected limits suggests greater cold tolerance than previously predicted; however, these populations might be ephemeral indications of strong dispersal abilities. In this study, we investigated potential physiological adaptations of S. invicta that would indicate acclimation to high elevation environments. We hypothesized that if S. invicta colonies can persist in colder climates than where they originated, we would find gradients in S. invicta worker cold tolerance along a montane elevational gradient. We also predicted that higher elevation S. invicta ants might incur greater physiological costs to persist in the colder climate, so we measured colony lipid content to assess health status. For comparison, we also collected physiological temperature tolerance data for the co-occurring dominant native woodland ant Aphaenogaster picea. We found that S. invicta occurring at higher elevations exhibited greater physiological tolerance for cold temperatures as compared to lower-elevation conspecifics-a cold tolerance pattern that paralleled of the native A. picea ants along the same gradient. Both S. invicta and A. picea similarly exhibited lower thermal tolerances for colder temperatures when moving up the elevational gradient, with A. picea consistently exhibiting a lower thermal tolerance overall. There was no change in S. invicta colony lipid content with elevation, suggesting that greater metabolic rates were not needed to sustain these ants at high elevations.	[Lytle, A. J.; Costa, J. T.] Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA; [Costa, J. T.] Highlands Biol Stn, Highlands, NC USA; [Warren, R. J., II] SUNY Buffalo State, Dept Biol, Buffalo, NY USA; [Lytle, A. J.] North Carolina State Univ, Raleigh, NC 27695 USA	University of North Carolina; Western Carolina University; State University of New York (SUNY) System; Buffalo State College; University of North Carolina; North Carolina State University	Lytle, AJ (corresponding author), Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA.; Lytle, AJ (corresponding author), North Carolina State Univ, Raleigh, NC 27695 USA.	ajlaffe2@ncsu.edu		Lytle, Amanda/0000-0003-2210-1147; Warren II, Robert/0000-0001-6765-2351; Costa, James/0000-0002-5519-2754	Highlands Biological Foundation, Inc [HBS-GIA-2017-05]	Highlands Biological Foundation, Inc	Amanda Lafferty (A.J.L) received funding from a Grant-in-Aid of Research and Ralph Sargent Scholarship provided by the Highlands Biological Foundation, Inc (Grant number HBS-GIA-2017-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; [Anonymous], 2021, LANG ENV STAT COMP; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Baudier KM, 2018, AM NAT, V192, P347, DOI 10.1086/698656; Bentley MT, 2016, ENVIRON ENTOMOL, V45, P1058, DOI 10.1093/ee/nvw050; Bertelsmeier C, 2015, BIODIVERS CONSERV, V24, P117, DOI 10.1007/s10531-014-0794-3; Bishop TR, 2017, ECOL ENTOMOL, V42, P105, DOI 10.1111/een.12364; BUREN W F, 1972, Journal of the Georgia Entomological Society, V7, P1; Diamond SE, 2017, BIOL J LINN SOC, V121, P248, DOI 10.1093/biolinnean/blw047; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; Korzukhin MD, 2001, ENVIRON ENTOMOL, V30, P645, DOI 10.1603/0046-225X-30.4.645; Lubertazzi David, 2012, Psyche (Cambridge), V2012, DOI 10.1155/2012/752815; Ness JH, 2009, OIKOS, V118, P1793, DOI 10.1111/j.1600-0706.2009.17430.x; RYKIEL EJ, 1985, AUST J ECOL, V10, P361, DOI 10.1111/j.1442-9993.1985.tb00897.x; Smith Chris R, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5243; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; Tschinkel WR, 2006, FIRE ANTS; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Warren RJ, 2020, BIOL INVASIONS, V22, P813, DOI 10.1007/s10530-019-02133-3; Warren RJ, 2016, INSECT SOC, V63, P593, DOI 10.1007/s00040-016-0504-0; Warren RJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00318.1; Warren RJ, 2013, GLOBAL CHANGE BIOL, V19, P2082, DOI 10.1111/gcb.12169; Wendt CF, 2016, SOUTHWEST NAT, V61, P79, DOI 10.1894/0038-4909-61.1.79; Wheeler WM, 1908, J NEW YORK ENTOMOL S, V16, P68; Yeary-Johnson K., 2014, I ENV HIGHL F SITE, P67	27	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232264	10.1371/journal.pone.0232264	http://dx.doi.org/10.1371/journal.pone.0232264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357179	Green Published, gold			2022-12-26	WOS:000536957700021
J	Scherbov, S; Gietel-Basten, S				Scherbov, Sergei; Gietel-Basten, Stuart			Measuring inequalities of development at the sub-national level: From the human development index to the human life indicator	PLOS ONE			English	Article							MORTALITY; QUALITY	Despite being one of the most common measures of development, the Human Development Index [HDI] has been much criticized for its consistency, data requirements, difficulty of interpretation and trade-offs between indicators. The 'Human Life Indicator' [HLI] has been proposed as a 'simple effective means' of measuring development and, more specifically, as a viable alternative to the HDI. Reducing inequalities within countries is a core component of the Sustainable Development Goals; yet sub-national HDIs are subject to the same criticisms as national level indices (potentially more so). Our goal in this paper is to demonstrate 'proof of concept' in terms of the systematic application of the HLI to measure development at the subnational level. Using life tables for the United States of America, we calculate, for the first time, HLIs for each state for the period 1959-2016. This country was chosen for the comparatively long run of available sub-national life tables. We also calculate the extent to which mortality is distributed across the life course-a further measure of inequality and the role of the social determinants of health. The HLI clearly shows how striking regional inequalities exist across the United States. We find that HLI and HDI for the most recent time period are strongly correlated. The analysis demonstrates that HLI represents an effective means of measuring development at the sub-national level. Compared to HDI, HLIs are characterized by simpler calculation and interpretation; fewer data requirements; less measurement error; more consistency over time; and no trade-offs between components. A current challenge of producing sub-national HLIs is the lack of comprehensive civil registration and vital statistics systems in many parts of the Global South from which sub-national life tables can be generated. However, as more and more countries develop these systems the potential to produce HLIs will inevitably increase.	[Scherbov, Sergei] Int Inst Appl Syst Anal, World Populat Program, Laxenburg, Austria; [Scherbov, Sergei] Russian Presidential Acad Natl Econ & Publ Adm, Int Lab Demog & Human Capital, Moscow, Russia; [Gietel-Basten, Stuart] Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Hong Kong, Peoples R China	International Institute for Applied Systems Analysis (IIASA); Russian Presidential Academy of National Economy & Public Administration; Hong Kong University of Science & Technology	Gietel-Basten, S (corresponding author), Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Hong Kong, Peoples R China.	sgb@ust.hk		Scherbov, Sergei/0000-0002-0881-1073	European Union [635316]	European Union(European Commission)	SS received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 635316 (Project Name: Ageing Trajectories of Health: Longitudinal Opportunities and Synergies, ATHLOS).	AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2; [Anonymous], 2010, HUMAN DEV REPORT 201; [Anonymous], 2018, QUARTZ          1108; Bedi RS, 2018, STAR; Castles I, 1998, POPUL DEV REV, V24, P831, DOI 10.2307/2808029; CDC, 2019, HIV US REG; CDC, 2019, DRUG OV MORT STAT; CDC, 2019, INF MORT RAT STAT; Centers for Disease Control and Prevention, 2001, Morbidity and Mortality Weekly Report, V50, P430; Dasgupta N, 2018, AM J PUBLIC HEALTH, V108, P182, DOI 10.2105/AJPH.2017.304187; DASGUPTA P, 1992, WORLD DEV, V20, P119, DOI 10.1016/0305-750X(92)90141-H; DC Fiscal Policy Institute, 2017, INC IN DC HIGH COUNT; Deaton A, 2017, AM ECON J-MACROECON, V9, P243, DOI 10.1257/mac.20150153; Dorling D., 2018, WHY DEMOGRAPHY MATTE; Ghislandi S, 2019, POPUL DEV REV, V45, P219, DOI 10.1111/padr.12205; Institute for Management Research Radboud University, 2019, SUBN HUM DEV IND; International Institute for Applied Systems Analysis (IIASA), 2019, US AG DAT SHEET 2019; Juran Sabrina, 2017, STAT J IAOS, V33, P399; KELLEY AC, 1991, POPUL DEV REV, V17, P315, DOI 10.2307/1973733; KLEINMAN JC, 1986, AM J PUBLIC HEALTH, V76, P681, DOI 10.2105/AJPH.76.6.681; KUMAR AKS, 1991, ECON POLIT WEEKLY, V26, P2343; Kundu T., 2015, WHY KERALA IS MALDIV; Larroca SGT, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1515-1; Lay B., 2018, MOTHERSHIP; Malik K., 2014, HUMAN DEV REPORT 201; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; MCGILLIVRAY M, 1991, WORLD DEV, V19, P1461, DOI 10.1016/0305-750X(91)90088-Y; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Mills Abouzahr S, 2017, CIVIL REGISTRATION V; Murray CJL, 2000, WHO SYSTEM MODEL LIF; Myrskyla M, 2009, NATURE, V460, P741, DOI 10.1038/nature08230; OGWANG T, 1994, WORLD DEV, V22, P2011, DOI 10.1016/0305-750X(94)90189-9; Ravallion M, 2010, TROUBLING TRADEOFFS; Sen A, 1998, ECON J, V108, P1, DOI 10.1111/1468-0297.00270; Skinner C, 2018, ANNU REV STAT APPL, V5, P49, DOI 10.1146/annurev-statistics-041715-033713; Smits J, 2019, SCI DATA, V6, DOI 10.1038/sdata.2019.38; StatsNZ, 2016, PER LIF TABL; Suryanarayana M.H., 2011, INEQUALITY ADJUSTED, P31; Suthar AB, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002929, 10.1371/journal.pmed.1002929.r001, 10.1371/journal.pmed.1002929.r002, 10.1371/journal.pmed.1002929.r003, 10.1371/journal.pmed.1002929.r004, 10.1371/journal.pmed.1002929.r005]; U.S. Census Bureau, 2017, 2013 2017 AM COMM SU; UNDP, 2021, HUMAN DEV INDEX HDI; UNDP, 2019, TECHN NOT CALC HUM D; UNDP China and Institute for Urban and Environmental Studies Chinese Academy of Social Sciences, 2013, CHIN NAT HUM DEV REP; United Nations Development Programme (UNDP) The Human Development Index (HDI), 2015, TRAIN MAT PROD NAT H; University of California Berkeley (USA), 2019, US MORT DATABASE; University of California Berkeley (USA) Max Planck Institute for Demographic Research (Germany), 2013, HUM MORT DAT; UNSD, 2019, RED IN COUNTR UN SUS; US Census Bureau, 2019, INC; Wilson T., 2018, GEO J GENDER L; Wolff H, 2011, ECON J, V121, P843, DOI 10.1111/j.1468-0297.2010.02408.x	50	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232014	10.1371/journal.pone.0232014	http://dx.doi.org/10.1371/journal.pone.0232014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32352971	Green Published, Green Accepted, gold			2022-12-26	WOS:000536673200034
J	Yang, YH; He, XM; Cheng, R; Chen, Q; Shan, CY; Chen, LM; Ma, JX				Yang Yanhui; He Xuemin; Cheng Rui; Chen Qian; Shan Chunyan; Chen Liming; Ma Jian-xing			Diabetes-induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation	FASEB JOURNAL			English	Article						diabetic nephropathy; fibrosis; hypoxia; kallikrein; kallistatin; kidney; RAS	KALLIKREIN-KININ SYSTEM; EPITHELIUM-DERIVED FACTOR; RENIN-ANGIOTENSIN SYSTEM; TISSUE KALLIKREIN; MICROVASCULAR COMPLICATIONS; RENAL-DISEASES; WNT PATHWAY; PPAR-ALPHA; INHIBITION; INFLAMMATION	Kallistatin is an inhibitor of tissue kallikrein and also inhibits the Wnt pathway. Its role in diabetic nephropathy (DN) is uncertain. Here we reported that serum kallistatin levels were significantly increased in diabetic patients with DN compared to those in diabetic patients without DN and healthy controls, and positively correlated with urinary albumin excretion. In addition, renal kallistatin levels were significantly upregulated in mouse models of type 1 (Akita, OVE26) and type 2 diabetes (db/db). To unveil the effects of kallistatin on DN and its underlying mechanism, we crossed transgenic mice overexpressing kallistatin with OVE26 mice (KS-tg/OVE). Kallistatin overexpression exacerbated albuminuria, renal fibrosis, inflammation, and oxidative stress in diabetes. Kallikrein activity was inhibited while the renin-angiotensin system (RAS) upregulated in the kidney of KS-tg/OVE mice compared to WT/OVE mice, suggesting a disturbed balance between the RAS and kallikrein-kinin systems. As shown by immunostaining of endothelial makers, renal vascular densities were decreased accompanied by increased HIF-1 alpha and erythropoietin levels in the kidneys of KS-tg/OVE mice. Taken together, high levels of kallistatin exacerbate DN at least partly by inducing RAS overactivation and hypoxia. The present study demonstrated a positive correlation between kallistatin levels and DN, suggesting a potential biomarker for prognosis of DN.	[Yang Yanhui; Shan Chunyan; Chen Liming] Tianjin Med Univ, Chu Hsien I Mem Hosp, NHC Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Yang Yanhui; Shan Chunyan; Chen Liming] Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Yang Yanhui; He Xuemin; Cheng Rui; Chen Qian; Ma Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, BSEB 328B,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA; [He Xuemin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol & Metab Dis, Guangzhou, Peoples R China	Tianjin Medical University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sun Yat Sen University	Ma, JX (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, BSEB 328B,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.; Chen, LM (corresponding author), Tianjin Med Univ, Chu Hsien I Mem Hosp, Tianjin 300134, Peoples R China.	xfx22081@vip.163.com; jian-xing-ma@ouhsc.edu	He, Xuemin/HGA-1805-2022	He, Xuemin/0000-0001-9231-4426	NIH [EY012231, EY018659, EY019309, EY028949, GM122744]; JDRF [SRA2019-711-S-B]; OCAST grant [HR16041]; National Nature Science Foundation of China [81700631]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); OCAST grant; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by NIH grants EY012231, EY018659, EY019309, EY028949, GM122744, JDRF grant SRA2019-711-S-B (JXM), OCAST grant HR16041, National Nature Science Foundation of China 81700631.	Amundsen E, 1979, Adv Exp Med Biol, V120A, P83; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Bodin S, 2009, KIDNEY INT, V76, P395, DOI 10.1038/ki.2009.208; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; CHAO J, 1990, J BIOL CHEM, V265, P16394; Chao J, 2001, BIOL CHEM, V382, P15, DOI 10.1515/BC.2001.003; Chao J, 1998, HUM GENE THER, V9, P21, DOI 10.1089/hum.1998.9.1-21; Chao JL, 1996, J LAB CLIN MED, V127, P612, DOI 10.1016/S0022-2143(96)90152-3; Chao J, 2006, BIOL CHEM, V387, P665, DOI 10.1515/BC.2006.085; Chen Y, 2013, DIABETES, V62, P261, DOI 10.2337/db11-0413; Cheng R, 2016, DIABETES, V65, P3730, DOI 10.2337/db16-0426; Colafella KMM, 2017, HYPERTENSION, V69, P994, DOI 10.1161/HYPERTENSIONAHA.117.08931; Diao Y, 2007, WORLD J GASTROENTERO, V13, P4615, DOI 10.3748/wjg.v13.i34.4615; El Din UAAS, 2017, J ADV RES, V8, P363, DOI 10.1016/j.jare.2017.04.004; El-Asrar MA, 2015, VASC MED, V20, P509, DOI 10.1177/1358863X15591089; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Fine LG, 2000, KIDNEY INT, V57, pS22, DOI 10.1046/j.1523-1755.2000.07512.x; Franzen S, 2016, AM J PHYSIOL-RENAL, V310, pF807, DOI 10.1152/ajprenal.00049.2016; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; He XM, 2017, KIDNEY INT, V91, P642, DOI 10.1016/j.kint.2016.09.036; Jenkins Alicia J, 2010, J Angiogenes Res, V2, P19, DOI 10.1186/2040-2384-2-19; Kamiyama M, 2013, INT J MOL SCI, V14, P23045, DOI 10.3390/ijms141123045; Kim S, 2000, PHARMACOL REV, V52, P11; Kobori H, 2013, PFLUG ARCH EUR J PHY, V465, P3, DOI 10.1007/s00424-012-1143-6; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Liu WJ, 2017, CURR OPIN NEPHROL HY, V26, P351, DOI 10.1097/MNH.0000000000000344; Liu XC, 2013, DIABETES, V62, P4228, DOI 10.2337/db12-1710; Ma JX, 1996, CURR EYE RES, V15, P1117, DOI 10.3109/02713689608995143; McBride JD, 2014, J INVEST DERMATOL, V134, P1725, DOI 10.1038/jid.2014.40; Mezzano S, 2003, KIDNEY INT, V64, pS64, DOI 10.1046/j.1523-1755.64.s86.12.x; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Mima A, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/248563; Naicker S, 1999, IMMUNOPHARMACOLOGY, V44, P183, DOI 10.1016/S0162-3109(99)00089-2; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Persson P, 2017, CURR OPIN NEPHROL HY, V26, P345, DOI 10.1097/MNH.0000000000000341; Riad A, 2007, CURR OPIN NEPHROL HY, V16, P22, DOI 10.1097/MNH.0b013e328011a20c; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P2222, DOI 10.1046/j.1523-1755.2001.00737.x; Roksnoer LCW, 2016, HYPERTENSION, V67, P927, DOI 10.1161/HYPERTENSIONAHA.115.07012; Rosatelli TB, 2005, BRIT J DERMATOL, V152, P650, DOI 10.1111/j.1365-2133.2005.06427.x; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Shen B, 2010, AM J PHYSIOL-HEART C, V299, pH1419, DOI 10.1152/ajpheart.00591.2010; Tomita H, 2012, KIDNEY INT, V81, P733, DOI 10.1038/ki.2011.499; VENIANT M, 1994, KIDNEY INT, V46, P421, DOI 10.1038/ki.1994.290; Wang CR, 2005, ARTHRITIS RHEUM-US, V52, P1319, DOI 10.1002/art.20991; Wang JJ, 2006, DIABETES, V55, P1678, DOI 10.2337/db05-1448; Xing Q, 2017, OPHTHALMIC RES, V57, P141, DOI 10.1159/000447776; Yin H, 2010, HYPERTENSION, V56, P260, DOI 10.1161/HYPERTENSIONAHA.110.152330; Yiu WH, 2016, KIDNEY INT, V89, P386, DOI 10.1038/ki.2015.331; Yoo TH, 2007, KIDNEY INT, V71, P1019, DOI 10.1038/sj.ki.5002195; Yuan HT, 2003, AM J PATHOL, V163, P2289, DOI 10.1016/S0002-9440(10)63586-9; Zhang B, 2010, DIABETES, V59, P1809, DOI 10.2337/db09-1056; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248; ZHOU GX, 1992, J BIOL CHEM, V267, P25873; Zhou T, 2012, DIABETOLOGIA, V55, P255, DOI 10.1007/s00125-011-2314-2; Zou X, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/310645	57	5	6	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8428	8441		10.1096/fj.201903149R	http://dx.doi.org/10.1096/fj.201903149R		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32352602	Green Published			2022-12-26	WOS:000530007600001
J	Yau, XH; Khe, CS; Saheed, MSM; Lai, CW; You, KY; Tan, WK				Yau, Xin Hui; Khe, Cheng Seong; Saheed, Mohamed Shuaib Mohamed; Lai, Chin Wei; You, Kok Yeow; Tan, Wai Kian			Magnetically recoverable magnetite-reduced graphene oxide as a demulsifier for surfactant stabilized crude oil-in-water emulsion	PLOS ONE			English	Article							IRON-OXIDE; NANOPARTICLES; SEPARATION; EFFICIENT; NANOCOMPOSITES; REMOVAL; NANOEMULSIONS; PERFORMANCE; ADSORPTION; COMPOSITE	Oily wastewater, especially water-oil emulsion has become serious environmental issue and received global attention. Chemical demulsifiers are widely used to treat oil-water emulsion, but the toxicity, non-recyclable and non-environmental friendly characteristic of chemical demulsifiers had limited their practical application in oil-water separation. Therefore, it is imperative to develop an efficient, simple, eco-friendly and recyclable demulsifiers for breaking up the emulsions from the oily wastewater. In this study, a magnetic demulsifier, magnetite-reduced graphene oxide (M-rGO) nanocomposites were proposed as a recyclable demulsifier to break up the surfactant stabilized crude oil-in-water (O/W) emulsion. M-rGO nanocomposites were prepared via in situ chemical synthesis by using only one type Fe salt and GO solid as precursor at room temperature. The prepared composites were fully characterized by various techniques. The effect of demulsifier dosage and pH of emulsion on demulsification efficiency (E-D) has been studied in detailed. The demulsification mechanism was also proposed in this study. Results showed that M-rGO nanocomposites were able to demulsify crude O/W emulsion. The E-D reaches 99.48% when 0.050 wt.% of M-rGO nanocomposites were added to crude O/W emulsion (pH = 4). Besides, M-rGO nanocomposites can be recycled up to 7 cycles without showing a significant change in terms of E-D. Thus, M-rGO nanocomposite is a promising demulsifier for surfactant stabilized crude O/W emulsion.	[Yau, Xin Hui; Khe, Cheng Seong; Saheed, Mohamed Shuaib Mohamed] Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Seri Iskandar, Perak, Malaysia; [Yau, Xin Hui; Khe, Cheng Seong; Saheed, Mohamed Shuaib Mohamed] Univ Teknol PETRONAS, Ctr Innovat Nanostruct & Nanodevices COINN, Seri Iskandar, Perak, Malaysia; [Lai, Chin Wei] Univ Malaya, Inst Adv Studies IAS, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur, Malaysia; [You, Kok Yeow] Univ Teknol Malaysia, Fac Elect Engn, Dept Commun Engn, Skudai, Johor, Malaysia; [Tan, Wai Kian] Toyohashi Univ Technol, Inst Liberal Arts & Sci, Toyohashi, Aichi, Japan	Universiti Teknologi Petronas; Universiti Teknologi Petronas; Universiti Malaya; Universiti Teknologi Malaysia; Toyohashi University of Technology	Khe, CS (corresponding author), Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Seri Iskandar, Perak, Malaysia.; Khe, CS (corresponding author), Univ Teknol PETRONAS, Ctr Innovat Nanostruct & Nanodevices COINN, Seri Iskandar, Perak, Malaysia.	chengseong.khe@utp.edu.my	Kian, Tan Wai/AAK-1044-2020; Lai, Chin Wei/E-7062-2013; You, Kok Yeow/HIR-3527-2022; Seong, Khe Cheng/AAA-1302-2020; Mohamed Saheed, Mohamed Shuaib/GXG-6686-2022	Kian, Tan Wai/0000-0002-0014-5475; Lai, Chin Wei/0000-0002-7549-5015; Seong, Khe Cheng/0000-0002-5494-8601; 	Yayasan Universiti Teknologi PETRONAS (YUTP) Grant [YUTP 0153AA-E40]; Fundamental Research Grant Scheme [FRGS/1/2019/STG07/UTP/02/6]	Yayasan Universiti Teknologi PETRONAS (YUTP) Grant; Fundamental Research Grant Scheme	This research is supported financially by the Yayasan Universiti Teknologi PETRONAS (YUTP) Grant (YUTP 0153AA-E40) and the Fundamental Research Grant Scheme (FRGS/1/2019/STG07/UTP/02/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman N.H., 2007, J APPL SCI, V7, P196, DOI DOI 10.3923/JAS.2007.196.201; Ahn GH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00516-5; Al-Sabagh AM, 2017, J DISPER SCI TECHNOL, V38, P288, DOI 10.1080/01932691.2016.1163720; Aunkor MTH, 2016, RSC ADV, V6, P27807, DOI 10.1039/c6ra03189g; Barroso-Solares S, 2016, RSC ADV, V6, P71100, DOI 10.1039/c6ra12246a; Bharath G, 2015, J MATER CHEM A, V3, P15529, DOI 10.1039/c5ta03179f; Boruah PK, 2017, CHEMOSPHERE, V168, P1058, DOI 10.1016/j.chemosphere.2016.10.103; Chandra V, 2010, ACS NANO, V4, P3979, DOI 10.1021/nn1008897; Cheryan M, 1998, J MEMBRANE SCI, V151, P13, DOI 10.1016/S0376-7388(98)00190-2; Costa JA, 2013, TALANTA, V107, P304, DOI 10.1016/j.talanta.2013.01.040; Lavin-Lopez MD, 2016, IND ENG CHEM RES, V55, P12836, DOI 10.1021/acs.iecr.6b03533; Elanchezhiyan SS, 2018, INT J BIOL MACROMOL, V112, P294, DOI 10.1016/j.ijbiomac.2018.01.118; Banda-Cruz EE, 2016, PETROL SCI TECHNOL, V34, P732, DOI 10.1080/10916466.2016.1161646; Farrokhi F, 2018, SEP SCI TECHNOL, V53, P551, DOI 10.1080/01496395.2017.1373676; Feng XH, 2009, ENERG FUEL, V23, P451, DOI 10.1021/ef800825n; Feng Y, 2017, J COLLOID INTERF SCI, V506, P154, DOI 10.1016/j.jcis.2017.07.036; Freire TM, 2016, CARBOHYD POLYM, V151, P760, DOI 10.1016/j.carbpol.2016.05.095; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hatel R, 2017, MATER CHEM PHYS, V193, P156, DOI 10.1016/j.matchemphys.2017.02.013; Hippmann S, 2018, COLLOID SURFACE A, V553, P71, DOI 10.1016/j.colsurfa.2018.05.031; Li Y, 2016, APPL SURF SCI, V369, P11, DOI 10.1016/j.apsusc.2016.02.019; Liang CL, 2014, J MATER CHEM A, V2, P7214, DOI 10.1039/c3ta15426b; Liang JL, 2015, COLLOID SURFACE A, V466, P197, DOI 10.1016/j.colsurfa.2014.11.050; Liang P, 2014, ENERG FUEL, V28, P6172, DOI 10.1021/ef501169m; Liu J, 2017, FUEL, V189, P79, DOI 10.1016/j.fuel.2016.10.066; Liu J, 2015, ENERG FUEL, V29, P4644, DOI 10.1021/acs.energyfuels.5b00966; Liu N, 2015, J MATER CHEM A, V3, P20113, DOI 10.1039/c5ta06314k; Low FW, 2015, J NANOSCI NANOTECHNO, V15, P6769, DOI 10.1166/jnn.2015.10903; Lu T, 2017, APPL SURF SCI, V396, P1604, DOI 10.1016/j.apsusc.2016.11.223; Ma SH, 2016, CHEMISTRYSELECT, V1, P4742, DOI 10.1002/slct.201601167; Mahmoudi M, 2008, J PHYS CHEM B, V112, P14470, DOI 10.1021/jp803016n; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Hoan NTV, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/2418172; Peng JX, 2012, ENERG FUEL, V26, P2705, DOI 10.1021/ef2014259; Rajak VK, 2016, PETROL SCI TECHNOL, V34, P1026, DOI 10.1080/10916466.2016.1181654; Rajak VK, 2015, PETROL SCI TECHNOL, V33, P1861, DOI 10.1080/10916466.2015.1108987; Sahu TK, 2017, ACS SUSTAIN CHEM ENG, V5, P5912, DOI 10.1021/acssuschemeng.7b00632; Saiphaneendra B, 2017, J ENVIRON CHEM ENG, V5, P26, DOI 10.1016/j.jece.2016.11.017; Sharif F, 2017, WATER RES, V114, P237, DOI 10.1016/j.watres.2017.02.042; Shebanova ON, 2003, J SOLID STATE CHEM, V174, P424, DOI 10.1016/S0022-4596(03)00294-9; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Tayebi M, 2015, POLYM ADVAN TECHNOL, V26, P1083, DOI 10.1002/pat.3537; Tayyebi A, 2016, RSC ADV, V6, P13898, DOI 10.1039/c5ra19057f; Teo PS, 2012, CERAM INT, V38, P6411, DOI 10.1016/j.ceramint.2012.05.014; Wang H, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600027; Wang HJ, 2018, J DISPER SCI TECHNOL, V39, P497, DOI [10.1080/01932691.2017.1298040, 10.12068/j.issn.1005-3026.2018.04.009]; Wang J, 2010, SEP PURIF TECHNOL, V73, P349, DOI 10.1016/j.seppur.2010.04.021; Wang XW, 2012, J ALLOY COMPD, V524, P5, DOI 10.1016/j.jallcom.2012.02.058; Xiong YJ, 2018, RENEW ENERG, V129, P786, DOI 10.1016/j.renene.2017.03.078; Xu HY, 2018, CHEM ENG J, V337, P10, DOI 10.1016/j.cej.2017.12.084; Ye NS, 2014, MAT SCI ENG C-MATER, V45, P8, DOI 10.1016/j.msec.2014.08.064; Zargar G, 2018, OIL GAS SCI TECHNOL, V73, DOI 10.2516/ogst/2018016; Zhang ZB, 2010, LANGMUIR, V26, P6676, DOI 10.1021/la904010y; Zhou YS, 2013, NEW J CHEM, V37, P2845, DOI 10.1039/c3nj00444a; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068	55	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232490	10.1371/journal.pone.0232490	http://dx.doi.org/10.1371/journal.pone.0232490			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353051	gold, Green Published			2022-12-26	WOS:000536673200102
J	Adamski, V; Hattermann, K; Kubelt, C; Cohrs, G; Lucius, R; Synowitz, M; Sebens, S; Held-Feindt, J				Adamski, Vivian; Hattermann, Kirsten; Kubelt, Carolin; Cohrs, Gesa; Lucius, Ralph; Synowitz, Michael; Sebens, Susanne; Held-Feindt, Janka			Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1	ONCOGENE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTRATUMOR HETEROGENEITY; ANGIOGENIC SWITCH; TUMOR DORMANCY; RECEPTOR CXCR7; TEMOZOLOMIDE; MECHANISMS; EXPRESSION; ESCAPE; PROLIFERATION	Glioblastoma multiforme (GBM) is a malignant brain tumor that evades therapy regimens. Since cellular dormancy is one strategy for surviving, and since chemokines determine the environmental conditions in which dormancy occurs, we investigated how chemokines affect temozolomide (TMZ)-promoted cellular dormancy entry and exit in GBM cells. TMZ administration over ten days promoted cellular dormancy entry, whereas discontinuing TMZ for a further 15 days resulted in resumption of proliferation. Co-administration of a chemokine cocktail containing CXCL12, CXCL16, and CX3CL1 resulted in both delayed entry and exit from cellular dormancy. A microarray-based transcriptome analysis in LN229 GBM cells revealed that cellular dormancy entry was characterized by an increased expression of CCL2 and SAA2, while THSD4, FSTL3, and VEGFC were upregulated during dormancy exit. Co-stimulation with the chemokine cocktail reduced upregulation of identified genes. After verifying the appearance of identified genes in human GBM primary cultures and ex vivo samples, we clarified whether each chemokine alone impacts cellular dormancy mechanisms using specific antagonists and selective CRISPR/Cas9 clones. While expression of CCL2 and SAA2 in LN229 cells was altered by the CXCL12-CXCR4-CXCR7 axis, CXCL16 and CX3CL1 contributed to reduced upregulation of THSD4 and, to a weaker extent, of VEGFC. The influence on FSTL3 expression depended on the entire chemokine cocktail. Effects of chemokines on dormancy entry and exit-associated genes were detectable in human GBM primary cells, too, even if in a more complex, cell-specific manner. Thus, chemokines play a significant role in the regulation of TMZ-promoted cellular dormancy in GBMs.	[Adamski, Vivian; Kubelt, Carolin; Cohrs, Gesa; Synowitz, Michael; Held-Feindt, Janka] Univ Med Ctr Schleswig Holstein UKSH, Dept Neurosurg, Campus Kiel, D-24105 Kiel, Germany; [Hattermann, Kirsten; Lucius, Ralph] Univ Kiel, Dept Anat, D-24118 Kiel, Germany; [Sebens, Susanne] Univ Kiel, Inst Expt Canc Res, Campus Kiel, D-24105 Kiel, Germany; [Sebens, Susanne] Univ Med Ctr Schleswig Holstein UKSH, Campus Kiel, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Held-Feindt, J (corresponding author), Univ Med Ctr Schleswig Holstein UKSH, Dept Neurosurg, Campus Kiel, D-24105 Kiel, Germany.	Janka.Held-Feindt@uksh.de	Sebens, Susanne/C-1222-2010; Hattermann, Kirsten/E-8043-2010		German Research Foundation (DFG) as part of the Research Training Group "Materials4Brain" [RTG2154]; University Medical Center Schleswig-Holstein, UKSH ("Anschubforderung 2020"); Projekt DEAL	German Research Foundation (DFG) as part of the Research Training Group "Materials4Brain"(German Research Foundation (DFG)); University Medical Center Schleswig-Holstein, UKSH ("Anschubforderung 2020"); Projekt DEAL	We thank Fereshteh Ebrahim, Brigitte Rehmke, and Judith Becker for expert technical assistance. This work was funded by the German Research Foundation (DFG) as part of the Research Training Group "Materials4Brain" (RTG2154; P8) and a sponsorship of the University Medical Center Schleswig-Holstein, UKSH ("Anschubforderung 2020" given to JHF). Open access funding was provided by Projekt DEAL.	Adamski V, 2017, ONCOTARGET, V8, P108064, DOI 10.18632/oncotarget.22514; Adamski V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071468; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Ammerpohl O., 2017, ECOLOGY EVOLUTION CA, P235, DOI [10.1016/B978-0-12-804310-3.00020-X, DOI 10.1016/B978-0-12-804310-3.00020-X]; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Bartholin L, 2007, GENE, V393, P153, DOI 10.1016/j.gene.2007.02.007; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Bowman RL, 2014, IMMUNOTHERAPY-UK, V6, P663, DOI [10.2217/IMT.14.48, 10.2217/imt.14.48]; Bruyere C, 2011, INT J ONCOL, V38, P1453, DOI 10.3892/ijo.2011.964; Chen L, 2018, INT J OPHTHALMOL-CHI, V11, P216, DOI 10.18240/ijo.2018.02.06; Christofides A, 2015, CYTOKINE, V71, P377, DOI 10.1016/j.cyto.2014.09.008; Clark AM, 2017, LAB CHIP, V17, P156, DOI 10.1039/c6lc01171c; Cohen H, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0464-0; Coppola D, 2014, J GERIATR ONCOL, V5, P389, DOI 10.1016/j.jgo.2014.08.003; De Cock JM, 2016, CANCER RES, V76, P6778, DOI 10.1158/0008-5472.CAN-16-0608; DESBAILLETS I, 1994, INT J CANCER, V58, P240, DOI 10.1002/ijc.2910580216; Ehtesham M, 2013, J NEURO-ONCOL, V113, P153, DOI 10.1007/s11060-013-1108-4; Endaya BB, 2016, MOL ONCOL, V10, P126, DOI 10.1016/j.molonc.2015.09.001; Facci L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1205-6; Goffart N, 2017, NEURO-ONCOLOGY, V19, P66, DOI 10.1093/neuonc/now136; Guo YC, 2017, AM J PATHOL, V187, P1736, DOI 10.1016/j.ajpath.2017.04.007; Hasan T, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1387-6; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hattermann K, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0149-7; Hattermann K, 2016, ELIFE, V5, DOI 10.7554/eLife.10820; Hattermann K, 2013, J NEUROIMMUNOL, V260, P47, DOI 10.1016/j.jneuroim.2013.04.006; Hattermann K, 2012, ONCOL REP, V27, P1348, DOI 10.3892/or.2012.1674; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Held-Feindt J, 2010, EXP CELL RES, V316, P1553, DOI 10.1016/j.yexcr.2010.02.018; Hirose Y, 2001, CANCER RES, V61, P1957; Jin X, 2017, CELL PHYSIOL BIOCHEM, V44, P1616, DOI 10.1159/000485759; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Khazali AS, 2018, BRIT J CANCER, V118, P566, DOI 10.1038/bjc.2017.414; Lacalle RA, 2017, INT REV CEL MOL BIO, V331, P181, DOI 10.1016/bs.ircmb.2016.09.011; Lee SY, 2016, GENES DIS, V3, P198, DOI 10.1016/j.gendis.2016.04.007; Li JH, 2017, CYTOKINE, V94, P45, DOI 10.1016/j.cyto.2017.04.010; Liu Y, 2015, ANTICANCER RES, V35, P53; Magnus N, 2013, J THROMB HAEMOST, V11, P1197, DOI 10.1111/jth.12242; Magnus N, 2014, THROMB RES, V133, pS1, DOI 10.1016/S0049-3848(14)50001-1; Magnus N, 2014, P NATL ACAD SCI USA, V111, P3544, DOI 10.1073/pnas.1314118111; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Nie E, 2019, ONCOGENE, V38, P2706, DOI 10.1038/s41388-018-0596-2; Nobutani K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130032; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Perazzoli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140131; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Ray A, 2002, MOL CELL BIOL, V22, P1027, DOI 10.1128/MCB.22.4.1027-1035.2002; Resende R. R., 2013, TRENDS STEM CELL PRO, P339; Satchi-Fainaro R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044395; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Senft D, 2016, PIGM CELL MELANOMA R, V29, P27, DOI 10.1111/pcmr.12432; Song YR, 2013, P NATL ACAD SCI USA, V110, P17933, DOI 10.1073/pnas.1317026110; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tabouret E, 2015, ONCOTARGET, V6, P11664, DOI 10.18632/oncotarget.3256; Tiram G, 2018, FASEB J, V1, pfj201701568R; Tivari S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0259-5; Tong LQ, 2018, ONCOL REP, V40, P463, DOI 10.3892/or.2018.6425; Vakilian A, 2017, NEUROCHEM INT, V103, P1, DOI 10.1016/j.neuint.2016.12.013; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yao M, 2016, ADV CANCER RES, V132, P265, DOI 10.1016/bs.acr.2016.05.005; Yeh AC, 2015, CANCER RES, V75, P5014, DOI 10.1158/0008-5472.CAN-15-1370; Zeng LC, 2016, ONCOL LETT, V12, P815, DOI 10.3892/ol.2016.4690; Zhang ZJ, 2012, CELL MOL NEUROBIOL, V32, P1003, DOI 10.1007/s10571-012-9816-4	70	16	16	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4421	4435		10.1038/s41388-020-1302-8	http://dx.doi.org/10.1038/s41388-020-1302-8		APR 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32346064	Green Published, hybrid			2022-12-26	WOS:000529462400001
J	Coassin, S; Hermann-Kleiter, N; Haun, M; Wahl, S; Wilson, R; Paulweber, B; Kunze, S; Meitinger, T; Strauch, K; Peters, A; Waldenberger, M; Kronenberg, F; Lamina, C				Coassin, Stefan; Hermann-Kleiter, Natascha; Haun, Margot; Wahl, Simone; Wilson, Rory; Paulweber, Bernhard; Kunze, Sonja; Meitinger, Thomas; Strauch, Konstantin; Peters, Annette; Waldenberger, Melanie; Kronenberg, Florian; Lamina, Claudia			A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter	PLOS ONE			English	Article							APOLIPOPROTEIN(A) GENE; ELEVATED LIPOPROTEIN(A); PLASMA LIPOPROTEIN(A); CARDIOVASCULAR-DISEASE; C/T POLYMORPHISM; INCREASED RISK; CPG-SNPS; POPULATION; APO(A); REGION	Lipoprotein(a) [Lp(a)] is a major cardiovascular risk factor, which is largely genetically determined by one major gene locus, the LPA gene. Many aspects of the transcriptional regulation of LPA are poorly understood and the role of epigenetics has not been addressed yet. Therefore, we conducted an epigenome-wide analysis of DNA methylation on Lp(a) levels in two population-based studies (total n = 2208). We identified a CpG site in the LPA promoter which was significantly associated with Lp(a) concentrations. Surprisingly, the identified CpG site was found to overlap the SNP rs76735376. We genotyped this SNP de-novo in three studies (total n = 7512). The minor allele of rs76735376 (1.1% minor allele frequency) was associated with increased Lp(a) values (p = 1.01e-59) and explained 3.5% of the variation of Lp(a). Statistical mediation analysis showed that the effect on Lp(a) is rather originating from the base change itself and is not mediated by DNA methylation levels. This finding is supported by eQTL data from 208 liver tissue samples from the GTEx project, which shows a significant association of the rs76735376 minor allele with increased LPA expression. To evaluate, whether the association signal at rs76735376 may actually be derived from a stronger eQTL signal in LD with this SNP, eQTL association results of all correlated SNPs (r(2)>= 0.1) were integrated with genetic association results. This analysis pinpointed to rs10455872 as the potential trigger of the effect of rs76735376. Furthermore, both SNPs coincide with short apo(a) isoforms. Adjusting for both, rs10455872 and the apo(a) isoforms diminished the effect size of rs76735376 to 5.38 mg/dL (p = 0.0463). This indicates that the effect of rs76735376 can be explained by both an independent effect of the SNP and a strong correlation with rs10455872 and apo(a) isoforms.	[Coassin, Stefan; Haun, Margot; Kronenberg, Florian; Lamina, Claudia] Med Univ Innsbruck, Inst Genet Epidemiol, Dept Genet & Pharmacol, Innsbruck, Austria; [Hermann-Kleiter, Natascha] Med Univ Innsbruck, Inst Cell Genet, Dept Genet & Pharmacol, Innsbruck, Austria; [Wahl, Simone; Wilson, Rory; Kunze, Sonja; Waldenberger, Melanie] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Wahl, Simone; Wilson, Rory; Kunze, Sonja; Peters, Annette; Waldenberger, Melanie] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Paulweber, Bernhard] Paracelsus Private Med Univ, Dept Internal Med 1, Salzburg, Austria; [Meitinger, Thomas; Peters, Annette; Waldenberger, Melanie] Partner Site Munich Heart Alliance, German Ctr Cardiovascular Res DZHK, Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Strauch, Konstantin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat IMBEI, Mainz, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Paracelsus Private Medical University; German Centre for Cardiovascular Research; Munich Heart Alliance; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Johannes Gutenberg University of Mainz	Lamina, C (corresponding author), Med Univ Innsbruck, Inst Genet Epidemiol, Dept Genet & Pharmacol, Innsbruck, Austria.	claudia.lamina@i-med.ac.at	Peters, Annette/A-6117-2011; Kronenberg, Florian/B-1736-2008; Coassin, Stefan/J-2611-2018; Kleiter, Natascha/I-5101-2018	Peters, Annette/0000-0001-6645-0985; Kronenberg, Florian/0000-0003-2229-1120; Coassin, Stefan/0000-0001-5677-8979; Kleiter, Natascha/0000-0003-4389-9813; Wilson, Rory/0000-0001-6135-3764	Austrian Science Fund (FWF) [P266600-B13]; Helmholtz Zentrum Munchen -German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; German Research Foundation [WA 4081/1-1]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Helmholtz Zentrum Munchen -German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Research Foundation(German Research Foundation (DFG))	The study was supported by the Austrian Science Fund (FWF) Project Number P266600-B13 to CL. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen -German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. This work was supported by a grant (WA 4081/1-1) from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; BOPP S, 1995, J LIPID RES, V36, P1721; Burgess S, 2018, JAMA CARDIOL, V3, P619, DOI 10.1001/jamacardio.2018.1470; Chen LS, 2008, BIOINFORMATICS, V24, P2260, DOI 10.1093/bioinformatics/btn411; Chennamsetty I, 2011, J CLIN INVEST, V121, P3724, DOI 10.1172/JCI45277; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Coassin S, 2017, EUR HEART J, V38, P1823, DOI 10.1093/eurheartj/ehx174; Dayeh TA, 2013, DIABETOLOGIA, V56, P1036, DOI 10.1007/s00125-012-2815-7; de Toro-Martin J, 2016, ANN NUTR METAB, V68, P203, DOI 10.1159/000445358; Dekkers KF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1000-6; DIEPLINGER H, 1995, J LIPID RES, V36, P813; Dos Santos C, 2009, DIABETES, V58, P489, DOI 10.2337/db08-0587; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emdin CA, 2016, J AM COLL CARDIOL, V68, P2761, DOI 10.1016/j.jacc.2016.10.033; Erhart G, 2018, ARTERIOSCL THROM VAS, V38, P1230, DOI 10.1161/ATVBAHA.118.310865; Erqou S, 2010, J AM COLL CARDIOL, V55, P2160, DOI 10.1016/j.jacc.2009.10.080; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Graham MJ, 2016, J LIPID RES, V57, P340, DOI 10.1194/jlr.R052258; Gudbjartsson DF, 2019, J AM COLL CARDIOL, V74, P2982, DOI 10.1016/j.jacc.2019.10.019; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; John G, 2011, MOL GENET METAB, V104, P174, DOI 10.1016/j.ymgme.2011.06.023; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kamstrup PR, 2016, JACC-HEART FAIL, V4, P78, DOI 10.1016/j.jchf.2015.08.006; Kamstrup PR, 2013, LANCET DIABETES ENDO, V1, P220, DOI 10.1016/S2213-8587(13)70064-0; Kamstrup PR, 2014, J AM COLL CARDIOL, V63, P470, DOI 10.1016/j.jacc.2013.09.038; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kostner KM, 2017, J LIPID RES, V58, P1, DOI 10.1194/jlr.R071571; Kraft HG, 1998, HUM MOL GENET, V7, P257, DOI 10.1093/hmg/7.2.257; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; KRONENBERG F, 1994, J LIPID RES, V35, P1318; Kronenberg F, 2019, ATHEROSCLEROSIS, V288, P163, DOI 10.1016/j.atherosclerosis.2019.07.003; Kronenberg F, 2016, CARDIOVASC DRUG THER, V30, P87, DOI 10.1007/s10557-016-6648-3; Kumar D, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0404-6; Lamina C, 2019, JAMA CARDIOL, V4, P575, DOI 10.1001/jamacardio.2019.1041; Lamina C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102113; Langsted A, 2019, J AM COLL CARDIOL, V74, P54, DOI 10.1016/j.jacc.2019.03.524; Langsted A, 2019, EUR HEART J, V40, P2760, DOI 10.1093/eurheartj/ehy902; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Laschkolnig A, 2014, CARDIOVASC RES, V103, P28, DOI 10.1093/cvr/cvu107; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Li J, 2015, J HUM GENET, V60, P755, DOI 10.1038/jhg.2015.107; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Ma BS, 2014, NUCLEIC ACIDS RES, V42, P3515, DOI 10.1093/nar/gkt1380; Macchi C, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104413; Mack S, 2017, J LIPID RES, V58, P1834, DOI 10.1194/jlr.M076232; Madsen CM, 2020, ARTERIOSCL THROM VAS, V40, P255, DOI 10.1161/ATVBAHA.119.312951; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mittelstrass K, 2018, CURR OPIN LIPIDOL, V29, P116, DOI 10.1097/MOL.0000000000000491; MOOSER V, 1995, HUM MOL GENET, V4, P173, DOI 10.1093/hmg/4.2.173; Mora S, 2010, CLIN CHEM, V56, P1252, DOI 10.1373/clinchem.2010.146779; Moriarty PM, 2017, ARTERIOSCL THROM VAS, V37, P580, DOI 10.1161/ATVBAHA.116.308704; Nordestgaard BG, 2016, J LIPID RES, V57, P1953, DOI 10.1194/jlr.R071233; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Ogorelkova M, 1999, HUM MOL GENET, V8, P2087, DOI 10.1093/hmg/8.11.2087; Parson W, 2004, HUM MUTAT, V24, P474, DOI 10.1002/humu.20101; PEROMBELON YFN, 1994, J CLIN INVEST, V93, P1481, DOI 10.1172/JCI117126; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Puckey LH, 1997, HUM MOL GENET, V6, P1099, DOI 10.1093/hmg/6.7.1099; Puckey LH, 2003, ATHEROSCLEROSIS, V166, P119, DOI 10.1016/S0021-9150(02)00315-5; Reynard LN, 2014, HUM GENET, V133, P1059, DOI 10.1007/s00439-014-1447-z; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saleheen D, 2017, LANCET DIABETES ENDO, V5, P524, DOI 10.1016/S2213-8587(17)30088-8; SANDHOLZER C, 1992, ARTERIOSCLER THROMB, V12, P1214, DOI 10.1161/01.ATV.12.10.1214; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schmidt K, 2006, EUR J HUM GENET, V14, P190, DOI 10.1038/sj.ejhg.5201512; Schmidt K, 2016, J LIPID RES, V57, P1339, DOI 10.1194/jlr.R067314; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taliun D., 2019, GENOMICS, DOI [10.1101/563866, DOI 10.1101/563866., DOI 10.1101/563866]; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Tregouet D-A, NAT GENET; TROMMSDORFF M, 1995, J CLIN INVEST, V96, P150, DOI 10.1172/JCI118015; Tsimikas S, 2017, J AM COLL CARDIOL, V69, P692, DOI 10.1016/j.jacc.2016.11.042; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; WADE DP, 1994, J BIOL CHEM, V269, P19757; WADE DP, 1993, P NATL ACAD SCI USA, V90, P1369, DOI 10.1073/pnas.90.4.1369; WHITE AL, 1994, CHEM PHYS LIPIDS, V67-8, P123, DOI 10.1016/0009-3084(94)90131-7; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58, DOI 10.1161/01.ATV.15.1.58	89	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232073	10.1371/journal.pone.0232073	http://dx.doi.org/10.1371/journal.pone.0232073			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343731	Green Published, Green Submitted, gold			2022-12-26	WOS:000536661300031
J	Xu, JX; Li, ZY; Lv, X; Yan, H; Zhou, GY; Cao, LX; Yang, Q; He, YH				Xu, Jin-Xin; Li, Zi-Yang; Lv, Xing; Yan, Hua; Zhou, Guo-Ying; Cao, Ling-Xue; Yang, Qin; He, Yuan-Hao			Isolation and characterization of Bacillus subtilis strain 1-L-29, an endophytic bacteria from Camellia oleifera with antimicrobial activity and efficient plant-root colonization	PLOS ONE			English	Article							COLLETOTRICHUM-GLOEOSPORIOIDES; ARABIDOPSIS-THALIANA; BIOLOGICAL-CONTROL; SPOT DISEASE; IDENTIFICATION; BIOCONTROL; ANTHRACNOSE; STREPTOMYCES; RESISTANCE; ACID	Endophytic bacteria, which are common in plant tissues, may help to control plant pathogens and enhance plant growth. Camellia oleifera, an oil-producing plant, is widely grown in warm, subtropical, hilly regions in China. However, C. oleifera is strongly negatively affected by C. oleifera anthracnose, which is caused by Colletetrichum fructicola. To find a suitable biocontrol agent for C. oleifera anthracnose, 41 endophytes were isolated from the stems, leaves, and roots of C. oleifera. Bacterial cultures were identified based on analyses of 16S rDNA sequences; most strains belonged to the genus Bacillus. The antagonistic effects of these strains on C. fructicola were tested in vitro. In total, 16 strains inhibited C. fructicola growth, with B. subtilis strain 1-L-29 being the most efficient. Strain 1-L-29 demonstrated antagonistic activity against C. siamense, C. asianum, Fusarium proliferatum, Agaricodochium camellia, and Pseudomonas syringae. In addition, this strain produced indole acetic acid, solubilized phosphate, grew on N-free media, and produced siderophores. To facilitate further microecological studies of this strain, a rifampicin-resistant, green fluorescent protein (GFP)-labeled strain, 1-L-29gfpr, was created using protoplast transformation. This plasmid had good segregational stability. Strain 1-L-29gfpr was re-introduced into C. oleifera and successfully colonized root, stem, and leaf tissues. This strain remained at a stable concentration in the root more than 20 d after inoculation. Fluorescence microscopic analysis showed that strain 1-L-29gfpr thoroughly colonized the root surfaces of C. fructicola as well as the root vascular tissues of Arabidopsis thaliana.	[Xu, Jin-Xin; Li, Zi-Yang; Lv, Xing; Yan, Hua; Zhou, Guo-Ying; Cao, Ling-Xue; Yang, Qin; He, Yuan-Hao] Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Peoples R China; [Li, Zi-Yang; Yan, Hua; Zhou, Guo-Ying; He, Yuan-Hao] Cent South Univ Forestry & Technol, Hunan Prov Key Lab Control Forest Dis & Pests, Changsha, Peoples R China; [Li, Zi-Yang; Yan, Hua; Zhou, Guo-Ying; He, Yuan-Hao] Cent South Univ Forestry & Technol, Key Lab Nonwood Forest Cultivat & Conservat, Minist Educ, Changsha, Peoples R China; [Li, Zi-Yang; Yan, Hua; Zhou, Guo-Ying; He, Yuan-Hao] Cent South Univ Forestry & Technol, Key Lab Natl Forestry & Grassland Adm Control Art, Changsha, Peoples R China	Central South University of Forestry & Technology; Central South University of Forestry & Technology; Central South University of Forestry & Technology; Central South University of Forestry & Technology	He, YH (corresponding author), Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Peoples R China.; He, YH (corresponding author), Cent South Univ Forestry & Technol, Hunan Prov Key Lab Control Forest Dis & Pests, Changsha, Peoples R China.; He, YH (corresponding author), Cent South Univ Forestry & Technol, Key Lab Nonwood Forest Cultivat & Conservat, Minist Educ, Changsha, Peoples R China.; He, YH (corresponding author), Cent South Univ Forestry & Technol, Key Lab Natl Forestry & Grassland Adm Control Art, Changsha, Peoples R China.	heyuanhao218@163.com			National Science Foundation for Young Scientists of China [31600515]; Natural Science Foundation of Hunan Province, China [2019JJ50999]	National Science Foundation for Young Scientists of China; Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province)	This work was supported by the National Science Foundation for Young Scientists of China (Grant No. 31600515, http://www.nsfc.gov.cn/) and the Natural Science Foundation of Hunan Province, China (Grant No. 2019JJ50999, http://kjt.hunan.gov.cn/zxgz/zkjj/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abass K, 2009, FUNGICIDES CHEM ENV, P25; Ardanov P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046802; Cheng YT, 2014, J AGR FOOD CHEM, V62, P642, DOI 10.1021/jf404614k; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; Lopes KBD, 2018, J APPL MICROBIOL, V125, P1466, DOI 10.1111/jam.14041; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P189, DOI 10.1007/s11274-008-9878-0; Etminani F, 2018, PLANT PATHOLOGY J, V34, P208, DOI 10.5423/PPJ.OA.07.2017.0158; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Forchetti G, 2007, APPL MICROBIOL BIOT, V76, P1145, DOI 10.1007/s00253-007-1077-7; Ghorbani S, 2018, FOREST PATHOL, V48, DOI 10.1111/efp.12403; GLANDORF DCM, 1992, PLANT SOIL, V147, P135, DOI 10.1007/BF00009379; Cabanas CGL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00427; Guo XH, 1982, ACTA MICROBIOLOGICA, V22, P263; Hall ME, 2019, AM J ENOL VITICULT, V70, P212, DOI 10.5344/ajev.2018.18033; He L, 2009, AFR J MICROBIOL RES, V3, P315; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; Kim N, 2019, PLANT PATHOL, V68, P434, DOI 10.1111/ppa.12960; Lakshmanan V, 2013, PLANTA, V238, P657, DOI 10.1007/s00425-013-1920-2; Lang JF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199466; Lee SW, 2010, EUR J PLANT PATHOL, V126, P1, DOI 10.1007/s10658-009-9514-3; Li HaiYun, 2018, Journal of Plant Protection, V45, P836; Li H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156841; Li J, 2019, CAN J MICROBIOL, V65, P214, DOI 10.1139/cjm-2018-0434; Liu J, 2018, SOIL TILL RES, V176, P45, DOI 10.1016/j.still.2017.09.013; Liu Junang, 2010, FOREST PEST DIS, V29, P7; Liu YouZhou, 2014, Acta Phytophylacica Sinica, V41, P416; Lu YP, 2012, LETT APPL MICROBIOL, V55, P9, DOI 10.1111/j.1472-765X.2012.03249.x; Ma JL, 2011, J VERBRAUCH LEBENSM, V6, P9, DOI 10.1007/s00003-010-0581-3; Manjunatha BS, 2019, MICROB ECOL, V77, P676, DOI 10.1007/s00248-018-1257-2; Martins SJ, 2019, BIOL CONTROL, V131, P36, DOI 10.1016/j.biocontrol.2019.01.003; Maldonado-Gonzalez MM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00266; Maldonado-Gonzalez MM, 2015, ENVIRON MICROBIOL, V17, P3139, DOI 10.1111/1462-2920.12725; Ha NT, 2018, CURR SCI INDIA, V115, P1921, DOI 10.18520/cs/v115/i10/1921-1927; Palaniyandi SA, 2011, J APPL MICROBIOL, V111, P443, DOI 10.1111/j.1365-2672.2011.05048.x; Prieto P, 2008, FEMS MICROBIOL ECOL, V64, P297, DOI 10.1111/j.1574-6941.2008.00450.x; Qin S, 2011, ANTON LEEUW INT J G, V99, P395, DOI 10.1007/s10482-010-9504-7; Rahman A, 2010, BIOSCI BIOTECH BIOCH, V74, P2202, DOI 10.1271/bbb.100360; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Schiliro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048646; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; Schulz Barbara J. E., 2006, V9, P1; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sunpapao A, 2018, BIOL CONTROL, V123, P36, DOI 10.1016/j.biocontrol.2018.04.017; Swamy CT, 2016, J BASIC MICROB, V56, P1369, DOI 10.1002/jobm.201600197; van der Meij A, 2018, ANTON LEEUW INT J G, V111, P679, DOI 10.1007/s10482-018-1014-z; Wang YX, 2017, EUR J PLANT PATHOL, V147, P103, DOI 10.1007/s10658-016-0983-x; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Wu LM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01395; Xu M, 2017, J PHYTOPATHOL, V165, P380, DOI 10.1111/jph.12571; Yao T, 2002, CHARACTERISTICS BIOF; Yao Zhen-Sheng, 2003, Sheng Wu Gong Cheng Xue Bao, V19, P551	51	15	21	11	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232096	10.1371/journal.pone.0232096	http://dx.doi.org/10.1371/journal.pone.0232096			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339210	Green Published, gold			2022-12-26	WOS:000536657400026
J	Davidov, T; Efraim, Y; Dahan, N; Baruch, L; Machluf, M				Davidov, Tzila; Efraim, Yael; Dahan, Nitsan; Baruch, Limor; Machluf, Marcelle			Porcine arterial ECM hydrogel: Designing an in vitro angiogenesis model for long-term high-throughput research	FASEB JOURNAL			English	Article						angiogenesis; arterial ECM; ECM hydrogel; in vitro model	EXTRACELLULAR-MATRIX; GROWTH-FACTOR; SUNITINIB; VIVO; DECELLULARIZATION; ENCAPSULATION; CULTURE; ASSAYS	The field of angiogenesis research provides deep understanding regarding this important process, which plays fundamental roles in tissue development and different abnormalities. In vitro models offer the advantages of low-cost high-throughput research of angiogenesis while sparing animal lives, and enabling the use of human cells. Nevertheless, prevailing in vitro models lack stability and are limited to a few days' assays. This study, therefore, examines the hypothesis that closely mimicking the vascular microenvironment can more reliably support longer angiogenesis processes in vitro. To this end, porcine arterial extracellular matrix (paECM)- a key component of blood vessels-was isolated and processed into a thermally induced hydrogel and characterized in terms of composition, structure, and mechanical properties, thus confirming the preservation of important characteristics of arterial extracellular matrix. This unique hydrogel was further tailored into a three-dimensional model of angiogenesis using endothelial cells and supporting cells, in a configuration that allows high-throughput quantitative analysis of cell viability and proliferation, cell migration, and apoptosis, thus revealing the advantages of paECM over frequently used biomaterials. Markedly, when applied with well-known effectors of angiogenesis, the model measures reflected the expected response, hence validating its efficacy and establishing its potential as a promising tool for the research of angiogenesis.	[Davidov, Tzila; Efraim, Yael; Baruch, Limor; Machluf, Marcelle] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Haifa, Israel; [Dahan, Nitsan] Technion Israel Inst Technol, Life Sci & Engn Ctr, Infrastruct Unit, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Machluf, M (corresponding author), Technion Israel Inst Technol, Life Sci & Engn Ctr, Haifa, Israel.	machlufm@bfe.technion.ac.il	Baruch, Limor/AAC-7019-2022		Technion-Israel Institute of Technology (Technion)	Technion-Israel Institute of Technology (Technion)	Technion-Israel Institute of Technology (Technion)	Abdel-Aziz AK, 2016, EXP NEUROL, V283, P129, DOI 10.1016/j.expneurol.2016.06.004; Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chaimov D, 2017, J CONTROL RELEASE, V257, P91, DOI 10.1016/j.jconrel.2016.07.045; Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414; Clause KC, 2013, CURR OPIN BIOTECH, V24, P830, DOI 10.1016/j.copbio.2013.04.011; Coronado RE, 2017, CELL TRANSPLANT, V26, P1840, DOI 10.1177/0963689717742157; Dahan N, 2017, TISSUE ENG PT A, V23, P69, DOI [10.1089/ten.tea.2016.0126, 10.1089/ten.TEA.2016.0126]; Dahan N, 2012, TISSUE ENG PT A, V18, P411, DOI [10.1089/ten.tea.2011.0173, 10.1089/ten.TEA.2011.0173]; de Bouard S, 2007, NEURO-ONCOLOGY, V9, P412, DOI 10.1215/15228517-2007-024; Deng L, 2003, J INVEST DERMATOL, V121, P1060, DOI 10.1046/j.1523-1747.2003.12565.x; DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]; Efraim Y, 2017, ACTA BIOMATER, V50, P220, DOI 10.1016/j.actbio.2016.12.015; Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]; Faibish M, 2011, JOVE-J VIS EXP, V55, P2; Feng XL, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/246986; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Grant CA, 2011, J MECH BEHAV BIOMED, V4, P535, DOI 10.1016/j.jmbbm.2010.12.011; Hao ZL, 2016, ONCOTARGETS THER, V9, P5495, DOI 10.2147/OTT.S112242; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Hinderer S, 2016, ADV DRUG DELIVER REV, V97, P260, DOI 10.1016/j.addr.2015.11.019; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Karamanos NK, 2019, MATRIX BIOL, V75-76, P1, DOI 10.1016/j.matbio.2018.08.007; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Maj E, 2016, INT J ONCOL, V49, P1773, DOI 10.3892/ijo.2016.3709; Martin S., 2009, ANGIOGENESIS PROTOCO; Massensini AR, 2015, ACTA BIOMATER, V27, P116, DOI 10.1016/j.actbio.2015.08.040; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Morin KT, 2013, EXP CELL RES, V319, P2409, DOI 10.1016/j.yexcr.2013.06.006; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Nemati S, 2017, BIOTECHNOL BIOENG, V114, P2920, DOI 10.1002/bit.26395; Rosalina I, 2002, CARBOHYD POLYM, V48, P191, DOI 10.1016/S0144-8617(01)00235-1; Sarig U, 2016, ACTA BIOMATER, V44, P209, DOI 10.1016/j.actbio.2016.08.031; Sarig U, 2015, TISSUE ENG PT A, V21, P1507, DOI [10.1089/ten.tea.2014.0477, 10.1089/ten.TEA.2014.0477]; Sarkanen JR, 2011, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00147; Schor AM, 2001, METH MOLEC MED, V46, P145, DOI 10.1385/1-59259-143-4:145; Taylor DA, 2018, ACTA BIOMATER, V74, P74, DOI 10.1016/j.actbio.2018.04.044; Ucuzian AA, 2014, MICROVASC RES, V14, P220; Ucuzian AA, 2007, WORLD J SURG, V31, P654, DOI 10.1007/s00268-006-0763-4; West DC, 2001, METH MOLEC MED, V46, P107, DOI 10.1385/1-59259-143-4:107; Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051; Wood DJ, 2014, J R SOC INTERFACE, V12, P20141079	47	4	5	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7745	7758		10.1096/fj.202000264	http://dx.doi.org/10.1096/fj.202000264		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32337805	Bronze			2022-12-26	WOS:000529407300001
J	Xie, RN; Jiang, P; Lin, L; Yu, B; Wang, CM; Pan, YY; Rao, JJ; Wei, W; Qiao, Y				Xie, Ruining; Jiang, Pei; Lin, Li; Yu, Bin; Wang, Chunmei; Pan, Yanyou; Rao, Jingjing; Wei, Wei; Qiao, Yi			Association of lymphoid tissue-resident commensal bacteria in mice with depressive-like behaviors induced by chronic social defeat stress	FASEB JOURNAL			English	Article						chronic social defeat stress; depressive-like behaviors; lymphoid-tissue-resident commensal bacteria; Peyer's patches; Treg cells	SEGMENTED FILAMENTOUS BACTERIA; GUT MICROBIOTA; T-CELLS; IMMUNE; INFLAMMATION; MATURATION; INDUCTION; CYTOKINES; MOUSE	Emerging evidence suggests that the microbiota-gut-brain axis affects a variety of complex behaviors, including social, emotional, and depressive-like behaviors. Peyer's patches (PPs), a well-characterized gut-associated lymphoid tissue, are the entry site for luminal antigens and the initiation site for antigen-specific immune responses. However, few studies have explored the composition of lymphoid tissue-resident commensal bacteria (LRCs) in stress-associated disorders. Male C57BL/6 mice exposed to chronic social stress were analyzed for microbiome on the interior of PPs and changes in inflammation. Susceptible mice (SUS) exhibited a composition of bacteria inside PPs that was distinct from that of control (CON) and resilient (RES) mice, including an increase in Candidatus Arthromitus (SFB) and a decrease in Lactobacillus. The CD4(+)CD25(+)Foxp3(+) T cells were significantly reduced in SUS mice. Relative mRNA levels of IL-2 were significantly reduced in SUS mice, and the mRNA levels of Bcl-6, IFN-gamma, IL-6, and the IgA protein levels in the ileum were significantly increased. Moreover, in the prefrontal cortex of SUS mice, IL-6 and TNF-alpha were increased, whereas IL-10 was decreased. The correlational analyses revealed that social interaction ratio was negatively correlated with SFB and positively associated with Lactobacillus and four other candidate protective organisms. These results pointed the possibility that the changes in the LRCs induced by chronic social defeat stress were ultimately associated with the inflammation of the brain and exacerbation of depressive-like behaviors.	[Xie, Ruining; Lin, Li; Wei, Wei; Qiao, Yi] Jining Med Univ, Dept Publ Hlth, Jining, Peoples R China; [Jiang, Pei] Jining First Peoples Hosp, Inst Clin Pharm & Pharmacol, Jining, Peoples R China; [Yu, Bin] Jining Med Univ, Coll Integrated Chinese & Western Med, Jining, Peoples R China; [Wang, Chunmei; Pan, Yanyou; Rao, Jingjing] Jining Med Univ, Inst Neurobiol, Jining, Peoples R China	Jining Medical University; Jining Medical University; Jining Medical University	Qiao, Y (corresponding author), Jining Med Univ, Dept Publ Hlth, Jining, Peoples R China.	qiaoyi2018@mail.jnmc.edu.cn			Teachersapos; research of Jining Medical University [JY2017KJ005]; National Natural Science Foundation of China (NSFC) [31600947, 81603509, 81602846]	Teachersapos; research of Jining Medical University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Teachers & apos; research of Jining Medical University, Grant/Award Number: JY2017KJ005; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31600947, 81603509 and 81602846	Al-Nedawi K, 2015, FASEB J, V29, P684, DOI 10.1096/fj.14-259721; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bharwani A, 2016, PSYCHONEUROENDOCRINO, V63, P217, DOI 10.1016/j.psyneuen.2015.10.001; Brambilla P, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.46; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chaouloff F, 2013, CELL TISSUE RES, V354, P179, DOI 10.1007/s00441-013-1606-x; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; De-Paula VDR, 2018, PHARMACOL RES, V136, P29, DOI 10.1016/j.phrs.2018.07.007; Emge JR, 2016, AM J PHYSIOL-GASTR L, V310, pG989, DOI 10.1152/ajpgi.00086.2016; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Galley JD, 2014, GUT MICROBES, V5, P748, DOI 10.4161/19490976.2014.972241; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Gur TL, 2017, BRAIN BEHAV IMMUN, V64, P50, DOI 10.1016/j.bbi.2016.12.021; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042054; Kiyone H., 2008, FUNDAMENTAL IMMUNOLO, P983; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li Y, 2010, J AFFECT DISORDERS, V124, P68, DOI 10.1016/j.jad.2009.10.018; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Martin V, 2017, SCI REP-UK, V7, DOI 10.1038/srep45907; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Qian YW, 2018, BRAIN BEHAV IMMUN, V70, P194, DOI 10.1016/j.bbi.2018.02.016; Qiao Y, 2015, J FUNCT FOODS, V14, P424, DOI 10.1016/j.jff.2015.02.013; Rios D, 2016, MUCOSAL IMMUNOL, V9, P907, DOI 10.1038/mi.2015.121; Rudzki L, 2019, PSYCHONEUROENDOCRINO, V100, P213, DOI 10.1016/j.psyneuen.2018.10.010; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schnupf P, 2015, NATURE, V520, P99, DOI 10.1038/nature14027; Schnupf P, 2013, SEMIN IMMUNOL, V25, P342, DOI 10.1016/j.smim.2013.09.001; SCOTT KA, 2016, FASEB J S1, V30, P749; Szyszkowicz JK, 2017, BRAIN BEHAV IMMUN, V66, P45, DOI 10.1016/j.bbi.2017.06.009; Talham GL, 1999, INFECT IMMUN, V67, P1992; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; VICENTINI FA, 2018, FASEB J S, V32, P921; Wong ML, 2016, MOL PSYCHIATR, V21, P797, DOI 10.1038/mp.2016.46; Wood AM, 2012, J AFFECT DISORDERS, V136, P882, DOI 10.1016/j.jad.2011.09.014; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yu M, 2017, J PHARMACEUT BIOMED, V138, P231, DOI 10.1016/j.jpba.2017.02.008; Zhang T, 2014, ANAESTH INTENS CARE, V42, P220, DOI 10.1177/0310057X1404200209; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44	54	3	3	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8310	8325		10.1096/fj.201902680RR	http://dx.doi.org/10.1096/fj.201902680RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333445				2022-12-26	WOS:000529447700001
J	Melville, DB; Studer, S; Schekman, R				Melville, David B.; Studer, Sean; Schekman, Randy			Small sequence variations between two mammalian paralogs of the small GTPase SAR1 underlie functional differences in coat protein complex II assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						COPII; GTPase; apolipoprotein; intracellular trafficking; membrane trafficking; secretion; SAR1A; SAR1B; SEC23; SEC31	CHYLOMICRON RETENTION DISEASE; COPII COAT; ENDOPLASMIC-RETICULUM; MEMBRANE CURVATURE; MUTATIONS; SECRETION; SEC23A; GENE; ER; MECHANISMS	Vesicles that are coated by coat protein complex II (COPII) are the primary mediators of vesicular traffic from the endoplasmic reticulum to the Golgi apparatus. Secretion-associated Ras-related GTPase 1 (SAR1) is a small GTPase that is part of COPII and, upon GTP binding, recruits the other COPII proteins to the endoplasmic reticulum membrane. Mammals have two SAR1 paralogs that genetic data suggest may have distinct physiological roles,e.g.in lipoprotein secretion in the case of SAR1B. Here we identified two amino acid clusters that have conserved SAR1 paralog?specific sequences. We observed that one cluster is adjacent to the SAR1 GTP-binding pocket and alters the kinetics of GTP exchange. The other cluster is adjacent to the binding site for two COPII components, SEC31 homolog A COPII coat complex component (SEC31) and SEC23. We found that the latter cluster confers to SAR1B a binding preference for SEC23A that is stronger than that of SAR1A for SEC23A. Unlike SAR1B, SAR1A was prone to oligomerize on a membrane surface. SAR1B knockdown caused loss of lipoprotein secretion, overexpression of SAR1B but not of SAR1A could restore secretion, and a divergent cluster adjacent to the SEC31/SEC23-binding site was critical for this SAR1B function. These results highlight that small primary sequence differences between the two mammalian SAR1 paralogs lead to pronounced biochemical differences that significantly affect COPII assembly and identify a specific function for SAR1B in lipoprotein secretion, providing insights into the mechanisms of large cargo secretion that may be relevant for COPII-related diseases.	[Melville, David B.; Studer, Sean; Schekman, Randy] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA; [Studer, Sean] Centroid Vaccines Inc, San Diego, CA USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Schekman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	schekman@berkeley.edu			NHLBI, National Institutes of Health [11287155]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	R. S. is supported as an Investigator of the Howard Hughes Medical Institute and the University of California, Berkeley, Miller Institute of Science. D. B. M. was supported in part by NHLBI, National Institutes of Health Grant 11287155. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bianchi P, 2009, HUM MUTAT, V30, P1292, DOI 10.1002/humu.21077; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Charcosset M, 2008, MOL GENET METAB, V93, P74, DOI 10.1016/j.ymgme.2007.08.120; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Fryer LGD, 2014, J BIOL CHEM, V289, P4244, DOI 10.1074/jbc.M113.479980; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; Hanna MG, 2016, J BIOL CHEM, V291, P1014, DOI 10.1074/jbc.M115.672287; Hariri H, 2014, J MOL BIOL, V426, P3811, DOI 10.1016/j.jmb.2014.08.023; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Hutchings J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06577-4; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kanapin A, 2003, GENOME RES, V13, P1335, DOI 10.1101/gr.978703; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Levic D, 2015, J MOL MED, V93, P165, DOI 10.1007/s00109-014-1247-x; Ma WF, 2016, P NATL ACAD SCI USA, V113, P10061, DOI 10.1073/pnas.1605916113; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Melville D, 2019, MOL BIOL CELL, V30, P387, DOI 10.1091/mbc.E18-09-0548; Melville DB, 2011, DIS MODEL MECH, V4, P763, DOI 10.1242/dmm.007625; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; NEMETH A, 1995, EUR J CLIN INVEST, V25, P271, DOI 10.1111/j.1365-2362.1995.tb01559.x; Niu XB, 2012, DEV BIOL, V367, P197, DOI 10.1016/j.ydbio.2012.05.004; Peretti N, 2009, MOL GENET METAB, V97, P136, DOI 10.1016/j.ymgme.2009.02.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Raote I, 2017, J CELL BIOL, V216, P901, DOI 10.1083/jcb.201608080; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Saito K, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00075; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sane A, 2019, J LIPID RES, V60, P1755, DOI 10.1194/jlr.RA119000119; Sane AT, 2017, ARTERIOSCL THROM VAS, V37, P2243, DOI 10.1161/ATVBAHA.117.310121; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schekman R., 2004, CELL, V116, pS13, DOI [10.1016/s0092-8674(03)00972-3, DOI 10.1016/S0092-8674(03)00972-3]; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silvain M, 2008, CLIN GENET, V74, P546, DOI 10.1111/j.1399-0004.2008.01069.x; Unlu G, 2014, INT J BIOCHEM CELL B, V47, P57, DOI 10.1016/j.biocel.2013.11.005; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	49	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8401	8412		10.1074/jbc.RA120.012964	http://dx.doi.org/10.1074/jbc.RA120.012964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358066	hybrid, Green Published			2022-12-26	WOS:000546986500005
J	He, XQ; You, P; Sun, YF				He, Xueqing; You, Pei; Sun, Yunfu			Lanthanum and abscisic acid coregulate chlorophyll production of seedling in switchgrass	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; PANICUM-VIRGATUM L.; GENE-EXPRESSION; ROOT-GROWTH; GERMINATION; PORPHYRIN; ABA; STRESS; IONS; PHOTOSYNTHESIS	The rare earth element lanthanum (La) has been proven to be beneficial for plant growth with a low concentration, and abscisic acid (ABA) which is a plant hormone also can regulate plant growth. In the present study, we investigated the germination and seedling growth of switchgrass (Panicum virgatum L.) under La (10 mu M), ABA (10 mu M) and La + ABA treatments. The results showed that La, ABA and La + ABA treatments could not significantly affect the germination and shoot length as compared to the control (P>0.05). However, La treatment increased the root activity and chlorophyll content, and ABA treatment enhanced root length and root activity (P< 0.05). La + ABA treatments demonstrated that La could not significantly alleviate the promotion of ABA in root length, while ABA reversed the increase of chlorophyll content caused by La. The coregulation of La and ABA on chlorophyll content was further explored by in vitro experiments and quantum chemical calculations. In vitro experiments revealed that La, ABA, and La + ABA treatments reduced the absorbance of chlorophyll, and quantum chemical calculations indicated that the reduction of absorbance was caused by the reactions between La, ABA and chlorophyll. In vivo and in vitro experiments, together with quantum chemical calculations, demonstrated that both ABA and La could stimulate the production of chlorophyll, while they also could react with chlorophyll to produce La-monochlorophyll, La-bischlorophyll, and ABA adsorbed chlorophyll, which had lower absorbance. La + ABA treatment significantly decreased the chlorophyll content in vivo. This phenomenon was due to the fact that La and ABA formed LaABA compound, which markedly reduced the concentrations of ABA and La, and the effect of promoting chlorophyll production was overcome by the effect of reducing chlorophyll absorbance.	[He, Xueqing; You, Pei; Sun, Yunfu] Northwest A&F Univ, Coll Grassland Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	He, XQ (corresponding author), Northwest A&F Univ, Coll Grassland Agr, Yangling, Shaanxi, Peoples R China.	hexueqing@nwsuaf.edu.cn		He, Xue qing/0000-0001-9809-3644	Key Industry Innovation Chain in Shaanxi Province of China [2019ZDLNY05-02]; National Natural Science Foundation of China [31502005]; Natural Science Basic Research Plan in Shaanxi Province of China [2018JQ3030]; Tibet Finance Department Project [XZNKY-2019-C-054]	Key Industry Innovation Chain in Shaanxi Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; Tibet Finance Department Project	The work was supported by the Key Industry Innovation Chain in Shaanxi Province of China (grant no. 2019ZDLNY05-02), the National Natural Science Foundation of China (grant no. 31502005), Natural Science Basic Research Plan in Shaanxi Province of China (grant no. 2018JQ3030) and the Tibet Finance Department Project (grant no. XZNKY-2019-C-054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathokleous E, 2018, ENVIRON POLLUT, V238, P1044, DOI 10.1016/j.envpol.2018.02.068; Barnsley JE, 2018, J MOL STRUCT, V1173, P665, DOI 10.1016/j.molstruc.2018.06.117; Boyko A, 2011, PLANT CELL REP, V30, P505, DOI 10.1007/s00299-010-0960-3; Chen DM, 2003, CHEM PHYS, V289, P397, DOI 10.1016/S0301-0104(03)00088-0; Chen WJ, 2001, BIOL TRACE ELEM RES, V79, P169, DOI 10.1385/BTER:79:2:169; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; d'Aquino L, 2009, CHEMOSPHERE, V75, P900, DOI 10.1016/j.chemosphere.2009.01.026; de Oliveira C, 2015, ECOTOX ENVIRON SAFE, V122, P136, DOI 10.1016/j.ecoenv.2015.07.020; De Smet I, 2003, PLANT J, V33, P543, DOI 10.1046/j.1365-313X.2003.01652.x; Duclos DV, 2014, IND CROP PROD, V58, P148, DOI 10.1016/j.indcrop.2014.04.011; Emi K, 2018, BIOMASS BIOENERG, V111, P31; Falahati K, 2018, PHYS CHEM CHEM PHYS, V20, P12483, DOI 10.1039/c8cp00657a; Feng XaioYing, 2010, Seed, V29, P45; Frisch G. W., 2013, GAUSSIAN 09; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Gampala SSL, 2001, J BIOL CHEM, V276, P9855, DOI 10.1074/jbc.M009168200; Hagenbeek D, 2000, PLANT PHYSIOL, V123, P1553, DOI 10.1104/pp.123.4.1553; He XQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212674; Hong FS, 2002, SCI CHINA SER C, V45, P166, DOI 10.1360/02yc9019; Hong J, 2017, J ELECTROCHEM SCI TE, V8, P1, DOI 10.5229/JECST.2017.8.1.1; Hong JH, 2013, PLANT CELL REP, V32, P971, DOI 10.1007/s00299-013-1439-9; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; [姜文君 Jiang Wenjun], 2008, [中国稀土学报, Journal of the Chinese Rare Earth Society], V26, P797; Jin SL, 2020, J HAZARD MATER, V381, DOI [10.1016/j.jhazinat.2019.121004, 10.1016/j.jhazmat.2019.121004]; Kimura E, 2015, BIOMASS BIOENERG, V80, P94, DOI 10.1016/j.biombioe.2015.04.036; Liao MS, 2006, J PHYS CHEM A, V110, P13089, DOI 10.1021/jp0632236; Liu M, 2008, J PLANT GROWTH REGUL, V27, P19, DOI 10.1007/s00344-007-9026-3; Mironov AF, 2013, RUSS CHEM REV+, V82, P333, DOI 10.1070/RC2013v082n04ABEH004300; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Negin B, 2016, PLANT SCI, V251, P82, DOI 10.1016/j.plantsci.2016.05.007; Nilima Chaturvedi, 2014, International Journal of Environmental Sciences, V4, P653; Ochi K, 2014, J IND MICROBIOL BIOT, V41, P403, DOI 10.1007/s10295-013-1349-4; Pang X, 2002, ENVIRON SCI POLLUT R, V9, P143, DOI [10.1007/BF02987462, 10.1007/BF02987718]; Pang X, 2002, CHEMOSPHERE, V47, P1033, DOI 10.1016/S0045-6535(02)00022-X; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rock CD, 1996, PLANT CELL REP, V15, P371, DOI 10.1007/BF00232374; Rowan K.S., 1989, PHOTOSYNTHETIC PIGME; Sarath G, 2006, PLANTA, V223, P1154, DOI 10.1007/s00425-005-0162-3; Sarath G, 2007, PLANTA, V226, P697, DOI 10.1007/s00425-007-0517-z; SCHNALL JA, 1992, PLANT PHYSIOL, V100, P216, DOI 10.1104/pp.100.1.216; Shi P, 2005, RUSS J PLANT PHYSL+, V52, P294, DOI 10.1007/s11183-005-0044-3; Sun QX, 2018, J RARE EARTH, V36, P898, DOI 10.1016/j.jre.2018.03.009; Thomas PJ, 2014, CHEMOSPHERE, V96, P57, DOI 10.1016/j.chemosphere.2013.07.020; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Wang JR, 2014, J RARE EARTH, V32, P78, DOI 10.1016/S1002-0721(14)60035-1; Wang LH, 2014, CHEMOSPHERE, V112, P355, DOI 10.1016/j.chemosphere.2014.04.069; Wang QQ, 2001, ANAL SCI, V17, P789, DOI 10.2116/analsci.17.789; Wen KJ, 2011, CHEMOSPHERE, V84, P601, DOI 10.1016/j.chemosphere.2011.03.054; Yang DongQing, 2013, Acta Agronomica Sinica, V39, P1096, DOI 10.3724/SP.J.1006.2013.01096; Yin YB, 2016, COMPUT THEOR CHEM, V1080, P38, DOI 10.1016/j.comptc.2016.01.022; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Ziegler CJ, 2013, J PHYS CHEM A, V117, P11499, DOI 10.1021/jp409013d	53	7	7	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232750	10.1371/journal.pone.0232750	http://dx.doi.org/10.1371/journal.pone.0232750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369520	Green Published, gold			2022-12-26	WOS:000537280000044
J	Shi, SF; Huang, X; Ma, X; Zhu, XY; Zhang, QX				Shi, Shifeng; Huang, Xin; Ma, Xiao; Zhu, Xiaoyan; Zhang, Qinxian			Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells	PLOS ONE			English	Article							BREAST-CANCER; TRANSCRIPTION FACTOR; EXPRESSION; THERAPY; TFAP2C; METASTASIS; MICRORNAS; TARGET; GROWTH; GENES	Purpose Chemotherapy resistance of esophageal cancer is a key factor affecting the postoperative treatment of esophageal cancer. Among the media that transmit signals between cells, the exosomes secreted by tumor cells mediate information transmission between tumor cells, which can make sensitive cells obtain resistance. Although some cellular exosomes play an important role in tumor's acquired drug resistance, the related action mechanism is still not explored specifically. Methods To elucidate this process, we constructed a cisplatin-resistant esophageal cancer cell line, and proved that exosomes conferring cellular resistance in esophageal cancer can promote cisplatin resistance in sensitive cells. Through high-throughput sequencing analysis of the exosome and of cells after stimulation by exosomes, we determined that the miRNA193 in exosomes conferring cellular resistance played a key role in sensitive cells acquiring resistance to cisplatin. In vitro experiments showed that miRNA193 can regulate the cell cycle of esophageal cancer cells and inhibit apoptosis, so that sensitive cells can acquire resistance to cisplatin. An in vivo experiment proved that miRNA193 can promote tumor proliferation through the exosomes, and provide sensitive cells with slight resistance to cisplatin. Results Small RNA sequencing of exosomes showed that exosomes in drug-resistant cells have 189 up-regulated and 304 down-regulated miRNAs; transcriptome results showed that drug-sensitive cells treated with drug-resistant cellular exosomes have 3446 high-expression and 1709 low-expression genes; correlation analysis showed that drug-resistant cellular exosomes mainly affect the drug resistance of sensitive cells through paths such as cytokine-cytokine receptor interaction, and the VEGF and Jak-STAT signaling pathways; miRNA193, one of the high-expression miRNAs in drug-resistant cellular exosomes, can promote drug resistance by removing cisplatin's inhibition of the cell cycle of sensitive cells. Conclusion Sensitive cells can become resistant to cisplatin through acquired drug-resistant cellular exosomes, and miRNA193 can make tumor cells acquire cisplatin resistance by regulating the cell cycle.	[Shi, Shifeng; Huang, Xin; Zhu, Xiaoyan; Zhang, Qinxian] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Peoples R China; [Shi, Shifeng] Xinxiang Med Univ, SanQuan Med Coll, Xinxiang, Henan, Peoples R China; [Ma, Xiao] Xinxiang Med Univ, Affiliated Hosp 3, Xinxiang, Henan, Peoples R China	Zhengzhou University; Xinxiang Medical University; Xinxiang Medical University	Zhu, XY; Zhang, QX (corresponding author), Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Peoples R China.	doctorzhuxy99@sina.com; doctorzhangqx99@sina.com						Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Baldi A, 2001, J CELL BIOCHEM, V83, P364, DOI 10.1002/jcb.1235; Bar-Eli M, 2001, PIGM CELL RES, V14, P78, DOI 10.1034/j.1600-0749.2001.140202.x; Bar-Eli M, 2011, EMBO J, V30, P1880, DOI 10.1038/emboj.2011.132; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Cao ZG, 2019, BIOCHEM BIOPH RES CO, V515, P345, DOI 10.1016/j.bbrc.2019.05.120; Challagundla KB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv135; Chen WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095240; Christie EL, 2017, ANN ONCOL, V28, P13, DOI 10.1093/annonc/mdx446; Colak S, 2014, FEBS J, V281, P4779, DOI 10.1111/febs.13023; De Andrade JP, 2016, MOL CANCER THER, V15, P503, DOI 10.1158/1535-7163.MCT-15-0548-T; Haisley KR, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dox015; He M, 2016, JALA-J LAB AUTOM, V21, P599, DOI 10.1177/2211068216651035; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hnasko TS, ELISA METHODS MOL BI, V1318, P87, DOI [10.1371/journal.pone.0095240, DOI 10.1371/JOURNAL.PONE.0095240]; Jia YL, 2017, ONCOTARGET, V8, P41717, DOI 10.18632/oncotarget.16684; Jiang Run-De, 2003, Ai Zheng, V22, P337; Joyce DP, 2016, INT J CANCER, V139, P1443, DOI 10.1002/ijc.30179; Kang HJ, 2014, CANCER RES, V74, P1484, DOI 10.1158/0008-5472.CAN-13-2020; Kuckenberg P, 2012, REPROD BIOMED ONLINE, V25, P12, DOI 10.1016/j.rbmo.2012.02.015; Liang Shuo, 2010, Zhejiang Da Xue Xue Bao Yi Xue Ban, V39, P430; Lin YS, 2017, ANN EPIDEMIOL, V27, P215, DOI 10.1016/j.annepidem.2016.11.004; Lv MM, 2014, TUMOR BIOL, V35, P10773, DOI 10.1007/s13277-014-2377-z; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Mobley AK, 2012, CANCER METAST REV, V31, P621, DOI 10.1007/s10555-012-9358-8; Pakravan K, 2017, CELL ONCOL, V40, P457, DOI 10.1007/s13402-017-0335-7; Pellikainen JM, 2007, INT J CANCER, V120, P2061, DOI 10.1002/ijc.22648; Perkins SM, 2015, BREAST CANCER RES TR, V152, P519, DOI 10.1007/s10549-015-3492-2; Qin XB, 2017, INT J NANOMED, V12, P3721, DOI 10.2147/IJN.S131516; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; SCHAFER S, 2011, INT J ANDROL, V34, pE15, DOI DOI 10.1016/J.SEMCANCER.2010.12.007; Schram AM, 2017, NAT REV CLIN ONCOL, V14, P735, DOI 10.1038/nrclinonc.2017.127; Scibetta AG, 2010, CELL CYCLE, V9, P4525, DOI 10.4161/cc.9.22.13746; Shah SH, 2015, CANCER BIOL THER, V16, P1671, DOI 10.1080/15384047.2015.1071742; Stickney Z, 2016, BIOCHEM BIOPH RES CO, V472, P53, DOI 10.1016/j.bbrc.2016.02.058; Suntharalingam M, 2017, JAMA ONCOL, V3, P1520, DOI 10.1001/jamaoncol.2017.1598; Syn N, 2016, TRENDS PHARMACOL SCI, V37, P606, DOI 10.1016/j.tips.2016.04.006; Thrumurthy SG, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4373; Urbanelli Lorena, 2015, Recent Pat CNS Drug Discov, V10, P10; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Wei YF, 2014, BREAST CANCER RES TR, V147, P423, DOI 10.1007/s10549-014-3037-0; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Yu DD, 2016, TUMOR BIOL, V37, P3227, DOI 10.1007/s13277-015-4161-0; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zheng PM, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0528-y	48	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0225290	10.1371/journal.pone.0225290	http://dx.doi.org/10.1371/journal.pone.0225290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369495	Green Submitted, Green Published, gold			2022-12-26	WOS:000537280000001
J	Kuma, A; Wang, XNH; Klein, JD; Tan, L; Naqvi, N; Rianto, F; Huang, Y; Yu, MS; Sands, JM				Kuma, Akihiro; Wang, Xiaonan H.; Klein, Janet D.; Tan, Lin; Naqvi, Nawazish; Rianto, Fitra; Huang, Ying; Yu, Manshu; Sands, Jeff M.			Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease	FASEB JOURNAL			English	Article						cardiac fibrosis; cardiovascular disease; dimethylthiourea; diuretics; hypertrophy	CONVERTING ENZYME-INHIBITORS; UT-A; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; CARDIAC FIBROSIS; RENAL-FUNCTION; HEART-FAILURE; HYPERTENSION; HYPERTROPHY	Uremic cardiomyopathy, characterized by hypertension, cardiac hypertrophy, and fibrosis, is a complication of chronic kidney disease (CKD). Urea transporter (UT) inhibition increases the excretion of water and urea, but the effect on uremic cardiomyopathy has not been studied. We tested UT inhibition by dimethylthiourea (DMTU) in 5/6 nephrectomy mice. This treatment suppressed CKD-induced hypertension and cardiac hypertrophy. In CKD mice, cardiac fibrosis was associated with upregulation of UT and vimentin abundance. Inhibition of UT suppressed vimentin amount. Left ventricular mass index in DMTU-treated CKD was less compared with non-treated CKD mice as measured by echocardiography. Nephrectomy was performed in UT-A1/A3 knockout (UT-KO) to further confirm our finding. UT-A1/A3 deletion attenuates the CKD-induced increase in cardiac fibrosis and hypertension. The amount of alpha-smooth muscle actin and tgf-beta were significantly less in UT-KO with CKD than WT/CKD mice. To study the possibility that UT inhibition could benefit heart, we measured the mRNA of renin and angiotensin-converting enzyme (ACE), and found both were sharply increased in CKD heart; DMTU treatment and UT-KO significantly abolished these increases. Conclusion: Inhibition of UT reduced hypertension, cardiac fibrosis, and improved heart function. These changes are accompanied by inhibition of renin and ACE.	[Kuma, Akihiro; Wang, Xiaonan H.; Klein, Janet D.; Rianto, Fitra; Huang, Ying; Yu, Manshu; Sands, Jeff M.] Emory Univ, Sch Med, Dept Med, Renal Div, 1639 Pierce Dr,WMB Rm 3313, Atlanta, GA 30322 USA; [Kuma, Akihiro] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan; [Tan, Lin; Naqvi, Nawazish] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Yu, Manshu] Nanjing Univ Chinese Med, Renal Div, Affiliated Hosp, Nanjing, Peoples R China	Emory University; University of Occupational & Environmental Health - Japan; Emory University; Nanjing University of Chinese Medicine	Wang, XNH; Sands, JM (corresponding author), Emory Univ, Sch Med, Dept Med, Renal Div, 1639 Pierce Dr,WMB Rm 3313, Atlanta, GA 30322 USA.	xwang03@emory.edu; jeff.sands@emory.edu	Kuma, Akihiro/AAT-7155-2020; Rianto, Fitra/AAN-3056-2021	Kuma, Akihiro/0000-0002-4242-7921; Rianto, Fitra/0000-0002-6241-6816	NIH/NIDDK [R01 DK41707]; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; American Heart Association Discover and Innovation Grants - Bayer Group [17IBDG33780000]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; American Heart Association Discover and Innovation Grants - Bayer Group	This work was supported by NIH/NIDDK grant R01 DK41707 to JMS; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad to AK; the American Heart Association Discover and Innovation Grants supported by Bayer Group (17IBDG33780000) to XHW The content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH, or the US Government	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; De Mello WC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00016; Doran JJ, 2006, AM J PHYSIOL-REG I, V290, pR1446, DOI 10.1152/ajpregu.00352.2004; Duchesne R, 2001, CIRC RES, V89, P139, DOI 10.1161/hh1401.093293; Efe O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88409; Esteva-Font C, 2014, FASEB J, V28, P3878, DOI 10.1096/fj.14-253872; Fenton RA, 2005, J AM SOC NEPHROL, V16, P1583, DOI 10.1681/ASN.2005010031; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Fenton RA, 2007, J AM SOC NEPHROL, V18, P679, DOI 10.1681/ASN.2006101108; Forrester SJ, 2018, PHYSIOL REV, V98, P1627, DOI 10.1152/physrev.00038.2017; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greene SJ, 2013, EUR J HEART FAIL, V15, P1401, DOI 10.1093/eurjhf/hft110; Gumprecht J, 2019, J HUM HYPERTENS, V33, P824, DOI 10.1038/s41371-019-0279-7; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Ilori TO, 2013, AM J PHYSIOL-RENAL, V304, pF103, DOI 10.1152/ajprenal.00385.2012; Inoue H, 2005, AM J PHYSIOL-RENAL, V289, pF451, DOI 10.1152/ajprenal.00376.2004; Jin NN, 2019, MED SCI MONITOR, V25, P6605, DOI 10.12659/MSM.914877; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Kinugawa S, 2000, CIRC RES, V87, P392; Kitada K, 2017, J CLIN INVEST, V127, P1944, DOI 10.1172/JCI88532; Klein JD, 2016, J AM SOC NEPHROL, V27, P1448, DOI 10.1681/ASN.2014121267; Klein JD, 2012, PFLUG ARCH EUR J PHY, V464, P561, DOI 10.1007/s00424-012-1157-0; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Laurino A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194912; London GM, 2003, SEMIN DIALYSIS, V16, P85, DOI 10.1046/j.1525-139X.2003.16023.x; Marquez DF, 2015, EXPERT OPIN PHARMACO, V16, P2283, DOI 10.1517/14656566.2015.1079623; Messerli FH, 2018, J AM COLL CARDIOL, V71, P1474, DOI 10.1016/j.jacc.2018.01.058; Perkovic V, 2007, J AM SOC NEPHROL, V18, P2766, DOI 10.1681/ASN.2007020256; Romero C, 2015, NAT REV ENDOCRINOL, V11, P242, DOI 10.1038/nrendo.2015.6; Sands JM, 2004, CURR OPIN NEPHROL HY, V13, P525, DOI 10.1097/00041552-200409000-00008; Trespalacios FC, 2003, AM J KIDNEY DIS, V41, P1267, DOI 10.1016/S0272-6386(03)00359-7; United States Renal Data System, 2018, ANN DAT REP, V4, P79; von Lueder TG, 2015, CIRC-HEART FAIL, V8, P71, DOI 10.1161/CIRCHEARTFAILURE.114.001785; Wang B, 2019, THERANOSTICS, V9, P1864, DOI 10.7150/thno.29579; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Yamakawa H, 2000, AM J PHYSIOL-HEART C, V279, pH2939, DOI 10.1152/ajpheart.2000.279.6.H2939; Yeih DF, 2009, AM J PHYSIOL-HEART C, V297, pH1411, DOI 10.1152/ajpheart.01269.2008; Zoccali C, 2017, J AM SOC NEPHROL, V28, P2491, DOI 10.1681/ASN.2016121341	43	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8296	8309		10.1096/fj.202000214RR	http://dx.doi.org/10.1096/fj.202000214RR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367640	Green Accepted			2022-12-26	WOS:000530924800001
J	Roglio, VS; Borges, EN; Rabelo-da-Ponte, FD; Scherer, JN; Schuch, JB; Passos, IC; Sanvicente-Vieira, B; Grassi-Oliveira, R; von Diemen, L; Pechansky, F; Kessler, FHP; Ornell, F				Roglio, Vinicius Serafini; Borges, Eduardo Nunes; Rabelo-da-Ponte, Francisco Diego; Scherer, Juliana Nichterwitz; Schuch, Jaqueline Bohrer; Passos, Ives Cavalcante; Sanvicente-Vieira, Breno; Grassi-Oliveira, Rodrigo; von Diemen, Lisia; Pechansky, Flavio; Paim Kessler, Felix Henrique; Ornell, Felipe			Prediction of attempted suicide in men and women with crack-cocaine use disorder in Brazil	PLOS ONE			English	Article							BIPOLAR DISORDER; SUBSTANCE-USE; GENDER-DIFFERENCES; CHILDHOOD-TRAUMA; COMMUNITY SAMPLE; SEXUAL-ABUSE; RISK-FACTORS; LIFE-SPAN; DIAGNOSIS; IDEATION	Background Suicide is a severe health problem, with high rates in individuals with addiction. Considering the lack of studies exploring suicide predictors in this population, we aimed to investigate factors associated with attempted suicide in inpatients diagnosed with cocaine use disorder using two analytical approaches. Methods This is a cross-sectional study using a secondary database with 247 men and 442 women hospitalized for cocaine use disorder. Clinical assessment included the Addiction Severity Index, the Childhood Trauma Questionnaire, and the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, totalling 58 variables. Descriptive Poisson regression and predictive Random Forest algorithm were used complementarily to estimate prevalence ratios and to build prediction models, respectively. All analyses were stratified by gender. Results The prevalence of attempted suicide was 34% for men and 50% for women. In both genders, depression (PRM = 1.56, PRW = 1.27) and hallucinations (PRM = 1.80, PRW = 1.39) were factors associated with attempted suicide. Other specific factors were found for men and women, such as childhood trauma, aggression, and drug use severity. The men's predictive model had prediction statistics of AUC = 0.68, Acc. = 0.66, Sens. = 0.82, Spec. = 0.50, PPV = 0.47 and NPV = 0.84. This model identified several variables as important predictors, mainly related to drug use severity. The women's model had higher predictive power (AUC = 0.73 and all other statistics were equal to 0.71) and was parsimonious. Conclusions Our findings indicate that attempted suicide is associated with depression, hallucinations and childhood trauma in both genders. Also, it suggests that severity of drug use may be a moderator between predictors and suicide among men, while psychiatric issues shown to be more important for women.	[Roglio, Vinicius Serafini; Borges, Eduardo Nunes; Rabelo-da-Ponte, Francisco Diego; Scherer, Juliana Nichterwitz; Schuch, Jaqueline Bohrer; von Diemen, Lisia; Pechansky, Flavio; Paim Kessler, Felix Henrique; Ornell, Felipe] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Ctr Drug & Alcohol Res, Porto Alegre, RS, Brazil; [Roglio, Vinicius Serafini; Rabelo-da-Ponte, Francisco Diego; Schuch, Jaqueline Bohrer; von Diemen, Lisia; Pechansky, Flavio; Paim Kessler, Felix Henrique; Ornell, Felipe] Univ Fed Rio Grande do Sul, Grad Program Psychiat & Behav Sci, Porto Alegre, RS, Brazil; [Borges, Eduardo Nunes] Univ Fed do Rio Grande, Ctr Computat Sci, Porto Alegre, RS, Brazil; [Rabelo-da-Ponte, Francisco Diego; Passos, Ives Cavalcante] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Mol Psychiat Lab, Porto Alegre, RS, Brazil; [Sanvicente-Vieira, Breno; Grassi-Oliveira, Rodrigo] Pontificia Univ Catolica Rio Grande do Sul, Dev Cognit Neurosci Lab, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Borges, EN (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Ctr Drug & Alcohol Res, Porto Alegre, RS, Brazil.; Borges, EN (corresponding author), Univ Fed do Rio Grande, Ctr Computat Sci, Porto Alegre, RS, Brazil.	eduardoborges@furg.br	KESSLER, FELIX HENRIQUE P/C-3798-2018; ornell, felipe/AAC-8207-2019; Borges, Eduardo N/N-5544-2017; Schuch, Jaqueline Bohrer/L-1249-2015; Passos, Ives Cavalcante/U-7366-2019; von Diemen, Lisia/D-5452-2015; Grassi-Oliveira, R/G-2623-2012; von Diemen, Lisia/GSE-1795-2022; Scherer, Juliana N/M-6344-2016; Sanvicente-Vieira, Breno/H-5530-2013	KESSLER, FELIX HENRIQUE P/0000-0001-7059-2564; ornell, felipe/0000-0002-3881-4283; Borges, Eduardo N/0000-0003-1595-7676; Schuch, Jaqueline Bohrer/0000-0002-2195-4407; Passos, Ives Cavalcante/0000-0001-6407-8219; von Diemen, Lisia/0000-0001-9228-7114; Grassi-Oliveira, R/0000-0001-9911-5921; Scherer, Juliana N/0000-0002-9235-0416; Sanvicente-Vieira, Breno/0000-0002-9922-966X; Rabelo-da-Ponte, Francisco Diego/0000-0001-9016-2414	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [466802/20145, 478492/2013-8]; Secretaria Nacional de Politicas sobre Drogas (SENAD)/Ministerio da Justica e Seguranca Publica [822647/2015, 08129.015636/2017-78]; Research Support Fund at Hospital de Clinicas de Porto Alegre (FIPE-HCPA) [20150234]; Fundacao de Amparo a pesquisa do Estado do RS (FAPERGS) [TO 17/2551-0000872-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Secretaria Nacional de Politicas sobre Drogas (SENAD)/Ministerio da Justica e Seguranca Publica; Research Support Fund at Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Fundacao de Amparo a pesquisa do Estado do RS (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant numbers 466802/20145 and 478492/2013-8] to RG-O and LVD, Secretaria Nacional de Politicas sobre Drogas (SENAD)/Ministerio da Justica e Seguranca Publica [grant numbers 822647/2015 and 08129.015636/2017-78] to RG-O and FHPK, Research Support Fund at Hospital de Clinicas de Porto Alegre (FIPE-HCPA) [grant number 20150234] to LVD, Fundacao de Amparo a pesquisa do Estado do RS (FAPERGS) [grant number TO 17/2551-0000872-3] to ENB and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES) - [finance code 001] to VSR and JBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla RR, 2019, BRAZ J PSYCHIAT, V41, P437, DOI 10.1590/1516-4446-2018-0054; Acion L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175383; Adiguzel V, 2019, NORD J PSYCHIAT, V73, P490, DOI 10.1080/08039488.2019.1655589; Angelakis I, 2020, PSYCHOL MED, V50, P1, DOI 10.1017/S0033291719002848; Arias F, 2016, ADICCIONES, V29, P186, DOI [10.20882/adicciones.782, DOI 10.20882/ADICCIONES.782]; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Bachmann S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071425; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bastos FI., 2017, 3 NATL SURVEY DRUG U, P528; Bastos FI, 2014, PESQUISA NACL USO CR; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Beyer JL, 2016, PSYCHIAT CLIN N AM, V39, P111, DOI 10.1016/j.psc.2015.09.002; Bilsen J, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00540; Borges G, 2000, AM J EPIDEMIOL, V151, P781; Bradvik L, 2003, SUICIDE LIFE-THREAT, V33, P186, DOI 10.1521/suli.33.2.186.22773; Breiman L., 2001, MACH LEARN, V45, P5; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Campos RC, 2017, J MENT HEALTH, V26, P66, DOI 10.1080/09638237.2016.1222066; Cardoso TD, 2015, J AFFECT DISORDERS, V187, P179, DOI 10.1016/j.jad.2015.08.046; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chartoff EH, 2014, BEHAV PHARMACOL, V25, P473, DOI 10.1097/FBP.0000000000000080; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Cibis A, 2012, J AFFECT DISORDERS, V136, P9, DOI 10.1016/j.jad.2011.08.032; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Daigre C, 2017, QUAL LIFE RES, V26, P3201, DOI 10.1007/s11136-017-1668-4; DeCou CR, 2016, PSYCHOL SERV, V13, P254, DOI 10.1037/ser0000096; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; Duailibi Lígia Bonacim, 2008, Cad. Saúde Pública, V24, ps545, DOI 10.1590/S0102-311X2008001600007; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Fayyad U, 1996, COMMUN ACM, V39, P27, DOI 10.1145/240455.240464; Forty L, 2014, BRIT J PSYCHIAT, V205, P465, DOI 10.1192/bjp.bp.114.152249; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Freeman A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1398-8; Fujita J, 2015, SCHIZOPHR RES, V168, P209, DOI 10.1016/j.schres.2015.07.028; Fusar-Poli P, 2016, ACTA PSYCHIAT SCAND, V133, P76, DOI 10.1111/acps.12480; Garami J, 2019, PSYCHOL REP, V122, P433, DOI 10.1177/0033294118764918; Gradus JL, 2020, JAMA PSYCHIAT, V77, P25, DOI 10.1001/jamapsychiatry.2019.2905; Grassi-Oliveira R, 2006, REV SAUDE PUBL, V40, P249, DOI 10.1590/S0034-89102006000200010; Greenwald MK, 2014, DRUG ALCOHOL DEPEN, V141, P27, DOI 10.1016/j.drugalcdep.2014.04.028; Halpern SC, 2018, CHILD ABUSE REV, V27, P344, DOI 10.1002/car.2534; Halpern SC, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00037517, 10.1590/0102-311x00037517]; Harford TC, 2014, CHILD ABUSE NEGLECT, V38, P1389, DOI 10.1016/j.chiabu.2014.02.011; Harkness KL, 2015, J ABNORM PSYCHOL, V124, P1, DOI 10.1037/abn0000041; Hauser M, 2013, BIPOLAR DISORD, V15, P507, DOI 10.1111/bdi.12094; Hoertel N, 2015, MOL PSYCHIATR, V20, P718, DOI 10.1038/mp.2015.19; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Ibrahim N, 2017, PSYCHOL RES BEHAV MA, V10, P129, DOI 10.2147/PRBM.S125176; Iemmi V, 2016, LANCET PSYCHIAT, V3, P774, DOI 10.1016/S2215-0366(16)30066-9; Ilgen MA, 2007, ALCOHOL CLIN EXP RES, V31, P635, DOI 10.1111/j.1530-0277.2007.00348.x; Ishii T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096272; Japkowicz N., 2000, P 2000 INT C ART INT; Karila L, 2012, CURR MED CHEM, V19, P5612, DOI 10.2174/092986712803988839; Kessler S, 2010, INC, V32, P48; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Laranjeira R., 2013, 2 LEVANTAMENTO NACL; Lejuez CW, 2007, EXP CLIN PSYCHOPHARM, V15, P165, DOI 10.1037/1064-1297.15.2.165; Maki N, 2012, J EPIDEMIOL COMMUN H, V66, P302, DOI 10.1136/jech.2009.105908; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Maser JD, 2002, SUICIDE LIFE-THREAT, V32, P10, DOI 10.1521/suli.32.1.10.22183; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; McMahon K, 2018, PSYCHIAT RES, V269, P386, DOI 10.1016/j.psychres.2018.08.059; Mergl R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129062; Min KB, 2015, PREV MED, V71, P72, DOI 10.1016/j.ypmed.2014.12.017; Miranda-Mendizabal A, 2019, INT J PUBLIC HEALTH, V64, P265, DOI 10.1007/s00038-018-1196-1; Mohammadzadeh A, 2019, PSYCHIAT RES, V275, P100, DOI 10.1016/j.psychres.2019.03.023; MOSCICKI EK, 1995, SUICIDE LIFE-THREAT, V25, P22; Narvaez JCM, 2014, COMPR PSYCHIAT, V55, P1369, DOI 10.1016/j.comppsych.2014.04.021; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; North CS, 2017, BEHAV SCI-BASEL, V7, DOI 10.3390/bs7040074; Kessler FHP, 2012, AM J ADDICTION, V21, P370, DOI 10.1111/j.1521-0391.2012.00245.x; Pope SK, 2011, AM J DRUG ALCOHOL AB, V37, P491, DOI 10.3109/00952990.2011.600380; Post RM, 2013, BRIT J PSYCHIAT, V202, P172, DOI 10.1192/bjp.bp.112.116855; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Sanvicente-Vieira B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218334; Scherer JN, 2019, ACCIDENT ANAL PREV, V123, P256, DOI 10.1016/j.aap.2018.12.003; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Siliquini R, 2005, EUR J PUBLIC HEALTH, V15, P580, DOI 10.1093/eurpub/cki031; Silva Dhiordan Cardoso da, 2017, J. bras. psiquiatr., V66, P89, DOI 10.1590/0047-2085000000155; Stefanello S, 2008, REV BRAS PSIQUIATR, V30, P139, DOI 10.1590/S1516-44462006005000063; Tsujii N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175249; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; van Buuren S, 2011, J STAT SOFTW, V45, P1; Watkins HB, 2013, BIPOLAR DISORD, V15, P542, DOI 10.1111/bdi.12090; Wilens TE, 2013, DRUG ALCOHOL DEPEN, V132, P114, DOI 10.1016/j.drugalcdep.2013.01.015; World Health Organization, PREV SUIC BEH TASK A; Yang JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199741; Yuodelis-Flores C, 2015, AM J ADDICTION, V24, P98, DOI 10.1111/ajad.12185	88	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232242	10.1371/journal.pone.0232242	http://dx.doi.org/10.1371/journal.pone.0232242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365094	gold, Green Published			2022-12-26	WOS:000536959700021
J	Mercurio, L; Failla, CM; Capriotti, L; Scarponi, C; Facchiano, F; Morelli, M; Rossi, S; Pagnanelli, G; Albanesi, C; Cavani, A; Madonna, S				Mercurio, Laura; Failla, Cristina M.; Capriotti, Lorena; Scarponi, Claudia; Facchiano, Francesco; Morelli, Martina; Rossi, Stefania; Pagnanelli, Gianluca; Albanesi, Cristina; Cavani, Andrea; Madonna, Stefania			Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses	PLOS ONE			English	Article							PSORIATIC SKIN; PROTEIN-KINASE; IL-17; ANGIOGENESIS; ACTIVATION; VEGF; EXPRESSION; IMMUNITY; GROWTH; TH17	In inflammatory skin conditions, such as psoriasis, vascular enlargement is associated with endothelial cell proliferation, release of cytokines and adhesion molecule expression. Interleukin (IL)-17A is a pro-inflammatory cytokine mainly secreted by T helper-17 cells that is critically involved in psoriasis pathogenesis. IL-36 alpha, IL-36 beta and IL-36 gamma are also inflammatory cytokines up-regulated in psoriasis and induced by various stimuli, including IL-17A. In this study, we found that human keratinocytes are the main source of IL-36, in particular of IL-36 gamma. This cytokine was strongly induced by IL-17A and, together with IL-17A, efficiently activated human dermal microvascular endothelial cells (HDMECs), which expressed both IL-17 and IL-36 receptors. Both IL-36 gamma and IL-17A induced cell proliferation through specific molecular cascades involving ERK1/2 only or ERK1/2, STAT3 and NF-kappa B, respectively. We highlighted the intense IL-17A- and IL-36 gamma-dependent interplay between keratinocytes and HDMECs, likely active in the psoriatic lesions and leading to the establishment of a cytokine network responsible for the development and maintenance of the inflamed state. IL-17A or IL-36 gamma showed in HDMECs a synergic activity with TNF-alpha by potently inducing inflammatory cytokine/chemokine release and ICAM-1 expression. We also investigated the involvement of IL-36 gamma and VEGF-A, substantially reduced in lesional skin of psoriatic patients pharmacologically treated with the anti-IL-17A antibody Secukinumab. Importantly, keratinocyte-derived IL-36 gamma represented an additional pro-angiogenic mediator of IL-17A. We observed that keratinocyte-derived VEGF-A influenced proliferation but did not act on expression of adhesion molecules in HDMECs. On the other hand, inhibition of IL-36 gamma released by IL-17A-treated keratinocytes impaired either proliferation or ICAM-1 expression both in HDMECs and in an in vivo murine model of psoriasis. Taken together, our data demonstrated that IL-17A and IL-36 gamma are highly involved in endothelial cells/keratinocytes crosstalk in inflammatory skin conditions.	[Mercurio, Laura; Failla, Cristina M.; Capriotti, Lorena; Scarponi, Claudia; Morelli, Martina; Albanesi, Cristina; Madonna, Stefania] IDI IRCCS, Lab Expt Immunol, Rome, Italy; [Facchiano, Francesco; Rossi, Stefania] Ist Super Sanita ISS, Dept Oncol & Mol Med, Rome, Italy; [Pagnanelli, Gianluca] IDI IRCCS, Dermatol Div 1, Rome, Italy; [Cavani, Andrea] Natl Inst Hlth Migrat & Poverty NIHMP, Rome, Italy; [Capriotti, Lorena] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Istituto Superiore di Sanita (ISS); IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome	Failla, CM (corresponding author), IDI IRCCS, Lab Expt Immunol, Rome, Italy.	c.failla@idi.it	Facchiano, Francesco/K-8716-2016; Albanesi, Cristina/K-4699-2016; Morelli, Martina/AAA-1982-2019; Madonna, stefania/AAC-3381-2022; Mercurio, Laura/K-2750-2018; Rossi, Stefania/J-8328-2016	Facchiano, Francesco/0000-0003-4313-0617; Albanesi, Cristina/0000-0002-7537-6833; Morelli, Martina/0000-0001-7299-2393; Mercurio, Laura/0000-0003-0629-1729; Rossi, Stefania/0000-0002-8854-7072; Failla, Cristina/0000-0001-5991-8914	Novartis Farma Italy; Italian Ministry of Health [RC18-2.2]	Novartis Farma Italy; Italian Ministry of Health(Ministry of Health, Italy)	CMF, SM, AC have received funding by Novartis Farma Italy. CMF and CA have received grants from the Italian Ministry of Health "Ricerca Corrente", RC18-2.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; Arnott C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150688; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Bosteen MH, 2014, PFLUG ARCH EUR J PHY, V466, P961, DOI 10.1007/s00424-013-1354-5; Boutet MA, 2016, CLIN EXP IMMUNOL, V184, P159, DOI 10.1111/cei.12761; Boutet MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061257; Brembilla NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01682; Bridgewood C, 2017, EXP DERMATOL, V26, P402, DOI 10.1111/exd.13228; Buhl AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01162; Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Dietrich D, 2016, CYTOKINE, V84, P88, DOI 10.1016/j.cyto.2016.05.012; Eyerich K, 2017, EUR J IMMUNOL, V47, P607, DOI 10.1002/eji.201646723; German B, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123390; Griffioen AW, 2008, CANCER IMMUNOL IMMUN, V57, P1553, DOI 10.1007/s00262-008-0524-3; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Honorati MC, 2006, OSTEOARTHR CARTILAGE, V14, P345, DOI 10.1016/j.joca.2005.10.004; Huggenberger R, 2011, J INVEST DERM SYMP P, V15, P24, DOI 10.1038/jidsymp.2011.5; Lion J, 2016, AM J TRANSPLANT, V16, P1408, DOI 10.1111/ajt.13644; Liu GQ, 2017, MOL MED REP, V16, P865, DOI 10.3892/mmr.2017.6623; Liu R, 2016, J IMMUNOL, V197, P2400, DOI 10.4049/jimmunol.1600138; Madonna S, 2008, FASEB J, V22, P3287, DOI 10.1096/fj.08-106831; Madonna S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133318; Mai JT, 2016, J BIOL CHEM, V291, P4939, DOI 10.1074/jbc.M115.690081; MALHOTRA R, 1989, LAB INVEST, V61, P162; Markham T, 2006, J AM ACAD DERMATOL, V54, P1003, DOI 10.1016/j.jaad.2006.01.038; Mercurio L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1143-3; Nofal A, 2009, J EUR ACAD DERMATOL, V23, P803, DOI 10.1111/j.1468-3083.2009.03181.x; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Orecchia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024307; Palombo R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.201; Palomo J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194667; Patel AB, 2018, EXP DERMATOL, V27, P135, DOI 10.1111/exd.13461; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbrc.2007.02.156; Schonthaler HB, 2009, P NATL ACAD SCI USA, V106, P21264, DOI 10.1073/pnas.0907550106; Schuler R, 2019, J INVEST DERMATOL, V139, P638, DOI 10.1016/j.jid.2018.09.021; Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288; Taflin C, 2011, P NATL ACAD SCI USA, V108, P2891, DOI 10.1073/pnas.1011811108; Takahashi H, 2005, IMMUNOL LETT, V98, P189, DOI 10.1016/j.imlet.2004.11.012; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Hooren L, 2016, ONCOTARGET, V7, P50277, DOI 10.18632/oncotarget.10364; Varricchi G, 2015, J AM ACAD DERMATOL, V73, P144, DOI 10.1016/j.jaad.2015.03.041; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; von Stebut E, 2019, J INVEST DERMATOL; Wang CQF, 2013, J INVEST DERMATOL, V133, P2741, DOI 10.1038/jid.2013.237; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wojkowska DW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051000; Yuan SP, 2015, CELL PHYSIOL BIOCHEM, V36, P2340, DOI 10.1159/000430197	51	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0222969	10.1371/journal.pone.0222969	http://dx.doi.org/10.1371/journal.pone.0222969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352958	Green Submitted, Green Published, gold			2022-12-26	WOS:000536673200002
J	Godinez, VG; Kabbara, S; Sherman, A; Wu, T; Cohen, S; Kong, XD; Maravillas-Montero, JL; Shi, ZX; Preece, D; Yokomori, K; Berns, MW				Godinez, Veronica Gomez; Kabbara, Sami; Sherman, Adria; Wu, Tao; Cohen, Shirli; Kong, Xiangduo; Maravillas-Montero, Jose Luis; Shi, Zhixia; Preece, Daryl; Yokomori, Kyoko; Berns, Michael W.			DNA damage induced during mitosis undergoes DNA repair synthesis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; HOMOLOGOUS RECOMBINATION; LASER MICROIRRADIATION; MITOTIC CATASTROPHE; ATM; RECRUITMENT; ACTIVATION; SITES; NHEJ	Understanding the mitotic DNA damage response (DDR) is critical to our comprehension of cancer, premature aging and developmental disorders which are marked by DNA repair deficiencies. In this study we use a micro-focused laser to induce DNA damage in selected mitotic chromosomes to study the subsequent repair response. Our findings demonstrate that (1) mitotic cells are capable of DNA repair as evidenced by DNA synthesis at damage sites, (2) Repair is attenuated when DNA-PKcs and ATM are simultaneously compromised, (3) Laser damage may permit the observation of previously undetected DDR proteins when damage is elicited by other methods in mitosis, and (4) Twenty five percent of mitotic DNA-damaged cells undergo a subsequent mitosis. Together these findings suggest that mitotic DDR is more complex than previously thought and may involve factors from multiple repair pathways that are better understood in interphase.	[Godinez, Veronica Gomez; Sherman, Adria; Cohen, Shirli; Shi, Zhixia; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA; [Kabbara, Sami; Berns, Michael W.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Kabbara, Sami; Sherman, Adria; Wu, Tao; Preece, Daryl; Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92697 USA; [Wu, Tao; Preece, Daryl; Berns, Michael W.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Kong, Xiangduo; Yokomori, Kyoko] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Maravillas-Montero, Jose Luis] Univ Calif Irvine, Dept Physiol, Irvine, CA USA; [Kabbara, Sami] Tulane Dept Opthalmol, New Orleans, LA USA; [Maravillas-Montero, Jose Luis] Univ Nacl Autonoma Mexico, Mexico Cdmx, Mexico	University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Universidad Nacional Autonoma de Mexico	Berns, MW (corresponding author), Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA.; Berns, MW (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.; Berns, MW (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92697 USA.; Berns, MW (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	mwberns@uci.edu	Maravillas-Montero, José Luis/U-5275-2019; MARAVILLAS, JOSE/AIC-9441-2022	Maravillas-Montero, José Luis/0000-0003-3755-662X; Cohen, Shirli/0000-0002-0253-786X	AFOSR [FA9550-08-1-0384]; Minority Health and Health Disparities International Research Training (MHIRT) Program NIH [MD-01485]; National Science Foundation [MCB-1615701]; Beckman Laser Institute Foundation	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Minority Health and Health Disparities International Research Training (MHIRT) Program NIH; National Science Foundation(National Science Foundation (NSF)); Beckman Laser Institute Foundation	This work is supported in part by AFOSR Grant #FA9550-08-1-0384(M.W.B.), Minority Health and Health Disparities International Research Training (MHIRT) Program NIH Grant MD-01485 (V.G.G.), National Science Foundation MCB-1615701 (K.Y.), and a gift from the Beckman Laser Institute Foundation (M.W.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhoum SF, 2017, TRENDS CANCER, V3, P225, DOI 10.1016/j.trecan.2017.02.001; Bakr A, 2015, NUCLEIC ACIDS RES, V43, P3154, DOI 10.1093/nar/gkv160; Benada J, 2015, CELL CYCLE, V14, P219, DOI 10.4161/15384101.2014.977067; Berns M W, 1978, Methods Cell Biol, V18, P277; BERNS MW, 1969, NATURE, V221, P74, DOI 10.1038/221074a0; BERNS MW, 1974, SCIENCE, V186, P700, DOI 10.1126/science.186.4165.700; BERNS MW, 1979, CHROMOSOMA, V73, P1, DOI 10.1007/BF00294839; BERNS MW, 1973, COLD SPRING HARB SYM, V38, P165, DOI 10.1101/SQB.1974.038.01.020; BERNS MW, 1971, NATURE, V233, P122, DOI 10.1038/233122a0; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bhowmick R, 2016, MOL CELL, V64, P1117, DOI 10.1016/j.molcel.2016.10.037; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Cruz GMS, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv976; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Dominguez-Bendala J, 2006, CELL BIOL INT, V30, P389, DOI 10.1016/j.cellbi.2005.12.005; Feng WR, 2017, COLD SH Q B, V82, P329, DOI 10.1101/sqb.2017.82.035006; Feng WR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00634-0; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gomez-Godinez V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq836; Gomez-Godinez V, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717684; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Huang XX, 2005, P NATL ACAD SCI USA, V102, P1065, DOI 10.1073/pnas.0409130102; Iarovaia OV, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-249; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kong XD, 2014, MOL CELL BIOL, V34, P685, DOI 10.1128/MCB.01503-13; Kong XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023548; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lee DH, 2014, MOL CELL, V54, P512, DOI 10.1016/j.molcel.2014.03.020; London RE, 2015, DNA REPAIR, V30, P90, DOI 10.1016/j.dnarep.2015.02.005; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Min J, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00226-17; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857; Nishiyama T, 2013, P NATL ACAD SCI USA, V110, P13404, DOI 10.1073/pnas.1305020110; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Pedersen RT, 2015, J CELL BIOL, V210, P565, DOI 10.1083/jcb.201502107; Perrault R, 2004, J CELL BIOCHEM, V92, P781, DOI 10.1002/jcb.20104; Peterson SE, 2011, J CELL BIOL, V194, P705, DOI 10.1083/jcb.201103103; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Rasband W., 2006, IMAGEJ; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sami Gomez Godinez VK, 2020, DATA DNA DAMAGE INDU, DOI [10.6075/J08W3BQK, DOI 10.6075/J08W3BQK]; Silva BA, 2014, J BIOL CHEM, V289, P22771, DOI 10.1074/jbc.M113.535955; Silva BA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.095003; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Terasawa M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004563; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wakasugi M, 2014, J BIOL CHEM, V289, P28730, DOI 10.1074/jbc.M114.589747; Wakida NM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718920; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690; Zhang Wei, 2011, J BIOL CHEM, V107, P6870	66	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0227849	10.1371/journal.pone.0227849	http://dx.doi.org/10.1371/journal.pone.0227849			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343690	Green Published, gold, Green Submitted			2022-12-26	WOS:000536661300005
J	Douglas, MR; Anthonysamy, WJB; Mussmann, SM; Davis, MA; Louis, W; Douglas, ME				Douglas, Marlis R.; Anthonysamy, Whitney J. B.; Mussmann, Steven M.; Davis, Mark A.; Louis, Wade; Douglas, Michael E.			Multi-targeted management of upland game birds at the agroecosystem interface in midwestern North America	PLOS ONE			English	Article							CONSERVATION RESERVE PROGRAM; R-PACKAGE; POLYMORPHIC MICROSATELLITES; HABITAT FRAGMENTATION; PAIRWISE RELATEDNESS; COMPUTER-PROGRAM; CLIMATE-CHANGE; POPULATION; BIODIVERSITY; LANDSCAPE	Despite its imperative, biodiversity conservation is chronically underfunded, a deficiency that often forces management agencies to prioritize. Single-species recovery thus becomes a focus (often with socio-political implications), whereas a more economical approach would be the transition to multi-targeted management (= MTM). This challenge is best represented in Midwestern North America where biodiversity has been impacted by 300+ years of chronic anthropogenic disturbance such that native tall-grass prairie is now supplanted by an agroecosystem. Here, we develop an MTM with a population genetic metric to collaboratively manage three Illinois upland gamebirds: common pheasant (Phasianus colchicus; pheasant), northern bobwhite quail (Colinus virginianus; quail), and threatened-endangered (T&E) greater prairie chicken (Tympanuchus cupido pinnatus; prairie chicken). We first genotyped our study pheasant at 19 microsatellite DNA loci and identified three captive breeding stocks (N = 143; IL Department of Natural Resources) as being significantly bottlenecked, with relatedness > 1st-cousin (mu R = 0.158). 'Wild' (non-stocked) pheasant [N = 543; 14 Pheasant-Habitat-Areas (PHAs)] were also bottlenecked, significantly interrelated (mu R = 0.150) and differentiated (mu FST = 0.047), yet distinct from propagation stock. PHAs that encompassed significantly with larger areas also reflected greater effective population sizes (mu NE = 43; P< 0.007). We juxtaposed these data against previously published results for prairie chicken and quail, and found population genetic structure driven by drift, habitat/climate impacts, and gender-biased selection via hunter-harvest. Each species (hunter-harvested or T&E) is independently managed, yet their composite population genetic baseline provides the quantitative criteria needed for an upland game bird MTM. Its implementation would require agricultural plots to be rehabilitated/reclaimed using a land-sharing/sparing portfolio that differs markedly from the Conservation Reserve Program (CRP), where sequestered land decreases as agricultural prices escalate. Cost-savings for an MTM would accrue by synchronizing single-species management with a dwindling hunter-harvest program, and by eliminating propagation/stocking programs. This would sustain not only native grasslands and their resident species, but also accelerate conservation at the wildlife-agroecosystem interface.	[Douglas, Marlis R.; Anthonysamy, Whitney J. B.; Mussmann, Steven M.; Douglas, Michael E.] Univ Arkansas, Biol Sci, Fayetteville, AR USA; [Davis, Mark A.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL USA; [Louis, Wade] Illinois Dept Nat Resources, Gibson City, IL USA; [Anthonysamy, Whitney J. B.] St Louis Coll Pharm, Basic Sci, St Louis, MO USA; [Mussmann, Steven M.] US Fish & Wildlife Serv, Southwestern Native Aquati Resource & Recovery Ct, Dexter, NM USA	University of Arkansas System; University of Arkansas Fayetteville; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of the Interior; US Fish & Wildlife Service	Douglas, ME (corresponding author), Univ Arkansas, Biol Sci, Fayetteville, AR USA.	med1@uark.edu	Douglas, Michael/T-1761-2019; Mussmann, Steven/AAZ-9388-2021	Douglas, Michael/0000-0001-9670-7825; Davis, Mark/0000-0001-9034-9430; Mussmann, Steven/0000-0002-5237-5088	U.S. Fish & Wildlife Service Federal Aid in Wildlife Restoration [W-155-R]; University of Arkansas; University of Arkansas Endowment: Bruker Professorship in Life Sciences; University of Arkansas Endowment: 21st Century Chair in Global Change Biology	U.S. Fish & Wildlife Service Federal Aid in Wildlife Restoration(US Fish & Wildlife Service); University of Arkansas; University of Arkansas Endowment: Bruker Professorship in Life Sciences; University of Arkansas Endowment: 21st Century Chair in Global Change Biology	MRD and MED received support from U.S. Fish & Wildlife Service Federal Aid in Wildlife Restoration, Project W-155-R. This had no role in study design, data collection, analyses, manuscript preparation, and decision to publish.; We thank the following individuals: B.D. Anderson (Illinois Natural History Survey) and J. Buhnerkempe (Illinois Department of Natural Resources). Sampling was done by Illinois Department of Natural Resources. This research was supported by: U.S. Fish & Wildlife Service Federal Aid in Wildlife Restoration, Project W-155-R to MRD and MED (Illinois Natural History Survey); University of Arkansas Distinguished Doctoral Fellowship to SMM; and two University of Arkansas Endowments: Bruker Professorship in Life Sciences (MRD) and 21st Century Chair in Global Change Biology (MED). Analytical resources were provided by the Arkansas Economic Development Commission (Arkansas Settlement Proceeds Act of 2000) and the Arkansas High Performance Computing Center (AHPCC). Opinions expressed herein represent those of the authors and do not reflect those of the Illinois Department of Natural Resources, the Illinois state government, or the U.S. Fish & Wildlife Service.	Adkins K, 2019, J WILDLIFE MANAGE, V83, P1415, DOI 10.1002/jwmg.21724; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Allendorf FW, 2017, MOL ECOL, V26, P420, DOI 10.1111/mec.13948; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 2016, IUCN RED LIST THREAT; [Anonymous], 2013, OP STAND PRACT CONS; [Anonymous], 2009, SARA SPEC RISK ACT P; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Artelle KA, 2019, AM SCI, V107, P38; Artelle KA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0167; Askins RA, 1999, STUD AVIAN BIOL, V31, P63; Balmford B, 2019, J APPL ECOL, V56, P73, DOI 10.1111/1365-2664.13282; Baratti M, 2001, ANIM GENET, V32, P222, DOI 10.1046/j.1365-2052.2001.00767.x; Baudron F, 2014, BIOL CONSERV, V170, P232, DOI 10.1016/j.biocon.2013.12.009; Bech N, 2010, GENET MOL RES, V9, P1121, DOI 10.4238/vol9-2gmr760; Berkman LK, 2013, J WILDLIFE MANAGE, V77, P1472, DOI 10.1002/jwmg.597; Berkman LK, 2013, CONSERV GENET, V14, P323, DOI 10.1007/s10592-013-0471-1; Berkman LK, 2012, THESIS; Blank PJ, 2013, J WILDLIFE MANAGE, V77, P68, DOI 10.1002/jwmg.457; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Briggs SV, 2009, CONSERV LETT, V2, P101, DOI 10.1111/j.1755-263X.2009.00055.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Cannon PG, 2019, GLOBAL CHANGE BIOL, V25, P1576, DOI 10.1111/gcb.14601; CHENG HH, 1995, POULTRY SCI, V74, P1855, DOI 10.3382/ps.0741855; Cook CN, 2017, CONSERV BIOL, V31, P501, DOI 10.1111/cobi.12863; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Davis MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131067; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farber S, 2006, BIOSCIENCE, V56, P121, DOI 10.1641/0006-3568(2006)056[0121:LEAEFE]2.0.CO;2; Ferrero ME, 2007, MOL ECOL NOTES, V7, P1349, DOI 10.1111/j.1471-8286.2007.01877.x; Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Geaumont BA, 2017, RANGELAND ECOL MANAG, V70, P569, DOI 10.1016/j.rama.2017.04.003; Geist V, 2001, T N AM WILDL NAT RES, P175; Giesel JT, 1997, J WILDLIFE MANAGE, V61, P1332, DOI 10.2307/3802134; Greenfield KC, 2002, WILDLIFE SOC B, V30, P527; Gu Langyu, 2012, Chinese Birds, V3, P103; Guillaumet A, 2019, ECOL APPL, V29, DOI 10.1002/eap.1953; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hellerstein DM, 2017, LAND USE POLICY, V63, P601, DOI 10.1016/j.landusepol.2015.07.017; Hiller TL, 2015, WILDLIFE SOC B, V39, P529, DOI 10.1002/wsb.568; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Johnson CN, 2017, SCIENCE, V356, P270, DOI 10.1126/science.aam9317; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kilen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095025; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Kotowska MM, 2015, GLOBAL CHANGE BIOL, V21, P3620, DOI 10.1111/gcb.12979; Kujala H, 2018, METHODS ECOL EVOL, V9, P1121, DOI 10.1111/2041-210X.12939; Kuparinen A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0035; Leopold A, 1931, REPORT GAME SURVEY N; Lute ML, 2018, SOC NATUR RESOUR, V31, P218, DOI 10.1080/08941920.2017.1376139; Martin-Lopez B, 2009, BIOL CONSERV, V142, P1370, DOI 10.1016/j.biocon.2009.01.030; Martinez-Blancas A, 2018, J APPL ECOL, V55, P1860, DOI 10.1111/1365-2664.13151; Matthews TW, 2013, J WILDLIFE MANAGE, V77, P1202, DOI 10.1002/jwmg.564; Matthews TW, 2012, J WILDLIFE MANAGE, V76, P1653, DOI 10.1002/jwmg.410; McTaggart S., AGR GRASSLAND WILDLI; Merrill MD, 1999, J WILDLIFE MANAGE, V63, P189, DOI 10.2307/3802500; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mora C, 2007, P ROY SOC B-BIOL SCI, V274, P1023, DOI 10.1098/rspb.2006.0338; Morefield PE, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094005; Mussmann SM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160736; MYERS N, 1995, SCIENCE, V269, P358, DOI 10.1126/science.269.5222.358; MYERS N, 1989, BIOSCIENCE, V39, P506, DOI 10.1093/bioscience/39.8.506; Nordstrom R, 2014, NATL CLIMATE ASSESSM, P418; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Otto CRV, 2018, P NATL ACAD SCI USA, V115, P7629, DOI 10.1073/pnas.1800057115; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Palkovacs EP, 2018, FRONT ECOL ENVIRON, V16, P20, DOI 10.1002/fee.1743; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Barral MP, 2015, AGR ECOSYST ENVIRON, V202, P223, DOI 10.1016/j.agee.2015.01.009; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pew J, 2015, MOL ECOL RESOUR, V15, P557, DOI 10.1111/1755-0998.12323; Phalan B, 2016, SCIENCE, V351, P450, DOI 10.1126/science.aad0055; Phalan BT, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061760; Pimm SL, 2008, CURR BIOL, V18, pR117, DOI 10.1016/j.cub.2007.11.055; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richmond T.C., 2014, CLIMATE CHANGE IMPAC, P257; Ridley MW, 1983, THESIS; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saether BE, 2009, ANIM CONSERV, V12, P488, DOI 10.1111/j.1469-1795.2009.00278.x; Segelbacher G, 2000, MOL ECOL, V9, P1934, DOI 10.1046/j.1365-294x.2000.0090111934.x; Sharp R., 2009, RECREATIONAL HUNTING, P25; Shogren JF, 1999, CONSERV BIOL, V13, P1257, DOI 10.1046/j.1523-1739.1999.98414.x; Singh SP, 1998, ENVIRON CONSERV, V25, P1, DOI 10.1017/S0376892998000010; Smith OM, 2017, POPUL ECOL, V59, P363, DOI 10.1007/s10144-017-0594-1; Sokos CK, 2008, WILDLIFE BIOL, V14, P412, DOI 10.2981/0909-6396-14.4.412; Taylor JS, 2018, WILDLIFE SOC B, V42, P184, DOI 10.1002/wsb.882; Tilman D, 2017, NATURE, V546, P73, DOI 10.1038/nature22900; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tulloch AIT, 2015, CONSERV BIOL, V29, P513, DOI 10.1111/cobi.12386; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandever MW, 2015, 507 US GEOL SURV, V507; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Wang J, 2011, HEREDITY, V107, P433, DOI 10.1038/hdy.2011.30; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2002, GENETICS, V160, P1203; Wang N, 2009, EUR J WILDLIFE RES, V55, P627, DOI 10.1007/s10344-009-0307-y; Warner RE, 1981, BIOL NOTES, V115; Willoughby JR, 2015, MOL ECOL, V24, P98, DOI 10.1111/mec.13020; Wilson E.O., 2016, HALF EARTH OUR PLANE; Wilson GA, 2003, GENETICS, V163, P1177; Wringe BF, 2017, MOL ECOL RESOUR, V17, P91, DOI 10.1111/1755-0998.12597	118	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0230735	10.1371/journal.pone.0230735	http://dx.doi.org/10.1371/journal.pone.0230735			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339176	Green Published, gold			2022-12-26	WOS:000536657400005
J	Eum, HL; Park, Y; Yi, TG; Lee, JW; Ha, KS; Choi, IY; Park, NI				Eum, Hyang Lan; Park, Yeri; Yi, Tae Gyu; Lee, Jae Wook; Ha, Keon-Soo; Choi, Ik-Young; Park, Nam Il			Effect of germination environment on the biochemical compounds and anti-inflammatory properties of soybean cultivars	PLOS ONE			English	Article							GLYCINE-MAX L.; ISOFLAVONE	In this study, we investigated changes in the isoflavone content, total phenolic content (TPC), total flavonoid content (TFC), antioxidant activities (DPPH, ABTS), and anti-inflammatory activities of small-seeded and large-seeded soybean cultivars during germination (light/dark conditions). Total isoflavone content was higher at the seed stage in large-seeded soybeans, while it increased after 7 days of germination in small-seeded soybeans, particularly in response to light conditions, under which they had high TPC, TFC, and anti-oxidant activities. In large-seeded soybeans, the germination environment did not significantly affect TFC or DPPH inhibition, whereas TPC and ABTS inhibition were high under dark germination conditions. Extracts of sprouts exhibited superior anti-inflammatory activities. Nitric oxide production was slightly lower in small-seeded and large-seeded soybeans germinated under light and dark conditions, respectively. Our findings indicate that germinated soybeans improved nutritionally, and that enhancement of bioactivity under different germination environments could contribute to the selection of appropriate soybean cultivars.	[Eum, Hyang Lan; Park, Yeri; Yi, Tae Gyu; Park, Nam Il] Gangneung Wonju Natl Univ, Dept Plant Sci, Kangnung, South Korea; [Lee, Jae Wook] Korea Inst Sci & Technol, Nat Prod Res Ctr, Kangnung, South Korea; [Ha, Keon-Soo] Gangwondo Agr Res & Extens Serv, Chunchon, South Korea; [Choi, Ik-Young] Kangwon Natl Univ, Dept Agr & Life Ind, Chunchon, South Korea	Kangnung Wonju National University; Korea Institute of Science & Technology (KIST); Kangwon National University	Park, NI (corresponding author), Gangneung Wonju Natl Univ, Dept Plant Sci, Kangnung, South Korea.	nipark@gwnu.ac.kr	CHOI, Ik-Young/ABI-6938-2020	Choi, Ik-Young/0000-0003-4168-0471				Abdul Qudeer Ahmed, 2018, Natural Product Sciences, V24, P171, DOI 10.20307/nps.2018.24.3.171; Anesini C, 2008, J AGR FOOD CHEM, V56, P9225, DOI 10.1021/jf8022782; 임정연, 2016, [Korean Journal of Food and Cookery Science, 한국식품조리과학회지], V32, P567; Devi MKA, 2009, FOOD CHEM, V114, P771, DOI 10.1016/j.foodchem.2008.10.011; Ding XH, 2005, CANCER SCI, V96, P157, DOI 10.1111/j.1349-7006.2005.00024.x; 김주숙, 2004, [Korean Journal of Food Science and Technology, 한국식품과학회지], V36, P294; Hangarter RP, 1997, PLANT CELL ENVIRON, V20, P796, DOI 10.1046/j.1365-3040.1997.d01-124.x; Huang GC, 2017, LWT-FOOD SCI TECHNOL, V75, P488, DOI 10.1016/j.lwt.2016.09.029; Huang XY, 2014, FOOD CHEM, V143, P268, DOI 10.1016/j.foodchem.2013.07.080; Jeong Il-Hyung, 2017, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V32, P371, DOI 10.13103/JFHS.2017.32.5.371; Kao TH, 2007, J AGR FOOD CHEM, V55, P11068, DOI 10.1021/jf071851u; Kaufman P B, 1997, J Altern Complement Med, V3, P7, DOI 10.1089/acm.1997.3.7; KIM CS, 2000, KOREAN J FOOD SCI TE, V32, P25; Kim YH, 1997, SOONCHUNHYANG J NAT, V3, P331; Ku YG, 2018, FOOD CHEM, V244, P349, DOI 10.1016/j.foodchem.2017.10.044; Lee CC, 2017, FOOD CHEM, V234, P486, DOI 10.1016/j.foodchem.2017.05.012; Lee J-W, 2018, KOREAN J CROP SCI, P63; Ma M, 2018, FOOD CHEM, V250, P259, DOI 10.1016/j.foodchem.2018.01.051; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41; Paradkar PN, 2004, CANCER LETT, V215, P21, DOI 10.1016/j.canlet.2004.05.019; Park JS, 2007, J PHARMACOL EXP THER, V320, P1237, DOI 10.1124/jpet.106.114322; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Shi HL, 2010, J AGR FOOD CHEM, V58, P4970, DOI 10.1021/jf100335j; Subramanian S, 2006, PLANT J, V48, P261, DOI 10.1111/j.1365-313X.2006.02874.x; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Wang FZ, 2015, J FUNCT FOODS, V14, P596, DOI 10.1016/j.jff.2015.02.016; Yang L, 2018, BIOMED RES INT, V2018; Yim JH, 2009, INT J MOL SCI, V10, P4742, DOI 10.3390/ijms10114742; Yun J-Y, 2008, KOREAN J MED CROP SC, V16, P326	30	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232159	10.1371/journal.pone.0232159	http://dx.doi.org/10.1371/journal.pone.0232159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339211	gold, Green Published			2022-12-26	WOS:000536657400031
J	Yin, Y; Frank, D; Zhou, WJ; Kaur, N; French, JB; Carpino, N				Yin, Yue; Frank, David; Zhou, Weijie; Kaur, Neena; French, Jarrod B.; Carpino, Nick			An unexpected 2-histidine phosphoesterase activity of suppressor of T-cell receptor signaling protein 1 contributes to the suppression of cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; enzyme; Suppressor of TCR signaling-1 (Sts-1); 2-histidine (2H) phosphoesterase; cyclic nucleotide; 2?; 3?-cyclic nicotinamide adenine dinucleotide phosphate (NADcP); phosphodiesterase; cell signaling; signal transduction; enzyme; cyclic nucleotide; phosphodiesterases; T-cell receptor (TCR); 2H phosphoesterase; Dectin-1 receptor; NADcP; Suppressor of TCR Signaling-1; 2	PHOSPHATASE; MECHANISM; STS-1; PHOSPHODIESTERASE; ACTIVATION; TULA-2; ZAP70; SITE; SYK	The suppressor of T-cell receptor (TCR) signaling (Sts) proteins Sts-1 and Sts-2 suppress receptor-mediated signaling pathways in various immune cells, including the TCR pathway in T cells and the Dectin-1 signaling pathway in phagocytes. As multidomain enzymes, they contain an N-terminal ubiquitin-association domain, a central Src homology 3 domain, and a C-terminal histidine phosphatase domain. Recently, a 2-histidine (2H) phosphoesterase motif was identified within the N-terminal portion of Sts. The 2H phosphoesterase motif defines an evolutionarily ancient protein domain present in several enzymes that hydrolyze cyclic phosphate bonds on different substrates, including cyclic nucleotides. It is characterized by two invariant histidine residues that play a critical role in catalytic activity. Consistent with its assignment as a phosphoesterase, we demonstrate here that the Sts-1 2H phosphoesterase domain displays catalytic, saturable phosphodiesterase activity toward the dinucleotide 2?,3?-cyclic NADP. The enzyme exhibited a high degree of substrate specificity and selectively generated the 3?-nucleotide as the sole product. Sts-1 also had phosphodiesterase catalytic activity toward a 5-mer RNA oligonucleotide containing a 2?,3?-cyclic phosphate group at its 3? terminus. To investigate the functional significance of Sts-1 2H phosphoesterase activity, we generated His-to-Ala variants and examined their ability to negatively regulate cellular signaling pathways. Substitution of either conserved histidine compromised the ability of Sts-1 to suppress signaling pathways downstream of both the TCR and the Dectin-1 receptor. Our results identify a heretofore unknown cellular enzyme activity associated with Sts-1 and indicate that this catalytic activity is linked to specific cell-signaling outcomes.	[Yin, Yue; Zhou, Weijie; French, Jarrod B.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [French, Jarrod B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Frank, David; Kaur, Neena; Carpino, Nick] SUNY Stony Brook, Med Ctr, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA; [French, Jarrod B.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Minnesota System	French, JB (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.; French, JB (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.; Carpino, N (corresponding author), SUNY Stony Brook, Med Ctr, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA.; French, JB (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	nicholas.carpino@stonybrook.edu; jfrench@umn.edu	French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309	NIAID, National Institutes of Health [R01AI141592, R21AI120859, R21AI133381]; NHLBI, National Institutes of Health [U01HL127522]; NIGMS, National Institutes of Health [R35GM124898]; Stony Brook University; Stony Brook University Center for Biotechnology (a New York State Center for Advanced Technology); Cold Spring Harbor Laboratory; Brookhaven National Laboratory; Feinstein Institute for Medical Research; Hormel Foundation	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stony Brook University; Stony Brook University Center for Biotechnology (a New York State Center for Advanced Technology); Cold Spring Harbor Laboratory; Brookhaven National Laboratory(United States Department of Energy (DOE)); Feinstein Institute for Medical Research; Hormel Foundation	This work was supported by NIAID, National Institutes of Health Grants R01AI141592 (to N. C. and J. B. F.), R21AI120859 (to N. C. and J. B. F.), and R21AI133381 (to N. C.), as well as by the NHLBI, National Institutes of Health Grant U01HL127522. In addition, parts of this work were supported by NIGMS, National Institutes of Health Grant R35GM124898 (to J. B. F.). Additional support was provided by Stony Brook University, the Stony Brook University Center for Biotechnology (a New York State Center for Advanced Technology), Cold Spring Harbor Laboratory, Brookhaven National Laboratory, the Feinstein Institute for Medical Research, and the Hormel Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cantrell D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018788; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; de Castro RO, 2012, J BIOL CHEM, V287, P8194, DOI 10.1074/jbc.M111.326850; del Fresno C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00804; Diaz-Gallo LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060646; Drummond RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003417; Frank D, 2018, MBIO, V9, DOI [10.1128/mBio.00782-18, 10.1128/mbio.00782-18]; Futosi K, 2016, IMMUNOL REV, V273, P121, DOI 10.1111/imr.12455; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; Hu HB, 2016, J EXP MED, V213, P399, DOI 10.1084/jem.20151426; Inshaw JRJ, 2018, NAT IMMUNOL, V19, P674, DOI 10.1038/s41590-018-0129-8; Kanai A, 2009, RNA, V15, P420, DOI 10.1261/rna.1122109; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kozicky LK, 2015, SEMIN IMMUNOL, V27, P276, DOI 10.1016/j.smim.2015.07.001; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Mitsutomi S, 2019, BIOCHIMIE, V165, P235, DOI 10.1016/j.biochi.2019.08.008; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Myllykoski M, 2016, BRAIN RES, V1641, P64, DOI 10.1016/j.brainres.2015.09.004; Myllykoski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032336; Naseem S, 2015, INFECT IMMUN, V83, P637, DOI 10.1128/IAI.02789-14; Ogawa S, 2019, ADV EXP MED BIOL, V1189, P85, DOI 10.1007/978-981-32-9717-3_4; Parashar K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00406-17; Raasakka A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16520; Remus BS, 2014, RNA, V20, P1697, DOI 10.1261/rna.046797.114; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; San Luis B, 2013, BIOCHEM J, V453, P27, DOI 10.1042/BJ20121769; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; SOGIN DC, 1976, J NEUROCHEM, V27, P1333, DOI 10.1111/j.1471-4159.1976.tb02612.x; Tanaka N, 2011, J BIOL CHEM, V286, P43134, DOI 10.1074/jbc.M111.302133; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; Todd JA, 2018, EUR J HUM GENET, V26, P925, DOI 10.1038/s41431-018-0142-2; Tsygankov AY, 2020, CELL SIGNAL, V65, DOI 10.1016/j.cellsig.2019.109424; Wang LK, 2005, RNA, V11, P966, DOI 10.1261/rna.2170305; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Zhou WJ, 2017, BIOCHEMISTRY-US, V56, P4637, DOI 10.1021/acs.biochem.7b00638	41	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8514	8523		10.1074/jbc.RA120.013482	http://dx.doi.org/10.1074/jbc.RA120.013482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371395	hybrid, Green Published			2022-12-26	WOS:000546986500016
J	Koo, N; Shin, AY; Oh, S; Kim, H; Hong, S; Park, SJ; Sim, YM; Byeon, I; Kim, KY; Lim, YP; Kwon, SY; Kim, YM				Koo, Namjin; Shin, Ah-Young; Oh, Sangho; Kim, Hyeongmin; Hong, Seongmin; Park, Seong-Jin; Sim, Young Mi; Byeon, Iksu; Kim, Kye Young; Lim, Yong Pyo; Kwon, Suk-Yoon; Kim, Yong-Min			Comprehensive analysis of Translationally Controlled Tumor Protein (TCTP) provides insights for lineage-specific evolution and functional divergence	PLOS ONE			English	Article							SECONDARY STRUCTURE; SEQUENCE; GROWTH; GENE; BINDING; IDENTIFICATION; PROLIFERATION; REVEALS	Background Translationally controlled tumor protein (TCTP) is a conserved, multifunctional protein involved in numerous cellular processes in eukaryotes. Although the functions of TCTP have been investigated sporadically in animals, invertebrates, and plants, few lineage-specific activities of this molecule, have been reported. An exception is in Arabidopsis thaliana, in which TCTP (AtTCTP1) functions in stomatal closuer by regulating microtubule stability. Further, although the development of next-generation sequencing technologies has facilitated the analysis of many eukaryotic genomes in public databases, inter-kingdom comparative analyses using available genome information are comparatively scarce. Methodology To carry out inter-kingdom comparative analysis of TCTP, TCTP genes were identified from 377 species. Then phylogenetic analysis, prediction of protein structure, molecular docking simulation and molecular dynamics analysis were performed to investigate the evolution of TCTP genes and their binding proteins. Results A total of 533 TCTP genes were identified from 377 eukaryotic species, including protozoa, fungi, invertebrates, vertebrates, and plants. Phylogenetic and secondary structure analyses reveal lineage-specific evolution of TCTP, and inter-kingdom comparisons highlight the lineage-specific emergence of, or changes in, secondary structure elements in TCTP proteins from different kingdoms. Furthermore, secondary structure comparisons between TCTP proteins within each kingdom, combined with measurements of the degree of sequence conservation, suggest that TCTP genes have evolved to conserve protein secondary structures in a lineage-specific manner. Additional tertiary structure analysis of TCTP-binding proteins and their interacting partners and docking simulations between these proteins further imply that TCTP gene variation may influence the tertiary structures of TCTP-binding proteins in a lineage-specific manner. Conclusions Our analysis suggests that TCTP has undergone lineage-specific evolution and that structural changes in TCTP proteins may correlate with the tertiary structure of TCTP-binding proteins and their binding partners in a lineage-specific manner.	[Koo, Namjin; Oh, Sangho; Kim, Hyeongmin; Hong, Seongmin; Park, Seong-Jin; Sim, Young Mi; Byeon, Iksu; Kim, Kye Young; Kim, Yong-Min] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Daejeon, South Korea; [Shin, Ah-Young; Kwon, Suk-Yoon] Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Daejeon, South Korea; [Kim, Hyeongmin] KCDC, Ctr Genome Sci, Dept Biomed Informat, Natl Inst Hlth, Choongchung Buk Do, South Korea; [Hong, Seongmin; Lim, Yong Pyo] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Hort, Mol Genet & Genom Lab, Daejeon, South Korea; [Koo, Namjin] SK Chem ECO Lab, Life Sci R&D Ctr, New Drug & Team, Seongnam, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Chungnam National University	Kim, YM (corresponding author), Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Daejeon, South Korea.	ymkim@kribb.re.kr			Korea Research Institute of Bioscience and Biotechnology (KRIBB) initiative program; Korea Atomic Energy Research Institute (KAERI) initiative program; Korea Forest Service of Korean government through R&D Program for Forestry Technology [2014071H10-2022-AA04]	Korea Research Institute of Bioscience and Biotechnology (KRIBB) initiative program; Korea Atomic Energy Research Institute (KAERI) initiative program; Korea Forest Service of Korean government through R&D Program for Forestry Technology	This work was supported by the Korea Research Institute of Bioscience and Biotechnology (KRIBB) initiative program, the Korea Atomic Energy Research Institute (KAERI) initiative program, and Korea Forest Service of Korean government through R&D Program for Forestry Technology (Project No. 2014071H10-2022-AA04) to Y.-M.K. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Amson R, 2013, TRENDS CELL BIOL, V23, P37, DOI 10.1016/j.tcb.2012.10.002; Benjamin W., 2014, MODELLER CURR PROTOC, V47, P5, DOI DOI 10.1002/CPBI.3; Berman H. M., 2006, INT TABLES CRYSTALLO, P675, DOI DOI 10.1107/97809553602060000722; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Feng YG, 2007, ARCH BIOCHEM BIOPHYS, V467, P48, DOI 10.1016/j.abb.2007.08.021; Fontana P, 2005, BIOINFORMATICS, V21, P393, DOI 10.1093/bioinformatics/bti013; Gachet Y, 1999, J CELL SCI, V112, P1257; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Hinojosa-Moya J, 2008, J MOL EVOL, V66, P472, DOI 10.1007/s00239-008-9099-z; Hoepflinger MC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-135; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jung J, 2000, PROTEIN ENG, V13, P535, DOI 10.1093/protein/13.8.535; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim YM, 2017, DNA RES, V24, P71, DOI 10.1093/dnares/dsw049; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Ko G, 2017, BIORXIV, DOI [10.1101/232298, DOI 10.1101/232298]; Koziol MJ, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/105203; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kundrotas PJ, 2006, BIOPHYS J, V91, P1724, DOI 10.1529/biophysj.106.086025; Langdon JM, 2004, BBA-MOL BASIS DIS, V1688, P232, DOI 10.1016/j.bbadis.2003.12.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mashiach E, 2010, PROTEINS, V78, P1503, DOI 10.1002/prot.22668; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santa Brigida AB, 2014, MOL BIOL REP, V41, P1787, DOI 10.1007/s11033-014-3028-6; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soltis PS, 2015, CURR OPIN GENET DEV, V35, P119, DOI 10.1016/j.gde.2015.11.003; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thebault S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19725; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thiele H, 2000, EUR J BIOCHEM, V267, P5473, DOI 10.1046/j.1432-1327.2000.01609.x; Toscano-Morales R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00468; Tsai YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024001; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Wang ZQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0500-y; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wu HW, 2015, J BIOL CHEM, V290, P8694, DOI 10.1074/jbc.M114.628594; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yao XZ, 2019, ARCH BIOCHEM BIOPHYS, V665, P23, DOI 10.1016/j.abb.2019.02.012	60	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232029	10.1371/journal.pone.0232029	http://dx.doi.org/10.1371/journal.pone.0232029			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374732	Green Published, gold			2022-12-26	WOS:000537283500016
J	Kurita, H; Haruta, N; Uchihashi, Y; Seto, T; Takashima, K				Kurita, Hirofumi; Haruta, Natsuki; Uchihashi, Yoshito; Seto, Takahito; Takashima, Kazunori			Strand breaks and chemical modification of intracellular DNA induced by cold atmospheric pressure plasma irradiation	PLOS ONE			English	Article							REACTIVE OXYGEN; DAMAGE	DNA damage in the A549 human lung cancer cell line treated with cold plasma irradiation was investigated. We confirmed that cold atmospheric plasma generated reactive oxygen and nitrogen species (RONS) in a liquid, and the intracellular RONS level was increased in plasma-irradiated cells. However, a notable decrease in cell viability was not observed 24 hours after plasma irradiation. Because RONS induce oxidative damage in cells, strand breaks and chemical modification of DNA in the cancer cells were investigated. We found that 8-oxoguanine (8-oxoG) formation as well as DNA strand breaks, which have been thoroughly investigated, were induced by plasma irradiation. In addition, up-regulation of 8-oxoG repair enzyme was observed after plasma irradiation.	[Kurita, Hirofumi; Haruta, Natsuki; Uchihashi, Yoshito; Seto, Takahito; Takashima, Kazunori] Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Toyohashi, Aichi, Japan	Toyohashi University of Technology	Kurita, H (corresponding author), Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Toyohashi, Aichi, Japan.	kurita@chem.tut.ac.jp	Kurita, Hirofumi/K-6757-2012	Kurita, Hirofumi/0000-0002-2538-6590	Japan Society for the Promotion of Science (JSPS) [26390096, 17K05095]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by a Grant-in-Aid for Scientific Research (C) (26390096, 17K05095 to HK) from the Japan Society for the Promotion of Science (JSPS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adachi T, 2015, FREE RADICAL BIO MED, V79, P28, DOI 10.1016/j.freeradbiomed.2014.11.014; Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Arjunan KP, 2015, INT J MOL SCI, V16, P2971, DOI 10.3390/ijms16022971; Attri P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08221; Bauer G, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101291; Bauer G, 2016, PLASMA PROCESS POLYM, V13, P1157, DOI 10.1002/ppap.201600089; Chang JW, 2014, ARCH BIOCHEM BIOPHYS, V545, P133, DOI 10.1016/j.abb.2014.01.022; Choi JY, 2016, ONCOTARGET, V7, P32980, DOI 10.18632/oncotarget.9087; Chung WH, 2016, ARCH PHARM RES, V39, P1, DOI 10.1007/s12272-015-0644-1; Daeschlein G, 2018, COMPREHENSIVE CLIN P, P113; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Girard PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29098; Graves DB, 2014, PLASMA PROCESS POLYM, V11, P1120, DOI 10.1002/ppap.201400068; Guo L, 2018, FREE RADICAL RES, V52, P783, DOI 10.1080/10715762.2018.1471476; Hirst AM, 2015, BRIT J CANCER, V112, P1536, DOI 10.1038/bjc.2015.113; Ishaq M, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4933366; Joh HM, 2017, AIP ADV, V7, DOI 10.1063/1.4994221; Keidar M, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/3/033001; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kim SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20332; Kurake N, 2016, ARCH BIOCHEM BIOPHYS, V605, P102, DOI 10.1016/j.abb.2016.01.011; Kurita H, 2017, MRS ADV, V2, P987, DOI 10.1557/adv.2017.34; Kurita H, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4939044; Lu X, 2016, PHYS REP, V630, P1, DOI 10.1016/j.physrep.2016.03.003; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; Markkanen E, 2017, DNA REPAIR, V59, P82, DOI 10.1016/j.dnarep.2017.09.007; Mirbahai L, 2010, DNA REPAIR, V9, P144, DOI 10.1016/j.dnarep.2009.11.009; Mizuno K, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa5dbb; Mizuno K, 2018, IEEE T RADIAT PLASMA, V2, P353, DOI 10.1109/TRPMS.2018.2809673; O'Connell D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3521502; Ohno M, 2009, METHODS MOL BIOL, V554, P199, DOI 10.1007/978-1-59745-521-3_13; Okazaki Y, 2014, J CLIN BIOCHEM NUTR, V55, P207, DOI 10.3164/jcbn.14-40; Ratovitski EA, 2014, PLASMA PROCESS POLYM, V11, P1128, DOI 10.1002/ppap.201400071; Rosani U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133173; Sato T, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/37/372001; Song K., 2014, PLASMA MED, V4, P193, DOI DOI 10.1615/PLASMAMED.2015012629; Stanicka J, 2015, J BIOL CHEM, V290, P9348, DOI 10.1074/jbc.M113.510495; Szili EJ, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa7501; Tanaka H, 2011, PLASMA MED, V1, P265, DOI DOI 10.1615/PLASMAMED.2012006275; Tanaka H., 2012, PLASMA MED, V2, P207, DOI [DOI 10.1615/PLASMAMED.2013008267, 10.1615/PlasmaMed.2013008267]; Tani A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729889; Utsumi F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-398; Van der Paal J, 2019, PHYS CHEM CHEM PHYS, V21, P19327, DOI 10.1039/c9cp03520f; Von Woedtke T., 2018, COMPREHENSIVE CLIN P, P3, DOI [10.1007/978-3-319-67627-2, DOI 10.1007/978-3-319-67627-2_1]; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Yokoyama M, 2014, BIOCHEM BIOPH RES CO, V450, P1266, DOI 10.1016/j.bbrc.2014.06.116	46	21	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232724	10.1371/journal.pone.0232724	http://dx.doi.org/10.1371/journal.pone.0232724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374749	gold, Green Published			2022-12-26	WOS:000537283500055
J	Fang, HT; Liu, HY; Ma, RS; Liu, YX; Li, JN; Yu, XY; Zhang, HY; Yang, YL; Zhang, GD				Fang, Haitian; Liu, Huiyan; Ma, Ruoshuang; Liu, Yuxuan; Li, Jinna; Yu, Xiaoyan; Zhang, Haoyu; Yang, Yali; Zhang, Guangdi			Genome-wide assessment of population structure and genetic diversity of Chinese Lou onion using specific length amplified fragment (SLAF) sequencing	PLOS ONE			English	Article							IMPROVED RAPD AMPLIFICATION; ABIOTIC STRESS TOLERANCE; SCAR MARKERS; RED ONION; IDENTIFICATION; RESISTANCE; SELECTION	Lou onion (Allium fistulosum L. var. viviparum) is an abundant source of flavonols which provides additional health benefits to diseases. Genome-wide specific length amplified fragment (SLAF) sequencing method is a rapidly developed deep sequencing technologies used for selection and identification of genetic loci or markers. This study aimed to elucidate the genetic diversity of 122 onion accessions in China using the SLAF-seq method. A set of 122 onion accessions including 107 A.fistulosum L. var. viviparum Makino, 3 A.fistulosum L. var. gigantum Makino, 3 A.mongolicum Regel and 9 A.cepa L. accessions (3 whites, 3 reds and 3 yellows) from different regions in China were enrolled. Genomic DNA was isolated from young leaves and prepared for the SLAF-seq, which generated a total of 1,387.55 M reads and 162,321 high quality SNPs (integrity > 0.5 and MAF > 0.05). These SNPs were used for the construction of neighbor-joining phylogenetic tree, in which 10 A.fistulosum L. var. viviparum Makino accessions from Yinchuan (Ningxia province) and Datong (Qinghai province) had close genetic relationship. The 3 A.cepa L. clusters (red, white and yellow) had close genetic relationship especially with the 97 A.fistulosum L. var. viviparum Makino accessions. Population structure analysis suggested entire population could be clustered into 3 groups, while principal component analysis (PCA) showed there were 4 genetic groups. We confirmed the SLAF-seq approach was effective in genetic diversity analysis in red onion accessions. The key findings would provide a reference to the Lou onion germplasm in China.	[Fang, Haitian; Liu, Huiyan; Ma, Ruoshuang; Liu, Yuxuan; Li, Jinna; Zhang, Haoyu; Yang, Yali; Zhang, Guangdi] Ningxia Univ, Sch Agr, Yinchuan, Ningxia, Peoples R China; [Fang, Haitian; Liu, Huiyan; Ma, Ruoshuang; Liu, Yuxuan; Li, Jinna; Zhang, Haoyu; Yang, Yali; Zhang, Guangdi] Ningxia Univ, Ningxia Key Lab Food Microbial Applicat Technol &, Yinchuan, Ningxia, Peoples R China; [Yu, Xiaoyan; Zhang, Guangdi] Ningxia Univ Ningxia, Technol Innovat Ctr Protected Hort, Yinchuan, Ningxia, Peoples R China; [Yu, Xiaoyan; Zhang, Guangdi] Ningxia Univ, Technol Innovat Ctr Hort, Yinchuan, Ningxia, Peoples R China	Ningxia University; Ningxia University; Ningxia University	Fang, HT; Zhang, GD (corresponding author), Ningxia Univ, Sch Agr, Yinchuan, Ningxia, Peoples R China.; Fang, HT; Zhang, GD (corresponding author), Ningxia Univ, Ningxia Key Lab Food Microbial Applicat Technol &, Yinchuan, Ningxia, Peoples R China.; Zhang, GD (corresponding author), Ningxia Univ Ningxia, Technol Innovat Ctr Protected Hort, Yinchuan, Ningxia, Peoples R China.; Zhang, GD (corresponding author), Ningxia Univ, Technol Innovat Ctr Hort, Yinchuan, Ningxia, Peoples R China.	fanght@nxu.edu.cn; zhangguangdi333909@sina.com	Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022; yang, yang/HGT-7999-2022	Fang, Haitian/0000-0003-3153-0648	Funds of Breeding project for Agricultural Science and Technology Park in Ningxia [201406]; Innovation Platform Funds of Ningxia Key Laboratory for Food Microbial-Applications Technology and Safety Control [2018DPC05026]; Key R&D Program of Ningxia [2017BY071]; Funds of the Western First-Class Disciplines (Horticulture) in Ningxia University (2015-2018)	Funds of Breeding project for Agricultural Science and Technology Park in Ningxia; Innovation Platform Funds of Ningxia Key Laboratory for Food Microbial-Applications Technology and Safety Control; Key R&D Program of Ningxia; Funds of the Western First-Class Disciplines (Horticulture) in Ningxia University (2015-2018)	This work was financially supported by the Funds of Breeding project for Agricultural Science and Technology Park in Ningxia (201406), Innovation Platform Funds of Ningxia Key Laboratory for Food Microbial-Applications Technology and Safety Control (2018DPC05026), the Key R&D Program of Ningxia (Grant No. 2017BY071), and Funds of the Western First-Class Disciplines (Horticulture) in Ningxia University (2015-2018).	Abdel-Latif A, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-016-0152-4; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], IMPROVING CROP RESIS, P1085; Atares A, 2011, PLANT CELL REP, V30, P1865, DOI 10.1007/s00299-011-1094-y; Baek G, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0697-6; Bhagyawant S. S., 2016, J BIOSCI MED, V4, P1, DOI DOI 10.4236/JBM.2016.41001; Chang YQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18768-y; Cheng JL, 2015, ELECTRON J BIOTECHN, V18, P35, DOI 10.1016/j.ejbt.2014.11.004; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dini I, 2008, FOOD CHEM, V107, P613, DOI 10.1016/j.foodchem.2007.08.053; Dunteman G.H., 1989, PRINCIPAL COMPONENTS; Eldin IMT, 2010, ENVIRON HEALTH INSIG, V4, P71, DOI 10.4137/EHI.S5540; Forster BP, 2000, J EXP BOT, V51, P19, DOI 10.1093/jexbot/51.342.19; Fu JJ, 2015, GENET MOL RES, V14, P5667, DOI 10.4238/2015.May.25.19; Henagan TM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0451-1; Jung JY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-18; Khandagale K, 2019, J HORTIC SCI BIOTECH, V94, P522, DOI 10.1080/14620316.2018.1543558; Khoury CK, 2015, BIOL CONSERV, V184, P259, DOI 10.1016/j.biocon.2015.01.032; Lee JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201229; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Y, 2008, J VEG SCI, V19, P245, DOI 10.3170/2007-8-18365; Liang Y.-C., 2008, THESIS; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Mandoulakani BA, 2015, THEOR APPL GENET, V128, P211, DOI 10.1007/s00122-014-2422-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitrova K, 2015, CZECH J GENET PLANT, V51, P62, DOI 10.17221/16/2015-CJGPB; Rimbert H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186329; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shigyo M, 2018, COMPEND PL GENOME; Singh BN, 2009, FOOD CHEM TOXICOL, V47, P1161, DOI 10.1016/j.fct.2009.02.004; Su WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172066; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang GY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204690; Wang JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181728; Wang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179717; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Wu K, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0274-7, 10.1186/s12870-014-0277-4]; Xu XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15829; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Zhao X, 2015, PLANT J, V82, P245, DOI 10.1111/tpj.12810; Zhou L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09350; Zhou QH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00648; 2018, COMPEND PL GENOME, P1, DOI DOI 10.1007/978-3-319-95825-5_2	47	5	6	10	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0231753	10.1371/journal.pone.0231753	http://dx.doi.org/10.1371/journal.pone.0231753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369481	Green Published, gold			2022-12-26	WOS:000537280000009
J	Ichinose, T; Murasawa, H; Ishijima, T; Okada, S; Abe, K; Matsumoto, S; Matsui, T; Furuya, S				Ichinose, Takashi; Murasawa, Hiroyasu; Ishijima, Tomoko; Okada, Shinji; Abe, Keiko; Matsumoto, Saki; Matsui, Toshiro; Furuya, Shigeki			Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer's disease	PLOS ONE			English	Article							LOCUS-COERULEUS; FERMENTED MILK; TYROSINE; TRANSPORTER; OLIGOPEPTIDE; PARKINSONS; PEPTIDE; PROTEIN; GENES	The physiological actions of orally ingested peptides on the brain remain poorly understood. This study examined the effects of 39 orally administered synthetic Tyr-containing dipeptides on the enhancement of brain norepinephrine metabolism in mice by comparing the concentration of 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG). Although Tyr-Tyr administration increased blood and cerebral cortex (Cx) Tyr concentrations the most, Tyr-Trp increased Cx MHPG concentration the most. The oral administration of Tyr-Trp ameliorated a short-term memory deficit of a mouse model of cognitive dysfunction induced by amyloid beta peptide 25-35. Gene expression profiling of mouse brain using a microarray indicated that Tyr-Trp administration led to a wide variety of changes in mRNA levels, including the upregulation of genes encoding molecules involved in catecholamine metabolism. A comparative metabolome analysis of the Cx of mice given Tyr-Trp or Tyr-Tyr demonstrated that Tyr-Trp administration yielded higher concentrations of Trp and kynurenine pathway metabolites than Tyr-Tyr administration, as well as higher L-dopa levels, which is the initial product of catecholamine metabolism. Catecholamines were not significantly increased in the Cx of the Tyr-Tyr group compared with the Tyr-Trp group, despite a marked increase in Tyr. Presumably, Tyr-Trp administration enhances catecholamine synthesis and metabolism via the upregulation of genes involved in Tyr and Trp metabolism as well as metabolites of Tyr and Trp. These findings strongly suggest that orally ingested Tyr-Trp modulates the brain metabolome involved in catecholamine metabolism and contributes to higher brain function.	[Ichinose, Takashi; Matsumoto, Saki; Matsui, Toshiro; Furuya, Shigeki] Kyushu Univ, Fac Agr, Grad Sch Bioresource & Bioenvironm Sci, Dept Innovat Sci & Technol Bioind, Fukuoka, Japan; [Murasawa, Hiroyasu] Nihon Biores Inc, Hashima Lab, Gifu, Japan; [Ishijima, Tomoko; Okada, Shinji; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Abe, Keiko] Kanagawa Inst Ind Sci & Technol, Grp Food Funct Assessment, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Furuya, Shigeki] Kyushu Univ, Fac Agr, Innovat Bioarchitecture Ctr, Fukuoka, Japan	Kyushu University; Nihon Bioresearch Inc; University of Tokyo; Kanagawa Academy Science & Technology; Kyushu University	Ichinose, T; Furuya, S (corresponding author), Kyushu Univ, Fac Agr, Grad Sch Bioresource & Bioenvironm Sci, Dept Innovat Sci & Technol Bioind, Fukuoka, Japan.; Furuya, S (corresponding author), Kyushu Univ, Fac Agr, Innovat Bioarchitecture Ctr, Fukuoka, Japan.	ichinose.takashi.203@s.kyushu-u.ac.jp; shigekifur@brs.kyushu-u.ac.jp	OKADA, Shinji/AFS-7710-2022	OKADA, Shinji/0000-0002-4465-9961; Furuya, Shigeki/0000-0001-9020-3597; Ichonose, Takashi/0000-0003-0755-368X	Kyushu University	Kyushu University	This study was supported by management expenses grants of Kyushu University. Nihon Bioresearch Inc. provided support in the form of salaries for H.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; Badawy AAB, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150197; BANDERET LE, 1989, BRAIN RES BULL, V22, P759, DOI 10.1016/0361-9230(89)90096-8; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Bondareff W, 1987, Alzheimer Dis Assoc Disord, V1, P256, DOI 10.1097/00002093-198701040-00005; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chalermpalanupap T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt175; CHRISTENSEN HN, 1994, J EXP BIOL, V196, P51; de Leeuw Francisca A, 2017, Alzheimers Dement (Amst), V8, P196, DOI 10.1016/j.dadm.2017.07.006; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Gannon M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00220; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOTTFRIES CG, 1983, NEUROBIOL AGING, V4, P261, DOI 10.1016/0197-4580(83)90002-7; Gunsolly C, 2010, J NEUROIMMUNOL, V225, P82, DOI 10.1016/j.jneuroim.2010.04.019; Hernandez-Ortega K, 2016, BRAIN PATHOL, V26, P593, DOI 10.1111/bpa.12335; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ichinose T, 2015, BIOSCI BIOTECH BIOCH, V79, P1542, DOI 10.1080/09168451.2015.1044932; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3502; Joyce JN, 1997, MOVEMENT DISORD, V12, P885, DOI 10.1002/mds.870120609; Kaddurah-Daouk R, 2011, ALZHEIMERS DEMENT, V7, P309, DOI 10.1016/j.jalz.2010.06.001; Kawasaki T, 2000, J HUM HYPERTENS, V14, P519, DOI 10.1038/sj.jhh.1001065; Kita M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00399; Kobayashi Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13368-2; Krumbholz M, 2007, J NEUROIMMUNOL, V190, P72, DOI 10.1016/j.jneuroim.2007.07.024; Lieberman HR, 2003, APPETITE, V40, P245, DOI 10.1016/S0195-6663(03)00010-2; Maebuchi M, 2007, FOOD SCI TECHNOL RES, V13, P45, DOI 10.3136/fstr.13.45; Martorana A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00252; Nagatsu T, 2016, J NEURAL TRANSM, V123, P1255, DOI 10.1007/s00702-016-1596-4; Ohsawa K, 2018, INT J FOOD SCI NUTR, V69, P369, DOI 10.1080/09637486.2017.1365824; Ponnusamy R, 2019, BRAIN RES, V1702, P3, DOI 10.1016/j.brainres.2017.09.035; R Team Core, 2017, LANG ENV STAT COMP; RINNE JO, 1986, J NEURAL TRANSM, V65, P51, DOI 10.1007/BF01249611; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Seppo L, 2003, AM J CLIN NUTR, V77, P326, DOI 10.1093/ajcn/77.2.326; TAKAHASHI M, 1994, BIOCHEM MOL BIOL INT, V33, P1151; Tekin I, 2014, J NEURAL TRANSM, V121, P1451, DOI 10.1007/s00702-014-1238-7; Trushina E, 2014, BBA-MOL BASIS DIS, V1842, P1232, DOI 10.1016/j.bbadis.2013.06.014; WURTMAN RJ, 1974, SCIENCE, V185, P183, DOI 10.1126/science.185.4146.183; Yamada K, 2000, PHARMACOL THERAPEUT, V88, P93, DOI 10.1016/S0163-7258(00)00081-4; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	43	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232233	10.1371/journal.pone.0232233	http://dx.doi.org/10.1371/journal.pone.0232233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365077	gold, Green Published			2022-12-26	WOS:000536959700020
J	Vivekanandhan, P; Swathy, K; Kalaimurugan, D; Ramachandran, M; Yuvaraj, A; Kumar, AN; Manikandan, AT; Poovarasan, N; Shivakumar, MS; Kweka, EJ				Vivekanandhan, Perumal; Swathy, Kannan; Kalaimurugan, Dharman; Ramachandran, Marimuthu; Yuvaraj, Ananthanarayanan; Kumar, Arjunan Naresh; Manikandan, Ayyavu Thendral; Poovarasan, Neelakandan; Shivakumar, Muthugoundar Subramanian; Kweka, Eliningaya J.			Larvicidal toxicity of Metarhizium anisopliae metabolites against three mosquito species and non-targeting organisms	PLOS ONE			English	Article							ENTOMOPATHOGENIC FUNGUS; CULEX-QUINQUEFASCIATUS	Background The fungal toxin acts as effective, low-cost chemical substances for pest control worldwide and also an alternative to synthetic insecticides. This study assessed the larvicidal potential of Metarhizium anisopliae fungi derived metabolites against Aedes aegypti, Anopheles stephensi, Culex quinquefasciatus and non-targeted organisms at 24hr post treatment. Method Isolation of entomopathogenic fungi M. anisopliae from natural traps confirmed by using 18s rDNA biotechnological tools. Crude extracts from M. anisopliae solvent extraction and their secondary metabolites were bio-assayed following WHO standard procedures against Ae. aegypti, An. stephensi and Cx. quinquefasciatus, Artemia nauplii, Eudrilus eugeniae, and Solanum lycopersicum after 24 hr exposure. Histopathological analysis of E. eugeniae treated with fungi metabolites toxicity compared to those treated with Monocrotophos after 24hrpost-treatment. M. anisopliae metabolites were characterized using GC-MS and FT-IR analysis. Results The larvicidal activity was recorded in highest concentration of 75 mu g/ml, with 85%, 97% and 89% mortality in Ae. aegypti, An. stephensi and Cx. quinquefasciatus respectively. M. anisopliae metabolites produced LC50 values in Ae. aegypti, 59.83 mu g/ml, in An. stephensi, 50.16 mu g/ml and in Cx. quinquefasciatus, 51.15 mu g/ml respectively. M. anisopliae metabolites produced lower toxic effects on A. nauplii, LC50 values were, 54.96 mu g/ml respectively. Bioindicator toxicity results show 18% and 58% mortality was recorded in E. eugeniae and A. nauplii and also there is no phytotoxicity that was observed on S. lycopersicum L. under semi-field condition. E. eugeniae histopathological studies shows fungal metabolites showed lower sub-lethal effects compared to synthetic chemical pesticide at 24hrs of the treatment. The GC-MS and FT-IR analysis identified five major components of active ingredients. Conclusion Findings of this study indicate that, M. anisopliae ethyl acetate derived secondary metabolites are effective against larvae of Ae. aegypti, An. stephensi and Cx. quinquefasciatus mosquito species, lower toxicity effects were observed on non-target organisms such as, Artemia nauplii, Eudrilus eugeniae as well as, no toxicity effect were observed on Solanum lycopersicum. Further research should be conducted in laboratory for separation of single pure molecule and be tested semifield conditions.	[Vivekanandhan, Perumal; Swathy, Kannan; Shivakumar, Muthugoundar Subramanian] Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem, Tamil Nadu, India; [Kalaimurugan, Dharman] Periyar Univ, Sch Life Sci, Dept Environm Sci, Salem, Tamil Nadu, India; [Ramachandran, Marimuthu] Periyar Univ, Sch Life Sci, Dept Bot, Plant Mol Stress Physiol Lab, Salem, Tamil Nadu, India; [Yuvaraj, Ananthanarayanan] Periyar Univ, Sch Life Sci, Dept Zool, Vermitechnol & Ecotoxicol Lab, Salem, Tamil Nadu, India; [Kumar, Arjunan Naresh; Manikandan, Ayyavu Thendral] Periyar Univ, Sch Life Sci, Dept Zool, Mol Entomol Lab, Salem, Tamil Nadu, India; [Poovarasan, Neelakandan] Natl Chung Hsing Univ, Dept Soil & Environm Sci, Taichung, Taiwan; [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Arusha, Tanzania; [Kweka, Eliningaya J.] Catholic Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, Mwanza, Tanzania	Periyar University; Periyar University; Periyar University; Periyar University; Periyar University; National Chung Hsing University	Shivakumar, MS (corresponding author), Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem, Tamil Nadu, India.; Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Arusha, Tanzania.; Kweka, EJ (corresponding author), Catholic Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, Mwanza, Tanzania.	skentomology@gmail.com; eliningaya.kweka@tpri.go.tz	Shivakumar, Muthugounder S./AAD-6241-2019; Kalaimurugan, Dharman/HDN-2094-2022; Marimuthu, Ramachandran/AAU-2415-2021; Perumal, Vivekanandhan/H-2783-2017	Shivakumar, Muthugounder S./0000-0002-1910-5510; Kalaimurugan, Dharman/0000-0002-5787-6893; Marimuthu, Ramachandran/0000-0001-5966-7481; Perumal, Vivekanandhan/0000-0002-3283-1306; Kweka, Eliningaya/0000-0002-8891-758X; Ayyavu, Thendralmanikandan/0000-0001-8330-5763	Periyar University Research Fellowship Scheme [PU/AD-3/URF/2016]	Periyar University Research Fellowship Scheme	Periyar University Research Fellowship Scheme (Ref No. PU/AD-3/URF/2016).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686; Chaurasia A, 2016, PESTIC BIOCHEM PHYS, V127, P28, DOI 10.1016/j.pestbp.2015.09.002; Jeger MJ, 2009, J THEOR BIOL, V258, P198, DOI 10.1016/j.jtbi.2009.01.012; Larsen J, 2008, SOIL BIOL BIOCHEM, V40, P360, DOI 10.1016/j.soilbio.2007.08.016; Logeswaran C, 2019, BIOCATAL AGR BIOTECH, V20, DOI 10.1016/j.bcab.2019.101253; MATHA V, 1988, FOLIA PARASIT, V35, P379; Maurya P, 2008, J ENVIRON BIOL, V29, P941; Mdoe FP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-426; Mdoe FP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-209; OECD (Organization for Economic Cooperation and Development), 2016, GUID TEST CHEM; Pratheeba T, 2019, BIOCATAL AGR BIOTECH, V19, DOI 10.1016/j.bcab.2019.101137; Priyanka, 2003, J AM MOSQUITO CONTR, V19, P404; Ragavendran C, 2017, RSC ADV, V7, P3838, DOI 10.1039/c6ra25859j; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Shahid AA, 2012, ARCH BIOL SCI, V64, P21, DOI 10.2298/ABS1201021S; Ullah Muhammad Irfan, 2019, Int J Insect Sci, V11, p1179543319867116, DOI 10.1177/1179543319867116; VIJAYAN V, 1991, INDIAN J MED RES-A, V93, P115; Vivekanandhan P, 2018, J CLUST SCI, V29, P1139, DOI 10.1007/s10876-018-1423-1; Vivekanandhan P, 2018, PATHOG GLOB HEALTH, V112, P37, DOI 10.1080/20477724.2018.1438228; Vivekanandhan P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030440; Vyas N., 2006, B BIO SCI, V4, P65; Vyas Neetu, 2006, J Commun Dis, V38, P176; Wang RY, 2019, SCI TOTAL ENVIRON, V669, P512, DOI 10.1016/j.scitotenv.2019.03.141; World Health Organization, 2005, WHOCDSWHOPESGCDPP200, P10; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410	26	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232172	10.1371/journal.pone.0232172	http://dx.doi.org/10.1371/journal.pone.0232172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365106	gold, Green Published			2022-12-26	WOS:000536959700018
J	Guo, XH; Eitnier, RA; Beard, RS; Meegan, JE; Yang, XY; Aponte, AM; Wang, F; Nelson, PR; Wu, MH				Guo, Xiaohua; Eitnier, Rebecca A.; Beard, Richard S., Jr.; Meegan, Jamie E.; Yang, Xiaoyuan; Aponte, Alexandra M.; Wang, Fang; Nelson, Peter R.; Wu, Mack H.			Focal adhesion kinase and Src mediate microvascular hyperpermeability caused by fibrinogen- gamma C- terminal fragments	PLOS ONE			English	Article							ENDOTHELIAL PERMEABILITY; TRANSCELLULAR TRANSPORT; VASCULAR LEAKAGE; CELL-ADHESION; RHOA ACTIVITY; FAK; PHOSPHORYLATION; CADHERIN; SH2; AUTOPHOSPHORYLATION	Objectives We previously reported microvascular leakage resulting from fibrinogen-gamma chain C-terminal products (gamma C) occurred via a RhoA-dependent mechanism. The objective of this study was to further elucidate the signaling mechanism by which gamma C induces endothelial hyperpermeability. Since it is known that gamma C binds and activates endothelial alpha v beta 3, a transmembrane integrin receptor involved in intracellular signaling mediated by the tyrosine kinases FAK and Src, we hypothesized that gamma C alters endothelial barrier function by activating the FAK-Src pathway leading to junction dissociation and RhoA driven cytoskeletal stress-fiber formation. Methods and results Using intravital microscopy of rat mesenteric microvessels, we show increased extravasation of plasma protein (albumin) resulting from gamma C administration. In addition, capillary fluid filtration coefficient (Kfc) indicated gamma C-induced elevated lung vascular permeability. Furthermore, gamma C decreased transendothelial barrier resistance in a time-dependent and dose-related fashion in cultured rat lung microvascular endothelial cells (RLMVECs), accompanied by increased FAK/Src phosphorylation detection by western blot. Experiments with pharmacological inhibition or gene silencing of FAK showed significantly reduced gamma C-induced albumin and fluid leakage across microvessels, stress-fiber formation, VE-cadherin tyrosine phosphorylation, and improved gamma C-induced endothelial barrier dysfunction, indicating the involvement of FAK in gamma C mediated hyperpermeability. Comparable results were found when Src was targeted in a similar manner, however inhibition of FAK prevented Src activation, suggesting that FAK is upstream of Src in gamma C-mediated hyperpermeability. In addition, gamma C-induced cytoskeletal stress-fiber formation was attenuated during inhibition or silencing of these tyrosine kinases, concomitantly with RhoA inhibition. Conclusion The FAK-Src pathway contributes to gamma C-induced microvascular barrier dysfunction, junction protein phosphorylation and disorganization in a manner that involves RhoA and stress-fiber formation.	[Guo, Xiaohua; Eitnier, Rebecca A.; Aponte, Alexandra M.; Wang, Fang; Wu, Mack H.] Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33620 USA; [Beard, Richard S., Jr.] Boise State Univ, Dept Biomol Res, Boise, ID 83725 USA; [Meegan, Jamie E.; Yang, Xiaoyuan] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Nelson, Peter R.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA	State University System of Florida; University of South Florida; Idaho; Boise State University; State University System of Florida; University of South Florida; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wu, MH (corresponding author), Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33620 USA.	mwu1@usf.edu	Nelson, Peter/B-2055-2009	Nelson, Peter/0000-0003-0398-2962	National Institutes of Health [GM109095, HL120954, HL096640]; American Heart Association [17SDG33660381]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants [HL120954 and HL096640]. R.S.B.J. was supported by career development funding from the National Institutes of Health [GM109095] and the American Heart Association [17SDG33660381]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2017, J PATHOL, V242, P358, DOI 10.1002/path.4911; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Alvarez-Perez FJ, 2011, J NEUROL NEUROSUR PS, V82, P986, DOI 10.1136/jnnp.2010.230870; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Beard RS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12823; Beard RS, 2018, J CEREB BLOOD FLOW M; Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003; Chapin JC, 2015, BLOOD REV, V29, P17, DOI 10.1016/j.blre.2014.09.003; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Gao XP, 2000, AM J PHYSIOL-LUNG C, V279, pL1218, DOI 10.1152/ajplung.2000.279.6.L1218; Grinnell KL, 2012, MICROVASC RES, V83, P12, DOI 10.1016/j.mvr.2011.04.005; Guo M, 2008, AM J PHYSIOL-CELL PH, V294, pC977, DOI 10.1152/ajpcell.90607.2007; Guo MZ, 2009, ARTERIOSCL THROM VAS, V29, P394, DOI 10.1161/ATVBAHA.108.180950; Guo MZ, 2005, MICROCIRCULATION, V12, P223, DOI 10.1080/10739680590905251; Hagiwara S, 2013, J TRAUMA ACUTE CARE, V74, P1275, DOI 10.1097/TA.0b013e31828cc967; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Heffler M, 2013, CANCER BIOL THER, V14, P761, DOI 10.4161/cbt.25185; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Hu GC, 2008, CHEM-BIOL INTERACT, V171, P177, DOI 10.1016/j.cbi.2007.08.006; Huang QB, 2003, SHOCK, V20, P363, DOI 10.1097/01.shk.0000079425.0000.db; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kontny F, 1999, EUR HEART J, V20, P808, DOI 10.1053/euhj.1998.1454; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Roa-Espitia AL, 2016, BIOL OPEN, V5, P1189, DOI 10.1242/bio.017558; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tinsley JH, 2002, AM J PHYSIOL-CELL PH, V283, pC1745, DOI 10.1152/ajpcell.00230.2002; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Wang LC, 2015, MICROVASC RES, V99, P102, DOI 10.1016/j.mvr.2015.03.007; Wu JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18476; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Wu MH, 2003, J PHYSIOL-LONDON, V552, P691, DOI 10.1113/jphysiol.2003.048405; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Yuan SY, 2010, INTEGRATED SYSTEMS P; Zacharowski K, 2006, J MOL MED, V84, P469, DOI 10.1007/s00109-006-0051-7; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14090	53	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231739	10.1371/journal.pone.0231739	http://dx.doi.org/10.1371/journal.pone.0231739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352989	Green Published, gold			2022-12-26	WOS:000536673200021
J	Reshetnikov, AS; Rozova, ON; Trotsenko, YA; But, SY; Khmelenina, VN; Mustakhimov, II				Reshetnikov, Aleksander S.; Rozova, Olga N.; Trotsenko, Yuri A.; But, Sergey Yu.; Khmelenina, Valentina N.; Mustakhimov, Ildar I.			Ectoine degradation pathway in halotolerant methylotrophs	PLOS ONE			English	Article							COMPATIBLE SOLUTES; CRYSTAL-STRUCTURE; SYSTEM; ENZYME; MSCS	Background Microorganisms living in saline environments are forced to regulate turgor via the synthesis of organic osmoprotective compounds. Microbial adaptation to fluctuations in external salinity includes degradation of compatible solutes. Here we have examined the biochemical pathway of degradation of the cyclic imino acid ectoine, the major osmoprotector in halotolerant methane-utilizing bacteria. Methods The BLAST search of the genes involved in ectoine degradation in the halotolerant methanotroph Methylotuvimicrobium alcaliphilum 20Z was performed with the reference sequences of Halomonas elongata. The genes for the key enzymes of the pathway were disrupted by insertion mutagenesis and the cellular metabolites in the methanol extracts of mutant cells were analyzed by HPLC. The doeA gene from Mm. alcaliphilum 20Z was heterologously expressed in Escherichia coli to identify the product of ectoine hydrolysis catalyzed by ectoine hydrolase DoeA. Results We have shown that the halotolerant methanotroph Mm. alcaliphilum 20Z possesses the doeBDAC gene cluster coding for putative ectoine hydrolase (DoeA), N alpha-acetyl-L-2,4-diaminobutyrate deacetylase (DoeB), diaminobutyrate transaminase (DoeD) and aspartate-semialdehyde dehydrogenase (DoeC). The deletion of the doeA gene resulted in accumulation of the higher level of ectoine compared to the wild type strain. N gamma-acetyl-L-2,4-diaminobutyrate (N gamma-acetyl-DAB), a substrate for ectoine synthase, was found in the cytoplasm of the wild type strain. N alpha-acetyl-L-2,4-diaminobutyrate (N alpha-acetyl-DAB), a substrate for the DoeB enzyme, appeared in the cells as a result of exposure of the doeB mutant to low osmotic pressure. The genes for the enzymes involved in ectoine degradation were found in all aerobic methylotrophs capable of ectoine biosynthesis. These results provide the first evidence for the in vivo operation of the ectoine degradation pathway in methanotrophs and thus expand our understanding of the regulation mechanisms of bacterial osmoadaptation. Conclusions During adaptation to the changes in external osmolarity, halophilic and halotolerant methylotrophs cleave ectoine, thereby entering the carbon and nitrogen of the compatible solute to the central metabolic pathways. The biochemical route of ectoine degradation in the halotolerant methanotroph Mm. alcaliphilum 20Z is similar to that in heterotrophic halophiles. We have shown that ectoine hydrolase DoeA in this methanotroph hydrolyzes ectoine with the formation of the only isomer: N alpha-acetyl-DAB. All aerobic methylotrophs capable of ectoine biosynthesis harbor the genetic determinants for ectoine degradation.	[Reshetnikov, Aleksander S.; Rozova, Olga N.; Trotsenko, Yuri A.; But, Sergey Yu.; Khmelenina, Valentina N.; Mustakhimov, Ildar I.] Russian Acad Sci, GK Skryabin Inst Biochem & Physiol Microorganisms, Fed Res Ctr, Pushchino Sci Ctr Biol Res, Pushchino, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Khmelenina, VN (corresponding author), Russian Acad Sci, GK Skryabin Inst Biochem & Physiol Microorganisms, Fed Res Ctr, Pushchino Sci Ctr Biol Res, Pushchino, Russia.	khmelenina@ibpm.pushchino.ru	Mustakhimov, Ildar/I-2381-2014; Rozova, Olga/E-6902-2014	Mustakhimov, Ildar/0000-0003-3406-0653; Rozova, Olga/0000-0001-6052-9756	Russian Science Foundation [18-14-00326]	Russian Science Foundation(Russian Science Foundation (RSF))	This research was supported by the Russian Science Foundation (#18-14-00326). PI Yuri A. Trotsenko.	Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Booth IR, 2014, CURR OPIN MICROBIOL, V18, P16, DOI 10.1016/j.mib.2014.01.005; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; But SY, 2013, MICROBIOLOGY+, V82, P253, DOI 10.1134/S0026261713020021; Cox CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3137; Czech L, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040177; Galinski E A, 1995, Adv Microb Physiol, V37, P272, DOI 10.1016/S0065-2911(08)60148-4; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Hanekop N, 2007, J MOL BIOL, V374, P1237, DOI 10.1016/j.jmb.2007.09.071; Jebbar M, 2005, J BACTERIOL, V187, P1293, DOI 10.1128/JB.187.4.1293-1304.2005; Khmelenina VN, 1999, ARCH MICROBIOL, V172, P321, DOI 10.1007/s002030050786; Kraegeloh A, 2002, EXTREMOPHILES, V6, P453, DOI 10.1007/s00792-002-0277-4; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Mustakhimov II, 2019, APPL BIOCHEM MICRO+, V55, P626, DOI 10.1134/S0003683819130015; Mustakhimov I I, 2016, Prikl Biokhim Mikrobiol, V52, P279, DOI 10.7868/S0555109916030156; Mustakhimov II, 2010, J BACTERIOL, V192, P410, DOI 10.1128/JB.00553-09; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; Reshetnikov AS, 2011, EXTREMOPHILES, V15, P653, DOI 10.1007/s00792-011-0396-x; Reshetnikov AS, 2011, METHOD ENZYMOL, V495, P216; Rodriguez-Moya J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-256; Rozova ON, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225054; Rozova ON, 2015, ANTON LEEUW INT J G, V108, P965, DOI 10.1007/s10482-015-0549-5; Sambrook J., 2001, MOL CLONING LAB MANU; Schulz A, 2017, ENVIRON MICROBIOL, V19, P926, DOI 10.1111/1462-2920.13414; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vargas C, 2006, J APPL MICROBIOL, V100, P98, DOI 10.1111/j.1365-2672.2005.02757.x; Welsh DT, 2000, FEMS MICROBIOL REV, V24, P263, DOI 10.1111/j.1574-6976.2000.tb00542.x; Widderich N, 2016, ENVIRON MICROBIOL, V18, P1227, DOI 10.1111/1462-2920.13156	34	6	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232244	10.1371/journal.pone.0232244	http://dx.doi.org/10.1371/journal.pone.0232244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353000	Green Published, gold			2022-12-26	WOS:000536673200057
J	Wright, G; Rodriguez, A; Li, J; Clark, PL; Milenkovic, T; Emrich, SJ				Wright, Gabriel; Rodriguez, Anabel; Li, Jun; Clark, Patricia L.; Milenkovic, Tijana; Emrich, Scott J.			Analysis of computational codon usage models and their association with translationally slow codons	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; IN-VIVO; SELECTION; RATES; BIAS	Improved computational modeling of protein translation rates, including better prediction of where translational slowdowns along an mRNA sequence may occur, is critical for understanding co-translational folding. Because codons within a synonymous codon group are translated at different rates, many computational translation models rely on analyzing synonymous codons. Some models rely on genome-wide codon usage bias (CUB), believing that globally rare and common codons are the most informative of slow and fast translation, respectively. Others use the CUB observed only in highly expressed genes, which should be under selective pressure to be translated efficiently (and whose CUB may therefore be more indicative of translation rates). No prior work has analyzed these models for their ability to predict translational slowdowns. Here, we evaluate five models for their association with slowly translated positions as denoted by two independent ribosome footprint (RFP) count experiments from S. cerevisiae, because RFP data is often considered as a "ground truth" for translation rates across mRNA sequences. We show that all five considered models strongly associate with the RFP data and therefore have potential for estimating translational slowdowns. However, we also show that there is a weak correlation between RFP counts for the same genes originating from independent experiments, even when their experimental conditions are similar. This raises concerns about the efficacy of using current RFP experimental data for estimating translation rates and highlights a potential advantage of using computational models to understand translation rates instead.	[Wright, Gabriel; Milenkovic, Tijana] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Rodriguez, Anabel; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Li, Jun] Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA; [Emrich, Scott J.] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Tennessee System; University of Tennessee Knoxville	Wright, G (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	gwright3@nd.edu		Wright, Gabriel/0000-0003-1706-0758; Milenkovic, Tijana/0000-0002-8023-6907	National Institutes of Health [1R01GM120733]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (nih.gov) grant 1R01GM120733 awarded to SE, TM, PC, and JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athey J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1793-7; Brule CE, 2017, TRENDS GENET, V33, P283, DOI 10.1016/j.tig.2017.02.001; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Chaney JL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005531; Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Diament A, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0127-4; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Eastman G, 2018, COMPUT STRUCT BIOTEC, V16, P167, DOI 10.1016/j.csbj.2018.04.001; Gilchrist MA, 2015, GENOME BIOL EVOL, V7, P1559, DOI 10.1093/gbe/evv087; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Hussmann JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005732; Jacobs WM, 2017, P NATL ACAD SCI USA, V114, P11434, DOI 10.1073/pnas.1705772114; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; O'Connor P, 2016, NATURE COMMUNICATION, P7; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rodriguez A, 2018, PROTEIN SCI, V27, P356, DOI 10.1002/pro.3336; Sabi R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S5; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tunney R, 2018, NAT STRUCT MOL BIOL, V25, P577, DOI 10.1038/s41594-018-0080-2; Walsh IM, 2020, P NATL ACAD SCI USA, V117, P3528, DOI 10.1073/pnas.1907126117; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Wright G, 2019, P 11 INT C BIOINF CO, DOI [10.1016/j.csbj.2018.04.001, DOI 10.1016/J.CSBJ.2018.04.001]	31	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232003	10.1371/journal.pone.0232003	http://dx.doi.org/10.1371/journal.pone.0232003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352987	gold, Green Published, Green Submitted			2022-12-26	WOS:000536673200032
J	Bi, CL; Fu, YL; Zhang, ZQ; Li, B				Bi, Changlong; Fu, Yili; Zhang, Zheqi; Li, Bo			Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway	FASEB JOURNAL			English	Article						CREB; BDNF; TrkB signaling pathway; diabetic coronary atherosclerosis; prostaglandin E2; M2 macrophage polarization	NEUROTROPHIC FACTOR; UP-REGULATION; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; BDNF; INFLAMMATION; BRAIN; INJURY	It has been documented that M2 macrophage polarization plays a suppressive role in atherosclerosis in diabetes mellitus (DM). In addition, prostaglandin E2 (PGE2) is implicated in the development of M2 macrophage polarization. Therefore, the study aimed to investigate the specific mechanism of PGE2 in M2 macrophage polarization in diabetic coronary atherosclerosis (DMAS). Initially, clinical samples were obtained and DMAS mouse model was established. The expression of BDNF was determined, and M1 and M2 macrophage polarizations were evaluated. Then, the levels of BDNF and PGE2 were modified in DMAS mice and the serum indicator, atherosclerotic plaque, lipid uptake by PBMCs, as well as M1 and M2 macrophage polarization were determined. Macrophages were isolated and the effects of PGE2 and the CREB/BDNF/TrkB signaling pathway on M2 macrophage polarization were explored. BDNF was downregulated and macrophages were differentiated into M1 in DMAS patients and mice. BDNF and PGE2 were observed to promote M2 macrophage polarization, where atherosclerotic plaque and lipid uptake by PBMCs were reduced, and DMAS was alleviated in mice. Overexpression of BDNF activated the CREB/BDNF/TrkB signaling pathway and stimulated M2 macrophage polarization in macrophages. PGE2 stimulated M2 macrophage polarization by inducing KLF4 via the activation of the CREB/BDNF/TrkB signaling pathway. This study demonstrates that PGE2 promotes M2 macrophage polarization by activating the CREB/BDNF/TrkB signaling pathway, thus alleviating DMAS.	[Bi, Changlong] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol, Shenzhen, Peoples R China; [Fu, Yili] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China; [Fu, Yili] Harbin Inst Technol, State Key Lab Robot & Syst, Harbin, Peoples R China; [Zhang, Zheqi; Li, Bo] Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 4, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China	Sun Yat Sen University; Harbin Institute of Technology; Harbin Institute of Technology; Harbin Medical University	Li, B (corresponding author), Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 4, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China.	BobbyLL123@163.com			National Natural Science Foundation of China [81800739, 81871562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81800739 & 81871562)	Ayuk SM, 2016, J PHOTOCH PHOTOBIO B, V161, P368, DOI 10.1016/j.jphotobiol.2016.05.027; Chatterjee T, 2019, FREE RADICAL BIO MED, V143, P309, DOI 10.1016/j.freeradbiomed.2019.07.034; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1397, DOI 10.1161/ATVBAHA.111.225508; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Fenyo IM, 2013, IMMUNOBIOLOGY, V218, P1376, DOI 10.1016/j.imbio.2013.06.005; Gong M, 2017, MED SCI MONIT BASIC, V23, P240, DOI 10.12659/MSMBR.904014; Gonzalez AA, 2017, AM J PHYSIOL-RENAL, V313, pF1038, DOI 10.1152/ajprenal.00194.2017; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hong JH, 2014, INT J CARDIOL, V176, P1405, DOI 10.1016/j.ijcard.2014.08.019; Hyam SR, 2013, EUR J PHARMACOL, V708, P21, DOI 10.1016/j.ejphar.2013.01.014; Ji XC, 2015, CELL MOL NEUROBIOL, V35, P881, DOI 10.1007/s10571-015-0182-x; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Lino M, 2018, ARTERIOSCL THROM VAS, V38, P1878, DOI 10.1161/ATVBAHA.118.311238; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Maiti Rituparna, 2007, Indian J Med Sci, V61, P292; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Miao HS, 2018, J NEUROPHYSIOL, V120, P1307, DOI 10.1152/jn.00234.2018; Mokou M, 2019, EBIOMEDICINE, V41, P91, DOI 10.1016/j.ebiom.2019.02.040; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; Wang CCL, 2016, CIRCULATION, V133, P2459, DOI 10.1161/CIRCULATIONAHA.116.022194; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115855; Yahagi K, 2017, ARTERIOSCL THROM VAS, V37, P191, DOI 10.1161/ATVBAHA.116.306256; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhao GF, 2016, FEBS LETT, V590, P1602, DOI 10.1002/1873-3468.12200	31	13	13	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7360	7371		10.1096/fj.201902055R	http://dx.doi.org/10.1096/fj.201902055R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350920				2022-12-26	WOS:000553673800001
J	Shen, T; Huang, ZH; Shi, CF; Pu, XF; Xu, XD; Wu, ZR; Ding, GP; Cao, LP				Shen, Tao; Huang, Zihang; Shi, Chengfei; Pu, Xiaofan; Xu, Xiaodong; Wu, Zhengrong; Ding, Guoping; Cao, Liping			Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress	FASEB JOURNAL			English	Article						apoptosis; endoplasmic reticulum stress; exosomes; p38 MAPK; pancreatic cancer; T lymphocytes	ACTIVATED PROTEIN-KINASE; INDUCED CELL-DEATH; VESICLES; PATHWAY; MICROVESICLES; INFILTRATION; PHOSPHATASES; EXPRESSION	Pancreatic cancer is the fourth most lethal malignancy and is characterized by poor immunogenicity. Pancreatic cancer cells have various strategies to suppress host immune response, evade immune defenses, and facilitate tumor growth and development. As a mode of long-range intercellular communication, cancer-derived exosomes contribute to impairment of the immune system. However, the mechanisms that induce changes in the activities of signal transduction pathways in immune cells, which are influenced by tumor-derived exosomes, are poorly understood. We (1) treated peripheral T lymphocytes with pancreatic cancer-derived exosomes, tagged CD63 with tdTomato, to trace exosome transfer from pancreatic cancer cells to T lymphocytes; (2) carried out a cytotoxicity assay of exosome-treated T lymphocytes using the Real Time Cellular Analysis system; (3) performed RNA sequencing and gene set enrichment analysis to explore the pivotal signaling pathway that mediates apoptosis in exosome-treated T lymphocytes; and (4) demonstrated the role of p38 mitogen-activated protein kinase (MAPK) and endoplasmic reticulum (ER) stress in exosome-induced T-lymphocyte apoptosis. In conclusion, these results indicate that pancreatic cancer cells secrete exosomes, which are taken up by T lymphocytes to activate p38 MAPK, and then induce ER stress-mediated apoptosis, ultimately causing immunosuppression.	[Shen, Tao; Huang, Zihang; Pu, Xiaofan; Xu, Xiaodong; Wu, Zhengrong; Ding, Guoping; Cao, Liping] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg, Hangzhou, Peoples R China; [Shi, Chengfei] Wenzhou Med Univ, Wenling Hosp, Sch Med, Dept Gen Surg, Wenling, Peoples R China; [Cao, Liping] Zhejiang Univ, Innovat Ctr Minimally Invas Tech & Device, Hangzhou, Peoples R China	Zhejiang University; Wenzhou Medical University; Zhejiang University	Ding, GP; Cao, LP (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg, Hangzhou, Peoples R China.	dinguop@zju.edu.cn; caolipingzju@zju.edu.cn		Xu, Xiaodong/0000-0002-5290-9705; cao, liping/0000-0003-4810-1495	Major Research Project of Science Technology, Department of Zhejiang Province [2019C03048]; National Natural Science Foundation of China [817, 02358]; Medical Science and Technology of Zhejiang Province [WKJ-ZJ-1824]; Zhejiang Traditional Chinese Medicine Research Fund Program [2019ZB071]	Major Research Project of Science Technology, Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology of Zhejiang Province; Zhejiang Traditional Chinese Medicine Research Fund Program	Major Research Project of Science Technology, Department of Zhejiang Province, Grant/Award Number: 2019C03048; National Natural Science Foundation of China, Grant/Award Number: 817 and 02358; Medical Science and Technology of Zhejiang Province, Grant/Award Number: WKJ-ZJ-1824; Zhejiang Traditional Chinese Medicine Research Fund Program, Grant/Award Number: 2019ZB071	Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Buscail L, 2017, NAT REV GASTRO HEPAT, V14, P636, DOI 10.1038/nrgastro.2017.113; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; Emmrich J, 1998, DIGESTION, V59, P192, DOI 10.1159/000007488; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Hartwig W, 2013, LANCET ONCOL, V14, pE476, DOI 10.1016/S1470-2045(13)70172-4; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim DS, 2010, BIOL PHARM BULL, V33, P545, DOI 10.1248/bpb.33.545; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Laheru D, 2005, NAT REV CANCER, V5, P459, DOI 10.1038/nrc1630; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Morganti AG, 2010, ANN SURG ONCOL, V17, P194, DOI 10.1245/s10434-009-0762-4; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Powolny A, 2003, J CELL BIOCHEM, V90, P1128, DOI 10.1002/jcb.10733; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ricklefs FL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2766; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Scott DW, 2008, DNA CELL BIOL, V27, P607, DOI 10.1089/dna.2008.0773; Shen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08479-9; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Terashima T, 2014, CANCER IMMUNOL IMMUN, V63, P479, DOI 10.1007/s00262-014-1529-8; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Boorn JG, 2013, ADV DRUG DELIVER REV, V65, P331, DOI 10.1016/j.addr.2012.06.011; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; von Bernstorff W, 2001, CLIN CANCER RES, V7, p925S; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Zhang J, 2000, J EXP MED, V191, P1017, DOI 10.1084/jem.191.6.1017; Zhang J, 1999, J IMMUNOL, V162, P3819; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	45	36	36	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8442	8458		10.1096/fj.201902186R	http://dx.doi.org/10.1096/fj.201902186R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350913	hybrid			2022-12-26	WOS:000553674200001
J	Baker, MG; Peckham, TK; Seixas, NS				Baker, Marissa G.; Peckham, Trevor K.; Seixas, Noah S.			Estimating the burden of United States workers exposed to infection or disease: A key factor in containing risk of COVID-19 infection	PLOS ONE			English	Article								Introduction With the global spread of COVID-19, there is a compelling public health interest in quantifying who is at increased risk of contracting disease. Occupational characteristics, such as interfacing with the public and being in close quarters with other workers, not only put workers at high risk for disease, but also make them a nexus of disease transmission to the community. This can further be exacerbated through presenteeism, the term used to describe the act of coming to work despite being symptomatic for disease. Quantifying the number of workers who are frequently exposed to infection and disease in the workplace, and understanding which occupational groups they represent, can help to prompt public health risk response and management for COVID-19 in the workplace, and subsequent infectious disease outbreaks. Methods To estimate the number of United States workers frequently exposed to infection and disease in the workplace, national employment data (by Standard Occupational Classification) maintained by the Bureau of Labor Statistics (BLS) was merged with a BLS O*NET survey measure reporting how frequently workers in each occupation are exposed to infection or disease at work. This allowed us to estimate the number of United States workers, across all occupations, exposed to disease or infection at work more than once a month. Results Based on our analyses, approximately 10% (14.4 M) of United States workers are employed in occupations where exposure to disease or infection occurs at least once per week. Approximately 18.4% (26.7 M) of all United States workers are employed in occupations where exposure to disease or infection occurs at least once per month. While the majority of exposed workers are employed in healthcare sectors, other occupational sectors also have high proportions of exposed workers. These include protective service occupations (e.g. police officers, correctional officers, firefighters), office and administrative support occupations (e.g. couriers and messengers, patient service representatives), education occupations (e.g. preschool and daycare teachers), community and social services occupations (community health workers, social workers, counselors), and even construction and extraction occupations (e.g. plumbers, septic tank installers, elevator repair). Conclusions The large number of persons employed in occupations with frequent exposure to infection and disease underscore the importance of all workplaces developing risk response plans for COVID-19. Given the proportion of the United States workforce exposed to disease or infection at work, this analysis also serves as an important reminder that the workplace is a key locus for public health interventions, which could protect both workers and the communities they serve.	[Baker, Marissa G.; Peckham, Trevor K.; Seixas, Noah S.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baker, MG (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	bakermg@uw.edu			National Institute for Occupational Safety and Health [T42OH008433]	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Research reported here was supported by the National Institute for Occupational Safety and Health under Federal Training Grant T42OH008433 to NSS. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIOSH.	Bergstrom G, 2009, J OCCUP ENV MED; Biron C, 2006, J PUBLIC MENTAL HLTH; Brousseau LM, 2020, ANN WORK EXPO HEAL; Cifuentes M, 2010, AM J IND MED, V53, P898, DOI 10.1002/ajim.20846; Danovaro-Holliday MC, 2000, J AM MED ASS; DeRigne LA, 2017, PREV MED BALTIM; Doubleday A, 2019, AM J IND MED; Drago R, 2010, I WOMENS POLICY RES, VB264; Edwards CH, 2016, EUROPEAN J PUBLIC HL; Johansen V, 2013, NORD J SOC RES; Kinman G, 2019, BRIT MED B; Koh D, 2020, OCCUPATIONAL RISKS C; Kumar S, 2013, AM J PUBLIC HLTH; Kurgat EK, 2019, INT J HYG ENV HLTH; Lui JNM, 2018, BMC HLTH SERVICES RE; O*NET Online, WORK CONT EXP DIS IN; O*NET Resource Center, 2018, O NET OCC SUMM UPD; O'Connor R, 2014, I WOMENS POLICY RES, VB337; Rebmann T, 2009, AM J INFECT CONTROL; Siqueira CE, 2014, AM J IND MED; U. S. Bureau of Labor Statistics, 2018, O NET QUEST; U. S. Bureau of Labor Statistics, 2018, O NET ONL; U.S. Department of Labor, 2012, O NET DAT COLL PROGR; United States Department of Labor Bureau of Labor Statistics, 2010, 2010 SOC US GUID; US Bureau of Labor Statistic, OCC EMPL STAT; Webster RK, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7138-x; Wu Z, 2020, JAMA; Yang T, 2017, INT J ENV RES PUBLIC	28	180	183	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232452	10.1371/journal.pone.0232452	http://dx.doi.org/10.1371/journal.pone.0232452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS1WY	32343747	gold, Green Published, Green Submitted			2022-12-26	WOS:000536183100001
J	Hosking, K; Stewart, G; Mobsby, M; Skov, S; Zhao, YJ; Su, JY; Tong, S; Nihill, P; Davis, J; Connors, C; Davies, J				Hosking, Kelly; Stewart, Geoffrey; Mobsby, Mikaela; Skov, Steven; Zhao, Yuejen; Su, Jiunn-Yih; Tong, Steven; Nihill, Peter; Davis, Joshua; Connors, Christine; Davies, Jane			Data linkage and computerised algorithmic coding to enhance individual clinical care for Aboriginal people living with chronic hepatitis B in the Northern Territory of Australia - Is it feasible?	PLOS ONE			English	Article							VIRUS; EPIDEMIOLOGY; PREVENTION; INFECTION; DATABASES	Background Chronic hepatitis B (CHB) is endemic in the Aboriginal population of Australia's Northern Territory (NT). However, many people's hepatitis B virus (HBV) status remains unknown. Objective 1. To maximise the utility of existing HBV test and vaccination data in the NT by creating a linked dataset and computerised algorithmic coding. 2. To undertake rigorous quality assurance processes to establish feasibility of using the linked dataset and computerised algorithmic coding for individual care for people living with CHB. Methods Step 1: We used deterministic data linkage to merge information from three separate patient databases. HBV testing and vaccination data from 2008-2016 was linked and extracted for 19,314 people from 21 remote Aboriginal communities in the Top End of the NT. Step 2: A computerised algorithm was developed to allocate one of ten HBV codes to each individual. Step 3: A quality assurance process was undertaken by a clinician, using standardised processes, manually reviewing all three databases, for a subset of 5,293 Aboriginal people from five communities to check the accuracy of each allocated code. Results The process of data linking individuals was highly accurate at 99.9%. The quality assurance process detected an overall error rate of 17.7% on the HBV code generated by the computerised algorithm. Errors occurred in source documentation, primarily from the historical upload of paper-based records to electronic health records. An overall HBV prevalence of 2.6% in five communities was found, which included ten cases of CHB who were previously unaware of infection and not engaged in care. Conclusions Data linkage of individuals was highly accurate. Data quality issues and poor sensitivity in the codes produced by the computerised algorithm were uncovered in the quality assurance process. By systematically, manually reviewing all available data we were able to allocate a HBV status to 91% of the study population.	[Hosking, Kelly; Stewart, Geoffrey; Mobsby, Mikaela; Nihill, Peter; Connors, Christine; Davies, Jane] Northern Terr Govt, Primary Hlth Care Branch, Top End Hlth Serv, Darwin, NT, Australia; [Hosking, Kelly; Su, Jiunn-Yih; Tong, Steven; Davis, Joshua; Davies, Jane] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Stewart, Geoffrey; Skov, Steven; Su, Jiunn-Yih] Northern Terr Govt, Ctr Dis Control, Darwin, NT, Australia; [Zhao, Yuejen] Northern Terr Govt, Innovat & Res, Darwin, NT, Australia; [Tong, Steven] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Tong, Steven] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Davis, Joshua] John Hunter Hosp, Dept Infect Dis, Newcastle, NSW, Australia	Northern Territory Government; Charles Darwin University; Menzies School of Health Research; Northern Territory Government; Northern Territory Government; Royal Melbourne Hospital; John Hunter Hospital	Hosking, K (corresponding author), Northern Terr Govt, Primary Hlth Care Branch, Top End Hlth Serv, Darwin, NT, Australia.; Hosking, K (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	kelly.hosking@nt.gov.au	Davies, Jane/AAD-8109-2019	Davies, Jane/0000-0002-3843-837X; Hosking, Kelly/0000-0002-6775-7089; Su, Jiunn-Yih/0000-0003-1345-8013				Allard N, 2018, B POSITIVE ALL YOU W; Alvarez LG, 2011, J HOSP INFECT, V79, P231, DOI 10.1016/j.jhin.2011.06.016; Asche CV, 2017, PHARMACOECONOMICS, V35, P759, DOI 10.1007/s40273-017-0513-5; Australia Government Department of Health, 2014, 2 NAT HEP B STRAT 20; Australian Government Department of Health, 2018, 5 NAT AB TORR STRAIT; Australian Government Department of Health, 2018, 3 NAT HEP B STRAT 20; Australian Institute of Health and Welfare, 2010, CONTR CHRON DIS GAP; Bohensky MA, 2011, ANAESTH INTENS CARE, V39, P202, DOI 10.1177/0310057X1103900208; Boyd JH, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0981-2; Carroll E, 2010, INTERN MED J, V40, P784, DOI 10.1111/j.1445-5994.2010.02316.x; Cheah BC, 2018, VACCINE, V36, P3533, DOI [10.1016/j.vaccine.2018.01.062, 10.1016/j.vaccine]; Davies J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184082; Davies J, 2013, J GASTROEN HEPATOL, V28, P1234, DOI 10.1111/jgh.12177; Dusetzina SB, 2014, LINKING DATA HLTH SE; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Graham S, 2019, SEX HEALTH, V16, P201, DOI [10.1071/SH18150, 10.1071/SH16013]; Harper G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017898; Harron KL, 2017, INT J EPIDEMIOL, V46, P1699, DOI 10.1093/ije/dyx177; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Littlejohn M, 2014, J MED VIROL, V86, P695, DOI 10.1002/jmv.23888; Liu B, 2012, VACCINE, V30, P7309, DOI 10.1016/j.vaccine.2012.09.033; Lok ASF, 2019, HEPATOL COMMUN, V3, P8, DOI 10.1002/hep4.1281; Lok ASF, 2002, NEW ENGL J MED, V346, P1682, DOI 10.1056/NEJM200205303462202; MacLachlan J., 2019, VIRAL HEPATITIS MAPP; Mak DB, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-118; National Health and Medical Research Council, 2018, ETH COND RES AB TORR; National Health and Medical Research Council, 2010, NHMRC ROAD MAP 2 STR; National Health and Medical Research Council, 2003, GUID ETH COND AB TOR; Northern Terriorty Government, 2014, NO TERR HEP B ACT PL; Northern Territory Government, 2013, NO TERR HEP B VACC P; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Parker C, 2014, MED J AUSTRALIA, V201, P470, DOI 10.5694/mja13.11117; Queensland Government, 2017, QUEENSL DAT LINK FRA; Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6; Robotin MC, 2009, J HEPATOL, V50, P990, DOI 10.1016/j.jhep.2008.12.022; Rowe SL, 2016, AUST NZ J PUBL HEAL, V40, P148, DOI 10.1111/1753-6405.12434; Tew K., 2008, VALIDATION PATIENT D; WHO, 2017, WHO PUBLISHES LIST B; Zhao YJ, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2803-1	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232207	10.1371/journal.pone.0232207	http://dx.doi.org/10.1371/journal.pone.0232207			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343712	gold, Green Published			2022-12-26	WOS:000536661300041
J	Du, SS; Shao, JZ; Xie, DD; Zhang, FY				Du, Shanshan; Shao, Jingzhi; Xie, Dandan; Zhang, Fengyan			Decorin inhibits glucose-induced lens epithelial cell apoptosis via suppressing p22(phox)-p38 MAPK signaling pathway	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXPRESSION; MIGRATION; MECHANISMS; GROWTH; P38	Purpose To determine the effect of decorin on oxidative stress and apoptosis of human lens epithelial (HLE) cells under high glucose condition. Methods HLE cell line (HLEB3) was incubated in normal glucose (5.5 mM) or high glucose (60 mM) medium. Decorin (50 nM) was applied 2 hours before high glucose medium was added. Apoptosis detection was executed by flow cytometry and western blotting (analysis of bcl-2 and bax). Oxidative stress level was measured by the generation of reactive oxygen species (ROS), glutathione peroxidase (GSH) and superoxide dismutase (SOD). P38 mitogen-activated protein kinase (MAPK) phosphorylation, the expression of p22(phox) of HLE cells and human lens anterior capsules were detected by western blotting. Small interfering RNA transfection to p22(phox) and p38 MAPK was also carried out on HLEB3. Results High glucose caused HLE cells oxidative stress and apoptosis exhibiting the increase of apoptotic cells and ROS production and decrease of bcl-2/bax ratio, GSH/GSSG ration and SOD activity. P22(phox) and phospho-p38 MAPK were upregulated in high glucose treated HLEB3 cells. Knocking down p22(phox) or p38 by siRNAs can reduce high glucose induced cell apoptosis and oxidative stress level. Silencing p22(phox) by siRNA can downregulate the phosphorylation of p38 MAPK. Decorin can inhibit the apoptosis, oxidative stress level and the induction of p22(phox) and phospho-p38 of HLEB3 induced by high glucose. Furthermore, the expression of p22(phox) and p38 were found significantly increased in lens anterior capsules of diabetic cataract patients compared to that of normal age-related cataract patients. Conclusions Results showed that p22(phox)-p38 pathway may be participated in high glucose induced lens epithelial cell injury, decorin may inhibit the high glucose induced apoptosis and oxidative stress injury by suppressing this pathway in part.	[Du, Shanshan; Shao, Jingzhi; Xie, Dandan; Zhang, Fengyan] Zhengzhou Univ, Henan Prov Eye Hosp, Dept Ophthalmol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Shao, Jingzhi] Zhengzhou Univ, Sch Basic Med, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Zhang, FY (corresponding author), Zhengzhou Univ, Henan Prov Eye Hosp, Dept Ophthalmol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	zhangfengyanx@aliyun.com		Shao, Jingzhi/0000-0002-8900-4838	National Nature Science Foundation of China [81970785]; scientific and technological project of Henan Province [192102310343]; medical scientific and technological project of Henan Province [2018020065]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific and technological project of Henan Province; medical scientific and technological project of Henan Province	This work was supported by the National Nature Science Foundation of China (NO. 81970785) to FZ, the scientific and technological project of Henan Province (NO. 192102310343) to FZ and the medical scientific and technological project of Henan Province (NO. 2018020065) to JS.	Chen F, 2013, CNS NEUROSCI THER, V19, P675, DOI 10.1111/cns.12131; Cui XK, 2015, BBA-MOL CELL RES, V1853, P746, DOI 10.1016/j.bbamcr.2015.01.004; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Du SS, 2013, EXP EYE RES, V116, P151, DOI 10.1016/j.exer.2013.08.019; Fan HP, 2008, INT J BIOCHEM CELL B, V40, P2120, DOI 10.1016/j.biocel.2008.02.009; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Haddad NMN, 2014, SEMIN OPHTHALMOL, V29, P329, DOI 10.3109/08820538.2014.959197; Jain AK, 2002, FREE RADICAL BIO MED, V33, P1615, DOI 10.1016/S0891-5849(02)01109-7; Kassan M, 2014, AM J PHYSIOL-HEART C, V306, pH972, DOI 10.1152/ajpheart.00872.2013; Lala N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097881; Mohan R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026846, 10.1371/journal.pone.0026432]; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Rastogi R, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00301; Rwei P, 2017, BIOCHEM BIOPH RES CO, V482, P954, DOI 10.1016/j.bbrc.2016.11.139; Shao JZ, 2018, INT J OPHTHALMOL-CHI, V11, P1253, DOI 10.18240/ijo.2018.08.02; Wang GQ, 2017, CURR EYE RES, V42, P72, DOI 10.3109/02713683.2016.1156133; Wang S, 2015, INVEST OPHTH VIS SCI, V56, P2971, DOI 10.1167/iovs.14-15874; Wride Michael A., 2006, Birth Defects Research, V78, P90, DOI 10.1002/bdrc.20063	18	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0224251	10.1371/journal.pone.0224251	http://dx.doi.org/10.1371/journal.pone.0224251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339204	Green Submitted, gold, Green Published			2022-12-26	WOS:000536657400001
J	Guerillon, C; Smedegaard, S; Hendriks, IA; Nielsen, ML; Mailand, N				Guerillon, Claire; Smedegaard, Stine; Hendriks, Ivo A.; Nielsen, Michael L.; Mailand, Niels			Multisite SUMOylation restrains DNA polymerase ? interactions with DNA damage sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sumoylation; DNA damage; DNA damage response; DNA polymerase; post-translational modification (PTM); proliferating cell nuclear antigen (PCNA); translesion DNA synthesis (TLS)	UBIQUITIN-BINDING DOMAINS; TRANSLESION SYNTHESIS; PCNA MONOUBIQUITINATION; STRUCTURAL BASIS; DVC1 C1ORF124; THYMINE DIMER; E3 LIGASE; POL-ETA; REPLICATION; RNF4	Translesion DNA synthesis (TLS) mediated by low-fidelity DNA polymerases is an essential cellular mechanism for bypassing DNA lesions that obstruct DNA replication progression. However, the access of TLS polymerases to the replication machinery must be kept tightly in check to avoid excessive mutagenesis. Recruitment of DNA polymerase ? (Pol ?) and other Y-family TLS polymerases to damaged DNA relies on proliferating cell nuclear antigen (PCNA) monoubiquitylation and is regulated at several levels. Using a microscopy-based RNAi screen, here we identified an important role of the SUMO modification pathway in limiting Pol ? interactions with DNA damage sites in human cells. We found that Pol ? undergoes DNA damage- and protein inhibitor of activated STAT 1 (PIAS1)-dependent polySUMOylation upon its association with monoubiquitylated PCNA, rendering it susceptible to extraction from DNA damage sites by SUMO-targeted ubiquitin ligase (STUbL) activity. Using proteomic profiling, we demonstrate that Pol ? is targeted for multisite SUMOylation, and that collectively these SUMO modifications are essential for PIAS1- and STUbL-mediated displacement of Pol ? from DNA damage sites. These findings suggest that a SUMO-driven feedback inhibition mechanism is an intrinsic feature of TLS-mediated lesion bypass functioning to curtail the interaction of Pol ? with PCNA at damaged DNA to prevent harmful mutagenesis.	[Guerillon, Claire; Smedegaard, Stine; Mailand, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Prot Res,Ubiquitin Signaling Grp, Novo Nordisk Fdn,Prot Signaling Program, Blegdamsvej 3B, Copenhagen, Denmark; [Hendriks, Ivo A.; Nielsen, Michael L.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Prot Res, Novo Nordisk Fdn,Prote Program, Blegdamsvej 3B, Copenhagen, Denmark	Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Mailand, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Prot Res,Ubiquitin Signaling Grp, Novo Nordisk Fdn,Prot Signaling Program, Blegdamsvej 3B, Copenhagen, Denmark.	niels.mailand@cpr.ku.dk	Guérillon, Claire/I-1010-2014	Guérillon, Claire/0000-0002-1982-6596; Hendriks, Ivo/0000-0002-1439-3701; Mailand, Niels/0000-0002-6623-709X; Nielsen, Michael/0000-0002-0067-9039	Novo Nordisk Foundation [NNF14CC0001]; European Research Council [616236]; Danish Cancer Society [R146-RP11394]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Danish Cancer Society(Danish Cancer Society)	This work was supported by Novo Nordisk Foundation Grant NNF14CC0001, European Research Council Grant 616236 (DDRegulation), and Danish Cancer Society Grant R146-RP11394.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Bertoletti F, 2017, NUCLEIC ACIDS RES, V45, P9441, DOI 10.1093/nar/gkx619; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bonne-Andrea C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2875; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cipolla L, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00105; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Despras E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13326; Despras E, 2012, ENVIRON MOL MUTAGEN, V53, P752, DOI 10.1002/em.21741; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gibbs-Seymour I, 2015, MOL CELL, V57, P150, DOI 10.1016/j.molcel.2014.12.001; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; He XY, 2017, NAT CHEM BIOL, V13, P1164, DOI [10.1038/nchembio.2463, 10.1038/NCHEMBIO.2463]; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Itoh T, 2000, J INVEST DERMATOL, V115, P981, DOI 10.1046/j.1523-1747.2000.00154.x; Jain R, 2018, CURR OPIN STRUC BIOL, V53, P77, DOI 10.1016/j.sbi.2018.06.003; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Jung YS, 2011, MOL CELL BIOL, V31, P3997, DOI 10.1128/MCB.05808-11; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kumar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01900-x; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2005, FEBS LETT, V579, P873, DOI 10.1016/j.febslet.2004.11.029; Lerner LK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58180-7; Lin QC, 2006, CANCER RES, V66, P87, DOI 10.1158/0008-5472.CAN-05-1862; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Ma XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02164-1; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Opletalova K, 2014, HUM MUTAT, V35, P117, DOI 10.1002/humu.22462; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Qian J, 2015, ONCOGENE, V34, P4791, DOI 10.1038/onc.2014.394; Sabbioneda S, 2009, P NATL ACAD SCI USA, V106, pE20, DOI 10.1073/pnas.0812744106; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Sriramachandran AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11549-3; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tsanov N, 2014, NUCLEIC ACIDS RES, V42, P3692, DOI 10.1093/nar/gkt1400; van Cuijk L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8499; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yang Y, 2018, CELL CYCLE, V17, P833, DOI 10.1080/15384101.2018.1456296; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	65	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8350	8362		10.1074/jbc.RA120.013780	http://dx.doi.org/10.1074/jbc.RA120.013780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32350109	Green Published, hybrid			2022-12-26	WOS:000546986500001
J	Ait-Bouziad, N; Chiki, A; Limorenko, G; Xiao, SF; Eliezer, D; Lashuel, HA				Ait-Bouziad, Nadine; Chiki, Anass; Limorenko, Galina; Xiao, Shifeng; Eliezer, David; Lashuel, Hilal A.			Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); tauopathy; neurodegenerative disease; phosphotyrosine; aggregation; microtubule; post-translational modification (PTM); phosphorylation; amyloid; lipid binding	PROGRESSIVE SUPRANUCLEAR PALSY; ACCOMPANIES DISEASE PROGRESSION; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; PROTEIN-TAU; C-ABL; NEUROFIBRILLARY TANGLES; 3RD REPEAT; ABNORMAL PHOSPHORYLATION; CORE PEPTIDE	The microtubule-associated protein Tau is implicated in the pathogenesis of several neurodegenerative disorders, including Alzheimer's disease. Increasing evidence suggests that post-translational modifications play critical roles in regulating Tau's normal functions and its pathogenic properties in tauopathies. Very little is known about how phosphorylation of tyrosine residues influences the structure, aggregation, and microtubule- and lipid-binding properties of Tau. Here, we sought to determine the relative contributions of phosphorylation of one or several of the five tyrosine residues in Tau (Tyr-18, -29, -197, -310, and -394) to the regulation of its biophysical, aggregation, and functional properties. We used a combination of site-specific mutagenesis and in vitro phosphorylation by c-Abl kinase to generate Tau species phosphorylated at all five tyrosine residues, all tyrosine residues except Tyr-310 or Tyr-394 (pTau-Y310F and pTau-Y394F, respectively) and Tau phosphorylated only at Tyr-310 or Tyr-394 (4F/pTyr-310 or 4F/pTyr-394). We observed that phosphorylation of all five tyrosine residues, multiple N-terminal tyrosine residues (Tyr-18, -29, and -197), or specific phosphorylation only at residue Tyr-310 abolishes Tau aggregation and inhibits its microtubule- and lipid-binding properties. NMR experiments indicated that these effects are mediated by a local decrease in ?-sheet propensity of Tau's PHF6 domain. Our findings underscore Tyr-310 phosphorylation has a unique role in the regulation of Tau aggregation, microtubule, and lipid interactions. These results also highlight the importance of conducting further studies to elucidate the role of Tyr-310 in the regulation of Tau's normal functions and pathogenic properties.	[Ait-Bouziad, Nadine; Chiki, Anass; Limorenko, Galina; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne EPFL, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Xiao, Shifeng] Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Coll Life Sci & Oceanog, Shenzhen, Peoples R China; [Xiao, Shifeng; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Xiao, Shifeng; Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Shenzhen University; Cornell University; Cornell University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	Hilal.lashuel@epfl.ch	Limorenko, Galina/AAX-9584-2020; Lashuel, Hilal/M-3500-2017	Limorenko, Galina/0000-0002-6319-0257; Ait-Bouziad, Nadine/0000-0003-3182-4179; Eliezer, David/0000-0002-1311-7537	Swiss Federal Institute of Technology Lausanne; National Institutes of Health [R37AG019391]; AC Immune	Swiss Federal Institute of Technology Lausanne; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AC Immune	This work was supported by grants from the Swiss Federal Institute of Technology Lausanne (to H. A. L.), AC Immune, and National Institutes of Health Grant R37AG019391 (to D. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Bouziad N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01575-4; Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Arima K, 1999, ACTA NEUROPATHOL, V97, P565, DOI 10.1007/s004010051032; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Barbier P, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00204; Barghorn Stefan, 2005, Methods Mol Biol, V299, P35; Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018; Barre P, 2013, PROTEIN SCI, V22, P1037, DOI 10.1002/pro.2290; Barthelemy NR, 2016, J ALZHEIMERS DIS, V51, P1033, DOI 10.3233/JAD-150962; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; DELACOURTE A, 1986, CR ACAD SCI III-VIE, V303, P439; Derisbourg M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09659; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Duka V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075025; Elbaum-Garfinkle S, 2010, BIOPHYS J, V98, P2722, DOI 10.1016/j.bpj.2010.03.013; Eliezer D, 2005, BIOCHEMISTRY-US, V44, P1026, DOI 10.1021/bi048953n; Ellmer D, 2019, ANGEW CHEM, V131, P1630, DOI [10.1002/ange.201805238, DOI 10.1002/ANGE.201805238]; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Ferrer I, 2008, BRAIN, V131, P1416, DOI 10.1093/brain/awm305; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Georgieva ER, 2014, BIOPHYS J, V107, P1441, DOI 10.1016/j.bpj.2014.07.046; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haj-Yahya M., 2019, ANGEW CHEM, V59, P4059; Haj-Yahya M, 2018, J AM CHEM SOC, V140, P6611, DOI 10.1021/jacs.8b02668; Harbison NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034679; Hirata A, 2007, BIOORG MED CHEM LETT, V17, P2971, DOI 10.1016/j.bmcl.2007.03.071; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Inoue M., 2009, T MAT RES SOC JAPAN, V34, P517, DOI [10.14723/tmrsj.34.517, DOI 10.14723/TMRSJ.34.517]; Inoue M, 2008, BIOCHEMISTRY-US, V47, P11847, DOI 10.1021/bi8010994; Inoue M, 2014, BIOORGAN MED CHEM, V22, P6471, DOI 10.1016/j.bmc.2014.09.032; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; Khatri A, 2016, J CELL SCI, V129, P9, DOI 10.1242/jcs.175521; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; Sayas CL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210864; Lebouvier T, 2008, BBA-MOL CELL RES, V1783, P188, DOI 10.1016/j.bbamcr.2007.11.005; Lebouvier T, 2009, J ALZHEIMERS DIS, V18, P1, DOI 10.3233/JAD-2009-1116; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Li CZ, 2018, J ALZHEIMERS DIS, V64, P205, DOI 10.3233/JAD-180054; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Mailliot C, 1998, FEBS LETT, V433, P201, DOI 10.1016/S0014-5793(98)00910-7; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Naruto K, 2010, FEBS LETT, V584, P4233, DOI 10.1016/j.febslet.2010.09.012; Nishiura C, 2010, J BIOCHEM, V147, P405, DOI 10.1093/jb/mvp181; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perez M, 2001, BIOCHEMISTRY-US, V40, P5983, DOI 10.1021/bi002961w; Santa-Maria I, 2006, BBA-MOL BASIS DIS, V1762, P683, DOI 10.1016/j.bbadis.2006.06.003; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Scales TME, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-12; Scaramozzino F, 2006, BIOCHEMISTRY-US, V45, P3684, DOI 10.1021/bi052167g; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; SHAPIRO IP, 1991, J NEUROCHEM, V56, P1154, DOI 10.1111/j.1471-4159.1991.tb11405.x; SHIRAZI SK, 1993, NEUROREPORT, V4, P435, DOI 10.1097/00001756-199304000-00024; Sogawa K, 2014, BIOPOLYMERS, V102, P288, DOI 10.1002/bip.22489; Sogawa K, 2012, J BIOCHEM, V152, P221, DOI 10.1093/jb/mvs061; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Vega IE, 2005, MOL BRAIN RES, V138, P135, DOI 10.1016/j.molbrainres.2005.04.015; VERMERSCH P, 1995, CR ACAD SCI III-VIE, V318, P439; Von Bergen M, 2001, ALZHEIMER'S DISEASE, P631, DOI 10.1002/0470846453.ch58; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen Martin, 2005, Methods Mol Biol, V299, P175; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WOOD JG, 1991, NEUROSCI LETT, V121, P12, DOI 10.1016/0304-3940(91)90637-9; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794; Zhang W, 2019, NOVEL TAU FILAMENT F, DOI [10.1101/811703, DOI 10.1101/811703]; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584	77	15	15	6	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7905	7922		10.1074/jbc.RA119.012517	http://dx.doi.org/10.1074/jbc.RA119.012517			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341125	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000540935400008
J	Yu, PF; Li, Y; Li, YL; Miao, ZJ; Peppelenbosch, MP; Pan, QW				Yu, Peifa; Li, Yang; Li, Yunlong; Miao, Zhijiang; Peppelenbosch, Maikel P.; Pan, Qiuwei			Guanylate-binding protein 2 orchestrates innate immune responses against murine norovirus and is antagonized by the viral protein NS7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; host defense; host-pathogen interaction; innate immunity; GTPase; antiviral restriction factor; guanylate-binding protein 2 (GBP2); interferon-stimulated gene (ISG); murine norovirus (MNV); non-structural protein 7 (NS7)	ANTIVIRAL ACTIVITY; MGBP2 CONTROLS; RIG-I; VIRUS; INFLAMMASOME; REPLICATION; LOCALIZATION; DEGRADATION; INFECTION; EFFECTOR	Noroviruses are the main causative agents of acute viral gastroenteritis, but the host factors that restrict their replication remain poorly identified. Guanylate-binding proteins (GBPs) are interferon (IFN)-inducible GTPases that exert broad antiviral activity and are important mediators of host defenses against viral infections. Here, we show that both IFN-? stimulation and murine norovirus (MNV) infection induce GBP2 expression in murine macrophages. Results from loss- and gain-of-function assays indicated that GBP2 is important for IFN-??dependent anti-MNV activity in murine macrophages. Ectopic expression of MNV receptor (CD300lf) in human HEK293T epithelial cells conferred susceptibility to MNV infection. Importantly, GBP2 potently inhibited MNV in these human epithelial cells. Results from mechanistic dissection experiments revealed that the N-terminal G domain of GBP2 mediates these anti-MNV effects. R48A and K51A substitutions in GBP2, associated with loss of GBP2 GTPase activity, attenuated the anti-MNV effects of GBP2. Finally, we found that nonstructural protein 7 (NS7) of MNV co-localizes with GBP2 and antagonizes the anti-MNV activity of GBP2. These findings reveal that GBP2 is an important mediator of host defenses against murine norovirus.	[Yu, Peifa; Li, Yang; Li, Yunlong; Miao, Zhijiang; Peppelenbosch, Maikel P.; Pan, Qiuwei] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Yu, PF; Pan, QW (corresponding author), Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.yu@erasmusmc.nl; q.pan@erasmusmc.nl		li, yang/0000-0002-3859-5690; Yu, Peifa/0000-0003-2255-0508; Peppelenbosch, Maikel/0000-0001-9112-6028; Pan, Qiuwei/0000-0001-9982-6184	China Scholarship Council Ph.D. Fellowships [201708620177, 201703250073, 201708530243, 201708530234]; Netherlands Organization for Scientific Research VIDI Grant [91719300]	China Scholarship Council Ph.D. Fellowships(China Scholarship Council); Netherlands Organization for Scientific Research VIDI Grant	This research is supported by China Scholarship Council Ph.D. Fellowships 201708620177 (to P. Y.), 201703250073 (Yang L.), 201708530243 (Yunlong L.), and 201708530234 (Z. M.) and Netherlands Organization for Scientific Research VIDI Grant 91719300 (to Q. P.).	Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Biering SB, 2017, CELL HOST MICROBE, V22, P74, DOI 10.1016/j.chom.2017.06.005; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Braun E, 2019, CELL REP, V27, P2092, DOI 10.1016/j.celrep.2019.04.063; Dang W, 2018, ANTIVIR RES, V155, P48, DOI 10.1016/j.antiviral.2018.05.004; Davies C, 2015, J VIROL, V89, P6057, DOI 10.1128/JVI.03673-14; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Dubois H, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007709; Feng J, 2017, J INNATE IMMUN, V9, P419, DOI 10.1159/000460294; Fernandez-Vega V, 2004, J VIROL, V78, P4827, DOI 10.1128/JVI.78.9.4827-4837.2004; Fritzlar S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010047; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Krapp C, 2016, CELL HOST MICROBE, V19, P504, DOI 10.1016/j.chom.2016.02.019; Kravets E, 2012, J BIOL CHEM, V287, P27452, DOI 10.1074/jbc.M112.379636; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Lee S, 2019, CELL HOST MICROBE, V25, P845, DOI 10.1016/j.chom.2019.04.005; Li LF, 2016, J VIROL, V90, P4412, DOI 10.1128/JVI.02718-15; Li P, 2017, NATURE, V551, P378, DOI 10.1038/nature24467; Li Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060541; Maloney NS, 2012, J VIROL, V86, P12655, DOI 10.1128/JVI.01564-12; Man SM, 2017, J LEUKOCYTE BIOL, V101, P143, DOI 10.1189/jlb.4MR0516-223R; McCune BT, 2017, MBIO, V8, DOI 10.1128/mBio.00668-17; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Pan W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-292; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Wandel MP, 2017, CELL HOST MICROBE, V22, P507, DOI 10.1016/j.chom.2017.09.007; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wang WS, 2017, TRENDS MICROBIOL, V25, P574, DOI 10.1016/j.tim.2017.01.001; Wang YJ, 2014, GASTROENTEROLOGY, V146, P1775, DOI 10.1053/j.gastro.2014.02.036; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xu L, 2017, HEPATOLOGY, V65, P1823, DOI 10.1002/hep.29105; Xu L, 2016, FASEB J, V30, P3352, DOI 10.1096/fj.201600356R; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592; Zhu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055920	50	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8036	8047		10.1074/jbc.RA120.013544	http://dx.doi.org/10.1074/jbc.RA120.013544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32354743	hybrid, Green Published			2022-12-26	WOS:000540935400017
J	Masuda, R				Masuda, Reiji			Tropical fishes vanished after the operation of a nuclear power plant was suspended in the Sea of Japan	PLOS ONE			English	Article							REEF FISH; ASSEMBLAGES; NUMBER; SHIFTS	Thermal discharge from a nuclear power plant (NPP) provides an opportunity to foresee changes in faunal communities that may be induced by ocean warming. I assessed these changes by identifying characteristics of the fish community near the thermal discharge from a NPP and by recording temporal changes that occurred after the suspension of the NPP. Underwater visual censuses were conducted near Takahama NPP in the Sea of Japan, and fish assemblages were compared to those in two other sites: a site with discharge from a coal-fired power plant and a control site. During the surveyed period (8 years) when the NPP was in operation, the sea water temperature at the site near the NPP was warmer, had a significantly higher fish abundance, and a higher species richness, including tropical fishes, than the other two sites. However, once the NPP was suspended, tropical fishes dramatically decreased near the NPP. This abrupt change in fish assemblage may be due to the lowest lethal temperatures of tropical fishes being only slightly higher than the winter temperature in this area. Relatively poor ecosystem structure in the local warming area may also have contributed to low resilience of tropical fish species to this temperature change.	[Masuda, Reiji] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto, Japan	Kyoto University	Masuda, R (corresponding author), Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto, Japan.	reiji@kais.kyoto-u.ac.jp			CREST program from the Japan Science and Technology Agency [JPMJCR13A2]; JSPS KAKENHI [19H05641]	CREST program from the Japan Science and Technology Agency; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by the CREST program from the Japan Science and Technology Agency (grant number: JPMJCR13A2; http://www.jst.go.jp/kisoken/crest/en/project/33/e33_13.html) and JSPS KAKENHI Grant Number 19H05641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional funding received for this study.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BOHNSACK JA, 1983, ENVIRON BIOL FISH, V9, P41, DOI 10.1007/BF00001057; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Bryhn AC, 2013, ENVIRON MONIT ASSESS, V185, P10073, DOI 10.1007/s10661-013-3313-1; Carreras-Carbonell J, 2007, MAR BIOL, V151, P719, DOI 10.1007/s00227-006-0513-z; Chen C. Y., 2004, J MAR SCI TECHNOL, V12, P404; Coulter DP, 2014, FISHERIES MANAG ECOL, V21, P196, DOI 10.1111/fme.12064; Cumming G., 2012, UNDERSTANDING NEW ST; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Froese R, FISHBASE; Gelman A., 2018, PACKAGE ARM; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Jajo J, 2016, PLOS ONE, V11; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; KISHIMOTO H, 1974, Japanese Journal of Ichthyology, V21, P101; Kokaji I., 1995, Progress in Nuclear Energy, V29, P413, DOI 10.1016/0149-1970(95)00070-Z; Kokita T, 2003, MAR BIOL, V143, P593, DOI 10.1007/s00227-003-1104-x; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Liu SYV, 2008, MAR BIOL, V154, P745, DOI 10.1007/s00227-008-0967-2; Masuda R, 2008, ENVIRON BIOL FISH, V82, P387, DOI 10.1007/s10641-007-9300-z; Masuda R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168261; Masuda R, 2012, ENVIRON BIOL FISH, V95, P335, DOI 10.1007/s10641-012-0006-5; Masuda R, 2009, HYDROBIOLOGIA, V616, P269, DOI 10.1007/s10750-008-9598-3; Nakabo T., 2013, FISHES JAPAN PICTORI; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081107; Nakazono A, 2012, FISH SCI S1, V68, P127; Ogawa M, 2004, NUCL ENG DES, V233, P5, DOI 10.1016/j.nucengdes.2004.07.018; Oksanen J, 2020, R CRAN; R Core Team, 2021, R LANGUAGE ENV STAT; Rasher DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15679-w; Rosen M.A., 2001, EXERGY INT J, V1, P180, DOI [10.1016/S1164-0235(01)00024-3, DOI 10.1016/S1164-0235(01)00024-3]; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Takao S, 2015, ECOL EVOL, V5, P213, DOI 10.1002/ece3.1358; Teixeira TP, 2012, HYDROBIOLOGIA, V684, P161, DOI 10.1007/s10750-011-0980-1; Tian YJ, 2012, J MARINE SYST, V91, P1, DOI 10.1016/j.jmarsys.2011.09.002; Ushio M, 2018, NATURE, V554, P360, DOI 10.1038/nature25504; Yamamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40368	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232065	10.1371/journal.pone.0232065	http://dx.doi.org/10.1371/journal.pone.0232065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374730	Green Published, gold			2022-12-26	WOS:000537283500018
J	Ballout, RA; Sviridov, D; Bukrinsky, MI; Remaley, AT				Ballout, Rami A.; Sviridov, Dmitri; Bukrinsky, Michael I.; Remaley, Alan T.			The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications	FASEB JOURNAL			English	Article						angiotensin-converting enzyme-2 (ACE2); cathepsins; cholesterol; COVID-19; lipid rafts; lysosomal storage diseases; pandemic	ACUTE RESPIRATORY SYNDROME; TRANSPORT INHIBITOR U18666A; CATHEPSIN-L; SARS-CORONAVIRUS; EBOLA-VIRUS; CHOLESTEROL TRANSPORT; CELL ENTRY; FUNCTIONAL RECEPTOR; TISSUE DISTRIBUTION; ANTIVIRAL ACTIVITY	Drug repurposing is potentially the fastest available option in the race to identify safe and efficacious drugs that can be used to prevent and/or treat COVID-19. By describing the life cycle of the newly emergent coronavirus, SARS-CoV-2, in light of emerging data on the therapeutic efficacy of various repurposed antimicrobials undergoing testing against the virus, we highlight in this review a possible mechanistic convergence between some of these tested compounds. Specifically, we propose that the lysosomotropic effects of hydroxychloroquine and several other drugs undergoing testing may be responsible for their demonstrated in vitro antiviral activities against COVID-19. Moreover, we propose that Niemann-Pick disease type C (NPC), a lysosomal storage disorder, may provide new insights into potential future therapeutic targets for SARS-CoV-2, by highlighting key established features of the disorder that together result in an "unfavorable" host cellular environment that may interfere with viral propagation. Our reasoning evolves from previous biochemical and cell biology findings related to NPC, coupled with the rapidly evolving data on COVID-19. Our overall aim is to suggest that pharmacological interventions targeting lysosomal function in general, and those particularly capable of reversibly inducing transient NPC-like cellular and biochemical phenotypes, constitute plausible mechanisms that could be used to therapeutically target COVID-19.	[Ballout, Rami A.; Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Translat Vasc Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Sviridov, Dmitri] Baker Heart & Diabet Inst, Lipoprot & Atherosclerosis Lab, Melbourne, Vic, Australia; [Bukrinsky, Michael I.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University	Ballout, RA; Remaley, AT (corresponding author), NHLBI, Lipoprot Metab Sect, Translat Vasc Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	rami-ballout@hotmail.com; alan.remaley@nih.gov		Ballout, Rami A./0000-0002-7543-0895	Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health [HL006092]; National Heart, Lung, and Blood Institute (NHLBI) [R01-HL131473]; District of Columbia Center for AIDS Research (DC-CFAR), an NIH [P30-AI117970]	Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); District of Columbia Center for AIDS Research (DC-CFAR), an NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RB and AR are supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) [HL006092] at the National Institutes of Health. MB and D.S are supported by a research grant from the National Heart, Lung, and Blood Institute (NHLBI) under award number [R01-HL131473]. MB is also supported by the District of Columbia Center for AIDS Research (DC-CFAR), an NIH-funded program [P30-AI117970]	Adedeji AO, 2014, ANTIMICROB AGENTS CH, V58, P4894, DOI 10.1128/AAC.02994-14; Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; Balzarini J, 2006, ANTIVIR RES, V72, P20, DOI 10.1016/j.antiviral.2006.03.005; Barcia-Macay M, 2008, J ANTIMICROB CHEMOTH, V61, P1288, DOI 10.1093/jac/dkn120; Baron SA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105944; BEAUCHAMP D, 1992, ANTIMICROB AGENTS CH, V36, P2204, DOI 10.1128/AAC.36.10.2204; Berg RD, 2016, CELL, V165, P139, DOI 10.1016/j.cell.2016.02.034; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cenedella RJ, 2004, J LIPID RES, V45, P1232, DOI 10.1194/jlr.M300469-JLR200; Cermak S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167428; Chen PM, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-10; Chen YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07242; Chung C, 2016, HUM MOL GENET, V25, P1434, DOI 10.1093/hmg/ddw025; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Doki T, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9010067; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Fan H. H., 2020, CHIN MED J; Fineran Paul, 2016, Wellcome Open Res, V1, P18, DOI 10.12688/wellcomeopenres.10036.2; Folts CJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002583; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; Fu R, 2010, MOL GENET METAB, V101, P214, DOI 10.1016/j.ymgme.2010.06.018; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Garver WS, 2002, J LIPID RES, V43, P579; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Glende J, 2008, VIROLOGY, V381, P215, DOI 10.1016/j.virol.2008.08.026; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Harrison C, 2020, NAT BIOTECHNOL, V38, P379, DOI 10.1038/d41587-020-00003-1; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Janac B, 2005, ANN NY ACAD SCI, V1048, P396, DOI 10.1196/annals.1342.048; Jelinek David, 2014, J Mol Biochem, V3, P14; Jensen K, 2012, N-S ARCH PHARMACOL, V385, P519, DOI 10.1007/s00210-011-0719-6; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Karypidou K, 2018, BIOORG MED CHEM LETT, V28, P3472, DOI 10.1016/j.bmcl.2018.09.019; Koo IC, 2008, P NATL ACAD SCI USA, V105, P710, DOI 10.1073/pnas.0708110105; Kosicek M, 2018, MOL CELL PROTEOMICS, V17, P631, DOI 10.1074/mcp.RA117.000129; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Li Guangdi, 2020, Nat Rev Drug Discov, V19, P149, DOI 10.1038/d41573-020-00016-0; Li L, 2016, ARCH VIROL, V161, P1883, DOI 10.1007/s00705-016-2838-3; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LINDLEY ER, 1993, BIOCHEM J, V290, P457, DOI 10.1042/bj2900457; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Liu Y, 2014, TOXICOLOGY, V320, P1, DOI 10.1016/j.tox.2014.02.014; Liu Y, 2014, JAMA OPHTHALMOL, V132, P226, DOI 10.1001/jamaophthalmol.2013.6030; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Long T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13917-5; Lusa S, 2001, J CELL SCI, V114, P1893; Lyu JF, 2017, CANCER LETT, V409, P91, DOI 10.1016/j.canlet.2017.09.009; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mingo RM, 2015, J VIROL, V89, P2931, DOI 10.1128/JVI.03398-14; Moreno-Caceres J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.294; multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]; Nujic K, 2012, CELL IMMUNOL, V279, P78, DOI 10.1016/j.cellimm.2012.09.007; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pagler TA, 2007, J LIPID RES, V48, P2141, DOI 10.1194/jlr.M700056-JLR200; Patterson M, 2000, GENEREVIEWS, P1993; Pedersen NC, 2019, J FELINE MED SURG, V21, P271, DOI 10.1177/1098612X19825701; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Reinke LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179177; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Rodriguez-Gil JL, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010012; Roszell BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067084; Roszell BR, 2012, AM J PHYSIOL-LUNG C, V302, pL919, DOI 10.1152/ajplung.00383.2011; SCHRIER DJ, 1986, J IMMUNOL, V137, P3284; Shah PP, 2010, MOL PHARMACOL, V78, P319, DOI 10.1124/mol.110.064261; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Shirato K, 2018, VIROLOGY, V517, P9, DOI 10.1016/j.virol.2017.11.012; Shivanna V, 2014, VIROLOGY, V464, P287, DOI 10.1016/j.virol.2014.07.025; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Sillence DJ, 2013, MOL GENET METAB, V109, P194, DOI 10.1016/j.ymgme.2013.03.015; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Takano T, 2019, VET RES, V50, DOI 10.1186/s13567-019-0625-3; Takano T, 2017, ANTIVIR RES, V145, P96, DOI 10.1016/j.antiviral.2017.07.022; TAYLOR MD, 1986, J MED CHEM, V29, P346, DOI 10.1021/jm00153a008; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597; Trinh MN, 2017, P NATL ACAD SCI USA, V114, P89, DOI 10.1073/pnas.1619571114; Vainio S, 2005, BIOCHEM J, V391, P465, DOI 10.1042/BJ20050460; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Visentin S, 2013, J NEUROSCI, V33, P15388, DOI 10.1523/JNEUROSCI.0558-13.2013; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; Willard KA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010020; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Wu JZ, 2003, J ANTIMICROB CHEMOTH, V52, P543, DOI 10.1093/jac/dkg405; Yang HY, 2017, GLIA, V65, P1728, DOI 10.1002/glia.23191; Yano T, 2015, FASEB J S, V29, P7771; Zaher NH, 2020, ACTA PHARMACEUT, V70, P145, DOI 10.2478/acph-2020-0024; Zarn JA, 2003, ENVIRON HEALTH PERSP, V111, P255, DOI 10.1289/ehp.5785; Zhang, 2020, TEICOPLANIN POTENTLY, DOI [10.1101/2020.02.05.935387, DOI 10.1101/2020.02.05.935387]; Zhang YH, 2019, VET MICROBIOL, V231, P129, DOI 10.1016/j.vetmic.2019.03.004; Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18; Zhong XZ, 2017, J BIOL CHEM, V292, P3445, DOI 10.1074/jbc.M116.743963; Zhou N, 2016, J BIOL CHEM, V291, P9218, DOI 10.1074/jbc.M116.716100; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	119	53	53	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7253	7264		10.1096/fj.202000654R	http://dx.doi.org/10.1096/fj.202000654R		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367579	Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000530303200001
J	Liu, MM; Lai, CY; Selopal, GS; Radu, DR				Liu, Mimi; Lai, Cheng-Yu; Selopal, Gurpreet Singh; Radu, Daniela R.			Synthesis and optoelectronic properties of Cu3VSe4 nanocrystals	PLOS ONE			English	Article							COLLOIDAL NANOCRYSTALS; CU(3)MCH(4) M; CARBON DOTS; THIN-FILMS; LOW-COST; NANOPARTICLES; SPECTROSCOPY; TRANSPORT; PROSPECTS; CU2ZNSNS4	The ternary chalcogenide Cu3VSe4 (CVSe) with sulvanite structure has been theoretically predicted to be a promising candidate for photovoltaic applications due to its suitable bandgap for solar absorption and the relatively earth-abundant elements in its composition. To realize the absorber layer via an inexpensive route, printed thin-films could be fabricated from dispersions of nano-sized Cu3VSe4 precursors. Herein, cubic Cu3VSe4 nanocrystals were successfully synthesized via a hot-injection method. Similar with reported Cu3VS4 nanocrystals, Cu3VSe4 nanocrystals with cubic structure exhibit three absorption bands in the UV-Visible range indicative of a potential intermediate bandgap existence. A thin film fabricated by depositing the nanoparticles Cu3VSe4 on FTO coated glass substrate, exhibited a p-type behavior and a photocurrent of similar to 4 mu A/cm(2) when measured in an electrochemical cell setting. This first demonstration of photocurrent exhibited by a CVSe nanocrystals thin film signifies a promising potential in photovoltaic applications.	[Liu, Mimi; Lai, Cheng-Yu; Radu, Daniela R.] Florida Int Univ, Dept Mech & Mat Engn, Coll Engn & Comp, Miami, FL 33199 USA; [Selopal, Gurpreet Singh] Inst Natl Rech Sci, Ctr Energie Mat & Telecommun, Varennes, PQ, Canada; [Selopal, Gurpreet Singh] Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, Chengdu, Peoples R China; [Radu, Daniela R.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA	State University System of Florida; Florida International University; University of Quebec; Institut national de la recherche scientifique (INRS); University of Electronic Science & Technology of China; University of Delaware	Radu, DR (corresponding author), Florida Int Univ, Dept Mech & Mat Engn, Coll Engn & Comp, Miami, FL 33199 USA.; Radu, DR (corresponding author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.	dradu@fiu.edu	Liu, Mimi/AAD-8046-2022	Liu, Mimi/0000-0002-8605-5947	 [80NSSC19M0201];  [1924412]	; 	ML Funding from D.Radu FIU startup funds; DR and CYL National Aeronautics and Space Administration, 80NSSC19M0201, https://www.nasa.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript CYL National Science Foundation Grant No. 1924412 https://www.nsf.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M.A., 2015, J SCI RES, V6, P407, DOI [10.3329/jsr.v6i3.19191, DOI 10.3329/JSR.V6I3.19191]; Bastola E, 2018, MRS COMMUN, V8, P970, DOI 10.1557/mrc.2018.117; Bernede JC, 2004, J ELECTRON SPECTROSC, V141, P61, DOI 10.1016/j.elspec.2004.07.003; Chen CC, 2018, MATER LETT, V211, P179, DOI 10.1016/j.matlet.2017.09.063; Chen GL, 2014, J POWER SOURCES, V262, P201, DOI 10.1016/j.jpowsour.2014.03.075; Dash S, 2018, J ELECTRON SPECTROSC, V223, P11, DOI 10.1016/j.elspec.2017.12.002; Hanna MC, 2006, J APPL PHYS, V100, DOI 10.1063/1.2356795; Hong AJ, 2017, J MATER CHEM A, V5, P9785, DOI 10.1039/c7ta02178j; Huang TJ, 2015, J MATER CHEM A, V3, P17788, DOI 10.1039/c5ta03640b; Ikeda S, 2019, CHEMSUSCHEM, V12, P1977, DOI 10.1002/cssc.201802702; Kehoe AB, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/17/175801; Kehoe AB, 2015, J MATER CHEM C, V3, P12236, DOI 10.1039/c5tc02760h; Kim MW, 2017, J ALLOY COMPD, V708, P444, DOI 10.1016/j.jallcom.2017.02.302; Laurenti M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41957; Lindstrom R, 2006, SURF INTERFACE ANAL, V38, P6, DOI 10.1002/sia.2141; Luque A, 2012, NAT PHOTONICS, V6, P146, DOI [10.1038/NPHOTON.2012.1, 10.1038/nphoton.2012.1]; Mantella V, 2019, CHEM MATER, V31, P532, DOI 10.1021/acs.chemmater.8b04610; Mohammadnezhad M, 2020, ELECTROCHIM ACTA, V340, DOI 10.1016/j.electacta.2020.135954; Nag A, 2011, J AM CHEM SOC, V133, P10612, DOI 10.1021/ja2029415; Ntholeng N, 2016, NEW J CHEM, V40, P10259, DOI 10.1039/c6nj02108e; OGUCHI T, 1980, J PHYS SOC JPN, V48, P123, DOI 10.1143/JPSJ.48.123; Pan DY, 2010, CHEM COMMUN, V46, P3681, DOI 10.1039/c000114g; Sun YP, 2006, J AM CHEM SOC, V128, P7756, DOI 10.1021/ja062677d; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Todorov T, 2011, THIN SOLID FILMS, V519, P7378, DOI 10.1016/j.tsf.2010.12.225; Valaski R, 2002, THIN SOLID FILMS, V415, P206, DOI 10.1016/S0040-6090(02)00553-9; van Embden J, 2015, CHEM MATER, V27, P2246, DOI 10.1021/cm5028964; Voros M, 2015, ACS NANO, V9, P6882, DOI 10.1021/acsnano.5b00332; Wang F, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201603254; Wang H, 2017, NANOSCALE, V9, P1909, DOI 10.1039/c6nr09200d; Wang WL, 2015, ACS APPL MATER INTER, V7, P2235, DOI 10.1021/am508844w; Wei XQ, 2015, RSC ADV, V5, P26675, DOI 10.1039/c5ra02816g; Zhang XY, 2020, CRYSTENGCOMM, V22, P1220, DOI 10.1039/c9ce01772k; Zhou JJ, 2012, MATER LETT, V66, P222, DOI 10.1016/j.matlet.2011.08.081; Zhou XM, 2015, CHEM MATER, V27, P6730, DOI 10.1021/acs.chemmater.5b02753	35	9	9	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232184	10.1371/journal.pone.0232184	http://dx.doi.org/10.1371/journal.pone.0232184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369508	gold, Green Published			2022-12-26	WOS:000537280000018
J	Vieland, VJ; Seok, SC; Stewart, WCL				Vieland, Veronica J.; Seok, Sang-Cheol; Stewart, William C. L.			A new linear regression-like residual for survival analysis, with application to genome wide association studies of time-to-event data	PLOS ONE			English	Article							POSTERIOR PROBABILITY; LINKAGE; TRAIT	In linear regression, a residual measures how far a subject's observation is from expectation; in survival analysis, a subject's Martingale or deviance residual is sometimes interpreted similarly. Here we consider ways in which a linear regression-like interpretation is not appropriate for Martingale and deviance residuals, and we develop a novel time-to-event residual which does have a linear regression-like interpretation. We illustrate the utility of this new residual via simulation of a time-to-event genome-wide association study, motivated by a real study seeking genetic modifiers of Duchenne Muscular Dystrophy. By virtue of its linear regression-like characteristics, our new residual may prove useful in other contexts as well.	[Vieland, Veronica J.; Seok, Sang-Cheol; Stewart, William C. L.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Vieland, Veronica J.; Stewart, William C. L.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Vieland, Veronica J.; Stewart, William C. L.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Vieland, VJ (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA.; Vieland, VJ (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.; Vieland, VJ (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	veronica.vieland@nationwidechildrens.org			National Institutes of Health [NINDS NS085238]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (www.nih.gov) grant NINDS NS085238 to VJV (KM Flanigan & RB Weiss coPIs). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203860; [Anonymous], 2016, REL 64; BARLOW WE, 1988, BIOMETRIKA, V75, P65; Bartlett CW, 2007, GENET EPIDEMIOL, V31, P91, DOI 10.1002/gepi.20193; Bello L, 2016, AM J HUM GENET, V99, P1163, DOI 10.1016/j.ajhg.2016.08.023; COX DR, 1972, J R STAT SOC B, V34, P187; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Flanigan KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/humu.21426; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Greenberg DA, 1998, AM J HUM GENET, V62, P202, DOI 10.1086/301690; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; Huang YG, 2010, GENET EPIDEMIOL, V34, P835, DOI 10.1002/gepi.20537; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keles S, 2002, STAT MED, V21, P313, DOI 10.1002/sim.981; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Royall R., 1997, STAT EVIDENCE LIKELI; Seok SC, 2009, J COMPUT BIOL, V16, P659, DOI 10.1089/cmb.2008.0175; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Soltanzadeh P, 2010, NEUROMUSCULAR DISORD, V20, P499, DOI 10.1016/j.nmd.2010.05.010; Therneau T, 1988, MARTINGALE BASED RES; Vieira NM, 2015, CELL, V163, P1204, DOI 10.1016/j.cell.2015.10.049; Vieland VJ, 2011, HUM HERED, V72, P276, DOI 10.1159/000330634; Vieland VJ, 1996, AM J HUM GENET, V58, P1072; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Weiss RB, 2018, ANN NEUROL, V84, P234, DOI 10.1002/ana.25283; Yang XQ, 2005, HUM HERED, V59, P210, DOI 10.1159/000086699	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232300	10.1371/journal.pone.0232300	http://dx.doi.org/10.1371/journal.pone.0232300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365095	Green Published, gold			2022-12-26	WOS:000536959700023
J	Li, J; Li, X; Song, J; Yan, BX; Rock, SA; Jia, JH; Liu, JP; Wang, C; Weiss, T; Weiss, HL; Gao, TY; Alam, A; Evers, BM				Li, Jing; Li, Xian; Song, Jun; Yan, Baoxiang; Rock, Stephanie A.; Jia, Jianhang; Liu, Jinpeng; Wang, Chi; Weiss, Todd; Weiss, Heidi L.; Gao, Tianyan; Alam, Ashfaqul; Evers, B. Mark			Absence of neurotensin attenuates intestinal dysbiosis and inflammation by maintaining Mmp7/alpha-defensin axis in diet-induced obese mice	FASEB JOURNAL			English	Article						NF-kappa B; obesity; Paneth cells; PKC tau/lambda	NF-KAPPA-B; CELL ALPHA-DEFENSINS; CORE GUT MICROBIOME; PANETH CELLS; EPITHELIAL-CELLS; INTERLEUKIN-8 EXPRESSION; ANTIMICROBIAL PEPTIDES; BARRIER DYSFUNCTION; INNATE IMMUNITY; ENERGY-BALANCE	We previously reported that high levels of plasma neurotensin (NT), a gut hormone released from enteroendocrine cells of the small bowel, contribute to obesity and comorbid conditions. Gut microbiota has been implicated in the obesity development. Paneth cells are critical in maintaining gut microbiota composition and homeostasis by releasing antimicrobial proteins including alpha-defensins. The purpose of our current study was to determine the possible role of NT in gut microbiota composition and alpha-defensin gene expression associated with obesity. Here we show that the ratio of Firmicutes/Bacteroidetes (F/B ratio) and intestinal proinflammatory cytokines is significantly increased in NT+/+ mice fed with a high-fat diet (HFD) which were improved in NT-deficient mice. HFD disrupted the intestinal Mmp7/alpha-defensin axis, which was completely prevented in NT-/- mice. In addition, NT treatment inhibited DEFA5 expression and concurrent NF-kappa B activity, which was blocked by a pan PKC inhibitor (Go6983) or an inhibitor for atypical PKCs (CRT0066854). More importantly, the shRNA-mediated knockdown of atypical PKC tau reversed NT-attenuated DEFA5 expression and increased NF-kappa B activity. NT contributes to the HFD-induced disruption of gut microbiota composition and alpha-defensin expression. PKC tau/lambda plays a central role in NT-mediated alpha-defensin gene expression which might be mediated through the inhibition of NF-kappa B signaling pathways in Paneth cells.	[Li, Jing; Li, Xian; Song, Jun; Yan, Baoxiang; Rock, Stephanie A.; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY USA; [Li, Jing; Li, Xian; Song, Jun; Yan, Baoxiang; Rock, Stephanie A.; Jia, Jianhang; Liu, Jinpeng; Wang, Chi; Weiss, Todd; Weiss, Heidi L.; Gao, Tianyan; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, CC140 Roach Bldg, Lexington, KY 40536 USA; [Alam, Ashfaqul] Univ Kentucky, Microbiol Immunol & Mol Genet, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Evers, BM (corresponding author), Univ Kentucky, Markey Canc Ctr, CC140 Roach Bldg, Lexington, KY 40536 USA.	mark.evers@uky.edu			University of Kentucky Markey Cancer Center [P30 CA177558]; NIH [DK112034, R01 DK48498, K01 DK114391]	University of Kentucky Markey Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	University of Kentucky Markey Cancer Center, Grant/Award Number: P30 CA177558; NIH, Grant/Award Number: R01, DK112034, R01 DK48498 and K01 DK114391	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Amir A., 2017, MSYSTEMS, V2, DOI [DOI 10.1128/MSYSTEMS.00191-16, 10.1128/mSystems.00191-16]; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bakirtzi K, 2011, GASTROENTEROLOGY, V141, P1749, DOI 10.1053/j.gastro.2011.07.038; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; BARBER DL, 1991, AM J PHYSIOL, V261, pG497, DOI 10.1152/ajpgi.1991.261.3.G497; Barchetta I, 2018, J CLIN ENDOCR METAB, V103, P2253, DOI 10.1210/jc.2017-02751; Beisner J, 2014, AM J PHYSIOL-GASTR L, V307, pG487, DOI 10.1152/ajpgi.00347.2013; Luna-Ulloa LB, 2011, IUBMB LIFE, V63, P915, DOI 10.1002/iub.559; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnet D, 2018, ADV STEM CELL NICHES, V2, P77, DOI 10.1016/bs.asn.2017.12.002; Brodrick B, 2011, J BIOL CHEM, V286, P18515, DOI 10.1074/jbc.M111.229252; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; CHUNG DH, 1992, GASTROENTEROLOGY, V103, P1254, DOI 10.1016/0016-5085(92)91512-3; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Correa JD, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/373765; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; da Silva L, 2011, BBA-MOL CELL RES, V1813, P1863, DOI 10.1016/j.bbamcr.2011.06.018; Dicou E, 2004, J NEUROSCI RES, V78, P92, DOI 10.1002/jnr.20231; DOBNER PR, 1987, P NATL ACAD SCI USA, V84, P3516, DOI 10.1073/pnas.84.10.3516; Drewe J, 2008, J CLIN ENDOCR METAB, V93, P1964, DOI 10.1210/jc.2007-2238; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; EVERS BM, 1992, GASTROENTEROLOGY, V103, P86, DOI 10.1016/0016-5085(92)91099-P; Ferrand A, 2019, CELL MOL GASTROENTER, V7, P357, DOI 10.1016/j.jcmgh.2018.10.009; FERRIS CF, 1985, ENDOCRINOLOGY, V116, P1133, DOI 10.1210/endo-116-3-1133; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; FUJIMURA M, 1989, GASTROENTEROLOGY, V96, P1502, DOI 10.1016/0016-5085(89)90518-0; Fuks G, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0396-x; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; GOLDMAN R, 1983, FEBS LETT, V159, P63, DOI 10.1016/0014-5793(83)80417-7; Greicius G, 2018, P NATL ACAD SCI USA, V115, pE3173, DOI 10.1073/pnas.1713510115; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gui XY, 2001, GASTROENTEROLOGY, V120, P151, DOI 10.1053/gast.2001.20876; Guo XL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9474896; Hodin CM, 2011, J PATHOL, V225, P276, DOI 10.1002/path.2917; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LANGER P, 1991, HORM METAB RES, V23, P370, DOI 10.1055/s-2007-1003703; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; LEMAIRE I, 1988, J IMMUNOL, V140, P2983; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li J, 2002, AM J PHYSIOL-GASTR L, V283, pG1197, DOI 10.1152/ajpgi.00177.2002; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Liu Y, 2012, J BIOL CHEM, V287, P20081, DOI 10.1074/jbc.M111.335463; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Miyashita Tadashi, 1992, Biological Signals, V1, P275; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Nakanishi Y, 2016, CELL REP, V16, P3297, DOI 10.1016/j.celrep.2016.08.054; OROURKE KP, 2016, BIO PROTOC, V6; Park KA, 2007, CARCINOGENESIS, V28, P71, DOI 10.1093/carcin/bgl094; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Qiao GL, 2008, MOL CELL BIOL, V28, P2470, DOI 10.1128/MCB.01505-07; Qiu S, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/6456257; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozengurt E, 2002, EUR J SURG, V168, P23; Saetang J, 2018, MOL MED REP, V17, P1403, DOI 10.3892/mmr.2017.8038; SAKAMOTO T, 1988, SURG GYNECOL OBSTET, V166, P11; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Schoenborn AA, 2019, GUT MICROBES, V10, P45, DOI 10.1080/19490976.2018.1474321; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; SIMOPOULOS C, 1989, GUT, V30, P600, DOI 10.1136/gut.30.5.600; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stappenbeck TS, 2009, GASTROENTEROLOGY, V137, P30, DOI 10.1053/j.gastro.2009.05.013; Tan G, 2016, ONCOTARGET, V7, P63651, DOI 10.18632/oncotarget.11467; Tan G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08383; Thaiss CA, 2018, SCIENCE, V362, P903, DOI 10.1126/science.aav6870; THEODORSSONNORHEIM E, 1983, ACTA PHYSIOL SCAND, V117, P439, DOI 10.1111/j.1748-1716.1983.tb00018.x; THOR K, 1982, GASTROENTEROLOGY, V83, P569; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang XF, 2006, CLIN CANCER RES, V12, P5346, DOI 10.1158/1078-0432.CCR-06-0968; Wang XF, 2011, J BIOL CHEM, V286, P542, DOI 10.1074/jbc.M110.145664; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Xiao HL, 2017, CELL PHYSIOL BIOCHEM, V43, P2133, DOI 10.1159/000484232; Yu LCH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0483-8; Zhao DZ, 2006, PEPTIDES, V27, P2434, DOI 10.1016/j.peptides.2005.12.016; Zhao DZ, 2005, MOL PHARMACOL, V67, P2025, DOI 10.1124/mol.104.010801; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	101	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8596	8610		10.1096/fj.201902374RR	http://dx.doi.org/10.1096/fj.201902374RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359121	Green Accepted			2022-12-26	WOS:000530046900001
J	Yamahara, KM; Keymer, DP; Layton, BA; Walters, SP; Thompson, RS; Rosener, M; Boehm, AB				Yamahara, Kevan M.; Keymer, Daniel P.; Layton, Blythe A.; Walters, Sarah P.; Thompson, Rachelle S.; Rosener, Matt; Boehm, Alexandria B.			Application of molecular source tracking and mass balance approach to identify potential sources of fecal indicator bacteria in a tropical river	PLOS ONE			English	Article							DISCRIMINANT-ANALYSIS; ESCHERICHIA-COLI; GENETIC-MARKERS; SOIL; ENTEROVIRUSES; BACTEROIDALES; WATERS; HAWAII; BEACH; FRESH	Microbial source tracking and a mass balance approach were used to identify sources of fecal indicator bacteria (FIB) in the Hanalei River, Kaua'i, Hawai'i. Historically, concentrations enterococci and Clostridium perfringens were significantly higher during storm flows compared to non-storm flows in the Hanalei River, and correlated to total suspended solids in the river. During targeted dry weather studies, the Hanalei River bed sediments and streambank soils were documented to harbor E. coli, enterococci, and the human- and pig-specific fecal markers in Bacteroidales, suggesting that sediments and soils may be potential sources of these microorganisms to the Hanalei river. The human-specific marker in Bacteroidales was four times as likely to be detected in sediment and soil samples as in water samples. Furthermore, the occurrence of host-specific source tracking markers is indicative that a portion of FIB present in the Hanalei River are of fecal origin. A mass balance approach was used to explore causes of observed FIB loadings and losses along different reaches of the river. Resuspension or deposition of FIB-laden river sediments cannot account for changes in E. coli and enterococci concentrations along the river during dry weather. Additionally, losses due to bacterial inactivation were insignificant. Groundwater and ditches draining agricultural and urban lands were shown to provide sufficient FIB fluxes to account for the observed loads along some river reaches. The presence of the human-specific Bacteroidales marker in the river water, sediments and adjacent soils, as well as the presence of the human enterovirus marker in the water, suggests that there is widespread human fecal contamination in the Hanalei River that is likely a result of nearby wastewater disposal systems.	[Yamahara, Kevan M.; Keymer, Daniel P.; Layton, Blythe A.; Walters, Sarah P.; Thompson, Rachelle S.; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Rosener, Matt] Waipa Fdn, Kauai, HI USA; [Yamahara, Kevan M.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Keymer, Daniel P.] Univ Wisconsin, Stevens Point, WI 54481 USA	Stanford University; Monterey Bay Aquarium Research Institute; University of Wisconsin System; University of Wisconsin Stevens Point	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	aboehm@stanford.edu		Boehm, Alexandria/0000-0002-8162-5090	United States National Science Foundation [ABB-OCE-0742048]	United States National Science Foundation(National Science Foundation (NSF))	ABB-OCE-0742048 United States National Science Foundation, www.nsf.gov - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, LOW FLOW ESTIMATION; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Boehm AB, 2009, J APPL MICROBIOL, V107, P1740, DOI 10.1111/j.1365-2672.2009.04440.x; Boehm AB, 2005, WATER RES, V39, P3565, DOI 10.1016/j.watres.2005.06.026; Boehm AB, 2003, ENVIRON SCI TECHNOL, V37, P673, DOI 10.1021/es025934x; Boehm AB, 2013, WATER RES, V47, P6812, DOI 10.1016/j.watres.2012.12.046; Boehm AB, 2011, ESTUAR COAST, V34, P925, DOI 10.1007/s12237-010-9352-8; Boehm AB, 2009, ENVIRON SCI TECHNOL, V43, P8046, DOI 10.1021/es9015124; Bradford SA, 2013, CRIT REV ENV SCI TEC, V43, P775, DOI 10.1080/10643389.2012.710449; Byappanahalli M, 2004, WATER SCI TECHNOL, V50, P27, DOI 10.2166/wst.2004.0009; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; Characklis GW, 2005, WATER RES, V39, P1773, DOI 10.1016/j.watres.2005.03.004; Cui HL, 2013, APPL ENVIRON MICROB, V79, P3601, DOI 10.1128/AEM.00135-13; Dick LK, 2005, APPL ENVIRON MICROB, V71, P3184, DOI 10.1128/AEM.71.6.3184-3191.2005; Fewtrell L., 2001, WATER QUALITY GUIDEL; Fries JS, 2006, J ENVIRON ENG-ASCE, V132, P1338, DOI 10.1061/(ASCE)0733-9372(2006)132:10(1338); Fuhrman JA, 2005, APPL ENVIRON MICROB, V71, P4523, DOI 10.1128/AEM.71.8.4523-4530.2005; FUJIOKA RS, 1988, TOXIC ASSESS, V3, P613, DOI 10.1002/tox.2540030514; Gawler AH, 2007, WATER RES, V41, P3780, DOI 10.1016/j.watres.2007.01.028; Griffith John F., 2003, Journal of Water and Health, V1, P141; HARDINA CM, 1991, ENVIRON TOXIC WATER, V6, P185, DOI 10.1002/tox.2530060208; Harwood VJ, 2000, APPL ENVIRON MICROB, V66, P3698, DOI 10.1128/AEM.66.9.3698-3704.2000; Huey GM, 2010, WATER-SUI, V2, P273, DOI 10.3390/w2020273; HURLEY MA, 1983, J APPL BACTERIOL, V55, P159, DOI 10.1111/j.1365-2672.1983.tb02660.x; Jordan TE, 1997, WATER RESOUR RES, V33, P2579, DOI 10.1029/97WR02005; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Knee KL, 2008, ESTUAR COAST, V31, P607, DOI 10.1007/s12237-008-9055-6; LANDRY EF, 1979, APPL ENVIRON MICROB, V38, P680, DOI 10.1128/AEM.38.4.680-687.1979; Layton BA, 2010, J APPL MICROBIOL, V109, P539, DOI 10.1111/j.1365-2672.2010.04675.x; Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06; Moce-Llivina L, 2005, APPL ENVIRON MICROB, V71, P6838, DOI 10.1128/AEM.71.11.6838-6844.2005; Noble RT, 2001, HYDROBIOLOGIA, V460, P175, DOI 10.1023/A:1013121416891; Olapade OA, 2006, APPL ENVIRON MICROB, V72, P1932, DOI 10.1128/AEM.72.3.1932-1938.2006; OSHIRO R, 1995, WATER SCI TECHNOL, V31, P251, DOI 10.2166/wst.1995.0617; Parveen S, 1999, APPL ENVIRON MICROB, V65, P3142; Probert H M, 2002, Curr Issues Intest Microbiol, V3, P23; Roll BM, 1997, WATER SCI TECHNOL, V35, P179, DOI 10.1016/S0273-1223(97)00255-2; Rosario K, 2009, APPL ENVIRON MICROB, V75, P7261, DOI 10.1128/AEM.00410-09; Santoro AE, 2007, ENVIRON MICROBIOL, V9, P2038, DOI 10.1111/j.1462-2920.2007.01319.x; Shanks OC, 2006, APPL ENVIRON MICROB, V72, P5537, DOI 10.1128/AEM.03059-05; Shanks OC, 2010, APPL ENVIRON MICROB, V76, P1359, DOI 10.1128/AEM.02033-09; Sinton LW, 2002, APPL ENVIRON MICROB, V68, P1122, DOI 10.1128/AEM.68.3.1122-1131.2002; Soller JA, 2010, WATER RES, V44, P4674, DOI 10.1016/j.watres.2010.06.049; STRAUB TM, 1994, APPL ENVIRON MICROB, V60, P1014, DOI 10.1128/AEM.60.3.1014-1017.1994; Surbeck CQ, 2006, ENVIRON SCI TECHNOL, V40, P4435, DOI 10.1021/es060701h; TetraTech Inc. State of Hawaii Department of Health, 2010, EPA NAT SUMM IMP WAT; USEPA (United States Environmental Protection Agency), 2019, NAT SUMM STAT INF AS; Viau EJ, 2011, WATER RES, V45, P3279, DOI 10.1016/j.watres.2011.03.033; Walters SP, 2006, APPL ENVIRON MICROB, V72, P4532, DOI 10.1128/AEM.00038-06; Walters SP, 2009, WATER RES, V43, P4929, DOI 10.1016/j.watres.2009.05.047; Walters SP, 2009, ENVIRON MICROBIOL, V11, P1410, DOI 10.1111/j.1462-2920.2009.01868.x; Yamahara KM, 2007, ENVIRON SCI TECHNOL, V41, P4515, DOI 10.1021/es062822n	52	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232054	10.1371/journal.pone.0232054	http://dx.doi.org/10.1371/journal.pone.0232054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352994	Green Published, gold			2022-12-26	WOS:000536673200039
J	Hirakawa, H; Uchida, M; Kurabayashi, K; Nishijima, F; Takita, A; Tomita, H				Hirakawa, Hidetada; Uchida, Motoyuki; Kurabayashi, Kumiko; Nishijima, Fuyuhiko; Takita, Ayako; Tomita, Haruyoshi			In vitro activity of AST-120 that suppresses indole signaling in Escherichia coli, which attenuates drug tolerance and virulence	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; INDOXYL SULFATE; PSEUDOMONAS-AERUGINOSA; TRANSDUCTION SYSTEM; EXPRESSION; RESISTANCE; GENES; SEROTONIN; ADSORBENT; CULTURE	AST-120 (Kremezin) is used to treat progressive chronic kidney disease (CKD) by adsorbing uremic toxin precursors produced by gut microbiota, such as indole and phenols. In this study, we propose that AST-120 reduces indole level, consequently suppresses indole effects on induction of drug tolerance and virulence in Escherichia coli including enterohaemorrhagic strains. In experiments, AST-120 adsorbed both indole and tryptophan, a precursor of indole production, and led to decreased expression of acrD and mdtEF which encode drug efflux pumps, and elevated glpT, which encodes a transporter for fosfomycin uptake and increases susceptibility to aztreonam, rhodamine 6G, and fosfomycin. AST-120 also decreased the production of EspB, which contributes to pathogenicity of enterohaemorrhagic E. coli (EHEC). Aztreonam, ciprofloxacin, minocycline, trimethoprim, and sulfamethoxazole were also adsorbed by AST-120. However, fosfomycin, in addition to rifampicin, colistin and amikacin were not adsorbed, thus AST-120 can be used together with these drugs for therapy to treat infections. These results suggest another benefit of AST-120, i.e., that it assists antibacterial chemotherapy.	[Hirakawa, Hidetada; Kurabayashi, Kumiko; Takita, Ayako; Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Dept Bacteriol, Maebashi, Gunma, Japan; [Uchida, Motoyuki; Nishijima, Fuyuhiko] Kureha Corp, Pharmaceut & Agrochem Div, Shinjuku Ku, Tokyo, Japan; [Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Lab Bacterial Drug Resistance, Maebashi, Gunma, Japan	Gunma University; Gunma University	Hirakawa, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Bacteriol, Maebashi, Gunma, Japan.	hirakawa@gunma-u.ac.jp			JSPS KAKENHI [19K07533]; Japan Agency for Medical Research and Development, AMED [19fk0108061h0502]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	The authors, Dr. Uchida and Dr. Nishijima belong to a commercial company, Kureha corp. They contributed to the study design, data interpretation and providing the AST-120 material in addition to financial support (20,000 dollars) to perform experiments and publish the results, but not salaries for authors as the funder. We believe that the financial support should be reasonable value, and I suggest that they did not directly participate in data collection. HH was supported by JSPS KAKENHI "Grant-in-Aid for Scientific Research (C) Grant Number 19K07533 (https://www.jsps.go.jp/) and HT was supported by Japan Agency for Medical Research and Development, AMED Grant Number 19fk0108061h0502 (https://www.amed.go.jp/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Beaumont M, 2018, FASEB J, V32, P6681, DOI 10.1096/fj.201800544; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Bush K, 2019, NAT REV MICROBIOL, V17, P295, DOI 10.1038/s41579-019-0159-8; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chu WH, 2012, APPL ENVIRON MICROB, V78, P411, DOI 10.1128/AEM.06396-11; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; Deguchi T, 2002, KIDNEY INT, V61, P1760, DOI 10.1046/j.1523-1755.2002.00318.x; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; Fishman A, 2005, J BIOL CHEM, V280, P506, DOI 10.1074/jbc.M410320200; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gelasco AK, 2006, AM J PHYSIOL-RENAL, V290, pF1551, DOI 10.1152/ajprenal.00281.2004; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01950; Hirakawa H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00114; Hirakawa H, 2009, MICROBIOL-SGM, V155, P541, DOI 10.1099/mic.0.020420-0; Kato N, 2006, J INCL PHENOM MACRO, V56, P55, DOI 10.1007/s10847-006-9060-y; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Kufel WD, 2017, PHARMACOTHERAPY, V37, P1298, DOI 10.1002/phar.1990; Kurabayashi K, 2015, J BACTERIOL, V197, P861, DOI 10.1128/JB.02491-14; Kurabayashi K, 2014, J BACTERIOL, V196, P248, DOI 10.1128/JB.01151-13; Lee JH, 2015, TRENDS MICROBIOL, V23, P707, DOI 10.1016/j.tim.2015.08.001; Lee JH, 2013, APPL MICROBIOL BIOT, V97, P4543, DOI 10.1007/s00253-012-4674-z; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Leong SC, 2016, TOXINS, V8, DOI 10.3390/toxins8120358; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; NIWA T, 1991, NEPHRON, V57, P84, DOI 10.1159/000186222; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Sun CY, 2013, NEPHROL DIAL TRANSPL, V28, P70, DOI 10.1093/ndt/gfs133; Swimm A, 2018, BLOOD, V132, P2506, DOI 10.1182/blood-2018-03-838193; TAKAKI M, 1985, NEUROSCIENCE, V16, P223, DOI 10.1016/0306-4522(85)90059-4; Ueda H, 2007, THER APHER DIAL, V11, P189, DOI 10.1111/j.1744-9987.2007.00430.x; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Wang Y, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01186-19; Whitfield-Cargile CM, 2016, GUT MICROBES, V7, P246, DOI 10.1080/19490976.2016.1156827; Windels EM, 2019, MBIO, V10, DOI 10.1128/mBio.02095-19; Yamamoto S, 2011, NEPHROL DIAL TRANSPL, V26, P2491, DOI 10.1093/ndt/gfq759; Yin B, 2005, INT BIODETER BIODEGR, V56, P243, DOI 10.1016/j.ibiod.2005.10.001; Zhang W, 2019, J APPL MICROBIOL, V127, P1768, DOI 10.1111/jam.14434	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232461	10.1371/journal.pone.0232461	http://dx.doi.org/10.1371/journal.pone.0232461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348373	Green Published, gold			2022-12-26	WOS:000536668200068
J	Sakai, M; Tokunaga, S; Kawai, M; Murai, M; Kobayashi, M; Kitayama, T; Saeki, S; Kawata, T				Sakai, Mariko; Tokunaga, Shin; Kawai, Mika; Murai, Miki; Kobayashi, Misaki; Kitayama, Tetsuya; Saeki, Satoshi; Kawata, Takehisa			Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; VITAMIN-D-RECEPTOR; CINACALCET HYDROCHLORIDE; HEMODIALYSIS-PATIENTS; GLAND VOLUME; VASCULAR CALCIFICATION; ARTERY CALCIFICATION; HORMONE SECRETION; CELL-GROWTH; IN-VITRO	Background Elevated parathyroid hormone (PTH) levels in secondary hyperparathyroidism (SHPT) lead to vascular calcification, which is associated with cardiovascular events and mortality. Increased PTH production is caused by the excessive proliferation of parathyroid gland cells, which is accelerated by abnormal mineral homeostasis. Evocalcet, an oral calcimimetic agent, inhibits the secretion of PTH from parathyroid gland cells and has been used for the management of SHPT in dialysis patients. We observed the effects of evocalcet on ectopic calcification and parathyroid hyperplasia using chronic kidney disease (CKD) rats with SHPT. Methods CKD rats with SHPT induced by adenine received evocalcet orally for 5 weeks. The calcium and inorganic phosphorus content in the aorta, heart and kidney was measured. Ectopic calcified tissues were also assessed histologically. To observe the effects on the proliferation of parathyroid gland cells, parathyroid glands were histologically assessed in CKD rats with SHPT induced by 5/6 nephrectomy (Nx) after receiving evocalcet orally for 4 weeks. Results Evocalcet prevented the increase in calcium and inorganic phosphorus content in the ectopic tissues and suppressed calcification of the aorta, heart and kidney in CKD rats with SHPT by reducing the serum PTH and calcium levels. Evocalcet suppressed the parathyroid gland cell proliferation and reduced the sizes of parathyroid cells in CKD rats with SHPT. Conclusions These findings suggest that evocalcet would prevent ectopic calcification and suppress parathyroid hyperplasia in patients with SHPT.	[Sakai, Mariko; Tokunaga, Shin; Kitayama, Tetsuya; Saeki, Satoshi; Kawata, Takehisa] Kyowa Kirin Co Ltd, Nephrol Res Labs, Nephrol R&D Unit, R&D Div, Shizuoka, Japan; [Kawai, Mika; Murai, Miki; Kobayashi, Misaki] Kyowa Kirin Co Ltd, Res Core Funct Labs, Res Funct Unit, R&D Div, Shizuoka, Japan	Kyowa Kirin Ltd; Kyowa Kirin Ltd	Kawata, T (corresponding author), Kyowa Kirin Co Ltd, Nephrol Res Labs, Nephrol R&D Unit, R&D Div, Shizuoka, Japan.	takehisa.kawata.kk@kyowakirin.com			Kyowa Kirin Co., Ltd.	Kyowa Kirin Co., Ltd.	Mitsubishi Tanabe Pharma Corporation provided evocalcet. All studies were performed and the cost of them were supported by Kyowa Kirin Co., Ltd. Mariko Sakai, Shin Tokunaga, Mika Kawai, Miki Murai, Misaki Kobayashi, Tetsuya Kitayama, Satoshi Saeki, and Takehisa Kawata are employees of Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd provided support in the form of salaries for authors, MS, ST, MK, MM, MK, TK, SS and TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akizawa T, 2011, CLIN J AM SOC NEPHRO, V6, P2280, DOI 10.2215/CJN.11501210; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2017, JAMA-J AM MED ASSOC, V317, P156, DOI 10.1001/jama.2016.19468; Charytan C, 2005, AM J KIDNEY DIS, V46, P58, DOI 10.1053/j.ajkd.2005.04.013; Coen G, 2008, KIDNEY INT, V74, P1229, DOI 10.1038/ki.2008.417; Colloton M, 2005, KIDNEY INT, V67, P467, DOI 10.1111/j.1523-1755.2005.67103.x; Cozzolino M, 2019, TOXINS, V11, DOI 10.3390/toxins11040213; Fukagawa M, 2008, NEPHROL DIAL TRANSPL, V23, P328, DOI 10.1093/ndt/gfm534; Fukagawa M, 2012, CLIN J AM SOC NEPHRO, V7, P1473, DOI 10.2215/CJN.13081211; Fukuma S, 2013, KIDNEY INT SUPPL, V3, P436, DOI 10.1038/kisup.2013.91; Gincherman Y, 2010, HEMODIAL INT, V14, P68, DOI 10.1111/j.1542-4758.2009.00397.x; Hamano N, 2017, EXPERT OPIN PHARMACO, V18, P529, DOI 10.1080/14656566.2017.1303482; Harris RZ, 2007, CLIN PHARMACOKINET, V46, P495, DOI 10.2165/00003088-200746060-00003; Hujairi NMA, 2004, AM J KIDNEY DIS, V43, P234, DOI 10.1053/j.ajkd.2003.10.014; Ichii M, 2010, NEPHRON CLIN PRACT, V115, pC195, DOI 10.1159/000313035; Imanishi Y, 2011, CALCIFIED TISSUE INT, V89, P29, DOI 10.1007/s00223-011-9490-4; Kakani E, 2019, SEMIN DIALYSIS, V32, P553, DOI 10.1111/sdi.12840; Kawata T, 2008, KIDNEY INT, V74, P1270, DOI 10.1038/ki.2008.407; Kawata T, 2006, J BONE MINER METAB, V24, P300, DOI 10.1007/s00774-006-0687-y; Kawata T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195316; Komaba H, 2010, CLIN J AM SOC NEPHRO, V5, P2305, DOI 10.2215/CJN.02110310; Lederer E, 2014, J PHYSIOL-LONDON, V592, P3985, DOI 10.1113/jphysiol.2014.273979; Lomonte C, 2008, CLIN J AM SOC NEPHRO, V3, P794, DOI 10.2215/CJN.04150907; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Miller G, 2012, NEPHROL DIAL TRANSPL, V27, P2198, DOI 10.1093/ndt/gfr589; Nagano N, 2006, PHARMACOL THERAPEUT, V109, P339, DOI 10.1016/j.pharmthera.2005.06.019; Nakashima D, 2007, J CLIN PHARMACOL, V47, P1311, DOI 10.1177/0091270007304103; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Taniguchi M, 2006, KIDNEY INT, V69, P464, DOI 10.1038/sj.ki.5000090; Tokumoto M, 2005, THER APHER DIAL, V9, pS27, DOI 10.1111/j.1744-9987.2005.00302.x; Tominaga Y, 2016, THER APHER DIAL, V20, P6, DOI 10.1111/1744-9987.12352; Wada M, 1997, J CLIN INVEST, V100, P2977, DOI 10.1172/JCI119851; Wang XR, 2019, RENAL FAILURE, V41, P244, DOI 10.1080/0886022X.2019.1595646; Wetmore JB, 2015, CLIN J AM SOC NEPHRO, V10, P1031, DOI 10.2215/CJN.07050714; Yamada S, 2015, THER APHER DIAL, V19, P367, DOI 10.1111/1744-9987.12292; Yokoyama K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42017-z	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232428	10.1371/journal.pone.0232428	http://dx.doi.org/10.1371/journal.pone.0232428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343734	gold, Green Published			2022-12-26	WOS:000536661300055
J	Bangratz, M; Wonni, I; Kini, K; Sondo, M; Brugidou, C; Bena, G; Gnacko, F; Barro, M; Koebnik, R; Silue, D; Tollenaere, C				Bangratz, Martine; Wonni, Issa; Kini, Kossi; Sondo, Moussa; Brugidou, Christophe; Bena, Gilles; Gnacko, Fatoumata; Barro, Mariam; Koebnik, Ralf; Silue, Drissa; Tollenaere, Charlotte			Design of a new multiplex PCR assay for rice pathogenic bacteria detection and its application to infer disease incidence and detect co-infection in rice fields in Burkina Faso	PLOS ONE			English	Article							ORYZAE-PV.-ORYZICOLA; LEAF-BLIGHT; BURKHOLDERIA-GLUMAE; PANTOEA-ANANATIS; 1ST REPORT; PSEUDOMONAS-FUSCOVAGINAE; AFRICAN RICE; SEEDS; STEWARTII; ROT	Crop diseases are responsible for considerable yield losses worldwide and particularly in sub-Saharan Africa. To implement efficient disease control measures, detection of the pathogens and understanding pathogen spatio-temporal dynamics is crucial and requires the use of molecular detection tools, especially to distinguish different pathogens causing more or less similar symptoms. We report here the design a new molecular diagnostic tool able to simultaneously detect five bacterial taxa causing important diseases on rice in Africa: (1) Pseudomonas fuscovaginae, (2) Xanthomonas oryzae, (3) Burkholderia glumae and Burkholderia gladioli, (4) Sphingomonas and (5) Pantoea species. This new detection tool consists of a multiplex PCR, which is cost effective and easily applicable. Validation of the method is presented through its application on a global collection of bacterial strains. Moreover, sensitivity assessment for the detection of all five bacteria is reported to be at 0.5 ng DNA by mu l. As a proof of concept, we applied the new molecular detection method to a set of 256 rice leaves collected from 16 fields in two irrigated areas in western Burkina Faso. Our results show high levels of Sphingomonas spp. (up to 100% of tested samples in one field), with significant variation in the incidence between the two sampled sites. Xanthomonas oryzae incidence levels were mostly congruent with bacterial leaf streak (BLS) and bacterial leaf blight (BLB) symptom observations in the field. Low levels of Pantoea spp. were found while none of the 256 analysed samples was positive for Burkholderia or Pseudomonas fuscovaginae. Finally, many samples (up to 37.5% in one studied field) were positive for more than one bacterium (co-infection). Documenting co-infection levels are important because of their drastic consequences on epidemiology, evolution of pathogen populations and yield losses. The newly designed multiplex PCR for multiple bacterial pathogens of rice is a significant improvement for disease monitoring in the field, thus contributing to efficient disease control and food safety.	[Bangratz, Martine; Kini, Kossi; Sondo, Moussa; Brugidou, Christophe; Bena, Gilles; Gnacko, Fatoumata; Barro, Mariam; Koebnik, Ralf; Tollenaere, Charlotte] Univ Montpellier, IRD, Cirad, IPME, Montpellier, France; [Bangratz, Martine; Wonni, Issa; Sondo, Moussa; Brugidou, Christophe; Gnacko, Fatoumata; Barro, Mariam; Tollenaere, Charlotte] INERA, LMI PathoBios, Lab Phytopathol, Bobo Dioulasso, Burkina Faso; [Kini, Kossi; Silue, Drissa] AfricaRice, Plant Pathol, Bouake, Cote Ivoire	CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CGIAR; Africa Rice Center	Tollenaere, C (corresponding author), Univ Montpellier, IRD, Cirad, IPME, Montpellier, France.; Tollenaere, C (corresponding author), INERA, LMI PathoBios, Lab Phytopathol, Bobo Dioulasso, Burkina Faso.	charlotte.tollenaere@ird.fr	Tollenaere, Charlotte/ABB-6175-2020; Bena, Gilles/GOG-7902-2022; Koebnik, Ralf/J-5627-2014	Tollenaere, Charlotte/0000-0003-2045-2824; Koebnik, Ralf/0000-0002-4419-0542	ANR (French National Research Agency) under "Investissements d'avenir" programme [ANR-10-LABX-001-01 Labex Agro, ANR-16-IDEX-006]; CGIAR Research Program on Rice Agri-food Systems (RICE)	ANR (French National Research Agency) under "Investissements d'avenir" programme(French National Research Agency (ANR)); CGIAR Research Program on Rice Agri-food Systems (RICE)	This work was publicly funded through ANR (the French National Research Agency) under "Investissements d'avenir" programme with the reference ANR-10-LABX-001-01 Labex Agro (ESpace and RiPaBIOME projects), coordinated by Agropolis Fondation under the frame of I-SITE MUSE (ANR-16-IDEX-006) and by THE CGIAR Research Program on Rice Agri-food Systems (RICE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorada DL, 2015, PLANT PATHOL, V64, P43, DOI 10.1111/ppa.12243; Barrett LG, 2009, NEW PHYTOL, V183, P513, DOI 10.1111/j.1469-8137.2009.02927.x; Bigirimana VD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01066; Buddenhagen I. W., 1979, International Rice Research Newsletter, V4, P11; Carvajal-Yepes M, 2019, SCIENCE, V364, P1237, DOI 10.1126/science.aaw1572; Cottyn B, 1996, PLANT DIS, V80, P429, DOI 10.1094/PD-80-0429; Cui Z, 2016, J APPL MICROBIOL, V120, P1357, DOI 10.1111/jam.13094; Cui ZQ, 2016, RICE SCI, V23, P111, DOI 10.1016/j.rsci.2016.01.007; Demont M, 2013, CAH AGRIC, V22, P345, DOI 10.1684/agr.2013.0664; Demont M, 2013, GLOB FOOD SECUR-AGR, V2, P172, DOI 10.1016/j.gfs.2013.07.001; Doni F, 2019, J PLANT DIS PROTECT, V126, P491, DOI 10.1007/s41348-019-00244-6; Dossou B, 2018, SEED SCI TECHNOL, V46, P31, DOI 10.15258/sst.2018.46.1.03; DUVEILLER E, 1990, TROP PEST MANAGE, V36, P151, DOI 10.1080/09670879009371461; Egorova M., 2015, New Disease Reports, V32, P21; Gonzalez AD, 2015, PLANT DIS, V99, P552, DOI 10.1094/PDIS-07-14-0736-PDN; Gonzalez C, 2007, MOL PLANT MICROBE IN, V20, P534, DOI 10.1094/MPMI-20-5-0534; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Kang IJ, 2016, PLANT PATHOLOGY J, V32, P575, DOI 10.5423/PPJ.NT.05.2016.0118; Kini K., 2017, New Disease Reports, V35, P32, DOI 10.5197/j.2044-0588.2017.035.032; Kini K, 2017, PLANT DIS, V101, P242, DOI [10.1094/pdis-06-16-0940-pdn, 10.1094/PDIS-06-16-0940-PDN]; Kini K., 2018, DIAGNOSTIC MULTIPLEX, DOI [10.1101/456806, DOI 10.1101/456806]; Kini TK, 2017, PLANT DIS, V101, P241, DOI [10.1094/PDIS-06-16-0939-PDN, 10.1094/pdis-06-16-0940-pdn]; Lang JM, 2010, PLANT DIS, V94, P311, DOI 10.1094/PDIS-94-3-0311; Lee HB, 2010, PLANT DIS, V94, P1372, DOI 10.1094/PDIS-05-10-0374; Li R, 2008, J VIROL METHODS, V154, P48, DOI 10.1016/j.jviromet.2008.09.008; Lu W, 2014, CROP J, V2, P398, DOI 10.1016/j.cj.2014.06.005; Martinelli F, 2015, AGRON SUSTAIN DEV, V35, P1, DOI 10.1007/s13593-014-0246-1; Mendez Del Villar P.M, 2013, CAH AGRIC, V2222, P336, DOI [10.1684/agr.2013.0657, DOI 10.1684/AGR.2013.0657]; Midha S, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01551; Mondal KK, 2011, PLANT DIS, V95, P1582, DOI 10.1094/PDIS-06-11-0533; Ou SH, 1985, RICE DIS; Ouedraogo S. L., 2004, Agronomie Africaine, V16, P9; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; R Core Team, 2018, R LANG ENV STAT COMP; Riera-Ruiz C, 2018, CAN J PLANT PATHOL, V40, P347, DOI 10.1080/07060661.2018.1478884; Savary S, 2019, NAT ECOL EVOL, V3, P430, DOI 10.1038/s41559-018-0793-y; Seck PA, 2013, REALIZING AFRICA'S RICE PROMISE, P24, DOI 10.1079/9781845938123.0024; Sere Y, 2013, REALIZING AFRICA'S RICE PROMISE, P213, DOI 10.1079/9781845938123.0213; TOLLENAERE C, 2017, FRONT PLANT SCI, V8, DOI DOI 10.3389/FPLS7.00645; Tollenaere C, 2016, TRENDS PLANT SCI, V21, P80, DOI 10.1016/j.tplants.2015.10.014; Ura Hiroyuki, 2006, Journal of General Plant Pathology, V72, P98, DOI 10.1007/s10327-005-0256-6; Weller-Stuart T, 2017, MOL PLANT PATHOL, V18, P1191, DOI 10.1111/mpp.12517; Wonni I, 2014, PHYTOPATHOLOGY, V104, P520, DOI 10.1094/PHYTO-07-13-0213-R; Wonni I, 2011, PHYTOPATHOLOGY, V101, pS193; Wonni I, 2016, J RICE RES, P162; Zhou XG, 2014, PLANT DIS, V98, P566, DOI 10.1094/PDIS-09-13-0913-PDN	46	8	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232115	10.1371/journal.pone.0232115	http://dx.doi.org/10.1371/journal.pone.0232115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339192	gold, Green Published			2022-12-26	WOS:000536657400028
J	Costa, MO; Fouhse, J; Silva, APP; Willing, B; Harding, JCS				Costa, Matheus O.; Fouhse, Janelle; Silva, Ana Paula P.; Willing, Benjamin; Harding, John C. S.			Putting the microbiota to work: Epigenetic effects of early life antibiotic treatment are associated with immune-related pathways and reduced epithelial necrosis following Salmonella Typhimurium challenge in vitro	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; MULTIDRUG-RESISTANT; GASTROINTESTINAL MICROBIOTA; CITROBACTER-RODENTIUM; HOST SUSCEPTIBILITY; GUT MICROBIOTA; INFECTION; OUTBREAK; VACCINATION; EXPRESSION	Salmonella enterica serovar Typhimurium is an animal welfare and public health concern due to its ability to parasite livestock and potentially contaminate pork products. To reduce Salmonella shedding and the risk of pork contamination, antibiotic therapy is used and can contribute to antimicrobial resistance. Here we hypothesized that immune system education by the microbiota can play a role in intestinal resilience to infection. We used amoxicillin (15mg/Kg) to modulate the intestinal microbiome of 10 piglets, paired with same age pigs that received a placebo (n = 10) from 0 to 14 days of age. Animals were euthanized at 4-weeks old. Each pig donated colon sections for ex vivo culture (n = 20 explants/pig). Explants were inoculated with S. Typhimurium, PBS or LPS (n = 6 explants/pig/group, plus technical controls). The gut bacteriome was characterized by sequencing of the 16S rRNA at 7, 21 days of age, and upon in vitro culture. Explants response to infection was profiled through high-throughput mRNA sequencing. In vivo antibiotic treatment led to beta-diversity differences between groups at all times (P<0.05), while a-diversity did not differ between amoxicillin and placebo groups on day 21 and at euthanasia (P< 0.03 on day 7). Explant microbiomes were not different from in vivo. In vitro challenge with S. Typhimurium led to lower necrosis scores in explants from amoxicillin-treated pigs, when compared to explants placebo-treated pigs (P< 0.05). This was coupled with the activation of immune-related pathways in explants from amoxicillin-treated pigs (IL-2 production, NO production, BCR activation), when compared to placebo-treated pigs. In addition, several DNA repair and intestinal wound healing pathways were also only activated in explants from amoxicillin-treated pigs. Taken together, these findings suggest that immune education by the amoxicillin-disturbed microbiota may have contributed to mitigate intestinal lesions following pathogen exposure.	[Costa, Matheus O.; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Large Anim Clin Sci, Saskatoon, SK, Canada; [Costa, Matheus O.] Univ Utrecht, Dept Populat Hlth Sci, Fac Vet Med, Utrecht, Netherlands; [Fouhse, Janelle; Willing, Benjamin] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Silva, Ana Paula P.] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil	University of Saskatchewan; Utrecht University; University of Alberta; Universidade Federal do Rio Grande do Sul	Costa, MO (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Large Anim Clin Sci, Saskatoon, SK, Canada.; Costa, MO (corresponding author), Univ Utrecht, Dept Populat Hlth Sci, Fac Vet Med, Utrecht, Netherlands.	matheus.costa@usask.ca		SERAFINI POETA SILVA, ANA PAULA/0000-0002-6069-5014	 [345169 - 2014]		JCSH - Grant number 345169 - 2014 Large-Scale Applied Research Project Competition - Genomics and Feeding the Future -https://www.genomecanada.ca/en/programs/large-scalescience/past-competitions/large-scale-research-project-competitions/2014-large The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bassis CM, 2014, ANTIMICROB AGENTS CH, V58, P2767, DOI 10.1128/AAC.02262-13; Bogomolnaya LM, 2013, MBIO, V4, DOI 10.1128/mBio.00630-13; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourgey M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz037; Cameron-Veas K, 2018, VET J, V234, P36, DOI 10.1016/j.tvjl.2018.02.002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Costa MO, 2018, METHODS MOL BIOL, V1817, P185, DOI 10.1007/978-1-4939-8600-2_18; Costa MO, 2016, IN VITRO CELL DEV-AN, V52, P942, DOI 10.1007/s11626-016-0060-y; de la Cruz ML, 2017, RES VET SCI, V114, P86, DOI 10.1016/j.rvsc.2017.03.005; Dechet AM, 2006, CLIN INFECT DIS, V42, P747, DOI 10.1086/500320; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Erdman MM, 2005, JAVMA-J AM VET MED A, V227, P460, DOI 10.2460/javma.2005.227.460; Foley S L, 2008, J Anim Sci, V86, pE149; Fouhse JM, 2019, ANIMAL, V13, P1591, DOI 10.1017/S1751731118003361; Garcia-Migura L, 2014, VET MICROBIOL, V170, P1, DOI 10.1016/j.vetmic.2014.01.013; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Ghosh S, 2011, AM J PHYSIOL-GASTR L, V301, pG39, DOI 10.1152/ajpgi.00509.2010; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Goldsmith JR, 2011, AM J PATHOL, V179, P673, DOI 10.1016/j.ajpath.2011.04.032; Grasa L, 2015, MICROB ECOL, V70, P835, DOI 10.1007/s00248-015-0613-8; Greenwood C, 2014, J PEDIATR-US, V165, P23, DOI 10.1016/j.jpeds.2014.01.010; Gronwall C, 2014, J CLIN IMMUNOL, V34, pS12, DOI 10.1007/s10875-014-0025-4; Gronwall C, 2012, P NATL ACAD SCI USA, V109, P19745, DOI 10.1073/pnas.1211868109; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hurd HS, 2001, AM J VET RES, V62, P1194, DOI 10.2460/ajvr.2001.62.1194; Iizumi T, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0143-z; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lichtman JS, 2016, CELL REP, V14, P1049, DOI 10.1016/j.celrep.2016.01.009; Lindsay JO, 2006, GUT, V55, P348, DOI 10.1136/gut.2005.074971; Ling ML, 2002, EPIDEMIOL INFECT, V128, P1, DOI 10.1017/S0950268801006367; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lopez P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24072; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manoharan I, 2016, J IMMUNOL, V196, P4739, DOI 10.4049/jimmunol.1501489; Markowiak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091021; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nollet N, 2005, VET RES, V36, P545, DOI 10.1051/vetres:2005014; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sun L, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00099; Threlfall EJ, 1996, LANCET, V347, P1053, DOI 10.1016/S0140-6736(96)90199-3; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Vallance BA, 2002, INFECT IMMUN, V70, P6424, DOI 10.1128/IAI.70.11.6424-6435.2002; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Vrieze A, 2014, J HEPATOL, V60, P824, DOI 10.1016/j.jhep.2013.11.034; Wales AD, 2017, ZOONOSES PUBLIC HLTH, V64, P1, DOI 10.1111/zph.12256; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yu KF, 2017, PHYSIOL GENOMICS, V49, P582, DOI 10.1152/physiolgenomics.00020.2017	61	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231942	10.1371/journal.pone.0231942	http://dx.doi.org/10.1371/journal.pone.0231942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339193	Green Published, gold			2022-12-26	WOS:000536657400020
J	Yamazaki, R; Nishiyama, O; Saeki, S; Sano, H; Iwanaga, T; Tohda, Y				Yamazaki, Ryo; Nishiyama, Osamu; Saeki, Sho; Sano, Hiroyuki; Iwanaga, Takashi; Tohda, Yuji			Characteristics of patients with chronic idiopathic interstitial pneumonia undergoing repeated respiratory-related hospitalizations: A retrospective cohort study	PLOS ONE			English	Article							PULMONARY-FIBROSIS; ACUTE EXACERBATION; CLINICAL-COURSE; VITAL CAPACITY; SURVIVAL; STANDARDIZATION; DIAGNOSIS	Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease. Chronic idiopathic interstitial pneumonia (c-IIP) is a group of lung diseases consisting mainly of fibrotic IIPs, and IPF is a type of c-IIP. Some patients with c-IIP undergo respiratory-related hospitalizations (RHs). With the hypothesis that the characteristics of patients who undergo RHs are related to the number of hospitalizations, we reviewed and investigated the RHs of patients with c-IIP. Methods We retrospectively examined the data of patients with c-IIP who were admitted to Kindai University Hospital between January 2008 and December 2018 for respiratory-related causes. Results During the study period, 243 patients with c-IIP were hospitalized a total of 544 times because of respiratory-related causes. The most common reasons for the first RH were acute exacerbation (48.1%) followed by pulmonary infection (32.5%). The most frequent reason for subsequent RHs was pulmonary infection. The in-hospital and 90-day mortality rate of patients with pulmonary infection increased with increasing numbers of RHs. Patients with multiple RHs had significantly worse long-term survival than patients hospitalized a single time. Conclusions Pulmonary infection was the most frequent reason for repeated RHs. The proportion of all patients hospitalized for pulmonary infection at each RH increased with increasing numbers of RHs, along with the mortality rate of patients with pulmonary infections. Furthermore, repeated RHs were associated with poor survival.	[Yamazaki, Ryo; Nishiyama, Osamu; Saeki, Sho; Sano, Hiroyuki; Iwanaga, Takashi; Tohda, Yuji] Kindai Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan		Nishiyama, O (corresponding author), Kindai Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan.	nishiyama_o@yahoo.co.jp		Nishiyama, Osamu/0000-0002-9163-9605				Brown AW, 2015, CHEST, V147, P173, DOI 10.1378/chest.13-2424; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Cottin V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166462; Durheim MT, 2015, LANCET RESP MED, V3, P388, DOI 10.1016/S2213-2600(15)00093-4; Hanamoto S, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P2051; Jeon K, 2006, RESP MED, V100, P451, DOI 10.1016/j.rmed.2005.06.013; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moua T, 2016, CHEST, V149, P1205, DOI 10.1016/j.chest.2015.12.026; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Nishiyama O, 2019, RESPIR INVESTIG, V57, P415, DOI 10.1016/j.resinv.2019.03.005; Nishiyama O, 2018, RESPIR INVESTIG, V56, P57, DOI 10.1016/j.resinv.2017.09.004; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Sumikawa H, 2006, RADIOLOGY, V241, P258, DOI 10.1148/radiol.2411050928; Takei R, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0412-8; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Yamazaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168164	23	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232212	10.1371/journal.pone.0232212	http://dx.doi.org/10.1371/journal.pone.0232212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330195	Green Published, gold			2022-12-26	WOS:000536647300064
J	Pham, VD; To, TA; Gagne-Thivierge, C; Couture, M; Lague, P; Yao, DQ; Picard, ME; Lortie, LA; Attere, SA; Zhu, XJ; Levesque, RC; Charette, SJ; Shi, R				Pham, Van Dung; To, Tuan Anh; Gagne-Thivierge, Cynthia; Couture, Manon; Lague, Patrick; Yao, Deqiang; Picard, Marie-Eve; Lortie, Louis-Andre; Attere, Sabrina A.; Zhu, Xiaojun; Levesque, Roger C.; Charette, Steve J.; Shi, Rong			Structural insights into the putative bacterial acetylcholinesterase ChoE and its substrate inhibition mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylcholinesterase; crystal structure; enzyme catalysis; catalytic triad; substrate inhibition; nonproductive binding; convergent evolution; acyl-enzyme; serine esterase; Pseudomonas aeruginosa; acetylcholinesterase (AChE)	PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; CATALYTIC SERINE; CHOLINESTERASE; ESTERASE; ENZYME; RESIDUES; BINDING; FAMILY	Mammalian acetylcholinesterase (AChE) is well-studied, being important in both cholinergic brain synapses and the peripheral nervous systems and also a key drug target for many diseases. In contrast, little is known about the structures and molecular mechanism of prokaryotic acetylcholinesterases. We report here the structural and biochemical characterization of ChoE, a putative bacterial acetylcholinesterase fromPseudomonas aeruginosa. Analysis of WT and mutant strains indicated that ChoE is indispensable forP. aeruginosagrowth with acetylcholine as the sole carbon and nitrogen source. The crystal structure of ChoE at 1.35 ? resolution revealed that this enzyme adopts a typical fold of the SGNH hydrolase family. Although ChoE and eukaryotic AChEs catalyze the same reaction, their overall structures bear no similarities constituting an interesting example of convergent evolution. Among Ser-38, Asp-285, and His-288 of the catalytic triad residues, only Asp-285 was not essential for ChoE activity. Combined with kinetic analyses of WT and mutant proteins, multiple crystal structures of ChoE complexed with substrates, products, or reaction intermediate revealed the structural determinants for substrate recognition, snapshots of the various catalytic steps, and the molecular basis of substrate inhibition at high substrate concentrations. Our results indicate that substrate inhibition in ChoE is due to acetate release being blocked by the binding of a substrate molecule in a nonproductive mode. Because of the distinct overall folds and significant differences of the active site between ChoE and eukaryotic AChEs, these structures will serve as a prototype for other prokaryotic acetylcholinesterases.	[Pham, Van Dung; To, Tuan Anh; Gagne-Thivierge, Cynthia; Couture, Manon; Lague, Patrick; Picard, Marie-Eve; Lortie, Louis-Andre; Attere, Sabrina A.; Zhu, Xiaojun; Charette, Steve J.; Shi, Rong] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Pham, Van Dung; To, Tuan Anh; Gagne-Thivierge, Cynthia; Couture, Manon; Lague, Patrick; Picard, Marie-Eve; Attere, Sabrina A.; Zhu, Xiaojun; Levesque, Roger C.; Charette, Steve J.; Shi, Rong] Univ Laval, Inst Biol Integrat & Syst IBIS, Quebec City, PQ, Canada; [Pham, Van Dung; To, Tuan Anh; Couture, Manon; Lague, Patrick; Picard, Marie-Eve; Zhu, Xiaojun; Shi, Rong] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada; [Gagne-Thivierge, Cynthia; Attere, Sabrina A.; Charette, Steve J.] Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Yao, Deqiang] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China	Laval University; Laval University; Laval University; ShanghaiTech University	Shi, R (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.; Shi, R (corresponding author), Univ Laval, Inst Biol Integrat & Syst IBIS, Quebec City, PQ, Canada.; Shi, R (corresponding author), PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada.	rong.shi@bcm.ulaval.ca	Charette, Steve/GYJ-3058-2022; Levesque, Roger C./ABD-8407-2021; Couture, Manon/F-8326-2015	ZHU, XIAOJUN/0000-0002-5409-3973; Charette, Steve/0000-0002-0199-2852; Couture, Manon/0000-0001-8296-8055; Lague, Patrick/0000-0002-5236-4979; Levesque, Roger/0000-0001-8315-5937; VAN DUNG, PHAM/0000-0002-2880-3898	Fonds de Recherche du Quebec-Nature et technologies (FRQNT) [183530];  [33092]	Fonds de Recherche du Quebec-Nature et technologies (FRQNT); 	This work was supported by Grant 183530 from the Fonds de Recherche du Quebec-Nature et technologies (FRQNT) (to R. C. L., S. J. C., and R. S.) and Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund Grant 33092 (to R. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; Azam MW, 2019, DRUG DISCOV TODAY, V24, P350, DOI 10.1016/j.drudis.2018.07.003; Baker P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004334; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Bourne Y, 2016, J AM CHEM SOC, V138, P1611, DOI 10.1021/jacs.5b11384; Bourne Y, 2015, J BIOL CHEM, V290, P1522, DOI 10.1074/jbc.M114.603902; Cavalcante SFD, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030414; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Dimitriou PS, 2019, PROTEIN SCI, V28, P344, DOI 10.1002/pro.3527; Ding JM, 2016, J BACTERIOL, V198, P311, DOI 10.1128/JB.00471-15; DOMENECH CE, 1981, MOL CELL BIOCHEM, V34, P95, DOI 10.1007/BF02354863; DOMENECH CE, 1991, FEMS MICROBIOL LETT, V82, P131, DOI 10.1111/j.1574-6968.1991.tb04853.x; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; GARBER N, 1980, J GEN MICROBIOL, V117, P279; Ghosh D, 2001, J BIOL CHEM, V276, P11159, DOI 10.1074/jbc.M008831200; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; GOLDSTEIN DB, 1953, J GEN MICROBIOL, V8, P8, DOI 10.1099/00221287-8-1-8; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; HOFER P, 1981, BIOPHYS STRUCT MECH, V8, P45, DOI 10.1007/BF01047105; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kawasaki K, 2002, ACTA CRYSTALLOGR D, V58, P1168, DOI 10.1107/S090744490200714X; KRUPKA RM, 1963, BIOCHEMISTRY-US, V2, P76, DOI 10.1021/bi00901a015; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazarevic-Pasti T, 2017, CURR MED CHEM, V24, P3283, DOI 10.2174/0929867324666170705123509; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LISA TA, 1994, CURR MICROBIOL, V29, P193, DOI 10.1007/BF01570153; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; Mazlan SNHS, 2018, INT J BIOL MACROMOL, V119, P1188, DOI 10.1016/j.ijbiomac.2018.08.022; McAuley KE, 2004, ACTA CRYSTALLOGR D, V60, P878, DOI 10.1107/S0907444904004937; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Olsen JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091232; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; PESIN SR, 1982, INVEST OPHTH VIS SCI, V22, P651; Pittelkow M, 2011, J MOL BIOL, V411, P53, DOI 10.1016/j.jmb.2011.05.037; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Rauwerdink A, 2015, ACS CATAL, V5, P6153, DOI 10.1021/acscatal.5b01539; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Riley LM, 2013, J BIOL CHEM, V288, P22299, DOI 10.1074/jbc.M113.484931; Rochu D, 1998, BBA-PROTEIN STRUCT M, V1385, P126, DOI 10.1016/S0167-4838(98)00042-9; Rosenberry TL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122098; Sanchez DG, 2012, MICROBIOL RES, V167, P317, DOI 10.1016/j.micres.2011.11.005; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; Shi R, 2007, J BIOL CHEM, V282, P13073, DOI 10.1074/jbc.M611912200; Shi R, 2011, P NATL ACAD SCI USA, V108, P1302, DOI 10.1073/pnas.1012596108; Silman I, 2017, J NEUROCHEM, V142, P19, DOI 10.1111/jnc.13992; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tougu V., 2001, Current Medicinal Chemistry - Central Nervous System Agents, V1, P155, DOI 10.2174/1568015013358536; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Wan Y, 2019, J BIOL CHEM, V294, P11391, DOI 10.1074/jbc.RA119.008280; Wargo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056850; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang N, 2016, BIOORG MED CHEM LETT, V26, P3594, DOI 10.1016/j.bmcl.2016.06.013; Zhou YZ, 2010, J PHYS CHEM B, V114, P8817, DOI 10.1021/jp104258d; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	75	3	3	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8708	8724		10.1074/jbc.RA119.011809	http://dx.doi.org/10.1074/jbc.RA119.011809			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32371400	Green Published, hybrid			2022-12-26	WOS:000546296800008
J	Saha, AK; Contreras-Galindo, R; Niknafs, YS; Iyer, M; Qin, TT; Padmanabhan, K; Siddiqui, J; Palande, M; Wang, C; Qian, BA; Ward, E; Tang, T; Tomlins, SA; Gitlin, SD; Sartor, MA; Omenn, GS; Chinnaiyan, AM; Markovitz, DM				Saha, Anjan K.; Contreras-Galindo, Rafael; Niknafs, Yashar S.; Iyer, Matthew; Qin, Tingting; Padmanabhan, Karthik; Siddiqui, Javed; Palande, Monica; Wang, Claire; Qian, Brian; Ward, Elizabeth; Tang, Tara; Tomlins, Scott A.; Gitlin, Scott D.; Sartor, Maureen A.; Omenn, Gilbert S.; Chinnaiyan, Arul M.; Markovitz, David M.			The role of the histone H3 variant CENPA in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centromere; prostate cancer; epigenetics; histone; gene expression; centromere protein A (CENPA); gene regulation; transcription; chromatin; cell proliferation; centromere	CENTROMERE PROTEIN-A; INTEGRATIVE CLINICAL GENOMICS; PROGNOSTIC VALUE; EXPRESSION; NUCLEOSOMES; GENE; CHROMATIN; MARKER; KI-67; HJURP	Overexpression of centromeric proteins has been identified in a number of human malignancies, but the functional and mechanistic contributions of these proteins to disease progression have not been characterized. The centromeric histone H3 variant centromere protein A (CENPA) is an epigenetic mark that determines centromere identity. Here, using an array of approaches, including RNA-sequencing and ChIP-sequencing analyses, immunohistochemistry-based tissue microarrays, and various cell biology assays, we demonstrate that CENPA is highly overexpressed in prostate cancer in both tissue and cell lines and that the level of CENPA expression correlates with the disease stage in a large cohort of patients. Gain-of-function and loss-of-function experiments confirmed that CENPA promotes prostate cancer cell line growth. The results from the integrated sequencing experiments suggested a previously unidentified function of CENPA as a transcriptional regulator that modulates expression of critical proliferation, cell-cycle, and centromere/kinetochore genes. Taken together, our findings show that CENPA overexpression is crucial to prostate cancer growth.	[Saha, Anjan K.; Niknafs, Yashar S.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Saha, Anjan K.; Chinnaiyan, Arul M.; Markovitz, David M.] Univ Michigan, Program Canc Biol, Ann Arbor, MI 48109 USA; [Saha, Anjan K.; Contreras-Galindo, Rafael; Palande, Monica; Wang, Claire; Qian, Brian; Ward, Elizabeth; Tang, Tara; Gitlin, Scott D.; Omenn, Gilbert S.; Markovitz, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Iyer, Matthew; Qin, Tingting; Padmanabhan, Karthik; Sartor, Maureen A.; Omenn, Gilbert S.; Chinnaiyan, Arul M.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Siddiqui, Javed; Tomlins, Scott A.; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Niknafs, Yashar S.; Chinnaiyan, Arul M.; Markovitz, David M.] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Niknafs, Yashar S.; Iyer, Matthew; Siddiqui, Javed; Tomlins, Scott A.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Markovitz, David M.] Univ Michigan, Program Immunol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Markovitz, DM (corresponding author), Univ Michigan, Program Canc Biol, Ann Arbor, MI 48109 USA.; Markovitz, DM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Markovitz, DM (corresponding author), Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA.; Markovitz, DM (corresponding author), Univ Michigan, Program Immunol, Ann Arbor, MI 48109 USA.	dmarkov@umich.edu		Saha, Anjan/0000-0001-6721-1599; Tang, Tara/0000-0002-8249-458X; Contreras-Galindo, Rafael/0000-0002-6284-3359	National Institutes of Health [R01-DK109188, 5T32GM007863-34, F30-CA-210379, F30-CA-200328, R01-CA-158286-S1, RM-08-029, P30U54ES017885]; University of Michigan Cancer Biology Fellowship; Scleroderma Foundation; Prostate Cancer Foundation [17YOUN13]; Biomedical Research Core Facilities Epigenomics Core at the University of Michigan; A. Alfred Taubman Medical Research Institute; Howard Hughes Medical Institute Investigatorship; A. Alfred Taubman Scholarship; American Cancer Society Professorship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Biology Fellowship; Scleroderma Foundation; Prostate Cancer Foundation; Biomedical Research Core Facilities Epigenomics Core at the University of Michigan; A. Alfred Taubman Medical Research Institute; Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); A. Alfred Taubman Scholarship; American Cancer Society Professorship(American Cancer Society)	This work was supported by National Institutes of Health Grants R01-DK109188 (to D. M. M.), 5T32GM007863-34 and F30-CA-210379 (to A. K. S.), F30-CA-200328 (to Y. S. N.), R01-DK109188 (to M. P., C. W., B. Q., E. W., and T. T.), R01-CA-158286-S1 (to M. A. S.), and RM-08-029 and P30U54ES017885 (to G. S. O.); a University of Michigan Cancer Biology Fellowship (to A. K. S.); the Scleroderma Foundation (to R. C.-G.); Prostate Cancer Foundation Grant 17YOUN13 (to Y. S. N.); the Biomedical Research Core Facilities Epigenomics Core at the University of Michigan (to T. Q. and K. P.); the A. Alfred Taubman Medical Research Institute (to S. A. T.); a Howard Hughes Medical Institute Investigatorship (to A. M. C.); an A. Alfred Taubman Scholarship (to A. M. C.); and an American Cancer Society Professorship (to A. M. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2018, AM CANC SOC CANC FAC; Athwal RK, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-2; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Bodor DL, 2014, ELIFE, V3, DOI 10.7554/eLife.02137; Bohrer LR, 2010, ENDOCRINOLOGY, V151, P5136, DOI 10.1210/en.2010-0436; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Contreras-Galindo R, 2017, GENOME RES, V27, P2040, DOI 10.1101/gr.219709.116; Cooperberg MR, 2014, NAT REV CLIN ONCOL, V11, P304, DOI 10.1038/nrclinonc.2014.58; de Oca RM, 2015, MOL ONCOL, V9, P657, DOI 10.1016/j.molonc.2014.11.002; Falk SJ, 2016, NAT STRUCT MOL BIOL, V23, P204, DOI 10.1038/nsmb.3175; Fisher G, 2013, BRIT J CANCER, V108, P271, DOI 10.1038/bjc.2012.598; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gu XM, 2014, PATHOL RES PRACT, V210, P228, DOI 10.1016/j.prp.2013.12.007; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayden KE, 2012, CHROMOSOME RES, V20, P621, DOI 10.1007/s10577-012-9295-y; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kim IS, 2012, MOL CELL, V46, P260, DOI 10.1016/j.molcel.2012.03.021; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Lee C, 2016, BIOINFORMATICS, V32, P1100, DOI 10.1093/bioinformatics/btv694; Li RL, 2004, CLIN CANCER RES, V10, P4118, DOI 10.1158/1078-0432.CCR-1052-03; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017794; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; McGovern SL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3181; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; Niikura Y, 2015, DEV CELL, V32, P589, DOI 10.1016/j.devcel.2015.01.024; Puto LA, 2015, J BIOL CHEM, V290, P15406, DOI 10.1074/jbc.M115.658765; Qiu JJ, 2013, TUMOR BIOL, V34, P2971, DOI 10.1007/s13277-013-0860-6; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Saha A. K., 2019, GENOMIC LANDSCAPE CE, DOI [10.1101/505800, DOI 10.1101/505800]; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Smith CL, 2018, NUCLEIC ACIDS RES, V46, pD836, DOI 10.1093/nar/gkx1006; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sun X, 2016, INT J CANCER, V139, P899, DOI 10.1002/ijc.30133; Thiru P, 2014, MOL BIOL CELL, V25, P1983, DOI 10.1091/mbc.E14-03-0837; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Valdivia MM, 2009, CURR GENOMICS, V10, P326, DOI 10.2174/138920209788920985; Vardabasso C, 2015, MOL CELL, V59, P75, DOI 10.1016/j.molcel.2015.05.009; Vardabasso C, 2014, CELL MOL LIFE SCI, V71, P379, DOI 10.1007/s00018-013-1343-z; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036; Welch RP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku463; Wu Q, 2012, LUNG CANCER, V77, P407, DOI 10.1016/j.lungcan.2012.04.007; Yuen BTK, 2013, CANCER CELL, V24, P567, DOI 10.1016/j.ccr.2013.09.015; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619	50	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8537	8549		10.1074/jbc.RA119.010080	http://dx.doi.org/10.1074/jbc.RA119.010080			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371391	Green Published, hybrid			2022-12-26	WOS:000546986500018
J	Eng, VA; Rayess, N; Nguyen, HV; Leng, T				Eng, Victor A.; Rayess, Nadim; Nguyen, Huy, V; Leng, Theodore			Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GEOGRAPHIC-ATROPHY; DISEASE; RISK; AFLIBERCEPT; MACULOPATHY; PREDICTOR; EYES	Importance Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness with several intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents available for its management such as aflibercept, bevacizumab, and ranibizumab. However, direct comparisons between these three agents among the same patient population are limited. Objective To assess the rate and growth of complete retinal pigment epithelium and outer retinal atrophy (cRORA) in eyes with nAMD treated with aflibercept, bevacizumab, and/or ranibizumab. Method Retrospective cohort study of patients with treatment-naive neovascular AMD seen at an academic hospital between October 2006 and February 2019. Study eyes were treated with intravitreal injections of aflibercept, bevacizumab, and/or ranibizumab and followed for two years. Main outcomes and measures cRORA prevalence, location, size, and growth rate. Eyes were imaged with Cirrus spectral domain optical coherence tomography (SD-OCT). Presence and size of cRORA were calculated using the FDA-approved Advanced RPE Analysis software. Linear regression models were used to correlate cRORA progression with baseline demographic and ocular characteristics, anti-VEGF drug, and number of injections. Unpaired t-tests, ANOVA, and linear regression models were computed with SAS 9.4. Results 197 eyes from 158 patients (mean age 78.9, 62.9% women) received an average of 13 anti-VEGF injections over 24 months. 22% developed new cRORA. Mean cRORA area increased from 1.71 mm(2) to 2.93 mm(2). At 24 months, eyes with 11+ injections had significantly less cRORA area (11+ injections, 4.02 mm(2);. 10 injections, 2.46 mm(2); p = 0.01) and growth rate (11+ injections, 0.41 mm(2)/year;. 10 injections, 1.05 mm(2)/year; p = 0.02). Choice of anti-VEGF drug yielded no significant difference in cRORA progression. Conclusions and relevance Treating nAMD with aflibercept, bevacizumab or ranibizumab demonstrated comparable cRORA development at 24 months. Number of injections inversely correlated with cRORA area and growth. These results warrant further investigation in the pathophysiology of cRORA in anti-VEGF treated eyes.	[Eng, Victor A.; Rayess, Nadim; Nguyen, Huy, V; Leng, Theodore] Stanford Univ, Sch Med, Byers Eye Inst Stanford, Palo Alto, CA 94304 USA	Stanford University	Leng, T (corresponding author), Stanford Univ, Sch Med, Byers Eye Inst Stanford, Palo Alto, CA 94304 USA.	tedleng@stanford.edu		Leng, Theodore/0000-0002-8461-3562; Nguyen, Huy/0000-0002-5463-1081	Stanford Medical School Medical Scholars Program; Research to Prevent Blindness; National Eye Institute [P30-EY026877]	Stanford Medical School Medical Scholars Program; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Victor Eng is supported by a research fellowship grant from the Stanford Medical School Medical Scholars Program. Theodore Leng is supported by an unrestricted grant from Research to Prevent Blindness, the National Eye Institute P30-EY026877. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfattah NS, 2016, RETINA-J RET VIT DIS, V36, P1843, DOI 10.1097/IAE.0000000000001059; Abdelfattah NS, 2016, INVEST OPHTH VIS SCI, V57, P1839, DOI 10.1167/iovs.15-18572; [Anonymous], 2015, MED LETT DRUGS THER, V57, P41; [Anonymous], 2015, OPHTHALMOLOGY, V122, P809, DOI [10.1016/j.ophtha.2014.11.007, DOI 10.1016/T0PHTHA.2014.11.00'7]; Ba J, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S86269; Brechner RJ, 2011, AM J OPHTHALMOL, V151, P887, DOI 10.1016/j.ajo.2010.11.017; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Finger RP, 2014, OPHTHALMOLOGY, V121, P1252, DOI 10.1016/j.ophtha.2013.12.034; Folgar FA, 2016, OPHTHALMOLOGY; Folk JC, 2010, NEW ENGL J MED, V363, P1648, DOI [10.1056/NERVIct1000495, DOI 10.1056/NERVICT1000495]; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gillies MC, 2015, OPHTHALMOLOGY, V122, P1837, DOI 10.1016/j.ophtha.2015.05.010; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Hariri A, 2015, OPHTHALMOLOGY, V122, P407, DOI 10.1016/j.ophtha.2014.08.035; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI [10.1016/6ophthe.2012.09.006, DOI 10.1016/6OPHTHE.2012.09.006]; Holladay JT, 1997, J REFRACT SURG, V13, P388; HYMAN L, 1987, EYE, V1, P330, DOI 10.1038/eye.1987.53; Klein R, 2003, OPHTHALMOLOGY, V110, P636, DOI 10.1016/S0161-6420(02)01448-3; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Lois N, 2013, RETINA-J RET VIT DIS, V33, P13, DOI 10.1097/IAE.0b013e3182657fff; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Munk MR, 2016, ACTA OPHTHALMOL, V94, pE757, DOI 10.1111/aos.13157; Murdoch IE, 1998, BRIT J OPHTHALMOL, V82, P971, DOI 10.1136/bjo.82.8.971; Nathoo NA, 2014, AM J OPHTHALMOL, V158, P757, DOI 10.1016/j.ajo.2014.06.021; Peden MC, 2015, OPHTHALMOLOGY, V122, P803, DOI 10.1016/j.ophtha.2014.11.018; Pinheiro-Costa J, 2015, OPHTHALMOLOGICA, V233, P155, DOI 10.1159/000381221; Sadda SR, 2018, OPHTHALMOLOGY, V125, P537, DOI 10.1016/j.ophtha.2017.09.028; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Semeraro F, 2013, DRUG DES DEV THER, V7, P711, DOI 10.2147/DDDT.S40215; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Steinbrook R., 2006, NEW ENGL J MED, V355, P1409, DOI [10.1056/NEJP61p068185, DOI 10.1056/NEJP61P068185]; VINDING T, 1992, ACTA OPHTHALMOL, V70, P66; Wong T, 2008, OPHTHALMOLOGY, V115, DOI [10.1016/tophtha.2007.03.008, DOI 10.1016/T0PHTHA.2007.03.008]; Wykoff CC, 2014, BRIT J OPHTHALMOL, V98, P951, DOI 10.1136/bjophthalmol-2013-304736; Xu LN, 2015, RETINA-J RET VIT DIS, V35, P176, DOI 10.1097/IAE.0000000000000374; Yehoshua Z, 2013, LASERS IMAGING RETIN, V44, P127; Young M, 2014, RETINA-J RET VIT DIS, V34, P1308, DOI 10.1097/IAE.0000000000000081	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232353	10.1371/journal.pone.0232353	http://dx.doi.org/10.1371/journal.pone.0232353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369500	gold, Green Published			2022-12-26	WOS:000537280000027
J	Qian, H; Cao, Y; Sun, JF; Zu, JN; Ma, L; Zhou, HZ; Tang, XL; Li, Y; Yu, HY; Zhang, MY; Bai, YL; Xu, CQ; Ishii, N; Hashimoto, T; Li, XG				Qian, Hua; Cao, Yan; Sun, Junfeng; Zu, Jianing; Ma, Liang; Zhou, Haizhou; Tang, Xianling; Li, Yan; Yu, Haiyang; Zhang, Mingyu; Bai, Yunlong; Xu, Chaoqian; Ishii, Norito; Hashimoto, Takashi; Li, Xiaoguang			Anti-human serum albumin autoantibody may be involved in the pathogenesis of autoimmune bullous skin diseases	FASEB JOURNAL			English	Article						anti-human serum albumin autoantibody; autoimmune bullous skin diseases; DNA damage-related signaling proteins; phospho-p38; skin lesion	C-TERMINAL DOMAIN; DNA-DAMAGE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INCREASED EXPRESSION; IGA AUTOANTIBODIES; NC16A DOMAIN; DIAGNOSIS; CANCER; ENZYME; ANTIBODIES	Although effective immunological diagnostic systems for autoimmune bullous skin diseases (AIBD) have been established, there are still unidentified cutaneous autoantigens. The purpose of this study is to investigative whether anti-human serum albumin (HSA) autoantibodies exist in AIBD sera and their potential pathogenesis. By immunoprecipitation-immunoblotting, immunofluorescence assay, anti-HSA autoantibodies could be detected in AIBD sera; by ELISAs, positive rates of AIBD sera for IgG and IgA anti-HSA autoantibodies were 29% and 34%, respectively. The IgG anti-HSA autoantibodies in ABID sera recognized a number of HSA antigen epitopes and therefore a polyclonal antibody against HSA were next employed to study its pathogenesis. In vitro cell and tissue culture models, anti-HSA antibody could influence DNA damage-related signaling proteins, via activation of phospho-p38 signaling pathway. This is the first report that an autoantibody may influence DNA damage-related signaling proteins. Statistical analyses also proved that anti-HSA autoantibodies were positively correlated with various known autoantibodies and clinical features of ABID patients. In summary, IgG and IgA autoantibodies to HSA may have diagnosis values for AIBD. DNA damage-related signaling proteins might be involved in the pathogenic role of anti-HSA autoantibodies in AIBD. Phospho-p38 signaling pathway is a potential target for treatment of AIBD positive for serum anti-HSA autoantibodies.	[Qian, Hua; Li, Xiaoguang] Nanchang Univ, Affiliated Dermatol Hosp, Dermatol Hosp Jiangxi Prov, Cent Lab,Dermatol Inst Jiangxi Prov, Nanchang, Jiangxi, Peoples R China; [Qian, Hua; Ma, Liang; Zhang, Mingyu; Bai, Yunlong; Hashimoto, Takashi; Li, Xiaoguang] Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin, Peoples R China; [Qian, Hua; Ma, Liang; Zhang, Mingyu; Bai, Yunlong; Hashimoto, Takashi; Li, Xiaoguang] Heilongjiang Acad Med Sci, Harbin, Peoples R China; [Cao, Yan] Harbin Med Univ, Canc Hosp, Dept Urol, Harbin, Peoples R China; [Sun, Junfeng] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Harbin, Peoples R China; [Zu, Jianing] Harbin Med Univ, Affiliated Hosp 2, Dept Orthopaed, Harbin, Peoples R China; [Zhou, Haizhou] Harbin Med Univ, Affiliated Hosp 1, Dept Lab Diag, Harbin, Peoples R China; [Tang, Xianling] Harbin Med Univ, Affiliated Hosp 1, Eye Hosp, Harbin, Peoples R China; [Li, Yan] Harbin Med Univ, Ctr Endem Dis Control, Chinese Ctr Dis Control & Prevent, Harbin, Peoples R China; [Yu, Haiyang] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Ophthalmol, Hangzhou, Peoples R China; [Xu, Chaoqian] Mudanjiang Med Univ, Dept Pharmacol, Mudanjiang, Peoples R China; [Ishii, Norito] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka, Japan; [Ishii, Norito] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka, Japan; [Hashimoto, Takashi] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan	Nanchang University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Chinese Center for Disease Control & Prevention; Harbin Medical University; Zhejiang University; Mudanjiang Medical University; Kurume University; Kurume University; Osaka Metropolitan University	Li, XG (corresponding author), Nanchang Univ, Dermatol Hosp Jiangxi Prov, Dermatol Inst Jiangxi Prov, Cent Lab, 388 Yingbinbei Rd, Nanchang 330001, Jiangxi, Peoples R China.; Li, XG (corresponding author), Nanchang Univ, Affiliated Dermatol Hosp, 388 Yingbinbei Rd, Nanchang 330001, Jiangxi, Peoples R China.; Hashimoto, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	hashyt@gmail.com; liqian0041@139.com	Zhang, mingyu/HGB-1069-2022		National Science and Technology Major Project [2018ZX10101003]; Natural Science Foundation of Heilongjiang Province of China [QC2016129]; Scientific Research Foundation of First Affiliated Hospital of Harbin Medical University, China [2017B013]; Ministry of Health Labour and Welfare, Japan [H24-038]; AMED, Japan [JP19lm0203007]	National Science and Technology Major Project; Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Scientific Research Foundation of First Affiliated Hospital of Harbin Medical University, China; Ministry of Health Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); AMED, Japan	The authors thank the patients for their participation. The authors also thank Dr Yoichiro Hamasaki and Dr Ken Igawa, Department of Dermatology, Dokkyo Medical University School of Medicine, for their kindly providing HE staining and direct IF results of the PNP patient. This work was supported by National Science and Technology Major Project (2018ZX10101003), the Natural Science Foundation of Heilongjiang Province of China (QC2016129), the Scientific Research Foundation of First Affiliated Hospital of Harbin Medical University (2017B013), China; and the Research on Measures for Intractable Diseases' Project: matching fund subsidy of Ministry of Health Labour and Welfare, Japan (H24-038), and AMED, Japan (JP19lm0203007).	Al-Shobaili HA, 2015, SAUDI MED J, V36, P1408, DOI 10.15537/smj.2015.12.12612; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Anstey A, 2015, BRIT J DERMATOL, V173, pE23, DOI 10.1111/bjd.14162; Arif Z, 2018, INT J BIOL MACROMOL, V106, P1240, DOI 10.1016/j.ijbiomac.2017.08.122; BROWN LF, 1995, J INVEST DERMATOL, V104, P744, DOI 10.1111/1523-1747.ep12606974; Cai RQ, 2015, FASEB J, V29, P2749, DOI 10.1096/fj.14-265801; Cornaby C, 2015, IMMUNOL LETT, V163, P56, DOI 10.1016/j.imlet.2014.11.001; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; di Masi A, 2018, J INFECT DIS, V218, P1424, DOI 10.1093/infdis/jiy338; Egu DT, 2017, BRIT J DERMATOL, V177, P1612, DOI 10.1111/bjd.15721; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fukumoto Y, 2014, J BIOL CHEM, V289, P12313, DOI 10.1074/jbc.M113.533752; Hashimoto T, 2016, BRIT J DERMATOL, V175, P953, DOI 10.1111/bjd.14692; Hashimoto T, 2001, ARCH DERMATOL, V137, P735; Hashimoto T, 2012, J PATHOL, V228, P1, DOI 10.1002/path.4062; Hayakawa T, 2016, EUR J DERMATOL, V26, P155, DOI 10.1684/ejd.2015.2719; Hayakawa T, 2014, OR SURG OR MED OR PA, V117, P483, DOI 10.1016/j.oooo.2013.12.402; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Ishii N, 2008, BRIT J DERMATOL, V158, P1151, DOI 10.1111/j.1365-2133.2008.08492.x; Ishii N, 2004, BRIT J DERMATOL, V150, P843, DOI 10.1111/j.1365-2133.2004.05933.x; Kanarek N, 2014, P NATL ACAD SCI USA, V111, pE702, DOI 10.1073/pnas.1322691111; Khan W. Z., 2015, IEEE COMMUNICATIONS, V17, P1, DOI DOI 10.2174/1389200216666151103115210; Khan WA, 2007, ARCH BIOCHEM BIOPHYS, V465, P293, DOI 10.1016/j.abb.2007.06.006; Lan YL, 2019, CELL BIOL TOXICOL, V35, P521, DOI 10.1007/s10565-019-09462-y; LENKEI R, 1977, J IMMUNOL METHODS, V16, P23, DOI 10.1016/0022-1759(77)90036-9; Leverkus M, 2001, BRIT J DERMATOL, V145, P998, DOI 10.1046/j.1365-2133.2001.04543.x; Li DH, 2002, MUTAT RES-GEN TOX EN, V513, P37, DOI 10.1016/S1383-5718(01)00291-1; Li X, 2014, BRIT J DERMATOL, V171, P1257, DOI 10.1111/bjd.13107; Li XG, 2016, EUR J DERMATOL, V26, P247, DOI 10.1684/ejd.2016.2772; Li XG, 2015, EUR J DERMATOL, V25, P418, DOI 10.1684/ejd.2015.2555; Li XD, 2015, METALL MATER TRANS E, V2, P1; Liu NA, 2015, FASEB J, V29, P2514, DOI 10.1096/fj.14-265546; Matsumura K, 1996, ARCH DERMATOL RES, V288, P507, DOI 10.1007/s004030050093; Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314; Nie ZX, 1999, J INVEST DERMATOL, V112, P254, DOI 10.1046/j.1523-1747.1999.00501.x; Noble PW, 2016, NAT REV RHEUMATOL, V12, P429, DOI 10.1038/nrrheum.2016.23; Otten JV, 2014, CURR MOL MED, V14, P69, DOI 10.2174/15665240113136660079; Phadke M, 2011, BIOCHEM BIOPH RES CO, V411, P409, DOI 10.1016/j.bbrc.2011.06.165; Reddy R, 2014, AM J PHYSIOL-LUNG C, V286, pL658; Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225; Saalbach A, 2000, J INVEST DERMATOL, V115, P882, DOI 10.1046/j.1523-1747.2000.00104.x; Schmidt E, 2010, AUTOIMMUN REV, V10, P84, DOI 10.1016/j.autrev.2010.08.007; Shain SA, 2004, MOL CANCER RES, V2, P653; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Shiokawa M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0997; SUGI T, 1989, J CLIN INVEST, V84, P1050, DOI 10.1172/JCI114266; Tsuchisaka A, 2014, J INVEST DERMATOL, V134, P2283, DOI 10.1038/jid.2014.151; Tsuruta D, 2012, IMMUNOTHERAPY-UK, V4, P735, DOI [10.2217/IMT.12.67, 10.2217/imt.12.67]; Wei X, 2019, EXP EYE RES, V180, P174, DOI 10.1016/j.exer.2018.12.020; Yan Y, 2018, MOL MED REP, V17, P5233; Yasukochi A, 2016, ACTA DERM-VENEREOL, V96, P762, DOI 10.2340/00015555-2407; Zhou T, 2013, PATIENT PREFER ADHER, V7, P1207, DOI 10.2147/PPA.S53484	55	5	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8574	8595		10.1096/fj.201903247RR	http://dx.doi.org/10.1096/fj.201903247RR		MAY 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32369236				2022-12-26	WOS:000530304300001
J	Bai, H; Sun, K; Wu, JH; Zhong, ZH; Xu, SL; Zhang, HR; Gu, YH; Lu, SF				Bai, Hua; Sun, Ke; Wu, Jia-Hong; Zhong, Ze-Hao; Xu, Sen-Lei; Zhang, Hong-Ru; Gu, Yi-Huang; Lu, Sheng-Feng			Proteomic and metabolomic characterization of cardiac tissue in acute myocardial ischemia injury rats	PLOS ONE			English	Article							ACID-METABOLISM; FATTY-ACID; INFARCTION; PROLIFERATION; GLUTAMATE; REPAIR	The pathological process and mechanism of myocardial ischemia (MI) is very complicated, and remains unclear. An integrated proteomic-metabolomics analysis was applied to comprehensively understand the pathological changes and mechanism of MI. Male Sprague-Dawley rats were randomly divided into a mock surgery (MS) group and an MI group. The MI model was made by ligating the left anterior descending coronary artery, twenty-four hours after which, echocardiography was employed to assess left ventricular (LV) function variables. Blood samples and left ventricular tissues were collected for ELISA, metabolomics and proteomics analysis. The results showed that LV function, including ejection fraction (EF) and fractional shortening (FS), was significantly reduced and the level of cTnT in the serum increased after MI. iTRAQ proteomics showed that a total of 169 proteins were altered including 52 and 117 proteins with increased and decreased expression, respectively, which were mainly involved in the following activities: complement and coagulation cascades, tight junction, regulation of actin cytoskeleton, MAPK signaling pathway, endocytosis, NOD-like receptor signaling pathway, as well as phagosome coupled with vitamin digestion and absorption. Altered metabolomic profiling of this transition was mostly enriched in pathways including ABC transporters, glycerophospholipid metabolism, protein digestion and absorption and aminoacyl-tRNA biosynthesis. The integrated metabolomics and proteomics analysis indicated that myocardial injury after MI is closely related to several metabolic pathways, especially energy metabolism, amino acid metabolism, vascular smooth muscle contraction, gap junction and neuroactive ligand-receptor interaction. These findings may contribute to understanding the mechanism of MI and have implication for new therapeutic targets.	[Bai, Hua; Sun, Ke; Wu, Jia-Hong; Zhong, Ze-Hao; Xu, Sen-Lei; Zhang, Hong-Ru; Gu, Yi-Huang; Lu, Sheng-Feng] Nanjing Univ Chinese Med, Acupuncture & Tuina Coll, Nanjing, Peoples R China; [Lu, Sheng-Feng] Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Gu, YH; Lu, SF (corresponding author), Nanjing Univ Chinese Med, Acupuncture & Tuina Coll, Nanjing, Peoples R China.; Lu, SF (corresponding author), Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing, Peoples R China.	270973@njucm.edu.cn; lushengfeng@njucm.edu.cn		lu, Shengfeng/0000-0001-5600-0999	Natural Science Foundation of China [81774210, 81674063, 81974583, 81704169]; Natural Science Foundation of Jiangsu Province [BK20171067]; Jiangsu Provincial Leading Talents in Chinese Medicine [SLJ0226]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Leading Talents in Chinese Medicine	This work was supported by the following fundings:Prof. LSF, Natural Science Foundation of China (No. 81774210); Prof. GYH, Natural Science Foundation of China (No.81674063, 81974583) and Jiangsu Provincial Leading Talents in Chinese Medicine (No.SLJ0226); Dr. ZHR, Natural Science Foundation of China (No.81704169) and the Natural Science Foundation of Jiangsu Province (No.BK20171067). All funders were participated the study, specifically, Hong-Ru Zhang revised the paper, Yi-Huang Gu and Sheng-Feng Lu designed the study. and revised the paper.	Amiri MP, 2019, CLIN CHIM ACTA, V495, P43, DOI 10.1016/j.cca.2019.03.1632; Andersen JV, 2019, CELL MOL LIFE SCI, V76, P2449, DOI 10.1007/s00018-019-03051-2; Binek A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11985-5; Burbaeva GS, 2014, CEREBELLUM, V13, P607, DOI 10.1007/s12311-014-0573-4; Cadete VJJ, 2012, PROTEOMICS, V12, P2366, DOI 10.1002/pmic.201100604; Cavill R, 2016, BRIEF BIOINFORM, V17, P891, DOI 10.1093/bib/bbv090; Chen PP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01778; Du CQ, 2019, INT J MOL MED, V43, P1991, DOI 10.3892/ijmm.2019.4137; Du JF, 2016, AM J PHYSIOL-CELL PH, V310, pC270, DOI 10.1152/ajpcell.00194.2015; Endo S, 2010, ARCH BIOCHEM BIOPHYS, V503, P230, DOI 10.1016/j.abb.2010.08.010; Evans RD, 2016, BBA-MOL CELL BIOL L, V1861, P1481, DOI 10.1016/j.bbalip.2016.03.010; Fu SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094604; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Hausner EA, 2019, DRUG METAB DISPOS, V47, P673, DOI 10.1124/dmd.119.086611; He XY, 2018, J ALZHEIMERS DIS, V62, P665, DOI 10.3233/JAD-170974; Huang J, 2014, MOL CELL BIOCHEM, V390, P115, DOI 10.1007/s11010-014-1962-1; Imperatore R, 2019, CLIN SCI, V133, P853, DOI 10.1042/CS20181036; Intachai K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092466; Kou Y, 2016, EUR REV MED PHARMACO, V20, P4286; Li YL, 2019, CIRCULATION, V140, P751, DOI 10.1161/CIRCULATIONAHA.118.039262; Li ZY, 2016, CELL MOL LIFE SCI, V73, P377, DOI 10.1007/s00018-015-2070-4; Ling QL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19661-y; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lu M, 2008, J THEOR BIOL, V254, P466, DOI 10.1016/j.jtbi.2008.05.033; McKirnan MD, 2019, LIFE SCI, V221, P212, DOI 10.1016/j.lfs.2019.01.040; Picoli C, 2019, ASSAY DRUG DEV TECHN, V17, P240, DOI 10.1089/adt.2019.927; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Ren XP, 2019, AM J PHYSIOL-HEART C, V316, pH543, DOI 10.1152/ajpheart.00094.2018; Schmidt EKA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226128; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Sun XL, 2014, PHARMACOLOGY, V93, P4, DOI 10.1159/000356311; Surendran A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48227-9; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Tao H, 2016, INFLAMM RES, V65, P415, DOI 10.1007/s00011-016-0925-2; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wang JQ, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/3618213; Wang XX, 2017, INT HEART J, V58, P441, DOI 10.1536/ihj.16-432; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu Y, 2018, ONCOTARGET, V9, P1969, DOI 10.18632/oncotarget.23025; Ye X, 2019, HEPATOLOGY, V69, P2489, DOI 10.1002/hep.30519; Yin MM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-85; Yoo BC, 2018, J PROTEOMICS, V188, P97, DOI 10.1016/j.jprot.2017.08.010; Yu H, 2019, FREE RADICAL BIO MED, V135, P182, DOI 10.1016/j.freeradbiomed.2019.02.031; Zhang HR, 2019, AM J CHINESE MED, V47, P1025, DOI 10.1142/S0192415X19500526; Zhang YQ, 2018, NEUROSCIENCE, V371, P207, DOI 10.1016/j.neuroscience.2017.12.001; Zhou WS, 2018, J IMMUNOL, V201, P1936, DOI 10.4049/jimmunol.1700605	46	10	11	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0231797	10.1371/journal.pone.0231797	http://dx.doi.org/10.1371/journal.pone.0231797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365112	Green Published, gold			2022-12-26	WOS:000536959700012
J	Gruber, MT; Witte, OW; Grosskreutz, J; Prell, T				Gruber, Maria Theresa; Witte, Otto W.; Grosskreutz, Julian; Prell, Tino			Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study	PLOS ONE			English	Article							MINI-NUTRITIONAL ASSESSMENT; NONMOTOR SYMPTOMS; CHINESE PATIENTS; THE-LITERATURE; PREVALENCE; COGNITION; WEIGHT; IMPACT; RISK; TOOL	Objective This study aimed to explore the association between malnutrition, clinical parameters, and health-related quality of life in elderly hospitalized patients with Parkinson's disease (PD). Methods Cross-sectional study of 92 hospitalized elderly patients with PD (mean age 73.6 +/- 6.7 years) without dementia. The Mini Nutritional Assessment (MNA) was used to evaluate nutritional status. Motor impairment and non-motor symptoms burden (Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale [MDSUPDRS], Non-Motor Symptoms Questionnaire, and Hoehn & Yahr staging), depression (Becks Depression Inventory-II), and health-related quality of life (PD quality of life Questionnaire-39) were assessed. Results Every second patient was malnourished or at risk of malnutrition. In the multivariable analysis, male gender, longer disease duration, higher Hoehn & Yahr and depression were associated with total MNA score. Besides non-motor symptoms and motor impairment, malnutrition was an independent predictor of poor health-related quality of life. In the multivariate analysis, malnutrition had a statistically significant effect on emotional well-being, mobility, social support, stigmatization, and cognition. The strongest association was found between malnutrition and emotional well-being. Conclusion Elderly male persons with longer PD duration and higher disease stages are more likely to be malnourished or at risk for malnutrition. Malnutrition was mainly associated with poor emotional well-being, suggesting that treatment of depression and anxiety beside diet and physical activity can help improving nutrition status in these subjects. The MNA should not be used independent of other measures of cognition and depression in people with advanced PD.	[Gruber, Maria Theresa; Witte, Otto W.; Grosskreutz, Julian; Prell, Tino] Jena Univ Hosp, Dept Neurol, Jena, Germany; [Witte, Otto W.; Grosskreutz, Julian; Prell, Tino] Jena Univ Hosp, Ctr Hlth Ageing, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Prell, T (corresponding author), Jena Univ Hosp, Dept Neurol, Jena, Germany.; Prell, T (corresponding author), Jena Univ Hosp, Ctr Hlth Ageing, Jena, Germany.	Tino.prell@med.uni-jena.de	Prell, Tino/AAE-5492-2020; Grosskreutz, Julian/G-2293-2010	Prell, Tino/0000-0002-6423-3108; Grosskreutz, Julian/0000-0001-9525-1424				Abd Aziz NAS, 2017, CLIN INTERV AGING, V12, P1615, DOI 10.2147/CIA.S140859; Ayers E, 2014, P NUTR SOC, V73, P302, DOI 10.1017/S0029665113003716; Cereda E, 2012, CURR OPIN CLIN NUTR, V15, P29, DOI 10.1097/MCO.0b013e32834d7647; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; Christner S, 2016, J HUM NUTR DIET, V29, P704, DOI 10.1111/jhn.12376; Fereshtehnejad SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091153; Ghimire S, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0881-5; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Harris D, 2005, J ROY SOC MED, V98, P411, DOI 10.1258/jrsm.98.9.411; Jensen G, 2006, J NUTR HEALTH AGING, V10, P485; Johansson Y, 2009, J CLIN NURS, V18, P1354, DOI 10.1111/j.1365-2702.2008.02552.x; Jones JD, 2014, PARKINSONISM RELAT D, V20, P1236, DOI 10.1016/j.parkreldis.2014.09.014; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Kim SR, 2016, INT J NURS PRACT, V22, P129, DOI 10.1111/ijn.12377; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Ma K, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00001; Malkki Hemi, 2013, Nat Rev Neurol, V9, P544, DOI 10.1038/nrneurol.2013.176; Martinez-Garcia PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136101; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ongun N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205100; Palhagen S, 2005, ACTA NEUROL SCAND, V111, P12, DOI 10.1111/j.1600-0404.2004.00364.x; Pilhatsch M, 2013, J NERV MENT DIS, V201, P76, DOI 10.1097/NMD.0b013e31827ab2cc; Pourhassan M, 2018, CLIN NUTR ESPEN, V27, P100, DOI 10.1016/j.clnesp.2018.05.013; Prell T, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00080; Richter D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020151; Santos-Garcia D, 2013, J NEUROL SCI, V332, P136, DOI 10.1016/j.jns.2013.07.005; Sheard JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0212-1; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057986; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Tomic S, 2017, J NEUROL SCI, V375, P235, DOI 10.1016/j.jns.2017.01.070; Tomic S, 2017, ACTA NEUROL BELG, V117, P207, DOI 10.1007/s13760-016-0739-6; van Bokhorst-de van der Schueren MAE, 2014, CLIN NUTR, V33, P39, DOI 10.1016/j.clnu.2013.04.008; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009; Wiesli D, 2017, DEMENT GER COGN D EX, V7, P297, DOI 10.1159/000478849	34	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232764	10.1371/journal.pone.0232764	http://dx.doi.org/10.1371/journal.pone.0232764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365092	Green Published, gold			2022-12-26	WOS:000536959700058
J	Murakami, Y; Magome, T; Matsumoto, K; Sato, T; Yoshioka, Y; Oguchi, M				Murakami, Yu; Magome, Taiki; Matsumoto, Kazuki; Sato, Tomoharu; Yoshioka, Yasuo; Oguchi, Masahiko			Fully automated dose prediction using generative adversarial networks in prostate cancer patients	PLOS ONE			English	Article							ARC THERAPY VMAT; HEAD; RADIOTHERAPY	Purpose Although dose prediction for intensity modulated radiation therapy (IMRT) has been accomplished by a deep learning approach, delineation of some structures is needed for the prediction. We sought to develop a fully automated dose-generation framework for IMRT of prostate cancer by entering the patient CT datasets without the contour information into a generative adversarial network (GAN) and to compare its prediction performance to a conventional prediction model trained from patient contours. Methods We propose a synthetic approach to translate patient CT datasets into a dose distribution for IMRT. The framework requires only paired-images, i.e., patient CT images and corresponding RT-doses. The model was trained from 81 IMRT plans of prostate cancer patients, and then produced the dose distribution for 9 test cases. To compare its prediction performance to that of another trained model, we created a model trained from structure images. Dosimetric parameters for the planning target volume (PTV) and organs at risk (OARs) were calculated from the generated and original dose distributions, and mean differences of dosimetric parameters were compared between the CT-based model and the structurebased model. Results The mean differences of all dosimetric parameters except for D98% and D95% for PTV were within approximately 2% and 3% of the prescription dose for OARs in the CT-based model, while the differences in the structure-based model were within approximately 1% for PTV and approximately 2% for OARs, with a mean prediction time of 5 seconds per patient. Conclusions Accurate and rapid dose prediction was achieved by the learning of patient CT datasets by a GAN-based framework. The CT-based dose prediction could reduce the time required for both the iterative optimization process and the structure contouring, allowing physicians and dosimetrists to focus their expertise on more challenging cases.	[Murakami, Yu; Magome, Taiki; Matsumoto, Kazuki] Komazawa Univ, Grad Div Hlth Sci, Setagaya Ku, Tokyo, Japan; [Murakami, Yu; Sato, Tomoharu; Yoshioka, Yasuo; Oguchi, Masahiko] Japanese Fdn Canc Res, Canc Inst Hosp, Radiat Oncol Dept, Koto Ku, Tokyo, Japan	Japanese Foundation for Cancer Research	Magome, T (corresponding author), Komazawa Univ, Grad Div Hlth Sci, Setagaya Ku, Tokyo, Japan.	magome@komazawa-u.ac.jp	Murakami, Yu/HHN-7987-2022	Murakami, Yu/0000-0001-7716-9427; Magome, Taiki/0000-0002-0133-5932	JSPS KAKENHI [18K15604]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part to TM by JSPS KAKENHI Grant Number 18K15604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babier A, 2018, ARXIV181209309V1; Barragan-Montero AM, 2019, MED PHYS, V46, P3679, DOI 10.1002/mp.13597; Ben-Cohen A, 2019, ENG APPL ARTIF INTEL, V78, P186, DOI 10.1016/j.engappai.2018.11.013; Castriconi R, 2019, PHYS MEDICA, V57, P231, DOI 10.1016/j.ejmp.2018.12.002; Chang ATY, 2016, INT J RADIAT ONCOL, V95, P981, DOI 10.1016/j.ijrobp.2016.02.017; Nguyen D, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab039b; Nguyen D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37741-x; Das Indra J, 2009, J Am Coll Radiol, V6, P514, DOI 10.1016/j.jacr.2008.12.013; Fan JW, 2019, MED PHYS, V46, P370, DOI 10.1002/mp.13271; Fogliata A, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0530-5; Isola P., 2017, ARXIV161107004V2; Jensen AR, 2007, RADIOTHER ONCOL, V84, P5, DOI 10.1016/j.radonc.2007.04.001; Jin CB, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19102361; Kamima T, 2019, PHYS MEDICA, V64, P174, DOI 10.1016/j.ejmp.2019.07.004; Kang E, 2019, MED PHYS, V46, P550, DOI 10.1002/mp.13284; Kearney V, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaef74; Khalvati F, 2018, BMC MED IMAGING, V18, DOI 10.1186/s12880-018-0258-4; Khalvati F, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0069-9; Kida S, 2019, ARXIV190105773V1; Kozuka T, 2017, JPN J RADIOL, V35, P269, DOI 10.1007/s11604-017-0630-2; Krayenbuehl J, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1113-z; Mahapatra D, 2019, COMPUT MED IMAG GRAP, V71, P30, DOI 10.1016/j.compmedimag.2018.10.005; Mahmood R, 2018, ARXIV180706489V1; Murakami Y, 2018, J RADIAT RES, V59, P327, DOI 10.1093/jrr/rry012; Nguyen D, 2019, ARXIV190604778; Nguyen D, 2019, ARXIV190805874; Stoyanova R, 2016, TRANSL CANCER RES, V5, P432, DOI 10.21037/tcr.2016.06.20; Tol JP, 2015, INT J RADIAT ONCOL, V91, P612, DOI 10.1016/j.ijrobp.2014.11.014; Ueda Y, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-0994-1; vantRiet A, 1997, INT J RADIAT ONCOL, V37, P731, DOI 10.1016/S0360-3016(96)00601-3; Wu H, 2016, J APPL CLIN MED PHYS, V17, P78, DOI 10.1120/jacmp.v17i6.6410; Zhang PP, 2010, INT J RADIAT ONCOL, V76, P1456, DOI 10.1016/j.ijrobp.2009.03.033	32	21	21	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232697	10.1371/journal.pone.0232697	http://dx.doi.org/10.1371/journal.pone.0232697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365088	Green Published, gold			2022-12-26	WOS:000536959700054
J	Chu, WG; Wang, FD; Sun, ZC; Ma, SB; Wang, X; Han, WJ; Wang, F; Bai, ZT; Wu, SX; Freichel, M; Xie, RG; Luo, C				Chu, Wen-Guang; Wang, Fu-Dong; Sun, Zhi-Chuan; Ma, Sui-Bin; Wang, Xu; Han, Wen-Juan; Wang, Fei; Bai, Zhan-Tao; Wu, Sheng-Xi; Freichel, Marc; Xie, Rou-Gang; Luo, Ceng			TRPC1/4/5 channels contribute to morphine-induced analgesic tolerance and hyperalgesia by enhancing spinal synaptic potentiation and structural plasticity	FASEB JOURNAL			English	Article						long-term potentiation; opioid-induced tolerance and hyperalgesia; spinal cord; spine remodeling; TRPC1; 4; 5 channels	LONG-TERM POTENTIATION; KINASE-II-ALPHA; FUNCTIONAL PLASTICITY; SUBSTANTIA-GELATINOSA; TRPC CHANNELS; RECEPTOR; ACTIVATION; PAIN; MODULATION; NEURONS	Opioid analgesics remain the mainstay for managing intractable chronic pain, but their use is limited by detrimental side effects such as analgesic tolerance and hyperalgesia. Calcium-dependent synaptic plasticity is a key determinant in opiates tolerance and hyperalgesia. However, the exact substrates for this calcium-dependent synaptic plasticity in mediating these maladaptive processes are largely unknown. Canonical transient receptor potential 1, 4, and 5 (TRPC1, 4, 5) proteins assemble into heteromultimeric nonselective cation channels with high Ca2+ permeability and influence various neuronal functions. However, whether and how TRPC1/4/5 channels contribute to the development of opiates tolerance and hyperalgesia remains elusive. Here, we show that TRPC1/4/5 channels contribute to the generation of morphine tolerance and hyperalgesia. Chronic morphine exposure leads to upregulation of TRPC1/4/5 channels in the spinal cord. Spinally expressed TRPC1, TPRC4, and TRPC5 are required for chronic morphine-induced synaptic long-term potentiation (LTP) as well as remodeling of synaptic spines in the dorsal horn, thereby orchestrating functional and structural plasticity during the course of morphine-induced hyperalgesia and tolerance. These effects are attributed to TRPC1/4/5-mediated Ca2+ elevation in the spinal dorsal horn induced by chronic morphine treatment. This study identifies TRPC1/4/5 channels as a promising novel target to prevent the unwanted morphine tolerance and hyperalgesia.	[Chu, Wen-Guang; Wang, Fu-Dong; Sun, Zhi-Chuan; Ma, Sui-Bin; Wang, Xu; Han, Wen-Juan; Wang, Fei; Wu, Sheng-Xi; Xie, Rou-Gang; Luo, Ceng] Fourth Mil Med Univ, Sch Basic Med, Dept Neurobiol, Xian 710032, Peoples R China; [Wang, Fu-Dong] Fourth Mil Med Univ, Sch Basic Med, Regiment 4, Xian, Peoples R China; [Sun, Zhi-Chuan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China; [Wang, Xu; Bai, Zhan-Tao] Yanan Univ, Res Ctr Resource Polypeptide Drugs, Yanan, Peoples R China; [Wang, Xu; Bai, Zhan-Tao] Yanan Univ, Coll Life Sci, Yanan, Peoples R China; [Freichel, Marc] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Yanan University; Yanan University; Ruprecht Karls University Heidelberg	Luo, C (corresponding author), Fourth Mil Med Univ, Sch Basic Med, Dept Neurobiol, Xian 710032, Peoples R China.	luoceng@fmmu.edu.cn		Xie, Rou-gang/0000-0001-7644-1492	Natural Science Foundation of China [31671088, 31471059, 81870867]; Natural Science Foundation of Shaanxi Province [2017ZDJC-01]; DFG-Forschergruppe [2289]; Collaborative Research Center [1118]; Transregional Collaborative Research Center [TR-SFB 152]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); DFG-Forschergruppe(German Research Foundation (DFG)); Collaborative Research Center; Transregional Collaborative Research Center	Natural Science Foundation of China, Grant/Award Number: 31671088, 31471059 and 81870867; Natural Science Foundation of Shaanxi Province, Grant/Award Number: 2017ZDJC-01; DFG-Forschergruppe, Grant/Award Number: 2289; Collaborative Research Center, Grant/Award Number: 1118; Transregional Collaborative Research Center, Grant/Award Number: TR-SFB 152	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; ADVOKAT C, 1989, BEHAV NEUROSCI, V103, P1091, DOI 10.1037/0735-7044.103.5.1091; Alawi KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02439-z; Alawi KM, 2017, ANN RHEUM DIS, V76, P252, DOI 10.1136/annrheumdis-2015-208886; Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Anderson M, 2018, NEUROSCI BULL, V34, P194, DOI 10.1007/s12264-017-0139-9; Bhargava HN, 1997, BRAIN RES, V771, P343, DOI 10.1016/S0006-8993(97)00914-1; Blair NT, 2019, IUPHAR BPS GUIDE PHA, V2019; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Chai ZY, 2017, CHANNELS, V11, P357, DOI 10.1080/19336950.2017.1324003; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen Y, 2010, J NEUROSCI, V30, P38, DOI 10.1523/JNEUROSCI.4346-09.2010; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Drdla-Schutting R, 2012, SCIENCE, V335, P235, DOI 10.1126/science.1211726; Elhabazi K, 2014, JOVE-J VIS EXP, DOI 10.3791/51264; Faber ESL, 2006, NEUROSCIENCE, V137, P781, DOI 10.1016/j.neuroscience.2005.09.027; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Hong C, 2015, BRAIN, V138, P3030, DOI 10.1093/brain/awv188; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Jeon JP, 2008, BIOCHEM BIOPH RES CO, V377, P538, DOI 10.1016/j.bbrc.2008.10.012; Jin H, 2017, NEUROSCI LETT, V639, P138, DOI 10.1016/j.neulet.2016.12.062; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Kuner R, 2017, NAT REV NEUROSCI, V18, DOI 10.1038/nrn.2017.5; Li MQ, 2012, CELL CALCIUM, V51, P486, DOI 10.1016/j.ceca.2012.04.014; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liang D, 2004, NEUROSCIENCE, V123, P769, DOI 10.1016/j.neuroscience.2003.10.007; Liu CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14335; Lu JN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7820; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Miller EC, 2012, MOL PHARMACOL, V82, P333, DOI 10.1124/mol.112.078162; Minard A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060052; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nakatsuka T, 2000, NEUROSCIENCE, V99, P549, DOI 10.1016/S0306-4522(00)00224-4; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Roeckel LA, 2016, NEUROSCIENCE, V338, P160, DOI 10.1016/j.neuroscience.2016.06.029; Rowan MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093688; Rubaiy HN, 2019, BRIT J PHARMACOL, V176, P832, DOI 10.1111/bph.14578; Rubaiy HN, 2017, CHANNELS, V11, P362, DOI 10.1080/19336950.2017.1317485; Rubaiy HN, 2017, J BIOL CHEM, V292, P8158, DOI 10.1074/jbc.M116.773556; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Simmons SC, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0435-6; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Stoicea N, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015425; Stroh O, 2012, J NEUROSCI, V32, P5737, DOI 10.1523/JNEUROSCI.3753-11.2012; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Wei H, 2015, NEUROSCI LETT, V608, P12, DOI 10.1016/j.neulet.2015.09.033; Weisberg DF, 2014, INT J DRUG POLICY, V25, P1124, DOI 10.1016/j.drugpo.2014.07.009; Westlund KN, 2014, NEUROSCIENCE, V262, P165, DOI 10.1016/j.neuroscience.2013.12.043; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Xu JT, 2014, J CLIN INVEST, V124, P592, DOI 10.1172/JCI70236; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Zholos AV, 2014, HANDB EXP PHARMACOL, V222, P129, DOI 10.1007/978-3-642-54215-2_6; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	69	6	6	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8526	8543		10.1096/fj.202000154RR	http://dx.doi.org/10.1096/fj.202000154RR		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359120				2022-12-26	WOS:000530047900001
J	Kamentseva, R; Kosheverova, V; Kharchenko, M; Zlobina, M; Salova, A; Belyaeva, T; Nikolsky, N; Kornilova, E				Kamentseva, Rimma; Kosheverova, Vera; Kharchenko, Marianna; Zlobina, Maria; Salova, Anna; Belyaeva, Tatiana; Nikolsky, Nikolay; Kornilova, Elena			Functional cycle of EEA1-positive early endosome: Direct evidence for pre-existing compartment of degradative pathway	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EGF RECEPTOR ENDOCYTOSIS; RAB5; EEA1; MEMBRANE; MATURATION; PROTEIN; TRANSFERRIN; RECRUITMENT; CONVERSION	Early endosomes, regarded as the main sorting station on endocytic pathway, are characterized by high frequency of homotypic fusions mediated by tethering protein EEA1. Despite intensive investigations, biogenesis of endosomes, boundaries between early and late endosomes, and process of cargo transition though them remain obscure. Here, using EGF/EGFR endocytosis as a model and confocal microscopy of fixed and live cells, we provide evidence favoring EEA1-vesicles being pre-existed vesicular compartment, that maintains its resident proteins' level and is sensitive to biosynthetic, but not endocytic pathway disturbance. EEA1-vesicles directly fuse with incoming EGF/EGFR-vesicles into hybrid endosomes with separated EEA1- and EGFR-domains, thus providing a platform for rapid achievement of an excess of surface-derived membrane that is used to form intraluminal vesicles (ILVs). Thus, multivesicular structures colocalized with EEA1 are still early endosomes. "EEA1-cycle" ends by exclusion of EGFR-containing domains with ILVs inside that turns into MVE and restoration of initial EEA1-vesicles population.	[Kamentseva, Rimma; Kosheverova, Vera; Kharchenko, Marianna; Zlobina, Maria; Salova, Anna; Belyaeva, Tatiana; Nikolsky, Nikolay; Kornilova, Elena] Russian Acad Sci, Inst Cytol, St Petersburg, Russia; [Kornilova, Elena] St Petersburg State Univ, St Petersburg, Russia; [Zlobina, Maria] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Saint Petersburg State University; Masaryk University Brno	Kamentseva, R; Kornilova, E (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg, Russia.; Kornilova, E (corresponding author), St Petersburg State Univ, St Petersburg, Russia.	rkamentseva@yandex.ru; elena.kornilova@gmail.com	Kosheverova, Vera/GZG-8204-2022; Kharchenko, Marianna/ABG-4849-2021; Tatiana, Belyaeva/ABB-3694-2020; Nikolsky, Nikolay/AAB-5657-2021; Kharchenko, Marianna/AAF-1077-2021; Kornilova, Elena Sergeevna/AAB-5559-2021; Kamentseva, Rimma Sergeevna/AAE-9116-2021; Salova, Anna/AAF-1023-2021	Kharchenko, Marianna/0000-0001-9588-5072; Tatiana, Belyaeva/0000-0001-8547-2880; Nikolsky, Nikolay/0000-0001-9914-874X; Kamentseva, Rimma Sergeevna/0000-0001-6923-1577; Salova, Anna/0000-0001-6191-9203	Russian Science Foundation [19-14-00108]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation grant No 19-14-00108.	Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Bright NA, 1997, J CELL SCI, V110, P2027; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Delos Santos RC, 2017, MOL BIOL CELL, V28, P2802, DOI 10.1091/mbc.E16-12-0871; DICKSON RB, 1983, BIOCHEMISTRY-US, V22, P5667, DOI 10.1021/bi00293a033; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Edgar JR, 2016, ELIFE, V5, DOI 10.7554/eLife.17180; Franke C, 2019, TRAFFIC, V20, P601, DOI 10.1111/tra.12671; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gosney JA, 2018, J BIOL CHEM, V293, P5895, DOI 10.1074/jbc.RA117.000632; Griffiths G, 1996, PROTOPLASMA, V195, P37, DOI 10.1007/BF01279185; Griffiths G, 1991, Trends Cell Biol, V1, P5, DOI 10.1016/0962-8924(91)90047-D; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kalaidzidis I, 2015, J CELL BIOL, V211, P123, DOI 10.1083/jcb.201311117; Kosheverova V V., 2016, CELL TISSUE BIOL, V10, P297, DOI [10.1134/S1990519X1604009X, DOI 10.1134/S1990519X1604009X]; Kosheverova VV, 2016, BIOCHEM BIOPH RES CO, V473, P17, DOI 10.1016/j.bbrc.2016.03.041; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Luzio JP, 2001, BIOCHEM SOC T, V29, P476, DOI 10.1042/BST0290476; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; Murphy R F, 1991, Trends Cell Biol, V1, P77, DOI 10.1016/0962-8924(91)90022-2; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; R Core Team, 2013, R LANG ENV STAT COMP; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Salova AV, 2017, ONCOTARGET, V8, P44335, DOI 10.18632/oncotarget.17873; Salova AV, 2016, ONCOTARGET, V7, P6029, DOI 10.18632/oncotarget.6720; Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SORKIN A, 1989, BIOCHIM BIOPHYS ACTA, V1011, P88, DOI 10.1016/0167-4889(89)90083-9; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tjelle TE, 1996, J CELL SCI, V109, P2905; Verma N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7064; Wenzel EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05345-8; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105; Zlobina M V, 2014, Tsitologiia, V56, P741; ZLOBINA MV, 2013, CELL TISSUE BIOL, V7, P382, DOI DOI 10.1134/S1990519X13040160	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232532	10.1371/journal.pone.0232532	http://dx.doi.org/10.1371/journal.pone.0232532			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357161	gold, Green Published			2022-12-26	WOS:000536957700039
J	Martinez, MR; Ferguson, M; Datta, AR				Martinez, Mira Rakic; Ferguson, Martine; Datta, Atin R.			Virulence assessment of Listeria monocytogenes grown in different foods using a Galleria mellonella model	PLOS ONE			English	Article							UNITED-STATES; MULTISTATE OUTBREAK; ADAPTATION; CANTALOUPE; EXPRESSION; LANDSCAPE; CHEESE; GENES; CELLS	Various produce including cantaloupe, caramel-coated apples, and packaged salads, have been recognized in recent years as vehicles for listeriosis, a human foodborne disease caused by intracellular pathogen Listeria monocytogenes. Our knowledge regarding the role of these foods in L. monocytogenes virulence, however, is limited. Understanding their role in modulating L. monocytogenes virulence can be useful in risk assessments and for developing control measures. In this study, we employed the Galleria mellonella larvae model to evaluate virulence potential of fifteen clinical, environmental and food isolates of L. monocytogenes, related to three major outbreaks, after growth on different foods. The non-human pathogen Listeria innocua was also included in the panel. Strains were inoculated in parallel in 5ml of brain heart infusion (BHI) broth, and on the surfaces of cantaloupe and apple fragments (5g each) at about 105 colony forming units (CFU)/ml/fragment. One set of inoculated broth and food fragments was incubated at 10 degrees C for 5 days while the second set was kept at 25 degrees C for 3 days. L. monocytogenes cells were recovered from the fruits and BHI, washed twice, re-suspended in saline, and used to inoculate G. mellonella larvae at final concentrations of 10(6) and 10(5) CFU/larva. The larvae were incubated at 37 degrees C and monitored for mortality (LT50-time taken to kill 50% of the larvae) and phenotypic changes over seven days. L. monocytogenes grown on cantaloupe and apple flesh surfaces resulted in higher virulence than when grown in BHI. L. monocytogenes infection at 10(6) CFU/larvae resulted in an average LT50 of. 30, 36 and 47 hours on cantaloupe, apples and BHI, respectively. These results represent a 2.5-4-fold increased mortality compared with an LT50.120 hours in larvae infected with the same doses of L. innocua grown in corresponding matrices. Similar trends were also recorded with doses of about 10(5) CFU/larvae.	[Martinez, Mira Rakic; Ferguson, Martine; Datta, Atin R.] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA	US Food & Drug Administration (FDA)	Martinez, MR (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA.	mira.rakicmartinez@fda.hhs.gov		Rakic Martinez, Mira/0000-0002-8758-2343				Andersen JB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-55; Angelo KM, 2017, EPIDEMIOL INFECT, V145, P848, DOI 10.1017/S0950268816003083; Bae D, 2013, APPL ENVIRON MICROB, V79, P6855, DOI 10.1128/AEM.01006-13; Brown DR., 2019, ESCHERICHIA COLI, V201; Burall LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150797; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; Charlier C, 2017, LANCET INFECT DIS, V17, P510, DOI [10.1016/s1473-3099(16)30521-7, 10.1016/S1473-3099(16)30521-7]; Chen Y, 2016, J FOOD PROTECT, V79, P1828, DOI 10.4315/0362-028X.JFP-16-208; Conte MP, 2002, INFECT IMMUN, V70, P4369, DOI 10.1128/IAI.70.8.4369-4378.2002; Conte MP, 2000, MICROB PATHOGENESIS, V29, P137, DOI 10.1006/mpat.2000.0379; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; de Zwart FJ, 2003, FOOD CHEM, V83, P197, DOI 10.1016/S0308-8146(03)00063-3; Faleiro ML, 2003, INT J FOOD MICROBIOL, V84, P207, DOI 10.1016/S0168-1605(02)00422-1; Garner MR, 2006, APPL ENVIRON MICROB, V72, P5384, DOI 10.1128/AEM.00764-06; Gaul LK, 2013, CLIN INFECT DIS, V56, P20, DOI 10.1093/cid/cis817; Hadjilouka A, 2016, FOOD MICROBIOL, V55, P7, DOI 10.1016/j.fm.2015.11.008; Harris L.J., 2003, COMPR REV FOOD SCI F, V2, P78, DOI [10.1111/j.1541-4337.2003.tb00031, DOI 10.1111/J.1541-4337.2003.TB00031]; Horn N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01962; Jackson BR, 2015, MMWR-MORBID MORTAL W, V64, P282; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joyce SA, 2010, MICROBIOL-SGM, V156, P3456, DOI 10.1099/mic.0.040782-0; Kang JH, 2019, FOOD MICROBIOL, V77, P192, DOI 10.1016/j.fm.2018.09.012; Larsen MH, 2010, FOODBORNE PATHOG DIS, V7, P1013, DOI 10.1089/fpd.2009.0470; Martinez MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184557; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Rietberg K, 2016, EPIDEMIOL INFECT, V144, P2728, DOI 10.1017/S0950268815003039; Sahu SN, 2017, FOOD CONTROL, V73, P1229, DOI 10.1016/j.foodcont.2016.10.044; Salazar JK, 2017, J FOOD PROTECT, V80, P1328, DOI [10.4315/0362-028X.JFP-16-516, 10.4315/0362-028x.jfp-16-516]; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schrama D, 2013, LETT APPL MICROBIOL, V56, P421, DOI 10.1111/lam.12064; Self JL, 2019, EMERG INFECT DIS, V25, P1461, DOI 10.3201/eid2508.180761; Shen Q, 2014, FOODBORNE PATHOG DIS, V11, P43, DOI 10.1089/fpd.2013.1611; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Tang SL, 2015, APPL ENVIRON MICROB, V81, P6812, DOI 10.1128/AEM.01752-15; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsai CJY, 2016, VIRULENCE, V7, P214, DOI 10.1080/21505594.2015.1135289; Wallace N, 2017, ARCH MICROBIOL, V199, P827, DOI 10.1007/s00203-017-1355-4; Walsh KA, 2014, FOODBORNE PATHOG DIS, V11, P945, DOI 10.1089/fpd.2014.1812	41	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232485	10.1371/journal.pone.0232485	http://dx.doi.org/10.1371/journal.pone.0232485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357157	gold, Green Published			2022-12-26	WOS:000536957700034
J	Aguilar-Vega, C; Fernandez-Carrion, E; Lucientes, J; Sanchez-Vizcaino, JM				Aguilar-Vega, Cecilia; Fernandez-Carrion, Eduardo; Lucientes, Javier; Manuel Sanchez-Vizcaino, Jose			A model for the assessment of bluetongue virus serotype 1 persistence in Spain	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; VECTORS CULICOIDES-IMICOLA; DIPTERA-CERATOPOGONIDAE; OBSOLETUS COMPLEX; NORTHERN EUROPE; BREEDING SITES; ABUNDANCE; CLIMATE; PERFORMANCE; CATTLE	Bluetongue virus (BTV) is an arbovirus of ruminants that has been circulating in Europe continuously for more than two decades and has become endemic in some countries such as Spain. Spain is ideal for BTV epidemiological studies since BTV outbreaks from different sources and serotypes have occurred continuously there since 2000; BTV-1 has been reported there from 2007 to 2017. Here we develop a model for BTV-1 endemic scenario to estimate the risk of an area becoming endemic, as well as to identify the most influential factors for BTV-1 persistence. We created abundance maps at 1-km(2) spatial resolution for the main vectors in Spain, Culicoides imicola and Obsoletus and Pulicaris complexes, by combining environmental satellite data with occurrence models and a random forest machine learning algorithm. The endemic model included vector abundance and host-related variables (farm density). The three most relevant variables in the endemic model were the abundance of C. imicola and Obsoletus complex and density of goat farms (AUC 0.86); this model suggests that BTV-1 is more likely to become endemic in central and southwestern regions of Spain. It only requires host- and vector-related variables to identify areas at greater risk of becoming endemic for bluetongue. Our results highlight the importance of suitable Culicoides spp. prediction maps for bluetongue epidemiological studies and decision-making about control and eradication measures.	[Aguilar-Vega, Cecilia; Fernandez-Carrion, Eduardo; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Fac Vet Med, VISAVET Hlth Surveillance Ctr, Anim Hlth Dept, Madrid, Spain; [Lucientes, Javier] Univ Zaragoza, Fac Vet Med, AgriFood Inst Aragon IA2, Dept Anim Pathol Anim Hlth, Zaragoza, Spain	Complutense University of Madrid; University of Zaragoza	Aguilar-Vega, C (corresponding author), Univ Complutense Madrid, Fac Vet Med, VISAVET Hlth Surveillance Ctr, Anim Hlth Dept, Madrid, Spain.	ceciagui@ucm.es		Aguilar-Vega, Cecilia/0000-0001-5981-7291	H2020 EU project 'Understanding pathogen, livestock, environment interactions involving bluetongue' [727393-2]; Spanish Government by the Spanish Ministry of Science, Innovation and Universities	H2020 EU project 'Understanding pathogen, livestock, environment interactions involving bluetongue'; Spanish Government by the Spanish Ministry of Science, Innovation and Universities	This study was funded by the H2020 EU project 'Understanding pathogen, livestock, environment interactions involving bluetongue' (project No: 727393-2). CA-V is the recipient of a Spanish Government-funded PhD fellowship for the Training of Future Scholars (FPU) given by the Spanish Ministry of Science, Innovation and Universities.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Aguilar-Vega C, 2019, TRANSBOUND EMERG DIS, V66, P1665, DOI 10.1111/tbed.13201; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Arenas-Montes A, 2016, TRANSBOUND EMERG DIS, V63, pE339, DOI 10.1111/tbed.12309; Ballabio C, 2016, GEODERMA, V261, P110, DOI 10.1016/j.geoderma.2015.07.006; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Batten C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096049; Baylis M, 1998, MED VET ENTOMOL, V12, P255, DOI 10.1046/j.1365-2915.1998.00109.x; Baylis M, 1997, MED VET ENTOMOL, V11, P203, DOI 10.1111/j.1365-2915.1997.tb00397.x; Bonneau KR, 2002, VET MICROBIOL, V88, P115, DOI 10.1016/S0378-1135(02)00106-2; Boyd D. S., 1998, REMOTE SENSING REV, V16, P293, DOI DOI 10.1080/02757259809532357; BRAVERMAN Y, 1974, MOSQ NEWS, V34, P303; Breard E, 2018, TRANSBOUND EMERG DIS, V65, pe251, DOI 10.1111/tbed.12780; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brugger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060330; Bumbarov V, 2020, TRANSBOUND EMERG DIS, V67, P171, DOI 10.1111/tbed.13338; Calistri P, 2003, J VET MED B, V50, P132, DOI 10.1046/j.1439-0442.2003.00513.x; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2006, VET REC, V158, P130, DOI 10.1136/vr.158.4.130; Calvete C, 2009, VET J, V182, P235, DOI 10.1016/j.tvjl.2008.06.010; Calvete C, 2009, ITEA-INF TEC ECON AG, V105, P147; Campbell J.B., 2011, INTRO REMOTE SENSING; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Chanda MM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40450-8; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Diarra M, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2920-7; Didan K., 2015, MOD13Q1 MODIS TERRA, DOI 10.5067/M0DIS/M0D13Q1.006; Ducheyne E, 2013, GEOSPATIAL HEALTH, V8, P241, DOI 10.4081/gh.2013.70; Durr PA, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00098; EFSA Panel Anim Hlth Welfare, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4698; Eksteen S, 2011, S AFR J SCI, V107, P19, DOI 10.4102/sajs.v107i7/8.404; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESA, LAND COVER CCI PRODU; European Centre for Disease Prevention and Control and European Food Safety Authority, 2018, IMP VECT AB SEAS RES; Fernandez-Carrion E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194573; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Giovannini A, 2004, RISK ANAL, V24, P1737, DOI 10.1111/j.0272-4332.2004.00563.x; Gonzalez M, 2013, VET PARASITOL, V191, P81, DOI 10.1016/j.vetpar.2012.08.025; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Instituto Nacional de Estadistica, 2018, AGR CENS 2009 2011; Ippoliti C, 2013, GEOSPATIAL HEALTH, V8, P267, DOI 10.4081/gh.2013.72; Jacquot M, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0919; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Jones RJA, 2005, EUR J SOIL SCI, V56, P655, DOI 10.1111/j.1365-2389.2005.00728.x; Kirkeby C, 2009, ENTOMOL FENNICA, V20, P228; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MAGRAMA, 2015, INF SIT VIR LENG TER; MAGRAMA, 2012, SIT EP LENG AZ TER A; MAGRAMA, 2015, INF DECL LIBR SER 1; Manso-Ribeiro J., 1957, B OFF INT EPIZOOT, V48, P350; MAPA, 2019, INF DECL LIBR SER 1; MAPA, 2018, GAN 2018; MARM, 2011, PROGR NAC VIG CONTR; MARM, 2008, LENG AZ SIT ENT ESP; Martinez-de la Puente J, 2017, MED VET ENTOMOL, V31, P333, DOI 10.1111/mve.12247; Martinez-de la Puente J, 2015, TRENDS PARASITOL, V31, P16, DOI 10.1016/j.pt.2014.11.002; Martinez-Lopez B, 2009, 12 S INT SOC VET EP, P94; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Meiswinkel R, 1997, ONDERSTEPOORT J VET, V64, P81; Meiswinkel R., 2004, Infectious diseases of livestock, Volume One, P93; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Miranda MA, 2004, VETER ITAL SER, V40, P292; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Napp S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151151; OIE, WAHIS INT 2019; Pascual-Linaza AV, 2014, PREV VET MED, V116, P279, DOI 10.1016/j.prevetmed.2014.05.009; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; de Diego ACP, 2014, TRANSBOUND EMERG DIS, V61, pE1, DOI 10.1111/tbed.12068; Peters J, 2011, PREV VET MED, V100, P15, DOI 10.1016/j.prevetmed.2011.03.004; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Purse BV, 2007, J APPL ECOL, V44, P1231, DOI 10.1111/j.1365-2664.2007.01342.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramilo DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180606; Lopez-Olvera JR, 2010, VET MICROBIOL, V145, P148, DOI 10.1016/j.vetmic.2010.03.012; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rossi S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100903; Rushton J, 2015, VET ITAL, V51, P401, DOI 10.12834/VetIt.646.3183.1; Scolamacchia F, 2014, MED VET ENTOMOL, V28, P143, DOI 10.1111/mve.12028; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Talavera S, 2015, PLOS ONE, V10, DOI [10.1371/journ, 10.1371/journal.pone.0141667]; Torgo L., 2010, DATA MINING R LEARNI; USGS, 1996, GLOB 30 ARC 2 EL GTO; Verwoerd D. W., 2004, Infectious diseases of livestock. Volume Two, P1201; Viennet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048120; Wan Z., 2015, MOD11A2 MODIS TERRA, DOI [10.5067/MODIS/MOD11A2.006, DOI 10.5067/MODIS/MOD11A2.006]; Wilson Anthony, 2008, Parasitol Res, V103 Suppl 1, pS69, DOI 10.1007/s00436-008-1053-x; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; WINT W, 2014, OPEN HLTH DATA, V2, pE1, DOI DOI 10.5334/0HD.AG); Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306; Zientara S, 2013, VET MICROBIOL, V165, P33, DOI 10.1016/j.vetmic.2013.01.010	97	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232534	10.1371/journal.pone.0232534	http://dx.doi.org/10.1371/journal.pone.0232534			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353863	Green Published, gold			2022-12-26	WOS:000536673200105
J	Dong, CJ; Li, Q; Wang, LL; Shang, QM				Dong, Chun-Juan; Li, Qian; Wang, Ling-Ling; Shang, Qing-Mao			Dynamic changes in bacterial communities in the recirculating nutrient solution of cucumber plug seedlings cultivated in an ebb-and-flow subirrigation system	PLOS ONE			English	Article							PHYTOPHTHORA-NICOTIANAE; PSEUDOMONAS-AERUGINOSA; IRRIGATION WATER; PLANT-PATHOGENS; TRANSMISSION; IDENTIFICATION; DIVERSITY; GROWTH; WILT; ROT	Ebb-and-flow subirrigation systems are highly efficient, water-saving and environmentally friendly. However, one concern with these recirculating systems is the possible transmission of plant pathogens. Here, through 16S rRNA-targeted Illumina sequencing, the bacterial dynamics in a recirculating nutrient solution were characterized for cucumber plug seedlings cultivated in an ebb-and-flow system in summer and winter. Both the bacterial number and diversity in the nutrient solution increased immediately after the first irrigation cycle; then, these values were gradually stable with recirculating irrigation. In summer and winter, different bacterial compositions and changing patterns were observed. In summer, the predominant genera in the nutrient solution included Comamonas, Pseudomonas, Acinetobacter, Reyranella, Sphingobium, Bradyrhizobium, Sphingomonas, and Acidovorax. Of those genera, during recirculating irrigation, the relative abundance of Bradyrhizobium gradually decreased, whereas those of Pseudomonas, Reyranella, Sphingobium, Sphingomonas, and Acidovorax gradually increased. In winter, the bacterial communities were mainly composed of Nevskia, Bosea, Sphingobium, Acidovorax, Pseudomonas, and Hydrocarboniphaga. Of those genera, the relative abundance of Bosea, Sphingobium, and Acidovorax showed an increasing trend, whereas those of Nevskia and Hydrocarboniphaga decreased overall. Furthermore, in both summer and winter, no plant pathogenic bacteria on cucumber could be detected; however, some potentially beneficial bacteria, including Comamonas testosteroni, Acinetobacter baumannii, Pseudomonas aeruginosa, P. koreensis and Sphingobium yanoikuyae, colonized the nutrient solution and exhibited increased relative abundances during irrigation. The colonization of these bacteria might facilitate the plant growth promotion. Inoculation of the microbes from the effluent nutrient solution also promoted the growth of cucumber seedlings, but did not lead to any disease. The present data elucidate the bacterial dynamics in a cucumber cultivation ebb-and-flow system and provide useful information for biological control during cucumber seedling production.	[Dong, Chun-Juan; Li, Qian; Wang, Ling-Ling; Shang, Qing-Mao] Chinese Acad Agr Sci, Minist Agr, Key Lab Hort Crop Biol & Germplasm Innovat, Inst Vegetables & Flowers, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Dong, CJ; Shang, QM (corresponding author), Chinese Acad Agr Sci, Minist Agr, Key Lab Hort Crop Biol & Germplasm Innovat, Inst Vegetables & Flowers, Beijing, Peoples R China.	dongchunjuan@caas.cn; dcj04@tsinghua.org.cn			National Key Research and Development Program of China [2016YED0201003]; China Agriculture Research System [CARS-25]; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAASASTIPIVFCAAS)	National Key Research and Development Program of China; China Agriculture Research System; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAASASTIPIVFCAAS)	This work was supported by grants from the National Key Research and Development Program of China (No. 2016YED0201003), the China Agriculture Research System (CARS-25), and the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAASASTIPIVFCAAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonsi MO, 2010, J MICROBIOL METH, V83, P260, DOI 10.1016/j.mimet.2010.08.019; ALIPPI A M, 1989, Revista Argentina de Microbiologia, V21, P15; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; ATMATJIDOU VP, 1991, PLANT DIS, V75, P1261, DOI 10.1094/PD-75-1261; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Bradley GG, 2010, CAN J MICROBIOL, V56, P896, DOI 10.1139/w10-076; BUWALDA F, 1994, ACTA HORTIC, P123, DOI 10.17660/ActaHortic.1994.361.10; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35386; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Cunliffe M, 2006, ENVIRON POLLUT, V144, P228, DOI 10.1016/j.envpol.2005.12.026; Deniel F, 2004, CAN J MICROBIOL, V50, P499, DOI [10.1139/w04-034, 10.1139/W04-034]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EVANS RD, 1994, ADV SPACE RES, V14, P367, DOI 10.1016/0273-1177(94)90323-9; Fernandez-Pavia SP, 2006, PLANT DIS, V90, P1552, DOI 10.1094/PD-90-1552C; Ferrarezi RS, 2017, AGR WATER MANAGE, V192, P21, DOI 10.1016/j.agwat.2017.06.017; Flowers JJ, 2013, WATER RES, V47, P7019, DOI 10.1016/j.watres.2013.07.054; Fu YJ, 2015, BIOTECHNOL BIOPROC E, V20, P931, DOI 10.1007/s12257-015-0228-4; Guo XA, 2002, APPL ENVIRON MICROB, V68, P3639, DOI 10.1128/AEM.68.7.3639-3643.2002; Harding CM, 2018, NAT REV MICROBIOL, V16, P91, DOI 10.1038/nrmicro.2017.148; Harighi B, 2007, PLANT DIS, V91, P769, DOI 10.1094/PDIS-91-6-0769A; Heungens K, 2015, Commun Agric Appl Biol Sci, V80, P539; Hong CX, 2005, CRIT REV PLANT SCI, V24, P189, DOI 10.1080/07352680591005838; Hultberg M, 2010, BIOCONTROL, V55, P435, DOI 10.1007/s10526-009-9261-6; Khan ST, 2002, APPL ENVIRON MICROB, V68, P3206, DOI 10.1128/AEM.68.7.3206-3214.2002; Lee S, 2015, SCI HORTIC-AMSTERDAM, V195, P206, DOI 10.1016/j.scienta.2015.09.011; Li HB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01268; Lin HR, 2018, MICROBIOL RES, V216, P30, DOI 10.1016/j.micres.2018.08.004; Liu L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1314-x; Luo LY, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0800-y; Mahaffee WF, 2016, PHYTOPATHOLOGY, V106, P420, DOI 10.1094/PHYTO-02-16-0060-RVW; McCoy ST, 2014, ENVIRON ENG SCI, V31, P32, DOI 10.1089/ees.2013.0174; Meng XL, 2017, PLANT DIS, V101, P279, DOI 10.1094/PDIS-05-16-0763-RE; Neves ALA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02445; Oh MM, 2008, SCI HORTIC-AMSTERDAM, V119, P75, DOI 10.1016/j.scienta.2008.07.026; Palm HW, 2018, AQUACULT INT, V26, P813, DOI 10.1007/s10499-018-0249-z; Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14; Prenafeta-Boldu FX, 2017, SCI TOTAL ENVIRON, V599, P780, DOI 10.1016/j.scitotenv.2017.04.221; Qin YX, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02620; Raudales RE, 2014, AGR WATER MANAGE, V143, P9, DOI 10.1016/j.agwat.2014.06.007; Rojas ES, 2015, PLANT DIS, V99, P564, DOI 10.1094/PDIS-10-14-1068-FE; SANOGO S, 1993, PLANT DIS, V77, P287, DOI 10.1094/PD-77-0287; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroth MN, 2018, J MED MICROBIOL, V67, P1191, DOI 10.1099/jmm.0.000758; Settanni L, 2013, INT J FOOD MICROBIOL, V160, P344, DOI 10.1016/j.ijfoodmicro.2012.11.011; Sh YW, 2015, J MICROBIOL, V53, P678, DOI 10.1007/s12275-015-5080-x; Stanghellini ME, 2000, PLANT DIS, V84, P1147, DOI 10.1094/PDIS.2000.84.10.1147; Stewart-Wade SM, 2011, IRRIGATION SCI, V29, P267, DOI 10.1007/s00271-011-0285-1; STRAYER RF, 1994, ADV SPACE RES, V14, P357, DOI 10.1016/0273-1177(94)90322-0; Strong SS, 1997, PLANT DIS, V81, P89, DOI 10.1094/PDIS.1997.81.1.89; Tewolde FT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00448; Toribio J, 2011, SYST APPL MICROBIOL, V34, P531, DOI 10.1016/j.syapm.2011.01.007; Vallance J, 2011, AGRON SUSTAIN DEV, V31, P191, DOI 10.1051/agro/2010018; Watanabe K, 2005, SOIL SCI PLANT NUTR, V51, P491, DOI 10.1111/j.1747-0765.2005.tb00057.x; West TP, 2005, J BASIC MICROB, V45, P160, DOI 10.1002/jobm.200410506; Zhao JS, 1999, CAN J MICROBIOL, V45, P427, DOI 10.1139/cjm-45-5-427	57	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232446	10.1371/journal.pone.0232446	http://dx.doi.org/10.1371/journal.pone.0232446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353053	Green Published, gold			2022-12-26	WOS:000536673200093
J	Reddy, GK; Leferink, NGH; Umemura, M; Ahmed, ST; Breitling, R; Scrutton, NS; Takano, E				Reddy, Gajendar Komati; Leferink, Nicole G. H.; Umemura, Maiko; Ahmed, Syed T.; Breitling, Rainer; Scrutton, Nigel S.; Takano, Eriko			Exploring novel bacterial terpene synthases	PLOS ONE			English	Article							RAPID CHEMICAL-CHARACTERIZATION; ESCHERICHIA-COLI; SESQUITERPENE SYNTHASE; SORANGIUM-CELLULOSUM; BIOSYNTHESIS; GENES; IDENTIFICATION; METABOLITE; EXPRESSION; GERMACRENE	Terpenes are the largest class of natural products with extensive structural diversity and are widely used as pharmaceuticals, herbicides, flavourings, fragrances, and biofuels. While they have mostly been isolated from plants and fungi, the availability and analysis of bacterial genome sequence data indicates that bacteria also possess many putative terpene synthase genes. In this study, we further explore this potential for terpene synthase activity in bacteria. Twenty two potential class I terpene synthase genes (TSs) were selected to represent the full sequence diversity of bacterial synthase candidates and recombinantly expressed in E. coli. Terpene synthase activity was detected for 15 of these enzymes, and included mono-, sesqui- and diterpene synthase activities. A number of confirmed sesquiterpene synthases also exhibited promiscuous monoterpene synthase activity, suggesting that bacteria are potentially a richer source of monoterpene synthase activity then previously assumed. Several terpenoid products not previously detected in bacteria were identified, including aromandendrene, acora-3,7(14)-diene and longiborneol. Overall, we have identified promiscuous terpene synthases in bacteria and demonstrated that terpene synthases with substrate promiscuity are widely distributed in nature, forming a rich resource for engineering terpene biosynthetic pathways for biotechnology.	[Reddy, Gajendar Komati; Leferink, Nicole G. H.; Ahmed, Syed T.; Breitling, Rainer; Scrutton, Nigel S.; Takano, Eriko] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester Synthet Biol Res Ctr SYNBIOCHEM, Manchester, England; [Leferink, Nicole G. H.; Scrutton, Nigel S.; Takano, Eriko] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Future Biomfg Res Hub FBRH, Manchester, England; [Umemura, Maiko] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Umemura, Maiko] AIST, AIST Waseda Univ Computat Bio Big Data Open Innov, Tsukuba, Ibaraki, Japan	University of Manchester; University of Manchester; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Takano, E (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester Synthet Biol Res Ctr SYNBIOCHEM, Manchester, England.; Takano, E (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Future Biomfg Res Hub FBRH, Manchester, England.	eriko.takano@manchester.ac.uk	Leferink, Nicole G H/I-6867-2012	Leferink, Nicole G H/0000-0003-4134-4339; Takano, Eriko/0000-0002-6791-3256; KOMATI REDDY, GAJENDAR/0000-0002-1471-4966	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M000354/1]; EPSRC/BBSRC Future Biomanufacturing Research Hub [EP/S01778X/1]; EPSRC [EP/J020192/1]; Engineering and Physical Sciences Research Council (EPSRC) [BB/M017702/1]; BBSRC; BBSRC [BB/M017702/1, BB/L027593/1, BB/M000354/1] Funding Source: UKRI; EPSRC [EP/S01778X/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC/BBSRC Future Biomanufacturing Research Hub(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Y RB, NGHL, GKR, NS, ET was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC) BB/M000354/1. NGHL was funded as a Research Fellow of the EPSRC/BBSRC Future Biomanufacturing Research Hub (EP/S01778X/1). N.S.S. was funded as an EPSRC Established Career Fellow (EP/J020192/1). RB, NS, ET was funded BBSRC and Engineering and Physical Sciences Research Council (EPSRC) (BB/M017702/1).	Adams R. P, 2007, IDENTIFICATION ESSEN, DOI [10.1163/_q3_SIM_00374, DOI 10.1163/_Q3_SIM_00374]; Agger SA, 2008, J BACTERIOL, V190, P6084, DOI 10.1128/JB.00759-08; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Alquezar B, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01481; Baer P, 2014, CHEMBIOCHEM, V15, P213, DOI 10.1002/cbic.201300708; Baser K.H.C., 2015, HDB ESSENTIAL OILS S, DOI DOI 10.1201/B19393; Behrendt U, 2007, INT J SYST EVOL MICR, V57, P1881, DOI 10.1099/ijs.0.65104-0; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; BOWERS WS, 1977, SCIENCE, V196, P680, DOI 10.1126/science.558651; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; CANE DE, 1994, BIOCHEMISTRY-US, V33, P5846, DOI 10.1021/bi00185a024; Chertkov O, 2011, STAND GENOMIC SCI, V4, P13, DOI 10.4056/sigs.1453580; Chow JY, 2015, P NATL ACAD SCI USA, V112, P5661, DOI 10.1073/pnas.1505127112; Christianson DW, 2017, CHEM REV, V117, P11570, DOI 10.1021/acs.chemrev.7b00287; Currin A, 2018, ACS CATAL, V8, P2012, DOI 10.1021/acscatal.7b04115; Dickschat JS, 2017, BEILSTEIN J ORG CHEM, V13, P1770, DOI 10.3762/bjoc.13.171; Dickschat JS, 2016, NAT PROD REP, V33, P87, DOI 10.1039/c5np00102a; Dickschat JS, 2014, CHEMBIOCHEM, V15, P810, DOI 10.1002/cbic.201300763; Egas C, 2014, Stand Genomic Sci, V9, P1062, DOI 10.4056/sigs.5661021; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; GE Healthcare, 2007, PD10 DESALT COLUMN; GERBER NN, 1969, J ANTIBIOT, V22, P508, DOI 10.7164/antibiotics.22.508; Gerber NN, 1965, APPL MICROBIOL; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Harris GG, 2015, BIOCHEMISTRY-US, V54, P7142, DOI 10.1021/acs.biochem.5b01143; Helfrich EJN, 2019, BEILSTEIN J ORG CHEM, V15, P2889, DOI 10.3762/bjoc.15.283; Jia QD, 2016, P NATL ACAD SCI USA, V113, P12328, DOI 10.1073/pnas.1607973113; Jiang JY, 2007, NAT CHEM BIOL, V3, P711, DOI 10.1038/nchembio.2007.29; Karunanithi PS, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01166; Karuppiah V, 2017, ACS CATAL, V7, P6268, DOI 10.1021/acscatal.7b01924; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koe BK, 1957, ANTIBIOT ANNU, P672; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Lee PC, 2005, METAB ENG, V7, P18, DOI 10.1016/j.ymben.2004.05.003; Leferink NGH, 2016, CHEMISTRYSELECT, V1, P1893, DOI 10.1002/slct.201600563; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li GL, 2012, P NATL ACAD SCI USA, V109, P14711, DOI 10.1073/pnas.1204300109; MARTIN DG, 1970, TETRAHEDRON LETT, P4901; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Minami A, 2018, NAT PROD REP, V35, P1330, DOI 10.1039/c8np00026c; Mulyaningsih S, 2010, PHYTOMEDICINE, V17, P1061, DOI 10.1016/j.phymed.2010.06.018; Nakano Chiaki, 2011, Chembiochem, V12, P2403, DOI 10.1002/cbic.201100501; Nakano C, 2011, CHEMBIOCHEM, V12, P1988, DOI 10.1002/cbic.201100330; Ong KS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02046; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pradella S, 2002, ARCH MICROBIOL, V178, P484, DOI 10.1007/s00203-002-0479-2; Rabe P, 2016, BEILSTEIN J ORG CHEM, V12, P1839, DOI 10.3762/bjoc.12.173; Rabe P, 2015, ANGEW CHEM INT EDIT, V54, P6041, DOI 10.1002/anie.201501119; Rabe P, 2013, ANGEW CHEM INT EDIT, V52, P1810, DOI 10.1002/anie.201209103; Rinkel J, 2019, ORG LETT, V21, P2426, DOI 10.1021/acs.orglett.9b00725; Rinkel J, 2019, ANGEW CHEM INT EDIT, V58, P452, DOI 10.1002/anie.201812216; Rinkel J, 2017, ANGEW CHEM INT EDIT, V56, P16385, DOI 10.1002/anie.201711142; Schifrin A, 2016, ORG BIOMOL CHEM, V14, P3385, DOI 10.1039/c6ob00130k; Styles MQ, 2017, FEBS J, V284, P1700, DOI 10.1111/febs.14072; TAKEUCHI S, 1969, TETRAHEDRON LETT, P2737; Tian BX, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005053; WEINHEIMER AJ, 1970, TETRAHEDRON LETT, P497; Yamada Y, 2015, J ANTIBIOT, V68, P385, DOI 10.1038/ja.2014.171; Yamada Y, 2015, P NATL ACAD SCI USA, V112, P857, DOI 10.1073/pnas.1422108112; Yuan YJ, 2019, CHEMBIOCHEM, V20, P677, DOI 10.1002/cbic.201800670	65	18	18	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232220	10.1371/journal.pone.0232220	http://dx.doi.org/10.1371/journal.pone.0232220			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353014	Green Published, gold			2022-12-26	WOS:000536673200053
J	Rahman, SMT; Zhou, WY; Deiters, A; Haugh, JM				Rahman, Shah Md. Toufiqur; Zhou, Wenyuan; Deiters, Alexander; Haugh, Jason M.			Optical control of MAP kinase kinase 6 (MKK6) reveals that it has divergent roles in pro-apoptotic and anti-proliferative signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						optogenetics; signal transduction; cell signaling; mitogen-activated protein kinases; apoptosis; cell death; cell stress; mitogen-activated protein kinase (MAPK)	ACTIVATED PROTEIN-KINASE; CYTOCHROME-C RELEASE; P38 MAPK; CELL-DEATH; CROSS-TALK; SPATIOTEMPORAL CONTROL; CASPASE-8 ACTIVATION; GENOTOXIC STRESS; GENE-FUNCTION; PATHWAYS	The selective pressure imposed by extrinsic death signals and stressors adds to the challenge of isolating and interpreting the roles of proteins in stress-activated signaling networks. By expressing a kinase with activating mutations and a caged lysine blocking the active site, we can rapidly switch on catalytic activity with light and monitor the ensuing dynamics. Applying this approach to MAP kinase 6 (MKK6), which activates the p38 subfamily of MAPKs, we found that decaging active MKK6 in fibroblasts is sufficient to trigger apoptosis in a p38-dependent manner. Both in fibroblasts and in a murine melanoma cell line expressing mutant B-Raf, MKK6 activation rapidly and potently inhibited the pro-proliferative extracellular signal?regulated kinase (ERK) pathway; to our surprise, this negative cross-regulation was equally robust when all p38 isoforms were inhibited. These results position MKK6 as a new pleiotropic signal transducer that promotes both pro-apoptotic and anti-proliferative signaling, and they highlight the utility of caged, light-activated kinases for dissecting stress-activated signaling networks.	[Rahman, Shah Md. Toufiqur; Haugh, Jason M.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Zhou, Wenyuan; Deiters, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Haugh, JM (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu	Deiters, Alexander/L-3722-2013; Rahman, Shah Md Toufiqur/AAP-8793-2020	Deiters, Alexander/0000-0003-0234-9209; Haugh, Jason/0000-0002-2476-4027; Rahman, Shah Md. Toufiqur/0000-0001-5419-0696	National Science Foundation [MCB-1330746, CBET-1603930]; UNC Lineberger Developmental Grant from the University Cancer Research Fund	National Science Foundation(National Science Foundation (NSF)); UNC Lineberger Developmental Grant from the University Cancer Research Fund	This work was supported by National Science Foundation Grants MCB-1330746 (to A. D. and J. M. H.) and CBET-1603930 (to A. D.) and a UNC Lineberger Developmental Grant from the University Cancer Research Fund.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Ankenbruck N, 2018, ANGEW CHEM INT EDIT, V57, P2768, DOI 10.1002/anie.201700171; Asokan SB, 2014, DEV CELL, V31, P747, DOI 10.1016/j.devcel.2014.10.024; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chalfoun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36984; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chou CJ, 2010, CHEMBIOCHEM, V11, P972, DOI 10.1002/cbic.201000041; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; COURTNEY T, 2019, NAT COMMUN, V10, P1, DOI DOI 10.1038/s41467-018-07882-8; Courtney T, 2018, CURR OPIN CHEM BIOL, V46, P99, DOI 10.1016/j.cbpa.2018.07.011; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Diaz-Martinez LA, 2014, EMBO J, V33, P1960, DOI 10.15252/embj.201487826; Edwards WF, 2009, ACS CHEM BIOL, V4, P441, DOI 10.1021/cb900041s; Engelke H, 2014, ACS SYNTH BIOL, V3, P731, DOI 10.1021/sb400192a; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Farley N, 2006, MOL CELL BIOL, V26, P2118, DOI 10.1128/MCB.26.6.2118-2129.2006; Finch AR, 2012, CELL SIGNAL, V24, P1002, DOI 10.1016/j.cellsig.2011.12.021; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gomez-Lazaro M, 2007, MOL PHARMACOL, V71, P736, DOI 10.1124/mol.106.030718; Graves LM, 2013, BIOCHEM J, V450, P1, DOI 10.1042/BJ20121456; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hanna SC, 2013, J CLIN INVEST, V123, P2078, DOI 10.1172/JCI66715; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hoppe J, 2002, EUR J CELL BIOL, V81, P567, DOI 10.1078/0171-9335-00276; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joo SS, 2009, J PINEAL RES, V47, P8, DOI 10.1111/j.1600-079X.2009.00682.x; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Lee J, 2002, BIOCHEM BIOPH RES CO, V298, P765, DOI 10.1016/S0006-291X(02)02562-7; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Lee SR, 2003, STROKE, V34, P2704, DOI 10.1161/01.STR.0000096540.40826.BA; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li SP, 2020, CANCER RES, V80, P364, DOI 10.1158/0008-5472.CAN-19-3320; Liaunardy-Jopeace A, 2017, NAT STRUCT MOL BIOL, V24, P1155, DOI 10.1038/nsmb.3492; Liu J, 2014, ASIAN PAC J CANCER P, V15, P4519, DOI 10.7314/APJCP.2014.15.11.4519; Liu JH, 2017, J AM CHEM SOC, V139, P9100, DOI 10.1021/jacs.7b02145; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Liu QY, 2014, ACCOUNTS CHEM RES, V47, P45, DOI 10.1021/ar400036a; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Nicholls SB, 2011, J BIOL CHEM, V286, P24977, DOI 10.1074/jbc.M111.221648; Pathak GP, 2013, BIOL CELL, V105, P59, DOI 10.1111/boc.201200056; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; She QB, 2001, CANCER RES, V61, P1604; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Shi QH, 2012, P NATL ACAD SCI USA, V109, P419, DOI 10.1073/pnas.1110865109; Shimo T, 2007, J CELL COMMUN SIGNAL, V1, P103, DOI 10.1007/s12079-007-0010-2; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Umeda N, 2011, J AM CHEM SOC, V133, P12, DOI 10.1021/ja108258d; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	88	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8494	8504		10.1074/jbc.RA119.012079	http://dx.doi.org/10.1074/jbc.RA119.012079			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371393	hybrid, Green Published			2022-12-26	WOS:000546986500014
J	Dawson-Rose, C; Gutin, SA; Mudender, F; Hunguana, E; Kevany, S				Dawson-Rose, Carol; Gutin, Sarah A.; Mudender, Florindo; Hunguana, Elsa; Kevany, Sebastian			Effects of a peer educator program for HIV status disclosure and health system strengthening: Findings from a clinic-based disclosure support program in Mozambique	PLOS ONE			English	Article							REFERRAL SERVICES; PARTNER SERVICES; SOUTHERN AFRICA; PREVENTION; CARE; THERAPY; TRENDS	Background In Mozambique, HIV counseling and testing (HCT) rates are low and the cascade (or continuum) of care is poor. Perhaps more importantly, low disclosure rates and low uptake of joint testing are also related to both (1) limitations on access to services and (2) the availability of trained staff. We describe the implementation and impact of a disclosure support implemented by peer educators (PE). Methods Ten PEs, previously trained in basic HIV and post-test counseling, completed additional training on providing disclosure support for newly-diagnosed persons living with HIV (PLH). Results Of the 6,092 persons who received HCT, 677 (11.1%) tested positive. Any newly-diagnosed PLH who was tested when PEs were present (606 / 677) was approached about participating in the disclosure program; of these, 94.2% of PLH (n = 574) agreed to participate. Of these, at follow-up (between 1 day and 3 months later, depending on client inclination and availability) 91.9% (n = 528) said that they had disclosed their HIV infection, of whom 66.9% (n = 384) were female and 24.1% (n = 144) male. In turn, 92.7% of partners (n = 508) who had received HIV-related exposure information were tested; of these, 78.7% (n = 400) were found to be HIV-positive. Of the latter, 96.3% (n = 385) were then seen by health care providers and referred for further diagnosis and treatment. Conclusions Supporting newly-diagnosed PLH is important both for their own health and that of others. For the newly-diagnosed, there are extensive challenges related to understanding the implications of their illness; social support from clinical care teams can be vital in planning and coping. Our study has shown that such support of PLH is also crucial to disclosure, in part via improving awareness of positive health implications for (and from) family, friends and other support networks.	[Dawson-Rose, Carol; Gutin, Sarah A.; Kevany, Sebastian] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mudender, Florindo; Hunguana, Elsa] Int Training & Educ Ctr Hlth I TECH, Maputo, Mozambique	University of California System; University of California San Francisco	Kevany, S (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	sebastian.kevany@ucsf.edu		Gutin, Sarah/0000-0002-7634-1296	NIMH NIH HHS [T32 MH019105] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abuelezam NN, 2019, EPIDEMIOLOGY INFECT, P147; Auld AF, 2016, JAIDS-J ACQ IMM DEF, V73, pE11, DOI 10.1097/QAI.0000000000001137; Centers for Disease Control and Prevention, 2014, INT ID HIV POS PEOPL; Chen M., 2010, AUSTRALASIAN CONTACT; Das M, 2010, PLOS ONE, V5; De Cock KM, 2019, AIDS, V33, P349, DOI [10.1097/qad.0000000000002096, 10.1097/QAD.0000000000002096]; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097547; Fifield J, 2018, AIDS BEHAV, V22, P3287, DOI 10.1007/s10461-018-2136-z; Golden MR, 2007, AM J PREV MED, V33, pS84, DOI 10.1016/j.amepre.2007.04.016; Golden MR, 2017, AIDS, V31, P1891, DOI 10.1097/QAD.0000000000001534; Gutin SA, 2014, EVAL PROGRAM PLANN, V43, P38, DOI 10.1016/j.evalprogplan.2013.10.006; Herbeck JT, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003673; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Human Development Report, 2015, WORK HUM DEV BRIEF N; Johnson M, 2018, AIDS, V32, pS75, DOI 10.1097/QAD.0000000000001880; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Kevany S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-459; Korenromp EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142908; Marseille Elliot A, 2011, Cost Eff Resour Alloc, V9, P18, DOI 10.1186/1478-7547-9-18; Moitra E, 2017, AIDS BEHAV, V21, P2641, DOI 10.1007/s10461-017-1780-z; Murphy DA, 2011, J CONSULT CLIN PSYCH, V79, P203, DOI 10.1037/a0022896; Myers RS, 2016, SEX TRANSM DIS, V43, P690, DOI 10.1097/OLQ.0000000000000529; Pearson CR, 2009, AIDS BEHAV, V13, P1189, DOI 10.1007/s10461-009-9596-0; Raker AR, 2019, J ASSOC NURSE AIDS C, DOI [10.1007/S10461-017-1780-Z, DOI 10.1007/S10461-017-1780-Z]; Rose CD, 2011, J ASSOC NURSE AIDS C, V22, P38, DOI 10.1016/j.jana.2010.04.001; UNAIDS GNP+, 2013, POS HLTH DIGN PREV O; Vermund SH, 2015, CURR HIV-AIDS REP, V12, P191, DOI 10.1007/s11904-015-0270-z; Williams BG, 2015, CURR HIV-AIDS REP, V12, P196, DOI 10.1007/s11904-015-0264-x	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232347	10.1371/journal.pone.0232347	http://dx.doi.org/10.1371/journal.pone.0232347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZB	32374752	Green Published, gold			2022-12-26	WOS:000537283500030
J	Horn, PE; Pereira, MJR; Trigo, TC; Eizirik, E; Tirelli, FP				Horn, Paula E.; Pereira, Maria J. R.; Trigo, Tatiane C.; Eizirik, Eduardo; Tirelli, Flavia P.			Margay (Leopardus wiedii) in the southernmost Atlantic Forest: Density and activity patterns under different levels of anthropogenic disturbance	PLOS ONE			English	Article							SPATIAL CAPTURE-RECAPTURE; DOMESTIC DOGS; RAIN-FOREST; RELATIVE ABUNDANCE; PUMA-YAGOUAROUNDI; CARNIVORA FELIDAE; TEMPORAL ACTIVITY; SYMPATRIC FELIDS; POPULATION-SIZE; PROTECTED AREAS	The margay (Leopardus wiedii) is a small Neotropical arboreal wild cat. This species is thought to be forest-dependent, although few studies so far have directly evaluated the relationships between spatiotemporal aspects of its ecology and landscape characteristics. The aim of this study was to estimate margay population density and activity patterns in six areas with different habitat types and levels of anthropogenic disturbance in the southernmost Atlantic Forest of Brazil. Our working hypothesis was that density and activity patterns differed between areas in response to differences in forest cover and anthropogenic disturbance. Margay records were obtained using camera trapping, during spring and summer from 2017 to 2019. In all areas, the sampling scheme consisted of 20 un-baited stations, set 1km apart, each containing two paired cameras. We assessed the potential effects of environmental variables, including anthropogenic factors, on margay density, rate of detection and space use by comparing nine spatial capture-recapture (SCR) models. Activity patterns of the margay, its potential prey, and competitors were described and compared using the date and time of the records. We obtained 66 records of margay. Two of the six sampled areas were excluded from subsequent analyses due to the small number of records. The density estimated by the top-ranked model varied from 9.6 +/- 6.4 individuals/100km(2) in the area with the highest human disturbance to 37.4 +/- 15.1 individuals/100km(2) in a less disturbed area. Margay densities responded positively to vegetation cover, supporting the hypothesis of forest dependence by the species. Both the margay and their potential prey (small rodents and marsupials) were found to be mostly nocturnal. Margay activity also overlapped with that of the ocelot, Leopardus pardalis, and with mammals associated with human presence (wild boar, cattle, domestic dogs and cats). This is the first multi-area study on patterns of density and activity of the margay in the Brazilian Atlantic Forest. We concluded that the margay is mostly nocturnal, and while its densities are positively influenced by forest cover and negatively influenced by human disturbance, the activity pattern of the species does not seem to change across landscapes with distinct levels of human modification. Margay populations seem to be able to persist under moderate levels of habitat modification, highlighting the importance of preserving even small native forest remnants in the highly fragmented Atlantic Forest.	[Horn, Paula E.; Pereira, Maria J. R.; Tirelli, Flavia P.] Univ Fed Rio Grande do Sul, Inst Biociencias, Programa Posgrad Biol Anim, Dept Zool, Porto Alegre, RS, Brazil; [Pereira, Maria J. R.] Univ Aveiro, Ctr Environm & Marine Studies, Aveiro, Portugal; [Trigo, Tatiane C.] Secretaria Meio Ambiente & Nfraestrutura, Museu Ciencias Nat, Dept Biodiversidade, Setor Mastozool, Porto Alegre, RS, Brazil; [Trigo, Tatiane C.; Eizirik, Eduardo; Tirelli, Flavia P.] Inst Procarnivoros, Atibaia, SP, Brazil; [Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Escola Ciencias Saude & Vida, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Aveiro; Pontificia Universidade Catolica Do Rio Grande Do Sul	Horn, PE (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Programa Posgrad Biol Anim, Dept Zool, Porto Alegre, RS, Brazil.	paula.ehorn@gmail.com	Eizirik, Eduardo/K-8034-2012; Pereira, Maria João Ramos/AAH-9411-2021; Trigo, Tatiane C/B-8142-2016	Eizirik, Eduardo/0000-0002-9658-0999; Pereira, Maria João Ramos/0000-0002-9365-5166; Trigo, Tatiane/0000-0003-3694-6802; Pereira Tirelli, Flavia/0000-0002-9748-8721; Horn, Paula/0000-0002-9197-5545	CAPES MSc Schoolarship; PNPD/CAPES Fellowship; CNPq; CNPq Productivity Grant CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Panthera; Rufford Foundation	CAPES MSc Schoolarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PNPD/CAPES Fellowship; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq Productivity Grant CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Panthera; Rufford Foundation	PEH: CAPES MSc Schoolarship FPT: PNPD/CAPES Fellowship MJRP: CNPq Productivity Grant EE: CNPq Productivity Grant CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (https://www.capes.gov.br/) CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (https://www.cnpq.br) Panthera (https://www.panthera.org) The Rufford Foundation (https://www.rufford.org/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2017, R PACKAGECIRCULARCIR; Amo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027576; [Anonymous], 2008, ECOLOGIA CONSERVAC A; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; BARNETT BD, 1983, INT J STUD ANIM PROB, V4, P44; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Bernardo CSS, 2011, WILSON J ORNITHOL, V123, P690, DOI 10.1676/10-140.1; Bianchi RD, 2011, ZOOLOGIA-CURITIBA, V28, P127, DOI 10.1590/S1984-46702011000100018; Boas Goulart Fernando Vilas, 2009, Neotropical Biology and Conservation, V4, P137, DOI 10.4013/nbc.2009.43.03; Bolze GJ, 2019, ECOLOGIA COMPORTAMEN; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Briones-Salas Miguel Angel, 2016, Therya, V7, P123, DOI 10.12933/therya-16-320; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham KP, 2002, MODEL SELECTION MULT, V7; Campos CB, 2007, J ZOOL, V273, P14, DOI 10.1111/j.1469-7998.2007.00291.x; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Caruso N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206513; Carvajal-Villarreal S, 2012, MAMMALIA, V76, P237, DOI 10.1515/mammalia-2011-0100; Carvalho WD, 2019, NEOBIOTA, P55, DOI 10.3897/neobiota.45.30645; Chaikina N.A., 2006, RANGELANDS, V28, P8, DOI DOI 10.2111/1551-501X(2006)28[8:TEOCGO]2.0.CO;2; CIESIN, 2018, GRIDD POP WORLD VERS; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Correa CMA, 2019, ECOL ENTOMOL, V44, P524, DOI 10.1111/een.12729; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Cruz P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200806; Cunningham SC, 2015, PERSPECT PLANT ECOL, V17, P301, DOI 10.1016/j.ppees.2015.06.001; Mohr LRD, 2017, ZOOLOGIA-CURITIBA, V34, DOI 10.3897/zoologia.34.e20783; Curi NHD, 2010, BIODIVERS CONSERV, V19, P3513, DOI 10.1007/s10531-010-9911-0; Silva KVD, 2018, PERSPECT ECOL CONSER, V16, P228, DOI 10.1016/j.pecon.2018.9.01; de Oliveira T, 2015, INF SYST TECHN CISTI, P1; de Oliveira Tadeu G., 1998, Mammalian Species, V579, P1; de Oliveira TG, 1997, GUIA IDENTIFICAO FEL, P1; De Oliveira TG, 2018, ASSESSING SMALL CATS; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Dundas SJ, 2019, WILDLIFE RES, V46, P104, DOI 10.1071/WR18074; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Espinosa CC, 2018, J MAMMAL, V99, P252, DOI 10.1093/jmammal/gyx152; Ferreira GA, 2014, WILDLIFE BIOL, V20, P167, DOI 10.2981/wlb.13131; Foster VC, 2013, BIOTROPICA, V45, P373, DOI 10.1111/btp.12021; Fundacao Estadual de Protecao Ambiental Henrique Luiz Roessler-FEPAM, 2019, BIBL DIG FEPAM; Gardner B, 2018, ECOL EVOL, V8, P10336, DOI 10.1002/ece3.4509; GASTON KJ, 1990, BIOL REV, V65, P105, DOI 10.1111/j.1469-185X.1990.tb01185.x; Gaynor KM, 2018, SCIENCE, V360, P1232, DOI 10.1126/science.aar7121; GAYNOR KM, 2018, ECOLOGICAL CONSEQUEN, V360, P1232, DOI DOI 10.1126/SCIENCE.AAR7121; Gomez-Ortiz Y, 2019, MAMMAL RES, V64, P333, DOI 10.1007/s13364-019-00415-8; Graves VM, 2019, IMPACT ANTHROPOGENIC; Hansen AJ, 1992, ECOL STUD, P92; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Hofmann GS, 2016, INT J BIOMETEOROL, V60, P421, DOI 10.1007/s00484-015-1040-8; Horn JA, 2011, J WILDLIFE MANAGE, V75, P1177, DOI 10.1002/jwmg.145; Hunter Luke, 2015, P1; Instituto Chico Mendes de Conservacao da Biodiversidade ICMBio Centro Nacional de Pesquisa e Conservacao de Mamiferos Carnivoros CENAP, 2018, PLAN AC NAC CONS PEQ, P10; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Kasper CB, 2016, BRAZ J BIOL, V76, P228, DOI 10.1590/1519-6984.19414; Kasper CB, 2007, REV BRAS ZOOL, V24, P1087, DOI 10.1590/S0101-81752007000400028; Kasper CB, 2015, IHERINGIA SER ZOOL, V105, P367, DOI 10.1590/1678-476620151053367371; KILTIE RA, 1984, OECOLOGIA, V61, P411, DOI 10.1007/BF00379644; Krauze-Gryz D, 2012, CAN J ZOOL, V90, P1402, DOI 10.1139/cjz-2012-0072; Lacerda ACR, 2009, ANIM CONSERV, V12, P477, DOI 10.1111/j.1469-1795.2009.00277.x; Lobler CA, 2015, REV ELECTRON GEST ED, V19, P1250, DOI 10.5902/2236117016038; Lopez-Hernandez LD, 2010, THESIS; Lucherini M, 2009, J MAMMAL, V90, P1404, DOI 10.1644/09-MAMM-A-002R.1; Macdonald D. W., 2010, BIOL CONSERVATION WI, P1; MapBiomas, 2019, PROJ MAPBIOIMAS COL; Marques R. V., 2011, Revista Brasileira de Biociencias, V9, P278; Marques Rosane Vera, 2018, Revista Brasileira de Zoociencias, V19, P38; Marty JT, 2005, CONSERV BIOL, V19, P1626, DOI 10.1111/j.1523-1739.2005.00198.x; Massara RL, 2016, J MAMMAL, V97, P1634, DOI 10.1093/jmammal/gyw129; Massara RL, 2018, MAMM BIOL, V92, P86, DOI 10.1016/j.mambio.2018.04.009; Massei Giovanna, 2004, Galemys, V16, P135; May SA, 1996, WILDLIFE RES, V23, P387, DOI 10.1071/WR9960387; Meredith AM, 2018, ESTIMATES COEFFICIEN, V20; Meredith M, 2018, OVERVIEW OVERLAP PAC, P1; Molina S, 2017, URSUS, V28, P117, DOI 10.2192/URSU-D-16-00030.1; Monterroso P, 2014, BEHAV ECOL SOCIOBIOL, V68, P1403, DOI 10.1007/s00265-014-1748-1; Morato RG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168176; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Moura L de A, 2011, PLANO MANJEO CTR PES; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy-Reis MB, 2019, MAMM BIOL, V95, P1, DOI 10.1016/j.mambio.2018.12.005; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Nunes de Sa D, 2017, REV INT INTERDISCIP, V13, P182; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira T.G., 2010, BIOL CONSERVATION WI, P559; Oliveira-Santos LGR, 2012, ZOOLOGIA-CURITIBA, V29, P115, DOI 10.1590/S1984-46702012000200003; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Pérez-Irineo Gabriela, 2017, Therya, V8, P217, DOI 10.12933/therya-17-487; Perez-Irineo G, 2016, SOUTHWEST NAT, V61, P33, DOI 10.1894/0038-4909-61.1.33; Porfirio G, 2016, MAMM BIOL, V81, P511, DOI 10.1016/j.mambio.2016.06.006; R Core Team, 2019, R LANG ENV STAT COMP; Ramirez-Mejia AF, 2016, HYSTRIX, V27, DOI 10.4404/hystrix-27.2-11319; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rich C., 2006, ECOLOGICAL CONSEQUEN; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Rocha-Mendes F, 2009, MAMMALIA, V73, P151, DOI 10.1515/MAMM.2009.017; Roesch L. F. W., 2009, Diversity, V1, P182; Rosa A., 2015, AREA PROTEC AMBIENTA; Royle JA, 2011, J WILDLIFE MANAGE, V75, P604, DOI 10.1002/jwmg.79; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sandell M., 1989, P164; Santos Maria de Fátima M. dos, 2004, Iheringia, Sér. Zool., V94, P235, DOI 10.1590/S0073-47212004000300003; Schmutzer AC, 2008, FRESHWATER BIOL, V53, P2613, DOI 10.1111/j.1365-2427.2008.02072.x; Seibert Jardel Brandao, 2015, Boletim do Museu de Biologia Mello Leitao Nova Serie, V37, P193; Silva LCR, 2011, ECOSYSTEMS, V14, P1354, DOI 10.1007/s10021-011-9486-y; Srbek-Araujo AC, 2008, BRAZ J BIOL, V68, P771, DOI 10.1590/S1519-69842008000400011; STRASSMANN BI, 1987, ENVIRON MANAGE, V11, P35, DOI 10.1007/BF01867177; Strier KB, 2000, BIOTROPICA, V32, P903; Sunquist F, 2014, WILD CAT BOOK EVERYT, P1; Sunquist M. E., 2002, WILD CATS WORLD, P1; Sutherland C, 2019, ECOGRAPHY, V42, P1459, DOI 10.1111/ecog.04551; Tortato Marcos Adriano, 2013, Biodiversidade Brasileira, V3, P76; Vanderhoff E. Natasha, 2011, Mastozool. neotrop., V18, P271; Villette P, 2016, J MAMMAL, V97, P32, DOI 10.1093/jmammal/gyv150; WOLFE JL, 1989, ANIM BEHAV, V37, P410, DOI 10.1016/0003-3472(89)90088-2	115	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232013	10.1371/journal.pone.0232013	http://dx.doi.org/10.1371/journal.pone.0232013			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374736	Green Published, gold			2022-12-26	WOS:000537283500015
J	Sugiura, K; Lei, ZH; Holley, C; Haga, T				Sugiura, Katsuaki; Lei, Zhihao; Holley, Caitlin; Haga, Takeshi			Assessing the risk of ASFV entry into Japan through pork products illegally brought in by air passengers from China and fed to pigs in Japan	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; DOMESTIC PIGS; VIRUS; TRANSMISSION; PATHOGENESIS; SURVIVAL	A risk assessment was conducted to assess the risk of ASFV entry into Japan through pork products illegally brought in by air passengers from China and fed to pigs in Japan. Scenario tree modelling was used with the following entry and exposure pathway considered to be the most likely route of ASF entry: an ASFV infected pork product is illegally brought into Japan by air travellers from China; this pork product is then used in a restaurant where scrap waste is recycled for animal feed and subsequently fed to pigs without being heat-treated. Input parameter values were based on surveys conducted by the authors, scientific data gathered from the literature and official data published by government agencies. The annual probability of ASFV entry into Japan via this pathway was predicted to be 0.20 (90% prediction interval: 0.00-0.90). The wide prediction interval was mainly caused by the uncertainty regarding the dose response relation of ASFV, followed by the probability of an ASF infected pig dying on affected farms, the loading of ASFV in an infected pig and the probability of an illegally imported pork product being heat-treated in China and used in restaurants. The results of scenario analysis revealed that the annual probability of ASFV entry into Japan will increase with an increase in the number of ASF affected farms in China. The probability of ASFV entry will increase substantially even if only a small proportion of Ecofeed is not heat-treated during the production process. The probability will decrease if an increased proportion of farms that feed swill apply heat-treatment before feeding swill to their pigs. These findings indicate that stringent application of heat-treatment of Ecofeed and swill is key to protecting the Japanese pig industry from the introduction of ASFV.	[Sugiura, Katsuaki; Lei, Zhihao] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan; [Holley, Caitlin] World Org Anim Hlth OIE, Reg Representat Asian & Pacific, Bunkyo Ku, Tokyo, Japan; [Haga, Takeshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Sugiura, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan.	aksugiura@mail.ecc.u-tokyo.ac.jp		Sugiura, Katsuaki/0000-0002-8807-7584	Ito Foundation	Ito Foundation	KS, TH Ken-163 The Ito Foundation https://www.itokinen-zaidan.or.jp/The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso C, 2018, J GEN VIROL, V99, P613, DOI 10.1099/jgv.0.001049; Animal Quarantine Service (AQS), POS CAS PRES GEN MAT; Animal Quarantine Service (AQS), 2019, NUMB QUANT AN PROD I; Centre for Fisheries Research, 2019, 18025 CVO CTR FISH R; China Animal Husbandry Yearbook Editorial Department, 2019, CHIN AN HUSB YB 2018; Costard S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061104; Davies K, 2017, TRANSBOUND EMERG DIS, V64, P425, DOI 10.1111/tbed.12381; Foundation Ito, REPORT RES GRANT PRO, V36, P229; GREIG A, 1972, J COMP PATHOL, V82, P73, DOI 10.1016/0021-9975(72)90028-X; Hartnett E, 2007, RISK ANAL, V27, P187, DOI 10.1111/j.1539-6924.2006.00869.x; Howey EB, 2013, VIRUS RES, V178, P328, DOI 10.1016/j.virusres.2013.09.024; Ito S, 2020, TRANSBOUND EMERG DIS, V67, P894, DOI 10.1111/tbed.13414; Japan Pig Producers Association (JPPA), REP ACT SIT PIG PROD; Jurado C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50403-w; Kolbasov D, 2018, EMERG INFECT DIS, V24, P796, DOI 10.3201/eid2404.171238; Lai JM, 2012, RISK ANAL, V32, P1093, DOI 10.1111/j.1539-6924.2011.01740.x; Lei ZH, 2020, PREV VET MED, V177, DOI 10.1016/j.prevetmed.2020.104947; Lin XW, 2009, RISK ANAL, V29, P601, DOI 10.1111/j.1539-6924.2008.01183.x; MCVICAR JW, 1984, AM J VET RES, V45, P1535; Ministry of Agriculture Forestry and Fisheries (MAFF), FOOD LOSS STAT SURV; Ministry of Agriculture Forestry and Fisheries (MAFF), QUAR DET DOGS; Ministry of Agriculture Forestry and Fisheries (MAFF), OUTBR AFR SWIN FEV A; Ministry of Agriculture Forestry and Fisheries (MAFF), BRING AN PROD JAP OV; Ministry of Agriculture Forestry and Fisheries (MAFF), GUID SAF ASS FEED PR; Ministry of Agriculture Forestry and Fisheries (MAFF), 2019, CURR SIT EC; Ministry of Justice (MOJ), IMM CONTR STAT 2018; Niederwerder MC, 2019, EMERG INFECT DIS, V25, P891, DOI 10.3201/eid2505.181495; OIE, 2018, CHIN IMM NOT; OIE, SIT UPD ASF AS PAC; Petrini S, 2019, PREV VET MED, V162, P126, DOI 10.1016/j.prevetmed.2018.11.013; Pietschmann J, 2015, ARCH VIROL, V160, P1657, DOI 10.1007/s00705-015-2430-2; PLOWRIGHT W, 1994, INFECT DIS LIVESTOCK, V1, P567; Sanchez-Vizcaino JM, 2012, TRANSBOUND EMERG DIS, V59, P27, DOI 10.1111/j.1865-1682.2011.01293.x; Shih TW, 2005, PREV VET MED, V68, P115, DOI 10.1016/j.prevetmed.2004.11.010; Sugiura K, 2018, J VET MED SCI, V80, P1743, DOI 10.1292/jvms.18-0543; ter Beek V., 2019, PIGPROGRESS; Vannier P, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1556; Veterinary Laboratories Agency (VLA), 2004, RISK ASS IMP CONT ME; World Organisation for Animal Health (OIE), 2019, REP M OIE TERR AN HL; World Organisation for Animal Health (OIE), PROC IN ASFV SWILL; World Organisation for Animal Health (OIE), TECHN DIS CARDS AFR; Zhou X, 2018, TRANSBOUND EMERG DIS, V2018, P1, DOI DOI 10.1109/I2MTC.2018.8409596	42	5	5	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232132	10.1371/journal.pone.0232132	http://dx.doi.org/10.1371/journal.pone.0232132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369517	Green Published, gold			2022-12-26	WOS:000537280000017
J	Chen, VCH; Lin, KY; Tsai, YH; Weng, JC				Chen, Vincent Chin-Hung; Lin, Kai-Yi; Tsai, Yuan-Hsiung; Weng, Jun-Cheng			Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy	PLOS ONE			English	Article							DEPRESSIVE DISORDER; COGNITIVE FUNCTION; ANGULAR GYRUS; FOLLOW-UP; ANXIETY; SYMPTOMS; VALIDITY	Purpose Treatment modalities for breast cancer, the leading cause of cancer-related deaths in women worldwide, include surgery, radiotherapy, adjuvant chemotherapy, targeted therapy, and hormonal therapy. The advancement in medical technology has facilitated substantial reduction in breast cancer mortality. However, patients may experience cognitive impairment after chemotherapy. This phenomenon called chemotherapy-induced cognitive impairment (i.e., "chemobrain") is common among breast cancer survivors. However, cognitive function deficits may exist before chemotherapy initiation. This study examined the functional network alterations in breast survivors by using resting-state functional magnetic resonance imaging (fMRI). Methods We recruited 172 female participants and separated them into three groups: C+ (57 breast cancer survivors who had finished 3-12-month-long chemotherapy), C- (45 breast cancer survivors who had not undergone chemotherapy), and HC (70 participants with no breast cancer history). We analyzed mean fractional amplitudes of low-frequency fluctuation and graph theoretical topologies from resting-state fMRI and applied network-based analysis to portray functional changes among the three groups. Results Among the three groups, the C- group demonstrated hyperactivity in the prefrontal cortex, bilateral middle temporal gyrus, right inferior temporal gyrus and right angular gyrus. Only the left caudate demonstrated significantly more hypoactivity in the C- group than in the C+ group. Graph theoretical analysis demonstrated that the brains of the C+ group became inclined toward regular networks and the brains of the C- group became inclined toward random networks. Conclusion Subtle alterations were noted in the brain activity and networks of our cancer survivors. Moreover, functional network disruptions occurred regardless of chemotherapeutic agent administration.	[Chen, Vincent Chin-Hung; Tsai, Yuan-Hsiung] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Chen, Vincent Chin-Hung; Weng, Jun-Cheng] Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Lin, Kai-Yi; Weng, Jun-Cheng] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tsai, Yuan-Hsiung] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Weng, Jun-Cheng] Chang Gung Univ, Med Imaging Res Ctr, Inst Radiol Res, Taoyuan, Taiwan; [Weng, Jun-Cheng] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Weng, JC (corresponding author), Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan.; Weng, JC (corresponding author), Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Weng, JC (corresponding author), Chang Gung Univ, Med Imaging Res Ctr, Inst Radiol Res, Taoyuan, Taiwan.; Weng, JC (corresponding author), Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan.	jcweng@mail.cgu.edu.tw			Ministry of Science and Technology, Taipei, Taiwan [MOST107-2221-E-182-054-MY3, MOST106-2221-E-182-079]; Chang Gung University, Taoyuan, Taiwan [BMRPD1H0101~3, BMRPD1G1321]; Chang Gung Memorial Hospital, Chiayi, Taiwan [CORPG6G0101~3, CORPG6G0121~3]	Ministry of Science and Technology, Taipei, Taiwan; Chang Gung University, Taoyuan, Taiwan; Chang Gung Memorial Hospital, Chiayi, Taiwan(Chang Gung Memorial Hospital)	This study was supported by the research grants MOST107-2221-E-182-054-MY3 and MOST106-2221-E-182-079 from the Ministry of Science and Technology, Taipei, Taiwan to JCW. This study was also supported by grants BMRPD1H0101~3 and BMRPD1G1321 from Chang Gung University, Taoyuan, Taiwan to JCW and CORPG6G0101~3 and CORPG6G0121~3 from Chang Gung Memorial Hospital, Chiayi, Taiwan to VCHC.	Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bergouignan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025349; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bruno J, 2012, NEUROBIOL DIS, V48, P329, DOI 10.1016/j.nbd.2012.07.009; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cancer Reserch U, BREAST CANC STAT; Chen VCH, 2017, PEERJ, V5, DOI 10.7717/peerj.3147; Cimprich B, 2010, J CLIN EXP NEUROPSYC, V32, P324, DOI 10.1080/13803390903032537; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Collins B, 2009, PSYCHO-ONCOLOGY, V18, P134, DOI 10.1002/pon.1379; Conn Herbert W., 1917, AM J PUBLIC HLTH N Y, V7, P480, DOI [10.2105/ajph.7.5.480, DOI 10.2105/AJPH.7.5.480]; Elklit A, 2011, BRIT J CLIN PSYCHOL, V50, P350, DOI 10.1348/014466510X527676; Fang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166049; Feng Y, 2019, BRAIN IMAGING BEHAV, V13, P1799, DOI 10.1007/s11682-019-00074-y; Hakamata Y, 2007, NEUROSCI RES, V59, P383, DOI 10.1016/j.neures.2007.08.012; Hermelink Kerstin, 2015, Journal of the National Cancer Institute Monographs, P67, DOI 10.1093/jncimonographs/lgv009; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Hosseini SMH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-28; Hung CI, 2019, J AFFECT DISORDERS, V243, P255, DOI 10.1016/j.jad.2018.09.068; Jayaweera HK, 2016, PSYCHOL MED, V46, P2189, DOI 10.1017/S0033291716000787; Kesler SR, 2016, JAMA ONCOL, V2, P185, DOI 10.1001/jamaoncol.2015.4333; Kim J, 2019, MOL NEUROBIOL, V56, P7731, DOI 10.1007/s12035-019-1625-z; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee CY, 2017, J PSYCHOSOM RES, V100, P29, DOI 10.1016/j.jpsychores.2017.07.002; Li Mingli, 2012, Shanghai Arch Psychiatry, V24, P322, DOI 10.3969/j.issn.1002-0829.2012.06.003; Li W, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00927; Liu SI, 2011, COMPR PSYCHIAT, V52, P96, DOI 10.1016/j.comppsych.2010.04.013; Liu W, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6871089; Mattfeld AT, 2015, HIPPOCAMPUS, V25, P900, DOI 10.1002/hipo.22411; McDonald BC, 2010, BREAST CANCER RES TR, V123, P819, DOI 10.1007/s10549-010-1088-4; Miao H, 2016, NEURORADIOLOGY, V58, P921, DOI 10.1007/s00234-016-1708-8; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Onitsuka T, 2004, AM J PSYCHIAT, V161, P1603, DOI 10.1176/appi.ajp.161.9.1603; Scherling C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00122; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Shad MU, 2012, J CHILD ADOL PSYCHOP, V22, P190, DOI 10.1089/cap.2011.0005; Shen CY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36380-6; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stanley ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123950; Thakral PP, 2017, J NEUROSCI, V37, P8142, DOI 10.1523/JNEUROSCI.1319-17.2017; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2017, J CLIN NEUROPHYSIOL, V34, P300, DOI 10.1097/WNP.0000000000000377; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Wang L, 2016, ACAD RADIOL, V23, P1264, DOI 10.1016/j.acra.2016.05.014; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zeng YC, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5576-6; Zhu X, 2018, J NEUROL SCI, V386, P29, DOI 10.1016/j.jns.2018.01.010	51	14	15	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232548	10.1371/journal.pone.0232548	http://dx.doi.org/10.1371/journal.pone.0232548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365133	gold, Green Published			2022-12-26	WOS:000536959700040
J	Hong, JY; Kim, JH				Hong, Joo Young; Kim, Ju Han			PG-path: Modeling and personalizing pharmacogenomics-based pathways	PLOS ONE			English	Article							DRUG; PHARMACODYNAMICS; PHARMACOKINETICS; SMPDB; SIFT	A pharmacogenomics-based pathway represents a series of reactions that occur between drugs and genes in the human body after drug administration. PG-path is a pharmacogenomics-based pathway that standardizes and visualizes the components (nodes) and actions (edges) involved in pharmacokinetic and pharmacodynamic processes. It provides an intuitive understanding of the drug response in the human body. A pharmacokinetic pathway visualizes the absorption, distribution, metabolism, and excretion (ADME) at the systemic level, and a pharmacodynamic pathway shows the action of the drug in the target cell at the cellular-molecular level. The genes in the pathway are displayed in locations similar to those inside the body. PG-path allows personalized pathways to be created by annotating each gene with the overall impact degree of deleterious variants in the gene. These personalized pathways play a role in assisting tailored individual prescriptions by predicting changes in the drug concentration in the plasma. PG-path also supports counseling for personalized drug therapy by providing visualization and documentation.	[Hong, Joo Young; Kim, Ju Han] Seoul Natl Univ, Div Biomed Informat, Coll Med, Seoul, South Korea; [Hong, Joo Young] Cipherome Inc, Seoul, South Korea; [Kim, Ju Han] Seoul Natl Univ, Seoul Natl Univ Biomed Informat SNUBI, Div Biomed Informat, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Div Biomed Informat, Coll Med, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Biomed Informat SNUBI, Div Biomed Informat, Coll Med, Seoul, South Korea.	juhan@snu.ac.kr		Kim, Ju Han/0000-0003-1522-9038; Hong, Joo Young/0000-0003-1583-7164				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barbarino JM, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1417; Behjati S, 2013, ARCH DIS CHILDHOOD-E, V98, P236, DOI 10.1136/archdischild-2013-304340; Breitling R, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00009; Caraballo PJ, 2017, GENET MED, V19, P421, DOI 10.1038/gim.2016.120; Devuyst O, 2015, PERITON DIALYSIS INT, V35, P676, DOI 10.3747/pdi.2015.00261; Drozda K, 2018, JACC-BASIC TRANSL SC, V3, P545, DOI 10.1016/j.jacbts.2018.06.001; Franconi F, 2014, BRIT J PHARMACOL, V171, P580, DOI 10.1111/bph.12362; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Garcia-Campos MA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00383; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Goldstein David B, 2012, PRINCIPLES PHARMACOG; Jewison T, 2014, NUCLEIC ACIDS RES, V42, pD478, DOI 10.1093/nar/gkt1067; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Luna A, 2011, BIOINFORMATICS, V27, P2165, DOI 10.1093/bioinformatics/btr336; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Park Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00654; Rajasethupathy P, 2005, CURR OPIN CHEM BIOL, V9, P400, DOI 10.1016/j.cbpa.2005.06.008; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Schultink AHMD, 2015, CLIN PHARMACOKINET, V54, P797, DOI 10.1007/s40262-015-0273-3; Seo H, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0323-4; Soukup T, 2018, J MULTIDISCIP HEALTH, V11, P49, DOI 10.2147/JMDH.S117945; Sousa M, 2008, J ANTIMICROB CHEMOTH, V62, P872, DOI 10.1093/jac/dkn330; Tannenbaum C, 2014, EXPERT REV CLIN PHAR, V7, P533, DOI 10.1586/17512433.2014.910111; Thorn C. F., 2007, Current Pharmacogenomics, V5, P79, DOI 10.2174/157016007780077167; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Zheng-Bradley X., 2016, BRIEF FUNCT GENOMICS	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0230950	10.1371/journal.pone.0230950	http://dx.doi.org/10.1371/journal.pone.0230950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365122	Green Published, gold			2022-12-26	WOS:000536959700006
J	Zhang, X; Zegar, T; Lucas, A; Morrison-Smith, C; Knox, T; French, CA; Knapp, S; Muller, S; Siveke, JT				Zhang, Xin; Zegar, Tim; Lucas, Anais; Morrison-Smith, Chevaun; Knox, Tatiana; French, Christopher A.; Knapp, Stefan; Muller, Susanne; Siveke, Jens T.			Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma	ONCOGENE			English	Article							BROMODOMAIN INHIBITOR; CBP/P300 BROMODOMAIN; THYMIC CARCINOMA; BET; REARRANGEMENT	Nuclear protein of the testis (NUT) midline carcinoma (NMC), is a rare and highly aggressive form of undifferentiated squamous cell carcinoma. NMC is molecularly characterized by chromosomal rearrangement of the NUT gene to another gene, most commonly the bromodomain and extraterminal domain (BET) gene BRD4, forming the BRD4-NUT fusion oncogene. Therefore, inhibiting BRD4-NUT oncogenic function directly by BET inhibitors represents an attractive therapeutic approach but toxicity may limit the use of pan-BET inhibitors treating this cancer. We thus performed a drug screening approach using a library consisting of epigenetic compounds and 'Donated Chemical Probes' collated by the Structural Genomics Consortium (SGC) and identified the p300/CBP HAT inhibitor A-485, in addition to the well-known BET inhibitor JQ1, to be the most active candidate for NMC treatment. In contrast to JQ1, A-485 was selectively potent in NMC compared to other cell lines tested. Mechanistically, A-485 inhibited p300-mediated histone acetylation, leading to disruption of BRD4-NUT binding to hyperacetylated megadomains. Consistently, BRD4-NUT megadomain-associated genes MYC, CCAT1 and TP63 were downregulated by A-485. A-485 strongly induced squamous differentiation, cell cycle arrest and apoptosis. Combined inhibition of p300/CBP and BET showed synergistic effects. In summary, we identified the p300/CBP HAT domain as a putative therapeutic target in highly therapy-resistant NMC.	[Zhang, Xin; Zegar, Tim; Siveke, Jens T.] Univ Hosp Essen, West German Canc Ctr, Inst Dev Canc Therapeut, Essen, Germany; [Zhang, Xin; Zegar, Tim; Siveke, Jens T.] German Canc Consortium DKTK, Partner Site Essen, Div Solid Tumor Translat Oncol, Heidelberg, Germany; [Zhang, Xin; Zegar, Tim; Siveke, Jens T.] DKFZ, German Canc Res Ctr, Heidelberg, Germany; [Lucas, Anais; Knapp, Stefan; Muller, Susanne] Goethe Univ Frankfurt, Buchmann Inst Life Sci, Struct Genom Consortium, D-60438 Frankfurt, Germany; [Lucas, Anais; Knapp, Stefan; Muller, Susanne] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany; [Lucas, Anais; Knapp, Stefan] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, D-60438 Frankfurt, Germany; [Lucas, Anais; Knapp, Stefan] Frankfurt Canc Inst FCI, D-60438 Frankfurt, Germany; [Morrison-Smith, Chevaun; Knox, Tatiana; French, Christopher A.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Siveke, JT (corresponding author), Univ Hosp Essen, West German Canc Ctr, Inst Dev Canc Therapeut, Essen, Germany.; Siveke, JT (corresponding author), German Canc Consortium DKTK, Partner Site Essen, Div Solid Tumor Translat Oncol, Heidelberg, Germany.; Siveke, JT (corresponding author), DKFZ, German Canc Res Ctr, Heidelberg, Germany.	jens.siveke@uk-essen.de	Knapp, Stefan/AAG-2347-2019; Siveke, Jens/AAQ-6170-2021	Knapp, Stefan/0000-0001-5995-6494; Muller-Knapp, Susanne/0000-0003-2402-4157; Siveke, Jens/0000-0002-8772-4778	AbbVie; Bayer Pharma AG; SGC [1097737]; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant] [115766]; Janssen; Merck KGaA; MSD; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; German Cancer Aid (PIPAC consortium) [70112505]; German Cancer Consortium (DKTK); Deutsche Forschungsgemeinschaft (DFG) [SI1549/3-1]; Deutsche Forschungsgemeinschaft (DFG) through Collaborative Research Center SFB824; Projekt DEAL	AbbVie(AbbVie); Bayer Pharma AG; SGC; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant]; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA; MSD; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); German Cancer Aid (PIPAC consortium); German Cancer Consortium (DKTK); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) through Collaborative Research Center SFB824(German Research Foundation (DFG)); Projekt DEAL	We are grateful for support by the SGC, a registered charity (no. 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. JTS and SK are supported by the German Cancer Aid (grant no. 70112505; PIPAC consortium). JTS is supported by the German Cancer Consortium (DKTK) and the Deutsche Forschungsgemeinschaft (DFG) through grant SI1549/3-1 (Clinical Research Unit KFO337) and Collaborative Research Center SFB824 (project C4). Open access funding provided by Projekt DEAL.	Alekseyenko AA, 2015, GENE DEV, V29, P1507, DOI 10.1101/gad.267583.115; Bauer DE, 2012, CLIN CANCER RES, V18, P5773, DOI 10.1158/1078-0432.CCR-12-1153; Brooks N, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.SABCS18-3826; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; GILES F, 2018, ANN ONCOL S8, V29, P279, DOI DOI 10.1093/annonc/mdy279.416; Hammitzsch A, 2015, P NATL ACAD SCI USA, V112, P10768, DOI 10.1073/pnas.1501956112; Haruki N, 2005, J MED GENET, V42, P558, DOI 10.1136/jmg.2004.029686; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; IGUCHI H, 1990, CANCER RES, V50, P3691; KEES UR, 1991, AM J PEDIAT HEMATOL, V13, P459; Kimura H, 2010, CHEM BIOL, V17, P1282, DOI 10.1016/j.chembiol.2010.10.011; KUZUME T, 1992, INT J CANCER, V50, P259, DOI 10.1002/ijc.2910500216; Lasko LM, 2017, NATURE, V550, P128, DOI 10.1038/nature24028; Lewin J, 2018, J CLIN ONCOL, V36, P3007, DOI 10.1200/JCO.2018.78.2292; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Muller S, 2018, ELIFE, V7, DOI 10.7554/eLife.34311; O'Dwyer PJ, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-CT014; Picaud S, 2015, CANCER RES, V75, P5106, DOI 10.1158/0008-5472.CAN-15-0236; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Scheer S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07905-4; Stathis A, 2018, CANCER DISCOV, V8, P24, DOI 10.1158/2159-8290.CD-17-0605; Stathis A, 2016, CANCER DISCOV, V6, P492, DOI 10.1158/2159-8290.CD-15-1335; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Toretsky JA, 2003, AM J CLIN ONCOL-CANC, V26, P300, DOI 10.1097/00000421-200306000-00019; Wu Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09672-2; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; Yan YQ, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.7_suppl.62	32	17	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4770	4779		10.1038/s41388-020-1301-9	http://dx.doi.org/10.1038/s41388-020-1301-9		MAY 2020	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32366905	Green Published, hybrid			2022-12-26	WOS:000530271400001
J	Lo, S; Fatokun, C; Boukar, O; Gepts, P; Close, TJ; Munoz-Amatriain, M				Lo, Sassoum; Fatokun, Christian; Boukar, Ousmane; Gepts, Paul; Close, Timothy J.; Munoz-Amatriain, Maria			Identification of QTL for perenniality and floral scent in cowpea (Vigna unguiculata [L.] Walp.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; O-METHYLTRANSFERASE; FLOWERING-TIME; GENE FAMILY; HABIT; BIOSYNTHESIS; DETERMINACY; EXPRESSION; EVOLUTION; DOMESTICATION	Perennial habit and floral scent are major traits that distinguish domesticated cowpeas from their wild relatives. However, the genetic basis of these two important traits remains largely unknown in cowpea. Plant longevity, a perenniality-related trait, and floral scent, an out-crossing trait, were investigated using a RIL population derived from a cross between a domesticated and a wild cowpea. QTL analysis revealed three significant loci, one on chromosome 8 associated with plant longevity and two, on chromosomes 1 and 11, for floral scent. Genes within the QTL regions were identified. Genes encoding an F-box protein (Vigun08g215300) and two kinases (Vigun08g217000, Vigun08g217800), and involved in physiological processes including regulation of flowering time and plant longevity, were identified within the perenniality QTL region. A cluster of O-methyltransferase genes (Vigun11g096800, Vigun11g096900, Vigun11g097000, Vigun11g097600, and Vigun11g097800) was identified within the floral scent QTL region. These O-methyltransferase cowpea genes are orthologs of the Arabidopsis N-acetylserotonin O-methyltransferase (ASMT) gene, which is involved in the biosynthesis of melatonin. Melatonin is an indole derivative, which is an essential molecule for plant interactions with pollinators. These findings lay the foundation for further exploration of the genetic mechanisms of perenniality and floral scent in cowpea. Knowledge from this study can help in the development of new extended-growth cycle lines with increased yield or lines with increased outcrossing for population breeding.	[Lo, Sassoum; Close, Timothy J.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Fatokun, Christian; Boukar, Ousmane] Int Inst Trop Agr, Ibadan, Nigeria; [Gepts, Paul] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Munoz-Amatriain, Maria] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA	University of California System; University of California Riverside; CGIAR; International Institute of Tropical Agriculture (IITA); University of California System; University of California Davis; Colorado State University	Lo, S (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.; Munoz-Amatriain, M (corresponding author), Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA.	Slo008@ucr.edu; Maria.Munoz_Amatriain@colostate.edu	Muñoz-Amatriaín, María/GNP-7350-2022; Gepts, Paul/O-8229-2019	Muñoz-Amatriaín, María/0000-0002-4476-1691; Gepts, Paul/0000-0002-1056-4665; Lo, Sassoum/0000-0002-0385-5691	Feed the Future Innovation Lab for Climate Resilient Cowpea [AIDOAA-A-13-00070]; National Science Foundation BREAD project "Advancing the Cowpea Genome for Food Security" [NSF IOS-1543963]; Bill and Melinda Gates Foundation;  [CA-R-BPS-5306-H]	Feed the Future Innovation Lab for Climate Resilient Cowpea; National Science Foundation BREAD project "Advancing the Cowpea Genome for Food Security"; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); 	This work was supported by grants from the Feed the Future Innovation Lab for Climate Resilient Cowpea (Cooperative Agreement AIDOAA-A-13-00070) T.C., the National Science Foundation BREAD project "Advancing the Cowpea Genome for Food Security" (NSF IOS-1543963) T. C, M.MA and Hatch Project CA-R-BPS-5306-H, T. C. The Bill and Melinda Gates Foundation is acknowledged for funds used to implement the activities carried out at IITA under Tropical Legumes Project, C.F.; O.B.	Andargie M, 2014, EUPHYTICA, V200, P401, DOI 10.1007/s10681-014-1170-9; Andargie M, 2014, PLANT BREEDING, V133, P92, DOI 10.1111/pbr.12112; Ariizumi T, 2011, PLANT SIGNAL BEHAV, V6, P831, DOI 10.4161/psb.6.6.15164; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Back K, 2016, J PINEAL RES, V61, P426, DOI 10.1111/jpi.12364; Barkman TJ, 2003, MOL BIOL EVOL, V20, P168, DOI 10.1093/molbev/msg030; Bartrina I, 2017, PLANT PHYSIOL; Beekwilder J, 2004, AM SOC PLANT BIOL; Berstad Arnold, 2015, Microbial Ecology in Health and Disease, V26, P27997, DOI 10.3402/mehd.v26.27997; Byeon Y, 2016, J PINEAL RES, V60, P65, DOI 10.1111/jpi.12289; Cox S, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010172; Cox TS, 2006, PROSPECTS DEV PERENN; D'Andrea AC, 2007, ANTIQUITY, V81, P686, DOI 10.1017/S0003598X00095661; Dotterl S, 2005, J CHEM ECOL, V31, P2993, DOI 10.1007/s10886-005-9152-y; FARIS DG, 1965, CAN J GENET CYTOL, V7, P433, DOI 10.1139/g65-058; FATOKUN CA, 1992, GENETICS, V132, P841; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Heidel AJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3274-1; Hu FY, 2003, P NATL ACAD SCI USA, V100, P4050, DOI 10.1073/pnas.0630531100; Jensen CS, 2001, PLANT PHYSIOL, V125, P1517, DOI 10.1104/pp.125.3.1517; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kell DB, 2011, ANN BOT-LONDON, V108, P407, DOI 10.1093/aob/mcr175; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kotoda N, 2006, J AM SOC HORTIC SCI, V131, P74, DOI 10.21273/JASHS.131.1.74; Lammer D, 2004, J EXP BOT, V55, P1715, DOI 10.1093/jxb/erh209; Lavid N, 2002, PLANT PHYSIOL, V129, P1899, DOI 10.1104/pp.005330; Lee HY, 2014, J PINEAL RES, V57, P418, DOI 10.1111/jpi.12181; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Lo S, 2019, THEORETICAL APPL GEN; Lo S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24349-4; Lonardi S, 2019, PLANT J, V98, P767, DOI 10.1111/tpj.14349; LUSH WM, 1981, EUPHYTICA, V30, P579, DOI 10.1007/BF00038783; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Mir RR, 2014, THEOR APPL GENET, V127, P2663, DOI 10.1007/s00122-014-2406-8; Mohamed R, 2010, PLANT J, V62, P674, DOI 10.1111/j.1365-313X.2010.04185.x; Munoz-Amatriain M, 2017, PLANT J, V89, P1042, DOI 10.1111/tpj.13404; Ng N. Q., 1985, COWPEA RES PRODUCTIO, P11; Nguyen TD, 2012, CROP PASTURE SCI, V63, P619, DOI 10.1071/CP12263; Padulosi S., 1997, Advances in cowpea research, P1; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; Pasquet RS., 1996, ADV LEGUME SYSTEMATI, P95; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Repinski SL, 2012, THEOR APPL GENET, V124, P1539, DOI 10.1007/s00122-012-1808-8; Sablowski R, 2007, J EXP BOT, V58, P899, DOI 10.1093/jxb/erm002; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Thomas H, 2002, MECH AGEING DEV, V123, P747, DOI 10.1016/S0047-6374(01)00420-1; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Westerbergh A, 2004, THEOR APPL GENET, V109, P1544, DOI 10.1007/s00122-004-1778-6; Wu SQ, 2004, PLANT PHYSIOL, V135, P95, DOI 10.1104/pp.103.037051; Wu SQ, 2003, J BIOSCI BIOENG, V96, P119, DOI 10.1016/S1389-1723(03)90113-7; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xu SZ, 2013, GENETICS, V195, P1209, DOI 10.1534/genetics.113.157032; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Yao SL, 2016, PLANT J, V88, P318, DOI 10.1111/tpj.13279	57	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0229167	10.1371/journal.pone.0229167	http://dx.doi.org/10.1371/journal.pone.0229167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343700	gold, Green Published			2022-12-26	WOS:000536661300007
J	Sadat-Hosseini, M; Bakhtiarizadeh, MR; Boroomand, N; Tohidfar, M; Vahdati, K				Sadat-Hosseini, Mohammad; Bakhtiarizadeh, Mohammad Reza; Boroomand, Naser; Tohidfar, Masoud; Vahdati, Kourosh			Combining independent de novo assemblies to optimize leaf transcriptome of Persian walnut	PLOS ONE			English	Article							RNA-SEQ ANALYSIS; MICROSATELLITE MARKERS; EXPRESSION	Transcriptome resources can facilitate to increase yield and quality of walnuts. Finding the best transcriptome assembly has not been the subject of walnuts research as yet. This research generated 240,179,782 reads from 11 walnut leaves according to cDNA libraries. The reads provided a complete de novo transcriptome assembly. Fifteen different transcriptome assemblies were constructed from five different well-known assemblers used in scientific literature with different k-mer lengths (Bridger, BinPacker, SOAPdenovo-Trans, Trinity and SPAdes) as well as two merging approaches (EvidentialGene and Transfuse). Based on the four quality metrics of assembly, the results indicated an efficiency in the process of merging the assemblies after being generated by de novo assemblers. Finally, EvidentialGene was recognized as the best assembler for the de novo assembly of the leaf transcriptome in walnut. Among a total number of 183,191 transcripts which were generated by EvidentialGene, there were 109,413 transcripts capable of protein potential (59.72%) and 104,926 were recognized as ORFs (57.27%). In addition, 79,185 transcripts were predicted to exist with at least one hit to the Pfam database. A number of 3,931 transcription factors were identified by BLAST searching against PlnTFDB. Furthermore, 6,591 of the predicted peptide sequences contained signaling peptides, while 92,704 contained transmembrane domains. Comparison of the assembled transcripts with transcripts of the walnut and published genome assembly for the 'Chandler' cultivar using the BLAST algorithm led to identify a total number of 27,304 and 19,178 homologue transcripts, respectively. De novo transcriptomes in walnut leaves can be developed for the future studies in functional genomics and genetic studies of walnuts.	[Sadat-Hosseini, Mohammad; Vahdati, Kourosh] Univ Tehran, Dept Hort, Coll Aburaihan, Tehran, Iran; [Sadat-Hosseini, Mohammad] Univ Jiroft, Dept Hort, Fac Agr, Jiroft, Iran; [Bakhtiarizadeh, Mohammad Reza] Univ Tehran, Dept Anim & Poultry Sci, Coll Aburaihan, Tehran, Iran; [Boroomand, Naser] Shahid Bahonar Univ Kerman, Dept Soil Sci, Fac Agr, Kerman, Iran; [Tohidfar, Masoud] Shahid Beheshti Univ, Fac Life Sci & Biotechnol, Dept Plant Biotechnol, Tehran, Iran	University of Tehran; University of Tehran; Shahid Bahonar University of Kerman (SBUK); Shahid Beheshti University	Vahdati, K (corresponding author), Univ Tehran, Dept Hort, Coll Aburaihan, Tehran, Iran.; Bakhtiarizadeh, MR (corresponding author), Univ Tehran, Dept Anim & Poultry Sci, Coll Aburaihan, Tehran, Iran.	mrbakhtiari@ut.ac.ir; kvahdati@ut.ac.ir		Vahdati, Kourosh/0000-0001-8458-8697; Sadat-Hosseini, Mohammad/0000-0002-7919-3532	Iran National Science Foundation (INSF); University of Tehran; Center of Excellence of Walnut Improvement and Technology of Iran; University of Jiroft	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); University of Tehran(University of Tehran); Center of Excellence of Walnut Improvement and Technology of Iran; University of Jiroft	4 The authors appreciate Iran National Science Foundation (INSF), Center of Excellence of Walnut Improvement and Technology of Iran, University of Jiroft and the University of Tehran for their	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bernard A, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-017-1214-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chakraborty S, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0182-3; Chang Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0596-2; Ciarmiello LF, 2011, MOL BIOL REP, V38, P1237, DOI 10.1007/s11033-010-0223-y; Dang M, 2016, FORESTS, V7, DOI 10.3390/f7100247; Dautt-Castro M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00062; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ellwood SR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-380; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hara Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2007-1; He B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1192-7; Hu YH, 2015, BIOCHEM SYST ECOL, V63, P201, DOI 10.1016/j.bse.2015.10.011; Hu Z, 2016, MOL GENET GENOMICS, V291, P849, DOI 10.1007/s00438-015-1147-y; Huylmans AK, 2016, GENOME BIOL EVOL, V8, P3120, DOI 10.1093/gbe/evw221; Jazi MM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3989-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Li HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083530; Liu JT, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004772; Loganantharaj R, 2016, COMPUTATIONAL METHOD, P270; MacManes MD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45125; Mamrot J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09334-7; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; Martinez-Garcia PJ, 2016, PLANT J, V87, P507, DOI 10.1111/tpj.13207; Mattison CP, 2017, J AGR FOOD CHEM, V65, P1443, DOI 10.1021/acs.jafc.6b04199; Moreton J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00190; Mousavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104541; Mudalkar S, 2014, PLANT MOL BIOL, V84, P159, DOI 10.1007/s11103-013-0125-1; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Stevens KA, 2018, G3 GENES GENOME GE G, Vg3, P20003; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Vahdati K, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P307, DOI 10.5772/56078; Visser EA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2277-7; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; You FM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-354; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhou ZC, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2504-8	43	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232005	10.1371/journal.pone.0232005	http://dx.doi.org/10.1371/journal.pone.0232005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343733	Green Published, gold			2022-12-26	WOS:000536661300026
J	Won, YK; Kang, KS; Gonzalez, YS; Razavi, H; Dugan, E; Han, KH; Ahn, SH; Jeon, MY; Kim, DY				Won, Yong Kyun; Kang, Kyung Sik; Gonzalez, Yuri Sanchez; Razavi, Homie; Dugan, Ellen; Han, Kwang-Hyub; Ahn, Sang Hoon; Jeon, Mi Young; Kim, Do Young			A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; VIRUS-INFECTION; SOUTH-KOREA; MULTICENTER	Background and aims Hepatitis C virus (HCV) and its sequelae present a significant source of economic and societal burden. Introduction of highly effective curative therapies has made HCV elimination attainable. The study used a predictive model to assess the clinical and economic impact of implementing national screening and treatment policies toward HCV elimination in Korea. Methods A previously validated Markov disease progression model of HCV infection was employed to analyze the clinical and economic impact of various strategies for HCV diagnosis and treatment in Korea. In this analysis, the model compared the clinical and economic outcomes of current HCV-related interventions in Korea (7,000 patients treated and 4,200 patients newly diagnosed annually, starting in 2017) to four elimination scenarios: 1) initiating sufficient diagnosis and treatment interventions to meet the World Health Organization's GHSS elimination targets by 2030, 2) delaying initiation of interventions by one year, 3) delaying initiation of interventions by two years and 4) accelerating initiation of interventions to meet elimination targets by 2025. Modelled historical incidence of HCV was calibrated to match a viremic HCV prevalence of 0.44% in 2009. Elimination scenarios required 24,000 treatments and 34,000 newly diagnosed patients annually, starting in 2018, to reach the 2030 targets. Results Compared to current "status quo" interventions, elimination (or accelerated elimination by 2025) would avert 23,700 (27,000) incident cases of HCV, 1,300 (1,400) liver-related deaths (LRDs) and 2,900 (3,100) cases of end-stage liver disease (ESLD) over the 2017-2030 time period. Postponing interventions by one (or two) years would avert 21,100 (18,600) new HCV infections, 920 (660) LRDs and 2,000 (1,400) cases of ESLD by 2030. Following elimination or accelerated elimination strategies would save 860 million USD or 1.1 billion USD by 2030, respectively, compared to the status quo, requiring an up-front investment in prevention that decreases spending on liver-related complications and death. Conclusions By projecting the impact of interventions and tracking progress toward GHSS elimination targets using modelling, we demonstrate that Korea can prevent significant morbidity, mortality and spending on HCV. Results should serve as the backbone for policy and decision-making, demonstrating how aggressive prevention measures are designed to reduce future costs and increase the health of the public.	[Won, Yong Kyun; Kang, Kyung Sik] AbbVie Korea Ltd, Seoul, South Korea; [Gonzalez, Yuri Sanchez] AbbVie Inc, Mettawa, IL USA; [Razavi, Homie; Dugan, Ellen] Ctr Dis Anal Fdn CDAF, Lafayette, CO USA; [Han, Kwang-Hyub; Ahn, Sang Hoon; Jeon, Mi Young; Kim, Do Young] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea	AbbVie; Yonsei University; Yonsei University Health System	Kim, DY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	dyk1025@yuhs.ac		Jeon, Mi Young/0000-0002-3980-4503; Ahn, Sang Hoon/0000-0002-3629-4624; Won, Yong Kyun/0000-0001-6861-7830; Razavi, Homie/0000-0002-2658-6930	AbbVie	AbbVie(AbbVie)	The design, study conduct, analysis, and financial support for the study were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication. All authors had access to all relevant data.; The authors would like to thank Sarah Blach of CDA for providing medical writing and editing services in the development of this manuscript. AbbVie provided funding to CDA for this work.	AbbVie Global Health Economics and Outcomes Research (GHEOR) Group, 2018, COST CALC DIR MED CO; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Cho EJ, 2017, CLIN MOL HEPATOL, V23, P205, DOI 10.3350/cmh.2017.0104; Chung YS, 2018, J CLIN VIROL, V106, P53, DOI 10.1016/j.jcv.2018.07.006; Cornberg M, 2018, EASL MON C FEBR 2 3; de Ledinghen V, 2019, INT LIV C APR 10 14; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Health I, 2015, IMS Q1 2015; Jeong SH, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017017; Ki M, 2017, GUT LIVER, V11, P835, DOI 10.5009/gnl17034; Kim DY, 2013, LIVER INT, V33, P586, DOI 10.1111/liv.12108; Kim H, 2013, KOREAN J INTERN MED, V28, P413, DOI 10.3904/kjim.2013.28.4.413; KNfO Sharing, 2013, 2013 STAT YB ORGAN T; KNHIS, 2017, KOR NAT HLTH INS SER; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lee Sung Gyu, 2005, Korean J Gastroenterol, V46, P75; Park J, 1998, KOREAN J MED, V55, P176; Park SH, 2012, GUT LIVER, V6, P98, DOI 10.5009/gnl.2012.6.1.98; Seong MH, 2013, J MED VIROL, V85, P1724, DOI 10.1002/jmv.23661; UNICEF Wa, 2018, REP KOR WHO UNICEF E; WHO, 2017, WHO PUBLISHES LIST B; World Health Organization, 2016, COMB HEP B C REACH E	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232186	10.1371/journal.pone.0232186	http://dx.doi.org/10.1371/journal.pone.0232186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343727	Green Published, gold			2022-12-26	WOS:000536661300038
J	Yamamoto, K; Sakakura, K; Tsukui, T; Seguchi, M; Taniguchi, Y; Wada, H; Momomura, S; Fujita, H				Yamamoto, Kei; Sakakura, Kenichi; Tsukui, Takunori; Seguchi, Masaru; Taniguchi, Yousuke; Wada, Hiroshi; Momomura, Shin-ichi; Fujita, Hideo			Factors associated with antegrade true-sub-true phenomenon in percutaneous coronary intervention for chronic total occlusion	PLOS ONE			English	Article							MULTICENTER CTO REGISTRY; INTRAVASCULAR ULTRASOUND; SUBINTIMAL TRACKING; RETROGRADE APPROACH; OUTCOMES; REENTRY; RECANALIZATION; STRATEGY; INSIGHTS; WIRE	Background Recently, the importance of chronic total occlusion (CTO)-percutaneous coronary intervention (PCI) has been emphasized with greater success rates. In the antegrade wire based approach, it is generally considered that the guidewire would not advance from the subintimal space to the intimal space without dissection re-entry device. However, it is sometimes observed by intravascular ultrasound (IVUS) that the guidewire within the subintimal space advanced into the distal true lumen. The purpose of this study was to investigate specific conditions or characteristics which were associated with "antegrade true-sub-true" phenomenon in CTO-PCI. Methods We retrospectively reviewed consecutive 320 CTO lesions that underwent CTO-PCI in our institution. Among them, 16 lesions in which the IVUS confirmed the "antegrade true-subtrue" phenomenon were categorized as the true-sub-true group, whereas 27 lesions that resulted in unsuccessful CTO-PCI were categorized as the unsuccessful group. We compared the clinical, lesion, and procedural characteristics between the true-sub-true group and the unsuccessful group. Results The prevalence of bifurcation with abrupt type in CTO exit-sites was significantly higher in the true-sub-true group in comparison to the unsuccessful group (75.0% vs. 25.9%, p = 0.002). The multivariate logistic regression analysis revealed that bifurcation with abrupt type in CTO exit-site (OR 8.017; 95%CI: 1.484-43.304; p = 0.016) was independent predictor of the antegrade true-sub-true phenomenon. Conclusions In CTO-PCI, the antegrade true-sub-true phenomenon is rare, but can be a last chance for successful PCI. Bifurcation with abrupt type in CTO exit-site was significantly associated with the antegrade true-sub-true phenomenon.	[Yamamoto, Kei; Sakakura, Kenichi; Tsukui, Takunori; Seguchi, Masaru; Taniguchi, Yousuke; Wada, Hiroshi; Momomura, Shin-ichi; Fujita, Hideo] Jichi Med Univ, Div Cardiovasc Med, Saitama Med Ctr, Saitama, Japan	Jichi Medical University	Sakakura, K (corresponding author), Jichi Med Univ, Div Cardiovasc Med, Saitama Med Ctr, Saitama, Japan.	ksakakura@jichi.ac.jp	Sakakura, Kenichi/AAK-4564-2020; FUJITA, HIDEO/AHC-6839-2022; Seguchi, Masaru/ABC-3463-2020	Sakakura, Kenichi/0000-0003-3566-0394; Seguchi, Masaru/0000-0002-5875-613X; Fujita, Hideo/0000-0002-4901-3502				Azzalini L, 2017, INT J CARDIOL, V231, P78, DOI 10.1016/j.ijcard.2016.11.273; Baks T, 2006, J AM COLL CARDIOL, V47, P721, DOI 10.1016/j.jacc.2005.10.042; Carlino M, 2008, CATHETER CARDIO INTE, V72, P790, DOI 10.1002/ccd.21699; Carlino M, 2018, CATHETER CARDIO INTE, V92, P497, DOI 10.1002/ccd.27470; Colombo A, 2005, CATHETER CARDIO INTE, V64, P407, DOI 10.1002/ccd.20307; Danek BA, 2016, INT J CARDIOL, V214, P429, DOI 10.1016/j.ijcard.2016.03.215; Galassi AR, 2012, CATHETER CARDIO INTE, V79, P30, DOI 10.1002/ccd.22998; George S, 2014, J AM COLL CARDIOL, V64, P235, DOI 10.1016/j.jacc.2014.04.040; Harding SA, 2017, JACC-CARDIOVASC INTE, V10, P2135, DOI 10.1016/j.jcin.2017.06.071; Huang WC, 2018, J INTERV CARDIOL, V31, P572, DOI 10.1111/joic.12518; Ito S, 2004, CIRC J, V68, P1088, DOI 10.1253/circj.68.1088; Karacsonyi J, 2017, AM J CARDIOL, V120, P40, DOI 10.1016/j.amjcard.2017.03.263; Kittiskulnam P, 2017, J CACHEXIA SARCOPENI, V8, P57, DOI 10.1002/jcsm.12130; Kwon O, 2019, EUROINTERVENTION, V15, pE354, DOI 10.4244/EIJ-D-18-00538; Lee SW, 2019, CIRCULATION, V139, P1674, DOI 10.1161/CIRCULATIONAHA.118.031313; Maeremans J, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004791; Matsuno S, 2018, EUROINTERVENTION, V14, P94, DOI 10.4244/EIJ-D-17-00867; MINTZ GS, 1995, CIRCULATION, V91, P1959, DOI 10.1161/01.CIR.91.7.1959; Mitsudo K, 2008, J INVASIVE CARDIOL, V20, P571; Morino Y, 2011, JACC-CARDIOVASC INTE, V4, P213, DOI 10.1016/j.jcin.2010.09.024; Morino Y, 2010, JACC-CARDIOVASC INTE, V3, P143, DOI 10.1016/j.jcin.2009.10.029; Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7; Park Y, 2011, INT J CARDIOL, V148, P174, DOI 10.1016/j.ijcard.2009.10.052; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Sakakura K, 2014, EUR HEART J, V35, P1683, DOI 10.1093/eurheartj/eht422; Salisbury AC, 2017, JACC-CARDIOVASC INTE, V10, P2174, DOI 10.1016/j.jcin.2017.08.043; Sapontis J, 2017, JACC-CARDIOVASC INTE, V10, P1523, DOI 10.1016/j.jcin.2017.05.065; Sumitsuji S, 2011, JACC-CARDIOVASC INTE, V4, P941, DOI 10.1016/j.jcin.2011.06.011; Suzuki Y, 2017, JACC-CARDIOVASC INTE, V10, P2144, DOI 10.1016/j.jcin.2017.06.024; Tsuchikane E, 2013, CATHETER CARDIO INTE, V82, pE654, DOI 10.1002/ccd.24823; Wang N, 2018, HEART, V104, P517, DOI 10.1136/heartjnl-2017-311986; Yamamoto K, 2018, J CARDIOL, V72, P227, DOI 10.1016/j.jjcc.2018.02.008; Yamamoto K, 2018, HEART VESSELS, V33, P33, DOI 10.1007/s00380-017-1033-0	33	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232158	10.1371/journal.pone.0232158	http://dx.doi.org/10.1371/journal.pone.0232158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330197	Green Published, gold			2022-12-26	WOS:000536647300056
J	Welberry, C; Macdonald, I; McElveen, J; Parsy-Kowalska, C; Allen, J; Healey, G; Irving, W; Murray, A; Chapman, C				Welberry, Christopher; Macdonald, Isabel; McElveen, Jane; Parsy-Kowalska, Celine; Allen, Jared; Healey, Graham; Irving, William; Murray, Andrea; Chapman, Caroline			Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma	PLOS ONE			English	Article							CANCER-TESTIS ANTIGENS; IMMUNE-SYSTEM; LUNG; BIOMARKERS; EXPRESSION; DIAGNOSIS; IDENTIFICATION; PROGNOSIS; RESPONSES; NY-ESO-1	Background Hepatocellular carcinoma (HCC) continues to be a leading challenge in modern oncology. Early detection via blood-based screening tests has the potential to cause a stage-shift at diagnosis and improve clinical outcomes. Tumor associated autoantibodies (TA-AAbs) have previously shown the ability to distinguish HCC from patients with high-risk liver disease. This research aimed to further show the utility of TA-AAbs as biomarkers of HCC and assess their use in combination with Alpha-fetoprotein (AFP) for detection of HCC across multiple tumor stages. Methods Levels of circulating G class antibodies to 44 recombinant tumor associated antigens and circulating AFP were measured in the serum of patients with HCC, non-cancerous chronic liver disease (NCCLD) and healthy controls via enzyme-linked immunosorbent assay (ELISA). TA-AAb cut-offs were set at the highest Youden's J statistic at a specificity >= 95.00%. Panels of TA-AAbs were formed using net reclassification improvement. AFP was assessed at a cut-off of 200 ng/ml. Results Sensitivities ranged from 1.01% to 12.24% at specificities of 95.96% to 100.00% for single TA-AAbs. An ELISA test measuring a panel of 10 of these TA-AAbs achieved a combined sensitivity of 36.73% at a specificity of 89.89% when distinguishing HCC from NCCLD controls. At a cut-off of 200 ng/ml, AFP achieved a sensitivity of 31.63% at a specificity of 100.00% in the same cohort. Combination of the TA-AAb panel with AFP significantly increased the sensitivity for stage one (40.00%) and two (55.00%) HCC over the TA-AAb panel or AFP alone. Conclusions A panel of TA-AAbs in combination with AFP could be clinically relevant as a replacement for measuring levels of AFP alone in surveillance and diagnosis strategies. The increased early stage sensitivity could lead to a stage shift with positive prognostic outcomes.	[Welberry, Christopher; Macdonald, Isabel; McElveen, Jane; Parsy-Kowalska, Celine; Allen, Jared; Healey, Graham; Murray, Andrea] Oncimmune Ltd, Nottingham, England; [Welberry, Christopher; Allen, Jared; Chapman, Caroline] Univ Nottingham, Sch Med, Nottingham, England; [Irving, William] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Irving, William] Univ Nottingham, Nottingham, England; [Chapman, Caroline] Nottingham Univ NHS Trust, Bowel Canc Screening Program, Nottingham, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; Nottingham University Hospital NHS Trust	Welberry, C (corresponding author), Oncimmune Ltd, Nottingham, England.; Welberry, C (corresponding author), Univ Nottingham, Sch Med, Nottingham, England.	cwelberry@googlemail.com		MACDONALD, ISABEL/0000-0002-0178-4463; Welberry, Christopher/0000-0001-7432-3361	Medical Research Council [MR/K01532X/1]; MRC [MR/K01532X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by an award to authors CW and AM (through the STOPHCV consortium) from the Medical Research Council (MR/K01532X/1) https://mrc.ukri.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Oncimmune ltd provided support in the form of salaries and research materials for authors CW, IM, JM, CPK, JA, GH and AM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.the form of salaries and research materials for authors CW, IM, JM, CPK, JA, GH and AM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Amin M., 2018, AJCC CANC STAGING MA; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Boyle P, 2010, CHEST, V138, p241A, DOI [10.1378/CHEST.10709, DOI 10.1378/CHEST.10709]; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cattaneo MD, 2010, J ECONOMETRICS, V155, P138, DOI 10.1016/j.jeconom.2009.09.023; Chaisaingmongkol J, 2017, CANCER CELL, V32, P57, DOI 10.1016/j.ccell.2017.05.009; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; Chapman CJ, 2011, CLIN CANCER RES, V17, P1474, DOI 10.1158/1078-0432.CCR-10-1363; Chen CH, 2001, CANCER LETT, V164, P189, DOI 10.1016/S0304-3835(01)00379-2; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Chen Y, 2010, CANCER LETT, V289, P32, DOI 10.1016/j.canlet.2009.07.016; Dai LP, 2014, CLIN IMMUNOL, V152, P127, DOI 10.1016/j.clim.2014.03.007; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doseeva V, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0419-y; Ezzeldin M, 2014, RALA SIGNALING PATHW, DOI [10.1016/j.molonc.2014.03.020, DOI 10.1016/J.MOLONC.2014.03.020]; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Gordeeva O, 2018, SEMIN CANCER BIOL, V53, P75, DOI 10.1016/j.semcancer.2018.08.006; Healey GF, 2013, J THORAC DIS, V5, P618, DOI 10.3978/j.issn.2072-1439.2013.08.65; Hong Y, 2015, EBIOMEDICINE, V2, P438, DOI 10.1016/j.ebiom.2015.03.010; Hong Y, 2015, WORLD J HEPATOL, V7, P1581, DOI 10.4254/wjh.v7.i11.1581; Hoshino I, 2017, CANCER SCI, V108, P308, DOI 10.1111/cas.13158; Hu B, 2013, INT J MOL SCI, V14, P23559, DOI 10.3390/ijms141223559; Kim H, 2017, MOL CELLS, V40, P54, DOI 10.14348/molcells.2017.2258; Korangy F, 2004, CLIN CANCER RES, V10, P4332, DOI 10.1158/1078-0432.CCR-04-0181; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Le Naour F, 2002, MOL CELL PROTEOMICS, V1, P197, DOI 10.1074/mcp.M100029-MCP200; Leidinger P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128235; Li L, 2008, J PROTEOME RES, V7, P611, DOI 10.1021/pr070525r; Li T, 2012, BREAST CANCER RES TR, V131, P891, DOI 10.1007/s10549-011-1519-x; Liu C, 2013, WORLD J GASTROENTERO, V19, P1811, DOI 10.3748/wjg.v19.i11.1811; Liu H, 2012, CANCER EPIDEMIOL, V36, P82, DOI 10.1016/j.canep.2011.04.001; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Macdonald IK, 2017, TRENDS CANCER, V3, P198, DOI 10.1016/j.trecan.2017.02.003; Macdonald IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040759; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Middleton CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103867; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Nakamura S, 2006, J GASTROEN HEPATOL, V21, P1281, DOI 10.1111/j.1440-1746.2006.04271.x; NISHIOKA M, 2018, NPJ SCHIZOPHR, V4, DOI DOI 10.20517/2394-5079.2017.46; Pan XR, 2016, TRANSL CANCER RES, V5, P845, DOI 10.21037/tcr.2016.11.70; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Pedersen JW, 2011, LABMEDICINE, V42, P623, DOI 10.1309/LM2T3OU3RZRTHKSN; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ruggeri M, 2012, RISK MANAG HEALTHC P, V5, P49, DOI 10.2147/RMHP.S18677; Sun C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0503-1; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Tzartzeva K, 2018, SURVEILLANCE IMAGING, DOI [10.1053/j.gastro.2018.01.064, DOI 10.1053/J.GASTRO.2018.01.064]; Wallstrom G, 2013, CANCER EPIDEM BIOMAR, V22, P747, DOI 10.1158/1055-9965.EPI-12-1236; Wang J, 2016, J THORAC ONCOL, V11, P334, DOI 10.1016/j.jtho.2015.11.011; Wang K, 2009, INT J IMMUNOPATH PH, V22, P735, DOI 10.1177/039463200902200319; Wang KJ, 2009, CANCER LETT, V281, P144, DOI 10.1016/j.canlet.2009.02.037; Wang M, 2015, INT J CLIN EXP PATHO, V8, P3513; Wong LL, 2017, CLIN MOL HEPATOL, V23, P239, DOI 10.3350/cmh.2017.0008; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yin F, 2016, WORLD J GASTROENTERO, V22, P2837, DOI 10.3748/wjg.v22.i9.2837; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zaenker P, 2013, CANCER EPIDEM BIOMAR, V22, P2161, DOI 10.1158/1055-9965.EPI-13-0621; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhang J., 2012, INT J ONCOL, DOI [10.3892/ijo.2012, DOI 10.3892/IJO.2012]; Zhang QF, 2018, MED SCI MONITOR, V24, P6218, DOI 10.12659/MSM.908510; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003; Zhou JW, 2016, TUMOR BIOL, V37, P2547, DOI 10.1007/s13277-015-4074-y; [周剑飞 Zhou Jianfei], 2018, [轻金属, Light Metals], P1	65	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232247	10.1371/journal.pone.0232247	http://dx.doi.org/10.1371/journal.pone.0232247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374744	Green Published, gold			2022-12-26	WOS:000537283500026
J	Laxmeshwar, C; Acharya, S; Das, M; Keskar, P; Pazare, A; Ingole, N; Mehta, P; Gori, P; Mansoor, H; Kalon, S; Singh, P; Mathur, T; Ferlazzo, G; Isaakidis, P				Laxmeshwar, Chinmay; Acharya, Shrikala; Das, Mrinalini; Keskar, Padmaja; Pazare, Amar; Ingole, Nayana; Mehta, Preeti; Gori, Pooja; Mansoor, Homa; Kalon, Stobdan; Singh, Pramila; Mathur, Taanya; Ferlazzo, Gabriella; Isaakidis, Petros			Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; HIV; SUPPRESSION; RESISTANCE; PROGRAMS; AFRICA	Background Routine viral-load (VL) measurements along with enhanced adherence counselling (EAC) are recommended to achieve virological suppression among people living with HIV/AIDS (PLHA) on anti-retroviral therapy (ART). The Mumbai Districts AIDS Control Society along with Medecins Sans Frontieres has provided routine VL measurements and EAC to PLHA on ART at King Edward Memorial (KEM) hospital, Mumbai since October-2016. This study aims to describe the initial VL results and impact of EAC on viral suppression and factors associated with initial viral non-suppression among patients with an initial detectable VL, in a cohort of patients tested between October-2016 and September-2018. Methods This is a descriptive study of PLHA on ART who received VL testing and EAC during October-2016 to September-2018. Log-binomial regression was used to identify factors associated with a high VL. Results Among 3849 PLHA who underwent VL testing, 1603(42%) were female and median age was 42 years (IQR:35-48). Majority were referred for routine testing (3432(89%)) and clinical/immunological failure (233(6%)). Overall, 3402(88%) PLHA had suppressed VL at initial testing. Among 3432 tested for routine monitoring, 3141(92%) had VL suppressed. Of 291 with VL>1000c/ml, 253(87%) received EAC and after repeat VL, 70(28%) had VL<1000c/ml. Among 233 referred for clinical/immunological failure, 122(52%) had VL>1000c/ml and 109 have been switched to second-line ART. CD4 count<500 (aOR-5.0[95%CI 3.8-6.5]), on ART for<5 years (aOR-1.5[1.1-2.0]) and age<15 years (aOR-5.2[3.0-8.9]) were associated with an initial VL>1000c/ml. Factors associated with follow-up VL suppression included EAC (p<0.05) and being on second-line ART (p<0.05). Conclusion Results from a routine VL program in public sector in India were encouraging and in line with UNAIDS 90-90-90 targets. Routine VL monitoring along with EAC resulted in early switch to alternative optimised regimens while also preventing unnecessary switches. Along with the vital scale up of routine VL monitoring, implementation of enhanced adherence strategies for patients with detectable viral load should be ensured.	[Laxmeshwar, Chinmay; Das, Mrinalini; Mansoor, Homa; Kalon, Stobdan; Singh, Pramila; Mathur, Taanya] Med Sans Frontieres, Mumbai, Maharashtra, India; [Acharya, Shrikala; Keskar, Padmaja] Mumbai Dist AIDS Control Soc, Mumbai, Maharashtra, India; [Pazare, Amar; Ingole, Nayana; Mehta, Preeti; Gori, Pooja] King Edward Mem Hosp, Bombay, Maharashtra, India; [Ferlazzo, Gabriella; Isaakidis, Petros] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa	Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Laxmeshwar, C (corresponding author), Med Sans Frontieres, Mumbai, Maharashtra, India.	chinmay2210@gmail.com	Laxmeshwar, Chinmay/AAC-3753-2021	Das, Mrinalini/0000-0002-1354-4299; Acharya, Shrikala/0000-0001-8968-4258; Isaakidis, Petros/0000-0002-7881-1554; Laxmeshwar, Chinmay/0000-0003-1561-3857	MDACS	MDACS	The authors would like to acknowledge all study participants and staff at ART centre, KEM Hospital and MDACS for their support.	Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Billioux A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127235; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Bulage L, 2017, BMC INFECT DIS, V17, P1, DOI DOI 10.1186/S12879-016-2122-X; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Census, CENS MUMB GREAT MUMB; Estill J, 2012, AIDS, V26, P1403, DOI 10.1097/QAD.0b013e3283536988; Ferrand RA, 2016, TROP MED INT HEALTH, V21, P325, DOI 10.1111/tmi.12656; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hingankar NK, 2012, CLIN INFECT DIS, V54, pS348, DOI 10.1093/cid/cis005; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Ingole N, 2013, AIDS RES HUM RETROV, V29, P541, DOI [10.1089/aid.2012.0266, 10.1089/AID.2012.0266]; Jobanputra Kiran, 2014, J Acquir Immune Defic Syndr, V67, P45, DOI 10.1097/QAI.0000000000000224; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mumbai Districts AIDS Control Society, CAR SUPP TREATM; Nasuuna E, 2018, BMC PUBLIC HEALTH, V18, P1, DOI [10.1016/j.neulet.2015.10.060, DOI 10.1016/J.NEULET.2015.10.060]; National AIDS Control Organisation, 2018, NAT TECHN GUID ANT T; National AIDS Control Organisation, 2018, NAT GUID HIV 1 VIR L; National AIDS Control Organisation, 2018, NAT OP GUID VIR LOAD, DOI [10.1016/S0168-8278(06)80734-8, DOI 10.1016/S0168-8278(06)80734-8]; O'Connor J, 2017, LANCET HIV, V4, pE295, DOI 10.1016/S2352-3018(17)30053-X; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Rangarajan S, 2016, J VIRUS ERAD, V2, P94; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; UNAIDS, 2018, 2017 GLOBAL HIV STAT; UNAIDS, 2014, 90 90 90 AMB TREATM; WHO, HIV AIDS 7 3 MON RES; World Health Organisation, 2013, CONS GUID US ANT DRU, V978; World Health Organization, 2016, CONS GUID US ANT DRU	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232576	10.1371/journal.pone.0232576	http://dx.doi.org/10.1371/journal.pone.0232576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369504	Green Published, gold			2022-12-26	WOS:000537280000033
J	Nijenkamp, LLAM; Bollenl, IAE; Niessen, HWM; dos Remedios, CG; Michele, M; Poggesi, C; Ho, CY; Kuster, DWD; van der Velden, J				Nijenkamp, Louise L. A. M.; Bollenl, Ilse A. E.; Niessen, Hans W. M.; dos Remedios, Cris G.; Michele, Michelle; Poggesi, Corrado; Ho, Carolyn Y.; Kuster, Diederik W. D.; van der Velden, Jolanda			Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy	PLOS ONE			English	Article							CORONARY MICROVASCULAR DYSFUNCTION; GENDER-RELATED DIFFERENCES; HEART-FAILURE; AMERICAN SOCIETY; RECOMMENDATIONS; PREVALENCE; ECHOCARDIOGRAPHY; PROGRESSION; MANAGEMENT; CARDIOLOGY	Hypertrophic cardiomyopathy (HCM) is the most frequent genetic cardiac disease with a prevalence of 1:500 to 1:200. While most patients show obstructive HCM and a relatively stable clinical phenotype (stage II), a small group of patients progresses to end-stage HCM (stage IV) within a relatively brief period. Previous research has shown sex-differences in stage II HCM with more diastolic dysfunction in female than in male patients. Moreover, female patients more often show progression to heart failure. Here we investigated if differences in functional and structural properties of the heart may underlie sex-differences in disease progression from stage II to stage IV HCM. Cardiac tissue from stage II and IV patients was obtained during myectomy (n = 54) and heart transplantation (n = 10), respectively. Isometric force was measured in membrane-permeabilized cardiomyocytes to define active and passive myofilament force development. Titin isoform composition was assessed using gel electrophoresis, and the amount of fibrosis and capillary density were determined with histology. In accordance with disease stage-dependent adverse cardiac remodeling end-stage patients showed a thinner interventricular septal wall and larger left ventricular and atrial diameters compared to stage II patients. Cardiomyocyte contractile properties and fibrosis were comparable between stage II and IV, while capillary density was significantly lower in stage IV compared to stage II. Women showed more adverse cellular remodeling compared to men at stage II, evident from more compliant titin, more fibrosis and lower capillary density. However, the disease stage-dependent reduction in capillary density was largest in men. In conclusion, the more severe cellular remodeling in female compared to male stage II patients suggests a more advanced disease stage at the time of myectomy in women. Changes in cardiomyocyte contractile properties do not explain the progression of stage II to stage IV, while reduced capillary density may underlie disease progression to end-stage heart failure.	[Nijenkamp, Louise L. A. M.; Bollenl, Ilse A. E.; Kuster, Diederik W. D.; van der Velden, Jolanda] Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Physiol, Amsterdam, Netherlands; [Niessen, Hans W. M.] Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Pathol & Cardiac Surg, Amsterdam, Netherlands; [dos Remedios, Cris G.] Univ Sydney, Bosch Inst, Muscle Res Unit, Sydney, NSW, Australia; [Michele, Michelle] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Poggesi, Corrado] Univ Firenze, Dipartimento Med Sperimentale & Clin, Florence, Italy; [Ho, Carolyn Y.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kuster, Diederik W. D.; van der Velden, Jolanda] Netherlands Heart Inst, Utrecht, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Sydney; Erasmus University Rotterdam; Erasmus MC; University of Florence; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Nijenkamp, LLAM (corresponding author), Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Physiol, Amsterdam, Netherlands.	la.nijenkamp@amsterdamumc.nl	Kuster, Diederik/AAD-9272-2019	Kuster, Diederik/0000-0003-1498-6862; van der Velden, Jolanda/0000-0001-5224-5788; dos Remedios, Cristobal/0000-0003-1052-7490; Niessen, Hans/0000-0001-9404-9822	Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation [CVON2011-11 ARENA, CVON2014-40 DOSIS]	Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation)	Grant support received by Jolanda van der Velden: The study was sponsored by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2011-11 ARENA and CVON2014-40 DOSIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No relations with industry.	Baudhuin LM, 2015, J AM COLL CARDIOL, V66, P1845, DOI 10.1016/j.jacc.2015.07.074; Biagini E, 2014, AM J CARDIOL, V114, P769, DOI 10.1016/j.amjcard.2014.05.065; Bollen IAE, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01103; Brouwer WP, 2011, EUR J CLIN INVEST, V41, P568, DOI 10.1111/j.1365-2362.2010.02439.x; Campbell DJ, 2011, HYPERTENSION, V57, P186, DOI 10.1161/HYPERTENSIONAHA.110.165043; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; FUJIWARA H, 1984, JPN CIRC J, V48, P1210, DOI 10.1253/jcj.48.1210; Galati G, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003090; Garcia-Pavia P, 2011, EUR J HEART FAIL, V13, P1193, DOI 10.1093/eurjhf/hfr110; Geske JB, 2017, EUR HEART J, V38, P3434, DOI 10.1093/eurheartj/ehx527; Guclu A, 2015, EUR J CLIN INVEST, V45, P1252, DOI 10.1111/eci.12544; Haas AV, 2018, DIABETES; Hamdani N, 2009, EUR HEART J, V30, P1863, DOI 10.1093/eurheartj/ehp189; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Keteyian SJ, 2003, AM HEART J, V145, P912, DOI 10.1016/S0002-8703(03)00075-9; Knaapen P, 2008, AM J PHYSIOL-HEART C, V294, pH986, DOI 10.1152/ajpheart.00233.2007; Kobayashi Y, 2015, JACC-CARDIOVASC INTE, V8, P1433, DOI 10.1016/j.jcin.2015.03.045; Kofflard MJ, 2007, NETH HEART J, V15, P209, DOI 10.1007/BF03085982; Kubo T, 2005, J AM COLL CARDIOL, V46, P1737, DOI 10.1016/j.jacc.2005.05.087; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Maron MS, 2009, J AM COLL CARDIOL, V54, P866, DOI 10.1016/j.jacc.2009.04.072; Melacini P, 2010, EUR HEART J, V31, P2111, DOI 10.1093/eurheartj/ehq136; Michels M, 2017, NETH HEART J, V25, P186, DOI 10.1007/s12471-016-0943-2; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nagueh SF, 2011, J AM SOC ECHOCARDIOG, V24, P473, DOI 10.1016/j.echo.2011.03.006; Nijenkamp LLAM, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004133; Nijenkamp LLAM, 2015, HEART RHYTHM, V12, P433, DOI 10.1016/j.hrthm.2014.10.032; Noci B, 2012, ANAT HISTOL EMBRYOL, V41, P453, DOI 10.1111/j.1439-0264.2012.01156.x; Olivotto I, 2006, J AM COLL CARDIOL, V47, P1043, DOI 10.1016/j.jacc.2005.10.050; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roma-Rodrigues C, 2014, APPL CLIN GENET, V7, P195, DOI 10.2147/TACG.S49126; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sotgia B, 2008, J NUCL MED, V49, P1090, DOI 10.2967/jnumed.107.050138; Taqueti VR, 2018, ADV EXP MED BIOL, V1065, P257, DOI [10.1007/978/-3-319-77932-4_17, 10.1007/978-3-319-77932-4_17]; van der Velden J, 1999, CARDIOVASC RES, V42, P706, DOI 10.1016/S0008-6363(98)00337-X; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; van Velzen HG, 2018, AM J CARDIOL, V122, P1947, DOI 10.1016/j.amjcard.2018.08.040; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Xiao, CLIN CHARACTERISTICS; Yacoub MH, 2007, NAT CLIN PRACT CARD, V4, P232, DOI 10.1038/ncpcardio0859; Zhu BL, 2016, CAN J PHYSIOL PHARM, V94, P1349, DOI 10.1139/cjpp-2016-0103	44	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232427	10.1371/journal.pone.0232427	http://dx.doi.org/10.1371/journal.pone.0232427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369506	Green Published, gold			2022-12-26	WOS:000537280000029
J	Zheng, XM; Chen, L; Li, XM; Zhang, Y; Xu, SG; Huang, XX				Zheng, Xueming; Chen, Long; Li, Xiuming; Zhang, Ying; Xu, Shungao; Huang, Xinxiang			Prediction of miRNA targets by learning from interaction sequences	PLOS ONE			English	Article							RNA-BINDING; MICRORNA; REVEALS; IDENTIFICATION; NETWORKS; LIGATION; PROTEINS	MicroRNAs (miRNAs) are involved in a diverse variety of biological processes through regulating the expression of target genes in the post-transcriptional level. So, it is of great importance to discover the targets of miRNAs in biological research. But, due to the short length of miRNAs and limited sequence complementarity to their gene targets in animals, it is challenging to develop algorithms to predict the targets of miRNA accurately. Here we developed a new miRNA target prediction algorithm using a multilayer convolutional neural network. Our model learned automatically the interaction patterns of the experiment-validated miRNA:target-site chimeras from the raw sequence, avoiding hand-craft selection of features by domain experts. The performance on test dataset is inspiring, indicating great generalization ability of our model. Moreover, considering the stability of miRNA:target-site duplexes, our method also showed good performance to predict the target transcripts of miRNAs.	[Zheng, Xueming; Zhang, Ying; Xu, Shungao; Huang, Xinxiang] Jiangsu Univ, Sch Med, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China; [Zheng, Xueming; Chen, Long] First Peoples Hosp Zhangjiagang, Dept Clin Lab, Zhangjiagang, Jiangsu, Peoples R China; [Li, Xiuming] Jiangsu Univ Sci & Technol, Sch Comp Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University of Science & Technology	Huang, XX (corresponding author), Jiangsu Univ, Sch Med, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China.	huxinx@ujs.edu.cn			China Postdoctoral Science Foundation [2018M642186]; National Natural Science Foundation of China [31670131]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China Postdoctoral Science Foundation Funded Project (2018M642186) and National Natural Science Foundation of China (31670131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Albuquerque Vieira JP, 2017, ANAL CONVOLUTIONAL N; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Baldi P, 2014, ARTIF INTELL, V210, P78, DOI 10.1016/j.artint.2014.02.004; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beh-Pajooh Abbas, 2018, J Stem Cells Regen Med, V14, P3; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bhaskaran M, 2014, VET PATHOL, V51, P759, DOI 10.1177/0300985813502820; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broughton JP, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0209-x; Chen JZ, 2020, IEEE T BIO-MED ENG, V67, P987, DOI 10.1109/TBME.2019.2927157; Chen W, 2017, GENE, V636, P87, DOI 10.1016/j.gene.2017.09.027; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Davis JA, 2017, NUCLEIC ACIDS RES, V45, P8745, DOI 10.1093/nar/gkx605; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huberdeau MQ, 2017, EMBO J, V36, P2088, DOI 10.15252/embj.201696386; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kingma DP., 2014, ADAM METHOD STOCHAST; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LQ, 2018, IEICE T INF SYST, VE101D, P1203, DOI 10.1587/transinf.2017EDL8248; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Mandujano-Tinoco EA, 2018, BREAST CANC RES TREA, DOI [10.1016/j.cell.2009.01.002, DOI 10.1016/J.CELL.2009.01.002]; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; Pla A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006185; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Riffo-Campos AL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121987; Roberts JT, 2017, METHODS MOL BIOL, V1617, P109, DOI 10.1007/978-1-4939-7046-9_8; Rong DW, 2017, ONCOTARGET, V8, P73271, DOI 10.18632/oncotarget.19154; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Wen M, 2018, BIOINFORMATICS, V34, P3781, DOI 10.1093/bioinformatics/bty424; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu XH, 2017, INT J UNCERTAIN QUAN, V7, P155, DOI 10.1615/Int.J.UncertaintyQuantification.2017019440; Yu X, 2015, IEEE T CYBERNETICS, V45, P506, DOI [10.1109/TCYB.2014.2329673, 10.1109/TCYB.2014.2327246]; Zhang XY, 2016, IEEE T PATTERN ANAL, V38, P1943, DOI 10.1109/TPAMI.2015.2502579; Zhang Z, 2017, IEEE T IMAGE PROCESS, V26, P1607, DOI 10.1109/TIP.2017.2654163	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232578	10.1371/journal.pone.0232578	http://dx.doi.org/10.1371/journal.pone.0232578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369518	Green Published, gold			2022-12-26	WOS:000537280000034
J	Bisognin, F; Lombardi, G; Finelli, C; Re, MC; Dal Monte, P				Bisognin, Francesco; Lombardi, Giulia; Finelli, Chiara; Re, Maria Carla; Dal Monte, Paola			Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB (R) Kit for the diagnosis of tuberculosis	PLOS ONE			English	Article								The MDR/MTB ELITe MGB (R) Kit on the ELITe InGenius (R) platform (ELITechGroup SpA, Italy) is the first system for simultaneous detection of the Mycobacterium tuberculosis complex (MTBc) genome and the main mutations responsible for resistance to Isoniazid (inhA, katG) and Rifampicin (rpoB), from decontaminated and heat inactivated samples. In this study we compared the performance of the MDR/MTB ELITe MGB (R) Kit (ELITe) with culture in 100 pulmonary and 160 extra-pulmonary samples. The sensitivity and specificity of ELITe compared to culture for pulmonary samples were 98.0% and 98.0% respectively; for extra-pulmonary samples the overall sensitivity was 86.3% (80% for urine, 85% for biopsy and gastric aspirate and 95% for cavitary fluid) and specificity was 100%. Genotypic Isoniazid and Rifampicin susceptibility typing was feasible in 96% of sputum MTBc-positive samples and 43% of extra-pulmonary samples; all samples were found to be drug susceptible by phenotypic and ELITe (100% agreement). Detection of mutations in the rpoB, kat G or inhA genes was evaluated on 300 spiked samples (60 per biological matrix) and all resistance profiles were correctly identified by ELITe. Molecular agreement between ELITe and Xpert was 98.0% and 93.3% for pulmonary and extra-pulmonary samples, respectively. In conclusion, our results provide evidence to support the use of MDR/MTB ELITe MGB (R) Kit in combination with ELITe InGenius (R) for the diagnosis of MTBc and the detection of Rifampicin and Isoniazid resistance-related mutations in both pulmonary and extra-pulmonary samples. This system simplifies the laboratory workflow, shortens report time and is an aid in choosing appropriate therapeutic treatment and patient management.	[Bisognin, Francesco; Lombardi, Giulia; Finelli, Chiara; Re, Maria Carla; Dal Monte, Paola] S Orsola Malpighi Univ Hosp, Microbiol Unit, Dept Expt Diagnost & Specialty Med, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Lombardi, G (corresponding author), S Orsola Malpighi Univ Hosp, Microbiol Unit, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	g.lombardi@unibo.it	LOMBARDI, GIULIA/HGC-4356-2022	LOMBARDI, GIULIA/0000-0001-6423-8358; BISOGNIN, FRANCESCO/0000-0002-3254-9239; DAL MONTE, PAOLA/0000-0003-2326-7464				Albanna AS, 2011, DRUGS, V71, P815, DOI 10.2165/11585440-000000000-00000; Bisognin F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201934; Clinical and Laboratory Standards Institute (CLSI), 2008, M48A2008 CLSI; Doig C, 2002, J CLIN PATHOL, V55, P778, DOI 10.1136/jcp.55.10.778; European Centre for Disease Prevention and Control, 2019, TUB SURV MON EUR 201; Gagneux S, 2018, NAT REV MICROBIOL, V16, P202, DOI 10.1038/nrmicro.2018.8; Lombardi G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176186; Mazzola Ester, 2016, Infez Med, V24, P304; Opota O, 2019, CLIN MICROBIOL INFEC, V25, P1370, DOI 10.1016/j.cmi.2019.03.021; Perez-Risco D, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00659-18, 10.1128/jcm.00659-18]; RAWLINS G A, 1955, J Med Lab Technol, V13, P133; Rockwood N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139017; Sabiiti W, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01778-18; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; WHO, 2019, GLOB TUB REP; World Health Organization, 2014, ANT RES GLOB REP SUR	16	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232632	10.1371/journal.pone.0232632	http://dx.doi.org/10.1371/journal.pone.0232632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365116	Green Published, gold			2022-12-26	WOS:000536959700049
J	Kim, KK; Turner, R; Khazan, N; Kodza, A; Jones, A; Singh, RK; Moore, RG				Kim, Kyu Kwang; Turner, Rachael; Khazan, Negar; Kodza, Arif; Jones, Aaron; Singh, Rakesh K.; Moore, Richard G.			Role of trypsin and protease-activated receptor-2 in ovarian cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED TRYPSIN; MATRIX METALLOPROTEINASES; PLASMINOGEN-ACTIVATOR; CELL INVASION; COLON-CANCER; CYST FLUID; EXPRESSION; GROWTH; INHIBITOR; TISSUE	Proteases have been implicated in the tumorigenesis and aggressiveness of a variety of cancer types. In fact, proteases have proven to be very clinically useful as tumor biomarkers in the blood of patients. Proteases are typically involved in complex systems of substrates, activators, and inhibitors, thus making our ability to establish their exact function in cancer more difficult. Trypsin, perhaps the most famous of proteases, has been shown to play a role in cancer progression, but its functional role in ovarian cancer has not been much studied. PAR2, a transmembrane receptor that is known to be activated by trypsin, has been reported to be associated with ovarian cancer. Here, we found that stimulation of ovarian cancer cell lines with trypsin or PAR2 activating peptide markedly increased MAPK signaling and cell proliferation. Additionally, HE4, a WAP-family glycoprotein and ovarian cancer biomarker, was found to inhibit trypsin degradation, thereby retaining its activity. Patient data seemed to support this phenomenon, as the serum of ovarian cancer patients with high HE4 expression, revealed significantly elevated trypsin levels. These data support the hypothesis that trypsin plays a tumorigenic role in ovarian cancer, which can be mediated by its receptor PAR2, and potentiated by HE4.	[Kim, Kyu Kwang; Turner, Rachael; Khazan, Negar; Kodza, Arif; Jones, Aaron; Singh, Rakesh K.; Moore, Richard G.] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA	University of Rochester	Kim, KK (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA.	kyukwang_kim@urmc.rochester.edu		Kodza, Arif/0000-0003-1415-3334	Fujirebio; ANGLE plc	Fujirebio; ANGLE plc	We appreciate Fujirebio and ANGLE plc for providing research support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingle L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-61; Chanakira A, 2017, GYNECOL ONCOL, V145, P167, DOI 10.1016/j.ygyno.2017.01.022; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hirahara F, 1998, GYNECOL ONCOL, V68, P162, DOI 10.1006/gyno.1997.4912; HIRAHARA F, 1995, INT J CANCER, V63, P176, DOI 10.1002/ijc.2910630205; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hua L, 2014, PROTEIN EXPRES PURIF, V102, P52, DOI 10.1016/j.pep.2014.08.004; Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI 10.2217/FON.09.10; Jahan I, 2007, ANN ONCOL, V18, P1506, DOI 10.1093/annonc/mdm190; James NE, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00124; Kawano N, 1997, HUM PATHOL, V28, P613, DOI 10.1016/S0046-8177(97)90085-X; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kim KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14296; Kirchhoff C, 1998, REV REPROD, V3, P86; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; KOBAYASHI H, 1992, CANCER RES, V52, P3610; KOIVUNEN E, 1990, CANCER RES, V50, P2375; KOIVUNEN E, 1989, J BIOL CHEM, V264, P14095; KOIVUNEN E, 1991, CANCER RES, V51, P2107; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lukkonen A, 2000, INT J CANCER, V86, P577, DOI 10.1002/(SICI)1097-0215(20000515)86:4<577::AID-IJC21>3.3.CO;2-A; Luo LY, 2006, TUMOR BIOL, V27, P227, DOI 10.1159/000094693; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Miyata S, 1998, CLIN EXP METASTAS, V16, P613, DOI 10.1023/A:1006576313979; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Moore RG, 2008, GYNECOL ONCOL, V110, P196, DOI 10.1016/j.ygyno.2008.04.002; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; Paju A, 2004, CLIN CANCER RES, V10, P4761, DOI 10.1158/1078-0432.CCR-0204-03; Paju A, 2001, BRIT J CANCER, V84, P1363, DOI 10.1054/bjoc.2001.1806; Sallenave J M, 2000, Respir Res, V1, P87, DOI 10.1186/rr18; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Williams SJ, 2001, INT J CANCER, V93, P67, DOI 10.1002/ijc.1304; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4	44	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232253	10.1371/journal.pone.0232253	http://dx.doi.org/10.1371/journal.pone.0232253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365084	gold, Green Published			2022-12-26	WOS:000536959700022
J	Chiou, YA; Cheng, LK; Lin, SF				Chiou, Yu-An; Cheng, Li-Kuan; Lin, Shien-Fong			Effects of high-frequency biphasic shocks on ventricular vulnerability and defibrillation outcomes through synchronized virtual electrode responses	PLOS ONE			English	Article							TRIPHASIC WAVE-FORMS; TRANSTHORACIC DEFIBRILLATION; CARDIAC TISSUE; UPPER LIMIT; INTRACELLULAR CALCIUM; ALTERNATING-CURRENT; FIBRILLATION; STIMULATION; THRESHOLD; MODEL	Electrical defibrillation is a well-established treatment for cardiac dysrhythmias. Studies have suggested that shock-induced spatial sawtooth patterns and virtual electrodes are responsible for defibrillation efficacy. We hypothesize that high-frequency shocks enhance defibrillation efficacy by generating temporal sawtooth patterns and using rapid virtual electrodes synchronized with shock frequency. High-speed optical mapping was performed on isolated rat hearts at 2000 frames/s. Two defibrillation electrodes were placed on opposite sides of the ventricles. An S1-S2 pacing protocol was used to induce ventricular tachyarrhythmia (VTA). High-frequency shocks of equal energy but varying frequencies of 1251000 Hz were used to evaluate VTA vulnerability and defibrillation success rate. The 1000Hz shock had the highest VTA induction rate in the shorter S1-S2 intervals (50 and 100 ms) and the highest VTA defibrillation rate (70%) among all frequencies. Temporal sawtooth patterns and synchronous shock-induced virtual electrode responses could be observed with frequencies of up to 1000 Hz. The improved defibrillation outcome with high-frequency shocks suggests a lower energy requirement than that of low-frequency shocks for successful ventricular defibrillation.	[Chiou, Yu-An; Lin, Shien-Fong] Natl Chiao Tung Univ, Coll Elect & Comp Engn, Dept Elect & Comp Engn, Hsinchu, Taiwan; [Cheng, Li-Kuan; Lin, Shien-Fong] Natl Chiao Tung Univ, Coll Elect & Comp Engn, Inst Biomed Engn, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, SF (corresponding author), Natl Chiao Tung Univ, Coll Elect & Comp Engn, Dept Elect & Comp Engn, Hsinchu, Taiwan.; Lin, SF (corresponding author), Natl Chiao Tung Univ, Coll Elect & Comp Engn, Inst Biomed Engn, Hsinchu, Taiwan.	linsf5402@nctu.edu.tw			Ministry of Science and Technology, Taipei, Taiwan [103-2221-E-009 -036]	Ministry of Science and Technology, Taipei, Taiwan	This study was supported by Ministry of Science and Technology (103-2221-E-009 -036), Taipei, Taiwan, to SFL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2001, AM J PHYSIOL-HEART C, V281, pH533, DOI 10.1152/ajpheart.2001.281.2.H533; Anderson C, 2000, J CARDIOVASC ELECTR, V11, P1386, DOI 10.1046/j.1540-8167.2000.01386.x; Boukens BJ, 2015, ADV EXP MED BIOL, V859, P343, DOI 10.1007/978-3-319-17641-3_14; Bray MA, 2000, IEEE T BIO-MED ENG, V47, P1382, DOI 10.1109/10.871412; CHEN PS, 1991, J AM COLL CARDIOL, V18, P1555, DOI 10.1016/0735-1097(91)90690-B; CHEN PS, 1988, CIRC RES, V62, P1191, DOI 10.1161/01.RES.62.6.1191; CHEN PS, 1986, CIRCULATION, V73, P1022, DOI 10.1161/01.CIR.73.5.1022; Dor-Haim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066658; Dosdall DJ, 2010, ANNU REV BIOMED ENG, V12, P233, DOI [10.1146/annurev-bioeng-070909-105305, 10.1146/armurev-bioeng-070909-105305]; Dosdall DJ, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-22; Dura B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036217; Efimov IR, 2000, J CARDIOVASC ELECTR, V11, P339, DOI 10.1111/j.1540-8167.2000.tb01805.x; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; FURMAN S, 1975, J SURG RES, V19, P149, DOI 10.1016/0022-4804(75)90074-8; GLINER BE, 1995, CIRCULATION, V92, P1634, DOI 10.1161/01.CIR.92.6.1634; Gotoh M, 1997, CIRCULATION, V95, P2141, DOI 10.1161/01.CIR.95.8.2141; Hayashi H, 2008, AM J PHYSIOL-HEART C, V295, pH1422, DOI 10.1152/ajpheart.00001.2008; HOLLEY LK, 1991, CARDIOVASC RES, V25, P979, DOI 10.1093/cvr/25.12.979; Hwang GS, 2008, J AM COLL CARDIOL, V52, P828, DOI 10.1016/j.jacc.2008.05.040; Hwang GS, 2006, CIRCULATION, V114, P2595, DOI 10.1161/CIRCULATIONAHA.106.630509; Jones JL, 1995, J ELECTROCARDIOL, V28, P25, DOI 10.1016/S0022-0736(95)80005-0; Keener JP, 1996, J THEOR BIOL, V178, P313, DOI 10.1006/jtbi.1996.0027; Kong CY, 2011, CANCER EPIDEM BIOMAR, V20, P2450, DOI 10.1158/1055-9965.EPI-11-0547; KRASSOWSKA W, 1987, IEEE T BIO-MED ENG, V34, P555, DOI 10.1109/TBME.1987.325986; Krinsky V, 1998, CHAOS, V8, P188, DOI 10.1063/1.166297; KROLL MW, 1994, PACE, V17, P1782, DOI 10.1111/j.1540-8159.1994.tb03746.x; Li YQ, 2010, RESUSCITATION, V81, P724, DOI 10.1016/j.resuscitation.2010.02.022; METZGER P, 1985, J PHYSIOL-LONDON, V366, P177, DOI 10.1113/jphysiol.1985.sp015791; Newton JC, 1999, J CARDIOVASC ELECTR, V10, P234, DOI 10.1111/j.1540-8167.1999.tb00666.x; Nikolski VP, 2002, AM J PHYSIOL-HEART C, V282, pH565, DOI 10.1152/ajpheart.00544.2001; PLONSEY R, 1986, MED BIOL ENG COMPUT, V24, P137, DOI 10.1007/BF02443926; Roberts SJ, 2003, PACE, V26, P599, DOI 10.1046/j.1460-9592.2003.00100.x; Sambelashvili AT, 2004, AM J PHYSIOL-HEART C, V286, pH2183, DOI 10.1152/ajpheart.00637.2003; SEPULVEDA NG, 1989, BIOPHYS J, V55, P987, DOI 10.1016/S0006-3495(89)82897-8; SEPULVEDA NG, 1994, J CARDIOVASC ELECTR, V5, P258, DOI 10.1111/j.1540-8167.1994.tb01162.x; Sung YL, 2018, COMPUT BIOL MED, V102, P390, DOI 10.1016/j.compbiomed.2018.08.016; Sweeney RJ, 1996, J CARDIOVASC ELECTR, V7, P134, DOI 10.1111/j.1540-8167.1996.tb00508.x; Swerdlow CD, 2007, PACE, V30, P258, DOI 10.1111/j.1540-8159.2007.00659.x; Swift LM, 2012, PFLUG ARCH EUR J PHY, V464, P503, DOI 10.1007/s00424-012-1147-2; Tandri H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002445; Tang C, 2016, RESUSCITATION, V102, P57, DOI 10.1016/j.resuscitation.2016.02.018; Tang WC, 2001, CHEST, V120, P948, DOI 10.1378/chest.120.3.948; Trayanova Natalia, 2011, IEEE Rev Biomed Eng, V4, P89, DOI 10.1109/RBME.2011.2173761; Varghese F, 2017, CARDIOVASC RES, V113, P1789, DOI 10.1093/cvr/cvx172; Viana MA, 2014, J THORAC CARDIOV SUR, V148, P3213, DOI 10.1016/j.jtcvs.2014.07.035; Weinberg SH, 2013, HEART RHYTHM, V10, P740, DOI 10.1016/j.hrthm.2013.01.016; WEIRICH J, 1983, BASIC RES CARDIOL, V78, P604, DOI 10.1007/BF01907207; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Wikswo JP, 1995, BIOPHYS J, V69, P2195, DOI 10.1016/S0006-3495(95)80115-3; Zhang Y, 2006, RESUSCITATION, V68, P251, DOI 10.1016/j.resuscitation.2005.05.025; Zhang Y, 2003, J AM COLL CARDIOL, V42, P568, DOI 10.1016/S0735-1097(03)00656-9	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232529	10.1371/journal.pone.0232529	http://dx.doi.org/10.1371/journal.pone.0232529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357163	gold, Green Published			2022-12-26	WOS:000536957700037
J	dos Reis, HLB; Boldrini, NAT; Rangel, AFR; Barros, VF; de Vargas, PRM; Miranda, AE				Barroso dos Reis, Helena Lucia; Tosato Boldrini, Neide Aparecida; Ribeiro Rangel, Ana Fernanda; Barros, Vinicius Felipe; Mercon de Vargas, Paulo Roberto; Miranda, Angelica Espinosa			Placental growth disorders and perinatal adverse outcomes in Brazilian HIV-infected pregnant women	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FETAL-GROWTH; PRETERM BIRTH; BELO-HORIZONTE; TRANSMISSION; ASSOCIATION; ABNORMALITIES; INFANTS; WEIGHT	Fetal and placental growth disorders are common in maternal human immunodeficiency virus (HIV) infection and can be attributed to both the infection and comorbidities not associated with HIV. We describe placental growth disorders and adverse reproductive outcomes in HIV-infected pregnant women whose delivery occurred between 2001-2014 in Vitoria, Brazil. Cases with gestational age (GA) >= than 22 weeks validated by ultrasonography, with placental and fetal weight dimensions at birth, were studied. Outcomes were summarized as proportions of small (SGA), appropriate (AGA), and large (LGA) for GA when the z-score values were below -1.28, between -1.28 and +1.28, or above +1.28, respectively. Of 187 fetal attachment requisitions, 122(65.2%) women and their newborns participated in the study. The median maternal age was 28 years and 81(66.4%) underwent >= 6 prenatal visits. A total of 81(66.4%) were diagnosed before current pregnancy; 68(55.7%) exhibited criteria for acquired immunodeficiency syndrome (AIDS); 64(52.4%) had detectable viral load; 25 (20.5%) cases presented SGA placental weight and 6(4.9%) SGA placental thickness. SGA placental area was observed in 41(33.6%) cases, and among the SGA placental weight cases 12(48%) were also SGA fetal weight. Preterm birth (PTB) occurred in 15.6%(19/122) of cases; perinatal death in 4.1%(5/122) and HIV vertical transmission in 6 of 122 (4.9%). Women, >= 36 years old, were 5.7 times more likely to have PTB than those under 36. Also, patients with AIDS-defining criteria were 3.7 times more likely to have PTB. Prenatal care was inversely associated with PTB. Statistically significant associations were observed between AGA placental area and Protease Inhibitor usage and between SGA placental weight and SGA area. We found a prevalence of placental growth disorders in HIV-infected pregnant women and values higher than international reference values. The restriction of placental growth was a common disorder, possibly attributed to virus effects or a combination of antiretroviral regimens.	[Barroso dos Reis, Helena Lucia; Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, ES, Brazil; [Tosato Boldrini, Neide Aparecida] Univ Fed Espirito Santo, Dept Gynecol & Obstet, Vitoria, ES, Brazil; [Ribeiro Rangel, Ana Fernanda; Barros, Vinicius Felipe; Mercon de Vargas, Paulo Roberto] Univ Fed Espirito Santo, Dept Pathol, Pathol Lab, Cassiano Antonio Moraes Univ Hosp, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	dos Reis, HLB (corresponding author), Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, ES, Brazil.	dr.hbarroso@gmail.com	Miranda, Angelica/AAE-5571-2021	BARROSO DOS REIS, HELENA LUCIA/0000-0003-2018-2529; Miranda, Angelica/0000-0002-5556-8379; Tosato Boldrini, Neide Aparecida/0000-0003-1140-5057				Aaron E., 2012, Infectious Diseases in Obstetrics and Gynecology, V2012, P135030, DOI 10.1155/2012/135030; Aebi C, 2000, AIDS, V14, P2913, DOI 10.1097/00002030-200012220-00013; Baptiste-Roberts Kesha, 2008, BMC Pregnancy Childbirth, V8, P44, DOI 10.1186/1471-2393-8-44; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; Dos Reis HLB, 2015, REV INST MED TROP SP, V57, P111, DOI 10.1590/S0036-46652015000200003; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; Blair JM, 2004, OBSTET GYNECOL, V103, P663, DOI 10.1097/01.AOG.0000117083.33239.b5; Boer K, 2007, BJOG-INT J OBSTET GY, V114, P148, DOI 10.1111/j.1471-0528.2006.01183.x; Lopes MAB, 2007, REV BRAS GINECOL OBS, V29, P497, DOI 10.1590/S0100-72032007001000002; Boyd W., 1998, ARMADILLO; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2016, INF EST VIT NASC VIV; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cailhol J, 2009, JAIDS-J ACQ IMM DEF, V50, P409, DOI 10.1097/QAI.0b013e3181958560; Cameron N, 2005, AM J HUM BIOL, V17, P412, DOI 10.1002/ajhb.20408; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Chetty T, 2018, PLOS ONE, V13; Coley JL, 2001, BRIT J OBSTET GYNAEC, V108, P1125, DOI 10.1016/S0306-5456(01)00269-8; da Costa TP, 2013, AIDS CARE, V25, P686, DOI 10.1080/09540121.2013.764382; Delicio AM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0513-8; do Prado TN, 2018, AIDS BEHAV, V22, pS92, DOI 10.1007/s10461-018-2172-8; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Fausto MA, 2011, REV SAUDE PUBL, V45, P652, DOI 10.1590/S0034-89102011005000040; Feinstein A, 2002, PRINCIPLES MED STAT; Fox H, 1978, Major Probl Pathol, V7, P1; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GICHANGI PB, 1993, E AFR MED J, V70, P85; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HELLMAN LM, 1970, AM J OBSTET GYNECOL, V108, P740, DOI 10.1016/0002-9378(70)90540-5; Howard CV, 2005, UNBIASED STEREOLOGY; Iqbal SN, 2010, AM J PERINAT, V27, P517, DOI 10.1055/s-0030-1248937; Ismail KI, 2020, J MATERN-FETAL NEO M, V33, P3632, DOI 10.1080/14767058.2019.1582628; JAUNIAUX E, 1988, PLACENTA, V9, P633, DOI 10.1016/0143-4004(88)90007-0; Kalanda BF, 2005, ARCH DIS CHILD-FETAL, V90, P161, DOI 10.1136/adc.2004.054650; Kalk E, 2017, TROP MED INT HEALTH, V22, P604, DOI 10.1111/tmi.12858; Lartey A, 2014, MATERN CHILD NUTR, V10, P604, DOI 10.1111/j.1740-8709.2012.00441.x; Lawn JE, 2006, LANCET, V367, P1541, DOI 10.1016/S0140-6736(06)68587-5; Li N, 2016, J INFECT DIS, V213, P1057, DOI 10.1093/infdis/jiv389; López Consuelo Lozoya, 2013, J. Bras. Patol. Med. Lab., V49, P437, DOI 10.1590/S1676-24442013000600010; Machado ES, 2009, SEX TRANSM INFECT, V85, P82, DOI 10.1136/sti.2008.032300; Melo VH, 2018, REV BRAS GINECOL OBS, V40, P59, DOI 10.1055/s-0037-1613689; Ministerio da Saude, 2019, GUIA VIG SAUD; Miranda AE, 2005, AIDS CARE, V17, P721, DOI 10.1080/09540120500038033; Mohammadi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24680-w; MOLTENI RA, 1978, J REPROD MED, V21, P327; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Obimbo MM, 2019, JAIDS-J ACQ IMM DEF, V80, P94, DOI 10.1097/QAI.0000000000001871; Salafia CM, 2009, PLACENTA, V30, P468, DOI 10.1016/j.placenta.2008.12.013; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Salavati N, 2016, PLACENTA, V38, P41, DOI 10.1016/j.placenta.2015.12.003; Schwartz DA, 2000, J INFECT DIS, V182, P1652, DOI 10.1086/317634; Snijdewind IJM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191389; Uthman OA, 2017, LANCET HIV, V4, pE21, DOI 10.1016/S2352-3018(16)30195-3; van der Merwe K, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-42; Vargas Paulo Roberto Merçon de, 2013, J. Bras. Patol. Med. Lab., V49, P386, DOI 10.1590/S1676-24442013000600001; Wang LM, 2018, INT J GYNECOL OBSTET, V142, P300, DOI 10.1002/ijgo.12532; Watts DH, 2002, NEW ENGL J MED, V346, P1879, DOI 10.1056/NEJMra013338; Weibel E., 1980, STEREOLOGICAL METHOD; Yampolsky M, 2008, PLACENTA, V29, P790, DOI 10.1016/j.placenta.2008.06.005	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231938	10.1371/journal.pone.0231938	http://dx.doi.org/10.1371/journal.pone.0231938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352999	Green Published, gold			2022-12-26	WOS:000536673200028
J	Nakaya, MA; Gudmundsson, KO; Komiya, Y; Keller, JR; Habas, R; Yamaguchi, TP; Ajima, R				Nakaya, Masa-aki; Gudmundsson, Kristibjorn Orri; Komiya, Yuko; Keller, Jonathan R.; Habas, Raymond; Yamaguchi, Terry P.; Ajima, Rieko			Placental defects lead to embryonic lethality in mice lacking the Formin and PCP proteins Daam1 and Daam2	PLOS ONE			English	Article							PLANAR-CELL-POLARITY; NEURAL-TUBE DEFECTS; CONVERGENT EXTENSION; RHO-GTPASES; BRANCHING MORPHOGENESIS; TRACT DEVELOPMENT; GENES CELSR1; MOUSE; VANGL2; ACTIVATION	The actin cytoskeleton plays a central role in establishing cell polarity and shape during embryonic morphogenesis. Daam1, a member of the Formin family of actin cytoskeleton regulators, is a Dvl2-binding protein that functions in the Wnt/Planar Cell Polarity (PCP) pathway. To examine the role of the Daam proteins in mammalian development, we generated Daam-deficient mice by gene targeting and found that Daam1, but not Daam2, is necessary for fetal survival. Embryonic development of Daam1 mutants was delayed most likely due to functional defects in the labyrinthine layer of the placenta. Examination of Daam2 and Daam1/2 double mutants revealed that Daam1 and Daam2 are functionally redundant during placental development. Of note, neural tube closure defects (NTD), which are observed in several mammalian PCP mutants, are not observed in Wnt5a or Daam1 single mutants, but arise in Daam1;Wnt5a double mutants. These findings demonstrate a unique function for Daam genes in placental development and are consistent with a role for Daam1 in the Wnt/PCP pathway in mammals.	[Nakaya, Masa-aki; Yamaguchi, Terry P.; Ajima, Rieko] Natl Canc Inst Frederick, Canc & Dev Biol Lab, NIH, Frederick, MD 21702 USA; [Gudmundsson, Kristibjorn Orri; Keller, Jonathan R.] Natl Canc Inst Frederick, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD USA; [Komiya, Yuko; Habas, Raymond] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Nakaya, Masa-aki] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa, Japan; [Komiya, Yuko] Tokyo Univ Sci, Fac Ind Sci & Technol, Oshamambe, Hokkaido, Japan; [Ajima, Rieko] Natl Inst Genet, Mammalian Dev Lab, Mishima, Shizuoka, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Yokohama City University; Tokyo University of Science; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Yamaguchi, TP; Ajima, R (corresponding author), Natl Canc Inst Frederick, Canc & Dev Biol Lab, NIH, Frederick, MD 21702 USA.; Ajima, R (corresponding author), Natl Inst Genet, Mammalian Dev Lab, Mishima, Shizuoka, Japan.	yamagute@mail.nih.gov; rajima@nig.ac.jp	Keller, Jonathan R./O-6677-2018		National Institutes of Health [ZIA BC 010345, HHSN26120080001E, GM078172]; JSPS KAKENHI grant [18K06324]; Japan Spina Bifida & Hydrocephalus Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Spina Bifida & Hydrocephalus Research Foundation	This project has been funded with federal funds from the National Institutes of Health, Z01 (ZIA BC 010345) to TPY, (HHSN26120080001E) to JRK, (GM078172) to RH, and by JSPS KAKENHI grant (18K06324) and The Japan Spina Bifida & Hydrocephalus Research Foundation to RA.	Abdelhamed ZA, 2015, DIS MODEL MECH, V8, P527, DOI 10.1242/dmm.019083; Ajima R, 2015, DEV BIOL, V408, P126, DOI 10.1016/j.ydbio.2015.10.003; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; Biris KK, 2007, DEV DYNAM, V236, P3167, DOI 10.1002/dvdy.21342; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Brzoska HL, 2016, KIDNEY INT, V90, P1274, DOI 10.1016/j.kint.2016.07.011; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Cross JC, 2003, CLIN GENET, V64, P96, DOI 10.1034/j.1399-0004.2003.00127.x; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Higashi T, 2010, J BIOL CHEM, V285, P16231, DOI 10.1074/jbc.M109.079236; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Ju R, 2010, P NATL ACAD SCI USA, V107, P6906, DOI 10.1073/pnas.1001075107; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Lee HK, 2012, DEV CELL, V22, P183, DOI 10.1016/j.devcel.2011.10.025; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Miller C, 1998, DEVELOPMENT, V125, P3201; Minegishi K, 2017, DEV CELL, V40, P439, DOI 10.1016/j.devcel.2017.02.010; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2014, DIS MODEL MECH, V7, P1153, DOI 10.1242/dmm.016758; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Nakaya MA, 2004, GENE EXPR PATTERNS, V5, P97, DOI 10.1016/j.modgep.2004.06.001; Nishimura T, 2016, J CELL BIOL, V215, P559, DOI 10.1083/jcb.201603107; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shi DB, 2014, DEVELOPMENT, V141, P4558, DOI 10.1242/dev.115659; Shindo A, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.293; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Stemmler MP, 2010, DEV DYNAM, V239, P2330, DOI 10.1002/dvdy.22375; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Tada M, 2000, DEVELOPMENT, V127, P2227; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yates LL, 2010, HUM MOL GENET, V19, P4663, DOI 10.1093/hmg/ddq397; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Yun KS, 2014, HUM MOL GENET, V23, P6807, DOI 10.1093/hmg/ddu397	91	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232025	10.1371/journal.pone.0232025	http://dx.doi.org/10.1371/journal.pone.0232025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353019	Green Published, gold			2022-12-26	WOS:000536673200037
J	Luiso, D; Villanueva, JA; Belarte-Tornero, LC; Fort, A; Blazquez-Bermejo, Z; Ruiz, S; Farre, R; Rigau, J; Marti-Almor, J; Farre, N				Luiso, Daniele; Villanueva, Jair A.; Belarte-Tornero, Laia C.; Fort, Aleix; Blazquez-Bermejo, Zorba; Ruiz, Sonia; Farre, Ramon; Rigau, Jordi; Marti-Almor, Julio; Farre, Nuria			Surface respiratory electromyography and dyspnea in acute heart failure patients	PLOS ONE			English	Article							MUSCLE-ACTIVITY; END-POINTS; DRIVE; EXACERBATIONS; VALIDATION; MECHANISMS; SCALENE; SOCIETY; TRIALS; EMG	Introduction and Objectives: Dyspnea is the most common symptom among hospitalized patients with heart failure (HF) but besides dyspnea questionnaires (which reflect the subjective patient sensation and are not fully validated in HF) there are no measurable physiological variables providing objective assessment of dyspnea in a setting of acute HF patients. Studies performed in respiratory patients suggest that the measurement of electromyographic (EMG) activity of the respiratory muscles with surface electrodes correlates well with dyspnea. Our aim was to test the hypothesis that respiratory muscles EMG activity is a potential marker of dyspnea severity in acute HF patients. Methods: Prospective and descriptive pilot study carried out in 25 adult patients admitted for acute HF. Measurements were carried out with a cardio-respiratory portable polygraph including EMG surface electrodes for measuring the activity of main (diaphragm) and accessory (scalene and pectoralis minor) respiratory muscles. Dyspnea sensation was assessed by means of the Likert 5 questionnaire. Data were recorded during 3 min of spontaneous breathing and after breathing at maximum effort for several cycles for normalizing data. An index to quantify the activity of each respiratory muscle was computed. This assessment was carried out within the first 24 h of admission, and at day 2 and 5. Results: Dyspnea score decreased along the three measured days. Diaphragm and scalene EMG index showed a positive and significant direct relationship with dyspnea score (p<0.001 and p = 0.003 respectively) whereas pectoralis minor muscle did not. Conclusion: In our pilot study, diaphragm and scalene EMG activity was associated with increasing severity of dyspnea. Surface respiratory EMG could be a useful objective tool to improve assessment of dyspnea in acute HF patients.	[Luiso, Daniele; Belarte-Tornero, Laia C.; Fort, Aleix; Blazquez-Bermejo, Zorba; Ruiz, Sonia; Marti-Almor, Julio; Farre, Nuria] Hosp del Mar, Dept Cardiol, Barcelona, Spain; [Luiso, Daniele; Marti-Almor, Julio; Farre, Nuria] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Villanueva, Jair A.; Farre, Ramon] Univ Barcelona, Sch Med & Hlth Sci, Unit Biophys & Bioengn, Barcelona, Spain; [Ruiz, Sonia; Farre, Nuria] IMIM Hosp del Mar Med Res Inst, Heart Dis Biomed Res Grp GREC, Barcelona, Spain; [Farre, Ramon] CIBER Resp Dis CIBERES, Madrid, Spain; [Farre, Ramon] Inst Biomed Res August Pi Sunyer IDIBAPS, Barcelona, Spain; [Rigau, Jordi] Sibel SAU, Res Dev & Innovat Dept, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Farre, N (corresponding author), Hosp del Mar, Dept Cardiol, Barcelona, Spain.; Farre, N (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.; Farre, N (corresponding author), IMIM Hosp del Mar Med Res Inst, Heart Dis Biomed Res Grp GREC, Barcelona, Spain.	NFarreLopez@parcdesalutmar.cat	Blázquez-Bermejo, Zorba/ABF-8557-2021; Farre, Nuria/I-2668-2019; Ruiz, Sonia/GRK-0102-2022; Farre, Ramon/L-2664-2017; VILLANUEVA, JAIR ASIR/K-4395-2015	Farre, Nuria/0000-0003-3110-6572; Farre, Ramon/0000-0002-9084-7824; Julio, Marti Almor/0000-0001-9927-1190; Ruiz Bustillo, Sonia/0000-0002-6074-914X; Luiso, Daniele/0000-0001-5095-584X; VILLANUEVA, JAIR ASIR/0000-0002-5672-2243; Belarte Tornero, Laia Carla/0000-0003-2774-1290; Blazquez-Bermejo, Zorba/0000-0001-7372-2950	Sibel S.A.U	Sibel S.A.U	This work was supported by Sibel S.A.U. The funder provided support in the form of salaries for authors [JR] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Bellani G, 2018, RESP CARE, V63, P1341, DOI 10.4187/respcare.06176; Chiti L, 2008, RESP PHYSIOL NEUROBI, V164, P441, DOI 10.1016/j.resp.2008.09.010; Easton PA, 2010, CHEST, V137, P558, DOI 10.1378/chest.09-0197; Estrada L, 2016, IEEE ENG MED BIO, P5769, DOI 10.1109/EMBC.2016.7592038; Greene SJ, 2018, CIRCULATION, V138, P1039, DOI 10.1161/CIRCULATIONAHA.118.034668; Huang TY, 2013, J NURS RES, V21, P49, DOI 10.1097/jnr.0b013e3182828d77; Hudson AL, 2007, J PHYSIOL-LONDON, V584, P261, DOI 10.1113/jphysiol.2007.137240; Hug F, 2011, RESP PHYSIOL NEUROBI, V178, P341, DOI 10.1016/j.resp.2011.06.007; Hughes PD, 1999, AM J RESP CRIT CARE, V160, P529, DOI 10.1164/ajrccm.160.2.9810081; Jolley CJ, 2009, EUR RESPIR J, V33, P289, DOI 10.1183/09031936.00093408; Kelley RC, 2017, HEART FAIL REV, V22, P191, DOI 10.1007/s10741-016-9549-4; Kupper N, 2016, J CARD FAIL, V22, P201, DOI 10.1016/j.cardfail.2015.09.016; Lin L, 2019, RESP PHYSIOL NEUROBI, V259, P45, DOI 10.1016/j.resp.2018.07.004; MANCINI DM, 1992, CIRCULATION, V86, P909, DOI 10.1161/01.CIR.86.3.909; Mebazaa A, 2010, EUR HEART J, V31, P832, DOI 10.1093/eurheartj/ehp458; Meyer FJ, 2001, CIRCULATION, V103, P2153; Murphy PB, 2011, THORAX, V66, P602, DOI 10.1136/thx.2010.151332; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Pang PS, 2008, EUR HEART J, V29, P816, DOI 10.1093/eurheartj/ehn048; Pang PS, 2017, HEART LUNG, V46, P300, DOI 10.1016/j.hrtlng.2017.03.003; Pang PS, 2014, ACAD EMERG MED, V21, P659, DOI 10.1111/acem.12390; Pang PS, 2009, EUR HEART J, V30, P2233, DOI 10.1093/eurheartj/ehp253; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Parshall MB, 2012, HEART LUNG, V41, P44, DOI 10.1016/j.hrtlng.2011.05.003; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ramsook AH, 2017, J APPL PHYSIOL, V122, P1267, DOI 10.1152/japplphysiol.00046.2017; Reilly CC, 2011, THORAX, V66, P240, DOI 10.1136/thx.2010.142646; Schmidt M, 2013, INTENS CARE MED, V39, P1368, DOI 10.1007/s00134-013-2910-3; Shoaib A, 2014, EUR J HEART FAIL, V16, P1283, DOI 10.1002/ejhf.153; Smithline Howard A, 2010, Congest Heart Fail, V16, P202, DOI 10.1111/j.1751-7133.2010.00152.x; Suh ES, 2015, THORAX, V70, P1123, DOI 10.1136/thoraxjnl-2015-207188; Torres R, 2017, MED DEVICES-EVID RES, V10, P47, DOI 10.2147/MDER.S125425; Walters TJ, 2013, J ELECTROMYOGR KINES, V23, P1012, DOI 10.1016/j.jelekin.2013.06.004; Zannad F, 2013, EUR J HEART FAIL, V15, P1082, DOI 10.1093/eurjhf/hft095	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232225	10.1371/journal.pone.0232225	http://dx.doi.org/10.1371/journal.pone.0232225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348374	Green Published, gold			2022-12-26	WOS:000536668200048
J	O'Day, J; Syrkin-Nikolau, J; Anidi, C; Kidzinski, L; Delp, S; Bronte-Stewart, H				O'Day, Johanna; Syrkin-Nikolau, Judy; Anidi, Chioma; Kidzinski, Lukasz; Delp, Scott; Bronte-Stewart, Helen			The turning and barrier course reveals gait parameters for detecting freezing of gait and measuring the efficacy of deep brain stimulation	PLOS ONE			English	Article							PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; LOW-FREQUENCY; POSTURAL CONTROL; DISORDERS; IMPROVES; TASKS	Freezing of gait (FOG) is a devastating motor symptom of Parkinson's disease that leads to falls, reduced mobility, and decreased quality of life. Reliably eliciting FOG has been difficult in the clinical setting, which has limited discovery of pathophysiology and/or documentation of the efficacy of treatments, such as different frequencies of subthalamic deep brain stimulation (STN DBS). In this study we validated an instrumented gait task, the turning and barrier course (TBC), with the international standard FOG questionnaire question 3 (FOG-Q3, r = 0.74, p < 0.001). The TBC is easily assembled and mimics real-life environments that elicit FOG. People with Parkinson's disease who experience FOG (freezers) spent more time freezing during the TBC compared to during forward walking (p = 0.007). Freezers also exhibited greater arrhythmicity during non-freezing gait when performing the TBC compared to forward walking (p = 0.006); this difference in gait arrhythmicity between tasks was not detected in non-freezers or controls. Freezers' non-freezing gait was more arrhythmic than that of non-freezers or controls during all walking tasks (p < 0.05). A logistic regression model determined that a combination of gait arrhythmicity, stride time, shank angular range, and asymmetry had the greatest probability of classifying a step as FOG (area under receiver operating characteristic curve = 0.754). Freezers' percent time freezing and non-freezing gait arrhythmicity decreased, and their shank angular velocity increased in the TBC during both 60 Hz and 140 Hz STN DBS (p < 0.05) to non-freezer values. The TBC is a standardized tool for eliciting FOG and demonstrating the efficacy of 60 Hz and 140 Hz STN DBS for gait impairment and FOG. The TBC revealed gait parameters that differentiated freezers from non-freezers and best predicted FOG; these may serve as relevant control variables for closed loop neurostimulation for FOG in Parkinson's disease.	[O'Day, Johanna; Kidzinski, Lukasz; Delp, Scott] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [O'Day, Johanna; Syrkin-Nikolau, Judy; Anidi, Chioma; Bronte-Stewart, Helen] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Bronte-Stewart, Helen] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Syrkin-Nikolau, Judy] Cala Hlth, Burlingame, CA USA; [Anidi, Chioma] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA	Stanford University; Stanford University; Stanford University; University of Michigan System; University of Michigan	Bronte-Stewart, H (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Bronte-Stewart, H (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.	hbs@stanford.edu		Delp, Scott/0000-0002-9643-7551; Anidi, Chioma/0000-0002-2457-2893	Michael J. Fox Foundation [9605]; National Institute of Neurological Disorders and Stroke (NINDS) [5 R21 NS096398-02]; Robert and Ruth Halperin Foundation; John A. Blume Foundation; Helen M. Cahill Award for Research in Parkinson's Disease; Stanford Bio-X Bowes Graduate Fellowship; National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence Grant [U54EB020405]; Stanford University	Michael J. Fox Foundation; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Robert and Ruth Halperin Foundation; John A. Blume Foundation; Helen M. Cahill Award for Research in Parkinson's Disease; Stanford Bio-X Bowes Graduate Fellowship; National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University)	This study was supported in part by the Michael J. Fox Foundation (9605, HBS), the National Institute of Neurological Disorders and Stroke (NINDS Grant 5 R21 NS096398-02; HBS, CA, JSN), the Robert and Ruth Halperin Foundation (HBS), the John A. Blume Foundation (HBS), the Helen M. Cahill Award for Research in Parkinson's Disease (HBS), the Stanford Bio-X Bowes Graduate Fellowship (JO), and the National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence Grant U54EB020405 (SD, JO). Medtronic Inc. provided the devices used in this study but no additional financial support. At the time that the data was collected and study performed, all the authors of the study were employees and funded by Stanford University and the project was funded by the funders listed in the study. Subsequent to this, one of the authors (JSN) became employed by Cala Health. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michael J Fox: https://www.michaeljfox.org/NINDS: https://www.ninds.nih.gov/Stanford Bio-X: https://biox.stanford.edu/NIH BD2K: https://commonfund.nih.gov/bd2k.	Amboni M, 2015, PARKINSONISM RELAT D, V21, P644, DOI 10.1016/j.parkreldis.2015.03.028; Anidi C, 2018, NEUROBIOL DIS, V120, P107, DOI 10.1016/j.nbd.2018.09.004; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Blumenfeld Z, 2017, MOVEMENT DISORD, V32, P80, DOI 10.1002/mds.26837; Bronte-Stewart HM, 2002, BRAIN, V125, P2100, DOI 10.1093/brain/awf207; Brozova H, 2009, NEUROENDOCRINOL LETT, V30, P453; Coste CA, 2014, SENSORS-BASEL, V14, P6819, DOI 10.3390/s140406819; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hell F, 2018, NEUROIMAGE-CLIN, V19, P396, DOI 10.1016/j.nicl.2018.05.001; Khemani P, 2015, JAMA NEUROL, V72, P499, DOI 10.1001/jamaneurol.2015.36; Kim H, 2015, IEEE ENG MED BIO, P3751, DOI 10.1109/EMBC.2015.7319209; Kwon Y, 2014, CLIN INTERV AGING, V9, P1709, DOI 10.2147/CIA.S69773; Lippa CF, 2007, NEUROLOGY; Mancini M, 2017, NEUROSCIENCE, V343, P222, DOI 10.1016/j.neuroscience.2016.11.045; Mancini M, 2012, IEEE ENG MED BIO, P1198, DOI 10.1109/EMBC.2012.6346151; Merola A, 2011, BRAIN, V134, P2074, DOI 10.1093/brain/awr121; Mitchell T, 2019, PARKINSONISM RELAT D, V64, P188, DOI 10.1016/j.parkreldis.2019.04.011; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Moore ST, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-19; Moreau C, 2008, NEUROLOGY, V71, P80, DOI 10.1212/01.wnl.0000303972.16279.46; Morgan D, 2007, CAN J AGING; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Nieuwboer A, 2008, Br J Neurosurg, V22 Suppl 1, pS16, DOI 10.1080/02688690802448376; Palmerini L., 2017, FRONT NEUROL, V8, P1; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Ramdhani RA, 2015, NEUROMODULATION, V18, P664, DOI 10.1111/ner.12288; Rezvanian S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16040475; Rochester L, 2008, MOVEMENT DISORD, V23, P2312, DOI 10.1002/mds.22219; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Schlenstedt C, 2017, EUR J NEUROL, V24, P18, DOI 10.1111/ene.13167; Shivitz N, 2006, MOVEMENT DISORD, V21, P1088, DOI 10.1002/mds.20905; Sieber BA, 2014, ANN NEUROL, V76, P469, DOI 10.1002/ana.24261; de Lima ALS, 2017, J NEUROL, V264, P1642, DOI 10.1007/s00415-017-8424-0; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Syrkin-Nikolau J, 2017, NEUROBIOL DIS, V108, P288, DOI 10.1016/j.nbd.2017.09.002; Vallabhajosula S, 2015, BRAIN STIMUL, V8, P64, DOI 10.1016/j.brs.2014.10.011; Xie T, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0083-7; Xie T, 2015, NEUROLOGY, V84, P415, DOI 10.1212/WNL.0000000000001184; Zach H, 2015, PARKINSONISM RELAT D, V21, P1362, DOI 10.1016/j.parkreldis.2015.09.051; Ziegler K, 2010, MOVEMENT DISORD, V25, P1012, DOI 10.1002/mds.22993	46	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231984	10.1371/journal.pone.0231984	http://dx.doi.org/10.1371/journal.pone.0231984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348346	Green Published, Green Submitted, gold			2022-12-26	WOS:000536668200035
J	Paredes, J; Marvin, JC; Vaughn, B; Andarawis-Puri, N				Paredes, Juan; Marvin, Jason C.; Vaughn, Brenna; Andarawis-Puri, Nelly			Innate tissue properties drive improved tendon healing in MRL/MpJ and harness cues that enhance behavior of canonical healing cells	FASEB JOURNAL			English	Article						decellularization; extracellular matrix; MRL; MpJ; regeneration; tendon; therapeutics	EXTRACELLULAR-MATRIX; COLLAGEN FIBRILS; SKELETAL-MUSCLE; MRL MICE; GROWTH; FIBROMODULIN; REGENERATION; DECORIN; HYDROGEL; INJURY	Development of tendon therapeutics has been hindered by the lack of informative adult mammalian models of regeneration. Murphy Roth's Large (MRL/MpJ) mice exhibit improved healing following acute tendon injuries, but the driver of this regenerative healing response remains unknown. The tissue-specific attributes of this healing response, despite a shared systemic environment within the mouse, support the hypothesis of a tissue-driven mechanism for scarless healing. Our objective was to investigate the potential of MRL/MpJ tendon extracellular matrix (ECM)-derived coatings to regulate scar-mediated healing. We found that deviations in the composition of key structural proteins within MRL/MpJ vs C57Bl/6 tendons occur synergistically to mediate the improvements in structure and mechanics following a 1-mm midsubstance injury. Improvement in mechanical properties of healing MRL/MpJ vs C57Bl/6 tendons that were isolated from systemic contributions via organ culture, highlighted the innate tendon environment as the driver of scarless healing. Finally, we established that decellularized coatings derived from early-deposited MRL/MpJ tendon provisional extracellular matrix (provisional-ECM), can modulate canonical healing B6 tendon cell behavior by inducing morphological changes and increasing proliferation in vitro. This study supports that the unique compositional cues in MRL/MpJ provisional-ECM have the therapeutic capability to motivate canonically healing cells toward improved behavior; enhancing our ability to develop effective therapeutics.	[Paredes, Juan; Marvin, Jason C.; Vaughn, Brenna] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA; [Andarawis-Puri, Nelly] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14850 USA; [Andarawis-Puri, Nelly] Hosp Special Surg, New York, NY 10021 USA	Cornell University; Cornell University	Andarawis-Puri, N (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14850 USA.	na424@cornell.edu	Marvin, Jason C./ADY-1804-2022; Marvin, Ph.D., Jason Chang/GZH-1204-2022	Marvin, Jason C./0000-0002-0741-595X; 	US National Institutes of Health (NIH) [NIAMS R01-AR068301, R01-AR052743]; NSF [GRFP DGE-1650441]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	The authors acknowledge technical contributions from Dr Claudia Fischbach-Teschl (Cornell University) and Dr Benjamin Cosgrove (Cornell University) for access to their epifluorescence microscope and ChemiDoc MP imager, respectively. This work was supported by the US National Institutes of Health (NIH) Grants NIAMS R01-AR068301 and R01-AR052743 and NSF GRFP DGE-1650441.	Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; Al-Sadi Onays, 2011, Muscles Ligaments Tendons J, V1, P68; Andarawis-Puri N, 2018, J ORTHOP RES, V36, P3115, DOI 10.1002/jor.24133; Banes AJ, 1999, CLIN ORTHOP RELAT R, pS356; Beason DP, 2012, J BIOMECH, V45, P1550, DOI 10.1016/j.jbiomech.2012.02.022; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Blankenhorn EP, 2003, MAMM GENOME, V14, P250, DOI 10.1007/s00335-002-2222-3; Born AK, 2009, EUR CELLS MATER, V18, P49; Chen WCW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600844; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Colwell AS, 2006, WOUND REPAIR REGEN, V14, P81, DOI 10.1111/j.1524-475X.2005.00092.x; Costa MA, 2006, TISSUE ENG, V12, P1937, DOI 10.1089/ten.2006.12.1937; DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31; Disser NP, 2019, FASEB J, V33, P12680, DOI 10.1096/fj.201901503R; Dunkman AA, 2014, ANN BIOMED ENG, V42, P619, DOI 10.1007/s10439-013-0915-2; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Franchi M, 2007, THESCIENTIFICWORLDJO, V7, P404, DOI 10.1100/TSW.2007.92; Gawriluk TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11164; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; Gilpin A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9831534; Heber-Katz E, 2004, WOUND REPAIR REGEN, V12, P384, DOI 10.1111/j.1067-1927.2004.012308.x; Heber-Katz E, 1999, SEMIN CELL DEV BIOL, V10, P415, DOI 10.1006/scdb.1999.0328; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079; Hussey GS, 2018, NAT REV MATER, V3, P159, DOI 10.1038/s41578-018-0023-x; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Lalley AL, 2015, J ORTHOP RES, V33, P1693, DOI 10.1002/jor.22928; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; Marturano JE, 2014, ACTA BIOMATER, V10, P1370, DOI 10.1016/j.actbio.2013.11.024; Moon DK, 2006, J BIOMECH, V39, P3071, DOI 10.1016/j.jbiomech.2005.10.029; Paredes J, 2018, CONNECT TISSUE RES, V59, P472, DOI 10.1080/03008207.2018.1485665; Pokhai GG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3194753; Poon CJ, 2013, ACTA BIOMATER, V9, P5609, DOI 10.1016/j.actbio.2012.11.003; Porzionato A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124117; Rao N, 2017, ACS NANO, V11, P3851, DOI 10.1021/acsnano.7b00093; Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07; Screen HRC, 2015, J ORTHOP RES, V33, P793, DOI 10.1002/jor.22818; Sereysky JB, 2013, INT J EXP PATHOL, V94, P293, DOI 10.1111/iep.12031; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Snedeker JG, 2017, ACTA BIOMATER, V63, P18, DOI 10.1016/j.actbio.2017.08.032; Subramanian A, 2018, ELIFE, V7, DOI 10.7554/eLife.38069; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Taylor DA, 2018, ACTA BIOMATER, V74, P74, DOI 10.1016/j.actbio.2018.04.044; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007; Wang L, 2014, J DENT RES, V93, P780, DOI 10.1177/0022034514541126; Xue AB, 2018, J BIOMED MATER RES A, V106, P805, DOI 10.1002/jbm.a.36279; Zhang L, 2013, TISSUE ENG PT A, V19, P1909, DOI [10.1089/ten.tea.2012.0622, 10.1089/ten.TEA.2012.0622]; Zheng Z, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.50; Zheng Z, 2016, AM J PATHOL, V186, P2824, DOI 10.1016/j.ajpath.2016.07.023	55	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8341	8356		10.1096/fj.201902825RR	http://dx.doi.org/10.1096/fj.201902825RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350938	Bronze, Green Accepted			2022-12-26	WOS:000553674600001
J	Jabbour, R; Ott, J; Eppel, W; Frigo, P				Jabbour, Rhea; Ott, Johannes; Eppel, Wolfgang; Frigo, Peter			Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; YOUNG-WOMEN; INSULIN-RESISTANCE; METABOLIC SYNDROME; ARTERIAL-WALL; ATHEROSCLEROSIS; FAT; CORONARY	Objective Polycystic ovary syndrome (PCOS) has been associated with an increased risk of metabolic disturbances and cardiovascular disease. Intima-media thickness of the common carotid artery (CIMT) represents a valid surrogate marker of early systemic atherosclerosis. This study aimed to investigate if CIMT is increased in PCOS patients compared to healthy controls and if there is an association with hormone and metabolic profiles. Methods In this prospective cross-sectional study, past medical history, anthropometrical measurements and hormonal, lipidemic and glycemic parameters were obtained in 41 PCOS patients and 43 age-matched healthy controls of similar body mass index (BMI) and frequency of smokers. B-mode ultrasound enabled CIMT measurement at the far wall of the left and right common carotid artery. Results Patients with PCOS showed significantly increased CIMT values compared to healthy controls (0.49 +/- 0.04mm vs. 0.37 +/- 0.04mm respectively, P<0.001). They featured a generally increased cardiovascular risk profile. Correlation analysis showed a positive association between CIMT and the adverse metabolic risk profile. The diagnosis of PCOS was the strongest predictor of CIMT, even after multiple adjustments for BMI, age and smoking status (beta = 0.797, P<0.001, R-2 = 0.73). A model among oligomenorrhoic patients revealed a relationship between CIMT and the suspected duration of disease (beta = 0.373, P = 0.021, R-2 = 0.14). Conclusions PCOS patients are likely to feature signs of premature systemic atherosclerosis at a young age. Early exposure to adverse cardiovascular risk factors may possibly have long-term consequences on the vascular system. An early vessel screening might thus already be beneficial in these patients at a younger age.	[Jabbour, Rhea; Ott, Johannes; Frigo, Peter] Med Univ Vienna, Div Gynecol Endocrinol & Reprod Med, Dept Obstet & Gynecol, Vienna, Austria; [Eppel, Wolfgang] Med Univ Vienna, Div Obstet & Fetomaternal Med, Dept Obstet & Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Jabbour, R (corresponding author), Med Univ Vienna, Div Gynecol Endocrinol & Reprod Med, Dept Obstet & Gynecol, Vienna, Austria.	rhea.jab@gmail.com		Ott, Johannes/0000-0002-2761-5262	Department of Radiology of the Medical University of Vienna; Department of Neurology of the Medical University of Vienna	Department of Radiology of the Medical University of Vienna; Department of Neurology of the Medical University of Vienna	Thanks to the Departments of Radiology and Neurology of the Medical University of Vienna for their support. We also thank Georg Dorffner, Ph.D., M.S. (Center for Medical Statistics, Informatics and Intelligent Systems, Institute of Artificial Intelligence) and Christian Gobl, M. D. (Department of Obstetrics and Gynecology, Medical University of Vienna) for their statistical advice.	Alexopoulos N, 2014, ATHEROSCLEROSIS, V233, P104, DOI 10.1016/j.atherosclerosis.2013.12.023; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2007, CONTEMP ENDOCRINOL S, P145; Bernini GP, 1999, J CLIN ENDOCR METAB, V84, P2008, DOI 10.1210/jc.84.6.2008; Blouin K, CLIN ENDOCRINOL OXF; Carmina E, 2007, J CLIN ENDOCR METAB, V92, P2500, DOI 10.1210/jc.2006-2725; Carmina E, 2007, CONTEMP ENDOCRINOL S, P235; Cascella T, 2008, HUM REPROD, V23, P153, DOI 10.1093/humrep/dem356; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Corbould A, 2007, J ENDOCRINOL, V192, P585, DOI 10.1677/joe.1.07070; de Groot PCM, 2011, HUM REPROD UPDATE, V17, P495, DOI 10.1093/humupd/dmr001; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEPERGOLA G, 2000, INT J OBESITY, V24, P59; Diamanti-Kandarakis E, 2005, CLIN ENDOCRINOL, V62, P37, DOI 10.1111/j.1365-2265.2004.02170.x; Diamanti-Kandarakis E, 2008, CLIN ENDOCRINOL, V69, P634, DOI 10.1111/j.1365-2265.2008.03247.x; Diamanti-Kandarakis E, 2007, HISTOCHEM CELL BIOL, V127, P581, DOI 10.1007/s00418-006-0265-3; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Dicker A, 2004, DIABETOLOGIA, V47, P420, DOI 10.1007/s00125-003-1324-0; Ek I, 2002, DIABETES, V51, P484, DOI 10.2337/diabetes.51.2.484; Fauser BCJM, 2011, J CLIN ENDOCR METAB, V96, P3675, DOI 10.1210/jc.2011-2935; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Garg N, INDIAN J ENDOCRINOL, V20, P662, DOI [10.4103/2230-8210.190552, DOI 10.4103/2230-8210.190552]; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Gunning MN, 2017, CLIMACTERIC, V20, P222, DOI 10.1080/13697137.2017.1316256; Guzick DS, 1996, AM J OBSTET GYNECOL, V174, P1224, DOI 10.1016/S0002-9378(96)70665-8; Heutling D, 2008, J CLIN ENDOCR METAB, V93, P82, DOI 10.1210/jc.2007-0842; Jakimiuk AJ, 2001, J CLIN ENDOCR METAB, V86, P1318, DOI 10.1210/jc.86.3.1318; Jonard S, 2004, HUM REPROD UPDATE, V10, P107, DOI 10.1093/humupd/dmh010; Karabulut A, 2012, GYNECOL ENDOCRINOL, V28, P111, DOI 10.3109/09513590.2011.589929; Karim R, 2008, J CLIN ENDOCR METAB, V93, P131, DOI 10.1210/jc.2007-1738; Kim JJ, 2014, FERTIL STERIL, V101, P1424, DOI 10.1016/j.fertnstert.2014.01.049; Kim Jin Ju, 2013, Obstet Gynecol Sci, V56, P249, DOI 10.5468/ogs.2013.56.4.249; Lagana AS, 2018, TRENDS ENDOCRIN MET, V29, P768, DOI 10.1016/j.tem.2018.09.001; Legro RS, 2003, ENDOCR REV, V24, P302, DOI 10.1210/er.2003-0004; Lo J, 2006, J CLIN ENDOCR METAB, V91, P1677, DOI 10.1210/jc.2005-2775; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luque-Ramirez M, 2007, HUM REPROD, V22, P3197, DOI 10.1093/humrep/dem324; McCrohon JA, 1999, CIRCULATION, V99, P2317, DOI 10.1161/01.CIR.99.17.2317; Meun C, 2018, J CLIN ENDOCR METAB, V103, P1622, DOI 10.1210/jc.2017-02421; Meyer ML, 2012, HUM REPROD UPDATE, V18, P112, DOI 10.1093/humupd/dmr046; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Nagele W, 2015, Z GEFASSMEDIZIN, V12, P5; Orio F, 2004, J CLIN ENDOCR METAB, V89, P4588, DOI 10.1210/jc.2003-031867; Pauletto P, 1979, HYPERTENS, V17; Peppa M, 2010, J BIOMED BIOTECHNOL, V2010, P13; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Poredos P, 2004, VASC MED, V9, P46, DOI 10.1191/1358863x04vm514ra; Rojas Joselyn, 2014, Int J Reprod Med, V2014, P719050, DOI 10.1155/2014/719050; Rosenfield RL, 1999, ENDOCRIN METAB CLIN, V28, P265, DOI 10.1016/S0889-8529(05)70070-0; Saha S, 2008, INDIAN J CLIN BIOCHE, V23, P262, DOI 10.1007/s12291-008-0059-6; Sathyapalan T, 2012, EUR J ENDOCRINOL, V166, P575, DOI 10.1530/EJE-11-0755; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; Studen KB, 2018, ENDOCR CONNECT, V7, pR238, DOI 10.1530/EC-18-0129; Suliman AM, 2003, CLIN CHEM, V49, P1504, DOI 10.1373/49.9.1504; Talbott EO, 2004, J CLIN ENDOCR METAB, V89, P5454, DOI 10.1210/jc.2003-032237; Talbott EO, 2000, ARTERIOSCL THROM VAS, V20, P2414, DOI 10.1161/01.ATV.20.11.2414; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; van der Meer IM, 2003, STROKE, V34, P2374, DOI 10.1161/01.STR.0000088643.07108.19; Vlassara H, 2005, ANN NY ACAD SCI, V1043, P452, DOI 10.1196/annals.1333.051; Vryonidou A, 2005, J CLIN ENDOCR METAB, V90, P2740, DOI 10.1210/jc.2004-2363; Vural B, 2005, HUM REPROD, V20, P2409, DOI 10.1093/humrep/dei100; Waist Circumference and Waist-Hip Ratio, 2008, INT J ENDOCRINOL; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025	64	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232299	10.1371/journal.pone.0232299	http://dx.doi.org/10.1371/journal.pone.0232299			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330202	gold, Green Published			2022-12-26	WOS:000536647300070
J	Good, NM; Fellner, M; Demirer, K; Hu, J; Hausinger, RP; Martinez-Gomez, NC				Good, Nathan M.; Fellner, Matthias; Demirer, Kemal; Hu, Jian; Hausinger, Robert P.; Martinez-Gomez, N. Cecilia			Lanthanide-dependent alcohol dehydrogenases require an essential aspartate residue for metal coordination and enzymatic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						one-carbon metabolism; metalloprotein; alcohol dehydrogenase (ADH); crystallography; aspartate (aspartic acid); cofactor coordination; ExaF; lanthanide; methanol dehydrogenase; XoxF; ethanol dehydrogenase; pyrroloquinoline quinone	QUINOPROTEIN ETHANOL DEHYDROGENASE; METHYLOBACTERIUM-EXTORQUENS AM1; METHANOL DEHYDROGENASE; PYRROLOQUINOLINE QUINONE; TRANSPOSON MUTAGENESIS; PSEUDOMONAS-AERUGINOSA; OXIDATION; XOXF; SYSTEM; LIFE	The lanthanide elements (Ln(3+)), those with atomic numbers 57?63 (excluding promethium, Pm3+), form a cofactor complex with pyrroloquinoline quinone (PQQ) in bacterial XoxF methanol dehydrogenases (MDHs) and ExaF ethanol dehydrogenases (EDHs), expanding the range of biological elements and opening novel areas of metabolism and ecology. Other MDHs, known as MxaFIs, are related in sequence and structure to these proteins, yet they instead possess a Ca2+-PQQ cofactor. An important missing piece of the Ln(3+)puzzle is defining what features distinguish enzymes that use Ln(3+)-PQQ cofactors from those that do not. Here, using XoxF1 MDH from the model methylotrophic bacteriumMethylorubrum extorquensAM1, we investigated the functional importance of a proposed lanthanide-coordinating aspartate residue. We report two crystal structures of XoxF1, one with and another without PQQ, both with La(3+)bound in the active-site region and coordinated by Asp(320). Using constructs to produce either recombinant XoxF1 or its D320A variant, we show that Asp(320)is needed forin vivocatalytic function,in vitroactivity, and La(3+)coordination. XoxF1 and XoxF1 D320A, when produced in the absence of La3+, coordinated Ca(2+)but exhibited little or no catalytic activity. We also generated the parallel substitution in ExaF to produce ExaF D319S and found that this variant loses the capacity for efficient ethanol oxidation with La3+. These results provide evidence that a Ln(3+)-coordinating aspartate is essential for the enzymatic functions of XoxF MDHs and ExaF EDHs, supporting the notion that sequences of these enzymes, and the genes that encode them, are markers for Ln(3+)metabolism.	[Good, Nathan M.; Demirer, Kemal; Hausinger, Robert P.; Martinez-Gomez, N. Cecilia] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Fellner, Matthias; Hu, Jian; Hausinger, Robert P.] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; [Fellner, Matthias] Univ Otago, Dept Biochem, Dunedin, Otago, New Zealand; [Demirer, Kemal] Okemos High Sch, Okemos, MI USA; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; University of Otago; Michigan State University	Martinez-Gomez, NC (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	mart1754@msu.edu	Fellner, Matthias/AAG-6443-2022; Fellner, Matthias/AFL-6357-2022	Fellner, Matthias/0000-0003-3192-6984; Fellner, Matthias/0000-0003-3192-6984; Martinez-Gomez, Norma/0000-0002-4071-7204; Good, Nathan/0000-0002-9490-5913; Hausinger, Robert/0000-0002-3643-2054	National Science Foundation [1750003, CHE-1516126]; University of Otago Health Sciences Postdoctoral Fellowship [HSCDPD1703]	National Science Foundation(National Science Foundation (NSF)); University of Otago Health Sciences Postdoctoral Fellowship	This material is based upon work supported by the National Science Foundation under Grants 1750003 (to N. C. M.-G. and N. M. G.) and CHE-1516126 (to R. P. H. and J. H.). M. F. was supported by University of Otago Health Sciences Postdoctoral Fellowship HSCDPD1703.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ANTHONY C, 1967, BIOCHEM J, V104, P960, DOI 10.1042/bj1040960; Anthony C, 1998, PROG BIOPHYS MOL BIO, V69, P1, DOI 10.1016/S0079-6107(97)00020-5; Anthony C, 1996, BIOCHEM J, V320, P697, DOI 10.1042/bj3200697; Anthony C, 2003, BBA-PROTEINS PROTEOM, V1647, P18, DOI 10.1016/S1570-9639(03)00042-6; Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; Anthony C., 1982, BIOCH METHYLOTROPHS; ARMSTRONG JM, 1964, BIOCHIM BIOPHYS ACTA, V86, P194; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bogart JA, 2015, CHEM-EUR J, V21, P1743, DOI 10.1002/chem.201405159; Cao TP, 2018, J MICROBIOL, V56, P246, DOI 10.1007/s12275-018-7483-y; Chistoserdova L., 2013, PROKARYOTES, P267; Chistoserdova L, 2019, MOL MICROBIOL, V111, P1127, DOI 10.1111/mmi.14210; Chistoserdova L, 2018, TRENDS MICROBIOL, V26, P703, DOI 10.1016/j.tim.2018.01.011; Chistoserdova L, 2016, WORLD J MICROB BIOT, V32, P138, DOI 10.1007/s11274-016-2088-2; Chistoserdova L, 2011, APPL ENVIRON MICROB, V77, P4705, DOI 10.1128/AEM.00314-11; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Chistoserdova LV, 1996, MICROBIOL-UK, V142, P1459, DOI 10.1099/13500872-142-6-1459; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Culpepper MA, 2014, BIOCHEMISTRY-US, V53, P6211, DOI 10.1021/bi500850j; Daumann LJ, 2019, ANGEW CHEM INT EDIT, V58, P12795, DOI 10.1002/anie.201904090; Delaney NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062957; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deng YW, 2018, J BIOL INORG CHEM, V23, P1037, DOI 10.1007/s00775-018-1604-2; Diehl A, 1998, EUR J BIOCHEM, V257, P409, DOI 10.1046/j.1432-1327.1998.2570409.x; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farhan Ul Haque M, 2015, APPL ENVIRON MICROB, V81, P7546, DOI 10.1128/AEM.02542-15; Featherston ER, 2019, CHEMBIOCHEM, V20, P2360, DOI 10.1002/cbic.201900184; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; Good NM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41043-1; Good NM, 2016, J BACTERIOL, V198, P3109, DOI 10.1128/JB.00478-16; GORISCH H, 1989, A VAN LEEUW J MICROB, V56, P35, DOI 10.1007/BF00822582; Gorisch H, 2003, BBA-PROTEINS PROTEOM, V1647, P98, DOI 10.1016/S1570-9639(03)00066-9; Green PN, 2018, INT J SYST EVOL MICR, V68, P2727, DOI 10.1099/ijsem.0.002856; Hibi Y, 2011, J BIOSCI BIOENG, V111, P547, DOI 10.1016/j.jbiosc.2010.12.017; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Huang J, 2019, ISME J, V13, P2005, DOI 10.1038/s41396-019-0414-z; Huang JH, 2018, FORESTS, V9, DOI 10.3390/f9010009; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Jahn B, 2018, CHEMBIOCHEM, V19, P1147, DOI 10.1002/cbic.201800130; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keitel T, 2000, J MOL BIOL, V297, P961, DOI 10.1006/jmbi.2000.3603; Keltjens JT, 2014, APPL MICROBIOL BIOT, V98, P6163, DOI 10.1007/s00253-014-5766-8; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Lumpe H, 2018, DALTON T, V47, P10463, DOI 10.1039/c8dt01238e; Martinez-Gomez NC, 2016, INORG CHEM, V55, P10083, DOI 10.1021/acs.inorgchem.6b00919; Marx CJ, 2003, J BACTERIOL, V185, P669, DOI 10.1128/JB.185.2.669-673.2003; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104851; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUTZEL A, 1991, AGR BIOL CHEM TOKYO, V55, P1721, DOI 10.1080/00021369.1991.10870854; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050480; NUNN DN, 1986, J BACTERIOL, V166, P581, DOI 10.1128/jb.166.2.581-590.1986; Ochsner AM, 2019, MOL MICROBIOL, V111, P1152, DOI 10.1111/mmi.14208; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oubrie A, 2002, J BIOL CHEM, V277, P3727, DOI 10.1074/jbc.M109403200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pol A, 2014, ENVIRON MICROBIOL, V16, P255, DOI 10.1111/1462-2920.12249; Prejano M, 2017, CHEM-EUR J, V23, P8652, DOI 10.1002/chem.201700381; RICHARDSON IW, 1992, BIOCHEM J, V287, P709, DOI 10.1042/bj2870709; Roszczenko-Jasinska P, 2020, BIORXIV, DOI [10.1101/647677., DOI 10.1101/647677]; RUPP M, 1988, BIOL CHEM H-S, V369, P431, DOI 10.1515/bchm3.1988.369.1.431; Sakuraba H, 2010, ARCH BIOCHEM BIOPHYS, V502, P81, DOI 10.1016/j.abb.2010.08.002; Schmidt S, 2010, MICROBIOL-SGM, V156, P2575, DOI 10.1099/mic.0.038570-0; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skovran E, 2019, CURR ISSUES MOL BIOL, V33, P101, DOI 10.21775/cimb.033.101; Skovran E, 2015, SCIENCE, V348, P862, DOI 10.1126/science.aaa9091; Skovran E, 2011, J BACTERIOL, V193, P6032, DOI 10.1128/JB.05367-11; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Takeda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115722; Taubert M, 2015, ENVIRON MICROBIOL, V17, P3937, DOI 10.1111/1462-2920.12896; Toyama H, 2004, ARCH BIOCHEM BIOPHYS, V428, P10, DOI 10.1016/j.abb.2004.03.037; Toyama H, 1998, FEMS MICROBIOL LETT, V166, P1; Tsushima S, 2019, PHYS CHEM CHEM PHYS, V21, P21979, DOI 10.1039/c9cp03953h; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Vu HN, 2016, J BACTERIOL, V198, P1250, DOI 10.1128/JB.00937-15; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Wang L, 2019, ENZYME MICROB TECH, V130, DOI 10.1016/j.enzmictec.2019.109371; Wegner CE, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01830-19; Wehrmann M, 2017, MBIO, V8, DOI 10.1128/mBio.00570-17; Williams PA, 2005, ACTA CRYSTALLOGR D, V61, P75, DOI 10.1107/S0907444904026964; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu ML, 2015, APPL ENVIRON MICROB, V81, P1442, DOI 10.1128/AEM.03292-14; XIA ZX, 1992, J BIOL CHEM, V267, P22289	88	20	21	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8272	8284		10.1074/jbc.RA120.013227	http://dx.doi.org/10.1074/jbc.RA120.013227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32366463	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000542965700015
J	Kesavardhana, S; Malireddi, RKS; Burton, AR; Porter, SN; Vogel, P; Pruett-Miller, SM; Kanneganti, TD				Kesavardhana, Sannula; Malireddi, R. K. Subbarao; Burton, Amanda R.; Porter, Shaina N.; Vogel, Peter; Pruett-Miller, Shondra M.; Kanneganti, Thirumala-Devi			The Z?2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; influenza virus; RNA virus; negative-strand RNA virus; infection; microbiology	Z-DNA; RNA; NECROPTOSIS; CASPASE-1; REVEALS; COMPLEX; RIP3	Z-DNA-binding protein 1 (ZBP1) is an innate immune sensor of nucleic acids that regulates host defense responses and development. ZBP1 activation triggers inflammation and pyroptosis, necroptosis, and apoptosis (PANoptosis) by activating receptor-interacting Ser/Thr kinase 3 (RIPK3), caspase-8, and the NLRP3 inflammasome. ZBP1 is unique among innate immune sensors because of its N-terminal Z?1 and Z?2 domains, which bind to nucleic acids in the Z-conformation. However, the specific role of these Z? domains in orchestrating ZBP1 activation and subsequent inflammation and cell death is not clear. Here we generatedZbp1(?Z?2/?Z?2)mice that express ZBP1 lacking the Z?2 domain and demonstrate that this domain is critical for influenza A virus?induced PANoptosis and underlies perinatal lethality in mice in which the RIP homotypic interaction motif domain of RIPK1 has been mutated (Ripk1(mRHIM/mRHIM)). Deletion of the Z?2 domain in ZBP1 abolished influenza A virus?induced PANoptosis and NLRP3 inflammasome activation. Furthermore, deletion of the Z?2 domain of ZBP1 was sufficient to rescueRipk1(mRHIM/mRHIM)mice from perinatal lethality caused by ZBP1-driven cell death and inflammation. Our findings identify the essential role of the Z?2 domain of ZBP1 in several physiological functions and establish a link between Z-RNA sensing via the Z?2 domain and promotion of influenza-induced PANoptosis and perinatal lethality.	[Kesavardhana, Sannula; Malireddi, R. K. Subbarao; Burton, Amanda R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Porter, Shaina N.; Pruett-Miller, Shondra M.] St Jude Childrens Res Hosp, Ctr Adv Genome Engn, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr & Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443	National Institutes of Health [AR056296, CA163507, AI101935, AI124346]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This study was supported by National Institutes of Health Grants AR056296, CA163507, AI101935, and AI124346 and the American Lebanese Syrian Associated Charities (to T.-D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; Fu YN, 1999, GENE, V240, P157, DOI 10.1016/S0378-1119(99)00419-9; Ha SC, 2008, P NATL ACAD SCI USA, V105, P20671, DOI 10.1073/pnas.0810463106; Jiao HP, 2020, NATURE, V580, P391, DOI 10.1038/s41586-020-2129-8; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Kim K, 2011, P NATL ACAD SCI USA, V108, P6921, DOI 10.1073/pnas.1014898107; Kuriakose T, 2018, TRENDS IMMUNOL, V39, P123, DOI 10.1016/j.it.2017.11.002; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lin J, 2016, NATURE, V540, P124, DOI 10.1038/nature20558; Maelfait J, 2017, EMBO J, V36, P2529, DOI 10.15252/embj.201796476; Malireddi RKS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00406; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Wang RC, 2020, NATURE, V580, P386, DOI 10.1038/s41586-020-2127-x; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050	27	49	50	10	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8325	8330		10.1074/jbc.RA120.013752	http://dx.doi.org/10.1074/jbc.RA120.013752			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350114	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000542965700018
J	Subramanian, K; Hutt, DM; Scott, SM; Gupta, V; Mao, S; Balch, WE				Subramanian, Kanagaraj; Hutt, Darren M.; Scott, Samantha M.; Gupta, Vijay; Mao, Shu; Balch, William E.			Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase inhibitor (HDAC inhibitor) (HDI); cholesterol; lysosome; intracellular trafficking; neurodegenerative disease; cholesterol homeostasis; choloroquine; Niemann-Pick type C disease; NPC1; valproic acid	STEROL-SENSING DOMAIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; N-TERMINAL DOMAIN; LYSINE ACETYLATION; MOUSE MODEL; NPC1 PROTEIN; CHOLESTEROL ACCUMULATION; LYSOSOMAL CHOLESTEROL; ENDOPLASMIC-RETICULUM; THERAPEUTIC PARADIGM	Niemann-Pick type C (NPC) disease is primarily caused by mutations in the NPC1 gene and is characterized by the accumulation of unesterified cholesterol and lipids in the late endosomal (LE) and lysosomal (Ly) compartments. The most prevalent disease-linked mutation is the I1061T variant of NPC1, which exhibits defective folding and trafficking from the endoplasmic reticulum to the LE/Ly compartments. We now show that the FDA-approved histone deacetylase inhibitor (HDACi) valproic acid (VPA) corrects the folding and trafficking defect associated with I1061T-NPC1 leading to restoration of cholesterol homeostasis, an effect that is largely driven by a reduction in HDAC7 expression. The VPA-mediated trafficking correction is in part associated with an increase in the acetylation of lysine residues in the cysteine-rich domain of NPC1. The HDACi-mediated correction is synergistically improved by combining it with the FDA-approved anti-malarial, chloroquine, a known lysosomotropic compound, which improved the stability of the LE/Ly-localized fraction of the I1061T variant. We posit that combining the activity of VPA, to modulate epigenetically the cellular acetylome, with chloroquine, to alter the lysosomal environment to favor stability of the trafficked I1061T variant protein can have a significant therapeutic benefit in patients carrying at least one copy of the I1061T variant of NPC1, the most common disease-associated mutation leading to NPC disease. Given its ability to cross the blood-brain barrier, we posit VPA provides a potential mechanism to improve the response to 2-hydroxypropyl-?-cyclodextrin, by restoring a functional NPC1 to the cholesterol managing compartment as an adjunct therapy.	[Subramanian, Kanagaraj; Hutt, Darren M.; Scott, Samantha M.; Gupta, Vijay; Balch, William E.] Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA; [Mao, Shu] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Scripps Research Institute; Cornell University	Balch, WE (corresponding author), Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA.	webalch@scripps.edu		Gupta, Dr. Vijay/0000-0002-3613-6378; Balch, William E./0000-0003-0899-8381	National Institutes of Health [AG049665, HL095524]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AG049665 and HL095524 (to W. E. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alam MS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9407; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Angles F, 2019, HUM MOL GENET, V28, P1982, DOI 10.1093/hmg/ddz026; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Banerjee Audreesh, 2012, Am J Respir Cell Mol Biol, V46, P132, DOI 10.1165/rcmb.2010-0276OC; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Bouchecareilh M, 2012, CURR MOL MED, V12, P815, DOI 10.2174/156652412801318782; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Bouchecareilh Marion, 2011, Proc Am Thorac Soc, V8, P189, DOI 10.1513/pats.201008-055MS; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Buckland Jenny, 2011, Nat Rev Rheumatol, V7, P682, DOI 10.1038/nrrheum.2011.162; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Chittur SV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-507; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; CORNFORD EM, 1985, J NEUROCHEM, V44, P1541, DOI 10.1111/j.1471-4159.1985.tb08793.x; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Davidson J, 2019, BBA-MOL CELL BIOL L, P1545, DOI 10.1016/j.bbalip.2019.04.011; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Deane CAS, 2016, CELL STRESS CHAPERON, V21, P837, DOI 10.1007/s12192-016-0708-2; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; Eriksson I, 2013, EXP CELL RES, V319, P12, DOI 10.1016/j.yexcr.2012.10.004; Estiu G, 2013, BIOCHEMISTRY-US, V52, P6879, DOI 10.1021/bi4005478; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Farmer CA, 2019, CNS DRUGS, V33, P677, DOI 10.1007/s40263-019-00642-2; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Fog CK, 2019, EXPERT OPIN DRUG DIS, V14, P499, DOI 10.1080/17460441.2019.1588882; Fog CK, 2018, EBIOMEDICINE, V38, P142, DOI 10.1016/j.ebiom.2018.11.037; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Garnock-Jones KP, 2015, DRUGS, V75, P695, DOI 10.1007/s40265-015-0388-8; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Grandjean JMD, 2019, ACS CHEM BIOL, V14, P784, DOI 10.1021/acschembio.9b00134; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Helquist P, 2013, NEUROTHERAPEUTICS, V10, P688, DOI 10.1007/s13311-013-0217-2; Hershey LA, 2019, DRUG AGING, V36, P309, DOI 10.1007/s40266-018-00636-7; Hindorff LA, 2018, NAT REV GENET, V19, P175, DOI 10.1038/nrg.2017.89; HUSSEIN Z, 1994, J CLIN PHARMACOL, V34, P754, DOI 10.1002/j.1552-4604.1994.tb02036.x; Hutt DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106224; Hutt DM, 2011, ACS MED CHEM LETT, V2, P703, DOI 10.1021/ml200136e; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Jagannath S, 2010, LEUKEMIA RES, V34, P1111, DOI 10.1016/j.leukres.2010.04.001; Kakee A, 2002, MICROVASC RES, V63, P233, DOI 10.1006/mvre.2001.2378; Ketter TA, 1999, CELL MOL NEUROBIOL, V19, P511, DOI 10.1023/A:1006990925122; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kirkegaard T, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9823; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; KROGSTAD DJ, 1987, AM J TROP MED HYG, V36, P213, DOI 10.4269/ajtmh.1987.36.213; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Leggatt GR, 2012, IMMUNOL CELL BIOL, V90, P33, DOI 10.1038/icb.2011.94; Leng Y, 2010, NEUROSCI LETT, V476, P127, DOI 10.1016/j.neulet.2010.04.013; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Marwick JA, 2010, DRUGS, V70, P929, DOI 10.2165/10898520-000000000-00000; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Mengel E, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-166; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Millat G, 2001, AM J HUM GENET, V68, P1373, DOI 10.1086/320606; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Nguyen MT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113661; Munkacsi AB, 2017, J BIOL CHEM, V292, P4395, DOI 10.1074/jbc.M116.770578; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Nunes MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053394; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ordonez MP, 2017, BRAIN RES, V1656, P63, DOI 10.1016/j.brainres.2016.03.007; Ory DS, 2017, LANCET, V390, P1758, DOI 10.1016/S0140-6736(17)31465-4; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pipalia NH, 2006, J LIPID RES, V47, P284, DOI 10.1194/jlr.M500388-JLR200; Pipalia NH, 2017, J LIPID RES, V58, P695, DOI 10.1194/jlr.M072140; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Poirier S, 2013, TRAFFIC, V14, P458, DOI 10.1111/tra.12046; Praggastis M, 2015, J NEUROSCI, V35, P8091, DOI 10.1523/JNEUROSCI.4173-14.2015; Pugach EK, 2018, HUM MOL GENET, V27, P2101, DOI 10.1093/hmg/ddy117; Qadri YJ, 2012, J BIOL CHEM, V287, P16781, DOI 10.1074/jbc.M111.332031; Rao R, 2012, ADV CANCER RES, V116, P239, DOI 10.1016/B978-0-12-394387-3.00007-0; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Royce SG, 2014, PHARMACOL THERAPEUT, V141, P250, DOI 10.1016/j.pharmthera.2013.10.008; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Schultz ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06115-2; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Singh AK, 2018, PHARMACOL RES, V132, P135, DOI 10.1016/j.phrs.2018.04.014; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Sohaebuddin Syed K, 2013, Methods Mol Biol, V991, P25, DOI 10.1007/978-1-62703-336-7_3; Sung EA, 2017, ONCOTARGET, V8, P85428, DOI 10.18632/oncotarget.19976; Suraweera A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00092; Tangemo C, 2011, J LIPID RES, V52, P813, DOI 10.1194/jlr.P013524; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; Torres S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00982; Totenhagen JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178179; Totenhagen JW, 2013, J MAGN RESON IMAGING, V37, P1195, DOI 10.1002/jmri.23902; Totenhagen JW, 2012, J MAGN RESON IMAGING, V35, P528, DOI 10.1002/jmri.22837; VAJDA FJE, 1981, NEUROLOGY, V31, P486; van den Bosch T, 2017, EPIGENOMICS-UK, V9, P1013, DOI 10.2217/epi-2017-0027; VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Vivas O, 2019, CELL REP, V27, P2636, DOI 10.1016/j.celrep.2019.04.099; Wang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12969-x; Wang C, 2018, CELL REP, V24, P2013, DOI 10.1016/j.celrep.2018.07.059; Wang C, 2017, METHODS MOL BIOL, V1639, P185, DOI 10.1007/978-1-4939-7163-3_18; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; WIESER HG, 1991, EPILEPSY RES, V9, P154, DOI 10.1016/0920-1211(91)90028-E; Xuan AG, 2015, MOL NEUROBIOL, V51, P300, DOI 10.1007/s12035-014-8751-4; Zaaraoui W, 2011, MOL GENET METAB, V103, P138, DOI 10.1016/j.ymgme.2011.02.013; Zech M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082879; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	136	9	9	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8017	8035		10.1074/jbc.RA119.010524	http://dx.doi.org/10.1074/jbc.RA119.010524			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32354745	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000540935400016
J	Underwood, R; Wang, B; Carico, C; Whitaker, RH; Placzek, WJ; Yacoubian, TA				Underwood, Rachel; Wang, Bing; Carico, Christine; Whitaker, Robert H.; Placzek, William J.; Yacoubian, Talene A.			The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of ?-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						?-synuclein; Rab; Parkinson's disease; autophagy; exosome (vesicle); neurodegeneration; protein misfolding; dementia with Lewy bodies; RAS oncogene family; synucleinopathy; Lewy body	ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; LEWY BODY; UNCONVENTIONAL SECRETION; SYNAPTIC-TRANSMISSION; EXOCYTOSIS; TRANSPORT; GRANULES; RAB3A; DYSFUNCTION	?-Synuclein (?syn) is the primary component of proteinaceous aggregates termed Lewy bodies that pathologically define synucleinopathies including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). ?syn is hypothesized to spread through the brain in a prion-like fashion by misfolded protein forming a template for aggregation of endogenous ?syn. The cell-to-cell release and uptake of ?syn are considered important processes for its prion-like spread. Rab27b is one of several GTPases essential to the endosomal-lysosomal pathway and is implicated in protein secretion and clearance, but its role in ?syn spread has yet to be characterized. In this study, we used a paracrine ?syn in vitro neuronal model to test the impact of Rab27b on ?syn release, clearance, and toxicity. shRNA-mediated knockdown (KD) of Rab27b increased ?syn-mediated paracrine toxicity. Rab27b reduced ?syn release primarily through nonexosomal pathways, but the ?syn released after Rab27b KD was of higher-molecular-weight species, as determined by size-exclusion chromatography. Rab27b KD increased intracellular levels of insoluble ?syn and led to an accumulation of endogenous light chain 3 (LC3)-positive puncta. Rab27b KD also decreased LC3 turnover after treatment with an autophagosome-lysosome fusion inhibitor, chloroquine, indicating that Rab27b KD induces a defect in autophagic flux. Rab27b protein levels were increased in brain lysates obtained from postmortem tissues of individuals with PD and DLB compared with healthy controls. These data indicate a role for Rab27b in the release, clearance, and toxicity of ?syn and, ultimately, in the pathogenesis of synucleinopathies.	[Underwood, Rachel; Wang, Bing; Yacoubian, Talene A.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA; [Carico, Christine; Whitaker, Robert H.; Placzek, William J.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yacoubian, TA (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA.	tyacoubian@uabmc.edu		Placzek, William/0000-0003-4096-8617; Underwood, Rachel/0000-0003-3630-7007; Yacoubian, Talene/0000-0003-2227-7310; Carico, Christine/0000-0001-7426-8200; Whitaker, Robert/0000-0002-9751-0423	NIA, National Institutes of Health [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; University of Alabama Birmingham High Resolution Imaging Facility	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; University of Alabama Birmingham High Resolution Imaging Facility	We are grateful to Drs. Geidy Serrano and Thomas Beach (Banner Sun Health Research Institute Brain and Body Donation Program, Sun City, AZ, USA) for the provision of human brain tissue. The Brain and Body Donation Program is supported by NIA, National Institutes of Health, Grant P30 AG19610 (Arizona Alzheimer's Disease Core Center); Arizona Department of Health Services Contract 211002 (Arizona Alzheimer's Research Center); Arizona Biomedical Research Commission Contracts 4001, 0011, 05-901, and 1001 to the Arizona Parkinson's Disease Consortium; and the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research. Research reported in this publication was also supported by the University of Alabama Birmingham High Resolution Imaging Facility.	Alessi DR, 2018, SCIENCE, V360, P36, DOI 10.1126/science.aar5683; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Binotti B, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010007; Breda C, 2015, HUM MOL GENET, V24, P1077, DOI 10.1093/hmg/ddu521; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Chiang LL, 2011, AM J PHYSIOL-CELL PH, V301, pC507, DOI 10.1152/ajpcell.00355.2010; Chu CT, 2019, NEUROBIOL DIS, V122, P23, DOI 10.1016/j.nbd.2018.07.015; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Coune PG, 2011, J PARKINSON DIS, V1, P373, DOI 10.3233/JPD-2011-11058; Dalfo E, 2004, NEUROBIOL DIS, V16, P92, DOI 10.1016/j.nbd.2004.01.001; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dinter E, 2016, J NEUROCHEM, V138, P758, DOI 10.1111/jnc.13712; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Gao YJ, 2018, MOVEMENT DISORD, V33, P196, DOI 10.1002/mds.27270; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Goncalves SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005995; Handley MTW, 2008, BIOCHEM BIOPH RES CO, V373, P275, DOI 10.1016/j.bbrc.2008.06.043; Herzfeld T, 2013, HUM MOL GENET, V22, P941, DOI 10.1093/hmg/dds499; Jae N, 2015, FEBS LETT, V589, P3182, DOI 10.1016/j.febslet.2015.08.040; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kurowska M, 2012, BLOOD, V119, P3879, DOI 10.1182/blood-2011-09-382556; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lesage S, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000009; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lorincz P, 2020, J MOL BIOL, V432, P2462, DOI 10.1016/j.jmb.2019.10.028; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Malik BR, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0504-x; Manzoni C, 2013, FASEB J, V27, P3424, DOI 10.1096/fj.12-223842; McFerrin MB, 2017, ANN CLIN TRANSL NEUR, V4, P466, DOI 10.1002/acn3.421; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Ngolab J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0445-5; Nozawa Takashi, 2018, Nihon Saikingaku Zasshi, V73, P193, DOI 10.3412/jsb.73.193; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Santpere G, 2018, BRAIN PATHOL, V28, P315, DOI 10.1111/bpa.12511; Shen YT, 2016, NEUROSCI BULL, V32, P331, DOI 10.1007/s12264-016-0045-6; Slone SR, 2015, NEUROBIOL DIS, V79, P1, DOI 10.1016/j.nbd.2015.02.032; Stuendl A, 2016, BRAIN, V139, P481, DOI 10.1093/brain/awv346; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Tsunemi T, 2019, J NEUROSCI, V39, P5760, DOI 10.1523/JNEUROSCI.3085-18.2019; Vidyadhara DJ, 2019, J NEUROCHEM, V150, P487, DOI 10.1111/jnc.14820; Wang B, 2018, J NEUROSCI, V38, P8211, DOI 10.1523/JNEUROSCI.1134-18.2018; Wilson GR, 2014, AM J HUM GENET, V95, P729, DOI 10.1016/j.ajhg.2014.10.015; Xilouri M, 2016, MOVEMENT DISORD, V31, P178, DOI 10.1002/mds.26477; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	62	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8005	8016		10.1074/jbc.RA120.013337	http://dx.doi.org/10.1074/jbc.RA120.013337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350025	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000540935400015
J	Liang, XH; Cui, JM; Yang, XK; Xia, NB; Li, YQ; Zhao, JL; Gupta, N; Shen, B				Liang, Xiaohan; Cui, Jianmin; Yang, Xuke; Xia, Ningbo; Li, Yaqiong; Zhao, Junlong; Gupta, Nishith; Shen, Bang			Acquisition of exogenous fatty acids renders apicoplast-based biosynthesis dispensable in tachyzoites of Toxoplasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; pathogenesis; Toxoplasma gondii; parasite metabolism; pyruvate dehydrogenase complex (PDC); apicoplast; FabD; FAS2; lytic cycle; virulence	PYRUVATE-DEHYDROGENASE COMPLEX; PLASMODIUM-FALCIPARUM; METABOLISM; GONDII; PARASITES; GLUCOSE	Toxoplasma gondii is a common protozoan parasite that infects a wide range of hosts, including livestock and humans. Previous studies have suggested that the type 2 fatty acid synthesis (FAS2) pathway, located in the apicoplast (a nonphotosynthetic plastid relict), is crucial for the parasite's survival. Here we examined the physiological relevance of fatty acid synthesis in T. gondii by focusing on the pyruvate dehydrogenase complex and malonyl-CoA-[acyl carrier protein] transacylase (FabD), which are located in the apicoplast to drive de novo fatty acid biosynthesis. Our results disclosed unexpected metabolic resilience of T. gondii tachyzoites, revealing that they can tolerate CRISPR/Cas9?assisted genetic deletions of three pyruvate dehydrogenase subunits or FabD. All mutants were fully viable in prolonged cultures, albeit with impaired growth and concurrent loss of the apicoplast. Even more surprisingly, these mutants displayed normal virulence in mice, suggesting an expendable role of the FAS2 pathway in vivo. Metabolic labeling of the ?pdh-e1? mutant showed reduced incorporation of glucose-derived carbon into fatty acids with medium chain lengths (C14:0 and C16:0), revealing that FAS2 activity was indeed compromised. Moreover, supplementation of exogenous C14:0 or C16:0 significantly reversed the growth defect in the ?pdh-e1? mutant, indicating salvage of these fatty acids. Together, these results demonstrate that the FAS2 pathway is dispensable during the lytic cycle of Toxoplasma because of its remarkable flexibility in acquiring fatty acids. Our findings question the long-held assumption that targeting this pathway has significant therapeutic potential for managing Toxoplasma infections.	[Liang, Xiaohan; Cui, Jianmin; Yang, Xuke; Xia, Ningbo; Li, Yaqiong; Zhao, Junlong; Gupta, Nishith; Shen, Bang] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhao, Junlong; Shen, Bang] Key Lab Prevent Med Hubei Prov, Wuhan, Hubei, Peoples R China; [Zhao, Junlong] Hubei Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Hubei, Peoples R China; [Gupta, Nishith] Humboldt Univ, Fac Life Sci, Inst Biol, Dept Mol Parasitol, Berlin, Germany	Huazhong Agricultural University; Humboldt University of Berlin	Gupta, N; Shen, B (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.; Shen, B (corresponding author), Key Lab Prevent Med Hubei Prov, Wuhan, Hubei, Peoples R China.; Gupta, N (corresponding author), Humboldt Univ, Fac Life Sci, Inst Biol, Dept Mol Parasitol, Berlin, Germany.	Gupta.Nishith@hu-berlin.de; shenbang@mail.hzau.edu.cn		Xia, Ningbo/0000-0002-6090-7400; Gupta, Nishith/0000-0003-1452-5126	National Key Research and Development Program of China [2017YFD0501304]; National Natural Science Foundation of China [31872463]; Fundamental Research Funds for the Central Universities in China [2662019PY079]; German Research Foundation (DFG) [GU1100/15, GU1100/16]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by National Key Research and Development Program of China Grant 2017YFD0501304, National Natural Science Foundation of China Grant 31872463, and Fundamental Research Funds for the Central Universities in China Grant 2662019PY079. The work performed by X. L. and B. S. during their visits to the Gupta laboratory was sponsored by German Research Foundation (DFG) Grants GU1100/15 and GU1100/16.	Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Cobbold SA, 2013, J BIOL CHEM, V288, P36338, DOI 10.1074/jbc.M113.503557; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Fleige T, 2007, EUKARYOT CELL, V6, P984, DOI 10.1128/EC.00061-07; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508; Krishnan A, 2020, CELL HOST MICROBE, V27, P290, DOI 10.1016/j.chom.2020.01.002; Long S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006379; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McFadden GI, 2017, INT J PARASITOL, V47, P137, DOI 10.1016/j.ijpara.2016.08.005; McFadden GI, 2001, PLANT PHYSIOL, V125, P50, DOI 10.1104/pp.125.1.50; Misra A, 2007, CHEM BIOL, V14, P775, DOI 10.1016/j.chembiol.2007.05.013; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Nolan SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006362; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Park S, 2018, DIABETES METAB J, V42, P270, DOI 10.4093/dmj.2018.0101; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Pei Y, 2010, MOL MICROBIOL, V75, P957, DOI 10.1111/j.1365-2958.2009.07034.x; Ramakrishnan S, 2015, MOL MICROBIOL, V97, P64, DOI 10.1111/mmi.13010; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Shears MJ, 2015, MOL BIOCHEM PARASIT, V199, P34, DOI 10.1016/j.molbiopara.2015.03.004; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Triana MAH, 2018, J EUKARYOT MICROBIOL, V65, P709, DOI 10.1111/jeu.12626; van Schaijk BCL, 2014, EUKARYOT CELL, V13, P550, DOI 10.1128/EC.00264-13; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Xia NB, 2019, MBIO, V10, DOI 10.1128/mBio.00898-19; Xia NB, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12794; Ye S, 2019, PARASITOL RES, V118, P935, DOI 10.1007/s00436-018-06197-3	37	18	18	7	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7743	7752		10.1074/jbc.RA120.013004	http://dx.doi.org/10.1074/jbc.RA120.013004			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32341123	Green Published, hybrid			2022-12-26	WOS:000538038900014
J	Mayr, G; Lechner, T; Bohme, M				Mayr, Gerald; Lechner, Thomas; Boehme, Madelaine			The large-sized darter Anhinga pannonica (Aves, Anhingidae) from the late Miocene hominid Hammerschmiede locality in Southern Germany	PLOS ONE			English	Article							MIDDLE MIOCENE; PLIOCENE; PELECANIFORMES; PATAGONIA; LOCOMOTION; SULIFORMES; PROVINCE; CLIMATE; WATER	We report fossils of the darter Anhinga pannonica Lambrecht, 1916 from two late Miocene (Tortonian, 11.62 and 11.44 Ma) avifaunas in Southern Germany. The material from the hominid locality Hammerschmiede near Pforzen represents the most comprehensive record of this species and includes most major postcranial elements except for the tarsometatarsus. We furthermore show that the putative cormorant Phalacrocorax brunhuberi (von Ammon, 1918) from the middle Miocene of Regensburg-Dechbetten is another, previously misclassified, record of A. pannonica, and this may also be true for early Miocene fossils described as P. intermedius Milne-Edwards, 1867. A. pannonica was distinctly larger than extant darters and reached the size of A. grandis from the late Miocene of North America. We detail that only fossils from the Miocene of Europe and Africa can be referred to A. pannonica, whereas putative records from Asia fall within the size range of extant darters. A. pannonica appears to have been a long-living species (16 to 6 Ma) with an extensive distribution from the equator to the northern mid-latitudes. The extinction of large-sized darters in Europe is likely to have been due to climatic cooling in the late Neogene, but the reasons for their disappearance in Africa and South America remain elusive.	[Mayr, Gerald] Senckenberg Res Inst, Frankfurt, Germany; [Mayr, Gerald] Nat Hist Museum Frankfurt, Ornithol Sect, Frankfurt, Germany; [Lechner, Thomas; Boehme, Madelaine] Eberhard Karls Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoecol HEP, Inst Geosci, Tubingen, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Mayr, G (corresponding author), Senckenberg Res Inst, Frankfurt, Germany.; Mayr, G (corresponding author), Nat Hist Museum Frankfurt, Ornithol Sect, Frankfurt, Germany.	Gerald.Mayr@senckenberg.de						Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; Alvarenga Herculano M.F., 1995, Courier Forschungsinstitut Senckenberg, V181, P149; Alvarenga HMF, 2003, J VERTEBR PALEONTOL, V23, P614, DOI 10.1671/1890; Areta JI, 2007, NEUES JAHRB GEOL P-A, V243, P343, DOI 10.1127/0077-7749/2007/0243-0343; Ballmann Peter, 1987, P113; BECKER JJ, 1986, AUK, V103, P804, DOI 10.1093/auk/103.4.804; BECKER JJ, 1987, P BIOL SOC WASH, V100, P358; BEHRENSMEYER A K, 1975, Bulletin of the Museum of Comparative Zoology, V146, P473; Boaz N. T., 2008, GEOLOGY E LIBYA, V3, P959; Bohme M, 2019, NATURE, V575, P489, DOI 10.1038/s41586-019-1731-0; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; BRODKORB P, 1982, Geobios (Villeurbanne), V15, P505, DOI 10.1016/S0016-6995(82)80071-5; Brodkorb P., 1980, NATURAL HIST MUSEUM, V330, P87; Campbell Kenneth E. Jr, 1992, Natural History Museum of Los Angeles County Science Series, V36, P395; Campbell Kenneth E. Jr, 1996, Contributions in Science (Los Angeles), V460, P1; Cheneval J., 1991, Journal of Southeast Asian Earth Sciences, V6, P117, DOI 10.1016/0743-9547(91)90103-5; Dalsatt J, 2006, PALAEONTOGR ABT A, V277, P113; Diederle JM, 2017, HIST BIOL, V29, P1056, DOI 10.1080/08912963.2017.1284835; Diederle JM, 2017, AMEGHINIANA, V54, P341, DOI 10.5710/AMGH.31.12.2016.3008; Diederle JM, 2015, ALCHERINGA, V39, P589, DOI 10.1080/03115518.2015.1079695; Dyke GJ, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3610[1:NROFWF]2.0.CO;2; FAHLBUSCH V, 1975, Palaeontologische Zeitschrift, V49, P78; Gal E., 1998, FOLIA HIST NATURALIA, V23, P33; Goehlich Ursula B., 2017, Zitteliana, V89, P331; Gohlich U.B., 2003, ANN NATURHIST MUS A, V104A, P237; Harrison C.J.O., 1982, Tertiary Research, V4, P53; HARRISON CJO, 1978, EMU, V78, P230, DOI 10.1071/MU9780230; Kennedy M, 2019, J ZOOL SYST EVOL RES, V57, P892, DOI 10.1111/jzs.12299; Kirscher U, 2016, NEWSL STRATIGR, V49, P445, DOI 10.1127/nos/2016/0288; Kretzoi M., 1982, Magyar Allami Foldtani Intezet Evi Jelentese, V1980, P385; Lambrecht, 1933, HDB PALAEORNITHOLOGI; Lambrecht K., 1916, MITTEILUNGEN JB KONI, V24, P1; Louchart Antoine, 2008, Oryctos, V7, P147; Mackness B, 1995, EMU, V95, P265, DOI 10.1071/MU9950265; Cenizo MM, 2010, ALCHERINGA, V34, P493, DOI 10.1080/03115511003793504; MARTIN LD, 1975, AUK, V92, P137, DOI 10.2307/4084425; Mayr G., 2017, AVIAN EVOLUTION FOSS; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2016, ACTA ZOOL-STOCKHOLM, V97, P196, DOI 10.1111/azo.12117; Milne-Edwards A., 1867, RECHERCHES ANATOMIQU, V1; MLIKOVSKY J, 1988, Annalen des Naturhistorischen Museums in Wien Serie A Mineralogie und Petrographie Geologie und Palaeontologie Anthropologie und Praehistorie, V92, P97; Mlikovsky J., 2002, CENOZOIC BIRDS WOR 1; Mlikovsky Jiri, 1998, Casopis Narodniho Muzea Rada Prirodovedna, V167, P103; Mors T., 2006, BEITRAGE PALAONTOLOG, V30, P329; Noriega JI, 2004, AMEGHINIANA, V41, P115; Noriega JI, 2001, ACTA PALAEONTOL POL, V46, P247; Noriega Jorge I., 2002, P51; Noriega Jorge I., 2002, P41; Noriega Jorge Ignacio, 1992, Notas del Museo de La Plata Paleontologia, V21, P217; Olson S.L., 1985, Avian Biology, V8, P79; Orta J., 1992, P354; Owre O. T., 1967, ORNITHOL MONOGR, V6, P1, DOI [DOI 10.2307/40166666, 10.2307/40166666]; Prieto J, 2011, CONTRIB ZOOL, V80, P179, DOI 10.1163/18759866-08003002; Rasmussen D. Tab, 1992, Natural History Museum of Los Angeles County Science Series, V36, P225; Rich P.V., 1972, NOTES SERVICE GEOLOG, V35, P29; Rinderknecht A, 2002, AMEGHINIANA, V39, P183; Ryan PG, 2007, J AVIAN BIOL, V38, P507, DOI 10.1111/j.0908-8857.2007.04070.x; Stewart J.R., 2006, HIST BIOL, V18, P103; Stidham T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177129; Tzanova A, 2015, EARTH PLANET SC LETT, V419, P71, DOI 10.1016/j.epsl.2015.03.016; von Ammon L., 1918, ABH NATURWISS VER RE, V12, P1; VOORHIES M R, 1969, Contributions to Geology Special Paper, P1; Worthy TH, 2012, AUK, V129, P96, DOI 10.1525/auk.2012.11204	63	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232179	10.1371/journal.pone.0232179	http://dx.doi.org/10.1371/journal.pone.0232179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374733	Green Published, gold			2022-12-26	WOS:000537283500022
J	Yu, Y; Bai, M; Ma, F; Zhang, W; Li, YP; Zhao, LJ; Li, L; Zhou, ML; Li, L; Sun, SR				Yu, Yan; Bai, Ming; Ma, Feng; Zhang, Wei; Li, Yangping; Zhao, Lijuan; Li, Li; Zhou, Meilan; Li, Lu; Sun, Shiren			Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; CRITICALLY-ILL PATIENTS; EFFICACY; SAFETY; HEMODIALYSIS; COAGULATION; METABOLISM; CIRRHOSIS; INJURY; CRRT	Objective There are controversial opinions on anticoagulation for continuous venovenous hemofiltration (CVVH) in patients with liver failure (LF) and increased bleeding risk. Therefore, we conducted a retrospective study to evaluate the efficacy and safety of regional citrate anticoagulation (RCA) versus no-anticoagulation for CVVH in these patients. Methods The included patients were divided into RCA and no-anticoagulation group according to the CVVH anticoagulation strategy they accepted for CVVH. Filter lifespan, bleeding, citrate accumulation, catheter occlusion, and totCa/ionCa ratio were evaluated as outcomes. Results In the original cohort, the filter lifespan of the RCA group (41 patients, 79 filters) was significantly longer than the no-anticoagulation group (62 patients, 162 filters) (> 72 hours vs 39.5 hours (IQR 31.2-47.8), P = 0.002). The adjusted results demonstrated that RCA could significantly reduce the risk of filter failure (HR = 0.459, 95%CI 0.26-0.82, P = 0.008). Four episodes of totCa/ionCa > 2.5 were observed in the RCA group and continuously accepted RCA-CVVH after the reduction of citrate dose and blood flow. No obvious citrate accumulation was observed in these patients. In the matched cohort, the filter lifespan of the RCA group was significantly longer than the no-anticoagulation group (P = 0.013) as well. No significant difference in the episodes of totCa/ionCa > 2.5 was observed between the two matched groups (P = 0.074). Both in the original cohort and the matched cohort, the bleeding, acidosis, alkalosis, and catheter occlusion incidences were not significantly different between the two groups. Conclusions In LF patients with increased bleeding risk who underwent CVVH, RCA could prolong the filter lifespan and be safely used with careful blood gas monitoring and citrate dose adjusting. Further prospective, randomized, control studies are warranted to obtain robust evidences.	[Yu, Yan; Bai, Ming; Ma, Feng; Zhang, Wei; Li, Yangping; Zhao, Lijuan; Li, Li; Zhou, Meilan; Li, Lu; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University	Bai, M; Sun, SR (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian, Shaanxi, Peoples R China.	mingbai1983@126.com; sunshiren@medmail.com.cn			National Natural Science Foundation of China [81700584]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81700584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2009, J HEPATOL, V51, P504, DOI 10.1016/j.jhep.2009.05.028; Allegretti AS, 2018, CLIN J AM SOC NEPHRO, V13, P16, DOI 10.2215/CJN.03610417; Amanzadeh J, 2006, SEMIN DIALYSIS, V19, P311, DOI 10.1111/j.1525-139X.2006.00178.x; Apsner R, 1997, WIEN KLIN WOCHENSCHR, V109, P123; Bai M, 2015, INTENS CARE MED, V41, P2098, DOI 10.1007/s00134-015-4099-0; Balogun RA, 2012, J NEPHROL, V25, P113, DOI 10.5301/JN.2011.8363; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Betrosian AP, 2007, WORLD J GASTROENTERO, V13, P5552, DOI DOI 10.3748/V0G.913.142.5552; Bittencourt PL, 2015, WORLD J HEPATOL, V7, P2336, DOI 10.4254/wjh.v7.i21.2336; Chua HR, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.08.016; Cutts MWJ, 2000, INTENS CARE MED, V26, P1694, DOI 10.1007/s001340000676; De Vico P, 2015, THER APHER DIAL, V19, P272, DOI 10.1111/1744-9987.12280; Durao MS, 2008, CRIT CARE MED, V36, P3024, DOI 10.1097/CCM.0b013e31818b9100; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Habib M, 2014, LIVER INT, V34, P672, DOI 10.1111/liv.12369; Hetzel GR, 2006, AM J KIDNEY DIS, V48, P806, DOI 10.1053/j.ajkd.2006.07.016; Hoste EAJ, 2012, CRIT CARE, V16, DOI 10.1186/cc10499; Khadzhynov D, 2014, J CRIT CARE, V29, P265, DOI 10.1016/j.jcrc.2013.10.015; Klingele M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1870-3; Kramer L, 2003, CRIT CARE MED, V31, P2450, DOI 10.1097/01.CCM.0000084871.76568.E6; Lahmer T, 2015, J CRIT CARE, V30, P1096, DOI 10.1016/j.jcrc.2015.06.006; Lee WM, 2012, HEPATOLOGY, V55, P965, DOI 10.1002/hep.25551; Meier-Kriesche HU, 2001, CRIT CARE MED, V29, P748, DOI 10.1097/00003246-200104000-00010; Monchi M, 2017, TRANSFUS APHER SCI, V56, P28, DOI 10.1016/j.transci.2016.12.013; Morabito S, 2014, CLIN J AM SOC NEPHRO, V9, P2173, DOI 10.2215/CJN.01280214; Oudemans-van Straaten HM, 2011, CRIT CARE, V15, DOI 10.1186/cc9358; Oudemans-van Straaten HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11645; Pertica N, 2017, TRANSPL P, V49, P674, DOI 10.1016/j.transproceed.2017.02.025; Ricci D, 2017, CONTRIB NEPHROL, V190, P19, DOI 10.1159/000468833; Saner FH, EFFICACY SAFETY REGI; Saner FH, 2012, NEPHROL DIAL TRANSPL, V27, P1651, DOI 10.1093/ndt/gfr510; Schilder L, CITRATE ANTICOAGULAT; Schultheiss C, 2012, CRIT CARE, V16, DOI 10.1186/cc11485; Sharara AI, 2001, NEW ENGL J MED, V345, P669, DOI 10.1056/NEJMra003007; Slowinski T, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1066-7; Sponholz C, 2015, THER APHER DIAL, V19, P8, DOI 10.1111/1744-9987.12196; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; Uchino S, 2003, INTENS CARE MED, V29, P575, DOI 10.1007/s00134-003-1672-8; Venkataraman Ramesh, 2007, J Intensive Care Med, V22, P187, DOI 10.1177/0885066607299510; Wendon J, 2017, J HEPATOL, V66, P1047, DOI DOI 10.1016/J.JHEP.2016.12.003; Wonnacott R, 2016, CRIT CARE NURS Q, V39, P241, DOI 10.1097/CNQ.0000000000000118; Zhang W, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2317-9	42	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232516	10.1371/journal.pone.0232516	http://dx.doi.org/10.1371/journal.pone.0232516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369523	gold, Green Published			2022-12-26	WOS:000537280000032
J	Ahmed, UAQ; Wagner, NJ; Joubert, JA				Ahmed, U. A. Q.; Wagner, N. J.; Joubert, J. A.			Quantification of U, Th and specific radionuclides in coal from selected coal fired power plants in South Africa	PLOS ONE			English	Article							NATURAL RADIOACTIVITY; TRACE-ELEMENTS; FLY-ASH; LIGNITE; SAMPLES	Most of South Africa's energy is derived from the combustion of coal in pulverized coal-fired power plants (CFPP). However, when compared with the rest of the world, limited information regarding the main radioactive elements (U and Th) and specific radionuclides of interest (K-40, Ra-226 and Th-232) from South African CFPP is available in the public domain. This paper aims to quantify the U, Th and specific radionuclides found in the coal used in selected South African CFPP in comparison to world averages found in literature. The U and Th concentrations were obtained by ICP-MS. The main radionuclides, K-40, Ra-226 and Th-238, were quantified using gamma spectrometry. The U concentration and Th concentrations for the coal used in all the power plants was above the world average of 1.9 mg/kg and 3.2 mg/kg respectively. The coals with the highest Th content originated from the Mpumalanga power plant, while the U content in the Freestate power plant samples was the highest of the three. The concentrations of the K-40 were between 88.43 +/- 10.75-110.76 +/- 8.92 Bq/kg, which are inline with world averages of 4-785 Bq/kg. Similarly, the Ra-226 and Th-232 values were between 21.69 +/- 2.83-52.63 +/- 4.04 Bq/kg and 19.91 +/- 1.24-22.97 +/- 1.75 Bq/kg respectively, which are also in line with the world averages of 1-206 Bq/kg and 1-170 Bq/kg respectively. Radiological hazard indices such as radium equivalent (Ra-eq); external hazard index (H-ex) and internal hazard index (H-in), that were estimated from these average radionuclide concentrations were less than the prescribed values found in literature. This indicated that no significant health risk was posed by the coal being used from these coal fields.	[Ahmed, U. A. Q.; Joubert, J. A.] Natl Nucl Regulator, Centurion, South Africa; [Ahmed, U. A. Q.; Wagner, N. J.] Univ Johannesburg, Dept Geol, DSI NRF CIMERA, Johannesburg, South Africa	University of Johannesburg	Ahmed, UAQ (corresponding author), Natl Nucl Regulator, Centurion, South Africa.; Ahmed, UAQ (corresponding author), Univ Johannesburg, Dept Geol, DSI NRF CIMERA, Johannesburg, South Africa.	uwais78692@yahoo.com		Ahmed, Uwais/0000-0003-0503-8035	National Research Foundation; Department of Science and Technology's Centre of Excellence for Integrated Mineral and Energy Resource Analysis (CIMERA); University of Johannesburg	National Research Foundation; Department of Science and Technology's Centre of Excellence for Integrated Mineral and Energy Resource Analysis (CIMERA); University of Johannesburg	This study was funded by the National Research Foundation together with the Department of Science and Technology's Centre of Excellence for Integrated Mineral and Energy Resource Analysis (CIMERA) as well as the University of Johannesburg for the funds to undertake ICP-MS analyses. The National Nuclear Regulator funded UAQA's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, J NUCL PART PHYS, DOI DOI 10.5923/J.JNPP.20130304.03; Asaduzzaman K, 2014, J ENVIRON RADIOACTIV, V135, P120, DOI 10.1016/j.jenvrad.2014.04.009; Badman DG, 1996, OTOLARYNG HEAD NECK, V114, P205, DOI 10.1016/S0194-5998(96)70166-3; BERETKA J, 1985, HEALTH PHYS, V48, P87, DOI 10.1097/00004032-198501000-00007; Bergh JP, 2011, FUEL PROCESS TECHNOL, V92, P812, DOI 10.1016/j.fuproc.2010.09.035; Cevik U, 2007, FUEL, V86, P2509, DOI 10.1016/j.fuel.2007.02.013; Dai SF, 2018, INT J COAL GEOL, V186, P155, DOI 10.1016/j.coal.2017.06.005; DOE. Department of Energy, 2018, COAL RES; El-Gamal A, 2007, RADIAT MEAS, V42, P457, DOI 10.1016/j.radmeas.2007.02.054; Hasani F, 2014, J ENVIRON RADIOACTIV, V138, P156, DOI 10.1016/j.jenvrad.2014.08.015; Hilal MA, 2014, J ENVIRON RADIOACTIV, V136, P121, DOI 10.1016/j.jenvrad.2014.05.016; Huang YJ, 2015, RADIAT PHYS CHEM, V107, P82, DOI 10.1016/j.radphyschem.2014.10.001; IAEA, 2003, EXT ENV CONT NAT OCC; International Standard, 2005, CLASS COALS; ISO, 2006, HARD COK COAL MAN SA; Jamil K, 1998, J ENVIRON RADIOACTIV, V41, P207, DOI 10.1016/S0265-931X(97)00094-5; Ketris MP, 2009, INT J COAL GEOL, V78, P135, DOI 10.1016/j.coal.2009.01.002; Khandaker MU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128790; Khandaker MU, 2013, RADIAT PHYS CHEM, V88, P1, DOI 10.1016/j.radphyschem.2013.02.034; Kisic DM, 2013, HEM IND, V67, P729, DOI 10.2298/HEMIND121016120K; Kolo MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158100; Lu XW, 2006, CURR SCI INDIA, V91, P1508; Lu XW, 2012, ENVIRON EARTH SCI, V66, P1925, DOI 10.1007/s12665-011-1417-x; Mandal A, 2003, ENVIRON GEOL, V44, P180, DOI 10.1007/s00254-002-0744-3; Martin A., 1997, MAT CONTAINING NATUR; Mora J.C., 2009, RADIOPROTECTION, V44, P577, DOI DOI 10.1051/radiopro/20095106; Munawer Muhammad Ehsan, 2018, Journal of Sustainable Mining, V17, P87, DOI 10.1016/j.jsm.2017.12.007; Ndhlalose M, 2015, J S AFR I MIN METALL, V115, P1167, DOI 10.17159/2411-9717/2015/v115n12a4; Ozden B, 2018, J ENVIRON RADIOACTIV, V188, P100, DOI 10.1016/j.jenvrad.2017.09.016; Papaefthymiou H, 2007, J RADIOANAL NUCL CH, V274, P123, DOI 10.1007/s10967-006-6880-6; Papastefanou C, 2010, J ENVIRON RADIOACTIV, V101, P191, DOI 10.1016/j.jenvrad.2009.11.006; Seames WS, 2000, FUEL PROCESS TECHNOL, V63, P179, DOI 10.1016/S0378-3820(99)00096-X; Singh LM, 2015, PHYSCS PROC, V80, P120, DOI 10.1016/j.phpro.2015.11.070; SWAINE DJ, 1994, FUEL PROCESS TECHNOL, V39, P121, DOI 10.1016/0378-3820(94)90176-7; Tso MW, 1996, J ENVIRON RADIOACTIV, V30, P1, DOI 10.1016/0265-931X(95)00042-9; Tufail M, 2012, ENVIRON MONIT ASSESS, V184, P5663, DOI 10.1007/s10661-011-2370-6; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, UNSCEAR 2000 REPORT; United States Geological Survey, 1997, RAD EL COAL FLY ASH; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 1982, ION RAD SOURC BIOL E; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 1993, SOURC EFF ION RAD; Wagner NJ, 2012, INT J COAL GEOL, V94, P225, DOI 10.1016/j.coal.2012.01.005	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0229452	10.1371/journal.pone.0229452	http://dx.doi.org/10.1371/journal.pone.0229452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357150	Green Published, gold			2022-12-26	WOS:000536957700003
J	Dosso, JA; Chow, KNT; Kim, JJ; Wong, NTW; Kingstone, A				Dosso, Jill A.; Chow, Katherine Nga Tsit; Kim, Jane J.; Wong, Natalie T. W.; Kingstone, Alan			Similar social presence effects when reaching for real and digital objects	PLOS ONE			English	Article							PERIPERSONAL SPACE; ATTENTION; FACILITATION; OTHERS; IMPACT; TASK; VIEW	Though digital images and real objects are represented differently at a neural level and can evoke different behaviours, little work has directly compared the magnitude of social effects on real and digitally represented stimuli. Object-directed reaches are modified in the near space of others, while image-directed reaches are not, but the exact role of the presence versus location of the other person is unknown (Dosso and Kingstone, 2018). The present work probed the unique contribution of social presence (a passive observer) in shaping object- and image-directed reaching behaviour. In a shape-matching game, movements were performed more slowly and less efficiently when participants were observed by the experimenter, regardless of whether participants handled real objects or digital images. Our finding that social presence affects real-and image-directed reaches similarly supports the continued use of computer-generated objects to approximate human behaviour towards real objects when social effects on object-directed actions are studied.	[Dosso, Jill A.; Chow, Katherine Nga Tsit; Kim, Jane J.; Wong, Natalie T. W.; Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Dosso, JA (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jill.dosso@psych.ubc.ca		Dosso, Jill/0000-0003-1570-9496	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-201604319]; Social Sciences and Humanities Research Council (SSHRC) [435-2013-2200]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-201604319) to AK., http://www.nserc-crsng.gc.ca/index_eng.asp; Social Sciences and Humanities Research Council (SSHRC) Insight Grant to AK (435-2013-2200), http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo JJ, 2005, J CONSUM RES, V32, P207, DOI 10.1086/432230; BAUMEISTER RF, 1982, PSYCHOL BULL, V91, P3, DOI 10.1037/0033-2909.91.1.3; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; BOND CF, 1983, PSYCHOL BULL, V94, P265, DOI 10.1037/0033-2909.94.2.265; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; Chainay H, 2001, COGNITIVE NEUROPSYCH, V18, P175, DOI 10.1080/02643290042000062; Constable MD, 2015, VIS COGN, V23, P699, DOI 10.1080/13506285.2015.1078426; DAVIDOFF J, 1994, BRAIN COGNITION, V24, P1, DOI 10.1006/brcg.1994.1001; di Pellegrino G, 2015, NEUROPSYCHOLOGIA, V66, P126, DOI 10.1016/j.neuropsychologia.2014.11.011; Dosso JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205830; Dosso JA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00874; Dudarev V, 2016, COGNITION, V146, P223, DOI 10.1016/j.cognition.2015.10.001; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015855; Gerhard TM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00827; Gigliotti MF, 2021, PSYCHOL RES-PSYCH FO, V85, P181, DOI 10.1007/s00426-019-01242-x; Gomez MA, 2018, PSYCHOL SCI, V29, P206, DOI 10.1177/0956797617730599; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; GUERIN B, 1986, J EXP SOC PSYCHOL, V22, P38, DOI 10.1016/0022-1031(86)90040-5; Ha V, 2006, FIRST IEEE INTERNATIONAL WORKSHOP ON HORIZONTAL INTERACTIVE HUMAN-COMPUTER SYSTEMS, P175; Heed T, 2010, CURR BIOL, V20, P1345, DOI 10.1016/j.cub.2010.05.068; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Huguet P, 1999, J PERS SOC PSYCHOL, V77, P1011, DOI 10.1037/0022-3514.77.5.1011; Inderbitzin MP, 2013, J EXP PSYCHOL HUMAN, V39, P62, DOI 10.1037/a0028317; Inkpen KM, 2002, COLLABORATION TABLET; JASP Team, 2019, JASP VERS 0 10 2 COM; Karlinsky A., 2017, P 39 ANN C COGN SCI, P2377; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; Milani S, 2019, CAN J HUM SEX, V28, P105, DOI 10.3138/cjhs.2019-0007; Muller D, 2007, J PERS SOC PSYCHOL, V93, P194, DOI 10.1037/0022-3514.93.2.194; Nasiopoulos E, 2019, EFFECTS IMPLIED SOCI; Nasiopoulos E, 2015, BRIT J PSYCHOL, V106, P209, DOI 10.1111/bjop.12080; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliva M, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517692814; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Perani D, 2001, NEUROIMAGE, V14, P749, DOI 10.1006/nimg.2001.0872; Risko EF, 2016, CURR DIR PSYCHOL SCI, V25, P70, DOI 10.1177/0963721415617806; Saccone EJ, 2018, ATTEN PERCEPT PSYCHO, V80, P54, DOI 10.3758/s13414-017-1413-7; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Snow JC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00837; Snow JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00130; Sun HM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00443; Szpak A, 2016, COGN NEUROSCI-UK, V7, P45, DOI 10.1080/17588928.2015.1048677; Szpak A, 2015, NEUROPSYCHOLOGIA, V70, P462, DOI 10.1016/j.neuropsychologia.2014.10.008; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Terrenghi L, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P1157; Triplett N., 1898, AM J PSYCHOL, V9, P507, DOI [10.2307/1412188, DOI 10.2307/1412188]; WICKLUND RA, 1971, J EXP SOC PSYCHOL, V7, P319, DOI 10.1016/0022-1031(71)90032-1; Wuhr P, 2010, SOC COGNITION, V28, P145	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232409	10.1371/journal.pone.0232409	http://dx.doi.org/10.1371/journal.pone.0232409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3FY	32357158	gold, Green Published			2022-12-26	WOS:000536957700029
J	Ballouhey, Q; Fourcade, L; Richard, L; Bellet, C; El Hamel, C; Vallat, JM; Sturtz, F; Bourthoumieu, S				Ballouhey, Quentin; Fourcade, Laurent; Richard, Laurence; Bellet, Camille; El Hamel, Chaharazed; Vallat, Jean Michel; Sturtz, Franck; Bourthoumieu, Sylvie			Epithelial changes of congenital intestinal obstruction in a rat model	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; REGENERATIVE CAPACITY; BOWEL; ATRESIA; ENTEROCOLITIS; POPULATION; EXPRESSION	Introduction Intestinal atresia is a rare congenital affliction that is often associated with severe bacterial infections despite adequate neonatal surgery. Previous studies have focused on enteric nervous system variations. We hypothesized that epithelial systems (ES) may also be involved in the pathophysiology of postnatal disorders. Materials and methods Global gene expression was measured by transcriptomic analysis in a rat model of induced intestinal atresia. The analyses then focused on genes involved in ES (enterocytes and goblet cells). Rat fetus small intestines at various stages of development (ED15, ED17, ED19, and ED21, n = 22), were used as non-operated controls and compared to the upper and lower segments of rat fetus small intestines with an induced atresia (n = 14; ligature at ED18). The pattern of gene expression was then confirmed by histochemistry, electron microscopy, and RT-qPCR. Results From ED15 to ED21, the expression of several genes exhibited a physiological increase of ES markers, with a significant increase at the end of gestation. The operated embryos exhibited significantly higher variations of gene expression in the proximal segment than in the distal segment in terms of absorption and the epithelial barrier. An increase in goblet cells and markers was observed in the proximal segment compared to the controls. Conclusion Fetal intestinal obstruction accelerates maturation in the proximal segment and disrupts the intestinal wall in the distal segment, with a decrease in the number of mucosal cells.	[Ballouhey, Quentin; Fourcade, Laurent; Richard, Laurence; Bellet, Camille; Vallat, Jean Michel; Sturtz, Franck; Bourthoumieu, Sylvie] Univ Limoges, Myelin Maintenance & Peripheral Neuropathies, EA6309, Limoges, France; [Ballouhey, Quentin; Fourcade, Laurent] UHC Limoges, Dept Pediat Surg, Limoges, France; [Richard, Laurence; Vallat, Jean Michel] UHC Limoges, Dept Neurol, Limoges, France; [Sturtz, Franck] CHU Limoges, Dept Biochem & Mol Genet, Limoges, France; [El Hamel, Chaharazed; Bourthoumieu, Sylvie] CHU Limoges, Dept Histol Cytol & Cytogenet, Limoges, France	Universite de Limoges; CHU Limoges; CHU Limoges	Ballouhey, Q; Bourthoumieu, S (corresponding author), Univ Limoges, Myelin Maintenance & Peripheral Neuropathies, EA6309, Limoges, France.; Ballouhey, Q (corresponding author), UHC Limoges, Dept Pediat Surg, Limoges, France.; Bourthoumieu, S (corresponding author), CHU Limoges, Dept Histol Cytol & Cytogenet, Limoges, France.	qballouhey@gmail.com; sylvie.bourthoumieu@unilim.fr		/0000-0001-6428-5162	CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees) - ARS Limousin	CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees) - ARS Limousin	This work was supported by a grant from CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees, 2013), funded by ARS Limousin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Ballouhey Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186507; Demehri FR, 2013, PEDIATR SURG INT, V29, P873, DOI 10.1007/s00383-013-3353-1; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Ensari A, 2018, VIRCHOWS ARCH, V472, P111, DOI 10.1007/s00428-017-2197-9; Farge E, 2011, CURR TOP DEV BIOL, V95, P243, DOI 10.1016/B978-0-12-385065-2.00008-6; Fourcade L, 2009, NEUROSCI LETT, V461, P126, DOI 10.1016/j.neulet.2009.06.009; Fourcade LM, 2010, J PEDIATR SURG, V45, P499, DOI 10.1016/j.jpedsurg.2009.07.031; Gum JR, 1999, AM J PHYSIOL-GASTR L, V276, pG666, DOI 10.1152/ajpgi.1999.276.3.G666; Hemming V, 2007, PRENATAL DIAG, V27, P1205, DOI 10.1002/pd.1886; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Khen N, 2004, PEDIATR RES, V56, P975, DOI 10.1203/01.PDR.0000145294.11800.71; Khen-Dunlop N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062292; Millar A.J.W., 2005, PEDIAT SURG, P416; Ozguner IF, 2005, J PEDIATR SURG, V40, P1232, DOI 10.1016/j.jpedsurg.2005.05.032; Pfeifle VA, 2017, EUR J PEDIATR SURG, V27, P200, DOI 10.1055/s-0036-1586200; Schaart MW, 2006, J PEDIATR GASTR NUTR, V43, P576, DOI 10.1097/01.mpg.0000235755.22111.83; Schaart MW, 2009, J PEDIATR GASTR NUTR, V49, P31, DOI 10.1097/MPG.0b013e318186d341; SHAW K, 1994, J PEDIATR SURG, V29, P376, DOI 10.1016/0022-3468(94)90570-3; Srinathan SK, 1997, J SURG RES, V68, P1, DOI 10.1006/jsre.1996.4986; Terry NA, 2014, AM J PHYSIOL-GASTR L, V307, pG979, DOI 10.1152/ajpgi.00390.2013; von Sochaczewski CO, 2017, J SURG RES, V209, P112, DOI 10.1016/j.jss.2016.09.035; Walker K, 2008, J PEDIATR SURG, V43, P484, DOI 10.1016/j.jpedsurg.2007.10.028; Wang XL, 2013, J PEDIATR SURG, V48, P2084, DOI 10.1016/j.jpedsurg.2013.05.025	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232023	10.1371/journal.pone.0232023	http://dx.doi.org/10.1371/journal.pone.0232023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352981	Green Published, gold			2022-12-26	WOS:000536673200036
J	Huang, YQ; Yu, YQ; Zhan, S; Tomberlin, JK; Huang, D; Cai, MM; Zheng, LY; Yu, ZN; Zhang, JB				Huang, Yaqing; Yu, Yongqiang; Zhan, Shuai; Tomberlin, Jeffery K.; Huang, Dian; Cai, Minmin; Zheng, Longyu; Yu, Ziniu; Zhang, Jibin			Dual oxidase Duox and Toll-like receptor 3 TLR3 in the Toll pathway suppress zoonotic pathogens through regulating the intestinal bacterial community homeostasis in Hermetia illucens L.	PLOS ONE			English	Article							BLACK SOLDIER FLY; ANTIMICROBIAL PEPTIDES; DIPTERA STRATIOMYIDAE; GUT MICROBIOTA; DISTAL GUT; DIVERSITY; SYSTEM; TIME; RECOGNITION; EXPRESSION	Black soldier fly (BSF; Hermetia illucens L.) larvae can convert fresh pig manure into protein and fat-rich biomass, which can then be used as aquafeed for select species. Currently, BSF is the only approved insect for such purposes in Canada, USA, and the European Union. Pig manure could serve as a feed substrate for BSF; however, it is contaminated with zoonotic pathogens (e.g., Staphylococcus aureus and Salmonella spp.). Fortunately, BSF larvae inhibit many of these zoonotic pathogens; however, the mechanisms employed are unclear. We employed RNAi, qRT-PCR, and Illumina MiSeq 16S rDNA high-throughput sequencing to examine the interaction between two immune genes (Duox in Duox-reactive oxygen species [ROS] immune system and TLR3 in the Toll signaling pathway) and select pathogens common in pig manure to decipher the mechanisms resulting in pathogen suppression. Results indicate Bsf Duox-TLR3 RNAi increased bacterial load but decreased relative abundance of Providencia and Dysgonomonas, which are thought to be commensals in the BSF larval gut. Bsf Duox-TLR3 RNAi also inactivated the NF-kappa B signaling pathway, downregulated the expression of antimicrobial peptides, and diminished inhibitory effects on zoonotic pathogen. The resulting dysbiosis stimulated an immune response by activating BsfDuox and promoting ROS, which regulated the composition and structure of the gut bacterial community. Thus, BsfDuox and BsfTLR3 are important factors in regulating these key gut microbes, while inhibiting target zoonotic pathogens.	[Huang, Yaqing; Yu, Yongqiang; Huang, Dian; Cai, Minmin; Zheng, Longyu; Yu, Ziniu; Zhang, Jibin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Natl Engn Res Ctr Microbial Pesticides, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China; [Zhan, Shuai] Chinese Acad Sci, SIBS, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Tomberlin, Jeffery K.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Huazhong Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Texas A&M University System; Texas A&M University College Station	Zhang, JB (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Natl Engn Res Ctr Microbial Pesticides, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	zhangjb@mail.hzau.edu.cn			National Natural Science Foundation of China [31770136]; National Key Technology R&D Program of China [2018YFD0500203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program)	National Natural Science Foundation of China (31770136); National Key Technology R&D Program of China (2018YFD0500203).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, GB4789102010 MOHPRC; [Anonymous], 2016, GB478942016 MOHPRC; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Bruno D, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01864-18; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceja-Navarro JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8618; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Duijff BJ, 1997, NEW PHYTOL, V135, P325, DOI 10.1046/j.1469-8137.1997.00646.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elhag O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169582; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Futo M, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01383; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guo XL, 2008, ANAEROBE, V14, P224, DOI 10.1016/j.anaerobe.2008.04.001; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hironaga M, 2008, JPN J INFECT DIS, V61, P212; Jiang CL, 2019, MICROB BIOTECHNOL, V12, P528, DOI 10.1111/1751-7915.13393; KAWAI Y, 1978, INT J SYST BACTERIOL, V28, P394, DOI 10.1099/00207713-28-3-394; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lalander CH, 2015, AGRON SUSTAIN DEV, V35, P261, DOI 10.1007/s13593-014-0235-4; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Liu QL, 2008, ENVIRON ENTOMOL, V37, P1525, DOI 10.1603/0046-225X-37.6.1525; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Rehman KU, 2017, J ENVIRON MANAGE, V196, P458, DOI 10.1016/j.jenvman.2017.03.047; Rokutan K, 2008, SEMIN IMMUNOPATHOL, V30, P315, DOI 10.1007/s00281-008-0124-5; Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Thong-On A, 2012, MICROBES ENVIRON, V27, P186, DOI 10.1264/jsme2.ME11325; Vogel H, 2018, DEV COMP IMMUNOL, V78, P141, DOI 10.1016/j.dci.2017.09.008; WALLACE PL, 1989, J CLIN MICROBIOL, V27, P735, DOI 10.1128/JCM.27.4.735-737.1989; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wynants E, 2019, MICROB ECOL, V77, P913, DOI 10.1007/s00248-018-1286-x; Xiao XP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.20; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P3768, DOI 10.1128/AEM.61.10.3768-3768.1995; Yao ZC, 2016, ISME J, V10, P1037, DOI 10.1038/ismej.2015.202; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Yoo JH, 2015, I SYMP CONSUM ELECTR, P98, DOI 10.1109/ICCE.2015.7066335; Zdybicka-Barabas A, 2017, ISJ-INVERT SURVIV J, V14, P9; Zhan S, 2020, CELL RES, V30, DOI 10.1038/s41422-019-0252-6; Zheng LY, 2013, J MED ENTOMOL, V50, P647, DOI 10.1603/ME12199	57	16	17	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0225873	10.1371/journal.pone.0225873	http://dx.doi.org/10.1371/journal.pone.0225873			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352968	gold, Green Published, Green Submitted			2022-12-26	WOS:000536673200006
J	Matambo, R; Takarinda, KC; Thekkur, P; Sandy, C; Mharakurwa, S; Makoni, T; Ncube, R; Charambira, K; Zishiri, C; Ngwenya, M; Nyathi, S; Chiteka, A; Chikaka, E; Mutero-Munyati, S				Matambo, Ronnie; Takarinda, Kudakwashe C.; Thekkur, Pruthu; Sandy, Charles; Mharakurwa, Sungano; Makoni, Talent; Ncube, Ronald; Charambira, Kelvin; Zishiri, Christopher; Ngwenya, Mkhokheli; Nyathi, Saziso; Chiteka, Albert; Chikaka, Elliot; Mutero-Munyati, Shungu			Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015	PLOS ONE			English	Article							PREDICTORS	Background Zimbabwe is one of the thirty countries globally with a high burden of multidrug-resistant tuberculosis (TB) or rifampicin-resistant TB (MDR/RR-TB). Since 2010, patients diagnosed with MDR/RR-TB are being treated with 20-24 months of standardized second-line drugs (SLDs). The profile, management and factors associated with unfavourable treatment outcomes of MDR/RR TB have not been systematically evaluated in Zimbabwe. Objective To assess treatment outcomes and factors associated with unfavourable outcomes among MDR/RR-TB patients registered and treated under the National Tuberculosis Programme in all the district hospitals and urban healthcare facilities in Zimbabwe between January 2010 and December 2015. Methods A cohort study using routinely collected programme data. The 'death', 'loss to follow-up' (LTFU), 'failure' and 'not evaluated' were considered as "unfavourable outcome". A generalized linear model with a log-link and binomial distribution or a Poisson distribution with robust error variances were used to assess factors associated with "unfavourable outcome". The unadjusted and adjusted relative risks were calculated as a measure of association. A pvalue< 0.05 was considered statistically significant. Results Of the 473 patients in the study, the median age was 34 years [interquartile range, 29-42] and 230 (49%) were males. There were 352 (74%) patients co-infected with HIV, of whom 321 (91%) were on antiretroviral therapy (ART). Severe adverse events (SAEs) were recorded in 118 (25%) patients; mostly hearing impairments (70%) and psychosis (11%). Overall, 184 (39%) patients had 'unfavourable' treatment outcomes [125 (26%) were deaths, 39 (8%) were lost to follow-up, 4 (<1%) were failures and 16 (3%) not evaluated]. Being co-infected with HIV but not on ART [adjusted relative risk (aRR) = 2.60; 95% CI: 1.33-5.09] was independently associated with unfavourable treatment outcomes. Conclusion The high unfavourable treatment outcomes among MDR/RR-TB patients on standardized SLDs were coupled with a high occurrence of SAEs in this predominantly HIV co-infected cohort. Switching to individualized all oral shorter treatment regimens should be considered to limit SAEs and improve treatment outcomes. Improving the ART uptake and timeliness of ART initiation can reduce unfavourable outcomes.	[Matambo, Ronnie; Ncube, Ronald; Charambira, Kelvin; Zishiri, Christopher] Int Union TB & Lung Dis, Harare, Zimbabwe; [Takarinda, Kudakwashe C.; Thekkur, Pruthu] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France; [Takarinda, Kudakwashe C.; Sandy, Charles; Makoni, Talent] Minist Hlth & Child Care, AIDS & TB Dept, Harare, Zimbabwe; [Thekkur, Pruthu] Union South East Asia USEA Off, New Delhi, India; [Mharakurwa, Sungano; Chiteka, Albert; Chikaka, Elliot] Africa Univ, Coll Hlth Agr & Nat Sci, Mutare, Zimbabwe; [Ngwenya, Mkhokheli] World Hlth Org, Zimbabwe Country Off, Harare, Zimbabwe; [Nyathi, Saziso] Hlth Serv Dept, City Of Bulawayo, Zimbabwe; [Mutero-Munyati, Shungu] Biomed Res & Training Inst, Harare, Zimbabwe	World Health Organization; Biomedical Research Training Institute	Matambo, R (corresponding author), Int Union TB & Lung Dis, Harare, Zimbabwe.	rmatambo2@gmail.com	Sandy, Charles/GPO-0717-2022; Charambira, Kelvin/AAC-5741-2020; Ncube, Ronald/AAE-4819-2019	Sandy, Charles/0000-0003-0264-7900; Ncube, Ronald/0000-0003-4668-0868	United Kingdom's Department for International Development (DFID); Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); World Health Organization; La Fondation Veuve Emile Metz-Tesch (Luxembourg); Department for International Development (DFID), UK	United Kingdom's Department for International Development (DFID); Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); World Health Organization(World Health Organization); La Fondation Veuve Emile Metz-Tesch (Luxembourg); Department for International Development (DFID), UK	The training course under which this study was conducted was funded by: the United Kingdom's Department for International Development (DFID); The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) and the World Health Organization. The open access publications costs were funded by the Department for International Development (DFID), UK and La Fondation Veuve Emile Metz-Tesch (Luxembourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016; Evans D, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3762-x; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kapata N, 2017, INFECTION, V45, P831, DOI 10.1007/s15010-017-1054-8; Kibret KT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0214-x; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Ministry of Health and Child Care, 2014, GUID PROGR MAN DRUG; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; [National Medicine and Therapeutics Policy Advisory Committee (NMTPAC) and The AIDS and TB Directorate M of H and CC (MoHCC) MOHCC], 2013, GUID ANT THER PREV T; Nunn AJ, 2019, NEW ENGL J MED, V380, P1201, DOI 10.1056/NEJMoa1811867; Parmar MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193903; Prasad Rajendra, 2016, Indian J Tuberc, V63, P106, DOI 10.1016/j.ijtb.2016.01.031; Shin SS, 2017, JAIDS-J ACQ IMM DEF, V74, P65, DOI 10.1097/QAI.0000000000001169; The World Health Organization, 2019, WHO CONSOLIDATED GUI; Thu MK, 2017, T ROY SOC TROP MED H, V111, P410, DOI 10.1093/trstmh/trx074; Timire C, 2018, T ROY SOC TROP MED H, V112, P285, DOI 10.1093/trstmh/try054; Umanah TA, 2015, T ROY SOC TROP MED H, V109, P340, DOI 10.1093/trstmh/trv025; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Verdecchia M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205601; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2010, GLOB PLAN STOP TB 20, DOI [10.1016/B978-1-4160-3988-4.00107-4, DOI 10.1016/B978-1-4160-3988-4.00107-4]; World Health Organization, 2016, GLOB TUB REP 2017; World Health Organization (WHO), 2000, WHO DOTS PLUS GREEN	28	2	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0230848	10.1371/journal.pone.0230848	http://dx.doi.org/10.1371/journal.pone.0230848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353043	gold, Green Published			2022-12-26	WOS:000536673200012
J	Vanaken, L; Bijttebier, P; Hermans, D				Vanaken, Lauranne; Bijttebier, Patricia; Hermans, Dirk			I like you better when you are coherent. Narrating autobiographical memories in a coherent manner has a positive impact on listeners' social evaluations	PLOS ONE			English	Article							GENDER-DIFFERENCES; PERSONAL NARRATIVES; SELF; SPECIFICITY; DEPRESSION; IDENTITY; SUPPORT; TRAITS; ASSOCIATIONS; EXPERIENCES	Introduction We all have stories to tell. The stories that prevail in our conversations frequently concern significant past personal experiences and are accordingly based on autobiographical memory retrieval and sharing. This is in line with the social function of autobiographical memory, which embodies the idea that we share memories with others to develop and maintain social relationships. However, the successful fulfilment of this social function is dependent on phenomenological properties of the memory, which are highly inter-individually different. One important individual difference is memory coherence, operationalized as narrative coherence. The objective of this study was to investigate the impact of memory coherence on the social evaluations of listeners. We hypothesized that being incoherent in the sharing of autobiographical memories, would evoke more negative social evaluations from listeners, in comparison to coherently sharing autobiographical memories. Methods In a within-subject experimental study, 96 participants listened to four pre-recorded audio clips in which the speaker narrated about an autobiographical experience, in either a coherent or an incoherent manner. Results Results were in line with our hypotheses. Participants showed more willingness to interact, more instrumental support, more positive feelings, more empathy and more trust towards those narrators who talked in a coherent manner about their autobiographical memories, as compared to those that talked in an incoherent manner. Negative feelings in the listener were evoked when the speaker talked incoherently, but especially when it concerned a positive memory. Discussion Results can be explained in terms of a reduction in the attraction effect when effortful processing is increased, which is in line with the dual processing theory of impression formation. Another explanation involves the idea that coherence is necessary to establish truthfulness in communication. The clinical relevance of these findings is further illustrated in light of the relation between social support and psychological well-being.	[Vanaken, Lauranne; Hermans, Dirk] Katholieke Univ Leuven, Ctr Psychol Learning & Expt Psychopathol, Leuven, Belgium; [Bijttebier, Patricia] Katholieke Univ Leuven, Sch Psychol & Dev Context, Leuven, Belgium	KU Leuven; KU Leuven	Vanaken, L (corresponding author), Katholieke Univ Leuven, Ctr Psychol Learning & Expt Psychopathol, Leuven, Belgium.	lauranne.vanaken@kuleuven.be	Hermans, Dirk/AAE-6657-2021	Hermans, Dirk/0000-0003-4497-3982; Bijttebier, Patricia/0000-0002-0648-7388; Vanaken, Lauranne/0000-0002-7793-9732	Fonds Wetenschappelijk Onderzoek (FWO) [G070217N]; KU Leuven Research Council [PF/10/005]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); KU Leuven Research Council(KU Leuven)	This article was funded by Fonds Wetenschappelijk Onderzoek (FWO) Research Project G070217N (PI: DH) and by a KU Leuven Research Council Grant PF/10/005 (DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JM, 2007, J RES PERS, V41, P1179, DOI 10.1016/j.jrp.2007.02.006; Adler JM, 2012, J PERS SOC PSYCHOL, V102, P367, DOI 10.1037/a0025289; Alea N, 2003, MEMORY, V11, P165, DOI 10.1080/741938207; Alea N, 2007, APPL COGNITIVE PSYCH, V21, P1091, DOI 10.1002/acp.1316; Alea N, 2013, INT J BEHAV DEV, V37, P395, DOI 10.1177/0165025413484244; Altunnar NH, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02466; Banks MV, 2013, MEMORY, V21, P10, DOI 10.1080/09658211.2012.707213; Barry TJ, 2019, MEMORY, V27, P916, DOI 10.1080/09658211.2019.1607876; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Benson D, 2016, ICARM 2016 2016 INT; Bisby JA, 2018, J EXP PSYCHOL GEN, V147, P243, DOI 10.1037/xge0000356; Bluck S, 2005, SOC COGNITION, V23, P91, DOI 10.1521/soco.23.1.91.59198; Bluck S, 2002, CRITICAL ADV REMINIS, P61; Bluck S, 2011, MEMORY, V19, P470, DOI 10.1080/09658211.2011.590500; Bluck S, 2009, APPL COGNITIVE PSYCH, V23, P1089, DOI 10.1002/acp.1612; Brewer M.B., 1988, ADV SOCIAL COGNITION, P1, DOI DOI 10.2307/1423264; Buckner JP, 2000, MEMORY, V8, P401, DOI 10.1080/09658210050156859; Burnell KJ, 2010, AGEING SOC, V30, P57, DOI 10.1017/S0144686X0999016X; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chen Y, 2012, MEMORY, V20, P667, DOI 10.1080/09658211.2012.693934; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; COYNE JC, 1976, J ABNORM PSYCHOL, V85, P186, DOI 10.1037/0021-843X.85.2.186; COYNE JC, 1976, PSYCHIATRY, V39, P28, DOI 10.1080/00332747.1976.11023874; de Beurs Edwin, 2014, Psychiatry J, V2014, P360193, DOI 10.1155/2014/360193; Denissen JJA, 2008, J PERS ASSESS, V90, P152, DOI 10.1080/00223890701845229; Diener E, 2009, SOC INDIC RES SER, V39, P1, DOI 10.1007/978-90-481-2354-4_1; Ellestrom L, 2018, SEMIOTICA, P423, DOI 10.1515/sem-2017-0001; Fiddick L, 2016, J RES PERS, V62, P6, DOI 10.1016/j.jrp.2016.02.007; Fiske SusanT., 1986, HDB MOTIVATION COGNI, P167; Fivush R, 2006, BRIT J DEV PSYCHOL, V24, P235, DOI 10.1348/026151005X57747; Fivush R, 2003, MEMORY, V11, P179, DOI 10.1080/741938209; Fivush R, 2004, PSYCHOL SCI, V15, P573, DOI 10.1111/j.0956-7976.2004.00722.x; Fivush R, 2012, J COGN DEV, V13, P295, DOI 10.1080/15248372.2011.590787; Fivush R, 2011, INT J PSYCHOL, V46, P321, DOI 10.1080/00207594.2011.596541; Fivush R, 2011, ANNU REV PSYCHOL, V62, P559, DOI 10.1146/annurev.psych.121208.131702; Forgas JP, 2017, EMOTIONS AND AFFECT IN HUMAN FACTORS AND HUMAN-COMPUTER INTERACTION, P89, DOI 10.1016/B978-0-12-801851-4.00003-3; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Grysman A, 2016, MEM COGNITION, V44, P856, DOI 10.3758/s13421-016-0610-2; Grysman A, 2013, DEV REV, V33, P239, DOI 10.1016/j.dr.2013.07.004; Habermas T, 2019, STUD EMO SO, P1, DOI 10.1017/9781139424615; Habermas T, 2010, EMOTION, V10, P312, DOI 10.1037/a0018001; Han JJ, 1998, DEV PSYCHOL, V34, P701, DOI 10.1037/0012-1649.34.4.701; Harandi Tayebeh Fasihi, 2017, Electron Physician, V9, P5212, DOI 10.19082/5212; Hayes AM, 2005, INT J BEHAV MED, V12, P111, DOI 10.1207/s15327558ijbm1202_9; Hermans HJM, 2006, J CONSTR PSYCHOL, V19, P147, DOI 10.1080/10720530500508779; Hilbig BE, 2014, J PERS SOC PSYCHOL, V107, P529, DOI 10.1037/a0036074; Hyman SM, 2003, J FAM VIOLENCE, V18, P295, DOI 10.1023/A:1025117311660; JONES EE, 1981, PERS SOC PSYCHOL B, V7, P523, DOI 10.1177/014616728173024; Kellas JK, 2010, J FAM COMMUN, V10, P174, DOI 10.1080/15267431.2010.489217; Klein K, 2001, J EXP PSYCHOL GEN, V130, P520, DOI 10.1037//0096-3445.130.3.520; Klein K, 2010, J SOC CLIN PSYCHOL, V29, P256, DOI 10.1521/jscp.2010.29.3.256; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lysaker PH, 2006, COUNS PSYCHOL Q, V19, P57, DOI 10.1080/09515070600673703; Lysaker PH, 2002, PSYCHIATRY, V65, P197, DOI 10.1521/psyc.65.3.197.20174; MCCORNACK SA, 1990, COMMUN MONOGR, V57, P119, DOI 10.1080/03637759009376190; McLean KC, 2010, J RES ADOLESCENCE, V20, P166, DOI 10.1111/j.1532-7795.2009.00633.x; MILLER GR, 1986, J SOC PERS RELAT, V3, P495, DOI 10.1177/0265407586034006; Mitchell C, 2020, J ADOLESCENCE, V79, P16, DOI 10.1016/j.adolescence.2019.12.003; Muller E, 2014, J FAM PSYCHOL, V28, P707, DOI 10.1037/a0037845; NELSON K, 1993, PSYCHOL SCI, V4, P7, DOI 10.1111/j.1467-9280.1993.tb00548.x; Orben AC, 2017, COMPUT HUM BEHAV, V73, P489, DOI 10.1016/j.chb.2017.04.006; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Palombo DJ, 2018, TRENDS COGN SCI, V22, P583, DOI 10.1016/j.tics.2018.04.007; PARK B, 1982, J PERS SOC PSYCHOL, V42, P1051, DOI 10.1037/0022-3514.42.6.1051; Pasupathi M, 2005, J PERS, V73, P1051, DOI 10.1111/j.1467-6494.2005.00338.x; Pasupathi M, 2002, DISCOURSE PROCESS, V34, P163, DOI 10.1207/S15326950DP3402_3; Polansky JR, 1989, PROGR CLIN BIOL RES, V312; Rasmussen AS, 2009, MEM COGNITION, V37, P477, DOI 10.3758/MC.37.4.477; Reese E, 2014, J ADOLESCENCE, V37, P727, DOI 10.1016/j.adolescence.2014.02.005; Reese E, 2011, J COGN DEV, V12, P424, DOI 10.1080/15248372.2011.587854; Rime B., 1998, EUROPEAN REV SOCIAL, P145, DOI [10.1080/14792779843000072, DOI 10.1080/14792779843000072]; Shakespeare-Finch J, 2011, J PERS ASSESS, V93, P483, DOI 10.1080/00223891.2011.594124; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Spreng RN, 2009, J PERS ASSESS, V91, P62, DOI 10.1080/00223890802484381; Stuijfzand S, 2016, SEX ROLES, V75, P434, DOI 10.1007/s11199-016-0649-3; Sutin AR, 2007, MEMORY, V15, P390, DOI 10.1080/09658210701256654; Tsuzuki T, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00896; Tuval-Mashiach R, 2004, PSYCHIATRY, V67, P280, DOI 10.1521/psyc.67.3.280.48977; van den Berg EM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01684; van Egmond K, 2009, FLOURISHING SCALE GE, V1, P266; Vanaken L, 2018, ONGEPUBLICEERDE GEAU; Vanderveren E, 2019, BEHAV RES THER, V116, P30, DOI 10.1016/j.brat.2019.02.003; Waters TEA, 2019, J PERS, V87, P151, DOI 10.1111/jopy.12377; Waters TEA, 2015, J PERS, V83, P441, DOI 10.1111/jopy.12120; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; WYER RS, 1986, PSYCHOL REV, V93, P322, DOI 10.1037/0033-295X.93.3.322	89	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232214	10.1371/journal.pone.0232214	http://dx.doi.org/10.1371/journal.pone.0232214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353027	Green Published, gold			2022-12-26	WOS:000536673200052
J	Oh, SA; Yea, JW; Park, JW; Park, J				Oh, Se An; Yea, Ji Woon; Park, Jae Won; Park, Jaehyeon			Use of a head-tilting baseplate during volumetric-modulated arc therapy (VMAT) to better protect organs at risk in hippocampal sparing whole brain radiotherapy (HS-WBRT)	PLOS ONE			English	Article							RADIATION-THERAPY; INTRACRANIAL METASTASES; AVOIDANCE; PROGNOSIS; MEMORY	Purpose Coplanar arcs are used with limited arc range to prevent direct beam entrance through the lens, which is challenging for satisfactory planning of hippocampal sparing in whole brain radiotherapy (HS-WBRT) with VMAT. We evaluated the dosimetric impact of applying a head-tilting technique during VMAT, which allows unrestricted use of the arc range. Methods and materials Twenty patients with multiple brain metastases who had received two computed tomography (CT)-simulation sessions between January 2016 and December 2018 were included. One session was delivered in a traditional supine position; the other was delivered with a tilting acrylic supine baseplate (MedTec, USA) to elevate the patients' head by 40 degrees. For each patient, a VMAT without (sVMAT) and with head-tilting (htVMAT) plan was generated. Conformity index (CI), homogeneity index (HI), and organ at risk (OAR) dose were evaluated. The Wilcoxon-signed test was used to compare the effect between two plans. Results The mean CI was 0.860 +/- 0.007 and 0.864 +/- 0.008 (p<0.05), and mean HI was 0.179 +/- 0.020 and 0.167 +/- 0.021 (p<0.05) for sVMAT and htVMAT, respectively. The mean dose to the hippocampus (9.91 +/- 0.30 Gy) was significantly lower in htVMAT than in sVMAT (10.36 +/- 0.29 Gy, P<0.05). htVMAT was associated with significantly reduced mean dose to the parotid gland, and right and left lens (4.77 +/- 1.97 Gy vs. 5.92 +/- 1.68 Gy, p<0.05; 3.29 +/- 0.44 Gy vs. 7.22 +/- 1.26 Gy, p<0.05; 3.33 +/- 0.45 Gy vs. 6.73 +/- 1.01 Gy, p<0.05, respectively). Conclusion This is the first study to demonstrate that the head-tilting technique might be useful for HS-WBRT planning with VMAT. This method could remove the limitations associated with the arc range, resulting in improved dose distribution and conformity, while sparing healthy organs, including the hippocampus, lens, and parotid gland.	[Oh, Se An; Yea, Ji Woon; Park, Jae Won; Park, Jaehyeon] Yeungnam Univ, Med Ctr, Dept Radiat Oncol, Daegu, South Korea; [Yea, Ji Woon; Park, Jae Won; Park, Jaehyeon] Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea	Yeungnam University; Yeungnam University	Park, J (corresponding author), Yeungnam Univ, Med Ctr, Dept Radiat Oncol, Daegu, South Korea.; Park, J (corresponding author), Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea.	drjhyeon@gmail.com		Park, Jaewon/0000-0003-1100-5301; park, jaehyeon/0000-0003-2546-4808; Oh, SeAn/0000-0002-8835-2814	2019 Yeungnam University Research Grant [219A580063]	2019 Yeungnam University Research Grant	This study was supported by the 2019 Yeungnam University Research Grant (219A580063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Buglione M, 2015, RADIOL MED, V120, P1146, DOI 10.1007/s11547-015-0542-0; Cagney DN, 2017, NEURO-ONCOLOGY, V19, P1511, DOI 10.1093/neuonc/nox077; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Dobi A, 2020, PATHOL ONCOL RES, V26, P149, DOI 10.1007/s12253-018-0383-y; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Gondi V, 2013, INT J RADIAT ONCOL, V85, P348, DOI 10.1016/j.ijrobp.2012.11.031; Gondi V, 2010, RADIOTHER ONCOL, V95, P327, DOI 10.1016/j.radonc.2010.02.030; Jiang AJ, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1255-7; Knisely JPS, 2011, INT J RADIAT ONCOL, V79, P957, DOI 10.1016/j.ijrobp.2010.11.001; Lee K, 2016, MED DOSIM, V41, P15, DOI 10.1016/j.meddos.2015.06.003; Neriishi K, 2012, RADIOLOGY, V265, P167, DOI 10.1148/radiol.12111947; Noh OK, 2011, RADIOTHER ONCOL, V98, P223, DOI 10.1016/j.radonc.2010.12.013; Park J, 2019, RADIAT ONCOL J, V37, P22, DOI 10.3857/roj.2019.00059; Rogers L, 2017, NEURO-ONCOLOGY, V19, P133; Rohan EA, 2018, CANCER CAUSE CONTROL, V29, P1277, DOI 10.1007/s10552-018-1107-z; Shen J, 2015, MED DOSIM, V40, P205, DOI 10.1016/j.meddos.2014.11.007; Sood S, 2017, MED DOSIM, V42, P375, DOI 10.1016/j.meddos.2017.07.005; Sun B, 2016, RADIOTHER ONCOL, V118, P181, DOI 10.1016/j.radonc.2015.11.010; Sundstrom JT, 1998, ANN MED, V30, P296, DOI 10.3109/07853899809005858; Wang K, 2019, JAMA ONCOL, V5, P221, DOI 10.1001/jamaoncol.2018.4951; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; ZIMM S, 1981, CANCER, V48, P384, DOI 10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232430	10.1371/journal.pone.0232430	http://dx.doi.org/10.1371/journal.pone.0232430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348379	Green Published, gold			2022-12-26	WOS:000536668200067
J	van Faassen, H; Ryan, S; Henry, KA; Raphael, S; Yang, QL; Rossotti, MA; Brunette, E; Jiang, SS; Haqqani, AS; Sulea, T; MacKenzie, CR; Tanha, J; Hussack, G				van Faassen, Henk; Ryan, Shannon; Henry, Kevin A.; Raphael, Shalini; Yang, Qingling; Rossotti, Martin A.; Brunette, Eric; Jiang, Susan; Haqqani, Arsalan S.; Sulea, Traian; MacKenzie, C. Roger; Tanha, Jamshid; Hussack, Greg			Serum albumin-binding V(H)Hs with variable pH sensitivities enable tailored half-life extension of biologics	FASEB JOURNAL			English	Article						antibody; half-life; nanobody; pH sensitivity; serum albumin; single-domain antibody	DOMAIN ANTIBODIES; IN-VIVO; FUSION PROTEINS; RECOGNITION; SALMONELLA; STRATEGY; PHARMACOKINETICS; GENERATION; LIBRARIES; AFFINITY	Prolonged serum half-life is required for the efficacy of most protein therapeutics. One strategy for half-life extension is to exploit the long circulating half-life of serum albumin by incorporating a binding moiety that recognizes albumin. Here, we describe camelid single-domain antibodies (V(H)Hs) that bind the serum albumins of multiple species with moderate to high affinity at both neutral and endosomal pH and significantly extend the serum half-lives of multiple proteins in rats from minutes to days. We serendipitously identified an additional VHH (M75) that is naturally pH-sensitive: at endosomal pH, binding affinity for human serum albumin (HSA) was dramatically weakened and binding to rat serum albumin (RSA) was undetectable. Domain mapping revealed that M75 bound to HSA domain 1 and 2. Moreover, alanine scanning of HSA His residues suggested a critical role for His247, located in HSA domain 2, in M75 binding and its pH dependence. Isothermal titration calorimetry experiments were suggestive of proton-linked binding of M75 to HSA, with differing binding enthalpies observed for full-length HSA and an HSA domain 1-domain 2 fusion protein in which surface-exposed His residues were substituted with Ala. M75 conferred moderate half-life extension in rats, from minutes to hours, likely due to rapid dissociation from RSA during FcRn-mediated endosomal recycling in tandem with albumin conformational changes induced by M75 binding that prevented interaction with FcRn. Humanized V(H)Hs maintained in vivo half-life extension capabilities. These V(H)Hs represent a new set of tools for extending protein therapeutic half-life and one (M75) demonstrates a unique pH-sensitive binding interaction that can be exploited to achieve modest in vivo half-life.	[van Faassen, Henk; Ryan, Shannon; Henry, Kevin A.; Raphael, Shalini; Yang, Qingling; Rossotti, Martin A.; Brunette, Eric; Jiang, Susan; Haqqani, Arsalan S.; MacKenzie, C. Roger; Tanha, Jamshid; Hussack, Greg] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Henry, Kevin A.; Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Sulea, Traian] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada	National Research Council Canada; University of Ottawa; National Research Council Canada	Hussack, G (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Greg.Hussack@nrc-cnrc.gc.ca						Adams R, 2016, MABS-AUSTIN, V8, P1336, DOI 10.1080/19420862.2016.1185581; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Blackler RJ, 2016, GLYCOBIOLOGY, V26, P181, DOI 10.1093/glycob/cwv093; Bonvin P, 2015, MABS-AUSTIN, V7, P294, DOI 10.1080/19420862.2015.1006993; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; Dave E, 2016, MABS-AUSTIN, V8, P1319, DOI 10.1080/19420862.2016.1210747; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Haqqani Arsalan S., 2008, V439, P241, DOI 10.1007/978-1-59745-188-8_17; Henry KA, 2015, PROTEIN ENG DES SEL, V28, P379, DOI 10.1093/protein/gzv039; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Hussack G, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0208978, 10.1371/journal.pone.0298978]; Hussack G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028218; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Jafari R, 2017, CURR MED CHEM, V24, P1228, DOI 10.2174/0929867324666170113112759; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Konning D, 2016, MAR BIOTECHNOL, V18, P161, DOI 10.1007/s10126-016-9690-z; Kontermann RE, 2016, EXPERT OPIN BIOL TH, V16, P903, DOI 10.1517/14712598.2016.1165661; Larsen Maja Thim, 2016, Mol Cell Ther, V4, P3, DOI 10.1186/s40591-016-0048-8; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Moreno M, 2010, Patent No. [US 2010/0279937, 20100279937]; Muller MR, 2012, MABS-AUSTIN, V4, P673, DOI 10.4161/mabs.22242; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Nilvebrant J, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303009; Podust VN, 2016, J CONTROL RELEASE, V240, P52, DOI 10.1016/j.jconrel.2015.10.038; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Schroter C, 2015, MABS-AUSTIN, V7, P138, DOI 10.4161/19420862.2014.985993; Sircar A, 2011, J IMMUNOL, V186, P6357, DOI 10.4049/jimmunol.1100116; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Steiner D, 2017, PROTEIN ENG DES SEL, V30, P583, DOI 10.1093/protein/gzx022; Strohl WR, 2015, BIODRUGS, V29, P215, DOI 10.1007/s40259-015-0133-6; Sulea T, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1682866; Swierczewska M, 2015, EXPERT OPIN EMERG DR, V20, P531, DOI 10.1517/14728214.2015.1113254; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Walker A, 2010, PROTEIN ENG DES SEL, V23, P271, DOI 10.1093/protein/gzp091; Young NM, 2014, PROTEIN ENG DES SEL, V27, P383, DOI 10.1093/protein/gzu018; Zhang Jianbing, 2009, V525, P323, DOI 10.1007/978-1-59745-554-1_17; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	54	18	18	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8155	8171		10.1096/fj.201903231R	http://dx.doi.org/10.1096/fj.201903231R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32342547				2022-12-26	WOS:000529515800001
J	Richards, DR; Fung, TK; Leong, RAT; Sachidhanandam, U; Drillet, Z; Edwards, PJ				Richards, Daniel R.; Fung, Tze Kwan; Leong, Rachel A. T.; Sachidhanandam, Uma; Drillet, Zuzana; Edwards, Peter J.			Demographic biases in engagement with nature in a tropical Asian city	PLOS ONE			English	Article							URBAN GREEN SPACE; CULTURAL ECOSYSTEM SERVICES; PUBLIC-HEALTH; ENVIRONMENTAL JUSTICE; NATURE RELATEDNESS; NATURE-RESERVE; SPATIAL SCALE; EXTINCTION; EXPERIENCE; INFRASTRUCTURE	Urban residents can benefit from spending time in outdoor spaces and engaging with nature-related activities. Such engagement can improve health and well-being, support community cohesion, and improve environmentally-friendly behaviours. However, engagement with nature may not be equal amongst different members of society. We investigated individual variation in engagement with nature in Singapore, a high-density city in tropical Southeast Asia. Through a survey of 1000 residents, we analysed relationships between demographic factors such as age, income, and sex, and the frequency of visitation to different ecosystem types, and the frequency of engagement with different nature-related activities. Parks and neighbourhood open spaces were among the most commonly-visited outdoor spaces, with nature reserves and other natural areas being visited less frequently. Common activities included sitting outdoors, art and photography, and running, while hiking and nature recreation were less frequent. In contrast with previous studies, we found relatively small differences among different groups of the population in their preferred types of outdoor activities. Older people, those with lower incomes, and without degrees were less likely to visit most types of outdoor space and engage with most types of nature-related activities. In the case of nature reserves, the distance from the visitor's home had a significantly negative influence on the frequency of visitation. These findings demonstrate that the benefits of engagement with nature are not equally enjoyed by all demographic groups, and that some groups lack engagement across the board. Strategies to increase nature engagement in tropical cities could include increasing the local availability and accessibility of different types of outdoor space, and education and public outreach programmes to encourage participation.	[Richards, Daniel R.; Fung, Tze Kwan; Leong, Rachel A. T.; Drillet, Zuzana; Edwards, Peter J.] Swiss Fed Inst Technol, Singapore ETH Ctr, Future Cities Lab, Zurich, Singapore; [Sachidhanandam, Uma] Republ Polytech, Woodlands, Singapore		Richards, DR (corresponding author), Swiss Fed Inst Technol, Singapore ETH Ctr, Future Cities Lab, Zurich, Singapore.	richards@arch.ethz.ch		Fung, Tze Kwan/0000-0002-3996-8807	Singapore's National Research Foundation [FI 370074016]; ETH Zurich [FI 370074016]	Singapore's National Research Foundation(National Research Foundation, Singapore); ETH Zurich(ETH Zurich)	The research was conducted at the Future Cities Laboratory at the Singapore-ETH Centre, which was established collaboratively between ETH Zurich and Singapore's National Research Foundation (FI 370074016) under its Campus for Research Excellence and Technological Enterprise programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmar A. A. Nor, 2011, Arboriculture & Urban Forestry, V37, P99; Amano T, 2018, ECOL APPL, V28, P1473, DOI 10.1002/eap.1748; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2018, R PACKAGE VERSION; Astell-burt T., 2014, BMC PUBLIC HEALTH, V14, P19, DOI [10. 1186/1471-2458-14-292 24678610, DOI 10.1186/1471-2458-14-29224678610]; Barbosa O, 2007, LANDSCAPE URBAN PLAN, V83, P187, DOI 10.1016/j.landurbplan.2007.04.004; Bertram C, 2015, ECOSYST SERV, V12, P187, DOI 10.1016/j.ecoser.2014.12.011; Boyd F, 2018, LANDSCAPE URBAN PLAN, V175, P102, DOI 10.1016/j.landurbplan.2018.03.016; Byrne J, 2009, J ENVIRON PLANN MAN, V52, P365, DOI 10.1080/09640560802703256; Cervinka R, 2012, J HEALTH PSYCHOL, V17, P379, DOI 10.1177/1359105311416873; Chatterjea K, 2007, LAND DEGRAD DEV, V18, P500, DOI 10.1002/ldr.793; Chatterjea K., 2019, Gardens' Bulletin (Singapore), V71, P419, DOI 10.26492/gbs71(suppl.1).2019-18; Chen XW, 2019, SCI TOTAL ENVIRON, V651, P2118, DOI 10.1016/j.scitotenv.2018.09.030; Chow WTL, 2016, URBAN FOR URBAN GREE, V16, P62, DOI 10.1016/j.ufug.2016.01.010; Collado S, 2015, J ENVIRON PSYCHOL, V41, P65, DOI 10.1016/j.jenvp.2014.11.001; Cox DTC, 2017, BIOSCIENCE, V67, P147, DOI 10.1093/biosci/biw173; Crawley MJ, 2013, R BOOK, P557; Cronin-de-Chavez A, 2019, HEALTH PLACE, V56, P118, DOI 10.1016/j.healthplace.2019.01.018; Dai D, 2011, LANDSCAPE URBAN PLAN, V102, P234, DOI 10.1016/j.landurbplan.2011.05.002; Dallimer M, 2014, INT J ENV RES PUB HE, V11, P7977, DOI 10.3390/ijerph110807977; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Dean JH, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071371; Drillet Z, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12052076; du Toit MJ, 2018, LANDSCAPE URBAN PLAN, V180, P249, DOI 10.1016/j.landurbplan.2018.06.001; Elliott LR, 2018, MAR POLICY, V97, P305, DOI 10.1016/j.marpol.2018.03.013; Ferguson M, 2018, LANDSCAPE URBAN PLAN, V175, P136, DOI 10.1016/j.landurbplan.2018.03.020; Frantz CM, 2014, STUD EDUC EVAL, V41, P85, DOI 10.1016/j.stueduc.2013.10.001; Freeman C, 2019, HEALTH PLACE, V56, P24, DOI 10.1016/j.healthplace.2019.01.010; Frumkin H, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1663; Grodzinska-Jurczak M, 2006, RESOUR CONSERV RECY, V46, P182, DOI 10.1016/j.resconrec.2005.06.010; Gupta N., 2010, ASIAN J EXERCISE SPO, V7, P61; Han SS, 2010, J TRANSP GEOGR, V18, P314, DOI 10.1016/j.jtrangeo.2009.06.010; Hartig T, 2016, SCIENCE, V352, P938, DOI 10.1126/science.aaf3759; Henderson J. C., 2013, Managing Leisure, V18, P213, DOI 10.1080/13606719.2013.796181; Heng S, 2018, HOT IS TOO HOT EVALU; Higgs G, 2012, ENVIRON PLANN B, V39, P326, DOI 10.1068/b37130; Hunter RF, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.104923; Hwang YH, 2015, BUILD ENVIRON, V94, P467, DOI 10.1016/j.buildenv.2015.10.003; Ibrahim MF, 2003, CITIES, V20, P205, DOI 10.1016/S0264-2751(03)00014-3; Jennings V., 2016, INT J ENV RES PUB HE, V13, DOI [10.3390/ijerph13020196, DOI 10.3390/ijerph13020196]; Jim CY, 2006, ENVIRON MANAGE, V38, P338, DOI 10.1007/s00267-005-0166-6; Kaczynski AT, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0146-4; Kardan O, 2015, SCI REP-UK, V5, DOI 10.1038/srep11610; Khew JYT, 2014, HUM ECOL, V42, P979, DOI 10.1007/s10745-014-9709-x; Kong L, 1999, TIJDSCHR ECON SOC GE, V90, P3, DOI 10.1111/1467-9663.00046; Kong LLL., 1997, LANDSCAPE RES, V22, P245, DOI [10.1080/01426399708706514, DOI 10.1080/01426399708706514]; La Rosa D, 2016, ECOL INDIC, V61, P74, DOI 10.1016/j.ecolind.2015.04.028; Lachowycz K, 2011, OBES REV, V12, pe183, DOI 10.1111/j.1467-789X.2010.00827.x; Lee CS, 2015, LECT NOTES COMPUT SC, V9469, P132, DOI 10.1007/978-3-319-27974-9_13; Lin BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087422; Liu HX, 2017, J CLEAN PROD, V163, pS181, DOI 10.1016/j.jclepro.2015.09.012; Lopez MCR, 2017, CASE STUD TRANSP POL, V5, P662, DOI 10.1016/j.cstp.2017.07.002; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Maas J, 2009, HEALTH PLACE, V15, P586, DOI 10.1016/j.healthplace.2008.09.006; Mansor M, 2015, PROCEDIA ENVIRON SCI, V28, P433, DOI 10.1016/j.proenv.2015.07.053; Markevych I, 2017, ENVIRON RES, V158, P301, DOI 10.1016/j.envres.2017.06.028; Martyn P, 2016, J HEALTH PSYCHOL, V21, P1436, DOI 10.1177/1359105314555169; McCurdy LE, 2010, CURR PROB PEDIATR AD, V40, P102, DOI 10.1016/j.cppeds.2010.02.003; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; National Parks Board, 2019, PARKS NAT RES; Neuvonen Mario, 2007, Urban Forestry & Urban Greening, V6, P235, DOI 10.1016/j.ufug.2007.05.003; Nisbet EK, 2011, J HAPPINESS STUD, V12, P303, DOI 10.1007/s10902-010-9197-7; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Prevot AC, 2018, ENVIRON EDUC RES, V24, P263, DOI 10.1080/13504622.2016.1249456; RAHMAN KMA, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/SU10113917; Read AD, 1999, RESOUR CONSERV RECY, V26, P217, DOI 10.1016/S0921-3449(99)00008-7; Richards DR, 2015, ECOL INDIC, V53, P187, DOI 10.1016/j.ecolind.2015.01.034; Saw LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133781; Singapore Department of Statistics, 2018, POP POP STRUCT; Singapore Department of Statistics, 2010, CENS POP 2010; Soga M, 2016, BIOL CONSERV, V203, P143, DOI 10.1016/j.biocon.2016.09.020; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Soga M, 2015, LANDSCAPE URBAN PLAN, V143, P69, DOI 10.1016/j.landurbplan.2015.06.003; Stigsdotter UK, 2011, URBAN FOR URBAN GREE, V10, P295, DOI 10.1016/j.ufug.2011.07.001; Tan KW, 2006, LANDSCAPE URBAN PLAN, V76, P45, DOI 10.1016/j.landurbplan.2004.09.040; Tan PY, 2017, LANDSCAPE URBAN PLAN, V158, P139, DOI 10.1016/j.landurbplan.2016.11.001; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Thiagarajah J, 2015, AMBIO, V44, P666, DOI 10.1007/s13280-015-0647-7; Thompson TL, 2002, INT J SCI EDUC, V24, P645, DOI 10.1080/09500690110110115; Toftager M, 2016, J PHYS ACT HEALTH, V8, P741, DOI [10.1123/jpah.8.6, DOI 10.1123/JPAH.8.6]; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; United Nations, 2016, REP INT EXP GROUP SU; van den Berg AE, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-74; Vollmer D, 2013, GLOBAL ENVIRON CHANG, V23, P1542, DOI 10.1016/j.gloenvcha.2013.10.001; Watkins SL, 2018, J ENVIRON MANAGE, V209, P152, DOI 10.1016/j.jenvman.2017.12.021; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; Wen M, 2013, ANN BEHAV MED, V45, pS18, DOI 10.1007/s12160-012-9426-x; Wolch JR, 2014, LANDSCAPE URBAN PLAN, V125, P234, DOI 10.1016/j.landurbplan.2014.01.017; Wolsink M, 2016, ENVIRON EDUC RES, V22, P1049, DOI 10.1080/13504622.2015.1077504; Yeo JH, 2010, SOC CULT GEOGR, V11, P681, DOI 10.1080/14649365.2010.508565; Yuen B., 1995, Habitat International, V19, P239, DOI 10.1016/0197-3975(94)E0012-P; Yuen B., 1999, GEOJOURNAL, V49, P323, DOI DOI 10.1023/A:1007060728210; Yung EHK, 2016, CITIES, V52, P114, DOI 10.1016/j.cities.2015.11.022; Zelenski JM, 2014, ENVIRON BEHAV, V46, P3, DOI 10.1177/0013916512451901; Zelenski JM, 2015, J ENVIRON PSYCHOL, V42, P24, DOI 10.1016/j.jenvp.2015.01.005; Zint MT, 2011, J ENVIRON EDUC, V42, P255, DOI 10.1080/00958964.2010.538091; [No title captured]	97	10	10	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231576	10.1371/journal.pone.0231576	http://dx.doi.org/10.1371/journal.pone.0231576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8VC	32339175	Green Published, gold, Green Submitted			2022-12-26	WOS:000536657400009
J	Cao, TF; Jiang, Y; Li, D; Sun, XL; Zhang, YY; Qin, LF; Tellides, G; Taylor, HS; Huang, YQ				Cao, Tiefeng; Jiang, Ying; Li, Da; Sun, Xiaoli; Zhang, Yuanyuan; Qin, Lingfeng; Tellides, George; Taylor, Hugh S.; Huang, Yingqun			H19/TET1 axis promotes TGF-beta signaling linked to endothelial-to-mesenchymal transition	FASEB JOURNAL			English	Article						atherosclerosis; cardiovascular; EndMT; epigenetic; LncRNA	METHYLATION GENOME-WIDE; SMOOTH-MUSCLE-CELLS; DNA METHYLATION; NEOINTIMA FORMATION; MASTER REGULATOR; H19; CONTRIBUTES; GROWTH; RECEPTOR; GENE	While emerging evidence suggests the link between endothelial activation of TGF-beta signaling, induction of endothelial-to-mesenchymal transition (EndMT), and cardiovascular disease (CVD), the molecular underpinning of this connection remains enigmatic. Here, we report aberrant expression of H19 lncRNA and TET1 in endothelial cells (ECs) of human atherosclerotic coronary arteries. Using primary human umbilical vein endothelial cells (HUVECs) and aortic endothelial cells (HAoECs) we show that TNF-alpha, a known risk factor for endothelial dysfunction and CVD, induces H19 expression which in turn activates TGF-beta signaling and EndMT via a TET1-dependent epigenetic mechanism. We also show that H19 regulates TET1 expression at the posttranscriptional level. Further, we provide evidence that this H19/TET1-mediated regulation of TGF-beta signaling and EndMT occurs in mouse pulmonary microvascular ECs in vivo under hyperglycemic conditions. We propose that endothelial activation of the H19/TET1 axis may play an important role in EndMT and perhaps CVD.	[Cao, Tiefeng; Jiang, Ying; Li, Da; Sun, Xiaoli; Zhang, Yuanyuan; Taylor, Hugh S.; Huang, Yingqun] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA; [Cao, Tiefeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Guangzhou, Peoples R China; [Jiang, Ying] Zhejiang Univ, Womens Hosp, Sch Med, Dept Obstet, Hangzhou, Peoples R China; [Li, Da] China Med Univ, Shengjing Hosp, Ctr Reprod Med, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Sun, Xiaoli] Nantong Univ, Affiliated Hosp, Ctr Reprod Med, Dept Obstet & Gynecol, Nantong, Peoples R China; [Zhang, Yuanyuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Peoples R China; [Qin, Lingfeng; Tellides, George] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA	Yale University; Sun Yat Sen University; Zhejiang University; China Medical University; Nantong University; Nanjing Medical University; Yale University	Huang, YQ (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.	Yingqun.huang@yale.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Cao TF, 2019, ONCOGENE, V38, P5356, DOI 10.1038/s41388-019-0808-4; Chen DH, 1999, CIRCULATION, V100, P849, DOI 10.1161/01.CIR.100.8.849; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; DIPIETRO LA, 1994, J VASC RES, V31, P178, DOI 10.1159/000319585; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Gao W, 2015, MUTAT RES-FUND MOL M, V772, P15, DOI 10.1016/j.mrfmmm.2014.12.009; Gao Y, 2014, NUCLEIC ACIDS RES, V42, P13799, DOI 10.1093/nar/gku1160; Geng TT, 2018, DIABETES, V67, P2183, DOI 10.2337/db18-0370; Ghazal S, 2015, EMBO MOL MED, V7, P996, DOI 10.15252/emmm.201505245; Greco S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0926-5; Greissel A, 2015, THROMB HAEMOSTASIS, V114, P390, DOI 10.1160/TH14-10-0852; Han DKM, 1996, J CLIN INVEST, V97, P1276, DOI 10.1172/JCI118543; Hofmann P, 2019, CARDIOVASC RES, V115, P230, DOI 10.1093/cvr/cvy206; Hong L, 2018, EUR J CELL BIOL, V97, P493, DOI 10.1016/j.ejcb.2018.07.005; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; Jiang YC, 2018, HEPATOL COMMUN, V2, P1356, DOI 10.1002/hep4.1252; Jimenez SA, 2016, MATRIX BIOL, V51, P26, DOI 10.1016/j.matbio.2016.01.012; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kessler T, 2015, CIRCULATION, V131, P1191, DOI 10.1161/CIRCULATIONAHA.114.014072; Khambhati J, 2018, ATHEROSCLEROSIS, V276, P1, DOI 10.1016/j.atherosclerosis.2018.07.007; KIM DK, 1994, J CLIN INVEST, V93, P355, DOI 10.1172/JCI116967; Kitao A, 2009, AM J PATHOL, V175, P616, DOI 10.2353/ajpath.2009.081061; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Li DY, 2018, CIRCULATION, V138, P1551, DOI 10.1161/CIRCULATIONAHA.117.032184; Li P, 2016, CIRCULATION, V134, P1752, DOI 10.1161/CIRCULATIONAHA.116.017949; Li TY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02401-7; Liu RJ, 2013, CIRCULATION, V128, P2047, DOI 10.1161/CIRCULATIONAHA.113.002887; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Martinet C, 2016, DEVELOPMENT, V143, P962, DOI 10.1242/dev.131771; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Moonen JRAJ, 2015, CARDIOVASC RES, V108, P377, DOI 10.1093/cvr/cvv175; Moura R, 2007, ARTERIOSCL THROM VAS, V27, P2163, DOI 10.1161/ATVBAHA.107.151282; Murphy-Ullrich JE, 2018, MATRIX BIOL, V68-69, P28, DOI 10.1016/j.matbio.2017.12.009; Peng J, 2016, ONCOTARGET, V7, P76423, DOI 10.18632/oncotarget.13121; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Popov D, 2001, MARC MALPIG SYMP SER, V7, P405; REED MJ, 1995, AM J PATHOL, V147, P1068; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Stenina-Adognravi O, 2014, MATRIX BIOL, V37, P69, DOI 10.1016/j.matbio.2014.02.001; Sun YL, 2019, J MOL CELL CARDIOL, V131, P66, DOI 10.1016/j.yjmcc.2019.04.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomas AA, 2019, DIABETOLOGIA, V62, P517, DOI 10.1007/s00125-018-4797-6; Uyy E, 2010, MICROVASC RES, V79, P154, DOI 10.1016/j.mvr.2009.11.008; Wesseling M, 2018, VASC PHARMACOL, V106, P1, DOI 10.1016/j.vph.2018.02.006; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Yamashita S, 2008, CANCER RES, V68, P2112, DOI 10.1158/0008-5472.CAN-07-5282; Yan L, 2015, ONCOGENE, V34, P3076, DOI 10.1038/onc.2014.236; Yang Q, 2016, ANN BIOMED ENG, V44, P2218, DOI 10.1007/s10439-015-1491-4; Yang YY, 2019, AGING-US, V11, P10016, DOI 10.18632/aging.102388; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang N, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120304; Zhang Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07611-z; Zhang ZW, 2016, J CLIN PATHOL, V69, P76, DOI 10.1136/jclinpath-2015-203275; Zhong T, 2017, ONCOGENE, V36, P2345, DOI 10.1038/onc.2016.391; Zhou JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10221; Zuckerwise L, 2016, ONCOTARGET, V7, P38398, DOI 10.18632/oncotarget.9534	65	9	9	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8625	8640		10.1096/fj.202000073RRRRR	http://dx.doi.org/10.1096/fj.202000073RRRRR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32374060	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000530737900001
J	Halvachizadeh, S; Teuber, H; Berk, T; Allemann, F; von Knel, R; Zelle, B; Cinelli, P; Pape, HC; Pfeifer, R				Halvachizadeh, Sascha; Teuber, Henrik; Berk, Till; Allemann, Florin; von Knel, Roland; Zelle, Boris; Cinelli, Paolo; Pape, Hans-Christoph; Pfeifer, Roman			Prevalence, injury-, and non-injury-related factors associated with anxiety and depression in polytrauma patients - A retrospective 20 year follow-up study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; MULTIPLE INJURIES; PSYCHIATRIC SEQUELAE; HEALTH; EPIDEMIOLOGY; DISORDER; SUPPORT	Introduction Survival rate after polytrauma increased over the past decades resulting in an increase of long-term complaints. These include physical and psychological impairments. The aim of this study was to describe the prevalence and risk factors for developing depression and anxiety more than twenty years after polytrauma. Methods We contacted patients who were treated due to a polytrauma between 1973 and 1990 at one level 1 trauma center after more than 20 years. These patients received a self-administered questionnaire, to assess symptoms of depression and anxiety. Analysis based on multivariable logistic regression models include injury severity and non-injury related factors to determine risk factors associated with the development of depression and anxiety. Results Patients included in this study (n = 337) had a mean ISS of 20.3 (4 to 50) points. In total, 173 (51.3%) showed psychiatric sequelae (depression n = 163, 48.2%; anxiety n = 14, 4.1%). Injury severity was not associated with the development of depression or anxiety. However, the patients, who required psychiatric therapy prior to the injury had higher risk of developing psychiatric symptoms (OR 1.3, 95%CI 1.1 to 1.8, p = 0.018) as did patients who suffered from additional psychiatric insults after the injury (OR 1.4, 95%CI 1.2 to 2.0, p = 0.049). Conclusion More than half of polytrauma patients developed psychiatric sequelae. Risk factors include mainly non-injury related factors such as psychiatric comorbidities and additional psychiatric insults after the injury.	[Halvachizadeh, Sascha; Teuber, Henrik; Berk, Till; Allemann, Florin; Cinelli, Paolo; Pape, Hans-Christoph; Pfeifer, Roman] Univ Spital Zurich, Dept Trauma, Zurich, Switzerland; [Halvachizadeh, Sascha; Cinelli, Paolo; Pape, Hans-Christoph; Pfeifer, Roman] Univ Zurich, Univ Hosp Zurich, Dept Trauma, Harald Tscherne Lab, Zurich, Switzerland; [von Knel, Roland] Univ Zurich, Univ Hosp Zurich, Dept Consultat Liaison Psychiat & Psychosomat Med, Zurich, Switzerland; [Zelle, Boris] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Texas System; University of Texas Health San Antonio	Halvachizadeh, S (corresponding author), Univ Spital Zurich, Dept Trauma, Zurich, Switzerland.; Halvachizadeh, S (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Trauma, Harald Tscherne Lab, Zurich, Switzerland.	sascha.halvachizadeh@usz.ch	Allemann, Florin/AAV-3854-2020; von Kanel, Roland/B-1811-2019	von Kanel, Roland/0000-0002-8929-5129; Cinelli, Paolo/0000-0002-0163-9055; Pape, Hans-Christoph/0000-0002-2059-4980				Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baranyi A, 2010, PSYCHOSOMATICS, V51, P237, DOI 10.1176/appi.psy.51.3.237; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; de Munter L, 2020, ARCH PHYS MED REHAB, V101, P877, DOI 10.1016/j.apmr.2019.10.196; Dienstknecht T, 2013, BONE JOINT J, V95B, P548, DOI 10.1302/0301-620X.95B4.30804; Guest R, 2016, INJURY, V47, P2415, DOI 10.1016/j.injury.2016.09.006; Halvachizadeh S, 2019, J TRAUMA ACUTE CARE, V86, P1027, DOI 10.1097/TA.0000000000002232; Harwood PJ, 2006, J TRAUMA, V60, P334, DOI 10.1097/01.ta.0000197148.86271.13; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Kang B, 2019, INT J GERIATR PSYCH, V34, P522, DOI 10.1002/gps.5055; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Luchette F, 2010, J TRAUMA, V69, P530; O'Donnell ML, 2016, J CLIN PSYCHIAT, V77, pE473, DOI 10.4088/JCP.14m09721; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Pape HC, 2009, EUR INSTRUCT COURSE, V9, P67, DOI 10.1007/978-3-642-00966-2_8; Patten SB, 2006, CAN J PSYCHIAT, V51, P84, DOI 10.1177/070674370605100204; Qureshi KL, 2019, POSTTRAUMATIC STRESS, V9; Reis F, 2019, PHYSIOTHER THEOR PR, V35, P533, DOI 10.1080/09593985.2018.1455122; Sayed S, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0612-y; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Singh R, 2019, BRAIN INJURY, V33, P584, DOI 10.1080/02699052.2019.1566837; Sittaro N A, 2007, Versicherungsmedizin, V59, P20; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Stein P, 2017, ANAESTHESIA, V72, P1317, DOI 10.1111/anae.13920; Tscherne H, 2013, CLIN ORTHOP RELAT R, V471, P2755, DOI 10.1007/s11999-013-3012-9; Van Praag DL, 2019, POSTTRAUMATIC STRESS; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; WHO, 2020, ROAD TRAFF INJ; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Woodward EC, 2018, COGNITIVE THER RES, V42, P823, DOI 10.1007/s10608-018-9943-4; World Health Organization, 2020, DEPRESSION	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232678	10.1371/journal.pone.0232678	http://dx.doi.org/10.1371/journal.pone.0232678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365087	Green Published, Green Accepted, gold			2022-12-26	WOS:000536959700052
J	Lokau, J; Kleinegger, F; Garbers, Y; Waetzig, GH; Grotzinger, J; Rose-John, S; Haybaeck, J; Garbers, C				Lokau, Juliane; Kleinegger, Florian; Garbers, Yvonne; Waetzig, Georg H.; Groetzinger, Joachim; Rose-John, Stefan; Haybaeck, Johannes; Garbers, Christoph			Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells	PLOS ONE			English	Article							RECEPTOR; CYTOKINE	Tocilizumab is a humanized monoclonal antibody that is approved for the treatment of different human inflammatory diseases, including rheumatoid arthritis and cytokine release syndrome. Tocilizumab binds to the interleukin-6 receptor (IL-6R) and thereby blocks signaling of the pro-inflammatory cytokine IL-6. Initial studies and all authority assessment reports state that tocilizumab is effective in humans, but cannot bind to the murine or rat IL-6R and thus not block IL-6 signaling in the mouse. However, several recent studies described the use of tocilizumab in mice and reported biological effects that were attributed to IL-6 block-ade. In this study, we investigate the capability of tocilizumab to block IL-6 signaling using different human and murine cell lines. Our results unequivocally confirm the original state of the art that tocilizumab blocks signaling via the human IL-6R, but does not block IL-6 signaling in murine cells.	[Lokau, Juliane; Haybaeck, Johannes; Garbers, Christoph] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany; [Kleinegger, Florian; Haybaeck, Johannes] Med Univ Graz, Diagnost & Res Ctr Mol BioMed, Inst Pathol, Graz, Austria; [Garbers, Yvonne] Univ Kiel, Inst Psychol, Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, Kiel, Germany; [Groetzinger, Joachim; Rose-John, Stefan] Univ Kiel, Inst Biochem, Kiel, Germany; [Haybaeck, Johannes] Med Univ Innsbruck, Dept Pathol Neuropathol & Mol Pathol, Innsbruck, Austria	Otto von Guericke University; Medical University of Graz; University of Kiel; University of Kiel; Medical University of Innsbruck	Garbers, C (corresponding author), Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany.	christoph.garbers@med.ovgu.de	Garbers, Christoph/D-9932-2015; Waetzig, Georg/AAV-7486-2021	Garbers, Christoph/0000-0003-4939-6950; 	Deutsche Forschungsgemeinschaft (DFG) [125440785 - SFB 877 A10, 125440785 - SFB 877 A14]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; project 125440785 - SFB 877 A10 and A14 to CG; http://www.dfg.de).CONARIS Research AG provided support in the form of salaries for author G.H.W. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; COULIE PG, 1989, EUR J IMMUNOL, V19, P2107, DOI 10.1002/eji.1830191121; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Grotzinger J, 1997, PROTEINS, V27, P96; Hu J, 2018, BRIT J ANAESTH, V120, P537, DOI 10.1016/j.bja.2017.11.096; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Kamiya N, 2019, OSTEOARTHR CARTILAGE, V27, P326, DOI 10.1016/j.joca.2018.10.010; Nishimoto N, 2000, ANN RHEUM DIS, V59, P21, DOI 10.1136/ard.59.suppl_1.i21; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; Orabona C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96244; Ueda O, 2013, SCI REP-UK, V3, DOI 10.1038/srep01196; VANDAM M, 1993, J BIOL CHEM, V268, P15285; Wiesinger MY, 2009, CHEM BIOL, V16, P783, DOI 10.1016/j.chembiol.2009.06.010; Wu R, 2018, METABOLISM, V83, P18, DOI 10.1016/j.metabol.2018.01.002	17	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232612	10.1371/journal.pone.0232612	http://dx.doi.org/10.1371/journal.pone.0232612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365119	gold, Green Published			2022-12-26	WOS:000536959700045
J	Wang, Y; Zhou, XQ; Zhao, D; Wang, X; Gurley, EC; Liu, RP; Li, XJY; Hylemon, PB; Chen, WD; Zhou, HP				Wang, Yanyan; Zhou, Xiqiao; Zhao, Derrick; Wang, Xuan; Gurley, Emily C.; Liu, Runping; Li, Xiaojiaoyang; Hylemon, Phillip B.; Chen, Weidong; Zhou, Huiping			Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; LIVER-DISEASE; INSULIN-RESISTANCE; SIGNALING PATHWAYS; ATHEROSCLEROSIS; DYSLIPIDEMIA; ACTIVATE; OBESITY; NAFLD	Inflammation plays an essential role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Berberine (BBR), an isoquinoline alkaloid isolated from Chinese medicinal herbs, has been widely used to treat various diseases, including liver diseases for hundreds of years. The previous studies have shown that BBR inhibits high fat-diet-induced steatosis and inflammation in rodent models of NAFLD. However, the underlying molecular mechanisms remain unclear. This study is aimed to identify the potential mechanisms by which BBR inhibits free fatty acid (FFA) and LPS-induced inflammatory response in mouse macrophages and hepatocytes. Mouse RAW264.7 macrophages and primary mouse hepatocytes were treated with palmitic acid (PA) or LPS or both with or without BBR (0-10 mu M) for different periods (0-24 h). The mRNA and protein levels of proinflammatory cytokines (TNF-alpha, IL-6, IL-1 beta, MCP-1) and ER stress genes (CHOP, ATF4, XBP-1) were detected by real-time RT-PCR, Western blot and ELISA, respectively. The results indicated that BBR significantly inhibited PA and LPS-induced activation of ER stress and expression of proinflammatory cytokines in macrophages and hepatocytes. PA/LPS-mediated activation of ERK1/2 was inhibited by BBR in a dose-dependent manner. In summary, BBR inhibits PA/LPS-induced inflammatory responses through modulating ER stress-mediated ERK1/2 activation in macrophages and hepatocytes.	[Wang, Yanyan; Chen, Weidong] Anhui Univ Chinese Med, Sch Pharmaceut Sci, Hefei, Peoples R China; [Wang, Yanyan; Zhou, Xiqiao; Zhao, Derrick; Wang, Xuan; Gurley, Emily C.; Liu, Runping; Li, Xiaojiaoyang; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Zhou, Xiqiao] Nanjing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Anhui University of Chinese Medicine; Virginia Commonwealth University; Nanjing Medical University	Chen, WD (corresponding author), Anhui Univ Chinese Med, Sch Pharmaceut Sci, Hefei, Peoples R China.; Zhou, HP (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	anzhongdong@126.com; huiping.zhou@vcuhealth.org	Li, Xiaojiaoyang/CAG-6603-2022	Li, Xiaojiaoyang/0000-0003-0291-5856; Zhou, Huiping/0000-0002-0050-372X	National Institutes of Health [R01 DK104893, R01DK-057543]; VA Merit Award [I01BX004033, 1I01BX001390]; Research Career Scientist Award [IK6BX004477]; Massey Cancer Center research fund; Jiangsu Province Special Program for Young Medical Talent Grant [QNRC2016568]; National Natural Science Foundation of China [XZ,81570522]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Research Career Scientist Award(US Department of Veterans Affairs); Massey Cancer Center research fund; Jiangsu Province Special Program for Young Medical Talent Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Institutes of Health Grant R01 DK104893 and R01DK-057543 (HZ and PBH); VA Merit Award I01BX004033 (HZ) and 1I01BX001390 (HZ); Research Career Scientist Award (HZ, IK6BX004477); Massey Cancer Center research fund (HZ); Jiangsu Province Special Program for Young Medical Talent Grant (XZ, QNRC2016568); National Natural Science Foundation of China (XZ,81570522).	Affuso F, 2010, WORLD J CARDIOL, V2, P71, DOI [10.4330/wjc.v2.i3.68, 10.4330/wjc.v2.i4.71]; Arrese M, 2016, DIGEST DIS SCI, V61, P1294, DOI 10.1007/s10620-016-4049-x; Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chang XX, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0982-x; Chen B, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01504; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Deng YJ, 2019, EXP THER MED, V17, P2091, DOI 10.3892/etm.2019.7208; Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544; Graham C, 2015, NUTR REV, V73, P376, DOI 10.1093/nutrit/nuv004; Haywood J, 2016, OSTEOARTHR CARTILAGE, V24, P942, DOI 10.1016/j.joca.2015.11.020; HEUMAN DM, 1988, HEPATOLOGY, V8, P358, DOI 10.1002/hep.1840080228; Hirayama D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010092; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jin JF, 2013, AM J PHYSIOL-ENDOC M, V305, pE853, DOI 10.1152/ajpendo.00251.2013; Juarez-Hernandez E, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0191-8; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kwong EK, 2019, DIGEST LIVER DIS, V51, P1154, DOI 10.1016/j.dld.2019.03.020; Li XJY, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010190; Li YC, 2018, AM J PHYSIOL-ENDOC M, V315, pE745, DOI 10.1152/ajpendo.00015.2018; Li Y, 2019, INT J MED SCI, V16, P1593, DOI 10.7150/ijms.37677; Li Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/289264; Ma JL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101124; Mali SS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03004; Musso G, 2018, GASTROENTEROLOGY, V155, P282, DOI 10.1053/j.gastro.2018.06.031; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Sun H.J., 2017, BMC COMPLEM ALTERN M, V17, P1; Wang Q, 2012, INVEST OPHTH VIS SCI, V53, P2395, DOI 10.1167/iovs.11-8982; Wang XH, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1017-4; Wang Y.F., 2005, J NAT FIBERS, V2, P1, DOI DOI 10.1002/HEP.29076; Wang Y, 2013, HEPATOLOGY, V57, P1005, DOI 10.1002/hep.26107; Wu LY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1706-y; Wu XD, 2010, GASTROENTEROLOGY, V138, P197, DOI 10.1053/j.gastro.2009.08.054; Xu X, 2019, FASEB J, V33, P7289, DOI 10.1096/fj.201802316R; Yan HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134172; Yang J, 2017, BIOMED PHARMACOTHER, V95, P1777, DOI 10.1016/j.biopha.2017.09.103; Zha WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054349; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang YP, 2019, CURR MED SCI, V39, P37, DOI 10.1007/s11596-019-1997-3; Zhang ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20848; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112; Zhu XP, 2019, FREE RADICAL BIO MED, V141, P192, DOI 10.1016/j.freeradbiomed.2019.06.019; Zhu XP, 2016, MOLECULES, V21, DOI 10.3390/molecules21101336; Zhu XZ, 2004, EUR J PHARMACOL, V500, P221, DOI 10.1016/j.ejphar.2004.07.027	50	29	29	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232630	10.1371/journal.pone.0232630	http://dx.doi.org/10.1371/journal.pone.0232630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357187	Green Published, gold			2022-12-26	WOS:000536957700043
J	Zulch, MF; Pilotte, N; Grant, JR; Minetti, C; Reimer, LJ; Williams, SA				Zulch, Michael F.; Pilotte, Nils; Grant, Jessica R.; Minetti, Corrado; Reimer, Lisa J.; Williams, Steven A.			Selection and exploitation of prevalent, tandemly repeated genomic targets for improved real-time PCR-based detection of Wuchereria bancrofti and Plasmodium falciparum in mosquitoes	PLOS ONE			English	Article							CHAIN-REACTION ASSAY; DIAGNOSTICS; INFECTIONS; BLOOD	Background Optimization of polymerase chain reaction (PCR)-based diagnostics requires the careful selection of molecular targets that are both highly repetitive and pathogen-specific. Advances in both next-generation sequencing (NGS) technologies and bioinformaticsbased analysis tools are facilitating this selection process, informing target choices and reducing labor. Once developed, such assays provide disease control and elimination programs with an additional set of tools capable of evaluating and monitoring intervention successes. The importance of such tools is heightened as intervention efforts approach their endpoints, as accurate and complete information is an essential component of the informed decision-making process. As global efforts for the control and elimination of both lymphatic filariasis and malaria continue to make significant gains, the benefits of diagnostics with improved analytical and clinical/field-based sensitivities and specificities will become increasingly apparent. Methodology/Principal findings Coupling Illumina-based NGS with informatics approaches, we have successfully identified the tandemly repeated elements in both the Wuchereria bancrofti and Plasmodium falciparum genomes of putatively greatest copy number. Utilizing these sequences as quantitative real-time PCR (qPCR)-based targets, we have developed assays capable of exploiting the most abundant tandem repeats for both organisms. For the detection of P. falciparum, analysis and development resulted in an assay with improved analytical and field-based sensitivity vs. an established ribosomal sequence-targeting assay. Surprisingly, analysis of the W. bancrofti genome predicted a ribosomal sequence to be the genome's most abundant tandem repeat. While resulting cycle quantification values comparing a qPCR assay targeting this ribosomal sequence and a commonly targeted repetitive DNA sequence from the literature supported our finding that this ribosomal sequence was the most prevalent tandemly repeated target in the W. bancrofti genome, the resulting assay did not significantly improve detection sensitivity in conjunction with field sample testing. Conclusions/Significance Examination of pathogen genomes facilitates the development of PCR-based diagnostics targeting the most abundant and specific genomic elements. While in some instances currently available tools may deliver equal or superior performance, systematic analysis of potential targets provides confidence that the selected assays represent the most advantageous options available and that informed assay selection is occurring in the context of a particular study's objectives.	[Zulch, Michael F.; Pilotte, Nils; Grant, Jessica R.; Williams, Steven A.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA; [Pilotte, Nils; Williams, Steven A.] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA; [Minetti, Corrado; Reimer, Lisa J.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England	Smith College; University of Massachusetts System; University of Massachusetts Amherst; Liverpool School of Tropical Medicine	Pilotte, N (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.; Pilotte, N (corresponding author), Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA.	npilotte@smith.edu	Minetti, Corrado/AAR-9931-2021	Minetti, Corrado/0000-0001-7862-4874; Reimer, Lisa/0000-0002-9711-4981; Zulch, Michael/0000-0001-5703-5675	Bill and Melinda Gates Foundation [OPP1154992]; Bill and Melinda Gates Foundation via the Neglected Tropical Disease Support Center at the Task Force for Global Health, Decatur, GA [OPP1053230]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill and Melinda Gates Foundation via the Neglected Tropical Disease Support Center at the Task Force for Global Health, Decatur, GA	This work was funded through an award to NP from the Bill and Melinda Gates Foundation (grant #OPP1154992) and an award to SAW from the Bill and Melinda Gates Foundation (grant # OPP1053230) via the Neglected Tropical Disease Support Center at the Task Force for Global Health, Decatur, GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-146; Alhassan A, 2015, TRENDS PARASITOL, V31, P391, DOI 10.1016/j.pt.2015.04.006; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Brady MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005097; Chu BK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002584; Cibulskis RE, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0151-8; Grant JR, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00883; Iwuafor Anthony Achizie, 2018, Niger Med J, V59, P64, DOI 10.4103/nmj.NMJ_165_18; JAUREGUIBERRY G, 1990, MOL CELL PROBE, V4, P409, DOI 10.1016/0890-8508(90)90031-T; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Keroack CD, 2018, INT J PARASITOL-PAR, V7, P147, DOI 10.1016/j.ijppaw.2018.04.001; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; Mathison BA, 2017, J CLIN MICROBIOL, V55, P2009, DOI [10.1128/JCM.02562-16, 10.1128/jcm.02562-16]; Ngasala B, 2019, AM J TROP MED HYG, V101, P809, DOI 10.4269/ajtmh.19-0394; Novak P, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx257; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Papaiakovou M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005734; Pilotte N, 2013, MOL BIOCHEM PARASIT, V189, P33, DOI 10.1016/j.molbiopara.2013.05.001; Pilotte N, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007593; Pilotte N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004641; Pilotte N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004578; Rabinovich RN, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002456; Rao RU, 2006, AM J TROP MED HYG, V74, P826, DOI 10.4269/ajtmh.2006.74.826; Rao RU, 2009, T ROY SOC TROP MED H, V103, P365, DOI 10.1016/j.trstmh.2008.07.012; Wanji S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1556-8; WHO, 2018, WORLD MAL REP 2018; Williams SA, 1996, T ROY SOC TROP MED H, V90, P384, DOI 10.1016/S0035-9203(96)90515-5; World Health Organisation, 2011, LYMPHATIC FILARIASIS; World Health Organization, 2013, UN ACC MAL DIAGN TES; World Health Organization WHO, 2018, WKLY EPIDEMIOL REC, V92, P594; Wu L, 2015, NATURE, V528, pS86, DOI 10.1038/nature16039; Zhong M, 1996, AM J TROP MED HYG, V54, P357, DOI 10.4269/ajtmh.1996.54.357	32	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232325	10.1371/journal.pone.0232325	http://dx.doi.org/10.1371/journal.pone.0232325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357154	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000536957700025
J	Jacobsen, T; Yi, G; Al Asafen, H; Jermusyk, AA; Beisel, CL; Reeves, GT				Jacobsen, Thomas; Yi, Gloria; Al Asafen, Hadel; Jermusyk, Ashley A.; Beisel, Chase L.; Reeves, Gregory T.			Tunable self-cleaving ribozymes for modulating gene expression in eukaryotic systems	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; RNA; PROTEIN; IDENTIFICATION; HUNCHBACK; NETWORKS; PLATFORM; CRISPR; LOCI	Advancements in the field of synthetic biology have been possible due to the development of genetic tools that are able to regulate gene expression. However, the current toolbox of gene regulatory tools for eukaryotic systems have been outpaced by those developed for simple, single-celled systems. Here, we engineered a set of gene regulatory tools by combining self-cleaving ribozymes with various upstream competing sequences that were designed to disrupt ribozyme self-cleavage. As a proof-of-concept, we were able to modulate GFP expression in mammalian cells, and then showed the feasibility of these tools in Drosophila embryos. For each system, the fold-reduction of gene expression was influenced by the location of the self-cleaving ribozyme/upstream competing sequence (i.e. 50 vs. 30 untranslated region) and the competing sequence used. Together, this work provides a set of genetic tools that can be used to tune gene expression across various eukaryotic systems.	[Jacobsen, Thomas; Yi, Gloria; Al Asafen, Hadel; Jermusyk, Ashley A.; Beisel, Chase L.; Reeves, Gregory T.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Beisel, Chase L.] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany; [Beisel, Chase L.] Univ Wurzburg, Med Fac, Wurzburg, Germany	University of North Carolina; North Carolina State University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Wurzburg	Beisel, CL; Reeves, GT (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.; Beisel, CL (corresponding author), Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany.; Beisel, CL (corresponding author), Univ Wurzburg, Med Fac, Wurzburg, Germany.	chase.beisel@helmholtz-hiri.de; gtreeves@ncsu.edu	Beisel, Chase L/D-4823-2015	Beisel, Chase L/0000-0003-0650-9943; Reeves, Gregory/0000-0003-0836-7766	U.S. Department of Education [P200A140020]; National Science Foundation [MCB-1413044]	U.S. Department of Education(US Department of Education); National Science Foundation(National Science Foundation (NSF))	This work was supported by the U.S. Department of Education [Graduate Assistance in Areas of National Need Biotechnology Fellowship (P200A140020)] (to T.J.) and the National Science Foundation (MCB-1413044) (to C.L.B and G.T.R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/NCHEMBIO.598, 10.1038/nchembio.598]; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Carrier TA, 1997, BIOTECHNOL PROGR, V13, P699, DOI 10.1021/bp970095h; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Jermusyk AA, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0330-z; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Link KH, 2007, BIOL CHEM, V388, P779, DOI 10.1515/BC.2007.105; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; Marr MT, 2007, GENE DEV, V21, P175, DOI 10.1101/gad.1506407; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Peace BE, 2005, MOL THER, V12, P128, DOI 10.1016/j.ymthe.2005.02.015; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rhee DY, 2014, CELL REP, V8, P2031, DOI 10.1016/j.celrep.2014.08.038; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Seela F, 1998, NUCLEIC ACIDS RES, V26, P1010, DOI 10.1093/nar/26.4.1010; Singh V, 2014, GENE, V535, P1, DOI 10.1016/j.gene.2013.11.025; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Wang CH, 2003, J BIOL CHEM, V278, P32423, DOI 10.1074/jbc.M207862200; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Wurmthaler LA, 2018, RNA BIOL, V15, P231, DOI 10.1080/15476286.2017.1397870; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232046	10.1371/journal.pone.0232046	http://dx.doi.org/10.1371/journal.pone.0232046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352996	Green Published, gold, Green Submitted			2022-12-26	WOS:000536673200038
J	Kirs, M; Kisand, V; Nelson, CE; Dudoit, T; Moravcik, PS				Kirs, Marek; Kisand, Veljo; Nelson, Craig E.; Dudoit, Tineill; Moravcik, Philip S.			Distinct bacterial communities in tropical island aquifers	PLOS ONE			English	Article							FECAL INDICATOR BACTERIA; MICROBIAL COMMUNITIES; GROUNDWATER; WATER; BIODIVERSITY; DIVERSITY; QUALITY; IMPACT; SOIL; CONTAMINATION	The groundwater biome is a poorly characterized habitat hypothesized to harbor uniquely diverse bacterial communities; the degree to which these communities differ from associated soils is a central question in environmental microbiology. We characterized the Bacterial community composition in 37 aquifer and 32 surface soil samples across the island of O'ahu, Hawai'i. Several bacterial phyla (Acetothermia, Omnitrophica, Parcubacteria, Peregrinibacteria) relatively abundant in the aquifer samples were rare to absent in the soils. Immense bacterial diversity detected in the deep aquifers indicates that these environments are not as homogenous as expected, but provide various niches and energy sources for wide variety of bacteria. A small proportion of OTUs were widespread in all the basal (0.63%) and all the dike aquifer (0.31%) samples. However, these core bacteria comprised an average of 31.8% (ranging 16.2%-62.0%) and 15.4% (0.1%-31.5%) of all sequences isolated from the basal and dike aquifers respectively. Bacterial community composition correlated significantly with the sodium, sulfate, potassium, total dissolved solids, nitrate, conductivity, and pH in the basal aquifers, while phosphate and bicarbonate levels were also highly important when dike water samples were included in the analyses. This was consistent with high relative abundance of putative chemolithoautoroph taxa in the aquifer communities relative to soils. Targeted molecular and culture-based fecal indicator microbial analyses indicated good water quality of aquifers. The dominance of unique, deeply branching lineages in tropical aquifers emphasizes a large adaptive potential in O'ahu's aquifers; variability among groundwater samples suggests that aquifer habitats are surprisingly variable potentially harboring a variety of chemolithotrophic energy sources. Although parallel analyses of conventional and alternative indicators indicated good groundwater quality, this study calls for groundwater monitoring programs which would consider public as well as ecosystem health.	[Kirs, Marek; Dudoit, Tineill; Moravcik, Philip S.] Univ Hawaii Manoa, Water Resources Res Ctr, Honolulu, HI 96822 USA; [Kisand, Veljo] Univ Tartu, Inst Technol, Tartu, Estonia; [Nelson, Craig E.] Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanog Res & Educ, Dept Oceanog, Honolulu, HI 96822 USA; [Nelson, Craig E.] Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanog Res & Educ, UH Sea Grant, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Tartu; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Kirs, M (corresponding author), Univ Hawaii Manoa, Water Resources Res Ctr, Honolulu, HI 96822 USA.	kirs@hawaii.edu	MORAVCIK, PHILIP/AAM-3868-2021; Nelson, Craig E/H-3323-2019; Kisand, Veljo/H-2466-2012	Nelson, Craig E/0000-0003-2525-3496; Kisand, Veljo/0000-0002-5535-1639; Kirs, Marek/0000-0002-7448-8323	National Institute of Water Resources [G16AP00049, 2016HI463B, 2017HI476B]; United States Geological Survey	National Institute of Water Resources; United States Geological Survey(United States Geological Survey)	M.K and C.E.N. and P.S.M Grant: G16AP00049, project numbers 2016HI463B and 2017HI476B by the National Institute of Water Resources and United States Geological Survey. https://water.usgs.gov/wrri/index.php Sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalfitano S, 2014, WATER RES, V65, P384, DOI 10.1016/j.watres.2014.08.004; Anantharaman K, 2016, PEERJ, V4, DOI 10.7717/peerj.1607; Bastian M., 2009, ICWSM, DOI DOI 10.1136/QSHC.2004.010033; BISSON JW, 1979, APPL ENVIRON MICROB, V37, P55, DOI 10.1128/AEM.37.1.55-66.1979; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bomberg M, 2016, BIOGEOSCIENCES, V13, P6031, DOI 10.5194/bg-13-6031-2016; Braun B, 2016, WATER RES, V107, P113, DOI 10.1016/j.watres.2016.10.040; Byappanahalli MN, 2012, MICROBES ENVIRON, V27, P164, DOI 10.1264/jsme2.ME11305; Danielopol DL, 2003, ENVIRON CONSERV, V30, P104, DOI 10.1017/S0376892903000109; Eisenhauer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034517; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; Fredrickson JK, 2006, GEOMICROBIOL J, V23, P345, DOI 10.1080/01490450600875571; Fujioka RS, 2003, P REP TROP WAT QUAL; Gibert J, 2009, FRESHWATER BIOL, V54, P639, DOI 10.1111/j.1365-2427.2009.02202.x; Gingerich SB, 2000, GROUNDWATER HAWAII; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; Goto DK, 2011, MICROBES ENVIRON, V26, P254, DOI 10.1264/jsme2.ME11115; Green HC, 2014, APPL ENVIRON MICROB, V80, P3086, DOI 10.1128/AEM.04137-13; Gregory SP, 2014, Q J ENG GEOL HYDROGE, V47, P145, DOI 10.1144/qjegh2013-059; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Griebler C, 2015, FRESHW SCI, V34, P355, DOI 10.1086/679903; Griebler C, 2014, CURR OPIN BIOTECH, V27, P159, DOI 10.1016/j.copbio.2014.01.018; HARDINA CM, 1991, ENVIRON TOXIC WATER, V6, P185, DOI 10.1002/tox.2530060208; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; He Z, 2019, WATER-SUI, V11, DOI 10.3390/w11040736; Herrmann M, 2017, MICROB ECOL, V74, P264, DOI 10.1007/s00248-017-0950-x; Hershey OS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02823; Hery M, 2014, FEMS MICROBIOL ECOL, V90, P922, DOI 10.1111/1574-6941.12445; Hidalgo KJ, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.135152; Holmes AJ, 2000, FEMS MICROBIOL ECOL, V33, P111, DOI 10.1016/S0168-6496(00)00051-9; Hu AY, 2017, ENVIRON MICROBIOL, V19, P4993, DOI 10.1111/1462-2920.13942; Humbert J.-F., 2005, Aquatic Ecosystem Health & Management, V8, P367, DOI 10.1080/14634980500457773; Illumina, 2018, 16S Metagenomic Sequencing Library Preparation (15044223 B)2018, P1, Patent No. 15044223; Ino K, 2016, ENV MICROBIOL REP, V8, P285, DOI 10.1111/1758-2229.12379; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Ise K, 2017, GEOMICROBIOL J, V34, P489, DOI 10.1080/01490451.2016.1152329; Korbel K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40702; Lavoie KH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169339; Leta OT, 2017, J WATER RES PLAN MAN, V143, DOI [10.1061/(ASCE)WR.1943-5452.0000839, 10.1061/(asce)wr.1943-5452.0000839]; Ma B, 2016, ISME J, V10, P1891, DOI 10.1038/ismej.2015.261; McQuaig SM, 2009, APPL ENVIRON MICROB, V75, P3379, DOI 10.1128/AEM.02302-08; Mehrshad M, 2018, ISME J, V12, P655, DOI 10.1038/s41396-017-0009-5; Pachepsky Y, 2012, LETT APPL MICROBIOL, V54, P217, DOI 10.1111/j.1472-765X.2011.03192.x; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rognes T, 2018, VSEARCH PIPELINE; Roll BM, 1997, WATER SCI TECHNOL, V35, P179, DOI 10.1016/S0273-1223(97)00255-2; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sampat P, 2000, DEEP TROUBLE HIDDEN; Schwab VF, 2017, BIOGEOSCIENCES, V14, P2697, DOI 10.5194/bg-14-2697-2017; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Simoes LC, 2013, RSC ADV, V3, P2520, DOI 10.1039/c2ra22243d; Sirisena KA, 2013, FEMS MICROBIOL ECOL, V86, P490, DOI 10.1111/1574-6941.12176; Somaratne N, 2015, WATER-SUI, V7, P3878, DOI 10.3390/w7073878; Starke R, 2017, J PROTEOMICS, V152, P153, DOI [10.1016/, 10.1016/j.jprot.2016.11.003]; Storlazzi CD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9741; Urbach E, 2001, LIMNOL OCEANOGR, V46, P557, DOI 10.4319/lo.2001.46.3.0557; USEPA, 2001, 1630 USEPA, P1	57	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232265	10.1371/journal.pone.0232265	http://dx.doi.org/10.1371/journal.pone.0232265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353009	gold, Green Published			2022-12-26	WOS:000536673200063
J	Alhayyan, AM; McSorley, ST; Kearns, RJ; Horgan, PG; Roxburgh, CSD; McMillan, DC				Alhayyan, Aliah M.; McSorley, Stephen T.; Kearns, Rachel J.; Horgan, Paul G.; Roxburgh, Campbell S. D.; McMillan, Donald C.			The relationship between anaesthetic technique, clinicopathological characteristics and the magnitude of the postoperative systemic inflammatory response in patients undergoing elective surgery for colon cancer	PLOS ONE			English	Article							COMPLICATIONS FOLLOWING SURGERY; GENERAL-ANESTHESIA; IMPACT; RESECTION; RECOVERY	Background/aim The magnitude of the postoperative systemic inflammatory response (SIR) is now recognised to be associated with both short and long-term outcomes in patients undergoing surgery for colon cancer. During such surgery, it is unclear whether the anaesthetic regimens influence the magnitude of the postoperative SIR, independent of other factors. The aim of the present study was to examine the association between anaesthetic agents, clinicopathological characteristics and the magnitude of the postoperative SIR in patients undergoing elective surgery for colon cancer. Methods Patients with colon cancer who underwent elective open or laparoscopic surgery between 2008 and 2016 (n = 409) were studied at a single center. The relationship between type of anaesthesia, surgical technique; open (n = 241) versus laparoscopic (n = 168) and clinicopathological characteristics was examined by using chi-square testing. The chi-square test was used to determine which anaesthetic group influences the POD 2 CRP for only patients undergoing elective open colon surgery. Results The majority of patients were <75 years old, male, normal weight or obese, underwent open surgery and had regional anaesthesia, in particular an epidural approach. There was a significant association between type of anaesthesia and post-operative CRP on day 2 (p < 0.001) in patients undergoing open surgery but not laparoscopic surgery. Other factors associated with type of anaesthesia included; year of operation (p <0.01), surgical technique (p <0.001), and preoperative dexamethasone (p <0.01). Conclusion In patients undergoing surgery for elective colon cancer, the type of anaesthesia varied over time. The type of anaesthesia appears to influence the magnitude of the postoperative SIR on post-operative day 2 in open surgery but not laparoscopic surgery. Future work using prospective study design is required to better define this relationship.	[Alhayyan, Aliah M.; McSorley, Stephen T.; Kearns, Rachel J.; Horgan, Paul G.; Roxburgh, Campbell S. D.; McMillan, Donald C.] Univ Glasgow, Sch Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [McSorley, Stephen T.] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland; [Kearns, Rachel J.] Univ Glasgow, Sch Med Dent & Nursing, Dept Anaesthet, Glasgow, Lanark, Scotland; [Horgan, Paul G.] Univ Glasgow, Sch Med Dent & Nursing, Inst Canc Sci, Glasgow, Lanark, Scotland; [Roxburgh, Campbell S. D.] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland; [McMillan, Donald C.] Univ Glasgow, Sch Med Dent & Nursing, Dept Surg, Inst Canc Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow	Alhayyan, AM (corresponding author), Univ Glasgow, Sch Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	a.alhayyan.1@research.gla.ac.uk	McSorley, Stephen/AAH-6449-2019	McSorley, Stephen/0000-0002-5459-8445; Kearns, Rachel/0000-0001-6156-6858	Ministry of Health, Riyadh, Kingdom of Saudi Arabia	Ministry of Health, Riyadh, Kingdom of Saudi Arabia	This study has been funded by Ministry of Health, Riyadh, Kingdom of Saudi Arabia.	Alhayyan A, 2020, SURG OPEN SCI, V2, P1, DOI 10.1016/j.sopen.2019.06.001; Borzellino Giuseppe, 2016, Surg Res Pract, V2016, P7543684, DOI 10.1155/2016/7543684; Chen WK, 2015, INT J COLORECTAL DIS, V30, P475, DOI 10.1007/s00384-014-2098-1; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Fitz-Henry J, 2011, ANN ROY COLL SURG, V93, P185, DOI 10.1308/rcsann.2011.93.3.185a; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gasiunaite D., 2012, ACTA MED LITUANICA, V19; Gustafsson UO, 2019, WORLD J SURG, V43, P659, DOI 10.1007/s00268-018-4844-y; McIsaac DI, 2015, BRIT J ANAESTH, V115, P46, DOI 10.1093/bja/aev376; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; McSorley ST, 2019, EJSO-EUR J SURG ONC, V45, P1613, DOI 10.1016/j.ejso.2019.05.020; McSorley ST, 2017, ANN SURG ONCOL, V24, P2104, DOI 10.1245/s10434-017-5817-3; McSorley ST, 2016, CRIT REV ONCOL HEMAT, V101, P139, DOI 10.1016/j.critrevonc.2016.03.011; Papadima A, 2009, J CLIN ANESTH, V21, P414, DOI 10.1016/j.jclinane.2008.10.015; Perry NJS, 2019, JAMA SURG, V154, P279, DOI 10.1001/jamasurg.2018.4619; Popping DM, 2014, ANN SURG, V259, P1056, DOI 10.1097/SLA.0000000000000237; Ramanathan ML, 2015, ANN SURG ONCOL, V22, P938, DOI 10.1245/s10434-014-4065-z; Straatman J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132995; Watt DG, 2017, ANN SURG ONCOL, V24, P2588, DOI 10.1245/s10434-017-5987-z; Watt DG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001286; Watt DG, 2015, SURGERY, V157, P362, DOI 10.1016/j.surg.2014.09.009	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0228580	10.1371/journal.pone.0228580	http://dx.doi.org/10.1371/journal.pone.0228580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348308	Green Published, Green Accepted, gold			2022-12-26	WOS:000536668200005
J	Carry, PM; Duke, VR; Brazell, CJ; Stence, N; Scholes, M; Rousie, DL; Miller, NH				Carry, Patrick M.; Duke, Victoria R.; Brazell, Christopher J.; Stence, Nicholas; Scholes, Melissa; Rousie, Dominique L.; Miller, Nancy Hadley			Lateral semi-circular canal asymmetry in females with idiopathic scoliosis	PLOS ONE			English	Article							ACTIVATED VESTIBULOSPINAL NEURONS; ADOLESCENTS; PATHWAYS; CHILDREN; ORIGIN; BRAIN	Purpose Adolescent idiopathic scoliosis (AIS) is a three-dimensional spinal structural deformity that occurs in otherwise normal individuals. Although curve progression and severity vary amongst individuals, AIS can lead to significant cosmetic and functional deformity. AIS etiology has been determined to be genetic, however, exact genetic and biological processes underlying this disorder remain unknown. Vestibular structure and function have potentially been related to the etiopathogenesis of AIS. Here, we aimed to characterize the anatomy of the semicircular canals (SCC) within the vestibular system through a novel approach utilizing T2-weighted magnetic resonance images (MRI). Methods Three dimensional, MRI-based models of the SCCs were generated from AIS subjects (n = 20) and healthy control subjects (n = 19). Linear mixed models were used to compare SCC morphological measurements in the two groups. We compared side-to-side differences in the SCC measurements between groups (group*side interaction). Results Side-to-side differences in the lateral SCC were different between the two groups [false discovery rate adjusted p-value: 0.0107]. Orientation of right versus left lateral SCC was significantly different in the AIS group compared to the control group [mean side-to-side difference: -4.1 degrees, 95% CI: -6.4 degrees to -1.7 degrees]. Overall, among subjects in the AIS group, the left lateral SCC tended to be oriented in a more horizontal position than subjects in the control group. Significance Asymmetry within the SCCs of the vestibular system of individuals with AIS potentially results in abnormal efferent activity to postural muscles. Consequences of this muscular activity during periods of rapid growth, which often coincides with AIS onset and progression, warrant consideration.	[Carry, Patrick M.; Duke, Victoria R.; Brazell, Christopher J.; Miller, Nancy Hadley] Childrens Hosp Colorado, Musculoskeletal Res Ctr, Dept Orthopaed Surg, Aurora, CO 80045 USA; [Stence, Nicholas] Childrens Hosp Colorado, Dept Radiol, Aurora, CO USA; [Scholes, Melissa] Childrens Hosp Colorado, Dept Otolaryngol, Aurora, CO USA; [Rousie, Dominique L.] Inst France, La Fdn Cotrel, Paris, France	Children's Hospital Colorado; Children's Hospital Colorado; Children's Hospital Colorado	Miller, NH (corresponding author), Childrens Hosp Colorado, Musculoskeletal Res Ctr, Dept Orthopaed Surg, Aurora, CO 80045 USA.	Nancy.Miller@childrenscolorado.org			Research Institute at Children's Hospital Colorado; NIH/NCATS Colorado CTSA Grant [UL1 TR002535]	Research Institute at Children's Hospital Colorado; NIH/NCATS Colorado CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by a pilot grant from the Research Institute at Children's Hospital Colorado. PC, VD, CB, NS, MS, and NHM received this award. There is no grant number. Website: https://www.childrenscolorado.org/researchinnovation.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by NIH/NCATS Colorado CTSA Grant Number UL1 TR002535. PC, VD, CB, NS, MS, and NHM received this award. Website: https://www.cuanschutz.edu/cctsi.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AS, 2003, J PHYSIOL-LONDON, V546, P615, DOI 10.1113/jphysiol.2002.030031; Assaiante C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040646; BARRIOS C, 1992, INT ORTHOP, V16, P146, DOI 10.1007/BF00180206; Benjamini Y, 1999, J STAT PLAN INFER, V82, P163, DOI 10.1016/S0378-3758(99)00040-3; Boselli F, 2013, BIOMECH MODEL MECHAN, V12, P335, DOI 10.1007/s10237-012-0402-y; Bradshaw AP, 2010, JARO-J ASSOC RES OTO, V11, P145, DOI 10.1007/s10162-009-0195-6; Burwell R G, 2003, Pediatr Rehabil, V6, P137; BYL NN, 1993, J ORTHOP RES, V11, P215, DOI 10.1002/jor.1100110209; Catanzariti J. -F., 2014, Annals of Physical and Rehabilitation Medicine, V57, P465, DOI 10.1016/j.rehab.2014.04.003; Cortes-Dominguez I, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9224904; Cox PG, 2007, J MORPHOL, V268, P878, DOI 10.1002/jmor.10559; Crelin ES, 1973, FUNCTIONAL ANATOMY N, P19; Curthoys IS, 2000, CURR OPIN NEUROL, V13, P27, DOI 10.1097/00019052-200002000-00006; DEWAELE C, 1989, EXP BRAIN RES, V77, P166, DOI 10.1007/BF00250579; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fong DYT, 2010, SPINE, V35, P1061, DOI 10.1097/BRS.0b013e3181bcc835; Guo X, 2006, SPINE, V31, pE437, DOI 10.1097/01.brs.0000222048.47010.bf; Hawasli AH, 2015, EUR SPINE J, V24, P227, DOI 10.1007/s00586-014-3701-4; HERMAN R, 1985, SPINE, V10, P1, DOI 10.1097/00007632-198501000-00001; Hitier M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131120; Ifediba MA, 2007, ANN BIOMED ENG, V35, P1247, DOI 10.1007/s10439-007-9277-y; Joshi VM, 2012, RADIOGRAPHICS, V32, P683, DOI 10.1148/rg.323115073; Kitajima N, 2006, NEUROSCI LETT, V406, P1, DOI 10.1016/j.neulet.2006.06.024; Kushiro K, 2008, EXP BRAIN RES, V191, P257, DOI 10.1007/s00221-008-1503-9; Lambert FM, 2013, J NEUROSCI, V33, P6845, DOI 10.1523/JNEUROSCI.4842-12.2013; Lambert FM, 2009, J NEUROSCI, V29, P12477, DOI 10.1523/JNEUROSCI.2583-09.2009; Obrist D., 2011, HABILITATION TREATIS; Park JS, 2010, J KOREAN MED SCI, V25, P135, DOI 10.3346/jkms.2010.25.1.135; PONSETI IV, 1950, J BONE JOINT SURG AM, V32-A, P381, DOI 10.2106/00004623-195032020-00017; Purves D, 2001, NEUROSCIENCE, DOI [10.1523/JNEUROSCI.21-06-02131.2001, DOI 10.1523/JNEUROSCI.21-06-02131.2001]; Rousie D, 1999, ANN NY ACAD SCI, V871, P439, DOI 10.1111/j.1749-6632.1999.tb09213.x; Rousie D, 2009, POSTERIOR BASICRANIU; Rousie DL, 2009, ANN NY ACAD SCI, V1164, P455, DOI 10.1111/j.1749-6632.2009.03857.x; Sato H, 1997, EXP BRAIN RES, V116, P381, DOI 10.1007/PL00005766; Sato H, 1996, EXP BRAIN RES, V112, P197; Shi L, 2011, NEUROIMAGE, V54, pS180, DOI 10.1016/j.neuroimage.2010.04.002; Simoneau M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-102; Sugita A, 2004, EXP BRAIN RES, V156, P478, DOI 10.1007/s00221-003-1805-x; Tokuda J, 2009, INT J MED ROBOT COMP, V5, P423, DOI 10.1002/rcs.274; Vaugoyeau M, 2008, GAIT POSTURE, V27, P294, DOI 10.1016/j.gaitpost.2007.04.003; Vezhnevets V., 2005, P GRAPH, V1, P150, DOI DOI 10.1016/J.AJ0D0.2004.07.036; VIDAL PP, 1993, PROG BRAIN RES, V97, P229; Viel S, 2009, MOTOR CONTROL, V13, P25, DOI 10.1123/mcj.13.1.25; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wiener-Vacher SR, 1998, J PEDIATR-US, V132, P1028, DOI 10.1016/S0022-3476(98)70403-2; Xin SQ, 2011, LECT NOTES COMPUT SC, V6892, P384, DOI 10.1007/978-3-642-23629-7_47; Zeng W, 2010, LECT NOTES COMPUT SC, V6363, P538	47	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232417	10.1371/journal.pone.0232417	http://dx.doi.org/10.1371/journal.pone.0232417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32349123	gold, Green Published			2022-12-26	WOS:000536668200065
J	Han, X; Guo, JL; You, YL; Zhan, JC; Huang, WD				Han, Xue; Guo, Jielong; You, Yilin; Zhan, Jicheng; Huang, Weidong			p-Coumaric acid prevents obesity via activating thermogenesis in brown adipose tissue mediated by mTORC1-RPS6	FASEB JOURNAL			English	Article						brown adipose tissue; mTORC1-RPS6; obesity; p-coumaric acid; thermogenesis	SASA-QUELPAERTENSIS; MAMMALIAN TARGET; LIPID-METABOLISM; FAT; GLUCOSE; MTOR; EXTRACT; WINE	Brown adipose tissue (BAT) has long been recognized as an energy-consuming organ and a possible target for combating metabolism disorder. Although numerous studies have demonstrated the ability of phytochemical phenolic acids to improve obesity by activating BAT, the underlying mechanism or mechanism therein remain obscure. In this study, diet-induced obese mice, genetically obese mice, and C3H10T1/2 cells were used to examine the effects of p-Coumaric acid (CA) on metabolism profiles. The results showed that CA prevented metabolic syndromes in the two mice models through the activation of BAT. This phenomenon was closely linked to the upregulation of uncoupling protein 1 (UCP1) and the accelerated burning of fatty acids and glucose, which consequently enhanced the energy expenditure and thermogenesis. Similar results were also obtained in vitro. Importantly, these effects were mediated by the mammalian target of rapamycin complex 1 (mTORC1)-RPS6 pathway. These findings reveal, to the best of our knowledge for the first time, the close correlation between mTORC1-RPS6 and BAT-mediated thermogenesis, and, in addition, the key role played by mTORC1-RPS6 in mediating phenolic acids-induced activation of BAT, thus preventing obesity.	[Han, Xue; Guo, Jielong; You, Yilin; Zhan, Jicheng; Huang, Weidong] China Agr Univ, Beijing Key Lab Viticulture & Enol, Coll Food Sci & Nutr Engn, Tsinghua East Rd 17, Beijing 100083, Peoples R China	China Agricultural University	You, YL; Zhan, JC; Huang, WD (corresponding author), China Agr Univ, Beijing Key Lab Viticulture & Enol, Coll Food Sci & Nutr Engn, Tsinghua East Rd 17, Beijing 100083, Peoples R China.	yilinyou@cau.edu.cn; zhanjicheng@cau.edu.cn; huanggwd@263.net	Zhan, Jicheng/ABF-8501-2021		National Natural Science Foundation of China [81900777]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81900777	Ambika S., 2013, BIOMEDICINE AGING PA, V3, P253, DOI DOI 10.1016/j.biomag.2013.09.004; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Din MU, 2018, CELL METAB, V28, P207, DOI 10.1016/j.cmet.2018.05.020; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Guo JL, 2019, ISCIENCE, V19, P676, DOI 10.1016/j.isci.2019.08.020; Han X, 2019, J FOOD SCI, V84, P3815, DOI 10.1111/1750-3841.14838; Han X, 2018, FOOD FUNCT, V9, P4366, DOI [10.1039/c8fo00978c, 10.1039/C8FO00978C]; Hanssen MJW, 2016, DIABETES, V65, P1179, DOI 10.2337/db15-1372; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Kang SW, 2013, FOOD CHEM TOXICOL, V59, P380, DOI 10.1016/j.fct.2013.06.033; Kim JH, 2013, BIOSCI BIOTECH BIOCH, V77, P1595, DOI 10.1271/bbb.130167; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Labbe SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37223; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Ma TT, 2019, FOOD FUNCT, V10, P1317, DOI 10.1039/c8fo02322k; Mele L, 2017, ADV NUTR, V8, P694, DOI 10.3945/an.117.015792; Pei KH, 2016, J SCI FOOD AGR, V96, P2952, DOI 10.1002/jsfa.7578; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sun XY, 2020, FOOD RES INT, V127, DOI 10.1016/j.foodres.2019.108704; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; Villarroya F, 2013, DIABETOLOGIA, V56, pS35; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wipperman MF, 2019, AM J PATHOL, V189, P492, DOI 10.1016/j.ajpath.2018.11.013; Xie WD, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/903258; Yoon SA, 2013, BIOCHEM BIOPH RES CO, V432, P553, DOI 10.1016/j.bbrc.2013.02.067; You YL, 2018, J FUNCT FOODS, V41, P62, DOI 10.1016/j.jff.2017.12.025; You YL, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700261; You YL, 2015, FOOD FUNCT, V6, P401, DOI 10.1039/c4fo00719k; Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459RR, 10.1096/fj.201600459rr]; Yuan XX, 2016, SCI BULL, V61, P1498, DOI 10.1007/s11434-016-1051-9; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	39	17	17	6	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7810	7824		10.1096/fj.202000333R	http://dx.doi.org/10.1096/fj.202000333R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350925				2022-12-26	WOS:000553674000001
J	Nejjari, W; Gerritsen, M; van Hout, R; Planken, B				Nejjari, Warda; Gerritsen, Marinel; van Hout, Roeland; Planken, Brigitte			Where does a 'foreign' accent matter? German, Spanish and Singaporean listeners' reactions to Dutch-accented English, and standard British and American English accents	PLOS ONE			English	Article							STUDENTS ATTITUDES; LANGUAGE ATTITUDES; WORLD ENGLISHES; LINGUA-FRANCA; INTELLIGIBILITY; SPEECH; COMPREHENSIBILITY; COMMUNICATION; PERSPECTIVE; LECTURERS	How well L2 English is understood and how L2 English speakers perceive one another within varying communication contexts has been studied relatively rarely, even though most speakers of English in the world are L2 speakers. In this matched-guise experiment (N = 1699) the effects of L1 and L2 English accents and communication context were tested on speech understandability (intelligibility, comprehensibility, interpretability) and speaker evaluations (status, affect, dynamism). German (N = 617), Spanish (N = 540), and Singaporean listeners (N = 542) were asked to evaluate three accents (Dutch-accented English, standard British English, standard American English) in three communication contexts (Lecture, Audio Tour, Job Pitch). The main finding is that the Dutch-accented English accent was understood as well as the two L1 English accents. Furthermore, Dutch-accented English evoked equally positive evaluations to the two L1 English accents in German listeners, and more positive evaluations than the two L1 English accents in Spanish and Singaporean listeners. These results suggest that accent training aimed at achieving an L1 English accent may not always be necessary for (Dutch) English language learners, especially when they are expected to mostly interact with other L2 speakers of English. More generally, our results indicate that L2 English speakers' understanding and their evaluation of L1 and L2 Englishes would not seem to reflect traditional language norms. Instead, they seem to reflect the socio-cultural embedding of a language norm in a Lingua Franca English speech community that does not view accent varieties as a hindrance to successful communication.	[Nejjari, Warda; Gerritsen, Marinel; van Hout, Roeland; Planken, Brigitte] Radboud Univ Nijmegen, Dept Language & Commun, Nijmegen, Netherlands	Radboud University Nijmegen	Nejjari, W (corresponding author), Radboud Univ Nijmegen, Dept Language & Commun, Nijmegen, Netherlands.	w.nejjari@let.ru.nl		Planken, Brigitte/0000-0001-6834-107X				Ahn H, 2014, WORLD ENGLISH, V33, P195, DOI 10.1111/weng.12081; Alexander Richard J, 1999, TEACHING LEARNING EN, P23; [Anonymous], 1999, SINGAPORE ENGLISH NU; Bayyurt Y, 2018, WORLD ENGLISH, V37, P407, DOI 10.1111/weng.12327; Beeker A, 2015, LEVENDE TALEN; Bent T, 2003, J ACOUST SOC AM, V114, P1600, DOI 10.1121/1.1603234; Bernaisch T, 2012, WORLD ENGLISH, V31, P279, DOI 10.1111/j.1467-971X.2012.01753.x; Berns M, 2018, WORLD ENGLISH, V37, P416, DOI 10.1111/weng.12328; Bokhorst-Heng WD, 2009, J MULTILING MULTICUL, V30, P235, DOI 10.1080/01434630802510121; Bolton K, 2018, WORLD ENGLISH, V37, P2, DOI 10.1111/weng.12298; Bolton K, 2012, J MULTILING MULTICUL, V33, P429, DOI 10.1080/01434632.2012.670241; Bouma K, 2016, VOLKSKRANT; British Library, 2019, MON ETHN ENGL; Broeders, 1997, ENGLISH PRONUNCIATIO; Bronkhorst X., 2015, DUB PANEL ENGELS ALS; Burgoon J., 1979, WESTERN J SPEECH COM, V43, P153; BURGOON JK, 1993, HUM COMMUN RES, V20, P67, DOI 10.1111/j.1468-2958.1993.tb00316.x; BURGOON JK, 2001, NEW HDB LANGUAGE SOC, P79; Canagarajah S, 2007, MOD LANG J, V91, P923, DOI 10.1111/j.1540-4781.2007.00678.x; Caraker R., 2016, RES B, V92, P23; Cargile AC, 1998, J APPL COMMUN RES, V26, P338, DOI 10.1080/00909889809365511; Cargile AC, 1997, J LANG SOC PSYCHOL, V16, P434, DOI 10.1177/0261927X970164004; Central Bureau for Statistics Netherlands, 2019, INT HAND CBS STATL; Chiba R., 1995, WORLD ENGLISH, V14, P77, DOI [10.1111/j.1467-971X.1995.tb00341.x, DOI 10.1111/J.1467-971X.1995.TB00341.X]; CORDER SP, 1967, IRAL-INT REV APPL LI, V5, P161, DOI 10.1515/iral.1967.5.1-4.161; Crystal D., 2009, ENGLISH GLOBAL LANGU; Dalton-Puffer C., 1997, WORLD ENGL, V16, P115, DOI [10.1111/1467-971X.00052, DOI 10.1111/1467-971X.00052]; Department of Statistics Singapore, 2018, ED LANG SPOK LIT; Derwing T. M., 1997, STUD SECOND LANG ACQ, V19, P1, DOI [10.1017/S0272263197001010, DOI 10.1017/S0272263197001010]; Edwards A, 2016, ENGLISH NETHERLANDS; EF, 2018, EF ENGL PROF IND EF; Ellis R., 1994, STUDY 2 LANGUAGE ACQ; FAYER JM, 1987, LANG LEARN, V37, P313, DOI 10.1111/j.1467-1770.1987.tb00573.x; Federal Foreign Office Germany, 2019, GERM NETH BIL REL; Firth A, 1997, MOD LANG J, V81, P285, DOI 10.2307/329302; Gass S., 1982, STUDIES 2 LANGUAGE A, V4, P114, DOI DOI 10.1017/S027226310000437X; Gass Susan., 1994, 2 LANGUAGE ACQUISITI; Gerritsen M., 2010, J GLOB MARK, V23, P1; Gerritsen M, 2016, WORLD ENGLISH, V35, P457, DOI 10.1111/weng.12206; Greven K, 2016, SPANJE KRIJGT DIT JA; Grondelaers S, 2016, LINGUA, V172, P62, DOI 10.1016/j.lingua.2015.10.012; He DY, 2011, WORLD ENGLISH, V30, P428, DOI 10.1111/j.1467-971X.2011.01716.x; He DY, 2010, TESOL QUART, V44, P769, DOI 10.5054/tq.2010.235995; He Q, 2007, I C WIREL COMM NETW, P1726, DOI 10.1109/WICOM.2007.434; Hellekjaer G. O., 2010, HERMES J LANGUAGE CO, V45, P11; Hendriks B, 2018, J ENGL ACAD PURP, V34, P28, DOI 10.1016/j.jeap.2018.03.001; Hendriks B, 2017, INT J APPL LINGUIST, V27, P44, DOI 10.1111/ijal.12101; Hendriks B, 2016, DUTCH J APPL LINGUIS, V5, P1, DOI 10.1075/dujal.5.1.01hen; Huygen M, 2017, NRC WEEKEND; Jenkins J, 2006, INT J APPL LINGUIST, V16, P137, DOI 10.1111/j.1473-4192.2006.00111.x; Kachru B., 1992, OTHER TONGUE ENGLISH; Kachru Y, 2008, ESL APPL LING PROF, P1; Kankaanranta A., 2010, J BUS COMMUN, V47, P380, DOI [DOI 10.1177/0021943610377301, 10.1177/0021943610377301]; Lee P, 2016, THE STRAIT TIMES; Lightbown P.M., 1999, LANGUAGES ARE LEARNE; Lindemann S, 2002, LANG SOC, V31, P419, DOI 10.1017/S0047404502020286; Major RC, 2005, LANG LEARN, V55, P37, DOI 10.1111/j.0023-8333.2005.00289.x; MATSUURA H, 1994, EVALUATING LANGUAGE, P52; McDonald C., 2010, ASIAN EFL, V12, P134; McKenzie RM, 2008, INT J APPL LINGUIST, V18, P63, DOI 10.1111/j.1473-4192.2008.00179.x; McKenzie RM, 2008, J MULTILING MULTICUL, V29, P139, DOI 10.2167/jmmd565.0; MUNRO MJ, 1995, LANG LEARN, V45, P73, DOI 10.1111/j.1467-1770.1995.tb00963.x; Munro MJ, 2006, STUD SECOND LANG ACQ, V28, P111, DOI 10.1017/S0272263106060049; Munro MJ, 1995, LANG SPEECH, V38, P289, DOI 10.1177/002383099503800305; Nejjari W, DUTCH LISTENER UNPUB; Nejjari W, 2019, LINGUA, V219, P90, DOI 10.1016/j.lingua.2018.12.001; Nejjari W, 2012, WORLD ENGLISH, V31, P248, DOI 10.1111/j.1467-971X.2012.01754.x; Nelson CL, 2011, ESL APPL LINGUIST, P1; Nickerson C, 2005, ENGL SPECIF PURP, V24, P367, DOI 10.1016/j.esp.2005.02.001; Pantos AJ, 2013, J LANG SOC PSYCHOL, V32, P3, DOI 10.1177/0261927X12463005; de Vries BWFP, 2020, LANG TEACH RES, V24, P714, DOI 10.1177/1362168818819027; Qualtrics, 2019, SURV SOFTW; Richards J., 1974, ERROR ANAL PERSPECTI; Rivers DJ, 2011, WORLD ENGLISH, V30, P375, DOI 10.1111/j.1467-971X.2011.01707.x; Ryan E. B., 1982, J LANG SOC PSYCHOL, V1, P51, DOI DOI 10.1177/0261927X8200100104; RYAN EB, 1980, BRIT J SOC CLIN PSYC, V19, P229, DOI 10.1111/j.2044-8260.1980.tb00348.x; Sasayama S, 2013, J MULTILING MULTICUL, V34, P264, DOI 10.1080/01434632.2013.767341; Seidlhofer B., 2006, ANNU REV APPL LINGUI, V26, P3, DOI [10.1017/S026719050600002X, DOI 10.1017/S026719050600002X]; SELINKER L, 1972, IRAL-INT REV APPL LI, V10, P209, DOI 10.1515/iral.1972.10.1-4.209; Smith L. E., 2006, HDB WORLD ENGLISHES, DOI DOI 10.1002/9780470757598.CH24; The Confederation of Netherlands Industry and Employers (VNO-NCW), 2018, SAM MET SING KANS BR; Trudgill P., 2008, INT ENGLISH GUIDE VA; van Gaal J, 2018, ENGELS MOET VOERTAAL; Van Oostendorp Marc, 2002, STEENKOLEN ENGELS; Verheyen R, 2015, LEVENDE TALEN; Wang Hongyan, 2007, ENGLISH LINGUA FRANC; Wang Hongyan, 2007, P 16 INT C PHON SCI, P1729; Yorkston KM., 1996, AM J SPEECH-LANG PAT, V5, P55, DOI DOI 10.1044/1058-0360.0501.55	88	5	5	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231089	10.1371/journal.pone.0231089	http://dx.doi.org/10.1371/journal.pone.0231089			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8ZG	32348318	Green Published, gold			2022-12-26	WOS:000536668200013
J	Sierra, JC; Piazuelo, MB; Luis, PB; Barry, DP; Allaman, MM; Asim, M; Sebrell, TA; Finley, JL; Rose, KL; Hill, S; Holshouser, SL; Casero, RA; Cleveland, JL; Woster, PM; Schey, KL; Bimczok, D; Schneider, C; Gobert, AP; Wilson, KT				Sierra, Johanna C.; Piazuelo, M. Blanca; Luis, Paula B.; Barry, Daniel P.; Allaman, Margaret M.; Asim, Mohammad; Sebrell, Thomas A.; Finley, Jordan L.; Rose, Kristie L.; Hill, Salisha; Holshouser, Steven L.; Casero, Robert A.; Cleveland, John L.; Woster, Patrick M.; Schey, Kevin L.; Bimczok, Diane; Schneider, Claus; Gobert, Alain P.; Wilson, Keith T.			Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signaling	ONCOGENE			English	Article							BETA-CATENIN; ORNITHINE-DECARBOXYLASE; MACROPHAGE ACTIVATION; NITRIC-OXIDE; CANCER RISK; INFECTION; POLYAMINES; APOPTOSIS; PATHWAY; EGFR	Helicobacter pylori infection is the main risk factor for the development of gastric cancer, the third leading cause of cancer death worldwide. H. pylori colonizes the human gastric mucosa and persists for decades. The inflammatory response is ineffective in clearing the infection, leading to disease progression that may result in gastric adenocarcinoma. We have shown that polyamines are regulators of the host response to H. pylori, and that spermine oxidase (SMOX), which metabolizes the polyamine spermine into spermidine plus H2O2, is associated with increased human gastric cancer risk. We now used a molecular approach to directly address the role of SMOX, and demonstrate that Smox-deficient mice exhibit significant reductions of gastric spermidine levels and H. pylori-induced inflammation. Proteomic analysis revealed that cancer was the most significantly altered functional pathway in Smox(-/-) gastric organoids. Moreover, there was also less DNA damage and beta-catenin activation in H. pylori-infected Smox(-/-) mice or gastric organoids, compared to infected wild-type animals or gastroids. The link between SMOX and beta-catenin activation was confirmed in human gastric organoids that were treated with a novel SMOX inhibitor. These findings indicate that SMOX promotes H. pylori-induced carcinogenesis by causing inflammation, DNA damage, and activation of beta-catenin signaling.	[Sierra, Johanna C.; Piazuelo, M. Blanca; Barry, Daniel P.; Allaman, Margaret M.; Asim, Mohammad; Finley, Jordan L.; Gobert, Alain P.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Sierra, Johanna C.; Piazuelo, M. Blanca; Schneider, Claus; Gobert, Alain P.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Ctr Mucosal Inflammat & Canc, Nashville, TN 37232 USA; [Luis, Paula B.; Schneider, Claus] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Sebrell, Thomas A.; Bimczok, Diane] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Rose, Kristie L.; Hill, Salisha; Schey, Kevin L.] Vanderbilt Univ, Med Ctr, Dept Biochem, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Holshouser, Steven L.; Woster, Patrick M.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Casero, Robert A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Cleveland, John L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Wilson, Keith T.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Montana State University System; Montana State University Bozeman; Vanderbilt University; Medical University of South Carolina; Johns Hopkins University; Johns Hopkins Medicine; H Lee Moffitt Cancer Center & Research Institute; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Mucosal Inflammat & Canc, Nashville, TN 37232 USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Wilson, KT (corresponding author), Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA.	keith.wilson@vumc.org	Allaman, Margaret/GNO-9854-2022; Gobert, Alain P/AHB-1368-2022	Allaman, Margaret M./0000-0002-2803-1365; Finley, Jordan/0000-0002-5600-4292	NIH [R01CA190612, P01CA116087, P01CA028842, R21AI142042, R01AT006896, R03DK107960, R01GM131408, R01CA204345, R01CA235863, R01CA100603, P30DK058404]; Veterans Affairs Merit Review grant [I01BX001453]; Department of Defense [W81XWH-18-1-0301]; Thomas F. Frist Sr. Endowment; Vanderbilt Center for Mucosal Inflammation and Cancer; NCI Comprehensive Cancer Grant [P30CA76292]; Cortner-Couch Endowed Chair for Cancer Research from the University of South Florida; American Heart Association [16POST27250138]; Vanderbilt Ingram Cancer Center support grant [P30CA068485]; Vanderbilt Digestive Disease Research Center; Vanderbilt University Medical Center Digestive Disease Research Center - NIH [P30DK058404]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grant(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); Thomas F. Frist Sr. Endowment; Vanderbilt Center for Mucosal Inflammation and Cancer; NCI Comprehensive Cancer Grant; Cortner-Couch Endowed Chair for Cancer Research from the University of South Florida; American Heart Association(American Heart Association); Vanderbilt Ingram Cancer Center support grant; Vanderbilt Digestive Disease Research Center; Vanderbilt University Medical Center Digestive Disease Research Center - NIH	This work was funded by NIH grants R01CA190612 (K.T.W.), P01CA116087 (K.T.W.), P01CA028842 (K.T.W.), and R21AI142042 (K.T.W.); Veterans Affairs Merit Review grant I01BX001453 (K.T.W.); Department of Defense grant W81XWH-18-1-0301 (K.T.W.); the Thomas F. Frist Sr. Endowment (K.T.W.); and the Vanderbilt Center for Mucosal Inflammation and Cancer (K.T.W.). This work was also supported by NIH grants R01AT006896 (C.S.), R03DK107960 (D.B.), R01GM131408 (D.B.), R01CA204345 (R.A.C. and P.M.W.), R01CA235863 (R.A.C.), and R01CA100603 (J.L.C.). J.L.C. was also supported by the Cortner-Couch Endowed Chair for Cancer Research from the University of South Florida (J.L.C.) and NCI Comprehensive Cancer Grant P30CA76292 to the H. Lee Moffitt Cancer Center and Research Institute. P.B.L. was supported by a postdoctoral fellowship award from the American Heart Association (16POST27250138). Mass spectrometry analyses were supported in part by Core Scholarships from the Vanderbilt University Medical Center Digestive Disease Research Center funded by NIH grant P30DK058404, and the Vanderbilt Ingram Cancer Center support grant P30CA068485. Immunofluorescence confocal imaging was performed in the Vanderbilt Cell Imaging Shared Resource, supported by the Vanderbilt Digestive Disease Research Center and NIH grant P30DK058404.	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chaturvedi R, 2015, ONCOGENE, V34, P3429, DOI 10.1038/onc.2014.273; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2014, GASTROENTEROLOGY, V146, P1739, DOI 10.1053/j.gastro.2014.02.005; Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Clements WM, 2002, CANCER RES, V62, P3503; CORREA P, 1988, CANCER RES, V48, P3554; Ebert MPA, 2002, CARCINOGENESIS, V23, P87, DOI 10.1093/carcin/23.1.87; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gobert AP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01242; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Guo X, 2002, AM J PHYSIOL-CELL PH, V283, pC722, DOI 10.1152/ajpcell.00054.2002; Hardbower DM, 2017, P NATL ACAD SCI USA, V114, pE751, DOI 10.1073/pnas.1614958114; Hardbower DM, 2016, J CLIN INVEST, V126, P3296, DOI 10.1172/JCI83585; Hardbower DM, 2013, GUT MICROBES, V4, P475, DOI 10.4161/gmic.25583; Holshouser S, 2019, MEDCHEMCOMM, V10, P778, DOI 10.1039/c8md00610e; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Jaiswal M, 2001, AM J PHYSIOL-GASTR L, V281, pG626, DOI 10.1152/ajpgi.2001.281.3.G626; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lewis ND, 2011, J IMMUNOL, V186, P3632, DOI 10.4049/jimmunol.1003431; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Mera RM, 2018, GUT, V67, P1239, DOI 10.1136/gutjnl-2016-311685; Morgan DR, 2013, JAMA-J AM MED ASSOC, V309, P578, DOI 10.1001/jama.2013.311; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; PATCHETT SE, 1995, GUT, V37, P13, DOI 10.1136/gut.37.1.13; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Radulescu S, 2013, ONCOGENE, V32, P2048, DOI 10.1038/onc.2012.224; Sebrell TA, 2018, CELL TISSUE RES, V371, P293, DOI 10.1007/s00441-017-2726-5; Sierra JC, 2019, P NATL ACAD SCI USA, V116, P5077, DOI 10.1073/pnas.1814497116; Sierra JC, 2018, GUT, V67, P1247, DOI 10.1136/gutjnl-2016-312888; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vujcic S, 2002, BIOCHEM J, V367, P665, DOI 10.1042/BJ20020720; Wang YL, 2001, CANCER RES, V61, P5370; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Xue JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7156; Yong X, 2016, CANCER LETT, V374, P292, DOI 10.1016/j.canlet.2016.02.032	40	25	25	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4465	4474		10.1038/s41388-020-1304-6	http://dx.doi.org/10.1038/s41388-020-1304-6		APR 2020	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32350444	Green Accepted			2022-12-26	WOS:000529589900001
J	Solomon-Moore, E; Salway, R; Emm-Collison, L; Thompson, JL; Sebire, SJ; Lawlor, DA; Jago, R				Solomon-Moore, Emma; Salway, Ruth; Emm-Collison, Lydia; Thompson, Janice L.; Sebire, Simon J.; Lawlor, Deborah A.; Jago, Russell			Associations of body mass index, physical activity and sedentary time with blood pressure in primary school children from south-west England: A prospective study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; CARDIOMETABOLIC RISK; CHILDHOOD OBESITY; FAT DISTRIBUTION; LIFE; POPULATION; ADIPOSITY; ADULTHOOD; FITNESS	Elevated blood pressure in children is a significant risk factor for the development of cardiovascular disease in adulthood. We examined how children's body mass index (BMI), physical activity and sedentary time at ages 9 and 11 are associated with blood pressure at age 11. Data were from 1283 children from Bristol, UK, who participated in the study aged 11 years, 797 of whom also participated in the study aged 9 years. Child height, weight and blood pressure were measured, and children wore accelerometers for five days, from which moderate-to-vigorous-intensity physical activity and sedentary minutes per day were derived. Multiple imputation of missing data and adjusted linear and logistic regression models were used to examine associations. Child BMI at 11 years was cross-sectionally associated with higher systolic and diastolic blood pressure (mean difference [95% confidence interval]: 0.91 [0.32 to 1.50] mm Hg and 1.08 [0.54 to 1.62] mm Hg, respectively, per standard deviation (SD) of BMI). BMI at age 9 was also positively associated with diastolic blood pressure at age 11 (1.16 mmHg per two years [0.49 to 1.84], per SD of BMI). For girls, sedentary time at age 9 years was associated with increased odds of having high systolic blood pressure at age 11 (odds ratio: 1.08 [1.01 to 1.16], per 10 minutes per day). There was no evidence of associations between sedentary time and blood pressure among boys. Similarly, there was little evidence that physical activity was associated with blood pressure in either cross-sectional or prospective analyses. Effective strategies are needed to prevent excess bodyweight among children in order to reduce cardiovascular disease risk.	[Solomon-Moore, Emma; Salway, Ruth; Emm-Collison, Lydia; Sebire, Simon J.; Jago, Russell] Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol, Avon, England; [Thompson, Janice L.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Lawlor, Deborah A.] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Deborah A.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Solomon-Moore, Emma] Univ Bath, Dept Hlth, Bath, Avon, England	University of Bristol; University of Birmingham; University of Bristol; University of Bristol; University of Bath	Emm-Collison, L (corresponding author), Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol, Avon, England.	Lydia.Emm-Collison@bristol.ac.uk	Jago, Russell/ABD-6271-2021	Jago, Russell/0000-0002-3394-0176; Emm-Collison, Lydia/0000-0002-5493-3223; Lawlor, Debbie A/0000-0002-6793-2262; Salway, Ruth/0000-0002-3242-3951; Thompson, Janice/0000-0002-7312-3226	British Heart Foundation [PG/11/51/28986, SP 14/4/31123]; University of Bristol [MC_UU_00011/6]; UK Medical Research Council [MC_UU_00011/6]; UK National Institute of Health and Research [NF-0616-10102]; MRC [MC_UU_00011/6] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); University of Bristol; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health and Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the British Heart Foundation (ref PG/11/51/28986 and SP 14/4/31123). DAL works in a unit that receives funding from the University of Bristol and UK Medical Research Council (MC_UU_00011/6); she is also a UK National Institute of Health and Research Senior Investigator (NF-0616-10102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Barba G, 2006, NUTR METAB CARDIOVAS, V16, P239, DOI 10.1016/j.numecd.2006.02.005; Bekkers MBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051801; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Berentzen NE, 2016, INT J OBESITY, V40, P58, DOI 10.1038/ijo.2015.196; Boreham C, 2002, INT J SPORTS MED, V23, pS22; Boreham C, 1999, PUBLIC HEALTH, V113, P7, DOI 10.1016/S0033-3506(99)00106-7; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Cesa CC, 2014, PREV MED, V69, P54, DOI 10.1016/j.ypmed.2014.08.014; Chaput JP, 2013, APPL PHYSIOL NUTR ME, V38, P477, DOI 10.1139/apnm-2012-0382; Charakida M, 2012, J AM COLL CARDIOL, V60, P2643, DOI 10.1016/j.jacc.2012.08.1017; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fagard RH, 2006, CLIN EXP PHARMACOL P, V33, P853, DOI 10.1111/j.1440-1681.2006.04453.x; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Falkner B, 2010, PEDIATR NEPHROL, V25, P1219, DOI 10.1007/s00467-009-1200-3; Ferreira de Moraes AC, 2015, INT J CARDIOL, V180, P165, DOI 10.1016/j.ijcard.2014.11.175; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gidding SS, 2006, PEDIATRICS, V118, P2388, DOI 10.1542/peds.2006-1785; Giussani M, 2013, J HYPERTENS, V31, P983, DOI 10.1097/HJH.0b013e32835f17c7; Grundy SM, 1999, CIRCULATION, V100, P988, DOI 10.1161/01.CIR.100.9.988; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Jago R, 2020, INT J OBESITY, V44, P104, DOI 10.1038/s41366-019-0459-0; Jago R, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0492-0; Jago R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-655; Jago R, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-54; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; 이종국, 2011, Clinical Hypertension, V17, P114; KLESGES RC, 1990, J PEDIATR-US, V116, P888, DOI 10.1016/S0022-3476(05)80645-6; Knowles G, 2013, HYPERTENSION, V61, P70, DOI 10.1161/HYPERTENSIONAHA.112.201277; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lazarou C, 2009, J HUM HYPERTENS, V23, P456, DOI 10.1038/jhh.2008.151; Leary SD, 2008, HYPERTENSION, V51, P92, DOI 10.1161/HYPERTENSIONAHA.107.099051; Lurbe E, 1998, AM J HYPERTENS, V11, P418, DOI 10.1016/S0895-7061(97)00493-7; Lurbe E, 2016, J HYPERTENS, V34, P176, DOI 10.1097/HJH.0000000000000790; Macdonald-Wallis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188618; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Mark AE, 2008, MED SCI SPORT EXER, V40, P1007, DOI 10.1249/MSS.0b013e318169032d; National Heart Lung and Blood Institute, 2012, EXP PAN INT GUID CAR; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; NHS Digital, 2019, STAT OBESITY PHYS AC; Oikonen M, 2016, HYPERTENSION, V67, P41, DOI 10.1161/HYPERTENSIONAHA.115.06395; Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Peters H, 2012, J HYPERTENS, V30, P1708, DOI 10.1097/HJH.0b013e3283562a6b; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Torrance B, 2007, VASC HEALTH RISK MAN, V3, P139; Vaisto J, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-55; Vale S, 2015, J PEDIATR-US, V167, P98, DOI 10.1016/j.jpeds.2015.04.031; Veijalainen A, 2016, SCAND J MED SCI SPOR, V26, P943, DOI 10.1111/sms.12523; World Health Organization, 2021, INJ VIOL, DOI DOI 10.1007/978-1-4419-1695-2_447	59	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232333	10.1371/journal.pone.0232333	http://dx.doi.org/10.1371/journal.pone.0232333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348363	Green Published, Green Submitted, gold			2022-12-26	WOS:000536668200055
J	Sundqvist, A; Vasilaki, E; Voytyuk, O; Bai, Y; Morikawa, M; Moustakas, A; Miyazono, K; Heldin, CH; ten Dijke, P; van Dam, H				Sundqvist, Anders; Vasilaki, Eleftheria; Voytyuk, Oleksandr; Bai, Yu; Morikawa, Masato; Moustakas, Aristidis; Miyazono, Kohei; Heldin, Carl-Henrik; ten Dijke, Peter; van Dam, Hans			TGF beta and EGF signaling orchestrates the AP-1-and p63 transcriptional regulation of breast cancer invasiveness	ONCOGENE			English	Article							NETWORK; TARGET; CELLS; FRA-1; CHEMOSENSITIVITY; EVOLUTION; PATHWAYS; PROTEIN; FOS	Activator protein (AP)-1 transcription factors are essential elements of the pro-oncogenic functions of transforming growth factor-beta (TGF beta)-SMAD signaling. Here we show that in multiple HER2+ and/or EGFR+ breast cancer cell lines these AP-1-dependent tumorigenic properties of TGF beta critically rely on epidermal growth factor receptor (EGFR) activation and expression of the Delta N isoform of transcriptional regulator p63. EGFR and Delta Np63 enabled and/or potentiated the activation of a subset of TGF beta-inducible invasion/migration-associated genes, e.g., ITGA2, LAMB3, and WNT7A/B, and enhanced the recruitment of SMAD2/3 to these genes. The TGF beta- and EGF-induced binding of SMAD2/3 and JUNB to these gene loci was accompanied by p63-SMAD2/3 and p63-JUNB complex formation. p63 and EGFR were also found to strongly potentiate TGF beta induction of AP-1 proteins and, in particular, FOS family members. Ectopic overexpression of FOS could counteract the decrease in TGF beta-induced gene activation after p63 depletion. p63 is also involved in the transcriptional regulation of heparin binding (HB)-EGF and EGFR genes, thereby establishing a self-amplification loop that facilitates and empowers the pro-invasive functions of TGF beta. These cooperative pro-oncogenic functions of EGFR, AP-1, p63, and TGF beta were efficiently inhibited by clinically relevant chemical inhibitors. Our findings may, therefore, be of importance for therapy of patients with breast cancers with an activated EGFR-RAS-RAF pathway.	[Sundqvist, Anders; Vasilaki, Eleftheria; Voytyuk, Oleksandr; Bai, Yu; Moustakas, Aristidis; Miyazono, Kohei; Heldin, Carl-Henrik; ten Dijke, Peter] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Morikawa, Masato; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [ten Dijke, Peter; van Dam, Hans] Leiden Univ, Med Ctr, Oncode Inst, Dept Cell & Chem Biol, NL-2300 RC Leiden, Netherlands	Uppsala University; University of Tokyo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sundqvist, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.; van Dam, H (corresponding author), Leiden Univ, Med Ctr, Oncode Inst, Dept Cell & Chem Biol, NL-2300 RC Leiden, Netherlands.	anders.sundqvist@imbim.uu.se; vdam@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Vasilaki, Eleftheria/AAY-6392-2020; Morikawa, Masato/D-1932-2011	Dijke, Peter ten/0000-0002-7234-342X; Morikawa, Masato/0000-0002-6191-7176; van Dam, Hans/0000-0002-8307-4325	Swedish Cancer Foundation [2016/468, 2018/439]; Swedish Research Council [2015-02757]; European Research Council [787472]; Cancer Genomics Centre Netherlands (CGC.NL)	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Genomics Centre Netherlands (CGC.NL)	S We thank our colleagues, in particular Maria Tsioumpekou, for valuable discussion. David Baker and David van IJzendoorn for the Flag-FOS lentiviral vector. The HCC-1954 cells were kindly provided by Otavia L. Caballero and Andrew J.G. Simpson, Ludwig Cancer Research, New York, USA, and the HCC1937 and HCC202 cells by SE Le Devedec, Leiden Academic Center for Drug Research, Leiden, the Netherlands. This work was supported by the Swedish Cancer Foundation (2016/468 to PtD, 2018/439 to KM); Swedish Research Council (2015-02757 to C-HH); European Research Council (787472 to C-HH); and Cancer Genomics Centre Netherlands (CGC.NL to PtD).	Akhurst RJ, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad0416; Ali R, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2016.42; Baan B, 2010, MOL CELL PROTEOMICS, V9, P1982, DOI 10.1074/mcp.M110.000943; Bakiri L, 2015, CELL DEATH DIFFER, V22, P336, DOI 10.1038/cdd.2014.157; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Buckley NE, 2011, CANCER RES, V71, P1933, DOI 10.1158/0008-5472.CAN-10-2717; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chen YL, 2018, CELL MOL LIFE SCI, V75, P965, DOI 10.1007/s00018-017-2666-y; Chow A, 2011, J MAMMARY GLAND BIOL, V16, P81, DOI 10.1007/s10911-011-9206-4; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Dawson PJ, 1996, AM J PATHOL, V148, P313; Derynck R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5183; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Dhillon AS, 2015, ONCOGENE, V34, P4421, DOI 10.1038/onc.2014.374; Durchdewald M, 2009, HISTOL HISTOPATHOL, V24, P14451, DOI 10.14670/HH-24.1451; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Gatti V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112683; Gatti V, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0073-3; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hill CS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022079; Hu LS, 2017, P NATL ACAD SCI USA, V114, pE3964, DOI 10.1073/pnas.1617816114; Huang F, 2018, CANCER RES, V78, P6073, DOI 10.1158/0008-5472.CAN-18-0136; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Lu D, 2012, CANCER RES, V72, P3451, DOI 10.1158/0008-5472.CAN-11-2536; Madrigal P, 2018, TRENDS CELL BIOL, V28, P509, DOI 10.1016/j.tcb.2018.04.009; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moses HL, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021865; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; ROBERTS AB, 1982, NATURE, V295, P417, DOI 10.1038/295417a0; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; SOULE HD, 1990, CANCER RES, V50, P6075; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Subramanian D, 2015, J BIOL CHEM, V290, P18636, DOI 10.1074/jbc.M115.636548; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Sundqvist A, 2018, NUCLEIC ACIDS RES, V46, P1180, DOI 10.1093/nar/gkx1190; Sundqvist A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3066; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; van IJzendoorn DGP, 2017, J BIOL CHEM, V292, P21282, DOI 10.1074/jbc.C117.815845; van Staalduinen J, 2018, ONCOGENE, V37, P6195, DOI 10.1038/s41388-018-0378-x; Vasilaki E, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aag3232; Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Wilson CA, 2005, BREAST CANCER RES, V7, pR1058, DOI 10.1186/bcr1343; Xue Z, 2018, CELL RES, V28, P719, DOI 10.1038/s41422-018-0044-4; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	59	32	33	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4436	4449		10.1038/s41388-020-1299-z	http://dx.doi.org/10.1038/s41388-020-1299-z		APR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32350443	Green Published, hybrid			2022-12-26	WOS:000529589900002
J	Kalous, KS; Wynia-Smith, SL; Summers, SB; Smith, BC				Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Summers, Steven B.; Smith, Brian C.			Human sirtuins are differentially sensitive to inhibition by nitrosating agents and other cysteine oxidants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sirtuin; nicotinamide adenine dinucleotide (NAD); nitric oxide; hydrogen peroxide; S-nitrosylation; glutathionylation; enzyme inactivation; protein acylation; reactive nitrogen species (RNS); redox signaling	NITRIC-OXIDE; POSTTRANSLATIONAL MODIFICATION; OXIDATIVE STRESS; S-NITROSYLATION; DEACETYLASE; MECHANISM; SIRT6; INSIGHTS; INACTIVATION; ACETYLATION	Sirtuins (e.g.human Sirt1?7) catalyze the removal of acyl groups from lysine residues in proteins in an NAD(+)-dependent manner, and loss of sirtuin deacylase activity correlates with the development of aging-related diseases. Although multiple reports suggest that sirtuin activity is regulated by oxidative post-translational modifications of cysteines during inflammation and aging, no systematic comparative study of potential direct sirtuin cysteine oxidative modifications has been performed. Here, using IC(50)andk(inact)/K(I)analyses, we quantified the ability of nitrosothiols (S-nitrosoglutathione andS-nitroso-N-acetyl-d,l-penicillamine), nitric oxide, oxidized GSH, and hydrogen peroxide to post-translationally modify and inhibit the deacylase activity of Sirt1, Sirt2, Sirt3, Sirt5, and Sirt6. The inhibition was correlated with cysteine modification and assessed with chemical-probe and blot-based assays for cysteineS-nitrosation, sulfenylation, and glutathionylation. We show that the primarily nuclear sirtuins Sirt1 and Sirt6, as well as the primarily cytosolic sirtuin Sirt2, are modified and inhibited by cysteineS-nitrosation in response to exposure to both free nitric oxide and nitrosothiols (k(inact)/K-I? 5m(?1)s(?1)), which is the first report of Sirt2 and Sirt6 inhibition byS-nitrosation. Surprisingly, the mitochondrial sirtuins Sirt3 and Sirt5 were resistant to inhibition by cysteine oxidants. Collectively, these results suggest that nitric oxide?derived oxidants may causatively link nuclear and cytosolic sirtuin inhibition to aging-related inflammatory disease development.	[Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Summers, Steven B.; Smith, Brian C.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Smith, BC (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	brismith@mcw.edu	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768	National Institutes of Health [R01 DK119359, F31 DK117588]; American Heart Association [15SDG25830057]; American Diabetes Association [1-18-IBS-068]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association)	This work was supported in part by National Institutes of Health Grants R01 DK119359 (to B. C. S.) and F31 DK117588 (to K. S. K. and B. C. S.), American Heart Association Grant 15SDG25830057 (to B. C. S.), and American Diabetes Association Grant 1-18-IBS-068 (to B. C. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Bearne SL, 1996, J BIOL CHEM, V271, P3052; Bheda P, 2016, ANNU REV BIOCHEM, V85, P405, DOI 10.1146/annurev-biochem-060815-014537; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016; Chen W. C., 2000, FMOC SOLID PHASE PEP; Dikalova AE, 2017, CIRC RES, V121, P564, DOI 10.1161/CIRCRESAHA.117.310933; Du CK, 2019, ANTIOXID REDOX SIGN, V30, P184, DOI 10.1089/ars.2017.7195; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Girotti AW, 1998, J LIPID RES, V39, P1529; Guarente L, 2018, INTRODUCTORY REVIEW ON SIRTUINS IN BIOLOGY, AGING, AND DISEASE, P1, DOI 10.1016/B978-0-12-813499-3.00001-0; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hoth JJ, 2018, J TRAUMA ACUTE CARE, V85, P367, DOI 10.1097/TA.0000000000001951; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu SG, 2015, FREE RADICAL BIO MED, V79, P176, DOI 10.1016/j.freeradbiomed.2014.11.011; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kalous KS, 2016, J BIOL CHEM, V291, P25398, DOI 10.1074/jbc.M116.754655; Keszler A, 2010, FREE RADICAL BIO MED, V48, P55, DOI 10.1016/j.freeradbiomed.2009.10.026; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Kim YM, 2018, BIOCHEM BIOPH RES CO, V501, P73, DOI 10.1016/j.bbrc.2018.04.155; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kozhukh J, 2012, INORG CHEM, V51, P7346, DOI 10.1021/ic3007684; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Lim CH, 2008, CHEM RES TOXICOL, V21, P2134, DOI 10.1021/tx800213b; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Long D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11388-6; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakazawa H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170391; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Obach RS, 2007, DRUG METAB DISPOS, V35, P246, DOI 10.1124/dmd.106.012633; Olp MD, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3513-y; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peralta D, 2015, NAT CHEM BIOL, V11, P156, DOI [10.1038/NCHEMBIO.1720, 10.1038/nchembio.1720]; Perez H, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8561892; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Sen T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6765; Shao D, 2014, J BIOL CHEM, V289, P7293, DOI 10.1074/jbc.M113.520403; Shinozaki S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005375; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; SQUADRITO GL, 1995, CHEM-BIOL INTERACT, V96, P203, DOI 10.1016/0009-2797(94)03591-U; Strelow JM, 2017, SLAS DISCOV, V22, P3, DOI 10.1177/1087057116671509; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tong Z, 2017, ACS CHEM BIOL, V12, P300, DOI 10.1021/acschembio.6b00954; Tong Z, 2016, ACS CHEM BIOL, V11, P742, DOI 10.1021/acschembio.5b01084; Truong T., 2012, CURR PROTOC CHEM BIO, V4, P101; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5776; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251; Zhou YY, 2012, J BIOL CHEM, V287, P28307, DOI 10.1074/jbc.M112.384511	64	10	10	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8524	8536		10.1074/jbc.RA119.011988	http://dx.doi.org/10.1074/jbc.RA119.011988			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371394	hybrid, Green Published			2022-12-26	WOS:000546986500017
J	Dai, Y; Sweeny, EA; Schlanger, S; Ghosh, A; Stuehr, DJ				Dai, Yue; Sweeny, Elizabeth A.; Schlanger, Simon; Ghosh, Arnab; Stuehr, Dennis J.			GAPDH delivers heme to soluble guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); cGMP; mitochondria; chaperone; NO; heme trafficking	SHOCK-PROTEIN 90; NITRIC-OXIDE; CELLULAR HEME; ACTIVATION; INSERTION; TARGET; NO; STABILIZATION; OXIDATION; DOMAIN	Soluble guanylyl cyclase (sGC) is a key component of NO?cGMP signaling in mammals. Although heme must bind in the sGC ?1 subunit (sGC?) for sGC to function, how heme is delivered to sGC? remains unknown. Given that GAPDH displays properties of a heme chaperone for inducible NO synthase, here we investigated whether heme delivery to apo-sGC? involves GAPDH. We utilized an sGC? reporter construct, tetra-Cys sGC?, whose heme insertion can be followed by fluorescence quenching in live cells, assessed how lowering cell GAPDH expression impacts heme delivery, and examined whether expressing WT GAPDH or a GAPDH variant defective in heme binding recovers heme delivery. We also studied interaction between GAPDH and sGC? in cells and their complex formation and potential heme transfer using purified proteins. We found that heme delivery to apo-sGC? correlates with cellular GAPDH expression levels and depends on the ability of GAPDH to bind intracellular heme, that apo-sGC? associates with GAPDH in cells and dissociates when heme binds sGC?, and that the purified GAPDH?heme complex binds to apo-sGC? and transfers its heme to sGC?. On the basis of these results, we propose a model where GAPDH obtains mitochondrial heme and then forms a complex with apo-sGC? to accomplish heme delivery to sGC?. Our findings illuminate a critical step in sGC maturation and uncover an additional mechanism that regulates its activity in health and disease.	[Dai, Yue; Sweeny, Elizabeth A.; Schlanger, Simon; Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA.	stuehrd@ccf.org		Sweeny, Elizabeth/0000-0001-7818-9112; Dai, Yue/0000-0001-9368-7769; Stuehr, Dennis/0000-0002-0960-6848; GHOSH, ARNAB/0000-0002-7498-1994	NHLBI, National Institutes of Health [P01HL081064, P01HL103453, K99HL144921]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants P01HL081064 and P01HL103453 (to D. J. S.), and K99HL144921 (to E. A. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ben Aissa M, 2016, CURR MED CHEM, V23, P2770, DOI 10.2174/0929867323666160812145454; Beuve A, 2019, ELIFE, V8, DOI 10.7554/eLife.52418; Chakravarti R, 2012, J BIOL CHEM, V287, P16179, DOI 10.1074/jbc.M112.342758; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Childers KC, 2019, J BIOL CHEM, V294, P18451, DOI 10.1074/jbc.RA119.011010; Dai Y, 2019, J BIOL CHEM, V294, P12880, DOI 10.1074/jbc.RA119.009016; Dai Y, 2017, J BIOL CHEM, V292, P6753, DOI 10.1074/jbc.M117.777219; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Friebe A, 2020, N-S ARCH PHARMACOL, V393, P287, DOI 10.1007/s00210-019-01779-z; Fritz BG, 2011, BIOCHEMISTRY-US, V50, P5813, DOI 10.1021/bi200794c; Galmozzi A, 2019, NATURE, V576, P138, DOI 10.1038/s41586-019-1774-2; GARDNER LC, 1991, J BIOL CHEM, V266, P22010; Ghosh A, 2017, ANTIOXID REDOX SIGN, V26, P182, DOI 10.1089/ars.2016.6690; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Hanna DA, 2018, J BIOL CHEM, V293, P12378, DOI 10.1074/jbc.RA118.002125; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hoffmann LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023596; Horst BG, 2019, ELIFE, V8, DOI 10.7554/eLife.50634; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kang YL, 2019, NATURE, V574, P206, DOI 10.1038/s41586-019-1584-6; Kim Y M, 1995, Adv Pharmacol, V34, P277; Kollau A, 2018, MOL PHARMACOL, V93, P73, DOI 10.1124/mol.117.109918; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Murad F, 2008, CAN J OPHTHALMOL, V43, P291, DOI 10.3129/i08-044; Pan J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43112; Rahaman MM, 2017, CIRC RES, V121, P137, DOI 10.1161/CIRCRESAHA.117.310705; Sarkar A, 2015, J BIOL CHEM, V290, P21615, DOI 10.1074/jbc.M115.645515; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2013, HANDB EXP PHARMACOL, V218, P279, DOI 10.1007/978-3-642-38664-0_12; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Surmeli NB, 2012, CHEMBIOCHEM, V13, P977, DOI 10.1002/cbic.201100809; Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Zhong FF, 2011, J BIOL INORG CHEM, V16, P1227, DOI 10.1007/s00775-011-0811-x	42	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8145	8154		10.1074/jbc.RA120.013802	http://dx.doi.org/10.1074/jbc.RA120.013802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358060	hybrid, Green Published			2022-12-26	WOS:000542965700003
J	Buch, BT; Halling, JF; Ringholm, S; Gudiksen, A; Kjobsted, R; Olsen, MA; Wojtaszewski, JFP; Pilegaard, H				Buch, Bjorg Thiellesen; Halling, Jens Frey; Ringholm, Stine; Gudiksen, Anders; Kjobsted, Rasmus; Olsen, Mette Algot; Wojtaszewski, Jorgen F. P.; Pilegaard, Henriette			Colchicine treatment impairs skeletal muscle mitochondrial function and insulin sensitivity in an age-specific manner	FASEB JOURNAL			English	Article						ADP sensitivity; aging; autophagy; ROS	OXIDATIVE STRESS; GLUCOSE-UTILIZATION; AUTOPHAGIC FLUX; GENE-EXPRESSION; H2O2 RELEASE; EX-VIVO; EXERCISE; PGC-1-ALPHA; RESISTANCE; DYSFUNCTION	The aim of the study was to investigate the impact of autophagy inhibition on skeletal muscle mitochondrial function and glucose homeostasis in young and aged mice. The transcriptional co-activator PGC-1 alpha regulates muscle oxidative phenotype which has been shown to be linked with basal autophagic capacity. Therefore, young and aged inducible muscle-specific PGC-1 alpha knockout (iMKO) mice and littermate lox/lox controls were used in three separate experiments performed after either saline or colchicine injections on two consecutive days: (1) Euthanization in the basal state obtaining skeletal muscle for mitochondrial respirometry, (2) whole body glucose tolerance test, and (3) in vivo insulin-stimulated 2-deoxyglucose (2-DG) uptake into skeletal muscle. Muscle PGC-1 alpha was not required for maintaining basal autophagy flux, regardless of age. Colchicine-induced inhibition of autophagy was associated with impairments of skeletal muscle mitochondrial function, including reduced ADP sensitivity and altered mitochondrial redox balance in both young and aged mice. Colchicine treatment reduced the glucose tolerance in aged, but not young mice, and similarly in iMKO and lox/lox mice. Colchicine reduced insulin-stimulated 2-DG uptake in soleus muscle in aged mice, independently of PGC-1 alpha, and without affecting insulin-regulated phosphorylation of proximal or distal mediators of insulin signaling. In conclusion, the results indicate that autophagy regulates the mitochondrial ADP sensitivity and redox balance as well as whole body glucose tolerance and skeletal muscle insulin sensitivity in aged mice, with no additional effects of inducible PGC-1 alpha deletion.	[Buch, Bjorg Thiellesen; Halling, Jens Frey; Ringholm, Stine; Gudiksen, Anders; Olsen, Mette Algot; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Kjobsted, Rasmus; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Pilegaard, H (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	hpilegaard@bio.ku.dk	Kjøbsted, Rasmus/AAY-8228-2020; Halling, Jens Frey/H-4700-2015	Kjøbsted, Rasmus/0000-0002-0628-4994; wojtaszewski, jorgen/0000-0001-8185-3408; Halling, Jens Frey/0000-0002-8638-6746	Danish Council for Independent Research [4181-00078]; Augustinus Fonden (Augustinus Foundation); Danish Diabetes Academy	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Augustinus Fonden (Augustinus Foundation); Danish Diabetes Academy	Danish Council for Independent Research, Grant/Award Number: 4181-00078; Augustinus Fonden (Augustinus Foundation); Danish Diabetes Academy	Ahlstrom P, 2017, J MOL ENDOCRINOL, V59, P339, DOI 10.1530/JME-17-0096; Ai H, 2003, AM J PHYSIOL-ENDOC M, V285, pE836, DOI 10.1152/ajpendo.00238.2002; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Cannavino J, 2014, J PHYSIOL-LONDON, V592, P4575, DOI 10.1113/jphysiol.2014.275545; Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001; Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Fazakerley DJ, 2018, J BIOL CHEM, V293, P7315, DOI 10.1074/jbc.RA117.001254; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; GIUGLIANO D, 1981, DIABETES, V30, P1008, DOI 10.2337/diabetes.30.12.1008; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Halling JF, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12698; Halling JF, 2019, AM J PHYSIOL-ENDOC M, V317, pE513, DOI 10.1152/ajpendo.00059.2019; Halling JF, 2017, EXP GERONTOL, V96, P1, DOI 10.1016/j.exger.2017.05.020; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hey-Mogensen M, 2015, J PHYSIOL-LONDON, V593, P3991, DOI 10.1113/JP270204; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Holloway GP, 2018, CELL REP, V22, P2837, DOI 10.1016/j.celrep.2018.02.069; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim YA, 2013, J PHYSIOL BIOCHEM, V69, P697, DOI 10.1007/s13105-013-0246-7; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Larsen S, 2009, DIABETOLOGIA, V52, P1400, DOI 10.1007/s00125-009-1353-4; Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011; Li HG, 2017, EXP CELL RES, V354, P18, DOI 10.1016/j.yexcr.2017.03.023; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Liu XL, 2015, METABOLISM, V64, P658, DOI 10.1016/j.metabol.2015.01.015; Liu Y, 2015, DIABETES, V64, P36, DOI 10.2337/db14-0267; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Ludzki A, 2015, DIABETES, V64, P2769, DOI 10.2337/db14-1838; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Miotto PM, 2018, DIABETES, V67, P2199, DOI 10.2337/db18-0417; Miotto PM, 2016, BIOCHEM J, V473, P2831, DOI 10.1042/BCJ20160373; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222; Perry CGR, 2012, J PHYSIOL-LONDON, V590, P5475, DOI 10.1113/jphysiol.2012.234682; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Rabol R, 2010, J CLIN ENDOCR METAB, V95, P857, DOI 10.1210/jc.2009-1844; Rodney GG, 2016, FREE RADICAL BIO MED, V98, P103, DOI 10.1016/j.freeradbiomed.2016.05.010; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Seiliez I, 2016, AUTOPHAGY, V12, P343, DOI 10.1080/15548627.2015.1117732; SHAH JH, 1978, DIABETES, V27, P925, DOI 10.2337/diabetes.27.9.925; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Smith BK, 2013, J PHYSIOL-LONDON, V591, P6089, DOI 10.1113/jphysiol.2013.259226; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinbusch LKM, 2010, AM J PHYSIOL-CELL PH, V298, pC1549, DOI 10.1152/ajpcell.00334.2009; Su ZD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13114-4; Timmers S, 2016, DIABETES CARE, V39, P2211, DOI 10.2337/dc16-0499; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, pC710, DOI 10.1152/ajpcell.00380.2014; Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x; Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	82	8	8	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8653	8670		10.1096/fj.201903113RR	http://dx.doi.org/10.1096/fj.201903113RR		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32372536				2022-12-26	WOS:000530736400001
J	Roddy, GW; Rinkoski, TA; Monson, KJ; Chowdhury, UR; Fautsch, MP				Roddy, Gavin W.; Rinkoski, Tommy A.; Monson, Kjersten J.; Chowdhury, Uttio Roy; Fautsch, Michael P.			Stanniocalcin-1 (STC-1), a downstream effector molecule in latanoprost signaling, acts independent of the FP receptor for intraocular pressure reduction	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; OUTFLOW FACILITY; GLAUCOMA; EXPRESSION; INHIBITOR; PROSTAGLANDINS; NONRESPONDERS; 0.005-PERCENT; INFLAMMATION; ASSOCIATION	Prostaglandin F2 alpha (PGF2 alpha) analogues such as latanoprost are common first-line intraocular pressure (IOP) lowering medications. However, their clinical use is limited in some patient populations due to minimal or no IOP lowering response or side effects. In searching for a more targeted approach for IOP reduction, our lab recently identified Stanniocalcin-1 (STC-1) as a molecule that was required for latanoprost-mediated IOP reduction and also acted as a stand-alone IOP lowering agent. In order to determine whether latanoprost and STC-1 were equivalent and/or additive for IOP reduction, we treated C57BL/6J mice with one or a combination of these agents and measured IOP. Importance of the FP receptor for latanoprost- and STC-1-mediated IOP reduction was examined in C57BL/6J mice utilizing the pharmacologic FP receptor inhibitor AL-8810 as well as FP receptor knockout mice generated in our laboratory. Latanoprost-free acid (LFA) and STC-1 reduced IOP to a similar degree and were non-additive in C57BL/6J mice. As expected, the IOP lowering effects of LFA were abrogated by pharmacologic inhibition of the FP receptor with AL-8810 and in FP receptor knockout mice. In contrast, STC-1 maintained IOP-lowering effects in the presence of AL-8810 and also in FP receptor knockout mice. These results suggest that LFA and STC-1 show equivalent and non-additive IOP reduction in C57BL/6J mice and that unlike LFA, STC-1-mediated IOP reduction occurs independent of the FP receptor.	[Roddy, Gavin W.; Rinkoski, Tommy A.; Monson, Kjersten J.; Chowdhury, Uttio Roy; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA	Mayo Clinic	Roddy, GW (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	roddy.gavin@mayo.edu			National Eye Institute [EY21727, EY26490]; Mayo Foundation; American Glaucoma Society; American Society of Cataract and Refractive Surgery; Heed Foundation (GWR)	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Mayo Foundation; American Glaucoma Society; American Society of Cataract and Refractive Surgery; Heed Foundation (GWR)	Research reported in this publication was supported by the National Eye Institute grants EY21727 (MPF) and EY26490 (MPF), Mayo Foundation (GWR, MPF), American Glaucoma Society (GWR), American Society of Cataract and Refractive Surgery (GWR), and Heed Foundation (GWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm A, 2014, CLIN OPHTHALMOL, V8, P1967, DOI 10.2147/OPTH.S59162; Bahler CK, 2008, AM J OPHTHALMOL, V145, P114, DOI 10.1016/j.ajo.2007.09.001; Camras CB, 2003, J GLAUCOMA, V12, P466, DOI 10.1097/00061198-200312000-00004; Chakraborty A, 2007, AM J PHYSIOL-RENAL, V292, pF895, DOI 10.1152/ajprenal.00219.2006; Crowston JG, 2004, INVEST OPHTH VIS SCI, V45, P2240, DOI 10.1167/iovs.03-0990; Cui XJ, 2017, J CLIN PHARM THER, V42, P87, DOI 10.1111/jcpt.12468; Dalvin LA, 2020, CURR EYE RES, V45, P46, DOI 10.1080/02713683.2019.1645184; Doucette LP, 2018, INVEST OPHTH VIS SCI, V59, P2548, DOI 10.1167/iovs.17-23223; Doucette LP, 2017, OPHTHALMIC GENET, V38, P108, DOI 10.3109/13816810.2016.1164193; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gerritsen ME, 2005, VITAM HORM, V70, P105, DOI 10.1016/S0083-6729(05)70004-2; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Huang LP, 2014, J AM SOC NEPHROL, V25, P2303, DOI 10.1681/ASN.2013070690; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Ikeda Y, 2006, JPN J OPHTHALMOL, V50, P153, DOI 10.1007/s10384-005-0293-x; Iwasa K, 2014, PROSTAG LEUKOTR ESS, V91, P175, DOI 10.1016/j.plefa.2014.08.004; JOHNSON DH, 1987, INVEST OPHTH VIS SCI, V28, P945; Kanellis J, 2004, AM J PHYSIOL-RENAL, V286, pF356, DOI 10.1152/ajprenal.00138.2003; Kim SH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003563; Kim YT, 2012, NEUROBIOL DIS, V48, P58, DOI 10.1016/j.nbd.2012.06.003; Li QT, 2018, CELL MOL LIFE SCI, V75, P4021, DOI 10.1007/s00018-018-2847-3; Murata S, 1997, PTERIDINES, V8, P1; Nyamandi VZ, 2014, OBESITY, V22, P721, DOI 10.1002/oby.20580; Ohkouchi S, 2012, MOL THER, V20, P417, DOI 10.1038/mt.2011.259; Peng Hoh Boon, 2007, Kobe J Med Sci, V53, P49; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Razeghinejad MR, 2019, OCUL IMMUNOL INFLAMM, V27, P181, DOI 10.1080/09273948.2017.1372485; Roch GJ, 2011, GENOME BIOL EVOL, V3, P284, DOI 10.1093/gbe/evr020; Roddy GW, 2017, INVEST OPHTH VIS SCI, V58, P2715, DOI 10.1167/iovs.16-21004; Roddy GW, 2012, MOL THER, V20, P788, DOI 10.1038/mt.2011.308; Sakurai M, 2007, OPHTHALMOLOGY, V114, P1039, DOI 10.1016/j.ophtha.2007.03.025; Sakurai M, 2014, BRIT J OPHTHALMOL, V98, P469, DOI 10.1136/bjophthalmol-2013-304267; Scherer WJ, 2002, J OCUL PHARMACOL TH, V18, P287, DOI 10.1089/108076802760116205; Sharif NA, 2019, BRIT J PHARMACOL, V176, P1059, DOI 10.1111/bph.14335; Sheikh-Hamad D, 2010, AM J PHYSIOL-RENAL, V298, pF248, DOI 10.1152/ajprenal.00260.2009; Smith SL, 1999, ACTA OPHTHALMOL SCAN, V77, P668, DOI 10.1034/j.1600-0420.1999.770612.x; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Tang SE, 2014, FREE RADICAL BIO MED, V71, P321, DOI 10.1016/j.freeradbiomed.2014.03.034; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tolvanen AD, 2013, NEUROSCIENCE, V229, P49, DOI 10.1016/j.neuroscience.2012.10.062; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; TORIS CB, 1993, OPHTHALMOLOGY, V100, P1297; Ussa F, 2015, OPHTHALMOLOGY, V122, P1040, DOI 10.1016/j.ophtha.2014.12.038; Rodrigues MDV, 2009, J GLAUCOMA, V18, P197, DOI 10.1097/IJG.0b013e31818153f4; Wang YL, 2009, J LEUKOCYTE BIOL, V86, P981, DOI 10.1189/jlb.0708454; Wang YY, 2018, DIABETES, V67, P1748, DOI 10.2337/db17-1521; Warwar RE, 1998, OPHTHALMOLOGY, V105, P263, DOI 10.1016/S0161-6420(98)92977-3; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang YR, 2018, INVEST OPHTH VIS SCI, V59, P3375, DOI 10.1167/iovs.18-24013; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Yoshiko Y, 2004, PEPTIDES, V25, P1663, DOI 10.1016/j.peptides.2004.04.015; Zhang KZ, 2000, P NATL ACAD SCI USA, V97, P3637, DOI 10.1073/pnas.070045897; Zhang P, 2016, CURR EYE RES, V41, P1561, DOI 10.3109/02713683.2016.1143013; ZIAI N, 1993, ARCH OPHTHALMOL-CHIC, V111, P1351, DOI 10.1001/archopht.1993.01090100059027	54	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232591	10.1371/journal.pone.0232591	http://dx.doi.org/10.1371/journal.pone.0232591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365129	gold, Green Published			2022-12-26	WOS:000536959700042
J	Xu, XQ; Wang, RL; Wu, R; Yan, WJ; Shi, TS; Jiang, Q; Shi, DQ				Xu, Xingquan; Wang, Rongliang; Wu, Rui; Yan, Wenjin; Shi, Tianshu; Jiang, Qing; Shi, Dongquan			Trehalose reduces bone loss in experimental biliary cirrhosis rats via ERK phosphorylation regulation by enhancing autophagosome formation	FASEB JOURNAL			English	Article						autophagosomes; ERK phosphorylation; osteoporosis in PBC; osteoclastogenesis; trehalose	CHOLESTATIC LIVER-DISEASE; HEPATIC OSTEODYSTROPHY; OSTEOPOROSIS; DIFFERENTIATION; METABOLISM; ETIDRONATE; OSTEOPENIA; RISK	Bone loss is a severe complication of primary biliary cirrhosis (PBC). Trehalose was intermittently administered in bile duct-ligated (BDL) male rats, a PBC-related osteoporosis model, for 4 weeks to reduce osteoporosis. Femoral bones were assessed ex vivo by micro computed tomography (CT) and histomorphometry. The potential mechanisms related to the reduction of osteoporosis were explored by evaluating the effect of trehalose on osteoblast autophagy, osteogenesis, osteoclastogenesis, and ERK phosphorylation. The results demonstrated that trehalose reduced osteoporosis of BDL rats and decreased osteoblast-mediated osteoclast differentiation by enhancing osteoblast autophagy to regulate osteoprotegerin (OPG) secretion. Hydroxychloroquine (HCQ) increased the expression of OPG and OPG/receptor activator genes for nuclear factor-kappa B ligand (RANKL) ratio, and reduced osteoblast-mediated osteoclastogenesis by inhibiting autophagy flux and inducing autophagosome formation. Furthermore, trehalose increased the phosphorylation of ERK1/2 in MC3T3-E1 cells, and the ERK inhibitor PD98059 reversed the upregulation of OPG gene and reduction of trehalose-induced osteoclastogeneis. The treatment with HCQ markedly increased the ERK phosphorylation. The correlation between autophagosome formation and ERK phosphorylation was confirmed in autophagy proteins (ATG) 4B or ATG5-deficient cells. Thus, trehalose could decrease osteoblast-mediated osteoclastogenesis and reduce PBC-related bone loss by regulating ERK phosphorylation via autophagosome formation.	[Xu, Xingquan; Wang, Rongliang; Wu, Rui; Yan, Wenjin; Shi, Tianshu; Jiang, Qing; Shi, Dongquan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp,Affiliated Hosp,Med Sch, Nanjing, Peoples R China; [Xu, Xingquan; Wang, Rongliang; Wu, Rui; Yan, Wenjin; Shi, Tianshu; Jiang, Qing; Shi, Dongquan] Nanjing Univ, Joint Res Ctr Bone & Joint Dis, Model Anim Res Ctr MARC, Nanjing, Peoples R China	Nanjing University; Nanjing University	Jiang, Q; Shi, DQ (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Sports Med & Adult Reconstruct Surg, Drum Tower Hosp,Sch Med, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	qingj@nju.edu.cn; shidongquan1215@163.com	shi, dongquan/ABH-3078-2021; Shi, Dongquan/ABG-6949-2021; shi, dongquan/AAE-9956-2020	shi, dongquan/0000-0002-4769-7816; 	National Science Foundation of China (NSFC) [81802196, 81572129]; Natural Science Foundation of Jiangsu Province [BK20180127]; Projects of International Cooperation and Exchanges NSFC [81420108021]; Key Program of NSFC [81730067]; Excellent Young Scholars NSFC [81622033]; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Projects of International Cooperation and Exchanges NSFC; Key Program of NSFC(National Natural Science Foundation of China (NSFC)); Excellent Young Scholars NSFC; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation	This study was supported by the National Science Foundation of China (NSFC, 81802196, 81572129), Natural Science Foundation of Jiangsu Province (BK20180127), Projects of International Cooperation and Exchanges NSFC (81420108021), Key Program of NSFC (81730067), Excellent Young Scholars NSFC (81622033), Jiangsu Provincial Key Medical Center Foundation, Jiangsu Provincial Medical Outstanding Talent Foundation, Jiangsu Provincial Medical Youth Talent Foundation, and Jiangsu Provincial Key Medical Talent Foundation.	Ackerman Z, 2002, LIVER, V22, P166, DOI 10.1046/j.0106-9543.2002.01566.x; Arai C, 2001, NUTR RES, V21, P993, DOI 10.1016/S0271-5317(01)00315-3; Belzile JP, 2016, J VIROL, V90, P1259, DOI 10.1128/JVI.02651-15; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Boone RH, 2006, DIGEST DIS SCI, V51, P1103, DOI 10.1007/s10620-006-8015-x; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chen XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19455; Dondorf F, 2017, WORLD J GASTROENTERO, V23, P4191, DOI 10.3748/wjg.v23.i23.4191; Dresner-Pollak R, 2008, GASTROENTEROLOGY, V134, P259, DOI 10.1053/j.gastro.2007.10.025; Endo Y, 2013, J CLIN PERIODONTOL, V40, P33, DOI 10.1111/jcpe.12032; Fan JY, 2017, CLIN RHEUMATOL, V36, P2565, DOI 10.1007/s10067-017-3844-x; Glass LM, 2016, GASTROENTEROL CLIN N, V45, P333, DOI 10.1016/j.gtc.2016.02.009; Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639; GUANABENS N, 1990, AM J GASTROENTEROL, V85, P1356; Guanabens N, 1997, GASTROENTEROLOGY, V113, P219, DOI 10.1016/S0016-5085(97)70098-2; Guanabens N, 2005, J HEPATOL, V42, P573, DOI 10.1016/j.jhep.2004.11.035; Guanabens N, 2010, GASTROENTEROLOGY, V138, P2348, DOI 10.1053/j.gastro.2010.02.016; Guichelaar MMJ, 2002, HEPATOLOGY, V36, P895, DOI 10.1053/jhep.2002.36357; Handzlik-Orlik G, 2016, THER ADV ENDOCRINOL, V7, P128, DOI 10.1177/2042018816641351; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeong YH, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/1927017; Jin HM, 2019, FOOD FUNCT, V10, P6556, DOI 10.1039/c9fo00206e; Levy Cynthia, 2003, Curr Treat Options Gastroenterol, V6, P93, DOI 10.1007/s11938-003-0010-0; Li GC, 2018, J CELL PHYSIOL, V233, P7379, DOI 10.1002/jcp.26574; Liao CY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194418; Lindor KD, 2000, J HEPATOL, V33, P878, DOI 10.1016/S0168-8278(00)80118-X; Liu F, 2013, J BONE MINER RES, V28, P2414, DOI 10.1002/jbmr.1971; Lopez-Larramona G, 2011, WORLD J HEPATOL, V3, P300, DOI 10.4254/wjh.v3.i12.300; Lu ZY, 2017, MOL IMMUNOL, V87, P161, DOI 10.1016/j.molimm.2017.04.013; Luo TW, 2018, TOXICOL IN VITRO, V52, P60, DOI 10.1016/j.tiv.2018.06.001; Luxon Bruce A, 2011, Curr Gastroenterol Rep, V13, P40, DOI 10.1007/s11894-010-0166-4; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mathews S, 2014, J TISSUE ENG REGEN M, V8, P143, DOI 10.1002/term.1507; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Pereira SP, 2004, ALIMENT PHARM THER, V19, P563, DOI 10.1111/j.1365-2036.2004.01890.x; Raszeja-Wyszomirska J, 2014, PRZ GASTROENTEROL, V9, P82, DOI 10.5114/pg.2014.42502; Rudic JS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009146.pub2; Rusmini P, 2019, AUTOPHAGY, V15, P631, DOI 10.1080/15548627.2018.1535292; Sciarretta S, 2018, J AM COLL CARDIOL, V71, P1999, DOI 10.1016/j.jacc.2018.02.066; Selva C, 2013, J PHARM SCI-US, V102, P649, DOI 10.1002/jps.23398; Sergin I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15750; Shen GY, 2018, CELL MOL LIFE SCI, V75, P2683, DOI 10.1007/s00018-018-2776-1; Shen MJ, 2018, CELL PHYSIOL BIOCHEM, V50, P1522, DOI 10.1159/000494651; Shiomi S, 1999, J GASTROENTEROL, V34, P241, DOI 10.1007/s005350050250; Solaymani-Dodaran M, 2006, GASTROENTEROLOGY, V131, P1752, DOI 10.1053/j.gastro.2006.09.012; STELLON AJ, 1987, HEPATOLOGY, V7, P137, DOI 10.1002/hep.1840070127; Weinreb M, 2004, J HEPATOL, V40, P385, DOI 10.1016/j.jhep.2003.11.032; Xu XQ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.73; Yang XX, 2018, BIOCONJUGATE CHEM, V29, P287, DOI 10.1021/acs.bioconjchem.7b00588; Yin YL, 2017, J ALZHEIMERS DIS, V59, P851, DOI 10.3233/JAD-170246; Zhang XC, 2018, INT J NANOMED, V13, P403, DOI 10.2147/IJN.S150875; Zhou ZH, 2020, EXP CELL RES, V388, DOI 10.1016/j.yexcr.2020.111857	54	10	10	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8402	8415		10.1096/fj.201902528RRR	http://dx.doi.org/10.1096/fj.201902528RRR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367591	hybrid			2022-12-26	WOS:000530738300001
J	Chamberlin, T; Thompson, V; Hillers-Ziemer, LE; Walton, BN; Arendt, LM				Chamberlin, Tamara; Thompson, Victoria; Hillers-Ziemer, Lauren E.; Walton, Brenna N.; Arendt, Lisa M.			Obesity reduces mammary epithelial cell TGF beta 1 activity through macrophage-mediated extracellular matrix remodeling	FASEB JOURNAL			English	Article						decorin; macrophages; mammary gland; obesity; transforming growth factor beta	TRANSFORMING-GROWTH-FACTOR; BODY-MASS INDEX; ELEVATED AROMATASE EXPRESSION; HUMAN ADIPOSE-TISSUE; FACTOR-BETA; BREAST-CANCER; STEM-CELLS; TGF-BETA; NEGATIVE REGULATION; RISK	Obesity is a risk factor for breast cancer in postmenopausal and high-risk premenopausal women. Changes within the obese breast microenvironment may increase breast cancer risk. Transforming growth factor beta-1 (TGF beta 1) is a major regulator of mammary epithelial stem/progenitor cells, and its activity is dysregulated under conditions of obesity. Using a high-fat diet model of obesity in mice and breast tissue from women, we observed that TGF beta 1 activity is reduced in breast epithelial cells in obesity. Breast ducts and lobules demonstrated increased decorin in the extracellular matrix (ECM) surrounding epithelial cells, and we observed that decorin and latent TGF beta 1 complexed together. Under conditions of obesity, macrophages expressed higher levels of decorin and were significantly increased in number surrounding breast epithelial cells. To investigate the relationship between macrophages and decorin expression, we treated obese mice with either IgG control or anti-F4/80 antibodies to deplete macrophages. Mice treated with anti-F4/80 antibodies demonstrated reduced decorin surrounding mammary ducts and enhanced TGF beta 1 activity within mammary epithelial cells. Given the role of TGF beta 1 as a tumor suppressor, reduced epithelial TGF beta 1 activity and enhanced TGF beta 1 within the ECM of obese mammary tissue may enhance breast cancer risk.	[Chamberlin, Tamara; Hillers-Ziemer, Lauren E.; Arendt, Lisa M.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Thompson, Victoria; Arendt, Lisa M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr,Rm 4354A, Madison, WI 53706 USA; [Walton, Brenna N.; Arendt, Lisa M.] Univ Wisconsin, Program Mol & Environm Toxicol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Arendt, LM (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr,Rm 4354A, Madison, WI 53706 USA.	lmarendt@wisc.edu			National Cancer Institute (NCI) [R01 CA227542, P30 CA014520]; National Institutes of Health (NIH) [T32 OD010423]; Susan G. Komen (SGK) [CCR1532611]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen (SGK)(Susan G. Komen Breast Cancer Foundation)	National Cancer Institute (NCI), Grant/Award Number: R01 CA227542 and P30 CA014520; National Institutes of Health (NIH), Grant/Award Number: T32 OD010423; Susan G. Komen (SGK), Grant/Award Number: CCR1532611	Afik R, 2016, J EXP MED, V213, P2315, DOI 10.1084/jem.20151193; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; Barcellos-Hoff MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005474; Best J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162286; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Boras-Granic K, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0487-6; Boulanger CA, 2001, ONCOGENE, V20, P2264, DOI 10.1038/sj.onc.1204312; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cecchini RS, 2012, CANCER PREV RES, V5, P583, DOI 10.1158/1940-6207.CAPR-11-0482; Chamberlin T, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0921-7; Costanza B, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010007; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DANIEL CW, 1989, DEV BIOL, V135, P20, DOI 10.1016/0012-1606(89)90154-1; de la Durantaye M, 2014, J ORTHOP RES, V32, P279, DOI 10.1002/jor.22504; Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865; Ewan KB, 2002, AM J PATHOL, V160, P2081, DOI 10.1016/S0002-9440(10)61158-3; Ewan KBR, 2005, AM J PATHOL, V167, P409, DOI 10.1016/S0002-9440(10)62985-9; Fain JN, 2005, METABOLISM, V54, P1546, DOI 10.1016/j.metabol.2005.05.024; Fang Lingling, 2015, J Proteomics Bioinform, V8, P133; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao CL, 2010, INT J MOL MED, V25, P71, DOI 10.3892/ijmm_00000315; Ginestier C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1741; Hida K, 2000, J LIPID RES, V41, P1615; Hillers LE, 2018, NEOPLASIA, V20, P1161, DOI 10.1016/j.neo.2018.09.004; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; KORDON EC, 1995, DEV BIOL, V168, P47, DOI 10.1006/dbio.1995.1060; Lee MJ, 2018, BBA-MOL BASIS DIS, V1864, P1160, DOI 10.1016/j.bbadis.2018.01.025; Lin D, 2016, BIOCHEM PHARMACOL, V119, P8, DOI 10.1016/j.bcp.2016.05.005; Lodyga M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aao3469; Maxwell CA, 2008, CANCER RES, V68, P8304, DOI 10.1158/0008-5472.CAN-08-1212; Miyazono K, 2000, J CELL SCI, V113, P1101; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; O'Brien J, 2010, J MAMMARY GLAND BIOL, V15, P353, DOI 10.1007/s10911-010-9185-x; Oda G, 2012, ONCOL REP, V28, P2003, DOI 10.3892/or.2012.2040; Phipps AI, 2008, CANCER EPIDEM BIOMAR, V17, P2078, DOI 10.1158/1055-9965.EPI-08-0206; Phipps AI, 2012, ANN EPIDEMIOL, V22, P340, DOI 10.1016/j.annepidem.2012.02.002; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Rendra E, 2019, IMMUNOBIOLOGY, V224, P242, DOI 10.1016/j.imbio.2018.11.010; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Seo BR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010467; Shieh Y, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1129-9; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Van Bockstal M, 2013, HISTOPATHOLOGY, V63, P520, DOI 10.1111/his.12188; Van Keymeulen A, 2017, CELL REP, V20, P1525, DOI 10.1016/j.celrep.2017.07.066; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; van't Land B, 2002, BRIT J CANCER, V87, P113, DOI 10.1038/sj.bjc.6600342; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Walker RA, 2007, J PATHOL, V211, P232, DOI 10.1002/path.2079; Wang CH, 2017, CELL REP, V18, P2825, DOI 10.1016/j.celrep.2017.02.071; Wang YY, 2017, J AM SOC NEPHROL, V28, P2053, DOI 10.1681/ASN.2016050573; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zarzynska JM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/141747; Zhang W, 2018, ONCOTARGET, V9, P5480, DOI 10.18632/oncotarget.23869; Zhang Y, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022145; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021	71	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8611	8624		10.1096/fj.202000228RR	http://dx.doi.org/10.1096/fj.202000228RR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359100	Green Published, hybrid			2022-12-26	WOS:000530047400001
J	Chen, XF; Liu, WL; Huang, XY; Fu, HH; Wang, QX; Wang, YF; Cao, JG				Chen, Xuefei; Liu, Wenli; Huang, Xianyan; Fu, Huanhuan; Wang, Quanxi; Wang, Youfang; Cao, Jianguo			Arg-type dihydroflavonol 4-reductase genes from the fern Dryopteris erythrosora play important roles in the biosynthesis of anthocyanins	PLOS ONE			English	Article							EXPRESSION ANALYSIS; FLAVONOID CONTENTS; IDENTIFICATION; ANTIOXIDANT; TISSUES	Dihydroflavonol 4-reductase (DFR), a key enzyme involved in the biosynthesis of anthocyanins, has been cloned from various species. However, little research has been conducted on this enzyme in ferns, which occupy a unique evolutionary position. In this study, we isolated two novel DFR genes from the fern Dryopteris erythrosora. In vitro enzymatic analysis revealed that DeDFR1 and DeDFR2 enzymes can catalyze dihydrokaempferol and dihydroquercetin but cannot catalyze dihydromyricetin. Amino acid sequence analysis showed that DeDFR1 and DeDFR2 have an arginine at the same substrate-specificity-determining site as that in the ferns Salvinia cucullata and Azolla filiculoides. Thus, we speculate that the Arg-type DFR is a new DFR functional type. To further verify the substrate preferences of the Arg-type DFR, an amino acid substitution assay was conducted. When N133 was mutated to R133, Arabidopsis DFR protein completely lost its catalytic activity for dihydromyricetin, as observed for DeDFR1 and DeDFR2. Additionally, heterologous expression of DeDFR2 in the Arabidopsis tt3-1 mutant resulted in increasing anthocyanin accumulation. In summary, DeDFR1 and DeDFR2 are considered to be a new type of DFR with unique structures and functions. The discovery of the Arg-type DFR provides new insights into the anthocyanin biosynthesis pathway in ferns.	[Chen, Xuefei; Wang, Youfang] East China Normal Univ, Coll Life Sci, Shanghai, Peoples R China; [Chen, Xuefei; Liu, Wenli; Huang, Xianyan; Fu, Huanhuan; Wang, Quanxi; Cao, Jianguo] Shanghai Normal Univ, Coll Life Sci, Shanghai, Peoples R China; [Wang, Quanxi] Shanghai Chenshan Bot Garden, Shanghai Key Lab Plant Funct Genom & Resource, Shanghai, Peoples R China	East China Normal University; Shanghai Normal University; Chinese Academy of Sciences	Wang, YF (corresponding author), East China Normal Univ, Coll Life Sci, Shanghai, Peoples R China.; Cao, JG (corresponding author), Shanghai Normal Univ, Coll Life Sci, Shanghai, Peoples R China.	yfwang@bio.ecnu.cn; cao101@shnu.edu.cn			Natural Science Foundation of Shanghai [13ZR1429700]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This research was supported by the Natural Science Foundation of Shanghai (13ZR1429700 to J.C.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 2014, GENE, V550, P46, DOI 10.1016/j.gene.2014.08.013; Bowerman Peter A, 2012, BMC Res Notes, V5, P485, DOI 10.1186/1756-0500-5-485; Campanella JJ, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-10; Cao JG, 2013, FOOD CHEM TOXICOL, V51, P242, DOI 10.1016/j.fct.2012.09.039; Cheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072017; Chu YX, 2015, GENET MOL RES, V14, P5010, DOI 10.4238/2015.May.12.4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng YX, 2018, MOLECULES, V23, DOI 10.3390/molecules23061467; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; HARBORNE JB, 1965, NATURE, V207, P984, DOI 10.1038/207984a0; Haselmair-Gosch C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00149; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HUITS HSM, 1994, PLANT J, V6, P295, DOI 10.1046/j.1365-313X.1994.06030295.x; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; Katsu K, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1200-6; Kim S, 2005, THEOR APPL GENET, V110, P588, DOI 10.1007/s00122-004-1882-7; Kim SJ, 2007, J AGR FOOD CHEM, V55, P6314, DOI 10.1021/jf0704716; Li FW, 2018, NAT PLANTS, V4, P460, DOI 10.1038/s41477-018-0188-8; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046070; Li SS, 2015, CELL MOL BIOL, V61, P25; Li YQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00428; Lightbourn GJ, 2008, J HERED, V99, P105, DOI 10.1093/jhered/esm108; Luo P, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01257; Miosic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112707; Nguyen P, 2009, PLANT PHYSIOL BIOCH, V47, P934, DOI 10.1016/j.plaphy.2009.06.006; OREILLY C, 1985, EMBO J, V4, P877, DOI 10.1002/j.1460-2075.1985.tb03713.x; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; Shi Ming-Zhu, 2014, Recent Pat Biotechnol, V8, P47, DOI 10.2174/1872208307666131218123538; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Silva S, 2017, CRIT REV FOOD SCI, V57, P3072, DOI 10.1080/10408398.2015.1087963; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Sun LL, 2014, CELL MOL BIOL, V60, P1; Tian J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12228; Valenti L, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/145421; Wallace TC, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010032; Wang HX, 2013, MICRO NANO LETT, V8, P11, DOI 10.1049/mnl.2012.0776; Wang L, 2016, MOLECULES, V21, DOI 10.3390/molecules21020032; Wang ZQ, 2018, J PROTEOMICS, V184, P39, DOI 10.1016/j.jprot.2018.06.006; Watanabe K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10715-1; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Xie YH, 2015, FOOD CHEM, V186, P113, DOI 10.1016/j.foodchem.2014.05.024; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang M, 2012, IRAN J PHARM RES, V11, P991; Zhang XX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0200174	49	8	10	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232090	10.1371/journal.pone.0232090	http://dx.doi.org/10.1371/journal.pone.0232090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357153	Green Published, gold			2022-12-26	WOS:000536957700014
J	Diriba, DC; Bekuma, TT; Bobo, FT				Diriba, Dereje Chala; Bekuma, Tariku Tesfaye; Bobo, Firew Tekle			Predictors of self-management practices among diabetic patients attending hospitals in western Oromia, Ethiopia	PLOS ONE			English	Article							CARE; ADHERENCE	Background Diabetes Mellitus recognized as one of the emerging public health problems in developing countries. Self-monitoring needs to be individualized and should assist people with diabetes. This study aimed to assess the predictors of self-management practices among diabetic patients attending hospitals in western Oromia, Ethiopia. Methods A facility-based cross-sectional study was conducted from November 2017 to February 2018 in hospitals located in western Oromia, Ethiopia. An interview was made with a total of 400 diabetic patients attending the diabetes center and admitted to ward in the study hospitals. The data were entered into Epi Info software version 3.5.4. Data analysis was made using a statistical package for the social sciences (SPSS) version 20. Odds ratio (OR) was used to show the association. The statistical significance was considered at P<0.05, and potential confounding variables were controlled using logistic regression. The analyzed data were presented in texts and tables. Results From a total of 398 interviewed patients, 129 (32.4%) practiced diabetes self-management. About 63.6% of the study participants' self-management practice was good. Most 103 (79.84%) of those who practiced self-management were presented with one of diabetes mellitus-related complications. Logistic regression analysis results showed that merchants were about six times higher in self-management practice [AOR of 5.945 (1.177-30.027 at 95% CI)] and those having family support in diabetes practiced self-management 2.87 times than others [AOR of 2.835 (1.386-5.801 at 95% CI)]. Conclusions Compared to the findings of previous studies, diabetes self-management practices of the participants was good. The study participants regular physical activity, food intake, medication adherence, and foot self-examination were moderate. Two variables, being a merchant and having family support were found to be the predictors of self-management practices. Predictors of self-management should be considered to boost self-management practice.	[Diriba, Dereje Chala] Wollega Univ, Dept Nursing, Nekemte, Oromia, Ethiopia; [Diriba, Dereje Chala] Hong Kong Polytech Univ, Sch Nursing, Kowloon, Hong Kong, Peoples R China; [Bekuma, Tariku Tesfaye; Bobo, Firew Tekle] Wollega Univ, Dept Publ Hlth, Nekemte, Oromia, Ethiopia; [Bobo, Firew Tekle] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia	Hong Kong Polytechnic University; University of Technology Sydney	Diriba, DC (corresponding author), Wollega Univ, Dept Nursing, Nekemte, Oromia, Ethiopia.; Diriba, DC (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Kowloon, Hong Kong, Peoples R China.	dereje-chala.diriba@connect.polyu.hk	Bobo, Firew/GSO-0416-2022	Bobo, Firew/0000-0003-2226-0797; Bobo, Firew Tekle/0000-0002-0960-1000	Wollega University [WU: 109,161/Research1-26]	Wollega University	Authors DCD TTB, and FTB received funding from Wollega University (https://www.wollegauniversity.edu.et/). Grant Number: WU: 109,161/Research1-26. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-97; American Diabetes Association, 2018, Clin Diabetes, V36, P14, DOI 10.2337/cd17-0119; American Diabetes Association, 2008, NUTR REC INT DIAB PO; [Anonymous], 2011, NAT DIAB FACT SHEET, V201, P2568; [Anonymous], 2014, WORLD J MED MED SCI, DOI DOI 10.21203/RS.3.RS-104748/V1; Ayele K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035515; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Berhe KK, 2013, GREEN J MED SCI, V3, P211, DOI DOI 10.15580/GJMS.2013.6.071813739; Bonger Z, 2018, PATIENT PREFER ADHER, V12, P963, DOI 10.2147/PPA.S156043; Borhaninejad V, 2017, DIABETES METAB SYND, V11, P163, DOI 10.1016/j.dsx.2016.08.017; Braunwald E., 2001, HARRISONS PRINCIPLES; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Coleman MT, 2005, AM FAM PHYSICIAN, V72, P1503; Feleke Yeweyenhareg, 2007, Ethiop Med J, V45, P275; Formosa C, 2016, J AM PODIAT MED ASSN, V106, P352, DOI 10.7547/15-071; Glasgow RE, 1998, ISSUES DIABETES SELF; Glasgow Russell E, 2003, Jt Comm J Qual Saf, V29, P563; Gunggu A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9158943; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Kaehaban S, 2010, J HEALTH RES, V24, P21; Kassahun T, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0114-x; Lin C, 2007, J CLIN NURS, V9, P1; Mariye Teklewoini, 2018, BMC Res Notes, V11, P380, DOI 10.1186/s13104-018-3489-0; Mayfield JA, 2004, DIABETES CARE, V27, pB39, DOI 10.2337/diacare.27.suppl_2.B39; Morgan CL, 2000, DIABETIC MED, V17, P146, DOI 10.1046/j.1464-5491.2000.00222.x; ORME CM, 1989, HEALTH PSYCHOL, V8, P27, DOI 10.1037/0278-6133.8.1.27; Paz-Pacheco E, 2017, PRIM HEALTH CARE RES, V18, P35, DOI 10.1017/S1463423616000335; RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640; Song Y, 2017, DIABETES EDUCATOR, V43, P396, DOI 10.1177/0145721717712457; Stephani V, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6050-0; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Tewahido D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169062; Thinyane K, 2013, CHARACTERISTICS PATI, V21; World Bank, 2020, ETH OV; World Health Organization, 2016, GLOBAL BURDEN DIABET; World Health Organization, 2018, HLTH DIET WHO; World Health Organization, 2002, DIAB REP; Yeweyenhareg Feleke, 2005, Ethiopian Journal of Health Development, V19, P203	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232524	10.1371/journal.pone.0232524	http://dx.doi.org/10.1371/journal.pone.0232524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3FY	32357177	Green Published, gold			2022-12-26	WOS:000536957700035
J	He, JM; Ge, QW; Lin, ZH; Shen, WY; Lin, RB; Wu, JG; Wang, BY; Lu, YK; Chen, LY; Liu, XS; Zheng, WF; Zhang, Y; Wang, L; Wang, K; Wang, LJ; Zhuo, W; Chen, SJ				He, Jiamin; Ge, Qiwei; Lin, Zhenghua; Shen, Weiyi; Lin, Renbin; Wu, Jiaguo; Wang, Boya; Lu, Yunkun; Chen, Luyi; Liu, Xiaosun; Zheng, Wenfang; Zhang, Ying; Wang, Lan; Wang, Kan; Wang, Liangjing; Zhuo, Wei; Chen, Shujie			MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression	FASEB JOURNAL			English	Article						cell cycle; cyclin D1; gastric cancer; HOXC10; miR-129-5p	UP-REGULATION; HOX GENES; PROLIFERATION; EXPRESSION; ANGIOGENESIS; APOPTOSIS; AUTOPHAGY; SURVIVAL; INVASION	MicroRNAs (miRNAs) play important roles in posttranscriptional regulation and may serve as targets for the diagnosis and treatment of cancers. Nevertheless, a comprehensive understanding of miRNAs profiles in gastric cancer progression is still lacking. Here, we report that miR-129-5p is downregulated in gastric cancer by analyzing TCGA database (n = 41) and clinical tumor samples (n = 60). MiR-129-5p transfection suppressed gastric cancer cell proliferation through inducing G1 phase arrest in vitro and inhibit xenograft tumor growth in vivo. MiR-129-5p directly targeted the 3 ' untranslated regions (3 ' UTR) of HOXC10 mRNA and downregulated its expression. Importantly, miR-129-5p could reverse the oncogenic effect induced by HOXC10. We systemically screened the downstream target of HOXC10 by ChIP sequencing, and found that HOXC10 could transcriptionally regulate the expression of Cyclin D1 and facilitate G1/S cell cycle transition. Notably, high levels of HOXC10 and Cyclin D1 were related with poor prognosis of gastric cancer patients (n = 90). These findings reveal a novel role of miR-129-5p/HOXC10/Cyclin D1 axis in modulating cell cycle and gastric tumorigenesis, which might provide potential prognostic biomarkers and therapeutic targets for gastric cancer patients.	[He, Jiamin; Shen, Weiyi; Lin, Renbin; Wu, Jiaguo; Chen, Luyi; Zheng, Wenfang; Zhang, Ying; Wang, Lan; Wang, Kan; Chen, Shujie] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China; [He, Jiamin; Ge, Qiwei; Lin, Zhenghua; Shen, Weiyi; Lin, Renbin; Wu, Jiaguo; Wang, Boya; Chen, Luyi; Zheng, Wenfang; Zhang, Ying; Wang, Lan; Wang, Kan; Wang, Liangjing; Zhuo, Wei; Chen, Shujie] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Peoples R China; [Ge, Qiwei; Lin, Zhenghua; Wang, Liangjing] Zhejiang Univ, Dept Gastroenterol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Wang, Boya] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Pharm, Sch Med, Hangzhou, Peoples R China; [Lu, Yunkun; Zhuo, Wei] Zhejiang Univ, Dept Cell Biol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Xiaosun] Zhejiang Univ, Affiliated Hosp 1, Dept Surg, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Chen, SJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China.; Wang, LJ (corresponding author), Zhejiang Univ, Dept Gastroenterol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China.; Zhuo, W (corresponding author), Zhejiang Univ, Dept Cell Biol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	wangljzju@zju.edu.cn; 0012049@zju.edu.cn; chenshujie77@zju.edu.cn		Lu, Yunkun/0000-0001-7605-1259; Zhuo, Wei/0000-0002-8251-4210	National Natural Science Foundation of China [31771540, 81802348, 81972276]; Natural Science Foundation of Zhejiang Province [LY18H160011, LYY19H310011]; Fundamental Research Funds for the Central Universities [2017QNA7005]; Zhejiang Provincial Medical and Health Science and Technology Project [2018KY464, 2018KY474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Medical and Health Science and Technology Project	National Natural Science Foundation of China, Grant/Award Number: 31771540, 81802348 and 81972276; Natural Science Foundation of Zhejiang Province, Grant/Award Number: LY18H160011 and LYY19H310011; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2017QNA7005; Zhejiang Provincial Medical and Health Science and Technology Project, Grant/Award Number: 2018KY464 and 2018KY474	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao JY, 2018, INT UROL NEPHROL, V50, P1811, DOI 10.1007/s11255-018-1959-x; Chen D, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00502; Chou WC, 2009, LEUKEMIA, V23, P1303, DOI 10.1038/leu.2009.25; Duarte HO, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12523; Dubova EA, 2009, B EXP BIOL MED+, V148, P908, DOI 10.1007/s10517-010-0849-8; Feng XY, 2015, MOL BIOSYST, V11, P2946, DOI 10.1039/c5mb00253b; Geng ZH, 2016, AM J TRANSL RES, V8, P1886; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Li BW, 2017, CANCER LETT, V410, P212, DOI 10.1016/j.canlet.2017.09.035; Liu Q, 2018, BIOMED PHARMACOTHER, V105, P420, DOI 10.1016/j.biopha.2018.05.105; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Ma Z, 2017, BIOCHEM BIOPH RES CO, V490, P309, DOI 10.1016/j.bbrc.2017.06.041; Morgan R, 2016, CURR MOL MED, V16, P322, DOI 10.2174/1566524016666160316145715; Ru Y, 2017, ONCOTARGET, V8, P73860, DOI 10.18632/oncotarget.18008; Sadik H, 2016, CANCER RES, V76, P4443, DOI 10.1158/0008-5472.CAN-16-0774; Seiler R, 2014, MODERN PATHOL, V27, P87, DOI 10.1038/modpathol.2013.125; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Tan ZY, 2018, THERANOSTICS, V8, P5143, DOI 10.7150/thno.27310; Wang QX, 2015, CELL PHYSIOL BIOCHEM, V35, P933, DOI 10.1159/000369750; Wang Q, 2018, BIOCHEM CELL BIOL, V96, P19, DOI 10.1139/bcb-2016-0254; Wang YF, 2018, CANCER BIOL THER, V19, P1162, DOI 10.1080/15384047.2018.1491497; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xie XK, 2018, ONCOTARGETS THER, V11, P473, DOI 10.2147/OTT.S143440; Yan L, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317706916; Yao S, 2018, BIOCHEM BIOPH RES CO, V501, P628, DOI 10.1016/j.bbrc.2018.05.019; You BR, 2017, MOL CARCINOGEN, V56, P2566, DOI 10.1002/mc.22701; Yu XC, 2013, GENE, V532, P87, DOI 10.1016/j.gene.2013.09.048; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Zheng B, 2012, ONCOGENE, V31, P4509, DOI 10.1038/onc.2011.581	34	16	17	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8544	8557		10.1096/fj.201903217R	http://dx.doi.org/10.1096/fj.201903217R		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32356314				2022-12-26	WOS:000530045700001
J	Li, C; Chen, L; Huo, N; Mishuk, AU; Hansen, RA; Harris, I; Kiptanui, Z; Wang, Z; Qian, JJ				Li, Chao; Chen, Li; Huo, Nan; Mishuk, Ahmed Ullah; Hansen, Richard A.; Harris, Ilene; Kiptanui, Zippora; Wang, Zhong; Qian, Jingjing			Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; BRAND-NAME; ANTIDEPRESSANT TREATMENT; COMPETING RISKS; INHIBITORS; EFFICACY; ANXIETY; DRUGS	Objectives To examine patterns of generic escitalopram initiation and substitution among Medicare beneficiaries. Methods This retrospective new user cohort used a 5% random sample of 2013-2015 Medicare administrative claims data. Fee-for-service Medicare beneficiaries continuously enrolled in Parts A, B, and D during a 6-month washout period prior to their initial generic or brand oral escitalopram prescriptions were included (n = 12,351). The primary outcomes were generic escitalopram treatment initiation, and among brand escitalopram initiators, generic substitution within 12 months. Patient demographics, health service utilization, and prescription level factors were measured and assessed. Results Among all escitalopram initiators, about 88.2% Medicare beneficiaries initiated generic escitalopram. Beneficiaries who were younger age, male, residing in non-Northeast regions or urban area, in the Part D plan deductible benefit phase, and filling prescriptions at community/retail pharmacies were more likely to initiate generic treatment. Among brand escitalopram initiators (n = 1,464), about 20.7% switched to generic escitalopram, 31.2% switched to another alternative antidepressant, 25.1% discontinued treatment, and 8.7% were lost to follow up or passed away within 12 months after brand initiation. Factors associated with generic escitalopram substitution included region (Midwest vs. Northeast, adjusted hazard ratio (HR) = 1.46, 95% CI = 1.04-2.05), pre-index hospitalization (HR = 1.31; 95% CI = 1.16-1.48) and lower escitalopram average daily dosage (HR = 0.97; 95% CI = 0.95-0.99). Conclusions In 2013-2015, almost 90% Medicare beneficiaries initiated generic escitalopram treatment. Among brand escitalopram initiators, about 1 in 5 patients switched to generic escitalopram within 1 year, as compared to 1 in 4 or 1 in 3 who discontinued current or switched to alternative treatment, respectively. Medicare beneficiary's geographic region was independently associated with generic escitalopram initiation and substitution. Findings from this study not only provide up-to-date evidence in generic escitalopram use patterns among Medicare population, but also can guide educational and practice interventions to further increase generic escitalopram use.	[Li, Chao; Mishuk, Ahmed Ullah; Hansen, Richard A.; Qian, Jingjing] Auburn Univ, Harrison Sch Pharm, Auburn, AL USA; [Chen, Li] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Huo, Nan] Mayo Clin, Rochester, MN USA; [Harris, Ilene; Kiptanui, Zippora] IMPAQ Int LLC, Columbia, MD USA; [Wang, Zhong] US FDA, Ctr Drug Evaluat & Res, Off Res & Stand, Off Gener Drugs, Silver Spring, MD USA	Auburn University System; Auburn University; Indiana University System; Indiana University Bloomington; Mayo Clinic; American Institutes for Research; US Food & Drug Administration (FDA)	Qian, JJ (corresponding author), Auburn Univ, Harrison Sch Pharm, Auburn, AL USA.	jzq0004@auburn.edu	Mishuk, Ahmed Ullah/GUF-6551-2022; Huo, Nan/AAO-3467-2021; Huo, Nan/AAD-9300-2022	Huo, Nan/0000-0002-4980-2421; Kiptanui, Zippora/0000-0003-1212-7642	U.S. Food and Drug Administration (FDA) [U01FD005875]	U.S. Food and Drug Administration (FDA)	Funding for this manuscript was made possible, in part, by the U.S. Food and Drug Administration (FDA, https://www.fda.gov/) grant #U01FD005875. Views expressed in written materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government. The funder provided support for the conduct of the study but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Am J Psychiatry, V157, P1; [Anonymous], GEN DRUGS OV BAS; [Anonymous], GEN DRUGS PAT ED PRE; [Anonymous], GEN DRUG ACC SAV REP; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Baldwin DS, 2016, EUR NEUROPSYCHOPHARM, V26, P1062, DOI 10.1016/j.euroneuro.2016.02.013; Bech P, 2006, PHARMACOPSYCHIATRY, V39, P128, DOI 10.1055/s-2006-946702; Beland SG, 2011, VALUE HEALTH, V14, P492, DOI 10.1016/j.jval.2010.11.015; Bosak M, 2017, DRUG DES DEV THER, V11, P2287, DOI 10.2147/DDDT.S138270; Buffery D, 2009, AM HEALTH DRUG BENEF, V2, P120; Bull SA, 2002, ANN PHARMACOTHER, V36, P578, DOI 10.1345/aph.1A254; Bull SA, 2002, JAMA-J AM MED ASSOC, V288, P1403, DOI 10.1001/jama.288.11.1403; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cipriani A, 2016, LANCET, V388, P881, DOI 10.1016/S0140-6736(16)30385-3; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; DeWitt EM, 2006, ARCH INTERN MED, V166, P57, DOI 10.1001/archinte.166.1.57; Dignam JJ, 2008, J CLIN ONCOL, V26, P4027, DOI 10.1200/JCO.2007.12.9866; Drugs@FDA: FDA Approved Drug Products, SEARCH RES ESC; Einarson TR, 2004, INT CLIN PSYCHOPHARM, V19, P305, DOI 10.1097/01.yic.0000139342.22133.77; Ereshefsky Larry, 2010, J Med Econ, V13, P527, DOI 10.3111/13696998.2010.511050; Fava M, 2000, J CLIN PSYCHIAT, V61, P10; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Fortney JC, 2011, J CLIN PSYCHIAT, V72, P827, DOI 10.4088/JCP.09m05528blu; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Hansen RA, 2018, CLIN PHARMACOL THER, V103, P310, DOI 10.1002/cpt.591; Hansen RA, 2017, PHARMACOTHERAPY, V37, P429, DOI 10.1002/phar.1908; Hassali Mohamed A A, 2009, Int J Pharm Pract, V17, P79; Himmel W, 2005, INT J CLIN PHARM TH, V43, P472; Iosifescu A, 2008, PATIENT EDUC COUNS, V73, P377, DOI 10.1016/j.pec.2008.07.012; Kaplan C, 2012, J MENT HEALTH POLICY, V15, P171; Keenum AJ, 2012, RES SOC ADMIN PHARM, V8, P574, DOI 10.1016/j.sapharm.2011.12.004; Keks N, 2019, AUST PRESCR, V42, P152, DOI 10.18773/austprescr.2019.052; Kennedy SH, 2006, J PSYCHIATR NEUROSCI, V31, P122; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Limited Data Set (LDS), 2020, FIL CMS; MacQueen G, 2017, CAN J PSYCHIAT, V62, P11, DOI 10.1177/0706743716664885; MAP, EXPR SCRIPTS; Mark TL, 2011, AM J GERIAT PSYCHIAT, V19, P211, DOI 10.1097/JGP.0b013e3181f1803d; Middleton H, 2005, BMJ-BRIT MED J, V330, P267, DOI 10.1136/bmj.330.7486.267; National Center for Health Statistics, 2016, HLTH US 2015 SPEC FE; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Pechlivanoglou P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-89; Qian JJ, 2017, PHARMACOEPIDEM DR S, V26, P819, DOI 10.1002/pds.4224; Raina Parminder S, 2007, Healthc Policy, V3, pe128; Ruhe HG, 2006, J CLIN PSYCHIAT, V67, P1836, DOI 10.4088/JCP.v67n1203; Sansone Randy A, 2012, Innov Clin Neurosci, V9, P41; Schondelmeyer SW, TRENDS RETAIL PRICES, P29; Sewell K, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120010; Shrank WH, 2009, HEALTH AFFAIR, V28, P546, DOI 10.1377/hlthaff.28.2.546; US Census Bureau, 2010, GEOGRAPHY; US Department of Health &Human Services, 2015, EXP US GEN DRUGS; Vasiliadis HM, 2013, CAN J PSYCHIAT, V58, P201, DOI 10.1177/070674371305800405; Wouters OJ, 2017, MILBANK Q, V95, P554, DOI 10.1111/1468-0009.12279; Zhang Mei-Jie, 2008, Expert Rev Clin Pharmacol, V1, P391, DOI 10.1586/17512433.1.3.391	55	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232226	10.1371/journal.pone.0232226	http://dx.doi.org/10.1371/journal.pone.0232226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353006	Green Published, gold			2022-12-26	WOS:000536673200055
J	Pelagatti, C; Binda, P; Vannucci, M				Pelagatti, Claudia; Binda, Paola; Vannucci, Manila			A closer look at the timecourse of mind wandering: Pupillary responses and behaviour	PLOS ONE			English	Article							INVOLUNTARY AUTOBIOGRAPHICAL MEMORIES; MENTAL TIME-TRAVEL; EYE-MOVEMENTS; SPONTANEOUS THOUGHT; OLDER-ADULTS; ATTENTION; FUTURE; PUPILLOMETRY; FREQUENCY; REFLECTS	Mind wandering (MW) refers to the shift of attention away from a primary task and/or external environment towards thoughts unrelated to the task. Recent evidence has shown that pupillometry can be used as an objective marker of the onset and maintenance of externally-driven MW episodes. In the present study we aimed to further investigate pupillary changes associated with the onset and duration of self-reported MW episodes. We used a modified version of the joint behavioural-pupillometry paradigm we recently introduced. Participants were asked to perform a monotonous vigilance task which was intermixed with task-irrelevant cue-phrases (visually presented verbal cues); they were instructed to interrupt the task whenever a thought came to mind (self-caught method) and to indicate the trigger of their thought, if any. We found systematic pupil dilation after the presentation of verbal cues reported to have triggered MW, compared with other verbal cues presented during a supposedly on-task period (i.e., the period immediately following the resuming of the task after a self-caught interruption and MW report). These results confirm that pupil diameter is sensitive to the changes associated with the onset of MW and its unfolding over time. Moreover, by computing the latency between the trigger presentation and the task interruption (self-catch), we could also estimate the duration of MW episodes triggered by verbal cues. However, a high variability was found, implying very large inter-event variability, which could not be explained by any of the MW properties we acquired (including: temporal focus, specificity, emotional valence). Our behavioural and pupillometry findings stress the need for objective measures about the temporal unfolding of MW (while most studies focus on arbitrary time-window preceding self-reports of MW).	[Pelagatti, Claudia; Vannucci, Manila] Univ Florence, Sect Psychol, Dept NEUROFARBA, Florence, Italy; [Binda, Paola] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy	University of Florence; University of Pisa	Vannucci, M (corresponding author), Univ Florence, Sect Psychol, Dept NEUROFARBA, Florence, Italy.; Binda, P (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	paola.binda@unipi.it; manila.vannucci@psico.unifi.it	Pelagatti, Claudia/GXV-5654-2022; BINDA, PAOLA/Q-6196-2016	BINDA, PAOLA/0000-0002-7200-353X; Pelagatti, Claudia/0000-0001-6350-1249; Vannucci, Manila/0000-0003-1782-0526	European Research Council (ERC) under the European Union [801715 -PUPILTRAITS]	European Research Council (ERC) under the European Union(European Research Council (ERC))	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement to P.B., No 801715 -PUPILTRAITS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTROBUS JS, 1968, BRIT J PSYCHOL, V59, P423, DOI 10.1111/j.2044-8295.1968.tb01157.x; Barzykowski K, 2019, PSYCHOL RES-PSYCH FO, V83, P666, DOI 10.1007/s00426-018-1120-6; Barzykowski K, 2018, BRIT J PSYCHOL, V109, P321, DOI 10.1111/bjop.12259; Barzykowski K, 2018, MEMORY, V26, P277, DOI 10.1080/09658211.2017.1353102; Barzykowski K, 2016, BRIT J PSYCHOL, V107, P519, DOI 10.1111/bjop.12160; Barzykowski K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157121; Binda P, 2017, TRENDS NEUROSCI, V40, P455, DOI 10.1016/j.tins.2017.06.007; Binda P, 2015, J VISION, V15, DOI 10.1167/15.2.1; Binda P, 2015, TRENDS COGN SCI, V19, P1, DOI 10.1016/j.tics.2014.11.002; Binda P, 2014, J NEUROPHYSIOL, V112, P3046, DOI 10.1152/jn.00502.2014; Binda P, 2013, J VISION, V13, DOI 10.1167/13.6.8; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Christoff K, 2018, TRENDS COGN SCI, V22, P957, DOI 10.1016/j.tics.2018.07.004; Christoff K, 2016, NAT REV NEUROSCI, V17, P718, DOI 10.1038/nrn.2016.113; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cole SN, 2016, MEM COGNITION, V44, P376, DOI 10.3758/s13421-015-0564-9; Cole SN, 2016, Q J EXP PSYCHOL, V69, P273, DOI 10.1080/17470218.2015.1044542; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Faber M, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0129-0; Frank DJ, 2015, PSYCHOL AGING, V30, P266, DOI 10.1037/pag0000031; Franklin MS, 2013, Q J EXP PSYCHOL, V66, P2289, DOI 10.1080/17470218.2013.858170; Gouraud J, 2018, CONSCIOUS COGN, V66, P54, DOI 10.1016/j.concog.2018.09.012; Grandchamp R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00031; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Jordao M, 2019, PSYCHOL RES-PSYCH FO, V83, P710, DOI 10.1007/s00426-019-01146-w; Jubera-Garcia E, 2020, ATTEN PERCEPT PSYCHO, V82, P1125, DOI 10.3758/s13414-019-01865-7; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Klinger Eric, 1978, STREAM CONSCIOUSNESS, P225, DOI DOI 10.1007/978-1-4684-2466-9_9; Konishi M, 2017, COGNITION, V168, P16, DOI 10.1016/j.cognition.2017.06.006; Kvavilashvili L, 2020, TRENDS COGN SCI, V24, P285, DOI 10.1016/j.tics.2020.01.005; Laeng B, 2012, P NATL ACAD SCI USA, V109, P2162, DOI 10.1073/pnas.1118298109; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Lindquist SI, 2011, LEARN INDIVID DIFFER, V21, P158, DOI 10.1016/j.lindif.2010.12.006; Ludecke D., 2019, SJSTATS STAT FUNCTIO; Maillet D, 2017, CONSCIOUS COGN, V52, P55, DOI 10.1016/j.concog.2017.04.014; Maillet D, 2016, PSYCHOL AGING, V31, P370, DOI 10.1037/pag0000099; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; McVay JC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00570; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Mills C, 2018, CONSCIOUS COGN, V58, P20, DOI 10.1016/j.concog.2017.10.003; Niedzwienska A, 2018, NEUROPSYCHOLOGY, V32, P711, DOI 10.1037/neu0000457; Pelagatti Claudia, 2018, J Cogn, V1, P38, DOI 10.5334/joc.41; Phillips Natalie E, 2016, Q J Exp Psychol (Hove), V69, P2338; Plimpton B, 2015, CONSCIOUS COGN, V33, P261, DOI 10.1016/j.concog.2015.01.014; Pope KS, 1977, THESIS; Reichle ED, 2010, PSYCHOL SCI, V21, P1300, DOI 10.1177/0956797610378686; Schlagman S, 2008, MEM COGNITION, V36, P920, DOI 10.3758/MC.36.5.920; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Seli P, 2018, TRENDS COGN SCI, V22, P959, DOI 10.1016/j.tics.2018.07.007; Seli P, 2018, TRENDS COGN SCI, V22, P479, DOI 10.1016/j.tics.2018.03.010; Seli P, 2016, TRENDS COGN SCI, V20, P605, DOI 10.1016/j.tics.2016.05.010; Seli P, 2013, J EXP PSYCHOL HUMAN, V39, P1, DOI 10.1037/a0030954; Smallwood J, 2008, MEM COGNITION, V36, P1144, DOI 10.3758/MC.36.6.1144; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033706; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Smith GK, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0141-4; Turi M, 2018, ELIFE, V7, DOI [10.7554/elife.32399, 10.7554/eLife.32399]; Unsworth N, 2018, COGN AFFECT BEHAV NE, V18, P638, DOI 10.3758/s13415-018-0594-4; Unsworth N, 2016, COGN AFFECT BEHAV NE, V16, P601, DOI 10.3758/s13415-016-0417-4; Uzzaman S, 2011, CONSCIOUS COGN, V20, P1882, DOI 10.1016/j.concog.2011.09.010; Vannucci M, 2019, MEM COGNITION, V47, P117, DOI 10.3758/s13421-018-0854-0; Vannucci M, 2017, CONSCIOUS COGN, V53, P61, DOI 10.1016/j.concog.2017.06.004; Vannucci M, 2016, MEMORY, V24, P455, DOI 10.1080/09658211.2015.1018277; Vannucci M, 2015, PSYCHOL RES-PSYCH FO, V79, P1077, DOI 10.1007/s00426-014-0632-y; Vannucci M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089582; Varao-Sousa TL, 2019, BEHAV RES METHODS, V51, P235, DOI 10.3758/s13428-018-1073-0; Weinstein Y, 2018, BEHAV RES METHODS, V50, P642, DOI 10.3758/s13428-017-0891-9	70	5	5	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0226792	10.1371/journal.pone.0226792	http://dx.doi.org/10.1371/journal.pone.0226792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353028	Green Published, gold			2022-12-26	WOS:000536673200007
J	Chanda, SK; Ahammed, B; Howlader, MH; Ashikuzzaman, M; Shovo, TEA; Hossain, MT				Chanda, Sanjoy Kumar; Ahammed, Benojir; Howlader, Md. Hasan; Ashikuzzaman, Md; Shovo, Taufiq-E-Ahmed; Hossain, Md. Tanvir			Factors associating different antenatal care contacts of women: A cross-sectional analysis of Bangladesh demographic and health survey 2014 data	PLOS ONE			English	Article							SERVICES; QUALITY; ACCESS; INDIA	Antenatal care (ANC) contacts have long been considered a critical component of the continuum of care for a pregnant mother along with the newborn baby. The latest maternal mortality survey in Bangladesh suggests that progress in reducing maternal mortality has stalled as only 37% of pregnant women have attended at least four ANC contacts. This paper aims to determine what factors are associated with ANC contacts for women in Bangladesh. We analysed the data, provided by Bangladesh demographic and health survey 2014, covering a nationally representative sample of 17,863 ever married women aged 1549 years. A two-stage stratified cluster sampling was used to collect the data. Data derived from 4,475 mothers who gave birth in the three years preceding the survey. Descriptive, inferential, and multivariate statistical techniques were used to analyse the data. An overall 78.4% of women had ANC contacts, but the WHO recommended >= 8 ANC contacts and ANC contacts by qualified doctors were only 8% for each. The logistic regression analysis revealed that division, maternal age, women's education, husband's education, wealth index and media exposure were associated with the ANC contacts. Likewise, place of residence, women's education, religion, and wealth index were also found to be associated with the WHO recommended ANC contacts. Furthermore, the husband's education, division, religion and husband's employment showed significant associations with ANC contacts by qualified doctors. However, Bangladeshi women in general revealed an unsatisfactory level of ANC contacts, the WHO recommended as well as ANC contacts by qualified doctors. In order to improve the situation, it is necessary to follow the most recent ANC contacts recommended by the WHO and to contact the qualified doctors. Moreover, an improvement in education as well as access to information along with an increase of transports, care centres and reduction of service costs would see an improvement of ANC contacts in Bangladesh.	[Chanda, Sanjoy Kumar] Univ Leeds, Sch Healthcare, Fac Med & Hlth, Leeds, W Yorkshire, England; [Chanda, Sanjoy Kumar; Shovo, Taufiq-E-Ahmed; Hossain, Md. Tanvir] Khulna Univ, Social Sci Sch, Sociol Discipline, Khulna, Bangladesh; [Ahammed, Benojir] Khulna Univ, Sci Engn & Technol Sch, Stat Discipline, Khulna, Bangladesh; [Howlader, Md. Hasan; Ashikuzzaman, Md] Khulna Univ, Social Sci Sch, Dev Studies Discipline, Khulna, Bangladesh; [Shovo, Taufiq-E-Ahmed] Univ Newcastle, Fac Educ & Arts, Sch Humanities & Social Sci, Callaghan, NSW, Australia	University of Leeds; Khulna University; Khulna University; Khulna University; University of Newcastle	Chanda, SK (corresponding author), Univ Leeds, Sch Healthcare, Fac Med & Hlth, Leeds, W Yorkshire, England.; Chanda, SK (corresponding author), Khulna Univ, Social Sci Sch, Sociol Discipline, Khulna, Bangladesh.	hcskch@leeds.ac.uk	Hossain, Md. Tanvir/AAS-3339-2021; Howlader, Md. Hasan/AFR-1027-2022	Hossain, Md. Tanvir/0000-0003-0315-6900; Howlader, Md. Hasan/0000-0001-6603-7189; Chanda, Sanjoy Kumar/0000-0001-5950-5511; Ashikuzzaman, MD/0000-0002-4109-9321				Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2016, BANGL DEM HLTH SURV; [Anonymous], 2017, BANGL MAT MORT HLTH; Arokiasamy P, 2013, PRIM HEALTH CARE RES, V14, P373, DOI 10.1017/S1463423612000552; Bin Nisar Y, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0829-8; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Ciceklioglu M, 2005, INT J QUAL HEALTH C, V17, P533, DOI 10.1093/intqhc/mzi076; Defar A, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1079-y; Desta M, 2019, J NUTR METABOLISM, P1; Fatmi Z, 2002, J Pak Med Assoc, V52, P138; FOSU GB, 1994, SOC SCI MED, V38, P1209, DOI 10.1016/0277-9536(94)90186-4; Hajizadeh M, 2014, INT J EQUITY HEALTH, V13, DOI [10.1186/s12939-014-0120-4, 10.1186/1475-9276-13-18]; Haruna-Ogun OA, 2018, HEALTH CARE WOMEN IN, V39, P34, DOI 10.1080/07399332.2017.1388804; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Huda TM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211113; Huda TM, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010416; Islam MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204752; Iyaniwura C A, 2009, Afr J Reprod Health, V13, P111; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kamal SMM, 2013, ASIA PACIFIC J PUBLI, V27, DOI [10.1177/org/10.1093/heapro/dag414, DOI 10.1177/ORG/10.1093/HEAPRO/DAG414]; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Kumar G, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2473-6; Ministry of Health and Family Welfare, 2018, MIN HLTH FAM WELF HL; Mumtaz Z, 2007, SOCIOL HEALTH ILL, V29, P1, DOI 10.1111/j.1467-9566.2007.00519.x; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Nsibu CN, 2016, OBSTET GYNECOL INT, V2016, DOI 10.1155/2016/5423413; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Ousman SK, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00161; Pan American Health Organization (PAHO)/World Health Organization (WHO), 2018, EV INT ACT HLTH HLTH; Ponna Satyendra Nath, 2017, J Family Med Prim Care, V6, P231, DOI 10.4103/2249-4863.220024; Prual A, 2000, HEALTH POLICY PLANN, V15, P11, DOI 10.1093/heapol/15.1.11; Rahman MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157760; Rahman MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202879; Rai RK, 2015, J PUBLIC HEALTH-HEID, V23, P37, DOI 10.1007/s10389-014-0651-6; Saha S, 2017, HEALTH CARE WOMEN IN, V38, P2, DOI 10.1080/07399332.2016.1217864; Sarker Mohammad Abul Bashar, 2015, BMC Res Notes, V8, P590, DOI 10.1186/s13104-015-1374-7; Shahjahan M, 2017, MIDWIFERY, V52, P42, DOI 10.1016/j.midw.2017.05.011; Siddique AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205149; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Tariku A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179056; Tegegne TK, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2550-x; Tekelab T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214848; Tey NP, 2013, SCI WORLD J, DOI 10.1155/2013/423403; Titaley CR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-485; UN, 2020, SUSTAINABLE DEV GOAL; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2015, BANGLADESH HLTH SYST; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2009, WHO REC INT IMPR MAT	52	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232257	10.1371/journal.pone.0232257	http://dx.doi.org/10.1371/journal.pone.0232257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8ZG	32348364	Green Published, gold			2022-12-26	WOS:000536668200051
J	Parzych, EM; Miura, K; Long, CA; Burns, JM				Parzych, Elizabeth M.; Miura, Kazutoyo; Long, Carole A.; Burns, James M., Jr.			Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination	PLOS ONE			English	Article							TRANSMISSION-BLOCKING VACCINE; MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; SACCHAROMYCES-CEREVISIAE; MONOCLONAL-ANTIBODIES; TERMINAL FRAGMENT; ANTIGEN PFS25; CANDIDATE; SAFETY; PARASITE	Background Eradication of Plasmodium falciparum malaria will likely require a multivalent vaccine, but the development of a highly efficacious subunit-based formulation has been challenging. We previously showed that production and immunogenicity of two leading vaccine targets, PfMSP1(19) (blood-stage) and Pfs25 (sexual stage), could be enhanced upon genetic fusion to merozoite surface protein 8 (PfMSP8). Here, we sought to optimize a Pfs25-based formulation for use in combination with rPfMSP1/8 with the goal of maintaining the immunogenicity of each subunit. Methods Comparative mouse studies were conducted to assess the effects of adjuvant selection (Alhydrogel vs. glucopyranosyl lipid adjuvant-stable emulsion (GLA-SE)) and antigen dose (2.5 vs. 0.5 mu g) on the induction of anti-Pfs25 immune responses. The antibody response (magnitude, IgG subclass profile, and transmission-reducing activity (TRA)) and cellular responses (proliferation, cytokine production) generated in response to each formulation were assessed. Similarly, immunogenicity of a bivalent vaccine containing rPfMSP1/8 and rPfs25/8 was evaluated. Results Alum-based formulations elicited strong and comparable humoral and cellular responses regardless of antigen form (unfused rPfs25 or chimeric rPfs25/8) or dose. In contrast, GLA-SE based formulations elicited differential responses as a function of both parameters, with 2.5 mu g of rPfs25/8 inducing the highest titers of functional anti-Pfs25 antibodies. Based on these data, chimeric rPfs25/8 was selected and tested in a bivalent formulation with rPfMSP1/8. Strong antibody titers against Pfs25 and PfMSP119 domains were induced with GLA-SE based formulations, with no indication of antigenic competition. Conclusions We were able to generate an immunogenic bivalent vaccine designed to target multiple parasite stages that could reduce both clinical disease and parasite transmission. The use of the same PfMSP8 carrier for two different vaccine components was effective in this bivalent formulation. As such, the incorporation of additional protective targets fused to the PfMSP8 carrier into the formulation should be feasible, further broadening the protective response.	[Parzych, Elizabeth M.; Long, Carole A.; Burns, James M., Jr.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19104 USA; [Miura, Kazutoyo; Long, Carole A.] NIAID, Malaria Immunol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA	Drexel University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Burns, JM (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19104 USA.	jmb53@drexel.edu	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	NIH-NIAID [AI114292]; Intramural Program of NIH-NIAID; PATH's Malaria Vaccine Initiative (SMFA Reference Laboratory at the Laboratory of Malaria and Vector Research, NIAID, NIH)	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Program of NIH-NIAID; PATH's Malaria Vaccine Initiative (SMFA Reference Laboratory at the Laboratory of Malaria and Vector Research, NIAID, NIH)	This work was supported by NIH-NIAID Grant AI114292 (JMB), the Intramural Program of NIH-NIAID (CAL), and PATH's Malaria Vaccine Initiative (via support of the SMFA Reference Laboratory at the Laboratory of Malaria and Vector Research, NIAID, NIH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alaro JR, 2013, INFECT IMMUN, V81, P3843, DOI 10.1128/IAI.00522-13; Alaro JR, 2012, INFECT IMMUN, V80, P2473, DOI 10.1128/IAI.00211-12; Alaro JR, 2010, VACCINE, V28, P6876, DOI 10.1016/j.vaccine.2010.08.018; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BURNS JM, 1989, J IMMUNOL, V142, P2835; CHAPPEL JA, 1993, MOL BIOCHEM PARASIT, V60, P303, DOI 10.1016/0166-6851(93)90141-J; Coban C, 2004, INFECT IMMUN, V72, P253, DOI 10.1128/IAI.72.1.253-259.2004; DALY TM, 1995, J IMMUNOL, V155, P236; Di Pasquale A, 2015, VACCINES-BASEL, V3, P320, DOI 10.3390/vaccines3020320; Draper SJ, 2015, VACCINE, V33, P7433, DOI 10.1016/j.vaccine.2015.09.093; Eacret JS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45440-4; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Forbes EK, 2011, J IMMUNOL, V187, P3738, DOI 10.4049/jimmunol.1003783; Ghimire TR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0972-0; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; KASLOW DC, 1992, MEM I OSWALDO CRUZ, V87, P175, DOI 10.1590/S0074-02761992000700028; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kaslow DC, 2002, CHEM IMMUNOL, V80, P287; Kumar R, 2014, INFECT IMMUN, V82, P1453, DOI 10.1128/IAI.01438-13; KUMAR S, 1995, MOL MED, V1, P325, DOI 10.1007/BF03401557; Lee SM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1464-6; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Miura K, 2016, VACCINE, V34, P4145, DOI 10.1016/j.vaccine.2016.06.066; Miura K, 2013, INFECT IMMUN, V81, P4377, DOI 10.1128/IAI.01056-13; Mlambo G, 2010, VACCINE, V28, P7025, DOI 10.1016/j.vaccine.2010.08.022; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Orr MT, 2013, EUR J IMMUNOL, V43, P2398, DOI 10.1002/eji.201243124; Otsyula N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-29; Parzych EM, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00486-17; Patra KP, 2015, INFECT IMMUN, V83, P1799, DOI 10.1128/IAI.02980-14; Pichyangkul S, 2009, VACCINE, V28, P452, DOI 10.1016/j.vaccine.2009.10.022; Radtke AJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40312; Sharma Babita, 2008, In Silico Biology, V8, P193; Shi QF, 2007, INFECT IMMUN, V75, P1349, DOI 10.1128/IAI.01467-06; Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034; Stoute JA, 2007, VACCINE, V25, P176, DOI 10.1016/j.vaccine.2005.11.037; Stowers AW, 2000, INFECT IMMUN, V68, P5530, DOI 10.1128/IAI.68.10.5530-5538.2000; Talaat KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163144; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; VANAMERONGEN A, 1989, PARASITE IMMUNOL, V11, P425, DOI 10.1111/j.1365-3024.1989.tb00679.x; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Zou LL, 2003, VACCINE, V21, P1650, DOI 10.1016/S0264-410X(02)00701-6	58	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232355	10.1371/journal.pone.0232355	http://dx.doi.org/10.1371/journal.pone.0232355			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348377	gold, Green Published			2022-12-26	WOS:000536668200059
J	Ruiter, ELM; Molleman, GRM; Fransen, GAJ; Wagenaar, M; van der Velden, K; Engels, RCME				Ruiter, Emilie L. M.; Molleman, Gerard R. M.; Fransen, Gerdine A. J.; Wagenaar, Marlijn; van der Velden, Koos; Engels, Rutger C. M. E.			A set of pedagogical recommendations for improving the integrated approach to childhood overweight and obesity: A Delphi study	PLOS ONE			English	Article							PREVENTION; INTERVENTIONS; CHILDREN; PARENTS; FAMILY; TOOL	Background Tackling the increasing global problem of childhood overweight and obesity requires an integrated approach. Studies increasingly emphasize the importance of the parents' role in interventions designed to prevent overweight in children. The aim of this study was to develop a unified set of recommendations for healthy parenting practices that can be applied by all professionals who work with children age 4-13 years and can contribute to strengthening the integrated approach to childhood overweight. Methods A modified Delphi procedure was used to reach consensus regarding what these pedagogical recommendations should encompass. The 30 panelists were professionals and researchers who work with children age 4-13 in the domains of health care, overweight, parenting, education, nutrition, and/or sports. The procedure consisted of: i) extracting existing pedagogical recommendations from national guidelines and professional protocols, ii) appraising and prioritizing these recommendations in terms of relevance through two rounds of questionnaires, and iii) meeting to discuss and approve the set of recommendations. Results Consensus was reached for one set of eleven pedagogical theme-based recommendations designed to support and instruct parents how to stimulate healthy energy balance-related behaviors in their child. Each recommendation contained information regarding: i) which behaviors in the child and/or parent are important, ii) why this is important, and iii) how parents can stimulate this behavior by applying parenting skills in daily life. The eleven themes were: modeling, positive parenting, breakfast, varied diet, sugar-sweetened beverages, snacks, physical activity, playing sports, quantity of screen time, screen time during meals, and sleep. Conclusion We developed a set of recommendations for healthy parenting that can be used by various professionals working with children age 4-13 and can contribute to creating an integrated approach to childhood overweight. We also developed a web-based app called "Recommendations for Healthy Parenting" as a convenient tool for following these recommendations.	[Ruiter, Emilie L. M.; Molleman, Gerard R. M.; Fransen, Gerdine A. J.; Wagenaar, Marlijn; van der Velden, Koos] Radboud Univ Nijmegen, Acad Collaborat Ctr AMPHI, Dept Primary & Community Care, Integrated Hlth Policy,Med Ctr, Nijmegen, Netherlands; [Engels, Rutger C. M. E.] Erasmus Univ, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam	Ruiter, ELM (corresponding author), Radboud Univ Nijmegen, Acad Collaborat Ctr AMPHI, Dept Primary & Community Care, Integrated Hlth Policy,Med Ctr, Nijmegen, Netherlands.	Emilie.Ruiter@Radboudumc.nl	van der Velden, J./H-8101-2014	Engels, Rutger/0000-0003-1944-9126	Netherlands Organization for Health Research and Development (ZonMW) [505010296015/200100001]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (ZonMW) [project number 505010296015/200100001]. This funding source played no role in the design of execution of this study and will not play any role in the analysis or interpretation of the data, nor in the decision to publish the results.	[Anonymous], 2010, POP BAS PREV STRAT C; [Anonymous], MOD FOC GROUPS; [Anonymous], 2011, VOEDINGSCENTRUM RICH; BANTEL KA, 1993, PSYCHOL REP, V73, P35, DOI 10.2466/pr0.1993.73.1.35; Baranowski T, 2002, AM J HEALTH BEHAV, V26, P486, DOI 10.5993/AJHB.26.6.9; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Brown CL, 2015, PEDIATR CLIN N AM, V62, P1241, DOI 10.1016/j.pcl.2015.05.013; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Bulk-Bunschoten A., 2005, METHODE INDIVIDUELE; Butterwick Dale J, 2006, J Allied Health, V35, P147; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Dalkey NC, 1969, DELPHI METHOD EXPT S; Faith MS, 2012, CIRCULATION, V125, P1186, DOI 10.1161/CIR.0b013e31824607ee; Fitch K., 2001, DTIC DOCUMENT; Fransen GAJ, 2012, FAM PRACT, V29, pi104, DOI 10.1093/fampra/cmr123; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; Graefe A, 2011, INT J FORECASTING, V27, P183, DOI 10.1016/j.ijforecast.2010.05.004; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; GUSTAFSON DH, 1973, ORGAN BEHAV HUM PERF, V9, P280, DOI 10.1016/0030-5073(73)90052-4; Hasson F, 2011, TECHNOL FORECAST SOC, V78, P1695, DOI 10.1016/j.techfore.2011.04.005; Holthe J.C.-o, 2012, JGZ TIJDSCHRIFT JEUG, V44, P62; Hsu CC, 2007, PARE, V12, P1; Kemper HGC, 2000, TIJDSCHR SOC GEZONDH, V78, P180; Knowlden AP, 2012, OBES REV, V13, P499, DOI 10.1111/j.1467-789X.2011.00976.x; Knowlden AP, 2014, HEALTH PROMOT PRACT, V15, P685, DOI 10.1177/1524839914523431; Kremers S, 2013, CHILD OBES, V9, pS22, DOI 10.1089/chi.2013.0026; Kremers SPJ, 2010, PATIENT EDUC COUNS, V79, P291, DOI 10.1016/j.pec.2010.03.002; Lafave MR, 2013, INT J SPORTS MED, V34, P170, DOI 10.1055/s-0032-1311651; Lafave M, 2008, ADV HEALTH SCI EDUC, V13, P397, DOI 10.1007/s10459-006-9050-2; Leece P., 2004, J MED INTERNET RES, V6; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Nederland P.O, 2011, ADDENDUM KINDEREN BI; Ng M., 2014, LANCET; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Pinard CA, 2012, PUBLIC HEALTH NUTR, V15, P97, DOI 10.1017/S1368980011002059; Renders C., 2010, TIJDSCHRIFT KINDERGE, V78, P100; Renders CM, 2010, OBESITY FACTS, V3, P267, DOI 10.1159/000319426; Sharma S, 2004, J AM DIET ASSOC, V104, P1873, DOI 10.1016/j.jada.2004.08.033; Shaya FT, 2008, J SCHOOL HEALTH, V78, P189, DOI 10.1111/j.1746-1561.2008.00285.x; Snoek H.M., 2010, PARENTAL INVOLVEMENT; Steenbakkers M, 2011, TIJDSCHR GEZONDHEIDS, V89, P266; Steenbakkers M., 2012, TIJDSCHRIFT GEZONDHE, V90, P184; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Swinburn B, 2009, CHILD ADOL PSYCH CL, V18, P209, DOI 10.1016/j.chc.2008.07.015; Thomas H, 2006, HEALTH EDUC RES, V21, P783, DOI 10.1093/her/cyl143; van Binsbergen J, 2010, HUISARTS WET, V53, P609; van der Kruk J.J., 2013, OBES REV; Van der Star M, 2010, KINDERMONITOR 2010 G; van Koperen Marije Tm, 2014, BMC Obes, V1, P5, DOI 10.1186/2052-9538-1-5; Warren JM, 2007, INT J PEDIATR OBES, V2, P73, DOI 10.1080/17477160601133671; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; Wofford Linda G, 2008, J Pediatr Nurs, V23, P5, DOI 10.1016/j.pedn.2007.07.006; World Health Organization, 2013, CHILDH OV OB; ZonMW, 2009, OND GEM MET INT AANP	58	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231245	10.1371/journal.pone.0231245	http://dx.doi.org/10.1371/journal.pone.0231245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8VC	32339183	gold, Green Published			2022-12-26	WOS:000536657400008
J	Wilson, DL; Howard, ME; Fung, AM; O'Donoghue, FJ; Barnes, M; Lappas, M; Walker, SP				Wilson, Danielle L.; Howard, Mark E.; Fung, Alison M.; O'Donoghue, Fergal J.; Barnes, Maree; Lappas, Martha; Walker, Susan P.			Sleep-disordered breathing does not impact maternal outcomes in women with hypertensive disorders of pregnancy	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; ANGIOGENIC FACTORS; BLOOD-PRESSURE; PREECLAMPSIA; APNEA; ASSOCIATION; PREVALENCE; ENDOTHELIN-1; HEMODYNAMICS; DEFINITION	Objective Sleep-disordered breathing (SDB) is characterised by intermittent hypoxemia, sympathetic activation and widespread endothelial dysfunction, sharing pathophysiologic features with the hypertensive disorders of pregnancy. We sought to determine whether coexisting SDB would adversely impact the outcomes of women with gestational hypertension (GH) and preeclampsia (PE), and healthy matched controls. Study design Women diagnosed with GH or PE along with BMI- and gestation-matched normotensive controls underwent polysomnography in late pregnancy to establish the presence or absence of SDB (RDI >= 5). Clinical outcomes of hypertensive disease severity were compared between groups, and venous blood samples were taken in the third trimester and at delivery to examine for any impact of SDB on the anti-angiogenic markers of PE. Results Data was available for 17 women with PE, 24 women with GH and 44 controls. SDB was diagnosed in 41% of the PE group, 63% of the GH group and 39% of the control group. Women with PE and co-existing SDB did not have worse outcomes in terms of gestation at diagnosis of PE (SDB = 29.1 (25.9, 32.1) weeks vs. no SDB = 32.0 (29.0, 33.9), p = n.s.) and days between diagnosis of PE and delivery (SDB = 20.0 (4.0, 35.0) days vs. no SDB = 10.5 (9.0, 14.0), p = n.s.). There were also no differences in severity of hypertension, anti-hypertensive treatment and biochemical, haematological and anti-angiogenic markers of PE between SDB and no SDB groups. Similar results were observed among women with GH. Healthy control women with SDB were no more likely to develop a hypertensive disorder of pregnancy in the later stages of pregnancy (SDB = 5.9% vs. no SDB = 7.4%, p = n.s.). Increasing the threshold for diagnosis of SDB to RDI. 15 did not unmask a worse prognosis. Conclusion The presence of SDB during pregnancy did not worsen the disease course of GH or PE, and was not associated with high blood pressure or anti-angiogenic markers of hypertensive disease amongst healthy pregnant women. Given the numerous reports of the relationship between SDB and diagnosis of hypertensive disorders of pregnancy, it appears more work is required to distinguish causal, versus confounding, pathways.	[Wilson, Danielle L.; Howard, Mark E.; O'Donoghue, Fergal J.; Barnes, Maree] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia; [Wilson, Danielle L.; Fung, Alison M.; Walker, Susan P.] Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia; [Wilson, Danielle L.; Howard, Mark E.; O'Donoghue, Fergal J.; Barnes, Maree] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Lappas, Martha; Walker, Susan P.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); University of Melbourne; University of Melbourne	Wilson, DL (corresponding author), Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia.; Wilson, DL (corresponding author), Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia.; Wilson, DL (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.	danielle.wilson@austin.org.au		Howard, Mark/0000-0001-7772-1496	Institute for Breathing and Sleep; Austin Medical Research Foundation; Norman Beischer Medical Research Foundation; National Health and Medical Research Council [APP1038747]; Department of Obstetrics and Gynaecology (University of Melbourne)	Institute for Breathing and Sleep; Austin Medical Research Foundation; Norman Beischer Medical Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Department of Obstetrics and Gynaecology (University of Melbourne)	This research was supported by the following - Institute for Breathing and Sleep (DW, MH, SW, FO, MB, AF) - https://ibas.org.au/Austin Medical Research Foundation (MB, MH, DW) - http://www.austinmrf.org.au/Medical Research Foundation for Women and Babies (now named Norman Beischer Medical Research Foundation) (DW, SW, AF) - http://www.nbmrf.org.au/National Health and Medical Research Council Postgraduate Scholarship (DW) - APP1038747 https://www.nhmrc.gov.au/Research Fellowship from the Department of Obstetrics and Gynaecology (University of Melbourne) (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksu B, 2005, INT J GYNECOL OBSTET, V90, P112, DOI 10.1016/j.ijgo.2005.04.018; Blyton DM, 2004, SLEEP, V27, P79, DOI 10.1093/sleep/27.1.79; Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; Bourjeily G, 2015, J PERINAT MED, V43, P81, DOI 10.1515/jpm-2014-0052; Brennecke S., 2011, AUSTR ACTION PREECLA; Budhiraja R, 2007, J CLIN SLEEP MED, V3, P409; Carlson JT, 1996, AM J RESP CRIT CARE, V154, P1490, DOI 10.1164/ajrccm.154.5.8912770; CARLSON JT, 1994, AM J RESP CRIT CARE, V150, P72, DOI 10.1164/ajrccm.150.1.8025776; CHAPLEAU MW, 1988, AM J MED SCI, V295, P327, DOI 10.1097/00000441-198804000-00019; Chen Bao-yuan, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P894; Chen YH, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.006; Dunietz GL, 2018, PAEDIATR PERINAT EP, V32, P504, DOI 10.1111/ppe.12511; Edwards N, 2000, AM J RESP CRIT CARE, V162, P252, DOI 10.1164/ajrccm.162.1.9905006; El Solh AA, 2007, AM J RESP CRIT CARE, V175, P1186, DOI 10.1164/rccm.200611-1598OC; Facco FL, 2017, OBSTET GYNECOL, V129, P31, DOI 10.1097/AOG.0000000000001805; Facco FL, 2014, AM J PERINAT, V31, P899, DOI 10.1055/s-0033-1363768; Facco FL, 2013, PREGNANCY HYPERTENS, V3, P133, DOI 10.1016/j.preghy.2013.01.005; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Foster GE, 2007, AM J RESP CRIT CARE, V175, P720, DOI 10.1164/rccm.200609-1271OC; Fung AM, 2012, J PERINATOL, V32, P399, DOI 10.1038/jp.2012.14; Gamaldo CE, 2016, AASM MANUAL SCORING; Ge X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148732; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; George EM, 2011, AM J HYPERTENS, V24, P964, DOI 10.1038/ajh.2011.99; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; Gonzalez-Quintero VH, 2004, AM J OBSTET GYNECOL, V191, P1418, DOI 10.1016/j.ajog.2004.06.044; Grote L, 2001, J HYPERTENS, V19, P683, DOI 10.1097/00004872-200104000-00004; Herraiz I, 2018, FETAL DIAGN THER, V43, P81, DOI 10.1159/000477903; Imadojemu VA, 2007, CHEST, V131, P1406, DOI 10.1378/chest.06-2580; Izci-Balserak B, 2010, CURR OPIN PULM MED, V16, P574, DOI 10.1097/MCP.0b013e32833f0d55; Jafari Behrouz, 2013, J Cardiovasc Dis Res, V4, P87, DOI 10.1016/j.jcdr.2013.04.001; Lefkou E, 2010, OBSTETRIC HEMATOLOGY, P203; Louis J, 2012, OBSTET GYNECOL, V120, P1085, DOI 10.1097/AOG.0b013e31826eb9d8; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; Maloney KF, 2012, FETAL PEDIATR PATHOL, V31, P319, DOI 10.3109/15513815.2012.659391; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mohsenin V, 2011, RESP MED, V105, P801, DOI 10.1016/j.rmed.2011.01.001; Monahan KD, 2006, J PHYSIOL-LONDON, V574, P605, DOI 10.1113/jphysiol.2006.108977; Nankervis A., 2014, ADIPS CONSENSUS GUID; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; O'Brien LM, 2014, BJOG-INT J OBSTET GY, V121, P1685, DOI 10.1111/1471-0528.12885; O'Brien LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.034; Phillips BG, 1999, J HYPERTENS, V17, P61, DOI 10.1097/00004872-199917010-00010; Pien GW, 2014, THORAX, V69, P371, DOI 10.1136/thoraxjnl-2012-202718; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Priou P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115666; Reid J, 2011, SLEEP, V34, P1033, DOI 10.5665/SLEEP.1156; Silver HM, 1998, AM J OBSTET GYNECOL, V179, P87, DOI 10.1016/S0002-9378(98)70255-8; TAYLOR RN, 1990, J CLIN ENDOCR METAB, V71, P1675, DOI 10.1210/jcem-71-6-1675; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Whitehead C, 2015, OBSTET GYNECOL, V125, P1106, DOI 10.1097/AOG.0000000000000508; Wilson DL, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12656; Worsnop CJ, 1998, AM J RESP CRIT CARE, V157, P111, DOI 10.1164/ajrccm.157.1.9609063; Yang JM, 1996, ACTA OBSTET GYN SCAN, V75, P120, DOI 10.3109/00016349609033302; Yinon D, 2006, EUR RESPIR J, V27, P328, DOI 10.1183/09031936.06.00010905	57	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232287	10.1371/journal.pone.0232287	http://dx.doi.org/10.1371/journal.pone.0232287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339208	gold, Green Published			2022-12-26	WOS:000536657400036
J	Contreras-Lopez, R; Elizondo-Vega, R; Paredes, MJ; Luque-Campos, N; Torres, MJ; Tejedor, G; Vega-Letter, AM; Figueroa-Valdes, A; Pradenas, C; Oyarce, K; Jorgensen, C; Khoury, M; Garcia-Robles, MD; Altamirano, C; Djouad, F; Luz-Crawford, P				Contreras-Lopez, Rafael; Elizondo-Vega, Roberto; Jose Paredes, Maria; Luque-Campos, Noymar; Torres, Maria Jose; Tejedor, Gautier; Maria Vega-Letter, Ana; Figueroa-Valdes, Aliosha; Pradenas, Carolina; Oyarce, Karina; Jorgensen, Christian; Khoury, Maroun; de los Angeles Garcia-Robles, Maria; Altamirano, Claudia; Djouad, Farida; Luz-Crawford, Patricia			HIF1 alpha-dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions	FASEB JOURNAL			English	Article						glycolytic; HIF1 alpha; immunomodulation; immunosuppression; metabolic reprogramming; metabolism; MSCs	STEM-CELLS; HIF-1-ALPHA EXPRESSION; THERAPEUTIC FUNCTION; ALPHA PROTEIN; HYPOXIA; PROMOTES; OSTEOGENESIS; ACTIVATION; KINASE; HIF-1	Hypoxia-inducible factor 1 alpha (HIF1 alpha), a regulator of metabolic change, is required for the survival and differentiation potential of mesenchymal stem/stromal cells (MSC). Its role in MSC immunoregulatory activity, however, has not been completely elucidated. In the present study, we evaluate the role of HIF1 alpha on MSC immunosuppressive potential. We show that HIF1 alpha silencing in MSC decreases their inhibitory potential on Th1 and Th17 cell generation and limits their capacity to generate regulatory T cells. This reduced immunosuppressive potential of MSC is associated with a metabolic switch from glycolysis to OXPHOS and a reduced capacity to express or produce some immunosuppressive mediators including Intercellular Adhesion Molecule (ICAM), IL-6, and nitric oxide (NO). Moreover, using the Delayed-Type Hypersensitivity murine model (DTH), we confirm, in vivo, the critical role of HIF1 alpha on MSC immunosuppressive effect. Indeed, we show that HIF1 alpha silencing impairs MSC capacity to reduce inflammation and inhibit the generation of pro-inflammatory T cells. This study reveals the pivotal role of HIF1 alpha on MSC immunosuppressive activity through the regulation of their metabolic status and identifies HIF1 alpha as a novel mediator of MSC immunotherapeutic potential.	[Contreras-Lopez, Rafael; Elizondo-Vega, Roberto; Jose Paredes, Maria; Luque-Campos, Noymar; Pradenas, Carolina; Luz-Crawford, Patricia] Univ Andes, Fac Med, Ctr Invest & Innovac Biomed, Lab Inmunol Celular & Mol, Santiago, Chile; [Elizondo-Vega, Roberto; de los Angeles Garcia-Robles, Maria] Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Lab Biol Celular, Concepcion, Chile; [Torres, Maria Jose; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Tejedor, Gautier; Jorgensen, Christian; Djouad, Farida] Univ Montpellier, INSERM, IRMB, Montpellier, France; [Maria Vega-Letter, Ana; Figueroa-Valdes, Aliosha; Khoury, Maroun] Consorcio Regenero, Cells Cells, Santiago, Chile; [Maria Vega-Letter, Ana; Figueroa-Valdes, Aliosha; Khoury, Maroun] Univ Andes, Fac Med, Lab Nanoregenerat Med, Santiago, Chile; [Oyarce, Karina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile	Universidad de los Andes - Chile; Universidad de Concepcion; Pontificia Universidad Catolica de Valparaiso; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universidad de los Andes - Chile; Universidad San Sebastian	Luz-Crawford, P (corresponding author), Univ Andes, Fac Med, Ctr Invest & Innovac Biomed, Lab Inmunol Celular & Mol, Santiago, Chile.; Djouad, F (corresponding author), Univ Montpellier, Hop St Eloi, INSERM U 1183, IRMB, 80 Ave Augustin Fliche, F-34295 Montpellier, France.	farida.djouad@inserm.fr; pluz@uandes.cl	Torres, Maria/GVU-3391-2022; Garcia-Robles, Maria/F-4900-2014; djouad, farida/P-1749-2017	djouad, farida/0000-0001-8248-6822; Figueroa Valdes, Aliosha Ivan/0000-0001-7431-5046; Khoury, Maroun/0000-0002-9965-6266; Oyarce, Karina/0000-0002-9591-3149; Contreras Lopez, Rafael/0000-0002-7221-5102; Luz Crawford, Patricia/0000-0003-0067-7743; Elizondo, Roberto/0000-0001-9790-0002	MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [11190690, 11160929, 21141173, 2191997, 80211, PC18S04-180032, 3190462, 1170852]; Fondo de Ayuda a la Investigacion (FAI), Universidad de los Andes; Vicerrectoria de Investigacion y desarrollo (VRID) [VRIDINICIACION 219.031.116-INI]; Agence Nationale de la Recherche (ANR) [ANR-18-CE18-0010-02, ANR-11-INSB-005]; Vicerrectoria de investigacion y desarrollo (VRID), Universidad de Concepcion [218.031.113-1]	MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo de Ayuda a la Investigacion (FAI), Universidad de los Andes; Vicerrectoria de Investigacion y desarrollo (VRID); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Vicerrectoria de investigacion y desarrollo (VRID), Universidad de Concepcion	MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Grant/Award Number: FONDECYT INICIACION 11190690, FONDECYT INICIACION No 11160929, BECA DOCTORADO NACIONAL No 21141173, BECA DOCTORADO NACIONAL No 2191997, PROYECTO REDES No 80211, PROYECTO ECOSUD No PC18S04-180032, FONDECYT POSTDOCTORADO No 3190462 and FONDECYT REGULAR 1170852; Fondo de Ayuda a la Investigacion (FAI), Universidad de los Andes, Grant/Award Number: Venida profesor extranjero,2018; Vicerrectoria de Investigacion y desarrollo (VRID), Grant/Award Number: VRIDINICIACION 219.031.116-INI; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-18-CE18-0010-02 and ANR-11-INSB-005; Vicerrectoria de investigacion y desarrollo (VRID), Universidad de Concepcion, Grant/Award Number: VRID-asociativo no 218.031.113-1	Antebi B, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1007-x; Bader AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138477; Chowdhury A, 2018, CELL REP, V25, P561, DOI 10.1016/j.celrep.2018.09.057; Contreras RA, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3162743; Dalloul A, 2013, METHODS MOL BIOL, V1035, P199, DOI 10.1007/978-1-62703-508-8_17; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Dorronsoro A, 2014, EUR J IMMUNOL, V44, P480, DOI 10.1002/eji.201343668; Drela K, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7012692; Foyt DA, 2019, ACTA BIOMATER, V89, P73, DOI 10.1016/j.actbio.2019.03.002; Gu QL, 2016, TOHOKU J EXP MED, V239, P287, DOI 10.1620/tjem.239.287; Hamann I, 2018, FASEB J, V32, P5104, DOI 10.1096/fj.201800360R; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Killer MC, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0553-y; Kim DS, 2018, EBIOMEDICINE, V28, P261, DOI 10.1016/j.ebiom.2018.01.002; Kim DS, 2016, CELL STRESS CHAPERON, V21, P1089, DOI 10.1007/s12192-016-0733-1; Kim KW, 2017, EXP EYE RES, V164, P74, DOI 10.1016/j.exer.2017.08.008; Kurte M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00802; Luque-Campos N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00798; Luz-Crawford P, 2016, ANN RHEUM DIS, V75, P2166, DOI 10.1136/annrheumdis-2015-208696; Luz-Crawford P, 2016, STEM CELLS, V34, P483, DOI 10.1002/stem.2254; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Luz-Crawford P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045272; Martinez VG, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0659-2; Maumus M, 2013, BIOCHIMIE, V95, P2229, DOI 10.1016/j.biochi.2013.04.017; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Naji A, 2019, CELL MOL LIFE SCI, V76, P3323, DOI 10.1007/s00018-019-03125-1; Ngo DC, 2015, MOL BIOL REP, V42, P819, DOI 10.1007/s11033-015-3857-y; Niecknig H, 2012, FREE RADICAL RES, V46, P705, DOI 10.3109/10715762.2012.669041; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; Stolze Ineke P, 2006, Novartis Found Symp, V272, P15; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vertelov G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt153; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wobma Holly M, 2018, J Immunol Regen Med, V1, P45, DOI 10.1016/j.regen.2018.01.001; Xue CL, 2018, STEM CELLS DEV, V27, P456, DOI 10.1089/scd.2017.0296; Zhang YJ, 2015, CURR CHIN ECON REPOR, P33, DOI 10.1007/978-3-662-46205-8_2; Zhu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35489; Zou D, 2011, CELL PROLIFERAT, V44, P234, DOI 10.1111/j.1365-2184.2011.00747.x	43	25	25	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8250	8264		10.1096/fj.201902232R	http://dx.doi.org/10.1096/fj.201902232R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333618				2022-12-26	WOS:000529448500001
J	Chang, RL; Zhang, X; Qiao, AN; Dai, AT; Belousoff, MJ; Tan, QX; Shao, LJ; Zhong, L; Lin, GY; Liang, YL; Ma, LM; Han, S; Yang, DH; Danev, R; Wang, MW; Wootten, D; Wu, BL; Sexton, PM				Chang, Rulue; Zhang, Xin; Qiao, Anna; Dai, Antao; Belousoff, Matthew J.; Tan, Qiuxiang; Shao, Lijun; Zhong, Li; Lin, Guangyao; Liang, Yi-Lynn; Ma, Limin; Han, Shuo; Yang, Dehua; Danev, Radostin; Wang, Ming-Wei; Wootten, Denise; Wu, Beili; Sexton, Patrick M.			Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucagon receptor; glucagon-like peptide-1 receptor; dual agonist; cryo-electron microscopy; single particle analysis; structure-function; structural biology; peptide 15 (P15); metabolic disorder; G protein?coupled receptor (GPCR); glucagon; GLP-1 receptor	CRYO-EM STRUCTURE; BEAM-INDUCED MOTION; GLP-1 RECEPTOR; BIASED AGONISM; RECOGNITION; RESIDUES; DYNAMICS; OBESITY	Unimolecular dual agonists of the glucagon (GCG) receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R) are a new class of drugs that are potentially superior to GLP-1R?specific agonists for the management of metabolic disease. The dual-agonist, peptide 15 (P15), is a glutamic acid 16 analog of GCG with GLP-1 peptide substitutions between amino acids 17 and 24 that has potency equivalent to those of the cognate peptide agonists at the GCGR and GLP-1R. Here, we have used cryo-EM to solve the structure of an active P15-GCGR-G(s)complex and compared this structure to our recently published structure of the GCGR-G(s)complex bound to GCG. This comparison revealed that P15 has a reduced interaction with the first extracellular loop (ECL1) and the top of transmembrane segment 1 (TM1) such that there is increased mobility of the GCGR extracellular domain and at the C terminus of the peptide compared with the GCG-bound receptor. We also observed a distinct conformation of ECL3 and could infer increased mobility of the far N-terminal His-1 residue in the P15-bound structure. These regions of conformational variance in the two peptide-bound GCGR structures were also regions that were distinct between GCGR structures and previously published peptide-bound structures of the GLP-1R, suggesting that greater conformational dynamics may contribute to the increased efficacy of P15 in activation of the GLP-1R compared with GCG. The variable domains in this receptor have previously been implicated in biased agonism at the GLP-1R and could result in altered signaling of P15 at the GCGR compared with GCG.	[Chang, Rulue; Wang, Ming-Wei] Fudan Univ, Shanghai Med Coll, Sch Pharm, Shanghai, Peoples R China; [Zhang, Xin; Belousoff, Matthew J.; Liang, Yi-Lynn; Wootten, Denise; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia; [Qiao, Anna; Dai, Antao; Tan, Qiuxiang; Shao, Lijun; Zhong, Li; Lin, Guangyao; Ma, Limin; Han, Shuo; Yang, Dehua; Wang, Ming-Wei; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China; [Qiao, Anna; Tan, Qiuxiang; Shao, Lijun; Zhong, Li; Lin, Guangyao; Wang, Ming-Wei; Wu, Beili] Univ Chinese Acad Sci, Beijing, Peoples R China; [Dai, Antao; Yang, Dehua; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [Shao, Lijun; Lin, Guangyao; Wang, Ming-Wei; Wu, Beili] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Danev, Radostin] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Fudan University; Monash University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; ShanghaiTech University; University of Tokyo	Wang, MW (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Pharm, Shanghai, Peoples R China.; Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia.; Wang, MW; Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China.; Wang, MW; Wu, BL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Wang, MW (corresponding author), Natl Ctr Drug Screening, Shanghai, Peoples R China.; Wang, MW; Wu, BL (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	mwwang@simm.ac.cn; denise.wootten@monash.edu; beiliwu@simm.ac.cn; Patrick.sexton@monash.edu	Wootten, Denise/ABD-5703-2021; Yang, Dehua/M-5789-2019; Belousoff, Matthew/N-4066-2017	Wootten, Denise/0000-0003-4563-1642; Zhang, Xin/0000-0001-9422-3499; Belousoff, Matthew/0000-0002-3229-474X	National Natural Science Foundation of China [81872915, 31825010, 81973373, 81773792]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China [2018ZX09735-001, 2018ZX09711002-002-005, 2018ZX09711002-001]; National Key R&D Program of China [2018YFA0507000]; Novo Nordisk-CAS Research Fund [NNCAS-2017-1-CC]; National Health and Medical Research Council of Australia (NHMRC) [1184726, 1126857, 1150083]; Takeda Science Foundation 2019 Medical Research Grant; Japan Science and Technology Agency (JST) [PRESTO 18069571]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China; National Key R&D Program of China; Novo Nordisk-CAS Research Fund; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Takeda Science Foundation 2019 Medical Research Grant; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by the National Natural Science Foundation of China Grants 81872915 (to M.-W. W.), 31825010 (to B. W.), 81973373 (to D. Y.), and 81773792 (to D. Y.); the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China, Grants 2018ZX09735-001 (to M.-W. W.), 2018ZX09711002-002-005 (to D. Y.), and 2018ZX09711002-001 (to L. M.); the National Key R&D Program of China Grant 2018YFA0507000 (to M.-W. W. and B. W.); Novo Nordisk-CAS Research Fund NNCAS-2017-1-CC (to D. Y.); the National Health and Medical Research Council of Australia (NHMRC) Project Grants 1184726 and 1126857 (to D. W.) and Program Grant 1150083 (to P. M. S.); Takeda Science Foundation 2019 Medical Research Grant (to R. D.); and Japan Science and Technology Agency (JST) PRESTO 18069571 (to R. D.). P. M. S. is a Senior Principal Research Fellow and D. W. a Senior Research Fellow of the NHMRC.	Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS21, DOI 10.1111/bph.14748; Ambery P, 2018, LANCET, V391, P2607, DOI 10.1016/S0140-6736(18)30726-8; Andersson A, 2019, ENVIRON SCI-WAT RES, V5, P861, DOI 10.1039/c9ew00034h; Aroda VR, 2018, DIABETES OBES METAB, V20, P22, DOI 10.1111/dom.13162; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Capozzi ME, 2018, ENDOCR REV, V39, P719, DOI 10.1210/er.2018-00117; Chudleigh RA, 2020, DIABETES METAB SYNDR, V13, P433, DOI 10.2147/DMSO.S193693; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; dal Maso E, 2019, ACS PHARMACOL TRANSL, V2, P31, DOI 10.1021/acsptsci.8b00056; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Du XB, 2012, AM J PHYSIOL-ENDOC M, V303, pE265, DOI 10.1152/ajpendo.00142.2012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Glukhova A, 2018, ACS PHARMACOL TRANSL, V1, P73, DOI 10.1021/acsptsci.8b00026; Knerr PJ, 2020, PEPTIDES, V125, DOI 10.1016/j.peptides.2019.170225; Kobayashi K, 2020, NAT STRUCT MOL BIOL, V27, P274, DOI 10.1038/s41594-020-0386-8; Kosinski JR, 2012, OBESITY, V20, P1566, DOI 10.1038/oby.2012.67; Lei SF, 2018, J BIOL CHEM, V293, P9370, DOI 10.1074/jbc.RA118.003278; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liang YL, 2020, ACS PHARMACOL TRANSL, V3, P263, DOI 10.1021/acsptsci.9b00080; Liang YL, 2020, MOL CELL, V77, P656, DOI 10.1016/j.molcel.2020.01.012; Liang YL, 2018, ACS PHARMACOL TRANSL, V1, P12, DOI 10.1021/acsptsci.8b00017; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Ma SS, 2020, MOL CELL, V77, P669, DOI 10.1016/j.molcel.2020.01.013; Parker VER, 2020, J CLIN ENDOCR METAB, V105, P803, DOI 10.1210/clinem/dgz047; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pocai A, 2014, MOL METAB, V3, P241, DOI 10.1016/j.molmet.2013.12.001; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qiao AN, 2020, SCIENCE, V367, P1346, DOI 10.1126/science.aaz5346; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sanchez-Garrido MA, 2017, DIABETOLOGIA, V60, P1851, DOI 10.1007/s00125-017-4354-8; Santoprete A, 2011, J PEPT SCI, V17, P270, DOI 10.1002/psc.1328; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Sekar R, 2016, INT REV CEL MOL BIO, V326, P279, DOI 10.1016/bs.ircmb.2016.05.002; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Tillner J, 2019, DIABETES OBES METAB, V21, P120, DOI 10.1111/dom.13494; Vertongen P, 2001, BRIT J PHARMACOL, V133, P1249, DOI 10.1038/sj.bjp.0704195; Visentin R, 2020, DIABETES OBES METAB, V22, P640, DOI 10.1111/dom.13939; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wang J, 2020, CELL RES, V30, P436, DOI 10.1038/s41422-020-0280-2; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao LH, 2019, SCIENCE, V364, P148, DOI 10.1126/science.aav7942; Zhao PS, 2020, NATURE, V577, P432, DOI 10.1038/s41586-019-1902-z; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	54	17	17	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9313	9325		10.1074/jbc.RA120.013793	http://dx.doi.org/10.1074/jbc.RA120.013793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32371397	hybrid, Green Published			2022-12-26	WOS:000552758600005
J	Cummings, CL; Kong, WY; Orminski, J				Cummings, Christopher L.; Kong, Wei Yi; Orminski, Jeanette			A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore	PLOS ONE			English	Article							COMMUNICATION; HESITANCY	Access to the influenza vaccine pose little barriers in developed countries such as Singapore and vaccination against influenza is highly recommended for at-risk populations including older adults. However, vaccination rates are much lower than recommended despite the significant morbidity and mortality associated with the disease among this vulnerable population. Given timely goals to increase vaccine acceptance and uptake, we explored Singaporean older adults' misperceptions about influenza disease and vaccine. Qualitative semistructured interviews were conducted among 76 Singaporean adults aged 65 and above with no focus on a specific area in Singapore. Data were analyzed with grounded theory methods to understand participants' attitudes, perceptions, and knowledge. We developed in vivo codes that reflect the verbiage used by participants and exhaustively catalogued themes through a constant comparison coding method. Focusing specifically on older adults' misperceptions, seven main themes about influenza disease or vaccine emerged from our data analysis: familiarity with influenza, misperceptions about influenza, personal susceptibility to influenza, familiarity with the influenza vaccine, misperceptions about the influenza vaccine, misperceptions about influenza vaccine usage, and opinions about and barriers to influenza vaccine uptake. Notably, there is a lack of adequate knowledge and motivation in vaccinating against influenza among older adults in Singapore. Health communication needs to be more tailored toward older adults' message processing systems and engage health professionals' involvement in addressing the influenza disease and vaccine misperceptions identified in this study.	[Cummings, Christopher L.] North Carolina State Univ, Decis Analyt LLC, Cary, NC 27695 USA; [Kong, Wei Yi] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Orminski, Jeanette] Nanyang Technol Univ, Wee Kim Wee Sch Commun & Informat, Singapore, Singapore	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cummings, CL (corresponding author), North Carolina State Univ, Decis Analyt LLC, Cary, NC 27695 USA.	christopherlcummings@gmail.com		Orminski, Jeanette/0000-0001-6178-0782	Ageing Research Institute for Society and Education at the Nanyang Technological University, Singapore [M4082069.060]	Ageing Research Institute for Society and Education at the Nanyang Technological University, Singapore	CLC: This work was supported by the Ageing Research Institute for Society and Education at the Nanyang Technological University, Singapore (M4082069.060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Boey L, 2018, VACCINE, V36, P3351, DOI 10.1016/j.vaccine.2018.04.044; Bresee J, 2018, EMERG INFECT DIS, V24, P1173, DOI 10.3201/eid2407.171270; Canning HS, 2005, J CLIN NURS, V14, P922, DOI 10.1111/j.1365-2702.2005.01190.x; Centers for Disease Control and Prevention, 2017, VACC EFF WELL DOES F; Centers for Disease Control and Prevention, 2018, WHAT YOU SHOULD KNOW; Centers for Disease Control and Prevention, 2018, DIAGN FLU; Centers for Disease Control and Prevention, 2016, CDC COLL STUD INFL S; Centers for Disease Control and Prevention, 2018, PEOPL HIGH RISK DEV; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chua A., 2017, TODAY ONLINE    1022; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Cummings CL, 2017, CONSUMER PERCEPTION, P153; Cutter JL, 2010, ANN ACAD MED SINGAP, V39, P273; FASICK FA, 1978, PUBLIC OPIN QUART, V41, P549; Finucane ML, 2008, J RISK RES, V11, P983, DOI 10.1080/13669870802261595; Foley G, 2015, HEALTH SERV RES, V50, P1195, DOI 10.1111/1475-6773.12275; Frey BB, 2018, SAGE ENCY ED RES MEA, V1-4, DOI [10.4135/9781506326139.n4261111/j.1365-2648.2010.05397.x, DOI 10.4135/9781506326139.N4261111/J.1365-2648.2010.05397.X]; Gan E., 2017, TODAY; Gan E., 2017, CHANNEL NEWSASI 1205; Given L., 2008, SAGE ENCY QUALITATIV, DOI [10.4135/9781412963909, DOI 10.4135/9781412963909]; Halcomb EJ, 2006, APPL NURS RES, V19, P38, DOI 10.1016/j.apnr.2005.06.001; Hallberg L.R.M., 2006, INT J QUALITATIVE ST, V1, P141, DOI [https://doi.org/10.1080/17482620600858399, 10.1080/17482620600858399, DOI 10.1080/17482620600858399]; Kwong EWY, 2010, J ADV NURS, V66, P2297, DOI 10.1111/j.1365-2648.2010.05397.x; Lai L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190247; Lang PO, 2012, CLIN INTERV AGING, V7, P55, DOI 10.2147/CIA.S25215; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lim SS, 2016, VACCINE BOOK, 2ND EDITION, pXXIX; luliano AD, 2018, LANCET, V31, P391; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Manning J., 2017, INT ENCYCL COMMUN RE, V24, P1, DOI [10.1002/9781118901731.iecrm0270, DOI 10.1002/9781118901731.IECRM0270]; Ministry of Health Singapore, 2018, MOH EST NAT AD IMM S; Ng Sophia, 2015, Curr Epidemiol Rep, V2, P89; Nguyen MH, 2015, PROC SINGAP HEALTHC, V24, P94, DOI 10.1177/201010581502400205; Orel NA, 2005, J APPL GERONTOL, V24, P490, DOI 10.1177/0733464805279155; Prematunge C, 2014, VACCINE, V32, P7128, DOI 10.1016/j.vaccine.2014.10.023; Rimer BK, 2006, J COMMUN, V56, pS184, DOI 10.1111/j.1460-2466.2006.00289.x; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Sparks L, 2008, PATIENT EDUC COUNS, V71, P345, DOI 10.1016/j.pec.2008.02.007; Sundaram N, 2018, VACCINE, V36, P1996, DOI 10.1016/j.vaccine.2018.02.102; Teo C., 2016, STRAITS TIMES; Tracy SJ, 2013, COLLECTING EVIDENCE; Ward L, 2008, J CLIN NURS, V17, P5, DOI 10.1111/j.1365-2702.2006.01861.x; Wellard S, 2001, Contemp Nurse, V11, P180; WHO, INFL VACC; Williams SL, 2007, CLIN INTERV AGING, V2, P453; Wong PT, 2018, TODAY ONLINE    0626; World Health Organization, 2018, POW VACC STILL NOT F; Wright K. B., 2013, HLTH COMMUNICATION 2, V2nd	50	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232472	10.1371/journal.pone.0232472	http://dx.doi.org/10.1371/journal.pone.0232472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZB	32374754	gold, Green Published			2022-12-26	WOS:000537283500036
J	Morohoshi, T; Oi, T; Suzuki, T; Sato, S				Morohoshi, Tomohiro; Oi, Taishiro; Suzuki, Tomohiro; Sato, Shunsuke			Identification and characterization of a novel extracellular polyhydroxyalkanoate depolymerase in the complete genome sequence of Undibacterium sp. KW1 and YM2 strains	PLOS ONE			English	Article							POLY(3-HYDROXYBUTYRATE) DEPOLYMERASE; POLYHYDROXYBUTYRATE; DEGRADATION; CLONING; WATER; NOV.; GENE	Polyhydroxyalkanoate (PHA) is a biodegradable polymer that is synthesized by a wide range of microorganisms. One of the derivatives of PHA, poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH) has flexible material properties and low melting temperature. We have previously demonstrated that PHBH is degradable in a freshwater environment via the formation of biofilm on the surface of the PHBH film. Undibacterium sp. KW1 and YM2, which were isolated from the biofilm present on the PHBH film in the freshwater sample, were shown to have PHBH-degrading activity. In this study, the complete genome sequence of KW1 and YM2 revealed that the extracellular PHA depolymerase gene, designated as phaZ(UD), was present in their chromosomes. Sequence analysis revealed that PhaZ(UD) contained four domains: a signal peptide, catalytic domain, linker domain, and substrate-binding domain. Escherichia coli harboring a PhaZ(UD)-expressing plasmid showed PHBH-degrading activity in LB medium containing 1 wt% PHBH powder. The recombinant His-tagged PhaZ(UD) from KW1 and YM2 was purified from the culture supernatant and shown to have PHBH-degrading activity at the optimum temperature of 35 and 40 degrees C, respectively. When the degradation product in the PHBH solution was treated with PhaZ(UD) and assayed by LC-TOF-MS, we detected various oligomer structures, but no more than pentamers, which consist of 3-hydroxybutyrate and 3-hydroxyhexanoate. These results demonstrated that PhaZ(UD) may have an endo-type extracellular PHA depolymerase activity.	[Morohoshi, Tomohiro; Oi, Taishiro] Utsunomiya Univ, Grad Sch Engn, Dept Mat & Environm Chem, Utsunomiya, Tochigi, Japan; [Suzuki, Tomohiro] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan; [Sato, Shunsuke] Kaneka Corp, Pharma & Supplemental Nutr Solut Vehicle, Biotechnol Labs, Takasago, Hyogo, Japan	Utsunomiya University; Utsunomiya University; Kaneka Corporation	Morohoshi, T (corresponding author), Utsunomiya Univ, Grad Sch Engn, Dept Mat & Environm Chem, Utsunomiya, Tochigi, Japan.	morohosi@cc.utsunomiya-u.ac.jp			Kaneka Corporation (Hyogo, Japan); Kaneka Corporation	Kaneka Corporation (Hyogo, Japan); Kaneka Corporation	T.M. reports a grant from the Kaneka Corporation (Hyogo, Japan), during the conduct of the study; and S.S. is an employee of the Kaneka Corporation. The funder provided support in the form of salaries for author SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; Bakir A, 2016, ENVIRON POLLUT, V219, P56, DOI 10.1016/j.envpol.2016.09.046; Chen GQ, 2000, CHINESE J POLYM SCI, V18, P389; Chen WM, 2017, INT J SYST EVOL MICR, V67, P5094, DOI 10.1099/ijsem.0.002422; Eder W, 2011, INT J SYST EVOL MICR, V61, P384, DOI 10.1099/ijs.0.018648-0; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kampfer P, 2016, INT J SYST EVOL MICR, V66, P3625, DOI 10.1099/ijsem.0.001244; Kasuya K, 2003, INT J BIOL MACROMOL, V33, P221, DOI 10.1016/j.ijbiomac.2003.08.006; KITA K, 1995, APPL ENVIRON MICROB, V61, P1727, DOI 10.1128/AEM.61.5.1727-1730.1995; Knoll M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-89; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu J, 2014, APPL ENVIRON MICROB, V80, P986, DOI 10.1128/AEM.03396-13; Morohoshi T, 2018, MICROBES ENVIRON, V33, P332, DOI 10.1264/jsme2.ME18033; Morohoshi T, 2018, MICROBES ENVIRON, V33, P19, DOI 10.1264/jsme2.ME17052; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Ohura T, 1999, APPL ENVIRON MICROB, V65, P189; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Tokiwa Y, 2007, J POLYM ENVIRON, V15, P259, DOI 10.1007/s10924-007-0066-3; Vigneswari S, 2015, Enzyme Res, V2015, P212159, DOI 10.1155/2015/212159; Volova TG, 2017, MICROB ECOL, V73, P353, DOI 10.1007/s00248-016-0852-3	24	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232698	10.1371/journal.pone.0232698	http://dx.doi.org/10.1371/journal.pone.0232698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369496	gold, Green Published			2022-12-26	WOS:000537280000041
J	Oniszczenko, W				Oniszczenko, Wlodzimierz			Affective Temperaments and Meteoropathy Among Women: A Cross-sectional Study	PLOS ONE			English	Article							WEATHER; DISORDER; ASSOCIATION; VALIDATION; SUNSHINE; ANXIETY; BELONG; RISK	The main goal of the study was to assess the relationship between affective temperaments and meteoropathy among women and examine meteorosensitivity as a mediator in this relationship. The issue of affective temperaments and meteoropathy has not been considered in the literature. The sample consisted of 450 Caucasian women gathered via the online recruitment platform. The participants' ages ranged from 18 to 70 years (M = 30.01; SD = 9.10). The Polish version of the Temperament Evaluation of Memphis, Pisa, Paris and San Diego Autoquestionnaire was used to assess affective temperaments (depressive, cyclothymic, hyperthymic, irritable and anxious). Meteorosensitivity and meteoropathy were assessed using the Polish adaptation of the METEO-Q questionnaire. A large positive correlation was found between meteorosensitivity and meteoropathy. Medium positive correlations were found between meteorosensitivity/meteoropathy and cyclothymic and anxious temperaments. Small positive correlations were revealed between depressive and irritable temperaments and both meteorosensitivity and meteoropathy scales. No correlation was found between hyperthymic temperament and meteorosensitivity/meteoropathy. Mediation analyses indicated cyclothymic and anxious temperaments affected meteoropathy both directly and indirectly through meteorosensitivity as a mediator. The most severe meteoropathy symptoms in the studied sample were asthenia, an indefinite feeling of malaise and irritability. The results suggest affective temperaments may be related to meteoropathy symptoms in women.	[Oniszczenko, Wlodzimierz] Univ Warsaw, Fac Psychol, Warsaw, Poland	University of Warsaw	Oniszczenko, W (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	wlodek@psych.uw.edu.pl		Oniszczenko, Wlodzimierz/0000-0003-4442-9186				Akiskal HS, 1998, ACTA PSYCHIAT SCAND, V98, P66, DOI 10.1111/j.1600-0447.1998.tb05969.x; Akiskal KK, 2005, J AFFECT DISORDERS, V85, P231, DOI 10.1016/j.jad.2004.08.002; Amann B, 2009, PSYCHOSOMATICS, V50, P605, DOI 10.1176/appi.psy.50.6.605; Baylis P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195750; Beecher ME, 2016, J AFFECT DISORDERS, V205, P234, DOI 10.1016/j.jad.2016.07.021; Benevolenza MA, 2019, J HUM BEHAV SOC ENVI, V29, P266, DOI 10.1080/10911359.2018.1527739; Bloink R, 2005, J AFFECT DISORDERS, V85, P77, DOI 10.1016/S0165-0327(03)00101-0; Borkowska A, 2010, J AFFECT DISORDERS, V123, P36, DOI 10.1016/j.jad.2009.09.024; Bulbena A, 2005, INT J BIOMETEOROL, V49, P238, DOI 10.1007/s00484-004-0236-0; Carhart-Harris RL, 2017, J PSYCHOPHARMACOL, V31, P1091, DOI 10.1177/0269881117725915; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connolly M, 2013, J HAPPINESS STUD, V14, P457, DOI 10.1007/s10902-012-9338-2; DeGeorge DP, 2014, J AFFECT DISORDERS, V164, P94, DOI 10.1016/j.jad.2014.04.006; Di Nicola M, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00095; Eory A, 2014, EUR J GEN PRACT, V20, P247, DOI 10.3109/13814788.2013.868431; Feddersen J, 2016, J R STAT SOC A STAT, V179, P203, DOI 10.1111/rssa.12118; Freti L, 2017, ALTERN INTEGR MED, V6, P252, DOI [10.4172/2327-5162.1000252, DOI 10.4172/2327-5162.1000252]; Hayes A.F., 2018, INTRO MEDIATION MODE, V2nd ed.; Hyphantis TN, 2013, J AFFECT DISORDERS, V150, P481, DOI 10.1016/j.jad.2013.04.043; IBM Corp, 2016, IBM SPSS STAT WIND V; Janiri L, 2009, ADV PSYCHIAT, VIII, P45; Jenkins TA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010056; Kampfer S, 2013, SOC INDIC RES, V110, P579, DOI 10.1007/s11205-011-9945-z; Khoury S, 2019, ANN NEUROL, V86, P168, DOI 10.1002/ana.25521; Lee M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081670; Lee YJ, 2014, CEPHALALGIA, V34, P656, DOI 10.1177/0333102413520083; Leonard BE, 2005, EUR PSYCHIAT, V20, pS302, DOI 10.1016/S0924-9338(05)80180-4; Mazza M, 2012, COMPR PSYCHIAT, V53, P103, DOI 10.1016/j.comppsych.2011.02.002; Mazza M, 2009, COMPR PSYCHIAT, V50, P240, DOI 10.1016/j.comppsych.2008.08.004; Ngan S, 2011, PAIN MED, V12, P1523, DOI 10.1111/j.1526-4637.2011.01227.x; Obradovich N, 2018, P NATL ACAD SCI USA, V115, P10953, DOI 10.1073/pnas.1801528115; Oniszczenko W, 2019, BEHAV SLEEP MED, V17, P355, DOI 10.1080/15402002.2017.1357121; Oniszczenko W, 2017, CURR ISS PERSONAL PS, V5, P73, DOI 10.5114/cipp.2017.65847; Ottoni GL, 2011, J AFFECT DISORDERS, V128, P120, DOI 10.1016/j.jad.2010.06.014; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rainville JR, 2019, NEUROPSYCHOPHARMACOL, V44, P184, DOI 10.1038/s41386-018-0124-7; Rifkin DI, 2018, SLEEP MED REV, V42, P3, DOI 10.1016/j.smrv.2018.07.007; Rihmer Z, 2010, CURR OPIN PSYCHIATR, V23, P12, DOI 10.1097/YCO.0b013e32833299d4; Rovai L, 2013, EUR REV MED PHARMACO, V17, P2065; Rubinow DR, 2019, NEUROPSYCHOPHARMACOL, V44, P111, DOI 10.1038/s41386-018-0148-z; Sato J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211297; Seney ML, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0017-3; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Vazquez GH, 2013, CURR PSYCHIATRY REV, V9, P21, DOI 10.2174/1573400511309010004; von Mackensen S, 2005, INT J BIOMETEOROL, V49, P156, DOI 10.1007/s00484-004-0226-2; Walsh MA, 2013, J AFFECT DISORDERS, V145, P179, DOI 10.1016/j.jad.2012.07.026; Watson D., 2000, MOOD TEMPERAMENT; Wirz-Justice A, 2019, EUR ARCH PSY CLIN N, V269, P833, DOI 10.1007/s00406-018-0921-3; Yang AC, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0533-5; Zikic M., 2018, MED PREGL, VLXXI, DOI 10.2298/MPNS1804131Z	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232725	10.1371/journal.pone.0232725	http://dx.doi.org/10.1371/journal.pone.0232725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365079	Green Published, gold			2022-12-26	WOS:000536959700057
J	Rutkowsky, JM; Knotts, TA; Allen, PD; Pessah, IN; Ramsey, JJ				Rutkowsky, Jennifer M.; Knotts, Trina A.; Allen, Paul D.; Pessah, Isaac N.; Ramsey, Jon J.			Sex-specific alterations in whole body energetics and voluntary activity in heterozygous R163C malignant hyperthermia-susceptible mice	FASEB JOURNAL			English	Article						body composition; energy expendtiure; metabolic rate; physical activity; thermoneutral zone	SKELETAL-MUSCLE; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; SUDDEN-DEATH; RYR1; THERMOGENESIS; PIGS	Malignant hyperthermia (MH) is characterized by induction of skeletal muscle hyperthermia in response to a dysregulated increase in myoplasmic calcium. Although altered energetics play a central role in MH, MH-susceptible humans and mouse models are often described as having no phenotype until exposure to a triggering agent. The purpose of this study was to determine the influence of the R163C ryanodine receptor 1 mutation, a common MH mutation in humans, on energy expenditure, and voluntary wheel running in mice. Energy expenditure was measured by indirect respiration calorimetry in wild-type (WT) and heterozygous R163C (HET) mice over a range of ambient temperatures. Energy expenditure adjusted for body weight or lean mass was increased (P < .05) in male, but not female, HET mice housed at 22 degrees C or when housed at 28 degrees C with a running wheel. In female mice, voluntary wheel running was decreased (P < .05) in the HET vs WT animals when analyzed across ambient temperatures. The thermoneutral zone was also widened in both male and female HET mice. The results of the study show that the R163C mutations alters energetics even at temperatures that do not typically induce MH.	[Rutkowsky, Jennifer M.; Knotts, Trina A.; Allen, Paul D.; Pessah, Isaac N.; Ramsey, Jon J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA; [Allen, Paul D.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England	University of California System; University of California Davis; University of Leeds	Ramsey, JJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA.	jjramsey@ucdavis.edu			National Institutes of Health (NIH) [PO1AR052354]; UC Davis Mouse Metabolic Phenotyping Center [U2CDK092993]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis Mouse Metabolic Phenotyping Center	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: PO1AR052354; UC Davis Mouse Metabolic Phenotyping Center, Grant/Award Number: U2CDK092993	AALHUS JL, 1991, ANIM PROD, V52, P347, DOI 10.1017/S0003356100012873; Abreu-Vieira G, 2015, MOL METAB, V4, P461, DOI 10.1016/j.molmet.2015.03.001; Allard B, 2018, NEUROMUSCULAR DISORD, V28, P394, DOI 10.1016/j.nmd.2018.03.004; Assaad HI, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0795-z; Bi JF, 2014, CELL METAB, V19, P861, DOI 10.1016/j.cmet.2014.03.028; BRITT BA, 1970, CAN ANAESTH SOC J, V17, P293, DOI 10.1007/BF03004694; Canato M, 2015, J MUSCLE RES CELL M, V36, P61, DOI 10.1007/s10974-014-9396-7; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chang L, 2019, BRIT J ANAESTH, V122, P613, DOI 10.1016/j.bja.2019.02.010; Cully TR, 2018, P NATL ACAD SCI USA, V115, P8215, DOI 10.1073/pnas.1800490115; De Crescenzo V, 2012, P NATL ACAD SCI USA, V109, P610, DOI 10.1073/pnas.1115111108; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P540, DOI 10.1016/j.nmd.2013.03.008; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Freymond D, 2000, ANESTHESIOLOGY, V93, P39, DOI 10.1097/00000542-200007000-00011; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Giulivi C, 2011, J BIOL CHEM, V286, P99, DOI 10.1074/jbc.M110.153247; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Grievink H, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-10; Hartmann S, 1997, AM J VET RES, V58, P738; Islander G, 2007, ACTA ANAESTH SCAND, V51, P614, DOI 10.1111/j.1399-6576.2007.01293.x; Knoblauch M, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-22; Kushnir A, 2010, FEBS LETT, V584, P1956, DOI 10.1016/j.febslet.2010.03.005; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Leach LM, 1996, J ANIM SCI, V74, P934; LUCKE JN, 1977, VET REC, V100, P45, DOI 10.1136/vr.100.3.45; Merritt A, 2017, BRIT J ANAESTH, V118, P533, DOI 10.1093/bja/aex042; Michelucci A, 2017, FASEB J, V31, P3649, DOI 10.1096/fj.201601292R; Miller DM, 2018, BRIT J ANAESTH, V121, P944, DOI 10.1016/j.bja.2018.06.028; Moreno CAI, 2019, ANESTHESIOLOGY, V131, P983, DOI 10.1097/ALN.0000000000002813; Periasamy M, 2017, DIABETES METAB J, V41, P327, DOI 10.4093/dmj.2017.41.5.327; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; Reddish FN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051024; Riazi S, 2018, ANESTHESIOLOGY, V128, P168, DOI 10.1097/ALN.0000000000001878; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rouviere C, 2012, MUSCLE NERVE, V45, P586, DOI 10.1002/mus.22343; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Thompson SJ, 2017, ANESTH ANALG, V125, P434, DOI 10.1213/ANE.0000000000002232; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yuen B, 2012, FASEB J, V26, P1311, DOI 10.1096/fj.11-197582	45	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8721	8733		10.1096/fj.202000403	http://dx.doi.org/10.1096/fj.202000403		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367593	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000530738200001
J	Davis, W; Mantsios, A; Karver, T; Murray, M; Punekar, Y; Ward, D; Bredeek, UF; Moreno, S; Merino, D; Knobel, H; Campis, A; Kerrigan, D				Davis, Wendy; Mantsios, Andrea; Karver, Tahilin; Murray, Miranda; Punekar, Yogesh; Ward, Douglas; Bredeek, U. Fritz; Moreno, Santiago; Merino, Dolores; Knobel, Hernando; Campis, Antonio; Kerrigan, Deanna			"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain	PLOS ONE			English	Article							HIGH-INCOME COUNTRIES; ANTIRETROVIRAL THERAPY; EXPERIENCED PATIENTS; DOLUTEGRAVIR; FACILITATORS; BARRIERS; ADULTS; NAIVE; CARE; SEX	Background Two-drug regimens (2DR) to treat HIV infection have the potential to reduce long-term toxicity and increase therapeutic options for people living with HIV (PLHIV). Prior phase III trials, SWORD-1 and SWORD-2, as well as GEMINI-1 and GEMINI-2, have demonstrated that a dolutegravir-based 2DR is as effective as three-or four-drug regimens among virologically suppressed patients. Limited information exists, however, on patient and provider experiences with 2DR to inform roll-out and integration into routine clinical care. Methods We conducted 39 in-depth interviews with PLHIV currently on 2DR in the context of routine care and 8 of their clinical care providers in the United States (U.S.) and Spain. Participants included 33 male and 6 female PLHIV and 8 providers. Interview topics explored perceptions of and experiences with 2DR compared to prior anti-retroviral regimens (ARVs), side effects, patient satisfaction, and clinical performance. Interviews were audio-recorded, transcribed and analyzed using thematic content analysis. Results Participants viewed 2DR as a significant and positive advance, in terms of its ability to effectively treat HIV with reduced toxicity and essentially no reported side effects. Patients noted the central role providers played in the decision to switch to a 2DR regimen and, among U. S. participants, the importance of insurance coverage making this preferred option feasible. Patients aynd providers agreed that a 2DR regimen would be appropriate for any PLHIV regardless of whether they were treatment naive or had significant experience with ARVs. Conclusions Participants' experiences with a 2DR regimen were positive with no participants, reporting side effects and all reporting continued viral suppression. Providers valued the reduced toxicity offered by 2DR and served as the primary gateway to a transition to 2DR for patients in both settings. This study provides a foundation for further research on the transition to 2DR regimens in other populations and contexts including low- and middle-income settings.	[Davis, Wendy; Mantsios, Andrea; Karver, Tahilin; Murray, Miranda; Kerrigan, Deanna] Amer Univ, Ctr Hlth Risk & Soc, Washington, DC 20016 USA; [Punekar, Yogesh] ViiV Healthcare, Raleigh, NC USA; [Ward, Douglas] Dupont Circle Phys Grp, Washington, DC USA; [Bredeek, U. Fritz] Metropolis Med Grp, San Francisco, CA USA; [Moreno, Santiago] Hosp Ramon & Cajal, Madrid, Spain; [Merino, Dolores] Hosp Infanta Elena, Huelva, Spain; [Knobel, Hernando] Hosp del Mar, Barcelona, Spain; [Campis, Antonio] Hosp Son Espases, Palma De Mallorca, Spain	American University; Hospital Universitario Ramon y Cajal; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Son Espases	Davis, W (corresponding author), Amer Univ, Ctr Hlth Risk & Soc, Washington, DC 20016 USA.	wdavis@american.edu	Knobel, Hernando/B-5223-2016	Knobel, Hernando/0000-0003-3186-6416; Karver, Tahilin Sanchez/0000-0001-7362-9377	ViiV Healthcare	ViiV Healthcare	This study was funded by ViiV Healthcare (www.viivhealthcare.com) and ViiV Healthcare was involved in the study design, decision to publish, and preparation of the manuscript. Additional support was provided by ViiV Healthcare in the form of a contract to the American University which supported a portion of salaries for WD,AM, TK, and DK.	[Anonymous], 2017, ADV RECYCL WASTE MAN, DOI [10.4172/2475-7675.1000124, DOI 10.4172/2475-7675.1000124]; Beach LB, 2018, AIDS PATIENT CARE ST, V32, P468, DOI 10.1089/apc.2018.0094; Boyd MA, 2009, CURR OPIN HIV AIDS, V4, P194, DOI 10.1097/COH.0b013e328329fc8d; Braksmajer A, 2018, AIDS EDUC PREV, V30, P1, DOI 10.1521/aeap.2018.30.1.1; Burch LS, 2016, AIDS, V30, P1147, DOI 10.1097/QAD.0000000000001068; Cahn P, 2019, LANCET, V393, P143, DOI 10.1016/S0140-6736(18)32462-0; Carey JW, 2018, AIDS PATIENT CARE ST, V32, P191, DOI 10.1089/apc.2018.0018; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Despiegel N, 2015, INFECT DIS THER, V4, P337, DOI 10.1007/s40121-015-0071-0; Dorman RM, 2019, BEHAV MED, V3, P1; Fields J, 2015, CURR THER RES CLIN E, V77, P79, DOI 10.1016/j.curtheres.2015.08.002; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hester EK, 2019, ANN PHARMACOTHER, V53, P860, DOI 10.1177/1060028019831674; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Llibre JM, 2018, LANCET, V391, P839, DOI 10.1016/S0140-6736(17)33095-7; Margolis AM, 2014, J MED TOXICOL, V10, P26, DOI 10.1007/s13181-013-0325-8; Patton M. Q., 2001, QUALITATIVE RES EVAL; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Punekar YS, 2019, IS DTG 3TC DTG RPV E; Rael CT, 2018, AIDS BEHAV, V22, P3627, DOI 10.1007/s10461-018-2102-9; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tressler R, 2012, DRUGS, V72, P2051, DOI 10.2165/11640830-000000000-00000; Vitoria M, 2018, AIDS, V32, P1551, DOI 10.1097/QAD.0000000000001845; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232473	10.1371/journal.pone.0232473	http://dx.doi.org/10.1371/journal.pone.0232473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3FY	32357195	gold, Green Published			2022-12-26	WOS:000536957700032
J	Hwang, IC; Bae, JH; Kim, JM; Lee, JM; Nguyen, QD				Hwang, In Cheol; Bae, Jeong Hun; Kim, Joon Mo; Lee, Jung Min; Quan Dong Nguyen			Adult body height and age-related macular degeneration in healthy individuals: A nationwide population-based survey from Korea	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; RISK-FACTORS; HEART-DISEASE; MASS INDEX; FOLLOW-UP; STROKE; MORTALITY; MACULOPATHY; PREVALENCE; COHORT	We sought to evaluate the relationship between adult body height and risk of age-related macular degeneration (AMD) among healthy Koreans using nationwide population-based data. We analyzed data derived from the Korea National Health and Nutrition Examination Survey 2008-2011. Participants over 40 years of age were included in the sample after excluding individuals with systemic comorbidities or missing relevant data. The presence and severity of AMD were graded using fundus photographs. The relationship between body height and risk of AMD was determined using multiple logistic regression analyses. Among a total of 8,435 participants, 544 (6.45%) had AMD: 502 (5.95%) with early AMD and 42 (0.5%) with late AMD. In multivariate-adjusted analyses, taller body height was significantly associated with a lower prevalence of AMD (odds ratio [OR], 0.89; 95% confidence interval [CI], 0.81-0.99), while body mass index (BMI) was not associated with AMD. An inverse association between body height and risk of AMD was observed most frequently in participants under 65 years of age (OR, 0.81; 95% CI, 0.70-0.94). Furthermore, body height showed an inverse association with risk of AMD among obese participants (BMI.25.0 kg/m(2)) (OR, 0.75; 95% CI, 0.60-0.93). Subgroup analysis by AMD type disclosed a significant inverse association between body height and early AMD (OR, 0.87; 95% CI, 0.79-0.97) but not late AMD. Our results suggest that shorter body height is independently associated with increased risk of AMD, especially early AMD, in a dose-response manner in people who are obese or under 65 years of age.	[Hwang, In Cheol] Gachon Univ, Coll Med, Gil Med Ctr, Dept Family Med, Incheon, South Korea; [Bae, Jeong Hun; Kim, Joon Mo; Lee, Jung Min] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Ophthalmol, Seoul, South Korea; [Quan Dong Nguyen] Stanford Univ, Sch Med, Byers Eye Inst, Palo Alto, CA 94304 USA	Gachon University; Sungkyunkwan University (SKKU); Samsung Medical Center; Stanford University	Bae, JH (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Ophthalmol, Seoul, South Korea.	jhbae94@hotmail.com		Bae, Jeong Hun/0000-0001-9028-1528				ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Bae JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136218; Batty GD, 2006, ANN ONCOL, V17, P157, DOI 10.1093/annonc/mdj018; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; COOK NR, 1994, AM J EPIDEMIOL, V139, P1066, DOI 10.1093/oxfordjournals.aje.a116950; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curcio CA, 2011, P NATL ACAD SCI USA, V108, P18569, DOI 10.1073/pnas.1115497108; Di Stefano A F, 2001, Optometry, V72, P619; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Haas P, 2015, ACTA OPHTHALMOL, V93, P533, DOI 10.1111/aos.12670; Hamburg NM, 2008, AM J CARDIOL, V101, P82, DOI 10.1016/j.amjcard.2007.07.053; Hozawa A, 2007, STROKE, V38, P22, DOI 10.1161/01.STR.0000251806.01676.60; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lavanya R, 2010, INVEST OPHTH VIS SCI, V51, P6247, DOI 10.1167/iovs.10-5229; Lechanteur YTE, 2012, INVEST OPHTH VIS SCI, V53, P5846, DOI 10.1167/iovs.11-7731; Mares JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P470, DOI 10.1001/archophthalmol.2010.314; Montgomery MP, 2010, OPHTHAL EPIDEMIOL, V17, P58, DOI 10.3109/09286580903450353; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nangia V, 2010, GRAEF ARCH CLIN EXP, V248, P1657, DOI 10.1007/s00417-010-1448-0; Nazari H, 2015, PROG RETIN EYE RES, V48, P1, DOI 10.1016/j.preteyeres.2015.06.004; Nelson CP, 2015, NEW ENGL J MED, V372, P1608, DOI 10.1056/NEJMoa1404881; Njolstad I, 1996, CIRCULATION, V94, P2877; Nuesch E, 2016, INT J EPIDEMIOL, V45, P1927, DOI 10.1093/ije/dyv074; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Park CS, 2018, INT J EPIDEMIOL, V47, P289, DOI 10.1093/ije/dyx175; Park SJ, 2014, OPHTHALMOLOGY, V121, P1756, DOI 10.1016/j.ophtha.2014.03.022; Schaumberg DA, 2000, AM J CLIN NUTR, V72, P1495; Schaumberg DA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1259; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P111, DOI 10.1007/s10654-013-9867-y; Sene A, 2014, TRENDS ENDOCRIN MET, V25, P107, DOI 10.1016/j.tem.2013.10.007; Shimizu Y, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-19; Sung J, 2009, AM J EPIDEMIOL, V170, P53, DOI 10.1093/aje/kwp088; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Vavvas DG, 2016, EBIOMEDICINE, V5, P198, DOI 10.1016/j.ebiom.2016.01.033; Wannamethee SG, 1998, AM J EPIDEMIOL, V148, P1069; Xie XW, 2009, GRAEF ARCH CLIN EXP, V247, P1651, DOI 10.1007/s00417-009-1161-z; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Yip JLY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132565; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zhang QY, 2016, INVEST OPHTH VIS SCI, V57, P1276, DOI 10.1167/iovs.15-18637	45	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232593	10.1371/journal.pone.0232593	http://dx.doi.org/10.1371/journal.pone.0232593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357183	gold, Green Published			2022-12-26	WOS:000536957700041
J	Hess, S; Hiltunen, T; Berendonk, TU; Kneis, D				Hess, Stefanie; Hiltunen, Teppo; Berendonk, Thomas U.; Kneis, David			High variability of plasmid uptake rates in Escherichia coli isolated from sewage and river sediments	PLOS ONE			English	Article							POPULATION-STRUCTURE; FRESH-WATER; ANTIBIOTICS; KINETICS; SOIL	The horizontal transfer of plasmids is a key mechanism behind the spread of antibiotic resistance in bacteria. So far, transfer rate constants were measured for a variety of plasmids, donors and recipients. The employed strains typically had a long history in laboratories. Existing data are, therefore, not necessarily representative for real-world environments. Moreover, information on the inter-strain variability of plasmid transfer rates is scarce. Using a high-throughput approach, we studied the uptake of RP4 by various Escherichia coli recipients using Serratia marcescens as the donor. The recipient strains were isolated from human-borne sewage and river sediments. The rate constants of plasmid transfer generally followed a log-normal distribution with considerable variance. The rate constants for good and poor recipients (95 and 5% quantile) differed by more than three orders of magnitude. Specifically, the inter-strain variability of the rate constant was large in comparison to alterations induced by low-level antibiotic exposure. We did not find evidence for diverging efficiencies of plasmid uptake between E. coli recipients of different origin. On average, strains isolated from river bottom sediments were equally efficient in the acquisition of RP4 as isolates extracted from sewage. We conclude that E. coli strains persisting in the aquatic environment and those of direct human origin share a similar intrinsic potential for the conjugative uptake of certain plasmids. In view of the large inter-strain variability, we propose to work towards probabilistic modeling of the environmental spread of antibiotic resistance.	[Hess, Stefanie; Hiltunen, Teppo] Univ Helsinki, Dept Microbiol, Helsinki, Finland; [Hiltunen, Teppo] Univ Turku, Dept Biol, Turku, Finland; [Berendonk, Thomas U.; Kneis, David] Tech Univ Dresden, Inst Hydrobiol, Dresden, Germany; [Kneis, David] Helmholtz Ctr Environm Res, Magdeburg, Germany; [Hess, Stefanie] Tech Univ Dresden, Dept Microbiol, Dresden, Germany	Finland National Institute for Health & Welfare; University of Helsinki; University of Turku; Technische Universitat Dresden; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technische Universitat Dresden	Hess, S (corresponding author), Univ Helsinki, Dept Microbiol, Helsinki, Finland.; Kneis, D (corresponding author), Tech Univ Dresden, Inst Hydrobiol, Dresden, Germany.; Kneis, D (corresponding author), Helmholtz Ctr Environm Res, Magdeburg, Germany.; Hess, S (corresponding author), Tech Univ Dresden, Dept Microbiol, Dresden, Germany.	stefanie.hess@tu-dresden.de; david.kneis@tu-dresden.de		Hess, Stefanie/0000-0002-9293-4622	Deutsche Forschungsgemeinschaft [HE8047/1, HE8047/3]; Finnish Academy [294666]; Helsinki Institute of Life Science (HiLIFE); German Federal Ministry of Education and Research [02WU1351A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Finnish Academy(Academy of Finland); Helsinki Institute of Life Science (HiLIFE); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	S.H. received funding from Deutsche Forschungsgemeinschaft [Grant numbers HE8047/1 and HE8047/3]. T.H. was supported by the Finnish Academy [Grant number 294666] and by the Helsinki Institute of Life Science (HiLIFE). D.K. acknowledges funding from the German Federal Ministry of Education and Research [Grant number 02WU1351A]. Open access fees were generously covered by the TU Dresden publication fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASAUDI SB, 1991, J APPL BACTERIOL, V71, P239, DOI 10.1111/j.1365-2672.1991.tb04454.x; Andrup L, 1999, MICROBIOL-UK, V145, P2001, DOI 10.1099/13500872-145-8-2001; Bahl MI, 2009, PLASMID, V62, P134, DOI 10.1016/j.plasmid.2009.05.004; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BARR V, 1986, J ANTIMICROB CHEMOTH, V17, P409, DOI 10.1093/jac/17.4.409; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; Fox RE, 2008, ISME J, V2, P1024, DOI 10.1038/ismej.2008.53; Fu JL, 2017, MOL ECOL, V26, P5318, DOI 10.1111/mec.14255; GORDON DM, 1992, J GEN MICROBIOL, V138, P17, DOI 10.1099/00221287-138-1-17; Gordon DM, 2002, MICROBIOL-SGM, V148, P1513, DOI 10.1099/00221287-148-5-1513; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Hess S, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy128; Hess S, 2019, ENVIRON SCI TECHNOL, V53, P13898, DOI 10.1021/acs.est.9b03236; JACOB AE, 1975, NATURE, V255, P504, DOI 10.1038/255504a0; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Klumper U, 2015, ISME J, V9, P934, DOI 10.1038/ismej.2014.191; Kneis D, 2019, PLASMID, V101, P28, DOI 10.1016/j.plasmid.2018.12.003; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lerminiaux NA, 2019, CAN J MICROBIOL, V65, P34, DOI 10.1139/cjm-2018-0275; LEVIN BR, 1979, PLASMID, V2, P247, DOI 10.1016/0147-619X(79)90043-X; Lopatkin AJ, 2016, BIOESSAYS, V38, P1283, DOI 10.1002/bies.201600133; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Perez-Mendoza D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-71; San Millan A, 2014, ISME J, V8, P601, DOI 10.1038/ismej.2013.182; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SIMONSEN L, 1990, J GEN MICROBIOL, V136, P2319, DOI 10.1099/00221287-136-11-2319; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Vital M, 2008, ENVIRON MICROBIOL, V10, P2387, DOI 10.1111/j.1462-2920.2008.01664.x; von Wintersdorff CJH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00173; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Wang Y, 2019, ISME J, V13, P509, DOI 10.1038/s41396-018-0275-x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang PY, 2013, FEMS MICROBIOL LETT, V348, P149, DOI 10.1111/1574-6968.12282; Zhong X, 2012, J THEOR BIOL, V294, P144, DOI 10.1016/j.jtbi.2011.10.034	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232130	10.1371/journal.pone.0232130	http://dx.doi.org/10.1371/journal.pone.0232130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353032	gold, Green Published			2022-12-26	WOS:000536673200042
J	Wang, MY; Li, ZZ; Zhang, M; Wang, H; Zhang, Y; Feng, YP; Liu, YA; Chen, JH				Wang, Mengying; Li, Zhengzheng; Zhang, Meng; Wang, Hui; Zhang, Ying; Feng, Yiping; Liu, Yinan; Chen, Jinghong			Decorin knockdown affects the gene expression profile of adhesion, growth and extracellular matrix metabolism in C-28/I2 chondrocytes	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; ARTICULAR-CARTILAGE; ANIMAL-MODEL; COLLAGEN; BIGLYCAN; PROLIFERATION; INTEGRINS; RECEPTOR; BINDING; FIBRILLOGENESIS	Decorin is a member of small leucine-rich proteoglycan family, which is involved in multiple biological functions mainly as a structural and signaling molecule, and disturbances in its own metabolism plays a crucial role in the pathogenesis of osteoarthropathy. In this study, we aim to further explore the biological function of decorin and their role in human chondrocyte cell line, C28/I2. Lentivirus-mediated shRNA was applied to down-regulate decorin expression in C28/I2 chondrocytes. Effect of decorin knockdown on gene expression profiles was determined by RNA sequencing followed by bioinformatics analysis. MTT, adhesion assays and flow cytometry were used to investigate the effect of decorin knockdown on cell proliferation, adhesion, and apoptosis. sGAG content in the culture medium was determined by DMMB assay. Stably transfected C28/I2 cells were seeded onto the cancellous bone matrix gelatin (BMG) to construct tissue-engineered cartilage. The histological patterns were evaluated by H&E and Toluidine blue staining. In this study, 1780 differentially expressed genes (DEGs) including 864 up-regulated and 916 down-regulated genes were identified using RNA-Seq. The reliability of the gene expression was further verified by qRT-PCR. GO and KEGG pathway enrichment analysis revealed diverse cellular processes were affected by decorin silencing such as: cell adhesion, growth, and metabolism of extracellular matrix. In addition, we confirmed that down-regulation of decorin significantly suppressed cell proliferation and adhesion and induced apoptosis. The sGAG content in the media was significantly increased after decorin silencing. Engineered articular tissues in the decorin knockdown group exhibited cartilage destruction and proteoglycan loss as evidenced by H&E and Toluidine blue stains. Overall, this combined data helps to provide a comprehensive understanding of the roles of decorin following its knockdown in C28/I2 cells.	[Wang, Mengying; Li, Zhengzheng; Zhang, Meng; Wang, Hui; Zhang, Ying; Feng, Yiping; Liu, Yinan; Chen, Jinghong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Endem Dis, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Chen, JH (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Endem Dis, Xian, Shaanxi, Peoples R China.	jixiang46@163.com			National Natural Science Foundation of China [81573102, 81273006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Jinghong Chen, National Natural Science Foundation of China [No. 81573102, No. 81273006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh KT, 2009, OPEN DENT J, V3, P177, DOI 10.2174/1874210600903010177; Almonte-Becerril M, 2014, J ORTHOP RES, V32, P1161, DOI 10.1002/jor.22649; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Appunni S, 2019, CLIN CHIM ACTA, V491, P1, DOI 10.1016/j.cca.2019.01.003; Baghy K, 2012, J HISTOCHEM CYTOCHEM, V60, P262, DOI 10.1369/0022155412438104; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Bock HC, 2001, OSTEOARTHR CARTILAGE, V9, P654, DOI 10.1053/joca.2001.0420; Brown S, 2012, EUR SPINE J, V21, pS154, DOI 10.1007/s00586-012-2179-1; Carrillo-Garcia C, 2014, DEVELOPMENT, V141, P773, DOI 10.1242/dev.096131; Chen S, 2014, MATRIX BIOL, V35, P103, DOI 10.1016/j.matbio.2014.01.004; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; CSSZABO G, 1995, ARTHRITIS RHEUM, V38, P660, DOI 10.1002/art.1780380514; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; Ehnis T, 1997, J BIOL CHEM, V272, P20414, DOI 10.1074/jbc.272.33.20414; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Font B, 1996, MATRIX BIOL, V15, P341, DOI 10.1016/S0945-053X(96)90137-7; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Gronau T, 2017, ANN RHEUM DIS, V76, P442, DOI 10.1136/annrheumdis-2016-209319; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Han B, 2019, ACS NANO, V13, P11320, DOI 10.1021/acsnano.9b04477; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kishioka Y, 2008, J CELL PHYSIOL, V215, P856, DOI 10.1002/jcp.21371; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040; Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007; Maldonado M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284873; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Melrose J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2453; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; MIOSGE N, 1994, HISTOCHEM J, V26, P939; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; Ornitz DM, 2019, CURR TOP DEV BIOL, V133, P195, DOI 10.1016/bs.ctdb.2018.11.020; Ostergaard K, 1998, ANN RHEUM DIS, V57, P303, DOI 10.1136/ard.57.5.303; Pang XX, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01649; Petry CJ, 2005, GROWTH HORM IGF RES, V15, P363, DOI 10.1016/j.ghir.2005.07.003; Polgar A, 2003, RHEUMATOLOGY, V42, P522, DOI 10.1093/rheumatology/keg168; Poole A R, 1993, Agents Actions Suppl, V39, P3; Poole AR, 1996, J ORTHOPAED RES, V14, P681, DOI 10.1002/jor.1100140502; Rezgui D, 2009, J MOL ENDOCRINOL, V42, P341, DOI 10.1677/JME-08-0154; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Tian J, 2015, RHEUMATOL INT, V35, P787, DOI 10.1007/s00296-014-3137-5; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; van Lent PLEM, 2005, ARTHRITIS RES THER, V7, pR885, DOI 10.1186/ar1760; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Wu HJ, 2008, NEPHROLOGY, V13, P607, DOI 10.1111/j.1440-1797.2008.00961.x; Xiao J, 2014, MOL MED REP, V10, P2409, DOI 10.3892/mmr.2014.2506; Yang B, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045003; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058; Young AA, 2005, ARTHRITIS RES THER, V7, pR852, DOI 10.1186/ar1756; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	67	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232321	10.1371/journal.pone.0232321	http://dx.doi.org/10.1371/journal.pone.0232321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353084	gold, Green Published			2022-12-26	WOS:000536673200076
J	Hoddinott, J; Dorosh, P; Filipski, M; Rosenbach, G; Tiburcio, E				Hoddinott, John; Dorosh, Paul; Filipski, Mateusz; Rosenbach, Gracie; Tiburcio, Ernesto			Food transfers, electronic food vouchers and child nutritional status among Rohingya children living in Bangladesh	PLOS ONE			English	Article								Objective To examine associations between receipt of an electronic food voucher (e-voucher) compared to food rations on the nutritional status of Rohingya children living in refugee camps in Bangladesh. Methods This is an associational study using cross-sectional data. We measured heights and weights of 523 children aged between 6 and 23 months in households receiving either a food ration consisting of rice, pulses, vegetable oil (362 children) or an e-voucher (161 children) that could be used to purchase 19 different foods. Data were also collected on the characteristics of their mothers and the households in which they lived, including household demographics, consumption and expenditure, coping strategies, livelihoods and income profiles, and access to assistance. Associations between measures of anthropometric status (height-for-age z scores, stunting, weight-for-height z scores, wasting, weight-for-age z scores and mid-upper arm circumference) and household receipt of the e-voucher were estimated using ordinary least squares regressions. Control variables included child, maternal, household and locality characteristics. The study received ethical approval from the Institutional Review Board of the International Food Policy Research Institute, Washington DC. Results Household receipt of an e-voucher was associated with improved linear growth in children. This association is robust to the inclusion of maternal, household and location characteristics. The magnitude of the association is 0.38 SD (CI: 0.01, 0.74), and statistically significant at the five percent level. We cannot reject the null hypothesis that these associations differ by child sex. Receipt of an e-voucher is not associated with stunting when a full set of control variables are included. There is no association between receipt of e-vouchers and weight-for-length, weight-for-age or mid-upper arm circumference. We cannot reject the null hypothesis that these associations differ by child sex. Conclusions In a humanitarian assistance setting, Rohingya refugee camps in Bangladesh, household receipt of an electronic food voucher instead of a food ration is associated with improvements in the linear growth of children between 6 and 23 months but not in measures of acute undernutrition or other anthropometric outcomes. Our associational evidence indicates that transitioning from food rations to electronic food vouchers does not adversely affect child nutritional status.	[Hoddinott, John] Cornell Univ, Ithaca, NY 14850 USA; [Hoddinott, John; Dorosh, Paul; Filipski, Mateusz; Rosenbach, Gracie; Tiburcio, Ernesto] Int Food Policy Res Inst IFPRI, Washington, DC 20005 USA; [Filipski, Mateusz] Univ Georgia, Athens, GA 30602 USA; [Tiburcio, Ernesto] Tufts Univ, Medford, MA 02155 USA	Cornell University; CGIAR; International Food Policy Research Institute (IFPRI); University System of Georgia; University of Georgia; Tufts University	Hoddinott, J (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.; Hoddinott, J (corresponding author), Int Food Policy Res Inst IFPRI, Washington, DC 20005 USA.	jfh246@cornell.edu		Dorosh, Paul/0000-0001-6049-6018; Hoddinott, John/0000-0002-0590-3917; Filipski, Mateusz/0000-0002-8997-0980				Barder, 2015, DOING CASH DIFFERENT; Bliss J, 2018, J GLOB HEALTH, V8, P1; Food Security Cluster (FSC), 2018, ROUND 24 FSS GEN FOO; Gentilini U, 2016, WORLD BANK RES OBSER, V31, P135, DOI 10.1093/wbro/lkv012; Grellety E, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0848-y; Hidrobo M, 2014, J DEV ECON, V107, P144, DOI 10.1016/j.jdeveco.2013.11.009; Hoddinott J, 2019, SAFETY NETS 2019; ISCG (Inter Sector Coordination Group), 2019, SIT REP ROH REF CRIS; Mahmood SS, 2017, LANCET, V389, P1841, DOI 10.1016/S0140-6736(16)00646-2; Seal A., 2017, REFANI SYNTHESIS REP; Semba RD, 2016, ADV NUTR, V7, P853, DOI 10.3945/an.116.013276; SMART, 2020, STAND MON ASS REL TR; Strategic Executive Group, 2018, JRP ROH HUM CRIS; UNHCR, GLOB TRENDS FORC DIS; UNICEF, 1997, STAT WORLDS CHILDR; WHO, 2006, WHO CHILD GROWTH STA; Woodward A, 2018, J INT HUMANITARIAN A, V3; World Food Programme (WFP), 2018, YEAR ROH REF EM RESP; Zaheer M, 2019, PROCEEDINGS OF THE TWELFTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'19), P186, DOI 10.1145/3289600.3291036	19	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0230457	10.1371/journal.pone.0230457	http://dx.doi.org/10.1371/journal.pone.0230457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348313	Green Published, gold			2022-12-26	WOS:000536668200009
J	Kalokora, OJ; Buriyo, AS; Asplund, ME; Gullstrom, M; Mtolera, MSP; Bjork, M				Kalokora, Olivia J.; Buriyo, Amelia S.; Asplund, Maria E.; Gullstrom, Martin; Mtolera, Matern S. P.; Bjork, Mats			An experimental assessment of algal calcification as a potential source of atmospheric CO2	PLOS ONE			English	Article							SEAGRASS PHOTOSYNTHESIS; CORAL-REEFS; ECOSYSTEM SERVICES; INORGANIC CARBON; CHEMISTRY; ZANZIBAR; DIOXIDE; MEADOWS	Marine vegetated ecosystems such as seagrass meadows are increasingly acknowledged as important carbon sinks based on their ability to capture and store atmospheric carbon dioxide, thereby contributing to climate change mitigation. Most studies on carbon storage in marine ecosystems have focused on organic carbon, leaving inorganic carbon processes such as calcification unaccounted for, despite of their critical role in the global carbon budget. This is probably because of uncertainties regarding the role of calcification in marine carbon budgets as either atmospheric CO2 source or sink. Here, we conducted a laboratory experiment to investigate the influence of a calcifying alga (Corallina officinalis L.) on seawater carbon content, using a non-calcifying alga (Ulva lactuca L.) as a control. In a first part, algae were incubated separately while measuring changes in seawater pH, total alkalinity (TA) and total dissolved inorganic carbon (DIC). The amount of carbon used in photosynthetic uptake and production of CaCO3 was then calculated. In a second, directly following, part the algae were removed and DIC levels were allowed to equilibrate with air until the pH stabilized and the loss of CO2 to air was calculated as the difference in total DIC from the start of part one, to the end of the second part. The results showed that C. officinalis caused a significant and persistent reduction in total dissolved inorganic carbon (DIC), TA and seawater pH, while no such permanent changes were caused by U. lactuca. These findings indicate that calcification can release a significant amount of CO2 to the atmosphere and thereby possibly counteract the carbon sequestration in marine vegetated ecosystems if this CO2 is not re-fixed in the system. Our research emphasises the importance of considering algal calcification in future assessments on carbon storage in coastal areas.	[Kalokora, Olivia J.] Dar Es Salaam Univ, Coll Educ DUCE, Dar Es Salaam, Tanzania; [Kalokora, Olivia J.; Buriyo, Amelia S.] Univ Dar Es Salaam, Dept Bot, Dar Es Salaam, Tanzania; [Asplund, Maria E.] Univ Gothenburg, Dept Marine Sci, Kristineberg, Fiskebackskil, Sweden; [Gullstrom, Martin; Bjork, Mats] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Gullstrom, Martin] Univ Gothenburg, Dept Biol & Environm Sci, Kristineberg, Fiskebackskil, Sweden; [Mtolera, Matern S. P.] Univ Dar Es Salaam, Inst Marine Sci, Zanzibar, Tanzania	University of Dar es Salaam; University of Dar es Salaam; University of Gothenburg; Stockholm University; University of Gothenburg; University of Dar es Salaam	Bjork, M (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden.	mats.bjork@su.se	Buriyo, Amelia/ABE-2981-2020; Björk, Mats/B-4299-2010	Björk, Mats/0000-0003-0363-110X	Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Programme Sweden; Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Programme Tanzania	Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Programme Sweden; Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Programme Tanzania	The participation of OJK, ASB and MSPM in this project was financed by the Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Programme between Sweden and Tanzania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Beer S., 2014, PHOTOSYNTHESIS MARIN; Bjork M, 1997, MAR BIOL, V129, P363, DOI 10.1007/s002270050176; Bjork M, 2009, SEAGRASS WATCH NEWS, V37; Brandano M, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00074; Brandano M, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00072; Buapet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083804; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Cullen-Unsworth L, 2013, ENVIRONMENT, V55, P14, DOI 10.1080/00139157.2013.785864; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Frankignoulle M, 1995, NATO ASI SERIES; Gattuso JP, 1999, AM ZOOL, V39, P160; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Gullstrom M, 2018, ECOSYSTEMS, V21, P551, DOI 10.1007/s10021-017-0170-8; Invers O, 1997, AQUAT BOT, V59, P185, DOI 10.1016/S0304-3770(97)00072-7; Invers O, 2001, J EXP MAR BIOL ECOL, V265, P203, DOI 10.1016/S0022-0981(01)00332-X; JENSEN PR, 1985, DEEP-SEA RES, V32, P451, DOI 10.1016/0198-0149(85)90091-3; Kennedy H, 2009, MANAGEMENT NATURAL C, P23; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Macreadie PI, 2017, LIMNOL OCEANOGR LETT, V2, P195, DOI 10.1002/lol2.10052; Mazarrasa I, 2015, BIOGEOSCIENCES, V12, P4993, DOI 10.5194/bg-12-4993-2015; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; Pelletier G, 1997, CO2 SYS XLS VERSION; PENTECOST A, 1978, BRIT PHYCOL J, V13, P383, DOI 10.1080/00071617800650431; Ruiz-Frau A, 2017, OCEAN COAST MANAGE, V149, P107, DOI 10.1016/j.ocecoaman.2017.10.004; Russell BD, 2013, MAR POLLUT BULL, V73, P463, DOI 10.1016/j.marpolbul.2013.01.031; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Semesi IS, 2009, MAR ECOL PROG SER, V382, P41, DOI 10.3354/meps07973; SMITH SV, 1975, LIMNOL OCEANOGR, V20, P493, DOI 10.4319/lo.1975.20.3.0493; WARE JR, 1992, CORAL REEFS, V11, P127, DOI 10.1007/BF00255465	32	5	5	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231971	10.1371/journal.pone.0231971	http://dx.doi.org/10.1371/journal.pone.0231971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348324	Green Published, gold			2022-12-26	WOS:000536668200033
J	Langsrud, S; Sorheim, O; Skuland, SE; Almli, VL; Jensen, MR; Grovlen, MS; Ueland, O; Moretro, T				Langsrud, Solveig; Sorheim, Oddvin; Skuland, Silje Elisabeth; Almli, Valerie Lengard; Jensen, Merete Rusas; Grovlen, Magnhild Seim; Ueland, Oydis; Moretro, Trond			Cooking chicken at home: Common or recommended approaches to judge doneness may not assure sufficient inactivation of pathogens	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI STRAINS; POULTRY MEAT; FOOD SAFETY; SOURCE ATTRIBUTION; THERMAL INACTIVATION; COLOR CHANGES; RISK-FACTORS; BREAST MEAT; SALMONELLA; SURVIVAL	About one third of foodborne illness outbreaks in Europe are acquired in the home and eating undercooked poultry is among consumption practices associated with illness. The aim of this study was to investigate whether actual and recommended practices for monitoring chicken doneness are safe. Seventy-five European households from five European countries were interviewed and videoed while cooking chicken in their private kitchens, including young single men, families with infants/in pregnancy and elderly over seventy years. A cross-national web-survey collected cooking practices for chicken from 3969 households. In a laboratory kitchen, chicken breast fillets were injected with cocktails of Salmonella and Campylobacter and cooked to core temperatures between 55 and 70 degrees C. Microbial survival in the core and surface of the meat were determined. In a parallel experiment, core colour, colour of juice and texture were recorded. Finally, a range of cooking thermometers from the consumer market were evaluated. The field study identified nine practical approaches for deciding if the chicken was properly cooked. Among these, checking the colour of the meat was commonly used and perceived as a way of mitigating risks among the consumers. Meanwhile, chicken was perceived as hedonically vulnerable to long cooking time. The quantitative survey revealed that households prevalently check cooking status from the inside colour (49.6%) and/or inside texture (39.2%) of the meat. Young men rely more often on the outside colour of the meat (34.7%) and less often on the juices (16.5%) than the elderly (>65 years old; 25.8% and 24.6%, respectively). The lab study showed that colour change of chicken meat happened below 60 degrees C, corresponding to less than 3 log reduction of Salmonella and Campylobacter. At a core temperature of 70 degrees C, pathogens survived on the fillet surface not in contact with the frying pan. No correlation between meat texture and microbial inactivation was found. A minority of respondents used a food thermometer, and a challenge with cooking thermometers for home use was long response time. In conclusion, the recommendations from the authorities on monitoring doneness of chicken and current consumer practices do not ensure reduction of pathogens to safe levels. For the domestic cook, determining doneness is both a question of avoiding potential harm and achieving a pleasurable meal. It is discussed how lack of an easy "rule-of-thumb" or tools to check safe cooking at consumer level, as well as national differences in contamination levels, food culture and economy make it difficult to develop international recommendations that are both safe and easily implemented.	[Langsrud, Solveig; Sorheim, Oddvin; Almli, Valerie Lengard; Jensen, Merete Rusas; Grovlen, Magnhild Seim; Ueland, Oydis; Moretro, Trond] Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway; [Skuland, Silje Elisabeth] Oslo Metropolitan Univ, Consumpt Res Norway SIFO, Oslo, Norway	Nofima; Oslo Metropolitan University (OsloMet)	Langsrud, S (corresponding author), Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway.	Solveig.langsrud@nofima.no	Langsrud, Solveig/I-1241-2012; Moretro, Trond/AAZ-5689-2021	Langsrud, Solveig/0000-0001-6415-017X; Moretro, Trond/0000-0001-5176-1158; Almli, Valerie/0000-0001-9641-3333	European Commission [727580]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by the European Commission through a grant, as part of the H2020 research project: Safeconsume (Grant Agreement No. 727580). SL, OS, VLA, MRJ, MSG, OU, and TM are employed by and recieve salary from Nofima AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Participants in SafeConsume (www.safeconsume.eu) are acknowledged for collecting field work data. Joachim Scholderer (University of Zurich) is acknowledged for being in charge of the survey data collection. We will thank Tove Maugesten for excellent technical laboratory assistance and Birgitte Moen for support on sequencing. Paula Teixeira (Catholic University of Porto), Susanne Knochel (University of Copenhagen) and Zsuzsanna Sreterne Lancz (National Food chain Safety Office, Hungary) are thanked for providing strains. Finally, Anca Nicolau (University Dunarea de Jos Galati) and Paula Teixeira are thanked for valuable discussions about the manuscript.	Abramson J., 2006, FOOD CULTURE FRANCE; Alter T, 2005, FOOD MICROBIOL, V22, P345, DOI 10.1016/j.fm.2004.08.008; [Anonymous], 2015, ESTIMATES GLOBAL BUR; [Anonymous], 5 KEYS SAF FOOD; Bae SM, 2018, KOREAN J FOOD SCI AN, V38, P417, DOI 10.5851/kosfa.2018.38.2.417; Barbanti D, 2005, LWT-FOOD SCI TECHNOL, V38, P895, DOI 10.1016/j.lwt.2004.08.017; Bergsma NJ, 2007, BRIT FOOD J, V109, P548, DOI 10.1108/00070700710761536; Bjorkhaug H, 2017, CHICKEN GAME ORG INT, P45; Bruhn C. M., 2014, Food Protection Trends, V34, P318; Byrd-Bredbenner C, 2007, BRIT FOOD J, V109, P519, DOI 10.1108/00070700710761518; Cebrian G, 2017, FOODS, V6, DOI 10.3390/foods6120107; Chen YX, 2016, FOODBORNE PATHOG DIS, V13, P689, DOI 10.1089/fpd.2016.2170; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P959, DOI 10.1017/S0950268811002172; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Feng YH, 2019, J FOOD PROTECT, V82, P128, DOI [10.4315/0362-028X.JFP-18-245, 10.4315/0362-028x.jfp-18-245]; Fischer ARH, 2005, SRA ANN M 2004 RISK; Fischer ARH, 2007, RISK ANAL, V27, P1065, DOI 10.1111/j.1539-6924.2007.00944.x; Fletcher DL, 2000, POULTRY SCI, V79, P784, DOI 10.1093/ps/79.5.784; Food Standards Agency UK, CAMP 2018; Glass K, 2016, RISK ANAL, V36, P561, DOI 10.1111/risa.12444; Helstosky C., 2009, FOOD CULT MED; Hoelzl C, 2013, J FOOD PROTECT, V76, P482, DOI 10.4315/0362-028X.JFP-12-231; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Jolley K, 2018, WELLCOME OPEN RES, V24, DOI [10.12688/vvelicerneepenres.4826.1, DOI 10.12688/VVELICERNEEPENRES.4826.1]; Kim JH, 2015, KOREAN J FOOD SCI AN, V35, P585, DOI 10.5851/kosfa.2015.35.5.585; Laureati M, 2020, FOOD QUAL PREFER, V80, DOI 10.1016/j.foodqual.2019.103828; Lay KS, 2011, J VET MED SCI, V73, P325, DOI 10.1292/jvms.10-0373; Liu MN, 2009, J MUSCLE FOODS, V20, P138, DOI 10.1111/j.1745-4573.2009.00140.x; LIU TS, 1968, POULTRY SCI, V47, P1155, DOI 10.3382/ps.0471155; Luber P, 2007, J APPL MICROBIOL, V102, P313, DOI 10.1111/j.1365-2672.2006.03105.x; Luber P, 2009, INT J FOOD MICROBIOL, V134, P21, DOI 10.1016/j.ijfoodmicro.2009.02.012; LYON CE, 1976, POULTRY SCI, V55, P2059; Magdelaine P, 2008, WORLD POULTRY SCI J, V64, P53, DOI [10.1017/S0043933907001717, 10.1079/PNS2004409]; Maughan C, 2019, J FOOD PROTECT, V82, P528, DOI 10.4315/0362-028X.JFP-18-392; Maughan C, 2016, J FOOD PROTECT, V79, P970, DOI 10.4315/0362-028X.JFP-15-311; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Membre JM, 2007, J FOOD PROTECT, V70, P2036, DOI 10.4315/0362-028X-70.9.2036; NG H, 1969, APPL MICROBIOL, V17, P78, DOI 10.1108/03321649810202991; On SLW, 2006, INT J MED MICROBIOL, V296, P353, DOI 10.1016/j.ijmm.2006.03.002; Rabeler F, 2019, FOOD CONTROL, V104, P42, DOI 10.1016/j.foodcont.2019.04.018; Rabeler F, 2018, FOOD BIOPROCESS TECH, V11, P1495, DOI 10.1007/s11947-018-2123-4; Roccato A, 2015, INT J FOOD MICROBIOL, V197, P1, DOI 10.1016/j.ijfoodmicro.2014.12.007; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Safefood Ireland, 2019, COOK MEAT SAF 2019; Sampers I, 2010, INT J FOOD MICROBIOL, V137, P147, DOI 10.1016/j.ijfoodmicro.2009.11.013; Sanlier N, 2009, FOOD CONTROL, V20, P538, DOI 10.1016/j.foodcont.2008.08.006; Skuland S.E., 2020, EUROPEAN FOOD SAFETY; Skunca D, 2017, BRIT FOOD J, V119, P1525, DOI 10.1108/BFJ-11-2016-0547; Stephen D., 2018, INT J ENG TECHNOLOGY, V7, P4, DOI [https://doi.org/10.14419/ijet.v7i3.18.16662, DOI 10.14419/IJET.V7I3.18.16662]; Straver JM, 2007, J FOOD PROTECT, V70, P2045, DOI 10.4315/0362-028X-70.9.2045; Suman SP, 2013, ANNU REV FOOD SCI T, V4, P79, DOI 10.1146/annurev-food-030212-182623; The European Food Information Council, FOOD HYG PREV FOODB; Tomescu A. M., 2014, 22nd Biennial International Congress, Tourism & Hospitality Industry 2014 (THI2014), Trends and challenges, Opatija, Croatia, 8-9 May 2014, P677; United States Department of Agriculture, 2011, FOOD SAF INF KITCH T; USDA, SAF MIN INT TEMP CHA; van Asselt ED, 2006, INT J FOOD MICROBIOL, V107, P73, DOI 10.1016/j.ijfoodmicro.2005.08.014; Wideman N, 2016, WORLD POULTRY SCI J, V72, P353, DOI 10.1017/S0043933916000015; Wills WJ, 2015, APPETITE, V85, P118, DOI 10.1016/j.appet.2014.11.022; Young A, 2016, CLIN J AM SOC NEPHRO, V11, P12, DOI 10.2215/CJN.12291115; Ziehm D, 2015, EPIDEMIOL INFECT, V143, P687, DOI 10.1017/S095026881400140X	61	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0230928	10.1371/journal.pone.0230928	http://dx.doi.org/10.1371/journal.pone.0230928			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348316	gold, Green Published			2022-12-26	WOS:000536668200011
J	Ongtengco, N; Thiam, H; Collins, Z; De Jesus, EL; Peterson, CE; Wang, TX; Hendrix, E; Ndiaye, Y; Gueye, B; Gassama, O; Kasse, AA; Faye, A; Smith, JS; Fitzgibbon, M; Dykens, JA				Ongtengco, Natalia; Thiam, Hamidou; Collins, Zola; De Jesus, Elly Lou; Peterson, Caryn E.; Wang, Tianxiu; Hendrix, Ellen; Ndiaye, Youssoupha; Gueye, Babacar; Gassama, Omar; Kasse, Abdoul Aziz; Faye, Adama; Smith, Jennifer S.; Fitzgibbon, Marian; Dykens, Jon Andrew			Role of gender in perspectives of discrimination, stigma, and attitudes relative to cervical cancer in rural Senegal	PLOS ONE			English	Article							HIV-RELATED STIGMA; VACCINE ACCEPTABILITY; HEALTH; MEN; SEEKING; RISK	Cervical cancer is the leading cause of female cancer deaths in Senegal which is ranked 17th in incidence globally, however, the screening rate there is very low. Nuanced gendered perceptions and health behaviors of both women and men play a significant role in women's health. Our study analyzed gender differences on perceptions of gender roles, discrimination, cancer attitudes, cancer stigma, and influences in healthcare decision making within our study population to inform ongoing cervical cancer prevention work in the rural region of Kedougou, Senegal. We conducted a cross-sectional survey of 158 participants, 101 women and 57 men (ages 30-59) across nine non-probability-sampled communities from October 2018 through February 2019. Bivariate analysis was conducted to assess gender differences across all variables. We also conducted analyses to determine whether there were significant differences in beliefs and attitudes, by screening behavior and by education. We found significant gender differences regarding the perception of a woman's role (P < 0.001) and a man's role (P = 0.007) as well as in the everyday discrimination questions of "decreased respect by spouse" (P < 0.001). Regarding cancer stigma, among women, 18.00% disagreed and 10.00% strongly disagreed while among men, 3.6% disagreed and 1.8% strongly disagreed that "If I had cancer, I would want my family to know that I have it." When making decisions about one's healthcare, women are more likely than men to trust social contacts such as their spouse (46.5% vs 5.3%, p < 0.001) while men are more likely than women to trust health service personnel such as a nurse (50.9% vs 18.8%, p < 0.001). Furthermore, men and women were both more likely to state that men have the final decision regarding the healthcare decisions of women (p < 0.001). Our data reveal structural disadvantages for women within our study population as well as gender differences in the adapted everyday discrimination scale and cancer stigma scale. Higher rates of both personal and perceived cancer stigma among women has profound implications for how population and community level communication strategies for cancer prevention and control should be designed. Efforts to advance the goal of the elimination of cervical cancer should, in the short-term, seek to gain a more profound understanding of the ways that gender, language, and other social determinants impact negative social influences and other barriers addressable through interventions. Social and behavior change communication may be one approach that can focus both on education while seeking to leverage the social influences that exist in achieving immediate and long-term goals.	[Ongtengco, Natalia] Univ Illinois, Chicago, IL USA; [Thiam, Hamidou] Kedougou Med Reg, Off Training Supervis & Res, Kedougou, Senegal; [Collins, Zola; De Jesus, Elly Lou; Peterson, Caryn E.; Wang, Tianxiu; Hendrix, Ellen; Fitzgibbon, Marian; Dykens, Jon Andrew] Univ Chicago, Inst Hlth Res & Policy, Chicago, IL 60637 USA; [Peterson, Caryn E.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Peterson, Caryn E.; Fitzgibbon, Marian; Dykens, Jon Andrew] Univ Chicago, Ctr Canc, Chicago, IL 60637 USA; [Ndiaye, Youssoupha] Senegal Minist Hlth & Social Act, Div Planning Res & Stat, Dakar, Senegal; [Gueye, Babacar] Senegal Minist Hlth & Social Act, Div Noncommunicable Dis, Ctr Dis Control, Dakar, Senegal; [Gassama, Omar] Univ Cheikh Anta Diop, Serv Obstet & Gynecol, Dakar, Senegal; [Kasse, Abdoul Aziz] Univ Cheikh Anta Diop, Inst Canc, Dakar, Senegal; [Faye, Adama] Univ Cheikh Anta Diop, Inst Hlth & Dev, Dakar, Senegal; [Smith, Jennifer S.] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Dykens, Jon Andrew] Univ Illinois, Coll Med, Ctr Global Hlth, Chicago, IL 60680 USA; [Dykens, Jon Andrew] Univ Illinois, Coll Med, Dept Family Med, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dykens, JA (corresponding author), Univ Chicago, Inst Hlth Res & Policy, Chicago, IL 60637 USA.; Dykens, JA (corresponding author), Univ Chicago, Ctr Canc, Chicago, IL 60637 USA.; Dykens, JA (corresponding author), Univ Illinois, Coll Med, Ctr Global Hlth, Chicago, IL 60680 USA.; Dykens, JA (corresponding author), Univ Illinois, Coll Med, Dept Family Med, Chicago, IL 60680 USA.	jdykens@uic.edu	; Dykens, Andrew/N-6983-2018	Hendrix, Ellen/0000-0003-3998-7183; De Jesus, Elly Lou/0000-0001-7719-231X; Dykens, Andrew/0000-0002-4194-8725	Fogarty International Center of the National Institutes of Health [K01TW010494]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under Award Number K01TW010494 to JAD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; The authors would like to acknowledge and thank the following individuals including all officials at the Kedougou regional level including Cheikh Senghor MD and Dr. David Ngom MD. We are also grateful to other health system personnel at the Kedougou district: Fatoumata Traore, Moussa Ndiaye MD, Marguerite Thiare, Bakary Boubou Traore, the Saraya District: Evrard Kabou MD, Daouda Gueye, and the Salemata District: Mamadou Moustapha Thioub. We are also extraordinarily indebted to the local research assistants who ensured that all of the work was accomplished. These amazing individuals include Hawa Diallo, Fatoumata Dia, Dib Faye, Tahibou Niang, Lamine Doucare, Moussa Salife Didibe, and Moussoucouta Samoura. We are also very grateful to the Peace Corps administrators and volunteers who have provided in-kind support for this project over the years. These extraordinary individuals include Chris Hedrick, Cheryl Faye, Mamadou Diaw, Vanessa Dickey, Maureen Cunningham, Adji Thiaw, Imane Sene, Pape Camara, Chris Brown, Leah Moriarty, Meera Sarathy, Marielle Goyette, Larocha LaRiviere, Chip Ko, Ivy Renfro, AnneLinn, Patrick Linn, Katie Wallner, Chris Coox, Sarah Mollenkopf, Aaron Persing, Tess Komarek, Laurie Ohlstein, Emily Johnson, Arielle Kempinsky, Lesa Young, Carmen Dibaya, Maria Castrillon, Ethan Quinn, Gracey McGrory, Aaron Macoubray, Sherry Vazhayil, Ashley Prettyman, Hans-Martin Ishida, Brendan Gray, Elizabeth Costello, Emma Murphy, Cason Kirby, Emma Luu Van Lang, and Gina Siedow. In addition, we are grateful for those who have provided in-kind support from the University of Illinois at Chicago for this project. Many thanks to John Hickner MD, Memoona Hasnain MD MHPE PhD, Stevan Weine MD, Marc Atkins PhD, Michael Berbauma PhD as well as those who have supported the grant management at the Institute of Health Policy and Research including Julieth Pineros, Erika Magallenos, Rocio Bueno, and Przemyslaw Racinski among many others. We are also grateful to David Peters MD DrPH for mentorship in the development of this project.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allen JD, 2010, VACCINE, V28, P4027, DOI 10.1016/j.vaccine.2010.03.063; [Anonymous], 2019, CANC N AM 2012 2016; Aranda S, 2017, INT J GYNECOL OBSTET, V138, P4, DOI 10.1002/ijgo.12182; Benoit C, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0206-7; Braunschweiger P, 2007, ACAD MED, V82, P861, DOI 10.1097/ACM.0b013e31812f7770; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L, 2019, HUMAN PAPILLIMAVIRUS; Bruni L.A.G., 2018, ICO IARC INFORM CTR; Daley EM, 2015, J HEALTH PSYCHOL, V20, P1073, DOI 10.1177/1359105313507963; Dao NT, 2014, INT J GERIATR PSYCH, V29, P987, DOI 10.1002/gps.4125; De Abreu CS, 2015, SOCIOCULTURAL FACTOR; Dykens JA, 2017, INT J WOMENS HEALTH, V9, P59, DOI 10.2147/IJWH.S115454; Ferlay J, 2018, GLOBAL CANC OBSERVAT; Freeman Harold P, 2005, Surg Oncol Clin N Am, V14, P655, DOI 10.1016/j.soc.2005.06.002; Haynes VE, 2019, SOCIOCULTURAL FACTOR; Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X; Hou XH, 2013, HEALTH POLICY PLANN, V28, P176, DOI 10.1093/heapol/czs042; Jacobs EA, 2014, J WOMENS HEALTH, V23, P138, DOI 10.1089/jwh.2013.4328; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Kakinami L, 2008, AIDS CARE, V20, P542, DOI 10.1080/09540120701867180; Karamouzian M, 2017, VULNERABLE CHILD YOU, V12, P241, DOI 10.1080/17450128.2016.1274462; Khan N, 2015, PAK J MED SCI, V31, P1432, DOI 10.12669/pjms.316.8454; Marlow LAV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-285; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Mugoya GCT, 2014, AIDS CARE, V26, P206, DOI 10.1080/09540121.2013.808733; Nam SK, 2010, J AM COLL HEALTH, V59, P110, DOI 10.1080/07448481.2010.483714; Newman PA, 2013, SEX TRANSM INFECT, V89, P568, DOI 10.1136/sextrans-2012-050980; Onah MN, 2018, SOC SCI MED, V204, P84, DOI 10.1016/j.socscimed.2018.03.033; Pedersen ER, 2014, PSYCHIAT RES, V219, P143, DOI 10.1016/j.psychres.2014.05.017; Poirier J, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1957; Pryor John B., 2013, Yale Journal of Biology and Medicine, V86, P189; Reid AE, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P263, DOI 10.1007/978-0-387-09488-5_19; Rogers EM., 2010, INTEGRATED APPROACH; Sabado P., 2014, EXPLORING INDIVIDUAL; Travis CB, 2012, WOMEN THER, V35, P207, DOI 10.1080/02703149.2012.684589; Treves-Kagan S, 2017, AIDS BEHAV, V21, P2579, DOI 10.1007/s10461-016-1671-8; WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002	39	7	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232291	10.1371/journal.pone.0232291	http://dx.doi.org/10.1371/journal.pone.0232291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8WP	32343755	gold, Green Published			2022-12-26	WOS:000536661300050
J	Ticha, K; Simon, OP; Houska, J; Pelakova, L; Douda, K				Ticha, Kamila; Simon, Ondrej P.; Houska, Jakub; Pelakova, Lucie; Douda, Karel			Helocrenic springs as sources of nutrient rich fine particulate organic matter in small foothill watershed	PLOS ONE			English	Article							RIVER CONTINUUM; FRESH-WATER; DETRITAL STOICHIOMETRY; HEADWATER STREAMS; MATERIAL FLOWS; DYNAMICS; TRANSPORT; CONNECTIVITY; CONSERVATION; DEPOSITION	Despite the large number of studies devoted to organic matter dynamics in fluvial ecosystems, the detrital pathways of spring headwater systems remain neglected. In particular, spring wetlands (helocrenes or seepages) might have considerable influence on downstream headwater stream systems due to the alteration of the nutrient and organic matter content of the water. In this study, we examined fine particulate organic matter (FPOM) drained from helocrenic springs to describe its downstream transport. We studied the quantity, nutrient content and physical components of FPOM gathered from the outflowing water using continuous sediment samplers. The nutrient content of local leaf litter deposits, residence time of water in the springs and concentration of dissolved nutrients in spring sources and outflows were also measured to characterize the inputs and outputs of the studied system. The results show that headwater spring wetlands represent a significant source of high-quality FPOM for downstream river networks. The estimated concentration of FPOM (< 1000 mu m) in the 11 investigated springs was 3.1 +/- 2.5 mg.L-1. In general, the FPOM was relatively nutrient-rich ( N = 19.25 +/- 4.73 mg.L-1; P = 2.04 +/- 0.78 mg.L-1; Ca = 9.65 +/- 2.63 mg. L-1; S = 4.07 +/- 1.16 mg.L-1; C = 278.68 +/- 80.81 mg.L-1). The C:N and C:P ratios in the local leaf litter deposits were higher than in FPOM (41.04 +/- 14.32 vs. 14.70 +/- 2.46 and 591.7 +/- 168.83 vs. 154,77 +/- 64,73, respectively), indicating that suspended FPOM is more nutritious for consumers. A significant trend in terms of size fractions of FPOM was identified: with decreasing C:N and C:P ratios particle size decreases as well. Overall, the data suggest that the relatively small helocrenes can serve as an organic matter transformers, receiving primary particles and dissolved organic matter, transforming them and favouring their transport downstream. These biotopes may represent a substantial discontinuity of the river continuum at its origin, important for nutrient dynamics and food supply of associated biotic communities.	[Ticha, Kamila; Simon, Ondrej P.] TGM Water Res Inst, Branch Appl Ecol, Dept Special Hydrobiol & Ecol, Prague, Czech Republic; [Ticha, Kamila; Simon, Ondrej P.; Pelakova, Lucie] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Houska, Jakub] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Soil Sci & Soil Protect, Prague, Czech Republic; [Douda, Karel] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic	T.G. Masaryk Water Research Institute; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Ticha, K (corresponding author), TGM Water Res Inst, Branch Appl Ecol, Dept Special Hydrobiol & Ecol, Prague, Czech Republic.; Ticha, K (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	kamila.ticha@vuv.cz	Simon, Ondřej/HDN-5128-2022; Houska, Jakub/K-4404-2012; Douda, Karel/D-4759-2011; Simon, Ondrej P./E-5560-2013	Houska, Jakub/0000-0003-2163-4486; Douda, Karel/0000-0002-7778-5147; Simon, Ondrej P./0000-0002-4580-3216	Ministry of Environment of the Czech Republic [MZP 0002071101]; Czech Science Foundation [1305872S]; IGA, Czech University of Life Sciences Prague [2010/42110/019]	Ministry of Environment of the Czech Republic; Czech Science Foundation(Grant Agency of the Czech Republic); IGA, Czech University of Life Sciences Prague	KT, OPS, LP: grant nr. MZP 0002071101, Ministry of Environment of the Czech Republic (https://www.mzp.cz/en) KD, JH: grant nr. 1305872S, Czech Science Foundation (https://gacr.cz/en/) KT, LP: IGA grant nr. 2010/42110/019, Czech University of Life Sciences Prague (https://www.czu.cz/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Laurie C., 2018, Journal of the American Water Resources Association, V54, P287, DOI 10.1111/1752-1688.12630; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; ANDERSON NH, 1979, ANNU REV ENTOMOL, V24, P351, DOI 10.1146/annurev.en.24.010179.002031; [Anonymous], 2007, ISO 11885; Audorff V, 2011, J LIMNOL, V70, P9, DOI 10.4081/jlimnol.2011.s1.9; Barquin J, 2011, J LIMNOL, V70, P134, DOI 10.4081/jlimnol.2011.s1.134; Benstead JP, 2009, ECOLOGY, V90, P2556, DOI 10.1890/08-0862.1; Cantonati M, 2020, ECOL INDIC, V110, DOI 10.1016/j.ecolind.2019.105803; Cantonati M, 2012, FRESHW SCI, V31, P463, DOI 10.1899/11-111.1; Cerna M, 2018, HYDROBIOLOGIA, V810, P393, DOI 10.1007/s10750-017-3236-x; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Cross WF, 2007, ECOLOGY, V88, P2563, DOI 10.1890/06-1348.1; CUFFNEY TF, 1988, CAN J FISH AQUAT SCI, V45, P2010, DOI 10.1139/f88-234; CUSHING CE, 1993, LIMNOL OCEANOGR, V38, P1101, DOI 10.4319/lo.1993.38.6.1101; Cushing CE, 1997, J N AM BENTHOL SOC, V16, P39, DOI 10.2307/1468229; Villanueva VD, 2016, HYDROBIOLOGIA, V771, P227, DOI 10.1007/s10750-015-2636-z; Dort B, 2007, UNPUB; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Flint SA, 2015, FRESHW SCI, V34, P456, DOI 10.1086/680985; Gerecke R, 2011, J LIMNOL, V70, P168, DOI 10.4081/jlimnol.2011.s1.168; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Heise B, 2010, J MARINE SYST, V82, pS62, DOI 10.1016/j.jmarsys.2010.02.006; Helton AM, 2018, FRESHWATER BIOL, V63, P128, DOI 10.1111/fwb.12990; Hoover TM, 2010, FRESHWATER BIOL, V55, P436, DOI 10.1111/j.1365-2427.2009.02292.x; Horsakova V, 2018, DIVERS DISTRIB, V24, P742, DOI 10.1111/ddi.12718; Ilmonen J, 2005, HYDROBIOLOGIA, V533, P99, DOI 10.1007/s10750-004-2399-4; ISO, 1995, 10694 ISO; IVERSEN TM, 1982, HOLARCTIC ECOL, V5, P10; Kominoski JS, 2012, FRESHW SCI, V31, P51, DOI 10.1899/10-160.1; Kubikova L, 2012, FRESHW SCI, V31, P668, DOI 10.1899/11-174.1; Kubikova L, 2011, BIOLOGIA, V66, P299, DOI 10.2478/s11756-011-0012-7; Lamberti G. A., 2017, METHODS STREAM ECOLO, V1; Leibundgut C, 2009, TRACERS HYDROLOGY; MANN KH, 1988, LIMNOL OCEANOGR, V33, P910, DOI 10.4319/lo.1988.33.4_part_2.0910; Manning DWP, 2016, ECOL APPL, V26, P1745, DOI 10.1890/15-1217.1; Manning DWP, 2015, ECOLOGY, V96, P2214, DOI 10.1890/14-1582.1; Marcarelli AM, 2011, ECOLOGY, V92, P1215, DOI 10.1890/10-2240.1; Menninger HL, 2007, FRESHWATER BIOL, V52, P1689, DOI 10.1111/j.1365-2427.2007.01797.x; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Nedbal V., 2008, SILVA GABRETA, V14, P199; Newbold JD, 2005, LIMNOL OCEANOGR, V50, P1571, DOI 10.4319/lo.2005.50.5.1571; Newbold JD, 1992, RIVERS HDB HYDROLOGI; Petruzelova J, INT REV HYDROBIOL; POZO J, 1994, WATER RES, V28, P125, DOI 10.1016/0043-1354(94)90126-0; Prater C, 2017, LIMNOL OCEANOGR, V62, pS194, DOI 10.1002/lno.10628; Rosemond AD, 2008, INT VER THEOR ANGEW, V30, P651; Rosi-Marshall EJ, 2016, FRESHW SCI, V35, P534, DOI 10.1086/686302; SINSABAUGH RL, 1990, FRESHWATER BIOL, V23, P301, DOI 10.1111/j.1365-2427.1990.tb00273.x; Sitters J, 2015, OIKOS, V124, P920, DOI 10.1111/oik.02392; SOLLINS P, 1985, ECOLOGY, V66, P297, DOI 10.2307/1941331; Springer AE, 2009, HYDROGEOL J, V17, P83, DOI 10.1007/s10040-008-0341-y; STANFORD JA, 1993, J N AM BENTHOL SOC, V12, P48, DOI 10.2307/1467685; STATZNER B, 1985, CAN J FISH AQUAT SCI, V42, P1038, DOI 10.1139/f85-129; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tant CJ, 2015, FRESHW SCI, V34, P1259, DOI 10.1086/683255; Thomas SA, 2001, LIMNOL OCEANOGR, V46, P1415, DOI 10.4319/lo.2001.46.6.1415; Thorp JH, 2002, OIKOS, V96, P543, DOI 10.1034/j.1600-0706.2002.960315.x; Ticha K, 2012, POL J ECOL, V60, P163; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WALLACE JB, 1991, LIMNOL OCEANOGR, V36, P670, DOI 10.4319/lo.1991.36.4.0670; Webster JR, 2007, J N AM BENTHOL SOC, V26, P375, DOI 10.1899/06-095.1; Webster JR, 1999, FRESHWATER BIOL, V41, P687, DOI 10.1046/j.1365-2427.1999.00409.x; Wollheim WM, 2018, BIOGEOCHEMISTRY, V141, P503, DOI 10.1007/s10533-018-0488-0; Wotton RS, 2007, J N AM BENTHOL SOC, V26, P1, DOI 10.1899/0887-3593(2007)26[1:DBBPEA]2.0.CO;2; Wurzbacher C, 2016, LIMNOLOGICA, V59, P109, DOI 10.1016/j.limno.2016.04.001; Zimmermann-Timm H, 2002, INT REV HYDROBIOL, V87, P197, DOI 10.1002/1522-2632(200205)87:2/3<197::AID-IROH197>3.0.CO;2-7; Zollhofer Jens Martin, 2000, Archiv fuer Hydrobiologie Supplement, V121, P349	67	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0230750	10.1371/journal.pone.0230750	http://dx.doi.org/10.1371/journal.pone.0230750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339172	gold, Green Published			2022-12-26	WOS:000536657400006
J	Osterlund, N; Lundqvist, M; Ilag, LL; Graslund, A; Emanuelsson, C				Osterlund, Nicklas; Lundqvist, Martin; Ilag, Leopold L.; Graslund, Astrid; Emanuelsson, Cecilia			Amyloid-? oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (A?); Alzheimer disease; chaperone DnaJ (DnaJ); protein aggregation; proteostasis; native mass spectrometry; peptide; protein aggregation; primary nucleation	ELECTROSPRAY-IONIZATION; ALZHEIMERS-DISEASE; BETA OLIGOMERS; AGGREGATION; PEPTIDE; HAIRPIN; BINDING; TRANSTHYRETIN; STABILIZATION; PATHOGENESIS	A human molecular chaperone protein, DnaJ heat shock protein family (Hsp40) member B6 (DNAJB6), efficiently inhibits amyloid aggregation. This inhibition depends on a unique motif with conserved serine and threonine (S/T) residues that have a high capacity for hydrogen bonding. Global analysis of kinetics data has previously shown that DNAJB6 especially inhibits the primary nucleation pathways. These observations indicated that DNAJB6 achieves this remarkably effective and sub-stoichiometric inhibition by interacting not with the monomeric unfolded conformations of the amyloid-? symbol (A?) peptide but with aggregated species. However, these pre-nucleation oligomeric aggregates are transient and difficult to study experimentally. Here, we employed a native MS-based approach to directly detect oligomeric forms of A? formed in solution. We found that WT DNAJB6 considerably reduces the signals from the various forms of A? (1?40) oligomers, whereas a mutational DNAJB6 variant in which the S/T residues have been substituted with alanines does not. We also detected signals that appeared to represent DNAJB6 dimers and trimers to which varying amounts of A? are bound. These data provide direct experimental evidence that it is the oligomeric forms of A? that are captured by DNAJB6 in a manner which depends on the S/T residues. We conclude that, in agreement with the previously observed decrease in primary nucleation rate, strong binding of A? oligomers to DNAJB6 inhibits the formation of amyloid nuclei.	[Osterlund, Nicklas; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Lundqvist, Martin; Emanuelsson, Cecilia] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Ilag, Leopold L.] Stockholm Univ, Dept Mat & Environm Chem, Stockholm, Sweden	Stockholm University; Lund University; Stockholm University	Emanuelsson, C (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden.	cecilia.emanuelsson@biochemistry.lu.se		Osterlund, Nicklas/0000-0003-0905-7911; Lundqvist, Martin/0000-0003-1175-9103; Ilag, Leopold/0000-0003-3678-7100; Emanuelsson, Cecilia/0000-0001-8762-477X	Crafoord Foundation; Alzheimer Foundation; Swedish Research Council; Sven and Lilly Lawski Foundation; Olle Engkvist Byggmastare Foundation; SciLifeLab Technology Development Grant from the Faculty of Science at Stockholm University	Crafoord Foundation; Alzheimer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sven and Lilly Lawski Foundation; Olle Engkvist Byggmastare Foundation; SciLifeLab Technology Development Grant from the Faculty of Science at Stockholm University	This work was supported by the Crafoord Foundation (to C. E.), The Alzheimer Foundation (to C. E.), The Swedish Research Council (to A. G.), The Sven and Lilly Lawski Foundation (to N. O.), and the Olle Engkvist Byggmastare Foundation (to L. L. I.). The Native IM-MS infrastructure was supported by a SciLifeLab Technology Development Grant from the Faculty of Science at Stockholm University (to L. L. I.).	Abelein A, 2014, J BIOL INORG CHEM, V19, P623, DOI 10.1007/s00775-014-1131-8; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Cohen SIA, 2018, NAT CHEM, V10, P523, DOI 10.1038/s41557-018-0023-x; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; De S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09477-3; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; Ghadami SA, 2020, BIOMACROMOLECULES, V21, P1112, DOI 10.1021/acs.biomac.9b01475; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hunter PJ, 1999, DEVELOPMENT, V126, P1247; Kakkar V, 2016, MOL CELL, V62, P272, DOI 10.1016/j.molcel.2016.03.017; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Konijnenberg A, 2016, ANAL CHEM, V88, P8468, DOI 10.1021/acs.analchem.6b00731; Kreutzer AG, 2018, ACCOUNTS CHEM RES, V51, P706, DOI 10.1021/acs.accounts.7b00554; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Li JY, 2016, MASS SPECTROM REV, V35, P111, DOI 10.1002/mas.21465; Lindberg H, 2015, BIOTECHNOL J, V10, P1707, DOI 10.1002/biot.201500131; Linse Sara, 2017, Biophys Rev, V9, P329, DOI 10.1007/s12551-017-0289-z; Liu L, 2019, CHEM COMMUN, V55, P5147, DOI 10.1039/c9cc01898k; Mansson C, 2018, BIOCHEMISTRY-US, V57, P4891, DOI 10.1021/acs.biochem.8b00353; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Michaels TCT, 2020, NAT CHEM, V12, P445, DOI 10.1038/s41557-020-0452-1; Moons R, 2019, J AM CHEM SOC, V141, P10440; Pagel K, 2013, ANGEW CHEM INT EDIT, V52, P361, DOI 10.1002/anie.201203047; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Soderberg CAG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23035-9; Testa Lorenzo, 2013, Intrinsically Disord Proteins, V1, pe25068, DOI 10.4161/idp.25068; Testa L, 2011, ANAL CHEM, V83, P6459, DOI 10.1021/ac201740z; Tiiman A, 2015, BIOCHEMISTRY-US, V54, P7203, DOI 10.1021/acs.biochem.5b00976; Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Yokoyama T, 2012, J STRUCT BIOL, V177, P283, DOI 10.1016/j.jsb.2011.12.022	44	14	14	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8135	8144		10.1074/jbc.RA120.013459	http://dx.doi.org/10.1074/jbc.RA120.013459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350108	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000542965700002
J	Dudakovic, A; Samsonraj, RM; Paradise, CR; Galeano-Garces, C; Mol, MO; Galeano-Garces, D; Zan, PF; Galvan, ML; Hevesi, M; Pichurin, O; Thaler, R; Begun, DL; Kloen, P; Karperien, M; Larson, AN; Westendorf, JJ; Cool, SM; van Wijnen, AJ				Dudakovic, Amel; Samsonraj, Rebekah M.; Paradise, Christopher R.; Galeano-Garces, Catalina; Mol, Merel O.; Galeano-Garces, Daniela; Zan, Pengfei; Galvan, M. Lizeth; Hevesi, Mario; Pichurin, Oksana; Thaler, Roman; Begun, Dana L.; Kloen, Peter; Karperien, Marcel; Larson, A. Noelle; Westendorf, Jennifer J.; Cool, Simon M.; van Wijnen, Andre J.			Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); osteoblast; mesenchymal stem cells (MSCs); epigenetics; histone methylation; chromatin regulation; BMP2; enhancer of zeste homolog; Ezh2; methyltransferase; osteogenesis; bone development	BONE MORPHOGENETIC PROTEIN-2; ZESTE HOMOLOG 2; MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; HISTONE MODIFICATIONS; TRANSCRIPTION FACTOR; TIBIAL FRACTURES; GENE-EXPRESSION; II RECEPTOR; RUNX2	Bone-stimulatory therapeutics include bone morphogenetic proteins (e.g. BMP2), parathyroid hormone, and antibody-based suppression of WNT antagonists. Inhibition of the epigenetic enzyme enhancer of zeste homolog 2 (EZH2) is both bone anabolic and osteoprotective. EZH2 inhibition stimulates key components of bone-stimulatory signaling pathways, including the BMP2 signaling cascade. Because of high costs and adverse effects associated with BMP2 use, here we investigated whether BMP2 dosing can be reduced by co-treatment with EZH2 inhibitors. Co-administration of BMP2 with the EZH2 inhibitor GSK126 enhanced differentiation of murine (MC3T3) osteoblasts, reflected by increased alkaline phosphatase activity, Alizarin Red staining, and expression of bone-related marker genes (e.g. Bglap and Phospho1). Strikingly, co-treatment with BMP2 (10 ng/ml) and GSK126 (5 ?m) was synergistic and was as effective as 50 ng/ml BMP2 at inducing MC3T3 osteoblastogenesis. Similarly, the BMP2?GSK126 co-treatment stimulated osteogenic differentiation of human bone marrow?derived mesenchymal stem/stromal cells, reflected by induction of key osteogenic markers (e.g. Osterix/SP7 and IBSP). A combination of BMP2 (300 ng local) and GSK126 (5 ?g local and 5 days of 50 mg/kg systemic) yielded more consistent bone healing than single treatments with either compound in a mouse calvarial critical-sized defect model according to results from ?CT, histomorphometry, and surgical grading of qualitative X-rays. We conclude that EZH2 inhibition facilitates BMP2-mediated induction of osteogenic differentiation of progenitor cells and maturation of committed osteoblasts. We propose that epigenetic priming, coupled with bone anabolic agents, enhances osteogenesis and could be leveraged in therapeutic strategies to improve bone mass.	[Dudakovic, Amel; Samsonraj, Rebekah M.; Galeano-Garces, Catalina; Galeano-Garces, Daniela; Zan, Pengfei; Galvan, M. Lizeth; Hevesi, Mario; Pichurin, Oksana; Thaler, Roman; Begun, Dana L.; Larson, A. Noelle; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Dudakovic, Amel; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Paradise, Christopher R.] Mayo Clin, Mayo Clin Grad Sch Biomed Sci, Rochester, MN USA; [Paradise, Christopher R.] Mayo Clin, Ctr Regenerat Med, Rochester, MN USA; [Mol, Merel O.; Kloen, Peter] Amsterdam Univ Med Ctr, Dept Orthoped Surg, Amsterdam, Netherlands; [Zan, Pengfei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, Hangzhou, Zhejiang, Peoples R China; [Zan, Pengfei] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Orthoped Surg, Shanghai, Peoples R China; [Karperien, Marcel] Univ Twente, Dept Dev BioEngn, Enschede, Netherlands; [Cool, Simon M.] ASTAR, Glycotherapeut Grp Inst Med Biol, Singapore, Singapore; [Cool, Simon M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore, Singapore	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Zhejiang University; Tongji University; University of Twente; Agency for Science Technology & Research (A*STAR); National University of Singapore	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.; van Wijnen, AJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	Cool, Simon McKenzie/AAG-4346-2021; van Wijnen, Andre J./AAG-3578-2019; Mol, Merel/AHA-6469-2022; Karperien, Marcel/R-3270-2018	van Wijnen, Andre J./0000-0002-4458-0946; Mol, Merel/0000-0003-2533-2530; Karperien, Marcel/0000-0003-0751-0604; Cool, Simon/0000-0001-8543-3056; Hevesi, Mario/0000-0001-6208-878X; Dudakovic, Amel/0000-0002-8850-3977	National Institutes of Health [R01 AR049069]; Career Development Award in Orthopedics Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award in Orthopedics Research	This work was supported by National Institutes of Health Grant R01 AR049069 (A. J. v. W.) and a Career Development Award in Orthopedics Research (to A. D.). We also appreciate the generous philanthropic support of William H. and Karen J. Eby and the charitable foundation in their names. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auh QS, 2016, ONCOTARGET, V7, P78320, DOI 10.18632/oncotarget.12460; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Baskin DS, 2003, SPINE, V28, P1219, DOI 10.1097/00007632-200306150-00003; BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309; Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012; Camilleri ET, 2018, J BIOL CHEM, V293, P19001, DOI 10.1074/jbc.RA118.003909; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen YH, 2016, STEM CELLS, V34, P2183, DOI 10.1002/stem.2400; Cho YD, 2014, J BIOL CHEM, V289, P20120, DOI 10.1074/jbc.M114.558064; Cho YD, 2012, J CELL PHYSIOL, V227, P2287, DOI 10.1002/jcp.24038; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Dudakovic A., 2017, CURR MOL BIOL REP, V3, P94, DOI [10.1007/s40610-017-0064-8, DOI 10.1007/S40610-017-0064-8]; Dudakovic A., 2016, GENE EXPRESSION OMNI; Dudakovic A, 2018, J BIOL CHEM, V293, P12894, DOI 10.1074/jbc.RA118.002983; Dudakovic A, 2017, GENE, V609, P28, DOI 10.1016/j.gene.2017.01.019; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425, DOI 10.2106/00004623-200308000-00002; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fang C, 2016, J IMMUNOL, V196, P4452, DOI 10.4049/jimmunol.1501466; Gao SM, 2017, J BIOL CHEM, V292, P12702, DOI 10.1074/jbc.M117.776278; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Ge K, 2012, BBA-GENE REGUL MECH, V1819, P727, DOI 10.1016/j.bbagrm.2011.12.008; Giannoudis PV, 2011, INJURY, V42, P549, DOI 10.1016/j.injury.2011.03.037; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hay E, 1999, J CELL BIOCHEM, V72, P81, DOI 10.1002/(SICI)1097-4644(19990101)72:1<81::AID-JCB9>3.0.CO;2-N; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Herberg S, 2017, J TISSUE ENG REGEN M, V11, P1806, DOI 10.1002/term.2078; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang WB, 2002, EXP CELL RES, V274, P226, DOI 10.1006/excr.2002.5483; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.TEB.2015.0357, 10.1089/ten.teb.2015.0357]; Javed A, 1999, MOL CELL BIOL, V19, P7491; Javed A, 2009, CELLS TISSUES ORGANS, V189, P133, DOI 10.1159/000151719; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Komori T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071694; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lee Zang Hee, 2015, J Bone Metab, V22, P51, DOI 10.11005/jbm.2015.22.2.51; Li KC, 2017, J TISSUE ENG REGEN M, V11, P3068, DOI 10.1002/term.2208; Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055; Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; Luppen CA, 2002, J BONE MINER RES, V17, P301, DOI 10.1359/jbmr.2002.17.2.301; Marchesi I, 2014, CELL CYCLE, V13, P516, DOI 10.4161/cc.27921; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ong KL, 2010, SPINE, V35, P1794, DOI 10.1097/BRS.0b013e3181ecf6e4; Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pike JW, 2015, BONE, V81, P757, DOI 10.1016/j.bone.2015.03.012; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reyes R, 2018, DRUG DELIV, V25, P750, DOI 10.1080/10717544.2018.1446473; Runyan CM, 2017, J CRANIOFAC SURG, V28, P1380, DOI 10.1097/SCS.0000000000003625; Russow G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010083; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; Samsonraj RM, 2018, STEM CELLS DEV, V27, P1136, DOI 10.1089/scd.2018.0037; Samsonraj RM, 2017, TISSUE ENG PART C-ME, V23, P686, DOI [10.1089/ten.tec.2017.0205, 10.1089/ten.TEC.2017.0205]; Scandura JM, 2011, BLOOD, V118, P1472, DOI 10.1182/blood-2010-11-320093; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Sciadini MF, 2000, J ORTHOP RES, V18, P289, DOI 10.1002/jor.1100180218; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Sun J, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0015-x; Swiontkowski MF, 2006, J BONE JOINT SURG AM, V88A, P1258, DOI 10.2106/JBJS.E.00499; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takazawa Y, 2000, J ENDOCRINOL, V165, P579, DOI 10.1677/joe.0.1650579; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tzioupis C, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(07)80003-9; van Wijnen AJ, 2019, J ORTHOP RES, V37, P1465, DOI 10.1002/jor.24305; Vicente-Duenas C, 2018, TRENDS CANCER, V4, P408, DOI 10.1016/j.trecan.2018.04.007; VILLANUEVA AR, 1977, AM J MED TECHNOL, V43, P536; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36988; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Woodhouse S, 2013, J CELL SCI, V126, P565, DOI 10.1242/jcs.114843; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Zhu XX, 2016, ONCOTARGET, V7, P63561, DOI 10.18632/oncotarget.11538; Zura R, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.2775	98	30	30	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7877	7893		10.1074/jbc.RA119.011685	http://dx.doi.org/10.1074/jbc.RA119.011685			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32332097	Green Published, hybrid			2022-12-26	WOS:000540935400006
J	Stocker, WA; Walton, KL; Richani, D; Chan, KL; Beilby, KH; Finger, BJ; Green, MP; Gilchrist, RB; Harrison, CA				Stocker, William A.; Walton, Kelly L.; Richani, Dulama; Chan, Karen L.; Beilby, Kiri H.; Finger, Bethany J.; Green, Mark P.; Gilchrist, Robert B.; Harrison, Craig A.			A variant of human growth differentiation factor-9 that improves oocyte developmental competence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						growth factor; bone morphogenetic protein (BMP); SMAD transcription factor; receptor protein serine; threonine kinase; ovary; BMP15; cumulin; GDF9; granulosa cells; oocyte maturation	BONE MORPHOGENETIC PROTEIN-15; CELL GENE-EXPRESSION; FACTOR-BETA; GRANULOSA-CELLS; I RECEPTOR; CRYSTAL-STRUCTURE; SECRETED FACTORS; MOLECULAR-BASIS; SINGLE RESIDUE; ACTIVIN	Growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are co-expressed exclusively in oocytes throughout most of folliculogenesis and play central roles in controlling ovarian physiology. Although both growth factors exist as homodimers, recent evidence indicates that GDF9 and BMP15 can also heterodimerize to form the potent growth factor cumulin. Within the cumulin complex, BMP15 ?activates? latent GDF9, enabling potent signaling in granulosa cells via type I receptors (i.e. activin receptor-like kinase-4/5 (ALK4/5)) and SMAD2/3 transcription factors. In the cumulin heterodimer, two distinct type I receptor interfaces are formed compared with homodimeric GDF9 and BMP15. Previous studies have highlighted the potential of cumulin to improve treatment of female infertility, but, as a noncovalent heterodimer, cumulin is difficult to produce and purify without contaminating GDF9 and BMP15 homodimers. In this study we addressed this challenge by focusing on the cumulin interface formed by the helix of the GDF9 chain and the fingers of the BMP15 chain. We demonstrate that unique BMP15 finger residues at this site (Arg(301), Gly(304), His(307), and Met(369)) enable potent activation of the SMAD2/3 pathway. Incorporating these BMP15 residues into latent GDF9 generated a highly potent growth factor, called hereafter Super-GDF9. Super-GDF9 was >1000-fold more potent than WT human GDF9 and 4-fold more potent than cumulin in SMAD2/3-responsive transcriptional assays in granulosa cells. Our demonstration that Super-GDF9 can effectively promote mouse cumulus cell expansion and improve oocyte quality in vitro represents a potential solution to the current challenges of producing and purifying intact cumulin.	[Stocker, William A.; Walton, Kelly L.; Chan, Karen L.; Harrison, Craig A.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Stocker, William A.; Walton, Kelly L.; Chan, Karen L.; Harrison, Craig A.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Stocker, William A.] Swinburne Univ Technol, Dept Chem & Biotechnol, Hawthorn, Vic, Australia; [Richani, Dulama; Gilchrist, Robert B.] Univ New South Wales Sydney, Sch Womens & Childrens Hlth, Discipline Obstet & Gynaecol, Sydney, NSW, Australia; [Beilby, Kiri H.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Finger, Bethany J.; Green, Mark P.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia	Monash University; Monash University; Swinburne University of Technology; University of New South Wales Sydney; Monash University; University of Melbourne	Harrison, CA (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia.; Harrison, CA (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.	craig.harrison@monash.edu	Stocker, William/GPK-2206-2022; Richani, Dulama/H-5807-2019; Walton, Kelly/ABF-7282-2020; Gilchrist, Robert/ABE-9594-2020	Richani, Dulama/0000-0003-1886-0423; Walton, Kelly/0000-0003-0627-2958; Gilchrist, Robert/0000-0003-1611-7142; Harrison, Craig/0000-0003-1059-3682	National Institutes of Health [P41 RR-01081]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. David Mottershead (Keele University, United Kingdom) for providing the GDF9 and BMP15 expression vectors and Lesley Ritter (The University of Adelaide, Australia) for providing advice about the culture of mouse granulosa cells. The Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, CA, was supported by National Institutes of Health Grant P41 RR-01081.	Al-Musawi SL, 2013, ENDOCRINOLOGY, V154, P888, DOI 10.1210/en.2012-2015; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Attisano L, 1996, MOL CELL BIOL, V16, P1066; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Belli M, 2018, VITAM HORM, V107, P317, DOI 10.1016/bs.vh.2017.12.003; BOYD FT, 1989, J BIOL CHEM, V264, P2272; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Cillo F, 2007, REPRODUCTION, V134, P645, DOI 10.1530/REP-07-0182; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dragovic RA, 2007, BIOL REPROD, V76, P848, DOI 10.1095/biolreprod.106.057471; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Gilchrist RB, 2004, BIOL REPROD, V71, P732, DOI 10.1095/biolreprod.104.028852; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; Goebel EJ, 2019, EXP BIOL MED, V244, P1530, DOI 10.1177/1535370219880894; Goebel EJ, 2019, P NATL ACAD SCI USA, V116, P15505, DOI 10.1073/pnas.1906253116; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Harrison CA, 2003, J BIOL CHEM, V278, P21129, DOI 10.1074/jbc.M302015200; Hinck AP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022103; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Li R, 2000, BIOL REPROD, V63, P839, DOI 10.1095/biolreprod63.3.839; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Mottershead DG, 2015, J BIOL CHEM, V290, P24007, DOI 10.1074/jbc.M115.671487; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Patino LC, 2017, J CLIN ENDOCR METAB, V102, P1009, DOI 10.1210/jc.2016-3503; Peng J, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.123158; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pulkki MM, 2011, MOL CELL ENDOCRINOL, V332, P106, DOI 10.1016/j.mce.2010.10.002; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Richani D, 2013, MOL HUM REPROD, V19, P500, DOI 10.1093/molehr/gat028; Richani D, 2019, ENDOCRINOLOGY, V160, P853, DOI 10.1210/en.2018-01026; Russell DL, 2007, HUM REPROD UPDATE, V13, P289, DOI 10.1093/humupd/dml062; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simpson CM, 2012, ENDOCRINOLOGY, V153, P1301, DOI 10.1210/en.2011-1632; Su YQ, 2010, MOL ENDOCRINOL, V24, P1230, DOI 10.1210/me.2009-0497; Sudiman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103563; Sugimura S, 2014, MOL HUM REPROD, V20, P499, DOI 10.1093/molehr/gau013; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Walker RG, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0350-1; Wathlet S, 2011, HUM REPROD, V26, P1035, DOI 10.1093/humrep/der036; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CX, 2008, HUM REPROD, V23, P67, DOI 10.1093/humrep/dem140	56	13	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7981	7991		10.1074/jbc.RA120.013050	http://dx.doi.org/10.1074/jbc.RA120.013050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350111	Green Published, hybrid			2022-12-26	WOS:000540935400013
J	Chikazawa, M; Yoshitake, J; Lim, SY; Iwata, S; Negishi, L; Shibata, T; Uchida, K				Chikazawa, Miho; Yoshitake, Jun; Lim, Sei-Young; Iwata, Shiori; Negishi, Lumi; Shibata, Takahiro; Uchida, Koji			Glycolaldehyde is an endogenous source of lysine N-pyrrolation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein E (ApoE); atherosclerosis; polyunsaturated fatty acid (PUFA); lipid peroxidation; immunology; posttranslational modification (PTM); glucose metabolism; immunity; oxidative stress	OXIDATION-SPECIFIC EPITOPES; GLYCATION END-PRODUCTS; LIPID-PEROXIDATION; PROTEIN ADDUCTS; GA-PYRIDINE; IDENTIFICATION; BIOMARKERS; MECHANISM; PLASMA; MODEL	Lysine N-pyrrolation converts lysine residues to N-?-pyrrole-l-lysine (pyrK) in a covalent modification reaction that significantly affects the chemical properties of proteins, causing them to mimic DNA. pyrK in proteins has been detected in vivo, indicating that pyrrolation occurs as an endogenous reaction. However, the source of pyrK remains unknown. In this study, on the basis of our observation in vitro that pyrK is present in oxidized low-density lipoprotein and in modified proteins with oxidized polyunsaturated fatty acids, we used LC?electrospray ionization?MS/MS coupled with a stable isotope dilution method to perform activity-guided separation of active molecules in oxidized lipids and identified glycolaldehyde (GA) as a pyrK source. The results from mechanistic experiments to study GA-mediated lysine N-pyrrolation suggested that the reactions might include GA oxidation, generating the dialdehyde glyoxal, followed by condensation reactions of lysine amino groups with GA and glyoxal. We also studied the functional significance of GA-mediated lysine N-pyrrolation in proteins and found that GA-modified proteins are recognized by apolipoprotein E, a binding target of pyrrolated proteins. Moreover, GA-modified proteins triggered an immune response to pyrrolated proteins, and monoclonal antibodies generated from mice immunized with GA-modified proteins specifically recognized pyrrolated proteins. These findings reveal that GA is an endogenous source of DNA-mimicking pyrrolated proteins and may provide mechanistic insights relevant for innate and autoimmune responses associated with glucose metabolism and oxidative stress.	[Chikazawa, Miho; Lim, Sei-Young; Iwata, Shiori; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yoshitake, Jun; Shibata, Takahiro] Nagoya Univ, Inst NanoLife Syst, Inst Innovat Future Soc, Nagoya, Aichi, Japan; [Negishi, Lumi] Univ Tokyo, Inst Quantitat Biosci, Cent Lab, Bunkyo Ku, Tokyo, Japan; [Shibata, Takahiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Nagoya University; University of Tokyo; Nagoya University	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	a-uchida@mail.ecc.u-tokyo.ac.jp	; Shibata, Takahiro/I-6872-2014	Chikazawa, Miho/0000-0002-7447-8387; Shibata, Takahiro/0000-0003-3194-607X; Negishi, Lumi/0000-0002-7297-0634	Ministry of Education, Sciences, Sports, Technology, Japan [17H06170, 26111011]; AMEDCREST from AMED	Ministry of Education, Sciences, Sports, Technology, Japan; AMEDCREST from AMED	This work was supported in part by Grant-in-Aid for Scientific Research (S) 17H06170 (to K. U.) and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" 26111011 (to K. U.) of the Ministry of Education, Sciences, Sports, Technology, Japan. This research was also supported by AMEDCREST from AMED (to K. U.).	ACHARYA AS, 1983, P NATL ACAD SCI-BIOL, V80, P3590, DOI 10.1073/pnas.80.12.3590; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Argirov OK, 2003, BBA-GEN SUBJECTS, V1620, P235, DOI 10.1016/S0304-4165(03)00002-3; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Greven WL, 2005, KIDNEY INT, V68, P595, DOI 10.1111/j.1523-1755.2005.00437.x; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; HIDALGO FJ, 1995, J LIPID RES, V36, P725; HIDALGO FJ, 1993, J BIOL CHEM, V268, P16190; Hirose S, 2019, J BIOL CHEM, V294, P11035, DOI 10.1074/jbc.RA118.006629; Ichihashi K, 2001, J BIOL CHEM, V276, P23903, DOI 10.1074/jbc.M101947200; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; Kaur K, 1997, CHEM RES TOXICOL, V10, P1387, DOI 10.1021/tx970112c; Milic I, 2013, ANAL CHEM, V85, P156, DOI 10.1021/ac302356z; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miyashita H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05343; Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200; Onyango AN, 2012, CHEM PHYS LIPIDS, V165, P777, DOI 10.1016/j.chemphyslip.2012.09.004; Otaki N, 2010, J BIOL CHEM, V285, P33834, DOI 10.1074/jbc.M110.165175; Salomon RG, 2000, CHEM RES TOXICOL, V13, P557, DOI 10.1021/tx000007u; Salomon RG, 1997, CHEM RES TOXICOL, V10, P750, DOI 10.1021/tx970016b; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Shibata T, 2017, J BIOL CHEM, V292, P8223, DOI 10.1074/jbc.M116.762609; Walsh CT, 2006, NAT PROD REP, V23, P517, DOI 10.1039/b605245m; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a	26	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7697	7709		10.1074/jbc.RA120.013179	http://dx.doi.org/10.1074/jbc.RA120.013179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32332094	Green Published, hybrid			2022-12-26	WOS:000538038900011
J	Hadgu, E; Seifu, D; Tigneh, W; Bokretsion, Y; Bekele, A; Abebe, M; Sollie, T; Karlsson, C; Karlsson, MG				Hadgu, Endale; Seifu, Daniel; Tigneh, Wondemagegnhu; Bokretsion, Yonas; Bekele, Abebe; Abebe, Markos; Sollie, Thomas; Karlsson, Christina; Karlsson, Mats G.			Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study	PLOS ONE			English	Article							TARGETED THERAPIES; POPULATION; EXPRESSION; CARCINOMA	Evaluation of the role of androgen receptor (AR) in the biology of breast cancer is an emerging area of research. There are compelling evidences that AR expression may be used to further refine breast cancer molecular subtyping with prognostic and therapeutic implications. Many studies indicated co-expression of AR with the hormonal receptors in breast cancer has a favorable prognosis. AR is also investigated by many researchers as a potential therapeutic target in treatment of breast cancer. Studies on the frequency and distribution of AR in breast cancer among Africans is barely available. Given the heightened interest to understand its role in breast cancer, we determined AR expression and assessed its association with clinicopathological parameters among Ethiopian women. In this study, 112 newly diagnosed patient with invasive breast cancer at Tikur Anbessa Specialized Hospital were enrolled. Immunohistochemical assessment of AR, ER, PR, Ki67 and HER2 were performed using tissue microarrays (TMA) constructed from their primary tumor block. Out of the 112 participants, 91 (81%) were positive for AR expression and the remaining 21 participants (19%) were negative for AR expression. Expression of AR in ER+, HER2+ and TNBC cases were 93%, 83% and 48% respectively. Our study reveals AR is expressed in a significant number of breast cancers patients and this may indicate that breast cancers cases in Ethiopia have favorable prognosis and could benefit from progresses in AR targeted treatments. Since AR expression has important consequences on the prognosis and treatment of breast cancer, further studies with an increased number of participants is necessary to confirm our reports.	[Hadgu, Endale; Seifu, Daniel] Addis Ababa Univ, Sch Med, Dept Biochem, Addis Ababa, Ethiopia; [Tigneh, Wondemagegnhu] Addis Ababa Univ, Sch Med, Dept Oncol, Addis Ababa, Ethiopia; [Bokretsion, Yonas] Addis Ababa Univ, Sch Med, Dept Pathol, Addis Ababa, Ethiopia; [Bekele, Abebe] Addis Ababa Univ, Sch Med, Dept Surg, Addis Ababa, Ethiopia; [Abebe, Markos] Armauer Hansen Res Inst AHRI, Addis Ababa, Ethiopia; [Sollie, Thomas; Karlsson, Mats G.] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Karlsson, Christina] Orebro Univ, Sch Hlth Sci, Orebro, Sweden; [Hadgu, Endale] St Pauls Hosp, Dept Biochem, Millennium Med Coll, Addis Ababa, Ethiopia; [Seifu, Daniel; Bekele, Abebe] Univ Global Hlth Equ, Kigali, Rwanda	Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Orebro University; Orebro University	Hadgu, E (corresponding author), Addis Ababa Univ, Sch Med, Dept Biochem, Addis Ababa, Ethiopia.; Hadgu, E (corresponding author), St Pauls Hosp, Dept Biochem, Millennium Med Coll, Addis Ababa, Ethiopia.	endale.hadgu@sphmmc.edu.et	Karlsson, Mats G/AAV-7542-2021	Karlsson, Mats G/0000-0001-6881-237X; Gebregzabher, Endale/0000-0002-5898-1337	Addis Ababa University, School of Graduate Studies, thematic research group "clinico-epidemiological characterization of breast cancer in Ethiopia"; Armauer Hansen Research Institute (AHRI); AHRI from Swedish International Developmental Agency (SIDA), Sweden	Addis Ababa University, School of Graduate Studies, thematic research group "clinico-epidemiological characterization of breast cancer in Ethiopia"; Armauer Hansen Research Institute (AHRI); AHRI from Swedish International Developmental Agency (SIDA), Sweden	This work is funded by Addis Ababa University, School of Graduate Studies, thematic research group "clinico-epidemiological characterization of breast cancer in Ethiopia" and Armauer Hansen Research Institute (AHRI). AHRI supported the study through funding obtained from Swedish International Developmental Agency (SIDA), Sweden.	Anestis A, 2015, CANCER TREAT REV, V41, P547, DOI 10.1016/j.ctrv.2015.04.009; Asano Y, 2017, CANCERS, V9, DOI 10.3390/cancers9010004; Asano Y, 2016, BRIT J CANCER, V114, P14, DOI 10.1038/bjc.2015.434; Basile D, 2017, CANCER TREAT REV, V61, P15, DOI 10.1016/j.ctrv.2017.09.006; Bhattarai S, 2019, CANCERS, V11, DOI 10.3390/cancers11070995; Bleach R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00594; Bozovic-Spasojevic I, 2017, CLIN CANCER RES, V23, P2702, DOI 10.1158/1078-0432.CCR-16-0979; Bravaccini S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00137; Chia K, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-014-0427-8; Christenson JL, 2018, HORM CANCER-US, V9, P82, DOI 10.1007/s12672-017-0314-5; Christopoulos PF, 2017, ANTICANCER RES, V37, P6533, DOI 10.21873/anticanres.12109; Deyarmin B, 2013, ANN SURG ONCOL, V20, P87, DOI 10.1245/s10434-012-2588-8; Eliyatkin N, 2015, J BREAST HEALTH, V11, P59, DOI 10.5152/tjbh.2015.1669; Fitzgibbons PL, 2014, ARCH PATHOL LAB MED, V138, P595, DOI 10.5858/arpa.2013-0566-CP; Gasparini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088525; Gerratana L, 2018, CANCER TREAT REV, V68, P102, DOI 10.1016/j.ctrv.2018.06.005; Giovannelli P, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00492; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gucalp A, 2017, ANN SURG ONCOL, V24, P2876, DOI 10.1245/s10434-017-5961-9; Hadgu E, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0531-2; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Islami F, 2017, CANCER EPIDEM BIOMAR, V26, P458, DOI 10.1158/1055-9965.EPI-16-0871; Jezequel P, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1148-6; Kono M, 2017, JAMA ONCOL, V3, P1266, DOI 10.1001/jamaoncol.2016.4975; Lukong KE, 2017, BBA CLIN, V7, P64, DOI 10.1016/j.bbacli.2017.01.001; Masoud V, 2017, WORLD J CLIN ONCOL, V8, P120, DOI 10.5306/wjco.v8.i2.120; McNamara KM, 2016, CURR OPIN ENDOCRINOL, V23, P249, DOI 10.1097/MED.0000000000000251; Narayanan R, 2016, CANCERS, V8, DOI 10.3390/cancers8120108; Pietri E, 2016, ENDOCR-RELAT CANCER, V23, pR485, DOI 10.1530/ERC-16-0190; Proctor E, 2015, ANN SURG ONCOL, V22, P3831, DOI 10.1245/s10434-015-4455-x; Rampurwala M, 2016, CLIN ADV HEMATOL ONC, V14, P186; Tremont A, 2017, OCHSNER J, V17, P405; Turashvili G, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00227; Vasiliou SK, 2019, CRIT REV CL LAB SCI, V56, P200, DOI 10.1080/10408363.2019.1575643; Venema CM, 2019, PHARMACOL THERAPEUT, V200, P135, DOI 10.1016/j.pharmthera.2019.05.005; Wu Y, 2017, Int J Cancer Res Mol Mech, V3, DOI 10.16966/2381-3318.129	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232519	10.1371/journal.pone.0232519	http://dx.doi.org/10.1371/journal.pone.0232519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374753	Green Published, gold			2022-12-26	WOS:000537283500038
J	Mansilla, FC; Turco, CS; Miraglia, MC; Bessone, FA; Franco, R; Perez-Filgueira, M; Sala, JM; Capozzo, AV				Celeste Mansilla, Florencia; Soledad Turco, Cecilia; Cruz Miraglia, Maria; Anibal Bessone, Fernando; Franco, Raul; Perez-Filgueira, Mariano; Manuel Sala, Juan; Victoria Capozzo, Alejandra			The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine	PLOS ONE			English	Article							ANTIBODY-RESPONSE; 12S PARTICLES; PROTECTION; CATTLE; 146S; DISSOCIATION; POTENCY; PIGS	The efficacy of foot-and-mouth disease virus (FMDV) inactivated vaccines is mainly dependent on the integrity of the whole (146S) viral particles. If the intact capsids disassemble to 12S subunits, antibodies against internal-not protective epitopes, may be induced. Serological correlates with protection may be hampered if antibodies against internal epitopes are measured. Here we compared the performance of different ELISAs with the virus-neutralization test (VNT) that measures antibodies against exposed epitopes. Sera from pigs immunized with one dose of an expired commercial FMDV vaccine were used. This vaccine contained about 50% of O1/Campos and over 90% of A24/Cruzeiro strains total antigen as whole 146S particles. Specific-total antibodies were measured with the standard liquid-phase blocking ELISA (LPBE). We also developed an indirect ELISA (IE) using sucrose gradient purified 146S particles as capture antigen to titrate total antibodies, IgM, IgG1 and IgG2. A good correlation was found between VNT titers and IgG-ELISAs for A24/Cruzeiro, with the lowest correlation coefficient estimated for IgG2 titers. For O1/Campos, however, the presence of antibodies against epitopes different from those of the whole capsid, elicited by the presence of 12S particles in the vaccine, hampered the correlation between LPBE and VNT, which was improved by using purified O1/Campos 146S-particles for the liquid-phase of the LPBE. Interestingly, 146S particles but not 12S were efficiently bound to the ELISA plates, confirming the efficiency of the IE to detect antibodies against exposed epitopes. Our results indicate that any serological test assessing total antibodies or IgG1 against epitopes exposed in intact 146S-particles correlate with the levels of serum neutralizing antibodies in vaccinated pigs, and might potentially replace the VNT, upon validation. We recommend that antigen used for serological assays aimed to measure protective antibodies against FMDV should be controlled to ensure the preservation of 146S viral particles.	[Celeste Mansilla, Florencia; Soledad Turco, Cecilia; Cruz Miraglia, Maria; Perez-Filgueira, Mariano; Victoria Capozzo, Alejandra] Consejo Nacl Invest Cient & Tecnol CONICET, Inst Nacl Tecnol Agr INTA, IVIT, Inst Virol & Innovac Tecnol, Hurlingham, Buenos Aires, Argentina; [Anibal Bessone, Fernando; Franco, Raul] INTA, Estn Expt Agr Marcos Juarez, Cordoba, Argentina; [Manuel Sala, Juan] INTA, Estn Expt Agr Mercedes, Merdeces, Corrientes, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Capozzo, AV (corresponding author), Consejo Nacl Invest Cient & Tecnol CONICET, Inst Nacl Tecnol Agr INTA, IVIT, Inst Virol & Innovac Tecnol, Hurlingham, Buenos Aires, Argentina.	capozzo.alejandra@inta.gob.ar	, Alejandra/C-2848-2019	, Alejandra/0000-0002-7117-9955	National Animal Health Program of INTA [PNSA 1115052]	National Animal Health Program of INTA	This work was supported by the National Animal Health Program of INTA through PNSA 1115052.	Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Lavoria MA, 2012, VACCINE, V30, P6845, DOI 10.1016/j.vaccine.2012.09.011; BARTELING SJ, 1974, ARCH GES VIRUSFORSCH, V45, P362, DOI 10.1007/BF01242879; Borrego B, 2017, ANTIVIR RES, V142, P30, DOI 10.1016/j.antiviral.2017.03.009; BROWN F, 1959, J IMMUNOL, V82, P444; BROWN F, 1961, NATURE, V192, P1163, DOI 10.1038/1921163a0; Bucafusco D, 2014, VACCINE, DOI [10.1016/s0264-410x(02)00691-6, DOI 10.1016/S0264-410X(02)00691-6]; Bucafusco D, 2015, VIROLOGY, V476, P11, DOI 10.1016/j.virol.2014.11.023; Capozzo AVE, 1997, VACCINE, V15, P624, DOI 10.1016/S0264-410X(96)00284-8; CARTWRIGHT B, 1980, J GEN VIROL, V50, P369, DOI 10.1099/0022-1317-50-2-369; Cox SJ, 2003, VACCINE, V21, P1336, DOI 10.1016/S0264-410X(02)00691-6; Crowther J R, 1986, Rev Sci Tech, V5, P299, DOI 10.20506/rst.5.2.235; DOEL TR, 1981, ARCH VIROL, V70, P21, DOI 10.1007/BF01320790; DOEL TR, 1982, ARCH VIROL, V73, P185, DOI 10.1007/BF01314726; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Donaldson A I, 1986, Rev Sci Tech, V5, P315, DOI 10.20506/rst.5.2.234; Fever Q, 2019, MANUAL DIAGNOSTIC TE; Harmsen MM, 2015, VACCINE, V33, P2477, DOI 10.1016/j.vaccine.2015.03.066; Harmsen MM, 2011, VACCINE, V29, P2682, DOI 10.1016/j.vaccine.2011.01.069; Maradei E, 2008, VACCINE, V26, P6577, DOI 10.1016/j.vaccine.2008.09.033; MCCULLOUGH KC, 1987, VIROLOGY, V157, P516, DOI 10.1016/0042-6822(87)90294-7; OULDRIDGE EJ, 1982, RES VET SCI, V32, P327, DOI 10.1016/S0034-5288(18)32389-0; Paton DJ, 2019, VACCINE, V37, P5515, DOI 10.1016/j.vaccine.2019.07.102; Brito BP, 2014, VACCINE, V32, P433, DOI 10.1016/j.vaccine.2013.12.007; PAY TWF, 1987, VACCINE, V5, P60, DOI 10.1016/0264-410X(87)90011-9; Pega J, 2013, J VIROL, V87, P2489, DOI 10.1128/JVI.02879-12; RAO MG, 1994, VET MICROBIOL, V39, P135, DOI 10.1016/0378-1135(94)90094-9; Smith MT, 2014, VACCINE, V32, P3902, DOI 10.1016/j.vaccine.2014.04.038; Yang YL, 2017, VACCINE, V35, P2413, DOI 10.1016/j.vaccine.2017.03.037; Zhang L, 2016, VIRUS RES, V220, P39, DOI 10.1016/j.virusres.2016.04.008	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232782	10.1371/journal.pone.0232782	http://dx.doi.org/10.1371/journal.pone.0232782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369529	Green Published, gold			2022-12-26	WOS:000537280000048
J	Hallinen, KM; Guardiola-Flores, KA; Wood, KB				Hallinen, Kelsey M.; Guardiola-Flores, Keanu A.; Wood, Kevin B.			Fluorescent reporter plasmids for single-cell and bulk-level composition assays in E. faecalis	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-FAECALIS; BIOFILM DEVELOPMENT; ESCHERICHIA-COLI; RESISTANCE; DNA; PROTEINS; TRANSFORMATION; CONSTRUCTION	Fluorescent reporters are an important tool for monitoring dynamics of bacterial populations at the single cell and community level. While there are a large range of reporter constructs available-particularly for common model organisms like E. coli-fewer options exist for other species, including E. faecalis, a gram-positive opportunistic pathogen. To expand the potential toolkit available for E. faecalis, we exchanged the original fluorescent reporter in a previously developed plasmid (pBSU101) with one of eight fluorescent reporters and confirmed that all constructs exhibited detectable fluorescence in single E. faecalis cells and mixed biofilm communities. To identify promising constructs for bulk-level experiments, we then measured the fluorescence spectra from E. faecalis populations in microwell plate (liquid) cultures during different phases of aerobic growth. Cultures showed density- and reporter-specific variations in fluorescent signal, though spectral signatures of all reporters become clear in late-exponential and stationary-phase populations. Based on these results, we identified six pairs of reporters that can be combined with simple spectral unmixing to accurately estimate population composition in 2-strain mixtures at or near stationary phase. This approach offers a simple and scalable method for selection and competition experiments in simple two-species populations under aerobic growth conditions. Finally, we incorporated codon-optimized variants of blue (BFP) and red (RFP) reporters and show that they lead to increased fluorescence in exponentially growing cells. As a whole, the results inform the scope of application of different reporters and identify both single reporters and reporter pairs that are promising for fluorescence-based assays at bulk and single-cell levels in E. faecalis.	[Hallinen, Kelsey M.; Guardiola-Flores, Keanu A.; Wood, Kevin B.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Wood, Kevin B.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wood, KB (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.; Wood, KB (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	kbwood@umich.edu		Wood, Kevin/0000-0002-0985-7401; Hallinen, Kelsey/0000-0003-4081-6699	National Science Foundation (NSF) [1553028]; National Science Foundation (NSF GRF) [DGE 1256260]; National Institutes of Health (NIH) [1R35GM124875-01]; Hartwell Foundation for Biomedical Research	National Science Foundation (NSF)(National Science Foundation (NSF)); National Science Foundation (NSF GRF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation for Biomedical Research	This work is supported by the National Science Foundation (NSF No. 1553028 to KW; NSF GRF No. DGE 1256260 to KMH-https://www.nsf.gov/), the National Institutes of Health (NIH No. 1R35GM124875-01 to KBW-https://www.nih.gov), and the Hartwell Foundation for Biomedical Research (to KBW-http://www.thehartwellfoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakra A, 2007, APPL ENVIRON MICROB, V73, P2207, DOI 10.1128/AEM.01599-06; [Anonymous], 2011, CANC DISCOV; Aymanns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019822; Breuer RJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006878; CHASSY BM, 1988, TRENDS BIOTECHNOL, V6, P303, DOI 10.1016/0167-7799(88)90025-X; CLEWELL DB, 1974, J BACTERIOL, V117, P283, DOI 10.1128/JB.117.1.283-289.1974; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Facklam RR, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P1; Foucault ML, 2010, P NATL ACAD SCI USA, V107, P16964, DOI 10.1073/pnas.1006855107; Garcia-Cayuela T, 2012, APPL MICROBIOL BIOT, V96, P171, DOI 10.1007/s00253-012-4087-z; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; Gokhale S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07703-y; Hallinen KM, 2020, ELIFE, V9, DOI 10.7554/eLife.52813; Hancock L, 2002, J BACTERIOL, V184, P5819, DOI 10.1128/JB.184.21.5819-5825.2002; Hancock LE, 2004, J BACTERIOL, V186, P7951, DOI 10.1128/JB.186.23.7951-7958.2004; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Haug MC, 2010, FEMS MICROBIOL LETT, V313, P111, DOI 10.1111/j.1574-6968.2010.02131.x; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kak V, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P355; Karampatzakis A, 2017, BIOMED PHYS ENG EXPR, V3, DOI 10.1088/2057-1976/aa6db7; Karslake J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005098; Keogh D, 2018, MBIO, V9, DOI 10.1128/mBio.00626-17; Klumper U, 2019, ISME J, P1; Lee K, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01182-17; Lichten CA, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-11; Linares DM, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0169-1; Malani PN, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P385; Manson JM, 2010, P NATL ACAD SCI USA, V107, P12269, DOI 10.1073/pnas.1000139107; Miller WR, 2014, EXPERT REV ANTI-INFE, V12, P1221, DOI 10.1586/14787210.2014.956092; Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Patterson GH, 2004, NAT BIOTECHNOL, V22, P1524, DOI 10.1038/nbt1204-1524; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stevens RH, 2011, FEMS MICROBIOL LETT, V317, P9, DOI 10.1111/j.1574-6968.2010.02203.x; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Tannock GW, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P101; Teixeira N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064740; Teixeira N, 2012, MICROBIOL-SGM, V158, P519, DOI 10.1099/mic.0.055574-0; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Vickerman MM, 2015, J MICROBIOL METH, V116, P15, DOI 10.1016/j.mimet.2015.06.010; Wessel AK, 2014, MBIO, V5, DOI 10.1128/mBio.00992-14; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; YORK D, 1966, CAN J PHYS, V44, P1079, DOI 10.1139/p66-090; Yurtsev EA, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.39; Yurtsev EA, 2016, P NATL ACAD SCI USA, V113, P6236, DOI 10.1073/pnas.1523317113	53	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232539	10.1371/journal.pone.0232539	http://dx.doi.org/10.1371/journal.pone.0232539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO4MT	32369497	Green Published, gold, Green Submitted			2022-12-26	WOS:000533604100001
J	Shao, Y; Peng, Y; Mao, BG; Lv, QM; Yuan, DY; Liu, XL; Zhao, BR				Shao, Ye; Peng, Yan; Mao, Bigang; Lv, Qiming; Yuan, Dingyang; Liu, Xionglun; Zhao, Bingran			Allelic variations of the Wx locus in cultivated rice and their use in the development of hybrid rice in China	PLOS ONE			English	Article							AMYLOSE CONTENT; STARCH SYNTHASE; GENE; EXPRESSION; ACCUMULATION; POLYMORPHISM	To make better use of global germplasm resources for improving the eating quality of hybrid rice, using the resequencing data from the 3,000 rice genomes project (3K RGP), the allelic variations of the rice Wx locus were analysed. With the exception of five rare alleles discovered for the first time in our study, most of these alleles were known alleles of Wx. Furthermore, a set of Kompetitive allele-specific PCR (KASP) markers based on these Wx alleles have been developed, and thirty-six main parents of hybrid rice from 1976 to 2018 were selected for Wx genotyping. The results showed that only three Wx alleles existed in the main parents of hybrids, and the allelic combination of the hybrids changed from Wx(a)/Wx(b) and Wx(lv)/Wx(b) to Wx(b)/Wx(b) with the development of hybrid rice. Wx(b) is widely used in the male parents of hybrid rice. Wx(a) and Wx(lv) were used in the female parents of early hybrid rice, and they were gradually replaced by Wx(b). In the future, more favourable Wx alleles from cultivated rice should be identified, introduced, and effectively used to improve hybrid rice quality.	[Shao, Ye; Liu, Xionglun] Hunan Agr Univ, Coll Agron, Changsha, Peoples R China; [Shao, Ye; Peng, Yan; Mao, Bigang; Lv, Qiming; Yuan, Dingyang; Zhao, Bingran] Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha, Peoples R China	Hunan Agricultural University; Hunan Academy of Agricultural Sciences	Liu, XL (corresponding author), Hunan Agr Univ, Coll Agron, Changsha, Peoples R China.; Zhao, BR (corresponding author), Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha, Peoples R China.	xionglun@hunau.edu.cn; brzhao123@163.com			Pre-cultivation Project of National Biological Seed Industry Technology Innovation Center [2018XK2005]; Key Project of Hunan Province [2018NK1020-1]; National Natural Science Foundation of China [31171526, U19A2032]	Pre-cultivation Project of National Biological Seed Industry Technology Innovation Center; Key Project of Hunan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by funds from the Pre-cultivation Project of National Biological Seed Industry Technology Innovation Center (2018XK2005), the Key Project of Hunan Province (2018NK1020-1), National Natural Science Foundation of China U19A2032, and the National Natural Science Foundation of China 31171526. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; [陈立云 Chen Liyun], 2015, [杂交水稻, Hybrid Rice], V30, P1; Cheng A, 2012, INT J MOL SCI, V13, P6156, DOI 10.3390/ijms13056156; Dobo M, 2010, J CEREAL SCI, V52, P450, DOI 10.1016/j.jcs.2010.07.010; He CL, 2014, METHODS MOL BIOL, V1145, P75, DOI 10.1007/978-1-4939-0446-4_7; Hirano HY, 1998, PLANT CELL PHYSIOL, V39, P807, DOI 10.1093/oxfordjournals.pcp.a029438; [胡忠孝 Hu Zhongxiao], 2016, [杂交水稻, Hybrid Rice], V31, P1; Isshiki M, 1998, PLANT J, V15, P133, DOI 10.1046/j.1365-313X.1998.00189.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larkin PD, 2003, MOL BREEDING, V12, P335, DOI 10.1023/B:MOLB.0000006797.51786.92; Larkin PD, 1999, PLANT MOL BIOL, V40, P719, DOI 10.1023/A:1006298608408; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li JY, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-8; Li Y H, 2000, ACTA AGRON SIN, V26, P171; Liu DR, 2014, PLANT BIOTECHNOL J, V12, P1297, DOI 10.1111/pbi.12228; Liu LL, 2009, PLANT MOL BIOL, V71, P609, DOI 10.1007/s11103-009-9544-4; Mikami I, 2008, THEOR APPL GENET, V116, P979, DOI 10.1007/s00122-008-0729-z; Mikami I, 2000, PLANT BREEDING, V119, P505, DOI 10.1046/j.1439-0523.2000.00533.x; Mikami I, 1999, EUPHYTICA, V105, P91, DOI 10.1023/A:1003457209225; Qian Q, 2016, NATL SCI REV, V3, P283, DOI 10.1093/nsr/nww006; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SANO Y, 1991, RICE GENETICS II, P11, DOI 10.1142/9789812814272_0002; Sato M., 1996, J PN J BREED S1, V40, P221; South A, 2011, R J, V3, P35; [唐文帮 Tang Wenbang], 2016, [杂交水稻, Hybrid Rice], V31, P1; Tian ZX, 2010, CHINESE SCI BULL, V55, P3768, DOI 10.1007/s11434-010-4124-1; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; UMEMOTO T, 1995, PHYTOCHEMISTRY, V40, P1613, DOI 10.1016/0031-9422(95)00380-P; Wang Cai-lin, 2009, Zhongguo Shuidao Kexue, V23, P25; Wang WS, 2018, NATURE, V557, P43, DOI 10.1038/s41586-018-0063-9; WILLIAMS PC, 1970, CEREAL CHEM, V47, P411; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yang J, 2013, PLANT BREEDING, V132, P595, DOI 10.1111/pbr.12088; Zhang CQ, 2019, MOL PLANT, V12, P1157, DOI 10.1016/j.molp.2019.05.011; Zhang HL, 2011, THEOR APPL GENET, V122, P49, DOI 10.1007/s00122-010-1421-7; ZHU Ji-hui, 2015, Chinese Journal of Rice Science, V29, P431, DOI 10.3969/j.issn.1001-7216.2015.04.013	36	7	8	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232279	10.1371/journal.pone.0232279	http://dx.doi.org/10.1371/journal.pone.0232279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369522	Green Published, gold			2022-12-26	WOS:000537280000022
J	Tayyab, N; Naz, R; Yasmin, H; Nosheen, A; Keyani, R; Sajjad, M; Hassan, MN; Roberts, TH				Tayyab, Nimrah; Naz, Rabia; Yasmin, Humaira; Nosheen, Asia; Keyani, Rumana; Sajjad, Muhammad; Hassan, Muhammad Nadeem; Roberts, Thomas H.			Combined seed and foliar pre-treatments with exogenous methyl jasmonate and salicylic acid mitigate drought-induced stress in maize	PLOS ONE			English	Article							WHEAT SEEDLINGS; PLANT-GROWTH; OXIDATIVE STRESS; GENE-EXPRESSION; DEFENSE; ACCUMULATION; TOLERANCE; GLYCINEBETAINE; FLUORESCENCE; CHLOROPHYLL	Susceptibility of plants to abiotic stresses, including extreme temperatures, salinity and drought, poses an increasing threat to crop productivity worldwide. Here the drought-induced response of maize was modulated by applications of methyl jasmonate (MeJA) and salicylic acid (SA) to seeds prior to sowing and to leaves prior to stress treatment. Pot experiments were conducted to ascertain the effects of exogenous applications of these hormones on maize growth, physiology and biochemistry under drought stress and well-watered (control) conditions. Maize plants were subjected to single as well as combined pre-treatments of MeJA and SA. Drought stress severely affected maize morphology and reduced relative water content, above and below-ground biomass, rates of photosynthesis, and protein content. The prolonged water deficit also led to increased relative membrane permeability and oxidative stress induced by the production of malondialdehyde (from lipid peroxidation), lipoxygenase activity (LOX) and the production of H2O2. The single applications of MeJA and SA were not found to be effective in maize for drought tolerance while the combined pre-treatments with exogenous MeJA+SA mitigated the adverse effects of drought-induced oxidative stress, as reflected in lower levels of lipid peroxidation, LOX activity and H2O2. The same pre-treatment also maintained adequate water status of the plants under drought stress by increasing osmolytes including proline, total carbohydrate content and total soluble sugars. Furthermore, exogenous applications of MeJA+SA approximately doubled the activities of the antioxidant enzymes catalase, peroxidase and superoxide dismutase. Pre-treatment with MeJA alone gave the highest increase in drought-induced production of endogenous abscisic acid (ABA). Pre-treatment with MeJA+SA partially prevented drought-induced oxidative stress by modulating levels of osmolytes and endogenous ABA, as well as the activities of antioxidant enzymes. Taken together, the results show that seed and foliar pre-treatments with exogenous MeJA and/or SA can have positive effects on the responses of maize seedlings to drought.	[Tayyab, Nimrah; Naz, Rabia; Yasmin, Humaira; Nosheen, Asia; Keyani, Rumana; Sajjad, Muhammad; Hassan, Muhammad Nadeem] COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan; [Roberts, Thomas H.] Univ Sydney, Plant Breeding Inst, Sydney Inst Agr, Sydney, NSW, Australia	COMSATS University Islamabad (CUI); University of Sydney	Naz, R (corresponding author), COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan.	rabia.naz@comsats.edu.pk	Sajjad, Muhammad/AAJ-5814-2020; Hassan, Mohammad/GZA-7507-2022; Yasmin, Humaira/ABB-1384-2021; Hassan, Muhammad/GWZ-4054-2022; Yasmin, Humaira/AAO-6630-2020; Yasmin, Humaira/AAS-9944-2020; Keyani, Rumana/AAN-2321-2020; Roberts, Thomas H/H-2071-2012; Sajjad, Muhammad/GZL-4962-2022	Sajjad, Muhammad/0000-0002-1036-2510; Hassan, Mohammad/0000-0002-1712-0004; Yasmin, Humaira/0000-0002-4220-4808; Yasmin, Humaira/0000-0002-8738-4216; Roberts, Thomas H/0000-0003-3831-3240; Sajjad, Muhammad/0000-0003-0006-1156; Naz, Rabia/0000-0002-2716-2267	COMSATS University Islamabad under "CUI research grant Program (CRGP)	COMSATS University Islamabad under "CUI research grant Program (CRGP)	Dr. Rabia Naz won the research grant to accomplish this study from COMSATS University Islamabad under "CUI research grant Program (CRGP)."	Abdelgawad Z. A., 2014, Agricultural Sciences, V5, P1077, DOI 10.4236/as.2014.512117; Aftab T, 2011, PROTOPLASMA, V248, P601, DOI 10.1007/s00709-010-0218-5; Ahmad B., 2019, PLANT ABIOTIC STRESS, P273, DOI [DOI 10.1007/978-3-030-06118-0_12, 10.1007/978-3-030-06118-0_12]; Ahmad P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00813; Ai L, 2008, J AGRON CROP SCI, V194, P360, DOI 10.1111/j.1439-037X.2008.00325.x; Alam M. M., 2013, Australian Journal of Crop Science, V7, P1053; Anjum NA, 2012, OXIDATIVE STRESS PLA; Anjum SA, 2011, J AGRON CROP SCI, V197, P177, DOI 10.1111/j.1439-037X.2010.00459.x; [Anonymous], 2017, INTRO CORN MAIZE; Asgher M, 2015, PROTOPLASMA, V252, P399, DOI 10.1007/s00709-014-0710-4; Avalbaev A, 2016, J PLANT PHYSIOL, V191, P101, DOI 10.1016/j.jplph.2015.11.013; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; [卜令铎 BU Lingduo], 2010, [生态学报, Acta Ecologica Sinica], V30, P1184; Burling K, 2013, ENVIRON EXP BOT, V89, P51, DOI 10.1016/j.envexpbot.2013.01.003; Cakir R, 2004, FIELD CROP RES, V89, P1, DOI 10.1016/j.fcr.2004.01.005; Cenzano A, 2003, ANN BOT-LONDON, V91, P915, DOI 10.1093/aob/mcg098; Chen J, 2014, ECOTOX ENVIRON SAFE, V104, P349, DOI 10.1016/j.ecoenv.2014.01.022; Delavar K, 2017, J PLANT NUTR, V40, P1475, DOI 10.1080/01904167.2016.1269344; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Farooq MA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00468; Fracasso A, 2016, J PLANT PHYSIOL, V190, P1, DOI 10.1016/j.jplph.2015.10.009; Gomez K.A., 1984, STAT PROCEDURES AGR, P13; GORIN N, 1976, J AGR FOOD CHEM, V24, P200, DOI 10.1021/jf60203a043; Gupta RB, 1996, J EXP BOT, V47, P1377, DOI 10.1093/jxb/47.9.1377; Habibi Ghader, 2012, Acta Biologica Szegediensis, V56, P57; HAHN H, 1992, IFAC WORK S, P208; Harrison HD, 2012, PROCEEDINGS OF THE ASME JOINT RAIL CONFERENCE 2012, P49; Hasanuzzaman M., 2013, CLIMATE CHANGE PLANT, P209, DOI DOI 10.1002/9783527675265.CH09; Hasanuzzaman M., 2017, PHYTOHORMONES SIGNAL, P31, DOI DOI 10.5772/INTECHOPEN.68213; Herbert D, 1971, METHODS MICROBIOLO B, V58, P265; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Huang H, 2017, J EXP BOT, V68, P1349, DOI 10.1093/jxb/erw495; Hudson B, 2009, FRENCH TARRAGON GARD; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Jain M., 2019, PLANT ABIOTIC STRESS, P129, DOI [DOI 10.1007/978-3-030-06118-0_5, 10.1007/978-3-030-06118-0_5]; Kang GZ, 2012, J PROTEOME RES, V11, P6066, DOI 10.1021/pr300728y; Khan M., 2012, PHYTOHORMONES ABIOTI, P277, DOI [10.1007/978-3-642-25829-9, DOI 10.1007/978-3-642-25829-9_12]; Khan MIR, 2012, PEDOSPHERE, V22, P746, DOI 10.1016/S1002-0160(12)60060-5; Khan N., 2010, INT J PLANT BIOL, V1, pe1, DOI [10.4081/pb.2010.e1, DOI 10.4081/pb.2010.e1]; Korkmaz A, 2007, ACTA PHYSIOL PLANT, V29, P503, DOI 10.1007/s11738-007-0060-3; Kumar M, 2010, INDIAN J BIOCHEM BIO, V47, P378; Loutfy N, 2012, J PLANT RES, V125, P173, DOI 10.1007/s10265-011-0419-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; MAJID NA, 2006, J BIOL SCI, V6, P55, DOI DOI 10.3923/JBS.2006.55.60; Mir MA, 2018, J PLANT GROWTH REGUL, V37, P1195, DOI 10.1007/s00344-018-9814-y; Miura K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00004; Munne-Bosch S, 2003, PLANTA, V217, P758, DOI 10.1007/s00425-003-1037-0; Nafie Eetezaz, 2011, Braz. J. Plant Physiol., V23, P161, DOI 10.1590/S1677-04202011000200008; Nahar K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01104; Nazarli H., 2011, Cercetari Agronomice in Moldova, V44, P35; Nazarli H., 2014, J HERBMED PHARM, V3, P87; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Patakas A, 2001, J PLANT PHYSIOL, V158, P63, DOI 10.1078/0176-1617-00003; Picaud JC, 2004, ACTA PAEDIATR, V93, P241, DOI 10.1080/08035250310022324; Razifah M. R., 2014, Journal of Biology, Agriculture and Healthcare, V4, P15; Reeb J., 1999, MOISTURE CONTENT OVE, DOI DOI 10.1016/J.APSUSC.2013.11.072; Rohwer CL, 2008, J HORTIC SCI BIOTECH, V83, P283, DOI 10.1080/14620316.2008.11512381; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; SALVADOR RJ, 1995, MAYDICA, V40, P141; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Saruhan N, 2012, ACTA PHYSIOL PLANT, V34, P97, DOI 10.1007/s11738-011-0808-7; Saxena S.C., 2013, PLANT ACCLIMATION EN, P197, DOI DOI 10.1007/978-1-4614-5001-6_9; Serraj R, 2002, PLANT CELL ENVIRON, V25, P333, DOI 10.1046/j.1365-3040.2002.00754.x; Shahid M. N., 2016, American Journal of Plant Sciences, V7, P789, DOI 10.4236/ajps.2016.76073; Shakirova FM, 2003, PLANT SCI, V164, P317, DOI 10.1016/S0168-9452(02)00415-6; Shyu C, 2015, J EXP BOT, V66, P4165, DOI 10.1093/jxb/erv011; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; Tavallali V, 2019, J PLANT PHYSIOL, V234, P98, DOI 10.1016/j.jplph.2019.02.001; Vardharajula S, 2011, J PLANT INTERACT, V6, P1, DOI 10.1080/17429145.2010.535178; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; VETTER JL, 1958, J AGR FOOD CHEM, V6, P39, DOI 10.1021/jf60083a006; Walia H, 2007, PLANT CELL ENVIRON, V30, P410, DOI 10.1111/j.1365-3040.2006.01628.x; Wang J, 2016, ECOTOX ENVIRON SAFE, V133, P146, DOI 10.1016/j.ecoenv.2016.07.002; Yang G.H., 2009, ACTA AGR BOREALI SIN, V24, P155; Yang GP, 1996, AUST J PLANT PHYSIOL, V23, P437, DOI 10.1071/PP9960437; Yoon Ji Young, 2009, Journal of Crop Science and Biotechnology, V12, P63; Zadehbagheri M., 2014, International Journal of Biosciences (IJB), V4, P187	80	39	39	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232269	10.1371/journal.pone.0232269	http://dx.doi.org/10.1371/journal.pone.0232269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357181	Green Published, gold			2022-12-26	WOS:000536957700023
J	Flores, EB; Bartee, MY; Bartee, E				Flores, Erica B.; Bartee, Mee Y.; Bartee, Eric			Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxviruses	PLOS ONE			English	Article							HEPARAN-SULFATE BIOSYNTHESIS; PROTEIN BINDS; MYXOMA; TARGET; ADSORPTION; VIRIONS; CELLS	Poxviruses are large enveloped viruses that replicate exclusively in the cytoplasm. Like all viruses, their replication cycle begins with virion adsorption to the cell surface. Unlike most other viral families, however, no unique poxviral receptor has ever been identified. In the absence of a unique receptor, poxviruses are instead thought to adhere to the cell surface primarily through electrostatic interactions between the positively charged viral envelope proteins and the negatively charged sulfate groups on cellular glycosaminoglycans (GAGs). While these negatively charged GAGs are an integral part of all eukaryotic membranes, their specific expression and sulfation patterns differ between cell types. Critically, while poxviral binding has been extensively studied using virally centered genetic strategies, the impact of cell-intrinsic changes to GAG charge has never been examined. Here we show that loss of heparin sulfation, accomplished by deleting the enzyme N-Deacetylase and N-Sulfotransferase-1 (NDST1) which is essential for GAG sulfation, significantly reduces the binding affinity of both vaccinia and myxoma viruses to the cell surface. Strikingly, however, while this lowered binding affinity inhibits the subsequent spread of myxoma virus, it actually enhances the overall spread of vaccinia by generating more diffuse regions of infection. These data indicate that cell-intrinsic GAG sulfation plays a major role in poxviral infection, however, this role varies significantly between different members of the poxviridae.	[Flores, Erica B.; Bartee, Mee Y.; Bartee, Eric] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Bartee, E (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, Albuquerque, NM 87131 USA.	ebartee@salud.unm.edu		Flores, Erica/0000-0002-1018-1883	NIH (NIAID) [R21AI123803]; NIH (NCI) [R01CA194090]; American Cancer Society [RSG-17-047-01]	NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society)	EB R21AI123803 NIH (NIAID) https://www.niaid.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EB R01CA194090 NIH (NCI) https://www.cancer.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EB RSG-17-047-01 American Cancer Society https://www.cancer.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartee E, 2012, BIOL BLOOD MARROW TR, V18, P1540, DOI 10.1016/j.bbmt.2012.04.004; Bartee MY, 2017, CANCER RES, V77, P2952, DOI 10.1158/0008-5472.CAN-16-1638; Burton C, 2018, ONCOLYTIC VIROTHER, V7, P107, DOI 10.2147/OV.S179335; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Dou WF, 2015, J BIOL CHEM, V290, P20427, DOI 10.1074/jbc.M115.664409; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Irwin CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084134; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Khanna M, 2017, J GEN VIROL, V98, P2556, DOI 10.1099/jgv.0.000921; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Kwon MJ, 2012, FEBS LETT, V586, P2207, DOI 10.1016/j.febslet.2012.05.037; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; PAYNE LG, 1978, J VIROL, V27, P19, DOI 10.1128/JVI.27.1.19-27.1978; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; SPEAR PG, 1992, ADV EXP MED BIOL, V313, P341; Villa NY, 2010, VIROLOGY, V401, P266, DOI 10.1016/j.virol.2010.02.027; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Wolfe AM, 2018, J VIROL, V92, DOI 10.1128/JVI.02186-17; Zachertowska A, 2006, J VIROL METHODS, V132, P1, DOI 10.1016/j.jviromet.2005.08.015	30	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231977	10.1371/journal.pone.0231977	http://dx.doi.org/10.1371/journal.pone.0231977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352982	Green Published, gold			2022-12-26	WOS:000536673200031
J	Ham-Duenas, JG; Canales-del-Castillo, R; Voelker, G; Ruvalcaba-Ortega, I; Aguirre-Calderon, CE; Gonzalez-Rojas, JI				Ham-Duenas, Jose G.; Canales-del-Castillo, Ricardo; Voelker, Gary; Ruvalcaba-Ortega, Irene; Aguirre-Calderon, Carlos E.; Gonzalez-Rojas, Jose I.			Adaptive genetic diversity and evidence of population genetic structure in the endangered Sierra Madre Sparrow (Xenospiza baileyi)	PLOS ONE			English	Article							RECEPTOR 2 TLR2; STATISTICAL TESTS; CLIMATE-CHANGE; HAPLOTYPE RECONSTRUCTION; PATHOGEN RICHNESS; NATURAL-SELECTION; CONSERVATION; NEUTRALITY; DIVERSIFICATION; IMMUNITY	The magnitude and distribution of genetic diversity through space and time can provide useful information relating to evolutionary potential and conservation status in threatened species. In assessing genetic diversity in species that are of conservation concern, several studies have focused on the use of Toll-like receptors (TLRs). TLRs are innate immune genes related to pathogen resistance, and polymorphisms may reflect not only levels of functional diversity, but may also be used to assess genetic diversity within and among populations. Here, we combined four potentially adaptive markers (TLRs) with one mitochondrial (COI) marker to evaluate genetic variation in the endangered Sierra Madre Sparrow (Xenospiza baileyi). This species offers an ideal model to investigate population and evolutionary genetic processes that may be occurring in a habitat restricted endangered species with disjunct populations (Mexico City and Durango), the census sizes of which differ by an order of magnitude. TLRs diversity in the Sierra Madre Sparrow was relatively high, which was not expected given its two small, geographically isolated populations. Genetic diversity was different (but not significantly so) between the two populations, with less diversity seen in the smaller Durango population. Population genetic structure between populations was due to isolation and different selective forces acting on different TLRs; population structure was also evident in COI. Reduction of genetic diversity in COI was observed over 20 years in the Durango population, a result likely caused by habitat loss, a factor which may be the main cause of diversity decline generally. Our results provide information related to the ways in which adaptive variation can be altered by demographic changes due to human-mediated habitat alterations. Furthermore, our findings may help to guide conservation schemes for both populations and their restricted habitat.	[Ham-Duenas, Jose G.; Canales-del-Castillo, Ricardo; Ruvalcaba-Ortega, Irene; Gonzalez-Rojas, Jose I.] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Lab Biol Conservac & Desarrollo Sustentable, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Voelker, Gary] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Biodivers Res & Teaching Collect, College Stn, TX 77843 USA; [Aguirre-Calderon, Carlos E.] Inst Tecnol El Salto, Durango, Mexico	Universidad Autonoma de Nuevo Leon; Texas A&M University System; Texas A&M University College Station	Canales-del-Castillo, R (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Lab Biol Conservac & Desarrollo Sustentable, San Nicolas De Los Garza, Nuevo Leon, Mexico.	ricardo.canalesdlc@uanl.edu.mx	Ham, Gerardo/AAS-1266-2021	Ham, Gerardo/0000-0002-4051-8299; Canales-del-Castillo, Ricardo/0000-0003-3902-9751; Ruvalcaba-Ortega, Irene/0000-0001-8309-7618; Gonzalez-Rojas, Jose I./0000-0003-2740-7305	U.S. Fish and Wildlife Service [F17AP00903]; Texas A&M University-CONACYT [2017001]; Apoyo para el fortalecimiento de los Cuerpos Academicos, Programa para el Desarrollo Profesional Docente, Tipo Superior (PRODEP) [511-6/18-5729]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Texas A&M University-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Apoyo para el fortalecimiento de los Cuerpos Academicos, Programa para el Desarrollo Profesional Docente, Tipo Superior (PRODEP)	This work was partially funded by U.S. Fish and Wildlife Service, through the project "Surveys to locate populations of the Sierra Madre Sparrow in southern Durango" (F17AP00903) and by Texas A&M University-CONACYT Research Grant Program (Regular research award 2017001). JGH-D and RC-C thank to Apoyo para el fortalecimiento de los Cuerpos Academicos, Programa para el Desarrollo Profesional Docente, Tipo Superior (PRODEP) for the Postdoctoral fellowship awarded for the completion of this study and financial support (511-6/18-5729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Antonides J, 2017, IMMUNOGENETICS, V69, P175, DOI 10.1007/s00251-016-0960-8; Arenas M., 2014, NATURAL SELECTION ME; Awadi A, 2018, CR BIOL, V341, P315, DOI 10.1016/j.crvi.2018.06.005; BAILEY ALFRED M., 1935, AUK, V52, P421; BANGS OUTRAM, 1931, PROC NEW ENGLAND ZOOL CLUB, V12, P85; Basu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046441; Bateson ZW, 2016, MOL ECOL, V25, P4730, DOI 10.1111/mec.13793; Berlanga H., 2009, BIODIVERSITAS, V87, P11; Berlanga H, 2009, CONSERVACION HABITA, P11; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Bird Life International, 2020, IUCN RED LIST BIRDS; BirdLife International, 2019, SPEC FACTSH XEN BAIL; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Boyd AC, 2012, J IMMUNOL, V189, P4930, DOI 10.4049/jimmunol.1101790; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Bryson RW, 2012, MOL PHYLOGENET EVOL, V62, P447, DOI 10.1016/j.ympev.2011.10.014; Bulgin NL, 2003, MOL ECOL, V12, P831, DOI 10.1046/j.1365-294X.2003.01774.x; Cabrera-Garcia L., 2006, LINKING SOCIAL ECOLO; Cabrera-Garcia L, 2006, ORYX, V40, P211, DOI 10.1017/S0030605306000615; Chavez-Trevino A, 2017, CONSERV GENET RESOUR, V9, P385, DOI 10.1007/s12686-017-0690-8; Cheptou PO, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0037; Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Coetzer WG, 2018, PEERJ, V6, DOI 10.7717/peerj.4953; Cui J, 2015, IMMUNOGENETICS, V67, P195, DOI 10.1007/s00251-014-0823-0; Dalton DL, 2016, SCI REP, V6, P1; de Ita AO, 2007, BIODIVERS CONSERV, V16, P1055, DOI 10.1007/s10531-006-9062-5; de Ita AO, 2012, CONSERV GENET, V13, P283, DOI 10.1007/s10592-011-0283-0; De Ita AO, 2006, BIRD CONSERV INT, V16, P25, DOI 10.1017/S0959270905000687; DICKERMAN RW, 1967, AUK, V84, P49, DOI 10.2307/4083254; Downing T, 2010, J IMMUNOL, V184, P6993, DOI 10.4049/jimmunol.0903092; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn RR, 2010, P ROY SOC B-BIOL SCI, V277, P2587, DOI 10.1098/rspb.2010.0340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Flanagan CD, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00058; Forsdyke S, 2012, SLAVES TELL TALES: AND OTHER EPISODES IN THE POLITICS OF POPULAR CULTURE IN ANCIENT GREECE, P1; Friis G, 2016, MOL ECOL, V25, P6175, DOI 10.1111/mec.13911; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1996, GENETICS, V143, P557; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2015, ECOL EVOL, V5, P676, DOI 10.1002/ece3.1388; Gilroy DL, 2017, ANIM CONSERV, V20, P235, DOI 10.1111/acv.12307; Gonzalez-Quevedo C, 2015, MOL ECOL, V24, P5852, DOI 10.1111/mec.13437; Grueber CE, 2015, CONSERV GENET, V16, P595, DOI 10.1007/s10592-014-0685-x; Grueber CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089632; Grueber CE, 2013, CONSERV GENET RESOUR, V5, P1043, DOI 10.1007/s12686-013-9965-x; Grueber CE, 2013, MOL ECOL, V22, P4470, DOI 10.1111/mec.12404; Grueber CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045011; Guevara-Herrera R., 2012, EVALUACION ECOLOGICA; Hartmann SA, 2014, MOL ECOL, V23, P5712, DOI 10.1111/mec.12975; Hebert Paul D. N., 2004, PLoS Biology, V2, P1657, DOI 10.1371/journal.pbio.0020312; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Martínez-Guerrero José Hugo, 2018, Acta Zool. Mex, V34, pe3412115, DOI 10.21829/azm.2018.3412115; IUCN, 2020, IUCN RED LIST THREAT; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kaeuffer R, 2007, HEREDITY, V99, P374, DOI 10.1038/sj.hdy.6801010; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keeling MJ, 2004, ECOLOGY GENETICS EVO, P415, DOI [10.1016/B978-012323448-3/50019-2, DOI 10.1016/B978-012323448-3/50019-2]; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kloch A, 2018, SCI REP, V8, P1; Knafler GJ, 2017, NEW ZEAL J ECOL, V41, P98, DOI 10.20417/nzjecol.41.8; KUMAR S, 2016, INDIAN J ECON DEV, V4; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Leroy G, 2018, EVOL APPL, V11, P1066, DOI 10.1111/eva.12564; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McCormack JE, 2008, MOL ECOL, V17, P2505, DOI 10.1111/j.1365-294X.2008.03776.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mila B, 2006, EVOLUTION, V60, P2403; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nelson-Flower MJ, 2018, J HERED, V109, P501, DOI 10.1093/jhered/esy027; Nerren JR, 2010, VET IMMUNOL IMMUNOP, V136, P151, DOI 10.1016/j.vetimm.2010.02.017; Oliver MK, 2012, MOL BIOL EVOL, V29, P1713, DOI 10.1093/molbev/mss063; Oliveras de Ita A, 2002, ORNITOL NEOTROP, P203; Ostfeld RS, 2009, ECOLOGY, V90, P903, DOI 10.1890/08-0659.1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson AT, 1998, IBIS, V140, P288, DOI 10.1111/j.1474-919X.1998.tb04391.x; PITELKA FRANK A., 1947, CONDOR, V49, P199, DOI 10.2307/1364341; Pritchard JK, 2000, GENETICS, V155, P945; Quemere E, 2015, MOL ECOL, V24, P3873, DOI 10.1111/mec.13292; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rojas-Soto OR, 2008, J FIELD ORNITHOL, V79, P245, DOI 10.1111/j.1557-9263.2008.00170.x; Shafer ABA, 2015, TRENDS ECOL EVOL, V30, P78, DOI 10.1016/j.tree.2014.11.009; Skevaki C, 2015, CLIN EXP IMMUNOL, V180, P165, DOI 10.1111/cei.12578; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Spurgin LG, 2012, OECOLOGIA, V168, P691, DOI 10.1007/s00442-011-2149-z; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Taylor SS, 2007, J EVOLUTION BIOL, V20, P2035, DOI 10.1111/j.1420-9101.2007.01362.x; Tschirren B, 2011, J EVOLUTION BIOL, V24, P1232, DOI 10.1111/j.1420-9101.2011.02254.x; Turner TR, 2016, AM J PHYS ANTHROPOL, V159, P17, DOI 10.1002/ajpa.22825; Velova H, 2018, MOL BIOL EVOL, V35, P2170, DOI 10.1093/molbev/msy119; Wang SP, 2017, MOL ECOL, V26, P4671, DOI 10.1111/mec.14242; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1946, GENETICS, V31, P39; Wright S., 1951, ANN EUGEN	109	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232282	10.1371/journal.pone.0232282	http://dx.doi.org/10.1371/journal.pone.0232282			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352998	Green Published, gold			2022-12-26	WOS:000536673200067
J	Tesema, T; Seyoum, D; Ejeta, E; Tsegaye, R				Tesema, Tariku; Seyoum, Dejene; Ejeta, Eyasu; Tsegaye, Reta			Determinants of tuberculosis treatment outcome under directly observed treatment short courses in Adama City, Ethiopia	PLOS ONE			English	Article								Background Tuberculosis (TB) is a leading cause of death among infectious agents, ranking above HIV/AIDS. Though much effort has been done, Ethiopia remained one of those countries which share the greatest burden of TB. Evaluating the TB treatment outcome is one method of TB control measures. Therefore, the aim of the current study was to assess TB treatment outcome and its determinants under directly observed treatment short courses in Adama City, Central Ethiopia. Method An institutional based cross sectional study was conducted in all public and private health facilities of Adama city from March 1st 2016 to December 31st, 2016. The data were entered and analyzed by using SPSS version 21.0 statistical software. The results were presented using descriptive statistics. Univariate and multivariate logistic regression model was used to evaluate the potential determinants of unsuccessful treatment outcome. Results Among 281 patients evaluated, 90(32%) were cured, 137(48.8%) have completed the treatment, 4(1.4%) were treatment failure, 36(12.8%) were lost to follow up, and 14 (5%) died. The overall treatment success rate was 80.8%. Age 15-24 (Adjusted odds ratio (AOR): 4.97; 95% Confidence interval (CI): 1.13-21.90), distance less than 5 kilometers from treatment center (AOR: 3.1; 95% CI: 1.42-6.77), being seronegative for human immunodeficiency virus (HIV) (AOR: 20.38; 95% CI: 7.80-53.24) were associated with successful TB treatment outcome. Conclusion The treatment outcome of all forms tuberculosis patients in Adama city was unsatisfactory when referred with the national pooled estimate of 86% and WHO 2030 international target of >= 90%. Thus, enhancing client supervision, treatment monitoring; and working on provision TB treatment services at nearby health facilities should be a priority concern to improve the success rate of treatment outcome. Further studies are also recommended to explore important factors which were not examined by current study.	[Tesema, Tariku] Oromia Hlth Bur, TB & Leprosy Control & Prevent Unit, Addis Ababa, Ethiopia; [Seyoum, Dejene] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Ejeta, Eyasu] Wollega Univ, Inst Hlth Sci, Dept Med Lab Sci, Nekemte, Ethiopia; [Tsegaye, Reta] Wollega Univ, Inst Hlth Sci, Dept Nursing, Nekemte, Ethiopia		Tsegaye, R (corresponding author), Wollega Univ, Inst Hlth Sci, Dept Nursing, Nekemte, Ethiopia.	retatg@gmail.com		Gebre, Dejene Seyoum/0000-0002-5195-1389; Tsegaye, Reta/0000-0003-4721-3647				Abebe G, 2019, INT J MYCOBACT, V8, P35, DOI 10.4103/ijmy.ijmy_177_18; Alem Y, 2017, J LUNG HLTH DIS, V1, P5; Alene KA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4099-8; Amante TD, 2014, ETHIOP J HLTH DEV, V28; [Anonymous], 2017, 12 NAT TB RES ANN C; [Anonymous], 2010, TREATM TUB GUID; [Anonymous], 2017, WHO STRATEGY TB END; [Anonymous], 2014, IMPLEMENTATION GUIDE; Atif Muhammad, 2018, BMC Res Notes, V11, P370, DOI 10.1186/s13104-018-3473-8; Ejeta E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205468; Eshetie S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194675; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Kigozi G, 2017, INT J INFECT DIS, V54, P95, DOI 10.1016/j.ijid.2016.11.407; Melese Addisu, 2018, BMC Res Notes, V11, P25, DOI 10.1186/s13104-018-3129-8; Muluye AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206227; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Otu A. A., 2013, Asian Pacific Journal of Tropical Disease, V3, P227, DOI 10.1016/S2222-1808(13)60045-6; Seid MA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022111; Tafesse K, 2018, FRONT MED, V5; Tola A, 2019, HINDAWI TUBERCULOSIS; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2017, GLOB TUB REP; Wondale Biniam, 2017, BMC Res Notes, V10, P680, DOI 10.1186/s13104-017-3020-z; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2019, GUID TUB INF PREV CO; Yakob B, 2018, HLTH SCI J, V12, P598; Zegeye A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210422; Zenebe T, 2016, BRAZ J INFECT DIS, V20, P635, DOI 10.1016/j.bjid.2016.07.012	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232468	10.1371/journal.pone.0232468	http://dx.doi.org/10.1371/journal.pone.0232468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348358	Green Published, gold			2022-12-26	WOS:000536668200069
J	Guiry, E; Royle, TCA; Matson, RG; Ward, H; Weir, T; Waber, N; Brown, TJ; Hunt, BPV; Price, MHH; Finney, BP; Kaeriyama, M; Qin, YX; Yang, DY; Szpak, P				Guiry, Eric; Royle, Thomas C. A.; Matson, R. G.; Ward, Hillary; Weir, Tyler; Waber, Nicholas; Brown, Thomas J.; Hunt, Brian P. V.; Price, Michael H. H.; Finney, Bruce P.; Kaeriyama, Masahide; Qin, Yuxue; Yang, Dongya Y.; Szpak, Paul			Differentiating salmonid migratory ecotypes through stable isotope analysis of collagen: Archaeological and ecological applications	PLOS ONE			English	Article							DNA SPECIES IDENTIFICATION; PACIFIC-NORTHWEST COAST; FRESH-WATER; SOCKEYE-SALMON; ANCIENT DNA; ONCORHYNCHUS SPP.; BONE-COLLAGEN; INDIVIDUAL IDENTIFICATION; DELTA-N-15 SIGNATURES; BRITISH-COLUMBIA	The ability to distinguish between different migratory behaviours (e.g., anadromy and potamodromy) in fish can provide important insights into the ecology, evolution, and conservation of many aquatic species. We present a simple stable carbon isotope (delta C-13) approach for distinguishing between sockeye (anadromous ocean migrants) and kokanee (potamodromous freshwater residents), two migratory ecotypes of Oncorhynchus nerka (Salmonidae) that is applicable throughout most of their range across coastal regions of the North Pacific Ocean. Analyses of kokanee (n = 239) and sockeye (n = 417) from 87 sites spanning the North Pacific (Russia to California) show that anadromous and potamodromous ecotypes are broadly distinguishable on the basis of the delta C-13 values of their scale and bone collagen. We present three case studies demonstrating how this approach can address questions in archaeology, archival, and conservation research. Relative to conventional methods for determining migratory status, which typically apply chemical analyses to otoliths or involve genetic analyses of tissues, the d13C approach outlined here has the benefit of being non-lethal (when applied to scales), cost-effective, widely available commercially, and should be much more broadly accessible for addressing archaeological questions since the recovery of otoliths at archaeological sites is rare.	[Guiry, Eric; Szpak, Paul] Trent Univ, Dept Anthropol, Peterborough, ON, Canada; [Guiry, Eric] Univ Leicester, Sch Archaeol & Ancient Hist, Leicester, Leics, England; [Guiry, Eric; Matson, R. G.; Waber, Nicholas; Brown, Thomas J.] Univ British Columbia, Dept Anthropol, Vancouver, BC, Canada; [Royle, Thomas C. A.; Yang, Dongya Y.] Simon Fraser Univ, Ancient DNA Lab, Dept Archaeol, Burnaby, BC, Canada; [Ward, Hillary; Weir, Tyler] Govt British Columbia, Minist Forests Lands Nat Resource Operat & Rural, Penticton, BC, Canada; [Hunt, Brian P. V.] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Hunt, Brian P. V.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada; [Hunt, Brian P. V.] Hakai Inst, Heriot Bay, BC, Canada; [Price, Michael H. H.] Simon Fraser Univ, Earth Ocean Res Grp, Dept Biol Sci, Burnaby, BC, Canada; [Finney, Bruce P.] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; [Finney, Bruce P.] Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA; [Kaeriyama, Masahide] Hokkaido Univ, Arctic Res Ctr, Sapporo, Hokkaido, Japan; [Qin, Yuxue] Dalian Ocean Univ, Sch Marine Sci & Environm Engn, Dalian, Liaoning, Peoples R China	Trent University; University of Leicester; University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia; Hakai Institute; Simon Fraser University; Idaho; Idaho State University; Idaho; Idaho State University; Hokkaido University; Dalian Ocean University	Guiry, E (corresponding author), Trent Univ, Dept Anthropol, Peterborough, ON, Canada.; Guiry, E (corresponding author), Univ Leicester, Sch Archaeol & Ancient Hist, Leicester, Leics, England.; Guiry, E (corresponding author), Univ British Columbia, Dept Anthropol, Vancouver, BC, Canada.; Royle, TCA (corresponding author), Simon Fraser Univ, Ancient DNA Lab, Dept Archaeol, Burnaby, BC, Canada.	eguiry@lakeheadu.ca; troyle@sfu.ca		Guiry, Eric/0000-0002-1467-1521; Kaeriyama, Masahide/0000-0002-0557-7111; Royle, Thomas C.A./0000-0001-8178-123X	Department of Anthropology, University of British Columbia; Social Sciences and Humanities Research Council of Canada (SSHRC) [430-201701120]; SSHRC Banting Postdoctoral Reseach Fellowship; Simon Fraser University Archaeology Graduate Student Caucus Travel and Research Grant; SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship (Doctoral Scholarship) [767-2014-1915]; Simon Fraser University; SSHRC Postdoctoral Research Fellowship [756-2016-0185]	Department of Anthropology, University of British Columbia; Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); SSHRC Banting Postdoctoral Reseach Fellowship; Simon Fraser University Archaeology Graduate Student Caucus Travel and Research Grant; SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship (Doctoral Scholarship); Simon Fraser University; SSHRC Postdoctoral Research Fellowship	This research was supported in part the Department of Anthropology, University of British Columbia (https://www.anth.ubc.ca), as well as a Social Sciences and Humanities Research Council of Canada (SSHRC) (https://www.sshrc-crsh.gc.ca) Insight Development Grant (Grant 430-201701120), SSHRC Postdoctoral Research Fellowship (Grant 756-2016-0185), and SSHRC Banting Postdoctoral Reseach Fellowship awarded to EG. TCAR was supported by a Simon Fraser University Archaeology Graduate Student Caucus Travel and Research Grant (http://www.sfugradsociety.ca), SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship (Doctoral Scholarship) (Grant 767-2014-1915), as well as scholarships and fellowships from Simon Fraser University (https://www.sfu.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sampling permissions and logistical assistance: Gavin Hanke and the Royal British Columbia Museum, Erling Holm and the Royal Ontario Museum, Eric Taylor and the Beaty Biodiversity Museum, Chief Jimmy Lulua and the Xeni Gwet'in First Nation, Dylan Hilliis (University of Victoria). Data: Many scholars provided access to their previously published raw data: Joachim Molkentin (Max Rubner-Institute), David Beauchamp (United States Geological Survey Western Fisheries Research Center). We also thank the following peer reviewers: Rachel C. Johnson (National Oceanic and Atmospheric Administration and University of California, Davis) and Malte Willmes (National Oceanic and Atmospheric Administration and University of California, Santa Cruz), as well as Adam Boethius (Lund University).	Acolas ML, 2016, INTRODUCTION TO FISH MIGRATION, P55; Akin S, 2011, FRESEN ENVIRON BULL, V20, P2419; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; [Anonymous], 1994, CHEM PROCESSING TECH; Ascough PL, 2010, RADIOCARBON, V52, P1098, DOI 10.1017/S003382220004618X; Baker RF, 2004, T AM FISH SOC, V133, P568, DOI 10.1577/T03-012.1; Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Beacham TD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183713; Beacham TD, 2010, CAN J FISH AQUAT SCI, V67, P1274, DOI 10.1139/F10-061; Blair A. A., 1938, Copeia Ann Arbor, V1938, P206, DOI 10.2307/1436524; Bohlin T, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P92; Bosley KL, 1999, CAN J FISH AQUAT SCI, V56, P2181, DOI 10.1139/cjfas-56-11-2181; Brugam RB, 2017, RIVER RES APPL, V33, P341, DOI 10.1002/rra.3099; Buckley M., 2018, ZOOARCHAEOLOGY PRACT, P227, DOI DOI 10.1007/978-3-319-64763-0_12; Bump JK, 2007, P ROY SOC B-BIOL SCI, V274, P2471, DOI 10.1098/rspb.2007.0700; Butler VL, 2004, J WORLD PREHIST, V18, P327, DOI 10.1007/s10963-004-5622-3; BUTLER VL, 1994, J ARCHAEOL SCI, V21, P413, DOI 10.1006/jasc.1994.1039; Butler VL, 1998, ANCIENT BIOMOLECULES, V2, P17; Cannon A, 2006, AM ANTIQUITY, V71, P123, DOI 10.2307/40035324; CANNON A, 1988, J FIELD ARCHAEOL, V15, P103, DOI 10.1179/009346988791974583; Cannon A, 2011, ARCHAEOLOGY OF NORTH PACIFIC FISHERIES, P57; Cannon D.Y., 1987, MARINE FISH OSTEOLOG; Carlson Catherine C., 1996, P274; Casteel RW, 1976, FISH REMAINS ARCHAEO; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Coll YD, 2015, THESIS; Colley S.M., 1990, Archaeological Method and Theory, V2, P207; Cook GT, 2001, RADIOCARBON, V43, P453; Cook PK, 2016, J ANAL ATOM SPECTROM, V31, P700, DOI 10.1039/c5ja00426h; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Disspain MCF, 2016, J ARCHAEOL SCI-REP, V6, P623, DOI 10.1016/j.jasrep.2015.05.012; Dixon HJ, 2012, ICES J MAR SCI, V69, P1646, DOI 10.1093/icesjms/fss122; Dodson JJ, 2013, BIOL REV, V88, P602, DOI 10.1111/brv.12019; Doucett RR, 1999, J FISH BIOL, V55, P84; Doucett RR, 1999, T AM FISH SOC, V128, P278, DOI 10.1577/1548-8659(1999)128<0278:IOAANA>2.0.CO;2; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dufour E, 2007, J ARCHAEOL SCI, V34, P1226, DOI 10.1016/j.jas.2006.10.014; Edwards MS, 2002, COPEIA, P1106; Eide M, 2017, GLOBAL BIOGEOCHEM CY, V31, P492, DOI [10.1002/2016GB005472, 10.1002/2016GB005473]; Elliott LD, 2019, THESIS; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Espinasse B, 2019, CAN J FISH AQUAT SCI, V76, P918, DOI 10.1139/cjfas-2018-0010; Ewonus PA, 2011, J ARCHAEOL SCI, V38, P2536, DOI 10.1016/j.jas.2011.04.005; Fagan B.M., 2017, FISHING SEA FED CIVI; Fanelli E, 2010, J EXP MAR BIOL ECOL, V395, P93, DOI 10.1016/j.jembe.2010.08.020; Fera SA, 2017, ECOLOGY, V98, P1681, DOI 10.1002/ecy.1836; Finlay JC, 2007, ECOL METHOD CONCEPT, P283, DOI 10.1002/9780470691854.ch10; Finlay JC, 2004, LIMNOL OCEANOGR, V49, P850, DOI 10.4319/lo.2004.49.3.0850; Finlay JC, 2003, BIOGEOCHEMISTRY, V62, P231, DOI 10.1023/A:1021183023963; FOLCH J, 1957, J BIOL CHEM, V226, P497; Godbout L, 2011, CAN J FISH AQUAT SCI, V68, P1590, DOI 10.1139/F2011-089; Godbout L, 2010, ENVIRON BIOL FISH, V89, P521, DOI 10.1007/s10641-010-9689-7; Grier C, 2013, J ARCHAEOL SCI, V40, P544, DOI 10.1016/j.jas.2012.07.013; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; Guiry EJ, 2020, MAR ENVIRON RES; Guiry E, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00313; Guiry E, 2017, EUR J ARCHAEOL, V20, P235, DOI 10.1017/eaa.2016.24; Guiry EJ, 2020, LIMNOL OCEANOGR, V65, P1921, DOI 10.1002/lno.11428; Guiry EJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36249; Guiry EJ, 2016, RAPID COMMUN MASS SP, V30, P1591, DOI 10.1002/rcm.7590; Gustafson RG, 1997, NMFSNWFSC33 NOAA US, P282; Halffman CM, 2015, P NATL ACAD SCI USA, V112, P12344, DOI 10.1073/pnas.1509747112; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris SL, 2011, 129 RD PROV BRIT COL; Hart JP, 2019, PEERJ, V7, DOI 10.7717/peerj.7174; Harvey VL, 2018, J ARCHAEOL SCI, V98, P102, DOI 10.1016/j.jas.2018.07.006; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; HESSLEIN RH, 1991, CAN J FISH AQUAT SCI, V48, P2258, DOI 10.1139/f91-265; Hilton GM, 2006, GLOBAL CHANGE BIOL, V12, P611, DOI 10.1111/j.1365-2486.2006.01130.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hofkamp AR, 2017, J ARCHAEOL SCI-REP, V12, P449, DOI 10.1016/j.jasrep.2017.02.010; Holmes MW, 2016, MOL ECOL, V25, P864, DOI 10.1111/mec.13529; Hoppe KA, 2003, INT J OSTEOARCHAEOL, V13, P20, DOI 10.1002/oa.663; Horii S, 2015, PLANKTON BENTHOS RES, V10, P91, DOI 10.3800/pbr.10.91; Huber HR, 2011, J ARCHAEOL SCI, V38, P136, DOI 10.1016/j.jas.2010.08.020; Hutchinson WF, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150199; Ingram BL, 1999, GEOLOGY, V27, P851; Ishikawa NF, 2012, OECOLOGIA, V170, P541, DOI 10.1007/s00442-012-2308-x; Johnson BM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190059; Johnson SP, 2012, MAR ECOL PROG SER, V460, P155, DOI 10.3354/meps09772; JOSEPHSON DB, 1984, J AGR FOOD CHEM, V32, P1344, DOI 10.1021/jf00126a031; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Kaeriyama M, 2004, FISH OCEANOGR, V13, P197, DOI 10.1111/j.1365-2419.2004.00286.x; Keaveney EM, 2012, J ARCHAEOL SCI, V39, P1306, DOI 10.1016/j.jas.2011.12.025; Kelly B, 2006, J FISH BIOL, V69, P1595, DOI 10.1111/j.1095-8649.2006.01226.x; Kelly MH, 2006, N AM J FISH MANAGE, V26, P921, DOI 10.1577/M05-084.1; Kendall C, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P519; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; KOCH PL, 1992, EARTH PLANET SC LETT, V108, P277, DOI 10.1016/0012-821X(92)90028-T; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lambrides ABJ, 2016, J ARCHAEOL RES, V24, P275, DOI 10.1007/s10814-016-9090-y; Lane RB, 1953, THESIS; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Lovell N.C., 1986, CAN J ARCHAEOL, V10, P99; Marchenko ZV, 2015, RADIOCARBON, V57, P595, DOI 10.2458/azu_rc.57.18435; Matson RG., 2007, ATHAPASKAN MIGRATION; Matsubayashi J, 2019, J ARCHAEOL SCI, V106, P37, DOI 10.1016/j.jas.2019.03.010; Matsui A, 1996, WORLD ARCHAEOL, V27, P444, DOI 10.1080/00438243.1996.9980319; McKechnie I, 2016, J ARCHAEOL SCI-REP, V8, P470, DOI 10.1016/j.jasrep.2016.04.006; McPhail J.D., 2007, FRESHWATER FISHES BR; Meeuwig MH, 2017, J FISH WILDL MANAG, V8, P449, DOI 10.3996/092016-JFWM-073; Miller JA, 2011, J EXP MAR BIOL ECOL, V405, P42, DOI 10.1016/j.jembe.2011.05.017; Misarti N, 2009, HOLOCENE, V19, P1139, DOI 10.1177/0959683609345075; Molkentin J, 2015, FOOD CONTROL, V53, P55, DOI 10.1016/j.foodcont.2015.01.003; Moss ML, 2014, J ARCHAEOL SCI, V41, P879, DOI 10.1016/j.jas.2013.10.017; Northcote TG, 1992, NORD J FRESHW RES, V67, P5; Oosting T, 2019, EVOL APPL, V12, P1513, DOI 10.1111/eva.12811; Orchard TJ, 2011, ARCHAEOLOGY OF NORTH PACIFIC FISHERIES, P111; Orchard TJ, 2011, ARCHAEOLOGY OF NORTH PACIFIC FISHERIES, P17; Overman NC, 2009, T AM FISH SOC, V138, P741, DOI 10.1577/T08-158.1; Philippsen B, 2013, HERIT SCI, V1, DOI 10.1186/2050-7445-1-24; Philippsen B, 2013, RADIOCARBON, V55, P1085, DOI 10.1017/S0033822200048001; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Qi HP, 2016, RAPID COMMUN MASS SP, V30, P859, DOI 10.1002/rcm.7510; Qi HP, 2003, RAPID COMMUN MASS SP, V17, P2483, DOI 10.1002/rcm.1219; Qin Yuxue, 2016, North Pacific Anadromous Fish Commission Bulletin, P469, DOI 10.23849/npafcb6/469.481; QUAY PD, 1992, SCIENCE, V256, P74, DOI 10.1126/science.256.5053.74; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Regenstein JM, 2006, WOODHEAD PUBL FOOD S, P279; Richter KK, 2020, J ARCHAEOL SCI, V116, DOI 10.1016/j.jas.2020.105116; Rick TC, 2013, CONSERV BIOL, V27, P45, DOI 10.1111/j.1523-1739.2012.01920.x; Roberts-Nkrumah LB, 2007, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2007.757.5; Robinson BS, 2009, J ARCHAEOL SCI, V36, P2184, DOI 10.1016/j.jas.2009.06.001; Robson HK, 2016, ENVIRON ARCHAEOL, V21, P105, DOI 10.1179/1749631415Y.0000000014; Royle TCA, 2020, J ARCHAEOL SCI-REP, V31, DOI 10.1016/j.jasrep.2020.102301; Royle TCA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193212; Sanderson BL, 2009, T AM FISH SOC, V138, P1166, DOI 10.1577/T08-086.1; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Satterfield FR, 2002, PROG OCEANOGR, V53, P231, DOI 10.1016/S0079-6611(02)00032-0; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989; Scott DC, 2017, LAKE RESERV MANAGE, V33, P14, DOI 10.1080/10402381.2016.1247391; Selbie DT, 2009, LIMNOL OCEANOGR, V54, P1733, DOI 10.4319/lo.2009.54.5.1733; SIGMAN DM, 2009, ENCY OCEAN SCI, P40, DOI DOI 10.1016/B978-012374473-9.00632-9; Sokal R.R., 2012, BIOMETRY; Speller CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051122; Speller CF, 2005, J ARCHAEOL SCI, V32, P1378, DOI 10.1016/j.jas.2005.03.016; Svyatko SV, 2015, RADIOCARBON, V57, P625, DOI 10.2458/azu_rc.57.18431; Sweeting CJ, 2004, RAPID COMMUN MASS SP, V18, P2587, DOI 10.1002/rcm.1661; Szpak P, 2018, GLOBAL CHANGE BIOL, V24, P490, DOI 10.1111/gcb.13880; Szpak P, 2017, J ARCHAEOL SCI-REP, V13, P609, DOI 10.1016/j.jasrep.2017.05.007; Szpak P, 2011, J ARCHAEOL SCI, V38, P3358, DOI 10.1016/j.jas.2011.07.022; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; Thompson TQ, 2019, P NATL ACAD SCI USA, V116, P177, DOI 10.1073/pnas.1811559115; Thurow RF, 2016, INTRODUCTION TO FISH MIGRATION, P29; Trueman CN, 2007, TERR ECOL SER, V1, P145; Turban-Just S, 1998, B SOC GEOL FR, V169, P109; Tyhurst RJS, 1984, THESIS; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Veale AJ, 2016, EVOL APPL, V9, P1301, DOI 10.1111/eva.12430; Verburg P, 2007, J PALEOLIMNOL, V37, P591, DOI 10.1007/s10933-006-9056-z; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wang YMV, 2018, FOOD CHEM, V256, P380, DOI 10.1016/j.foodchem.2018.02.095; Welch David W., 1993, Fisheries Oceanography, V2, P11, DOI 10.1111/j.1365-2419.1993.tb00008.x; Yang DY, 2008, J ARCHAEOL SCI, V35, P2778, DOI 10.1016/j.jas.2008.05.010; Yang DY, 2005, J ARCHAEOL SCI, V32, P331, DOI 10.1016/j.jas.2004.09.008; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Yang DYY, 2004, J ARCHAEOL SCI, V31, P619, DOI 10.1016/j.jas.2003.10.008; Zazzo A, 2006, EARTH PLANET SC LETT, V249, P200, DOI 10.1016/j.epsl.2006.07.003	166	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232180	10.1371/journal.pone.0232180	http://dx.doi.org/10.1371/journal.pone.0232180			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8WP	32343728	Green Published, gold			2022-12-26	WOS:000536661300037
J	Tomida, S; Takata, M; Hirata, T; Nagae, M; Nakano, M; Kizuka, Y				Tomida, Seita; Takata, Misaki; Hirata, Tetsuya; Nagae, Masamichi; Nakano, Miyako; Kizuka, Yasuhiko			The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src homology 3 domain (SH3 domain); glycosyltransferase; N-linked glycosylation; glycosylation; fucosyltransferase; ?1; 6-fucosyltransferase; core fucosylation; ribophorin I; posttranslational modification; protein-protein interaction; glycan	RIBOPHORIN-I; MAMMALIAN ALPHA-1,6-FUCOSYL-TRANSFERASE; N-ACETYLGLUCOSAMINE; CDNA CLONING; COMPLEX; GLYCOSYLATION; ASSOCIATION; BINDING; SPERM; ALPHA-2,6-SIALYLTRANSFERASE	Core fucose is an N-glycan structure synthesized by ?1,6-fucosyltransferase 8 (FUT8) localized to the Golgi apparatus and critically regulates the functions of various glycoproteins. However, how FUT8 activity is regulated in cells remains largely unclear. At the luminal side and uncommon for Golgi proteins, FUT8 has an Src homology 3 (SH3) domain, which is usually found in cytosolic signal transduction molecules and generally mediates protein-protein interactions in the cytosol. However, the SH3 domain has not been identified in other glycosyltransferases, suggesting that FUT8's functions are selectively regulated by this domain. In this study, using truncated FUT8 constructs, immunofluorescence staining, FACS analysis, cell-surface biotinylation, proteomics, and LC-electrospray ionization MS analyses, we reveal that the SH3 domain is essential for FUT8 activity both in cells and in vitro and identified His-535 in the SH3 domain as the critical residue for enzymatic activity of FUT8. Furthermore, we found that although FUT8 is mainly localized to the Golgi, it also partially localizes to the cell surface in an SH3-dependent manner, indicating that the SH3 domain is also involved in FUT8 trafficking. Finally, we identified ribophorin I (RPN1), a subunit of the oligosaccharyltransferase complex, as an SH3-dependent binding protein of FUT8. RPN1 knockdown decreased both FUT8 activity and core fucose levels, indicating that RPN1 stimulates FUT8 activity. Our findings indicate that the SH3 domain critically controls FUT8 catalytic activity and localization and is required for binding by RPN1, which promotes FUT8 activity and core fucosylation.	[Tomida, Seita; Hirata, Tetsuya; Kizuka, Yasuhiko] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan; [Tomida, Seita] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Takata, Misaki; Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan; [Nagae, Masamichi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka, Japan; [Nagae, Masamichi] Osaka Univ, Lab Mol Immunol, Immunol Frontier Res Ctr IFReC, Suita, Osaka, Japan; [Kizuka, Yasuhiko] Tokai Natl Higher Educ & Res Syst, Inst Glycocore Res iGCORE, Gifu, Japan	Gifu University; Gifu University; Hiroshima University; Osaka University; Osaka University	Kizuka, Y (corresponding author), Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan.; Kizuka, Y (corresponding author), Tokai Natl Higher Educ & Res Syst, Inst Glycocore Res iGCORE, Gifu, Japan.	kizuka@gifu-u.ac.jp		Nagae, Masamichi/0000-0002-5470-3807; Kizuka, Yasuhiko/0000-0002-3181-9743; Hirata, Tetsuya/0000-0003-1965-5405	Leading Initiative for Excellent Young Researchers (LEADER) project from the Japan Society for the Promotion of Science (JSPS); CREST Grant from the Japan Science and Technology Agency (JST) [18070267]; Takeda Science Foundation; Uehara Memorial Foundation;  [17K07356]	Leading Initiative for Excellent Young Researchers (LEADER) project from the Japan Society for the Promotion of Science (JSPS); CREST Grant from the Japan Science and Technology Agency (JST); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); 	This work was supported in part by Grant-in-Aid for Scientific Research (C) 17K07356 (to Y. K.), a Leading Initiative for Excellent Young Researchers (LEADER) project (to Y. K.) from the Japan Society for the Promotion of Science (JSPS), CREST Grant 18070267 (to Y. K.) from the Japan Science and Technology Agency (JST), grants from the Takeda Science Foundation (to Y. K.), and a grant from the Uehara Memorial Foundation (to Y. K.).	Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; BEGOVAC PC, 1991, J CELL BIOL, V113, P637, DOI 10.1083/jcb.113.3.637; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; EVANS SC, 1995, BIOESSAYS, V17, P261, DOI 10.1002/bies.950170313; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Garcia-Basteiro Alberto L, 2020, Nat Commun, V11, P3500, DOI 10.1038/s41467-020-17318-x; Granovsky M, 2000, NAT MED, V6, P306; Gu W, 2015, J BIOL CHEM, V290, P17566, DOI 10.1074/jbc.M114.579938; Harada Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236074; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hathaway HJ, 2003, J CELL SCI, V116, P4319, DOI 10.1242/jcs.00720; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Ihara H, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129596; Jarva MA, 2020, J BIOL CHEM, V295, P6677, DOI 10.1074/jbc.RA120.013291; Kawamoto S, 2011, INT J ONCOL, V39, P203, DOI 10.3892/ijo.2011.1005; Khoder-Agha F, 2019, J BIOL CHEM, V294, P14383, DOI 10.1074/jbc.RA119.009539; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2017, CELL CHEM BIOL, V24, P1467, DOI 10.1016/j.chembiol.2017.08.023; Kizuka Y, 2016, PROTEOMICS, V16, P2854, DOI 10.1002/pmic.201600053; Kizuka Y, 2016, CELL CHEM BIOL, V23, P782, DOI 10.1016/j.chembiol.2016.06.010; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Kotzler MP, 2013, ACS CHEM BIOL, V8, P1830, DOI 10.1021/cb400140u; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lu QX, 1997, DEVELOPMENT, V124, P4121; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Moremen KW, 2019, NAT CHEM BIOL, V15, P853, DOI 10.1038/s41589-019-0350-2; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nakano M, 2019, MOL CELL PROTEOMICS, V18, P2044, DOI 10.1074/mcp.RA119.001534; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Qin SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394288; RAM PA, 1989, GAMETE RES, V22, P321, DOI 10.1002/mrd.1120220309; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramirez AS, 2019, SCIENCE, V366, P1372, DOI 10.1126/science.aaz3505; Rocha J, 2016, PLANT CELL, V28, P2352, DOI 10.1105/tpc.16.00519; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Shrimal S, 2019, GLYCOBIOLOGY, V29, P288, DOI 10.1093/glycob/cwy093; Stanley P., 2017, ESSENTIALS GLYCOBIOL; Sun SS, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9254-0; Takeda K, 2014, BIOCHEM BIOPH RES CO, V454, P436, DOI 10.1016/j.bbrc.2014.10.102; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Uozumi N, 1996, J BIOCHEM, V120, P385; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070; Zafra-Ruano A, 2012, FEBS LETT, V586, P2619, DOI 10.1016/j.febslet.2012.04.057; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x	64	13	13	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7992	8004		10.1074/jbc.RA120.013079	http://dx.doi.org/10.1074/jbc.RA120.013079			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350116	hybrid, Green Published			2022-12-26	WOS:000540935400014
J	Adjibade, P; Simoneau, B; Ledoux, N; Gauthier, WN; Nkurunziza, M; Khandjian, EW; Mazroui, R				Adjibade, Pauline; Simoneau, Bryan; Ledoux, Nassim; Gauthier, William-Naud; Nkurunziza, Melisse; Khandjian, Edouard W.; Mazroui, Rachid			Treatment of cancer cells with Lapatinib negatively regulates general translation and induces stress granules formation	PLOS ONE			English	Article							MESSENGER-RNA; BREAST-CANCER; INHIBITION; RESISTANCE; RECRUITMENT; EIF2-ALPHA; INITIATION; APOPTOSIS; KINASES; PROTEIN	Stress granules (SG) are cytoplasmic RNA granules that form during various types of stress known to inhibit general translation, including oxidative stress, hypoxia, endoplasmic reticulum stress (ER), ionizing radiations or viral infection. Induction of these SG promotes cell survival in part through sequestration of proapoptotic molecules, resulting in the inactivation of cell death pathways. SG also form in cancer cells, but studies investigating their formation upon treatment with chemotherapeutics are very limited. Here we identified Lapatinib (Tykerb / Tyverb (R)), a tyrosine kinase inhibitor used for the treatment of breast cancers as a new inducer of SG in breast cancer cells. Lapatinib-induced SG formation correlates with the inhibition of general translation initiation which involves the phosphorylation of the translation initiation factor eIF2 alpha through the kinase PERK. Disrupting PERK-SG formation by PERK depletion experiments sensitizes resistant breast cancer cells to Lapatinib. This study further supports the assumption that treatment with anticancer drugs activates the SG pathway, which may constitute an intrinsic stress response used by cancer cells to resist treatment.	[Adjibade, Pauline; Simoneau, Bryan; Ledoux, Nassim; Gauthier, William-Naud; Nkurunziza, Melisse; Mazroui, Rachid] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Ctr Rech Cancerol, Ctr Rech,CHU Quebec,Fac Med, Parti Quebecois, PQ, Canada; [Khandjian, Edouard W.] Univ Laval, Inst Univ Sante Mentale Quebec, Fac Med, Dept Psychiat & Neurosci,Ctr Rech, Parti Quebecois, PQ, Canada	Laval University; Laval University	Mazroui, R (corresponding author), Univ Laval, Dept Biol Mol Biochim Med & Pathol, Ctr Rech Cancerol, Ctr Rech,CHU Quebec,Fac Med, Parti Quebecois, PQ, Canada.	Rachid.Mazroui@crchudequebec.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [MOP-CG095386]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (MOP-CG095386) to R. Mazroui. Scholarship: "the Bourse d'excellence de recherche en cance ' rologie Jean-Francois Bergeron de l'universite Laval" to P. Adjibade. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjibade P, 2015, ONCOTARGET, V6, P43927, DOI 10.18632/oncotarget.5980; Adjibade P, 2014, SEMIN CELL DEV BIOL, V34, P15, DOI 10.1016/j.semcdb.2014.05.013; Anders M, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800113; Arimoto K., 2008, NAT CELL BIOL; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Chu I, 2005, CANCER RES, V65, P18; Cruickshanks N, 2012, MOL PHARMACOL, V82, P1217, DOI 10.1124/mol.112.081539; D'Amato V, 2015, CANCER TREAT REV, V41, P877, DOI 10.1016/j.ctrv.2015.08.001; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fournier MJ, 2013, MOL CELL BIOL, V33, P2285, DOI 10.1128/MCB.01517-12; Fournier MJ, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-12; Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566; Gao XM, 2019, BRIT J PHARMACOL, V176, P4421, DOI 10.1111/bph.14790; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Huang HL, 2020, TRENDS GENET, V36, P44, DOI 10.1016/j.tig.2019.10.011; Joncas FH, 2014, M S-MED SCI, V30, P882, DOI 10.1051/medsci/20143010015; Kaehler C, 2014, NUCLEIC ACIDS RES, V42, P6436, DOI 10.1093/nar/gku264; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Koromilas AE, 2015, BBA-GENE REGUL MECH, V1849, P871, DOI 10.1016/j.bbagrm.2014.12.007; MacFarlane RJ, 2011, EXPERT OPIN DRUG SAF, V10, P109, DOI 10.1517/14740338.2011.533168; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Shi HP, 2016, TUMOR BIOL, V37, P15411, DOI 10.1007/s13277-016-5467-2; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Szaflarski W, 2016, ONCOTARGET, V7, P30307, DOI 10.18632/oncotarget.8728; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Van Treeck B, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033068; Van Treeck B, 2018, CELL, V174, P791, DOI 10.1016/j.cell.2018.07.023; Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0231894	10.1371/journal.pone.0231894	http://dx.doi.org/10.1371/journal.pone.0231894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365111	Green Published, gold			2022-12-26	WOS:000536959700013
J	Borgmann, M; Ivanda, M; Hadizamani, Y; Mohaupt, M; Bals, R; Lucas, R; Hamacherf, J; Kollner, V				Borgmann, Michele; Ivanda, Martina; Hadizamani, Yalda; Mohaupt, Markus; Bals, Robert; Lucas, Rudolf; Hamacherf, Juerg; Koellner, Volker			Short report: Does the 6-minute walk test in hospitalized COPD patients exclusively correlate with lung function parameters or should psychological factors also be taken into account?	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CARDIAC RESYNCHRONIZATION THERAPY; HEART-FAILURE; DEPRESSIVE SYMPTOMS; ACUTE EXACERBATIONS; FOLLOW-UP; DISTANCE; PREVALENCE; METAANALYSIS; ASSOCIATION	The 6-minute walk test is generally considered a standard test for the evaluation of shortterm maximal physical performance. It has not been evaluated whether psychological factors, such as anxiety or depression, affect the performance or the results of the test. The main aim of this study was to investigate whether a correlation exists between psychological factors and the data from the 6-minute walking test. The study cohort consisted of 85 (female = 34 and male = 51) 66 +/- 10 (mean +/- SD) year-old patients with chronic obstructive pulmonary disease (COPD) hospitalized for disease exacerbation. Forced Expiratory Volume in the first second (FEV1) (% predicted) as predictor for lung function, as well as anxiety and depression symptoms assessed using the Hospital Anxiety and Depression Scale (HADS) as psychological predictors were collected. Bivariate correlations and hierarchical linear regression models were used to analyse the correlations. Walking distance was on average 260m +/- 107m and ranged from 64m to 480m. HADS was negatively correlated with 6-min walking distance (r = 0.441, p =.0009, r = -.523, p = 00006). Hierarchical linear regression showed that FEV1 alone explained 33%, and together with the psychological variables anxiety and depression explained 42% of the variance of results from the 6-minute walking test. These findings demonstrated that 11% of the data correlated with the psychological variables alone (p =.011). The effect size for lung function (f(2) =.717) and psychological variables (f(2) =.352) were high, whereas the socio-demographic variables sex, age, educational level and BMI could not explain any additional variance in our cohort. In conclusion, our study indicates that psychological factors such as symptoms of depression and anxiety are associated with lower physical functional performance in the 6-minute walking test. As such, these factors should also be assessed. Future research is needed to show if treatments of anxiety and depression can improve the walking distance in COPD patients.	[Borgmann, Michele; Hadizamani, Yalda; Hamacherf, Juerg] Lindenhofspital, Internal Med & Pneumol, Bern, Switzerland; [Borgmann, Michele; Hadizamani, Yalda; Lucas, Rudolf; Hamacherf, Juerg] Lungen & Atmungsstiftung Bern, Bern, Switzerland; [Ivanda, Martina] MediClin Rose Clin, Bad Meinberg, Germany; [Mohaupt, Markus] Sonnenhofspital Bern, Internal Med, Bern, Switzerland; [Bals, Robert] Saarland Univ, Fac Med, Internal Med 5, Pneumol Allergol Resp & Environm Med, Homburg Saar, Germany; [Lucas, Rudolf] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Div Pulm Med, Augusta, GA USA; [Koellner, Volker] Fed German Pens Agcy, Dept Behav Therapy & Psychosomat Med, Rehabil Ctr Seehof, Teltow, Germany; [Koellner, Volker] Charite, Ctr Internal Med & Dermatol, Dept Psychosomat Med, Psychosomat Rehabil Res Grp, Berlin, Germany	University System of Georgia; Augusta University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hamacherf, J (corresponding author), Lindenhofspital, Internal Med & Pneumol, Bern, Switzerland.; Hamacherf, J (corresponding author), Lungen & Atmungsstiftung Bern, Bern, Switzerland.	hamacher@greenmail.ch	Lucas, Rudolf/ABA-3011-2020	Lucas, Rudolf/0000-0003-3805-8868	Lungenund Atmungsstiftung Bern [R01 HL138410]; NIH/NHLBI	Lungenund Atmungsstiftung Bern; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	unrestricted funding from the Lungenund Atmungsstiftung Bern. No grant numbers, no URL given, the sponsors did not play a role in the study design or collection, etc. RL was supported by grant R01 HL138410 from NIH/NHLBI.	Agusti AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013; Al-Shair K, 2009, RESP MED, V103, P1572, DOI 10.1016/j.rmed.2008.11.021; Albus C, 2018, KARDIOLOGE, V12, P312, DOI 10.1007/s12181-018-0271-4; Andrianopoulos V, 2015, RESP MED, V109, P1138, DOI 10.1016/j.rmed.2015.06.013; Annegarn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037329; [Anonymous], 2020, GLOBAL STRATEGY DIAG; Beekman E, 2013, J PHYSIOTHER, V59, P169, DOI 10.1016/S1836-9553(13)70181-4; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Borgmann M, 2019, Z PSYCHOSOM MED PSYC, P258; Carr SJ, 2007, CHEST, V132, P127, DOI 10.1378/chest.07-0269; Carter R, 2003, CHEST, V123, P1408, DOI 10.1378/chest.123.5.1408; Casanova C, 2007, EUR RESPIR J, V29, P535, DOI 10.1183/09031936.00071506; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli B, 2016, AM J RESP CRIT CARE, V194, P1483, DOI 10.1164/rccm.201508-1653OC; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2007, CHEST, V132, P1778, DOI 10.1378/chest.07-2050; de Oca MM, 2005, EUR RESPIR J, V26, P390, DOI 10.1183/09031936.05.00107404; Doring N., 2016, FORSCHUNGSMETHODEN E, V5th; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Goscinska-Bis K, 2008, EUR J HEART FAIL, V10, P498, DOI 10.1016/j.ejheart.2008.03.007; Hamacher J, 2002, EUR RESPIR J, V19, P54, DOI 10.1183/09031936.02.00462001; Huijsmans RJ, 2008, RESP MED, V102, P162, DOI 10.1016/j.rmed.2007.07.008; Ingle L, 2006, EUR J HEART FAIL, V8, P321, DOI 10.1016/j.ejheart.2005.08.006; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Jennings JH, 2009, LUNG, V187, P128, DOI 10.1007/s00408-009-9135-9; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kozora Elizabeth, 2002, J Cardiopulm Rehabil, V22, P426, DOI 10.1097/00008483-200211000-00008; Lavoie KL, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00013-2019; Lee YK, 2008, LUNG, V186, P157, DOI 10.1007/s00408-008-9071-0; Lou PA, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-53; Macias A, 2008, EUR J HEART FAIL, V10, P421, DOI 10.1016/j.ejheart.2008.02.019; Marin JM, 2009, RESP MED, V103, P373, DOI 10.1016/j.rmed.2008.10.004; Matte DL, 2016, RESP MED, V117, P154, DOI 10.1016/j.rmed.2016.06.006; Maurer J, 2008, CHEST, V134, p43S, DOI 10.1378/chest.08-0342; Meijer A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-130; Mendoza L, 2015, EUR RESPIR J, V45, P347, DOI 10.1183/09031936.00084514; Metra M, 2007, EUR J HEART FAIL, V9, P684, DOI 10.1016/j.ejheart.2007.04.003; Moy ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060400; Orlandi Luciana de Carvalho Lopes, 2016, BMC Res Notes, V9, P65, DOI 10.1186/s13104-016-1883-z; Panagioti M, 2014, INT J CHRONIC OBSTR, V9, P1289, DOI 10.2147/COPD.S72073; Paz-Diaz H, 2007, AM J PHYS MED REHAB, V86, P30, DOI 10.1097/PHM.0b013e31802b8eca; Petermann F., 2015, Z PSYCHIAT PSYCHOL P; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Polkey MI, 2013, AM J RESP CRIT CARE, V187, P382, DOI 10.1164/rccm.201209-1596OC; Pumar MI, 2019, J THORAC DIS, V11, pS2238, DOI 10.21037/jtd.2019.10.23; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabelo ER, 2008, EUR J HEART FAIL, V10, P758, DOI 10.1016/j.ejheart.2008.06.010; Roul G, 1998, AM HEART J, V136, P449, DOI 10.1016/S0002-8703(98)70219-4; Rubin LJ, 2005, ANN INTERN MED, V143, P282, DOI 10.7326/0003-4819-143-4-200508160-00009; Schneider C, 2010, CHEST, V137, P341, DOI 10.1378/chest.09-0614; Schuler M, 2018, J AFFECT DISORDERS, V232, P268, DOI 10.1016/j.jad.2018.02.037; Serra AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117359; Spruit MA, 2010, RESP MED, V104, P849, DOI 10.1016/j.rmed.2009.12.007; van Manen JG, 2002, THORAX, V57, P412, DOI 10.1136/thorax.57.5.412; von Leupoldt A, 2016, PNEUMOLOGE, V13, P156, DOI 10.1007/s10405-015-0026-x; Zhang MWB, 2011, GEN HOSP PSYCHIAT, V33, P217, DOI 10.1016/j.genhosppsych.2011.03.009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232587	10.1371/journal.pone.0232587	http://dx.doi.org/10.1371/journal.pone.0232587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365134	Green Published, gold			2022-12-26	WOS:000536959700041
J	Clauss, S; Schuttler, D; Bleyer, C; Vlcek, J; Shakarami, M; Tomsits, P; Schneider, S; Maderspacher, F; Chataut, K; Trebo, A; Wang, C; Kleeberger, J; Xia, RB; Baloch, E; Hildebrand, B; Massberg, S; Wakili, R; Kaab, S				Clauss, Sebastian; Schuettler, Dominik; Bleyer, Christina; Vlcek, Julia; Shakarami, Mehdi; Tomsits, Philipp; Schneider, Sarah; Maderspacher, Florian; Chataut, Kavi; Trebo, Anna; Wang, Christine; Kleeberger, Jan; Xia, Ruibing; Baloch, Elisabeth; Hildebrand, Bianca; Massberg, Steffen; Wakili, Reza; Kaeaeb, Stefan			Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; RISK-FACTORS; FIBRILLATION; MECHANISMS; STRETCH	Atrial fibrillation (AF) is a major healthcare challenge contributing to high morbidity and mortality. Treatment options are still limited, mainly due to insufficient understanding of the underlying pathophysiology. Further research and the development of reliable animal models resembling the human disease phenotype is therefore necessary to develop novel, innovative and ideally causal therapies. Since ischaemic heart failure (IHF) is a major cause for AF in patients we investigated AF in the context of IHF in a close-tohuman porcine ischaemia-reperfusion model. Myocardial infarction (AMI) was induced in propofol/fentanyl/ midazolam-anaesthetized pigs by occluding the left anterior descending artery for 90 minutes to model ischaemia with reperfusion. After 30 days ejection fraction (EF) was significantly reduced and haemodynamic parameters (pulmonary capillary wedge pressure (PCWP), right atrial pressure (RAP), left ventricular enddiastolic pressure (LVEDP)) were significantly elevated compared to age/weight matched control pigs without AMI, demonstrating an IHF phenotype. Electrophysiological properties (sinus node recovery time (SNRT), atrial/AV nodal refractory periods (AERP, AVERP)) did not differ between groups. Atrial burst pacing at 1200 bpm, however, revealed a significantly higher inducibility of atrial arrhythmia episodes including AF in IHF pigs (3/15 vs. 10/16, p = 0.029). Histological analysis showed pronounced left atrial and left ventricular fibrosis demonstrating a structural substrate underlying the increased arrhythmogenicity. Consequently, selective ventricular infarction via LAD occlusion causes haemodynamic alterations inducing structural atrial remodeling which results in increased atrial fibrosis as the arrhythmogenic atrial substrate in pigs with IHF.	[Clauss, Sebastian; Schuettler, Dominik; Bleyer, Christina; Vlcek, Julia; Tomsits, Philipp; Schneider, Sarah; Maderspacher, Florian; Chataut, Kavi; Trebo, Anna; Wang, Christine; Kleeberger, Jan; Xia, Ruibing; Baloch, Elisabeth; Hildebrand, Bianca; Massberg, Steffen; Kaeaeb, Stefan] Ludwig Maximilians Univ Munich LMU, Univ Hosp Munich, Dept Med 1, Campus Grosshadern, Munich, Germany; [Clauss, Sebastian; Schuettler, Dominik; Bleyer, Christina; Vlcek, Julia; Tomsits, Philipp; Schneider, Sarah; Maderspacher, Florian; Chataut, Kavi; Trebo, Anna; Wang, Christine; Kleeberger, Jan; Xia, Ruibing; Massberg, Steffen; Wakili, Reza; Kaeaeb, Stefan] Munich Heart Alliance MHA, Partner Site Munich, DZHK German Ctr Cardiovasc Res, Munich, Germany; [Clauss, Sebastian; Schuettler, Dominik; Bleyer, Christina; Vlcek, Julia; Shakarami, Mehdi; Massberg, Steffen] Ludwig Maximilians Univ Munich LMU, Walter Brendel Ctr Expt Med, Munich, Germany; [Wakili, Reza] Univ Klinikum Essen, Westdeutsch Herz & Gefasszentrum Essen, Essen, Germany	University of Munich; German Centre for Cardiovascular Research; University of Munich; University of Duisburg Essen	Clauss, S (corresponding author), Ludwig Maximilians Univ Munich LMU, Univ Hosp Munich, Dept Med 1, Campus Grosshadern, Munich, Germany.; Clauss, S (corresponding author), Munich Heart Alliance MHA, Partner Site Munich, DZHK German Ctr Cardiovasc Res, Munich, Germany.; Clauss, S (corresponding author), Ludwig Maximilians Univ Munich LMU, Walter Brendel Ctr Expt Med, Munich, Germany.	sebastian.clauss@meu.uni-niuenchen.de	Xia, Ruibing/HGE-9870-2022; Tomsits, Philipp/AAY-2641-2021; Massberg, Steffen/AAN-6054-2021; Clauss, Sebastian/HDL-7189-2022	Xia, Ruibing/0000-0003-4073-7704; Clauss, Sebastian/0000-0002-5675-6128	German Centre for Cardiovascular Research (DZHK) [81X2600210, 81X2600204, 81X3600208, 81X2600249, 81Z4600241, 81X2600234, 81X2600232]; European Union [633193]; LMU Munich's Institutional Strategy LMUexcellent; Forderprogramm fur Forschung und Lehre (FoFoLe) [962]; German Research Council (DFG) [SFB1123, SFB914]; Clinician Scientist Program In Vascular Medicine (PRIME) [MA 2186/14-1]; Heinrich-and-Lotte-Muhlfenzl Stiftung	German Centre for Cardiovascular Research (DZHK); European Union(European Commission); LMU Munich's Institutional Strategy LMUexcellent; Forderprogramm fur Forschung und Lehre (FoFoLe); German Research Council (DFG)(German Research Foundation (DFG)); Clinician Scientist Program In Vascular Medicine (PRIME); Heinrich-and-Lotte-Muhlfenzl Stiftung	This work was supported by the German Centre for Cardiovascular Research (DZHK; 81X2600210, 81X2600204 to SC, SK; 81X3600208, 81X2600249 to SC; 81Z4600241 to SK; 81X2600234, 81X2600232 to SK, RW), by the European Union's Horizon 2020 research and innovation Programme under grant agreement No 633193 (CATCH ME to SK), by the LMU Munich`s Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative (to SC, SM), the Forderprogramm fur Forschung und Lehre (FoFoLe; 962 to SC), the German Research Council (DFG; SFB1123 and SFB914 to SM; Clinician Scientist Program In Vascular Medicine (PRIME, MA 2186/14-1) to DS and PT), and the Heinrich-and-Lotte-Muhlfenzl Stiftung (to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanin M, 2006, INT J CARDIOL, V109, P235, DOI 10.1016/j.ijcard.2005.06.009; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bertolet BD, 1997, HEART, V78, P88, DOI 10.1136/hrt.78.1.88; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Clauss S, 2019, NATURE REV CARDIOLOG; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; Ducas Robin, 2013, J Atr Fibrillation, V5, P535, DOI 10.4022/jafib.535; Hanna N, 2004, CARDIOVASC RES, V63, P236, DOI 10.1016/j.cardiores.2004.03.026; Hedstrom E, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-38; Ishikawa K, 2018, J AM COLL CARDIOL, V72, P738, DOI 10.1016/j.jacc.2018.05.059; Kettlewell S, 2013, CARDIOVASC RES, V99, P215, DOI 10.1093/cvr/cvt087; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855; Meris A, 2009, EUR HEART J, V30, P56, DOI 10.1093/eurheartj/ehn499; Miyauchi Y, 2003, CIRCULATION, V108, P360, DOI 10.1161/01.CIR.0000080327.32573.7C; Nattel S, 2016, NAT REV CARDIOL, V13, P575, DOI 10.1038/nrcardio.2016.118; Qureshi W, 2014, AM J CARDIOL, V114, P1368, DOI 10.1016/j.amjcard.2014.07.073; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579; Sinno H, 2003, CIRCULATION, V107, P1930, DOI 10.1161/01.CIR.0000058743.15215.03; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232374	10.1371/journal.pone.0232374	http://dx.doi.org/10.1371/journal.pone.0232374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365085	Green Published, gold			2022-12-26	WOS:000536959700026
J	Valenzuela, R; Codina, N; Pestana, JV				Valenzuela, Rafael; Codina, Nuria; Vicente Pestana, Jose			Gender-differences in conservatoire music practice maladjustment. Can contextual professional goals and context-derived psychological needs satisfaction account for amotivation variations?	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; INTRINSIC MOTIVATION; PSYCHOMETRIC PROPERTIES; PERCEIVED COMPETENCE; EXTRINSIC REWARDS; PERFORMANCE; AUTONOMY; MODEL; EDUCATION; STUDENTS	In music education, women are present in great numbers. In professional settings, however, women musicians are not as predominant. With some exceptions, such as Scandinavian countries, women still pursue gender equality in professional music practice. To inquire about the causes of this, we considered if gender-differences in amotivation in conservatoire instrument practice could be associated with aspects of learning environment. Self-determination theory (SDT) posits that learning environments may influence motivation, by satisfying or thwarting students' psychological needs and by selectively endorsing specific extrinsic goals. Thus, we analysed if-women and men-amotivation variations could be explained by differences in behavioural regulations and satisfaction of their psychological needs for competence and autonomy. Participants (67 women and 74 men, 18-47 years old) completed validated scales for amotivation, behavioural regulations, and needs satisfaction. Students exhibited high intrinsic and introjected regulations, and high autonomy and competence needs satisfaction. Students' identified regulation levels were modest, and external regulation and amotivation levels were low. Women students' perceived competence was lower, and their amotivation was higher than men's. Amotivation variations were explained positively by identified regulation and negatively by context-derived satisfaction of the psychological needs for competence (and autonomy, only among women). Results suggest that internalization of extrinsic goals can pose difficulties and that psychological needs satisfaction may counteract amotivation (autonomy being potentially more important for women musicians).	[Valenzuela, Rafael; Codina, Nuria; Vicente Pestana, Jose] Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Barcelona, Spain	University of Barcelona	Codina, N (corresponding author), Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Barcelona, Spain.	ncodina@ub.edu	Valenzuela, Rafael/F-7031-2016; Valenzuela, Rafael/AAY-5044-2020; Codina, Nuria/H-9663-2013	Valenzuela, Rafael/0000-0002-9935-1745; Valenzuela, Rafael/0000-0002-9935-1745; Codina, Nuria/0000-0003-0280-3651	Institut de Ciencies de l'Educacio from the University of Barcelona [REDICE18-2260]; Ministry of Sciences, Innovation and Universities of Spain [RTI2018-094405-B-100]; European Regional Development Fund [RTI2018-094405-B-100]; PsicoSAO Research Group in Social, Environmental, and Organizational Psychology [2017 SGR 564]	Institut de Ciencies de l'Educacio from the University of Barcelona; Ministry of Sciences, Innovation and Universities of Spain; European Regional Development Fund(European Commission); PsicoSAO Research Group in Social, Environmental, and Organizational Psychology	This research was conjointly supported by the projects REDICE18-2260 (funded by the Institut de Ciencies de l'Educacio from the University of Barcelona), RTI2018-094405-B-100 (co-funded by the Ministry of Sciences, Innovation and Universities of Spain and the European Regional Development Fund) and PsicoSAO Research Group in Social, Environmental, and Organizational Psychology (2017 SGR 564; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement, Generalitat de Catalunya).	[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Balaguer I, 2008, REV PSICOL DEPORTE, V17, P123; Balaguer I, 2007, REV MEX PSICOL, V24, P197; Barkoukis V, 2013, EUR J PSYCHOL EDUC, V28, P353, DOI 10.1007/s10212-012-0118-5; Bonneville-Roussy A, 2017, CONTEMP EDUC PSYCHOL, V48, P28, DOI 10.1016/j.cedpsych.2016.08.003; Bowerman B.L., 1990, LINEAR STAT MODELS A; Braten I, 2000, LEARN INDIVID DIFFER, V12, P177, DOI 10.1016/S1041-6080(01)00036-X; Briere NM, 1995, INT J SPORT PSYCHOL, V26, P465; Bunce L, 2019, BRIT J SOC WORK, V49, P2092, DOI 10.1093/bjsw/bcz008; Burton KD, 2006, J PERS SOC PSYCHOL, V91, P750, DOI 10.1037/0022-3514.91.4.750; Creech A, 2012, BRIT J MUSIC EDUC, V29, P387, DOI 10.1017/S026505171200006X; Cyders MA, 2013, ASSESSMENT, V20, P86, DOI 10.1177/1073191111428762; Deci E., 1975, INTRINSIC MOTIVATION; Deci E. L., 2012, OXFORD LIB PSYCHOL, P85, DOI DOI 10.1093/OXFORDHB/9780195399820.013.0006; Deci EL, 2008, CAN PSYCHOL, V49, P14, DOI 10.1037/0708-5591.49.1.14; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DECI EL, 1971, J PERS SOC PSYCHOL, V18, P105, DOI 10.1037/h0030644; Deci EL, 1985, INTRINSIC MOTIVATION; Eum K, 2011, ANXIETY STRESS COPIN, V24, P167, DOI 10.1080/10615806.2010.488723; Evans P, 2019, J RES MUSIC EDUC, V67, P83, DOI 10.1177/0022429418812769; Evans P, 2016, PSYCHOL MUSIC, V44, P1095, DOI 10.1177/0305735615610926; Evans P, 2015, MUSIC SCI, V19, P65, DOI 10.1177/1029864914568044; Evans P, 2013, PSYCHOL MUSIC, V41, P600, DOI 10.1177/0305735612441736; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Fung A., 2018, INT J ADULT COMMUN P, V24, P1, DOI [10.18848/2328-6318/CGP/v24i03/27-44, DOI 10.18848/2328-6318/CGP/V24I03/27-44]; Gaspard H, 2017, CONTEMP EDUC PSYCHOL, V48, P67, DOI 10.1016/j.cedpsych.2016.09.003; Green L, 2002, FEM PSYCHOL, V12, P137, DOI 10.1177/0959353502012002003; Green L., 1997, MUSIC GENDER ED; Green-Demers I, 2008, EDUC PSYCHOL MEAS, V68, P862, DOI 10.1177/0013164407313368; Hagger MS, 2012, EUR J PSYCHOL EDUC, V27, P195, DOI 10.1007/s10212-011-0082-5; Hallam S, 2008, INT J MUSIC EDUC, V26, P7, DOI 10.1177/0255761407085646; Hallam S, 2014, SEMPRE STUD PSYCHOL, P333; Hallam S, 2017, PSYCHOL MUSIC, V45, P116, DOI 10.1177/0305735616650994; Hallam S, 2016, MUSIC SCI, V20, P528, DOI 10.1177/1029864916634420; HARGREAVES DJ, 1995, J RES MUSIC EDUC, V43, P242, DOI 10.2307/3345639; Hendricks KS, 2014, PSYCHOL MUSIC, V42, P347, DOI 10.1177/0305735612471238; Jungert T, 2019, EUR J PSYCHOL EDUC, V34, P479, DOI 10.1007/s10212-018-0390-0; Lamont A, 2011, MUSIC EDUC RES, V13, P369, DOI 10.1080/14613808.2011.638505; LeBlanc A, 1999, B COUN RES MUSIC ED, P72; Lens W., 2009, PSYCHOLOGICA-COIMBRA, V50, P21, DOI [10.14195/1647-8606_50_2, DOI 10.14195/1647-8606_50_2]; Markland D, 1999, J SPORT EXERCISE PSY, V21, P351, DOI 10.1123/jsep.21.4.351; Mawang LL, 2020, PSYCHOL MUSIC, V48, P421, DOI 10.1177/0305735618805837; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; McPherson G.E., 2005, PSYCHOL MUSIC, V33, P5, DOI [10.1177/0305735605048012, DOI 10.1177/0305735605048012]; McPherson GE, 2015, RES STUD MUSIC EDUC, V37, P141, DOI 10.1177/1321103X15600914; Menard S., 2002, APPL LOGISTIC REGRES; Nielsen S., 2004, PSYCHOL MUSIC, V32, P418, DOI [10.1177/0305735604046099, DOI 10.1177/0305735604046099]; Niemiec CP, 2009, THEORY RES EDUC, V7, P133, DOI 10.1177/1477878509104318; Ntoumanis N, 2004, J SPORT EXERCISE PSY, V26, P197, DOI 10.1123/jsep.26.2.197; Pajares F, 2002, THEOR PRACT, V41, P116, DOI 10.1207/s15430421tip4102_8; Papageorgi I, 2013, PSYCHOL MUSIC, V41, P18, DOI 10.1177/0305735611408995; Papageorgi I, 2010, PSYCHOL MUSIC, V38, P31, DOI 10.1177/0305735609336044; Perlman D, 2017, J COMMUNITY PSYCHOL, V45, P1026, DOI 10.1002/jcop.21908; Ratelle CF, 2007, J EDUC PSYCHOL, V99, P734, DOI 10.1037/0022-0663.99.4.734; Reinboth M, 2006, PSYCHOL SPORT EXERC, V7, P269, DOI 10.1016/j.psychsport.2005.06.002; Renwick J. M., 2009, P INT S PERF SCI 200, P469; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; RYAN RM, 1995, J PERS, V63, P397, DOI 10.1111/j.1467-6494.1995.tb00501.x; Schuler J, 2010, J RES PERS, V44, P1, DOI 10.1016/j.jrp.2009.09.002; Shen B, 2010, J TEACH PHYS EDUC, V29, P72, DOI 10.1123/jtpe.29.1.72; Stebbins R, 1992, PROFESSIONALS SERIOU; Stebbins R.A., 2001, NEW DIRECTIONS THEOR; Stevens J.P., 2009, APPL MULTIVARIATE ST; Syrjala M., 2004, GIFTED ED INT, V19, P275, DOI DOI 10.1177/; Trigueros R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221461; Valenzuela R, 2018, PSYCHOL MUSIC, V46, P33, DOI 10.1177/0305735617694502; VALLERAND RJ, 1984, J SPORT PSYCHOL, V6, P94, DOI 10.1123/jsp.6.1.94; Vallerand RJ, 1997, ADV EXP SOC PSYCHOL, V29, P271, DOI 10.1016/S0065-2601(08)60019-2; Van Nuland HJC, 2012, EUR J PSYCHOL EDUC, V27, P467, DOI 10.1007/s10212-011-0089-y; Vianello M, 2013, PERS INDIV DIFFER, V55, P994, DOI 10.1016/j.paid.2013.08.008; Wang JCK, 2016, J SPORT EXERCISE PSY, V38, P612, DOI 10.1123/jsep.2016-0153; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Welch G, 2008, RES PAP EDUC, V23, P203, DOI 10.1080/02671520802048752; WIERSMA UJ, 1992, J OCCUP ORGAN PSYCH, V65, P101, DOI 10.1111/j.2044-8325.1992.tb00488.x; Wosnitza M, 2012, EUR J PSYCHOL EDUC, V27, P177, DOI 10.1007/s10212-011-0081-6	77	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232711	10.1371/journal.pone.0232711	http://dx.doi.org/10.1371/journal.pone.0232711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365101	Green Published, gold			2022-12-26	WOS:000536959700055
J	Cai, J; Wang, DM; Liang, SL; Peng, JR; Zhao, FQ; Liu, JX				Cai, Jie; Wang, Diming; Liang, Shulin; Peng, Jinrong; Zhao, Fengqi; Liu, Jianxin			Excessive supply of glucose elicits an NF-kappa B2-dependent glycolysis in lactating goat mammary glands	FASEB JOURNAL			English	Article						coexpression; glycolysis; lactation; mammary gland; NF-kappa B; transcriptome	NF-KAPPA-B; EPITHELIAL-CELLS; GANODERIC ACID; DNA-REPAIR; AVAILABILITY; METABOLISM; EXPRESSION; ROLES; DIET; P53	During lactation, an improper glucose supply often threatens mammary gland (MG) health. However, information is limited on the metabolic trajectories and molecules that regulate lactating MGs with an excessive glucose supply. Based on the network analysis of transcriptome and microRNAs, we found that the oversupply of glucose-induced severe glucose metabolic disorders in MGs of lactating goats, shifting lactose synthesis to acute fermentative glycolysis which caused increased flux of glucose metabolism into lactate. Moreover, NF-kappa B2 played a key role in regulating glycolysis, exhibiting a metabolic shift when MGs had an excessive supply of glucose. In primary mammary epithelial cells, fermentative glycolysis, and intracellular concentration of reactive oxygen species (ROS) were reduced by ganoderic acid A through blocking NF-kappa B2, while activation of NF-kappa B2 with phorbol myristate acetate (PMA) upregulated fermentative glycolysis and increased cellular ROS accumulation under excessive glucose. Thus, we established an NF-kappa B2-targeting method to reform the metabolic shift toward glycolysis caused by glucose oversupply by integrating NF-kappa B2 blockade and intracellular ROS scavenging.	[Cai, Jie; Wang, Diming; Liang, Shulin; Peng, Jinrong; Zhao, Fengqi; Liu, Jianxin] Zhejiang Univ, Inst Dairy Sci, Coll Anim Sci, Minist Educ,Key Lab Mol Anim Nutr, Hangzhou, Zhejiang, Peoples R China; [Zhao, Fengqi] Univ Vermont, Dept Anim & Vet Sci, Burlington, VT USA	Zhejiang University; University of Vermont	Liu, JX (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou, Zhejiang, Peoples R China.	liujx@zju.edu.cn			National Nature Science Foundation of China [31930107]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Nature Science Foundation of China, Grant/Award Number: 31930107	Akers M. R., 2002, LACTATION MAMMARY GL, P88; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cai J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01467; Cao FR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00101; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Cerella C, 2014, BIOCHEM PHARMACOL, V92, P22, DOI 10.1016/j.bcp.2014.07.005; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Cui Y, 2016, MED SCI MONITOR, V22, P4699, DOI 10.12659/MSM.896772; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Elswood J, 2021, AUTOPHAGY, V17, P420, DOI 10.1080/15548627.2020.1720427; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; Diaz FE, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1218297; Farabegoli F, 2012, EUR J PHARM SCI, V47, P729, DOI 10.1016/j.ejps.2012.08.012; Gill BS, 2018, INTERDISCIP SCI, V10, P233, DOI 10.1007/s12539-016-0182-7; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Guan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10372; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ingman WV, 2014, J MAMMARY GLAND BIOL, V19, P161, DOI 10.1007/s10911-014-9325-9; Kumar S, 2014, INT J CANCER, V134, P2798, DOI 10.1002/ijc.28623; Lapierre H, 2007, P CORN NUTR C FEED M; Lemosquet S, 2002, AM J PHYSIOL-REG I, V282, pR464, DOI 10.1152/ajpregu.2002.282.2.R464; Lemosquet S, 2009, J DAIRY SCI, V92, P3244, DOI 10.3168/jds.2008-1610; Li JJ, 2006, PROTEIN PEPTIDE LETT, V13, P391, DOI 10.2174/092986606775974339; Li Q, 2015, TOXICOL APPL PHARM, V289, P133, DOI 10.1016/j.taap.2015.09.025; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066092; Liu ZD, 2018, EUR J PHARMACOL, V824, P72, DOI 10.1016/j.ejphar.2018.01.026; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; Martinez-Outschoorn UE, 2013, CELL CYCLE, V12, P2580, DOI 10.4161/cc.25510; Mathias PCF, 2014, EUR J NUTR, V53, P711, DOI 10.1007/s00394-014-0654-7; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Purup S, 2012, ANIMAL, V6, P423, DOI 10.1017/S1751731111002540; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Sala G, 2016, NEUROTOXICOLOGY, V54, P161, DOI 10.1016/j.neuro.2016.04.018; Santos JM, 2019, NUTR CANC, V22, P1; SCHULZEOSTHOFF K, 1995, BIOCHEM PHARMACOL, V50, P735, DOI 10.1016/0006-2952(95)02011-Z; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Shi HP, 2014, ANIM SCI J, V85, P735, DOI 10.1111/asj.12206; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Tarazona A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wang Y, 2019, MICROB PATHOGENESIS, V128, P390, DOI 10.1016/j.micpath.2019.01.038; Wang ZY, 2019, IMMUNOL LETT, V206, P1, DOI 10.1016/j.imlet.2018.11.014; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu TY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020578; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Yang JL, 2018, ONCOTARGET, V9, P1063, DOI 10.18632/oncotarget.23148; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YL, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/621264; Zhao K, 2012, ANIMAL, V6, P488, DOI 10.1017/S1751731111001893; Zhu J, 2018, CHEM-BIOL INTERACT, V290, P77, DOI 10.1016/j.cbi.2018.05.014	57	2	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8671	8685		10.1096/fj.201903088R	http://dx.doi.org/10.1096/fj.201903088R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359096				2022-12-26	WOS:000530048100001
J	Suarez, CA; Franceschelli, JJ; Tasselli, SE; Morbidoni, HR				Alejandro Suarez, Cristian; Judith Franceschelli, Jorgelina; Emilse Tasselli, Sabrina; Ricardo Morbidoni, Hector			Weirdo19ES is a novel singleton mycobacteriophage that selects for glycolipid deficient phage-resistant M. smegmatis mutants	PLOS ONE			English	Article							PROTEIN; EXPRESSION; EVOLUTION; GENES; GILES; HOST; TOOL; DNA	The sequencing and bioinformatics analysis of bacteriophages infecting mycobacteria has yielded a large amount of information on their evolution, including that on their environmental propagation on other genera such as Gordonia, closely related to Mycobacterium. However, little is known on mycobacteriophages cell biology such as the nature of their receptor (s) or their replication cycle. As part of our on-going screening for novel mycobacteriophages, we herein report the isolation and genome bioinformatics analysis of Weirdo19ES, a singleton Siphoviridae temperate mycobacteriophage with a 70.19% GC content. Nucleotide and protein sequence comparison to actinobacteriophage databases revealed that Weirdo19ES shows low homology to Gordonia phage Ruthy and mycobacteriophages falling in clusters Q and G and to singleton DS6A.Weirdo19ES also displays uncommon features such as a very short Lysin A gene (with only one enzymatic domain) and two putative HNH endonucleases. Mycobacterium smegmatis mutants resistant to Weirdo19ES are cross- resistant to I3. In agreement with that phenotype, analysis of cell envelope of those mutants showed that Weirdo19ES shares receptors with the transducing mycobacteriophage I3.This singleton mycobacteriophage adds up to the uncommonness of local mycobacteriophages previously isolated by our group and helps understanding the nature of mycobacteriophage receptors.	[Alejandro Suarez, Cristian; Judith Franceschelli, Jorgelina; Emilse Tasselli, Sabrina; Ricardo Morbidoni, Hector] Univ Nacl Rosario, Fac Ciencias Med, Lab Microbiol Mol, Rosario, Argentina	National University of Rosario	Morbidoni, HR (corresponding author), Univ Nacl Rosario, Fac Ciencias Med, Lab Microbiol Mol, Rosario, Argentina.	morbiatny@yahoo.com			ANPCyT (MinCyT, Argentina) [PICT 3795]	ANPCyT (MinCyT, Argentina)	HRM has received grant ANPCyT PICT 3795 (MinCyT, Argentina) https://www.argentina.gob.ar/ciencia/agencia/fondo-para-la-investigacioncientifica-y-tecnologica-foncyt The funder played no role in the study, the preparation of the article or the decision to publish.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Suarez CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212365; BISSO G, 1976, BIOCHIMIE, V58, P87, DOI 10.1016/S0300-9084(76)80359-8; Borodovsky Mark, 2011, Curr Protoc Bioinformatics, VChapter 4, DOI [10.1002/0471250953.bi0406s35, 10.1002/0471250953.bi0405s35]; Broussard GW, 2013, MOL CELL, V49, P237, DOI 10.1016/j.molcel.2012.11.012; Burguiere A, 2005, MICROBIOL-SGM, V151, P2087, DOI 10.1099/mic.0.27938-0; Cangelosi GA, 1999, MICROBIOL-UK, V145, P1317, DOI 10.1099/13500872-145-6-1317; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Catalao MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080428; Chen JM, 2009, MICROBIOL-SGM, V155, P4050, DOI 10.1099/mic.0.033209-0; Chiaradia L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12718-4; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; DAVID HL, 1980, ANTIMICROB AGENTS CH, V18, P357, DOI 10.1128/AAC.18.2.357; Dedrick RM, 2013, MOL MICROBIOL, V88, P577, DOI 10.1111/mmi.12210; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Esposito LA, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000079; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Halleran A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141100; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Joshi H, 2019, MICROBIOL-SGM, V165, P1013, DOI 10.1099/mic.0.000831; Franceschelli JJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00181-14; Khoo KH, 1996, BIOCHEMISTRY-US, V35, P11812, DOI 10.1021/bi961055+; Kocincova D, 2008, TUBERCULOSIS, V88, P390, DOI 10.1016/j.tube.2008.02.005; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lima JD, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0734-3; Lunt BL, 2016, J MOL BIOL, V428, P2289, DOI 10.1016/j.jmb.2016.04.023; Mavrich TN, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.112; McNerney R, 1998, RES MICROBIOL, V149, P487, DOI 10.1016/S0923-2508(98)80003-X; Mehla J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16303-7; Mehla J, 2015, J BACTERIOL, V197, P2508, DOI 10.1128/JB.00164-15; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Olm MR, 2017, ISME J, V11, P2864, DOI 10.1038/ismej.2017.126; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pope WH, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00595-16; Pope WH, 2017, MBIO, V8, DOI 10.1128/mBio.01069-17; Pope WH, 2014, MBIO, V5, DOI 10.1128/mBio.02145-14; Potter SC, 2018, NUCLEIC ACIDS RES, V46, pW200, DOI 10.1093/nar/gky448; Smith KC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-410; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; Stella EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056384; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Villanueva VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137187; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007; 2012, BACTERIOPHAGE, V3, P137, DOI DOI 10.4161/BACT.18778	50	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0231881	10.1371/journal.pone.0231881	http://dx.doi.org/10.1371/journal.pone.0231881			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357186	Green Published, gold			2022-12-26	WOS:000536957700011
J	Dale, MP; Moses, T; Johnston, EJ; Rosser, SJ				Dale, Matthew P.; Moses, Tessa; Johnston, Emily J.; Rosser, Susan J.			A systematic comparison of triterpenoid biosynthetic enzymes for the production of oleanolic acid in Saccharomyces cerevisiae	PLOS ONE			English	Article							BETA-AMYRIN SYNTHASE; COMBINATORIAL BIOSYNTHESIS; SAPONINS; CLONING; GENES; MOTIF; P450	Triterpenoids are high-value plant metabolites with numerous applications in medicine, agriculture, food, and home and personal care products. However, plants produce triterpenoids in low abundance, and their complex structures make their chemical synthesis prohibitively expensive and often impossible. As such, the yeast Saccharomyces cerevisiae has been explored as an alternative means of production. An important triterpenoid is oleanolic acid because it is the precursor to many bioactive triterpenoids of commercial interest, such as QS-21 which is being evaluated as a vaccine adjuvant in clinical trials against HIV and malaria. Oleanolic acid is derived from 2,3-oxidosqualene (natively produced by yeast) via a cyclisation and a multi-step oxidation reaction, catalysed by a beta-amyrin synthase and a cytochrome P450 of the CYP716A subfamily, respectively. Although many homologues have been characterised, previous studies have used arbitrarily chosen beta-amyrin synthases and CYP716As to produce oleanolic acid and its derivatives in yeast. This study presents the first comprehensive comparison of beta-amyrin synthase and CYP716A enzyme activities in yeast. Strains expressing different homologues are compared for production, revealing 6.3and 4.5-fold differences in beta-amyrin and oleanolic acid productivities and varying CYP716A product profiles, which are important to consider when engineering strains for the production of bioactive oleanolic acid derivatives.	[Dale, Matthew P.; Moses, Tessa; Johnston, Emily J.; Rosser, Susan J.] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Dale, MP; Rosser, SJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	matt.dale@ed.ac.ul; susan.rosser@ed.ac.uk	Moses, Tessa/AAU-7383-2021	Moses, Tessa/0000-0001-9366-4727; Dale, Matthew/0000-0002-6010-3509; Johnston, Emily/0000-0003-0592-0992	Industrial Biotechnology Innovation Centre [2016-150]; Biotechnology and Biological Sciences Research Council (BBSRC) [102297]; East of Scotland Bioscience Doctoral Training Partnership (EASTBIO DTP); BBSRC	Industrial Biotechnology Innovation Centre; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); East of Scotland Bioscience Doctoral Training Partnership (EASTBIO DTP); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants awarded by the Industrial Biotechnology Innovation Centre (Project-2016-150; www.ibioic.com; author TM) and the Biotechnology and Biological Sciences Research Council (BBSRC; IBCatalyst: Project No. 102297; author EJJ). MD was funded by the East of Scotland Bioscience Doctoral Training Partnership (EASTBIO DTP) with BBSRC for a doctoral fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt P, 2017, METAB ENG, V40, P165, DOI 10.1016/j.ymben.2017.02.007; Augustin JM, 2012, PLANT PHYSIOL, V160, P1881, DOI 10.1104/pp.112.202747; Carelli M, 2011, PLANT CELL, V23, P3070, DOI 10.1105/tpc.111.087312; Dai ZB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03698; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Fukushima EO, 2013, PLANT CELL PHYSIOL, V54, P740, DOI 10.1093/pcp/pct015; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Hayashi H, 2001, BIOL PHARM BULL, V24, P912, DOI 10.1248/bpb.24.912; Hoshino T, 2017, ORG BIOMOL CHEM, V15, P2869, DOI 10.1039/c7ob00238f; Ito R, 2013, FEBS J, V280, P1267, DOI 10.1111/febs.12119; Khakimov B, 2015, PLANT J, V84, P478, DOI 10.1111/tpj.13012; Kirby J, 2008, FEBS J, V275, P1852, DOI 10.1111/j.1742-4658.2008.06343.x; Kushiro T, 2000, J AM CHEM SOC, V122, P6816, DOI 10.1021/ja0010709; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Miettinen K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14153; Moses T, 2015, MOL PLANT, V8, P122, DOI 10.1016/j.molp.2014.11.004; Moses T, 2014, PHYTOCHEMISTRY, V108, P47, DOI 10.1016/j.phytochem.2014.10.002; Moses T, 2014, P NATL ACAD SCI USA, V111, P1634, DOI 10.1073/pnas.1323369111; Moses T, 2013, NEW PHYTOL, V200, P27, DOI 10.1111/nph.12325; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; PORALLA K, 1994, BIOORG MED CHEM LETT, V4, P285, DOI 10.1016/S0960-894X(01)80130-X; Salmon M, 2016, P NATL ACAD SCI USA, V113, pE4407, DOI 10.1073/pnas.1605509113; Schuckel J, 2012, CHEMBIOCHEM, V13, P2758, DOI 10.1002/cbic.201200572; Shakhidoyatov Kh. M., 1997, Chemistry of Natural Compounds, V33, P605, DOI 10.1007/BF02249623; Strawser C, 2017, EXPERT REV NEUROTHER, V17, P895, DOI 10.1080/14737175.2017.1356721; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Zainal B, 2014, NAT PROD CHEM RES, V2; Zhao YJ, 2018, BIORESOURCE TECHNOL, V257, P339, DOI 10.1016/j.biortech.2018.02.096; Zhu M, 2018, METAB ENG, V45, P43, DOI 10.1016/j.ymben.2017.11.009	31	3	4	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0231980	10.1371/journal.pone.0231980	http://dx.doi.org/10.1371/journal.pone.0231980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357188	gold, Green Published			2022-12-26	WOS:000536957700012
J	Dertien, JS; Self, S; Ross, BE; Barrett, K; Baldwin, RF				Dertien, Jeremy S.; Self, Stella; Ross, Beth E.; Barrett, Kyle; Baldwin, Robert F.			The relationship between biodiversity and wetland cover varies across regions of the conterminous United States	PLOS ONE			English	Article							PRAIRIE POTHOLE REGION; SPECIES RICHNESS; BIRD COMMUNITIES; DIVERSITY; ENERGY; MODEL; CONSEQUENCES; CONSERVATION; AMPHIBIANS; MANAGEMENT	Identifying the factors that determine the spatial distribution of biodiversity is a major focus of ecological research. These factors vary with scale from interspecific interactions to global climatic cycles. Wetlands are important biodiversity hotspots and contributors of ecosystem services, but the association between proportional wetland cover and species richness has shown mixed results. It is not well known as to what extent there is a relationship between proportional wetland cover and species richness, especially at the sub-continental scale. We used the National Wetlands Inventory (NWI) to model wetland cover for the conterminous United States and the National Land Cover Database to estimate wetland change between 2001 and 2011. We used a Bayesian spatial Poisson model to estimate a spatially varying coefficient surface describing the effect of proportional wetland cover on the distribution of amphibians, birds, mammals, and reptiles and the cumulative distribution of terrestrial endemic species. Species richness and wetland cover were significantly correlated, and this relationship varied both spatially and by taxonomic group. Rather than a continental-scale association, however, we found that this relationship changed more closely among ecoregions. The species richness of each of the five groups was positively associated with wetland cover in some or all of the Great Plains; additionally, a positive association was found for mammals in the Southeastern Plains and Piedmont of the eastern U.S. Model results indicated negative association especially in the Cold Deserts and Northern Lakes & Forests of Minnesota and Wisconsin, though these varied greatly between groups. Our results highlight the need for wetland conservation initiatives that focus efforts at the level II and III ecoregional scale rather than along political boundaries.	[Dertien, Jeremy S.; Ross, Beth E.; Barrett, Kyle; Baldwin, Robert F.] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA; [Self, Stella] Univ South Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Ross, Beth E.] Clemson Univ, US Geol Survey, South Carolina Cooperat Fish & Wildlife Res Unit, Clemson, SC USA	University of South Carolina System; University of South Carolina Columbia; Clemson University; United States Department of the Interior; United States Geological Survey	Dertien, JS (corresponding author), Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA.	jdertie@clemson.edu	Dertien, Jeremy/AAJ-6925-2021	Dertien, Jeremy/0000-0003-4011-0258	Margaret H. Lloyd-SmartState Endowment at Clemson University	Margaret H. Lloyd-SmartState Endowment at Clemson University	Margaret H. Lloyd-SmartState Endowment at Clemson University https://www.clemson.edu/cafls/lloyd_project/about/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2017, ECOL APPL, V27, P916, DOI 10.1002/eap.1493; [Anonymous], 2013, BIRDLIFE INT HDB BIR; Babbitt Kimberly J., 2005, Wetlands Ecology and Management, V13, P269, DOI 10.1007/s11273-004-7521-x; Baldwin RF, 2018, BIOSCIENCE, V68, P60, DOI 10.1093/biosci/bix142; Banerjee S., 2015, HIERARCHICAL MODELIN; Beas BJ, 2014, WETLANDS, V34, P1247, DOI 10.1007/s13157-014-0584-4; Benson CE, 2018, WETL ECOL MANAG, V26, P195, DOI 10.1007/s11273-017-9565-8; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Brander L, 2013, ECOL ENG, V56, P89, DOI 10.1016/j.ecoleng.2012.12.104; Brezger A, 2006, COMPUT STAT DATA AN, V50, P967, DOI 10.1016/j.csda.2004.10.011; Churchfield S, 1997, J ZOOL, V241, P55, DOI 10.1111/j.1469-7998.1997.tb05499.x; Cimon-Morin J, 2016, ENVIRON CONSERV, V43, P56, DOI 10.1017/S0376892915000132; Corcuera P, 2019, CUATR CIEN BASIN, P189, DOI 10.1007/978-3-030-11262-2_14; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dahl TE, 2011, STATUS TRENDS WETLAN; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; de Boor C., 2001, APPL MATH SCI, V27; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fairbairn SE, 2001, WETLANDS, V21, P41, DOI 10.1672/0277-5212(2001)021[0041:LALLIO]2.0.CO;2; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Finlayson CM, 2012, AQUAT CONSERV, V22, P139, DOI 10.1002/aqc.2233; Gelman A., 2004, BAYESIAN DATA ANAL; Gibbs JP, 2000, CONSERV BIOL, V14, P314, DOI 10.1046/j.1523-1739.2000.98608.x; GILL F.B., 2006, ORNITHOLOGY; HAIRSTON NG, 1949, ECOL MONOGR, V19, P49, DOI 10.2307/1943584; Hartel T, 2014, BASIC APPL ECOL, V15, P385, DOI 10.1016/j.baae.2014.06.007; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Horwitz P, 2012, 6 RAMS; Houlahan JE, 2006, WETLANDS, V26, P79, DOI 10.1672/0277-5212(2006)26[79:TEOALU]2.0.CO;2; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; IUCN, 2013, IUCN RED LIST THREAT; Jenkins CN, 2015, P NATL ACAD SCI USA, V112, P5081, DOI 10.1073/pnas.1418034112; Johnson BA, 2016, FOREST ECOL MANAG, V379, P124, DOI 10.1016/j.foreco.2016.08.012; JOHNSTON CA, 1994, WETLANDS, V14, P49, DOI 10.1007/BF03160621; Kozak KH, 2017, HERPETOLOGICA, V73, P220, DOI 10.1655/HERPETOLOGICA-D-16-00085.1; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Lehikoinen P, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Lehtinen RM, 1999, WETLANDS, V19, P1, DOI 10.1007/BF03161728; Leibowitz SG, 2003, WETLANDS, V23, P517, DOI 10.1672/0277-5212(2003)023[0517:IWATFA]2.0.CO;2; Lowe WH, 2002, CONSERV BIOL, V16, P183, DOI 10.1046/j.1523-1739.2002.00360.x; Luo ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035514; Marsh L.C., 2001, SPLINE REGRESSION MO; McCullagh P, 1989, GEN LINEAR MODELS; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mitsch WJ, 2015, WETLANDS, DOI [10.1007/s13157-015-0632-8, DOI 10.1007/S13157-015-0632-8]; Nagelkerken I, 2018, SCI TOTAL ENVIRON, V645, P615, DOI 10.1016/j.scitotenv.2018.07.168; NatureServe, 2008, NAT SPEC DAT; NCAR Community, 2011, COMMUNITY CLIMATE SY; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; Garcia-Vazquez UO, 2019, CUATR CIEN BASIN, P175, DOI 10.1007/978-3-030-11262-2_13; Petranka JW, 2007, BIOL CONSERV, V138, P371, DOI 10.1016/j.biocon.2007.05.002; Petranka JW, 2005, FOREST ECOL MANAG, V210, P443, DOI 10.1016/j.foreco.2005.02.040; PRISM Climate Group, 2019, 30 YEAR PREC NORM AN; Ramsay AT, 2002, J ROY STAT SOC B, V64, P307, DOI 10.1111/1467-9868.00339; Rekabdarkolaee HM, 2019, SPAT STAT-NETH, V29, P351, DOI 10.1016/j.spasta.2018.12.006; Robert, 2015, METROPOLIS HASTINGS, P1, DOI [DOI 10.1002/9781118445112.STAT07834, 10.1002/9781118445112.stat07834]; Seaber PR., 1987, HYDROLOGIC UNIT MAPS, DOI [10.3133/wsp2294, DOI 10.3133/WSP2294]; Semlitsch RD, 2000, J WILDLIFE MANAGE, V64, P615, DOI 10.2307/3802732; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; Steen VA, 2016, WETLANDS, V36, pS445, DOI 10.1007/s13157-016-0791-2; Strain GF, 2017, WILDLIFE RES, V44, P354, DOI 10.1071/WR15177; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terando AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102261; Ugarte MD, 2017, SPAT STAT-NETH, V22, P451, DOI 10.1016/j.spasta.2017.04.002; Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6; Venne LS, 2012, WETLANDS, V32, P619, DOI 10.1007/s13157-012-0305-9; Votteler TH, 1996, WETLAND PROTECTION L; Wells KD., ECOLOGY BEHAV AMPHIB; Wood SN, 2008, J ROY STAT SOC B, V70, P931, DOI 10.1111/j.1467-9868.2008.00665.x; Xu HY, 2015, RES J BIOTECHNOL, V10, P1	73	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232052	10.1371/journal.pone.0232052	http://dx.doi.org/10.1371/journal.pone.0232052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357185	gold, Green Published			2022-12-26	WOS:000536957700013
J	Awoke, N; Tekalign, T; Lemma, T				Awoke, Nefsu; Tekalign, Tiwabwork; Lemma, Tesfanesh			Predictors of optimal breastfeeding practices in Worabe town, Silte zone, South Ethiopia	PLOS ONE			English	Article								Background Studies in sub-Saharan Africa indicated the overall prevalence of optimal breast feeding ranged between a lowest of 17.63% in East Africa and a highest of 46.37% in West Africa. It's estimated that 823,000 deaths of children could be prevented every year through optimal breastfeeding practices. However optimal breastfeeding practices is low in most setting of Ethiopia. Therefore, this study aimed to assess optimal breastfeeding practices and associated factors in Worabe town. Method A community-based analytical cross-sectional study was conducted from April 15th-25th, 2018. A systematic sampling technique was applied on 347 sampled mothers who had children greater than or equal to 2 years old. The data was entered into EpiData (version 3.1) and subsequently exported to SPSS Statistics (version 22) for analysis. Descriptive statistics were used for presenting summary data using tables and graph. Bivariate and multi variable logistic regression analysis to identify were used to identify associated factors. The statistical significance was declared at P<0.05. Result Optimal breastfeeding was exhibited by 42.1% of mothers. Government employees (AOR = 8.0; 95% CI: 1.7, 36.4), families with a household income of 1,500-3,000 Ethiopian birr (AOR = 4.6; 95% CI: 1.0, 20.1), individuals knowledgeable about optimal breastfeeding practices (AOR: 5.5 95% CI: 1.6, 18.1), individuals counselled about breastfeeding practices during postnatal follow-ups (AOR = 4.940, 95% CI: 1.313, 10.195), and individuals that had a caesarean section delivery (AOR = 4.2, 95% CI: 1.2, 14.1) had a higher chance of practicing optimal breastfeeding. However, mothers who did not attend or have access to antenatal care follow-ups (AOR = 0.1, 95% CI: 0.04, 0.5) were less likely to practice optimal breastfeeding. Conclusions Less than half of mothers breastfed their children optimally. Factors that influenced this included knowledge of optimal breastfeeding practices, total household income, the woman's occupation, access to breastfeeding counselling during postnatal care follow-ups, access to antenatal care follow-ups, and mode of delivery. It is strongly recommended that optimal breastfeeding awareness programs through health education be done in collaboration with health extension workers, and zonal health offices.	[Awoke, Nefsu; Tekalign, Tiwabwork] Wolaita Sodo Univ, Coll Hlth Sci & Med, Dept Nursing, Sodo, Ethiopia; [Lemma, Tesfanesh] Wolaita Sodo Univ, Coll Hlth Sci & Med, Dept Midwifery, Sodo, Ethiopia		Awoke, N (corresponding author), Wolaita Sodo Univ, Coll Hlth Sci & Med, Dept Nursing, Sodo, Ethiopia.	nefsea@gmail.com	Awoke, Nefsu/AFV-2432-2022	Awoke, Nefsu/0000-0002-1037-5004; Lemma, Tesfanesh/0000-0003-3038-5821				Abageda M, 2015, J PREG CHILD HLTH, V2, P182, DOI 10.4172/2376-127X.1000182; Asare BYA, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0156-y; Boatin AA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k55; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia] ICF, 2016, ETH DEM HLTH SURV 20; FDRE, 2015, HLTH SECT TRANSF PLA; FDRE (Federal Democratic Republic of Ethiopia), NAT NUTR PROGR 2016; FDRE (Federal Democratic Republic of Ethiopia), 2015, SEQ DECL; Hazir T, 2013, PUBLIC HEALTH NUTR, V16, P659, DOI 10.1017/S1368980012002935; Issaka AI, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014145; Kebede Z., 2015, SCI J PUBLIC HLTH, V3, P544, DOI [10.11648/j.sjph.20150304.23, DOI 10.11648/J.SJPH.20150304.23]; Motilewa OO, 2019, ASIAN J MED HLTH, P1; Nigatu Yeshambel T, 2014, E AFRICAN J PUBLIC H, V11; Ogbo FA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1595-7; Quinn Victoria, NUTR BREASTF PROM; Rameeza K., 2017, PROFESSIONAL MED J, V24, P1387, DOI [10.17957/TPMJ/17.3903, DOI 10.17957/TPMJ/17.3903]; Shibru Hoche, 2017, ETHIOP J HLTH SCI, V28, P49, DOI [10.4314/ejhs.v28i1, DOI 10.4314/EJHS.V28I1]; Tamiru D., 2013, INT J NUTR FOOD SCI, V2, P122, DOI [10.11648/j.ijnfs.20130203.15, DOI 10.11648/J.IJNFS.20130203.15]; Tamiru D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-363; Taye T., 2013, SCI J CLIN MED, V2, P153, DOI 10.11648/j.sjcm.20130206.12; Tessema M, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.75.1630; UNICEF, 2010, IMPR EXCL BREASTF PR; UNICEF, 2016, OPT BREASTF PRACT SU; Victor R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001529; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Worabe administrative health office, 2018, ANN PLAN, P1; World Health Organization, 2018, INF YOUNG CHILD TEED; Zakarija-Grkovic I, 2016, EUR J PUBLIC HEALTH, V26, P282, DOI 10.1093/eurpub/ckv203	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232316	10.1371/journal.pone.0232316	http://dx.doi.org/10.1371/journal.pone.0232316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353021	gold, Green Published			2022-12-26	WOS:000536673200073
J	Im, H; Ham, S				Im, Haeri; Ham, Sihyun			Effect of linker on the binding free energy of stapled p53/HDM2 complex	PLOS ONE			English	Article							P53; PROTEIN; MDM2; PEPTIDES	Inactivation of the tumor suppressor p53 resulting from the binding with a negative regulator HDM2 is among the predominant defects in human cancers. p53-mimicking peptides whose conformational and proteolytic stability is enhanced by an all-hydrocarbon staple are being recognized as promising anticancer agents for disrupting the p53-HDM2 binding and reactivating p53. Herein, we conduct a computational modeling and thermodynamic characterization of stapled p53/HDM2 complex via molecular docking, simulations, and binding free energy analysis. The binding thermodynamics analysis is done based on the end-point calculation of the effective binding energy-a sum of the direct peptide-protein interaction energy and the dehydration penalty-and on its decomposition into contributions from specific groups constituting the complex. This allows us to investigate how individual amino acids in the stapled p53 and HDM2 contribute to the binding affinity. We find that not only the epitope residues (F19, W23 and L26), but also the hydrocarbon linker of the stapled p53 impart significant contributions. Our computational approach will be useful in designing new stapled peptides in which the staple location is also optimized to improve the binding affinity.	[Im, Haeri; Ham, Sihyun] Sookmyung Womens Univ, Res Inst Nat Sci, Dept Chem, Seoul, South Korea	Sookmyung Women's University	Ham, S (corresponding author), Sookmyung Womens Univ, Res Inst Nat Sci, Dept Chem, Seoul, South Korea.	sihyun@sookmyung.ac.kr			Samsung Science and Technology Foundation [SSTF-BA1401-52]; National Research Foundation of Korea (NRF) [NRF-2017R1A2B3010053]	Samsung Science and Technology Foundation(Samsung); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was funded by the Samsung Science and Technology Foundation under Project Number SSTF-BA1401-52 and the National Research Foundation of Korea (NRF) (No. NRF-2017R1A2B3010053) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Brown CJ, 2013, ACS CHEM BIOL, V8, P506, DOI 10.1021/cb3005148; Case D. A., AMBER 2016; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Chong SH, 2016, J CHEM THEORY COMPUT, V12, P2509, DOI 10.1021/acs.jctc.6b00174; Chong SH, 2015, ACCOUNTS CHEM RES, V48, P956, DOI 10.1021/acs.accounts.5b00032; Chong SH, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3610550; Dennington R., 2016, GAUSSVIEW VERSION 6; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Tran DP, 2019, J PHYS CHEM B, V123, P2469, DOI 10.1021/acs.jpcb.8b10309; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Frisch G. W., 2013, GAUSSIAN 09; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Imai T, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2213980; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph TL, 2010, CELL CYCLE, V9, P4560, DOI 10.4161/cc.9.22.13816; Kovalenko A, 2003, UNDERS CH R, V24, P169; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Morrone JA, 2017, J CHEM THEORY COMPUT, V13, P870, DOI 10.1021/acs.jctc.6b00977; Morrone JA, 2017, J CHEM THEORY COMPUT, V13, P863, DOI 10.1021/acs.jctc.6b00978; Onel K, 2004, MOL CANCER RES, V2, P1; Paul F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01163-6; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wanzel I, 2016, NAT CHEM BIOL, V12, P22, DOI [10.1038/NCHEMBIO.1965, 10.1038/nchembio.1965]; Zwier MC, 2016, J PHYS CHEM LETT, V7, P3440, DOI 10.1021/acs.jpclett.6b01502	35	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232613	10.1371/journal.pone.0232613	http://dx.doi.org/10.1371/journal.pone.0232613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353067	gold, Green Published			2022-12-26	WOS:000536673200110
J	Yi, X; Kazlauskas, R; Travisano, M				Yi, Xiao; Kazlauskas, Romas; Travisano, Michael			Evolutionary innovation using EDGE, a system for localized elevated mutagenesis	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHASE VARIATION; DNA; GENE; MUTATION; FITNESS; MECHANISM; SELECTION; MUTANTS; ELEMENT	Mutations arising across the whole genome can hinder the emergence of evolutionary innovation required for adaptation because many mutations are deleterious. This trade-off is overcome by elevated mutagenesis to localized loci. Examples include phase variation and diversity-generating retroelements. However, these mechanisms are rare in nature; and all have narrow mutational spectra limiting evolutionary innovation. Here, we engineer a platform of Experimental Designed Genic Evolution (EDGE) to study the potential for evolutionary novelty at a single locus. Experimental evolution with EDGE shows that bacterial resistance to a novel antibiotic readily evolves, provided that elevated mutagenesis is focused on a relevant gene. A model is proposed to account for the cost and benefit of such single loci to adaptation in a changing environment and explains their high mutation rates, limited innovation, and the rarity of localized mutagenesis in nature. Overall, our results suggest that localized mutation systems can facilitate continuing adaptive evolution without necessarily restricting the spectrum of mutations. EDGE has utility in dissecting the complex process of adaptation with its localized, efficient evolution.	[Yi, Xiao; Kazlauskas, Romas; Travisano, Michael] Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA; [Kazlauskas, Romas] Univ Minnesota, Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Travisano, Michael] Univ Minnesota, Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Travisano, M (corresponding author), Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA.; Travisano, M (corresponding author), Univ Minnesota, Ecol Evolut & Behav, St Paul, MN 55108 USA.	travisan@umn.edu		Kazlauskas, Romas/0000-0002-3570-2411; Travisano, Michael/0000-0001-8168-0842	Biotechnology Institute, University of Minnesota	Biotechnology Institute, University of Minnesota(University of Minnesota System)	XY, RK, MT. Biotechnology Institute, University of Minnesota The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; Chang Y, 2015, NUCLEIC ACIDS RES, V43, P6459, DOI 10.1093/nar/gkv565; Couce A, 2017, P NATL ACAD SCI USA, V114, pE9026, DOI 10.1073/pnas.1705887114; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Ellegren H, 1997, NATURE, V389, P593, DOI 10.1038/39303; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; FITCH WM, 1982, EVOLUTION, V36, P1133, DOI 10.1111/j.1558-5646.1982.tb05484.x; Gerrish PJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0329; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Graves CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003766; GRIFFITH JK, 1994, MOL MEMBR BIOL, V11, P271, DOI 10.3109/09687689409160437; Halperin SO, 2018, NATURE, V560, P248, DOI 10.1038/s41586-018-0384-8; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KUZMINOV A, 1994, EMBO J, V13, P2764, DOI 10.1002/j.1460-2075.1994.tb06570.x; Lenski RE, 1991, AM NAT; Linkevicius M, 2016, J ANTIMICROB CHEMOTH, V71, P1307, DOI 10.1093/jac/dkv486; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Lynch M, 2016, NAT REV GENET, V17, P704, DOI 10.1038/nrg.2016.104; MacLean RC, 2013, NAT REV GENET, V14, P221, DOI 10.1038/nrg3415; Mallik S, 2015, J BACTERIOL, V197, P2792, DOI 10.1128/JB.00101-15; Masel J, 2005, GENETICS, V170, P1359, DOI 10.1534/genetics.105.040493; MCNICHOLAS P, 1992, J BACTERIOL, V174, P7926, DOI 10.1128/JB.174.24.7926-7933.1992; Migliore L, 2013, DOSE-RESPONSE, V11, P550, DOI 10.2203/dose-response.13-002.Migliore; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Naorem SS, 2017, P NATL ACAD SCI USA, V114, pE10187, DOI 10.1073/pnas.1715952114; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Shaw FH, 2002, EVOLUTION, V56, P453, DOI 10.1111/j.0014-3820.2002.tb01358.x; Singh T, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0849; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sokal R. R., 2012, PRINCIPLES PRACTICE; Springer B, 2001, ANTIMICROB AGENTS CH, V45, P2877, DOI 10.1128/AAC.45.10.2877-2884.2001; STAPLETON JT, 1987, J VIROL, V61, P491, DOI 10.1128/JVI.61.2.491-498.1987; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Travisano M, 1996, GENETICS; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Verhey TB, 2018, MOL MICROBIOL, V107, P104, DOI 10.1111/mmi.13873; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	46	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232330	10.1371/journal.pone.0232330	http://dx.doi.org/10.1371/journal.pone.0232330			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353078	gold, Green Published			2022-12-26	WOS:000536673200077
J	Dong, XM; Zhao, K; Zheng, WW; Xu, CW; Zhang, MJ; Yin, RH; Gao, R; Tang, LJ; Liu, JF; Chen, H; Zhan, YQ; Yu, M; Ge, CH; Gao, HY; Li, X; Luo, T; Ning, HM; Yang, XM; Li, CY				Dong, Xiao-Ming; Zhao, Ke; Zheng, Wei-Wei; Xu, Cheng-Wang; Zhang, Mei-Jiang; Yin, Rong-Hua; Gao, Rui; Tang, Liu-jun; Liu, Jin-Fang; Chen, Hui; Zhan, Yi-Qun; Yu, Miao; Ge, Chang-Hui; Gao, Hui-Ying; Li, Xiu; Luo, Teng; Ning, Hong-Mei; Yang, Xiao-Ming; Li, Chang-Yan			EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome	FASEB JOURNAL			English	Article						dyserythropoiesis; EDAG; Hsp70; myelodysplastic syndrome; nuclear localization	ERYTHROID-DIFFERENTIATION; PROTEIN; CELLS; EXPRESSION; GATA1; ERYTHROPOIESIS; IDENTIFICATION; PROLIFERATION; PROGENITORS; ACTIVATION	During human erythroid maturation, Hsp70 translocates into the nucleus and protects GATA-1 from caspase-3 cleavage. Failure of Hsp70 to localize to the nucleus was found in Myelodysplastic syndrome (MDS) erythroblasts and can induce dyserythropoiesis, with arrest of maturation and death of erythroblasts. However, the mechanism of the nuclear trafficking of Hsp70 in erythroblasts remains unknown. Here, we found the hematopoietic transcriptional regulator, EDAG, to be a novel binding partner of Hsp70 that forms a protein complex with Hsp70 and GATA-1 during human normal erythroid differentiation. EDAG overexpression blocked the cytoplasmic translocation of Hsp70 induced by EPO deprivation, inhibited GATA-1 degradation, thereby promoting erythroid maturation in an Hsp70-dependent manner. Furthermore, in myelodysplastic syndrome (MDS) patients with dyserythropoiesis, EDAG is dramatically down-regulated, and forced expression of EDAG has been found to restore the localization of Hsp70 in the nucleus and elevate the protein level of GATA-1 to a significant extent. In addition, EDAG rescued the dyserythropoiesis of MDS patients by increasing erythroid differentiation and decreasing cell apoptosis. This study demonstrates the molecular mechanism of Hsp70 nuclear sustaining during erythroid maturation and establishes that EDAG might be a suitable therapeutic target for dyserythropoiesis in MDS patients.	[Dong, Xiao-Ming; Zhao, Ke; Zheng, Wei-Wei; Xu, Cheng-Wang; Zhang, Mei-Jiang; Yin, Rong-Hua; Gao, Rui; Tang, Liu-jun; Liu, Jin-Fang; Chen, Hui; Zhan, Yi-Qun; Yu, Miao; Gao, Hui-Ying; Luo, Teng; Yang, Xiao-Ming; Li, Chang-Yan] Beijing Inst Lifeom, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Dong, Xiao-Ming; Zhang, Mei-Jiang; Yang, Xiao-Ming] Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin, Peoples R China; [Dong, Xiao-Ming] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Ge, Chang-Hui] Beijing Inst Radiat Med, Dept Expt Hematol & Biochem, Beijing, Peoples R China; [Li, Xiu; Yang, Xiao-Ming; Li, Chang-Yan] Anhui Med Univ, Sch Postgrad, Hefei, Peoples R China; [Ning, Hong-Mei] Chinese Peoples Liberat Army Gen Hosp, Dept Hematopoiet Stem Cell Transplantat, Med Ctr 5, Beijing, Peoples R China	Tianjin University; Shaanxi Normal University; Anhui Medical University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Ning, HM (corresponding author), 307 Hosp PLA, Dept Hematopoiet Stem Cell Transplantat, Beijing 100071, Peoples R China.; Yang, XM; Li, CY (corresponding author), Beijing Inst Lifeom, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	ninghongmei72@sina.com; xiaomingyang@sina.com; fmmli@163.com		Dong, xiao-ming/0000-0003-2413-8541	Ministry of Science and Technology of the People's Republic of China [2017YFA0103400]; National Natural Science Foundation of China [81222005, 81770108, 30570781]; National Center for Protein Sciences [SKLP-K201802, SKLP-O20180, 4]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Protein Sciences	Ministry of Science and Technology of the People's Republic of China, Grant/Award Number: 2017YFA0103400; National Natural Science Foundation of China, Grant/Award Number: 81222005, 81770108 and 30570781; National Center for Protein Sciences, Grant/Award Number: SKLP-K201802, SKLP-O20180 and 4	Ahn SG, 2005, BIOCHEM J, V392, P145, DOI 10.1042/BJ20050412; Ali AM, 2018, BLOOD ADV, V2, P1393, DOI 10.1182/bloodadvances.2018018440; An LL, 2005, LEUKEMIA, V19, P1499, DOI 10.1038/sj.leu.2403808; Arlet JB, 2016, EXPERT REV PROTEOMIC, V13, P983, DOI 10.1080/14789450.2016.1240622; Arlet JB, 2014, NATURE, V514, P242, DOI 10.1038/nature13614; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Claessens YE, 2002, BLOOD, V99, P1594, DOI 10.1182/blood.V99.5.1594; CLARK WELG, 1947, NATURE, V159, P579; Ding YL, 2010, J CELL BIOCHEM, V110, P866, DOI 10.1002/jcb.22597; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Frisan E, 2012, BLOOD, V119, P1532, DOI 10.1182/blood-2011-03-343475; Gyan E, 2008, LEUKEMIA, V22, P1864, DOI 10.1038/leu.2008.172; Han X, 2017, BLOOD, V129, P226, DOI 10.1182/blood-2016-09-739268; Kose S, 2014, BBA-GEN SUBJECTS, V1840, P2953, DOI 10.1016/j.bbagen.2014.04.022; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kruger A, 2002, DEV DYNAM, V223, P414, DOI 10.1002/dvdy.10067; Li CY, 2007, LEUKEMIA, V21, P2277, DOI 10.1038/sj.leu.2404901; Li CY, 2008, BBA-GENE REGUL MECH, V1779, P606, DOI 10.1016/j.bbagrm.2008.06.004; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Lu J, 2001, ACTA BIOCH BIOPH SIN, V33, P641; MERCHAV S, 1991, LEUKEMIA, V5, P340; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Peters MJ, 2018, BIOL OPEN, V7, DOI 10.1242/bio.035576; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Shulga N, 1999, J BIOL CHEM, V274, P16501, DOI 10.1074/jbc.274.23.16501; Tehranchi R, 2005, BLOOD, V106, P247, DOI 10.1182/blood-2004-12-4649; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wurtz T, 2001, EXP CELL RES, V263, P236, DOI 10.1006/excr.2000.5114; Yang LV, 2006, LEUKEMIA, V20, P417, DOI 10.1038/sj.leu.2404105; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8; Zhang MJ, 2012, FEBS J, V279, P2848, DOI 10.1111/j.1742-4658.2012.08663.x; Zhao K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190794; Zheng WW, 2014, STEM CELLS, V32, P2278, DOI 10.1002/stem.1723	36	6	7	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8416	8427		10.1096/fj.201902946R	http://dx.doi.org/10.1096/fj.201902946R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350948	Bronze			2022-12-26	WOS:000553674400001
J	Krishna, VD; Kim, Y; Yang, M; Vannucci, F; Molitor, T; Torremorell, M; Cheeran, MCJ				Krishna, Venkatramana D.; Kim, Yonghyan; Yang, My; Vannucci, Fabio; Molitor, Thomas; Torremorell, Montserrat; Cheeran, Maxim C. -J.			Immune responses to porcine epidemic diarrhea virus (PEDV) in swine and protection against subsequent infection	PLOS ONE			English	Article							ANTIBODY-RESPONSES; PATHOGENESIS; INOCULATION; COLOSTRUM; VIRULENT; MUCOSAL; SERUM; GILTS; MILK; PIGS	Understanding the immune responses against Porcine epidemic diarrhea virus (PEDV) is important to prevent infection and to design control strategies. We evaluated both systemic and mucosal immune responses to PEDV in pigs and assessed if prior exposure to virus protects against re-infection. Three-week-old pigs were infected with PEDV and immune response in blood, intestine, and mesenteric lymph node (MLN) was evaluated. At 30 dpi, virus exposed pigs were challenged with a field isolate of PEDV and immune response at 5 d post challenge was evaluated. We found that PEDV RNA persists in the intestine even after fecal shedding of the virus was stopped at 28 dpi and pigs previously exposed to PEDV are protected from virus shedding after re-infection. PEDV infection induced both humoral and cell mediated immune response with an increase in PEDV specific IgA and IgG antibodies in intestine and serum. Flow cytometry analysis showed a significantly higher frequency of B cells and lower frequency of T cells at 4 dpi. The frequency of CD4/CD8 double positive (DP) memory T cells was significantly increased in the MLN of challenged animals. These studies may provide further insights into understanding the mucosal immune response to PEDV and its role in protection against disease.	[Krishna, Venkatramana D.; Kim, Yonghyan; Yang, My; Vannucci, Fabio; Molitor, Thomas; Torremorell, Montserrat; Cheeran, Maxim C. -J.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Cheeran, MCJ (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	cheeran@umn.edu	Cheeran, Maxim C-J/C-2135-2009; Krishna, Venkatramana/AAB-1227-2021	Cheeran, Maxim C-J/0000-0002-5331-4746; Divana Krishna, Venkatramana/0000-0002-1980-5525	State of Minnesota [84600/13621]; University of Minnesota College of Veterinary Medicine Emerging and Zoonotic Diseases Signature program [MN-62-092]; National Pork Board, Des Moines, Iowa, USA [14-275]	State of Minnesota(University of Minnesota System); University of Minnesota College of Veterinary Medicine Emerging and Zoonotic Diseases Signature program; National Pork Board, Des Moines, Iowa, USA	This study was funded in part by the State of Minnesota (#84600/13621), the University of Minnesota College of Veterinary Medicine Emerging and Zoonotic Diseases Signature program (#MN-62-092), and the National Pork Board, Des Moines, Iowa, USA (#14-275). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai T, 2017, VET RES, V48, DOI 10.1186/s13567-017-0469-7; BOHL EH, 1972, INFECT IMMUN, V6, P289, DOI 10.1128/IAI.6.3.289-301.1972; Chattha KS, 2015, ANNU REV ANIM BIOSCI, V3, P375, DOI 10.1146/annurev-animal-022114-111038; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Clement T, 2016, J SWINE HEALTH PROD, V24, P147; Crawford K, 2015, VET RES, V46, DOI 10.1186/s13567-015-0180-5; de Arriba ML, 2002, VET IMMUNOL IMMUNOP, V85, P85, DOI 10.1016/S0165-2427(01)00417-2; de Arriba ML, 2002, J VIROL METHODS, V105, P37, DOI 10.1016/S0166-0934(02)00063-0; Goede D, 2015, VET MICROBIOL, V176, P161, DOI 10.1016/j.vetmic.2014.12.019; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kim Y, 2018, VET SCI, V5, DOI 10.3390/vetsci5010021; Kim Y, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1017-4; Langel SN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00727; Langel SN, 2016, VIRUS RES, V226, P93, DOI 10.1016/j.virusres.2016.05.016; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Madson DM, 2014, VET MICROBIOL, V174, P60, DOI 10.1016/j.vetmic.2014.09.002; Niederwerder MC, 2016, J VET DIAGN INVEST, V28, P671, DOI 10.1177/1040638716663251; Ober BT, 1998, J VIROL, V72, P4866, DOI 10.1128/JVI.72.6.4866-4873.1998; Olanratmanee EO, 2010, ANIM REPROD SCI, V122, P42, DOI 10.1016/j.anireprosci.2010.07.004; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Rose MA, 2014, HUM VACC IMMUNOTHER, V10, P2115, DOI 10.4161/hv.29609; SAALMULLER A, 1987, EUR J IMMUNOL, V17, P1297, DOI 10.1002/eji.1830170912; Shibata I, 2000, VET MICROBIOL, V72, P173, DOI 10.1016/S0378-1135(99)00199-6; Song DS, 2007, RES VET SCI, V82, P134, DOI 10.1016/j.rvsc.2006.03.007; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Song QY, 2016, VIRUS RES, V226, P85, DOI 10.1016/j.virusres.2016.06.002; Srijangwad A, 2017, ARCH VIROL, V162, P2029, DOI 10.1007/s00705-017-3307-3; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; UNDERDAHL NR, 1975, AM J VET RES, V36, P1473; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Zhou YS, 2019, VET MICROBIOL, V228, P83, DOI 10.1016/j.vetmic.2018.11.019; Zuckermann FA, 1996, IMMUNOLOGY, V87, P500, DOI 10.1046/j.1365-2567.1996.494570.x	35	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231723	10.1371/journal.pone.0231723	http://dx.doi.org/10.1371/journal.pone.0231723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343704	gold, Green Published			2022-12-26	WOS:000536661300014
J	Perez-Barberia, FJ; Guinness, FE; Lopez-Quintanilla, M; Garcia, AJ; Gallego, L; Cappelli, J; Serrano, MP; Landete-Castillejos, T				Perez-Barberia, F. J.; Guinness, F. E.; Lopez-Quintanilla, M.; Garcia, A. J.; Gallego, L.; Cappelli, J.; Serrano, M. P.; Landete-Castillejos, T.			What do rates of deposition of dental cementum tell us? Functional and evolutionary hypotheses in red deer	PLOS ONE			English	Article							ANTLER GROWTH; TOOTH WEAR; RANGIFER-TARANDUS; AGE; MINERALIZATION; INCREMENTS; SENESCENCE; ATTACHMENT; SELECTION; PATTERNS	Cementum is a bone connective tissue that provides a flexible attachment for the tooth to the alveolar bone in many mammalian species. It does not undergo continuous remodelling, unlike non-dental bone, which combined with its growth pattern of seasonal layering makes this tissue uniquely suitable as a proxy for tracking changes in body repair investment throughout an animal's life. We tested functional and sexual selection hypotheses on the rate of cementum deposition related to the highly polygynous mating strategy of red deer. We used a sample of 156 first lower molars from wild Scottish red deer of known age between 1 and 17 years old, approximately balanced by sex and age class. Cementum deposition on the inter-radicular pad increased with age at a constant average rate of 0.26 mm per year, with no significant differences between sexes. Cementum deposition was independent of (i) tooth wear, other than that associated with age, and (ii) enamel and dentine micro-hardness. The results partially supported the hypothesis that the main function of cementum is the repositioning of the tooth to maintain opposing teeth in occlusion. However, teeth that had more wear or males' teeth that had faster rates of tooth wear than those of females did not present the expected higher rates of cementum deposition.	[Perez-Barberia, F. J.; Lopez-Quintanilla, M.; Garcia, A. J.; Gallego, L.; Cappelli, J.; Serrano, M. P.; Landete-Castillejos, T.] Univ Castilla La Mancha, Game & Livestock Resources Unit, IDR, IREC, Albacete, Spain; [Perez-Barberia, F. J.] Univ Cordoba, Wildlife Res Unit UIRCP, Cordoba, Spain; [Guinness, F. E.] Univ Cambridge, Large Anim Res Grp, Dept Zool, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidad de Cordoba; University of Cambridge	Perez-Barberia, FJ (corresponding author), Univ Castilla La Mancha, Game & Livestock Resources Unit, IDR, IREC, Albacete, Spain.; Perez-Barberia, FJ (corresponding author), Univ Cordoba, Wildlife Res Unit UIRCP, Cordoba, Spain.	j.perezbarberia@gmail.com	; Perez Barberia, Francisco Javier/M-9847-2017; Garcia Diaz, Andres Jose/A-9162-2012	Perez, Martina/0000-0003-4232-8461; Perez Barberia, Francisco Javier/0000-0001-7513-5418; Landete Castillejos, Tomas/0000-0001-9753-5295; Lopez Quintanilla, Maria/0000-0001-6263-4269; Garcia Diaz, Andres Jose/0000-0002-4662-2185	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana [RTC-20165327-2]; Junta de Comunidades de Castilla-La Mancha [SBPLY/19/180501/000115]; UK Natural Environment Research Council; Scottish Natural Heritage; European Union	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana(Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Natural Heritage; European Union(European Commission)	The study was supported by projects Ministerio de Economi ' a, Industria y Competitividad, Gobierno de Espana RTC-20165327-2 (Dr. T Landete-Castillejos); Junta de Comunidades de Castilla-La Mancha SBPLY/19/180501/000115 (Dr. MP Serrano). The red deer study on the Isle of Rum National Nature Reserve takes place with the support of the UK Natural Environment Research Council and Scottish Natural Heritage. The European Union Lifelong learning programme (Leonardo da Vinci) for supporting the postgraduate students who collaborated in this study.	Arzac A, 2018, DENDROCHRONOLOGIA, V51, P76, DOI 10.1016/j.dendro.2018.08.005; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; BANKS WJ, 1968, ANAT REC, V162, P387, DOI 10.1002/ar.1091620401; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baxter BJ, 1999, ANAT REC, V256, P14, DOI 10.1002/(SICI)1097-0185(19990901)256:1<14::AID-AR3>3.0.CO;2-A; Berkovitz B.K.B., 2017, ORAL ANATOMY HISTOLO, V5th; Bosshardt DD, 1997, PERIODONTOL 2000, V13, P41, DOI 10.1111/j.1600-0757.1997.tb00095.x; BOWYER RT, 1981, J MAMMAL, V62, P574, DOI 10.2307/1380404; Caldwell MW, 2003, J VERTEBR PALEONTOL, V23, P622, DOI 10.1671/0272-4634(2003)023[0622:HOTATI]2.0.CO;2; Carranza J, 2007, AM NAT, V170, P370, DOI 10.1086/519852; Caruso S, 2016, EUR J PAEDIATR DENT, V17, P322; DEAN MC, 1995, INT J OSTEOARCHAEOL, V5, P349, DOI 10.1002/oa.1390050405; Erben R.G., 2003, HDB HISTOLOGY METHOD, P99, DOI 10.1007/978-1-59259-417-7_5; Gaspar-Lopez E, 2010, REPROD DOMEST ANIM, V45, P243, DOI 10.1111/j.1439-0531.2008.01271.x; Gomez S, 2013, BONE, V52, P506, DOI 10.1016/j.bone.2012.09.015; Hastie T., 1986, STAT SCI, V1986, P297, DOI [DOI 10.1214/SS/1177013604, 10.1214/ss/1177013604]; HILLMAN JR, 1973, CALC TISS RES, V12, P323, DOI 10.1007/BF02013745; Hillson S., 1986, TEETH CAMBRIDGE MANU; HIROTANI A, 1989, APPL ANIM BEHAV SCI, V24, P183, DOI 10.1016/0168-1591(89)90066-X; KATO K, 1992, CARIES RES, V26, P418, DOI 10.1159/000261480; KAWASAKI K, 1979, ARCH ORAL BIOL, V24, P939, DOI 10.1016/0003-9969(79)90221-8; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kubo MO, 2013, BIOL J LINN SOC, V110, P384, DOI 10.1111/bij.12128; Kuznetsova A, 2015, PROC CVPR IEEE, P28, DOI 10.1109/CVPR.2015.7298597; LeBlanc AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065351; LIEBERMAN DE, 1994, J ARCHAEOL SCI, V21, P525, DOI 10.1006/jasc.1994.1052; LIEBERMAN DE, 1992, MAMMAL REV, V22, P57, DOI 10.1111/j.1365-2907.1992.tb00120.x; LIEBERMAN DE, 1993, SCIENCE, V261, P1162, DOI 10.1126/science.8356448; Loe LE, 2003, OECOLOGIA, V135, P346, DOI 10.1007/s00442-003-1192-9; Loison A, 2001, WILDLIFE BIOL, V7, P263, DOI 10.2981/wlb.2001.031; Lucas P., 2004, DENT FUNCTIONAL MORP; Luque Sebastian P., 2007, Aquatic Mammals, V33, P241, DOI 10.1578/AM.33.2.2007.241; Margolis HC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00339; MCEWAN EH, 1968, CAN J ZOOLOG, V46, P1023, DOI 10.1139/z68-143; MITCHELL B, 1963, NATURE, V198, P350, DOI 10.1038/198350a0; MITCHELL B, 1967, J ANIM ECOL, V36, P279, DOI 10.2307/2912; Mitchell B., 1977, Ecology of red deer. A research review relevant to their management in Scotland.; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nowak R.M, 1999, WALKERS MAMMALS WORL, V6th; Nussey DH, 2009, AM NAT, V174, P342, DOI 10.1086/603615; Osborn J.W., 1999, COMPANION DENT STUDI, V1; PARKER K L, 1989, Rangifer, V9, P9; Perez-Barberia FJ, 2019, ECOL INDIC, V103, P735, DOI 10.1016/j.ecolind.2019.04.065; Perez-Barberia FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134788; Perez-Barberia FJ, 2015, CAN J ZOOL, V93, P249, DOI 10.1139/cjz-2015-0042; Perez-Barberia FJ, 2015, CAN J ZOOL, V93, P61, DOI 10.1139/cjz-2014-0150; Perez-Barberia FJ, 2014, J ZOOL, V294, P180, DOI 10.1111/jzo.12166; Perez-Barberia FJ, 1998, BIOL J LINN SOC, V63, P233, DOI 10.1111/j.1095-8312.1998.tb01516.x; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; SAXON A, 1968, NATURE, V219, P634, DOI 10.1038/219634a0; SIMS MR, 1980, J PERIODONTAL RES, V15, P638, DOI 10.1111/j.1600-0765.1980.tb00323.x; Smith R.L., 1922, P I MECH ENG, V102, P623, DOI DOI 10.1243/PIME_PROC_1922_102_033_02; Tsuchiya S, 2013, ANAT REC, V296, P1255, DOI 10.1002/ar.22731; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wickham H., 2009, GGPLOT2 ELEGANT GRAP; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	60	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231957	10.1371/journal.pone.0231957	http://dx.doi.org/10.1371/journal.pone.0231957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8WP	32343718	Green Published, gold			2022-12-26	WOS:000536661300022
J	Chernetsov, N; Pakhomov, A; Davydov, A; Cellarius, F; Mouritsen, H				Chernetsov, Nikita; Pakhomov, Alexander; Davydov, Alexander; Cellarius, Fedor; Mouritsen, Henrik			No evidence for the use of magnetic declination for migratory navigation in two songbird species	PLOS ONE			English	Article							EURASIAN REED WARBLERS; COMPASS; ORIENTATION; MAGNETORECEPTION; DISPLACEMENT; MAP	Determining the East-West position was a classical problem in human sea navigation until accurate clocks were manufactured and sailors were able to measure the difference between local time and a fixed reference to determine longitude. Experienced night-migratory songbirds can correct for East-West physical and virtual magnetic displacements to unknown locations. Migratory birds do not appear to possess a time-different clock sense; therefore, they must solve the longitude problem in a different way. We showed earlier that experienced adult (but not juvenile) Eurasian reed warblers (Acrocephalus scirpaceus) can use magnetic declination (the difference in direction between geographic and magnetic North) to solve this problem when they were virtually displaced from Rybachy on the eastern Baltic coast to Scotland. In this study, we aimed to test how general this effect was. Adult and juvenile European robins (Erithacus rubecula) and adult garden warblers (Sylvia borin) under the same experimental conditions did not respond to this virtual magnetic displacement, suggesting significant variation in how navigational maps are organised in different songbird migrants.	[Chernetsov, Nikita; Pakhomov, Alexander; Davydov, Alexander] Zool Inst RAS, Biol Stn Rybachy, St Petersburg, Russia; [Chernetsov, Nikita] St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia; [Cellarius, Fedor] Lomonosov Moscow State Univ, Dept Vertebrate Zool, Moscow, Russia; [Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, AG Neurosensory Sci Anim Nav, Inst Biol & Umweltwissensch, Oldenburg, Germany; [Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Saint Petersburg State University; Lomonosov Moscow State University; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Chernetsov, N (corresponding author), Zool Inst RAS, Biol Stn Rybachy, St Petersburg, Russia.; Chernetsov, N (corresponding author), St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia.	nikita.chernetsov@gmail.com	Davydov, Alexander/AAR-1354-2020; Chernetsov, Nikita/K-7957-2012; Mouritsen, Henrik/A-5401-2010; Pakhomov, Alexander/P-6404-2015	Chernetsov, Nikita/0000-0001-7299-6829; Mouritsen, Henrik/0000-0001-7082-4839; Pakhomov, Alexander/0000-0001-8092-4817; Cellarius, Fedor/0000-0001-6908-997X	Russian Science Foundation [17-14-01147]; Russian Foundation for Basic Research [20-04-01059, 18-04-00265]; Deutsche Forschungsgemeinschaft [SFB 1372]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	N.C. Grant number 17-14-01147 Russian Science Foundation; https://rscf.ru/en/N.C.Grant number 18-04-00265 Russian Foundation for Basic Research; https://www.rfbr.ru/rffi/eng A.P. Grant number 20-04-01059 Russian Foundation for Basic Research; https://www.rfbr.ru/rffi/eng H. M. Grant number SFB 1372 Deutsche Forschungsgemeinschaft; https://www.dfg.de/en/index.jsp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewes W. J. H., 1996, P LONG S HARV U CAMB; [Anonymous], 1992, HDB BIRDS EUROPE MID; Batschelet E, 1981, CIRCULAR STAT BIOL; Bolshakov Casimir V., 2002, Avian Ecology and Behaviour Supplement, V5, P1; Bolshakov Casimir V., 2001, Avian Ecology and Behaviour Supplement, V1, P1; Bostrom JE, 2012, ECOGRAPHY, V35, P1039, DOI 10.1111/j.1600-0587.2012.07507.x; Chernetsov N, 2008, CURR BIOL, V18, P188, DOI 10.1016/j.cub.2008.01.018; Chernetsov N, 2017, CURR BIOL, V27, P2647, DOI 10.1016/j.cub.2017.07.024; Chernetsov N, 2015, J AVIAN BIOL, V46, P342, DOI 10.1111/jav.00593; Chernetsov N, 2011, J EXP BIOL, V214, P2540, DOI 10.1242/jeb.057729; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Cramp S., 1988, BIRDS W PALEARCTIC, V5; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; Holland RA, 2014, J ZOOL, V293, P1, DOI 10.1111/jzo.12107; Kavokin K, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0451; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kishkinev D, 2020, J ORNITHOL, V161, P47, DOI 10.1007/s10336-019-01698-z; Kishkinev D, 2016, SCI REP-UK, V6, DOI 10.1038/srep37326; Kishkinev D, 2015, CURR BIOL, V25, pR822, DOI 10.1016/j.cub.2015.08.012; Kishkinev D, 2010, AUK, V127, P773, DOI 10.1525/auk.2010.10032; Lefeldt N, 2015, J EXP BIOL, V218, P206, DOI 10.1242/jeb.107235; Mora CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072869; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2018, NATURE, V558, P50, DOI 10.1038/s41586-018-0176-1; Pakhomov A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30477-8; Pakhomov A, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0364; Schwarze S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00055; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62	32	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232136	10.1371/journal.pone.0232136	http://dx.doi.org/10.1371/journal.pone.0232136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330188	Green Published, gold			2022-12-26	WOS:000536647300053
J	Ekblom-Bak, E; Stenling, A; Eriksson, JS; Hemmingsson, E; Kallings, LV; Andersson, G; Wallin, P; Ekblom, O; Ekblom, B; Lindwall, M				Ekblom-Bak, Elin; Stenling, Andreas; Eriksson, Jane Salier; Hemmingsson, Erik; Kallings, Lena V.; Andersson, Gunnar; Wallin, Peter; Ekblom, Orjan; Ekblom, Bjorn; Lindwall, Magnus			Latent profile analysis patterns of exercise, sitting and fitness in adults - Associations with metabolic risk factors, perceived health, and perceived symptoms	PLOS ONE			English	Article							MEASURED PHYSICAL-ACTIVITY; MODELS; TIME	Aim To identify and describe the characteristics of naturally occurring patterns of exercise, sitting in leisure time and at work and cardiorespiratory fitness, and the association of such profiles with metabolic risk factors, perceived health, and perceived symptoms. Methods 64,970 participants (42% women, 18-75 years) participating in an occupational health service screening in 2014-2018 were included. Exercise and sitting were self-reported. Cardiorespiratory fitness was estimated using a submaximal cycle test. Latent profile analysis was used to identify profiles. BMI and blood pressure were assessed through physical examination. Perceived back/neck pain, overall stress, global health, and sleeping problems were self-reported. Results Six profiles based on exercise, sitting in leisure time and at work and cardiorespiratory fitness were identified and labelled; Profile 1 "Inactive, low fit and average sitting in leisure, with less sitting at work"; Profile 2 "Inactive, low fit and sedentary"; Profile 3 "Active and average fit, with less sitting at work"; Profile 4 "Active, average fit and sedentary in leisure, with a sedentary work" (the most common profile, 35% of the population); Profile 5 "Active and fit, with a sedentary work"; Profile 6 "Active and fit, with less sitting at work". Some pairwise similarities were found between profiles (1 and 2, 3 and 4, 5 and 6), mainly based on similar levels of exercise, leisure time sitting and fitness, which translated into similar dose-response associations with the outcomes. In general, profile 1 and 2 demonstrated most adverse metabolic and perceived health, profile 4 had a more beneficial health than profile 3, as did profile 6 compared to profile 5. Conclusions The present results implies a large variation in exercise, sitting, and fitness when studying naturally occurring patterns, and emphasize the possibility to target exercise, sitting time, and/or fitness in health enhancing promotion intervention and strategies.	[Ekblom-Bak, Elin; Eriksson, Jane Salier; Hemmingsson, Erik; Kallings, Lena V.; Ekblom, Orjan; Ekblom, Bjorn; Lindwall, Magnus] Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden; [Stenling, Andreas] Umea Univ, Dept Psychol, Umea, Sweden; [Andersson, Gunnar; Wallin, Peter] HPI Hlth Profile Inst, Res Dept, Danderyd, Sweden; [Lindwall, Magnus] Univ Gothenburg, Dept Psychol, Gothenburg, Sweden	Swedish School of Sport & Health Sciences; Umea University; University of Gothenburg	Ekblom-Bak, E (corresponding author), Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden.	eline@gih.se	Ekblom-Bak, Elin/AFR-0681-2022; Kallings, Lena V/ABA-7635-2020	Ekblom-Bak, Elin/0000-0002-3901-7833; Kallings, Lena V/0000-0002-3185-9702; Andersson, Gunnar/0000-0002-2818-779X	Swedish Research Council for Health, Working Life and Welfare [2018-00384]; Swedish Heart-Lung Foundation [20180636]; Swedish Research Council [2017-00273]; HPI Health Profile Institute	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); HPI Health Profile Institute	This work was supported by The Swedish Research Council for Health, Working Life and Welfare https://forte.se/en/(Grant no 2018-00384, grant recieved by author EEB) and The Swedish Heart-Lung Foundation https://www.hjartlungfonden.se/HLF/Om-Hjart-lungfonden/About-HLF/(Grant no 20180636, grant recieved by author EEB). AS is supported by an international postdoc grant from the Swedish Research Council www.vr.se/english.html (Grant no2017-00273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder HPI Health Profile Institute provided support in the form of salaries for authors [GA, PW] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Al-Mallah MH, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0711-4; ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1; Bauer DJ, 2004, PSYCHOL METHODS, V9, P3, DOI 10.1037/1082-989X.9.1.3; Bergman LR, 2010, Z PSYCHOL, V218, P155, DOI 10.1027/0044-3409/a000025; Bjorkman F, 2016, EUR J APPL PHYSIOL, V116, P1627, DOI 10.1007/s00421-016-3412-0; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Du Y, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7597; Ekblom B, 2007, SCAND J MED SCI SPOR, V17, P267, DOI 10.1111/j.1600-0838.2006.00531.x; Ekblom-Bak E, 2018, J PHYS ACT HEALTH, V15, P661, DOI 10.1123/jpah.2017-0083; Ekblom-Bak E, 2019, SCAND J MED SCI SPOR, V29, P232, DOI 10.1111/sms.13328; Evenson KR, 2017, AM J PREV MED, V52, P135, DOI 10.1016/j.amepre.2016.10.033; Gustafsson H, 2018, PSYCHOL SPORT EXERC, V35, P118, DOI 10.1016/j.psychsport.2017.11.009; Hagstromer M, 2015, J SCI MED SPORT, V18, P553, DOI 10.1016/j.jsams.2014.07.012; Hipp JR, 2006, PSYCHOL METHODS, V11, P36, DOI 10.1037/1082-989X.11.1.36; Holtermann A, 2018, BRIT J SPORT MED, V52, P149, DOI 10.1136/bjsports-2017-097965; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Jones SA, 2016, J SCI MED SPORT, V19, P1020, DOI 10.1016/j.jsams.2016.03.009; Kallings LV, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234766; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Lavie CJ, 2015, CIRC RES, V117, P207, DOI 10.1161/CIRCRESAHA.117.305205; Lindwall M, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0464-4; Lubke G, 2007, STRUCT EQU MODELING, V14, P26, DOI 10.1207/s15328007sem1401_2; Marsh HW, 2009, STRUCT EQU MODELING, V16, P191, DOI 10.1080/10705510902751010; McLachlan G., 2000, WILEY SER PROB STAT; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Metzger JS, 2010, AM J HEALTH PROMOT, V24, P161, DOI 10.4278/ajhp.08051151; Mikkola TM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026280; Muthen B., 2010, MPLUS USERS GUIDE; Pastor DA, 2007, CONTEMP EDUC PSYCHOL, V32, P8, DOI 10.1016/j.cedpsych.2006.10.003; Patterson R, 2018, EUR J EPIDEMIOL, V33, P811, DOI 10.1007/s10654-018-0380-1; Peugh JL, 2013, STRUCT EQU MODELING, V20, P314, DOI [10.1080/10705511.2013.769395, 10.1080/10705511.2013.824780]; Pinto D, 2012, VALUE HEALTH, V15, P1, DOI 10.1016/j.jval.2011.09.003; Tein JY, 2013, STRUCT EQU MODELING, V20, P640, DOI 10.1080/10705511.2013.824781; Uebersax J., 2000, BRIEF STUDY LOCAL MA; Vuillemin A, 2012, J SCI MED SPORT, V15, pS1, DOI [10.1016/j.jsams.2012.11.044, DOI 10.1016/J.JSAMS.2012.11.044]	35	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232210	10.1371/journal.pone.0232210	http://dx.doi.org/10.1371/journal.pone.0232210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8RF	32330191	Green Published, Green Submitted, gold			2022-12-26	WOS:000536647300062
J	Randhawa, GS; Soltysiak, MPM; El Roz, H; de Souza, CPE; Hill, KA; Kari, L				Randhawa, Gurjit S.; Soltysiak, Maximillian P. M.; El Roz, Hadi; de Souza, Camila P. E.; Hill, Kathleen A.; Kari, Lila			Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study	PLOS ONE			English	Article							BAT CORONAVIRUS; SARS-LIKE; RNA; VIRUSES; RECOMBINATION; IDENTIFICATION; PNEUMONIA; OUTBREAK; INSIGHTS; ORIGIN	The 2019 novel coronavirus (renamed SARS-CoV-2, and generally referred to as the COVID-19 virus) has spread to 184 countries with over 1.5 million confirmed cases. Such major viral outbreaks demand early elucidation of taxonomic classification and origin of the virus genomic sequence, for strategic planning, containment, and treatment. This paper identifies an intrinsic COVID-19 virus genomic signature and uses it together with a machine learning-based alignment-free approach for an ultra-fast, scalable, and highly accurate classification of whole COVID-19 virus genomes. The proposed method combines supervised machine learning with digital signal processing (MLDSP) for genome analyses, augmented by a decision tree approach to the machine learning component, and a Spearman's rank correlation coefficient analysis for result validation. These tools are used to analyze a large dataset of over 5000 unique viral genomic sequences, totalling 61.8 million bp, including the 29 COVID-19 virus sequences available on January 27, 2020. Our results support a hypothesis of a bat origin and classify the COVID-19 virus as Sarbecovirus, within Betacoronavirus. Our method achieves 100% accurate classification of the COVID-19 virus sequences, and discovers the most relevant relationships among over 5000 viral genomes within a few minutes, ab initio, using raw DNA sequence data alone, and without any specialized biological knowledge, training, gene or genome annotations. This suggests that, for novel viral and pathogen genome sequences, this alignment-free whole-genome machine-learning approach can provide a reliable real-time option for taxonomic classification.	[Randhawa, Gurjit S.] Univ Western Ontario, Dept Comp Sci, London, ON, Canada; [Soltysiak, Maximillian P. M.; El Roz, Hadi; Hill, Kathleen A.] Univ Western Ontario, Dept Biol, London, ON, Canada; [de Souza, Camila P. E.] Univ Western Ontario, Dept Stat & Actuarial Sci, London, ON, Canada; [Kari, Lila] Univ Waterloo, Sch Comp Sci, Waterloo, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Waterloo	Randhawa, GS (corresponding author), Univ Western Ontario, Dept Comp Sci, London, ON, Canada.	grandha8@uwo.ca		Randhawa, Gurjit/0000-0003-1054-125X; El Roz, Hadi/0000-0002-4020-701X; Soltysiak, Maximillian/0000-0001-7495-5203; Hill, Kathleen/0000-0002-7788-5105	NSERC (Natural Science and Engineering Research Council of Canada) [R2824A01, R3511A12]	NSERC (Natural Science and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	LK, R2824A01, NSERC (Natural Science and Engineering Research Council of Canada), https://www.nserc-crsng.gc.ca/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KAH, R3511A12, NSERC (Natural Science and Engineering Research Council of Canada), https://www.nserc-crsng.gc.ca/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaili Abdulaziz N, 2014, mBio, V5, pe00884, DOI 10.1128/mBio.00884-14; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; [Anonymous], 2020, CORONAVIRUS DIS 2019; [Anonymous], 2020, EXP NCOV SPREAD CHIN; [Anonymous], 2020, VIR WEIGH NOV COR CH; [Anonymous], 2020, NCOVS RELATIONSHIP B; [Anonymous], 2020, XINHUANET NEWS; Asuero AG, 2006, CRIT REV ANAL CHEM, V36, P41, DOI 10.1080/10408340500526766; Berkhout B, 2015, VIRUS RES, V202, P41, DOI 10.1016/j.virusres.2014.11.031; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Carneiro RL, 2019, NUCLEIC ACIDS RES, V47, P2216, DOI 10.1093/nar/gkz033; Cavanagh D., 2005, Coronaviruses with special emphasis on first insights concerning SARS, P1, DOI 10.1007/3-7643-7339-3_1; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen Z, 2020, BIORXIV, DOI [10.1101/2020.01.24.919241v3, DOI 10.1101/2020.01.24.919241V3]; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Cui J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16561; DONG N, 2020, GENOMIC PROTEIN STRU, DOI [10.12688/f1000research.22357.1, DOI 10.12688/F1000RESEARCH.22357.1, 10.1101/2020.01.20.913368]; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hayward JA, 2018, MOL BIOL EVOL, V35, P1626, DOI 10.1093/molbev/msy048; Hayward JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-35; He BA, 2014, J VIROL, V88, P7070, DOI 10.1128/JVI.00631-14; Hollander M., 2013, NONPARAMETRIC STAT M, V751, DOI DOI 10.1002/9781119196037; Hu B, 2017, BLOOD, V130; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682; Karamichalis R, 2017, BIOINFORMATICS, V33, P3091, DOI 10.1093/bioinformatics/btx367; Karamichalis R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0655-4; Kari L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119815; Karumathil S, 2018, EVOL BIOINFORM, V14, DOI 10.1177/1176934318761368; Kindler E, 2014, CURR OPIN MICROBIOL, V20, P69, DOI 10.1016/j.mib.2014.05.005; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lacroix A, 2017, INFECT GENET EVOL, V48, P10, DOI 10.1016/j.meegid.2016.11.029; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau Susanna K P, 2012, J Virol, V86, P11906, DOI 10.1128/JVI.01305-12; Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y., 2020, BIORXIV, DOI [10.1101/2020.01.28.922922, 10.1101/2020.01.28.922922v2, DOI 10.1101/2020.01.28.922922]; Liu T, 2020, BIORXIV, DOI [10.1101/2020.01.25.919787v1, DOI 10.1101/2020.01.25.919787V1]; Liu X, 2020, J GENET GENOMICS, V47, P119, DOI 10.1016/j.jgg.2020.02.001; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luk HKH, 2019, INFECT GENET EVOL, V71, P21, DOI 10.1016/j.meegid.2019.03.001; Milewska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24448-2; Nagy PD, 1997, VIROLOGY, V235, P1, DOI 10.1006/viro.1997.8681; Nukoolkarn V, 2008, J THEOR BIOL, V254, P861, DOI 10.1016/j.jtbi.2008.07.030; Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Pyrc K, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-7; Randhawa GS, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5571-y; Rihtaric D, 2010, ARCH VIROL, V155, P507, DOI 10.1007/s00705-010-0612-5; Rowe CL, 1997, J VIROL, V71, P6183, DOI 10.1128/JVI.71.8.6183-6190.1997; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0; Shao P, 2020, BIORXIV, DOI [10.1101/2020.01.28.923169v1, DOI 10.1101/2020.01.28.923169V1]; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Solis-Reyes S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206409; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Vinogradov AE, 2017, MAMM GENOME, V28, P455, DOI 10.1007/s00335-017-9713-8; Wacharapluesadee S, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0289-1; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Wertheim JO, 2013, J VIROL, V87, P7039, DOI 10.1128/JVI.03273-12; Wong ACP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020174; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xu Z., 2020, NELFINAVIR WAS PREDI, DOI [10.1101/2020.01.27.921627, DOI 10.1101/2020.01.27.921627]; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zhao Y., 2020, SINGLE CELL RNA EXPR, DOI 10.1101/2020.01.26.919985; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu H., 2020, HOST INFECTIVITY PRE, DOI 10.1101/2020.01.21.914044; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7	94	157	157	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232391	10.1371/journal.pone.0232391	http://dx.doi.org/10.1371/journal.pone.0232391			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330208	Green Published, gold, Green Submitted			2022-12-26	WOS:000536647300074
J	Rogan, PK; Mucaki, EJ; Lu, RP; Shirley, BC; Waller, E; Knoll, JHM				Rogan, Peter K.; Mucaki, Eliseos J.; Lu, Ruipeng; Shirley, Ben C.; Waller, Edward; Knoll, Joan H. M.			Meeting radiation dosimetry capacity requirements of population-scale exposures by geostatistical sampling	PLOS ONE			English	Article							NUCLEAR	Background Accurate radiation dose estimates are critical for determining eligibility for therapies by timely triaging of exposed individuals after large-scale radiation events. However, the universal assessment of a large population subjected to a nuclear spill incident or detonation is not feasible. Even with high-throughput dosimetry analysis, test volumes far exceed the capacities of first responders to measure radiation exposures directly, or to acquire and process samples for follow-on biodosimetry testing. Aim To significantly reduce data acquisition and processing requirements for triaging of treatment-eligible exposures in population-scale radiation incidents. Methods Physical radiation plumes modelled nuclear detonation scenarios of simulated exposures at 22 US locations. Models assumed only location of the epicenter and historical, prevailing wind directions/speeds. The spatial boundaries of graduated radiation exposures were determined by targeted, multistep geostatistical analysis of small population samples. Initially, locations proximate to these sites were randomly sampled (generally 0.1% of population). Empirical Bayesian kriging established radiation dose contour levels circumscribing these sites. Densification of each plume identified critical locations for additional sampling. After repeated kriging and densification, overlapping grids between each pair of contours of successive plumes were compared based on their diagonal Bray-Curtis distances and root-mean-square deviations, which provided criteria (< 10% difference) to discontinue sampling. Results/Conclusions We modeled 30 scenarios, including 22 urban/high-density and 2 rural/low-density scenarios under various weather conditions. Multiple (3-10) rounds of sampling and kriging were required for the dosimetry maps to converge, requiring between 58 and 347 samples for different scenarios. On average, 70 +/- 10% of locations where populations are expected to receive an exposure >= 2Gy were identified. Under sub-optimal sampling conditions, the number of iterations and samples were increased, and accuracy was reduced. Geostatistical mapping limits the number of required dose assessments, the time required, and radiation exposure to first responders. Geostatistical analysis will expedite triaging of acute radiation exposure in population-scale nuclear events.	[Rogan, Peter K.; Mucaki, Eliseos J.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Rogan, Peter K.; Shirley, Ben C.; Knoll, Joan H. M.] CytoGnomix Inc, London, ON, Canada; [Lu, Ruipeng; Knoll, Joan H. M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada; [Waller, Edward] OntarioTech Univ, Fac Energy Syst & Nucl Sci, Oshawa, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Rogan, PK (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada.; Rogan, PK (corresponding author), CytoGnomix Inc, London, ON, Canada.	progan@uwo.ca	; Rogan, Peter/B-9845-2017	Knoll, Joan/0000-0001-6691-1710; Rogan, Peter/0000-0003-2070-5254	SOSCIP Smart Computing for Innovation Consortium; Natural Sciences and Engineering Research Council of Canada; Ontario Centres of Excellence (Talent Edge Postdoctoral Fellowship Program); CytoGnomix	SOSCIP Smart Computing for Innovation Consortium; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Centres of Excellence (Talent Edge Postdoctoral Fellowship Program); CytoGnomix	We are grateful to the SOSCIP Smart Computing for Innovation Consortium (J.H.M.K., P. K.R.), Natural Sciences and Engineering Research Council of Canada (Engage Program; E.W., P.K.R), Ontario Centres of Excellence (Talent Edge Postdoctoral Fellowship Program; J.H.M.K., P.K. R.), CytoGnomix (P.K.R.) for support of this project. We are grateful to Dr. Ruth C Wilkins (Health Canada) for valuable comments on this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the SOSCIP Smart Computing for Innovation Consortium (J.H.M.K., P.K. R.), Natural Sciences and Engineering Research Council of Canada (Engage Program; E.W., P. K.R), Ontario Centres of Excellence (Talent Edge Postdoctoral Fellowship Program; J.H.M.K., P.K.R.), and CytoGnomix (P.K.R., B.C.S, J.H.M.K) for support. We are grateful to Dr. Ruth C Wilkins (Health Canada) for valuable comments on this manuscript.	Ainsbury EA, 2017, INT J RADIAT BIOL, V93, P127, DOI 10.1080/09553002.2016.1227106; ANNO GH, 1989, HEALTH PHYS, V56, P821, DOI 10.1097/00004032-198906000-00001; [Anonymous], J AM PHY SURG; Bauchinger M., 1984, BIOL DOSIMETRY, P15; Buddemeier BR, 2010, BRIDGE WASH DC, V40, P28; Coleman CN, 2019, DISASTER MED PUBLIC, V13, P995, DOI 10.1017/dmp.2018.163; Coleman CN, 2011, DISASTER MED PUBLIC, V5, pS111, DOI 10.1001/dmp.2011.22; Dainiak N, 2019, RAD PROT DOSIMETRY; Demidenko E, 2009, RADIAT RES, V171, P310, DOI 10.1667/RR1552.1; DiCarlo AL, 2011, DISASTER MED PUBLIC, V5, pS32, DOI 10.1001/dmp.2011.17; Fliedner TM, 2006, CURR OPIN HEMATOL, V13, P436, DOI 10.1097/01.moh.0000245696.77758.e6; Greenacre M., 2014, MULTIVARIATE ANAL EC; Jenness S, 2006, 33 CIFA FAO; Kang Chang-Mo, 2016, Genome Integr, V7, P11, DOI 10.4103/2041-9414.197168; Karam PA, 2017, AM NUCL SOC NUCL CAF; Kearny CH, 1979, NUCL WAR SURVIVAL SK; Krige D., 1951, STAT APPROACH SOME M; Krivoruchko K, 2012, ARCUSER FALL, V6; KUBELKA D, 1992, MUTAT RES, V283, P169, DOI 10.1016/0165-7992(92)90103-O; Leuangthong O, 2008, SOLVED PROBLEMS GEOS, P85; Li Y, 2019, RAD PROT DOSIMETRY; Li YX, 2016, MICROSC RES TECHNIQ, V79, P393, DOI 10.1002/jemt.22642; LLOYD DC, 1986, RADIAT PROT DOSIM, V15, P83, DOI 10.1093/oxfordjournals.rpd.a079681; Lu R., 2019, F1000RESEARCH, V7, P1933, DOI 10.12688/f1000research.17363.2; Maznyk NA, 2012, RADIAT PROT DOSIM, V151, P611, DOI 10.1093/rpd/ncs156; Mickelson AB., 2013, MED CONSEQUENCES RAD; National Council on Radiation Protection and Measurements, 2010, 165 NCRP; Pajic J, 2014, MUTAT RES-GEN TOX EN, V773, P23, DOI 10.1016/j.mrgentox.2014.07.009; Rogan PK, 2016, RADIAT PROT DOSIM, V172, P207, DOI 10.1093/rpd/ncw161; Rogan PK, 2014, RADIAT PROT DOSIM, V159, P95, DOI 10.1093/rpd/ncu133; Rogan PK, 2019, BIORXIV; Rushworth AM, 2015, ENVIRONMETRICS, V26, P327, DOI 10.1002/env.2340; Sales M, 2017, SPAT STAT-NETH, V21, P304, DOI 10.1016/j.spasta.2017.06.003; Shirley B, 2017, JOVE-J VIS EXP, DOI 10.3791/56245; Sichel H.S., 1952, T INS MIN METALL, V61, P261; Simon SL, 2019, RADIAT RES, V191, P297, DOI 10.1667/RR15247.1; Waller E, 2009, HEALTH PHYS, V97, P145, DOI 10.1097/01.HP.0000348464.78396.23; Wilkins RC, 2016, RADIAT PROT DOSIM, V172, P47, DOI 10.1093/rpd/ncw154	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232008	10.1371/journal.pone.0232008	http://dx.doi.org/10.1371/journal.pone.0232008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330192	gold, Green Submitted, Green Published			2022-12-26	WOS:000536647300039
J	Wang, ZJ; Blanco, I; Hayoz, S; Brelidze, TI				Wang, Ze-Jun; Blanco, Ismary; Hayoz, Sebastien; Brelidze, Tinatin I.			The HCN domain is required for HCN channel cell-surface expression and couples voltage- and cAMP-dependent gating mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; TRANSMEMBRANE PROTEINS; PACEMAKER CHANNELS; HYPERPOLARIZATION; ACTIVATION; IDENTIFICATION; MUTATION; DEACTIVATION; DYSFUNCTION; MODULATION	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are major regulators of synaptic plasticity and rhythmic activity in the heart and brain. Opening of HCN channels requires membrane hyperpolarization and is further facilitated by intracellular cyclic nucleotides (cNMPs). In HCN channels, membrane hyperpolarization is sensed by the membrane-spanning voltage sensor domain (VSD), and the cNMP-dependent gating is mediated by the intracellular cyclic nucleotide-binding domain (CNBD) connected to the pore-forming S6 transmembrane segment via the C-linker. Previous functional analysis of HCN channels has suggested a direct or allosteric coupling between the voltage- and cNMP-dependent activation mechanisms. However, the specifics of this coupling remain unclear. The first cryo-EM structure of an HCN1 channel revealed that a novel structural element, dubbed the HCN domain (HCND), forms a direct structural link between the VSD and C-linker-CNBD. In this study, we investigated the functional significance of the HCND. Deletion of the HCND prevented surface expression of HCN2 channels. Based on the HCN1 structure analysis, we identified Arg(237)and Gly(239)residues on the S2 of the VSD that form direct interactions with Ile(135)on the HCND. Disrupting these interactions abolished HCN2 currents. We also identified three residues on the C-linker?CNBD (Glu(478), Gln(482), and His(559)) that form direct interactions with residues Arg(154)and Ser(158)on the HCND. Disrupting these interactions affected both voltage- and cAMP-dependent gating of HCN2 channels. These findings indicate that the HCND is necessary for the cell-surface expression of HCN channels and provides a functional link between voltage- and cAMP-dependent mechanisms of HCN channel gating.	[Wang, Ze-Jun; Hayoz, Sebastien; Brelidze, Tinatin I.] Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20007 USA; [Blanco, Ismary; Brelidze, Tinatin I.] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Hayoz, Sebastien] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Georgetown University; Georgetown University; California Institute of Technology	Brelidze, TI (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20007 USA.; Brelidze, TI (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	tib5@georgetown.edu		Blanco, Ismary/0000-0003-4499-1427; Brelidze, Tinatin/0000-0003-3046-8184	NIGMS, National Institutes of Health [R01GM124020]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM124020 (to T. I. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Cowgill J, 2019, P NATL ACAD SCI USA, V116, P670, DOI 10.1073/pnas.1816724116; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Dai GC, 2019, NAT STRUCT MOL BIOL, V26, P686, DOI 10.1038/s41594-019-0259-1; Dibbens LM, 2010, ANN NEUROL, V67, P542, DOI 10.1002/ana.21909; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Flynn GE, 2018, P NATL ACAD SCI USA, V115, pE8086, DOI 10.1073/pnas.1805596115; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Hummert S, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006045; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kasimova MA, 2019, ELIFE, V8, DOI 10.7554/eLife.53400; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; King BR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r68; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lee CH, 2019, CELL, V179, P1582, DOI 10.1016/j.cell.2019.11.006; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Moller M, 2018, CELL PHYSIOL BIOCHEM, V49, P1238, DOI 10.1159/000493301; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080376; Nava C, 2014, NAT GENET, V46, P640, DOI 10.1038/ng.2952; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Pan Y, 2015, INVEST OPHTH VIS SCI, V56, P3514, DOI 10.1167/iovs.15-16902; Porro A, 2019, ELIFE, V8, DOI 10.7554/eLife.49672; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Shi WM, 1999, CIRC RES, V85, pE1; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Tang B, 2008, NEUROBIOL DIS, V29, P59, DOI 10.1016/j.nbd.2007.08.006; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang ZJ, 2019, BIOPHYS J, V116, p103A, DOI 10.1016/j.bpj.2018.11.592; Wicks NL, 2009, PFLUG ARCH EUR J PHY, V458, P877, DOI 10.1007/s00424-009-0687-6; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	42	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8164	8173		10.1074/jbc.RA120.013281	http://dx.doi.org/10.1074/jbc.RA120.013281			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32341127	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000542965700005
J	Kiatpakdee, B; Sato, K; Otsuka, Y; Arashiki, N; Chen, YQ; Tsumita, T; Otsu, W; Yamamoto, A; Kawata, R; Yamazaki, J; Sugimoto, Y; Takada, K; Mohandas, N; Inaba, M				Kiatpakdee, Benjaporn; Sato, Kota; Otsuka, Yayoi; Arashiki, Nobuto; Chen, Yuqi; Tsumita, Takuya; Otsu, Wataru; Yamamoto, Akito; Kawata, Reo; Yamazaki, Jumpei; Sugimoto, Yoshikazu; Takada, Kensuke; Mohandas, Narla; Inaba, Mutsumi			Cholesterol-binding protein TSPO2 coordinates maturation and proliferation of terminally differentiating erythroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cytokinesis; cell cycle; erythropoiesis; erythrocyte; Na plus; K plus -ATPase; erythroblast; TSPO2	CELL-CYCLE; METHYLTRANSFERASE SETD8; 18 KDA; ERYTHROCYTE; EXPRESSION; APOPTOSIS; MICE; HYPOCHOLESTEROLEMIA; ACCUMULATION; DEGRADATION	TSPO2 (translocator protein 2) is a transmembrane protein specifically expressed in late erythroblasts and has been postulated to mediate intracellular redistribution of cholesterol. We identified TSPO2 as the causative gene for the HK (high-K+) trait with immature red cell phenotypes in dogs and investigated the effects of the TSPO2 defects on erythropoiesis in HK dogs with the TSPO2 mutation and Tspo2 knockout (Tspo2(?/?)) mouse models. Bone marrow?derived erythroblasts from HK dogs showed increased binucleated and apoptotic cells at various stages of maturation and shed large nuclei with incomplete condensation when cultured in the presence of erythropoietin, indicating impaired maturation and cytokinesis. The canine TSPO2 induces cholesterol accumulation in the endoplasmic reticulum and could thereby regulate cholesterol availability by changing intracellular cholesterol distribution in erythroblasts. Tspo2(?/?) mice consistently showed impaired cytokinesis with increased binucleated erythroblasts, resulting in compensated anemia, and their red cell membranes had increased Na,K-ATPase, resembling the HK phenotype in dogs. Tspo2-deficient mouse embryonic stem cell?derived erythroid progenitor (MEDEP) cells exhibited similar morphological defects associated with a cell-cycle arrest at the G(2)/M phase, resulting in decreased cell proliferation and had a depletion in intracellular unesterified and esterified cholesterol. When the terminal maturation was induced, Tspo2(?/?) MEDEP cells showed delays in hemoglobinization; maturation-associated phenotypic changes in CD44, CD71, and TER119 expression; and cell-cycle progression. Taken together, these findings imply that TSPO2 is essential for coordination of maturation and proliferation of erythroblasts during normal erythropoiesis.	[Kiatpakdee, Benjaporn; Sato, Kota; Otsuka, Yayoi; Arashiki, Nobuto; Chen, Yuqi; Tsumita, Takuya; Otsu, Wataru; Yamamoto, Akito; Kawata, Reo; Yamazaki, Jumpei; Takada, Kensuke; Inaba, Mutsumi] Hokkaido Univ, Lab Mol Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Shirakawa, Japan; [Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA; [Sato, Kota] Natl Vet Assay Lab, Tokyo, Japan; [Otsuka, Yayoi] Iwate Univ, Cooperat Dept Vet Med, Fac Agr, Morioka, Iwate, Japan; [Arashiki, Nobuto] Tokyo Womens Med Univ, Dept Biochem, Tokyo, Japan; [Otsu, Wataru] Gifu Pharmaceut Univ, Biomed Res Lab, Gifu, Japan; [Kawata, Reo] Otsuka Pharmaceut Tokushima Res Inst, Tokushima, Japan	Hokkaido University; New York Blood Center; Iwate University; Tokyo Women's Medical University; Gifu Pharmaceutical University	Inaba, M (corresponding author), Hokkaido Univ, Lab Mol Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	inazo@vetmed.hokudai.ac.jp	Arashiki, Nobuto/AAH-6776-2019	Arashiki, Nobuto/0000-0001-5306-9405; Otsu, Wataru/0000-0002-5930-1954	Japan Society for Promotion of Science [19208027, 25282177, 15K14861, 16H05031, 20H03138]; NCI, National Institutes of Health [DK32094]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grants-in-aid for Scientific Research 19208027, 25282177, 15K14861, 16H05031, and 20H03138 from the Japan Society for Promotion of Science (to M. I.). N. M. was supported in part by NCI, National Institutes of Health, Grant DK32094. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; CHAN PC, 1964, BIOCHIM BIOPHYS ACTA, V79, P242; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CIOE L, 1981, CANCER RES, V41, P237; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Fernandez C, 2005, J LIPID RES, V46, P920, DOI 10.1194/jlr.M400407-JLR200; Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029; Gautier EF, 2020, BLOOD ADV, V4, P1464, DOI 10.1182/bloodadvances.2020001652; Gnanapragasam MN, 2016, BLOOD, V128, P1631, DOI 10.1182/blood-2016-03-706671; HANSPAL M, 1987, J CELL BIOL, V105, P1417, DOI 10.1083/jcb.105.3.1417; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; INABA M, 1989, COMP BIOCHEM PHYS B, V92, P151, DOI 10.1016/0305-0491(89)90328-3; INABA M, 1986, J BIOL CHEM, V261, P6099; Inaba M., 2010, SCHALMS VET HEMATOLO, P187; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; Keerthivasan G, 2010, BLOOD, V116, P3331, DOI 10.1182/blood-2010-03-277426; Kettle E, 2015, TRAFFIC, V16, P1174, DOI 10.1111/tra.12328; Komatsu T, 2010, J VET MED SCI, V72, P893, DOI 10.1292/jvms.10-0030; Konstantinidis DG, 2015, BLOOD, V126, P1473, DOI 10.1182/blood-2014-12-616169; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; LAZARIDES E, 1984, CELL, V37, P354, DOI 10.1016/0092-8674(84)90364-7; Liu J, 2013, BLOOD, V121, pE43, DOI 10.1182/blood-2012-09-456079; MAEDE Y, 1985, J BIOL CHEM, V260, P3337; MAEDE Y, 1983, BLOOD, V61, P493; MAEDE Y, 1987, AM J VET RES, V48, P114; Malik J, 2017, CELL REP, V21, P2376, DOI 10.1016/j.celrep.2017.11.011; Malik J, 2015, MOL CELL BIOL, V35, P2059, DOI 10.1128/MCB.01413-14; Marginedas-Freixa I, 2016, SCI REP-UK, V6, DOI 10.1038/srep33516; Marginedas-Freixa I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29885-7; Martinez-Botas J, 1999, FASEB J, V13, P1359, DOI 10.1096/fasebj.13.11.1359; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Minami R, 2003, EXP HEMATOL, V31, P355, DOI 10.1016/S0301-472X(03)00040-7; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Otsu W, 2013, J BIOL CHEM, V288, P18521, DOI 10.1074/jbc.M112.443325; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papayannopoulou T., 2017, HEMATOLOGY BASIC PRI; Peller S, 2003, ONCOGENE, V22, P4648, DOI 10.1038/sj.onc.1206541; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Runz H, 2006, EMBO J, V25, P2953, DOI 10.1038/sj.emboj.7601205; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Shalev H, 2007, AM J HEMATOL, V82, P199, DOI 10.1002/ajh.20804; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; VITOLS S, 1985, LANCET, V2, P1150; Wang CC, 2012, J VET MED SCI, V74, P17, DOI 10.1292/jvms.11-0345; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Zamai L, 2000, BLOOD, V95, P3716; Zhang SY, 2017, HUM MOL GENET, V26, P3823, DOI 10.1093/hmg/ddx269; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001	61	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8048	8063		10.1074/jbc.RA119.011679	http://dx.doi.org/10.1074/jbc.RA119.011679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32358067	Green Published, hybrid			2022-12-26	WOS:000540935400018
J	Bare, DJ; Cherny, VV; DeCoursey, TE; Abukhdeir, AM; Morgan, D				Bare, Dan J.; Cherny, Vladimir V.; DeCoursey, Thomas E.; Abukhdeir, Abde M.; Morgan, Deri			Expression and function of voltage gated proton channels (H(v)1) in MDA-MB-231 cells	PLOS ONE			English	Article							HYDROGEN-ION CURRENTS; ALVEOLAR EPITHELIAL-CELLS; OXIDASE-RELATED PROTON; NADPH OXIDASE; ELECTRON CURRENTS; HUMAN-NEUTROPHILS; HUMAN EOSINOPHILS; HUMAN SPERMATOZOA; STEM-CELLS; PH	Expression of the voltage gated proton channel (H(v)1) as identified by immunocytochemistry has been reported previously in breast cancer tissue. Increased expression of H(V)1 was correlated with poor prognosis and decreased overall and disease-free survival but the mechanism of its involvement in the disease is unknown. Here we present electrophysiological recordings of H(V)1 channel activity, confirming its presence and function in the plasma membrane of a breast cancer cell line, MDA-MB-231. With western blotting we identify significant levels of H(V)1 expression in 3 out of 8 "triple negative" breast cancer cell lines (estrogen, progesterone, and HER2 receptor expression negative). We examine the function of H(V)1 in breast cancer using MDA-MB-231 cells as a model by suppressing the expression of H(V)1 using shRNA (knock-down; KD) and by eliminating H(V)1 using CRISPR/Cas9 gene editing (knock-out; KO). Surprisingly, these two approaches produced incongruous effects. Knock-down of H(V)1 using shRNA resulted in slower cell migration in a scratch assay and a significant reduction in H2O2 release. In contrast, H(V)1 Knock-out cells did not show reduced migration or H2O2 release. H(V)1 KO but not KD cells showed an increased glycolytic rate accompanied by an increase in p-AKT (phospho-AKT, Ser473) activity. The expression of CD171/LCAM-1, an adhesion molecule and prognostic indicator for breast cancer, was reduced in H(V)1 KO cells. When we compared MDA-MB-231 xenograft growth rates in immunocompromised mice, tumors from H(V)1 KO cells grew less than WT in mass, with lower staining for the Ki-67 marker for cell proliferation rate. Therefore, deletion of H(V)1 expression in MDA-MB-231 cells limits tumor growth rate. The limited growth thus appears to be independent of oxidant production by NADPH oxidase molecules and to be mediated by cell adhesion molecules. Although H(V)1 KO and KD affect certain cellular mechanisms differently, both implicate H(V)1-mediated pathways for control of tumor growth in the MDA-MB-231 cell line.	[Bare, Dan J.; Cherny, Vladimir V.; DeCoursey, Thomas E.] Rush Univ, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Abukhdeir, Abde M.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Morgan, Deri] Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, MO USA	Rush University; Rush University; University of Kansas	Morgan, D (corresponding author), Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, MO USA.	dmorgan7@KUMC.edu	DeCoursey, Thomas/A-6820-2009	DeCoursey, Thomas/0000-0002-4263-180X; Morgan, Deri/0000-0002-0795-0485	National Institutes of Health [GM121462, GM126902]; Bears Care; Brian Piccolo Cancer Research Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bears Care; Brian Piccolo Cancer Research Fund	This work was supported by National Institutes of Health Grants GM121462 and GM126902 (to T.E.D.), Bears Care and The Brian Piccolo Cancer Research Fund (DM and AMA).	Andersen AP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0098; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Berger TK, 2017, J PHYSIOL-LONDON, V595, P1533, DOI 10.1113/JP273189; BERNHEIM L, 1993, J PHYSIOL-LONDON, V470, P313, DOI 10.1113/jphysiol.1993.sp019860; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Cherny VV, 2015, J GEN PHYSIOL, V146, P343, DOI 10.1085/jgp.201511456; Cherny VV, 2001, J PHYSIOL-LONDON, V535, P783, DOI 10.1111/j.1469-7793.2001.00783.x; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Ciuffi A, 2008, CURR GENE THER, V8, P419, DOI 10.2174/156652308786848021; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1991, BIOPHYS J, V60, P1243, DOI 10.1016/S0006-3495(91)82158-0; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; EDER C, 1995, PFLUG ARCH EUR J PHY, V430, P526, DOI 10.1007/BF00373889; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 1996, CANCER RES, V56, P5745; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hondares E, 2014, P NATL ACAD SCI USA, V111, P18078, DOI 10.1073/pnas.1411390111; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Karakas B, 2007, CANCER BIOL THER, V6, P1025, DOI 10.4161/cbt.6.7.4202; Khan GN, 2017, ANTICANCER RES, V37, P2343, DOI 10.21873/anticanres.11572; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li YP, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-34; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; MAHAUTSMITH MP, 1989, J EXP BIOL, V145, P455; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morgan D, 2002, J GEN PHYSIOL, V119, P571, DOI 10.1085/jgp.20018544; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Musset B, 2012, J BIOL CHEM, V287, P9376, DOI 10.1074/jbc.M111.314955; Musset B, 2012, AM J PHYSIOL-CELL PH, V302, pC286, DOI 10.1152/ajpcell.00335.2011; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Reshkin SJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0100; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; Smith RY, 2019, HUM REPROD, V34, P1974, DOI 10.1093/humrep/dez178; Son YS, 2011, STEM CELLS, V29, P2094, DOI 10.1002/stem.754; Terraneo N, 2020, CANCERS, V12, DOI 10.3390/cancers12010217; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang YF, 2012, J BIOL CHEM, V287, P13877, DOI 10.1074/jbc.M112.345280; Wang YF, 2011, BIOCHEM BIOPH RES CO, V412, P353, DOI 10.1016/j.bbrc.2011.07.102; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Yu ZR, 2012, INT J BIOCHEM CELL B, V44, P2144, DOI 10.1016/j.biocel.2012.08.022; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365	67	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0227522	10.1371/journal.pone.0227522	http://dx.doi.org/10.1371/journal.pone.0227522			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374759	Green Submitted, gold, Green Published			2022-12-26	WOS:000537283500003
J	Boardman, WSJ; Baker, ML; Boyd, V; Crameri, G; Peck, GR; Reardon, T; Smith, IG; Caraguel, CGB; Prowse, TAA				Boardman, Wayne S. J.; Baker, Michelle L.; Boyd, Victoria; Crameri, Gary; Peck, Grantley R.; Reardon, Terry; Smith, Ian G.; Caraguel, Charles G. B.; Prowse, Thomas A. A.			Seroprevalence of three paramyxoviruses; Hendra virus, Tioman virus, Cedar virus and a rhabdovirus, Australian bat lyssavirus, in a range expanding fruit bat, the Grey-headed flying fox (Pteropus poliocephalus)	PLOS ONE			English	Article							RESERVOIR HOSTS; MENANGLE VIRUS; HENIPAVIRUS; INFECTION; ANTIBODIES; CHIROPTERA; PREVALENCE; MULTIPLE; SEROLOGY; ORIGIN	Habitat-mediated global change is driving shifts in species' distributions which can alter the spatial risks associated with emerging zoonotic pathogens. Many emerging infectious pathogens are transmitted by highly mobile species, including bats, which can act as spill-over hosts for pathogenic viruses. Over three years, we investigated the seroepidemiology of paramyxoviruses and Australian bat lyssavirus in a range-expanding fruit bat, the Grey-headed flying fox (Pteropus poliocephalus), in a new camp in Adelaide, South Australia. Over six, biannual, sampling sessions, we quantified median florescent intensity (MFI) antibody levels for four viruses for a total of 297 individual bats using a multiplex Luminex binding assay. Where appropriate, florescence thresholds were determined using finite mixture modelling to classify bats' serological status. Overall, apparent seroprevalence of antibodies directed at Hendra, Cedar and Tioman virus antigens was 43.2%, 26.6% and 95.7%, respectively. We used hurdle models to explore correlates of seropositivity and antibody levels when seropositive. Increased body condition was significantly associated with Hendra seropositivity (Odds ratio = 3.67; p = 0.002) and Hendra virus levels were significantly higher in pregnant females (p = 0.002). While most bats were seropositive for Tioman virus, antibody levels for this virus were significantly higher in adults (p < 0.001). Unexpectedly, all sera were negative for Australian bat lyssavirus. Temporal variation in antibody levels suggests that antibodies to Hendra virus and Tioman virus may wax and wane on a seasonal basis. These findings suggest a common exposure to Hendra virus and other paramyxoviruses in this flying fox camp in South Australia.	[Boardman, Wayne S. J.; Smith, Ian G.; Caraguel, Charles G. B.] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Baker, Michelle L.; Boyd, Victoria; Crameri, Gary] CSIRO, Australia Anim Hlth Lab, Hlth & Biosecur Business Unit, Geelong, Vic, Australia; [Peck, Grantley R.] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Reardon, Terry] South Australia Museum, Adelaide, SA, Australia; [Smith, Ian G.] Zoos South Australia, Adelaide, SA, Australia; [Prowse, Thomas A. A.] Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); South Australian Museum; University of Adelaide	Boardman, WSJ (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	wayne.boardman@adelaide.edu.au	Caraguel, Charles/P-6631-2019; Baker, Michelle/AAX-9171-2020; Baker, Michelle L/C-9694-2013; Boardman, Wayne/ABE-7528-2020	Caraguel, Charles/0000-0003-0019-4813; Baker, Michelle/0000-0002-7993-9971; Baker, Michelle L/0000-0002-7993-9971; Boardman, Wayne/0000-0002-1746-0682; Smith, Ian G/0000-0003-3813-2917				Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Barr J, 2015, J GEN VIROL, V96, P24, DOI 10.1099/vir.0.068106-0; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Breed AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028816; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Burroughs AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155252; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cameron A, 2015, RISK BASED DIS SURVE; Chua KB, 2001, VIROLOGY, V283, P215, DOI 10.1006/viro.2000.0882; Cox-Witten K, 2019, AUSTR BAT LYSSAVIRUS; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Eby P, 2008, RANKING FEEDING HABI, DOI [10.1371/journal.pone.0067584, DOI 10.1371/JOURNAL.PONE.006758423826322]; Eby Peggy, 1999, Australian Zoologist, V31, P240; Edson D, 2019, EPIDEMIOL INFECT, V147, P1, DOI [10.1017/s0950268819001237, 10.1017/S0950268819001237]; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140670; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Epstein JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067584; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field HE, 2018, ZOONOSES PUBLIC HLTH, V65, P742, DOI 10.1111/zph.12480; Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; Giles JR, 2016, ECOL EVOL, V6, P7230, DOI 10.1002/ece3.2382; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2008, J GEN VIROL, V1, P1927; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hayman DTS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025256; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Horby PW, 2017, INFLUENZA OTHER RESP, V11, P2, DOI 10.1111/irv.12411; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Kessler MK, 2018, ANN NY ACAD SCI, V1429, P78, DOI 10.1111/nyas.13910; Laing E, 2016, INT J INFECT DIS, V53, P108, DOI 10.1016/j.ijid.2016.11.272; McNabb L, 2014, J VIROL METHODS, V200, P22, DOI 10.1016/j.jviromet.2014.01.010; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Parsons JG, 2010, ACTA CHIROPTEROL, V12, P301, DOI 10.3161/150811010X537882; Peel AJ, 2019, EMERG MICROBES INFEC, V8, P1314, DOI 10.1080/22221751.2019.1661217; Peel AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22236-6; Peel AJ, 2013, J VIROL METHODS, V193, P295, DOI 10.1016/j.jviromet.2013.06.030; Peel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030346; Petraityte R, 2009, VIRUS RES, V145, P92, DOI 10.1016/j.virusres.2009.06.013; Philbey AW, 2008, AUST VET J, V86, P449, DOI 10.1111/j.1751-0813.2008.00361.x; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004796; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Prada D, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010046; Rahmadane I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006079; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Schulz JE, 2020, J INFECT DIS, pjiz648, DOI [10.1093/infdis/jiz648, DOI 10.1093/INFDIS/JIZ64832034942]; Sendow I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069544; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Tait J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109810; Threatened Species Scientific Committee, 2001, COMM LIST ADV PTER P; Tidemann CR, 1999, ACTA CHIROPTEROL, V1, P151; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; van der Ree R, 2006, J ZOOL, V268, P177, DOI 10.1111/j.1469-7998.2005.00005.x; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080430; Williams NSG, 2006, AUSTRAL ECOL, V31, P190, DOI 10.1111/j.1442-9993.2006.01590.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wong ACP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020174; Yaiw KC, 2008, J VIROL, V82, P565, DOI 10.1128/JVI.01660-07	63	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232339	10.1371/journal.pone.0232339	http://dx.doi.org/10.1371/journal.pone.0232339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS6OQ	32374743	gold, Green Published			2022-12-26	WOS:000536501300001
J	de Oliveira, RM; da Cunha, FF; da Silva, GH; Andrade, LM; de Morais, CV; Ferreira, PMO; Raimundi, FPG; Freitas, ARD; de Souza, CM; de Oliveira, RA				de Oliveira, Reginaldo Miranda; da Cunha, Fernando Franca; da Silva, Gustavo Henrique; Andrade, Lucas Maltoni; de Morais, Caio Vieira; Oliveira Ferreira, Pedro Mauricio; Gomes Raimundi, Flavio Pereira; de Jesus Freitas, Agnaldo Roberto; de Souza, Caetano Marciano; de Oliveira, Rubens Alves			Evapotranspiration and crop coefficients of Italian zucchini cultivated with recycled paper as mulch	PLOS ONE			English	Article							CUCUMBER CUCUMIS-SATIVUS; WATER-USE EFFICIENCY; DRIP IRRIGATION; PLASTIC MULCH; SOIL; L.; YIELD; PERFORMANCE; EVAPORATION	Recycled paper has the potential to be used as a mulch for vegetable production and can be adopted for the cultivation of Italian zucchini. However, there have been no studies about the water savings or crop coefficient values used in irrigation management in this system; therefore, there is a need for more research. In view of the above, this study aimed to evaluate the effects of recycled paper mulch on evaporation and evapotranspiration in Italian zucchini and to determine the crop coefficients in its developmental stages. The study was carried out in two cultivation cycles conducted at the Lysimetric Station in Vicosa, MG, Brazil. The experiments were installed in a randomized block design with four replicates. Four lysimeter cultivation treatments were applied: without mulch (C); with recycled paper as mulch (CP); with only recycled paper (P); and with Bahia grass (G). Irrigation and drainage measurements were performed daily to calculate the crop and reference evapotranspiration, and thus the crop coefficient (Kc) values. The following characteristics were evaluated: fruit yield, NDVI and water productivity. For the cultivation of Italian zucchini using paper as mulch, Kc values of 0.54, 0.77 and 0.44 and Kcb values of 0.15, 0.45 and 0.18 are recommended for the initial, intermediate and final stages, respectively. NDVI can be used to estimate the Kc values for Italian zucchini. The use of recycled paper as mulch reduces the water consumption of Italian zucchini.	[de Oliveira, Reginaldo Miranda; da Cunha, Fernando Franca; da Silva, Gustavo Henrique; Andrade, Lucas Maltoni; de Oliveira, Rubens Alves] Univ Fed Vicosa, Ctr Agr Sci, Dept Agr Engn, Vicosa, MG, Brazil; [de Morais, Caio Vieira; Oliveira Ferreira, Pedro Mauricio; Gomes Raimundi, Flavio Pereira; de Jesus Freitas, Agnaldo Roberto; de Souza, Caetano Marciano] Univ Fed Vicosa, Ctr Agr Sci, Dept Agron, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	da Cunha, FF (corresponding author), Univ Fed Vicosa, Ctr Agr Sci, Dept Agr Engn, Vicosa, MG, Brazil.	fernando.cunha@ufv.br	Henrique da Silva, Gustavo/GPC-8495-2022; Franca da Cunha, Fernando/M-6713-2016	Henrique da Silva, Gustavo/0000-0002-1046-7646; Franca da Cunha, Fernando/0000-0002-1671-1021; Andrade, Lucas/0000-0003-0715-8989	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq -Brazil [434484/2018-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Capes -Brazil [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq -Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Capes -Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq -Brazil (Project code 434484/2018-0) and Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Capes -Brazil (Finance code 001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alface AB, 2019, REV BRAS ENG AGR AMB, V23, P330, DOI 10.1590/1807-1929/agriambi.v23n5p330-335; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen RG, 2005, J IRRIG DRAIN ENG, V131, P2, DOI 10.1061/(ASCE)0733-9437(2005)131:1(2); [Anonymous], 2018, THESIS; Bernardi ACD, 2014, REV BRAS ENG AGR AMB, V18, P623, DOI 10.1590/S1415-43662014000600009; Biswas SK, 2015, PLANT SOIL ENVIRON, V61, P97, DOI 10.17221/804/2014-PSE; Chakraborty D, 2010, AGR WATER MANAGE, V97, P738, DOI 10.1016/j.agwat.2010.01.006; Chen YS, 2013, ENVIRON EARTH SCI, V70, P239, DOI 10.1007/s12665-012-2119-8; Coolong T, 2010, HORTTECHNOLOGY, V20, P319, DOI 10.21273/HORTTECH.20.2.319; da Silva CA, 2018, LAND USE POLICY, V76, P10, DOI 10.1016/j.landusepol.2018.04.019; Dolezal F, 2018, VAD ZONE J, V17, P1; Esquerdo JCDM, 2011, INT J REMOTE SENS, V32, P3711, DOI 10.1080/01431161003764112; Garcia-Tejero IF, 2018, SCI HORTIC-AMSTERDAM, V231, P233, DOI 10.1016/j.scienta.2017.12.020; Guimaraes CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224264; Haapala T, 2015, AGR FOOD SCI, V24, P52, DOI 10.23986/afsci.47220; Haapala T, 2014, AGR FOOD SCI, V23, P60, DOI 10.23986/afsci.8542; Jabran K, 2015, J AGRON CROP SCI, V201, P389, DOI 10.1111/jac.12099; Kader MA, 2017, SOIL TILL RES, V168, P155, DOI 10.1016/j.still.2017.01.001; Kamble B, 2013, REMOTE SENS-BASEL, V5, P1588, DOI 10.3390/rs5041588; Liu EK, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/091001; Liu XY, 2017, AGR WATER MANAGE, V184, P145, DOI 10.1016/j.agwat.2017.01.017; Mahdavi SM, 2017, CATENA, V151, P34, DOI 10.1016/j.catena.2016.12.010; Moreno MM, 2013, SCI AGR, V70, P250, DOI 10.1590/S0103-90162013000400005; Moorhead JE, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020099; Paris HS, 2016, EUPHYTICA, V208, P415, DOI 10.1007/s10681-015-1605-y; Qin SJ, 2016, AGR WATER MANAGE, V177, P128, DOI 10.1016/j.agwat.2016.06.022; Qin W., 2015, SCI REP, DOI [DOI 10.1038/SREP16210, DOI 10.HTTPS://D0I.0RG/10.1038/SREP16210]; R Development Core Team, 2017, R LANG ENV STAT COMP; Scarpare FV, 2013, REV BRAS FRUTIC, V35, P782, DOI 10.1590/S0100-29452013000300015; Shrestha NK, 2014, AGR WATER MANAGE, V143, P29, DOI 10.1016/j.agwat.2014.05.011; Singh RK, 2009, J IRRIG DRAIN ENG, V135, P597, DOI 10.1061/(ASCE)IR.1943-4774.0000052; Trani P. E., 2014, CALAGEM ADUBACAO ABO; Wortman SE, 2016, HORTTECHNOLOGY, V26, P148, DOI 10.21273/HORTTECH.26.2.148; Yaghi T, 2013, AGR WATER MANAGE, V128, P149, DOI 10.1016/j.agwat.2013.06.002; Yang N, 2015, MATER MANUF PROCESS, V30, P143, DOI 10.1080/10426914.2014.930958; Yavuz D, 2015, SCI HORTIC-AMSTERDAM, V197, P33, DOI 10.1016/j.scienta.2015.11.010; Yuan XL, 2019, AGR FOREST METEOROL, V265, P435, DOI 10.1016/j.agrformet.2018.11.028; Zhao P, 2015, AGR WATER MANAGE, V160, P41, DOI 10.1016/j.agwat.2015.06.026	38	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232554	10.1371/journal.pone.0232554	http://dx.doi.org/10.1371/journal.pone.0232554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374758	Green Published, gold			2022-12-26	WOS:000537283500042
J	Ding, CT				Ding, Changtao			Dynamic performances of a bird-like flapping wing robot under randomly uncertain disturbances	PLOS ONE			English	Article							CHAOS; SYSTEM	The nonlinear dynamics of a bird-like flapping wing robot under randomly uncertain disturbances was studied in this study. The bird-like flapping wing robot was first simplified into a two-rod model with a spring connection. Then, the dynamic model of the robot under randomly uncertain disturbances was established according to the principle of moment equilibrium, and the disturbances were modeled in the form of bounded noise. Next, the energy model of the robot was established. Finally, numerical simulations and experiments were carried out based on the above models. The results show that the robot is more likely to deviate from its normal trajectory when the randomly uncertain disturbances are applied in a chaotic state than in a periodic state. With the increase of the spring stiffness under the randomly uncertain disturbances, the robot has a stronger ability to reject the disturbances. The mass center of the robot is vital to realize stable flights. The greater the amplitude of randomly uncertain disturbances, the more likely it is for the robot to be in a divergent state.	[Ding, Changtao] Zhejiang Ind Polytech Coll, Shaoxing, Zhejiang, Peoples R China		Ding, CT (corresponding author), Zhejiang Ind Polytech Coll, Shaoxing, Zhejiang, Peoples R China.	ctdingzju@yeah.net		Ding, Changtao/0000-0002-5962-2280	Scientific Research Project of Zhejiang Provincial Education Department [Y201941701, Y201839184]; Public Welfare Project of Zhejiang Province [GG20F010005]	Scientific Research Project of Zhejiang Provincial Education Department; Public Welfare Project of Zhejiang Province	This study was supported by the Scientific Research Project of Zhejiang Provincial Education Department (No. Y201941701, No. Y201839184), and the Public Welfare Project of Zhejiang Province (No. GG20F010005).	Altartouri H, 2019, INT J MICRO AIR VEH, V11, DOI 10.1177/1756829319841817; Badrya C., 2019, J AIRCRAFT, P1; Bose C, 2018, J COMPUT NONLIN DYN, V13, DOI 10.1115/1.4038447; Bowen Deng, 2012, 2012 Sixth International Conference on Innovative Mobile and Internet Services in Ubiquitous Computing (IMIS 2012), P237, DOI 10.1109/IMIS.2012.90; Brunton SL, 2013, J FLUID MECH, V724, P203, DOI 10.1017/jfm.2013.163; Chen B, 2018, AUTOMATICA, V98, P159, DOI 10.1016/j.automatica.2018.09.029; Chirarattananon P., 2015, INT C INT ROB SYST; Ding CT, 2018, J ENG TECHNOL SCI, V50, P650, DOI 10.5614/j.eng.technol.sci.2018.50.5.5; Fujikawa T., 2008, INT C ROB BIOM; Fujikawa T., 2009, INT C ROB BIOM; Gan CB, 2014, ACTA MECH SINICA-PRC, V30, P983, DOI 10.1007/s10409-014-0074-1; Gan CB, 2011, J SOUND VIB, V330, P2174, DOI 10.1016/j.jsv.2010.09.025; Gijsman F., 2018, 2018 APPL AER C, P3175; Hase T., 2009, INT C ROB BIOM; Hassene G., 2016, ADV APPL NONLINEAR C; He W, 2018, J SOUND VIB, V423, P472, DOI 10.1016/j.jsv.2017.12.027; Higuera-Chan CG, 2016, APPL MATH OPT, V74, P197, DOI 10.1007/s00245-015-9312-6; Huang Y, 2015, EUR PHYS J-SPEC TOP, V224, P3175, DOI [10.1140/epjst/e2015-50092-0, 10.1140/epjst/e2015-02549-9]; Huang YY, 2016, J FLUID MECH, V804, P531, DOI 10.1017/jfm.2016.535; Huang ZL, 2002, J SOUND VIB, V254, P245, DOI 10.1006/jsvi.2001.4093; Jahanbin Z, 2016, J BRAZ SOC MECH SCI, V38, P133, DOI 10.1007/s40430-015-0350-4; Kajak K. M., 2019, BIOINSPIRATION BIOMI; Khazen N. E., 2014, BIOMEDICAL ROBOTICS; Korayem M. H., 2008, INT C INT ROB APPL; Leng XL, 2007, J SOUND VIB, V299, P621, DOI 10.1016/j.jsv.2006.07.006; Li C., 2017, CHINESE J PHYS, V55; Li Y. F., 2014, ADV MAT RES, V3, P816; Mushage BO, 2017, NONLINEAR DYNAM, V87, P2021, DOI 10.1007/s11071-016-3173-7; Ozaki T, 2018, IEEE ROBOT AUTOM LET, V3, P4217, DOI 10.1109/LRA.2018.2863104; Pohly JA, 2018, FLUIDS, V3, DOI 10.3390/fluids3040081; Pourtakdoust SH, 2012, J SYST DES DYN, V6, P1; Roenby J, 2010, P ROY SOC A-MATH PHY, V466, P1871, DOI 10.1098/rspa.2009.0619; Schwab R, 2019, J VIB ACOUST, V141, DOI 10.1115/1.4044268; Sentis L., 2013, INT C INT ROB SYST; Souza D.D., 2014, PHYS REV A, V90; Stefan H., 2012, 50 AIAA AER SCI M IN; Temurtas F, 2006, ROBOT AUTON SYST, V54, P74, DOI 10.1016/j.robot.2005.09.013; Tuwa PRN, 2018, ISA T, V72, P100, DOI 10.1016/j.isatra.2017.10.003; Wu RH, 2014, NONLINEAR DYNAM, V77, P1209, DOI 10.1007/s11071-014-1371-8; Xu Y, 2017, NEURAL COMPUT APPL, V30, P1, DOI 10.1109/naps.2017.8107385; Yang XL, 2014, PHYSICA A, V393, P617, DOI 10.1016/j.physa.2013.09.021; Zaoui C, 2009, MULTIBODY SYST DYN, V21, P261, DOI 10.1007/s11044-008-9143-1; Zhang WM, 2011, IEEE-ASME T MECH, V16, P1063, DOI 10.1109/TMECH.2010.2073715; Zhang WM, 2011, PHYS LETT A, V375, P2903, DOI 10.1016/j.physleta.2011.06.020; Zhao M., 2012, INT C ROB BIOM; Zhuang Y, 2013, IEEE T INSTRUM MEAS, V62, P438, DOI 10.1109/TIM.2012.2216475	46	3	3	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232202	10.1371/journal.pone.0232202	http://dx.doi.org/10.1371/journal.pone.0232202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369521	gold, Green Published			2022-12-26	WOS:000537280000020
J	Schirmer, A; Chiu, MH; Lo, C; Feng, YJ; Penney, TB				Schirmer, Annett; Chiu, Man Hey; Lo, Clive; Feng, Yen-Ju; Penney, Trevor B.			Angry, old, male - and trustworthy? How expressive and person voice characteristics shape listener trust	PLOS ONE			English	Article							1ST IMPRESSIONS; JUDGING PERSONALITY; PITCH; ATTRACTIVENESS; PERCEPTIONS; JUDGMENTS; EMOTION; BIAS; MEN	This study examined how trustworthiness impressions depend on vocal expressive and person characteristics and how their dependence may be explained by acoustical profiles. Sentences spoken in a range of emotional and conversational expressions by 20 speakers differing in age and sex were presented to 80 age and sex matched listeners who rated speaker trustworthiness. Positive speaker valence but not arousal consistently predicted greater perceived trustworthiness. Additionally, voices from younger as compared with older and female as compared with male speakers were judged more trustworthy. Acoustic analysis highlighted several parameters as relevant for being perceived as trustworthy (i.e., accelerated tempo, low harmonic-to-noise ratio, more shimmer, low fundamental frequency, more jitter, large intensity range) and showed that effects partially overlapped with those for perceived speaker affect, age, but not sex. Specifically, a fast speech rate and a lower harmonic-to-noise ratio differentiated trustworthy from untrustworthy, positive from negative, and younger from older voices. Male and female voices differed in other ways. Together, these results show that a speaker's expressive as well as person characteristics shape trustworthiness impressions and that their effect likely results from a combination of lowlevel perceptual and higher-order conceptual processes.	[Schirmer, Annett; Chiu, Man Hey; Lo, Clive; Penney, Trevor B.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Schirmer, Annett; Penney, Trevor B.] Chinese Univ Hong Kong, Brain & Mind Inst, Shatin, Hong Kong, Peoples R China; [Feng, Yen-Ju] Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan	Chinese University of Hong Kong; Chinese University of Hong Kong; National Taiwan University	Schirmer, A (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.; Schirmer, A (corresponding author), Chinese Univ Hong Kong, Brain & Mind Inst, Shatin, Hong Kong, Peoples R China.	schirmer@cuhk.edu.hk		Schirmer, Annett/0000-0003-1474-2788; Lo, Clive/0000-0001-5382-6170	GRF grant - Hong Kong Research Grants Council [14612318]	GRF grant - Hong Kong Research Grants Council	This research was supported by a GRF grant awarded by the Hong Kong Research Grants Council (https://www.ugc.edu.hk/eng/rgc/) to AS (14612318). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2019, CONTRIB STAT, P75, DOI 10.1007/978-3-030-17519-1_6; Allport GW, 1934, J SOC PSYCHOL, V5, P37, DOI 10.1080/00224545.1934.9921582; [Anonymous], 2013, MESQUITE MODULAR SYS; ARONOVITCH CD, 1976, J SOC PSYCHOL, V99, P207, DOI 10.1080/00224545.1976.9924774; Bailey PE, 2015, PSYCHOL AGING, V30, P977, DOI 10.1037/a0039736; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Banziger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136675; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baus C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36518-6; Becker DV, 2007, J PERS SOC PSYCHOL, V92, P179, DOI 10.1037/0022-3514.92.2.179; Belin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185651; BERRY DS, 1990, J NONVERBAL BEHAV, V14, P141, DOI 10.1007/BF00996223; Bonnefon JF, 2015, TRENDS COGN SCI, V19, P421, DOI 10.1016/j.tics.2015.05.002; Bonnefon JF, 2013, J EXP PSYCHOL GEN, V142, P143, DOI 10.1037/a0028930; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Carstensen LL, 2011, PSYCHOL AGING, V26, P21, DOI 10.1037/a0021285; Christensen R. H. B., 2018, ORDINAL REGRESSION M, V2018, P8; Ciardo F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04746; Costa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172739; Dehqan A, 2012, FOLIA PHONIATR LOGO, V64, P265, DOI 10.1159/000343998; Fant G., 1960, ACOUSTIC THEORY SPEE; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Gill D, 2014, PSYCHOL SCI, V25, P1079, DOI 10.1177/0956797614522274; Gonzalez J, 2004, MED SCI MONITOR, V10, pCR649; Gordon RA, 2004, J APPL SOC PSYCHOL, V34, P468, DOI 10.1111/j.1559-1816.2004.tb02557.x; Hall JA, 2017, J PERS, V85, P583, DOI 10.1111/jopy.12262; Jack RE, 2017, ANNU REV PSYCHOL, V68, P269, DOI 10.1146/annurev-psych-010416-044242; Kiiski HSM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00437; Klofstad CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133779; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Kovacs-Balint Z, 2013, BRIT J PSYCHOL, V104, P563, DOI 10.1111/bjop.12007; KRAMER E, 1964, J SOC PSYCHOL, V62, P247, DOI 10.1080/00224545.1964.9919523; Levine EE, 2018, J PERS SOC PSYCHOL, V115, P468, DOI 10.1037/pspi0000136; Lortie CL, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2016.02.015; Mattarozzi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135529; Mileva M, 2018, J EXP PSYCHOL HUMAN, V44, P128, DOI 10.1037/xhp0000439; Montano KJ, 2017, EVOL HUM BEHAV, V38, P293, DOI 10.1016/j.evolhumbehav.2016.10.010; O'Connor JJM, 2017, EVOL HUM BEHAV, V38, P506, DOI 10.1016/j.evolhumbehav.2017.03.001; O'Connor JJM, 2011, EVOL PSYCHOL-US, V9, P64, DOI 10.1177/147470491100900109; Olivola CY, 2014, TRENDS COGN SCI, V18, P566, DOI 10.1016/j.tics.2014.09.007; Olszanowski M, 2017, COGNITION EMOTION, P1, DOI [DOI 10.1080/02699931.2017.1386622, 10.1080/02699931.2017.1386622]; Over H, 2018, COGNITION, V170, P190, DOI 10.1016/j.cognition.2017.10.002; Palumbo R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01704; Pear T. H., 1931, VOICE PERSONALITY AP; Ponsot E, 2018, P NATL ACAD SCI USA, V115, P3972, DOI 10.1073/pnas.1716090115; Powlishta KK, 2004, DEVELOPMENT OF THE SOCIAL SELF, P103, DOI 10.4324/9780203391099_chapter_4; R Core Team, 2021, R LANGUAGE ENV STAT; Re DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032719; Rhodes MG, 2012, PSYCHOL BULL, V138, P146, DOI 10.1037/a0025750; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SCHERER KR, 1972, J PERS, V40, P191, DOI 10.1111/j.1467-6494.1972.tb00998.x; Schirmer A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229473; Schirmer A, 2019, SOC COGN AFFECT NEUR, V14, P727, DOI 10.1093/scan/nsz044; Schirmer A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210555; Schroeder J, 2017, PSYCHOL SCI, V28, P1745, DOI 10.1177/0956797617713798; SECORD PF, 1960, J SOC PSYCHOL, V52, P329, DOI 10.1080/00224545.1960.9922088; Secord PF., 1958, PERSON PERCEPTION IN, P300; Sen A, 2018, COGNITION EMOTION, V32, P1189, DOI 10.1080/02699931.2017.1393399; Sutherland CAM, 2017, BRIT J PSYCHOL, V108, P397, DOI 10.1111/bjop.12206; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Tognetti A, 2013, EVOL HUM BEHAV, V34, P427, DOI 10.1016/j.evolhumbehav.2013.08.002; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; Tsantani MS, 2016, PERCEPTION, V45, P946, DOI 10.1177/0301006616643675; Walker M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181306; Zebrowitz LA, 2003, PERS SOC PSYCHOL REV, V7, P194, DOI 10.1207/S15327957PSPR0703_01; Zebrowitz LA, 2013, PSYCHOL AGING, V28, P202, DOI 10.1037/a0030927; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990; ZEBROWITZMCARTHUR L, 1989, J NONVERBAL BEHAV, V13, P189, DOI 10.1007/BF00987049	68	1	1	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232431	10.1371/journal.pone.0232431	http://dx.doi.org/10.1371/journal.pone.0232431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365066	Green Published, gold			2022-12-26	WOS:000536959700031
J	Ampofo, AG; Adumatta, AD; Owusu, E; Awuviry-Newton, K				Ampofo, Ama G.; Adumatta, Afia D.; Owusu, Esther; Awuviry-Newton, Kofi			A cross-sectional study of barriers to cervical cancer screening uptake in Ghana: An application of the health belief model	PLOS ONE			English	Article							KNOWLEDGE; BEHAVIOR; WOMEN; INCOME; PERCEPTIONS; ATTITUDES; PROGRAMS; STUDENTS	Background The high incidence (32.9, age-standardized per 100,000) and mortality (23.0, age-standardized per 100,000) of cervical cancer (CC) in Ghana have been largely attributed to low screening uptake (0.8%). Although the low cost (Visual inspection with acetic acid) screening services available at various local health facilities screening uptake is meager. Objective The purpose of the study is to determine the barriers influencing CC screening among women in the Ashanti Region of Ghana using the health belief model. Methods A analytical cross-sectional study design was conducted between January and March 2019 at Kenyase, the Ashanti Region of Ghana. The study employed self-administered questionnaires were used to collect data from 200 women. Descriptive statistics were used to examine the differences in interest and non-interest in participating in CC screening on barriers affecting CC screening. Multivariable logistic regression was used to determine factors affecting CC screening at a significance level of p< 0.05. Results Unemployed women were less likely to have an interest in CC screening than those who were employed (adjustes odds ratio (aOR) = 0.005, 95%CI:0.001-0.041, p = 0.005). Women who were highly educated were 122 times very likely to be interested in CC screening than those with no or low formal education (aOR = 121.915 95%CI: 14.096-1054.469, p< 0.001) and those who were unmarried were less likely to be interested in CC screening than those with those who were married (aOR = 0.124, 95%CI: 0.024-0.647, p = 0.013). Also, perceived threat, perceived benefits, perceived barriers and cues for action showed significant differences with interest in participating in screening with a P-values < 0.003. The association was different for long waiting time, prioritizing early morning and late evening screening which showed no significant difference (P-value > 0.003). Conclusions Married women, unemployed and those with no formal education are less likely to participate in CC screening. The study details significant barriers to cervical cancer screening uptake in Ghana. It is recommended that the Ghana health services should develop appropriate, culturally tailored educational materials to inform individuals with no formal education through health campaigns in schools, churches and communities to enhance CC screening uptake.	[Ampofo, Ama G.; Adumatta, Afia D.; Owusu, Esther] Garden City Univ Coll, Dept Nursing, Kumasi, Ghana; [Ampofo, Ama G.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Hlth Behav, Hlth Behav Res Collaborat, Newcastle, NSW, Australia; [Ampofo, Ama G.] Hunter Med Res Inst, New Lambton Hts, Australia; [Awuviry-Newton, Kofi] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Ampofo, AG (corresponding author), Garden City Univ Coll, Dept Nursing, Kumasi, Ghana.; Ampofo, AG (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Hlth Behav, Hlth Behav Res Collaborat, Newcastle, NSW, Australia.; Ampofo, AG (corresponding author), Hunter Med Res Inst, New Lambton Hts, Australia.	tyzy2009@hotmail.com	Awuviry-Newton, Kofi/AAP-1846-2020	Awuviry-Newton, Kofi/0000-0001-9109-0694; Ampofo, Ama/0000-0003-3730-6313				Abotchie PN, 2009, INT J GYNECOL CANCER, V19, P412, DOI 10.1111/IGC.0b013e3181a1d6de; Adanu R M K, 2010, Ghana Med J, V44, P59; Adegoke O, 2012, J WOMENS HEALTH, V21, P1031, DOI 10.1089/jwh.2011.3385; AKINBAMI A, 2012, AFRICAN J REPROD HLT, V12; Ampofo A.G, PAN AFRICAN MED J; Basu P, 2006, CANCER DETECT PREV, V30, P369, DOI 10.1016/j.cdp.2006.07.004; Binka C, 2016, J CANCER EDUC, V31, P322, DOI 10.1007/s13187-015-0852-x; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L., 2016, SUMMARY REPORT; Chan DNS, 2017, CANCER NURS, V40, pE1, DOI 10.1097/NCC.0000000000000436; Chen G. L., 2005, INT J TROP MED, V1, P7; Chinaka CC, 2013, AFR J CELL PATH, V1, P47; Cochran WG., 1963, SAMPLING TECHNIQUES; Devarapalli P, 2018, INDIAN J CANCER, V55, P318, DOI [10.4103/ijc.IJC_253_18, 10.4103/ijc.ijc_253_18]; Duda RB, 2005, J TROP MED, V1, P1; Ebu N, 2014, INT J WOMENS HLTH, V7, P31; Ebu Nancy Innocentia, 2018, Gynecol Oncol Res Pract, V5, P3, DOI 10.1186/s40661-018-0060-6; Everett T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002834.pub2; Eze JN, 2012, ANN AFR MED, V11, P238, DOI 10.4103/1596-3519.102856; Fort VK, 2011, PATIENT PREFER ADHER, V5, P125, DOI 10.2147/PPA.S17317; Gerald E.I., 2014, J ED POLICY ENTREPRE, V1, P311; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Group IW, 2005, IARC HDB CANC PREVEN, V10; Gu C, 2010, CANCER NURS, V33, P445, DOI 10.1097/NCC.0b013e3181e456dc; Johnson LG, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0718-9; Kahesa C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1093; Kokuro M., 2017, FACTORS AFFECTING UT; Kuie TS, 2009, CERVICAL CANC ELECT; Lim JNW, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12444; McFarland DM, 2016, J NURS SCHOLARSHIP, V48, P490, DOI 10.1111/jnu.12232; Mupepi SC, 2011, J WOMENS HEALTH, V20, P943, DOI 10.1089/jwh.2010.2062; Mutyaba Twaha, 2007, Reprod Health, V4, P4, DOI 10.1186/1742-4755-4-4; Nadarzynski T, 2012, SEX TRANSM INFECT, V88, P400, DOI 10.1136/sextrans-2012-050482; Nartey Y, 2017, J GLOB ONCOL, V3, P782, DOI 10.1200/JGO.2016.005744; Ndikom CM, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-11; Ngugi CW, 2012, HEALTH CARE WOMEN IN, V33, P595, DOI 10.1080/07399332.2011.646367; Nwankwo KC, 2011, EUR J CANCER CARE, V20, P362, DOI 10.1111/j.1365-2354.2009.01175.x; Nwobodo H, 2015, J PUBLIC HEALTH AFR, V6, DOI 10.4081/jphia.2015.484; Olson B, 2016, INT J GYNECOL OBSTET, V134, P239, DOI 10.1016/j.ijgo.2016.03.011; Parkin A, 2002, SIGHTS OF CONTESTATION: LOCALISM, GLOBALISM AND CULTURAL PRODUCTION IN ASIA AND THE PACIFIC, P155; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Schluterman NH, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-4; Seymour-Smith S, 2002, J HEALTH PSYCHOL, V7, P253, DOI 10.1177/1359105302007003220; Teame H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213546; Teng FF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004783; van Ballegooijen M, 2000, EUR J CANCER, V36, P2244, DOI 10.1016/S0959-8049(00)00317-8; White HL, 2012, J PSYCHOSOM OBST GYN, V33, P91, DOI 10.3109/0167482X.2012.656161	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231459	10.1371/journal.pone.0231459	http://dx.doi.org/10.1371/journal.pone.0231459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352983	gold, Green Published			2022-12-26	WOS:000536673200017
J	Cai, R; Mao, NY; Dai, JJ; Xiang, XY; Xu, J; Ma, YW; Li, Z; Han, GY; Yu, DS; Yin, J; Cui, AL; Zhang, Y; Li, H; Yu, PB; Guan, LY; Tian, YL; Sun, LW; Li, Y; Wei, YM; Zhu, Z; Xu, WB				Cai, Ru; Mao, Naiying; Dai, Jingjing; Xiang, Xingyu; Xu, Jing; Ma, Yingwei; Li, Zhong; Han, Guangyue; Yu, Deshan; Yin, Jie; Cui, Aili; Zhang, Yan; Li, Hong; Yu, Pengbo; Guan, Luyuan; Tian, Yuling; Sun, Liwei; Li, Yan; Wei, Yamei; Zhu, Zhen; Xu, Wenbo			Genetic variability of human adenovirus type 7 circulating in mainland China	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; MOLECULAR EPIDEMIOLOGY; OUTBREAK; PNEUMONIA; INFECTIONS; CHILDREN; HADV-7; KOREA; USA	Human adenovirus (HAdV-7) is a highly contagious pathogen that causes severe respiratory illnesses. However, the epidemic patterns and genetic variability of HAdV-7 circulating in mainland China have not been well elucidated. In this study, we used Chinese HAdV sentinel surveillance data obtained from 2012-2015 to investigate the clinical features of 122 HAdV-7-positive cases and performed amplification and sequence determination of three capsid genes (penton base, hexon, and fiber) from 69 isolated viruses covering from seven provinces of China. Additionally, we compared with data from representative sequences of 21 strains covering seven more provinces in China and 32 international HAdV-7 strains obtained from GenBank database to determine the phylogenetic, sequence variations, and molecular evolution of HAdV-7. The results indicated that HAdV-7 infection occurred throughout the year, and a high proportion of severe cases (27 cases, 22.1%) exhibited infantile pneumonia. Moreover, phylogenetic analysis showed that all HAdV-7 strains could be divided into two major evolutionary branches, including subtype 1 and subtype 2, and subtype 3 was also formed according to analysis of the penton base gene. Subtypes 1 and 2 co-circulated in China before 2008, and HAdV-7 strains currently circulating in China belonged to subtype 2, which was also the predominant strain circulating worldwide in recent years. Further sequence variation analysis indicated that three genes of HAdV-7 were relatively stable across time and geographic space, particularly for viruses within subtypes, which shared almost the same variation sites. Owing to continuous outbreaks caused by HAdV-7, resulting in increased illness severity and fatality rates in China, the establishment of a national HAdV surveillance system is urgently needed for the development of effective preventive and infection-control interventions for adenovirus respiratory infections in China.	[Cai, Ru; Dai, Jingjing; Li, Hong; Xu, Wenbo] Anhui Univ Sci & Technol, Med Sch, Huainan City, Anhui, Peoples R China; [Mao, Naiying; Cui, Aili; Zhang, Yan; Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, NHC Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Dai, Jingjing] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Lab Med, Huaian City, Jiangsu, Peoples R China; [Xiang, Xingyu] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Xu, Jing; Yu, Pengbo; Guan, Luyuan] Shaanxi Prov Ctr Dis Control & Prevent, Xian, Shaanxi, Peoples R China; [Ma, Yingwei; Tian, Yuling; Sun, Liwei] Changchun Childrens Hosp, Changchun, Jilin, Peoples R China; [Li, Zhong] Shandong Prov Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Han, Guangyue; Li, Yan; Wei, Yamei] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Yu, Deshan] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Yin, Jie] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Li, Hong] Southwest Med Univ, Affiliated Hosp, Luzhou City, Sichuan, Peoples R China	Anhui University of Science & Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Nanjing Medical University; Southwest Medical University	Xu, WB (corresponding author), Anhui Univ Sci & Technol, Med Sch, Huainan City, Anhui, Peoples R China.; Zhu, Z; Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, NHC Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	zhuzhen76@163.com; wenbo_xu1@aliyun.com	yu, pengbo/GRN-8989-2022	dai, jingjing/0000-0001-8337-7281	Key Technologies R&D Program of the National Ministry of Science [2018ZX10713002, 2017ZX10104001-002, 2018ZX10713001-003]; National Key Research and Development Program [2017YFC1200303]	Key Technologies R&D Program of the National Ministry of Science; National Key Research and Development Program	This work was supported by the Key Technologies R&D Program of the National Ministry of Science with the grant number 2018ZX10713002 (WX), 2017ZX10104001-002 (YZ), and 2018ZX10713001-003 (AC) (http://www.nmp.gov.cn/).In addition, this work was supported by the National Key Research and Development Program grant number 2017YFC1200303 (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasiole DA, 2004, J CLIN MICROBIOL, V42, P1686, DOI 10.1128/JCM.42.4.1686-1693.2004; Chen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121375; Cheng J, 2016, AM J TRANSL RES, V8, P2331; Choi EH, 2005, EMERG INFECT DIS, V11, P649, DOI 10.3201/eid1105.041211; Choi EH, 2006, J CLIN VIROL, V35, P388, DOI 10.1016/j.jcv.2006.01.001; Chroboczek J, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P163; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Erdman DD, 2002, EMERG INFECT DIS, V8, P269, DOI 10.3201/eid0803.010190; FU WY, 1989, CHINESE MED J-PEKING, V102, P857; Fu YX, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3651-2; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064254; Ismail AM, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0004-y; Kajon AE, 2016, EMERG INFECT DIS, V22, P730, DOI 10.3201/eid2204.151403; Killerby ME, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz017; Kim YJ, 2003, J CLIN MICROBIOL, V41, P4594, DOI 10.1128/JCM.41.10.4594-4599.2003; Li QG, 1996, J MED VIROL, V49, P170, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;170::AID-JMV3&gt;3.0.CO;2-1; LI QG, 1986, J VIROL, V60, P331, DOI 10.1128/JVI.60.1.331-335.1986; Lin YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127377; Lu QB, 2014, INFLUENZA OTHER RESP, V8, P302, DOI 10.1111/irv.12232; Mahadevan P, 2010, VIROLOGY, V397, P113, DOI 10.1016/j.virol.2009.10.052; Mao NY, 2019, INFECT GENET EVOL, V76, DOI 10.1016/j.meegid.2019.104035; Noda M, 2002, J CLIN MICROBIOL, V40, P140, DOI 10.1128/JCM.40.1.140-145.2002; Purkayastha A, 2005, VIROLOGY, V332, P114, DOI 10.1016/j.virol.2004.10.041; Qiu SF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13617; Scott MK, 2016, EMERG INFECT DIS, V22, P1044, DOI 10.3201/eid2206.151898; Tang LY, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00182-12; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; Tian XG, 2014, VIRUS GENES, V49, P22, DOI 10.1007/s11262-014-1071-y; Tsou TP, 2012, EMERG INFECT DIS, V18, P1825, DOI 10.3201/eid1811.120629; Wang HP, 2015, INT J CLIN EXP MED, V8, P15011; Wo Y, 2015, ARCH VIROL, V160, P633, DOI 10.1007/s00705-014-2308-8; Yu PB, 2013, MICROBIOL IMMUNOL, V57, P553, DOI 10.1111/1348-0421.12074; Yu ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep37216; Yusof MA, 2012, EMERG INFECT DIS, V18, P852, DOI 10.3201/eid1805.110865; Zhao SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07365	35	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232092	10.1371/journal.pone.0232092	http://dx.doi.org/10.1371/journal.pone.0232092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352995	Green Published, gold			2022-12-26	WOS:000536673200041
J	Avila-Herrera, A; Thissen, J; Urbaniak, C; Be, NA; Smith, DJ; Karouia, F; Mehta, S; Venkateswaran, K; Jaing, C				Avila-Herrera, Aram; Thissen, James; Urbaniak, Camilla; Be, Nicholas A.; Smith, David J.; Karouia, Fathi; Mehta, Satish; Venkateswaran, Kasthuri; Jaing, Crystal			Crewmember microbiome may influence microbial composition of ISS habitable surfaces	PLOS ONE			English	Article							VIRULENCE; DIVERSITY	The International Space Station (ISS) is a complex built environment physically isolated from Earth. Assessing the interplay between the microbial community of the ISS and its crew is important for preventing biomedical and structural complications for long term human spaceflight missions. In this study, we describe one crewmember's microbial profile from body swabs of mouth, nose, ear, skin and saliva that were collected at eight different time points pre-, during and post-flight. Additionally, environmental surface samples from eight different habitable locations in the ISS were collected from two flights. Environmental samples from one flight were collected by the crewmember and samples from the next flight were collected after the crewmember departed. The microbial composition in both environment and crewmember samples was measured using shotgun metagenomic sequencing and processed using the Livermore Metagenomics Analysis Toolkit. Ordination of sample to sample distances showed that of the eight crew body sites analyzed, skin, nostril, and ear samples are more similar in microbial composition to the ISS surfaces than mouth and saliva samples; and that the microbial composition of the crewmember's skin samples are more closely related to the ISS surface samples collected by the crewmember on the same flight than ISS surface samples collected by other crewmembers on different flights. In these collections, species alpha diversity in saliva samples appears to decrease during flight and rebound after returning to Earth. This is the first study to compare the ISS microbiome to a crewmember's microbiome via shotgun metagenomic sequencing. We observed that the microbiome of the surfaces inside the ISS resemble those of the crew's skin. These data support future crew and ISS microbial surveillance efforts and the design of preventive measures to maintain crew habitat onboard spacecraft destined for long term space travel.	[Avila-Herrera, Aram] Lawrence Livermore Natl Lab, Computating Directorate, Livermore, CA 94550 USA; [Thissen, James; Be, Nicholas A.; Jaing, Crystal] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Urbaniak, Camilla; Venkateswaran, Kasthuri] NASA, Jet Prop Lab, Biotechnol & Planetary Protect Grp, Pasadena, CA USA; [Smith, David J.] NASA, Ames Res Ctr, Space Biosci Res Branch, Moffett Field, CA 94035 USA; [Karouia, Fathi] NASA, Ames Res Ctr, KBRwyle, Moffett Field, CA 94035 USA; [Karouia, Fathi] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Mehta, Satish] NASA, Johnson Space Ctr, Wyle Labs, Microbiol Lab, Houston, TX USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California San Francisco; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Jaing, C (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	jaing2@llnl.gov	Urbaniak, Camilla/AAX-4845-2021	Jaing, Crystal/0000-0001-9933-3005; Karouia, Fathi/0000-0002-1142-9684; Thissen, James/0000-0002-4693-5886	NASA Space Biology [80NSSC18K0113]; NASA Space Biology Task Plan [47-700062]; NASA Ames Space Biology program; KBRwyle/FILMSS subcontract; Department of Pharmaceutical Chemistry at the University of California San Francisco, at NASA Ames Research Center [NNA14AB82C]	NASA Space Biology; NASA Space Biology Task Plan; NASA Ames Space Biology program; KBRwyle/FILMSS subcontract; Department of Pharmaceutical Chemistry at the University of California San Francisco, at NASA Ames Research Center	Aram Avila-Herrera, James Thissen, Nicholas A Be, Crystal Jaing were funded by NASA Space Biology under contract #: 80NSSC18K0113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Camilla Urbaniak and Kasthuri Venkateswaran were funded by NASA Space Biology Task Plan #47-700062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Satish Mehta were funded by NASA Space Biology under contract #: 80NSSC18K0113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. David J Smith was funded by NASA Ames Space Biology program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fathi Karouia was supported through the KBRwyle/FILMSS subcontract with the Department of Pharmaceutical Chemistry at the University of California San Francisco, #NNA14AB82C, at NASA Ames Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2016, BUILD ENVIRON, V109, P224, DOI 10.1016/j.buildenv.2016.09.001; Afshinnekoo E, 2015, CELL SYST, V1, P97, DOI 10.1016/j.cels.2015.07.006; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Alonso-Echanove J, 2001, J INFECT DIS, V184, P754, DOI 10.1086/323080; Ames SK, 2015, GENOME RES, V25, P1056, DOI 10.1101/gr.184879.114; Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; Anderson M. J., 2017, PERMUTATIONAL MULTIV; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barrila J., 2016, EFFECT SPACEFLIGHT S, P209; Be NA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0292-4; Fajardo-Cavazos P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00999; Fajardo-Cavazos P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.TBS-0020-2014; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Foster Jamie S., 2014, Life-Basel, V4, P250, DOI 10.3390/life4020250; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hospodsky D, 2015, INDOOR AIR, V25, P641, DOI 10.1111/ina.12172; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Kilian M, 2016, BRIT DENT J, V221, P657, DOI 10.1038/sj.bdj.2016.865; Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lindgreen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19233; Mayer T, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0167-0; McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meadow JF, 2015, PEERJ, V3, DOI 10.7717/peerj.1258; Mehta SK, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0015-y; National Academies of Sciences E and Medicine, 2017, MICR BUILT ENV RES A; Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007; Ortiz S, 2019, J ORAL MICROBIOL, V11, DOI 10.1080/20002297.2019.1653124; Palmer RJ, 2014, PERIODONTOL 2000, V64, P20, DOI 10.1111/j.1600-0757.2012.00453.x; Patil S, 2015, J GLOB INFECT DIS, V7, P3, DOI 10.4103/0974-777X.150881; Pei LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043501; Plummer C, 2006, FEMS IMMUNOL MED MIC, V48, P390, DOI 10.1111/j.1574-695X.2006.00161.x; Rooney BV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00016; Sielaff AC, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0666-x; Sielaff AC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01263-16; Singh NK, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0585-2; Taylor PW, 2015, INFECT DRUG RESIST, V8, P249, DOI 10.2147/IDR.S67275; Trinh P, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00235; Upsher JF, 1994, MICROBIOLOGICAL COND; Urbaniak C, 2018, 42 COSPAR SCI ASS; Urbaniak C, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00326-18, 10.1128/genomea.00326-18]; Venkateswaran K, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00680-17; Venkateswaran K, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00021-17; Voorhies AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46303-8; Voorhies AA, 2016, FRONT ASTRON SPACE, V3, DOI 10.3389/fspas.2016.00023; Wang J., 2019, HUMAN ORAL MICROBIOM, DOI [10.1101/732123, DOI 10.1101/732123]; Weiss H, 2019, MICROB ECOL, V77, P87, DOI 10.1007/s00248-018-1191-3; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Wong WC, 2017, ADV ENV MICROBIOLOGY, V4, P3, DOI 10.1007/978-3-319-60616-3_1; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zea L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01598	56	30	30	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231838	10.1371/journal.pone.0231838	http://dx.doi.org/10.1371/journal.pone.0231838			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348348	Green Published, gold, Green Submitted			2022-12-26	WOS:000536668200028
J	de Azevedo, WM; de Oliveira, LFR; Alcantara, MA; Cordeiro, AMTD; Damasceno, KSFDC; de Araujo, NK; de Assis, CF; de Sousa, FC				de Azevedo, Wendell Medeiros; Ribeiro de Oliveira, Larissa Ferreira; Alcantara, Maristela Alves; Tribuzy de Magalhaes Cordeiro, Angela Maria; Florentino da Silva Chaves Damasceno, Karla Suzanne; de Araujo, Nathalia Kelly; de Assis, Cristiane Fernandes; de Sousa Junior, Francisco Caninde			Physicochemical characterization, fatty acid profile, antioxidant activity and antibacterial potential of cacay oil, coconut oil and cacay butter	PLOS ONE			English	Article							VEGETABLE-OILS; CAPACITY; EXTRACTION; MECHANISM; COLD; L.	The Amazon region is rich in genetic resources such as oilseeds which have potentially important local commercial exploitation. Despite its high concentration of bioactive compounds, cacay (Caryodendron orinocense Karst.) oil is poorly investigated and explored. Thus, this study focuses on the physicochemical characterization (moisture, density, and saponification, iodine, and acidity values), fatty acid composition as determined by gas chromatograph mass spectrometry (GC/MS), total phenolic content (TPC), and antioxidant activity (DPPH and ABTS radical scavenging assay) of cacay oil, coconut oil and a coconut/cacay oil blend, also known as cacay butter. The antibacterial activity of cacay oil was additionally evaluated. Our study demonstrated that cacay oil presents a high amount of polyunsaturated fatty acid (PUFA) (58.3%) with an emphasis on linoleic acid and a lower acidity value (2.67 +/- 0.01 cg I-2/g) than butter and coconut oil, indicating a low concentration of free fatty acids. In contrast, cacay butter and coconut oil presented higher saturated fatty acid percentages (69.1% and 78.4%, respectively) and higher saponification values (242.78 and 252.22 mg KOH/g, respectively). The samples showed low moisture and relative density between 912 and 916 kg/m(3). The hydrophilic fraction of cacay oil was highlighted in the quantification of TPC (326.27 +/- 6.79 mg GAE/kg) and antioxidant capacity in vitro by DPPH radical scavenging assay (156.57 +/- 2.25 mu mol TE/g). Cacay oil inhibited the growth of Bacillus cereus (44.99 +/- 7.68%), Enterococcus faecalis (27.76 +/- 0.00%), and Staphylococcus aureus (11.81 +/- 3.75%). At long last, this is the first study reporting the physicochemical characterization and bioactive properties of cacay butter. Coconut oil and cacay butter showed great oxidative stability potential due to higher contents of saturated fatty acids. Moreover, cacay oil presents as an alternative source of raw materials for cosmetic and biotechnology industries due to its high concentration of PUFA and for being a rich source of phenolic compounds.	[de Azevedo, Wendell Medeiros; de Sousa Junior, Francisco Caninde] Univ Fed Rio Grande do Norte, Pharmaceut Sci Grad Program, Natal, RN, Brazil; [Ribeiro de Oliveira, Larissa Ferreira; de Araujo, Nathalia Kelly; de Assis, Cristiane Fernandes; de Sousa Junior, Francisco Caninde] Univ Fed Rio Grande do Norte, Dept Pharm, Natal, RN, Brazil; [Alcantara, Maristela Alves; Tribuzy de Magalhaes Cordeiro, Angela Maria] Univ Fed Paraiba, Food Sci & Technol Grad Program, Joao Pessoa, Paraiba, Brazil; [Florentino da Silva Chaves Damasceno, Karla Suzanne] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal da Paraiba; Universidade Federal do Rio Grande do Norte	de Sousa, FC (corresponding author), Univ Fed Rio Grande do Norte, Pharmaceut Sci Grad Program, Natal, RN, Brazil.; de Sousa, FC (corresponding author), Univ Fed Rio Grande do Norte, Dept Pharm, Natal, RN, Brazil.	fcfarma@yahoo.com.br	Assis, Cristiane Fernandes de/AAY-9213-2021; Azevedo, Wendell/AAP-2952-2020	Assis, Cristiane Fernandes de/0000-0001-7595-5395; Azevedo, Wendell/0000-0001-8707-2493; Araujo, Nathalia/0000-0001-6429-1538	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; CAPES fellowship	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partly financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. WMdA was supported by a CAPES fellowship. Plantus LTDA (Nisia Floresta, Brazil) provided the cacay and coconut oils, and cacay butter utilized to conduct this research. There was no additional external funding received for this study.	Abolle A, 2009, BIOMASS BIOENERG, V33, P1653, DOI 10.1016/j.biombioe.2009.08.008; Adaramola B., 2017, CHEM INT, V3, P1, DOI DOI 10.31221/osf.io/yvpa7; Alcantara MA, 2019, POWDER TECHNOL, V354, P877, DOI 10.1016/j.powtec.2019.06.026; Ali BH, 2003, PHYTOTHER RES, V17, P299, DOI 10.1002/ptr.1309; AOCS, 2003, OFFICIAL METHODS REC; Arranz S, 2008, EUR FOOD RES TECHNOL, V227, P425, DOI 10.1007/s00217-007-0737-2; Baharfar R, 2015, J FOOD SCI TECH MYS, V52, P6777, DOI 10.1007/s13197-015-1752-0; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Ribeiro PPC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183935; Castelo-Branco VN, 2011, REV NUTR, V24, P173, DOI 10.1590/S1415-52732011000100017; Chanioti S, 2017, LWT-FOOD SCI TECHNOL, V79, P178, DOI 10.1016/j.lwt.2017.01.029; Chouhan Sonam, 2017, Medicines (Basel), V4, DOI 10.3390/medicines4030058; Clinical and Laboratory Standards Institute, 2018, METHODS DILUTION ANT, Veleventh; CODEX ALIMENTARIUS COMMISSION, 2003, 331981 CODEX FAOWHO; Condelli N, 2015, FOOD CHEM, V177, P233, DOI 10.1016/j.foodchem.2015.01.001; Correia IMS., 2014, SCI PLENA, V10, P1, DOI [10.34119/bjhrv4n2-056, DOI 10.34119/BJHRV4N2-056]; Cunha MAE, 2012, J SUPERCRIT FLUID, V66, P181, DOI 10.1016/j.supflu.2011.10.021; de Azevedo WM, 2020, PREP BIOCHEM BIOTECH, V50, P689, DOI 10.1080/10826068.2020.1728698; Dorni C, 2018, FOOD CHEM, V238, P9, DOI 10.1016/j.foodchem.2017.05.072; Espin JC, 2000, J AGR FOOD CHEM, V48, P648, DOI 10.1021/jf9908188; Ghani NAA, 2018, FOOD SCI NUTR, V6, P1298, DOI 10.1002/fsn3.671; Gharibi S, 2015, J ESSENT OIL BEAR PL, V18, P1382, DOI 10.1080/0972060X.2014.981600; Hartman L, 1973, Lab Pract, V22, P475; Koolen HHF, 2013, FOOD RES INT, V51, P467, DOI 10.1016/j.foodres.2013.01.039; Koubaa M, 2017, J SCI FOOD AGR, V97, P613, DOI 10.1002/jsfa.7774; Mansor T. S. T., 2012, International Food Research Journal, V19, P837; Meng XX, 2016, J ETHNOPHARMACOL, V194, P698, DOI 10.1016/j.jep.2016.10.050; Oroian M, 2015, FOOD RES INT, V74, P10, DOI 10.1016/j.foodres.2015.04.018; Padilla FC, 1996, FOOD CHEM, V57, P191, DOI 10.1016/0308-8146(95)00108-5; Perez de R. M. N., 1999, International Journal of Cosmetic Science, V21, P151, DOI 10.1046/j.1467-2494.1999.196565.x; Radice M, 2014, J OLEO SCI, V63, P1243, DOI 10.5650/jos.ess14007; Rahim NS, 2017, PHARM BIOL, V55, P825, DOI 10.1080/13880209.2017.1280688; Rohman A, 2021, FOOD REV INT, V37, P46, DOI 10.1080/87559129.2019.1687515; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Seneviratne KN, 2009, FOOD CHEM, V114, P1444, DOI 10.1016/j.foodchem.2008.11.038; Serra JL, 2019, FOOD RES INT, V116, P12, DOI 10.1016/j.foodres.2018.12.028; Shahidi F, 2015, J FUNCT FOODS, V18, P757, DOI 10.1016/j.jff.2015.01.047; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Teh SS, 2013, J FOOD COMPOS ANAL, V30, P26, DOI 10.1016/j.jfca.2013.01.004; Tohidi B, 2017, FOOD CHEM, V220, P153, DOI 10.1016/j.foodchem.2016.09.203; Varma SR, 2019, J TRADIT COMPL MED, V9, P5, DOI 10.1016/j.jtcme.2017.06.012; Vieira JSC, 2018, QUIM NOVA, V41, P10, DOI 10.21577/0100-4042.20170148; Zhang YB, 2016, FOOD CONTROL, V59, P282, DOI 10.1016/j.foodcont.2015.05.032	43	13	14	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232224	10.1371/journal.pone.0232224	http://dx.doi.org/10.1371/journal.pone.0232224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343717	Green Published, gold			2022-12-26	WOS:000536661300043
J	Aggarwal, A; Patel, P; Lewison, G; Ekzayez, A; Coutts, A; Fouad, FM; Shamieh, O; Giacaman, R; Kutluk, T; Khalek, RA; Lawler, M; Boyle, P; Sarfati, D; Sullivan, R				Aggarwal, Ajay; Patel, Preeti; Lewison, Grant; Ekzayez, Abdulkarim; Coutts, Adam; Fouad, Fouad M.; Shamieh, Omar; Giacaman, Rita; Kutluk, Tezer; Khalek, Rima Abdul; Lawler, Mark; Boyle, Peter; Sarfati, Diana; Sullivan, Richard			The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration	PLOS ONE			English	Article							CANCER-RESEARCH; LOW MORTALITY; HEALTH-CARE; ROUTES	Objectives Despite the rising risk factor exposure and non-communicable disease (NCD) mortality across the Middle East and the North African (MENA) region, public health policy responses have been slow and appear discordant with the social, economic and political circumstances in each country. Good health policy and outcomes are intimately linked to a research-active culture, particularly in NCD. In this study we present the results of a comprehensive analysis of NCD research with particular a focus on cancer, diabetes and cardiovascular disease in 10 key countries that represent a spectrum across MENA between 1991 and 2018. Methods The study uses a well validated bibliometric approach to undertake a quantitative analysis of research output in the ten leading countries in biomedical research in the MENA region on the basis of articles and reviews in the Web of Science database. We used filters for each of the three NCDs and biomedical research to identify relevant papers in the WoS. The countries selected for the analyses were based on the volume of research outputs during the period of analysis and stability, included Egypt, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey and the United Arab Emirates. Results A total of 495,108 biomedical papers were found in 12,341 journals for the ten MENA countries (here we consider Turkey in the context of MENA). For all three NCDs, Turkey's output is consistently the highest. Iran has had considerable growth in research output to occupy second place across all three NCDs. It appears that, relative to their wealth (measured by GDP), some MENA countries, particularly Oman, Qatar, Kuwait and the United Arab Emirates, are substantially under-investing in biomedical research. In terms of investment on particular NCDs, we note the relatively greater commitment on cancer research compared with diabetes or cardiovascular disease in most MENA countries, despite cardiovascular disease causing the greatest health-related burden. When considering the citation impact of research outputs, there have been marked rises in citation scores in Qatar, Lebanon, United Arab Emirates and Oman. However, Turkey, which has the largest biomedical research output in the Middle East has the lowest citation scores overall. The level of intra-regional collaboration in NCD research is highly variable. Saudi Arabia and Egypt are the dominant research collaborators across the MENA region. However, Turkey and Iran, which are amongst the leading research-active countries in the area, show little evidence of collaboration. With respect to international collaboration, the United States and United Kingdom are the dominant research partners across the region followed by Germany and France. Conclusion The increase in research activity in NCDs across the MENA region countries during the time period of analysis may signal both an increasing focus on NCDs which reflects general global trends, and greater investment in research in some countries. However, there are several risks to the sustainability of these improvements that have been identified in particular countries within the region. For example, a lack of suitably trained researchers, low political commitment and poor financial support, and minimal international collaboration which is essential for wider global impact.	[Aggarwal, Ajay; Lewison, Grant; Sullivan, Richard] Kings Coll London, Sch Canc Sci, Inst Canc Policy Canc Epidemiol Populat & Global, London, England; [Aggarwal, Ajay] Guys & St Thomas NHS Trust, Dept Clin Oncol, London, England; [Patel, Preeti; Ekzayez, Abdulkarim] Kings Coll London, Dept War Studies, London, England; [Patel, Preeti; Ekzayez, Abdulkarim; Sullivan, Richard] Kings Coll London, Conflict & Hlth Res Grp, London, England; [Coutts, Adam] Univ Cambridge, Dept Sociol, Cambridge, England; [Fouad, Fouad M.; Khalek, Rima Abdul] Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Global Hlth Inst, Beirut, Lebanon; [Shamieh, Omar] King Hussein Canc Ctr, Amman, Jordan; [Giacaman, Rita] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, West Bank, Palestine; [Kutluk, Tezer] Hacettepe Univ, Fac Med, Dept Pediat Oncol, Ankara, Turkey; [Lawler, Mark] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Boyle, Peter] Int Prevent Res Inst, Lyon, France; [Sarfati, Diana] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of Cambridge; American University of Beirut; King Hussein Cancer Center; Birzeit University; Hacettepe University; Queens University Belfast; University of Otago	Aggarwal, A (corresponding author), Kings Coll London, Sch Canc Sci, Inst Canc Policy Canc Epidemiol Populat & Global, London, England.; Aggarwal, A (corresponding author), Guys & St Thomas NHS Trust, Dept Clin Oncol, London, England.	ajay.aggarwal@kcl.ac.uk	Abdul-Khalek, Rima/ABC-4694-2020	Sullivan, Richard/0000-0002-6435-1825; Patel, Preeti/0000-0003-3875-453X; Abdul-Khalek, Rima A./0000-0001-7082-8098; Aggarwal, Ajay/0000-0001-9645-6659; Ekzayez, Abdulkarim/0000-0002-2104-3363	UK Research and Innovation GCRF RESEARCH FOR HEALTH IN CONFLICT (R4HC-MENA); developing capability, partnerships and research in the Middle and Near East (MENA) [ES/P010962/1]; ESRC [ES/P010962/1] Funding Source: UKRI	UK Research and Innovation GCRF RESEARCH FOR HEALTH IN CONFLICT (R4HC-MENA); developing capability, partnerships and research in the Middle and Near East (MENA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This publication is funded through the UK Research and Innovation GCRF RESEARCH FOR HEALTH IN CONFLICT (R4HC-MENA); developing capability, partnerships and research in the Middle and Near East (MENA) ES/P010962/1.	Aggarwal A, 2018, INT J RADIAT ONCOL, V101, P767, DOI 10.1016/j.ijrobp.2018.03.009; Aggarwal A, 2016, J THORAC ONCOL, V11, P1040, DOI 10.1016/j.jtho.2016.03.010; Akala FA, 2006, LANCET, V367, P961, DOI 10.1016/S0140-6736(06)68402-X; Batniji R, 2014, LANCET, V383, P343, DOI 10.1016/S0140-6736(13)62185-6; Begum M, 2017, DIABETIC MED, V34, P1354, DOI 10.1111/dme.13411; Begum M, 2018, EUR J CANCER, V100, P75, DOI 10.1016/j.ejca.2018.04.017; Begum M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154197; Belter CW, 2015, J MED LIBR ASSOC, V103, P219, DOI 10.3163/1536-5050.103.4.014; Brown R, 2012, LANCET ONCOL, V13, pE501, DOI 10.1016/S1470-2045(12)70461-8; CALDWELL JC, 1986, POPUL DEV REV, V12, P171, DOI 10.2307/1973108; Hajjar RR, 2013, ANN ONCOL, V24, P11, DOI 10.1093/annonc/mdt268; Hillhouse E, 2014, LANCET, V383, P126, DOI 10.1016/S0140-6736(14)60025-8; Horton R, 2013, LANCET, V381, P509, DOI 10.1016/S0140-6736(13)60100-2; Huffman MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083440; Joulaei H, 2018, AIDS REV, V20, P83, DOI 10.24875/AIDSRev.M18000020; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kilic B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-373; Krzyzanowska MK, 2011, ANN ONCOL, V22, P10, DOI 10.1093/annonc/mdr420; Kuhn R, 2010, POPUL DEV REV, V36, P655, DOI 10.1111/j.1728-4457.2010.00353.x; Lewison G, 2004, SCIENTOMETRICS, V60, P145, DOI 10.1023/B:SCIE.0000027677.79173.b8; Lewison G, 1999, SCIENTOMETRICS, V46, P529, DOI 10.1007/BF02459609; Lewison G, 2011, DESIDOC J LIB INF TE, V31, P333, DOI 10.14429/djlit.31.5.1189; Mandil A, 2013, INT J EPIDEMIOL, V42, P616, DOI 10.1093/ije/dyt026; Meiro-Lorenzo MVT, 2011, EFFECTIVE RESPONSES; Musaiger AO, 2012, INT J GEN MED, V5, P199, DOI 10.2147/IJGM.S29663; Olcott D, 2010, HIGHER ED MIDDLE E S; Program UND, 2013, WORLD POPULATION PRO; Randeree K, 2012, WORKFORCE NATL GULF; Uhlenberg P., 2009, INT HDB POPULATION A, P277, DOI DOI 10.1007/978-1-4020-8356-3_13; UNESCO, 2016, UNESCO SCI REP 2030; Wang HH, 2017, HEALTH SYST REFORM, V3, P7, DOI 10.1080/23288604.2016.1272983; Whitworth JAG, 2008, LANCET, V372, P1590, DOI 10.1016/S0140-6736(08)61660-8; WHO, 2015, WHO GLOB REP TRENDS; World Health Organization, 2011, GLOBAL STATUS REPORT	34	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232077	10.1371/journal.pone.0232077	http://dx.doi.org/10.1371/journal.pone.0232077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8VC	32339197	Green Published, gold			2022-12-26	WOS:000536657400025
J	Qi, YJ; Ma, YZ; Peng, ZQ; Wang, L; Li, LX; Tang, YL; He, JQ; Zheng, JF				Qi, Yijun; Ma, Yuanzhen; Peng, Zhiqiang; Wang, Lei; Li, Lanxin; Tang, Yilan; He, Junqi; Zheng, Junfang			Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation	ONCOGENE			English	Article							COMPETING ENDOGENOUS RNA; ESTROGEN; CANCER; NEPHRECTOMY; HYPOTHESIS; BIOMARKERS; PREDICTS; SURVIVAL; GENE	PDZK1 downregulation was reported to independently predict poor prognosis of clear cell renal cell carcinoma (ccRCC) patients and induce ccRCC development and progression. However, the underlying mechanism of PDZK1 downregulation remains unknown. Competing endogenous RNA (ceRNA) networks are emerging as new players in gene regulation and are associated with cancer development. ceRNAs regulate other RNA transcripts by competing for shared miRNAs. To investigate the role and mechanism of ceRNAs in PDZK1 downregulation and the development of ccRCC, we searched databases for miRNAs and lncRNAs that regulate PDZK1 expression in ccRCC tissues and assessed their effects in ccRCC. We found that miR-15b was expressed at higher levels in ccRCC tissues, and its upregulation was clinically associated with lower PDZK1 level, larger tumor size and shorter survival time of ccRCC patients. Conversely, a novel lncRNA (lncPENG) was expressed at a lower level in ccRCC tissues, and its downregulation was associated with the same effects as upregulation of miR-15b. Downregulation of miR-15b and upregulation of lncPENG resulted in a significant increase in PDZK1 level and inhibition of proliferation in vitro and in vivo. Mechanistically, lncPENG directly bound to miR-15b and effectively functioned as a sponge for miR-15b to modulate the expression of PDZK1. Thus, lncPENG may function as a ceRNA to attenuate miR-15b-dependent PDZK1 downregulation and inhibit cell proliferation, suggesting that it may be clinically valuable as a therapeutic target and a prognostic biomarker of ccRCC.	[Qi, Yijun; Ma, Yuanzhen; Peng, Zhiqiang; Li, Lanxin; Tang, Yilan; He, Junqi; Zheng, Junfang] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing Key Lab Canc Invas & Metastasis Res, Beijing 100069, Peoples R China; [Wang, Lei] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing 100050, Peoples R China	Capital Medical University; Capital Medical University	Zheng, JF (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing Key Lab Canc Invas & Metastasis Res, Beijing 100069, Peoples R China.	zhengjf@ccmu.edu.cn		Zheng, Junfang/0000-0003-4071-4764; He, jq/0000-0002-5921-1297	National Natural Science Foundation of the People's Republic of China [81672521, 81974415, 81372739]; Natural Science Foundation of Beijing [7192021]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by grants from the National Natural Science Foundation of the People's Republic of China (Nos. 81672521, 81974415, 81372739) and the Natural Science Foundation of Beijing (No. 7192021).	Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen Y, 2015, MED SCI MONITOR, V21, P1864, DOI 10.12659/MSM.893082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eggener SE, 2006, J CLIN ONCOL, V24, P3101, DOI 10.1200/JCO.2005.04.8280; Ellinger J, 2015, EXPERT REV MOL DIAGN, V15, P505, DOI 10.1586/14737159.2015.1019477; Flanigan RC, 2004, CLIN CANCER RES, V10, p6335S, DOI 10.1158/1078-0432.CCR-sup-040026; Ghosh MG, 2000, CANCER RES, V60, P6367; Hadoux J, 2010, CLIN MED INSIGHTS-ON, V4, P143, DOI 10.4137/CMO.S4482; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Inoue J, 2004, AM J PATHOL, V165, P71, DOI 10.1016/S0002-9440(10)63276-2; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kim H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0589-7; Kim HY, 2013, MOL MED, V19, P253, DOI 10.2119/molmed.2011.00001; Kocher O, 1998, LAB INVEST, V78, P117; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu CY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.114; Ma YZ, 2019, FREE RADICAL BIO MED, V134, P468, DOI 10.1016/j.freeradbiomed.2019.01.030; Miah S, 2012, BRIT J CANCER, V107, P123, DOI 10.1038/bjc.2012.221; MINASIAN LM, 1993, J CLIN ONCOL, V11, P1368, DOI 10.1200/JCO.1993.11.7.1368; Olejniczak M, 2018, CELL MOL LIFE SCI, V75, P177, DOI 10.1007/s00018-017-2591-0; Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prestin K, 2017, AM J PHYSIOL-RENAL, V313, pF973, DOI 10.1152/ajprenal.00650.2016; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960; Schmitz U, 2016, BRIEF BIOINFORM, V17, P380, DOI 10.1093/bib/bbv061; Tachibana K, 2008, FEBS LETT, V582, P3884, DOI 10.1016/j.febslet.2008.10.027; Tao T, 2017, ONCOGENE, V36, P6119, DOI 10.1038/onc.2017.199; Walker G, 2007, GYNECOL ONCOL, V106, P461, DOI 10.1016/j.ygyno.2007.05.009; Weirauch U, 2013, NEOPLASIA, V15, P783, DOI 10.1593/neo.13172; Wen LZ, 2018, CANCER RES, V78, P4680, DOI 10.1158/0008-5472.CAN-17-3896; Xia T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13445; Xiao HB, 2015, ONCOTARGET, V6, P38005, DOI 10.18632/oncotarget.5357; Yang C, 2016, ONCOTARGET, V7, P13479, DOI 10.18632/oncotarget.7266; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Zhao C, 2016, TUMOR BIOL, V37, P177, DOI 10.1007/s13277-015-4269-2; Zheng JF, 2017, EBIOMEDICINE, V15, P62, DOI 10.1016/j.ebiom.2016.12.003; Zhu HX, 2012, CANCER BIOL THER, V13, P401, DOI 10.4161/cbt.19291	40	18	18	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4404	4420		10.1038/s41388-020-1297-1	http://dx.doi.org/10.1038/s41388-020-1297-1		APR 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32341409				2022-12-26	WOS:000528992700001
J	Woo, BM; Schaller, M				Woo, Brandon M.; Schaller, Mark			"Parental" responses to human infants (and puppy dogs): Evidence that the perception of eyes is especially influential, but eye contact is not	PLOS ONE			English	Article							CARE MOTIVATIONAL SYSTEM; BABY SCHEMA; GAZE; CUTENESS; LOOKING; WINDOWS	The present investigation tests: (i) whether the perception of an human infant's eyes, relative to other facial features, especially strongly elicits "parental" responses (e.g., appraisals of cuteness and vulnerability); (ii) if, so, whether effects of the visual perception of eyes may be partially attributable to eye contact; (iii) whether the perception of non-human animals' (puppy dogs') eyes also especially strongly influence appraisals of their cuteness and vulnerability; and (iv) whether individual differences in caregiving motives moderate effects. Results from 5 experiments (total N = 1458 parents and non-parents) provided empirical evidence to evaluate these hypotheses: Appraisals of human infants were influenced especially strongly by the visual perception of human infants' eyes (compared to other facial features); these effects do not appear to be attributable to eye contact; the visual perception of eyes influenced appraisals of puppy dogs, but not exactly in the same way that it influenced appraisals of human infants; and there was no consistent evidence of moderation by individual differences in caregiving motives. These results make novel contributions to several psychological literatures, including literatures on the motivational psychology of parental care and on person perception.	[Woo, Brandon M.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Schaller, Mark] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Harvard University; University of British Columbia	Woo, BM (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	bmwoo@g.harvard.edu			Social Sciences and Humanities Research Council of Canada [435-2012-0519]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	MS received the Insight Grant #435-2012-0519 from the Social Sciences and Humanities Research Council of Canada (sshrc-crsh.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Amiot CE, 2015, PSYCHOL BULL, V141, P6, DOI 10.1037/a0038147; Archer J, 1997, EVOL HUM BEHAV, V18, P237, DOI 10.1016/S0162-3095(99)80001-4; Axelsson J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2430; Balas B, 2012, PERCEPTION, V41, P361, DOI 10.1068/p7166; Borgi M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00411; Bos PA, 2018, SOC COGN AFFECT NEUR, V13, P1099, DOI 10.1093/scan/nsy080; Bos PA, 2017, DEV PSYCHOPATHOL, V29, P971, DOI 10.1017/S0954579416000973; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Buckels EE, 2015, J PERS SOC PSYCHOL, V108, P497, DOI 10.1037/pspp0000023; Chen FS, 2013, PSYCHOL SCI, V24, P2254, DOI 10.1177/0956797613491968; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Golle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058248; Grossmann T, 2017, PERSPECT PSYCHOL SCI, V12, P107, DOI 10.1177/1745691616654457; Hahn AC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0978; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HILDEBRANDT KA, 1979, INFANT BEHAV DEV, V2, P329, DOI 10.1016/S0163-6383(79)80043-0; Hofer MK, 2018, SOC PSYCHOL PERS SCI, V9, P907, DOI 10.1177/1948550617728994; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; KELLERMAN J, 1989, J RES PERS, V23, P145, DOI 10.1016/0092-6566(89)90020-2; Khalid S, 2016, PERS SOC PSYCHOL B, V42, P1666, DOI 10.1177/0146167216669124; Kim S, 2014, BRAIN RES, V1580, P133, DOI 10.1016/j.brainres.2013.10.050; Kringelbach ML, 2016, TRENDS COGN SCI, V20, P545, DOI 10.1016/j.tics.2016.05.003; Little AC, 2012, ETHOLOGY, V118, P775, DOI 10.1111/j.1439-0310.2012.02068.x; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Macrae CN, 2002, PSYCHOL SCI, V13, P460, DOI 10.1111/1467-9280.00481; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Piazza J, 2018, ANTHROZOOS, V31, P319, DOI 10.1080/08927936.2018.1455456; Rilling JK, 2013, NEUROPSYCHOLOGIA, V51, P731, DOI 10.1016/j.neuropsychologia.2012.12.017; Schaller M, 2018, CURR DIR PSYCHOL SCI, V27, P295, DOI 10.1177/0963721418767873; Sherman GD, 2011, EMOT REV, V3, P245, DOI 10.1177/1754073911402396; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Stoeckel LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107205; Sundelin T, 2013, SLEEP, V36, P1355, DOI 10.5665/sleep.2964; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	41	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232059	10.1371/journal.pone.0232059	http://dx.doi.org/10.1371/journal.pone.0232059			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZB	32374738	Green Published, gold			2022-12-26	WOS:000537283500017
J	La Greca, A; Scarafia, MA; Canas, MCH; Perez, N; Castaneda, S; Colli, C; Mobbs, AM; Velazque, NLS; Neiman, G; Garate, X; Aban, C; Waisman, A; Moro, LN; Sevlever, G; Luzzani, C; Miriuka, SG				La Greca, Alejandro; Agustina Scarafia, Maria; Hernandez Canas, Maria Clara; Perez, Nelba; Castaneda, Sheila; Colli, Carolina; Miqueas Mobbs, Alan; Santin Velazque, Natalia Lucia; Neiman, Gabriel; Garate, Ximena; Aban, Cyntia; Waisman, Ariel; Natalia Moro, Lucoa; Sevlever, Gustavo; Luzzani, Carlos; Gabriel Miriuka, Santiago			PIWI-interacting RNAs are differentially expressed during cardiac differentiation of human pluripotent stem cells	PLOS ONE			English	Article							NONCODING RNAS; PIRNA PATHWAY; BIOGENESIS; HEART; MICRORNAS; PROTEINS; DISEASE	PIWI-interacting RNAs (piRNAs) are a class of non-coding RNAs initially thought to be restricted exclusively to germline cells. In recent years, accumulating evidence has demonstrated that piRNAs are actually expressed in pluripotent, neural, cardiac and even cancer cells. However, controversy remains around the existence and function of somatic piRNAs. Using small RNA-seq samples from H9 pluripotent cells differentiated to mesoderm progenitors and cardiomyocytes we identified the expression of 447 piRNA transcripts, of which 241 were detected in pluripotency, 218 in mesoderm and 171 in cardiac cells. The majority of them originated from the sense strand of protein coding and lncRNAs genes in all stages of differentiation, though no evidences of amplification loop (ping-pong) were found. Genes hosting piRNA transcripts in cardiac samples were related to critical biological processes in the heart, like contraction and cardiac muscle development. Our results indicate that these piRNAs might have a role in fine-tuning the expression of genes involved in differentiation of pluripotent cells to cardiomyocytes.	[La Greca, Alejandro; Agustina Scarafia, Maria; Hernandez Canas, Maria Clara; Perez, Nelba; Castaneda, Sheila; Colli, Carolina; Miqueas Mobbs, Alan; Santin Velazque, Natalia Lucia; Neiman, Gabriel; Garate, Ximena; Aban, Cyntia; Waisman, Ariel; Natalia Moro, Lucoa; Sevlever, Gustavo; Luzzani, Carlos; Gabriel Miriuka, Santiago] Consejo Nacl Invest Cient & Tecn, LIAN, Fleni Inst, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Miriuka, SG (corresponding author), Consejo Nacl Invest Cient & Tecn, LIAN, Fleni Inst, Buenos Aires, DF, Argentina.	smiriuka@fleni.org.ar		Hernandez Canas, Maria Clara/0000-0002-3261-8636; Scarafia, Maria Agustina/0000-0001-9361-6637; Perez, Nelba/0000-0002-8193-4168	National Scientific and Technical Research Council (CONICET) [PIP 11220150100723]; Scientific and Technical Research Fund (FONCyT) [PICT-20151469]	National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Scientific and Technical Research Fund (FONCyT)(FONCyT)	This work was supported by grants (to S. G.M.): from the National Scientific and Technical Research Council (CONICET) PIP 11220150100723, and from the Scientific and Technical Research Fund (FONCyT) PICT-20151469. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cichocki F, 2010, J IMMUNOL, V185, P2009, DOI 10.4049/jimmunol.1000855; Devaux Y, 2015, NAT REV CARDIOL, V12, P415, DOI 10.1038/nrcardio.2015.55; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Espinoza-Lewis RA, 2012, CURR TOP DEV BIOL, V100, P279, DOI 10.1016/B978-0-12-387786-4.00009-9; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Garate X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26156-3; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han YN, 2017, CELL PHYSIOL BIOCHEM, V44, P1, DOI 10.1159/000484541; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kwon C, 2014, BIOCHEM BIOPH RES CO, V446, P218, DOI 10.1016/j.bbrc.2014.02.112; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Leung YY, 2016, NUCLEIC ACIDS RES, V44, pD216, DOI 10.1093/nar/gkv1188; Li QT, 2008, CELL STEM CELL, V2, P195, DOI 10.1016/j.stem.2008.02.008; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Liu Q, 2017, CIRC RES, V121, P376, DOI 10.1161/CIRCRESAHA.116.310456; Liu YJ, 2018, TSINGHUA SCI TECHNOL, V23, P115, DOI 10.26599/TST.2018.9010056; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Ng KW, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0491-9; Ozata DM, 2019, NAT REV GENET, V20, P89, DOI 10.1038/s41576-018-0073-3; Pezic D, 2014, GENE DEV, V28, P1410, DOI 10.1101/gad.240895.114; Phay M, 2018, MOL NEUROBIOL, V55, P483, DOI 10.1007/s12035-016-0340-2; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajan KS, 2014, INT J BIOCHEM CELL B, V55, P153, DOI 10.1016/j.biocel.2014.09.001; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Roy J, 2017, MOL BIOSYST, V13, P565, DOI 10.1039/c6mb00699j; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sato K, 2013, ESSAYS BIOCHEM, V54, P39, DOI [10.1042/bse0540039, 10.1042/BSE0540039]; Sha YT, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/aaf928; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Tosar JP, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0001-7; Uhrig S, 2019, BIOINFORMATICS, V35, P335, DOI 10.1093/bioinformatics/bty578; Vella S, 2016, INT J BIOCHEM CELL B, V76, P1, DOI 10.1016/j.biocel.2016.04.012; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Wang JJ, 2019, NUCLEIC ACIDS RES, V47, pD175, DOI 10.1093/nar/gky1043; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zong XY, 2016, NUCLEIC ACIDS RES, V44, P2898, DOI 10.1093/nar/gkw047	56	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232715	10.1371/journal.pone.0232715	http://dx.doi.org/10.1371/journal.pone.0232715			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369512	Green Published, gold			2022-12-26	WOS:000537280000042
J	Bityutskii, NP; Yakkonen, KL; Lukina, KA; Semenov, KN				Bityutskii, Nikolai P.; Yakkonen, Kirill L.; Lukina, Kseniia A.; Semenov, Konstantin N.			Fullerenol increases effectiveness of foliar iron fertilization in iron-deficient cucumber	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; PLANT; NANOMATERIALS; CHLOROSIS; RESPONSES; SILICON; GROWTH; LEAVES; WATER; C-60	The water-soluble fullerenols are novel carbon-based nanomaterials with unique properties, which afford them with wide agricultural applications. Iron (Fe) deficiency is the most common and widespread nutrition disorder affecting plants. Foliar Fe treatments of plants have been carried out with solutions devoid of fullerenol. In this study, the role of fullerenol [C-60(OH)(22-24)] in alleviation of Fe deficiency in Cucumis sativus (a Strategy I plant) via foliar fertilization was investigated. Cucumber plants were grown hydroponically, either with (Fe) or in Fe-free (- Fe) nutrient solution. The following foliar spray treatments were applied: fullerenol at final concentrations of 1 (F1) and 10 (F10) mg L-1; Fe(II)SO4 center dot 7H(2)O; Fe(II)-EDTA (ethylenediaminetetraacetic acid); and Fe(II)-F1 and Fe(II)-F10. The best used compound was a combination of Fe(II)-sulfate with fullerenol, especially Fe-F1. The addition of fullerenol to Fe(II)-sulfate solutions significantly increased leaf-active Fe (extracted by an Fe(II) chelator) and re-greening at the site of application. The fullerenol-induced mutual influences did not appear when fullerenol was sprayed alone, suggesting a beneficial role of Fe(II)-fullerenol interactions in the penetration of Fe(II) in the leaves and re-greening under Fe-limited conditions. The results are of importance to enhancing the potential of foliar Fe fertilization as the commonly used strategy for ameliorating Fe deficiency and improving crop yield and quality.	[Bityutskii, Nikolai P.; Yakkonen, Kirill L.; Lukina, Kseniia A.] St Petersburg State Univ, Dept Agr Chem, St Petersburg, Russia; [Semenov, Konstantin N.] First Pavlov State Med Univ, Dept Gen & Bioorgan Chem, St Petersburg, Russia	Saint Petersburg State University; Pavlov First Saint Petersburg State Medical University	Bityutskii, NP (corresponding author), St Petersburg State Univ, Dept Agr Chem, St Petersburg, Russia.	n.bityutskii@spbu.ru	Bityutskii, Nikolai/AAH-7268-2021; Yakkonen, Kirill L/H-9689-2013; Lukina, Kseniia/G-8790-2019; Semenov, Konstantin/K-4070-2013	Bityutskii, Nikolai/0000-0001-7348-3793; Yakkonen, Kirill L/0000-0002-9745-1654; Lukina, Kseniia/0000-0001-5477-8684; Semenov, Konstantin/0000-0003-2239-2044	Russian Foundation for Basic Research grant [19-016-00003a]	Russian Foundation for Basic Research grant(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research grant 19-016-00003a to NPB (https://www.rfbr.ru/rffi/ru/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADIA J, 1984, J PLANT NUTR, V7, P777, DOI 10.1080/01904168409363241; Aciksoz SB, 2011, PLANT SOIL, V349, P215, DOI 10.1007/s11104-011-0863-2; Alloway Brian J., 2008, P1, DOI 10.1007/978-1-4020-6860-7_1; Alvarez-Fernandez A, 2004, PLANT SOIL, V263, P5, DOI 10.1023/B:PLSO.0000047717.97167.d4; Alvarez-Fernandez A, 2001, COMMUN SOIL SCI PLAN, V32, P157, DOI 10.1081/CSS-100103000; Alvarez-Fernandez A, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P85, DOI 10.1007/1-4020-4743-6_4; Anderson R, 2005, J AM CHEM SOC, V127, P10458, DOI 10.1021/ja051659d; Balk J, 2014, ANNU REV PLANT BIOL, V65, P125, DOI 10.1146/annurev-arplant-050213-035759; Bityutskii NP, 2017, J PLANT PHYSIOL, V218, P100, DOI 10.1016/j.jplph.2017.08.003; Borisev M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166248; Chen R, 2010, SMALL, V6, P612, DOI 10.1002/smll.200901911; Eichert T, 2002, ACTA HORTIC, P85, DOI 10.17660/ActaHortic.2002.594.6; El-Jendoubi H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00002; Fernandez V, 2005, J PLANT NUTR, V28, P2113, DOI 10.1080/01904160500320954; Fernandez V, 2006, PLANT SOIL, V289, P239, DOI 10.1007/s11104-006-9132-1; Gao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019976; He WL, 2013, FOOD CHEM, V141, P4122, DOI 10.1016/j.foodchem.2013.07.005; HUSEN A, 2014, J NANOBIOTECHNOL, V12, P6, DOI DOI 10.1186/1477-3155-12-16; Jeong J, 2009, PLANT SCI, V176, P709, DOI 10.1016/j.plantsci.2009.02.011; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KATYAL JC, 1980, PLANT SOIL, V55, P105, DOI 10.1007/BF02149714; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Kole C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-37; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Liang CZ, 2018, ENVIRON POLLUT, V235, P330, DOI 10.1016/j.envpol.2017.12.062; Lucena C, 2007, FUNCT PLANT BIOL, V34, P1002, DOI 10.1071/FP07136; Lucena JJ, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P103, DOI 10.1007/1-4020-4743-6_5; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MENGEL K, 1994, PLANT SOIL, V165, P275, DOI 10.1007/BF00008070; Panova GG, 2016, PLANT GROWTH REGUL, V79, P309, DOI 10.1007/s10725-015-0135-x; Pavlovic J, 2013, NEW PHYTOL, V198, P1096, DOI 10.1111/nph.12213; Podolsky NE, 2019, J MOL LIQ, V278, P342, DOI 10.1016/j.molliq.2018.12.148; Robin A, 2008, ADV AGRON, V99, P183, DOI 10.1016/S0065-2113(08)00404-5; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Salahi B, 2017, URBAN FOR URBAN GREE, V21, P175, DOI 10.1016/j.ufug.2016.12.001; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Schmidt W, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P229, DOI 10.1007/1-4020-4743-6_11; Schonherr J, 2005, J AGR FOOD CHEM, V53, P4484, DOI 10.1021/jf050453t; Schonherr J, 2000, PLANTA, V212, P112, DOI 10.1007/s004250000373; Seke M, 2019, J NANOPART RES, V21, DOI 10.1007/s11051-019-4681-4; Semenov KN, The Russian Federation patent for the invention, Patent No. [RU2495821C2, 2495821]; Semenov KN, 2017, PROG SOLID STATE CH, V47-48, P19, DOI 10.1016/j.progsolidstchem.2017.09.001; Semenov KN, 2011, J CHEM ENG DATA, V56, P230, DOI 10.1021/je100755v; Tagliavini M., 1995, Iron nutrition in soils and plants. Proceedings of the seventh international symposium, Zaragoza, Spain, 27 June-2 July 1993., P191; Tiwari DK, 2014, APPL NANOSCI, V4, P577, DOI 10.1007/s13204-013-0236-7; VOSE PB, 1982, J PLANT NUTR, V5, P233, DOI 10.1080/01904168209362954; Wang P, 2016, TRENDS PLANT SCI, V21, P699, DOI 10.1016/j.tplants.2016.04.005; Zaytseva O, 2016, CHEM BIOL TECHNOL AG, V3, DOI 10.1186/s40538-016-0070-8; Zhou P, 2020, CHEM ENG J, V387, DOI 10.1016/j.cej.2020.124126; Zuverza-Mena N, 2017, PLANT PHYSIOL BIOCH, V110, P236, DOI 10.1016/j.plaphy.2016.05.037	50	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232765	10.1371/journal.pone.0232765	http://dx.doi.org/10.1371/journal.pone.0232765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365099	gold, Green Published			2022-12-26	WOS:000536959700059
J	Hoogeweg, C; Kearns, B; Pai, N; Thomas, M; van Wesenbeeck, I; Kirk, A; Baxter, J				Hoogeweg, Cornelis; Kearns, Brian; Pai, Naresh; Thomas, Mark; van Wesenbeeck, Ian; Kirk, Annette; Baxter, Jim		Acetochlor Registration Partnershi	Assessment of acetochlor use areas in the sahel region of Western Africa using geospatial methods	PLOS ONE			English	Article							GROUNDWATER VULNERABILITY; AQUIFER	The goal of this study was to determine the co-occurrence between acetochlor use on crops and potentially vulnerable soils in the Permanent Interstate Committee for Drought Control in the Sahel region of Western Africa. Acetochlor, a pre-emergence herbicide, is used primarily on row crops and has the potential to reach groundwater or surface water following a rain event shortly after application. Off-field transport is often determined by soil properties; therefore, soils within potential use areas were assessed and mapped to establish areas with soils vulnerable to leaching and/or runoff. Corn and cotton production areas were used as surrogate crops for high potential use areas of acetochlor within areas identified using GlobCover land use data and the Spatial Production Allocation Model agricultural statistics data. The geospatial analysis identified approximately 462 million ha of potentially vulnerable soils in the Sahel region of which 65.7 million ha are within agricultural areas. An adjustment for corn and cotton production areas showed that 2.2 million ha or 3.3% of agricultural fields could have potential restrictions for acetochlor use. Approximately 0.159 million ha of soils or 0.24% of agricultural fields are in the presence of shallow groundwater, defined by depth < 9 m. In addition, 0.0128 million ha or 0.02% were determined to be adjacent to surface water bodies. To understand the uncertainty associated with the use of specific land cover datasets, an overlay assessment was conducted using alternative data sources. Overlap between selected land cover datasets in the Sahel region varies and ranges from 24.7% to 75.5% based on a merged 2009 GlobCover and CCI LC datasets. In comparison with the merged 2005 and 2009 GlobCover dataset, the cropland overlaps range from 38.9% to 85.0%. This demonstrates that the choice of land cover dataset can have a significant impact on a spatial assessment. Results from this assessment demonstrate that only a small fraction of vulnerable agricultural soils across the region may be a risk for contamination by acetochlor of groundwater or surface resources, based on product label recommendations. Given the availability of spatial data in a region, the methods contained herein may additionally be used in other localities to provide similar information that can be helpful for water quality management.	[Hoogeweg, Cornelis; Kearns, Brian] Waterborne Environm Inc, Leesburg, VA 20175 USA; [Pai, Naresh; Thomas, Mark; Kirk, Annette] Bayer US, Crop Sci Div, Chesterfield, MO USA; [van Wesenbeeck, Ian; Baxter, Jim] Corteva Agrisci, Indianapolis, IN USA		Hoogeweg, C (corresponding author), Waterborne Environm Inc, Leesburg, VA 20175 USA.	hoogewegg@waterborne-env.com		Hoogeweg, Gerco/0000-0001-5852-602X	Monsanto Company; Dow AgroSciences [4512672972]	Monsanto Company; Dow AgroSciences	The work presented in the article was conducted by Waterborne Environmental, Inc. CH and BK are affiliated with Waterborne Environmental, Inc and received funding in the form of salaries. This study was funded by the Acetochlor Registration Partnership, Monsanto Company and Dow AgroSciences (funding number #4512672972). MT, NP, and AK are affiliated with Bayer and Monsanto, and the study received funding in the form of salaries for the said authors. IW and JB were affiliated with Dow AgroSciences or Corteva Agriscience, and the study received funding in the form of salaries for the said authors. The specific roles of these authors are articulated in the 'author contributions' section. The funders were involved in the decision to publish, review of report and review of the manuscript. They had no role in study design, data collection and analysis.	Ahmed AA, 2009, HYDROGEOL J, V17, P1203, DOI 10.1007/s10040-009-0433-3; Aller L, 1985, EPA600285018; arpinfo.com, 2019, AC REG PARTN NEW ER; Batjes N., 2002, 200202C ISRIC IFPRI; Bicheron P., 2008, GLOBCOVER PRODUCTS D; Bontemps S, 2009, GLOBCOVER2009 PRODUC; Bontemps S., 2011, GLOBCOVER 2009 PRODU; cilss.int, 2018, MAND CILSS; esri.com, 2016, ESRI DAT MAP 10 5; esri.com, 2017, WORLD HYDR MAP; European Space Agency (ESA), 2014, CCI LAND COV PROD US; Fan Y, 2013, SCIENCE, V339, P940, DOI 10.1126/science.1229881; FAO, 1997, AFRICOVER LAND COV C; Fritz S., 2010, INT J REMOTE SENS, V25, P1527; Fritz S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046213; Gad M.I., 2015, ASIAN REV ENV EARTH, V2, P9; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Heydens WF, 2010, HAYES' HANDBOOK OF PESTICIDE TOXICOLOGY, VOLS 1 AND 2, 3RD EDITION, P1753, DOI 10.1016/B978-0-12-374367-1.00082-3; Jarray H, 2017, GEOFIS INT, V56, P157; Joglekar AKB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212281; Jovanovic NZ, 2006, WIT TRANS ECOL ENVIR, V92, P393, DOI 10.2495/WM060421; Kawo NS, 2018, J AFR EARTH SCI, V147, P300, DOI 10.1016/j.jafrearsci.2018.06.034; Koo Jawoo, 2016, F1000Res, V5, P2490; Leenaars J.G.B., 201401 ISRIC; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Mongwe HG, 2004, 30307 WRC; Mongwe HG, 2013, J CHEM INF MODEL, V53, P1689; Monsanto, 2014, WARR HERB SPEC LAB; Musekiwa C, 2013, S AFR J GEOMAT, V2, P152; National Research Council, 1993, GROUND WAT VULN ASS; Newcombe AC, 2005, J ENVIRON QUAL, V34, P1004, DOI 10.2134/jeq2004.0428; Ouedraogo I, 2017, THESIS; Ouedraogo I, 2016, HYDROL EARTH SYST SC, V20, P2353, DOI 10.5194/hess-20-2353-2016; Perez-Hoyos A, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9111118; Robins NS, 2007, J AFR EARTH SCI, V47, P30, DOI 10.1016/j.jafrearsci.2006.10.003; SAAYMAN IC, 2007, 1432107 WRC; Samasse K, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111785; Shi X. Z., 2004, Soil Survey Horizons, V45, P129; State of Minnesota, 2018, MINNESOTA BUFFER LAW; Tan JY, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.085197; Thiuone PBD, 2017, J SCI ENG RES, V4, P247; Tsendbazar NE, 2015, REMOTE SENS-BASEL, V7, P15804, DOI 10.3390/rs71215804; Wei Y., 2018, ISPRS INT ARCH PHOTO, VXLII-3, P1863, DOI [10.5194/isprs-archives-XLII-3-1863-2018, DOI 10.5194/ISPRS-ARCHIVES-XLII-3-1863-2018]; You L., 2017, SPATIAL PRODUCTION A; You LZ, 2014, AGR SYST, V127, P53, DOI 10.1016/j.agsy.2014.01.002	48	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0230990	10.1371/journal.pone.0230990	http://dx.doi.org/10.1371/journal.pone.0230990			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357151	gold, Green Published			2022-12-26	WOS:000536957700005
J	Liang, SY; Wang, CP; Ahmed, F; Yin, XJ; Hu, Y; Mo, JC				Liang, Shiyou; Wang, Chengpan; Ahmed, Farhan; Yin, Xuejie; Hu, Yin; Mo, Jianchu			Exploring the effect of plant substrates on bacterial community structure in termite fungus-combs	PLOS ONE			English	Article							SEQUENCING BATCH REACTOR; LEAF-CUTTING ANTS; H-2 PLUS CO2; GUT MICROBIOTA; NITROGEN-FIXATION; REMOVAL PERFORMANCE; DEGRADING BACTERIA; GROWING TERMITES; SYMBIOTIC FUNGI; RIBOSOMAL-RNA	Fungus-cultivating termites are successful herbivores largely rely on the external symbiotic fungus-combs to decompose plant polysaccharides. The comb harbors both fungi and bacteria. However, the complementary roles and functions of the bacteria are out of the box. To this purpose, we look into different decomposition stages of fungus-combs using high-throughput sequencing of the 16S rRNA gene to examine bacterial community structure. We also explored the bacterial response to physicochemical indexes (such as moisture, ash content and organic matter) and plant substrates (leaves or branches or mix food). Some specific families such as Lachnospiraceae, Ruminococcaceae, and Peptostreptococcaceae may be involved in lignocellulose degradation, whereas Burkholderiaceae may be associated with aromatic compounds degradation. We observed that as the comb mature there is a shift of community composition which may be an adjustment of specific bacteria to deal with different lignocellulosic material. Our results indicated that threshold amount of physicochemical indexes are beneficial for bacterial diversity but too high moisture, low organic matter and high ash content may reduce their diversity. Furthermore, the average highest bacterial diversity was recorded from the comb built by branches followed by mix food and leaves. Besides, this study could help in the use of bacteria from the comb of fungus-cultivating termites in forestry and agricultural residues making them easier to digest as fodder.	[Liang, Shiyou; Wang, Chengpan; Ahmed, Farhan; Yin, Xuejie; Mo, Jianchu] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou, Zhejiang, Peoples R China; [Ahmed, Farhan] Cent Cotton Res Inst Sakrand, Entomol Sect, Shaheed Benazirabad, Sindh, Pakistan; [Hu, Yin] Natl Termite Control Ctr, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University	Mo, JC (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou, Zhejiang, Peoples R China.	mojianchu@zju.edu.cn			National Natural Science Foundation of China [31770686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	JM Grant numbers: 31770686 National Natural Science Foundation of China http://www.nsfc.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, TRENDS PLANT SCI, V10, P594, DOI 10.1016/j.tplants.2005.10.005; Ahasan MS, 2019, ENVIRON MICROBIOL, V21, P2871, DOI 10.1111/1462-2920.14644; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Amoozegar MA, 2013, INT J SYST EVOL MICR, V63, P1562, DOI 10.1099/ijs.0.041236-0; ASTM, 2000, ASTM BOOK STAND, P1, DOI [DOI 10.1520/D0854-14.D854.2458000, 10.1520/E0646-16, DOI 10.1520/E0646-16]; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Azizi A, 2018, J ANIM FEED SCI, V27, P211, DOI 10.22358/jafs/92423/2018; Babic I, 2000, MICROBIOL-UK, V146, P709, DOI 10.1099/00221287-146-3-709; Bakhtiari Alireza Riyahi, 2010, EnvironmentAsia, V3, P13; Bang-Andreasen T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01400; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-78; Benndorf R, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7030083; Birnbaum SSL, 2018, ENTOMOL EXP APPL, V166, P357, DOI 10.1111/eea.12659; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; BUXTON RD, 1981, OECOLOGIA, V51, P379, DOI 10.1007/BF00540909; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; Chen C, 2016, BIOL FERT SOILS, V52, P455, DOI 10.1007/s00374-016-1089-5; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chen K, 2013, ECOTOX ENVIRON SAFE, V98, P361, DOI 10.1016/j.ecoenv.2013.08.012; Chen SX, 2017, INT J SYST EVOL MICR, V67, P4266, DOI 10.1099/ijsem.0.002309; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Cui JQ, 2020, BIOPROC BIOSYST ENG, V43, P303, DOI 10.1007/s00449-019-02227-1; da Costa RR, 2019, INSECTS, V10, DOI 10.3390/insects10040087; da Costa RR, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01815-17; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dill-McFarland KA, 2016, ENVIRON MICROBIOL, V18, P1391, DOI 10.1111/1462-2920.13022; Duarte S, 2016, MADERAS-CIENC TECNOL, V18, P191, DOI 10.4067/S0718-221X2016005000019; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards C, 2009, ADV APPL MICROBIOL, V67, P109, DOI 10.1016/S0065-2164(08)01004-6; El Khalloufi F, 2016, SCI TOTAL ENVIRON, V539, P135, DOI 10.1016/j.scitotenv.2015.08.127; Escobar JS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0311-6; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Gomez E, 2006, BIORESOURCE TECHNOL, V97, P1484, DOI 10.1016/j.biortech.2005.06.021; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004; Graf J, 2014, PROKARYOTES, P857, DOI [10.1007/978-3-642-38954-2, DOI 10.1007/978-3-642-38954-2_134]; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Henckel T, 1999, APPL ENVIRON MICROB, V65, P1980; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hu YJ, 2014, SOIL BIOL BIOCHEM, V77, P51, DOI 10.1016/j.soilbio.2014.06.014; Huang XF, 2013, MICROB ECOL, V65, P531, DOI 10.1007/s00248-013-0219-y; Hyodo F, 2003, FUNCT ECOL, V17, P186, DOI 10.1046/j.1365-2435.2003.00718.x; Itakura M, 2009, ISME J, V3, P326, DOI 10.1038/ismej.2008.88; Jiang HL, 2004, APPL ENVIRON MICROB, V70, P6767, DOI 10.1128/AEM.70.11.6767-6775.2004; Jiang Y, 2016, BIORESOURCE TECHNOL, V218, P146, DOI 10.1016/j.biortech.2016.06.055; Kim TJ, 2003, WORLD J MICROB BIOT, V19, P411, DOI 10.1023/A:1023998719787; Korshunova TY, 2017, BIOL BULL+, V44, P493, DOI 10.1134/S1062359017050090; Kuhnigk T, 1997, J BASIC MICROB, V37, P205, DOI 10.1002/jobm.3620370309; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Li HJ, 2017, P NATL ACAD SCI USA, V114, P4709, DOI 10.1073/pnas.1618360114; Li HJ, 2016, ENVIRON MICROBIOL, V18, P1440, DOI 10.1111/1462-2920.13046; Li HJ, 2015, J ECON ENTOMOL, V108, P266, DOI 10.1093/jee/tou005; Li XL, 2019, PROCESS BIOCHEM, V84, P134, DOI 10.1016/j.procbio.2019.06.010; Licht HHDF, 2013, P NATL ACAD SCI USA, V110, P583, DOI 10.1073/pnas.1212709110; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069184; Long YH, 2010, INSECT SCI, V17, P265, DOI 10.1111/j.1744-7917.2010.01327.x; Makonde HM, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1262-6; Mikaelyan A., 2013, THESIS; Mikaelyan A, 2015, SYST APPL MICROBIOL, V38, P472, DOI 10.1016/j.syapm.2015.07.004; Mikaelyan A, 2014, ENVIRON MICROBIOL, V16, P2711, DOI 10.1111/1462-2920.12425; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Moreira-Soto RD, 2017, MICROBIOL-SGM, V163, P1578, DOI 10.1099/mic.0.000546; Mukherjee S, 2002, BIOTECHNOL PROGR, V18, P1195, DOI 10.1021/bp020116u; Namuli A, 2011, J MED PLANTS RES, V5, P3982; Nobre Tania, 2012, Insects, V3, P307, DOI 10.3390/insects3010307; Ohkuma M, 2015, P NATL ACAD SCI USA, V112, P10224, DOI 10.1073/pnas.1423979112; Otani S, 2016, MICROB ECOL, V71, P207, DOI 10.1007/s00248-015-0692-6; Otani S, 2014, MOL ECOL, V23, P4631, DOI 10.1111/mec.12874; Pachiadaki MG, 2017, SCIENCE, V358, P1046, DOI 10.1126/science.aan8260; Pfennig N, 1997, ARCH MICROBIOL, V168, P39, DOI 10.1007/s002030050467; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Poulsen M, 2014, P NATL ACAD SCI USA, V111, P14500, DOI 10.1073/pnas.1319718111; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radzi NASM, 2015, ENVIRON EARTH SCI, V74, P5383, DOI 10.1007/s12665-015-4552-y; Sakamoto M., 2014, PROKARYOTES OTHER MA, P811, DOI [10.1007/978-3-642-38954-2_132, DOI 10.1007/978-3-642-38954-2_132]; Sapountzis P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01993; SCALBERT A, 1988, PHYTOCHEMISTRY, V27, P3483, DOI 10.1016/0031-9422(88)80753-2; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seo JS, 2007, BIODEGRADATION, V18, P123, DOI 10.1007/s10532-006-9048-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sherry A, 2013, INT BIODETER BIODEGR, V81, P105, DOI 10.1016/j.ibiod.2012.04.009; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Su LJ, 2015, GENET MOL RES, V14, P13954, DOI 10.4238/2015.October.29.16; Su SW, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iev152; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Supramaniam Y, 2016, APPL SOIL ECOL, V107, P279, DOI 10.1016/j.apsoil.2016.07.003; Taprab Y, 2005, APPL ENVIRON MICROB, V71, P7696, DOI 10.1128/AEM.71.12.7696-7704.2005; Tillmann S, 2005, FEMS MICROBIOL ECOL, V52, P207, DOI 10.1016/j.femsec.2004.11.014; Tomizawa S, 2014, ACS SUSTAIN CHEM ENG, V2, P1106, DOI 10.1021/sc500066f; Trivedi P, 2013, TRENDS MICROBIOL, V21, P641, DOI 10.1016/j.tim.2013.09.005; Tsegaye B, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1471-0; Uffen RL, 1997, J IND MICROBIOL BIOT, V19, P1, DOI 10.1038/sj.jim.2900417; Van Horn DJ, 2014, APPL ENVIRON MICROB, V80, P3034, DOI 10.1128/AEM.03414-13; Visser AA, 2012, MICROB ECOL, V63, P975, DOI 10.1007/s00248-011-9987-4; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Wilhelm RC, 2019, ISME J, V13, P413, DOI 10.1038/s41396-018-0279-6; Wu YR, 2013, BIORESOURCE TECHNOL, V139, P5, DOI 10.1016/j.biortech.2013.03.103; Xu Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185590; Yang CX, 2017, J APPL MICROBIOL, V123, P1447, DOI 10.1111/jam.13562; Yin YiNing, 2014, Scientia Silvae Sinicae, V50, P30; Zahran HH, 1997, BIOL FERT SOILS, V25, P211, DOI 10.1007/s003740050306; Zhang ML, 2014, MICROB ECOL, V68, P416, DOI 10.1007/s00248-014-0388-3	111	9	12	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232329	10.1371/journal.pone.0232329	http://dx.doi.org/10.1371/journal.pone.0232329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357167	gold, Green Published			2022-12-26	WOS:000536957700026
J	Liccardo, A; Fierro, A; Garganese, F; Picciotti, U; Porcelli, F				Liccardo, Antonella; Fierro, Annalisa; Garganese, Francesca; Picciotti, Ugo; Porcelli, Francesco			A biological control model to manage the vector and the infection of Xylella fastidiosa on olive trees	PLOS ONE			English	Article							ZELUS-RENARDII KOLENATI; INTRAGUILD PREDATION; ARTHROPOD PREDATORS; ASSASSIN BUG; 1ST RECORD; HETEROPTERA; REDUVIIDAE; IDENTIFICATION; BEHAVIOR; APULIA	Xylella fastidiosa pauca ST53 is the bacterium responsible for the Olive Quick Decline Syndrome that has killed millions of olive trees in Southern Italy. A recent work demonstrates that a rational integration of vector and transmission control measures, into a strategy based on chemical and physical control means, can manage Xylella fastidiosa invasion and impact below an acceptable economic threshold. In the present study, we propose a biological alternative to the chemical control action, which involves the predetermined use of an available natural enemy of Philaenus spumarius, i.e., Zelus renardii, for adult vector population and infection biocontrol. The paper combines two different approaches: a laboratory experiment to test the predation dynamics of Zelus renardii on Philaenus spumarius and its attitude as candidate for an inundation strategy; a simulated experiment of inundation, to preliminary test the efficacy of such strategy, before eventually proceeding to an in-field experimentation. With this double-fold approach we show that an inundation strategy with Zelus renardii has the potential to furnish an efficient and "green" solution to Xylella fastidiosa invasion, with a reduction of the pathogen incidence below 10%. The biocontrol model presented here could be promising for containing the impact and spread of Xylella fastidiosa, after an in-field validation of the inundation technique. Saving the fruit orchard, the production and the industry in susceptible areas could thus become an attainable goal, within comfortable parameters for sustainability, environmental safety, and effective plant health protection in organic orchard management.	[Liccardo, Antonella] Univ Napoli Federico II, Phys Dept, Naples, Italy; [Fierro, Annalisa] CNR, Inst Supercond Oxides & Other Innovat Mat & Devic, Naples, Italy; [Garganese, Francesca; Porcelli, Francesco] Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Apulia, Italy; [Picciotti, Ugo] Univ Alicante, Dept Ciencias Mar & Biol Aplicada, Alicante, Spain; [Porcelli, Francesco] CIHEAM IAMB, Valenzano, Italy; [Picciotti, Ugo] Dyrecya Lab Conversano, Bari, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro; Universitat d'Alacant; CIHEAM; CIHEAM BARI	Liccardo, A (corresponding author), Univ Napoli Federico II, Phys Dept, Naples, Italy.	antonella.liccardo@unina.it	Picciotti, Ugo/AAQ-2779-2021; Garganese, Francesca/AAC-2152-2020	Picciotti, Ugo/0000-0002-7009-6891; Garganese, Francesca/0000-0002-7386-8543; Liccardo, Antonella/0000-0002-7534-0574	European Union [635646, 727987]	European Union(European Commission)	AF, AL, FG and UP received no specific funding for this work. FP European Union's Horizon 2020 research and innovation programme under Grant Agreements No. 635646 - POnTE "Pest Organisms Threatening Europe" and No. 727987 XF-ACTORS "Xylella Fastidiosa Active Containment Through a multidisciplinary-Oriented Research Strategy".	Abeijon LM, 2019, BIOSCI J, V35, P941, DOI 10.14393/BJ-v35n3a2019-41728; ABLES JR, 1978, ANN ENTOMOL SOC AM, V71, P476, DOI 10.1093/aesa/71.4.476; Ahmad Hamdan, 2019, Int J Insect Sci, V11, p1179543318823533, DOI 10.1177/1179543318823533; Ali A-S A, 1978, THESIS; Ambrose DP, 2016, ECOFRIENDLY PEST MANAGEMENT FOR FOOD SECURITY, P217, DOI 10.1016/B978-0-12-803265-7.00007-5; Baena Manuel, 2012, Boletin de la Asociacion Espanola de Entomologia, V36, P351; Bellows T.S., 1999, HDB BIOL CONTROL PRI; Benhadi-Marin J, 2020, INSECTS, V11, DOI 10.3390/insects11020100; Bragard C, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5665; Cerci Baris, 2016, Journal of Insect Biodiversity, V4, P1, DOI 10.12976/jib/2016.4.15; Cisneros JJ, 1997, ECOL ENTOMOL, V22, P399, DOI 10.1046/j.1365-2311.1997.00065.x; Cisneros JJ, 1998, ENVIRON ENTOMOL, V27, P949, DOI 10.1093/ee/27.4.949; Cohen AC, 1997, ENVIRON ENTOMOL, V26, P559, DOI 10.1093/ee/26.3.559; Cornara D, 2020, ENTOMOL GEN, V40, P125, DOI 10.1127/entomologia/2020/0912; Cornara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199154; Cornara D, 2017, J PEST SCI, V90, P521, DOI 10.1007/s10340-016-0793-0; Davranoglou Leonidas Romanos, 2011, Entomologist's Monthly Magazine, V147, P157; De Pascali M, 2019, PLANTS-BASEL, V8, DOI [10.3390/plants8110437, 10.3390/]; Dioli P., 2013, QUADERNO STUDI NOTIZ, V38, P227; Disney RHL, 2008, ANNU REV ENTOMOL, V53, P39, DOI 10.1146/annurev.ento.53.103106.093415; El-Tom HA, 1965, THESIS; Emergenza Xylella, 2018, GEOGR INF SYST PUGL; Fierro A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44997-4; Frilli Franco, 2001, Entomologica (Bari), V35, P27; Garantonakis N, 2017, PHYTOPARASITICA, V45, P461, DOI 10.1007/s12600-017-0597-7; Gerber E, 2016, REV INVERTEBRATE BIO, P194; Giampetruzzi A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01538-14; Gippet JMW, 2019, CURR OPIN INSECT SCI, V35, P96, DOI 10.1016/j.cois.2019.07.005; Girolami V., 1999, Informatore Agrario, V55, P87; GNEZDILOV VM, 2003, NOTES LATILICA MACUL, V86, P147; Hajek A.E., 2004, NATURAL ENEMIES INTR; Hajek AE, 2015, BIOL INVASIONS; Heyden T. van der, 2018, Revista Chilena de Entomologia, V44, P463; Heyden T. van der, 2015, BV NEWS PUBLICACIONE, V4, P55; Hornero A, 2020, REMOTE SENS ENVIRON, V236, DOI 10.1016/j.rse.2019.111480; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kolenati FA, 1856, B SOC IMPERIALE NATU, V502; Liccardo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141065; Liccardo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063935; LINGREN PD, 1968, ANN ENTOMOL SOC AM, V61, P613, DOI 10.1093/aesa/61.3.613; Loconsole G, 2016, EUR J PLANT PATHOL, V146, P85, DOI 10.1007/s10658-016-0894-x; Meier U., 2001, BBCH MONOGRAPH, DOI [10.5073/bbch0515, DOI 10.5073/BBCH0515]; Mesmin X, 2019, PEERJ PREPRINTS, V7, DOI [10.7287/peerj.preprints.27941v1, DOI 10.7287/PEERJ.PREPRINTS.27941V1]; Moretti TD, 2009, ENTOMOL GEN, V31, P349; Nugnes F, 2020, INSECTS, V11, DOI 10.3390/insects11010042; Nunney L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112463; ORPHANIDES GM, 1971, J ECON ENTOMOL, V64, P421, DOI 10.1093/jee/64.2.421; Parajulee MN, 2006, ENVIRON ENTOMOL, V35, P379, DOI 10.1603/0046-225X-35.2.379; Pedigo LP, 2009, PEDIGO RICE ENTOMOLO, P231; Petrakis P. V., 2011, Entomologia Hellenica, V20, P75; Pinzari Manuela, 2018, Fragmenta Entomologica, V50, P31, DOI 10.4081/fe.2018.281; Porcelli F., 2008, Bulletin OEPP, V38, P516, DOI 10.1111/j.1365-2338.2008.01273.x; Putchkov P.V., 2013, UKR ENTOMOL J, V2, P11; Lozano BR, 2018, T AM ENTOMOL SOC, V144, P551, DOI 10.3157/061.144.0305; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; ROSENHEIM JA, 1993, OECOLOGIA, V96, P439, DOI 10.1007/BF00317517; Ruesink W.G., 1975, P309; Salerno M., 2017, P EUROPEAN C XYLELLA, P22; Saponari M, 2013, J PLANT PATHOL, V95, P668; Serio F. di, 2019, EFSA Supporting Publications, V16, p1628E; STONER A, 1975, Journal of the Kansas Entomological Society, V48, P185; Torres JB, 2009, BRAZ ARCH BIOL TECHN, V52, P1199, DOI 10.1590/S1516-89132009000500018; Van den Bosch R., 1982, INTRO BIOL CONTROL; van der Heyden Torsten, 2017, Arquivos Entomoloxicos, V18, P49; Vivas L., 2012, BVNPC, V1, P34; Vos S, 2019, EFSA SUPPORTING PUBL; Weaver C., 1954, RES B, V741, P1; Weirauch C, 2012, FLA ENTOMOL, V95, P641, DOI 10.1653/024.095.0315; WHITTAKER J, 1969, PROC R ENTOMOL SOC A, V44, P17; WHITTAKER JB, 1973, J ANIM ECOL, V42, P163, DOI 10.2307/3410; Yurtsever Selcuk, 2000, Turkish Journal of Zoology, V24, P447; Zhang GY, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e8150; Zhao ZH, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2682; Zimmerman EC, 1948, BISHOP MUSEUM EXPT S, V3, P255	74	14	15	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232363	10.1371/journal.pone.0232363	http://dx.doi.org/10.1371/journal.pone.0232363			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353044	gold, Green Published			2022-12-26	WOS:000536673200085
J	Zhang, JG; Li, SJ; Cai, Q; Wang, ZH; Cao, JS; Yu, T; Xie, TL				Zhang, Jianguo; Li, Shujun; Cai, Quan; Wang, Zhenhua; Cao, Jingsheng; Yu, Tao; Xie, Tenglong			Exogenous diethyl aminoethyl hexanoate ameliorates low temperature stress by improving nitrogen metabolism in maize seedlings	PLOS ONE			English	Article							ASSIMILATION; NITRATE; PEROXIDASE; GROWTH; YIELD; WATER; PURIFICATION; EXPRESSION; TOXICITY; AMMONIUM	Spring maize sowing occurs during a period of low temperature (LT) in Northeast China, and the LT suppresses nitrogen (N) metabolism and photosynthesis, further reducing dry matter accumulation. Diethyl aminoethyl hexanoate (DA-6) improves N metabolism; hence, we studied the effects of DA-6 on maize seedlings under LT conditions. The shoot and root fresh weight and dry weight decreased by 17.70%similar to 20.82% in the LT treatment, and decreased by 5.81%similar to 13.57% in the LT + DA-6 treatment on the 7th day, respectively. Exogenous DA-6 suppressed the increases in ammonium (NH4+) content and glutamate dehydrogenase (GDH) activity, and suppressed the decreases in nitrate (NO3-) and nitrite (NO2-) contents, and activities of nitrate reductase (NR), nitrite reductase (NiR), glutamine synthetase (GS), glutamate synthase (GOGAT) and transaminase activities. NiR activity was most affected by DA-6 under LT conditions. Additionally, exogenous DA-6 suppressed the net photosynthetic rate (Pn) decrease, and the suppressed the increases of superoxide anion radical (O-2 center dot(-)) generation rate and hydrogen peroxide (H2O2) content. Taken together, our results suggest that exogenous DA-6 mitigated the repressive effects of LT on N metabolism by improving photosynthesis and modulating oxygen metabolism, and subsequently enhanced the LT tolerance of maize seedlings.	[Zhang, Jianguo; Wang, Zhenhua; Xie, Tenglong] Northeast Agr Univ, Coll Agr, Harbin, Peoples R China; [Zhang, Jianguo; Li, Shujun; Cai, Quan; Cao, Jingsheng; Yu, Tao] Heilongjiang Acad Agr Sci, Maize Res Inst, Harbin, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences	Wang, ZH (corresponding author), Northeast Agr Univ, Coll Agr, Harbin, Peoples R China.	zhenhuawang_2006@163.com	Yu, Tao/ACO-7190-2022	Yu, Tao/0000-0003-1252-3055	National Key Research and Development Program of China [2017YFD0101101]; Special Construction of Modern Agricultural Industry Technology System [CARS-02-05]	National Key Research and Development Program of China; Special Construction of Modern Agricultural Industry Technology System	The National Key Research and Development Program of China (2017YFD0101101), and the Special Construction of Modern Agricultural Industry Technology System(CARS-02-05).	Aebi H, 1984, Methods Enzymol, V105, P121; Arbona V, 2013, INT J MOL SCI, V14, P4885, DOI 10.3390/ijms14034885; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Balestrasse KB, 2006, PLANT SOIL, V284, P187, DOI 10.1007/s11104-006-0050-z; BARRO F, 1991, PLANT SOIL, V135, P251, DOI 10.1007/BF00010913; Bartucca ML, 2019, CHEM ECOL, V35, P720, DOI 10.1080/02757540.2019.1641493; Bashri G, 2018, J PLANT GROWTH REGUL, V37, P233, DOI 10.1007/s00344-017-9721-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brautigam A, 2007, ANAL BIOCHEM, V362, P151, DOI 10.1016/j.ab.2006.12.033; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chen X, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1155/2014/956141; Drapeau G., 1974, METHOD ENZYMOL, P469; Du J, 2017, PLANT GROWTH REGUL, V81, P103, DOI 10.1007/s10725-016-0193-8; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Foyer CH, 2011, J EXP BOT, V62, P1467, DOI 10.1093/jxb/erq453; Gangwar S, 2011, SCI HORTIC-AMSTERDAM, V129, P321, DOI 10.1016/j.scienta.2011.03.026; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GROAT RG, 1981, PLANT PHYSIOL, V67, P1198, DOI 10.1104/pp.67.6.1198; Hameed A, 2011, PLANT PHYSIOL BIOCH, V49, P178, DOI 10.1016/j.plaphy.2010.11.009; Heidarvand L, 2017, CRIT REV PLANT SCI, V36, P217, DOI 10.1080/07352689.2017.1375836; IDA S, 1973, PLANT CELL PHYSIOL, V14, P661; JANA S, 1982, AQUAT BOT, V12, P345, DOI 10.1016/0304-3770(82)90026-2; Jia Y, 2015, FIELD CROP RES, V175, P16, DOI 10.1016/j.fcr.2015.01.004; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Li ZW, 2018, INT J PHYTOREMEDIAT, V20, P1121, DOI 10.1080/15226514.2017.1365348; Liu YJ, 2012, J PLANT PHYSIOL, V169, P183, DOI 10.1016/j.jplph.2011.08.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Perez L, 2007, INT J PLANT SCI, V168, P1141, DOI 10.1086/520722; Luo J, 2013, PLANTA, V237, P919, DOI 10.1007/s00425-012-1807-7; Mafakheri A, 2011, AUST J CROP SCI, V5, P1255; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nuccio ML, 2015, NAT BIOTECHNOL, V33, P862, DOI 10.1038/nbt.3277; Omoto E, 2012, J PLANT PHYSIOL, V169, P469, DOI 10.1016/j.jplph.2011.11.009; ONEAL D, 1973, ARCH BIOCHEM BIOPHYS, V159, P113, DOI 10.1016/0003-9861(73)90435-9; Qi RuiJuan, 2013, Australian Journal of Crop Science, V7, P2021; Schluter DK, 2012, BIOPHYS J, V103, P1141, DOI 10.1016/j.bpj.2012.07.048; Sharma P, 2005, J PLANT PHYSIOL, V162, P854, DOI 10.1016/j.jplph.2004.09.011; Shen XJ, 2017, METEOROL APPL, V24, P135, DOI 10.1002/met.1612; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Theocharis A, 2012, PLANTA, V235, P1091, DOI 10.1007/s00425-012-1641-y; Tian LX, 2018, ACTA PHYSIOL PLANT, V40, DOI 10.1007/s11738-018-2655-2; Wang H, 2017, AGRON J, V109, P39, DOI 10.2134/agronj2016.01.0030; Wang L, 2018, FIELD CROP RES, V216, P89, DOI 10.1016/j.fcr.2017.11.010; Wang Y, 2018, CROP PASTURE SCI, V69, P587, DOI 10.1071/CP17401; Wen DX, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1925-5; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Xie TL, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9110676; Xie TL, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1710-5; Xie TL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12977-1; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209; Zhang CP, 2016, J PLANT GROWTH REGUL, V35, P330, DOI 10.1007/s00344-015-9536-3; ZHENG X, 1992, PLANT SCI, V81, P47, DOI 10.1016/0168-9452(92)90023-F; Zhou WG, 2019, J EXP BOT, V70, P101, DOI 10.1093/jxb/ery247; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8; Zhu XC, 2015, CROP PASTURE SCI, V66, P62, DOI 10.1071/CP14159	55	10	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232294	10.1371/journal.pone.0232294	http://dx.doi.org/10.1371/journal.pone.0232294			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353025	Green Published, gold			2022-12-26	WOS:000536673200070
J	Potluri, R; Kumar, A; Maheshwari, V; Smith, C; Mathieu, VO; Luhn, K; Callendret, B; Bhandari, H				Potluri, Ravi; Kumar, Amit; Maheshwari, Vikalp; Smith, Charlie; Mathieu, Valerie Oriol; Luhn, Kerstin; Callendret, Benoit; Bhandari, Hitesh			Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis	PLOS ONE			English	Article							HEALTH-CARE WORKERS; SIERRA-LEONE; WEST-AFRICA; DISEASE; EPIDEMIC; OUTBREAK; EFFICACY; VACCINES; DYNAMICS; TIME	Ebola epidemics constitute serious public health emergencies. Multiple vaccines are under development to prevent these epidemics and avoid the associated morbidity and mortality. Assessing the potential impact of these vaccines on morbidity and mortality of Ebola is essential for devising prevention strategies. A mean-field compartmental stochastic model was developed for this purpose and validated by simulating the 2014 Sierra Leone epidemic. We assessed the impacts of prophylactic vaccination of healthcare workers (HCW) both alone and in combination with the vaccination of the general population (entire susceptible population other than HCW). The model simulated 8,706 (95% confidence intervals [CI]: 478-21,942) cases and 3,575 (95%CI: 179-9,031) deaths in Sierra Leone, in line with WHO-reported statistics for the 2014 epidemic (8,704 cases and 3,587 deaths). Relative to this base case, the model then estimated that prophylactic vaccination of only 10% of HCW will avert 12% (95% CI: 6%-14%) of overall cases and deaths, while vaccination of 30% of HCW will avert 34% of overall cases (95% CI: 30%-64%) and deaths (95% CI: 30%-65%). Prophylactic vaccination of 1% and 5% of the general population in addition to vaccinating 30% of HCW was estimated to result in reduction in cases by 44% (95% CI: 39%-61%) and 72% (95% CI: 68%-84%) respectively, and deaths by 45% (95% CI: 40%-61%) and 74% (95% CI: 70%-85%) respectively. Prophylactic vaccination of even small proportions of HCW is estimated to significantly reduce incidence of Ebola and associated mortality. The effect is greatly enhanced by the additional vaccination even of small percentages of the general population. These findings could be used to inform the planning of prevention strategies.	[Potluri, Ravi] SmartAnalyst Inc, New York, NY USA; [Kumar, Amit; Maheshwari, Vikalp; Bhandari, Hitesh] SmartAnalyst India Pvt Ltd, Gurgaon, India; [Smith, Charlie] Janssen Vaccines & Prevent, Raritan, NJ USA; [Mathieu, Valerie Oriol; Luhn, Kerstin; Callendret, Benoit] Janssen Vaccines & Prevent BV, Leiden, Netherlands		Potluri, R (corresponding author), SmartAnalyst Inc, New York, NY USA.	rpotluri@smartanalyst.com		Potluri, Ravi/0000-0002-0509-2659	Janssen Vaccines & Prevention of Johnson and Johnson	Janssen Vaccines & Prevention of Johnson and Johnson	The study was commissioned and funded by Janssen Vaccines & Prevention of Johnson and Johnson. The funders had no role in model design, data collection and analysis, decision to publish, or preparation of the manuscript. At the time of writing this manuscript, CS was employed by Janssen Vaccines & Prevention, Raritan, NJ, USA, and VOM, KL and BC were employed by Janssen Vaccines & Prevention B.V., Leiden, The Netherlands and RP, AK, VM and HB were employed by SmartAnalyst Inc, New York, NY, USA or its subsidiaries. While Janssen Vaccines & Prevention and Janssen Vaccines & Prevention B.V. provided support in the form of salaries to authors CS, VOM, KL and BC, they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. Additionally, assistance in the preparation of this manuscript was provided by Asclepius Medical Communications LLC, Ridgewood, NJ.	[Anonymous], 2019, EB VIR DIS DEM REP C; Asher J, 2018, EPIDEMICS-NETH, V22, P50, DOI 10.1016/j.epidem.2017.02.009; Atkins KE, 2016, AM J TROP MED HYG, V94, P833, DOI 10.4269/ajtmh.15-0328; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Blumenstein Rebecca, 2015, WALL STREET J; Bodine EN, 2018, MATH BIOSCI ENG, V15, P337, DOI 10.3934/mbe.2018015; Bundu I, 2016, J ROY ARMY MED CORPS, V162, P212, DOI 10.1136/jramc-2015-000582; Coltart CEM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0477-2; Denes A, 2019, INFECT DIS MODEL, V4, P12, DOI 10.1016/j.idm.2019.01.003; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548; Evans D, 2015, 7344 WPS; Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Guo ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152438; Kelly JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213190; Kieny MP, 2016, LANCET, V387, P1509, DOI [10.1016/S0140-6736(16)00686-3, 10.1016/S0140-6736(16)32621-6]; Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Luo DM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38397-3; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Meakin SR, 2019, BIORXIV, DOI [10.1101/465062, DOI 10.1101/465062]; Mire CE, 2016, EXPERT REV VACCINES, V15, P1421, DOI 10.1080/14760584.2016.1178068; Nielsen CF, 2015, MMWR-MORBID MORTAL W, V64, P20; Parpia AS, 2016, EMERG INFECT DIS, V22, P433, DOI 10.3201/eid2203.150977; Robert A, 2017, BIORXIV, DOI [10.1101/113506, DOI 10.1101/113506]; Robert A, 2019, EPIDEMICS-NETH, V27, P106, DOI 10.1016/j.epidem.2019.03.001; Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438; The World Bank, 2014, POP TOT; Tuncer N, 2018, J BIOL DYNAM, V12, P913, DOI 10.1080/17513758.2018.1535095; Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6; Walldorf JA, 2017, EMERG INFECT DIS, V23, pS210, DOI 10.3201/eid2313.170550; Wells CR, 2019, P NATL ACAD SCI USA, V116, P10178, DOI 10.1073/pnas.1817329116; WHO, 2019, EB DEM REP CONG HLTH; WHO, 2014, WHO STAT 1 M IHR EM; Worden L, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007512; World Health Organization, 2016, EB SIT REP 2014; World Health Organization, 2017, UPD DEV EB VACC IMPL; World Health Organization, 2015, EB SIT REP 4 NOV 201; World Health Organization, 2017, EB OUTBR 2014 2015; World Health Organization, 2016, BERLIN HAYOM; Xie Zhifu, 2019, Osong Public Health Res Perspect, V10, P187, DOI 10.24171/j.phrp.2019.10.3.10; 2014, LANCET LONDON ENGLAN, V383, P1946, DOI DOI 10.1016/S0140-6736(14)60938-7	45	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0230406	10.1371/journal.pone.0230406	http://dx.doi.org/10.1371/journal.pone.0230406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339195	Green Published, gold			2022-12-26	WOS:000536657400003
J	Zajac, M; Ye, JB; Mukhopadhyay, P; Jin, XP; Ben, Y; Antal, J; Gupta, AK; Rebelatto, MC; Williams, JA; Walker, J				Zajac, Magdalena; Ye, Jiabu; Mukhopadhyay, Pralay; Jin, Xiaoping; Ben, Yong; Antal, Joyce; Gupta, Ashok K.; Rebelatto, Marlon C.; Williams, J. Andrew; Walker, Jill			Optimal PD-L1-high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy	PLOS ONE			English	Article							DEATH LIGAND-1; IMMUNE ESCAPE; SINGLE-ARM; IMMUNOTHERAPY; MULTICENTER; PEMBROLIZUMAB; ATEZOLIZUMAB; CHECKPOINT; EXPRESSION; CARCINOMA	Background Studies have indicated that programmed death ligand 1 (PD-L1) expression may have utility as a predictive biomarker in patients with advanced/metastatic urothelial carcinoma (UC). Different immunohistochemical (IHC) assays are in development to assess PD-L1 expression on tumor cells (TCs) and tumor-infiltrating immune cells (ICs). Methods In this post hoc analysis of the single-arm, phase 1/2 Study 1108 (NCT01693562), PD-L1 expression was evaluated from tumor samples obtained prior to second-line treatment with durvalumab in patients with advanced/metastatic UC using the VENTANA (SP263) IHC Assay. The primary objective was to determine whether the TC >= 25%/IC >= 25% algorithm (i.e., cutoff of. 25% TC or >= 25% IC with PD-L1 staining at any intensity above background) was optimal for predicting response to durvalumab. PD-L1 expression data were available from 188 patients. Results After a median follow-up of 15.8 and 14.6 months, higher PD-L1 expression was associated with longer overall survival (OS) and progression-free survival (PFS), respectively, with significant separation in survival curves for PD-L1-high and-low expressing patients for the TC. 25%/IC. 25% cutoff (median OS: 19.8 vs 4.8 months; hazard ratio: 0.46; 90% confidence interval: 0.33, 0.639). OS was also prolonged for PD-L1-high compared with-low patients when samples were categorized using TC/IC combined positive score >= 10 and IC >= 5% cutoffs. In multivariate analysis, IC but not TC PD-L1 expression was significantly associated with OS, PFS, and objective response rate (P < 0.001 for each), although interaction analysis showed similar directionality of benefit for ICs and TCs. Conclusions These findings support the utility of a combined TC/IC algorithm for predicting response to durvalumab in patients with UC, with the TC >= 25%/IC >= 25% cutoff optimal when used with the VENTANA (SP263) IHC Assay.	[Zajac, Magdalena; Williams, J. Andrew; Walker, Jill] AstraZeneca, Cambridge, England; [Ye, Jiabu; Mukhopadhyay, Pralay] AstraZeneca, Gaithersburg, MD USA; [Jin, Xiaoping; Antal, Joyce; Gupta, Ashok K.; Rebelatto, Marlon C.] MedImmune, Gaithersburg, MD USA; [Ben, Yong] AstraZeneca, Gaithersburg, MD USA; [Jin, Xiaoping; Ben, Yong] Akesobio, Zhongshan, Guangdong, Peoples R China; [Ben, Yong] BeiGene, San Francisco, CA USA; [Antal, Joyce] G1 Therapeut Inc, Res Triangle Pk, NC USA	AstraZeneca; AstraZeneca; Medimmune; AstraZeneca	Walker, J (corresponding author), AstraZeneca, Cambridge, England.	Jill.Walker@astrazeneca.com	Mukhopadhyay, Pralay/AAO-3497-2021	Walker, Jill/0000-0001-7943-583X	AstraZeneca	AstraZeneca(AstraZeneca)	The funder (AstraZeneca) provided support in the form of salaries for all authors, who contributed to the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2017, PD L1 IHC 22C3 PHARM; [Anonymous], 2015, PD L1 IHC 28 8 PHARM; [Anonymous], 2018, IMF DURV; Apolo AB, 2017, J CLIN ONCOL, V35, P2117, DOI 10.1200/JCO.2016.71.6795; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Bellmunt J, 2015, ANN ONCOL, V26, P812, DOI 10.1093/annonc/mdv009; Bernard-Tessier A, 2018, B CANCER, V105, P140, DOI 10.1016/j.bulcan.2017.10.030; Buttner R, 2017, J CLIN ONCOL, V35, P3867, DOI 10.1200/JCO.2017.74.7642; Chan AWH, 2018, MODERN PATHOL, V31, P1381, DOI 10.1038/s41379-018-0053-3; Davarpanah NN, 2017, CURR OPIN ONCOL, V29, P184, DOI 10.1097/CCO.0000000000000366; Diggs LP, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0093-8; Donin NM, 2017, J UROLOGY, V197, P14, DOI 10.1016/j.juro.2016.02.3005; European Medicines Agency (EMA), 2018, EMA RESTR US KEYTR T; Frydenlund N, 2017, HUM PATHOL, V66, P13, DOI 10.1016/j.humpath.2017.06.012; Gopalakrishnan D, 2018, THER CLIN RISK MANAG, V14, DOI 10.2147/TCRM.S158753; Gwynn ME, 2018, ANN PHARMACOTHER, V52, P60, DOI 10.1177/1060028017727546; Krabbe LM, 2017, J UROLOGY, V198, P1254, DOI 10.1016/j.juro.2017.06.086; Massard C, 2016, J CLIN ONCOL, V34, P3119, DOI 10.1200/JCO.2016.67.9761; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X; Powles T, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2411; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Raimondi C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1315488; Sakane Tadashi, 2018, Oncotarget, V9, P6993, DOI 10.18632/oncotarget.24075; Schats KA, 2018, ARCH PATHOL LAB MED, V142, P982, DOI 10.5858/arpa.2017-0159-OA; Sharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Ventana Medical Systems Inc, 2016, VENTANA PD L1 SP142; Ventana Medical Systems Inc, 2017, **DROPPED REF**; Vuky J, 2018, AM SOC CLIN ONC JUN; Wang QQ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006369; Wu P., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0131403; Zhou TC, 2017, UROL ONCOL-SEMIN ORI, V35, P14, DOI 10.1016/j.urolonc.2016.10.004	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231936	10.1371/journal.pone.0231936	http://dx.doi.org/10.1371/journal.pone.0231936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339189	Green Published, gold			2022-12-26	WOS:000536657400019
J	Licon, MH; Yates, PA				Licon, M. Haley; Yates, Phillip A.			Purine-responsive expression of theLeishmania donovaniNT3 purine nucleobase transporter is mediated by a conserved RNA stem?loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Leishmania; posttranscriptional regulation; purine; mRNA; parasitology; stress response; transporter; adaptation; starvation	GENE-EXPRESSION; LEISHMANIA; CULTIVATION; STARVATION; METABOLISM; PARASITE; PROTEINS; SYSTEM; FLY	The ability to modulate gene expression in response to changes in the host environment is essential for survival of the kinetoplastid parasiteLeishmania. Unlike most eukaryotes, gene expression in kinetoplastids is predominately regulated posttranscriptionally. Consequently, RNA-binding proteins and mRNA-encoded sequence elements serve as primary determinants of gene regulation in these organisms; however, few have defined roles in specific stress response pathways.Leishmaniaspecies cannot synthesize purinesde novoand must scavenge these essential nutrients from the host.Leishmaniahave evolved a robust stress response to withstand sustained periods of purine scarcity during their life cycle. The purine nucleobase transporter LdNT3 is among the most substantially up-regulated proteins in purine-starvedLeishmania donovaniparasites. Here we report that the posttranslational stability of the LdNT3 protein is unchanged in response to purine starvation. Instead, LdNT3 up-regulation is primarily mediated by a 33-nucleotide-long sequence in theLdNT3mRNA 3? UTR that is predicted to adopt a stem?loop structure. Although this sequence is highly conserved within the mRNAs of orthologous transporters in multiple kinetoplastid species, putative stem?loops fromL. donovaniandTrypanosoma bruceinucleobase transporter mRNAs were not functionally interchangeable for purine-responsive regulation. Through mutational analysis of the element, we demonstrate that species specificity is attributable to just three variant bases within the predicted loop. Finally, we provide evidence that the abundance of thetrans-acting factor that binds theLdNT3stem?loopin vivois substantially higher than required for regulation of LdNT3 alone, implying a potential role in regulating other purine-responsive genes.	[Licon, M. Haley] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Yates, Phillip A.] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Yates, PA (corresponding author), Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA.	yatesp@ohsu.edu			NIAID, National Institutes of Health [R03 AI137636, T32 AI007472-22]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant R03 AI137636 (to P. A. Y.). A select few reagents were purchased with funds available through NIAID, National Institutes of Health Grant T32 AI007472-22 (to M. H. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; Boitz JM, 2012, TRENDS PARASITOL, V28, P345, DOI 10.1016/j.pt.2012.05.005; Carter NS, 2010, MOL MICROBIOL, V78, P92, DOI 10.1111/j.1365-2958.2010.07327.x; Clayton C, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190072; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dillon LAL, 2015, NUCLEIC ACIDS RES, V43, P6799, DOI 10.1093/nar/gkv656; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Fernandez-Moya SM, 2014, NUCLEIC ACIDS RES, V42, P7201, DOI 10.1093/nar/gku358; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jolma A, 2019, BINDING SPECIFICITIE, P317909, DOI [10.1101/317909, DOI 10.1101/317909]; Louradour I, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12755; Martin JL, 2016, MOL MICROBIOL, V101, P299, DOI 10.1111/mmi.13390; Martin JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003938; Opperdoes FR, 2016, J EUKARYOT MICROBIOL, V63, P657, DOI 10.1111/jeu.12315; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Serafim TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001833; Somanna A, 2002, ACTA TROP, V83, P37, DOI 10.1016/S0001-706X(02)00054-2; Soysa R, 2015, MOL BIOCHEM PARASIT, V204, P89, DOI 10.1016/j.molbiopara.2016.01.008; Soysa R, 2014, MOL BIOCHEM PARASIT, V195, P1, DOI 10.1016/j.molbiopara.2014.05.002; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; 2010, WHO TECH REP SER, V949, pXII	29	2	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8449	8459		10.1074/jbc.RA120.012696	http://dx.doi.org/10.1074/jbc.RA120.012696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32354744	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000546986500009
J	Liang, FS; Miller, AS; Tang, C; Maranon, D; Williamson, EA; Hromas, R; Wiese, C; Zhao, WX; Sung, P; Kupfer, GM				Liang, Fengshan; Miller, Adam S.; Tang, Caroline; Maranon, David; Williamson, Elizabeth A.; Hromas, Robert; Wiese, Claudia; Zhao, Weixing; Sung, Patrick; Kupfer, Gary M.			The DNA-binding activity of USP1-associated factor 1 is required for efficient RAD51-mediated homologous DNA pairing and homology-directed DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; homologous recombination; DNA-binding protein; DNA damage response; DNA damage; deubiquitination; Fanconi anemia; interstrand cross-linking (ICL); UAF1?RAD51AP1; ubiquitin-specific peptidase 1 (USP1)	STRAND BREAK REPAIR; FANCONI-ANEMIA; DAMAGE RESPONSE; FANCD2; RAD51AP1; COMPLEX; BRCA2; MONOUBIQUITINATION; RECOMBINATION; INACTIVATION	USP1-associated factor 1 (UAF1) is an integral component of the RAD51-associated protein 1 (RAD51AP1)?UAF1-ubiquitin-specific peptidase 1 (USP1) trimeric deubiquitinase complex. This complex acts on DNA-bound, monoubiquitinated Fanconi anemia complementation group D2 (FANCD2) protein in the Fanconi anemia pathway of the DNA damage response. Moreover, RAD51AP1 and UAF1 cooperate to enhance homologous DNA pairing mediated by the recombinase RAD51 in DNA repair via the homologous recombination (HR) pathway. However, whereas the DNA-binding activity of RAD51AP1 has been shown to be important for RAD51-mediated homologous DNA pairing and HR-mediated DNA repair, the role of DNA binding by UAF1 in these processes is unclear. We have isolated mutant UAF1 variants that are impaired in DNA binding and tested them together with RAD51AP1 in RAD51-mediated HR. This biochemical analysis revealed that the DNA-binding activity of UAF1 is indispensable for enhanced RAD51 recombinase activity within the context of the UAF1?RAD51AP1 complex. In cells, DNA-binding deficiency of UAF1 increased DNA damage sensitivity and impaired HR efficiency, suggesting that UAF1 and RAD51AP1 have coordinated roles in DNA binding during HR and DNA damage repair. Our findings show that even though UAF1's DNA-binding activity is redundant with that of RAD51AP1 in FANCD2 deubiquitination, it is required for efficient HR-mediated chromosome damage repair.	[Liang, Fengshan; Miller, Adam S.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Liang, Fengshan; Tang, Caroline; Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pediat, Sect Hematol Oncol, New Haven, CT 06510 USA; [Tang, Caroline; Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Maranon, David; Wiese, Claudia] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Williamson, Elizabeth A.; Hromas, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Zhao, Weixing; Sung, Patrick] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA	Yale University; Yale University; Yale University; Colorado State University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Kupfer, GM (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Hematol Oncol, New Haven, CT 06510 USA.; Kupfer, GM (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Sung, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA.	sungp@uthscsa.edu; gary.kupfer@yale.edu	Classen, Scott/AAY-8176-2020	Hromas, Robert/0000-0002-1916-6276	CPRIT REI Award [RR180029]; Gray Foundation Team Science Grant; National Institutes of Health [RO1 CA168635, R35 CA241801, U54 DK106857, RO1 CA205224, RO1 ES007061, RO1 GM109645, PO1 CA92584, P30 CA054174]; Robert A. Welch Distinguished Chair in Chemistry Grant [AQ-0012]; V Foundation Scholarship	CPRIT REI Award; Gray Foundation Team Science Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Distinguished Chair in Chemistry Grant; V Foundation Scholarship	This work was supported by CPRIT REI Award RR180029 (to P. S.), a Gray Foundation Team Science Grant, and National Institutes of Health Grants RO1 CA168635, R35 CA241801, U54 DK106857, RO1 CA205224, RO1 ES007061, RO1 GM109645, PO1 CA92584, and P30 CA054174 (to P. S. and G. M. K.). This work was also supported in part by a Robert A. Welch Distinguished Chair in Chemistry Grant AQ-0012 (to P. S.) and a V Foundation Scholarship (to W. Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barroso-Gonzalez J, 2019, MOL CELL, V76, P11, DOI 10.1016/j.molcel.2019.06.043; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Dunlop MH, 2012, J BIOL CHEM, V287, P12343, DOI 10.1074/jbc.C112.352161; Duxin JP, 2015, CURR OPIN CELL BIOL, V37, P49, DOI 10.1016/j.ceb.2015.09.002; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Hashimoto S, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0037-9; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Knies K, 2017, J CLIN INVEST, V127, P3013, DOI 10.1172/JCI92069; Liang FS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10408-5; Liang FS, 2016, CELL REP, V15, P2118, DOI 10.1016/j.celrep.2016.05.007; Liang ZB, 2019, CELL REP, V26, P564, DOI 10.1016/j.celrep.2018.12.084; Lim KS, 2018, MOL CELL, V72, P925, DOI 10.1016/j.molcel.2018.10.045; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Mladenova V, 2006, FEBS LETT, V580, P1631, DOI 10.1016/j.febslet.2006.02.009; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Morita Eiji, 2012, Biotechniques, V0, P1, DOI 10.2144/000113909; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niraj J, 2019, ANNU REV CANC BIOL, V3, P457, DOI 10.1146/annurev-cancerbio-030617-050422; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Park E, 2013, MOL CELL BIOL, V33, P4360, DOI 10.1128/MCB.00870-13; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wang AT, 2015, MOL CELL, V59, P478, DOI 10.1016/j.molcel.2015.07.009; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	38	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8186	8194		10.1074/jbc.RA120.013714	http://dx.doi.org/10.1074/jbc.RA120.013714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350107	Green Published, hybrid			2022-12-26	WOS:000542965700007
J	Rowe, JB; Taghon, GJ; Kapolka, NJ; Morgan, WM; Isom, DG				Rowe, Jacob B.; Taghon, Geoffrey J.; Kapolka, Nicholas J.; Morgan, William M.; Isom, Daniel G.			CRISPR-addressable yeast strains with applications in human G protein?coupled receptor profiling and synthetic biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; G protein?coupled receptor (GPCR); Saccharomyces cerevisiae; synthetic biology; bioengineering; DNA payloads; genome barcoding; landing pad; pathway engineering; safe harbor locus	ASSAYS	Genome stability is essential for engineering cell-based devices and reporter systems. With the advent of CRISPR technology, it is now possible to build such systems by installing the necessary genetic parts directly into an organism's genome. Here, we used this approach to build a set of 10 versatile yeast-based reporter strains for studying human G protein?coupled receptors (GPCRs), the largest class of membrane receptors in humans. These reporter strains contain the necessary genetically encoded parts for studying human GPCR signaling in yeast, as well as four CRISPR-addressable expression cassettes,i.e.landing pads, installed at known safe-harbor sites in the yeast genome. We showcase the utility of these strains in two applications. First, we demonstrate that increasing GPCR expression by incrementally increasing GPCR gene copy number potentiates G? coupling of the pharmacologically dark receptor GPR68. Second, we used two CRISPR-addressable landing pads for autocrine activation of a GPCR (the somatostatin receptor SSTR5) with its peptide agonist SRIF-14. The utility of these reporter strains can be extended far beyond these select examples to include applications such as nanobody development, mutational analysis, drug discovery, and studies of GPCR chaperoning. Additionally, we present a BY4741 yeast strain created for broad applications in the yeast and synthetic biology communities that contains only the four CRISPR-addressable landing pads. The general utility of these yeast strains provides an inexpensive, scalable, and easy means of installing and expressing genes directly from the yeast genome to build genome-barcoded sensors, reporter systems, and cell-based factories.	[Rowe, Jacob B.; Taghon, Geoffrey J.; Kapolka, Nicholas J.; Morgan, William M.; Isom, Daniel G.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Isom, Daniel G.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33146 USA; [Isom, Daniel G.] Univ Miami, Ctr Computat Sci, Miami, FL 33146 USA	University of Miami; University of Miami; University of Miami	Isom, DG (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.; Isom, DG (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33146 USA.; Isom, DG (corresponding author), Univ Miami, Ctr Computat Sci, Miami, FL 33146 USA.	disom@miami.edu	Taghon, Geoffrey/GON-5639-2022	Rowe, Jacob/0000-0001-7147-5407; Kapolka, Nicholas/0000-0003-2223-8207; Taghon, Geoffrey/0000-0002-5350-5075	NIGMS, National Institutes of Health [R35GM119518]; Common Fund for Illuminating the Druggable Genome through National Institutes of Health [R03TR002908]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Common Fund for Illuminating the Druggable Genome through National Institutes of Health	This work was supported by NIGMS, National Institutes of Health Grant R35GM119518 and by the Common Fund for Illuminating the Druggable Genome through National Institutes of Health Grant R03TR002908 (to D. G. I.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Besada-Lombana PB, 2018, CURR OPIN BIOTECH, V53, P39, DOI 10.1016/j.copbio.2017.12.002; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dowell SJ, 2009, METHODS MOL BIOL, V552, P213, DOI 10.1007/978-1-60327-317-6_15; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Ishii J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037136; Kapolka N., 2020, DCYFIR HIGH THROUGHP, DOI [10.1101/2020.01.16.909325, DOI 10.1101/2020.01.16.909325]; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Laughery MF, 2015, YEAST, V32, P711, DOI 10.1002/yea.3098; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nielsen J, 2013, BIOENGINEERED, V4, P207, DOI 10.4161/bioe.22856; OCARROLL AM, 1994, MOL PHARMACOL, V46, P291; Ronda C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0288-3; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Tran TNT, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0751-y; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Voth WP, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e59; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wu XL, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0872-3	25	6	7	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8262	8271		10.1074/jbc.RA120.013066	http://dx.doi.org/10.1074/jbc.RA120.013066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358068	Green Published, hybrid			2022-12-26	WOS:000542965700014
J	Fujita, H; Oikawa, R; Hayakawa, M; Tomoike, F; Kimura, Y; Okuno, H; Hatashita, Y; Oliveros, CF; Bito, H; Ohshima, T; Tsuneda, S; Abe, H; Inoue, T				Fujita, Hirotaka; Oikawa, Ryota; Hayakawa, Mayu; Tomoike, Fumiaki; Kimura, Yasuaki; Okuno, Hiroyuki; Hatashita, Yoshiki; Fiallos Oliveros, Carolina; Bito, Haruhiko; Ohshima, Toshio; Tsuneda, Satoshi; Abe, Hiroshi; Inoue, Takafumi			Quantification of native mRNA dynamics in living neurons using fluorescence correlation spectroscopy and reduction-triggered fluorescent probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence correlation spectroscopy (FCS); mRNA; neuron; RNA transport; live-cell imaging; reduction-triggered fluorescence (RETF); transcription; gene regulation; hippocampus; cellular dynamics	IMMEDIATE-EARLY GENE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; LOCAL TRANSLATION; MICE LACKING; GAG PROTEIN; TRANSPORT; ARC; LOCALIZATION; DIFFUSION; VISUALIZATION	RNA localization in subcellular compartments is essential for spatial and temporal regulation of protein expression in neurons. Several techniques have been developed to visualize mRNAs inside cells, but the study of the behavior of endogenous and nonengineered mRNAs in living neurons has just started. In this study, we combined reduction-triggered fluorescent (RETF) probes and fluorescence correlation spectroscopy (FCS) to investigate the diffusion properties of activity-regulated cytoskeleton-associated protein (Arc) and inositol 1,4,5-trisphosphate receptor type 1 (Ip3r1) mRNAs. This approach enabled us to discriminate between RNA-bound and unbound fluorescent probes and to quantify mRNA diffusion parameters and concentrations in living rat primary hippocampal neurons. Specifically, we detected the induction of Arc mRNA production after neuronal activation in real time. Results from computer simulations with mRNA diffusion coefficients obtained in these analyses supported the idea that free diffusion is incapable of transporting mRNA of sizes close to those of Arc or Ip3r1 to distal dendrites. In conclusion, the combined RETF-FCS approach reported here enables analyses of the dynamics of endogenous, unmodified mRNAs in living neurons, affording a glimpse into the intracellular dynamics of RNA in live cells.	[Fujita, Hirotaka; Hatashita, Yoshiki; Fiallos Oliveros, Carolina; Ohshima, Toshio; Tsuneda, Satoshi; Inoue, Takafumi] Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Tokyo, Japan; [Oikawa, Ryota; Hayakawa, Mayu; Tomoike, Fumiaki; Kimura, Yasuaki; Abe, Hiroshi] Nagoya Univ, Dept Chem, Grad Sch Sci, Nagoya, Aichi, Japan; [Okuno, Hiroyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Tokyo, Japan	Waseda University; Nagoya University; Kagoshima University; University of Tokyo	Inoue, T (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Tokyo, Japan.	inoue.t@waseda.jp	ABE, Hiroshi/CAG-4088-2022; Inoue, Takafumi/AAM-9533-2020; Bito, Haruhiko/A-8635-2008	ABE, Hiroshi/0000-0003-0048-3789; Inoue, Takafumi/0000-0002-2728-0060; Hatashita, Yoshiki/0000-0002-5108-5986; Kimura, Yasuaki/0000-0002-3609-602X; OKUNO, HIROYUKI/0000-0001-6237-6503; Bito, Haruhiko/0000-0001-6315-9594	Japan Society for the Promotion of Science (JSPS) [23300121, 26640016]; Private University Research Branding Project (MEXT, Japan); Waseda University	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Private University Research Branding Project (MEXT, Japan); Waseda University	This work was supported by Grants-in-Aid for Scientific Research 23300121 and 26640016 from the Japan Society for the Promotion of Science (JSPS) (to T. I.), the Private University Research Branding Project (MEXT, Japan) (to T. I.), and Waseda University Grants for Special Research Projects.	Abe H, 2008, BIOCONJUGATE CHEM, V19, P1219, DOI 10.1021/bc800014d; Ashley J, 2018, CELL, V172, P262, DOI 10.1016/j.cell.2017.12.022; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128241; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Das S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3448; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Dynes JL, 2012, J COMP NEUROL, V520, P3105, DOI 10.1002/cne.23073; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Eliscovich C, 2013, J BIOL CHEM, V288, P20361, DOI 10.1074/jbc.R113.452094; Farris S, 2014, J NEUROSCI, V34, P4481, DOI 10.1523/JNEUROSCI.4944-13.2014; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fujii S, 2000, LEARN MEMORY, V7, P312, DOI 10.1101/lm.34100; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Furukawa K, 2011, ANGEW CHEM INT EDIT, V50, P12020, DOI 10.1002/anie.201104425; Furukawa K, 2009, BIOCONJUGATE CHEM, V20, P1026, DOI 10.1021/bc900040t; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gennerich A, 2000, BIOPHYS J, V79, P3294, DOI 10.1016/S0006-3495(00)76561-1; Gennerich A, 2002, BIOPHYS J, V83, P510, DOI 10.1016/S0006-3495(02)75187-4; Glock C, 2017, CURR OPIN NEUROBIOL, V45, P169, DOI 10.1016/j.conb.2017.05.005; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Heidarinejad M, 2018, NEUROSCI RES, V136, P13, DOI 10.1016/j.neures.2018.01.003; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Holt CE, 2019, NAT STRUCT MOL BIOL, V26, P557, DOI 10.1038/s41594-019-0263-5; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Inoue T, 2018, MICROSCOPY-JPN, V67, P129, DOI 10.1093/jmicro/dfy015; Itoh S, 2001, BRAIN RES, V901, P237, DOI 10.1016/S0006-8993(01)02373-3; Jacobs M. H., 1967, DIFFUSION PROCESSES, P67; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kinjo M., 2010, LIVE CELL IMAGING LA, P229; Lifland AW, 2011, TRAFFIC, V12, P1000, DOI 10.1111/j.1600-0854.2011.01209.x; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Mikl M, 2011, EMBO REP, V12, P1077, DOI 10.1038/embor.2011.149; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Pastuzyn ED, 2018, CELL, V172, P275, DOI 10.1016/j.cell.2017.12.024; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Savas JN, 2010, J BIOL CHEM, V285, P13142, DOI 10.1074/jbc.M110.114561; Shin HS, 2013, J PHYS CHEM A, V117, P27, DOI 10.1021/jp307018k; Turner-Bridger B, 2018, P NATL ACAD SCI USA, V115, pE9697, DOI 10.1073/pnas.1806189115; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Urbanek MO, 2014, RNA BIOL, V11, P1083, DOI 10.4161/rna.35506; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wallace CS, 1998, J NEUROSCI, V18, P26; Walton SP, 2002, BIOPHYS J, V82, P366, DOI 10.1016/S0006-3495(02)75401-5; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Wohland T, 2001, BIOPHYS J, V80, P2987, DOI 10.1016/S0006-3495(01)76264-9; Wu B, 2015, CELL, V162, P211, DOI 10.1016/j.cell.2015.05.054; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Yamada T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38910	67	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7923	7940		10.1074/jbc.RA119.010921	http://dx.doi.org/10.1074/jbc.RA119.010921			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341124	hybrid, Green Published			2022-12-26	WOS:000540935400009
J	Li, J; Li, J; Zhao, WG; Sun, HD; Guo, ZG; Liu, XY; Tang, XY; She, ZF; Yuan, T; Liu, SN; Liu, Q; Fu, Y; Sun, W				Li, Jing; Li, Juan; Zhao, Wei-Gang; Sun, Hai-Dan; Guo, Zheng-Guang; Liu, Xiao-Yan; Tang, Xiao-Yue; She, Zhu-Fang; Yuan, Tao; Liu, Shuai-Nan; Liu, Quan; Fu, Yong; Sun, Wei			Comprehensive proteomics and functional annotation of mouse brown adipose tissue	PLOS ONE			English	Article							FATTY-ACID OXIDATION; GENE-EXPRESSION; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; PROTEIN; ADIPOCYTES; OBESITY; WHITE; NOREPINEPHRINE; CELL	Knowledge about the mouse brown adipose tissue (BAT) proteome can provide a deeper understanding of the function of mammalian BAT. Herein, a comprehensive analysis of interscapular BAT from C57BL/6J female mice was conducted by 2DLC and high-resolution mass spectrometry to construct a comprehensive proteome dataset of mouse BAT proteins. A total of 4949 nonredundant proteins were identified, and 4495 were quantified using the iBAQ method. According to the iBAQ values, the BAT proteome was divided into high-, middle- and low-abundance proteins. The functions of the high-abundance proteins were mainly related to glucose and fatty acid oxidation to produce heat for thermoregulation, while the functions of the middle- and low-abundance proteins were mainly related to protein synthesis and apoptosis, respectively. Additionally, 497 proteins were predicted to have signal peptides using SignalP4 software, and 75 were confirmed in previous studies. This study, for the first time, comprehensively profiled and functionally annotated the BAT proteome. This study will be helpful for future studies focused on biomarker identification and BAT molecular mechanisms.	[Li, Jing; Sun, Hai-Dan; Guo, Zheng-Guang; Liu, Xiao-Yan; Tang, Xiao-Yue; Sun, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Core Facil Instrument, Beijing, Peoples R China; [Li, Juan; Zhao, Wei-Gang; Yuan, Tao; Fu, Yong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Minist Hlth, Beijing, Peoples R China; [Li, Juan; Zhao, Wei-Gang; Yuan, Tao; Fu, Yong] Peking Union Med Coll, Beijing, Peoples R China; [She, Zhu-Fang; Liu, Shuai-Nan; Liu, Quan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China; [She, Zhu-Fang; Liu, Shuai-Nan; Liu, Quan] Chinese Acad Med Sci, Peking Union Med Coll, Diabet Res Ctr, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Sun, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Core Facil Instrument, Beijing, Peoples R China.; Zhao, WG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Minist Hlth, Beijing, Peoples R China.; Zhao, WG (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	xiehezhaoweigang@163.com; sunwei1018@sina.com			National Basic Research Program of China [2013CB530805, 2014CBA02005]; National Key Research and Development Program of China [2016 YFC 1306300, 2018YFC0910202]; Key Basic Research Program of the Ministry of Science and Technology of China [2013FY114100]; National Natural Science Foundation of China [30970650, 31200614, 31400669, 81371515, 81170665, 81560121]; Beijing Natural Science Foundation [7173264, 7172076]; Beijing cooperative construction project [110651103]; Beijing Science Program for the Top Young [2015000021223TD04]; Beijing Normal University [11100704]; Peking Union Medical College Hospital [2016-2.27]; CAMS Innovation Fund for Medical Sciences [2017-I2M-1-009]; Biologic Medicine Information Center of China, National Scientific Data Sharing Platform for Population and Health	National Basic Research Program of China(National Basic Research Program of China); National Key Research and Development Program of China; Key Basic Research Program of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing cooperative construction project; Beijing Science Program for the Top Young; Beijing Normal University; Peking Union Medical College Hospital; CAMS Innovation Fund for Medical Sciences; Biologic Medicine Information Center of China, National Scientific Data Sharing Platform for Population and Health	This work was supported by National Basic Research Program of China (No. 2013CB530805, 2014CBA02005), National Key Research and Development Program of China (No. 2016 YFC 1306300,2018YFC0910202), Key Basic Research Program of the Ministry of Science and Technology of China (No. 2013FY114100), National Natural Science Foundation of China (No. 30970650, 31200614, 31400669, 81371515, 81170665, 81560121), Beijing Natural Science Foundation (No. 7173264, 7172076), Beijing cooperative construction project (No.110651103), Beijing Science Program for the Top Young (No.2015000021223TD04), Beijing Normal University (No.11100704), Peking Union Medical College Hospital (No.2016-2.27), CAMS Innovation Fund for Medical Sciences (2017-I2M-1-009) and Biologic Medicine Information Center of China, National Scientific Data Sharing Platform for Population and Health.	Ali Khan A., 2018, MOL CELL PROTEOMICS; [Anonymous], 2018, F1000RESEARCH; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Ballinger MA, 2016, AM J PHYSIOL-REG I, V311, pR325, DOI 10.1152/ajpregu.00463.2015; Briscini L, 1998, FEBS LETT, V431, P80, DOI 10.1016/S0014-5793(98)00730-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chatterjee R, 2011, J MOL ENDOCRINOL, V46, P175, DOI 10.1530/JME-10-0172; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Chondronikola Maria, 2015, Diabetes, V64, pe14, DOI 10.2337/db15-0147; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; da Silva CPV, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010009; Desautels M, 1996, AM J PHYSIOL-REG I, V270, pR1287; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang B, 2018, J DAIRY SCI, V101, P4853, DOI 10.3168/jds.2017-13731; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Fu QF, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0117-5; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gunawardana SC, 2012, ADIPOCYTE, V1, P250, DOI 10.4161/adip.21042; Hankir MK, 2018, EMBO REP, V19, DOI 10.15252/embr.201846404; Harshaw C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087405; Heeren J, 2018, CURR OPIN LIPIDOL, V29, P180, DOI 10.1097/MOL.0000000000000504; HELLMAN B, 1961, ACTA PATHOL MIC SC, V51, P347; HIMMSHAGEN J, 1989, PROG LIPID RES, V28, P67, DOI 10.1016/0163-7827(89)90009-X; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kamal AM, 2013, J PROTEOMICS, V94, P327, DOI 10.1016/j.jprot.2013.10.005; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Klepac K, 2019, MOL ASPECTS MED, V68, P90, DOI 10.1016/j.mam.2019.07.001; Kuipers EN, 2019, AM J PHYSIOL-ENDOC M, V317, pE820, DOI 10.1152/ajpendo.00123.2019; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Li G, 2002, NEUROSCIENCE, V115, P879, DOI 10.1016/S0306-4522(02)00447-5; Li J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119350; LI JX, 1988, BIOCHEMISTRY-US, V27, P5995, DOI 10.1021/bi00416a025; Lin HB, 2014, J PROTEOMICS, V106, P74, DOI 10.1016/j.jprot.2014.04.026; Lindquist JM, 1998, J BIOL CHEM, V273, P30147, DOI 10.1074/jbc.273.46.30147; Liu XY, 2017, J PROTEOME RES, V16, P2680, DOI 10.1021/acs.jproteome.6b00914; Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P541, DOI 10.1139/Y02-078; Muller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30030; Navet R, 2007, J PROTEOME RES, V6, P25, DOI 10.1021/pr060064u; Nedergaard J., 2018, BIOCH BIOPHYS ACTA; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Payab M, 2018, ADV EXP MED BIOL, V1089, P1, DOI 10.1007/5584_2018_227; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pisani DF, 2016, ADIPOCYTE, V5, P186, DOI 10.1080/21623945.2015.1122854; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sanchez JC, 2001, PROTEOMICS, V1, P136; Sanchez-Delgado G, 2015, ANN NUTR METAB, V67, P21, DOI 10.1159/000437173; Scheja L, 2016, J HEPATOL, V64, P1176, DOI 10.1016/j.jhep.2016.01.025; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Schosserer M, 2018, GERONTOLOGY, V64, P229, DOI 10.1159/000485183; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Sebaa R, 2019, MOL METAB, V25, P35, DOI 10.1016/j.molmet.2019.04.008; Small L, 2018, J ENDOCRINOL, V239, P313, DOI 10.1530/JOE-18-0279; Song SH, 2010, DOMEST ANIM ENDOCRIN, V39, P97, DOI 10.1016/j.domaniend.2010.02.007; van der Veen DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047692; van der Veen DR, 2012, OBESITY, V20, P1527, DOI 10.1038/oby.2012.78; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Villarroya J., 2019, J ENDOCRINOL, DOI [10.1038/srep30030, DOI 10.1038/SREP30030]; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; WALDBILLIG D, 1992, AM J PHYSIOL, V263, pR1003; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wisniewski JR, 2018, METHODS MOL BIOL, V1841, P3, DOI 10.1007/978-1-4939-8695-8_1; Wu ZL, 2012, CURR OPIN CLIN NUTR, V15, P529, DOI 10.1097/MCO.0b013e3283595cff; Yamada K., 2018, J HUM GENET, DOI [10.1016/j.jprot.2014.04.026, DOI 10.1016/J.JPROT.2014.04.026]; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	77	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232084	10.1371/journal.pone.0232084	http://dx.doi.org/10.1371/journal.pone.0232084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374735	gold, Green Published			2022-12-26	WOS:000537283500020
J	El-Gabri, D; Barcenas, LK; Meier, B; Mvungi, M; Haglund, M; Gerardo, CJ; Vissoci, JRN; Staton, CA				El-Gabri, Deena; Barcenas, Loren K.; Meier, Brian; Mvungi, Mark; Haglund, Michael; Gerardo, Charles J.; Vissoci, Joao Ricardo N.; Staton, Catherine A.			Injury patients' perceptions of drink-driving: A qualitative assessment of drink-driving behavior in Moshi, Tanzania	PLOS ONE			English	Article							DRIVERS; ALCOHOL; SAFETY	Background Globally, about 2.3 billion people are current alcohol drinkers, and 283 million have an alcohol use disorder. Alcohol use while driving is a major contributor to road traffic injuries (RTI). We need to understand the culture and perception of drink-driving in this setting to understand why people continue to drink drive and allow policymakers to develop more effective ways to address drink-driving behavior. This study aims to qualitatively determine what injury patients, their families, and community advisory board members in Tanzania believe about drink-driving to help inform policies to address this problem. Methods The semi-structured focus group was designed based on the grounded theory and assessed using thematic analysis. Focus groups participants were a convenience sample of injury patients, their families, and community advisory board (CAB) members. Analysis was iterative throughout the study. All transcripts were coded using a thematic narrative approach. Representative quotes for each theme were then selected based on comparative analysis of coding with input from research team members. Results A total of ten focus groups were conducted (4 patient, 4 family, and 2 CAB) with a total of 104 participants (37 females and 67 males). The normalization of drinking among drivers has allowed this behavior to become ingrained in the culture. Participants expressed notions that passengers are responsible for their own safety, rather than drivers being responsible for their passengers. Most participants believe it is a citizen's duty to inform the police of suspected drink-driving, however there were differing opinions about how effective informed police officers can be in practice. Focus group discussions between all three population types highlighted major themes of 'drinking is ingrained in boda boda driver culture', 'individuals have a personal responsibility to address drink-driving', and a 'police enforcement on drink-driving is necessary'. Conclusions Normalization of drink-driving in commercial driver culture creates a dangerous environment for passengers which can be mitigated by education and health promotion. As most passengers already take personal responsibility for their own road traffic safety, they may be likely to make use of safe ride options, if available. While legislation is in place against drink-driving, police officers need to be empowered with appropriate training and funding to enforce them.	[El-Gabri, Deena; Barcenas, Loren K.; Meier, Brian; Gerardo, Charles J.; Vissoci, Joao Ricardo N.; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Meier, Brian; Gerardo, Charles J.; Vissoci, Joao Ricardo N.; Staton, Catherine A.] Duke Univ, Dept Surg, Sch Med, Div Emergency Med, Durham, NC 27708 USA; [Mvungi, Mark] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Haglund, Michael] Duke Univ, Sch Med, Dept Neurosurg, Div Neurosurg & Neurol, Durham, NC USA	Duke University; Duke University; Kilimanjaro Christian Medical Centre; Duke University	Vissoci, JRN (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Vissoci, JRN (corresponding author), Duke Univ, Dept Surg, Sch Med, Div Emergency Med, Durham, NC 27708 USA.	jnv4@duke.edu		Meier, Brian/0000-0002-5848-8163; Staton, Catherine/0000-0002-6468-2894	Fogarty International Center of the National Institutes of Health [K01TW010000]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the Fogarty International Center of the National Institutes of Health under Award Number K01TW010000 (PI, Staton). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Astrom AN, 2006, ACCIDENT ANAL PREV, V38, P54, DOI 10.1016/j.aap.2005.06.022; Chun Tie Y, 2019, SAGE OPEN MED, P7; Corbin JH, 2016, GLOB HEALTH PROMOT, V23, P72, DOI 10.1177/1757975915569514; Decina LE, 2009, ALTERNATIVE TRANSPOR; Erke A, 2009, ACCIDENT ANAL PREV, V41, P914, DOI 10.1016/j.aap.2009.05.005; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Goel N, 2008, CAN CON EL COMP EN, P1036; Goodwin AH, 2015, COUNTERMEASURES WORK, V2015; Jiang H, 2015, INJURY PREV, V21, P77, DOI 10.1136/injuryprev-2014-041303; Kircher K, 2013, TRAFFIC INJ PREV, V14, P103, DOI 10.1080/15389588.2012.671982; Le Gal G, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.064010; Li Q, 2015, ADDICTION, V110, P68, DOI 10.1111/add.12784; Livingood WC, 2016, HEALTH EDUC BEHAV, V43, P133, DOI 10.1177/1090198115626914; Longabaugh R, 2001, J STUD ALCOHOL, V62, P806, DOI 10.15288/jsa.2001.62.806; Lyft, ZERO TOL DRUG ALC PO; Lyft, BEC RIV GET RID NOW; McQueen J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005191, 10.1002/14651858.CD005191.pub3]; Ministry of Infrastructure Development Dar es Salaam, 2009, UN REP TANZ NAT ROAD; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Organization, 2019, GLOB STAT REP ALC HL; Riessman CK., 1993, NARRATIVE ANAL, V30; Ristic B, 2013, EUR J TRAUMA EMERG S, V39, P363, DOI 10.1007/s00068-013-0276-4; ROSS HL, 1984, ANNU REV SOCIOL, V10, P21; Staton C., 2015, ADDRESSING HIGH RISK; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Staton CA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5144-z; Sumner SA, 2014, INJURY, V45, P1681, DOI 10.1016/j.injury.2014.04.034; Tusekwa AB, 2000, INT J FOOD SCI NUTR, V51, P135, DOI [10.1080/096374899101337, 10.1080/096374800100831]; Uber, EARN MON DRIV GET RI; Waldon M, 2018, INT J INJ CONTROL SA, P1; Walsh I, 2015, ORGAN RES METHODS, V18, P581, DOI 10.1177/1094428114565028; Weiss HA, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020153; World Health Organization, 2009, GLOB STAT REP ROAD S; Zimmerman K, 2012, ACCIDENT ANAL PREV, V45, P204, DOI 10.1016/j.aap.2011.06.018	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0230662	10.1371/journal.pone.0230662	http://dx.doi.org/10.1371/journal.pone.0230662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7XS	32369492	gold, Green Published			2022-12-26	WOS:000537280000004
J	Wang, CH; Wu, LD; Wang, ZY; Alabady, MS; Parson, D; Molumo, Z; Fankhauser, SC				Wang, Charlotte H.; Wu, Linda; Wang, Zengyan; Alabady, Magdy S.; Parson, Daniel; Molumo, Zainab; Fankhauser, Sarah C.			Characterizing changes in soil microbiome abundance and diversity due to different cover crop techniques	PLOS ONE			English	Article							ORGANIC-CARBON; COMMUNITY; BIOMASS; MANAGEMENT; GROWTH	Soil-based microorganisms assume a direct and crucial role in the promotion of soil health, quality and fertility, all factors known to contribute heavily to the quality and yield of agricultural products. Cover cropping, used in both traditional and organic farming, is a particularly efficient and environmentally favorable tool for manipulating microbiome composition in agricultural soils and has had clear benefits for soil quality and crop output. Several long-term investigations have evaluated the influence of multi-mix (multiple species) cover crop treatments on soil health and microbial diversity. The present study investigated the short-term effects of a seven species multi-mix cover crop treatment on soil nutrient content and microbial diversity, compared to a single-mix cover crop treatment and control. Analysis of 16S sequencing data of isolated soil DNA revealed that the single-mix cover crop treatment decreased overall microbial abundance and diversity, whereas the control and multi-mix treatments altered the overall microbial composition in similar fluctuating trends. Furthermore, we observed significant changes in specific bacteria belonging to the phyla Acidobacteria, Actinobacteria, Planctomycetes, Proteobacteria and Verrucombicrobia for all treatments, but only the single-mix significantly decreased in abundance of the selected bacteria over time. Our findings indicate that the control and multi-mix treatments are better at maintaining overall microbial composition and diversity compared to the single-mix. Further study is required to elucidate the specific difference between the treatment effect of the multi-mix treatment and the control, given that their microbial composition changes over time were similar but they diverge into two populations of unique bacterial types by the end of this short-term study.	[Wang, Charlotte H.; Parson, Daniel; Molumo, Zainab; Fankhauser, Sarah C.] Emory Univ, Oxford Coll, Oxford, GA 30054 USA; [Wang, Charlotte H.; Wu, Linda] Emory Univ, Atlanta, GA 30322 USA; [Wang, Zengyan] Univ Georgia, Comp Sci Dept, Athens, GA 30602 USA; [Alabady, Magdy S.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Parson, Daniel] Oxford Coll Organ Farm, Oxford, GA USA	Emory University; Emory University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Fankhauser, SC (corresponding author), Emory Univ, Oxford Coll, Oxford, GA 30054 USA.	sarah.fankhauser@emory.edu	Alabady, Magdy/AGZ-6286-2022	Wang, Charlotte Hui/0000-0001-7588-2077; Alabady, Magdy/0000-0002-1601-682X; Fankhauser, Sarah/0000-0001-5121-4509	Oxford College of Emory University	Oxford College of Emory University	We are grateful to Oxford College of Emory University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; Allen DE, 2011, SOIL BIOL, V29, P25, DOI 10.1007/978-3-642-20256-8_2; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P317, DOI 10.1016/S0038-0717(98)00121-7; Beulig F, 2015, ISME J, V9, P746, DOI 10.1038/ismej.2014.148; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chen C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09258-y; Chen S, 2020, MICROBIOL RES, V231, DOI 10.1016/j.micres.2019.126373; Chu MW, 2017, AGR ENV LETT, V2, DOI 10.2134/ael2017.09.0030; Creamer N, SUMMER COVER CROPS N; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Santos MOD, 2019, FLORESTA AMBIENTE, V26, DOI 10.1590/2179-8087.103717; Fuerst JA, 2017, MICROBIAL RESOURCES: FROM FUNCTIONAL EXISTENCE IN NATURE TO APPLICATIONS, P1, DOI 10.1016/B978-0-12-804765-1.00001-1; Gaby J.C., 2014, DATABASE, V2014; Glockner FO, 2017, J BIOTECHNOL, V261, P169, DOI 10.1016/j.jbiotec.2017.06.1198; Haramoto ER, 2004, RENEW AGR FOOD SYST, V19, P187, DOI [10.1079/RAFS200490, 10.1079/RAF200490]; Illumina, 2013, 15044223 ILL; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kusserow Kalina, 2017, J Genomics, V5, P75, DOI 10.7150/jgen.19673; Li L, 2018, PLOS ONE, V13; Locke MA, 2013, SOIL SCI SOC AM J, V77, P974, DOI 10.2136/sssaj2012.0325; Mazzoncini M, 2011, SOIL TILL RES, V114, P165, DOI 10.1016/j.still.2011.05.001; Mert MC, 2016, MATH GEOSCI, V48, P941, DOI 10.1007/s11004-016-9646-x; Nair A, 2012, APPL SOIL ECOL, V58, P45, DOI 10.1016/j.apsoil.2012.03.008; Qin S, 2011, APPL MICROBIOL BIOT, V89, P457, DOI 10.1007/s00253-010-2923-6; Ruwanza S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11010140; Sage RF, 2011, J EXP BOT, V62, P2989, DOI 10.1093/jxb/err179; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Shannon C.E., 1999, MATH THEORY COMMUNIC; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Shiri J, 2017, COMPUT ELECTRON AGR, V135, P242, DOI 10.1016/j.compag.2017.02.016; Tecon R, 2017, FEMS MICROBIOL REV, V41, P599, DOI 10.1093/femsre/fux039; Tilak KVBR, 2005, CURR SCI INDIA, V89, P136; Tveit AT, 2019, P NATL ACAD SCI USA, V116, P8515, DOI 10.1073/pnas.1817812116; Vukicevich E, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0385-7; Weil R. R., 2003, American Journal of Alternative Agriculture, V18, P3, DOI 10.1079/AJAA2003003; Wolinska A, 2017, APPL SOIL ECOL, V119, P128, DOI 10.1016/j.apsoil.2017.06.009; Xun WB, 2015, SOIL BIOL BIOCHEM, V90, P10, DOI 10.1016/j.soilbio.2015.07.018; Zavalloni C, 2011, APPL SOIL ECOL, V50, P45, DOI 10.1016/j.apsoil.2011.07.012	43	10	10	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232453	10.1371/journal.pone.0232453	http://dx.doi.org/10.1371/journal.pone.0232453			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369501	gold, Green Published			2022-12-26	WOS:000537280000030
J	Lee, YJ; Ting, WH; Yang, YW; Lin, CJ; Hsieh, YT; Huang, CY; Lo, FS; Chu, CC; Lin, CL; Lin, WS; Lai, TS				Lee, Yann-Jinn; Ting, Wei-Hsin; Yang, Yi-Wen; Lin, Cheng-Jui; Hsieh, Yu-Ting; Huang, Chi-Yu; Lo, Fu-Sung; Chu, Chen-Chung; Lin, Chiung-Ling; Lin, Wen-Shan; Lai, Thung-S.			HLA-DQ genotype and biochemical characterization of anti-transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan	FASEB JOURNAL			English	Article						autoantibodies; celiac disease; Gliadin; Gluten; HLA-DQB1 genotyping; transglutaminase 2	CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; AUTOANTIBODIES; BINDING; RISK; PREVALENCE; GENETICS; DOMAINS; SURFACE	Human Leukocyte Antigen (HLA)-DQ2 and HLA-DQ8 are genetic risk factors for Type 1 Diabetes Mellitus (T1DM) and Celiac disease (CD) in Caucasians, but their association with Taiwanese Han population is unknown. We screened 532 Taiwanese T1DM patients for CD biomarkers including anti-tissue transglutaminase (TGM2), anti-gliadin and anti-neoepitope antibodies (Abs), sequencing DQB1 genotypes, and characterized the TGM2 Abs. We report that 3.76% of Taiwanese patients had TGM2-Abs and all had no CD's symptoms. In contrast to Caucasian's CD patients, DQ2/DQ8 only constituted 4/5 of TGM2-Abs positive patients, while the other 1/5 patients belonged to different HLA genotypes. Either anti-gliadin or anti-neoepitope Abs coexisted with 3/4 of TGM2-Abs positive patients that were likely due to gluten-ingestion, while the cause of TGM2-Abs production for other 1/4 of patients was unknown. Purified anti-TGM2 IgA (TGA) and anti-TGM2 IgG (TGG) could bind on endothelial cells surface, recognized native better than denatured forms of TGM2, and TGA inhibited TGM2's transamidation activity by up to 80% but TGG had no effects. Epitope mapping of all TGM2-Abs positive sera demonstrated that TGM2-Abs had heterogeneity in specificities. This is the first study on the differences between Taiwanese Han group and Caucasian in HLA genotypes and properties of TGM2-Abs.	[Lee, Yann-Jinn; Yang, Yi-Wen; Hsieh, Yu-Ting; Lai, Thung-S.] MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan; [Lee, Yann-Jinn; Ting, Wei-Hsin; Huang, Chi-Yu] MaKkay Med Coll, Dept Med, New Taipei, Taiwan; [Lee, Yann-Jinn; Ting, Wei-Hsin; Huang, Chi-Yu] MacKay Childrens Hosp, Dept Pediat Endocrinol, Taipei, Taiwan; [Lee, Yann-Jinn; Chu, Chen-Chung; Lin, Chiung-Ling; Lin, Wen-Shan] MacKay Mem Hosp Tamsui Dist, Dept Med Res, New Taipei, Taiwan; [Lee, Yann-Jinn] Taipei Med Univ, Sch Med, Dept Pediat, Coll Med, Taipei, Taiwan; [Ting, Wei-Hsin; Lin, Cheng-Jui; Huang, Chi-Yu] MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Lin, Cheng-Jui] Mackay Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Hsieh, Yu-Ting] MacKay Mem Hosp, Dept Clin Lab, Taipei, Taiwan; [Lo, Fu-Sung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lo, Fu-Sung] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan	Mackay Medical College; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Mackay Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Lai, TS (corresponding author), MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.	lai00002@mmc.edu.tw			MacKay Memorial Hospital [MMH104, MMH105, MMH106, MMH E-105-07]; MacKay Medical College [1022D03, 1012A08, 1041B14, 1041C01]	MacKay Memorial Hospital; MacKay Medical College	MacKay Memorial Hospital, Grant/Award Number: MMH104, MMH105, MMH106 and MMH E-105-07; MacKay Medical College, Grant/Award Number: 1022D03, 1012A08, 1041B14 and 1041C01	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; American Diabetes Association, 2020, Diabetes Care, V43, pS163, DOI 10.2337/dc20-S013; Araya M, 2015, NUTRIENTS, V7, P4955, DOI 10.3390/nu7064955; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Bodd M, 2012, HUM IMMUNOL, V73, P376, DOI 10.1016/j.humimm.2012.01.016; Byrne G, 2007, GUT, V56, P336, DOI 10.1136/gut.2006.092908; Caputo I, 2009, AMINO ACIDS, V36, P693, DOI 10.1007/s00726-008-0120-z; Cardoso I, 2017, AMINO ACIDS, V49, P489, DOI 10.1007/s00726-016-2296-y; Cardoso I, 2015, FEBS J, V282, P2063, DOI 10.1111/febs.13276; Choung RS, 2019, GASTROENTEROLOGY, V156, P582, DOI 10.1053/j.gastro.2018.10.025; Ciclitira Paul J., 2005, Molecular Aspects of Medicine, V26, P421, DOI 10.1016/j.mam.2005.05.001; Comerford R, 2012, J PEDIATR GASTR NUTR, V55, P445, DOI 10.1097/MPG.0b013e318251419f; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; DeMelo EN, 2015, CAN J DIABETES, V39, P513, DOI 10.1016/j.jcjd.2015.06.006; Dieterich W, 2003, GUT, V52, P1562, DOI 10.1136/gut.52.11.1562; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Ferrara F, 2010, CLIN EXP IMMUNOL, V159, P217, DOI 10.1111/j.1365-2249.2009.04054.x; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kiraly R, 2008, DOCTOR PHILOS, P1; Kurppa K, 2014, GASTROENTEROLOGY, V147, P610, DOI 10.1053/j.gastro.2014.05.003; Lai TS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16342-0; Lai TS, 2017, AMINO ACIDS, V49, P501, DOI 10.1007/s00726-016-2270-8; Lai TS, 2013, FRONT BIOSCI-LANDMRK, V18, P504, DOI 10.2741/4117; Lai TS, 1996, J BIOL CHEM, V271, P31191, DOI 10.1074/jbc.271.49.31191; Lebwohl B, 2018, LANCET, V391, P70, DOI 10.1016/S0140-6736(17)31796-8; Lerner A, 2016, J IMMUNOL METHODS, V429, P15, DOI 10.1016/j.jim.2015.12.006; LIBLAU RS, 1992, APMIS, V100, P709, DOI 10.1111/j.1699-0463.1992.tb03988.x; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lundin KEA, 2015, NAT REV GASTRO HEPAT, V12, P507, DOI 10.1038/nrgastro.2015.136; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Peracchi M, 2002, AM J GASTROENTEROL, V97, P2850; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rauhavirta Tiina, 2019, Clin Rev Allergy Immunol, V57, P23, DOI 10.1007/s12016-016-8557-4; Seissler J, 2001, CLIN EXP IMMUNOL, V125, P216, DOI 10.1046/j.1365-2249.2001.01584.x; Simon-Vecsei Z, 2012, P NATL ACAD SCI USA, V109, P431, DOI 10.1073/pnas.1107811108; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; Sollid LM, 2005, CLIN GASTROENTEROL H, V3, P843, DOI 10.1016/S1542-3565(05)00532-X; Tinto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138324; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Wang HL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001779	50	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8459	8474		10.1096/fj.202000269R	http://dx.doi.org/10.1096/fj.202000269R		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32362042	hybrid			2022-12-26	WOS:000530050400001
J	Roche, JA; Roche, R				Roche, Joseph A.; Roche, Renuka			A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications	FASEB JOURNAL			English	Article						bradykinin; bradykinin receptor; coronavirus; icatibant; inflammation; injury	B-2 RECEPTOR ANTAGONIST; ENZYME 2 ACE2; HEREDITARY ANGIOEDEMA; ICATIBANT; INHIBITORS; HYPERRESPONSIVENESS; EOSINOPHILIA; ATTACKS; CELLS; TRIAL	As of April 20, 2020, over time, the COVID-19 pandemic has resulted in 157 970 deaths out of 2 319 066 confirmed cases, at a Case Fatality Rate of similar to 6.8%. With the pandemic rapidly spreading, and health delivery systems being overwhelmed, it is imperative that safe and effective pharmacotherapeutic strategies are rapidly explored to improve survival. In this paper, we use established and emerging evidence to propose a testable hypothesis that, a vicious positive feedback loop of des-Arg(9)-bradykinin- and bradykinin-mediated inflammation -> injury -> inflammation, likely precipitates life threatening respiratory complications in COVID-19. Through our hypothesis, we make the prediction that the FDA-approved molecule, icatibant, might be able to interrupt this feedback loop and, thereby, improve the clinical outcomes. This hypothesis could lead to basic, translational, and clinical studies aimed at reducing COVID-19 morbidity and mortality.	[Roche, Joseph A.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, 259 Mack Ave, Detroit, MI 48201 USA; [Roche, Renuka] Eastern Michigan Univ, Coll Hlth & Human Serv, Ypsilanti, MI 48197 USA	Wayne State University; Eastern Michigan University	Roche, JA (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, 259 Mack Ave, Detroit, MI 48201 USA.	joseph.roche@wayne.edu			Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University	Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University	Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University (EACPHS, WSU)	Al-Shamlan F, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1060-8; Allen TC, 2014, ARCH PATHOL LAB MED, V138, P266, DOI 10.5858/arpa.2013-0182-RA; American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), 2020, COVID 19 AN REP TOOL, V2020; Bas M, 2015, NEW ENGL J MED, V372, P418, DOI 10.1056/NEJMoa1312524; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Breil I, 1997, ACTA PHYSIOL SCAND, V159, P189, DOI 10.1046/j.1365-201X.1997.549324000.x; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; Cabrini DA, 1997, EUR J PHARMACOL, V331, P31, DOI 10.1016/S0014-2999(97)01010-8; Cadnapaphornchai MA, 2004, AM J PHYSIOL-RENAL, V286, pF875, DOI 10.1152/ajprenal.00243.2003; Charignon D, 2012, EXPERT OPIN PHARMACO, V13, P2233, DOI 10.1517/14656566.2012.723692; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Copaken D, 2020, MY WHOLE HOUSEHOLD H, V2020; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Duchene J, 2009, CURR OPIN PHARMACOL, V9, P125, DOI 10.1016/j.coph.2008.11.011; Farkas H, 2011, CLIN COSMET INVESTI, V4, P61, DOI 10.2147/CCID.S10322; FARMER SG, 1992, BRIT J PHARMACOL, V107, P653, DOI 10.1111/j.1476-5381.1992.tb14502.x; Fung TS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00296; Gainer JV, 1996, J ALLERGY CLIN IMMUN, V98, P283, DOI 10.1016/S0091-6749(96)70151-3; Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114; GAVRAS I, 1992, KIDNEY INT, V42, P1020, DOI 10.1038/ki.1992.383; Gibbs CR, 1999, BRIT J CLIN PHARMACO, V48, P861; Giwa Al, 2020, Emerg Med Pract, V22, P1; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hudey SN, 2017, J ALLER CL IMM-PRACT, V5, P610, DOI 10.1016/j.jaip.2017.03.017; Ingelheim B, 2014, SAFETY TOLERABILITY; Ingelheim B, 2010, SAFETY TOLERABILITY; Jia HP, 2016, SHOCK, V46, P239, DOI 10.1097/SHK.0000000000000633; Johns Hopkins University and Medicine, 2020, RAC DAT TRANSP STAT, V2020; Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lim Yvonne Xinyi, 2016, Diseases, V4, DOI 10.3390/diseases4030026; Lumry WR, 2011, ANN ALLERG ASTHMA IM, V107, P529, DOI 10.1016/j.anai.2011.08.015; Maas C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02046; Manolis AJ, 2010, HYPERTENS RES, V33, P772, DOI 10.1038/hr.2010.82; Mo P., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]; Molinaro G, 2006, KIDNEY INT, V70, P1823, DOI 10.1038/sj.ki.5001873; Molinaro G, 2002, J PHARMACOL EXP THER, V303, P232, DOI 10.1124/jpet.102.038067; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Murray J, 2020, THIS REALLY HURTS MA, V2020; Murugesan P, 2016, J INFECT DIS, V213, P532, DOI 10.1093/infdis/jiv426; NEILDWYER G, 1989, J HUM HYPERTENS, V3, P169; Perricone C, 2011, ALLERGY, V66, P149, DOI 10.1111/j.1398-9995.2010.02453.x; RHALEB NE, 1992, EUR J PHARMACOL, V210, P115, DOI 10.1016/0014-2999(92)90661-M; Saule C, 2013, CLIN EXP ALLERGY, V43, P475, DOI 10.1111/cea.12055; Shafiq A, 2020, INT J BREAST CANCER, V2020, DOI 10.1155/2020/4824813; Sodhi CP, 2018, AM J PHYSIOL-LUNG C, V314, pL17, DOI 10.1152/ajplung.00498.2016; Tom B, 2002, BRIT J PHARMACOL, V137, P276, DOI 10.1038/sj.bjp.0704862; Turner P, 2001, J ALLERGY CLIN IMMUN, V107, P105, DOI 10.1067/mai.2001.111145; Walter LA, 2020, WEST J EMERG MED, V21, P507, DOI 10.5811/westjem.2020.4.47536; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Woodard-Grice AV, 2010, PHARMACOGENET GENOM, V20, P532, DOI 10.1097/FPC.0b013e32833d3acb; World Health Organization (WHO), 2020, WHO HLTH EM DASHB WH, V2020; World Health Organization (WHO), OFF LAB US MED COVID, V2020; Yan CH, 2020, INT FORUM ALLERGY RH, V10, P806, DOI 10.1002/alr.22579; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yeung YS, 2008, VIROLOGY, V371, P32, DOI 10.1016/j.virol.2007.09.016; Zanichelli A, 2017, ALLERGY, V72, P994, DOI 10.1111/all.13103	60	79	79	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7265	7269		10.1096/fj.202000967	http://dx.doi.org/10.1096/fj.202000967		MAY 2020	5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359101	Green Published			2022-12-26	WOS:000530047600001
J	Yu, L; Dong, L; Li, H; Liu, ZJ; Luo, Z; Duan, GJ; Dai, XT; Lin, ZH				Yu, Le; Dong, Ling; Li, Hui; Liu, Zhaojian; Luo, Zhong; Duan, Guangjie; Dai, Xiaotian; Lin, Zhenghong			Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis	ONCOGENE			English	Article							DEPENDENT DEGRADATION; DEACETYLASE ACTIVITY; CANCER STATISTICS; PROTEIN SIR2; LIGASE; TRANSCRIPTION; ACTIVATION; REPRESSION; REGULATOR; INTERACTS	The NAD-dependent deacetylase sirtuin 1 (SIRT1), a member of the mammalian sirtuin family, plays a pivotal role in deacetylating histone and nonhistone proteins. Recently, it has been reported that SIRT1 is upregulated in various kinds of tumors and is associated with cell growth and metastasis. However, the factors and molecular mechanism regulating its cellular levels remain to be clarified. Here, we reported that the E3 ubiquitin ligase SMURF2 interacts with SIRT1 and mediates its ubiquitination and degradation. Depletion of SMURF2 leads to SIRT1 upregulation and induces the tumor formation and growth of colorectal cancer in vitro and in vivo. Furthermore, we show a negative correlation between SIRT1 and SMURF2 expression in human colorectal cancer. Thus, we propose a novel mechanism of colorectal tumorigenesis via SIRT1 regulation by SMURF2, which could potentially give rise to a new strategy for the treatment of colorectal cancer.	[Yu, Le; Dong, Ling; Li, Hui; Luo, Zhong; Lin, Zhenghong] Chongqing Univ, Sch Life Sci, Chongqing 401331, Peoples R China; [Liu, Zhaojian] Shandong Univ, Dept Cell Biol, Sch Med, Jinan 250012, Peoples R China; [Duan, Guangjie; Dai, Xiaotian] Third Mil Med Univ, Dept Pulmonol, Southwest Hosp, Chongqing 400038, Peoples R China	Chongqing University; Shandong University; Army Medical University	Lin, ZH (corresponding author), Chongqing Univ, Sch Life Sci, Chongqing 401331, Peoples R China.; Dai, XT (corresponding author), Third Mil Med Univ, Dept Pulmonol, Southwest Hosp, Chongqing 400038, Peoples R China.	daixt1973@163.com; zhenghonglin@cqu.edu.cn	Luo, Zhong/AAU-2225-2020; , Owen/AHE-6976-2022	Luo, Zhong/0000-0002-9019-3314; Lin, Zhenghong/0000-0002-6354-0042	National Natural Science Foundation of China [31571454, 31801181]; 61st Batch of China Postdoctoral Science Fund [2017M610588]; Special Fund for Postdoctoral Research Projects of Chongqing City [Xm2017080]; Fundamental Research Funds for the Central Universities [106112017CDJQJ298833]; Key Laboratory for Experimental Teratology of the Ministry of Education of Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 61st Batch of China Postdoctoral Science Fund; Special Fund for Postdoctoral Research Projects of Chongqing City; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Laboratory for Experimental Teratology of the Ministry of Education of Shandong University	The National Natural Science Foundation of China (Grant Nos. 31571454 and 31801181), the 61st Batch of China Postdoctoral Science Fund (Grant No. 2017M610588), the Special Fund for Postdoctoral Research Projects of Chongqing City (Grant No. Xm2017080), the Fundamental Research Funds for the Central Universities (Project No. 106112017CDJQJ298833), and the funding from Key Laboratory for Experimental Teratology of the Ministry of Education of Shandong University supported this study. We also thank the Analytical and Testing Center of Chongqing University for confocal fluorescence microscopy assistance.	Behrouzfar K, 2017, CELL BIOCHEM FUNCT, V35, P327, DOI 10.1002/cbf.3279; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cha B, 2015, MOL CELLS, V38, P723, DOI 10.14348/molcells.2015.0113; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng FF, 2016, CANCER LETT, V375, P274, DOI 10.1016/j.canlet.2016.03.010; Dong L, 2018, ONCOGENE, V37, P2702, DOI 10.1038/s41388-018-0137-z; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Elias D, 2015, ANN SURG, V261, P157, DOI 10.1097/SLA.0000000000000582; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jeong HM, 2014, BBA-MOL CELL RES, V1843, P2005, DOI 10.1016/j.bbamcr.2014.04.023; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee YS, 2019, ASTROPHYS SPACE SCI, V364, DOI 10.1007/s10509-019-3691-0; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Li Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00299-9; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Olmos Y, 2011, DRUG RESIST UPDATE, V14, P35, DOI 10.1016/j.drup.2010.12.001; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wilking MJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P94, DOI 10.1016/j.abb.2014.04.001; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu L, 2019, CANCER LETT, V448, P40, DOI 10.1016/j.canlet.2019.01.039; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388	51	32	32	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4450	4464		10.1038/s41388-020-1298-0	http://dx.doi.org/10.1038/s41388-020-1298-0		MAY 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32361710				2022-12-26	WOS:000530258200001
J	Choi, JS; Oh, SJ; Sung, YW; Moon, HJ; Lee, JS				Choi, Jae-Sung; Oh, Se Jin; Sung, Yong Won; Moon, Hyeon Jong; Lee, Jeong Sang			Pulse wave velocity is a new predictor of acute kidney injury development after off-pump coronary artery bypass grafting	PLOS ONE			English	Article							RENAL-FUNCTION; STIFFNESS; PRESSURE; DYSFUNCTION; MORTALITY; OUTCOMES; RISK	Background Brachial-ankle pulse wave velocity (baPWV) is the simple, non-invasive, gold-standard method for assessing arterial stiffness. However, baPWV has been shown to be associated with renal dyfunction, with a few reports demonstrating an association between baPWV and postoperative acute kidney injury (AKI) among surgical patients. Methods We retrospectively analyzed preoperative baPWV data that were prospectively collected from 164 patients who underwent off-pump coronary artery bypass grafting (CABG) between April 2013 and July 2019 (mean age: 66.2 +/- 10.3 years, 29.3% females). Primarily, baPWV was investigated as an independent predictor of postoperative AKI development; secondarily, the patients were divided into high and low PWV groups according to the optimal baPWV cut-off value. Postoperative complications, mortality, and mid-term survival were compared between the two groups. Results AKI developed in 30 patients (18.3%). Univariate analysis showed that AKI was significantly associated with baPWV (20.2 +/- 7.3 vs. 16.2 +/- 2.8 m/s, p < 0.001), age, preoperative serum creatinine, and EuroSCORE. Multivariable logistic regression analysis revealed baPWV as independently associated with postoperative AKI even after adjustment for preoperative creatinine, old age (> 75 years), hypertension, diabetes under insulin therapy, and EuroSCORE. Moreover, area under the curve (AUC) analysis indicated that PWV can predict AKI better than preoperative creatinine levels (AUC, 0.781 [95% confidence interval, 0.688-0.874] vs. 0.680 [0.568-0.792]). The group-dividing baPWV cut-off value for AKI was 19 m/s. There were no 30-day mortality. The in-hospital mortality rates in the high and the low PWV groups were 2.2% (n = 1) and 0.8% (n = 1), respectively (p = 0.484). Midterm survival rates were not different between the two groups, but the rate of composite neurologic complication composed of stroke and delirium, was higher, and rate of mechanical ventilatory support was longer, in the high PWV group. Conclusion Brachial-ankle pulse wave velocity was an independent predictor of postoperative AKI following off-pump CABG, and high baPWVs may affect the composite neurologic outcome and the duration of mechanical ventilatory support.	[Choi, Jae-Sung; Oh, Se Jin; Sung, Yong Won; Moon, Hyeon Jong; Lee, Jeong Sang] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Lee, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Boramae Med Ctr, Seoul, South Korea.	jeongsl@snu.ac.kr		Seong, Yongwon/0000-0002-3218-468X; Moon, Hyeon Jong/0000-0001-6038-0197; Lee, Jeong Sang/0000-0003-3239-6452				Benjo A, 2007, HYPERTENSION, V50, P630, DOI 10.1161/HYPERTENSIONAHA.107.095513; Choi JS, 2016, J CARDIOVASC RES, V5, P5; Domanski MJ, 1999, HYPERTENSION, V34, P375, DOI 10.1161/01.HYP.34.3.375; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fontes ML, 2008, ANESTH ANALG, V107, P1122, DOI 10.1213/ane.0b013e31816ba404; Greenwood SA, 2019, J CARDIOTHORAC SURG, V14, DOI 10.1186/s13019-019-0873-3; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Kidher E, 2014, INTERACT CARDIOV TH, V19, P595, DOI 10.1093/icvts/ivu194; Lagny MG, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0066-9; Lazzeri C, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/634903; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Mottram PM, 2005, HEART, V91, P1551, DOI 10.1136/hrt.2004.046805; Nakagawa N, 2008, HYPERTENS RES, V31, P193, DOI 10.1291/hypres.31.193; Ryden L, 2014, CIRCULATION, V130, P2005, DOI 10.1161/CIRCULATIONAHA.114.010622; Schillaci G, 2006, HYPERTENSION, V48, P616, DOI 10.1161/01.HYP.0000240346.42873.f6; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Verhave JC, 2005, HYPERTENSION, V45, P586, DOI 10.1161/01.HYP.0000158843.60830.cf; Williams B, 2010, EUR HEART J, V31, P1819, DOI 10.1093/eurheartj/ehq125	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232377	10.1371/journal.pone.0232377	http://dx.doi.org/10.1371/journal.pone.0232377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353061	gold, Green Published			2022-12-26	WOS:000536673200086
J	Domingues, CHD; Borges, JAR; Ruviaro, CF; Guidolin, DGF; Carrijo, JRM				de Faria Domingues, Carla Heloisa; Rossi Borges, Joao Augusto; Ruviaro, Clandio Favarini; Freire Guidolin, Diego Gomes; Mauad Carrijo, Juliana Rosa			Understanding the factors influencing consumer willingness to accept the use of insects to feed poultry, cattle, pigs and fish in Brazil	PLOS ONE			English	Article							CONVENTIONAL TECHNOLOGIES; FOOD; DETERMINANTS; ATTITUDES; GERMANY; IMPACT	The aim of this study is to investigate the factors influencing consumer willingness to accept the use of insects to feed poultry, cattle, pigs, and fish. To reach this objective, we conducted an online survey with Brazilian consumers. 600 questionnaires were collected. We analyzed data using descriptive statistics and logistic regression models. In general, the use of insects to feed poultry, pigs and cattle was not widely accepted. A more widely acceptance was found for the use of insects to feed fish. The results of logistic regressions models show that positive attitudes are associated with a higher probability of accepting the use of insects to feed poultry, pigs, cattle, and fish. Perceived benefits were associated with a higher likelihood of accepting the use of insects to feed fish. However, perceived benefits were also associated with a lower likelihood of accepting the use of insects to feed poultry. Perceived challenges were associated with a higher likelihood of accepting the use of insects to feed poultry. However, perceived challenges were associated with a lower likelihood of accepting the use of insects to feed pigs.	[de Faria Domingues, Carla Heloisa; Rossi Borges, Joao Augusto; Ruviaro, Clandio Favarini; Mauad Carrijo, Juliana Rosa] Fed Univ Grande Dourados, Dourados, MS, Brazil; [Freire Guidolin, Diego Gomes] Anhanguera Univ Uniderp, Campo Grande, MS, Brazil	Universidade Federal da Grande Dourados	Domingues, CHD (corresponding author), Fed Univ Grande Dourados, Dourados, MS, Brazil.	carlafariadomingues@hotmail.com	Ruviaro, Clandio/E-9988-2010; Borges, Joao Augusto Rossi/F-4306-2016; Domingues, Carla H F/H-2300-2016	Ruviaro, Clandio/0000-0003-3117-5359; Borges, Joao Augusto Rossi/0000-0002-2580-051X; Domingues, Carla H F/0000-0002-0878-2014; Rosa Carrijo Mauad, Juliana/0000-0003-3901-1105	Coordination for Improvement of Higher Education Personnel-CAPES	Coordination for Improvement of Higher Education Personnel-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thank the Coordination for Improvement of Higher Education Personnel-CAPES for the support.	Allegretti G, 2018, J CLEAN PROD, V171, P403, DOI 10.1016/j.jclepro.2017.09.244; Belluco S, 2017, FOOD SECUR, V9, P803, DOI 10.1007/s12571-017-0704-0; da Costa MC, 2000, TRENDS FOOD SCI TECH, V11, P188, DOI 10.1016/S0924-2244(00)00052-2; Llagostera PF, 2019, J CLEAN PROD, V229, P10, DOI 10.1016/j.jclepro.2019.05.012; Fischer ARH, 2009, FOOD QUAL PREFER, V20, P576, DOI 10.1016/j.foodqual.2009.06.008; Gere A, 2017, FOOD QUAL PREFER, V59, P81, DOI 10.1016/j.foodqual.2017.02.005; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hartmann C, 2015, FOOD QUAL PREFER, V44, P148, DOI 10.1016/j.foodqual.2015.04.013; Huis A., 2013, EDIBLE INSECTS FUTUR; Kim WS, 2019, ANNU REV ANIM BIOSCI, V7; Kimenju SC, 2008, AGR ECON-BLACKWELL, V38, P35, DOI 10.1111/j.1574-0862.2007.00279.x; Kline R.B., 2011, PRINCIPLES PRACTICE; Krosnick JA, 2002, PUBLIC OPIN QUART, V66, P371; La Barbera F, 2020, FOOD QUAL PREFER, V79, DOI 10.1016/j.foodqual.2019.103757; Lusk JL, 2003, AM J AGR ECON, V85, P16, DOI 10.1111/1467-8276.00100; Martins Y, 2005, APPETITE, V45, P214, DOI 10.1016/j.appet.2005.08.002; Meyer-Rochow VB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-18; Napier TL, 2004, J FOOD SCI, V69, pR69; Nowlis SM, 2002, J CONSUM RES, V29, P319, DOI 10.1086/344431; Ruviaro CF, 2012, J CLEAN PROD, V28, P9, DOI 10.1016/j.jclepro.2011.10.015; Schosler H, 2012, APPETITE, V58, P39, DOI 10.1016/j.appet.2011.09.009; Sogari G, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9040119; Tan HSG, 2016, FOOD QUAL PREFER, V48, P293, DOI 10.1016/j.foodqual.2015.11.001; Tan HSG, 2015, FOOD QUAL PREFER, V42, P78, DOI 10.1016/j.foodqual.2015.01.013; van Huis A, 2020, J INSECTS FOOD FEED, V6, P27, DOI 10.3920/JIFF2019.0017; Vanhonacker F, 2013, APPETITE, V62, P7, DOI 10.1016/j.appet.2012.11.003; Verbeke W, 2015, ANIM FEED SCI TECH, V204, P72, DOI 10.1016/j.anifeedsci.2015.04.001; Vidigal MCTR, 2015, LWT-FOOD SCI TECHNOL, V60, P832, DOI 10.1016/j.lwt.2014.10.058; Vilela LM, 2018, PRODUCAO INSETOS USO	29	20	21	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0224059	10.1371/journal.pone.0224059	http://dx.doi.org/10.1371/journal.pone.0224059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32352963	Green Published, gold			2022-12-26	WOS:000536673200003
J	Pillay, D; Stankevitz, K; Lanham, M; Ridgeway, K; Murire, M; Briedenhann, E; Jenkins, S; Subedar, H; Hoke, T; Mullick, S				Pillay, Diantha; Stankevitz, Kayla; Lanham, Michele; Ridgeway, Kathleen; Murire, Mercy; Briedenhann, Elmari; Jenkins, Sarah; Subedar, Hasina; Hoke, Theresa; Mullick, Saiqa			Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV	Background South Africa became the first country in Africa to introduce oral PrEP in June 2016. The National Department of Health has used a phased approach to rollout, allowing for a dynamic learn-and-adapt process which will lead ultimately to scale-up. Phased rollout began with provision of oral PrEP at facilities providing services to sex workers in 2016 and was expanded in 2017, first to facilities providing services to MSM and then to students at selected university campus clinics, followed by provision at primary health care facilities. Programmatic data shows variability in initiation and continuation between these populations. This study examines factors related to PrEP initiation, continuation, and discontinuation at facilities providing services to sex workers and MSM during the national PrEP rollout. Methods A cross-sectional survey was administered September 2017-January 2018 among clients (ages 18-62 and providers at 9 facilities implementing oral PrEP in South Africa, followed by in-depth interviews. The client survey captured PrEP initiation, continuation and discontinuation. Analysis was performed in STATA 13 for survey data and thematic analysis was performed in NViVO 11 for in-depth interview data. Results 299 clients (203 from sex worker facilities, 96 from MSM facilities) participated in the survey and additionally, in-depth interviews were conducted with 29 clients. Participants self-identified as either current users (n = 94; 36.2%), past users (n = 80; 30.8%) and never users of PrEP (n = 86; 33.1%). Participants who had never used PrEP either cited not being offered PrEP by a provider (57%, n = 49) or declining PrEP (43%, n = 37) as reasons for lack of uptake. The primary reason for declining to use oral PrEP was fear of side effects (41.7%, n = 15). The primary reasons for initiating and continuing on oral PrEP were all related to perceived risk associated with sexual activity. The majority of participants (87.9%, n = 153) also noted that printed IEC materials influenced their decision to initiate PrEP. Qualitative data suggested that several clients initiated on PrEP because they wanted additional protection beyond using condoms due to challenges such as partners refusing to use condoms, having partners with unknown HIV status, having multiple partners, involvement in sex work, or having a partner living with HIV. The majority (73.8%, n = 59) of participants who discontinued oral PrEP cited side effects as the primary reason for discontinuation, followed by feeling stigmatized (18.8%, n = 15). Conclusion This study provides valuable insights on early rollout of PrEP of how clients perceive oral PrEP and where to target efforts to improve the uptake of this highly effective HIV prevention product. By identifying strengths and areas for improvement, the ACCESS study has generated evidence that can be used to guide high quality scale-up in South Africa and may be instructive for other countries' efforts to expand quality access to oral PrEP.	[Pillay, Diantha; Murire, Mercy; Briedenhann, Elmari; Mullick, Saiqa] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Stankevitz, Kayla; Lanham, Michele; Ridgeway, Kathleen; Hoke, Theresa] FHI 360, Durham, NC USA; [Jenkins, Sarah] Clinton Hlth Access Initiat, Pretoria, South Africa; [Subedar, Hasina] Natl Dept Hlth, Pretoria, South Africa	University of Witwatersrand; FHI 360	Pillay, D (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.	dpillay@wrhi.ac.za		Briedenhann, Elmari/0000-0001-8107-6223; Mullick, Saiqa/0000-0001-7039-1949; Lanham, Michele/0000-0003-3012-5683; Ridgeway, Kathleen/0000-0003-0839-2830	OPTIONS project - U.S. Agency for International Development; Prevention Market Manager project - Bill and Melinda Gates Foundation; PEPFAR [AID-OAA-A-15-00035]	OPTIONS project - U.S. Agency for International Development; Prevention Market Manager project - Bill and Melinda Gates Foundation; PEPFAR	his study was supported by the OPTIONS project, funded by the U.S. Agency for International Development (https://www.usaid.gov) in partnership with PEPFAR (Cooperative Agreement No. AID-OAA-A-15-00035); and by the Prevention Market Manager project, funded by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org).The contents do not necessarily reflect the views of the funders. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the OPTIONS project, funded by the U.S. Agency for International Development (USAID) in partnership with PEPFAR (Cooperative Agreement No. AIDOAA-A-15-00035), and by the Prevention Market Manager project, funded by the Bill and Melinda Gates Foundation. The contents do not necessarily reflect the views of the funders.	Albert B, 2016, KEOD: PROCEEDINGS OF THE 8TH INTERNATIONAL JOINT CONFERENCE ON KNOWLEDGE DISCOVERY, KNOWLEDGE ENGINEERING AND KNOWLEDGE MANAGEMENT - VOL. 2, P21, DOI 10.5220/0006048300210030; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Council SANA, 2017, NAT STRAT PLAN HIV T; Delabre RM, HIV RES PREV C MADR; Elzette R-J, 2018, EARLY PERSISTENCE HI; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Golub S., 2018, PREP MESSAGING TAKIN; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holsti O. R., 1969, CONTENT ANAL SOCIAL; Matthew S, 2018, EXAMINING PREP INTER; NDoH, 2018, S AFR NAT DEP HLTH M; Newman AM, 2016, ADOLESCENT IDENTITY AND SCHOOLING: DIVERSE PERSPECTIVES, P21; Nicholas T, SO I DONT GET INFECT; Pillay Y, 2018, INT AIDS C AMST; PrEPWatch, 2018, OR PREP RISK ASS TOO; PSI, BREAK CYCL TRANSM 20; Scheibe A, 2011, GAP ANAL KEY POPULAT; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Tolley E, 2016, QUALITATIVE METHODS, P85; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2018, AIDS INF S AFR; World Health Organization, 2016, CONS GUID US ANT DRU	22	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0228620	10.1371/journal.pone.0228620	http://dx.doi.org/10.1371/journal.pone.0228620			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32352969	Green Published, gold			2022-12-26	WOS:000536673200008
J	De Pinto, A; Cenacchi, N; Kwon, HY; Koo, J; Dunston, S				De Pinto, Alessandro; Cenacchi, Nicola; Kwon, Ho-Young; Koo, Jawoo; Dunston, Shahnila			Climate smart agriculture and global food-crop production	PLOS ONE			English	Article							NITROUS-OXIDE; CONSERVATION AGRICULTURE; ORGANIC-MATTER; DEEP PLACEMENT; CHANGE IMPACTS; TECHNOLOGIES; ADAPTATION; SOIL; EMISSIONS; FUTURE	Most business-as-usual scenarios for farming under changing climate regimes project that the agriculture sector will be significantly impacted from increased temperatures and shifting precipitation patterns. Perhaps ironically, agricultural production contributes substantially to the problem with yearly greenhouse gas (GHG) emissions of about 11% of total anthropogenic GHG emissions, not including land use change. It is partly because of this tension that Climate Smart Agriculture (CSA) has attracted interest given its promise to increase agricultural productivity under a changing climate while reducing emissions. Considerable resources have been mobilized to promote CSA globally even though the potential effects of its widespread adoption have not yet been studied. Here we show that a subset of agronomic practices that are often included under the rubric of CSA can contribute to increasing agricultural production under unfavorable climate regimes while contributing to the reduction of GHG. However, for CSA to make a significant impact important investments and coordination are required and its principles must be implemented widely across the entire sector.	[De Pinto, Alessandro; Cenacchi, Nicola; Koo, Jawoo; Dunston, Shahnila] Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA; [Kwon, Ho-Young] Argonne Natl Labs, Energy Syst Div, Lemont, IL USA	CGIAR; International Food Policy Research Institute (IFPRI); United States Department of Energy (DOE); Argonne National Laboratory	De Pinto, A (corresponding author), Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA.	a.depinto@cgiar.org	; Koo, Jawoo/F-9397-2010	Kwon, Hoyoung/0000-0002-3421-9292; De Pinto, Alex/0000-0003-0327-494X; Koo, Jawoo/0000-0003-3424-9229	CGIAR Research Program on Policies, Institutions, and Markets (PIM) - CGIAR Fund Donors; CGIAR Research Program on Climate Change, Agriculture, and Food Security; CGIAR Fund Donors	CGIAR Research Program on Policies, Institutions, and Markets (PIM) - CGIAR Fund Donors(CGIAR); CGIAR Research Program on Climate Change, Agriculture, and Food Security(CGIAR); CGIAR Fund Donors(CGIAR)	The authors acknowledge the generous support of the CGIAR Research Program on Policies, Institutions, and Markets (PIM) funded by CGIAR Fund Donors and the CGIAR Research Program on Climate Change, Agriculture, and Food Security, which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements.	Agegnehu G, 2014, J SOIL SCI PLANT NUT, V14, P532, DOI 10.4067/S0718-95162014005000042; Ainsworth EA, 2008, PLANT CELL ENVIRON, V31, P1317, DOI 10.1111/j.1365-3040.2008.01841.x; Bandaogo A, 2015, NUTR CYCL AGROECOSYS, V102, P79, DOI 10.1007/s10705-014-9653-6; Bank World, 2009, WORLD DEV REP 2010 D; Barbier EB, 1997, LAND ECON, V73, P174, DOI 10.2307/3147281; Below TB, 2012, GLOBAL ENVIRON CHANG, V22, P223, DOI 10.1016/j.gloenvcha.2011.11.012; Bewket W, 2007, LAND USE POLICY, V24, P404, DOI 10.1016/j.landusepol.2006.05.004; BORLAUG NE, 1983, SCIENCE, V219, P689, DOI 10.1126/science.219.4585.689; Carlson KM, 2017, NAT CLIM CHANGE, V7, P63, DOI [10.1038/nclimate3158, 10.1038/NCLIMATE3158]; Chandra A, 2018, CLIM POLICY, V18, P526, DOI 10.1080/14693062.2017.1316968; Chivenge P, 2011, PLANT SOIL, V342, P1, DOI 10.1007/s11104-010-0626-5; de Klein C.A.M., 2006, 2006 IPCC GUIDELINES, V4; De Pinto A, 2016, WORLD DEV, V87, P180, DOI 10.1016/j.worlddev.2016.06.013; Derpsch R, 2010, INT J AGR BIOL ENG, P3; Derpsch R, 2009, P LEAD PAP NEW DELH; Devkota KP, 2013, FIELD CROP RES, V149, P115, DOI 10.1016/j.fcr.2013.04.015; Dhanush Dinesh, 2017, Agriculture for Development, P4; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Enfors EI, 2008, GLOBAL ENVIRON CHANG, V18, P607, DOI 10.1016/j.gloenvcha.2008.07.006; Erenstein O, 2008, SOIL TILL RES, V100, P1, DOI 10.1016/j.still.2008.05.001; Erenstein O, 2012, J SUSTAIN AGR, V36, P180, DOI 10.1080/10440046.2011.620230; FAO, 2013, MODULE 7 CLIMATE SMA; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Frank S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8c83; Gaihre YK, 2015, GEODERMA, V259, P370, DOI 10.1016/j.geoderma.2015.06.001; Gentile R, 2008, SOIL BIOL BIOCHEM, V40, P2375, DOI 10.1016/j.soilbio.2008.05.018; Gockowski J, 2011, ENVIRON MANAGE, V48, P307, DOI 10.1007/s00267-010-9602-3; Hasegawa T, 2018, NAT CLIM CHANGE, V8, P699, DOI 10.1038/s41558-018-0230-x; Hobbs PR, 2008, PHILOS T R SOC B, V363, P543, DOI 10.1098/rstb.2007.2169; Huda A, 2016, NUTR CYCL AGROECOSYS, V104, P53, DOI 10.1007/s10705-015-9758-6; Islam S, 2016, GLOB FOOD SECUR-AGR, V10, P63, DOI 10.1016/j.gfs.2016.08.003; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Levine S, 2014, ASSESSING RESILIENCE; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; Lipper L, 2014, NATURE CLIMATE CHANG; Lipper L., 2018, CLIMATE SMART AGR BU; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; McCarthy BJ, 2011, PRINCIPLES AND PRACTICE OF NEURO-ONCOLOGY: A MULTIDISCIPLINARY APPROACH, P4; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mora C, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002167; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Muller C, 2014, AGR ECON-BLACKWELL, V45, P37, DOI 10.1111/agec.12088; Nelson GC, 2010, RES MONOGRAPH, P140, DOI [10.1111/an.1995.36.5.41, DOI 10.1111/AN.1995.36.5.41]; Nelson G, 2018, NAT SUSTAIN, V1, P773, DOI 10.1038/s41893-018-0192-z; Nelson GC, 2014, AGR ECON-BLACKWELL, V45, P85, DOI 10.1111/agec.12091; Neufeldt H, 2013, AGR FOOD SECUR, V2, P12, DOI DOI 10.1186/2048-7010-2-12; O'Neill BC, 2017, GLOBAL ENVIRON CHANG, V42, P169, DOI 10.1016/j.gloenvcha.2015.01.004; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Pandey A, 2014, AGR ECOSYST ENVIRON, V196, P137, DOI 10.1016/j.agee.2014.06.010; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; Porter ME, 2011, HARVARD BUS REV, V89, P2, DOI DOI 10.1111/J.1467-9310.2011.00672.X; Potter P, 2010, EARTH INTERACT, V14, DOI 10.1175/2009EI288.1; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; Pugh TAM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12608; Rejesus RM, 2011, FOOD POLICY, V36, P280, DOI 10.1016/j.foodpol.2010.11.026; Robinson S, 2015, IFPRI DISCUSSION PAP, V1483; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Sabbagh P., 2014, FOOD SECURITY WORLD; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Shiferaw Bekele A., 2009, Environment Development and Sustainability, V11, P601, DOI 10.1007/s10668-007-9132-1; Smith L.C., 2000, EXPLAINING CHILD MAL; Smith P.M., 2015, CLIMATE CHANGE 2014; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Taylor M, 2018, J PEASANT STUD, V45, P89, DOI 10.1080/03066150.2017.1312355; Teklewold H, 2011, J SOIL WATER CONSERV, V66, P87, DOI 10.2489/jswc.66.2.87; Tyagi L, 2010, SCI TOTAL ENVIRON, V408, P1085, DOI 10.1016/j.scitotenv.2009.09.010; United Nations, 2021, REPORT C PARTIES UN; Valin H, 2014, AGR ECON-BLACKWELL, V45, P51, DOI 10.1111/agec.12089; van Meij H, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabdc4; Vanlauwe B, 2011, PLANT SOIL, V339, P35, DOI 10.1007/s11104-010-0462-7; Watts Michael, 2014, BIOINSECURITY VULNER, P145; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wiebe K, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085010; Wiebe KeithD., 2019, PALM OIL DILEMMA POL; Wollenberg E, 2016, GLOBAL CHANGE BIOL, V22, P3859, DOI 10.1111/gcb.13340; Yan XY, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003299; You LZ, 2006, SPATIAL PRODUCTION A	82	10	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231764	10.1371/journal.pone.0231764	http://dx.doi.org/10.1371/journal.pone.0231764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8ZG	32348336	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000536668200026
J	Yang, XY; Bergenholtz, S; Maliskova, L; Pebworth, MP; Kriegstein, AR; Li, Y; Shen, Y				Yang, Xiaoyu; Bergenholtz, Seth; Maliskova, Lenka; Pebworth, Mark-Phillip; Kriegstein, Arnold R.; Li, Yun; Shen, Yin			SMART-Q: An Integrative Pipeline Quantifying Cell Type-Specific RNA Transcription	PLOS ONE			English	Article							GENE-EXPRESSION; SINGLE; QUANTIFICATION; HYBRIDIZATION; TISSUE; FISH; DNA; 3D	Accurate RNA quantification at the single-cell level is critical for understanding the dynamics of gene expression and regulation across space and time. Single molecule FISH (smFISH), such as RNAscope, provides spatial and quantitative measurements of individual transcripts, therefore, can be used to explore differential gene expression among a heterogeneous cell population if combined with cell identify information. However, such analysis is not straightforward, and existing image analysis pipelines cannot integrate both RNA transcripts and cellular staining information to automatically output cell type-specific gene expression. We developed an efficient and customizable analysis method, Single-Molecule Automatic RNA Transcription Quantification (SMART-Q), to enable the analysis of gene transcripts in a cell type-specific manner. SMART-Q efficiently infers cell identity information from multiplexed immuno-staining and quantifies cell type-specific transcripts using a 3D Gaussian fitting algorithm. Furthermore, we have optimized SMART-Q for user experiences, such as flexible parameters specification, batch data outputs, and visualization of analysis results. SMART-Q meets the demands for efficient quantification of single-molecule RNA and can be widely used for cell type-specific RNA transcript analysis.	[Yang, Xiaoyu; Bergenholtz, Seth; Maliskova, Lenka; Shen, Yin] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pebworth, Mark-Phillip] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Pebworth, Mark-Phillip; Kriegstein, Arnold R.] UCSF, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Kriegstein, Arnold R.; Shen, Yin] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Shen, Y (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Shen, Y (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	yin.shen@ucsf.edu	YANG, Xiaoyu/AFF-7937-2022	YANG, Xiaoyu/0000-0003-2508-4805; Pebworth, Mark-Phillip/0000-0001-8224-9480; Shen, Yin/0000-0001-9901-5613	National Institutes of Health (NIH) [R01AG057497, R01EY027789, UM1HG009402]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) grants R01AG057497, R01EY027789 and UM1HG009402 to Y.S.	Bai M, 2017, P IEEE C COMP VIS PA; Beucher S., 1994, WATERSHED HIERARCHIC, P69, DOI DOI 10.1007/978-94-011-1040-2_10; Chan S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207619; Chen F, 2016, NAT METHODS, V13, P679, DOI 10.1038/nmeth.3899; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Codeluppi S, 2018, NAT METHODS, V15, P932, DOI 10.1038/s41592-018-0175-z; Deng RJ, 2018, CHEM-US, V4, P1373, DOI 10.1016/j.chempr.2018.03.003; Dogra A., 2014, BIOMED PHARMACOL J, V7, P707, DOI [10.13005/bpj/545, DOI 10.13005/bpj/545]; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Johnson H., 2015, ITK SOFTWARE GUIDE B; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Mueller F, 2013, NAT METHODS, V10, P277, DOI 10.1038/nmeth.2406; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; PARDUE ML, 1969, P NATL ACAD SCI USA, V64, P600, DOI 10.1073/pnas.64.2.600; Pichon X, 2018, MOL CELL, V71, P468, DOI 10.1016/j.molcel.2018.07.022; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; SINGER RH, 1982, P NATL ACAD SCI-BIOL, V79, P7331, DOI 10.1073/pnas.79.23.7331; Stapel LC, 2016, DEVELOPMENT, V143, P540, DOI 10.1242/dev.128918; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Trcek T, 2017, NAT PROTOC, V12, P1326, DOI 10.1038/nprot.2017.030; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0228760	10.1371/journal.pone.0228760	http://dx.doi.org/10.1371/journal.pone.0228760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348304	gold, Green Published, Green Submitted			2022-12-26	WOS:000536668200006
J	Bajaj, R; Ambaru, B; Gupta, CM				Bajaj, Rani; Ambaru, Bindu; Gupta, Chhitar M.			Deciphering the role of UBA-like domains in intraflagellar distribution and functions of myosin XXI in Leishmania	PLOS ONE			English	Article							AURORA KINASE; MOLECULAR MOTOR; CYTOKINESIS; FLAGELLUM; GOLGI; ACTIN; MORPHOGENESIS; ADF/COFILIN; EXPRESSION; MOTILITY	Myosin XXI (Myo21) is a novel class of myosin present in all kinetoplastid parasites, such as Trypanosoma and Leishmania. This protein in Leishmania promastigotes is predominantly localized to the proximal region of the flagellum, and is involved in the flagellum assembly, cell motility and intracellular vesicle transport. As Myo21 contains two ubiquitin associated (UBA)-like domains (UBLD) in its amino acid sequence, we considered it of interest to analyze the role of these domains in the intracellular distribution and functions of this protein in Leishmania cells. In this context, we created green fluorescent protein (GFP)-conjugates of Myo21 constructs lacking one of the two UBLDs at a time or both the UBLDs as well as GFP-conjugates of only the two UBLDs and Myo21 tail lacking the two UBLDs and separately expressed them in the Leishmania cells. Our results show that unlike Myo21-GFP, Myo21-GFP constructs lacking either one or both the UBLDs failed to concentrate and co-distribute with actin in the proximal region of the flagellum. Nevertheless, the GFP conjugate of only the two UBLDs was found to predominantly localize to the flagellum base. Additionally, the cells that expressed only one or both the UBLDs-deleted Myo21-GFP constructs possessed shorter flagellum and displayed slower motility, compared to Myo21-GFP expressing cells. Further, the intracellular vesicle transport and cell growth were severely impaired in the cells that expressed both the UBLDs deleted Myo21-GFP construct, but in contrast, virtually no effect was observed on the intracellular vesicle transport and growth in the cells that expressed single UBLD deleted mutant proteins. Moreover, the observed slower growth of both the UBLDs-deleted Myo21-GFP expressing cells was primarily due to delayed G2/M phase caused by aberrant nuclear and daughter cell segregation during their cell division process. These results taken together clearly reveal that the presence of UBLDs in Myo21 are essentially required for its predominant localization to the flagellum base, and perhaps also in its involvement in the flagellum assembly and cell division. Possible role of UBLDs in involvement of Myo21 during Leishmania flagellum assembly and cell cycle is discussed.	[Bajaj, Rani; Ambaru, Bindu; Gupta, Chhitar M.] Inst Bioinformat & Appl Biotechnol, Bengaluru, Karnataka, India; [Bajaj, Rani; Ambaru, Bindu] Manipal Acad Higher Educ, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Gupta, CM (corresponding author), Inst Bioinformat & Appl Biotechnol, Bengaluru, Karnataka, India.	cm44gupta@gmail.com		Ambaru (Ph.D), Purna Sudha Bindu/0000-0003-0131-0353; BAJAJ, RANI/0000-0002-8185-3560	Corpus grant by Infosys Foundation; Department of IT, BT and S&T, Government of Karnataka; University Grant Commission, New Delhi (India); IBAB	Corpus grant by Infosys Foundation; Department of IT, BT and S&T, Government of Karnataka; University Grant Commission, New Delhi (India)(University Grants Commission, India); IBAB	This study was supported by the Corpus grant given by Infosys Foundation to IBAB and the Department of IT, BT and S&T, Government of Karnataka. RB is a recipient of Senior Research Fellowship from University Grant Commission, New Delhi (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CMG expresses his sincere gratitude to Prof. N. Yathindra (Ex-Director, IBAB) for providing him and his group the lab space, facilities and financial support to continue research activities at IBAB, and also to Dr. H. S. Subramanya (Current Director, IBAB) for continuing the same level of support. RB would like to acknowledge Dr. T. V. Satish Tammana for technical advice, as and when required, only in the initial phase, and Dr. S. Thiyagarajan for useful suggestions. We thank Dr. Amogh Sahasrabuddhe (CDRI, Lucknow, India) for providing us the LdAct clone.	Adhiambo C, 2005, MOL BIOCHEM PARASIT, V143, P216, DOI 10.1016/j.molbiopara.2005.04.017; Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Batters C, 2014, P NATL ACAD SCI USA, V111, pE227, DOI 10.1073/pnas.1319285110; Batters C, 2012, J BIOL CHEM, V287, P27556, DOI 10.1074/jbc.M112.381301; Burgess DR, 2005, CURR BIOL, V15, pR310, DOI 10.1016/j.cub.2005.04.008; Chhajer R, 2016, BBA-GEN SUBJECTS, V1860, P1973, DOI 10.1016/j.bbagen.2016.06.005; Cole DG, 2009, CELL, V137, P784, DOI 10.1016/j.cell.2009.04.053; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Durrbach A, 2000, TRAFFIC, V1, P411, DOI 10.1034/j.1600-0854.2000.010506.x; Durrbach A, 1996, P NATL ACAD SCI USA, V93, P7053, DOI 10.1073/pnas.93.14.7053; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Gilberto S, 2017, J CELL BIOL, V216, P2259, DOI 10.1083/jcb.201703170; Gull K, 2003, CURR OPIN MICROBIOL, V6, P365, DOI 10.1016/S1369-5274(03)00092-4; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Katta SS, 2010, J CELL SCI, V123, P2034, DOI 10.1242/jcs.064725; Katta SS, 2009, MOL BIOCHEM PARASIT, V164, P105, DOI 10.1016/j.molbiopara.2008.12.002; Khare S, 2016, NATURE, V537, P229, DOI 10.1038/nature19339; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kurien BT, 2009, METHODS MOL BIOL, V536, P201, DOI 10.1007/978-1-59745-542-8_22; Landfear SM, 2001, MOL BIOCHEM PARASIT, V115, P1, DOI 10.1016/S0166-6851(01)00262-6; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Madura K, 2002, CELL CYCLE, V1, P233, DOI 10.4161/cc.1.4.130; Maga JA, 1999, TRENDS CELL BIOL, V9, P409, DOI 10.1016/S0962-8924(99)01635-9; Maga JA, 1999, J CELL SCI, V112, P2753; Mueller C, 2017, CURR OPIN MICROBIOL, V40, P113, DOI 10.1016/j.mib.2017.11.003; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rump A, 2011, J CELL SCI, V124, P2521, DOI 10.1242/jcs.084335; Sahasrabuddhe AA, 2004, MOL BIOCHEM PARASIT, V134, P105, DOI 10.1016/j.molbiopara.2003.11.008; Sahin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001620; Sceniak MP, 2019, J CELL SCI, V132, DOI 10.1242/jcs.232892; Sparkes IA, 2008, J EXP BOT, V59, P2499, DOI 10.1093/jxb/ern114; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; SUN DY, 2009, PLOS PATHOG, V5, DOI DOI 10.1371/JOURNAL.PPAT.1000575; Tammana TVS, 2008, MOL MICROBIOL, V70, P837, DOI 10.1111/j.1365-2958.2008.06448.x; Tammana TVS, 2010, J CELL SCI, V123, P1894, DOI 10.1242/jcs.068494; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Tull D, 2010, J CELL SCI, V123, P544, DOI 10.1242/jcs.059097; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232116	10.1371/journal.pone.0232116	http://dx.doi.org/10.1371/journal.pone.0232116			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343719	Green Published, gold			2022-12-26	WOS:000536661300034
J	Gong, JM; Du, JS; Han, DM; Wang, XY; Qi, SL				Gong, Jian-Mei; Du, Jian-Shi; Han, Dong-Mei; Wang, Xin-Yu; Qi, Shao-Long			Reasons for patient non-compliance with compression stockings as a treatment for varicose veins in the lower limbs: A qualitative study	PLOS ONE			English	Article							CHRONIC VENOUS INSUFFICIENCY; ULCER RECURRENCE; ADHERENCE; DISEASE	The study aims to explore the comprehensive reasons for patients' non-compliance with graded elastic compression stockings (GECS) as the treatment for lower limb varicose veins. Phenomenological analysis was applied in this qualitative study. The patients diagnosed with lower limb varicose veins and undergoing elective surgery who showed non-compliance with GECS as the treatment were invited to have semi-structured, in-depth, face-to-face interviews. Colaizzi method was employed to analyze the data for emerging themes associated with the reasons for patients' non-compliance. Four main themes and nine sub-themes related to the reasons for non-compliance with GECS for lower limb varicose veins were summarized. The main themes that emerged were (1) gaps in the knowledge of GECS therapy as a treatment for lower limb varicose veins, (2) few recommendations from the doctors and nurses, (3) disadvantages of GECS, and (4) sociopsychological factors. These themes provide data for policy and planning to improve patients' compliance with GECS in China. Patients, healthcare professionals, and policy makers should share the responsibility to improve patients' compliance with GECS therapy.	[Gong, Jian-Mei; Du, Jian-Shi] Jilin Univ, Sch Nursing, Changchun, Peoples R China; [Du, Jian-Shi; Han, Dong-Mei; Wang, Xin-Yu; Qi, Shao-Long] Jilin Univ, Dept Lymphat & Vasc Surg, China Japan Union Hosp, Changchun, Peoples R China	Jilin University; Jilin University	Du, JS (corresponding author), Jilin Univ, Sch Nursing, Changchun, Peoples R China.; Du, JS (corresponding author), Jilin Univ, Dept Lymphat & Vasc Surg, China Japan Union Hosp, Changchun, Peoples R China.	dujs@jlu.edu.cn	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Du, Jianshi/0000-0002-1521-9756	Graduate Innovation Fund of Jilin University [101832018C086]; Education Department of Jilin Province [JJKH20201125KJ]; Jilin University	Graduate Innovation Fund of Jilin University(Jilin University); Education Department of Jilin Province; Jilin University(Jilin University)	This research was supported by Graduate Innovation Fund of Jilin University (No. 101832018C086). The first author JMG received the award that was 6000 RNB. The full name of funder was Jilin University. URL: http://59.72.66.138/applied/add/24b543f092baf6a44ab7d1692090aae7 This research was also supported by the Education Department of Jilin Province (No. JJKH20201125KJ) to DMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaert FA, 2019, PHLEBOLOGY, V34, P25, DOI 10.1177/0268355518762824; Apenteng PN, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013839; Bentley J, 2001, Br J Community Nurs, V6, P136; Cataldo JL, 2012, PHLEBOLOGY, V27, P33, DOI 10.1258/phleb.2011.010088; Chen J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220304; Chi YW, 2018, PHLEBOLOGY, V33, P425, DOI 10.1177/0268355517717425; Clarke-Moloney M, 2014, INT WOUND J, V11, P404, DOI 10.1111/j.1742-481X.2012.01108.x; Edward KL, 2011, CONTEMP NURSE, V39, P163, DOI 10.5172/conu.2011.163; He J, 2018, CHINESE J VASCULAR S, V10, P76, DOI [10.3969/j.issn.1674-7429.2018.01.019, DOI 10.3969/J.ISSN.1674-7429.2018.01.019]; Heyer K, 2017, INT WOUND J, V14, P1148, DOI 10.1111/iwj.12773; Jonathan A, 1996, PSYCHOL HEALTH, V11, P261, DOI [10.1080/08870449608400256, DOI 10.1080/08870449608400256]; Kankam HKN, 2018, EUR J VASC ENDOVASC, V55, P406, DOI 10.1016/j.ejvs.2017.11.025; Kapp S, 2013, INT J LOW EXTR WOUND, V12, P189, DOI 10.1177/1534734613502034; Kones R, 2019, LANCET, V393, P105, DOI 10.1016/S0140-6736(18)33079-4; Makoto M, 2018, VEINS LYMPHATICS, V7, P64; Manduz S, 2018, PATIENT PREFER ADHER, V12, P399, DOI 10.2147/PPA.S157344; Pliuskevicius R., 1993, COMPUTATIONAL LOGIC, V713, P289, DOI [10.1007/BFb0022577, DOI 10.1007/BFB0022577]; Raju S, 2007, ANN VASC SURG, V21, P790, DOI 10.1016/j.avsg.2007.07.014; Rastel D, 2014, J Mal Vasc, V39, P389, DOI 10.1016/j.jmv.2014.09.001; Reich-Schupke S, 2009, INT ANGIOL, V28, P385; Sippel K, 2015, EUR J VASC ENDOVASC, V49, P221, DOI 10.1016/j.ejvs.2014.11.005; Suehiro K, 2016, PHLEBOLOGY, V31, P723, DOI 10.1177/0268355515608992; Uhl JF, 2018, PHLEBOLOGY, V33, P36, DOI 10.1177/0268355516682886; van Hoeven LR, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0089-8; Vascular surgery group Surgery branch Chinese Medical Association, 2014, CHINESE J VASCULAR S, V6, P143, DOI [10.3969/j.issn.1674-7429.2014.03.008, DOI 10.3969/J.ISSN.1674-7429.2014.03.008]; Wade R, 2017, J ADV NURS, V73, P336, DOI 10.1111/jan.13148; Webb C, 1999, J CLIN NURS, V8, P576; Winslow EH, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000334973.82359.11; Xu YP, 2019, J THROMB THROMBOLYS, V47, P102, DOI 10.1007/s11239-018-1749-4; Ziaja D, 2011, PHLEBOLOGY, V26, P353, DOI 10.1258/phleb.2010.010086	30	4	4	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231218	10.1371/journal.pone.0231218	http://dx.doi.org/10.1371/journal.pone.0231218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8WP	32343695	Green Published, gold			2022-12-26	WOS:000536661300010
J	Ngom, D; Fauconnier, ML; Malumba, P; Dia, CAKMP; Thiaw, C; Sembene, M				Ngom, Dethie; Fauconnier, Marie-Laure; Malumba, Paul; Dia, Cheikh Abdou Khadre Mbacke Prime; Thiaw, Cheikh; Sembene, Mbacke			Varietal susceptibility of maize to larger grain borer, Prostephanus truncatus (Horn) (Coleoptera; Bostrichidae), based on grain physicochemical parameters	PLOS ONE			English	Article							WEEVIL SITOPHILUS-ZEAMAIS; ACID-AMIDES; RESISTANCE; HARDNESS; INFESTATION; ENDOSPERM; SELECTION; AMYLOSE; STORES; CEREAL	Maize (Zea mays L) is one of main nutrients sources for humans and animals worldwide. In Africa, storage of maize ensures food resources availability throughout the year. However, it often suffers losses exceeding 20% due to insects such as the larger grain borer, Prostephanus truncatus (Horn) (Coleoptera; Bostrichidae), major pest of stored maize in the tropical countries. This study aims to select resistant varieties to reduce maize storage losses and explain the physicochemical parameters role in grains susceptibility. In the first study, maize grains were artificially infested under no-choice method with insects. Susceptibility parameters such as weight loss, grain damage, number of emerged insects, median development time and susceptibility index varied significantly through maize varieties. Dobie susceptibility index (SI) was assessed as a major indicator of resistance. The most resistant varieties were Early-Thai, DMR-ES and Tzee-Yellow. Conversely, Synth-9243, Obatampa and Synth-C varieties were susceptible. SWAN, Across-Pool and Tzee-White were classified as moderately resistant varieties. The insect reproductive potential was significantly different in the nine maize varieties and Early-Thai, DMR-ES and Tzee-Yellow varieties were the least favourable host. To assess the relationship between grains physicochemical characteristics and varietal susceptibility, moisture, total phenolics, palmitic acid, proteins, amylose, density and grain hardness were evaluated according to standardized methods. Palmitic acid, SI, insects emerged and grain damage were significantly and positively correlated with each other, and negatively correlated with grains hardness, phenolics and amylose contents. Maize susceptibility index was significantly and negatively correlated to amylose, and phenolics contents and positively correlated to palmitic acid content. This study identified three resistant maize varieties to P. tuncatus and revealed that the major factors involved in this resistance were hardness, phenolic and amylose contents of grains.	[Ngom, Dethie; Dia, Cheikh Abdou Khadre Mbacke Prime; Sembene, Mbacke] Cheikh Anta DIOP Univ, Fac Sci & Tech, Dept Anim Biol, Lab Entomol & Acarol, Dakar, Senegal; [Ngom, Dethie; Thiaw, Cheikh] Senegalese Inst Agr Res ISRA, Dakar, Senegal; [Fauconnier, Marie-Laure] Univ Liege, Agrobiosyst Chem Agron Bioengn & Chem AgroBioChem, Gembloux Agrobio Tech, Gembloux, Belgium; [Malumba, Paul] Univ Liege, TERRA Teaching & Res Ctr, FoodIsLife Care, Gembloux Agrobio Tech, Gembloux, Belgium; [Sembene, Mbacke] Res Inst Dev IRD, Biol Lab Sahelo Sudanese Anim Populat BIOPASS, Dakar, Senegal	University Cheikh Anta Diop Dakar; University of Liege; University of Liege	Ngom, D (corresponding author), Cheikh Anta DIOP Univ, Fac Sci & Tech, Dept Anim Biol, Lab Entomol & Acarol, Dakar, Senegal.; Ngom, D (corresponding author), Senegalese Inst Agr Res ISRA, Dakar, Senegal.	dethie.ngom@ucad.edu.sn		NGOM, Dethie/0000-0002-7036-266X; Fauconnier, Marie-Laure/0000-0002-2027-3896	Cheikh Anta Diop University [8729]	Cheikh Anta Diop University	Funding: This study has been totally funded by Cheikh Anta Diop University (grant number: 8729). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Mr. Issa CISSE (COPROSA/Nioro-Senegal) and Dr. Moustapha GUEYE (CNRA-ISRA Seed Service/Senegal) for their collaboration in collecting maize samples. We gratefully acknowledge Gembloux Agro Bio-Tech Faculty of Liege University (Belgium), particularly General and Organic Chemistry laboratory staff (Mr Danny TRISMAN, Mr Thomas BERTRAND,...) and TERRA Teaching and Research Center staff (Vanessa ARDITO, Nathalie, Romain,...) for their unfailing support on maize grains physicochemical characterization.	Abebe F, 2009, AFR J BIOTECHNOL, V8, P5937; Adjile A, 2012, ACQUISITIONS MASSVES; Agbaka A, 1999, J SOACHIM, V008, P87; AOAC International, 1990, OFFICIAL METHODS ANA; Arnason J.T., 1995, CAH AGRIC, V4, P85; ARNASON JT, 1992, J STORED PROD RES, V28, P119, DOI 10.1016/0022-474X(92)90019-M; ARNASON JT, 1994, EUPHYTICA, V74, P227, DOI 10.1007/BF00040405; Bauer JL, 2012, LWT-FOOD SCI TECHNOL, V47, P246, DOI 10.1016/j.lwt.2012.01.012; Blandino M, 2010, J SCI FOOD AGR, V90, P1870, DOI 10.1002/jsfa.4027; Bloomfield VA, 2014, CHAPMAN HALL CRC R S; BORGEMEISTER C, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P906; Bourgou S., 2016, J NEW SCI AGR BIOTEC, V28, P1649; Boxall R. A., 1986, CRITICAL REV METHODO, P139; CLASSEN D, 1990, J CHEM ECOL, V16, P301, DOI 10.1007/BF01021766; Delobel A, 1993, COLE DENREES ALIMENT; DEMIANYK CJ, 1987, ENVIRON ENTOMOL, V16, P618, DOI 10.1093/ee/16.3.618; Demissie G., 2015, Journal of Stored Products and Postharvest Research, V6, P1; Dobie P., 1977, Tropical Stored Products Information, P7; DOBIE P, 1974, J STORED PROD RES, V10, P183, DOI 10.1016/0022-474X(74)90006-X; DOMBRINKKURTZMAN MA, 1993, CEREAL CHEM, V70, P105; Ejiro O., 2018, Journal of Crop Protection, V7, P337; Eyherabide GH, 1996, CEREAL CHEM, V73, P775; FAO, 2012, PERT GASP AL MOND CA; Fixon-Owoo S, 2003, PHYTOCHEMISTRY, V63, P315, DOI 10.1016/S0031-9422(03)00133-X; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fourar-Belaifa R, 2015, CAH AGRIC, V24, P283, DOI 10.1684/agr.2015.0767; Fox G, 2009, J AGR FOOD CHEM, V57, P5647, DOI 10.1021/jf900623w; Freeman P, 1980, NATURAL HIST EC SER, V15; Gallo J., 2007, ENCY PEST MANAGEMENT, P60; Garcia-Lara S, 2004, CROP SCI, V44, P1546, DOI 10.2135/cropsci2004.1546; Garcia-Lara S, 2014, CROP SCI, V54, P2423, DOI 10.2135/cropsci2014.03.0223; Goergen G., 2005, PETIT MANUEL IDENTIF; Gueye MT, 2008, AFR ENTOMOL, V16, P309, DOI 10.4001/1021-3589-16.2.309; Gueye MT, 2008, ITA ECHOS, V3; Helbig J, 1995, ECOLOGIE PROSTEPHANU; Kevin JM, 2002, MAIZE KERNEL COMPONE, P17; KOSSOU DK, 1993, J STORED PROD RES, V29, P333, DOI 10.1016/0022-474X(93)90049-A; Lamboni Yendouban, 2009, International Journal of Tropical Insect Science, V29, P31, DOI 10.1017/S1742758409391511; LibbeyEurotext John, 1989, ACT C INT TECHN CER, P141; Lopez-Castillo LM, 2018, J STORED PROD RES, V77, P66, DOI 10.1016/j.jspr.2018.03.004; Meikle WG, 1998, J STORED PROD RES, V34, P45, DOI 10.1016/S0022-474X(97)00020-9; Mendiola-Olaya E, 2000, COMP BIOCHEM PHYS B, V126, P425, DOI 10.1016/S0305-0491(00)00216-9; MORRISON WR, 1983, J CEREAL SCI, V1, P9, DOI 10.1016/S0733-5210(83)80004-6; Mwololo JK, 2012, J PEST SCI, V85, P267, DOI 10.1007/s10340-012-0427-0; Ngamo L. S. T., 2007, Tropicultura, V25, P215; PANTENIUS CU, 1988, INSECT SCI APPL, V9, P725, DOI 10.1017/S1742758400005610; PETERS LL, 1972, J ECON ENTOMOL, V65, P1168, DOI 10.1093/jee/65.4.1168; POMERANZ Y, 1986, CEREAL CHEM, V63, P349; Robutti JL, 1997, CEREAL CHEM, V74, P75, DOI 10.1094/CCHEM.1997.74.1.75; Roy N, 2014, J KANSAS ENTOMOL SOC, V87, P22, DOI 10.2317/JKES130521.1; Santiago R, 2010, INT J MOL SCI, V11, P691, DOI 10.3390/ijms11020691; SEN A, 1994, J AGR FOOD CHEM, V42, P1879, DOI 10.1021/jf00045a009; SERRATOS A, 1987, J CHEM ECOL, V13, P751, DOI 10.1007/BF01020157; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; SHIRES SW, 1976, J STORED PROD RES, V12, P273, DOI 10.1016/0022-474X(76)90044-8; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Subramanyam B, 1995, INTEGRATED MANAGEMEN, V11, P331; VERSTRAETEN C, 1987, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V52, P235; Yadu Y. K., 2000, Indian Journal of Agricultural Research, V34, P243; Youn Kumju, 2012, Prev Nutr Food Sci, V17, P310, DOI 10.3746/pnf.2012.17.4.310	60	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232164	10.1371/journal.pone.0232164	http://dx.doi.org/10.1371/journal.pone.0232164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330189	Green Published, gold			2022-12-26	WOS:000536647300058
J	Pellarin, I; Dall'Acqua, A; Gambelli, A; Pellizzari, I; D'Andrea, S; Sonego, M; Lorenzon, I; Schiappacassi, M; Belletti, B; Baldassarre, G				Pellarin, Ilenia; Dall'Acqua, Alessandra; Gambelli, Alice; Pellizzari, Ilenia; D'Andrea, Sara; Sonego, Maura; Lorenzon, Ilaria; Schiappacassi, Monica; Belletti, Barbara; Baldassarre, Gustavo			Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity	ONCOGENE			English	Article							RNA-BINDING PROTEIN; REPAIR; PSF; EXPRESSION; APOPTOSIS; NONO; RESISTANCE; VARIANT; DOMAIN; ERCC1	In epithelial ovarian cancer (EOC), response to platinum (PT)-based chemotherapy dictates subsequent treatments and predicts patients' prognosis. Alternative splicing is often deregulated in human cancers and can be altered by chemotherapy. Whether and how changes in alternative splicing regulation could impact on the response of EOC to PT-based chemotherapy is still not clarified. We identified the splicing factor proline and glutamine rich (SFPQ) as a critical mediator of response to PT in an unbiased functional genomic screening in EOC cells and, using a large cohort of primary and recurrent EOC samples, we observed that it is frequently overexpressed in recurrent PT-treated samples and that its overexpression correlates with PT resistance. At mechanistic level, we show that, under PT treatment, SFPQ, in complex with p54(nrb), binds and regulates the activity of the splicing factor SRSF2. SFPQ/p54(nrb) complex decreases SRSF2 binding to caspase-9 RNA, favoring the expression of its alternative spliced antiapoptotic form. As a consequence, SFPQ/p54(nrb) protects cells from PT-induced death, eventually contributing to chemoresistance. Overall, our work unveils a previously unreported SFPQ/p54(nrb)/SRSF2 pathway that in EOC cells plays a central role in regulating alternative splicing and PT-induced apoptosis and that could result in the design of new possible ways of intervention to overcome PT resistance.	[Pellarin, Ilenia; Dall'Acqua, Alessandra; Gambelli, Alice; Pellizzari, Ilenia; D'Andrea, Sara; Sonego, Maura; Lorenzon, Ilaria; Schiappacassi, Monica; Belletti, Barbara; Baldassarre, Gustavo] NCI, IRCCS, Ctr Riferimento Oncol Aviano CRO, Div Mol Oncol, I-33081 Aviano, PN, Italy	IRCCS Aviano (CRO)	Baldassarre, G (corresponding author), NCI, IRCCS, Ctr Riferimento Oncol Aviano CRO, Div Mol Oncol, I-33081 Aviano, PN, Italy.	gbaldassarre@cro.it	GAMBELLI, ALICE/ABD-4280-2020; Belletti, Barbara/J-2028-2018; Dall'Acqua, Alessandra/ABF-8020-2020; Baldassarre, Gustavo/K-1350-2016; Sonego, Maura/AAX-5529-2020; Lorenzon, Ilaria/AAY-6372-2020; Schiappacassi, Monica/AAX-5505-2020; Pellarin, Ilenia/AAY-2238-2020	GAMBELLI, ALICE/0000-0003-0223-9798; Belletti, Barbara/0000-0003-2249-0285; Dall'Acqua, Alessandra/0000-0003-2297-1361; Baldassarre, Gustavo/0000-0002-9750-8825; Sonego, Maura/0000-0002-9505-9771; Lorenzon, Ilaria/0000-0001-6336-4678; Schiappacassi, Monica/0000-0003-4804-4291; Pellarin, Ilenia/0000-0002-1041-1722	Ministero della Salute [RCR-2019-23669115, RF-2016-02361040, GR-2016-02361041]; Ministero degli Affari Esteri e Cooperazione Internazionale [PGR01036]; CRO-Ricerca Corrente core grant (linea 1); 5x1000 CRO Intramural; Regione Friuli Venezia Giulia (POR-FERS TICHEP grant)	Ministero della Salute(Ministry of Health, Italy); Ministero degli Affari Esteri e Cooperazione Internazionale; CRO-Ricerca Corrente core grant (linea 1); 5x1000 CRO Intramural; Regione Friuli Venezia Giulia (POR-FERS TICHEP grant)	We are grateful to the patients who consented to donating their samples. We thank Dr Benjamin Blencowe for providing the p54<SUP>nrb</SUP> and the SFPQ wild type and mutant expression vectors (through Addgene) and Dr Beatrice Eymin for providing the SRSF2 vector. We like to thank all members of the SCICC lab for fruitful scientific discussion, Dr Riccardo Bomben for helping us with the analysis of gene expression profiles and Dr Francesca Rossi for FACS analyses. This work was supported by grants from Ministero della Salute (RCR-2019-23669115 and RF-2016-02361040 to GB and GR-2016-02361041 to MS); Ministero degli Affari Esteri e Cooperazione Internazionale (PGR01036 to GB), CRO-Ricerca Corrente core grant (linea 1); 5x1000 CRO Intramural to GB and Regione Friuli Venezia Giulia (POR-FERS TICHEP grant to GB).	Dall'Acqua A, 2017, EMBO MOL MED, V9, P1415, DOI 10.15252/emmm.201607012; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Fischer DC, 2004, ONCOL REP, V11, P1085; Freimund AE, 2018, HEMATOL ONCOL CLIN N, V32, P983, DOI 10.1016/j.hoc.2018.07.007; Gabriel M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1259-0; Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Jaafar L, 2017, NUCLEIC ACIDS RES, V45, P1848, DOI 10.1093/nar/gkw1209; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kedzierska H, 2017, CANCER LETT, V396, P53, DOI 10.1016/j.canlet.2017.03.013; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Konstantinopoulos PA, 2018, HEMATOL ONCOL CLIN N, V32, P997, DOI 10.1016/j.hoc.2018.07.006; Lambert CA, 2017, INT J BIOCHEM CELL B, V91, P84, DOI 10.1016/j.biocel.2017.04.006; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097; Lheureux S, 2019, LANCET, V393, P1240, DOI 10.1016/S0140-6736(18)32552-2; Li SY, 2017, DNA REPAIR, V51, P70, DOI 10.1016/j.dnarep.2017.02.002; Lorenzon I, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010036; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Meyer S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.264; Nicoloso MS, 2017, CANC BREAK NEWS, P25, DOI DOI 10.19156/CBN.2017.0056; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Segatto I, 2019, CANCER RES, V79, P397, DOI 10.1158/0008-5472.CAN-18-2488; Seiler M, 2018, NAT MED, V24, P497, DOI 10.1038/nm.4493; Sevcik J, 2013, CELL SIGNAL, V25, P1186, DOI 10.1016/j.cellsig.2013.02.008; Sevcik J, 2012, CELL SIGNAL, V24, P1023, DOI 10.1016/j.cellsig.2011.12.023; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shav-Tal Y, 2001, MOL BIOL CELL, V12, P2328, DOI 10.1091/mbc.12.8.2328; Sonego M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3235; Sonego M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07005-1; Sonego M, 2013, EMBO MOL MED, V5, P707, DOI 10.1002/emmm.201201504; Sun YH, 2009, CANCER INVEST, V27, P891, DOI 10.3109/07357900902744536; Takayama K, 2017, P NATL ACAD SCI USA, V114, P10461, DOI 10.1073/pnas.1706076114; Tsukahara T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/204973; Wu W, 2010, MUTAT RES-FUND MOL M, V691, P1, DOI 10.1016/j.mrfmmm.2010.06.002; Yarosh CA, 2015, WIRES RNA, V6, P351, DOI 10.1002/wrna.1280; Yu JJ, 1998, INT J MOL MED, V1, P617; Zhang GL, 2012, MUTAT RES-GEN TOX EN, V746, P66, DOI 10.1016/j.mrgentox.2012.03.004; Zhu JY, 2018, GYNECOL ONCOL, V148, P368, DOI 10.1016/j.ygyno.2017.11.028	39	23	24	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4390	4403		10.1038/s41388-020-1292-6	http://dx.doi.org/10.1038/s41388-020-1292-6		APR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32332923	Green Published, hybrid			2022-12-26	WOS:000528417800001
J	Catlin, DS; Yang, XH; Bennett, B; Holz, RC; Liu, DL				Catlin, Daniel S.; Yang, Xinhang; Bennett, Brian; Holz, Richard C.; Liu, Dali			Structural basis for the hydrolytic dehalogenation of the fungicide chlorothalonil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; zinc; enzyme catalysis; enzyme mechanism; enzyme kinetics; bioremediation; Chd; chlorothalonil; dechlorination; dehalogenase	METALLO-BETA-LACTAMASES; MECHANISM; ALKYLSULFATASE; PURIFICATION; DEGRADATION; DOCKING; ENZYMES; ZINC	Cleavage of aromatic carbon?chlorine bonds is critical for the degradation of toxic industrial compounds. Here, we solved the X-ray crystal structure of chlorothalonil dehalogenase (Chd) fromPseudomonassp. CTN-3, with 15 of its N-terminal residues truncated (Chd(T)), using single-wavelength anomalous dispersion refined to 1.96 ? resolution. Chd has low sequence identity (<15%) compared with all other proteins whose structures are currently available, and to the best of our knowledge, we present the first structure of a Zn(II)-dependent aromatic dehalogenase that does not require a coenzyme. Chd(T)forms a ?head-to-tail? homodimer, formed between two ?-helices from each monomer, with three Zn(II)-binding sites, two of which occupy the active sites, whereas the third anchors a structural site at the homodimer interface. The catalytic Zn(II) ions are solvent-accessible via a large hydrophobic (8.5 ? 17.8 ?) opening to bulk solvent and two hydrophilic branched channels. Each active-site Zn(II) ion resides in a distorted trigonal bipyramid geometry with His(117), His(257), Asp(116), Asn(216), and a water/hydroxide as ligands. A conserved His residue, His(114), is hydrogen-bonded to the Zn(II)-bound water/hydroxide and likely functions as the general acid-base. We examined substrate binding by docking chlorothalonil (2,4,5,6-tetrachloroisophtalonitrile, TPN) into the hydrophobic channel and observed that the most energetically favorable pose includes a TPN orientation that coordinates to the active-site Zn(II) ions via a CN and that maximizes a ??? interaction with Trp(227). On the basis of these results, along with previously reported kinetics data, we propose a refined catalytic mechanism for Chd-mediated TPN dehalogenation.	[Yang, Xinhang; Holz, Richard C.] Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA; [Bennett, Brian] Marquette Univ, Dept Phys, Milwaukee, WI 53233 USA; [Catlin, Daniel S.; Liu, Dali] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA; [Holz, Richard C.] Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA	Marquette University; Marquette University; Loyola University Chicago; Colorado School of Mines	Holz, RC (corresponding author), Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA.; Liu, DL (corresponding author), Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA.; Holz, RC (corresponding author), Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA.	rholz@mines.edu; dliu@luc.edu	; Liu, Dali/D-2571-2014	Holz, Richard/0000-0001-6093-2799; Liu, Dali/0000-0002-7587-703X	National Science Foundation [CHE-1808711]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant CHE-1808711 (to B. B. and R. C. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ang TF, 2018, MOLECULES, V23, DOI 10.3390/molecules23051100; Arora PK, 2014, J CHEM-NY, V2014, P1, DOI 10.1155/2014/265140; Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Baxter J, 2006, ANTON LEEUW INT J G, V90, P1, DOI 10.1007/s10482-006-9057-y; Beil S, 1998, J BACTERIOL, V180, P5520, DOI 10.1128/JB.180.21.5520-5528.1998; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Carlo-Rojas Z, 2004, WATER AIR SOIL POLL, V151, P397, DOI 10.1023/B:WATE.0000009918.70113.c5; Caux PY, 1996, CRIT REV ENV SCI TEC, V26, P45, DOI 10.1080/10643389609388486; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Copley SD, 1998, CURR OPIN CHEM BIOL, V2, P613, DOI 10.1016/S1367-5931(98)80092-6; Cosper NJ, 2003, J AM CHEM SOC, V125, P14654, DOI 10.1021/ja036650v; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Desmarais W, 2006, J BIOL INORG CHEM, V11, P398, DOI 10.1007/s00775-006-0093-x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fryszczyn BG, 2014, PROTEIN SCI, V23, P1235, DOI 10.1002/pro.2505; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu JM, 2019, PROTEIN SCI, V28, P68, DOI 10.1002/pro.3479; Janssen DB, 2001, CURR OPIN BIOTECH, V12, P254, DOI 10.1016/S0958-1669(00)00208-1; Knaus T, 2012, FEBS J, V279, P4374, DOI 10.1111/febs.12027; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kussmann M, 2000, METH MOL B, V146, P405, DOI 10.1385/1-59259-045-4:405; Leisinger Thomas, 1994, Biodegradation, V5, P237, DOI 10.1007/BF00696462; Liang B, 2011, APPL ENVIRON MICROB, V77, P4268, DOI 10.1128/AEM.02457-10; Mozzachio AM, 2008, ENVIRON RES, V108, P400, DOI 10.1016/j.envres.2008.07.018; ORSER CS, 1993, J BACTERIOL, V175, P2640, DOI 10.1128/JB.175.9.2640-2644.1993; Peat TS, 2015, ACTA CRYSTALLOGR D, V71, P710, DOI 10.1107/S1399004715000619; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quiroga R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155183; Reddy GVB, 2000, MICROBIOL-UK, V146, P405, DOI 10.1099/00221287-146-2-405; Ren XJ, 2011, CURR MICROBIOL, V62, P1068, DOI 10.1007/s00284-010-9824-x; Sakkas VA, 2002, CHEMOSPHERE, V48, P939, DOI 10.1016/S0045-6535(02)00121-2; Sakurai M, 1995, J PHYS CHEM-US, V99, P17789, DOI 10.1021/j100050a019; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Signor L, 2013, JOVE-J VIS EXP, DOI 10.3791/50635; Sims J. L., 1991, REDUCTIVE DEHALOGENA; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Viciu MS, 2001, ORGANOMETALLICS, V20, P3607, DOI 10.1021/om010332s; VICKERS AEM, 1985, ENVIRON HEALTH PERSP, V59, P121, DOI 10.2307/3429884; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang GL, 2010, J BACTERIOL, V192, P2737, DOI 10.1128/JB.01547-09; XUN LY, 1992, J BACTERIOL, V174, P8003, DOI 10.1128/JB.174.24.8003-8007.1992; Yang XH, 2019, J BIOL CHEM, V294, P13411, DOI 10.1074/jbc.RA119.009094; Yang XH, 2018, ARCH BIOCHEM BIOPHYS, V657, P1, DOI 10.1016/j.abb.2018.08.013; YOKOTA T, 1986, AGR BIOL CHEM TOKYO, V50, P453, DOI 10.1080/00021369.1986.10867402; Yue WL, 2015, J BIOSCI BIOENG, V120, P544, DOI 10.1016/j.jbiosc.2015.03.013	51	2	2	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8668	8677		10.1074/jbc.RA120.013150	http://dx.doi.org/10.1074/jbc.RA120.013150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32358058	Green Published, hybrid			2022-12-26	WOS:000546296800004
J	Ruben, EA; Gandhi, PS; Chen, ZW; Koester, SK; DeKoster, GT; Frieden, C; Di Cera, E				Ruben, Eliza A.; Gandhi, Prafull S.; Chen, Zhiwei; Koester, Sarah K.; DeKoster, Gregory T.; Frieden, Carl; Di Cera, Enrico			F-19 NMR reveals the conformational properties of free thrombin and its zymogen precursor prethrombin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); X-ray crystallography; thrombin; serine protease; protein conformation; blood coagulation; ligand binding; protein dynamics; zymogen	RAY CRYSTAL-STRUCTURE; NA+ BINDING; BOVINE TRYPSINOGEN; PROTEIN-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; RAPID KINETICS; INDUCED FIT; SPECIFICITY; MECHANISM	The conformational properties of trypsin-like proteases and their zymogen forms remain controversial because of a lack of sufficient information on their free forms. Specifically, it is unclear whether the free protease is zymogen-like and shifts to its mature form upon a ligand-induced fit or exists in multiple conformations in equilibrium from which the ligand selects the optimal fit via conformational selection. Here we report the results of(19)F NMR measurements that reveal the conformational properties of a protease and its zymogen precursor in the free form. Using the trypsin-like, clotting protease thrombin as a relevant model system, we show that its conformation is quite different from that of its direct zymogen precursor prethrombin-2 and more similar to that of its fully active Na+-bound form. The results cast doubts on recent hypotheses that free thrombin is zymogen-like and transitions to protease-like forms upon ligand binding. Rather, they validate the scenario emerged from previous findings of X-ray crystallography and rapid kinetics supporting a pre-existing equilibrium between open (E) and closed (E*) forms of the active site. In this scenario, prethrombin-2 is more dynamic and exists predominantly in the E* form, whereas thrombin is more rigid and exists predominantly in the E form. Ligand binding to thrombin takes place exclusively in the E form without significant changes in the overall conformation. In summary, these results disclose the structural architecture of the free forms of thrombin and prethrombin-2, consistent with an E*?E equilibrium and providing no evidence that free thrombin is zymogen-like.	[Ruben, Eliza A.; Chen, Zhiwei; Koester, Sarah K.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Gandhi, Prafull S.] Novo Nordisk, Global Res, Malov, Denmark; [DeKoster, Gregory T.; Frieden, Carl] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Saint Louis University; Novo Nordisk; Washington University (WUSTL)	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu		DeKoster, Gregory/0000-0001-9928-8195; Koester, Sarah/0000-0003-4626-504X	National Institutes of Health [HL049413, HL139554, HL147821]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants HL049413, HL139554, and HL147821 (to E. D. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aramini JM, 2014, STRUCTURE, V22, P515, DOI 10.1016/j.str.2014.01.010; Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Bann JG, 2002, P NATL ACAD SCI USA, V99, P709, DOI 10.1073/pnas.022649599; BODE W, 1976, J MOL BIOL, V106, P325, DOI 10.1016/0022-2836(76)90089-9; BODE W, 1978, FEBS LETT, V90, P265, DOI 10.1016/0014-5793(78)80382-2; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1992, PROTEIN SCI, V1, P426; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Chakraborty P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21728-9; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Danielson MA, 1996, ANNU REV BIOPH BIOM, V25, P163, DOI 10.1146/annurev.bb.25.060196.001115; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frieden C, 2004, METHOD ENZYMOL, V380, P400; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Fuglestad B, 2012, BIOPHYS J, V103, P79, DOI 10.1016/j.bpj.2012.05.047; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Handley LD, 2017, SCI REP-UK, V7, DOI 10.1038/srep39575; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Kahler U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57822-0; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Landgraf KE, 2014, NAT CHEM BIOL, V10, P567, DOI [10.1038/nchembio.1533, 10.1038/NCHEMBIO.1533]; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; Mazur A, 2013, BIOINFORMATICS, V29, P1819, DOI 10.1093/bioinformatics/btt286; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pelc LA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48839-1; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Pozzi N, 2011, BIOPHYS CHEM, V159, P6, DOI 10.1016/j.bpc.2011.04.003; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; Rohr KB, 2006, J MOL BIOL, V357, P195, DOI 10.1016/j.jmb.2005.12.037; Stojanovski BM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54564-6; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Vogt AD, 2010, J PHYS CHEM B, V114, P16125, DOI 10.1021/jp105502c; Wakeham N, 2002, PROTEIN ENG, V15, P753, DOI 10.1093/protein/15.9.753; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008	53	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8227	8235		10.1074/jbc.RA120.013419	http://dx.doi.org/10.1074/jbc.RA120.013419			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358061	hybrid, Green Published			2022-12-26	WOS:000542965700011
J	Traughber, CA; Opoku, E; Brubaker, G; Major, J; Lu, HX; Lorkowski, SW; Neumann, C; Hardaway, A; Chung, YM; Gulshan, K; Sharifi, N; Brown, JM; Smith, JD				Traughber, C. Alicia; Opoku, Emmanuel; Brubaker, Gregory; Major, Jennifer; Lu, Hanxu; Lorkowski, Shuhui Wang; Neumann, Chase; Hardaway, Aimalie; Chung, Yoon-Mi; Gulshan, Kailash; Sharifi, Nima; Brown, J. Mark; Smith, Jonathan D.			Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; high-density lipoprotein (HDL); lipoprotein metabolism; lipoprotein receptor; prostate cancer; scavenger receptor; CRISPR; Cas; SCARB1; scavenger receptor class B; type 1	CHOLESTERYL ESTER ACCUMULATION; APOLIPOPROTEIN-A-I; SR-BI; STEROIDOGENIC CELLS; STATIN USE; RISK; HDL; EXPRESSION; CARCINOMA; BLOOD	High-density lipoprotein (HDL) metabolism is facilitated in part by scavenger receptor class B, type 1 (SR-B1) that mediates HDL uptake into cells. Higher levels of HDL have been associated with protection in other diseases, however, its role in prostate cancer is not definitive. SR-B1 is up-regulated in prostate cancer tissue, suggesting a possible role of this receptor in tumor progression. Here, we report that knockout (KO) of SR-B1 in both human and mouse prostate cancer cell lines through CRISPR/Cas9-mediated genome editing reduces HDL uptake into the prostate cancer cells and reduces their proliferation in response to HDL.In vivostudies using syngeneic SR-B1 WT (SR-B1(+/+)) and SR-B1 KO (SR-B1(?/?)) prostate cancer cells in WT and apolipoprotein-AI KO (apoA1-KO) C57BL/6J mice revealed that WT hosts, containing higher levels of total and HDL-cholesterol, grew larger tumors than apoA1-KO hosts with lower levels of total and HDL-cholesterol. Furthermore, SR-B1(?/?)prostate cancer cells formed smaller tumors in WT hosts than SR-B1(+/+)cells in the same host model. Increased tumor volume was overall associated with reduced survival. We conclude that knocking out SR-B1 in prostate cancer tumors reduces HDL-associated increases in prostate cancer cell proliferation and disease progression.	[Traughber, C. Alicia; Opoku, Emmanuel; Brubaker, Gregory; Major, Jennifer; Lu, Hanxu; Lorkowski, Shuhui Wang; Neumann, Chase; Gulshan, Kailash; Brown, J. Mark; Smith, Jonathan D.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Hardaway, Aimalie; Chung, Yoon-Mi; Sharifi, Nima] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Traughber, C. Alicia; Neumann, Chase; Brown, J. Mark; Smith, Jonathan D.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Brown, J. Mark] Case Western Reserve Univ, Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Brown, J. Mark] Cleveland Clin Fdn, Ctr Microbiome & Human Hlth, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Major, Jennifer] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Smith, JD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA.; Smith, JD (corresponding author), Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	smithj4@ccf.org		Opoku, Emmanuel/0000-0003-2816-7761	National Institutes of Health [R01HL128628, R01DK120679, P50AA024333, P01HL147823, R01CA172382, R01CA190289, R01CA236780, F31HL134231, R01HL148158]; American Heart Association [SDG25710128]; Case Comprehensive Cancer Center pilot Grant [RES511106]; VeloSano Foundation; NCI National Institutes of Health [P30CA043703]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Case Comprehensive Cancer Center pilot Grant; VeloSano Foundation; NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01HL128628 (to J. D. S.), R01DK120679 (to J. M. B.), P50AA024333 (to J. M. B.), P01HL147823 (to J. M. B.), R01CA172382 (to N. S.), R01CA190289 (to N. S.), R01CA236780 (to N. S.), and F31HL134231 (to C. A. T.), American Heart Association Grant SDG25710128 (to K. G.), the Case Comprehensive Cancer Center pilot Grant RES511106 (to J. D. S.), the VeloSano Foundation (to J. D. S.), National Institutes of Health Grant R01HL148158 (to K. G.), and Case Comprehensive Cancer Center pilot grant program supported by NCI National Institutes of Health Grant P30CA043703. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Bull CJ, 2016, CANCER MED-US, V5, P1125, DOI 10.1002/cam4.695; CALVO D, 1993, J BIOL CHEM, V268, P18929; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Davis CE, 1996, AM J EPIDEMIOL, V143, P1100; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Eissa MA, 2016, J PEDIATR-US, V170, P199, DOI 10.1016/j.jpeds.2015.11.018; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; Gordon JA, 2019, CANCER RES, V79, P3320, DOI 10.1158/0008-5472.CAN-18-2529; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hammarsten J, 2004, BLOOD PRESSURE, V13, P47, DOI 10.1080/08037050310025735; Huggins C, 1941, CANCER RES, V1, P293; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Jacobs EJ, 2012, CANCER CAUSE CONTROL, V23, P1289, DOI 10.1007/s10552-012-0006-y; Jafri H, 2010, J AM COLL CARDIOL, V55, P2846, DOI 10.1016/j.jacc.2009.12.069; Jamnagerwalla J, 2018, PROSTATE CANCER P D, V21, P252, DOI 10.1038/s41391-017-0030-9; Kim J, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158525; KIRKLAND RT, 1987, JAMA-J AM MED ASSOC, V257, P502, DOI 10.1001/jama.257.4.502; Kok DEG, 2011, PROSTATE CANCER P D, V14, P340, DOI 10.1038/pcan.2011.30; Langer C, 2002, BIOCHEM BIOPH RES CO, V296, P1051, DOI 10.1016/S0006-291X(02)02038-7; Lee BH, 2013, CANCER RES, V73, P1211, DOI 10.1158/0008-5472.CAN-12-3128; Li K, 2018, METHODS MOL BIOL, V1740, P139, DOI 10.1007/978-1-4939-7652-2_11; Liu YP, 2015, CANCER EPIDEM BIOMAR, V24, P1086, DOI 10.1158/1055-9965.EPI-14-1329; Llaverias G, 2010, AM J PATHOL, V177, P3180, DOI 10.2353/ajpath.2010.100568; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACHIDA T, 1981, HORM BEHAV, V15, P238, DOI 10.1016/0018-506X(81)90013-1; Machiela MJ, 2018, BIOINFORMATICS, V34, P887, DOI 10.1093/bioinformatics/btx561; Martin RM, 2009, CANCER CAUSE CONTROL, V20, P1181, DOI 10.1007/s10552-009-9319-x; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Meng Y, 2016, ONCOTARGETS THER, V9, P1689, DOI 10.2147/OTT.S97993; Murtola TJ, 2017, EUR UROL FOCUS, V3, P212, DOI 10.1016/j.euf.2016.05.004; Oka R, 2016, INT J CLIN ONCOL, V21, P389, DOI 10.1007/s10147-015-0891-7; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Pirro M, 2018, PROG LIPID RES, V71, P54, DOI 10.1016/j.plipres.2018.06.001; Plump AS, 1996, J CLIN INVEST, V97, P2660, DOI 10.1172/JCI118716; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Raval AD, 2016, PROSTATE CANCER P D, V19, P151, DOI 10.1038/pcan.2015.58; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Schorghofer D, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0087-z; Sekine Y, 2010, MOL CANCER RES, V8, P1284, DOI 10.1158/1541-7786.MCR-10-0008; Shen WJ, 2018, ANNU REV PHYSIOL, V80, P95, DOI 10.1146/annurev-physiol-021317-121550; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Tan P, 2017, ASIAN J ANDROL, V19, P666, DOI 10.4103/1008-682X.190327; Tilly-Kiesi M, 1997, ARTERIOSCL THROM VAS, V17, P3513, DOI 10.1161/01.ATV.17.12.3513; Van Hemelrijck M, 2011, CANCER CAUSE CONTROL, V22, P1011, DOI 10.1007/s10552-011-9774-z; Velagapudi S, 2018, J LIPID RES, V59, P2188, DOI 10.1194/jlr.M083311; Wang SH, 2014, BIOFACTORS, V40, P547, DOI 10.1002/biof.1187; Williamson CM, 2017, PHYSIOL BEHAV, V171, P110, DOI 10.1016/j.physbeh.2016.12.038; Witt W, 2000, J LIPID RES, V41, P2009; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Xu GH, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3761-z; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zamanian-Daryoush M, 2017, ONCOTARGET, V8, P71965, DOI 10.18632/oncotarget.18666; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967	60	9	9	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8252	8261		10.1074/jbc.RA120.013694	http://dx.doi.org/10.1074/jbc.RA120.013694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358065	Green Published, hybrid			2022-12-26	WOS:000542965700013
J	Morel, M; Shah, KN; Long, WW				Morel, Marion; Shah, Krushangi N.; Long, Weiwen			The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); E3 ubiquitin ligase; protein stability; ubiquitylation (ubiquitination); cancer; cell migration; F-box and leucine-rich repeat protein 16 (FBXL16); F-box protein; F-box; WD repeat-containing protein 7 (FBW7); protein homeostasis; proto-oncogene C-Myc (C-MYC)	UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; STEM-CELLS; CANCER; MECHANISMS; RECOGNITION; DEGRADATION; COMPLEX; GROWTH	F-box proteins, such as F-box/WD repeat-containing protein 7 (FBW7), are essential components of the SKP1-CUL1-F-box (SCF) E3 ubiquitin ligases. They bind to S-phase kinase-associated protein 1 (SKP1) through the F-box motif and deliver their protein substrate to the E3 ligase complex for ubiquitination and subsequent degradation. F-box and leucine-rich repeat protein 16 (FBXL16) is a poorly studied F-box protein. Because it does not interact with the scaffold protein cullin 1 (CUL1), we hypothesized that FBXL16 might not form a functional SCF-E3 ligase complex. In the present study, we found that FBXL16 up-regulates the levels of proteins targeted by SCF-E3 ligases, such as C-MYC, ?-catenin, and steroid receptor coactivator 3 (SRC-3). Focusing on C-MYC, a well-known oncoprotein overexpressed in most human cancers, we show that FBXL16 stabilizes C-MYC by antagonizing FBW7-mediated C-MYC ubiquitination and degradation. Further, we found that, although FBXL16 does not interact with CUL1, it interacts with SKP1 via its N-terminal F-box domain and with its substrate C-MYC via its C-terminal leucine-rich repeats (LRRs) domain. We found that both the F-box domain and the LRR domain are important for FBXL16-mediated C-MYC stabilization. In line with its role in up-regulating the levels of the C-MYC and SRC-3 oncoproteins, FBXL16 promoted cancer cell growth and migration and colony formation in soft agar. Our findings reveal that FBXL16 is an F-box protein that antagonizes the activity of another F-box protein, FBW7, and thereby increases C-MYC stability, resulting in increased cancer cell growth and invasiveness.	[Morel, Marion; Shah, Krushangi N.; Long, Weiwen] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Long, WW (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	weiwen.long@wright.edu	Shah, Krushangi N/AAL-9331-2020; Morel, Marion/X-4104-2019	Shah, Krushangi N/0000-0002-7908-6462; Morel, Marion/0000-0002-1439-5360	NCI, National Institutes of Health [1R01CA193264-01]; Wright State University	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wright State University	This work was supported by NCI, National Institutes of Health Grant 1R01CA193264-01 (to W. L.). This work was also supported by a start-up fund of Wright State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cremona CA, 2016, SEMIN CANCER BIOL, V36, P52, DOI 10.1016/j.semcancer.2015.09.006; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Elkhadragy L, 2018, J BIOL CHEM, V293, P16193, DOI 10.1074/jbc.RA118.003699; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Heo JH, 2016, SEMIN CANCER BIOL, V36, P33, DOI 10.1016/j.semcancer.2015.09.015; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Honarpour N, 2014, MOL CELL PROTEOMICS, V13, P780, DOI 10.1074/mcp.M113.031765; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Liu X, 2018, MOL CELL, V69, P773, DOI 10.1016/j.molcel.2018.01.038; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Roworth AP, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970480; Sato K, 2010, INT J ONCOL, V36, P479, DOI 10.3892/ijo_00000522; Shimizu K, 2018, CELL SIGNAL, V46, P15, DOI 10.1016/j.cellsig.2018.02.009; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Vo BT, 2016, CANCER CELL, V29, P5, DOI 10.1016/j.ccell.2015.12.003; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	37	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7970	7980		10.1074/jbc.RA120.012658	http://dx.doi.org/10.1074/jbc.RA120.012658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32345600	Green Published, hybrid			2022-12-26	WOS:000540935400012
J	Kroenke, CH; Le, GM; Conroy, SM; Canchola, AJ; Shariff-Marco, S; Gomez, SL				Kroenke, Candyce H.; Le, Gem M.; Conroy, Shannon M.; Canchola, Alison J.; Shariff-Marco, Salma; Gomez, Scarlett Lin			Egocentric social networks, lifestyle behaviors, and body size in the Asian Community Health Initiative (CHI) cohort	PLOS ONE			English	Article							DIETARY HABITS; RISK-FACTORS; SMOKING-BEHAVIOR; US ACCULTURATION; WOMENS-HEALTH; OLDER WOMEN; MASS INDEX; OBESITY; AMERICANS; FOOD	Background Social networks have been shown to influence lifestyle behaviors in non-Latinx white (NLW) populations. We examined their influence in Asian American, Native Hawaiian and Pacific Islander (AANHPI) women. Methods We included 477 AANHPI women from the Asian Community Health Initiative Study who provided egocentric (degree, density, composition) and epidemiologic (size, types of ties) social network data and data on alcohol intake, physical activity, smoking, diet, and body size. We used logistic regression to evaluate associations of social network measures and dichotomous outcomes, and linear regression for continuous outcomes. Results In multivariable-adjusted analyses, higher degree and/or proportion of friends were significantly related to higher Western diet, higher odds of any alcohol consumption, and lower odds of physical inactivity and body mass index (BMI)>= 23 kg/m(2). Additionally, a higher proportion of NLW in women's networks was related to lower Asian diet but also lower waist size. Community participation was related to higher Western diet and lower Asian diet. By contrast, degree and/or proportion of relatives were positively related to BMI, waist size and to a higher odds of BMI >= 23 kg/m(2) and of ever smoking 100 cigarettes. Being married was related to fewer alcoholic drinks per week and higher Asian diet. A higher density of relationships with frequent contact was also associated with higher Asian diet. Conclusions AANHPI women with larger proportions of friends and NLWs in their networks had more Western health behaviors and smaller body size. Norms for health behaviors and body size may be influenced by the size, composition, and structure of social networks, relevant to chronic disease prevention.	[Kroenke, Candyce H.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94611 USA; [Le, Gem M.; Conroy, Shannon M.] UCSF, Ctr Vulnerable Populat, Dept Med, Div Gen Internal Med, San Francisco, CA USA; [Canchola, Alison J.; Shariff-Marco, Salma; Gomez, Scarlett Lin] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Canchola, Alison J.; Shariff-Marco, Salma; Gomez, Scarlett Lin] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Kroenke, CH (corresponding author), Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94611 USA.	candyce.h.kroenke@kp.org		Kroenke, Candyce/0000-0002-6128-3118	National Institutes of Health, National Cancer Institute [K07 CA187403, R01 CA230440]; California Breast Cancer Research Program [17UB-8602]	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Breast Cancer Research Program	This work was supported by the National Institutes of Health, National Cancer Institute Grant K07 CA187403 (PI: C. Kroenke), Grant R01 CA230440 (PI: C. Kroenke), and California Breast Cancer Research Program Grant 17UB-8602 (PI: S. Gomez).	Ajrouch KJ, 2005, J GERONTOL B-PSYCHOL, V60, pS311, DOI 10.1093/geronb/60.6.S311; Alidu L, 2018, PSYCHOL HEALTH, V33, P724, DOI 10.1080/08870446.2017.1398327; Allen JD, 2014, SOC SCI MED, V123, P26, DOI 10.1016/j.socscimed.2014.10.034; Ayers JW, 2011, ALCOHOL, V45, P89, DOI 10.1016/j.alcohol.2010.08.006; Barefoot JC, 2005, AM J EPIDEMIOL, V161, P960, DOI 10.1093/aje/kwi128; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chua V, 2015, AM BEHAV SCI, V59, P903, DOI 10.1177/0002764215580585; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cornwell B, 2009, J AGING HEALTH, V21, P129, DOI 10.1177/0898264308328649; DiGuiseppi GT, 2018, PSYCHOL ADDICT BEHAV, V32, P914, DOI 10.1037/adb0000402; Eyre H, 2004, DIABETES CARE, V27, P1812, DOI 10.2337/diacare.27.7.1812; Fardet A, 2014, NUTR REV, V72, P741, DOI 10.1111/nure.12153; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Gomez SL, 2004, AM J PUBLIC HEALTH, V94, P1977, DOI 10.2105/AJPH.94.11.1977; Gordon BHJ, 2000, J AM DIET ASSOC, V100, P1198, DOI 10.1016/S0002-8223(00)00346-1; Gorman BK, 2014, SOC SCI MED, V106, P110, DOI 10.1016/j.socscimed.2014.02.002; Gotay CC, 2015, CAN J PUBLIC HEALTH, V106, pE333, DOI 10.17269/cjph.106.4762; Harmon BE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3166-y; HUNG SS, 1995, J NUTR EDUC, V27, P63, DOI 10.1016/S0022-3182(12)80341-4; Jepson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045333; Jih J, 2014, PREV MED, V65, P1, DOI 10.1016/j.ypmed.2014.04.010; Johnson-Kozlow M, 2011, J NUTR EDUC BEHAV, V43, P505, DOI 10.1016/j.jneb.2010.09.001; Josey MJ, 2018, HEALTH PLACE, V54, P62, DOI 10.1016/j.healthplace.2018.08.016; Kim J, 2004, BRIT J NUTR, V91, P469, DOI 10.1079/BJN20031068; Kroenke CH, 2018, TRANSL BEHAV MED, V8, P629, DOI 10.1093/tbm/ibx061; Kroenke CH, 2017, PSYCHO-ONCOLOGY, V26, P544, DOI 10.1002/pon.4059; Kudo Y, 2000, EUR J CLIN NUTR, V54, P665, DOI 10.1038/sj.ejcn.1601072; Kuerban A, 2016, J IMMIGR MINOR HEALT, V18, P94, DOI 10.1007/s10903-014-0155-z; Lancki N, 2018, OBESITY MED, V11; Lee SK, 1999, J AM DIET ASSOC, V99, P1084, DOI 10.1016/S0002-8223(99)00258-8; Lopez G, 2017, FACT TANK NEWS NUMBE; Marquez B, 2014, HEALTH PSYCHOL, V33, P544, DOI 10.1037/hea0000092; McLaren L, 2004, SOC SCI MED, V58, P1575, DOI 10.1016/S0277-9536(03)00209-0; Motteli S, 2020, J SPORT HEALTH SCI, V9, P339, DOI 10.1016/j.jshs.2017.01.002; Morey BN, 2018, NATIVITY DIFFERENCES, V11, P28; Mowbray O, 2014, AM J DRUG ALCOHOL AB, V40, P181, DOI 10.3109/00952990.2013.860984; Novotny R, 2012, J ACAD NUTR DIET, V112, P649, DOI 10.1016/j.jand.2012.02.002; Novotny R, 2009, J AM DIET ASSOC, V109, P1712, DOI 10.1016/j.jada.2009.07.013; Pachucki MA, 2011, AM J PUBLIC HEALTH, V101, P2170, DOI 10.2105/AJPH.2011.300282; Park S, 2016, AM J HEALTH PROMOT, V30, P357, DOI 10.1177/0890117116646343; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; Phan T, 2006, J COUNS PSYCHOL, V53, P36, DOI 10.1037/0022-0167.53.1.36; Pokhrel P, 2016, AM J COMMUN PSYCHOL, V57, P353, DOI 10.1002/ajcp.12063; Raj S, 1999, J AM DIET ASSOC, V99, P1106, DOI 10.1016/S0002-8223(99)00266-7; Ro A, 2015, SOC SCI MED, V144, P39, DOI 10.1016/j.socscimed.2015.09.001; Ro A, 2014, INT J ENV RES PUB HE, V11, P8038, DOI 10.3390/ijerph110808038; Satia JA, 2001, J AM DIET ASSOC, V101, P548, DOI 10.1016/S0002-8223(01)00137-7; Schweizer T, 1998, SOC NETWORKS, V20, P1, DOI 10.1016/S0378-8733(96)00304-8; Simonsick EM, 1998, J GERONTOL B-PSYCHOL, V53, pS209, DOI 10.1093/geronb/53B.4.S209; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sorensen G, 2007, AM J PUBLIC HEALTH, V97, P1216, DOI 10.2105/AJPH.2006.088120; Stein CJ, 2004, BRIT J CANCER, V90, P299, DOI 10.1038/sj.bjc.6601509; Sugisawa H, 2020, AM J HEALTH BEHAV, V44, P100, DOI 10.5993/AJHB.44.1.11; Tsai G, 2003, J NERV MENT DIS, V191, P309, DOI 10.1097/00005053-200305000-00006; Tseng M, 2015, J IMMIGR MINOR HEALT, V17, P400, DOI 10.1007/s10903-014-0118-4; Tsoh JY, 2015, NICOTINE TOB RES, V17, P1029, DOI 10.1093/ntr/ntv088; U.S. Department of Health and Human Services National Institutes of Health NIfMH Institute for Social Research Indiana University, 1991, IND NETW MENT HTLH S; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Wong CK, 2016, J EPIDEMIOL COMMUN H, V70, P974, DOI 10.1136/jech-2015-206905; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Yi Stella S, 2016, Prev Med Rep, V4, P404, DOI 10.1016/j.pmedr.2016.08.007; Zou P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010111	62	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232239	10.1371/journal.pone.0232239	http://dx.doi.org/10.1371/journal.pone.0232239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZB	32374741	Green Published, gold			2022-12-26	WOS:000537283500025
J	Vubil, A; Zicai, AF; Sitoe, N; Nhachigule, C; Meggi, B; Loquiha, O; Viegas, S; Mabunda, N; Scott, L; Jani, I				Vubil, Adolfo; Zicai, Ana Flora; Sitoe, Nadia; Nhachigule, Carina; Meggi, Bindiya; Loquiha, Osvaldo; Viegas, Sofia; Mabunda, Nedio; Scott, Lesley; Jani, Ilesh			Accurate HIV viral load measurement in primary health care settings using the cobas (R) plasma separation card	PLOS ONE			English	Article							DRIED BLOOD SPOTS; ANTIRETROVIRAL TREATMENT; RNA; ASSAYS	Introduction Plasma is considered the gold standard for HIV viral load (VL) testing, however its use is challenging due to the need for phlebotomy and centrifugation services, as well as cold chain for transporting to laboratories for testing. The use of Dried Blood Spot (DBS) specimen has allowed a rapid expansion of antiretroviral therapy (ART) monitoring in remote areas in many African countries, however, the VL in DBS may overestimate the copies of viral RNA result at the clinically relevant range of 1000 copies/ml, due to proviral DNA and intracellular RNA. The characteristics of the cobas (R) Plasma Separation Card (PSC) specimen are similar to fresh plasma (gold standard), so a better performance of HIV VL is expetected in PSC specimen and can be an alternative to DBS. This study aims to evaluate the performance of cobas (R) PSC for VL testing at primary health care facilities in Mozambique. Methodology HIV-1 infected adults on ART were enrolled consecutively in two health facilities in Mozambique, between August 2018 and October 2018. Capillary and venous cobas (R) PSC, DBS and fresh plasma specimens were collected from each patient. All specimens were tested for VL using CAP/CTM v2.0. Sensitivity and specificity of viral load using DBS, capillary and venous PSC specimens were estimated. Viral load obtained in fresh plasma specimen was used as reference and a threshold of 1000 copies/ml was considered for the analyses. Results From the total 613 patients included for the study, 2444 specimens including DBS (613), plasma (613), venous cobas (R) PSC (609) and capillary cobas (R) PSC (609) were collected and 2407 results were obtained. Sensitivity and specificity of the VL using venous cobas (R) PSC specimen at 1000 copies/ml threshold were 99.8% and 98.1% respectively, whereas for capillary cobas (R) PSC sensitivity was 99.6% and specificity was 97.2%. For DBS VL, sensitivity was 96.9% and specificity was 81.8%. Misclassification rate was more prominent in DBS specimens (5.9%), but lower in venous and capillary cobas (R) PSC with a rate of 0.3% and 0.7% respectively. Conclusion The cobas (R) PSC specimen has improved performance over DBS for more accurate VL testing aligned with plasma testing. The use of this specimen type can increase the rates of reliable VL results and this will improve the quality of VL monitoring of HIV-positive patients in low-income settings.	[Vubil, Adolfo; Zicai, Ana Flora; Sitoe, Nadia; Nhachigule, Carina; Meggi, Bindiya; Viegas, Sofia; Mabunda, Nedio; Jani, Ilesh] Inst Nacl Saude, Marracuene, Mozambique; [Loquiha, Osvaldo] Clinton Hlth Access Initiat, Maputo, Mozambique; [Scott, Lesley] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa	University of Witwatersrand	Vubil, A (corresponding author), Inst Nacl Saude, Marracuene, Mozambique.	avubil@gmail.com		Sitoe, Nadia/0000-0001-7310-8221; Scott, Lesley/0000-0001-6573-9525	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We acknowledge the Bill and Melinda Gates Foundation for funding opportunity #OPP1171455.	Alvarez P, 2017, PEDIATR RES, V81, P80, DOI 10.1038/pr.2016.183; Alvarez P, 2015, J INFECTION, V71, P368, DOI 10.1016/j.jinf.2015.05.011; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Carmona S, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01336-18; Chang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181054; Ending AIDS, 2017, GLOBAL AIDS UPDATE; Erba F, 2015, SAMJ S AFR MED J, V105, P1036, DOI [10.7196/SAMJ.2015.v105i12.9673, 10.7196/SAMJ.2015.V105I12.9673]; Ginocchio CC, 1997, J CLIN MICROBIOL, V35, P2886, DOI 10.1128/JCM.35.11.2886-2893.1997; Guichet E, 2018, J VIROL METHODS, V251, P75, DOI 10.1016/j.jviromet.2017.10.014; Jani IV, 2012, J CLIN MICROBIOL, V50, P1458, DOI 10.1128/JCM.00107-12; Lin L, 1998, PDA J PHARM SCI TECH, V52, P55; Makadzange AT, 2017, J CLIN MICROBIOL, V55, P2172, DOI 10.1128/JCM.00176-17; Nichols BE, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25206; Pham MD, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01683-18; Sawadogo S, 2014, J CLIN MICROBIOL, V52, P3878, DOI 10.1128/JCM.02063-14; Schmitz ME, 2017, JAIDS-J ACQ IMM DEF, V74, P399, DOI [10.1097/QAI.0000000000001275, 10.1097/qai.0000000000001275]; Scott L, 2009, J CLIN MICROBIOL, V47, P3400, DOI 10.1128/JCM.00727-09; Scott LE, 2009, J CLIN MICROBIOL, V47, P2209, DOI 10.1128/JCM.01761-08; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Tang N, 2017, J CLIN VIROL, V92, P56, DOI 10.1016/j.jcv.2017.05.002; van Rensburg EJ, 2011, J CLIN MICROBIOL, V49, P377, DOI 10.1128/JCM.01285-10; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2017, HIV TREAT CARE; Zeh C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179316	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232122	10.1371/journal.pone.0232122	http://dx.doi.org/10.1371/journal.pone.0232122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374748	Green Published, gold			2022-12-26	WOS:000537283500021
J	Feng, JB; Zhang, Y; Ren, X; Li, D; Fu, HJ; Liu, CH; Zhou, W; Liu, Q; Liu, Q; Wu, MH				Feng, Jianbo; Zhang, Yan; Ren, Xing; Li, Di; Fu, Haijuan; Liu, Changhong; Zhou, Wen; Liu, Qing; Liu, Qiang; Wu, Minghua			Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide	ONCOGENE			English	Article							COLORECTAL-CANCER; GLIOMA-CELLS; BETA-TRCP; RESISTANCE; MTOR; CHEMORESISTANCE; PROLIFERATION; EXPRESSION; APOPTOSIS; CYTOKINE	Temozolomide (TMZ) insensitivity and resistance are major causes of treatment failure and poor prognosis for GBM patients. Here, we identify LRRC4 as a novel autophagy inhibitor that restores the sensitivity of GBMs to TMZ. LRRC4 was associated with the DEPTOR/mTOR complex, and this interaction resulted in autophagy inhibition. Further investigation demonstrated that the PDZ binding domain of LRRC4 binds to the PDZ domain of DEPTOR. This binding decreases the half-life of DEPTOR via ubiquitination, thus inhibiting GBM cell autophagy and increasing the TMZ treatment response of GBM. Combined LRRC4 expression and TMZ treatment prolonged the survival of mice with tumour xenografts. Furthermore, the levels of LRRC4, DEPTOR and autophagy are clinically relevant for GBM, indicating that LRRC4 is likely to have significant potential as a therapeutic marker and target for TMZ treatment in glioma patients.	[Feng, Jianbo; Zhang, Yan; Ren, Xing; Li, Di; Fu, Haijuan; Liu, Changhong; Wu, Minghua] Cent South Univ, Hunan Prov Tumor Hosp, Changsha 410006, Hunan, Peoples R China; [Feng, Jianbo; Zhang, Yan; Ren, Xing; Li, Di; Fu, Haijuan; Liu, Changhong; Wu, Minghua] Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha 410006, Hunan, Peoples R China; [Feng, Jianbo; Zhang, Yan; Ren, Xing; Li, Di; Fu, Haijuan; Liu, Changhong; Zhou, Wen; Wu, Minghua] Cent South Univ, Canc Res Inst, Sch Basic Med Sci, Changsha 410078, Hunan, Peoples R China; [Feng, Jianbo; Zhang, Yan; Ren, Xing; Li, Di; Fu, Haijuan; Liu, Changhong; Zhou, Wen; Wu, Minghua] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China; [Feng, Jianbo; Zhang, Yan; Ren, Xing; Li, Di; Fu, Haijuan; Liu, Changhong; Zhou, Wen; Wu, Minghua] Minist Hlth, Key Lab Carcinogenesis, Changsha 410078, Hunan, Peoples R China; [Liu, Changhong] Shandong Univ, Hosp 2, Inst Med Sci, Jinan 250033, Shandong, Peoples R China; [Liu, Qing] Cent South Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Liu, Qiang] Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China	Central South University; Central South University; Central South University; Shandong University; Central South University; Central South University	Wu, MH (corresponding author), Cent South Univ, Hunan Prov Tumor Hosp, Changsha 410006, Hunan, Peoples R China.; Wu, MH (corresponding author), Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha 410006, Hunan, Peoples R China.; Wu, MH (corresponding author), Cent South Univ, Canc Res Inst, Sch Basic Med Sci, Changsha 410078, Hunan, Peoples R China.; Wu, MH (corresponding author), Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China.; Wu, MH (corresponding author), Minist Hlth, Key Lab Carcinogenesis, Changsha 410078, Hunan, Peoples R China.	wuminghua554@aliyun.com			National Natural Science Foundation of China [81874150]; Graduate Student Research Innovation Project in Hunan Province [2019zzts084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Research Innovation Project in Hunan Province	This works was supported by the National Natural Science Foundation of China (Grant No. 81874150) and Graduate Student Research Innovation Project in Hunan Province (2019zzts084).	Catena V, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0484-y; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Cosin-Roger J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00213-3; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Hombach-Klonisch S, 2018, PHARMACOL THERAPEUT, V184, P13, DOI 10.1016/j.pharmthera.2017.10.017; Hori YS, 2015, J NEURO-ONCOL, V122, P11, DOI 10.1007/s11060-014-1686-9; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Li PY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01748; Li PY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-266; Masui K, 2012, NEUROPATH APPL NEURO, V38, P271, DOI 10.1111/j.1365-2990.2011.01238.x; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Minghua W, 2010, J CELL BIOCHEM, V103, P245; Mokarram P, 2017, AUTOPHAGY, V13, P781, DOI 10.1080/15548627.2017.1290751; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nanegrungsunk D, 2015, NEUROL RES, V37, P167, DOI 10.1179/1743132814Y.0000000423; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Soto F, 2018, ELIFE, V7, DOI 10.7554/eLife.30388; Um SM, 2018, CELL REP, V23, P3839, DOI 10.1016/j.celrep.2018.05.087; Wang JR, 2002, PROG BIOCHEM BIOPHYS, V29, P233; Wang QD, 2018, CANCER RES, V78, P3163, DOI 10.1158/0008-5472.CAN-17-3107; Wang ZY, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0355-1; Wang ZW, 2012, NEOPLASIA, V14, P368, DOI 10.1593/neo.12542; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wick W, 2014, CANCER DISCOV, V4, P1120, DOI 10.1158/2159-8290.CD-14-0918; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Wu MH, 2008, J CELL PHYSIOL, V214, P65, DOI 10.1002/jcp.21163; Wu MH, 2006, MOL BIOL CELL, V17, P3534, DOI 10.1091/mbc.E05-11-1082; Xu G, 2015, J NEUROSCI, V35, P7153, DOI 10.1523/JNEUROSCI.4726-14.2015; Yan YL, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0303-5; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Yu TF, 2018, CANCER LETT, V433, P210, DOI 10.1016/j.canlet.2018.06.041; Zanotto-Filho A, 2015, CANCER LETT, V358, P220, DOI 10.1016/j.canlet.2014.12.044; Zhang W, 2008, GENES BRAIN BEHAV, V7, P385, DOI 10.1111/j.1601-183X.2007.00361.x; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zhou WC, 2017, CELL STEM CELL, V21, P591, DOI 10.1016/j.stem.2017.10.002	48	5	5	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4551	4566		10.1038/s41388-020-1312-6	http://dx.doi.org/10.1038/s41388-020-1312-6		MAY 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32372061	Green Published, hybrid			2022-12-26	WOS:000530617200002
J	de Lima, ABF; de Sa, KSG; Torres, MKD; Soares, LD; Resques, HR; Azevedo, VN; Feitosa, RNM; Monteiro, JC; da Silva, ANMR; Ribeiro, ALR; de Oliveira, AB; Vallinoto, ACR; Machado, LFA				Figueiredo de Lima, Ana Beatriz; Guedes de Sa, Keyla Santos; da Silva Torres, Maria Karoliny; Soares, Luana da Silva; Resques, Hugo Reis; Azevedo, Vania Nakauth; Martins Feitosa, Rosimar Neris; Monteiro, Jacqueline Cortinhas; Monteiro Rangel da Silva, Andrea Nazare; Ribeiro Ribeiro, Andre Luis; de Oliveira-Filho, Aldemir Branco; Rosario Vallinoto, Antonio Carlos; Almeida Machado, Luiz Fernando			Low prevalence of human pegivirus 1 (HPgV-1) in HTLV-1 carriers from Bele ' m, Para, North Region of Brazil	PLOS ONE			English	Article							GB-VIRUS-C; C/HEPATITIS-G VIRUS; HEPATITIS-G VIRUS; INFECTED PATIENTS; HIV; TRANSMISSION; COINFECTION; GENOTYPES; COHORT	Introduction Human pegivirus 1 (HPgV-1) is a single-stranded, positive-sense RNA virus belonging to the Flaviviridae family with limited cause-effect evidence of the causation of human diseases. However, studies have shown a potential beneficial impact of HPgV-1 coinfection in HIV disease progression. Human T lymphotropic virus-1 (HTLV-1) is a retrovirus known for causing diseases, especially in muscle and white blood cells, in approximately 5% of patients. Thus, this study aimed to investigate the potential effects of an HPgV-1 infection in patients carrying HTLV-1 in the state of Para in the North Region of Brazil. Methods A group of HTLV-1 carriers was compared to healthy controls. Blood samples were collected, data from medical regards were collected, and a questionnaire was administered. HPgV-1 and HTLV-1 positivity was determined by quantitative polymerase chain reaction (qRT-PCR). The data were analyzed to correlate the effects of HPgV-1 coinfection in HTLV-1 carriers. Results A total of 158 samples were included in the study: 74 HTLV-1-positive patients (46,8%) and 84 healthy controls (53,2%). The overall HPgV-1 positivity rate was 7.6% (12/158), resulting in a prevalence of 5.4% (4/74) and 9.5% (8/84) in HTLV-1 carriers and healthy controls, respectively. No significant differences were found when comparing any clinical or demographic data between groups. Conclusion This study indicated that the prevalence of HPgV-1 infection is low in HTLV-1 carriers in Bele m, Para, and probably does not alter the clinical course of HTLV-1 infection, however, further studies are still needed.	[Figueiredo de Lima, Ana Beatriz; Guedes de Sa, Keyla Santos; da Silva Torres, Maria Karoliny; Almeida Machado, Luiz Fernando] Univ Fed Para, Inst Ciencias Biol, Programa Posgrad Biol Agentes Infecciosos & Paras, Belem, Para, Brazil; [Soares, Luana da Silva; Resques, Hugo Reis; Almeida Machado, Luiz Fernando] Minist Saude, Serv Vigilancia Saude, Lab Virol, Inst Evandro Chagas, Ananindeua, Para, Brazil; [Azevedo, Vania Nakauth; Martins Feitosa, Rosimar Neris; Monteiro, Jacqueline Cortinhas; Monteiro Rangel da Silva, Andrea Nazare; Ribeiro Ribeiro, Andre Luis; Rosario Vallinoto, Antonio Carlos; Almeida Machado, Luiz Fernando] Univ Fed Para, Inst Ciencias Biol, Lab Virol, Belem, Para, Brazil; [de Oliveira-Filho, Aldemir Branco; Almeida Machado, Luiz Fernando] Univ Fed Para, Inst Estudos Costeiros, Grp Estudo & Pesquisa Populacoes Vulneraveis, Braganca, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Para	Machado, LFA (corresponding author), Univ Fed Para, Inst Ciencias Biol, Programa Posgrad Biol Agentes Infecciosos & Paras, Belem, Para, Brazil.; Machado, LFA (corresponding author), Univ Fed Para, Inst Ciencias Biol, Lab Virol, Belem, Para, Brazil.	lfam@ufpa.br	Vallinoto, Antonio Carlos/AAL-9501-2020; de Sá, Keyla Santos Guedes/E-9261-2012; Feitosa, Rosimar/AAH-9855-2020; Machado, Luiz Fernando Almeida/I-2246-2019; de Oliveira Filho, Aldemir Branco/N-1530-2019; Soares, Luana Silva/AAC-9134-2019; Ribeiro, Andre/C-9338-2019	Vallinoto, Antonio Carlos/0000-0003-1135-6507; de Sá, Keyla Santos Guedes/0000-0001-6950-589X; Feitosa, Rosimar/0000-0003-2044-9350; Machado, Luiz Fernando Almeida/0000-0002-4571-4715; de Oliveira Filho, Aldemir Branco/0000-0002-4888-3530; Soares, Luana Silva/0000-0001-9509-4019; Ribeiro, Andre/0000-0001-8124-2156; Torres, Karoliny/0000-0002-5894-304X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2016, ARCH VIROL, V161, P2921, DOI 10.1007/s00705-016-2977-6; Anggorowati N, 2013, MICROBIOL IMMUNOL, V57, P298, DOI 10.1111/1348-0421.12033; Balcom EF, 2018, ANN NEUROL, V84, P781, DOI 10.1002/ana.25343; de Miranda BKB, 2017, ARCH VIROL, V162, P3431, DOI 10.1007/s00705-017-3514-y; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Bukowska-Osko I, 2018, EMERG INFECT DIS, V24, P1785, DOI 10.3201/eid2410.180161; Campos AF, 2011, INT J STD AIDS, V22, P209, DOI 10.1258/ijsa.2011.010283; Carpentier A, 2015, VIRUSES-BASEL, V7, P3603, DOI 10.3390/v7072793; Chivero ET, 2015, J GEN VIROL, V96, P1521, DOI 10.1099/vir.0.000086; Chiyoda S, 1997, INFECTION, V25, P129, DOI 10.1007/BF02113595; Da Mota LD, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8048670; Da Mota LD, 2016, J MED VIROL, V88, P2106, DOI 10.1002/jmv.24574; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jogeda EL, 2017, J MED VIROL, V89, P632, DOI 10.1002/jmv.24683; Kamoi K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00270; Lampe E, 1998, J MED VIROL, V56, P39, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;39::AID-JMV7&gt;3.0.CO;2-O; Lauck M, 2015, J VIROL, V89, P2425, DOI 10.1128/JVI.02752-14; Laurentino RV, 2005, MEM I OSWALDO CRUZ, V100, P371, DOI 10.1590/S0074-02762005000400006; Miao ZJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9020028; Miyanaga M, 2009, OCUL IMMUNOL INFLAMM, V17, P335, DOI 10.3109/09273940903137667; Oliveira LA, 2002, MEM I OSWALDO CRUZ, V97, P953, DOI 10.1590/S0074-02762002000700005; Polgreen PM, 2003, MICROBES INFECT, V5, P1255, DOI 10.1016/j.micinf.2003.08.006; Santos LM, 2017, INT J GYNECOL OBSTET, V138, P113, DOI 10.1002/ijgo.12175; Singh S, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1951; Slavov SN, 2019, TRANSFUS APHER SCI, V58, P174, DOI 10.1016/j.transci.2019.01.002; Stapleton Jack T, 2014, Trans Am Clin Climatol Assoc, V125, P14; Supapol WB, 2009, J INFECT DIS, V200, P227, DOI 10.1086/599793; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Vahidnia F, 2012, J INFECT DIS, V205, P1436, DOI 10.1093/infdis/jis209; Willems L, 2017, ANTIVIR RES, V137, P41, DOI 10.1016/j.antiviral.2016.10.015; Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232783	10.1371/journal.pone.0232783	http://dx.doi.org/10.1371/journal.pone.0232783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369533	Green Published, gold			2022-12-26	WOS:000537280000049
J	Liu, S; Liu, YN; Zhu, XD; Cui, JW; Zhang, QX; Ding, T; Zhang, K; Wu, ZK; Yang, Y				Liu, Shuai; Liu, Yuanning; Zhu, Xiaodong; Cui, Jingwei; Zhang, Qixian; Ding, Tong; Zhang, Kuo; Wu, Zukang; Yang, Yanan			Constrained unsteady-state iris fast certification for lightweight training samples based on the scale change stable feature and multi-algorithm voting	PLOS ONE			English	Article							RECOGNITION	Aiming at the problem of fast certification for a constrained iris in the same category caused by the unstable iris features caused by the change of the iris acquisition environment and shooting status under lightweight training samples, a one-to-one fast certification algorithm for constrained unsteady-state iris based on the scale change stable feature and multi-algorithm voting is proposed. Scale change stable features are found by constructing an isometric differential Gaussian space, and a local binary pattern algorithm with extended statistics (ES-LBP), the Haar wavelet with over threshold detection and the Gabor filter algorithm with immune particle swarm optimization (IPSO) are used to represent the stable features as binary feature codes. Iris certification is performed by the Hamming distance. According to the certification results of three algorithms, the final result is obtained by multi-algorithm voting. Experiments with the JLU and CASIA iris libraries under the iris prerequisite conditions show that the correct recognition rate of this algorithm can reach a high level of 98% or more, indicating that this algorithm can improve the operation speed, accuracy and robustness of certification.	[Liu, Shuai; Liu, Yuanning; Zhu, Xiaodong; Zhang, Kuo; Wu, Zukang; Yang, Yanan] Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China; [Liu, Shuai; Liu, Yuanning; Zhu, Xiaodong; Cui, Jingwei; Zhang, Qixian; Ding, Tong; Zhang, Kuo; Wu, Zukang; Yang, Yanan] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun, Peoples R China; [Cui, Jingwei; Zhang, Qixian; Ding, Tong] Jilin Univ, Coll Software, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Zhu, XD (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China.; Zhu, XD (corresponding author), Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun, Peoples R China.	zhuxd@jlu.edu.cn	Liu, Shuai/G-8181-2018	Liu, Shuai/0000-0003-1337-6034	National Natural Science Foundation of China (NSFC) [61471181]; Natural Science Foundation of Jilin Province [20140101194JC, 20150101056JC]; Jilin Province Industrial Innovation Special Fund Project [2019C053-2]; Jilin Provincial Key Laboratory of Biometrics New Technology	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Jilin Province Industrial Innovation Special Fund Project; Jilin Provincial Key Laboratory of Biometrics New Technology	The authors would like to thank the referee's advice and acknowledge the support of the National Natural Science Foundation of China (NSFC) under Grant No. 61471181, Natural Science Foundation of Jilin Province under Grant No. 20140101194JC, 20150101056JC. Jilin Province Industrial Innovation Special Fund Project under Grant No. 2019C053-2. Thanks to the Jilin Provincial Key Laboratory of Biometrics New Technology for supporting this project.	Bazrafkan S, 2018, NEURAL NETWORKS, V106, P79, DOI 10.1016/j.neunet.2018.06.011; Cheng H, 2019, IEEE ACCESS, V7, P29989, DOI 10.1109/ACCESS.2019.2897799; Daugman J, 2004, IEEE T CIRC SYST VID, V14, P21, DOI 10.1109/TCSVT.2003.818350; Dong Hongxing, 2015, J COMPUTATIONAL INFO, V11, P333; Gangwar A, 2016, IEEE IMAGE PROC, P2301, DOI 10.1109/ICIP.2016.7532769; Ghazvinian H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217634; Guy Nason, 2015, PLOS ONE, V12; [姜华 Jiang Hua], 2018, [东北师大学报. 自然科学版, Journal of Northeast Normal University], V50, P58; [冷晓旭 Leng Xiaoxu], 2013, [中国科学院研究生院学报, Journal of the Graduate School of the Academy of Sciences], V30, P410; Li Huan-Li, 2013, Optics and Precision Engineering, V21, P2129, DOI 10.3788/OPE.20132108.2129; Li YH, 2019, MOB INF SYST, V2019, DOI 10.1155/2019/4568929; Li YH, 2017, MOB INF SYST, V2017, DOI 10.1155/2017/1281020; Lie WL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43171-0; Liu NAF, 2016, PATTERN RECOGN LETT, V82, P154, DOI 10.1016/j.patrec.2015.09.016; Liu S., 2019, J JILIN U SCI ED, V57, P331; Liu S, 2020, J ELECTRON IMAGING, V29, DOI 10.1117/1.JEI.29.1.013012; Liu S, 2019, LECT NOTES COMPUT SC, V11818, P337, DOI 10.1007/978-3-030-31456-9_38; Liu S, 2019, ALGORITHMS, V12, DOI 10.3390/a12090194; [刘帅 Liu Shuai], 2018, [计算机辅助设计与图形学学报, Journal of Computer-Aided Design & Computer Graphics], V30, P1604; Liu Shuai, 2018, Computer Engineering and Applications, V54, P212, DOI 10.3778/j.issn.1002-8331.1706-0022; Liu S, 2017, J ELECTRON IMAGING, V26, DOI 10.1117/1.JEI.26.6.063023; Liu Shuai, 2019, IEEE ACCESS, V7; [刘笑楠 Liu Xiaonan], 2014, [仪器仪表学报, Chinese Journal of Scientific Instrument], V35, P1900; [刘元宁 Liu Yuanning], 2019, [吉林大学学报. 工学版, Journal of Jilin University. Engineering and Technology Edition], V49, P1329; [刘元宁 Liu Yuanning], 2019, [吉林大学学报. 工学版, Journal of Jilin University. Engineering and Technology Edition], V49, P221; [刘元宁 Liu Yuanning], 2018, [吉林大学学报. 工学版, Journal of Jilin University. Engineering and Technology Edition], V48, P1606; Ma TS, 2019, IEEE ACCESS, V7, P25308, DOI 10.1109/ACCESS.2019.2900362; Monro DM, 2007, IEEE T PATTERN ANAL, V29, P586, DOI 10.1109/TPAMI.2007.1002; NGUYEN K, 2018, IEEE ACCESS, V6, P18848, DOI DOI 10.1109/ACCESS.2017.2784352; Peng Yamian, 2017, USDA TECHNICAL B, V55, P224; Ren RM, 2016, ACTA PHYS SIN-CH ED, V65, DOI 10.7498/aps.65.114101; Richter P, 2017, MOB INF SYST, V2017, DOI 10.1155/2017/8260746; Saktiawati AMI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217963; Sheng L, 2017, ENG OPTIMIZ, V49, P1463, DOI 10.1080/0305215X.2016.1250894; SHUAI L, 2018, J JILIN U SCI ED, V56, P1156; Shuai Liu, 2017, Biometric Recognition. 12th Chinese Conference, CCBR 2017. Proceedings: LNCS 10568, P383, DOI 10.1007/978-3-319-69923-3_41; Velmurugan S, 2019, CLUSTER COMPUT, V22, P13429, DOI 10.1007/s10586-018-1952-2; Won Lee Young, 2019, SENSORS, V19, P842; Yang WK, 2020, NEUROCOMPUTING, V373, P109, DOI 10.1016/j.neucom.2019.09.102; Yao Peng, 2007, Journal of Computer Aided Design & Computer Graphics, V19, P563; [苑玮琦 Yuan Weiqi], 2015, [仪器仪表学报, Chinese Journal of Scientific Instrument], V36, P1363; Zhang M, 2019, NEUROCOMPUTING, V330, P238, DOI 10.1016/j.neucom.2017.12.053; Zhang SS, 2019, STUD HEALTH TECHNOL, V264, P477, DOI 10.3233/SHTI190267; Zhao TM, 2019, IEEE ACCESS, V7, P49691, DOI 10.1109/ACCESS.2019.2911056; [朱立军 Zhu Lijun], 2015, [仪器仪表学报, Chinese Journal of Scientific Instrument], V36, P2714	45	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232319	10.1371/journal.pone.0232319	http://dx.doi.org/10.1371/journal.pone.0232319			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369515	Green Published, gold			2022-12-26	WOS:000537280000024
J	Berrazaga, I; Bourlieu-Lacanal, C; Laleg, K; Jardin, J; Briard-Bion, V; Dupont, D; Walrand, S; Micard, V				Berrazaga, Insaf; Bourlieu-Lacanal, Claire; Laleg, Karima; Jardin, Julien; Briard-Bion, Valerie; Dupont, Didier; Walrand, Stephane; Micard, Valerie			Effect of protein aggregation in wheat-legume mixed pasta diets on their in vitro digestion kinetics in comparison to "rapid" and "slow" animal proteins	PLOS ONE			English	Article							PEA PISUM-SATIVUM; HUMAN-MILK PASTEURIZATION; LIMITING AMINO-ACIDS; FUNCTIONAL-PROPERTIES; ANTINUTRITIONAL FACTORS; PEPTIDE RELEASE; VICIA-FABA; GASTROINTESTINAL DIGESTION; QUALITY CHARACTERISTICS; GASTRIC DIGESTION	The aim of this work was to evaluate the impact of incorporating different legume flours (faba bean, lentil or split pea flours) on the pasta protein network and its repercussion on in vitro protein digestibility, in comparison with reference dairy proteins. Kinetics and yields of protein hydrolysis in legume enriched pasta and, for the first time, the peptidomes generated by the pasta at the end of the in vitro gastric and intestinal phases of digestion are presented. Three isoproteic (21%) legume enriched pasta with balanced essential amino acids, were made from wheat semolina and 62% to 79% of legume flours (faba bean or F-pasta; lentil or L-pasta and split pea or P-pasta). Pasta were prepared following the conventional pastification steps (hydration, mixing, extrusion, drying, cooking). Amino acid composition and protein network structure of the pasta were determined along with their culinary and rheological properties and residual trypsin inhibitor activity (3-5% of the activity initially present in raw legume flour). F- and L-pasta had contrasted firmness and proportion of covalently linked proteins. F-pasta had a generally weaker protein network and matrix structure, however far from the weakly linked soluble milk proteins (SMP) and casein proteins, which in addition contained no antitrypsin inhibitors and more theoretical cleavage sites for digestive enzymes. The differences in protein network reticulation between the different pasta and between pasta and dairy proteins were in agreement in each kinetic phase with the yield of the in vitro protein hydrolysis, which reached 84% for SMP, and 66% for casein at the end of intestinal phase, versus 50% for L- and P-pasta and 58% for F-pasta. The peptidome of legume enriched pasta is described for the first time and compared with the peptidome of dairy proteins for each phase of digestion. The gastric and intestinal phases were important stages of peptide differentiation between legumes and wheat. However, peptidome analysis revealed no difference in wheat-derived peptides in the three pasta diets regardless of the digestion phase, indicating that there was a low covalent interaction between wheat gluten and legume proteins.	[Berrazaga, Insaf; Bourlieu-Lacanal, Claire; Laleg, Karima; Micard, Valerie] Univ Montpellier, IATE Agropolymers Engn & Emerging Technol, Montpellier SupAgro, CIRAD INRA, Montpellier, France; [Berrazaga, Insaf; Laleg, Karima; Walrand, Stephane] Univ Clermont Auvergne, INRA, CRNH, UNH, Clermont Ferrand, Auvergne, France; [Jardin, Julien; Briard-Bion, Valerie; Dupont, Didier] INRA, Agrocampus Ouest, UMR STLO 1253, Rennes, Ille & Vilaine, France; [Walrand, Stephane] Ctr Hosp Univ CHU Gabriel Montpied, Serv Nutr Clin, Clermont Ferrand, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Universite Clermont Auvergne (UCA); INRAE; Institut Agro; Agrocampus Ouest; CHU Clermont Ferrand	Micard, V (corresponding author), Univ Montpellier, IATE Agropolymers Engn & Emerging Technol, Montpellier SupAgro, CIRAD INRA, Montpellier, France.	valerie.micard@supagro.fr	JARDIN, Julien/A-3241-2012; Dupont, Didier/ABA-8197-2020	JARDIN, Julien/0000-0003-0520-9391; Dupont, Didier/0000-0001-5304-6561; MICARD, VALERIE/0000-0002-5193-9136; Walrand, Stephane/0000-0002-4349-3664; Bourlieu, Claire/0000-0001-5497-9224	Qualiment Institut Carnot; INRA metaprogram (Did'it); Regional thesis grant (Auvergne region, France)	Qualiment Institut Carnot; INRA metaprogram (Did'it); Regional thesis grant (Auvergne region, France)	This work is part of the "VEGAGE" project, carried out with the financial support of the "Qualiment Institut Carnot" (https://www.institutscarnot.eu/fr/institut-carnot/qualiment).In addition, it was financially supported by the INRA metaprogram (Did'it). IB received a Regional thesis grant (Auvergne region, France).	Abdel-Aal ESM, 2002, J FOOD COMPOS ANAL, V15, P737, DOI 10.1006/jfca.2002.1094; Babault N, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-36; Barac M, 2011, INT J MOL SCI, V12, P8372, DOI 10.3390/ijms12128372; Berrazaga I, 2019, J DAIRY SCI, V102, P1066, DOI 10.3168/jds.2018-14610; Berrazaga I, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081825; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003; Cheison SC, 2011, FOOD CHEM, V125, P1241, DOI 10.1016/j.foodchem.2010.10.042; COZZONE P, 1970, BIOCHIM BIOPHYS ACTA, V207, P490; CROY RRD, 1984, BIOCHEM J, V218, P795, DOI 10.1042/bj2180795; Deglaire A, 2019, FOOD CHEM, V281, P294, DOI 10.1016/j.foodchem.2018.12.086; Deglaire A, 2016, ELECTROPHORESIS, V37, P1839, DOI 10.1002/elps.201500573; Duodu KG, 2003, J CEREAL SCI, V38, P117, DOI 10.1016/S0733-5210(03)00016-X; Duranti M, 2006, FITOTERAPIA, V77, P67, DOI 10.1016/j.fitote.2005.11.008; Duranti M., 1999, Journal of New Seeds, V1, P17, DOI 10.1300/J153v01n01_03; Duranti M, 1997, FIELD CROP RES, V53, P31, DOI 10.1016/S0378-4290(97)00021-X; El Fiel HEA, 2002, FOOD CHEM, V76, P219, DOI 10.1016/S0308-8146(00)00314-9; Freitas D, 2018, FOOD FUNCT, V9, P200, DOI [10.1039/c7fo01484h, 10.1039/C7FO01484H]; Gilani GS, 2003, J NUTR, V133, P220, DOI 10.1093/jn/133.1.220; Gimenez MA, 2012, FOOD CHEM, V134, P200, DOI 10.1016/j.foodchem.2012.02.093; Greffeuille V, 2015, FOOD FUNCT, V6, P2996, DOI [10.1039/c5fo00382b, 10.1039/C5FO00382B]; GUEGUEN J, 1988, J SCI FOOD AGR, V42, P209, DOI 10.1002/jsfa.2740420304; Guillamon E, 2008, FOOD CHEM, V107, P68, DOI 10.1016/j.foodchem.2007.07.029; He T, 2013, INT J FOOD SCI NUTR, V64, P787, DOI 10.3109/09637486.2013.793300; HOVE EL, 1979, NEW ZEAL J AGR RES, V22, P41, DOI 10.1080/00288233.1979.10420841; Jarpa-Parra M, 2018, INT J FOOD SCI TECH, V53, P892, DOI 10.1111/ijfs.13685; Jayasena V, 2012, J TEXTURE STUD, V43, P153, DOI 10.1111/j.1745-4603.2011.00326.x; Johnson CR, 2013, FOOD RES INT, V51, P107, DOI 10.1016/j.foodres.2012.11.025; Laguna L, 2017, LWT-FOOD SCI TECHNOL, V84, P511, DOI 10.1016/j.lwt.2017.06.021; Laleg K., 2016, Patent, Patent No. [2016097328 A1, 2016097328]; Laleg K, 2017, LWT-FOOD SCI TECHNOL, V79, P471, DOI 10.1016/j.lwt.2017.01.069; Laleg K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160721; Laleg K, 2016, FOOD FUNCT, V7, P1196, DOI [10.1039/C5FO01231G, 10.1039/c5fo01231g]; Ma Z, 2011, FOOD RES INT, V44, P2534, DOI 10.1016/j.foodres.2010.12.017; Marcone MF, 1998, FOOD CHEM, V63, P85, DOI 10.1016/S0308-8146(97)00168-4; Mathai JK, 2017, BRIT J NUTR, V117, P490, DOI 10.1017/S0007114517000125; Mession JL, 2017, FOOD HYDROCOLLOID, V67, P229, DOI 10.1016/j.foodhyd.2015.12.015; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Morel MH, 2000, CEREAL CHEM, V77, P685, DOI 10.1094/CCHEM.2000.77.5.685; Nguyen TTP, 2015, FOOD RES INT, V76, P348, DOI 10.1016/j.foodres.2015.07.030; Osborne T.B., 1907, PROTEINS WHEAT KERNE; Overduin J, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.25622; Petitot M, 2010, FOOD RES INT, V43, P634, DOI 10.1016/j.foodres.2009.07.020; Petitot M, 2009, FOOD CHEM, V116, P401, DOI 10.1016/j.foodchem.2009.01.001; Pisulewska E, 2000, ANIM FEED SCI TECH, V86, P261, DOI 10.1016/S0377-8401(00)00167-X; PLIETZ P, 1984, BIOCHIM BIOPHYS ACTA, V784, P140, DOI 10.1016/0167-4838(84)90120-1; Prochazkova S, 1999, CARBOHYD POLYM, V38, P115, DOI 10.1016/S0144-8617(98)00108-8; Rafiq A, 2017, J CEREAL SCI, V74, P279, DOI 10.1016/j.jcs.2017.03.001; Rafiq S, 2016, ASIAN AUSTRAL J ANIM, V29, P1022, DOI 10.5713/ajas.15.0452; RayasDuarte P, 1996, CEREAL CHEM, V73, P381; Rizzello CG, 2017, FOOD FUNCT, V8, P860, DOI [10.1039/c6fo01808d, 10.1039/C6FO01808D]; Rosa-Sibakov N, 2016, LWT-FOOD SCI TECHNOL, V67, P27, DOI 10.1016/j.lwt.2015.11.032; Rubio LA, 2014, J SCI FOOD AGR, V94, P280, DOI 10.1002/jsfa.6250; Sah BNP, 2016, INT DAIRY J, V62, P10, DOI 10.1016/j.idairyj.2016.07.003; Sanchon J, 2018, FOOD CHEM, V239, P486, DOI 10.1016/j.foodchem.2017.06.134; Sarwar G, 1997, J NUTR, V127, P758, DOI 10.1093/jn/127.5.758; SARWAR G, 1989, PLANT FOOD HUM NUTR, V39, P23, DOI 10.1007/BF01092398; SARWAR G, 1986, J NUTR, V116, P1172, DOI 10.1093/jn/116.7.1172; Savoie L, 2005, J AOAC INT, V88, P935; Shi L, 2017, J FOOD SCI TECH MYS, V54, P1014, DOI 10.1007/s13197-017-2519-6; Smith F, 2015, MOL NUTR FOOD RES, V59, P2034, DOI 10.1002/mnfr.201500262; Torres A, 2007, J SCI FOOD AGR, V87, P74, DOI 10.1002/jsfa.2673; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; Vasagam KPK, 2011, AQUACULT NUTR, V17, pE188, DOI 10.1111/j.1365-2095.2009.00748.x; WHO, 2007, WHO TECH REP SER, V935, P1; Wojtowicz A, 2014, LWT-FOOD SCI TECHNOL, V59, P1175, DOI 10.1016/j.lwt.2014.06.010; Wood JA, 2009, J CEREAL SCI, V49, P128, DOI 10.1016/j.jcs.2008.07.016; Zhao YH, 2005, J FOOD SCI, V70, pS371, DOI 10.1111/j.1365-2621.2005.tb11458.x; Zilic S, 2011, INT J MOL SCI, V12, P5878, DOI 10.3390/ijms12095878	69	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232425	10.1371/journal.pone.0232425	http://dx.doi.org/10.1371/journal.pone.0232425			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365065	Green Published, gold			2022-12-26	WOS:000536959700030
J	Coffin, PO; Rowe, C; Oman, N; Sinchek, K; Santos, GM; Paul, M; Bagnulo, R; Mohamed, D; Vittinghoff, E				Coffin, Phillip O.; Rowe, Christopher; Oman, Natalie; Sinchek, Katie; Santos, Glenn-Milo; Paul, Mark; Bagnulo, Rita; Mohamed, Deeqa; Vittinghoff, Eric			Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain	PLOS ONE			English	Article							LIFETIME DRINKING HISTORY; OVERDOSE DEATHS; DRUG-USE; RELIABILITY; THERAPY; COHORT; FREQUENCY; PATTERNS; CLIENTS; FLORIDA	Background After decades of increased opioid pain reliever prescribing, providers are rapidly reducing prescribing. We hypothesized that reduced access to prescribed opioid pain relievers among patients previously reliant upon opioid pain relievers would result in increased illicit opioid use. Methods and findings We conducted a retrospective cohort study among 602 publicly insured primary care patients who had been prescribed opioids for chronic non-cancer pain for at least three consecutive months in San Francisco, recruited through convenience sampling. We conducted a historical reconstruction interview and medical chart abstraction focused on illicit substance use and opioid pain reliever prescriptions, respectively, from 2012 through the interview date in 2017-2018. We used a nested-cohort design, in which patients were classified, based on opioid pain reliever dose change, into a series of nested cohorts starting with each follow-up quarter. Using continuation-ratio models, we estimated associations between opioid prescription discontinuation or 30% increase or decrease in dose, relative to no change, and subsequent frequency of heroin and non-prescribed opioid pain reliever use, separately. Models controlled for demographics, clinical and behavioral characteristics, and past use of heroin or non-prescribed opioid pain relievers. A total of 56,372 and 56,484 participant-quarter observations were included from the 597 and 598 participants available for analyses of heroin and non-prescribed opioid pain reliever outcomes, respectively. Participants discontinued from prescribed opioids were more likely to use heroin (Adjusted Odds Ratio (AOR) = 1.57, 95% CI: 1.25-1.97) and non-prescribed opioid pain relievers (AOR = 1.75, 1.45-2.11) more frequently in subsequent quarters compared to participants with unchanged opioid prescriptions. Participants whose opioid pain reliever dose increased were more likely to use heroin more frequently (AOR = 1.67, 1.32-2.12). Results held throughout sensitivity analyses. The main limitations were the observational nature of results and limited generalizability beyond safety-net settings. Conclusions Discontinuation of prescribed opioid pain relievers was associated with more frequent non-prescribed opioid pain reliever and heroin use; increased dose was also associated with more frequent heroin use. Clinicians should be aware of these risks in determining pain management approaches.	[Coffin, Phillip O.; Rowe, Christopher; Oman, Natalie; Sinchek, Katie; Santos, Glenn-Milo; Bagnulo, Rita; Mohamed, Deeqa] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Coffin, Phillip O.; Santos, Glenn-Milo; Vittinghoff, Eric] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Rowe, Christopher] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Paul, Mark] Ctr Dis Control & Prevent, Atlanta, GA USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Centers for Disease Control & Prevention - USA	Coffin, PO (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA.; Coffin, PO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	phillip.coffin@ucsf.edu	Coffin, Phillip/G-3286-2012	Coffin, Phillip/0000-0002-3891-6570; Sinchek, Katherine/0000-0002-7049-8241; Faul, Mark/0000-0002-7683-0348; Vittinghoff, Eric/0000-0001-8535-0920	Centers for Disease Control and Prevention (CDC) [U01CE002793]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	PC received grant U01CE002793 from the Centers for Disease Control and Prevention (CDC; cdc.gov). The funder did not assist with the conduct of the study and collection, management, analysis, and interpretation of the data. The CDC reviewed the manuscript, but did not have a role in preparation or approval of the manuscript, or the decision to submit for publication. The CDC author had a role in preparation, review, and approval of the manuscript and the decision to submit the manuscript for publication.	[Anonymous], 2018, STATA J, V18, P924; Bohnert ASB, 2018, ANN INTERN MED, V169, P367, DOI 10.7326/M18-1243; Centers for Disease Control and Prevention, 2017, POCK GUID TAP OP CHR; CHAIKELSON JS, 1994, J STUD ALCOHOL, V55, P133, DOI 10.15288/jsa.1994.55.133; Chou R, 2014, NIH PATHWAYS PREVENT, P29; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Czermak C, 2005, ADDICT BEHAV, V30, P361, DOI 10.1016/j.addbeh.2004.05.005; Darke S, 2014, ADDICTION, V109, P1237, DOI 10.1111/add.12456; Dasgupta N, 2014, DRUG ALCOHOL DEPEN, V145, P238, DOI 10.1016/j.drugalcdep.2014.10.005; Dowell D, 2019, NEW ENGL J MED, V380, P2285, DOI 10.1056/NEJMp1904190; Dowell D, 2016, AM FAM PHYSICIAN, V93, P970; Frank JW, 2017, ANN INTERN MED, V167, P181, DOI 10.7326/M17-0598; Gladden RM, 2016, MMWR-MORBID MORTAL W, V65, P837, DOI 10.15585/mmwr.mm6533a2; GLADSJO JA, 1992, ADDICT BEHAV, V17, P347, DOI 10.1016/0306-4603(92)90040-3; Guarino H, 2018, ADDICT BEHAV, V86, P118, DOI 10.1016/j.addbeh.2018.04.017; Harocopos A, 2016, INT J DRUG POLICY, V28, P106, DOI 10.1016/j.drugpo.2015.12.021; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Huang XW, 2018, AM J PUBLIC HEALTH, V108, P131, DOI 10.2105/AJPH.2017.304142; Jacob T, 2006, PSYCHOL ADDICT BEHAV, V20, P333, DOI 10.1037/0893-164X.20.3.333; Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569; Kennedy-Hendricks A, 2016, AM J PUBLIC HEALTH, V106, P291, DOI 10.2105/AJPH.2015.302953; Koenig LB, 2009, J STUD ALCOHOL DRUGS, V70, P296, DOI 10.15288/jsad.2009.70.296; Lake S, 2015, AM J DRUG ALCOHOL AB, V41, P257, DOI 10.3109/00952990.2014.998366; Larance B, 2015, J SUBST ABUSE TREAT, V58, P51, DOI 10.1016/j.jsat.2015.06.001; Latimer J, 2016, INT J DRUG POLICY, V37, P111, DOI 10.1016/j.drugpo.2016.08.004; Liebling EJ, 2018, ADDICT BEHAV, V76, P20, DOI 10.1016/j.addbeh.2017.07.017; Mark TL, 2019, J SUBST ABUSE TREAT, V103, P58, DOI 10.1016/j.jsat.2019.05.001; Mars SG, 2015, SOC SCI MED, V140, P44, DOI 10.1016/j.socscimed.2015.06.032; Means B, 1989, NATL CTR HLTH STAT A; Paulozzi LJ, 2007, INJURY PREV, V13, P130, DOI 10.1136/ip.2006.014357; Pitt AL, 2018, AM J PUBLIC HEALTH, V108, P1394, DOI 10.2105/AJPH.2018.304590; Pouget ER, 2017, SUBST USE MISUSE, P1, DOI [10.1080/08897077.2017.1281646, DOI 10.1080/08897077.2017.1281646]; Robins JM, 1999, J AM STAT ASSOC, V94, P687, DOI 10.2307/2669978; Roxburg A, 2017, DRUG ALCOHOL DEPEN, V176, P126, DOI 10.1016/j.drugalcdep.2017.02.027; SAMUELS JF, 1992, BRIT J ADDICT, V87, P417; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; SOBELL LC, 1988, J STUD ALCOHOL, V49, P225, DOI 10.15288/jsa.1988.49.225; VLAHOV D, 1990, AM J EPIDEMIOL, V132, P847, DOI 10.1093/oxfordjournals.aje.a115727	42	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232538	10.1371/journal.pone.0232538	http://dx.doi.org/10.1371/journal.pone.0232538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365132	Green Published, gold			2022-12-26	WOS:000536959700038
J	Gilbertson, T; Arkadir, D; Steele, JD				Gilbertson, Tom; Arkadir, David; Steele, J. Douglas			Opposing patterns of abnormal D1 and D2 receptor dependent cortico-striatal plasticity explain increased risk taking in patients with DYT1 dystonia	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DOPAMINE NEURONS; MOUSE MODEL	Patients with DYT1 dystonia caused by the mutated TOR1A gene exhibit risk neutral behaviour compared to controls who are risk averse in the same reinforcement learning task. It is unclear whether this behaviour can be linked to changes in cortico-striatal plasticity demonstrated in animal models which share the same TOR1A mutation. We hypothesised that we could reproduce the experimental risk taking behaviour using a model of the basal ganglia under conditions where cortico-striatal plasticity was abnormal. As dopamine exerts opposing effects on cortico-striatal plasticity via different receptors expressed on medium spiny neurons (MSN) of the direct (D1R dominant, dMSNs) and indirect (D2R dominant, iMSNs) pathways, we tested whether abnormalities in cortico-striatal plasticity in one or both of these pathways could explain the patient's behaviour. Our model could generate simulated behaviour indistinguishable from patients when cortico-striatal plasticity was abnormal in both dMSNs and iMSNs in opposite directions. The risk neutral behaviour of the patients was replicated when increased cortico-striatal long term potentiation in dMSN's was in combination with increased long term depression in iMSN's. This result is consistent with previous observations in rodent models of increased cortico-striatal plasticity at in dMSNs, but contrasts with the pattern reported in vitro of dopamine D2 receptor dependant increases in cortico-striatal LTP and loss of LTD at iMSNs. These results suggest that additional factors in patients who manifest motor symptoms may lead to divergent effects on D2 receptor dependant cortico-striatal plasticity that are not apparent in rodent models of this disease.	[Gilbertson, Tom; Steele, J. Douglas] Ninewells Hosp & Med Sch, Dept Neurol, Dundee, Scotland; [Gilbertson, Tom; Steele, J. Douglas] Univ Dundee, Med Sch, Div Imaging Sci & Technol, Dundee, Scotland; [Arkadir, David] Hadassah Med Ctr, Dept Neurol, Jerusalem, Israel; [Arkadir, David] Hebrew Univ Jerusalem, Jerusalem, Israel	University of Dundee; University of Dundee; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Gilbertson, T (corresponding author), Ninewells Hosp & Med Sch, Dept Neurol, Dundee, Scotland.; Gilbertson, T (corresponding author), Univ Dundee, Med Sch, Div Imaging Sci & Technol, Dundee, Scotland.	tgilbertson@dundee.ac.uk		Gilbertson, Tom/0000-0002-9866-1565; Steele, J Douglas/0000-0002-9822-8753	Dystonia UK; University of Dundee movement disorders endowment fund	Dystonia UK; University of Dundee movement disorders endowment fund	The work was supported by a grant to TG from Dystonia UK and the University of Dundee movement disorders endowment fund.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Arkadir D, 2016, ELIFE, V5, DOI 10.7554/eLife.14155; Bariselli S, 2019, BRAIN RES, V1713, P70, DOI 10.1016/j.brainres.2018.10.009; Bonsi P, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809283; Carbon M, 2009, NEUROLOGY, V72, P2097, DOI 10.1212/WNL.0b013e3181aa538f; Chang CY, 2016, NAT NEUROSCI, V19, P111, DOI 10.1038/nn.4191; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; Cox SML, 2015, NEUROIMAGE, V109, P95, DOI 10.1016/j.neuroimage.2014.12.070; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Downs AM, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104526; Edwards MJ, 2006, MOVEMENT DISORD, V21, P2181, DOI 10.1002/mds.21160; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Franklin NT, 2015, ELIFE, V4, DOI 10.7554/eLife.12029; Gilbertson T, 2019, EUR J NEUROSCI, V50, P3191, DOI 10.1111/ejn.14414; Grundmann K, 2012, NEUROBIOL DIS, V47, P61, DOI 10.1016/j.nbd.2012.03.024; Gurney KN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002034; Iacono D, 2019, PARKINSONISM RELAT D, V58, P63, DOI 10.1016/j.parkreldis.2018.08.020; Ip CW, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0375-7; Ma TF, 2018, NAT NEUROSCI, V21, P373, DOI 10.1038/s41593-018-0081-9; Martella G, 2014, NEUROBIOL DIS, V65, P124, DOI 10.1016/j.nbd.2014.01.016; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Napolitano F, 2010, NEUROBIOL DIS, V38, P434, DOI 10.1016/j.nbd.2010.03.003; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; Ozelius LJ, 1997, AM J HUM GENET, V61, pA11; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Zalocusky KA, 2016, NATURE, V531, P642, DOI 10.1038/nature17400	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0226790	10.1371/journal.pone.0226790	http://dx.doi.org/10.1371/journal.pone.0226790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365120	gold, Green Published, Green Submitted			2022-12-26	WOS:000536959700004
J	Liu, CC; Mohmood, A; Hamzah, N; Lau, JH; Khaliddin, N; Rahmat, J				Liu, Chee Chung; Mohmood, Adzleen; Hamzah, Norhafizah; Lau, Jia Him; Khaliddin, Nurliza; Rahmat, Jamalia			Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia	PLOS ONE			English	Article							INTERNATIONAL-CLASSIFICATION; INTRAOCULAR RETINOBLASTOMA; MELPHALAN; CHEMOREDUCTION; MANAGEMENT; OUTCOMES; EYES	Aim To report our first three-and-a-half years' experience with intra-arterial chemotherapy (IAC) in managing retinoblastoma (RB). Methods Single institution, retrospective, interventional case series of 14 retinoblastoma patients managed with IAC from December 2014 to June 2018. Demographics were described. Outcomes measures were tumor response, treatment complications and globe salvage. Results Subjects' mean age at the first administration of IAC was 31.4 months. 57.1% of the eyes were Group D and E retinoblastoma, while 79% were bilateral disease. 93% of the eyes were as secondary treatment. Of 32 IAC cannulations performed, 23 (71.8%) were successful and received chemotherapy drug melphalan. Each eye received a mean of 1.8 (range 1-4) IAC injections. 53% of the eyes showed regression post treatment. After a mean follow up period of 19 months, globe salvage rate was 38%. Most of the adverse effects experienced were localized and transient. Conclusion IAC has provided an added recourse in the armamentarium of retinoblastoma treatment in our center. IAC treatment is a viable alternative in the treatment of retinoblastoma to salvage globe, for eyes that would conventionally require enucleation especially in bilateral disease.	[Liu, Chee Chung; Khaliddin, Nurliza] Univ Malaya, Eye Res Ctr, Kuala Lumpur, Malaysia; [Liu, Chee Chung; Mohmood, Adzleen; Hamzah, Norhafizah; Rahmat, Jamalia] Hosp Kuala Lumpur, Dept Ophthalmol, Kuala Lumpur, Malaysia; [Mohmood, Adzleen] Univ Kebangsaan Malaysia, Dept Ophthalmol, Bangi, Selangor, Malaysia; [Lau, Jia Him] Hosp Kuala Lumpur, Dept Radiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia	Liu, CC (corresponding author), Univ Malaya, Eye Res Ctr, Kuala Lumpur, Malaysia.; Liu, CC; Rahmat, J (corresponding author), Hosp Kuala Lumpur, Dept Ophthalmol, Kuala Lumpur, Malaysia.	arspata@gmail.com; jamalia.rahmat@gmail.com	KHALIDDIN, NURLIZA/AHE-2379-2022	KHALIDDIN, NURLIZA/0000-0003-1167-5313; Liu, Chee Chung/0000-0002-0779-2296				Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146582; Abramson DH, 2012, BRIT J OPHTHALMOL, V96, P499, DOI 10.1136/bjophthalmol-2011-300498; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Jabbour P, 2012, J NEUROSURG-PEDIATR, V10, P175, DOI 10.3171/2012.5.PEDS1277; Jamalia R, 2010, Med J Malaysia, V65 Suppl A, P128; Jiang H, 2018, J CANCER RES THER, V14, P106, DOI 10.4103/jcrt.JCRT_722_17; Marr BP, 2012, BRIT J OPHTHALMOL, V96, P1300, DOI 10.1136/bjophthalmol-2012-301925; Menon BS, 2009, PEDIATR BLOOD CANCER, V52, P215, DOI 10.1002/pbc.21791; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Parareda A, 2014, ACTA OPHTHALMOL, V92, P209, DOI 10.1111/aos.12295; Reddy SC, 2010, INT J OPHTHALMOL-CHI, V3, P64, DOI 10.3980/j.issn.2222-3959.2010.01.15; Shields CL, 2015, J FR OPHTALMOL, V38, P542, DOI 10.1016/j.jfo.2015.03.004; Shields CL, 2014, OPHTHALMOLOGY, V121, P1453, DOI 10.1016/j.ophtha.2014.01.026; Shields CL, 2013, RETINA-J RET VIT DIS, V33, P2103, DOI 10.1097/IAE.0b013e318295f783; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1407, DOI 10.1001/archophthalmol.2011.151; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P282, DOI 10.1001/archophthalmol.2008.626; Singh G, 2016, SEMIN OPHTHALMOL, V31, P310, DOI 10.3109/08820538.2016.1154177; Tuncer S, 2016, ACTA OPHTHALMOL, V94, pE644, DOI 10.1111/aos.13077; Yousef YA, 2016, JAMA OPHTHALMOL, V134, P584, DOI 10.1001/jamaophthalmol.2016.0244	21	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232249	10.1371/journal.pone.0232249	http://dx.doi.org/10.1371/journal.pone.0232249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357178	Green Published, gold			2022-12-26	WOS:000536957700020
J	Park, S; Choi, JR; Kim, SK; Lee, S; Lee, K; Kim, JY; Oh, SS; Koh, SB				Park, Sungjin; Choi, Jung Ran; Kim, Sung-Kyung; Lee, Solam; Lee, Kyungsuk; Kim, Jang-Young; Oh, Sung-Soo; Koh, Sang-Baek			Increased risk of atherosclerosis associated with pesticide exposure in rural areas in Korea	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; NATIONAL-HEALTH; ARTERIAL-WALL; TASK-FORCE; PATHOPHYSIOLOGY; POPULATION; PREVALENCE	Atherosclerosis is a progressive inflammation in systemic vessels, and pesticide exposure has been emerging as its risk factor. This cross-sectional study investigated the association between pesticide exposure and the risk of atherosclerosis in a rural population in Korea using carotid intima-media thickness (CIMT). This study used dataset from the baseline survey of the Korea Farmers Cohort Study between November 2005 and January 2008, and the final analysis included 477 participants. Well-structured questionnaires were used to estimate pesticide exposure. CIMT >= 0.9 mm was established for carotid atherosclerosis. Multiple logistic regression analyses were undertaken to evaluate the association between pesticide exposure and atherosclerosis, adjusting demographic and health-related confounders. Even after adjustments, the increased risk of atherosclerosis was significantly associated with pesticide exposure, such as a lifetime history of farming (odds ratio [OR] 3.25 95% confidence interval [CI] 1.51-6.98), a history of using pesticide (OR 3.42 95% CI 1.63-7.16), using pesticide 10 times or more annually (OR 2.55 95% CI 1.21-5.39), and higher cumulative exposure index level (OR 3.63 95% CI 1.65-7.97). Further prospective studies are required to elucidate effects of pesticide exposure on the risk of atherosclerosis.	[Park, Sungjin] Cheonan Med Ctr, Dept Occupat & Environm Med, Cheonan, South Korea; [Choi, Jung Ran; Kim, Jang-Young; Koh, Sang-Baek] Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Wonju, South Korea; [Kim, Sung-Kyung; Oh, Sung-Soo; Koh, Sang-Baek] Yonsei Univ, Wonju Severance Christian Hosp, Wonju Coll Med, Dept Occupat & Environm Med, Wonju, South Korea; [Kim, Sung-Kyung; Lee, Solam; Oh, Sung-Soo; Koh, Sang-Baek] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea; [Kim, Sung-Kyung; Oh, Sung-Soo; Koh, Sang-Baek] Yonsei Univ, Wonju Coll Med, Inst Occupat & Environm Med, Wonju, South Korea; [Lee, Kyungsuk] Rural Dev Adm, Natl Acad Agr Sci, Jeonju, South Korea; [Kim, Jang-Young] Yonsei Univ, Wonju Coll Med, Div Cardiol Internal Med, Wonju, South Korea; [Koh, Sang-Baek] Yonsei Univ, Inst Poverty Alleviat & Int Dev, Ctr Global Hlth & Social Med, Wonju, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Rural Development Administration (RDA); Yonsei University; Yonsei University	Koh, SB (corresponding author), Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Wonju, South Korea.; Koh, SB (corresponding author), Yonsei Univ, Wonju Severance Christian Hosp, Wonju Coll Med, Dept Occupat & Environm Med, Wonju, South Korea.; Koh, SB (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea.; Koh, SB (corresponding author), Yonsei Univ, Wonju Coll Med, Inst Occupat & Environm Med, Wonju, South Korea.; Koh, SB (corresponding author), Yonsei Univ, Inst Poverty Alleviat & Int Dev, Ctr Global Hlth & Social Med, Wonju, South Korea.	kohhj@yonsei.ac.kr	Lee, Solam/ABE-9674-2021	Kim, Sung-Kyung/0000-0002-2742-6410; park, sungjin/0000-0002-9240-9684	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ01250901]; Medical Research Center (MRC) Program, Ministry of Science, ICT and Future Planning, Republic of Korea [2017R1A5A2015369]	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Medical Research Center (MRC) Program, Ministry of Science, ICT and Future Planning, Republic of Korea	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01250901)" Rural Development Administration, Republic of Korea. This research was also supported by the Medical Research Center (MRC) Program, Ministry of Science, ICT and Future Planning (2017R1A5A2015369), Republic of Korea.	Ahn MS, 2010, J KOREAN MED SCI, V25, P1045, DOI 10.3346/jkms.2010.25.7.1045; Ataoglu HE, 2009, J DIABETES, V1, P188, DOI 10.1111/j.1753-0407.2009.00032.x; Cha ES, 2014, J AGROMEDICINE, V19, P281, DOI 10.1080/1059924X.2014.917349; Coble J, 2005, J OCCUP ENVIRON HYG, V2, P194, DOI 10.1080/15459620590923343; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Dosemeci M, 2002, ANN OCCUP HYG, V46, P245, DOI 10.1093/annhyg/mef011; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Goncharov A, 2008, ENVIRON RES, V106, P226, DOI 10.1016/j.envres.2007.10.006; Ha MH, 2007, ENVIRON HEALTH PERSP, V115, P1204, DOI 10.1289/ehp.10184; Ham SY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29863-z; Johri AM, 2014, CURR CARDIOVASC RISK, V8, DOI 10.1007/s12170-014-0386-5; Kim JY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213738; Koh SB, 2017, NEUROTOXICOLOGY, V62, P181, DOI 10.1016/j.neuro.2017.07.005; Lee JH, 2013, J KOREAN MED SCI, V28, P1762, DOI 10.3346/jkms.2013.28.12.1762; Lee KM, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0162-3; Lee Yo Han, 2010, J Prev Med Public Health, V43, P535, DOI 10.3961/jpmph.2010.43.6.535; Li JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209566; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lind PM, 2012, ENVIRON HEALTH PERSP, V120, P38, DOI 10.1289/ehp.1103563; Mallika V, 2007, ANGIOLOGY, V58, P513, DOI 10.1177/0003319707303443; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mangum LC., 2015, THESIS; Mangum LC, 2016, J TOXICOL ENV HEAL A, V79, P210, DOI 10.1080/15287394.2016.1143901; Maroni M, 2000, TOXICOLOGY, V143, P1; Min JY, 2011, ATHEROSCLEROSIS, V218, P200, DOI 10.1016/j.atherosclerosis.2011.04.044; Park S, 2019, NEUROTOXICOLOGY, V70, P12, DOI 10.1016/j.neuro.2018.10.007; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Schreinemachers DM, 2006, ENVIRON HEALTH PERSP, V114, P186, DOI 10.1289/ehp.8352; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Takasu J, 2010, ATHEROSCLEROSIS, V209, P142, DOI 10.1016/j.atherosclerosis.2009.09.013; Thomas KW, 2010, J EXPO SCI ENV EPID, V20, P559, DOI 10.1038/jes.2009.54; Wahab A, 2016, INT J COMMUNITY MED, V3, P1, DOI DOI 10.18203/2394-6040.IJCMPH20151542; Yoon JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119731; Youn YJ, 2011, J KOREAN MED SCI, V26, P365, DOI 10.3346/jkms.2011.26.3.365	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232531	10.1371/journal.pone.0232531	http://dx.doi.org/10.1371/journal.pone.0232531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357160	Green Published, gold			2022-12-26	WOS:000536957700038
J	Van Hook, MJ				Van Hook, Matthew J.			Temperature effects on synaptic transmission and neuronal function in the visual thalamus	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; THALAMOCORTICAL RELAY NEURONS; SPIKE-FREQUENCY ADAPTATION; RECEPTIVE-FIELD PROPERTIES; CALCIUM-CHANNEL; MOUSE; RAT; BURST; CELLS; EXCITABILITY	Numerous neuronal properties including the synaptic vesicle release process, neurotransmitter receptor complement, and postsynaptic ion channels are involved in transforming synaptic inputs into postsynaptic spiking. Temperature is a significant influencer of neuronal function and synaptic integration. Changing temperature can affect neuronal physiology in a diversity of ways depending on how it affects different members of the cell's ion channel complement. Temperature's effects on neuronal function are critical for pathological states such as fever, which can trigger seizure activity, but are also important in interpreting and comparing results of experiments conducted at room vs physiological temperature. The goal of this study was to examine the influence of temperature on synaptic properties and ion channel function in thalamocortical (TC) relay neurons in acute brain slices of the dorsal lateral geniculate nucleus, a key synaptic target of retinal ganglion cells in the thalamus. Warming the superfusate in patch clamp experiments with acutely-prepared brain slices led to an overall inhibition of synaptically-driven spiking behavior in TC neurons in response to a retinal ganglion cell spike train. Further study revealed that this was associated with an increase in presynaptic synaptic vesicle release probability and synaptic depression and altered passive and active membrane properties. Additionally, warming the superfusate triggered activation of an inwardly rectifying potassium current and altered the voltage-dependence of voltage-gated Na+ currents and T-type calcium currents. This study highlights the importance of careful temperature control in ex vivo physiological experiments and illustrates how numerous properties such as synaptic inputs, active conductances, and passive membrane properties converge to determine spike output.	[Van Hook, Matthew J.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Truhlsen Eye Inst, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Van Hook, MJ (corresponding author), Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Truhlsen Eye Inst, Omaha, NE 68198 USA.	matt.vanhook@unmc.edu		Van Hook, Matthew/0000-0003-1615-4314	BrightFocus Foundation National Glaucoma Research Program [G2017027]; National Institute of Health/National Eye Institute [R01 EY030507]	BrightFocus Foundation National Glaucoma Research Program(BrightFocus Foundation); National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	MJVH: BrightFocus Foundation National Glaucoma Research Program G2017027; https://www.brightfocus.org/MJVH: National Institute of Health/National Eye Institute R01 EY030507; https://www.nei.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Bhandari A, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00426; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; Borin M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00223; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; Buzatu S, 2009, RIV BIOL-BIOL FORUM, V102, P199; Chanaday NL, 2018, FEBS LETT, V592, P3606, DOI 10.1002/1873-3468.13268; Chao OY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41120-5; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen MH, 2019, J NEUROSCI, V39, P7260, DOI 10.1523/JNEUROSCI.2510-18.2019; Coulon P, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00132; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; Cox CL, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000141; Dinkelacker V, 2000, J NEUROSCI, V20, P8377, DOI 10.1523/JNEUROSCI.20-22-08377.2000; Egri C, 2012, EPILEPSIA, V53, P494, DOI 10.1111/j.1528-1167.2011.03389.x; Elinder F, 2006, J PHYSIOL-LONDON, V575, P417, DOI 10.1113/jphysiol.2006.110437; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Graham BA, 2008, J NEUROPHYSIOL, V99, P2048, DOI 10.1152/jn.01176.2007; Grubb MS, 2005, J NEUROPHYSIOL, V93, P3224, DOI 10.1152/jn.00445.2004; Guido W, 1998, VISUAL NEUROSCI, V15, P231, DOI 10.1017/S0952523898152033; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; GUIDO W, 1995, VISUAL NEUROSCI, V12, P723, DOI 10.1017/S0952523800008993; Guido W, 2018, J NEUROPHYSIOL, V120, P211, DOI 10.1152/jn.00651.2017; Ha GE, 2017, EXP NEUROBIOL, V26, P179, DOI 10.5607/en.2017.26.4.179; Ha GE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13791; Hardingham NR, 1998, J PHYSIOL-LONDON, V507, P249, DOI 10.1111/j.1469-7793.1998.249bu.x; HEITLER WJ, 1977, J COMP PHYSIOL, V117, P163, DOI 10.1007/BF00612785; Hong SZ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00098; Huson V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47487-9; Iftinca M, 2006, NEUROSCIENCE, V142, P1031, DOI 10.1016/j.neuroscience.2006.07.010; Kanda H, 2017, J NEUROCHEM, V141, P532, DOI 10.1111/jnc.13511; Kanyshkova T, 2012, NEUROBIOL DIS, V45, P450, DOI 10.1016/j.nbd.2011.08.032; Kanyshkova T, 2009, J NEUROSCI, V29, P8847, DOI 10.1523/JNEUROSCI.0689-09.2009; Kerschensteiner D, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000062; Kim JA, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00027; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; Litvina EY, 2017, NEURON, V96, P330, DOI 10.1016/j.neuron.2017.09.037; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; Mitsuiye T, 1997, JPN J PHYSIOL, V47, P73, DOI 10.2170/jjphysiol.47.73; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080376; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Nouvian R, 2007, J PHYSIOL-LONDON, V584, P535, DOI 10.1113/jphysiol.2007.139675; O'Leary T, 2016, CURR BIOL, V26, P2935, DOI 10.1016/j.cub.2016.08.061; Orio P, 2009, J PHYSIOL-LONDON, V587, P1961, DOI 10.1113/jphysiol.2008.165738; Paajanen V, 2004, AM J PHYSIOL-REG I, V286, pR405, DOI 10.1152/ajpregu.00500.2003; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Parajuli LK, 2010, J COMP NEUROL, V518, P4362, DOI 10.1002/cne.22461; Pena F, 2006, EXP BRAIN RES, V173, P282, DOI 10.1007/s00221-006-0473-z; Postlethwaite M, 2007, J PHYSIOL-LONDON, V579, P69, DOI 10.1113/jphysiol.2006.123612; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; REGAN D, 1977, J NEUROL NEUROSUR PS, V40, P1083, DOI 10.1136/jnnp.40.11.1083; Renstrom E, 1996, J PHYSIOL-LONDON, V494, P41, DOI 10.1113/jphysiol.1996.sp021474; Rey-Funes M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07294-6; Rosen AD, 2001, BBA-BIOMEMBRANES, V1511, P391, DOI 10.1016/S0005-2736(01)00301-7; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Sarria I, 2012, J NEUROCHEM, V122, P1145, DOI 10.1111/j.1471-4159.2012.07839.x; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Ting JT, 2018, JOVE-J VIS EXP, DOI 10.3791/53825; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; Volgushev M, 2004, J NEUROPHYSIOL, V92, P212, DOI 10.1152/jn.01166.2003; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Yang F, 2014, ELIFE, V3, DOI 10.7554/eLife.03255; Ye MY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17344-8; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; Zobeiri M, 2019, CEREB CORTEX, V29, P2291, DOI 10.1093/cercor/bhz047	74	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232451	10.1371/journal.pone.0232451	http://dx.doi.org/10.1371/journal.pone.0232451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353050	gold, Green Published			2022-12-26	WOS:000536673200094
J	Wojcik, E; Sokol, A				Wojcik, Ewa; Sokol, Agnieszka			Assessment of chromosome stability in boars	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGE; FRAGILE SITES; COMET ASSAY; DNA-DAMAGE; MOLECULAR-BASIS; INSTABILITY; BLEOMYCIN; COMMON; ELECTROPHORESIS; REPLICATION	Chromosome instability adversely affects animal fertility and reproduction. Analysis of instability can be a valuable diagnostic tool. Helpful tests for assessment of instabilities include the sister chromatid exchange assay, identification of fragile sites, the bleomycin assay and the comet assay. These techniques can be used to assess and compare the chromosome stability of individual breeds of animals. The aim of the study was to assess chromosome stability in boars: Duroc, Duroc x Pietrain and Pietrain x Duroc crossbreds, Polish Large White, and the Neckar, P76 and PIC lines. The study assessed the chromosome stability of boars. The distribution of instabilities in individual breeds was varied. The average frequency of chromatid exchange was 4.8 +/- 1.5, while that of fragile sites was 3.9 +/- 1.4. The mean level of DNA damage (% tail DNA) was 9.4 +/- 8.3, while in the bleomycin assay b/c and %AM were 0.6 +/- 0.7 and 44.4 +/- 4.1. A higher rate of instability was found in older individuals than in younger ones. The cytogenetic assays used to identify various forms of chromosome instability can be used to evaluate boars intended for breeding.	[Wojcik, Ewa; Sokol, Agnieszka] Siedlce Univ Nat Sci & Humanities, Inst Anim Sci & Fisheries, Siedlce, Poland		Wojcik, E (corresponding author), Siedlce Univ Nat Sci & Humanities, Inst Anim Sci & Fisheries, Siedlce, Poland.	ewa.wojcik@uph.edu.pl		Wojcik, Ewa/0000-0002-9446-7132				Albarella S, 2009, MUTAGENESIS, V24, P471, DOI 10.1093/mutage/gep030; Bacaksiz A, 2014, INT J ENVIRON HEAL R, V24, P11, DOI 10.1080/09603123.2013.773586; Basrur PK, 2008, CYTOGENET GENOME RES, V120, P11, DOI 10.1159/000118737; Ciotola F, 2014, FOLIA BIOL-KRAKOW, V62, P23, DOI 10.3409/fb62_1.23; Czubaszek M, 2020, THERIOGENOLOGY, V147, P176, DOI 10.1016/j.theriogenology.2019.11.018; Danielak-Czech B, 2004, J ANIM FEED SCI, V13, P257, DOI 10.22358/jafs/67410/2004; Danielak-Czech B., 2012, Annales Universitatis Mariae Curie-Sklodowska. Sectio EE Zootechnica, V30, P18; Dezfouli SMA, 2012, IRAN J VET RES, V13, P161; Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699; Feng SL, 2005, ECOTOX ENVIRON SAFE, V61, P239, DOI 10.1016/j.ecoenv.2004.10.005; Franchitto A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/730714; Franchitto A, 2011, CELL CYCLE, V10, P4039, DOI 10.4161/cc.10.23.18409; Fraser L, 2004, FOLIA HISTOCHEM CYTO, V42, P49; Gao L, 2019, EXP PHYSIOL, V104, P1942, DOI 10.1113/EP088028; GEDIK CM, 1992, INT J RADIAT BIOL, V62, P313, DOI 10.1080/09553009214552161; Genualdo V, 2018, LIVEST SCI, V216, P36, DOI 10.1016/j.livsci.2018.07.005; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Horvatovich K, 2013, ACTA VET HUNG, V61, P175, DOI 10.1556/AVet.2013.010; HSU TC, 1989, INT J CANCER, V43, P403, DOI 10.1002/ijc.2910430310; IANNUZZI L, 1991, HEREDITAS, V114, P201, DOI 10.1111/j.1601-5223.1991.tb00325.x; Iannuzzi L, 2004, MUTAGENESIS, V19, P355, DOI 10.1093/mutage/geh041; Iannuzzi L, 2007, ITAL J ANIM SCI, V6, P713, DOI DOI 10.4081/IJAS.2007.1S.23; Johnson LA, 2005, J BIOCHEM BIOPH METH, V63, P53, DOI 10.1016/j.jbbm.2005.02.002; Khatun MR, 2011, ASIAN J ANIM VET ADV, V6, P117, DOI 10.3923/ajava.2011.117.125; Kuchta-Gladysz M, 2015, CAN J ANIM SCI, V95, P543, DOI 10.4141/CJAS-2015-073; Laffon B, 2002, TOXICOLOGY, V171, P175, DOI 10.1016/S0300-483X(01)00572-8; Luna HS, 2004, REPROD TOXICOL, V19, P97, DOI 10.1016/j.reprotox.2004.05.010; Nino-Soto Maria I., 2004, Medecin Veterinaire du Quebec, V34, P71; Peretti V, 2008, CYTOGENET GENOME RES, V120, P183, DOI 10.1159/000118761; Peretti V, 2006, HEREDITAS, V143, P113, DOI 10.1111/j.2006.0018-0661.01937.x; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Riggs PK, 2009, CYTOGENET GENOME RES, V126, P97, DOI 10.1159/000245910; RONNE M, 1995, HEREDITAS, V122, P153, DOI 10.1111/j.1601-5223.1995.00153.x; Schoket B, 1999, MUTAT RES-FUND MOL M, V424, P143, DOI 10.1016/S0027-5107(99)00015-9; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sram RJ, 1999, MUTAT RES-FUND MOL M, V428, P203, DOI 10.1016/S1383-5742(99)00048-4; Szekely G, 2003, MUTAGENESIS, V18, P59, DOI 10.1093/mutage/18.1.59; Szyfter K, 2006, POSTEP CHIR GLOWY SZ, V5, P53; Tuduri S, 2010, CELL CYCLE, V9, P1886, DOI 10.4161/cc.9.10.11539; Tzancheva M, 1997, HUM GENET, V99, P47; Wierzbicka Malgorzata, 2004, Otolaryngol Pol, V58, P441; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Wnuk M, 2011, MECH AGEING DEV, V132, P257, DOI 10.1016/j.mad.2011.04.009; Wojcik E, 2013, POULTRY SCI, V92, P84, DOI 10.3382/ps.2012-02564; Wojcik E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217799; Wojcik E, 2018, CAN J ANIM SCI, V98, P818, DOI 10.1139/cjas-2017-0078; Wojcik E, 2013, FOLIA BIOL-KRAKOW, V61, P199, DOI 10.3409/fb61_3-4.199; Wojcik E, 2012, FOLIA BIOL-KRAKOW, V60, P141, DOI 10.3409/fb60_3-4.141-146; Wojcik E, 2012, CAN J ANIM SCI, V92, P49, DOI 10.4141/CJAS2011-112; Wojcik E, 2011, ARCH TIERZUCHT, V54, P107, DOI 10.5194/aab-54-107-2011; WOLFF S, 1974, CHROMOSOMA, V48, P341, DOI 10.1007/BF00290991; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	54	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231928	10.1371/journal.pone.0231928	http://dx.doi.org/10.1371/journal.pone.0231928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352977	gold, Green Published			2022-12-26	WOS:000536673200026
J	Norrell, AE; Jones, KL; Saillant, EA				Norrell, Adrienne E.; Jones, Kenneth L.; Saillant, Eric A.			Development and characterization of genomic resources for a non-model marine teleost, the red snapper (Lutjanus campechanus, Lutjanidae): Construction of a high-density linkage map, anchoring of genome contigs and comparative genomic analysis	PLOS ONE			English	Article							RESOLUTION GENETIC-MAP; EVOLUTION	The red snapper Lutjanus campechanus is an exploited reef fish of major economic importance in the Gulf of Mexico region. Studies of genome wide genetic variation are needed to understand the structure of wild populations and develop breeding programs for aquaculture but interpretation of these genome scans is limited by the absence of reference genome. In this work, the first draft of a reference genome was developed and characterized for the red snapper. P-454 and Illumina sequencing were conducted to produce paired-end reads that were assembled into reference contigs and scaffolds. The current assembly spans over 770 Mb, representing an estimated 69% of the red snapper genome in 67,254 scaffolds (N50 = 16,803 bp). The genome contigs were applied to map double digest Restriction-Site Associated DNA Tags and characterize Single Nucleotide Polymorphisms (SNPs) in five outbred full-sib families. The identified SNPs and 97 microsatellite loci were used to generate a high-density linkage map that includes 7,420 markers distributed across 24 linkage groups and spans 1,346.64 cM with an average inter-marker distance of 0.18 cM. Sex-specific maps revealed a 1.10:1 female to male map length ratio. A total of 4,422 genome contigs (10.5% of the assembly) were anchored to the map and used in a comparative genomic analysis of the red snapper and two model teleosts. Red snapper showed a high degree of chromosome level syntenic conservation with both medaka and spotted green puffer and a near one to one correspondence between the 24 red snapper linkage groups and corresponding medaka chromosomes was observed. This work established the first draft of a reference genome for a lutjanid fish. The obtained genomic resources will serve as a framework for the interpretation of genome scans during studies of wild populations and captive breeding programs.	[Norrell, Adrienne E.; Saillant, Eric A.] Univ Southern Mississippi, Gulf Coast Res Lab, Sch Ocean Sci & Engn, Ocean Springs, MS 39564 USA; [Jones, Kenneth L.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA	University of Southern Mississippi; University of Colorado System; University of Colorado Anschutz Medical Campus	Saillant, EA (corresponding author), Univ Southern Mississippi, Gulf Coast Res Lab, Sch Ocean Sci & Engn, Ocean Springs, MS 39564 USA.	eric.saillant@usm.edu	Jones, Kenneth/GXF-4945-2022; Saillant, Eric/AAJ-3640-2021	Saillant, Eric/0000-0002-1480-4515	National Oceanic and Atmospheric Administration (NOAA) Sea Grant through the National Marine Aquaculture Initiative program [NAMI NA10OAR4170078 -R/SSS-04-NSI]; Mississippi Department of Marine Resources, Mississippi Tidelands Trust Funds Program [S-13-USM/GCRL01]	National Oceanic and Atmospheric Administration (NOAA) Sea Grant through the National Marine Aquaculture Initiative program; Mississippi Department of Marine Resources, Mississippi Tidelands Trust Funds Program	EAS and KLJ: Award #NAMI NA10OAR4170078 -R/SSS-04-NSI; National Oceanic and Atmospheric Administration (NOAA) Sea Grant through the National Marine Aquaculture Initiative program; https://seagrant.noaa.gov/EAS: award #S-13-USM/GCRL01; Mississippi Department of Marine Resources, Mississippi Tidelands Trust Funds Program; http://www.dmr.ms.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2006, CONSERV GENET, P664; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Brandvain Y, 2012, GENETICS, V190, P709, DOI 10.1534/genetics.111.136721; BURT A, 1991, J EVOLUTION BIOL, V4, P259, DOI 10.1046/j.1420-9101.1991.4020259.x; Chistiakov DA, 2005, GENETICS, V170, P1821, DOI 10.1534/genetics.104.039719; Danzmann RG, 2005, LINKMFEX LINKAGE ANA; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Fierst JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00220; Fischer AJ, 2004, FISHERY B; Garrison E, 2012, ARXIV12073907QBIO; Gilchrist AS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1153; Gold JR, 2007, AM FISH S S, V60, P201; Gold JR, 2001, MAR BIOTECHNOL, V3, P293, DOI 10.1007/s10126-001-0004-7; Gregory TR, 2002, ANIMAL GENOME SIZE D; Guo WJ, 2013, AQUACULTURE, V412, P97, DOI 10.1016/j.aquaculture.2013.06.027; Hedgecock D, 2015, G3-GENES GENOM GENET, V5, P2007, DOI 10.1534/g3.115.019570; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Hollenbeck CM, 2016, HEREDITY, V117, P207, DOI 10.1038/hdy.2016.30; Kai W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-233; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lenormand T, 2005, PLOS BIOL, V3, P396, DOI 10.1371/journal.pbio.0030063; Li H., 2013, QUANT BIOL; Li X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7648; Li Y, 2015, DNA RES, V22, P39, DOI 10.1093/dnares/dsu038; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Liu SX, 2012, MAR BIOTECHNOL, V14, P237, DOI 10.1007/s10126-011-9407-2; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Maroso F, 2018, DNA RES, V25, P439, DOI 10.1093/dnares/dsy015; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; MINTON RV, 1983, AQUACULTURE, V30, P363, DOI 10.1016/0044-8486(83)90177-1; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Norrell AE, 2014, AQUACULTURE, V430, P128, DOI 10.1016/j.aquaculture.2014.04.005; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pruett C, 2005, MAR BIOL, V147, P593, DOI 10.1007/s00227-005-1615-8; Puritz JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep36095; Puritz JB, 2014, PEERJ, V2, DOI 10.7717/peerj.431; Rastas P, 2016, GENOME BIOL EVOL, V8, P78, DOI 10.1093/gbe/evv250; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Renshaw MA, 2006, AQUACULTURE, V253, P731, DOI 10.1016/j.aquaculture.2005.09.012; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Richards S, 2015, CURR OPIN INSECT SCI, V7, P1, DOI 10.1016/j.cois.2015.02.013; Rocha EC, 2008, GENET MOL BIOL, V31, P461, DOI 10.1590/S1415-47572008000300011; Saillant E, 2010, ICES J MAR SCI, V67, P1240, DOI 10.1093/icesjms/fsq011; Sambrook J., 1987, MOL CLONING LAB MANU; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schweyen H, 2014, BIOL BULL-US, V227, P146, DOI 10.1086/BBLv227n2p146; Shao CW, 2015, DNA RES, V22, P161, DOI 10.1093/dnares/dsv001; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Sun CF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3830-3; Tang HB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0573-1; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Woods MK, 2003, SIZE AGE MATURITY FE; You XX, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-113; Yuan ZH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4516-1; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020	62	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232402	10.1371/journal.pone.0232402	http://dx.doi.org/10.1371/journal.pone.0232402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348345	Green Published, gold			2022-12-26	WOS:000536668200063
J	Perot, P; Falguieres, M; Arowas, L; Laude, H; Foy, JP; Goudot, P; Corre-Catelin, N; Ungeheuer, MN; Caro, V; Heard, I; Eloit, M; Gessain, A; Bertolus, C; Berthet, N				Perot, Philippe; Falguieres, Michael; Arowas, Laurence; Laude, Helene; Foy, Jean-Philippe; Goudot, Patrick; Corre-Catelin, Nicole; Ungeheuer, Marie-Noelle; Caro, Valerie; Heard, Isabelle; Eloit, Marc; Gessain, Antoine; Bertolus, Chloe; Berthet, Nicolas			Investigation of viral etiology in potentially malignant disorders and oral squamous cell carcinomas in non-smoking, non-drinking patients	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; RISK HUMAN-PAPILLOMAVIRUS; TRICHOMONAS-VAGINALIS; EPIDERMODYSPLASIA-VERRUCIFORMIS; GLOBAL EPIDEMIOLOGY; CANCER INCIDENCE; CUTANEOUS BETA; NECK CANCERS; INFECTION; HEAD	Head and neck squamous cell carcinomas (HNSCC) are the seventh most frequent cancers. Among HNSCCs, oral squamous cell carcinomas (OSCCs) include several anatomical locations of the oral cavity, but exclude the oropharynx. The known risk factors for OSCCs are mainly alcohol consumption and tobacco use for at least 75-80% of cases. In addition to these risk factors, Human papillomavirus (HPV) types 16 and 18, classified as high-risk (HR) HPV genotypes, are considered as risk factors for oropharyngeal cancers, but their role in the development of OSCC remains unclear. We tested the hypothesis of viral etiology in a series of 68 well-characterized OSCCs and 14 potentially malignant disorders (PMD) in non-smoking, non-drinking (NSND) patients using broad-range, sensitive molecular methodologies. Deep-sequencing of the transcriptome did not reveal any vertebrate virus sequences other than HPV transcripts, detected in only one case. In contrast, HPV DNA was detected in 41.2% (28/68) and 35.7% (5/14) of OSCC and PMD cases, respectively. Importantly, 90.9% (30/33) of these belonged to the Betapapillomavirus genus, but no viral transcripts were detected. Finally, high-throughput sequencing revealed reads corresponding to transcripts of the Trichomonas vaginalis virus (TVV), which were confirmed by RT-PCR in two OSCCs. Our results strongly suggest that Alphapapillomavirus genotypes classified as HR are not involved in the development of OSCCs in NSND patients and that known oncogenic infectious agents are absent in these specific OSCCs. Any possible direct or indirect role of Betapapillomavirus genus members and TVV in OSCCs remains speculative and requires further investigation.	[Perot, Philippe; Eloit, Marc] Inst Pasteur, Biol Infect Unit, Pathogen Discovery Lab, Paris, France; [Falguieres, Michael; Arowas, Laurence; Laude, Helene; Heard, Isabelle] Inst Pasteur, Ctr Natl Reference CNR Papillomavirus Humains HPV, Paris, France; [Foy, Jean-Philippe] Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard, Lyon, France; [Goudot, Patrick; Bertolus, Chloe] Hop La Pitie Salpetriere, Dept Oral & Maxillofacial Surg, Paris, France; [Corre-Catelin, Nicole; Ungeheuer, Marie-Noelle] Inst Pasteur, Clin Invest & Acces Bioresources Dept, Paris, France; [Caro, Valerie; Berthet, Nicolas] Inst Pasteur, Unite Environm & Risques Infect, Cellule Intervent Biol Urgence, Paris, France; [Eloit, Marc] Paris Est Univ, Natl Vet Sch Alfort, Maisons Alfort, France; [Gessain, Antoine; Berthet, Nicolas] Inst Pasteur, CNRS, UMR3569, Unite Epidemiol & Physiopathol Virus Oncogenes, Paris, France; [Bertolus, Chloe] Sorbonne Univ, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Bertolus, C (corresponding author), Hop La Pitie Salpetriere, Dept Oral & Maxillofacial Surg, Paris, France.; Berthet, N (corresponding author), Inst Pasteur, Unite Environm & Risques Infect, Cellule Intervent Biol Urgence, Paris, France.; Berthet, N (corresponding author), Inst Pasteur, CNRS, UMR3569, Unite Epidemiol & Physiopathol Virus Oncogenes, Paris, France.; Bertolus, C (corresponding author), Sorbonne Univ, Paris, France.	chloe.bertolus@aphp.fr; nicolas.berthet@pasteur.fr	Pérot, Philippe/ABD-2025-2021; Foy, Jean-Philippe/AGV-8988-2022	Pérot, Philippe/0000-0002-5194-8200; Foy, Jean-Philippe/0000-0002-4271-5093				Agalliu I, 2016, JAMA ONCOL, V2, P599, DOI 10.1001/jamaoncol.2015.5504; [Anonymous], 2019, F1000RESEARCH, DOI DOI 10.12688/F1000RESEARCH.18776.1; Antonsson A, 2010, VIROLOGY, V407, P26, DOI 10.1016/j.virol.2010.07.046; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Azevedo A, 2011, WORLD J CLIN ONCOL, V2, P384, DOI 10.5306/wjco.v2.i12.384; Beachler DC, 2013, CURR OPIN ONCOL, V25, P503, DOI 10.1097/CCO.0b013e32836242b4; BERKHOUT RJM, 1995, J CLIN MICROBIOL, V33, P690, DOI 10.1128/JCM.33.3.690-695.1995; Bertolus C, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-13; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; BLOT WJ, 1988, CANCER RES, V48, P3282; Brennan M, 2007, ORAL SURG ORAL MED O, V103, pS19, DOI 10.1016/j.tripleo.2006.10.015; Campisi G, 2007, INT J ONCOL, V30, P813; Cardoso JC, 2011, ACTA DERMATOVEN ALP, V20, P145; Castellsague X, 2004, INT J CANCER, V108, P741, DOI 10.1002/ijc.11627; Chahoud J, 2016, JAMA DERMATOL, V152, P1354, DOI 10.1001/jamadermatol.2015.4530; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Chung CH, 2014, ORAL ONCOL, V50, P364, DOI 10.1016/j.oraloncology.2013.09.003; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Donders GGG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086266; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Figuero Ruiz Elena, 2004, Med Oral, V9, P14; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Garcia AF, 2005, INFECT IMMUN, V73, P2602, DOI 10.1128/IAI.73.5.2602-2610.2005; Goodman RP, 2011, J VIROL, V85, P4258, DOI 10.1128/JVI.00220-11; Grulich AE, 2010, SEX HEALTH, V7, P244, DOI 10.1071/SH10020; Hampras SS, 2017, J INFECT DIS, V216, P92, DOI 10.1093/infdis/jix245; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Isayeva T, 2012, HEAD NECK PATHOL, V6, pS104, DOI 10.1007/s12105-012-0368-1; JABLONSKA S, 1972, CANCER RES, V32, P583; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Kouvousi M, 2013, J ONCOL, V2013, DOI 10.1155/2013/756510; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kucknoor AS, 2007, CELL MICROBIOL, V9, P2586, DOI 10.1111/j.1462-5822.2007.00979.x; Laco J, 2011, VIRCHOWS ARCH, V458, P179, DOI 10.1007/s00428-010-1037-y; Lee KW, 2005, INT J CANCER, V117, P831, DOI 10.1002/ijc.21237; Li R, 2015, HEAD NECK-J SCI SPEC, V37, P1642, DOI 10.1002/hed.23807; Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002; Lopes V, 2011, ORAL ONCOL, V47, P698, DOI 10.1016/j.oraloncology.2011.04.022; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Mehta V, 2010, LARYNGOSCOPE, V120, P2203, DOI 10.1002/lary.21129; Michael KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000091; Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392; Netter F.H., 1989, ATLAS HUMAN ANATOMY; Nunes EM, 2016, VIROLOGY, V495, P33, DOI 10.1016/j.virol.2016.04.031; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Reuschenbach M, 2013, ORAL ONCOL, V49, P937, DOI 10.1016/j.oraloncology.2013.03.451; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Scheifele C, 2003, ORAL ONCOL, V39, P470, DOI 10.1016/S1368-8375(03)00006-X; SCHUTZE M, 2011, BMJ CLIN RES ED, V342, DOI DOI 10.1136/BMJ.D1584; Seitz HK, 2000, GUT, V47, P748, DOI 10.1136/gut.47.6.748; Sichero L, 2017, CANCER EPIDEM BIOMAR, V26, P1312, DOI 10.1158/1055-9965.EPI-17-0081; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Stark JR, 2009, JNCI-J NATL CANCER I, V101, P1406, DOI 10.1093/jnci/djp306; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P939, DOI 10.1158/1055-9965.EPI-05-0781; Syrjanen S, 2007, NEW ENGL J MED, V356, P1993, DOI 10.1056/NEJMe078004; SYRJANEN K, 1983, INT J ORAL MAXILLOF, V12, P418, DOI 10.1016/S0300-9785(83)80033-7; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Twu O, 2014, P NATL ACAD SCI USA, V111, P8179, DOI 10.1073/pnas.1321884111; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; Vatanshenassan M, 2010, EXP PARASITOL, V126, P187, DOI 10.1016/j.exppara.2010.04.021; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x; Weissenborn SJ, 2009, J VIROL, V83, P811, DOI 10.1128/JVI.01338-08; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yete S, 2018, ONCOLOGY-BASEL, V94, P133, DOI 10.1159/000485322	75	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232138	10.1371/journal.pone.0232138	http://dx.doi.org/10.1371/journal.pone.0232138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348362	Green Published, gold			2022-12-26	WOS:000536668200040
J	Ansari, M; Alanazi, A; Moin, A				Ansari, Mukhtar; Alanazi, Abdulrahman; Moin, Afrasim			Consumers' awareness, attitude and associated factors towards self-medication in Hail, Saudi Arabia	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; PATTERNS; RISKS	Objectives To determine the factors motivating the consumers towards self-medication, the intended indications and the consumers' perceptions about complications that may arise due to its use. Design Cross-sectional community based prospective study Place and duration of study Community pharmacies located at various locations of Hail, Saudi Arabia from January 2019 to March 2019. Methods The subjects of this cross-sectional study were people visiting community pharmacies for self-medication. Data on 663 participants was collected through a validated questionnaire prepared on the basis of WHO guidelines for the regulatory assessment of medicinal products for use in self-medication. Two trained data collectors visited the randomly selected community pharmacies, approached and interviewed the consumers purchasing medicines without prescriptions. Data was entered in SPSS and analyzed using descriptive and inferential analyses (alpha level = 0.05). Results Out of 663 respondents, 68.6% were university graduates; and 33.9% were healthcare professionals. Consumers preferred self-medication mainly for headache (85.8%), cold and sore throat (80.8%), cough (75.7%) and fever (71.8%) with the justification that these illnesses were minor (90.2%), time saving (82.2%), convenient (74.7%), quicker relief (66.1%), and economical (61.2%). Occupation was significantly associated with the reasons for preferring self-medication (p<0.001). Similarly, age, gender and education were also significantly associated with most of the reasons for opting self-medication. People were quite aware about harmful consequences of self-medication. Multivariate logistic regression analysis showed that the respondents with lower education (AOR = 2.404 [95% CI: 1.579-3.661]), non-healthcare professionals (AOR = 1.712 [95% CI: 1.143-2.565]) and higher monthly income (AOR = 0.376 [95% CI: 0.236-0.599]) preferred self-medication (p < 0.001, p = 0.009, p <0.001) respectively. Conclusion Self-medication was prevalent among young university graduate males for minor ailments mainly due to convenience and time saving. Despite people beliefs about the harmful consequences of self-medication, its use was omnipresent particularly among the respondents with lower education, non-healthcare professionals and people with higher monthly income.	[Ansari, Mukhtar; Alanazi, Abdulrahman] Univ Hail, Dept Clin Pharm, Coll Pharm, Hail, Saudi Arabia; [Moin, Afrasim] Univ Hail, Dept Pharmaceut, Coll Pharm, Hail, Saudi Arabia	University Ha'il; University Ha'il	Ansari, M (corresponding author), Univ Hail, Dept Clin Pharm, Coll Pharm, Hail, Saudi Arabia.	mukhtaransari@hotmail.com	ansari, mukhtar/A-1506-2017; moin, afrasim/A-9254-2012	ansari, mukhtar/0000-0002-5247-6356; moin, afrasim/0000-0002-3902-1162	Research Deanship of University of Ha'il -Saudi Arabia [160873]	Research Deanship of University of Ha'il -Saudi Arabia	This research was funded by Research Deanship of University of Ha'il -Saudi Arabia through project grant number (160873). However, the funding agency had no role in study design, data collection, analyses, preparation of the manuscript and decision to publish.	Abahussain E, 2005, MED PRIN PRACT, V14, P161, DOI 10.1159/000084633; Al Flaiti M, 2014, J ACUTE DIS, V3, P249, DOI 10.1016/S2221-6189(14)60056-1; Albawani SM., 2016, INT J PHARM PHARM SC, V8, P119, DOI 10.22159/ijpps.2016v8i10.12748; Albusalih FA, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5030051; Alghanim S. A., 2011, Eastern Mediterranean Health Journal, V17, P409; Aljadhey H, 2015, SAUDI MED J, V36, P328, DOI 10.15537/smj.2015.3.10523; Almalak H, 2014, SAUDI PHARM J, V22, P107, DOI 10.1016/j.jsps.2013.02.004; Alnemri AR, 2016, CURR PEDIAT RES, V20, P169; [Anonymous], 2016, RAOSOFT SAMPLE SIZE; Araia ZZ, 2019, J PHARM POLICY PRACT, V12, DOI 10.1186/s40545-019-0165-2; Awad AI, 2006, EUR J CLIN PHARMACOL, V62, P317, DOI 10.1007/s00228-006-0107-1; Bin Nafisah S, 2017, J INFECT PUBLIC HEAL, V10, P522, DOI 10.1016/j.jiph.2016.09.016; Clavijo H A, 1995, World Health Forum, V16, P403; Eldalo AS, 2013, ARCH PHARM PRACT, V4, P57, DOI 10.4103/2045-080X.112985; Ruiz ME, 2010, CURR DRUG SAF, V5, P315, DOI 10.2174/157488610792245966; Eticha T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097464; Albarran KF, 2008, PHARM WORLD SCI, V30, P863, DOI 10.1007/s11096-008-9241-4; Gelayee DA, 2017, J PHARMACEUTICS, V2017, DOI 10.1155/2017/8680714; Genral Authority for Statistics Kingdom of Saudi Arabia, 2015, POP HAIL REG GEND AG; George D, 2003, SPSS WINDOWS STEP ST; Hamel MJ, 2001, B WORLD HEALTH ORGAN, V79, P1014; Hughes CM, 2001, DRUG SAFETY, V24, P1027, DOI 10.2165/00002018-200124140-00002; James H, 2006, MED PRIN PRACT, V15, P270, DOI 10.1159/000092989; Jassim Abdul-Mohsin, 2010, Oman Med J, V25, P79, DOI 10.5001/omj.2010.25; Karimy M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7302-3; Keshari SS, 2014, INDIAN J CLIN PRACT, V25, P636; Lei XS, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010068; Livemint, 2008, SELF MED POP MED STU; Loyola Filho Antônio I. de, 2004, Cad. Saúde Pública, V20, P1661, DOI 10.1590/S0102-311X2004000600025; Phalke VD, 2006, INDIAN J COMMUNITY M, V31, P34, DOI DOI 10.4103/0970-0218.54933; Saeed MS, 2014, ARCH PHARM PRACT, V5, P149, DOI 10.4103/2045-080X.142049; Saudi Business Directory, 2019, PHARM HAIL; Selvaraj Kalaiselvi, 2014, Perspect Clin Res, V5, P32, DOI 10.4103/2229-3485.124569; Shankar P R, 2002, BMC Fam Pract, V3, P17, DOI 10.1186/1471-2296-3-17; Sharif S., 2015, PHARM PHARMACOL-RUSS, V6, P428, DOI [10.4236/pp.2015.69044, DOI 10.4236/PP.2015.69044]; Sridhar Sathvik B, 2018, Int J Appl Basic Med Res, V8, P3, DOI 10.4103/ijabmr.IJABMR_46_17; Suleiman AK, 2013, ARCH PHARM PRACT, V4, P180, DOI 10.4103/2045-080X.123228; World Health Organization, 2000, REG GUID TEL PROD; World Health Organization, 2002, WHO POL PERSP MED PR; World Health Organization, 2000, GUID REG ASS MED PRO; Yousef AMM, 2008, PHARM WORLD SCI, V30, P24, DOI 10.1007/s11096-007-9135-x	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232322	10.1371/journal.pone.0232322	http://dx.doi.org/10.1371/journal.pone.0232322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343748	Green Published, gold			2022-12-26	WOS:000536661300052
J	Lavau, CP; Aumann, WK; Sze, SGK; Gupta, V; Ripple, K; Port, SA; Kehlenbach, RH; Wechsler, DS				Lavau, Catherine P.; Aumann, Waitman K.; Sze, Sei-Gyung K.; Gupta, Veerain; Ripple, Katelyn; Port, Sarah A.; Kehlenbach, Ralph H.; Wechsler, Daniel S.			The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice	PLOS ONE			English	Article							NUCLEAR EXPORT; CELLS; EXPRESSION; DIFFERENTIATION; OVEREXPRESSION; TRANSFORMATION; TRANSCRIPTION; SET-NUP214; INDUCTION; COMPLEXES	The NUP98 and NUP214 nucleoporins (NUPs) are recurrently fused to heterologous proteins in leukemia. The resulting chimeric oncoproteins retain the phenylalanine-glycine (FG) repeat motifs of the NUP moiety that mediate interaction with the nuclear export receptor Crm1. NUP fusion leukemias are characterized by HOXA gene upregulation; however, their molecular pathogenesis remains poorly understood. To investigate the role of Crm1 in mediating the leukemogenic properties of NUP chimeric proteins, we took advantage of the Sequestosome-1 (SQSTM1)-NUP214 fusion. SQSTM1-NUP214 retains only a short C-terminal portion of NUP214 which contains FG motifs that mediate interaction with Crm1. We introduced point mutations targeting these FG motifs and found that the ability of the resulting SQSTM1-NUP214(FGmut) protein to interact with Crm1 was reduced by more than 50% compared with SQSTM1-NUP214. Mutation of FG motifs affected transforming potential: while SQSTM1-NUP214 impaired myeloid maturation and conferred robust colony formation to transduced hematopoietic progenitors in a serial replating assay, the effect of SQSTM1-NUP214(FGmut) was considerably diminished. Moreover, SQSTM1-NUP214 caused myeloid leukemia in all transplanted mice, whereas none of the SQSTM1-NUP214(FGmut) reconstituted mice developed leukemia. These oncogenic effects coincided with the ability of SQSTM1-NUP214 and SQSTM1-NUP214(FGmut) to upregulate the expression of Hoxa and Meis1 genes in hematopoietic progenitors. Indeed, chromatin immunoprecipitation assays demonstrated that impaired SQSTM1-NUP214 interaction with Crm1 correlated with impaired binding of the fusion protein to Hoxa and Meis1 genes. These findings highlight the importance of Crm1 in mediating the leukemogenic properties of SQSTM1-NUP214, and suggest a conserved role of Crm1 in recruiting oncoproteins to their effector genes.	[Lavau, Catherine P.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA; [Aumann, Waitman K.; Wechsler, Daniel S.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Aumann, Waitman K.; Wechsler, Daniel S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Sze, Sei-Gyung K.] Maine Childrens Canc Program, Scarborough, ME USA; [Gupta, Veerain; Ripple, Katelyn] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Port, Sarah A.] Princeton Univ, Dept Mol Biol, Princeton, NJ USA; [Kehlenbach, Ralph H.] Fac Med, Dept Mol Biol, Gottingen, Germany; [Kehlenbach, Ralph H.] Gottingen Ctr Mol Biosci GZMB, Dept Mol Biol, Gottingen, Germany	Duke University; Children's Healthcare of Atlanta (CHOA); Emory University; Duke University; Princeton University	Lavau, CP (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA.; Wechsler, DS (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA.; Wechsler, DS (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	catherine.lavau@duke.edu; dan.wechsler@emory.edu	Lavau, Catherine/Q-2928-2019; Aumann, Waitman/AAX-1226-2020	Kehlenbach, Ralph/0000-0003-4920-9916; Gupta, Veerain/0000-0002-6909-0361; Lavau, Catherine/0000-0003-4800-1320; Wechsler, Daniel/0000-0002-8170-862X	ASH Research Training Award for Fellows; Hyundai Hope On Wheels Young Investigator Grant; NHLBI [T32 5T32HL007057-40]; German Research Foundation [SFB860]; Hyundai Hope On Wheels Scholar Award; St. Baldrick's Foundation Research Award; Schiffman Family Foundation; Hyundai Hope on Wheels Grant; INSERM	ASH Research Training Award for Fellows; Hyundai Hope On Wheels Young Investigator Grant; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation(German Research Foundation (DFG)); Hyundai Hope On Wheels Scholar Award; St. Baldrick's Foundation Research Award; Schiffman Family Foundation; Hyundai Hope on Wheels Grant; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	WKA -ASH Research Training Award for Fellows; Hyundai Hope On Wheels Young Investigator Grant. SKS -NHLBI T32 5T32HL007057-40. RHK -German Research Foundation (RHK; SFB860). DSW -Hyundai Hope On Wheels Scholar Award, St. Baldrick's Foundation Research Award; Schiffman Family Foundation. CPL -Hyundai Hope on Wheels Grant; INSERM scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander TB, 2016, J CLIN ONCOL, V34, P4094, DOI 10.1200/JCO.2016.67.5066; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Brown FC, 2017, BRIT J HAEMATOL, V176, P86, DOI 10.1111/bjh.14413; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Conway AE, 2015, LEUKEMIA, V29, P423, DOI 10.1038/leu.2014.221; Conway AE, 2013, BLOOD, V121, P4758, DOI 10.1182/blood-2012-06-435792; Dickmanns A, 2015, CELLS-BASEL, V4, P538, DOI 10.3390/cells4030538; Dik WA, 2005, LEUKEMIA, V19, P1948, DOI 10.1038/sj.leu.2403891; Fahrenkrog B., 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/468306, DOI 10.1155/2014/468306]; Gorello P, 2010, HAEMATOL-HEMATOL J, V95, P2161, DOI 10.3324/haematol.2010.029769; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Holden NS, 2011, J PHARMACOL TOX MET, V63, P7, DOI 10.1016/j.vascn.2010.03.002; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lew M, 2007, BRIT J PHARMACOL, V152, P299, DOI 10.1038/sj.bjp.0707372; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Mendes A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010076; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nguyen N, 2019, LEUKEMIA, V33, P2758, DOI 10.1038/s41375-019-0521-x; Oka M, 2019, ELIFE, V8, DOI 10.7554/eLife.46667; Oka M, 2016, ELIFE, V5, DOI 10.7554/eLife.09540; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pascual-Garcia P, 2014, CELL REP, V9, P433, DOI 10.1016/j.celrep.2014.09.002; Port SA, 2016, J BIOL CHEM, V291, P23068, DOI 10.1074/jbc.M116.735340; Port SA, 2015, CELL REP, V13, P690, DOI 10.1016/j.celrep.2015.09.042; Qin H, 2016, ONCOGENE, V35, P5686, DOI 10.1038/onc.2016.118; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Saito S, 2008, J CELL PHYSIOL, V214, P322, DOI 10.1002/jcp.21199; Senapedis WT, 2014, SEMIN CANCER BIOL, V27, P74, DOI 10.1016/j.semcancer.2014.04.005; Spencer DH, 2015, LEUKEMIA, V29, P1279, DOI 10.1038/leu.2015.6; Takeda A, 2014, SEMIN CANCER BIOL, V27, P3, DOI 10.1016/j.semcancer.2014.02.009; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Xu HM, 2016, CANCER CELL, V30, P863, DOI 10.1016/j.ccell.2016.10.019; Zhou MH, 2014, ONCOL LETT, V8, P959, DOI 10.3892/ol.2014.2263	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232036	10.1371/journal.pone.0232036	http://dx.doi.org/10.1371/journal.pone.0232036			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343715	Green Published, gold			2022-12-26	WOS:000536661300029
J	Chen, RY; Li, ZY; Yuan, YL; Zhu, ZJ; Zhang, J; Tian, X; Zhang, XJ				Chen Ruiying; Li Zeyun; Yuan Yongliang; Zhu Zijia; Zhang Ji; Tian Xin; Zhang Xiaojian			A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer	PLOS ONE			English	Article							SERUM; BIOMARKERS; DECREASE; BREAST	Non-small cell lung cancer (NSCLC) remains a leading cause of cancer death globally. More accurate and reliable diagnostic methods/biomarkers are urgently needed. Joint application of metabolomics and transcriptomics technologies possesses the high efficiency of identifying key metabolic pathways and functional genes in lung cancer patients. In this study, we performed an untargeted metabolomics analysis of 142 NSCLC patients and 159 healthy controls; 35 identified metabolites were significantly different between NSCLC patients and healthy controls, of which 6 metabolites (hypoxanthine, inosine, L-tryptophan, indoleacrylic acid, acyl-carnitine C10:1, and lysoPC(18:2)) were chosen as combinational potential biomarkers for NSCLC. The area under the curve (AUC) value, sensitivity (SE), and specificity (SP) of these six biomarkers were 0.99, 0.98, and 0.99, respectively. Potential diagnostic implications of the metabolic characteristics in NSCLC was studied. The metabolomics results were further verified by transcriptomics analysis of 1027 NSCLC patients and 108 adjacent peritumoral tissues from TCGA database. This analysis identified 2202 genes with significantly different expressions in cancer cells compared to normal controls, which in turn defined pathways implicated in the metabolism of the compounds revealed by metabolomics analysis. We built a fully connected network of metabolites and genes, which shows a good correspondence between the transcriptome analysis and the metabolites selected for diagnosis. In conclusion, this work provides evidence that the metabolic biomarkers identified may be used for NSCLC diagnosis and screening. Comprehensive analysis of metabolomics and transcriptomics data offered a validated and comprehensive understanding of metabolism in NSCLC.	[Chen Ruiying] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp Med, Zhengzhou, Peoples R China; [Li Zeyun; Yuan Yongliang; Zhu Zijia; Zhang Ji; Tian Xin; Zhang Xiaojian] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharm, Zhengzhou, Peoples R China; [Li Zeyun; Yuan Yongliang; Zhu Zijia; Zhang Ji; Tian Xin; Zhang Xiaojian] Zhengzhou Univ, Henan Key Lab Precis Clin Pharm, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Tian, X; Zhang, XJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Pharm, Zhengzhou, Peoples R China.; Tian, X; Zhang, XJ (corresponding author), Zhengzhou Univ, Henan Key Lab Precis Clin Pharm, Zhengzhou, Peoples R China.	tianx@zzu.edu.cn; xjzhangyfy@163.com			National Natural Science Foundation of China [31870809, 31670895]; China Postdoctoral Science Foundation [2019M662555]; Postdoctoral Research Grant in Henan Province [1902004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Research Grant in Henan Province	This work was funded by the National Natural Science Foundation of China (31870809, 31670895), China Postdoctoral Science Foundation (2019M662555), and a Postdoctoral Research Grant in Henan Province (1902004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade F, 2015, METABOLOMICS, V11, P468, DOI 10.1007/s11306-014-0710-6; Bell JG, 2000, PROSTAG LEUKOTR ESS, V63, P21, DOI 10.1054/plef.2000.0186; Boger DL, 1998, CURR PHARM DESIGN, V4, P303; Chen Y, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/3505371; Chen YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25552-z; Chen YR, 2015, J CANCER RES CLIN, V141, P705, DOI 10.1007/s00432-014-1846-5; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Das UN, 2006, CURR PHARM BIOTECHNO, V7; de Castro J, 2009, EXP MOL PATHOL, V87, P226, DOI 10.1016/j.yexmp.2009.08.002; De Petrocellis L, 2000, CHEM PHYS LIPIDS, V108, P191, DOI 10.1016/S0009-3084(00)00196-1; FU B, 2017, J CELL BIOCHEM, V118, DOI DOI 10.1103/PHYSREVLETT.118.146401; He ZX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00920; Hori S, 2011, LUNG CANCER, V74, P284, DOI 10.1016/j.lungcan.2011.02.008; Jin Y, 2019, IDENTIFICATION NOVEL; Knapp P, 2010, PROSTAG OTH LIPID M, V92, P62, DOI 10.1016/j.prostaglandins.2010.03.002; Knific T, 2018, J STEROID BIOCHEM, V178; Kumar N, 2017, BIOINFORMATION, V13, P202, DOI 10.6026/97320630013202; Laguna TA, 2015, PEDIATR PULM, V50, P869, DOI 10.1002/ppul.23225; Lam VW, 2010, HEPATOL RES, V38, pS107; Li YJ, 2014, J CHROMATOGR B, V966, P147, DOI 10.1016/j.jchromb.2014.04.047; Liu Y, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-99; Malaguarnera M, 2006, WORLD J GASTROENTERO, V12, P4541, DOI 10.3748/wjg.v12.i28.4541; Marien E, 2015, INT J CANCER, V137, P1539, DOI 10.1002/ijc.29517; Narayanan A, 2015, INT J MOL SCI, V16, P5014, DOI 10.3390/ijms16035014; Pradhan MP, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-141; Proenza AM, 2003, J NUTR BIOCHEM, V14, P133, DOI 10.1016/S0955-2863(02)00225-5; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Shang XC, 2016, TUMOR BIOL, V37, P11163, DOI 10.1007/s13277-016-4996-z; Shi XY, 2017, EUR J LIPID SCI TECH, V119, DOI 10.1002/ejlt.201600120; Uchiyama K, 2017, J GASTROENTEROL, V52, P677, DOI 10.1007/s00535-016-1261-6; Walz JZ, 2017, VET COMP ONCOLOGY, V16; Yonezawa K, 2013, CANCER GENOM PROTEOM, V10, P233; Zhao YY, 2014, CHEM-BIOL INTERACT, V215, P7, DOI 10.1016/j.cbi.2014.02.014	34	20	22	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232272	10.1371/journal.pone.0232272	http://dx.doi.org/10.1371/journal.pone.0232272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374740	Green Published, gold			2022-12-26	WOS:000537283500028
J	Newman, D; Tong, M; Levine, E; Kishore, S				Newman, Daniel; Tong, Michelle; Levine, Erica; Kishore, Sandeep			Prevalence of multiple chronic conditions by US state and territory, 2017	PLOS ONE			English	Article							MULTIMORBIDITY; IMPACT	Having multiple (two or more) chronic conditions (MCC) is associated with an increased risk of mortality and functional decline, health resource utilization, and healthcare expenditures. As a result, understanding the prevalence of MCC is increasingly being recognized as a public health imperative. This research describes the prevalence and distribution of adults with MCC across the United States using 2017 data from the Behavioral Risk Factors Surveillance System (BRFSS). Prevalence of MCC was calculated for each U.S. state and territory overall, by sex and by age. Additionally, the most common condition dyads (two condition combinations) and triads (three condition combinations) were assessed for each state. Prevalence of MCC ranged from 37.9% in the District of Columbia to 64.4% in West Virginia. Females had a higher prevalence than males in 47 of 53 states and territories, and MCC prevalence increased with age in every state and territory. Overall prevalence estimates were higher than estimates using data from the National Health Interview Survey (NHIS), especially in the younger population (aged 18-44), due partly to the inclusion of high cholesterol, obesity, and depression as chronic conditions. Analysis of the most prevalent dyads and triads revealed the greatest state-by-state variability in the 18-44-year-old population. Multiple states' most prevalent dyads and triads for this population included obesity and depression. These findings build an accurate picture of the prevalence of multiple chronic conditions across the United States and will aid public health officials in creating programs targeted to their region.	[Newman, Daniel; Tong, Michelle; Levine, Erica; Kishore, Sandeep] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA; [Kishore, Sandeep] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Newman, D (corresponding author), Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA.	daniel.newman@icahn.mssm.edu		Tong, Michelle/0000-0002-8945-5946; Newman, Daniel/0000-0002-5954-5668				Adams ML, 2017, PREV MED, V105, P169, DOI 10.1016/j.ypmed.2017.09.013; Allen LN, 2020, LANCET GLOB HEALTH, V8, pE50, DOI 10.1016/S2214-109X(19)30446-2; Anderson G, 2010, CHRONIC CARE MAKING; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Beasley JW, 2004, ANN FAM MED, V2, P405, DOI 10.1370/afm.94; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Gerteis J., 2014, AHRQ PUB, VQ14-0038; Goodman RA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120239; Gupta S, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160264; Kishore SP, 2020, LANCET GLOB HEALTH, V8, pE4, DOI 10.1016/S2214-109X(19)30496-6; LOCHNER KA, 2013, MED MED RES REV, V3, P1; Lochner KA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120137; Machlin SR, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120172; MacMahon SC., 2018, MULTIMORBIDITY PRIOR; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; McLean G, 2014, BRIT J GEN PRACT, V64, pE440, DOI 10.3399/bjgp14X680545; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; Newman AB, 2008, J GERONTOL A-BIOL, V63, P603, DOI 10.1093/gerona/63.6.603; Newman D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211965; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; U.S. Centers for Medicare & Medicaid Services, 2017, CHRON COND; United State Centers for Disease Control and Prevention, BEH RISK FACT SURV S; United State Centers for Disease Control and Prevention, 2018, BEH RISK FACT SURV S; United States Department of Health and Human Services, 2010, MULT CHRON COND STRA; US Department of Health and Human Services, HHS IN MULT CHRON CO; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; Ward BW, 2016, MMWR-MORBID MORTAL W, P65; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232346	10.1371/journal.pone.0232346	http://dx.doi.org/10.1371/journal.pone.0232346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369509	gold, Green Published			2022-12-26	WOS:000537280000026
J	Hochmair, HH; Scheffrahn, RH; Basille, M; Boone, M				Hochmair, Hartwig H.; Scheffrahn, Rudolf H.; Basille, Mathieu; Boone, Matthew			Evaluating the data quality of iNaturalist termite records	PLOS ONE			English	Article							CITIZEN SCIENCE; SPECIES DISTRIBUTION; INVASIVE TERMITES; ISOPTERA; COMPLETENESS; INFESTATIONS; MODELS; WORLD	Citizen science (CS) contributes to the knowledge about species distributions, which is a critical foundation in the studies of invasive species, biological conservation, and response to climatic change. In this study, we assessed the value of CS for termites worldwide. First, we compared the abundance and species diversity of geo-tagged termite records in iNaturalist to that of the University of Florida termite collection (UFTC) and the Global Biodiversity Information Facility (GBIF). Second, we quantified how the combination of these data sources affected the number of genera that satisfy data requirements for ecological niche modeling. Third, we assessed the taxonomic correctness of iNaturalist termite records in the Americas at the genus and family level through expert review based on photo identification. Results showed that iNaturalist records were less abundant than those in the UFTC and in GBIF, although they complemented the latter two in selected world regions. A combination of GBIF and the UFTC led to a significant increase in the number of termite genera satisfying the abundance criterion for niche modeling compared to either of those two sources alone, whereas adding iNaturalist observations as a third source only had a moderate effect on the number of termite genera satisfying that criterion. Although research grade observations in iNaturalist require a community-supported and agreed upon identification (ID) below the family taxonomic rank, our results indicated that iNaturalist data do not exhibit a higher taxonomic classification accuracy when they are designated research grade. This means that non-research grade observations can be used to more completely map the presence of termite locations in certain geographic locations without significantly jeopardizing data quality. We concluded that CS termite observation records can, to some extent, complement expert termite collections in terms of geographic coverage and species diversity. Based on recent data contribution patterns in CS data, the role of CS termite contributions is expected to grow significantly in the near future.	[Hochmair, Hartwig H.; Scheffrahn, Rudolf H.; Basille, Mathieu; Boone, Matthew] Univ Florida, Ft Lauderdale Res & Educ Ctr Davie, Gainesville, FL 32611 USA; [Hochmair, Hartwig H.] Univ Florida, Sch Forest Resources & Conservat, Davie, FL 33314 USA; [Scheffrahn, Rudolf H.] Univ Florida, Dept Entomol & Nematol, Davie, FL USA; [Basille, Mathieu; Boone, Matthew] Univ Florida, Dept Wildlife Ecol & Conservat, Davie, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hochmair, HH (corresponding author), Univ Florida, Ft Lauderdale Res & Educ Ctr Davie, Gainesville, FL 32611 USA.; Hochmair, HH (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Davie, FL 33314 USA.	hhhochmair@ufl.edu		Boone, Matthew/0000-0002-8070-4715	University of Florida Biodiversity Institute (UFBI); University of Florida Informatics Institute (UFII) through the Faculty Interdisciplinary Seed Grants 2018 Research Initiative [UF] [00128670]	University of Florida Biodiversity Institute (UFBI); University of Florida Informatics Institute (UFII) through the Faculty Interdisciplinary Seed Grants 2018 Research Initiative [UF]	This study was partially funded by the University of Florida Biodiversity Institute (UFBI) and the University of Florida Informatics Institute (UFII) through the Faculty Interdisciplinary Seed Grants 2018 Research Initiative [UF Project #00128670]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2019, GBIF OCC DOWNL, DOI [10.15468/dl.mwuexs, DOI 10.15468/DL.MWUEXS]; Antoniou V, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5050064; Bidinger K, 2012, J APPL ENTOMOL, V136, P109, DOI 10.1111/j.1439-0418.2010.01598.x; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Chandler M, 2017, BIOL CONSERV, V213, P280, DOI 10.1016/j.biocon.2016.09.004; Constantino R, TERMITE DATABASE 201; Del Toro I, 2012, MYRMECOL NEWS, V17, P133; Gaiji S, 2013, BIODIVERSITY INFORM, V8; GBIF, 2020, DAT QUAL REQ OCC ONL; Goodchild MF, 2007, INT J SPAT DATA INFR, V2, P24; Govorushko S, 2019, ENTOMOL SCI, V22, P21, DOI 10.1111/ens.12328; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hochmair HH, 2010, J ECON ENTOMOL, V103, P1338, DOI 10.1603/EC09428; Husseneder C, 2006, INSECT SOC, V53, P212, DOI 10.1007/s00040-005-0860-7; iNaturalist, 2020, CHANG QUAL GRAD 2015; International Organization for Standardization, 2009, 20111 ISOTC; Jacobs C, 2017, GEO-SPAT INF SCI, V20, P3, DOI 10.1080/10095020.2017.1288424; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Lard CF., 2006, EC IMPACT IMPORTED F; McKinley DC, 2017, BIOL CONSERV, V208, P15, DOI 10.1016/j.biocon.2016.05.015; Mullins AJ, 2015, J ECON ENTOMOL, V108, P707, DOI 10.1093/jee/tov022; NOIROT C, 1989, ETHOL ECOL EVOL, V1, P1, DOI 10.1080/08927014.1989.9525528; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pebesma E, 2018, R J, V10, P439; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Platts PJ, 2010, DIVERS DISTRIB, V16, P628, DOI 10.1111/j.1472-4642.2010.00668.x; Rust MK, 2012, ANNU REV ENTOMOL, V57, P355, DOI 10.1146/annurev-ento-120710-100634; Scheffrahn RH, 2018, SOCIOBIOLOGY, V65, P88, DOI 10.13102/sociobiology.v65i1.2097; Scheffrahn RH, 2020, UF TERMITE DATA 2019; Scheffrahn RH, 2011, FLA ENTOMOL, V94, P57, DOI 10.1653/024.094.0108; South A, 2011, R J, V3, P35; Su NY, 2002, SOCIOBIOLOGY, V40, P95; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; Tonini F, 2014, ECOL INFORM, V24, P222, DOI 10.1016/j.ecoinf.2014.09.011; Troia MJ, 2016, ECOL EVOL, V6, P4654, DOI 10.1002/ece3.2225	37	29	33	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0226534	10.1371/journal.pone.0226534	http://dx.doi.org/10.1371/journal.pone.0226534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365126	Green Submitted, gold, Green Published			2022-12-26	WOS:000536959700003
J	Petzold, G; Lasser, J; Ruhl, J; Bremer, SCB; Knoop, RF; Ellenrieder, V; Kunsch, S; Neesse, A				Petzold, Golo; Lasser, Julian; Ruehl, Janina; Bremer, Sebastian C. B.; Knoop, Richard F.; Ellenrieder, Volker; Kunsch, Steffen; Neesse, Albrecht			Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease	PLOS ONE			English	Article							QUANTIFICATION; VARIABILITY; BIOPSY; TOOL	Background/Aims The aim of our study was to evaluate the diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index (HRI) by high-end devices for the detection and classification of hepatic steatosis in patients with various causes of chronic liver disease (CLD). Methods We retrospectively enrolled patients with CLD who underwent liver biopsy and baseline ultrasound between March 2016 and May 2019. Sonographic graduation of steatosis (0 degrees-III degrees) using B-Mode criteria and HRI were correlated with the histological graduation (S0 (<5% fat), S1 (>= 5-33%), S2 (>33-66%) and S3 (>66%). Interobserver agreement was calculated. Results 157 patients were evaluated. B-Mode ultrasound had a sensitivity of 75.6% and a specificity of 76.0% to differentiate between steatosis and no steatosis (AUROC 0.758). Using B-Mode criteria for advanced steatosis (>= II degrees), specificity for presence of histological steatosis was >= 98.7%. For detection of advanced steatosis (>= S2), sensitivity of B-mode criteria was 90.9%. In a subgroup of patients with advanced liver fibrosis, sensitivity of B-mode criteria was 95.0% for detection of advanced steatosis (S >= 2). A HRI cut-off-value of 1.46 differentiates between patients with steatosis and patients without steatosis with a sensitivity of 42.7% and a specificity of 90.7% (AUROC 0.680). Interobserver agreement of both B-Mode and HRI was good to excellent. Conclusion B-Mode ultrasound using high-end devices is an excellent method to detect advanced steatosis in patients with various CLD. For diagnosis of mild steatosis, modern ultrasound devices may have higher sensitivity but at the expense of specificity. Stage of fibrosis and etiology of CLD seem not to impact on diagnostic accuracy. The additional calculation of HRI seems to have no additional benefit with regard to detect or grade hepatic steatosis in our study population.	[Petzold, Golo; Lasser, Julian; Ruehl, Janina; Bremer, Sebastian C. B.; Knoop, Richard F.; Ellenrieder, Volker; Kunsch, Steffen; Neesse, Albrecht] Univ Med Ctr Goettingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany	University of Gottingen	Neesse, A (corresponding author), Univ Med Ctr Goettingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany.	albrecht.neesse@med.uni-goettingen.de		Petzold, Golo/0000-0001-8318-0315; Bremer, Sebastian Christopher Benjamin/0000-0001-5481-0429				Ajmera V, 2018, GASTROENTEROLOGY, V155, P307, DOI 10.1053/j.gastro.2018.04.014; Almeida AD, 2008, WORLD J GASTROENTERO, V14, P1415, DOI 10.3748/wjg.14.1415; Araujo AR, 2018, LIVER INT, V38, P47, DOI 10.1111/liv.13643; Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774; Chan AWH, 2017, J GASTROEN HEPATOL, V32, P667, DOI 10.1111/jgh.13536; Chauhan A, 2016, J CLIN ULTRASOUND, V44, P580, DOI 10.1002/jcu.22382; Clark VC, 2018, J HEPATOL, V69, P1357, DOI 10.1016/j.jhep.2018.08.005; Borges VFDE, 2013, J CLIN ULTRASOUND, V41, P18, DOI 10.1002/jcu.21994; De Luca-Johnson J, 2016, DIGEST DIS SCI, V61, P2710, DOI 10.1007/s10620-016-4213-3; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Hepburn MJ, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-14; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee DH, 2017, CLIN MOL HEPATOL, V23, P290, DOI 10.3350/cmh.2017.0042; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; Marshall RH, 2012, AM J ROENTGENOL, V199, P997, DOI 10.2214/AJR.11.6677; Palmentieri B, 2006, DIGEST LIVER DIS, V38, P485, DOI 10.1016/j.dld.2006.03.021; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schirmacher P, 2004, PATHOLOGE, V25, P337; Stattermayer AF, 2015, J HEPATOL, V63, P156, DOI 10.1016/j.jhep.2015.01.034; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Strnad P, 2019, GUT, V68, P1099, DOI 10.1136/gutjnl-2018-316228; Strobel D, 2015, ULTRASCHALL MED, V36, P122, DOI 10.1055/s-0034-1399282; van Werven JR, 2010, RADIOLOGY, V256, P159, DOI 10.1148/radiol.10091790; Wang JH, 2013, DIGEST DIS SCI, V58, P2993, DOI 10.1007/s10620-013-2769-8; Watanabe S, 2015, J GASTROENTEROL, V50, P364, DOI 10.1007/s00535-015-1050-7; Webb M, 2009, AM J ROENTGENOL, V192, P909, DOI 10.2214/AJR.07.4016; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109	28	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0231044	10.1371/journal.pone.0231044	http://dx.doi.org/10.1371/journal.pone.0231044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357147	Green Published, gold			2022-12-26	WOS:000536957700006
J	Ravindran, R; Chakrapani, G; Mitra, K; Doble, M				Ravindran, Radhika; Chakrapani, Gayathri; Mitra, Kartik; Doble, Mukesh			Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein	PLOS ONE			English	Article							VITRO ANTIMYCOBACTERIAL ACTIVITY; D-PINITOL; ANTITUBERCULAR ACTIVITY; MEDICINAL-PLANTS; TUBERCULOSIS; RIFAMPICIN; CONSTITUENTS; COMBINATION; EXTRACTS; FTSZ	The study was designed to assess whether plant extracts /phytochemical (D-Pinitol) synergistically combine with antituberculosis drugs and act on Mycobacterium smegmatis (M. smegmatis) as well as assess their mode of action on Mycobacterium tuberculosis (M.tb) Filamenting temperature sensitive mutant Z (FtsZ) protein. Resazurin microtitre plate assay (Checker board) was performed to analyze the activity of plant extracts against M. smegmatis. Synergistic behaviour of plant extracts /D-Pinitol with Isoniazid (INH) and Rifampicin (RIF) were determined by time-kill and checker board assays. Elongation of M. smegmatis cells due to this treatment was determined by light microscopy. The effect of Hexane methanol extract (HXM) plant extracts on cell viability was determined using PI/SYTO9 dual dye reporter Live/Dead assay. Action of HXM plant extracts /D-Pinitol on inhibition of FtsZ protein was done using Guanosine triphosphatase (GTPase) light scattering assay and quantitative Polymerase Chain Reaction (qPCR). The Hexane-methanolic plant extract of Acacia nilotica, Aegle marmelos and Glycyrrhiza glabra showed antimycobacterial activity at 1.56 +/- 0.03, 1.32 +/- 0.02 and 1.25 +/- 0.03 mg/mL respectively and that of INH and RIF were 4.00 +/- 0.06 mu g/mL and 2.00 +/- 0.04 mu g/mL respectively. These plant extracts and major phytochemical exudate D-Pinitol was found to act synergistically with antimycobacterial drugs INH and RIF with an FIC index similar to 0.20. Time-Kill kinetics studies indicate that, these plant extracts were bacteriostatic in nature. D-Pinitol in conjunction with INH and RIF exhibited a 2 Log reduction in the growth of viable cells compared to untreated. Attempt to elucidate their mode of action through phenotypic analysis indicated that these plant extracts and D-Pinitol was found to interfere in cell division there by leading to an abnormal elongated cellular morphology. HXM extracts and D-Pinitol synergistically combined with the first line tuberculosis drugs, INH and RIF, to act on M. smegmatis. The increase in the length of M. smegmatis cells on treatment with D-Pinitol and HXM extract of the plants indicated that they hinder the cell division mechanism thereby leading to a filamentous phenotype, and finally leading to cell death. In addition, the integrity of the bacterial cell membrane is also altered causing cell death. Further gene expression analysis showed that these plant extracts and D-Pinitol hampers with function of FtsZ protein which was confirmed through in vitro inhibition of FtsZ-GTPase enzymatic activity.	[Ravindran, Radhika; Chakrapani, Gayathri; Mitra, Kartik; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Bioengn & Drug Design Lab, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Doble, M (corresponding author), Indian Inst Technol, Dept Biotechnol, Bioengn & Drug Design Lab, Madras, Tamil Nadu, India.	mukeshd@iitm.ac.in	Mitra, Kartik/AAP-9567-2021	Mitra, Kartik/0000-0003-4891-1463; Chakrapani, Gayathri/0000-0002-6691-5794; Ravindran, Radhika/0000-0003-3131-0987				Al-Snafi A.E., 2018, J PHARM CAIRO, V8, P1, DOI DOI 10.5772/58918; Amir M, 2016, NAT PROD RES, V30, P715, DOI 10.1080/14786419.2015.1039001; Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; Aro AO, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1355-y; Atif Ali, 2012, Journal of Medicinal Plants Research, V6, P1492, DOI 10.5897/JMPR11.1275; Banfi E, 2003, J ANTIMICROB CHEMOTH, V52, P796, DOI 10.1093/jac/dkg439; Bao ZJ, 2017, INT J CLIN EXP MED, V10, P12343; Bapela NB, 2006, PHYTOMEDICINE, V13, P630, DOI 10.1016/j.phymed.2006.08.001; Barua S, 2014, MATER RES EXPRESS, V1, DOI 10.1088/2053-1591/1/4/045402; Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Bhattacharya A, 2013, FEBS J, V280, P4585, DOI 10.1111/febs.12429; Bhatter P, 2015, J EVID-BASED INTEGR, V20, P3, DOI 10.1177/2156587214553303; Bishai JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012843; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chauhan PS, 2011, INT IMMUNOPHARMACOL, V11, P286, DOI 10.1016/j.intimp.2010.11.028; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chidambaram S, 2016, INT J PHARM SCI RES, V7, P4130, DOI 10.13040/IJPSR.0975-8232.7(10).4130-33; Chinchansure AA SNH, 2015, INT J BASIC APPL CHE, V5, P39; Domadia PN, 2008, BIOCHEMISTRY-US, V47, P3225, DOI 10.1021/bi7018546; Evina JN, 2017, REV BRAS FARMACOGN, V27, P739, DOI 10.1016/j.bjp.2017.09.006; Farzana MUZN., 2014, J PHARMACOGN PHYTOCH, V3, P84; Favrot L, 2012, EXPERT REV ANTI-INFE, V10, P1023, DOI [10.1586/eri.12.91, 10.1586/ERI.12.91]; Fyhrquist P, 2014, S AFR J BOT, V90, P1, DOI 10.1016/j.sajb.2013.08.018; Gao Y, 2019, INT J AVIAT AERONAUT, V6; Ge F, 2010, J MED MICROBIOL, V59, P567, DOI 10.1099/jmm.0.014837-0; Gecthan PKMA, 2008, J BIOCHEM MOL TOXIC, V22, P220, DOI 10.1002/jbt.20218; Gowrish A., 2015, Journal of Applied Pharmaceutical Science, V5, P137; Gupta VK, 2018, J ETHNOPHARMACOL, V227, P113, DOI 10.1016/j.jep.2018.08.031; Hannapel DJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00257; Harper CJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-138; Hemaiswarya S, 2010, J MED MICROBIOL, V59, P1469, DOI 10.1099/jmm.0.022426-0; Hou S, 2012, J BIOL CHEM, V287, P23878, DOI 10.1074/jbc.M111.309492; Kahaliw W, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1563-0; Kalaivani T, 2010, FOOD CHEM TOXICOL, V48, P298, DOI 10.1016/j.fct.2009.10.013; Kaur Mandeep, 2016, Metab Eng Commun, V3, P15, DOI 10.1016/j.meteno.2016.01.003; Kaur R, 2015, ORIENT J CHEM, V31, P597, DOI 10.13005/ojc/310176; Labuschagne A, 2012, EVID-BASED COMPL ALT, P9; Lahiri R, 2005, J MED MICROBIOL, V54, P235, DOI 10.1099/jmm.0.45700-0; Lechner D, 2008, PHYTOCHEM LETT, V1, P71, DOI 10.1016/j.phytol.2008.01.002; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Lin TH, 2013, INT J MOL SCI, V14, P9790, DOI 10.3390/ijms14059790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Misra LN, 2004, CURR SCI INDIA, V87, P1507; Mitra K, 2019, EUR J PHARM SCI, V135, P103, DOI 10.1016/j.ejps.2019.04.023; Mossa JS, 2004, PHYTOTHER RES, V18, P934, DOI 10.1002/ptr.1420; Murti Vijay B. Lambole Krishna, 2010, INT J PHARM SCI RES, V5, P67; Nair SS, 2015, J PHARM PHARMACOGN R, V3, P80; Newton David W, 2011, Int J Pharm Compd, V15, P32; NUMATA A, 1990, CHEM PHARM BULL, V38, P2862, DOI 10.1248/cpb.38.2862; Oladosu PO, 2013, J MICROBIOL RES, V3, P247; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Patel YS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02075; Poongothai G., 2013, International Journal of Pharma and Bio Sciences, V4, pP; Rahgozar N, 2018, IRANIAN BIOMEDICAL J; Rastogi N, 2008, INDIAN J EXP BIOL, V46, P783; Reddy VM, 2010, ANTIMICROB AGENTS CH, V54, P2840, DOI 10.1128/AAC.01601-09; Rengarajan T, 2012, J EXPT THERAPEUTICS, V10; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Saxena S, 2005, GLYCYRRHIZA GLABRA M; Schulte S, 2019, APPL MICROBIOL BIOT, V103, P7567, DOI 10.1007/s00253-019-10023-w; Sedighinia F, 2012, AVICENNA J PHYTOMEDI, V2, P118; Sethi G, 2008, MOL CANCER THER, V7, P1604, DOI 10.1158/1535-7163.MCT-07-2424; Shahedur Rahman, 2014, Asian Pacific Journal of Tropical Disease, V4, P71; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Solanki R, 2017, INT J DRUG RES TECHN, V2, P4; Sridevi D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00578; Suja K, 2017, J COMMUN DIS, V49, P4; Taneja NK, 2007, J ANTIMICROB CHEMOTH, V60, P288, DOI 10.1093/jac/dkm207; Tyagi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121313; Yagi A, 2017, J ANTIBIOT, V70, P685, DOI 10.1038/ja.2017.23; Yu ZQ, 2005, INT IMMUNOPHARMACOL, V5, P571, DOI 10.1016/j.intimp.2004.11.004; Zhan TR, 2007, CARBOHYD RES, V342, P865, DOI 10.1016/j.carres.2007.01.004; Zhao X., 2015, PLOS ONE, V10, pE137166	74	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232482	10.1371/journal.pone.0232482	http://dx.doi.org/10.1371/journal.pone.0232482			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357366	gold, Green Published			2022-12-26	WOS:000536957700033
J	Chen, Y; Chen, YH; Pouillot, R; Dennis, S; Xian, ZH; Luchansky, JB; Porto-Fett, ACS; Lindsay, JA; Hammack, TS; Allard, M; Van Doren, JM; Brown, EW				Chen, Yi; Chen, Yuhuan; Pouillot, Regis; Dennis, Sherri; Xian, Zhihan; Luchansky, John B.; Porto-Fett, Anna C. S.; Lindsay, James A.; Hammack, Thomas S.; Allard, Marc; Van Doren, Jane M.; Brown, Eric W.			Genetic diversity and profiles of genes associated with virulence and stress resistance among isolates from the 2010-2013 interagency Listeria monocytogenes market basket survey	PLOS ONE			English	Article							TO-EAT FOODS; PREMATURE STOP CODON; RISK-ASSESSMENT; DOSE-RESPONSE; ATTENUATING MUTATIONS; RETAIL DELICATESSENS; FOODBORNE ILLNESS; SMOKED SALMON; STRAINS; INLA	Whole genome sequencing (WGS) was performed on 201 Listeria monocytogenes isolates recovered from 102 of 27,389 refrigerated ready-to-eat (RTE) food samples purchased at retail in U.S. FoodNet sites as part of the 2010-2013 interagency L. monocytogenes Market Basket Survey (Lm MBS). Core genome multi-locus sequence typing (cgMLST) and in-silico analyses were conducted, and these data were analyzed with metadata for isolates from five food groups: produce, seafood, dairy, meat, and combination foods. Six of 201 isolates, from 3 samples, were subsequently confirmed as L. welshimeri. Three samples contained one isolate per sample; mmong the 96 samples that contained two isolates per sample, 3 samples each contained two different strains and 93 samples each contained duplicate isolates. After 93 duplicate isolates were removed, the remaining 102 isolates were delineated into 29 clonal complexes (CCs) or singletons based on their sequence type. The five most prevalent CCs were CC155, CC1, CC5, CC87, and CC321. The Shannon's diversity index for clones per food group ranged from 1.49 for dairy to 2.32 for produce isolates, which were not significantly different in pairwise comparisons. The most common molecular serogroup as determined by in-silico analysis was IIa (45.6%), followed by IIb (27.2%), IVb (20.4%), and IIc (4.9%). The proportions of isolates within lineages I, II, and III were 48.0%, 50.0% and 2.0%, respectively. Full-length inlA was present in 89.3% of isolates. Listeria pathogenicity island 3 (LIPI-3) and LIPI-4 were found in 51% and 30.6% of lineage I isolates, respectively. Stress survival islet 1 (SSI-1) was present in 34.7% of lineage I isolates, 80.4% of lineage II isolates and the 2 lineage III isolates; SSI-2 was present only in the CC121 isolate. Plasmids were found in 48% of isolates, including 24.5% of lineage I isolates and 72.5% of lineage II isolates. Among the plasmid-carrying isolates, 100% contained at least one cadmium resistance cassette and 89.8% contained bcrABC, involved in quaternary ammonium compound tolerance. Multiple clusters of isolates from different food samples were identified by cgMLST which, along with available metadata, could aid in the investigation of possible cross-contamination and persistence events.	[Chen, Yi; Chen, Yuhuan; Dennis, Sherri; Xian, Zhihan; Hammack, Thomas S.; Allard, Marc; Van Doren, Jane M.; Brown, Eric W.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Luchansky, John B.; Porto-Fett, Anna C. S.] ARS, USDA, Wyndmoor, PA USA; [Lindsay, James A.] ARS, USDA, Beltsville, MD USA	US Food & Drug Administration (FDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Chen, Y (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	yi.chen@fda.hhs.gov		Pouillot, Regis/0000-0002-6107-5212	Joint Institute for Food Safety and Applied Nutrition [FDU001418]; Food and Drug Administration [HHFS223201710033I]; Goldbelt C6, LLC	Joint Institute for Food Safety and Applied Nutrition; Food and Drug Administration(United States Department of Health & Human Services); Goldbelt C6, LLC	ZX was funded (in part) by the Joint Institute for Food Safety and Applied Nutrition (jifsan.umd.edu) through a cooperative agreement with the FDA, #FDU001418. RP was supported by the Food and Drug Administration (www.fda.gov) contract HHFS223201710033I with Goldbelt C6, LLC. The funders' role in study design, data collection and analysis, decision to publish, or preparation of the manuscript is limited to the contributions of co-authors ZX and RP, as described in the contribution form.	Acciari VA, 2017, J FOOD PROTECT, V80, P271, DOI [10.4315/0362-028X.JFP-15-599, 10.4315/0362-028x.jfp-15-599]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bergholz TM, 2018, APPL MICROBIOL BIOT, V102, P3475, DOI 10.1007/s00253-018-8852-5; Buchanan RL, 2017, FOOD CONTROL, V75, P1, DOI 10.1016/j.foodcont.2016.12.016; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chau ML, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0956-z; Chen JS, 2010, FOODBORNE PATHOG DIS, V7, P31, DOI 10.1089/fpd.2009.0353; Chen YH, 2003, J FOOD PROTECT, V66, P570, DOI 10.4315/0362-028X-66.4.570; Chen Y, 2016, APPL ENVIRON MICROB, V82, P7030, DOI 10.1128/AEM.01486-16; Chen Y, 2016, APPL ENVIRON MICROB, V82, P6258, DOI 10.1128/AEM.01532-16; Chen YH, 2011, APPL ENVIRON MICROB, V77, P1171, DOI 10.1128/AEM.01564-10; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; Corcoran D, 2006, INT J HYG ENVIR HEAL, V209, P527, DOI 10.1016/j.ijheh.2006.06.001; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Draughon AF, 2009, USDA FSIS M INT RET; Ebner R, 2015, FOOD CONTROL, V57, P321, DOI 10.1016/j.foodcont.2015.04.030; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; EFSA, 2013, EFSA J, V11, P75; Endrikat S, 2010, J FOOD PROTECT, V73, P612, DOI 10.4315/0362-028X-73.4.612; Gall K., 2004, FOOD PROT TRENDS, V24, P3302; Gallagher D, 2016, J FOOD PROTECT, V79, P1076, DOI 10.4315/0362-028X.JFP-15-336; Gilbreth SE, 2005, APPL ENVIRON MICROB, V71, P8115, DOI 10.1128/AEM.71.12.8115-8122.2005; Gombas DE, 2003, J FOOD PROTECT, V66, P559, DOI 10.4315/0362-028X-66.4.559; Gorski L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167566; Gray MJ, 2004, APPL ENVIRON MICROB, V70, P5833, DOI 10.1128/AEM.70.10.5833-5841.2004; Grocery Manufacturers Association (GMA), 2013, SAN LEX COLL TERMS D; Haase JK, 2014, ENVIRON MICROBIOL, V16, P405, DOI 10.1111/1462-2920.12342; Henriques AR, 2017, J FOOD PROTECT, V80, P551, DOI 10.4315/0362-028X.JFP-16-310; Hoelzer K, 2013, RISK ANAL, V33, P1568, DOI 10.1111/risa.12005; Hong E, 2007, INT J FOOD MICROBIOL, V114, P187, DOI 10.1016/j.ijfoodmicro.2006.09.011; Innovation Center for U.S. Dairy, 2015, CONTR LIST MON GUID; Interagency Risk Assessment Consortium (IRAC), 2017, IRAC WORK GROUP PROJ; Jennison AV, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00603; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kim SW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197053; Kleta S, 2017, EMERG INFECT DIS, V23, P1680, DOI 10.3201/eid2310.161623; Kuenne C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012511; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee S, 2018, MBIO, V9, DOI 10.1128/mBio.00396-18; Luchansky JB, 2017, J FOOD PROTECT, V80, P903, DOI 10.4315/0362-028X.JFP-16-420; Manfreda G, 2005, INT J FOOD MICROBIOL, V102, P287, DOI 10.1016/j.ijfoodmicro.2004.11.045; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P8339, DOI 10.1128/AEM.02752-15; Maury MM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10380-0; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; Meloni D, 2009, INT J FOOD MICROBIOL, V129, P166, DOI 10.1016/j.ijfoodmicro.2008.11.014; Minor T, 2015, RISK ANAL, V35, P1125, DOI 10.1111/risa.12316; Moura A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.185; Nielsen E.M., 2017, EFSA SUPP PUBL, V14, DOI 10.2903/sp.efsa.2017.en-1151; Nightingale KK, 2008, APPL ENVIRON MICROB, V74, P6570, DOI 10.1128/AEM.00997-08; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Pouillot R, 2015, RISK ANAL, V35, P90, DOI 10.1111/risa.12235; Pouillot R, 2015, J FOOD PROTECT, V78, P134, DOI 10.4315/0362-028X.JFP-14-235; R Core Team, 2013, R LANG ENV STAT COMP; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Ricci A, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5134; Rousseaux S, 2004, APPL ENVIRON MICROB, V70, P2180, DOI 10.1128/AEM.70.4.2180-2185.2004; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; Sanaa M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213039; Sauders BD, 2009, J FOOD PROTECT, V72, P2337, DOI 10.4315/0362-028X-72.11.2337; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scott V. N., 2005, Food Protection Trends, V25, P818; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; U.S. Department of Agriculture Food Safety and Inspection Service, 2012, FSIS COMPL GUID CONT; U.S. Department of Health and Human Service Food and Drug Administration and U.S. Department of Agriculture Food Safety and Inspection Service, 2013, INT RISK ASS LIST MO; U.S. Department of Health and Human Services Food and Drug Administration and U.S. Department of Agriculture Food Safety and Inspection Service, QUANT ASS REL RISK P; U.S. Food and Drug Administration, 2017, CONTR LIST MON READ; U.S. Food and Drug Adminstration, 2018, GENOMETRAKR NETW; US FDA (Food and Drug Administration)/Health Canada, 2015, JOINT FDA HLTH CAN Q; Van Stelten A, 2008, APPL ENVIRON MICROB, V74, P7365, DOI 10.1128/AEM.01138-08; Van Stelten A, 2016, J FOOD PROTECT, V79, P1733, DOI 10.4315/0362-028X.JFP-16-145; Van Stelten A, 2011, APPL ENVIRON MICROB, V77, P2479, DOI 10.1128/AEM.02626-10; Van Stelten A, 2010, APPL ENVIRON MICROB, V76, P2783, DOI 10.1128/AEM.02651-09; Wallace FM, 2003, J FOOD PROTECT, V66, P584, DOI 10.4315/0362-028X-66.4.584; Wang JJ, 2015, FOODBORNE PATHOG DIS, V12, P151, DOI 10.1089/fpd.2014.1837; Ward TJ, 2010, J FOOD PROTECT, V73, P861, DOI 10.4315/0362-028X-73.5.861; Wu S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00168; Yoshikawa Y, 2018, JPN J INFECT DIS, V71, P373, DOI 10.7883/yoken.JJID.2017.582; Zhang GD, 2018, J FOOD PROTECT, V81, P400, DOI 10.4315/0362-028X.JFP-17-253	80	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231393	10.1371/journal.pone.0231393	http://dx.doi.org/10.1371/journal.pone.0231393			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352974	Green Published, gold			2022-12-26	WOS:000536673200016
J	Corradi, GR; Mazzitelli, LR; Petrovich, GD; Grenon, P; Sorensen, DM; Palmgren, M; Pinto, FD; Adamo, HP				Corradi, Gerardo R.; Mazzitelli, Luciana R.; Petrovich, Guido D.; Grenon, Paula; Sorensen, Danny M.; Palmgren, Michael; de Tezanos Pinto, Felicitas; Adamo, Hugo P.			Reduction of the P5A-ATPase Spf1p phosphoenzyme by a Ca2+-dependent phosphatase	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; ATPASE; ACYLPHOSPHATASE; TRANSPORT; DEPHOSPHORYLATION; PARKINSONISM; HOMEOSTASIS; MUTATIONS; ATP13A2; PUMP	P5 ATPases are eukaryotic pumps important for cellular metal ion, lipid and protein homeostasis; however, their transported substrate, if any, remains to be identified. Ca2+ was proposed to act as a ligand of P5 ATPases because it decreases the level of phosphoenzyme of the Spf1p P5A ATPase from Saccharomyces cerevisiae. Repeating previous purification protocols, we obtained a purified preparation of Spf1p that was close to homogeneity and exhibited ATP hydrolytic activity that was stimulated by the addition of CaCl2. Strikingly, a preparation of a catalytically dead mutant Spf1p ((DN)-N-487) also exhibited Ca2+-dependent ATP hydrolytic activity. These results indicated that the Spf1p preparation contained a co-purifying protein capable of hydrolyzing ATP at a high rate. The activity was likely due to a phosphatase, since the protein i) was highly active when pNPP was used as substrate, ii) required Ca2+ or Zn2+ for activity, and iii) was strongly inhibited by molybdate, beryllium and other phosphatase substrates. Mass spectrometry identified the phosphatase Pho8p as a contaminant of the Spf1p preparation. Modification of the purification procedure led to a contaminant-free Spf1p preparation that was neither stimulated by Ca2+ nor inhibited by EGTA or molybdate. The phosphoenzyme levels of a contaminant-free Spf1p preparation were not affected by Ca2+. These results indicate that the reported effects of Ca2+ on Spf1p do not reflect the intrinsic properties of Spf1p but are mediated by the activity of the accompanying phosphatase.	[Corradi, Gerardo R.; Mazzitelli, Luciana R.; Petrovich, Guido D.; Grenon, Paula; de Tezanos Pinto, Felicitas; Adamo, Hugo P.] Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn CONICET,Inst Qui, Buenos Aires, DF, Argentina; [Sorensen, Danny M.; Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Sorensen, Danny M.] Lundbeck Pharma AS, SOE Ana Dev & Met Trans, Copenhagen, Denmark	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Copenhagen	Adamo, HP (corresponding author), Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn CONICET,Inst Qui, Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Palmgren, Michael/A-9808-2013; Adamo, Hugo Pedro/ABB-8338-2021	Palmgren, Michael/0000-0002-9982-6114; Adamo, Hugo Pedro/0000-0002-1712-8049; Petrovich, Guido Daniel/0000-0003-3908-2544; Corradi, Gerardo Raul/0000-0003-0354-7709	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1690]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 773]; UBACyT from Universidad de Buenos Aires	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; UBACyT from Universidad de Buenos Aires	This work was supported by Grant PICT 1690 from Agencia Nacional de Promocion Cientifica y Tecnologica (HPA), Grant PIP 773 from Consejo Nacional de Investigaciones Cientificas y Tecnologicas (HPA), and UBACyT from Universidad de Buenos Aires (HPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; Cohen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085519; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Pinto FD, 2018, NEUROCHEM INT, V112, P108, DOI 10.1016/j.neuint.2017.11.008; Demenis MA, 2000, IUBMB LIFE, V49, P113; Demirsoy S, 2017, HUM MOL GENET, V26, P1656, DOI 10.1093/hmg/ddx070; DONELLADEANA A, 1993, BIOCHIM BIOPHYS ACTA, V1177, P221, DOI 10.1016/0167-4889(93)90044-P; Estrada-Cuzcano A, 2017, BRAIN, V140, P287, DOI 10.1093/brain/aww307; GALLAGHER SR, 1982, PLANT PHYSIOL, V70, P1335, DOI 10.1104/pp.70.5.1335; Graf S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03672-4; KLEMPERER FW, 1949, J BIOL CHEM, V180, P281; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lustoza ACDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027843; Mazzitelli LR, 2007, BBA-BIOMEMBRANES, V1768, P1777, DOI 10.1016/j.bbamem.2007.04.019; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; NASSI P, 1991, J BIOL CHEM, V266, P10867; NEDIANI C, 1995, BIOCHEMISTRY-US, V34, P6668, DOI 10.1021/bi00020a012; Nediani C, 1996, J BIOL CHEM, V271, P19066, DOI 10.1074/jbc.271.32.19066; Olivera-La Rosa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158690; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Plankert U., 1961, EUR J BIOCHEM, V196, P191; POST RL, 1965, J BIOL CHEM, V240, P1437; Qu Y., 2019, CURRENT GENETICS; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Song LS, 2006, APPL BIOCHEM BIOTECH, V128, P149, DOI 10.1385/ABAB:128:2:149; Sorensen DM, 2019, MOL BIOL CELL, V30, P1069, DOI 10.1091/mbc.E18-06-0365; Sorensen DM, 2015, BBA-GEN SUBJECTS, V1850, P524, DOI 10.1016/j.bbagen.2014.05.008; Sorensen DM, 2012, J BIOL CHEM, V287, P28336, DOI 10.1074/jbc.M112.387191; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Yu QL, 2012, MICROBIOL-SGM, V158, P2272, DOI 10.1099/mic.0.057232-0	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232476	10.1371/journal.pone.0232476	http://dx.doi.org/10.1371/journal.pone.0232476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353073	Green Published, gold			2022-12-26	WOS:000536673200100
J	Rocha, AD; Bernardi, JR; Matos, S; Kretzer, DC; Schoffel, AC; Goldani, MZ; Magalhaes, JAD				Rocha, Alexandre da Silva; Bernardi, Juliana Rombaldi; Matos, Salete; Kretzer, Daniela Cortes; Schoffel, Alice Carvalhal; Goldani, Marcelo Zubaran; de Azevedo Magalhaes, Jose Antonio			Maternal visceral adipose tissue during the first half of pregnancy predicts gestational diabetes at the time of delivery - a cohort study	PLOS ONE			English	Article							ABDOMINAL ADIPOSITY; RISK-FACTORS; FAT; PREVENTION; GLUCOSE; OBESITY	Background Gestational diabetes mellitus (GDM) is a common condition, often associated with high maternal and fetal morbidity. The use of new tools for early GDM screening can contribute to metabolic control to reduce maternal and fetal risk. This study aimed to ascertain whether maternal visceral adipose tissue (VAT) measurement by ultrasound during the first half of pregnancy can predict the occurrence of GDM during the third trimester. Methods A prospective cohort study of 133 pregnant women with gestational age.20 weeks in an outpatient setting. VAT depth was measured by ultrasound at the maternal periumbilical region. GDM status was obtained through hospital charts during hospitalization to delivery. A Receiver Operator Characteristic (ROC) curve was used to determine the optimum threshold to predict GDM. Results According to the ROC curve, a 45mm threshold was identified as the best cut-off value, with 66% of accuracy to predict GDM. Crude and adjusted odds ratios (OR) for GDM were 13.4 (95%CI 2.9-61.1) and 8.9 (95%CI 1.9-42.2), respectively. A similar result was obtained among pre-gravid non-obese women, with crude and adjusted OR of 16.6 (95%CI 1.9-142.6) and 14.4 (95%CI 1.7-125.7), respectively. Among pre-gravid obese patients, a 45mm threshold did not reach statistical significance to predict GDM. Conclusion The high and significant OR found before and after adjustments provides additional evidence of a strong association between VAT and GDM. It appears that VAT measurement during the first half of pregnancy has great potential in identifying non-obese women at high risk for GDM. This evidence can assist obstetricians in correctly allocating resources among populations of pregnant women at risk, determined not only by pre-gravid body mass index (BMI).	[Rocha, Alexandre da Silva] Univ Fed Rio Grande do Sul, Grad Program Gynecol & Obstet, Porto Alegre, RS, Brazil; [Bernardi, Juliana Rombaldi] Univ Fed Rio Grande do Sul, Sch Med, Hosp Clin Porto Alegre, Dept Nutr,Grad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil; [Bernardi, Juliana Rombaldi] Univ Fed Rio Grande do Sul, Sch Med, Hosp Clin Porto Alegre, Grad Program Food Nutr & Hlth, Porto Alegre, RS, Brazil; [Matos, Salete; Kretzer, Daniela Cortes] Univ Fed Rio Grande do Sul, Grad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil; [Schoffel, Alice Carvalhal] Univ Toronto, Dept Social & Behav Hlth Sci, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Goldani, Marcelo Zubaran] Univ Fed Rio Grande do Sul, Sch Med, Hosp Clin Porto Alegre, Dept Pediat, Porto Alegre, RS, Brazil; [de Azevedo Magalhaes, Jose Antonio] Univ Fed Rio Grande do Sul, Maternal Fetal Div, Hosp Clin Porto Alegre, Sch Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; University of Toronto; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Rocha, AD (corresponding author), Univ Fed Rio Grande do Sul, Grad Program Gynecol & Obstet, Porto Alegre, RS, Brazil.	rochagin2@gmail.com	Bernardi, Juliana Rombaldi/P-4106-2015; Bernardi, Juliana Rombaldi/U-2198-2019	Bernardi, Juliana Rombaldi/0000-0002-6803-4472; Cortes Kretzer, Daniela/0000-0002-4712-3572	Hospital de Cli'nicas de Porto Alegre Research and Event Incentive Fund (Fundo de Incentivo a Pesquisa e Eventos, FIPE)	Hospital de Cli'nicas de Porto Alegre Research and Event Incentive Fund (Fundo de Incentivo a Pesquisa e Eventos, FIPE)	Financial support to english review was provided by the Hospital de Cli ' nicas de Porto Alegre Research and Event Incentive Fund (Fundo de Incentivo a Pesquisa e Eventos, FIPE) https://www.hcpa.edu.br/pesquisa/pesquisa-area-dopesquisador/pesquisa-area-do-pesquisador-apoio-financeiro.	ARMELLINI F, 1991, INT J OBESITY, V15, P847; Bartha JL, 2007, OBESITY, V15, P2233, DOI 10.1038/oby.2007.265; Bourdages M, 2018, J OBSTET GYNAECOL CA, V40, P883, DOI 10.1016/j.jogc.2017.09.026; D'Ambrosi F, 2018, FETAL DIAGN THER, V43, P143, DOI 10.1159/000475988; De Souza LR, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.39; De Souza LR, 2016, DIABETES CARE, V39, P61, DOI 10.2337/dc15-2027; De Souza LR, 2014, J OBSTET GYNAECOL CA, V36, P969, DOI 10.1016/S1701-2163(15)30409-6; Falavigna M, 2012, DIABETES RES CLIN PR, V98, P396, DOI 10.1016/j.diabres.2012.09.002; Foy CG, 2008, AM J HYPERTENS, V21, P910, DOI 10.1038/ajh.2008.213; HADLOCK FP, 1984, RADIOLOGY, V152, P497, DOI 10.1148/radiology.152.2.6739822; Kennelly MA, 2016, EUR J OBSTET GYN R B, V202, P92, DOI 10.1016/j.ejogrb.2016.03.032; LEMIEUX S, 1994, DIABETES METAB, V20, P375; Martin AM, 2009, DIABETES CARE, V32, P1308, DOI 10.2337/dc09-0290; McIntyre HD, 2015, BEST PRACT RES CL OB, V29, P194, DOI 10.1016/j.bpobgyn.2014.04.022; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nicolaides KH, 2011, PRENATAL DIAG, V31, P7, DOI 10.1002/pd.2637; Pontual AC, 2016, MATERN CHILD HLTH J, V20, P1720, DOI 10.1007/s10995-016-1975-3; Ray JG, 2017, J OBSTET GYNAECOL CA, V39, P78, DOI 10.1016/j.jogc.2016.10.007; */* S  99, 2016, DIABETES CARE S1, V39, pS9, DOI DOI 10.2337/DC16-S016; Shields M, 2012, HEALTH REP, V23, P7; Thaware PK, 2019, DIABETIC MED, V36, P898, DOI 10.1111/dme.13906; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; United Nations, 2013, DIAGN CRIT CLASS HYP, P1	23	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232155	10.1371/journal.pone.0232155	http://dx.doi.org/10.1371/journal.pone.0232155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353068	Green Published, gold			2022-12-26	WOS:000536673200045
J	Wegner-Clemens, K; Rennig, J; Beauchamp, MS				Wegner-Clemens, Kira; Rennig, Johannes; Beauchamp, Michael S.			A relationship between Autism-Spectrum Quotient and face viewing behavior in 98 participants	PLOS ONE			English	Article							EYE-MOVEMENTS; INDIVIDUAL-DIFFERENCES; RECOGNITION; METAANALYSIS; FIXATIONS; PATTERNS; LOOKING; GAZE	Faces are one of the most important stimuli that we encounter, but humans vary dramatically in their behavior when viewing a face: some individuals preferentially fixate the eyes, others fixate the mouth, and still others show an intermediate pattern. The determinants of these large individual differences are unknown. However, individuals with Autism Spectrum Disorder (ASD) spend less time fixating the eyes of a viewed face than controls, suggesting the hypothesis that autistic traits in healthy adults might explain individual differences in face viewing behavior. Autistic traits were measured in 98 healthy adults recruited from an academic setting using the Autism-Spectrum Quotient, a validated 50-statement questionnaire. Fixations were measured using a video-based eye tracker while participants viewed two different types of audiovisual movies: short videos of talker speaking single syllables and longer videos of talkers speaking sentences in a social context. For both types of movies, there was a positive correlation between Autism-Spectrum Quotient score and percent of time fixating the lower half of the face that explained from 4% to 10% of the variance in individual face viewing behavior. This effect suggests that in healthy adults, autistic traits are one of many factors that contribute to individual differences in face viewing behavior.	[Wegner-Clemens, Kira; Rennig, Johannes; Beauchamp, Michael S.] Baylor Coll Med, Dept Neurosurg & Core Adv MRI, Houston, TX 77030 USA	Baylor College of Medicine	Beauchamp, MS (corresponding author), Baylor Coll Med, Dept Neurosurg & Core Adv MRI, Houston, TX 77030 USA.	michael.beauchamp@bcm.edu		Beauchamp, Michael/0000-0002-7599-9934; Wegner-Clemens, Kira/0000-0001-9521-755X	 [R01NS065395]		This research was funded by R01NS065395 to MSB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Buchan JN, 2007, SOC NEUROSCI-UK, V2, P1, DOI 10.1080/17470910601043644; Chita-Tegmark M, 2016, REV J AUTISM DEV DIS, V3, P209, DOI 10.1007/s40489-016-0077-x; Davis J, 2017, BRIT J PSYCHOL, V108, P191, DOI 10.1111/bjop.12188; Dugas MJ, 1998, BEHAV RES THER, V36, P215, DOI 10.1016/S0005-7967(97)00070-3; Frazier TW, 2017, J AM ACAD CHILD PSY, V56, P546, DOI 10.1016/j.jaac.2017.05.005; Gurler D, 2015, ATTEN PERCEPT PSYCHO, V77, P1333, DOI 10.3758/s13414-014-0821-1; Heisz JJ, 2008, J VISION, V8, DOI 10.1167/8.1.9; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Kanan C, 2015, VISION RES, V108, P67, DOI 10.1016/j.visres.2015.01.013; Kanner L, 1943, NERV CHILD, V2, P217; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2003, PHILOS T R SOC B, P358; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Magnotti JF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202908; Mehoudar E, 2014, J VISION, V14, DOI 10.1167/14.7.6; Neumann D, 2006, SOC COGN AFFECT NEUR, V1, P194, DOI 10.1093/scan/nsl030; Papagiannopoulou EA, 2014, SOC NEUROSCI-UK, V9, P610, DOI 10.1080/17470919.2014.934966; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Peterson MF, 2016, J VISION, V16, DOI 10.1167/16.7.12; Peterson MF, 2013, PSYCHOL SCI, V24, P1216, DOI 10.1177/0956797612471684; Rayner K, 2009, PSYCHOL SCI, V20, P6, DOI 10.1111/j.1467-9280.2008.02243.x; Rennig J, 2018, PSYCHON B REV; Royer J, 2018, COGNITION, V181, P12, DOI 10.1016/j.cognition.2018.08.004; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; South M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00020; Sterling L, 2008, J AUTISM DEV DISORD, V38, P1011, DOI 10.1007/s10803-007-0477-y; Tanaka JW, 2016, J AUTISM DEV DISORD, V46, P1538, DOI 10.1007/s10803-013-1976-7; Tardif J, 2019, PSYCHOL SCI, V30, P300, DOI 10.1177/0956797618811338; Thye MD, 2018, DEV COGN NEUROS-NETH, V29, P151, DOI 10.1016/j.dcn.2017.04.010; Vabalas A, 2016, J AUTISM DEV DISORD, V46, P305, DOI 10.1007/s10803-015-2546-y; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Wegner-Clemens K, 2019, J VISION, V19, DOI 10.1167/19.13.2; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	36	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0230866	10.1371/journal.pone.0230866	http://dx.doi.org/10.1371/journal.pone.0230866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32352984	Green Published, Green Submitted, gold			2022-12-26	WOS:000536673200013
J	Lu, JY; Yang, ZC; Ma, XW; Ma, MM; Zhang, ZB				Lu, Jianyun; Yang, Zhicong; Ma, Xiaowei; Ma, Mengmeng; Zhang, Zhoubin			The role of meteorological factors on mumps incidence among children in Guangzhou, Southern China	PLOS ONE			English	Article							MOUTH-DISEASE; ASSOCIATION; VACCINE; FOOT; HAND	Mumps, a common childhood disease, has a high incidence in Guangzhou city, China. It has been proven that mumps is influenced by seasonality. However, the role of meteorological factors among children is yet to be fully ascertained. This study explored the association between meteorological factors and the incidence of mumps among children in Guangzhou. Distributed lag nonlinear models were used to evaluate the correlation between meteorological factors and the incidence of mumps among children from 2014-2018. The nonlinear lag effects of some meteorological factors were detected. Mean temperature, atmospheric pressure, and relative humidity were positively correlated with mumps incidence, contrary to that of wind speed. Extreme effects of temperature, wind speed, atmospheric pressure, and relative humidity on the incidence of mumps among children in Guangzhou were evaluated in a subgroup analysis according to gender and age. Our preliminary results offered fundamental information to better understand the epidemic trends of mumps among children to develop an early warning system, and strengthen the intervention and prevention of mumps.	[Lu, Jianyun; Ma, Mengmeng] Guangzhou Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Yang, Zhicong; Zhang, Zhoubin] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Ma, Xiaowei] Guangzhou Ctr Dis Control & Prevent, Dept Publ Hlth Emergency Preparedness & Response, Guangzhou, Guangdong, Peoples R China		Zhang, ZB (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	zhoubinzhanggz@21cn.com	Lu, Jianyun/AAU-4620-2020	Lu, Jianyun/0000-0002-1721-1862	Medical Health Technology Project for Guangzhou [20181A011051]; Science and Technology Project of Guangzhou [201804010093]; Project for Key Medicine Discipline Construction of Guangzhou Municipality [2017-2019-07]	Medical Health Technology Project for Guangzhou; Science and Technology Project of Guangzhou; Project for Key Medicine Discipline Construction of Guangzhou Municipality	This study was supported by the Medical Health Technology Project for Guangzhou (20181A011051) and the Science and Technology Project of Guangzhou (201804010093) and the Project for Key Medicine Discipline Construction of Guangzhou Municipality (2017-2019-07).	Aasheim ET, 2014, HUM VACC IMMUNOTHER, V10, P2446, DOI 10.4161/hv.29484; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; Cheng Q, 2018, SCI TOTAL ENVIRON, V625, P828, DOI 10.1016/j.scitotenv.2018.01.006; Cui AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169561; Fu CX, 2013, HUM VACC IMMUNOTHER, V9, P2524, DOI 10.4161/hv.26113; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Grennan Dara, 2019, JAMA, V322, P1022, DOI 10.1001/jama.2019.10982; Guo QZ, 2019, INFLUENZA OTHER RESP, V13, P166, DOI 10.1111/irv.12617; Hao JY, 2019, ENVIRON RES, V177, DOI 10.1016/j.envres.2019.108660; Hao Y, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4011-6; Ho YC, 2015, HUM VACC IMMUNOTHER, V11, P1406, DOI 10.1080/21645515.2015.1029687; Hu WQ, 2018, SCI TOTAL ENVIRON, V619, P1286, DOI 10.1016/j.scitotenv.2017.11.108; Hubalek Z, 2005, EUR J EPIDEMIOL, V20, P263, DOI 10.1007/s10654-004-6518-3; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Kaffenberger BH, 2017, J AM ACAD DERMATOL, V76, P140, DOI 10.1016/j.jaad.2016.08.014; Li RZ, 2016, SCI TOTAL ENVIRON, V568, P1069, DOI 10.1016/j.scitotenv.2016.06.158; Mahmud AS, COMP DYNAMICS SEASON, P1469, DOI [10.1080/21645515.2015.1029687, DOI 10.1080/21645515.2015.1029687]; May M, 2018, INT J INFECT DIS, V66, P1, DOI 10.1016/j.ijid.2017.09.024; Onozuka D, 2011, EPIDEMIOL INFECT, V139, P1692, DOI 10.1017/S0950268810002967; Pan M, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268818003485, 10.1017/s0950268818003485]; Peci A, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02426-18; Phung D, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0193246m, DOI 10.1371/JOURNAL.PONE.0193246M]; Richardson M, 2001, PEDIATR INFECT DIS J, V20, P380, DOI 10.1097/00006454-200104000-00004; Rubin S, 2015, J PATHOL, V235, P242, DOI 10.1002/path.4445; Sabariego S, 2000, INT J BIOMETEOROL, V44, P1, DOI 10.1007/s004840050131; Sane J, 2014, EMERG INFECT DIS, V20, P643, DOI 10.3201/eid2004.131681; Su Q R, 2016, Zhonghua Yu Fang Yi Xue Za Zhi, V50, P611, DOI 10.3760/cma.j.issn.0253-9624.2016.07.009; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Vygen S, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.10.30156; WHO, 2017, WKLY EPIDEMIOL REC, V82, P51; Whyte D, 2009, EURO SURVEILL, V14; Xu QQ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080925; Yang Q, 2017, CIKM'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P5, DOI 10.1145/3132847.3137175; Yang YQ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1507-1; Yu GQ, 2019, SCI TOTAL ENVIRON, V646, P460, DOI 10.1016/j.scitotenv.2018.07.329; Yu GQ, 2018, ENVIRON RES, V166, P577, DOI 10.1016/j.envres.2018.06.047; Yu L, 2010, ARCH SEX BEHAV, V39, P807, DOI 10.1007/s10508-008-9403-4; Zhang DD, 2019, SCI TOTAL ENVIRON, V695, DOI 10.1016/j.scitotenv.2019.133758; Zhong X, 2016, ATMOS ENVIRON, V140, P506, DOI 10.1016/j.atmosenv.2016.06.034; Zhou ZF, 2020, PUBLIC HEALTH, V179, P178, DOI 10.1016/j.puhe.2019.10.023; Zhu H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173052	43	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232273	10.1371/journal.pone.0232273	http://dx.doi.org/10.1371/journal.pone.0232273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348370	Green Published, gold			2022-12-26	WOS:000536668200053
J	Shi, LM; Liu, BH; Wei, QH; Ge, BB; Zhang, KC				Shi, Liming; Liu, Binghua; Wei, Qiuhe; Ge, Beibei; Zhang, Kecheng			Genome-wide transcriptomic analysis of the response of Botrytis cinerea to wuyiencin	PLOS ONE			English	Article							NATURAL TOXIC COMPOUNDS; GENE-EXPRESSION; NUCLEOSIDE ANTIBIOTICS; VIRULENCE FACTORS; AMBIENT PH; ACID; BIOSYNTHESIS; ASPARTATE; AMINOTRANSFERASES; TRANSPORTERS	Grey mould is caused by the ascomycetes Botrytis cinerea in a range of crop hosts. As a biological control agent, the nucleoside antibiotic wuyiencin has been industrially produced and widely used as an effective fungicide. To elucidate the effects of wuyiencin on the transcriptional regulation in B. cinerea, we, for the first time, report a genome-wide transcriptomic analysis of B. cinerea treated with wuyiencin. 2067 genes were differentially expressed, of them, 886 and 1181 genes were significantly upregulated and downregulated, respectively. Functional categorization indicated that transcript levels of genes involved in amino acid metabolism and those encoding putative secreted proteins were altered in response to wuyiencin treatment. Moreover, the expression of genes involved in protein synthesis and energy metabolism (oxidative phosphorylation) and of those encoding ATP-binding cassette transporters was markedly upregulated, whereas that of genes participating in DNA replication, cell cycle, and stress response was downregulated. Furthermore, wuyiencin resulted in mycelial malformation and negatively influenced cell growth rate and conidial yield in B. cinerea. Our results suggest that this nucleoside antibiotic regulates all aspects of cell growth and differentiation in B. cinerea. To summarize, some new candidate pathways and target genes that may related to the protective and antagonistic mechanisms in B. cinerea were identified underlying the action of biological control agents.	[Shi, Liming; Liu, Binghua; Wei, Qiuhe; Ge, Beibei; Zhang, Kecheng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Ge, BB; Zhang, KC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	gbbcsx@126.com; zhangkecheng@sina.com			National Natural Science Foundation [31601684]; Special Fund for Basic Scientific Research of the Chinese Academy of Agricultural Sciences [Y2017JC12]; National Key Research and Development Plan [2017YFD0201100]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of the Chinese Academy of Agricultural Sciences; National Key Research and Development Plan	This work was supported by the National Natural Science Foundation (31601684), the Special Fund for Basic Scientific Research of the Chinese Academy of Agricultural Sciences (Y2017JC12), and the National Key Research and Development Plan (2017YFD0201100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Blanco-Ulate B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00435; Brito N, 2006, MOL PLANT MICROBE IN, V19, P25, DOI 10.1094/MPMI-19-0025; Brutus A, 2005, BIOCHEM BIOPH RES CO, V337, P160, DOI 10.1016/j.bbrc.2005.09.030; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; CHAPMAN T, 1992, ANTIMICROB AGENTS CH, V36, P1909, DOI 10.1128/AAC.36.9.1909; Choquer M, 2007, FEMS MICROBIOL LETT, V277, P1, DOI 10.1111/j.1574-6968.2007.00930.x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Fan C, 2017, CARBOHYD POLYM, V172, P322, DOI 10.1016/j.carbpol.2017.05.050; Ge BB, 2016, APPL MICROBIOL BIOT, V100, P8819, DOI 10.1007/s00253-016-7661-y; GELFAND DH, 1977, J BACTERIOL, V130, P429, DOI 10.1128/JB.130.1.429-440.1977; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Hayashi K, 2002, APPL ENVIRON MICROB, V68, P4996, DOI 10.1128/AEM.68.10.4996-5004.2002; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; ISONO K, 1988, J ANTIBIOT, V41, P1711, DOI 10.7164/antibiotics.41.1711; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Leroch M, 2013, EUKARYOT CELL, V12, P614, DOI 10.1128/EC.00295-12; Li BQ, 2012, J PROTEOME RES, V11, P4249, DOI 10.1021/pr300365f; Liu YY, 2014, J MICROBIOL BIOTECHN, V24, P1644, DOI 10.4014/jmb.1405.05017; MAVRIDES C, 1975, J BIOL CHEM, V250, P4128; Melendez HG, 2009, FUNGAL GENET BIOL, V46, P308, DOI 10.1016/j.fgb.2008.11.011; Niu GQ, 2015, TRENDS MICROBIOL, V23, P110, DOI 10.1016/j.tim.2014.10.007; Parthasarathy A, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00029; PEDERSEN JC, 1992, APPL ENVIRON MICROB, V58, P1064, DOI 10.1128/AEM.58.3.1064-1066.1992; Prabhu PR, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/549572; Prins TW, 2000, FUNGAL PATHOLOGY, P33; Reignault P, 2008, EUR J PLANT PATHOL, V120, P1, DOI 10.1007/s10658-007-9184-y; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; STAPLES RC, 1995, FEMS MICROBIOL LETT, V134, P1, DOI 10.1111/j.1574-6968.1995.tb07905.x; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; Sun Y, 2003, ACTA PHYTOPATHOLOGIC, V33; ten Have A, 2001, FUNGAL GENET BIOL, V33, P97, DOI 10.1006/fgbi.2001.1269; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; TISON F, 1991, NEUROSCI LETT, V127, P203, DOI 10.1016/0304-3940(91)90794-T; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Van Kan JAL, 2017, MOL PLANT PATHOL, V18, P75, DOI 10.1111/mpp.12384; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; WHITAKER RJ, 1982, J BIOL CHEM, V257, P13550; Williams BAP, 2008, J MOL BIOL, V375, P1249, DOI 10.1016/j.jmb.2007.11.005; WILSON CL, 1991, CROP PROT, V10, P172, DOI 10.1016/0261-2194(91)90039-T; Wubben JP, 2000, CURR GENET, V37, P152, DOI 10.1007/s002940050022; Yang YK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02535; Zhang Y, 2015, BIOCHEM BIOPH RES CO, V457, P627, DOI 10.1016/j.bbrc.2015.01.038; Zheng CL, 2011, FUNGAL BIOL-UK, V115, P815, DOI 10.1016/j.funbio.2011.06.009; Zhu CC, 2016, APPL MICROBIOL BIOT, V100, P1811, DOI 10.1007/s00253-015-7082-3	51	1	2	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0224643	10.1371/journal.pone.0224643	http://dx.doi.org/10.1371/journal.pone.0224643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348310	Green Published, Green Submitted, gold			2022-12-26	WOS:000536668200001
J	Koncicka, M; Cervenka, J; Jahn, D; Sucha, R; Vodicka, P; Gad, A; Alsheimer, M; Susor, A				Koncicka, Marketa; Cervenka, Jakub; Jahn, Daniel; Sucha, Rita; Vodicka, Petr; Gad, Ahmed; Alsheimer, Manfred; Susor, Andrej			Expression of lamin C2 in mammalian oocytes	PLOS ONE			English	Article							A-TYPE LAMIN; NUCLEAR-ENVELOPE; PACHYTENE SPERMATOCYTES; MOUSE; MEIOSIS; CLONING; IDENTIFICATION; ARCHITECTURE; PROTEINS; CELLS	Lamin C2 (LMN C2) is a short product of the lamin a gene. It is a germ cell-specific lamin and has been extensively studied in male germ cells. In this study, we focussed on the expression and localization of LMN C2 in fully-grown germinal vesicle (GV) oocytes. We detected LMN C2 in the fully-grown germinal vesicle oocytes of various mammalian species with confirmation done by immunoblotting the wild type and Lmnc2 gene deleted testes. Expression of LMN C2 tagged with GFP showed localization of LMN C2 to the nuclear membrane of the oocyte. Moreover, the LMN C2 protein notably disappeared after nuclear envelope breakdown (NEBD) and the expression of LMN C2 was significantly reduced in the oocytes from aged females and ceased altogether during meiotic maturation. These results provide new insights regarding LMN C2 expression in the oocytes of various mammalian species.	[Koncicka, Marketa; Susor, Andrej] Czech Acad Sci, Lab Biochem & Mol Biol Germ Cells, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Cervenka, Jakub; Sucha, Rita; Vodicka, Petr] Czech Acad Sci, Lab Appl Proteome Anal, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Jahn, Daniel; Alsheimer, Manfred] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany; [Gad, Ahmed] Czech Acad Sci, Dev Biol Lab, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Gad, Ahmed] Cairo Univ, Dept Anim Prod, Fac Agr, Giza, Egypt; [Koncicka, Marketa] Natl Inst Mental Hlth, Klecany, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Wurzburg; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Egyptian Knowledge Bank (EKB); Cairo University; National Institute of Mental Health - Czech Republic	Susor, A (corresponding author), Czech Acad Sci, Lab Biochem & Mol Biol Germ Cells, Inst Anim Physiol & Genet, Libechov, Czech Republic.	susor@iapg.cas.cz	Sucha, Rita/ABA-9387-2021; Vodicka, Petr/AAF-3442-2019; Gad, Ahmed/M-7273-2013; Červenka, Jakub/M-6236-2017; Vodicka, Petr/C-3845-2009	Sucha, Rita/0000-0002-2808-4870; Vodicka, Petr/0000-0002-6605-9158; Gad, Ahmed/0000-0001-9741-2105; Červenka, Jakub/0000-0002-9947-2045; Vodicka, Petr/0000-0002-6605-9158; Susor, Andrej/0000-0003-2926-4096	German Research Foundation (DFG) [Al 1090/2-1];  [GACR1819395S];  [EXCELLENCECZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE];  [RVO67985904]	German Research Foundation (DFG)(German Research Foundation (DFG)); ; ; 	This research was funded by GACR1819395S and EXCELLENCECZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE and Institutional Research Concept RVO67985904. MA received support from the German Research Foundation (DFG), grant Al 1090/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2012, HUM MOL GENET, V21, P2476, DOI 10.1093/hmg/dds061; Alsheimer M, 1996, EXP CELL RES, V228, P181, DOI 10.1006/excr.1996.0315; Alsheimer M, 2000, P NATL ACAD SCI USA, V97, P13120, DOI 10.1073/pnas.240466597; Alsheimer M, 1999, MOL BIOL CELL, V10, P1235, DOI 10.1091/mbc.10.4.1235; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Cheng JM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071578; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Cimadomo D, 2018, FRONT ENDOCRINOL, P9, DOI [10.3389/fendo.2018, DOI 10.3389/FENDO.2018]; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; FURUKAWA K, 1994, EXP CELL RES, V212, P426, DOI 10.1006/excr.1994.1164; FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x; GOLDMAN AE, 1986, P NATL ACAD SCI USA, V83, P3839, DOI 10.1073/pnas.83.11.3839; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Jahn D, 2010, NUCLEUS-PHILA, V1, P273, DOI 10.4161/nucl.1.3.11800; Jansova D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192544; Koncicka M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092841; LIN F, 1993, J BIOL CHEM, V268, P16321; Link J, 2016, METHODS MOL BIOL, V1411, P195, DOI 10.1007/978-1-4939-3530-7_12; Link J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003261; Liskova L, 2010, REPROD FERT DEVELOP, V22, P644, DOI 10.1071/RD09068; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; MacLennan M, 2015, SEMIN CELL DEV BIOL, V45, P68, DOI 10.1016/j.semcdb.2015.10.005; Masek T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041254; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; NAKAJIMA N, 1995, FEBS LETT, V365, P108, DOI 10.1016/0014-5793(95)00453-G; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1989, J MOL BIOL, V208, P393, DOI 10.1016/0022-2836(89)90504-4; Raz V, 2008, J CELL SCI, V121, P4018, DOI 10.1242/jcs.034876; Righolt CH, 2011, AGING-US, V3, P1192, DOI 10.18632/aging.100414; SMITH A, 1992, DIFFERENTIATION, V52, P55, DOI 10.1111/j.1432-0436.1992.tb00499.x; Tetkova A., 2016, CULTIV RNA MICROBIOP, V6, pe1729; Tetkova A, 2019, BIOL REPROD, V101, P719, DOI 10.1093/biolre/ioz117; VESTER B, 1993, J CELL SCI, V104, P557	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0229781	10.1371/journal.pone.0229781	http://dx.doi.org/10.1371/journal.pone.0229781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343699	Green Published, gold			2022-12-26	WOS:000536661300008
J	Bracher, A; Paul, SS; Wang, HP; Wischnewski, N; Hartl, FU; Hayer-Hartl, M				Bracher, Andreas; Paul, Simanta S.; Wang, Huping; Wischnewski, Nadine; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Structure and conformational cycle of a bacteriophage-encoded chaperonin	PLOS ONE			English	Article							GROEL-GROES; RING SEPARATION; CO-CHAPERONIN; SINGLE-RING; NANO-CAGE; MECHANISM; PROTEINS; BINDING; INTERFACE; SUBSTRATE	Chaperonins are ubiquitous molecular chaperones found in all domains of life. They form ring-shaped complexes that assist in the folding of substrate proteins in an ATP-dependent reaction cycle. Key to the folding cycle is the transient encapsulation of substrate proteins by the chaperonin. Here we present a structural and functional characterization of the chaperonin gp146 (phi EL) from the phage EL of Pseudomonas aeruginosa. phi EL, an evolutionarily distant homolog of bacterial GroEL, is active in ATP hydrolysis and prevents the aggregation of denatured protein in a nucleotide-dependent manner. However, phi EL failed to refold the encapsulation-dependent model substrate rhodanese and did not interact with E. coli GroES, the lid-shaped co-chaperone of GroEL. phi EL forms tetradecameric double-ring complexes, which dissociate into single rings in the presence of ATP. Crystal structures of phi EL (at 3.54 and 4.03 angstrom) in presence of ATP.BeFx revealed two distinct single-ring conformational states, both with open access to the ring cavity. One state showed uniform ATP-bound subunit conformations (symmetric state), whereas the second combined distinct ATP- and ADP-bound subunit conformations (asymmetric state). Cryo-electron microscopy of apo-phi EL revealed a double-ring structure composed of rings in the asymmetric state (3.45 angstrom resolution). We propose that the phage chaperonin undergoes nucleotide-dependent conformational switching between double- and single rings and functions in aggregation prevention without substrate protein encapsulation. Thus, phi EL may represent an evolutionarily more ancient chaperonin prior to acquisition of the encapsulation mechanism.	[Bracher, Andreas; Paul, Simanta S.; Wang, Huping; Wischnewski, Nadine; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, Martinsried, Germany; [Paul, Simanta S.] Univ Alberta, Dept Phys, Edmonton, AB, Canada	Max Planck Society; University of Alberta	Bracher, A; Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Martinsried, Germany.	bracher@biochem.mpg.de; mhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742	Deutsche Forschungsgemeinschaft (DFG) [SFB1035]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant SFB1035 to MH-H and FUH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang D, 2000, ANNU REV GENET, V34, P439, DOI 10.1146/annurev.genet.34.1.439; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bartolucci C, 2005, J MOL BIOL, V354, P940, DOI 10.1016/j.jmb.2005.09.096; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gruber R, 2016, CHEM REV, V116, P6588, DOI 10.1021/acs.chemrev.5b00556; Gupta AJ, 2014, J MOL BIOL, V426, P2739, DOI 10.1016/j.jmb.2014.04.018; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hertveldt K, 2005, J MOL BIOL, V354, P536, DOI 10.1016/j.jmb.2005.08.075; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawe M, 2006, J MOL BIOL, V357, P411, DOI 10.1016/j.jmb.2005.12.005; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Kurochkina LP, 2012, J VIROL, V86, P10103, DOI 10.1128/JVI.00940-12; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Marine RL, 2017, ISME J, V11, P2479, DOI 10.1038/ismej.2017.102; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P279, DOI 10.1038/366279a0; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Molugu SK, 2016, STRUCTURE, V24, P537, DOI 10.1016/j.str.2016.02.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poso D, 2004, J MOL BIOL, V338, P969, DOI 10.1016/j.jmb.2004.03.010; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Radaev S, 2002, J APPL CRYSTALLOGR, V35, P674, DOI 10.1107/S0021889802013973; Radaev S, 2006, ACTA CRYSTALLOGR D, V62, P605, DOI 10.1107/S0907444906011735; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Semenyuk PI, 2015, BIOCHEMISTRY-MOSCOW+, V80, P172, DOI 10.1134/S0006297915020042; Stanishneva-Konovalova TB, 2020, J STRUCT BIOL, V209, DOI 10.1016/j.jsb.2019.107439; Tafoya D.A., 2013, BACTERIOPHAGE, V3, DOI [10.4161/bact.25449, DOI 10.4161/BACT.25449]; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; Weber F, 2000, METH MOL B, V140, P117; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yan X, 2018, CELL, V172, P605, DOI 10.1016/j.cell.2017.12.010; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0230090	10.1371/journal.pone.0230090	http://dx.doi.org/10.1371/journal.pone.0230090			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339190	Green Published, gold, Green Submitted			2022-12-26	WOS:000536657400002
J	Martin, RA; Couture, R; Tasker, N; Carter, C; Copeland, DM; Kibler, M; Whittle, JS				Martin, Rebecca A.; Couture, Rosanna; Tasker, Nicole; Carter, Christine; Copeland, David M.; Kibler, Mary; Whittle, Jessica S.			Emergency medical care of incarcerated patients: Opportunities for improvement and cost savings	PLOS ONE			English	Article							INJURY SURVEILLANCE; PUBLIC-HEALTH; ADDICTION; TRAUMA; SYSTEM; DRUG	In the United States (US), the lifetime incidence of incarceration is 6.6%, exceeding that of any other nation. Compared to the general US population, incarcerated individuals are disproportionally affected by chronic health conditions, mental illness, and substance use disorders. Barriers to accessing medical care are common in correctional facilities. We sought to characterize the local incarcerated patient population and explore barriers to medical care in these patients. We conducted a retrospective, observational cohort study by reviewing the medical records of incarcerated patients presenting to the adult emergency department (ED) of a single academic, tertiary care facility with medical or psychiatric (med/psych) and trauma-related emergencies between January 2012 and December 2014. Data on demographics, medical complexity, trauma intentionality, and barriers to medical care were analyzed using descriptive statistics, unpaired student's t-test or one-way analysis of variance for continuous variables, and chi-square analysis or Fisher's exact test as appropriate. Trauma patients were younger with fewer medical comorbidities and were less likely to be admitted to the hospital than med/psych patients. 47.8% of injuries resulted from violence or were self-inflicted. Most trauma-related complaints were managed by the emergency medicine physician in the ED. While barriers to medical care were not correlated with hospital admission, 5.4% of med/psych and 2.9% of trauma patients reported barriers as a contributing factor to the ED encounter. Med/psych patients commonly reported a lack of access to medications, while trauma patients reported a delay in medical care. Trauma-related presentations were less medically complex than med/psych-related complaints. Medical management of most injuries required no hospital resources outside of the ED, indicating a potential role for outpatient management of trauma-related complaints. Additional opportunities for health care improvement and cost savings include the implementation of programs that target violence, prevent injuries, and promote the continuity of medical care while incarcerated.	[Martin, Rebecca A.; Couture, Rosanna; Tasker, Nicole; Whittle, Jessica S.] Univ Tennessee, Hlth Sci Ctr, Coll Med Chattanooga, Dept Emergency Med, Chattanooga, TN 37403 USA; [Martin, Rebecca A.; Couture, Rosanna; Tasker, Nicole; Kibler, Mary; Whittle, Jessica S.] Erlanger Hlth Syst, Chattanooga, TN 37403 USA; [Carter, Christine; Copeland, David M.] Univ Tennessee, Coll Med, Memphis, TN USA; [Couture, Rosanna] Riverside Med Grp, Emergency Med, Newport News, VA USA; [Tasker, Nicole] Med Associates LLC, Emergency Med, Indianapolis, IN USA; [Carter, Christine] Univ Maryland, Med Ctr, Dept Emergency Med, Baltimore, MD 21201 USA; [Copeland, David M.] Univ Washington, Med Ctr, Dept Anesthesiol, Seattle, WA 98195 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle	Martin, RA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Med Chattanooga, Dept Emergency Med, Chattanooga, TN 37403 USA.; Martin, RA (corresponding author), Erlanger Hlth Syst, Chattanooga, TN 37403 USA.	Rebecca.martin@erlanger.org						ACEP Public Health Committee. Recognizing the Needs of Incarcerated Patients in the Emergency Department, 2006, REC NEEDS INC PAT EM; Ahalt C, 2015, ANN INTERN MED, V162, P345, DOI 10.7326/M14-2161; Ahalt C, 2012, J GEN INTERN MED, V27, P160, DOI 10.1007/s11606-011-1858-7; [Anonymous], 2016, INM AG STAT; [Anonymous], 2002, HLTH STAT SOON TO BE, V1; [Anonymous], 2018, MASS INCARCERATION W; [Anonymous], 2017, NEWS; Bauer A, 2008, BURDEN TOBACCO TENNE; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Bonczar T., 2003, PREVALENCE IMPRISONM; Bronson J., 2017, INDICATORS MENTAL HL; CDC, 2012, NAT HOSP AMB MED CAR; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Chattanooga-Hamilton County Health Department Office of Assessment and Planning, 2015, PICT OUR HLTH HAM CO; Dumont DM, 2012, ANNU REV PUBL HEALTH, V33, P325, DOI 10.1146/annurev-publhealth-031811-124614; Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214; Kinsella Chad, 2004, CORRECTIONS HLTH CAR; Ludwig A, 2012, AM J PUBLIC HEALTH, V102, P1108, DOI 10.2105/AJPH.2011.300306; Minton TD, 2015, CENSUS JAILS POPULAT, P1; Nacci P, 2002, IMPLEMENTING TELEMED; Nyamathi AM, 2017, NURS RES, V66, P432, DOI 10.1097/NNR.0000000000000249; Pfortmueller CA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13753; Rui PKK, 2014, NATL HOSP AMBULATORY; Siegler A, 2017, J HEALTH CARE POOR U, V28, P1042, DOI 10.1353/hpu.2017.0095; Spaulding AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191643; Sung Hung-En, 2010, J Correct Health Care, V16, P178, DOI 10.1177/1078345810366287; US Census Bureau, 2012, AM COMM SURV DEM HOU; Wagner Peter, 2016, STATES INCARCERATION; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Wolff N, 2015, J ANXIETY DISORD, V30, P66, DOI 10.1016/j.janxdis.2014.10.009	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232243	10.1371/journal.pone.0232243	http://dx.doi.org/10.1371/journal.pone.0232243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8VC	32339213	gold, Green Published			2022-12-26	WOS:000536657400035
J	Ouellette, DJ; Van Staalduinen, E; Hussaini, SH; Govindarajan, ST; Stefancin, P; Hsu, DL; Duong, TQ				Ouellette, David J.; Van Staalduinen, Eric; Hussaini, Syed H.; Govindarajan, Sindhuja T.; Stefancin, Patricia; Hsu, Dan-Ling; Duong, Timothy Q.			Functional, anatomical and diffusion tensor MRI study of radiology expertise	PLOS ONE			English	Article							BRAIN ACTIVITY; FMRI; PERFORMANCE; NETWORKS; ACTIVATIONS; PRECISION; CORTEX; BASE	Background Repeated practice to acquire expertise could result in the structural and functional changes in relevant brain circuits as a result of long-term potentiation, neurogenesis, glial genesis, and remodeling. Purpose The goal of this study is to use task fMRI to study the brain of expert radiologists performing a diagnosis task where a series of medical images were presented during fMRI acquisition for 12s and participants were asked to choose a diagnosis. Structural and diffusion-tensor MRI were also acquired. Methods Radiologists (N = 12, 11M, 38.2 +/- 10.3 years old) and non-radiologists (N = 17, 15M, 30.6 +/- 5.5 years old) were recruited with informed consent. Medical images were presented for 12 s and three multiple choices were displayed and the participants were asked to choose a diagnosis. fMRI, structural and diffusion-tensor MRI were acquired. fMRI analysis used FSL to determine differences in fMRI responses between groups. Voxel-wise analysis was performed to determine if subcortical volume, cortical thickness and fractional anisotropy differed between groups. Correction for multiple comparisons used false discovery rate. Results Radiologists showed overall lower task-related brain activation than non-radiologists. Radiologists showed significantly lower activation in the left lateral occipital cortex, left superior parietal lobule, occipital pole, right superior frontal and precentral gyri, lingual gyrus, and the left intraparietal sulcus (p< 0.05). There were no significant differences between groups in cortical thickness, subcortical volume and fractional anisotropy (p> 0.05). Conclusions Radiologists and non-radiologists had no significant difference in structural metrics. However, in diagnosis tasks, radiologists showed markedly lower task-related brain activations overall as well as a number of high-order visual and non-visual brain regions than non-radiologists. Some brain circuits appear to be uniquely associated with differential-diagnosis paradigm expertise that are not involved in simpler object-recognition cases. Improved understanding of the brain circuitry involved in acquisition of expertise might be used to design optimal training paradigms.	[Ouellette, David J.; Govindarajan, Sindhuja T.] SUNY Stony Brook, Biomed Engn, Stony Brook, NY 11794 USA; [Van Staalduinen, Eric; Hussaini, Syed H.; Stefancin, Patricia; Hsu, Dan-Ling; Duong, Timothy Q.] SUNY Stony Brook, Radiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Duong, TQ (corresponding author), SUNY Stony Brook, Radiol, Stony Brook, NY 11794 USA.	tim.duong@stonybrookmedicine.edu	Govindarajan, Sindhuja Tirumalai/ABI-8368-2020; Duong, Tim/AAL-8357-2021	Govindarajan, Sindhuja Tirumalai/0000-0003-1741-0906; Duong, Tim/0000-0001-6403-2827; Ouellette, David/0000-0003-1922-5456				Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bernardi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077764; Bilalic M, 2016, CEREB CORTEX, V26, P1004, DOI 10.1093/cercor/bhu272; Bruno MA, 2018, RADIOLOGY, V289, P809, DOI 10.1148/radiol.2018180690; Deng F, 2018, BRAIN STRUCT FUNCT, V223, P1849, DOI 10.1007/s00429-017-1594-9; Di X, 2013, CEREB CORTEX, V23, P255, DOI 10.1093/cercor/bhs001; Dong MH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00099; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Dresler M, 2017, NEURON, V93, P1227, DOI 10.1016/j.neuron.2017.02.003; Duan XJ, 2012, NEUROIMAGE, V60, P1280, DOI 10.1016/j.neuroimage.2012.01.047; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P1, DOI 10.2277/ 0521600812; ERICSSON KA, 1985, CAN J PSYCHOL, V39, P188, DOI 10.1037/h0080059; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gaser C, 2003, J NEUROSCI, V23, P9240; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Hanggi J, 2014, NEUROPSYCHOLOGIA, V62, P152, DOI 10.1016/j.neuropsychologia.2014.07.019; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Haller S, 2005, RADIOLOGY, V236, P983, DOI 10.1148/radiol.2363041370; Harley EM, 2009, CEREB CORTEX, V19, P2746, DOI 10.1093/cercor/bhp051; Hawes Z, 2019, NEUROSCI BIOBEHAV R, V103, P316, DOI 10.1016/j.neubiorev.2019.05.007; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; KUNDEL HL, 1975, RADIOLOGY, V116, P527, DOI 10.1148/116.3.527; LARKIN J, 1980, SCIENCE, V208, P1335, DOI 10.1126/science.208.4450.1335; Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q; Maguire EA, 2003, NAT NEUROSCI, V6, P90, DOI 10.1038/nn988; Melo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028752; Milton J, 2007, NEUROIMAGE, V35, P804, DOI 10.1016/j.neuroimage.2007.01.003; Nutley SB, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00926; Osada T, 2019, J NEUROSCI, V39, P2509, DOI 10.1523/JNEUROSCI.2244-18.2019; Parker JG, 2014, BRAIN BEHAV, V4, P227, DOI 10.1002/brb3.213; PATEL VL, 1986, COGNITIVE SCI, V10, P91, DOI 10.1016/S0364-0213(86)80010-6; Ruchman RB, 2007, AM J ROENTGENOL, V189, P523, DOI 10.2214/AJR.07.2307; SAARILUOMA P, 1991, ACTA PSYCHOL, V77, P65, DOI 10.1016/0001-6918(91)90065-8; Sack AT, 2009, BEHAV BRAIN RES, V202, P153, DOI 10.1016/j.bbr.2009.03.012; Simon O, 2004, NEUROIMAGE, V23, P1192, DOI 10.1016/j.neuroimage.2004.09.023; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tanaka S, 2005, J NEUROSCI, V25, P496, DOI 10.1523/JNEUROSCI.4324-04.2005; Tavor I, 2020, HUM BRAIN MAPP, V41, P442, DOI 10.1002/hbm.24814; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wright MJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00851; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231900	10.1371/journal.pone.0231900	http://dx.doi.org/10.1371/journal.pone.0231900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339188	Green Published, gold			2022-12-26	WOS:000536657400018
J	Duszka, K; Gregor, A; Reichel, MW; Baierl, A; Fahrngruber, C; Konig, J				Duszka, Kalina; Gregor, Andras; Reichel, Martin Willibald; Baierl, Andreas; Fahrngruber, Christine; Koenig, Juergen			Visual stimulation with food pictures in the regulation of hunger hormones and nutrient deposition, a potential contributor to the obesity crisis	PLOS ONE			English	Article							PLASMA GHRELIN LEVELS; CEPHALIC PHASE RESPONSES; CIRCULATING GHRELIN; MENSTRUAL-CYCLE; POSTPRANDIAL RESPONSE; INSULIN-RESISTANCE; ACYLATED GHRELIN; BRAIN ACTIVATION; DOPAMINE; APPETITE	Food cues affect hunger and nutritional choices. Omnipresent stimulation with palatable food contributes to the epidemics of obesity. The objective of the study was to investigate the impact of food cues on appetite-related hormones and to assess the functionality of the secreted hormones on macronutrient uptake in healthy subjects. Additionally, we aimed at verifying differences in the response of total and active ghrelin to stimulation with food pictures and to a meal followed by the stimulation. We were also interested in the identification of factors contributing to response to food cues. We recruited healthy, non-obese participants for two independent cross-over studies. During the first study, the subjects were presented random non-food pictures on the first day and pictures of foods on the second day of the study. Throughout the second study, following the picture session, the participants were additionally asked to drink a milkshake. Concentrations of blood glucose, triglycerides and hunger-related hormones were measured. The results showed that concentrations of several hormones measured in the blood are interdependent. In the case of ghrelin and gastric inhibitory peptide (GIP) as well as ghrelin and glucagon-like peptide-1 (GLP-1), this co-occurrence relies on the visual cues. Regulation of total ghrelin concentration following food stimulation is highly individual and responders showed upregulated total ghrelin, while the concentration of active ghrelin decreases following a meal. Protein content and colour intensity of food pictures reversely correlated with participants' rating of the pictures. We conclude that observation of food pictures influences the concentration of several appetiterelated hormones. The close link of visual clues to physiological responses is likely of clinical relevance. Additionally, the protein content of displayed foods and green colour intensity in pictures may serve as a predictor of subjective attractiveness of the presented meal.	[Duszka, Kalina; Gregor, Andras; Reichel, Martin Willibald; Fahrngruber, Christine; Koenig, Juergen] Univ Vienna, Dept Nutr Sci, Vienna, Austria; [Baierl, Andreas] Univ Vienna, Dept Stat & Operat Res, Vienna, Austria	University of Vienna; University of Vienna	Duszka, K (corresponding author), Univ Vienna, Dept Nutr Sci, Vienna, Austria.	kalina.duszka@univie.ac.at	Duszka, Kalina/L-3515-2019; Koenig, juergen/I-8130-2014	Duszka, Kalina/0000-0002-7455-6090; Koenig, juergen/0000-0003-2184-9372; Baierl, Andreas/0000-0002-5329-9507; Fahrngruber-Velasquez, Christine/0000-0002-5719-1982	Hochschuljubilaumsstiftung der Stadt Wien [AG H-211758/2018]	Hochschuljubilaumsstiftung der Stadt Wien	AG H-211758/2018, Hochschuljubilaumsstiftung der Stadt Wien, https://www.wien.gv.at/recht/gemeinderecht-wien/fonds-stiftungen/stiftungen/wissenschaft.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Massadi O, 2011, PEPTIDES, V32, P2301, DOI 10.1016/j.peptides.2011.08.020; Alberti-Fidanza A, 1998, INT J VITAM NUTR RES, V68, P149; Arosio M, 2004, J CLIN ENDOCR METAB, V89, P5101, DOI 10.1210/jc.2003-032222; Avery A, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12428; Bauer JM, 2010, J GERONTOL A-BIOL, V65, P307, DOI 10.1093/gerona/glp174; Belfort-DeAguiar R, 2016, INT J OBESITY, V40, P1679, DOI 10.1038/ijo.2016.152; Berteus-Forslund H, 2005, INT J OBESITY, V29, P711, DOI 10.1038/sj.ijo.0802950; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; BITAR M, 1986, J PHARMACOL EXP THER, V236, P432; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Bouros D, 2006, CLIN CHEM, V52, P777, DOI 10.1373/clinchem.2005.065243; BOWEN DJ, 1990, PHYSIOL BEHAV, V47, P287, DOI 10.1016/0031-9384(90)90144-S; Brede S, 2017, APPETITE, V117, P255, DOI 10.1016/j.appet.2017.07.001; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Collings PJ, 2018, OBESITY, V26, P1619, DOI 10.1002/oby.22288; Cone JJ, 2015, J NEUROCHEM, V133, P844, DOI 10.1111/jnc.13080; Crowley WR, 2005, NEUROSCIENCE, V132, P167, DOI 10.1016/j.neuroscience.2004.11.037; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; Cummings DE, 2003, ARCH SURG-CHICAGO, V138, P389, DOI 10.1001/archsurg.138.4.389; Dardzinska JA, 2018, VIDEOSURGERY MINIINV, V13, P366, DOI 10.5114/wiitm.2018.75868; Daws LC, 2011, NEUROPHARMACOLOGY, V61, P1123, DOI 10.1016/j.neuropharm.2011.02.028; De Silva A, 2011, CELL METAB, V14, P700, DOI 10.1016/j.cmet.2011.09.010; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Drazen DL, 2006, ENDOCRINOLOGY, V147, P23, DOI 10.1210/en.2005-0973; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; Dye L, 1997, HUM REPROD, V12, P1142; Erdmann J, 2003, REGUL PEPTIDES, V116, P101, DOI 10.1016/S0167-0115(03)00195-2; Fagerberg B, 2003, METABOLISM, V52, P1460, DOI 10.1016/S0026-0495(03)00274-9; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Garber LL, 2001, J FOOD PROD MARK, V7, P3, DOI 10.1300/J038v07n03_02; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; Geier A, 2012, HEALTH PSYCHOL, V31, P398, DOI 10.1037/a0027221; Goldstone AP, 2014, AM J CLIN NUTR, V99, P1319, DOI 10.3945/ajcn.113.075291; Gregersen NT, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7028; Haase L, 2011, APPETITE, V57, P421, DOI 10.1016/j.appet.2011.06.009; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hendrickson KL, 2017, HEALTH PSYCHOL, V36, P226, DOI 10.1037/hea0000440; Heni M, 2015, MOL METAB, V4, P971, DOI 10.1016/j.molmet.2015.09.007; Heppner KM, 2014, DIABETES, V63, P122, DOI 10.2337/db13-0414; Hoegg J, 2007, J CONSUM RES, V33, P490, DOI 10.1086/510222; JOUHANEAU J, 1980, NEUROSCI BIOBEHAV R, V4, P53, DOI 10.1016/0149-7634(80)90049-4; Kahn BE, 2004, J CONSUM RES, V30, P519, DOI 10.1086/380286; Kim DJ, 2005, ALCOHOL ALCOHOLISM, V40, P76, DOI 10.1093/alcalc/agh108; KOMATSU R, 1989, DIABETES, V38, P902, DOI 10.2337/diabetes.38.7.902; KONO T, 1994, BRAIN RES, V634, P155, DOI 10.1016/0006-8993(94)90269-0; Koopman KE, 2014, HEPATOLOGY, V60, P545, DOI 10.1002/hep.27149; Kraus T, 2005, ALCOHOL CLIN EXP RES, V29, P2154, DOI 10.1097/01.alc.0000191753.82554.7e; Kroemer NB, 2013, ADDICT BIOL, V18, P855, DOI 10.1111/j.1369-1600.2012.00489.x; Kroemer NB, 2013, HUM BRAIN MAPP, V34, P2367, DOI 10.1002/hbm.22071; Larsen JK, 2012, APPETITE, V58, P907, DOI 10.1016/j.appet.2012.02.004; Lippl F, 2004, REGUL PEPTIDES, V119, P93, DOI 10.1016/j.regpep.2004.01.003; Lucidi P, 2004, J ENDOCRINOL INVEST, V27, pRC12; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Manippa V, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00597; Marathe CS, 2013, DIABETES CARE, V36, P1396, DOI 10.2337/dc12-1609; Martin LJM, 2010, BRIT J NUTR, V103, P1610, DOI 10.1017/S000711450999359X; Massolt ET, 2010, REGUL PEPTIDES, V161, P81, DOI 10.1016/j.regpep.2010.01.005; McVay MA, 2012, APPETITE, V59, P591, DOI 10.1016/j.appet.2012.07.011; Monteleone P, 2005, PSYCHONEUROENDOCRINO, V30, P243, DOI 10.1016/j.psyneuen.2004.07.004; Monteleone P, 2008, BIOL PSYCHIAT, V64, P1005, DOI 10.1016/j.biopsych.2008.04.006; Monteleone P, 2012, J CLIN ENDOCR METAB, V97, pE917, DOI 10.1210/jc.2011-3018; Monteleone P, 2010, PSYCHONEUROENDOCRINO, V35, P284, DOI 10.1016/j.psyneuen.2009.07.001; Naznin F, 2015, J ENDOCRINOL, V226, P81, DOI 10.1530/JOE-15-0139; Nederkoorn C, 2000, APPETITE, V35, P45, DOI 10.1006/appe.2000.0328; Ott V, 2012, PSYCHONEUROENDOCRINO, V37, P1096, DOI 10.1016/j.psyneuen.2011.10.007; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Rizi EP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191609; RODIN J, 1985, HEALTH PSYCHOL, V4, P1, DOI 10.1037/0278-6133.4.1.1; ROLLS BJ, 1982, PHYSIOL BEHAV, V29, P409, DOI 10.1016/0031-9384(82)90259-1; Rozin P, 2012, APPETITE, V59, P448, DOI 10.1016/j.appet.2012.06.001; SALLER CF, 1984, NEUROSCI LETT, V49, P301, DOI 10.1016/0304-3940(84)90306-9; Sankoda A, 2019, J DIABETES INVEST, DOI [10.1016/0304-3940(84)90306-9, DOI 10.1016/0304-3940(84)90306-9]; SCHMIDT WE, 1985, DIABETOLOGIA, V28, P704, DOI 10.1007/BF00291980; Schoffelmeer ANM, 2011, J NEUROSCI, V31, P1284, DOI 10.1523/JNEUROSCI.3779-10.2011; Schussler P, 2012, OBESITY, V20, P1212, DOI 10.1038/oby.2011.385; Schuz B, 2015, APPETITE, V87, P310, DOI 10.1016/j.appet.2015.01.002; Smeets PAM, 2010, NUTR REV, V68, P643, DOI 10.1111/j.1753-4887.2010.00334.x; St-Onge V, 2016, HORM BEHAV, V78, P141, DOI 10.1016/j.yhbeh.2015.11.005; Stouffer MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9543; Sugino T, 2002, BIOCHEM BIOPH RES CO, V295, P255, DOI 10.1016/S0006-291X(02)00654-X; Sztainert T, 2018, BIOL PSYCHOL, V139, P115, DOI 10.1016/j.biopsycho.2018.10.011; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; TOMELLERI R, 1987, J AM DIET ASSOC, V87, P311; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; TRULSON ME, 1983, J NEUROCHEM, V40, P1456, DOI 10.1111/j.1471-4159.1983.tb13590.x; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Verdich C, 2001, INT J OBESITY, V25, P1206, DOI 10.1038/sj.ijo.0801655; Versini M, 2014, AUTOIMMUN REV, V13, P981, DOI 10.1016/j.autrev.2014.07.001; Vozzo R, 2002, METABOLISM, V51, P949, DOI 10.1053/meta.2002.34012; Walker AK, 2012, PHYSIOL BEHAV, V108, P34, DOI 10.1016/j.physbeh.2012.10.003; Warren JM, 2017, NUTR RES REV, V30, P272, DOI 10.1017/S0954422417000154; Yach Derek, 2004, Bull World Health Organ, V82, P308; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101	96	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232099	10.1371/journal.pone.0232099	http://dx.doi.org/10.1371/journal.pone.0232099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8RF	32330183	gold, Green Published			2022-12-26	WOS:000536647300051
J	Pratedrat, P; Chuaypen, N; Nimsamer, P; Payungporn, S; Pinjaroen, N; Sirichindakul, B; Tangkijvanich, P				Pratedrat, Pornpitra; Chuaypen, Natthaya; Nimsamer, Pattaraporn; Payungporn, Sunchai; Pinjaroen, Nutcha; Sirichindakul, Boonchoo; Tangkijvanich, Pisit			Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma	PLOS ONE			English	Article							CELL-PROLIFERATION; MICRORNAS; EXPRESSION; BIOMARKERS; APOPTOSIS; MIR-223; ASSOCIATION; MIGRATION; CANCER	Background Circulating microRNAs (miRNAs) have been shown to dysregulate in many cancer types including hepatocellular carcinoma (HCC). The purpose of this study was to examine the potential diagnostic or prognostic roles of circulating miRNAs in patients with hepatitis B virus (HBV)-related HCC. Methods Paired cancerous and adjacent non-cancerous liver tissue specimens of patients with HBV-related HCC were used as a discovery set for screening 800 miRNAs by a Nanostring quantitative assay. Differentially expressed miRNAs were then examined by SYBR green quantitative RT-PCR in a validation cohort of serum samples obtained from 70 patients with HBV-related HCC, 70 HBV patients without HCC and 50 healthy controls. Results The discovery set identified miR-223-3p, miR-199a-5p and miR-451a significantly lower expressed in cancerous tissues compared with non-cancerous tissues. In the validated cohort, circulating miR-223-3p levels were significantly lower in the HCC group compared with the other groups. The combined use of serum alpha-fetoprotein and miR-223-3p displayed high sensitivity for detecting early HCC (85%) and intermediate/advanced stage HCC (100%). Additionally, serum miR-223-3p had a negative correlation with tumor size and BCLC stage. On multivariate analysis, serum miR-223-3p was identified as an independent prognostic factor of overall survival in patients with HCC. In contrast, circulating miRNA-199a-5p and miR-451a did not show any clinical benefit for the diagnosis and prognostic prediction of HCC. Conclusions Our results demonstrated that miR-223-3p was differentially expressed in cancerous compared with paired adjacent non-cancerous tissues. In addition, circulating miRNA-223-3p could represent a novel diagnostic and prognostic marker for patients with HBV-related HCC.	[Pratedrat, Pornpitra; Chuaypen, Natthaya; Tangkijvanich, Pisit] Chulalongkorn Univ, Ctr Excellence Hepatitis & Liver Canc, Fac Med, Bangkok, Thailand; [Nimsamer, Pattaraporn; Payungporn, Sunchai] Chulalongkorn Univ, Dept Biochem, Fac Med, Bangkok, Thailand; [Pinjaroen, Nutcha] Chulalongkorn Univ, Dept Radiol, Fac Med, Bangkok, Thailand; [Sirichindakul, Boonchoo] Chulalongkorn Univ, Dept Surg, Fac Med, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Tangkijvanich, P (corresponding author), Chulalongkorn Univ, Ctr Excellence Hepatitis & Liver Canc, Fac Med, Bangkok, Thailand.	pisittkvn@yahoo.com		Chuaypen, Natthaya/0000-0002-5415-510X	Thailand Research Fund [RTA6280004]; Grant for Chula Research Scholar [CU-GRS-60-06-30-03]; Royal Golden Jubilee Ph.D. Program [PHD/0061/2559]; Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University	Thailand Research Fund(Thailand Research Fund (TRF)); Grant for Chula Research Scholar; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University	Research reported in this publication was supported by the Thailand Research Fund (RTA6280004), the Grant for Chula Research Scholar (CU-GRS-60-06-30-03), the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0061/2559) and Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bhattacharya S, 2016, AM J PATHOL, V186, P242, DOI 10.1016/j.ajpath.2015.10.003; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Dong YW, 2014, J HEPATOL, V60, P792, DOI 10.1016/j.jhep.2013.12.004; Dong Z, 2017, BIOCHEM BIOPH RES CO, V483, P630, DOI 10.1016/j.bbrc.2016.12.091; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forner A, 2009, GASTROENTEROLOGY, V137, P26, DOI [10.1053/j.gastro.2009.05.014, 10.1053/j.gastro.2009.05.021]; Giray BG, 2014, MOL BIOL REP, V41, P4513, DOI 10.1007/s11033-014-3322-3; Jiang X, 2014, WORLD J GASTROENTERO, V20, P7197, DOI 10.3748/wjg.v20.i23.7197; Khairy Ahmed, 2016, Asian Pac J Cancer Prev, V17, P2699; Klingenberg M, 2017, J HEPATOL, V67, P603, DOI 10.1016/j.jhep.2017.04.009; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Li HP, 2013, CARCINOGENESIS, V34, P2443, DOI 10.1093/carcin/bgt206; Liu XM, 2016, ONCOL REP, V36, P1385, DOI 10.3892/or.2016.4971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv GX, 2014, ONCOL REP, V32, P1021, DOI 10.3892/or.2014.3296; Nahand JS, 2019, J CELL PHYSIOL, V234, P12188, DOI 10.1002/jcp.27956; Peng C, 2019, DIGEST LIVER DIS, V51, P621, DOI 10.1016/j.dld.2018.12.011; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Sarkar N, 2015, J VIRAL HEPATITIS, V22, P817, DOI 10.1111/jvh.12390; Shi WX, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007764; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Sulas P, 2018, AM J PATHOL, V188, P785, DOI 10.1016/j.ajpath.2017.10.024; Tang GS, 2015, MED SCI MONITOR, V21, P617, DOI 10.12659/MSM.891028; Tangkijvanich P, 1999, J GASTROENTEROL, V34, P227, DOI 10.1007/s005350050248; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wan LF, 2018, EXP THER MED, V15, P2429, DOI 10.3892/etm.2017.5667; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wong CM, 2018, NAT REV GASTRO HEPAT, V15, P137, DOI 10.1038/nrgastro.2017.169; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Zhang C, 2018, EXP THER MED, V15, P4325, DOI 10.3892/etm.2018.5929; Zhang W, 2018, GENE, V659, P22, DOI 10.1016/j.gene.2018.03.053; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124266	36	17	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232211	10.1371/journal.pone.0232211	http://dx.doi.org/10.1371/journal.pone.0232211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330203	gold, Green Published			2022-12-26	WOS:000536647300063
J	Kadeethum, T; Jorgensen, TM; Nick, HM				Kadeethum, Teeratorn; Jorgensen, Thomas M.; Nick, Hamidreza M.			Physics-informed neural networks for solving nonlinear diffusivity and Biot's equations	PLOS ONE			English	Article							FINITE-ELEMENT-METHOD; MODEL; FLOW; PROPAGATION; SIMULATION; FRAMEWORK; PRESSURE; DRIVEN	This paper presents the potential of applying physics-informed neural networks for solving nonlinear multiphysics problems, which are essential to many fields such as biomedical engineering, earthquake prediction, and underground energy harvesting. Specifically, we investigate how to extend the methodology of physics-informed neural networks to solve both the forward and inverse problems in relation to the nonlinear diffusivity and Biot's equations. We explore the accuracy of the physics-informed neural networks with different training example sizes and choices of hyperparameters. The impacts of the stochastic variations between various training realizations are also investigated. In the inverse case, we also study the effects of noisy measurements. Furthermore, we address the challenge of selecting the hyperparameters of the inverse model and illustrate how this challenge is linked to the hyperparameters selection performed for the forward one.	[Kadeethum, Teeratorn; Jorgensen, Thomas M.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark; [Kadeethum, Teeratorn; Nick, Hamidreza M.] Tech Univ Denmark, Danish Hydrocarbon Res & Technol Ctr, Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Kadeethum, T (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark.; Kadeethum, T (corresponding author), Tech Univ Denmark, Danish Hydrocarbon Res & Technol Ctr, Lyngby, Denmark.	teekad@dtu.dk	Jørgensen, Thomas Martini/AAE-2303-2019; Kadeethum, Teeratorn/AAN-8549-2021; Nick, Hamidreza M./N-2625-2014; MartiniJørgensen, Thomas/I-5995-2012	Jørgensen, Thomas Martini/0000-0003-2920-1343; Kadeethum, Teeratorn/0000-0002-6815-9179; Nick, Hamidreza M./0000-0002-0623-6095; MartiniJørgensen, Thomas/0000-0003-2920-1343	Danish Hydrocarbon Research and Technology Centre under the Advanced Water Flooding program	Danish Hydrocarbon Research and Technology Centre under the Advanced Water Flooding program	The research leading to these results has received funding from the Danish Hydrocarbon Research and Technology Centre under the Advanced Water Flooding program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Abou-Kassem J.H., 2013, PETROLEUM RESERVOIR; Ahmed E., 2015, PROC CVPR IEEE, DOI [10.1109/cvpr.2015.7299016, DOI 10.1109/CVPR.2015.7299016]; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Baudin M, 2015, PYDOE EXPT DESIGN PA; Biot M, 1957, J APPL MECH, V15, P594; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Bisdom K, 2016, TECTONOPHYSICS, V690, P63, DOI 10.1016/j.tecto.2016.04.006; Bouklas N, 2015, J APPL MECH-T ASME, V82, DOI 10.1115/1.4030587; Bouklas N, 2015, J MECH PHYS SOLIDS, V79, P21, DOI 10.1016/j.jmps.2015.03.004; Choo J, 2018, COMPUT METHOD APPL M, V341, P311, DOI 10.1016/j.cma.2018.06.022; Coussy O., 2004, POROMECHANICS; Du J, 2007, J CAN PETROL TECHNOL, V46, P55; DURLOFSKY LJ, 1991, WATER RESOUR RES, V27, P699, DOI 10.1029/91WR00107; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Griewank A., 1989, MATH PROGRAMMING REC, V6, P83; Haga JB, 2012, INT J NUMER ANAL MET, V36, P1507, DOI 10.1002/nag.1062; Hansen P. C., 2010, DISCRETE INVERSE PRO, V7; Hesthaven J, 2016, CERTIFIED REDUCED BA, DOI DOI 10.1007/978-3-319-22470-1; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; HOLDEN L, 1992, TRANSPORT POROUS MED, V8, P37, DOI 10.1007/BF00616891; Jaeger J, 2010, FUNDAMENTALS ROCK ME; Juanes R, 2016, GEOPHYS RES LETT, V43, P6891, DOI 10.1002/2016GL069284; Kadeethum T., 2019, 20 ANN C INT ASS MAT; Kadeethum T., 2019, 53 US ROCK MECH GEOM; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kutz JN, 2017, J FLUID MECH, V814, P1, DOI 10.1017/jfm.2016.803; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee S, 2016, COMPUT METHOD APPL M, V305, P111, DOI 10.1016/j.cma.2016.02.037; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Liu JG, 2018, SIAM J SCI COMPUT, V40, pB1229, DOI 10.1137/17M1145677; Liu R, 2009, COMPUT METHOD APPL M, V198, P3499, DOI 10.1016/j.cma.2009.07.005; Masson YJ, 2010, GEOPHYSICS, V75, pN33, DOI 10.1190/1.3332589; Murad MA, 2013, COMPUT GEOTECH, V48, P192, DOI 10.1016/j.compgeo.2012.06.010; Nick HM, 2013, J CONTAM HYDROL, V145, P90, DOI 10.1016/j.jconhyd.2012.12.005; Nordbotten JM, 2014, INT J NUMER METH ENG, V100, P399, DOI 10.1002/nme.4734; Raissi M, 2019, J COMPUT PHYS, V378, P686, DOI 10.1016/j.jcp.2018.10.045; Raissi M, 2018, J MACH LEARN RES, V19; Raissi M, 2017, J COMPUT PHYS, V335, P736, DOI 10.1016/j.jcp.2017.01.060; Ruiz Baier R, 2019, COMMUNICATIONS COMPU; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Sokolova I, 2019, J COMPUT PHYS, V379, P309, DOI 10.1016/j.jcp.2018.11.039; Terzaghi K., 1951, THEORETICAL SOIL MEC; TETKO IV, 1995, J CHEM INF COMP SCI, V35, P826, DOI 10.1021/ci00027a006; van der Beek L, 2002, LANG COMPUT, P8; Vinje V, 2018, NEURORADIOL J, V31, P482, DOI 10.1177/1971400918795482; Wang H.F., 2000, PRI SER GEO; Wang JX, 2017, PHYS REV FLUIDS, V2, DOI 10.1103/PhysRevFluids.2.034603; Wang Z, 2018, INT J NUMER METH FL, V86, P255, DOI 10.1002/fld.4416; Wenzlau F, 2009, GEOPHYSICS, V74, pT55, DOI 10.1190/1.3122928; Wheeler M, 2014, COMPUTAT GEOSCI, V18, P57, DOI 10.1007/s10596-013-9382-y; Xiao H, 2016, J COMPUT PHYS, V324, P115, DOI 10.1016/j.jcp.2016.07.038; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519	56	30	30	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232683	10.1371/journal.pone.0232683	http://dx.doi.org/10.1371/journal.pone.0232683			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374751	Green Submitted, Green Published, gold			2022-12-26	WOS:000537283500049
J	Low, K; Ducrest, AL; San-Jose, LM; Simon, C; Uva, V; Seidah, NG; Pasquato, A; Kunz, S; Roulin, A				Loew, Karin; Ducrest, Anne-Lyse; San-Jose, Luis M.; Simon, Celine; Uva, Vera; Seidah, Nabil G.; Pasquato, Antonella; Kunz, Stefan; Roulin, Alexandre			Molecular evolution of the proopiomelanocortin system in Barn owl species	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; N-TERMINAL SEGMENT; MELANOCORTIN SYSTEM; PROTEIN 7B2; FOOD-INTAKE; EXPRESSION; MUTATIONS; PHYLOGENY; OBESITY; WEIGHT	Examination of genetic polymorphisms in outbred wild-living species provides insights into the evolution of complex systems. In higher vertebrates, the proopiomelanocortin (POMC) precursor gives rise to alpha-, beta-, and gamma-melanocyte-stimulating hormones (MSH), which are involved in numerous physiological aspects. Genetic defects in POMC are linked to metabolic disorders in humans and animals. In the present study, we undertook an evolutionary genetic approach complemented with biochemistry to investigate the functional consequences of genetic polymorphisms in the POMC system of free-living outbred barn owl species (family Tytonidae) at the molecular level. Our phylogenetic studies revealed a striking correlation between a loss-of-function H9P mutation in the beta-MSH receptor-binding motif and an extension of a poly-serine stretch in gamma 3-MSH to >= 7 residues that arose in the barn owl group 6-8 MYA ago. We found that extension of the poly-serine stretches in the gamma-MSH locus affects POMC precursor processing, increasing gamma 3-MSH production at the expense of gamma 2-MSH and resulting in an overall reduction of gamma-MSH signaling, which may be part of a negative feedback mechanism. Extension of the gamma 3-MSH poly-serine stretches >= 7 further markedly increases peptide hormone stability in plasma, which is conserved in humans, and is likely relevant to its endocrine function. In sum, our phylogenetic analysis of POMC in wild living owls uncovered a H9P beta-MSH mutation subsequent to serine extension in gamma 3-MSH to 7 residues, which was then followed by further serine extension. The linked MSH mutations highlight the genetic plasticity enabled by the modular design of the POMC gene.	[Loew, Karin; Ducrest, Anne-Lyse; San-Jose, Luis M.; Simon, Celine; Uva, Vera; Roulin, Alexandre] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Loew, Karin; Pasquato, Antonella; Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Loew, Karin; Pasquato, Antonella; Kunz, Stefan] Univ Lausanne, Lausanne, Switzerland; [Seidah, Nabil G.] Univ Montreal, Lab Biochem Neuroendocrinol, Clin Res Inst Montreal, Montreal, PQ, Canada	University of Lausanne; University of Lausanne; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Roulin, A (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	alexandre.roulin@unil.ch	; Seidah, Nabil/I-3596-2013	Low, Karin/0000-0002-5052-3892; Seidah, Nabil/0000-0001-6503-9342	Interdisciplinary Research Grant of the Faculty of Biology and Medicine of the University of Lausanne; Novartis Foundation for Biomedical Research [14B062]; Swiss National Science Foundation [310030_170108, 31003A_173178, 31003A_153467]	Interdisciplinary Research Grant of the Faculty of Biology and Medicine of the University of Lausanne; Novartis Foundation for Biomedical Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by an Interdisciplinary Research Grant of the Faculty of Biology and Medicine of the University of Lausanne (www.unil.ch/central/en/home/menuinst/formations/fbm-faculte-de-biologie-et-demedecin.html) to A.R. and S.K., Grant 14B062 of the Novartis Foundation for Biomedical Research (www.stiftungmedbiol.novartis.com) to A.R., Grant 310030_170108 of the Swiss National Science Foundation (www.snf.ch) to S.K., and Grants 31003A_173178 and 31003A_153467 of the Swiss National Science Foundation (www.snf.ch) to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2000, BRAIN RES, V869, P203, DOI 10.1016/S0006-8993(00)02386-6; Aliabadian M, 2016, BIOL J LINN SOC, V119, P904, DOI 10.1111/bij.12824; Bachert C, 2013, TRAFFIC, V14, P47, DOI 10.1111/tra.12019; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENNETT HPJ, 1986, INT J PEPT PROT RES, V27, P306; Bessonnard S, 2015, J CELL BIOL, V210, P1185, DOI 10.1083/jcb.201503042; Bicknell KA, 2009, MOL CELL ENDOCRINOL, V300, P71, DOI 10.1016/j.mce.2008.09.032; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; BOHLEN P, 1981, FEBS LETT, V128, P67, DOI 10.1016/0014-5793(81)81081-2; Buono P, 2005, CLIN CHEM, V51, P1358, DOI 10.1373/clinchem.2005.047886; Caruso V, 2014, NAT REV NEUROSCI, V15, P98, DOI 10.1038/nrn3657; Catania A, 2010, THESCIENTIFICWORLDJO, V10, P1840, DOI 10.1100/tsw.2010.173; Challis BG, 2002, HUM MOL GENET, V11, P1997, DOI 10.1093/hmg/11.17.1997; Clark AJL, 2016, J MOL ENDOCRINOL, V56, pT27, DOI 10.1530/JME-15-0268; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; D'Agostino G, 2010, J MOL MED, V88, P1195, DOI 10.1007/s00109-010-0651-0; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubern B, 2008, PEDIATR RES, V63, P211, DOI 10.1203/PDR.0b013e31815ed62b; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; EKMAN R, 1982, ENDOCRINOLOGY, V111, P578, DOI 10.1210/endo-111-2-578; EKMAN R, 1989, LIFE SCI, V45, P787, DOI 10.1016/0024-3205(89)90171-9; Emaresi G, 2013, MOL ECOL, V22, P4915, DOI 10.1111/mec.12438; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fricke K, 2005, ENDOCRINOLOGY, V146, P2060, DOI 10.1210/en.2004-1097; Getting SJ, 2001, J LEUKOCYTE BIOL, V69, P98; Harmer SC, 2008, J ENDOCRINOL, V196, P149, DOI 10.1677/JOE-07-0391; Hinney A, 1998, J CLIN ENDOCR METAB, V83, P3737, DOI 10.1210/jc.83.10.3737; LARIVIERE N, 1980, FEBS LETT, V122, P279, DOI 10.1016/0014-5793(80)80456-X; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Lowry P, 2016, J MOL ENDOCRINOL, V56, pT1, DOI 10.1530/JME-15-0260; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; MBIKAY M, 1989, INT J PEPT PROT RES, V33, P39; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nylander JAA, 2004, PROGRAM DISTRIBUTED, P581; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Py I, 2006, EVOL ECOL RES, V8, P483; Raffan E, 2016, CELL METAB, V23, P893, DOI 10.1016/j.cmet.2016.04.012; Rambaut A., 2014, TRACER V1 6; Roulin A, 2011, OECOLOGIA, V166, P913, DOI 10.1007/s00442-011-1955-7; Roulin A, 2011, EUR J PHARMACOL, V660, P226, DOI 10.1016/j.ejphar.2011.01.036; Samuels ME, 2013, J CLIN ENDOCR METAB, V98, P736, DOI 10.1210/jc.2012-3199; San-Jose LM, 2017, MOL ECOL, V26, P259, DOI 10.1111/mec.13861; Schwyzer R, 1977, Ann N Y Acad Sci, V297, P3, DOI 10.1111/j.1749-6632.1977.tb41843.x; SEIDAH NG, 1981, J BIOL CHEM, V256, P7977; SEIDAH NG, 1981, P NATL ACAD SCI-BIOL, V78, P4236, DOI 10.1073/pnas.78.7.4236; SICILIANO RA, 1993, GLYCOBIOLOGY, V3, P225, DOI 10.1093/glycob/3.3.225; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; Uva V, 2018, MOL PHYLOGENET EVOL, V125, P127, DOI 10.1016/j.ympev.2018.03.013; ZHOU A, 1993, J BIOL CHEM, V268, P1763; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641	55	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0231163	10.1371/journal.pone.0231163	http://dx.doi.org/10.1371/journal.pone.0231163			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369484	gold, Green Published			2022-12-26	WOS:000537280000005
J	Lopez-Goldar, X; Lundborg, L; Borg-Karlson, AK; Zas, R; Sampedro, L				Lopez-Goldar, Xose; Lundborg, Lina; Borg-Karlson, Anna Karin; Zas, Rafael; Sampedro, Luis			Resin acids as inducible chemical defences of pine seedlings against chewing insects	PLOS ONE			English	Article							HYLOBIUS-ABIETIS; METHYL JASMONATE; INDUCED RESISTANCE; INDUCED RESPONSES; HOST SELECTION; PLANT DEFENSE; PICEA-ABIES; SCOTS PINE; PINASTER; INDUCTION	Inducibility of defences in response to biotic stimuli is considered an important trait in plant resistance. In conifers, previous research has mostly focused on the inducibility of the volatile fraction of the oleoresin (mono- and sesquiterpenes), leaving the inducibility of the nonvolatile resin acids largely unexplored, particularly in response to real herbivory. Here we investigated the differences in the inducibility of resin acids in two pine species, one native from Europe (Pinus pinaster Ait.) and another from North America (Pinus radiata D. Don), in response to wounding by two European insects: a bark chewer, the pine weevil (Hylobius abietis L.), and a defoliator, the pine processionary caterpillar (Thaumetopoea pityocampa Schiff.). We quantified the constitutive (control) and induced concentrations of resin acids in the stem and needles of both pine species by gas chromatography techniques. Both pine species strongly increased the concentration of resin acids in the stem after pine weevil feeding, although the response was greater in P. pinaster than in P. radiata. However, systemic defensive responses in the needles were negligible in both pine species after pine weevil feeding in the stem. On the other hand, P. radiata locally reduced the resin acid concentration in the needles after pine caterpillar feeding, whereas in P. pinaster resin acid concentration was apparently unaffected. Nevertheless, systemic induction of resin acids was only observed in the stem of P. pinaster in response to pine caterpillar feeding. In summary, pine induced responses were found highly compartmentalized, and specific to herbivore identity. Particularly, plant defence suppression mechanisms by the pine caterpillar, and ontogenetic factors might be potentially affecting the induced response of resin acids in both pine species.	[Lopez-Goldar, Xose] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Lopez-Goldar, Xose; Zas, Rafael; Sampedro, Luis] CSIC, MBG, Pontevedra, Galicia, Spain; [Lundborg, Lina; Borg-Karlson, Anna Karin] Royal Inst Technol KTH, Sch Engn Sci Chem Biotechnol & Hlth, Dept Chem, Stockholm, Sweden	Cornell University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG); Royal Institute of Technology	Lopez-Goldar, X (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.; Lopez-Goldar, X (corresponding author), CSIC, MBG, Pontevedra, Galicia, Spain.	xlgoldar@mbg.csic.es	Sampedro, Luis/B-7187-2011; Zas, Rafael/I-5729-2014; López-Goldar, Xosé/N-8053-2019; Lopez Goldar, Xose/GRS-4732-2022	Sampedro, Luis/0000-0002-3921-2575; Zas, Rafael/0000-0001-6563-2461; López-Goldar, Xosé/0000-0003-2049-7758; 	Ministerio de Ciencia, Innovacion y Universidades; Fondo Europeo de Desarrollo Regional (MCIU/AEI/FEDER), UE [AGL2015-68274C03-02-R, RTI2018-094691-B-C33]; Fundacion Pedro Barriede la Maza; Ministerio de Economia y Competitividad (MINECO) [BES-2013-62663]; Swedish Foundation of Strategic Research (Parasite Resistant Tree Project) [RBb08-0003]; Agencia Estatal de Investigacion	Ministerio de Ciencia, Innovacion y Universidades; Fondo Europeo de Desarrollo Regional (MCIU/AEI/FEDER), UE; Fundacion Pedro Barriede la Maza; Ministerio de Economia y Competitividad (MINECO); Swedish Foundation of Strategic Research (Parasite Resistant Tree Project); Agencia Estatal de Investigacion	This research was supported by the Ministerio de Ciencia, Innovacion y Universidades, Agencia Estatal de Investigacion and Fondo Europeo de Desarrollo Regional (MCIU/AEI/FEDER), UE grants (FUTURPIN, AGL2015-68274C03-02-R; RESILPIN, RTI2018-094691-B-C33). XLG received financial support from Fundacion Pedro Barriede la Maza and FPI Grant programs from former Ministerio de Economia y Competitividad (MINECO, BES-2013-62663). LL received financial support for Ph.D. program from the Swedish Foundation of Strategic Research (Parasite Resistant Tree Project, grant number RBb08-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achotegui-Castells A, 2013, ACTA PHYSIOL PLANT, V35, P3047, DOI 10.1007/s11738-013-1337-3; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Agrawal AA, 2015, ECOL LETT, V18, P985, DOI 10.1111/ele.12482; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Arrabal C, 2005, BIOCHEM SYST ECOL, V33, P1007, DOI 10.1016/j.bse.2005.03.003; Arrabal C, 2002, HOLZFORSCHUNG, V56, P261, DOI 10.1515/HF.2002.043; Arrabal C, 2012, PLANT SYST EVOL, V298, P511, DOI 10.1007/s00606-011-0562-8; Bede JC, 2006, PLANT MOL BIOL, V60, P519, DOI 10.1007/s11103-005-4923-y; Berasategui A, 2017, MOL ECOL, V26, P4099, DOI 10.1111/mec.14186; Blodgett JT, 2007, TREE PHYSIOL, V27, P511, DOI 10.1093/treephys/27.4.511; Bonello P, 2008, TREE PHYSIOL, V28, P1653, DOI 10.1093/treephys/28.11.1653; Boone CK, 2013, J CHEM ECOL, V39, P1003, DOI 10.1007/s10886-013-0313-0; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; CODELLA SG, 1995, OECOLOGIA, V104, P1, DOI 10.1007/BF00365555; Consales F, 2012, J EXP BOT, V63, P727, DOI 10.1093/jxb/err308; DEMOLIN G, 1969, Annales des Sciences Forestieres (Paris), V26, P81; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Erbilgin N, 2012, TREE PHYSIOL, V32, P946, DOI 10.1093/treephys/tps047; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Forman V, 2017, MOLECULES, V22, DOI 10.3390/molecules22060981; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Giertych MJ, 2007, FOREST ECOL MANAG, V242, P700, DOI 10.1016/j.foreco.2007.02.005; Heijari J, 2005, ENTOMOL EXP APPL, V115, P117, DOI 10.1111/j.1570-7458.2005.00263.x; Hudgins JW, 2004, TREE PHYSIOL, V24, P251, DOI 10.1093/treephys/24.3.251; IKEDA T, 1977, SCIENCE, V197, P497, DOI 10.1126/science.197.4302.497; Jactel H, 2011, OECOLOGIA, V166, P703, DOI 10.1007/s00442-011-1918-z; Jactel H, 2014, PROCESSIONARY MOTHS, P265; Keefover-Ring K, 2016, J CHEM ECOL, V42, P1, DOI 10.1007/s10886-015-0659-6; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Kolosova N, 2012, GROWTH DEFENCE PLANT; Kusumoto N, 2014, FOREST PATHOL, V44, P353, DOI 10.1111/efp.12106; Langstrom B, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P415; Larsson S, 2000, OIKOS, V89, P440, DOI 10.1034/j.1600-0706.2000.890303.x; Leather SR, 1999, B ENTOMOL RES, V89, P3, DOI 10.1017/S0007485399000024; LEWINSOHN E, 1993, PLANT PHYSIOL, V101, P1021, DOI 10.1104/pp.101.3.1021; Littell R. C., 2006, SAS SYSTEM MIXED MOD; Lombardero MJ, 2016, FOREST ECOL MANAG, V382, P39, DOI 10.1016/j.foreco.2016.10.003; Lombardero MJ, 2012, FOREST ECOL MANAG, V281, P121, DOI 10.1016/j.foreco.2012.06.036; Lopez-Goldar X, 2019, J ECOL, V107, P2464, DOI 10.1111/1365-2745.13159; Lopez-Goldar X, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01651; Lopez-Goldar X, 2016, ENVIRON EXP BOT, V130, P141, DOI 10.1016/j.envexpbot.2016.05.010; Lopez-Villamor A, 2019, FOREST ECOL MANAG, V444, P290, DOI 10.1016/j.foreco.2019.04.027; Lundborg L, 2018, TREES-STRUCT FUNCT, V33, P53; Lundborg L, 2016, J CHEM ECOL, V42, P1237, DOI 10.1007/s10886-016-0790-z; Mason CJ, 2017, FUNCT ECOL, V31, P2034, DOI 10.1111/1365-2435.12911; Mason CJ, 2015, J CHEM ECOL, V41, P524, DOI 10.1007/s10886-015-0588-4; Mason CJ, 2014, OECOLOGIA, V175, P901, DOI 10.1007/s00442-014-2950-6; Mason CJ, 2018, PLANT CELL ENV; Moreira X, 2013, PHYTOCHEMISTRY, V94, P113, DOI 10.1016/j.phytochem.2013.05.008; Moreira X, 2009, ENVIRON EXP BOT, V67, P94, DOI 10.1016/j.envexpbot.2009.05.015; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Niccoli A, 2008, PHYTOPARASITICA, V36, P313, DOI 10.1007/BF02980810; Nordlander G, 1997, ENTOMOL EXP APPL, V85, P1, DOI 10.1023/A:1003026010586; Nordlander G, 1987, SCAND J FOREST RES, V2, P199, DOI 10.1080/02827588709382458; Paiva MR, 2011, J APPL ENTOMOL, V135, P195, DOI 10.1111/j.1439-0418.2010.01550.x; Palacio S, 2012, TREES-STRUCT FUNCT, V26, P1627, DOI 10.1007/s00468-012-0739-y; Petrakis PV, 2005, BEHAV PROCESS, V69, P303, DOI 10.1016/j.beproc.2004.12.008; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Powell JS, 1999, ENVIRON ENTOMOL, V28, P7; Raffa KF, 2017, PLANT CELL ENVIRON, V40, P1791, DOI 10.1111/pce.12985; Rasmann S, 2015, J EXP BOT, V66, P2527, DOI 10.1093/jxb/erv033; Regolini M, 2014, FOREST ECOL MANAG, V334, P185, DOI 10.1016/j.foreco.2014.08.038; Sampedro L, 2011, PLANT ECOL, V212, P397, DOI 10.1007/s11258-010-9830-x; Sampedro L, 2010, J EXP BOT, V61, P4437, DOI 10.1093/jxb/erq246; Schiebe C, 2012, OECOLOGIA, V170, P183, DOI 10.1007/s00442-012-2298-8; Schmidt A, 2011, PLANT MOL BIOL, V77, P577, DOI 10.1007/s11103-011-9832-7; Sherwood P, 2016, PHYSIOL MOL PLANT P, V94, P118, DOI 10.1016/j.pmpp.2016.06.002; Smith RGB, 2014, AUST FORESTRY, V77, P105, DOI 10.1080/00049158.2014.935269; Suarez-Vidal E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01452; WAGNER MR, 1983, J CHEM ECOL, V9, P119, DOI 10.1007/BF00987776; Walter J, 1989, TREES-STRUCT FUNCT, V3, P210, DOI 10.1007/BF00225354; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Whitehill JGA, 2019, NEW PHYTOL, V221, P1503, DOI 10.1111/nph.15477; Zas R, 2014, FOREST ECOL MANAG, V313, P212, DOI 10.1016/j.foreco.2013.11.014; Zas R, 2011, J ECOL, V99, P1316, DOI 10.1111/j.1365-2745.2011.01872.x; Zeneli G, 2006, TREE PHYSIOL, V26, P977, DOI 10.1093/treephys/26.8.977; Zhao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026649; Zulak KG, 2010, J INTEGR PLANT BIOL, V52, P86, DOI 10.1111/j.1744-7909.2010.00910.x	81	6	6	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232692	10.1371/journal.pone.0232692	http://dx.doi.org/10.1371/journal.pone.0232692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357193	Green Published, gold			2022-12-26	WOS:000536957700045
J	Dai, Z; Liu, SR; Wu, JF; Li, MD; Liu, JL; Li, K				Dai, Zheng; Liu, Siru; Wu, Jinfa; Li, Mengdie; Liu, Jialin; Li, Ke			Analysis of adult disease characteristics and mortality on MIMIC-III	PLOS ONE			English	Article							ASSOCIATION	Purpose To deeply analyze the basic information and disease information of adult patients in the MIMIC-III (Medical Information Mart for Intensive Care III) database, and provide data reference for clinicians and researchers. Materials and methods Tableau2019.1.0 and Navicat12.0.29 were used for data analysis and extraction of disease distribution of adult patients in the MIMIC-III database. Result A total of 38,163 adult patients were included in the MIMIC-III database. Only 38,156 patients with the first diagnosis were selected. Among them, 21,598 were males accounting for 56.6% the median age was 66 years (Q1-Q3: 53-78), the median length of a hospital stay was 7 days (Q1-Q3: 4-12), and the median length of an ICU stay was 2.1 days (Q1-Q3: 1.2-4.1). Septicemia was the disease with the highest mortality rate among patients and the total mortality rate was 48.9%. The disease with the largest number of patients at the last time was other forms of chronic ischemic heart disease. Conclusion By analyzing the patients' basic information, the admission spectrum and the disease morbidity and mortality can help more researchers understand the MIMIC-III database and facilitate further research.	[Dai, Zheng; Wu, Jinfa; Li, Mengdie; Li, Ke] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu, Sichuan, Peoples R China; [Liu, Siru] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Liu, Jialin] Sichuan Univ, West China Med Sch, Dept Med Informat, Chengdu, Sichuan, Peoples R China; [Liu, Jialin] Sichuan Univ, West China Hosp, Informat Ctr, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Utah System of Higher Education; University of Utah; Sichuan University; Sichuan University	Li, K (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu, Sichuan, Peoples R China.; Liu, JL (corresponding author), Sichuan Univ, West China Med Sch, Dept Med Informat, Chengdu, Sichuan, Peoples R China.; Liu, JL (corresponding author), Sichuan Univ, West China Hosp, Informat Ctr, Chengdu, Sichuan, Peoples R China.	DLJL8@163.com; colinlike@163.com	Liu, Siru/AAM-8737-2021; Liu, Siru/GYA-2297-2022	Liu, Siru/0000-0002-5003-5354; Dai, zheng/0000-0003-1084-1762				Aboelsoud MM, 2017, J CRIT CARE, V41, P9, DOI 10.1016/j.jcrc.2017.04.040; [Anonymous], 2017, 9 REVISION INT CLASS; Beaulieu-Jones BK, 2018, PAC S BIOC PAC S BIO; Calvert J, 2016, ANN MED SURG, V11, P52, DOI 10.1016/j.amsu.2016.09.002; Desautels T, 2016, JMIR MED INF, V4, P67, DOI 10.2196/medinform.5909; Fan Yong, 2018, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V30, P531, DOI 10.3760/cma.j.issn.2095-4352.2018.06.006; Feng ML, 2018, INTENS CARE MED, V44, P884, DOI 10.1007/s00134-018-5208-7; Johnson AEW, 2018, J AM MED INFORM ASSN, V25, P32, DOI 10.1093/jamia/ocx084; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kurniati AP, 2018, J PHYS CONF SER, V971, DOI 10.1088/1742-6596/971/1/012008; Lacroix J, 2011, TRANSFUS MED REV, V25, P197, DOI 10.1016/j.tmrv.2011.03.001; Lee J, 2017, JMIR MED INF, V5, DOI 10.2196/medinform.6690; Marshall DC, 2017, J CRIT CARE, V40, P63, DOI 10.1016/j.jcrc.2017.02.012; Parreco JP, 2018, J CRIT CARE, V45, P156, DOI 10.1016/j.jcrc.2018.02.010; Purushotham S, 2018, J BIOMED INFORM, V83, P112, DOI 10.1016/j.jbi.2018.04.007; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Rhee KJ, 2015, INT J MOL SCI, V16, P30015, DOI 10.3390/ijms161226215; Rood PJT, 2019, J CRIT CARE, V53, P120, DOI 10.1016/j.jcrc.2019.06.007; Sharukh Lokhandwala, 2018, PLOS ONE, V13; Shen YF, 2018, J CRIT CARE, V44, P273, DOI 10.1016/j.jcrc.2017.11.041; Hoang TN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162844; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	22	2	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232176	10.1371/journal.pone.0232176	http://dx.doi.org/10.1371/journal.pone.0232176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353003	gold, Green Published			2022-12-26	WOS:000536673200048
J	Gangcuangco, LMA; Mitchell, BI; Siriwardhana, C; Kohorn, LB; Chew, GM; Bowler, S; Kallianpur, KJ; Chow, DC; Ndhlovu, LC; Gerschenson, M; Shikuma, CM				Gangcuangco, Louie Mar A.; Mitchell, Brooks I.; Siriwardhana, Chathura; Kohorn, Lindsay B.; Chew, Glen M.; Bowler, Scott; Kallianpur, Kalpana J.; Chow, Dominic C.; Ndhlovu, Lishomwa C.; Gerschenson, Mariana; Shikuma, Cecilia M.			Mitochondrial oxidative phosphorylation in peripheral blood mononuclear cells is decreased in chronic HIV and correlates with immune dysregulation	PLOS ONE			English	Article							DNA DAMAGE; DYSFUNCTION	Background Cellular immunometabolism among people living with HIV (PLWH) on antiretroviral therapy (ART) remains under investigated. We assessed the relationships between mitochondrial oxidative phosphorylation (OXPHOS) in peripheral blood mononuclear cells (PBMCs) and blood parameters associated with HIV immune dysregulation. Methods PLWH >= 40 years old and on stable ART >= 3 months were enrolled (N = 149). OXPHOS complex I (CI, NADH dehydrogenase) and complex IV (CIV, cytochrome c oxidase) protein levels in PBMCs were quantified using immunoassays. Monocyte subsets and markers of T-cell activation, senescence, and exhaustion were measured on PBMC by flow cytometry. Plasma inflammatory mediators were quantified using a multiplex assay. HIV-uninfected group (N = 44) of similar age, gender, and ethnicity had available OXPHOS levels. Results PLWH had a median age of 51 years. Majority were male (88.6%), Caucasian (57.7%), and with undetectable plasma HIV RNA < 50 copies/mL (84.6%). Median CI level was lower in PLWH compared with the HIV-seronegative group (65.5 vs 155.0 optical density/mu g protein x 10(3), p < 0.0001). There was no significant difference in median CIV levels. Lower OXPHOS levels correlated with lower CD4% and CD4/CD8 ratio. On multivariable linear regression adjusted for age, current use of zidovudine/didanosine, and HIV RNA (detectable versus undetectable), lower OXPHOS levels were significantly associated with higher MPO, SAA, SAP, and sVCAM, and higher frequencies of intermediate (CD14(++)CD16(+)) monocytes and TIGIT+TIM3+ CD4 T-cell (p<0.01). Conclusion CI PBMC protein levels were decreased in PLWH on ART. Decreased OXPHOS correlated with disease severity and inflammation. Further studies on the relationship between immunometabolism and immune dysregulation in HIV are warranted.	[Gangcuangco, Louie Mar A.; Mitchell, Brooks I.; Siriwardhana, Chathura; Kohorn, Lindsay B.; Chew, Glen M.; Bowler, Scott; Kallianpur, Kalpana J.; Chow, Dominic C.; Ndhlovu, Lishomwa C.; Gerschenson, Mariana; Shikuma, Cecilia M.] Univ Hawaii, Honolulu, HI 96822 USA	University of Hawaii System	Shikuma, CM (corresponding author), Univ Hawaii, Honolulu, HI 96822 USA.	shikuma@hawaii.edu	Gangcuangco, Louie Mar/P-9579-2019; n, l/AAX-3992-2020	Gangcuangco, Louie Mar/0000-0002-6714-9294; Chow, Dominic/0000-0001-7395-038X; Bowler, Scott/0000-0001-8881-6941	National Institute of Health [R01HL095135, U54MD007584, U54MD007601, P20GM113134]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was made possible by the funding and clinical research support from National Institute of Health grants R01HL095135 (CMS), U54MD007584, U54MD007601 and P20GM113134 (MG). Details of the grants may be accessed through: https://report.nih.gov/index.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Ahmed D, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/6238978; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Chao T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00473; Chew GM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005349; Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002; Cogliati S, 2018, J MOL BIOL, V430, P4849, DOI 10.1016/j.jmb.2018.09.016; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Gerschenson M, 2009, J ANTIMICROB CHEMOTH, V63, P1244, DOI 10.1093/jac/dkp100; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Hulgan T, 2012, J INFECT DIS, V205, P1769, DOI 10.1093/infdis/jis105; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Ivanov AV, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8910396; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Kallianpur KJ, 2016, MITOCHONDRION, V28, P8, DOI 10.1016/j.mito.2016.02.006; Kleiveland C.R., 2015, IMPACT FOOD BIOACTIV, P161, DOI [10.1007/978-3-319-16104-4_15, DOI 10.1007/978-3-319-16104-4_15]; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Lecoeur H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.21; Miro O, 2004, CLIN INFECT DIS, V39, P710, DOI 10.1086/423176; Mitchell BI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153758; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Palmer CS, 2016, J IMMUNOL, V196, P4437, DOI 10.4049/jimmunol.1600120; Rodriguez-Mora S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0203-3; Rontoyanni VG, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00141; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Shikuma CM, 2008, AIDS RES HUM RETROV, V24, P1255, DOI 10.1089/aid.2007.0262; Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Szalardy L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/498401; Teodorof-Diedrich C, 2018, J VIROL, V92, DOI 10.1128/JVI.00993-18; Tomas C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186802; Vaamonde-Garcia C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508; van Horssen J, 2017, NEUROSCIENCE LETT; Velu V, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0144-x; Zielinski LP, 2016, MITOCHONDRION, V31, P45, DOI 10.1016/j.mito.2016.09.003	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231761	10.1371/journal.pone.0231761	http://dx.doi.org/10.1371/journal.pone.0231761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353005	Green Published, gold			2022-12-26	WOS:000536673200022
J	Ly, SN; Garavito, A; De Block, P; Asselman, P; Guyeux, C; Charr, JC; Janssens, S; Mouly, A; Hamon, P; Guyot, R				Ly, Serigne Ndiawar; Garavito, Andrea; De Block, Petra; Asselman, Pieter; Guyeux, Christophe; Charr, Jean-Claude; Janssens, Steven; Mouly, Arnaud; Hamon, Perla; Guyot, Romain			Chloroplast genomes of Rubiaceae: Comparative genomics and molecular phylogeny in subfamily Ixoroideae	PLOS ONE			English	Article							COMPLETE PLASTOME SEQUENCE; COFFEE COFFEA; EVOLUTION; REVEALS; FAMILY; RPS16; TREE; CIRCUMSCRIPTIONS; ANGIOSPERMS; DIVERSITY	In Rubiaceae phylogenetics, the number of markers often proved a limitation with authors failing to provide well-supported trees at tribal and generic levels. A robust phylogeny is a prerequisite to study the evolutionary patterns of traits at different taxonomic levels. Advances in next-generation sequencing technologies have revolutionized biology by providing, at reduced cost, huge amounts of data for an increased number of species. Due to their highly conserved structure, generally recombination-free, and mostly uniparental inheritance, chloroplast DNA sequences have long been used as choice markers for plant phylogeny reconstruction. The main objectives of this study are: 1) to gain insight in chloroplast genome evolution in the Rubiaceae (Ixoroideae) through efficient methodology for de novo assembly of plastid genomes; and, 2) to test the efficiency of mining SNPs in the nuclear genome of Ixoroideae based on the use of a coffee reference genome to produce well-supported nuclear trees. We assembled whole chloroplast genome sequences for 27 species of the Rubiaceae subfamily Ixoroideae using next-generation sequences. Analysis of the plastid genome structure reveals a relatively good conservation of gene content and order. Generally, low variation was observed between taxa in the boundary regions with the exception of the inverted repeat at both the large and short single copy junctions for some taxa. An average of 79% of the SNP determined in the Coffea genus are transferable to Ixoroideae, with variation ranging from 35% to 96%. In general, the plastid and the nuclear genome phylogenies are congruent with each other. They are well-resolved with well-supported branches. Generally, the tribes form well-identified clades but the tribe Sherbournieae is shown to be polyphyletic. The results are discussed relative to the methodology used and the chloroplast genome features in Rubiaceae and compared to previous Rubiaceae phylogenies.	[Ly, Serigne Ndiawar; Hamon, Perla; Guyot, Romain] Univ Montpellier, UMR DIADE, Inst Rech Dev, Montpellier, France; [Garavito, Andrea] Univ Caldas, Dept Ciencias Biol, Manizales, Colombia; [De Block, Petra; Asselman, Pieter; Janssens, Steven] Meise Bot Garden, Meise, Belgium; [Asselman, Pieter] Univ Ghent, Ghent, Belgium; [Guyeux, Christophe; Charr, Jean-Claude] Univ Bourgogne Franche Comte, CNRS, UMR 6174, Femto ST Inst, Besancon, France; [Mouly, Arnaud] Univ Bourgogne Franche Comte, CNRS, UMR 6249, Lab Chronoenvironm, Besancon, France; [Mouly, Arnaud] Univ Bourgogne Franche Comte, Besancon Bot Garden, Besancon, France; [Guyot, Romain] Univ Autonoma Manizales, Dept Elect & Automatizat, Manizales, Colombia	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad de Caldas; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Universidad Autonoma de Manizales	Guyot, R (corresponding author), Univ Montpellier, UMR DIADE, Inst Rech Dev, Montpellier, France.; Guyot, R (corresponding author), Univ Autonoma Manizales, Dept Elect & Automatizat, Manizales, Colombia.	romain.guyot@ird.fr	guyot, romain/AAE-2262-2021; Guyeux, Christophe/C-2153-2011	guyot, romain/0000-0002-7016-7485; LY, Serigne/0000-0003-2969-9591; Garavito, Andrea/0000-0002-0864-8608; Guyeux, Christophe/0000-0003-0195-4378	Meise Botanic Garden; Institut de Recherche pour le Developpement (IRD); Laboratory Chrono-Environment, Universite de Bourgogne Franche-Comte	Meise Botanic Garden; Institut de Recherche pour le Developpement (IRD); Laboratory Chrono-Environment, Universite de Bourgogne Franche-Comte	We thank the gardeners, Mr. H. Leqeux, Mr. J. Van Eeckhoudt, and the scientific curators, Ms. V. leyman and Dr. M. Reynders, for their care for the living Rubiaceae collection at Meise Botanic Garden. We thank Mr. F. Van Caekenberghe for help with the collection of plant material. We are grateful to the manager of the molecular laboratory at Meise Botanic Garden, Mr. W. Baert, for his goodwill towards this project. We thank Meise Botanic Garden for funding sequencing work, travel and publication fees. We thank the Institut de Recherche pour le Developpement (IRD) for funding sequencing work and for providing a fellowship for S.N. Ly. The Laboratory Chrono-Environment, Universite de Bourgogne Franche-Comte, also funded part of the sequencing.	Alexander LW, 2014, TREE GENET GENOMES, V10, P803, DOI 10.1007/s11295-013-0681-1; Andreasen K, 2000, AM J BOT, V87, P1731, DOI 10.2307/2656750; Barrett CF, 2016, NEW PHYTOL, V209, P855, DOI 10.1111/nph.13617; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bremer B, 2009, ANN MO BOT GARD, V96, P4, DOI 10.3417/2006197; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Cristians S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00666; Curk F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125628; Dane F, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0840-7; Dann M, 2018, NATL CTR BIOTECHNOLO; DARWIN SP, 1976, TAXON, V25, P595, DOI 10.2307/1220118; Davis AP, 2009, ANN MO BOT GARD, V96, P68, DOI 10.3417/2006205; De Block P, 2018, PHYTOKEYS, P1, DOI 10.3897/phytokeys.99.23713; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Doyle J. J., 1987, PHYTOCHEM B, P11; Duan RY, 2017, CONSERV GENET RESOUR, V9, P459, DOI 10.1007/s12686-016-0681-1; Duan TT, 2018, MOL PHYLOGENET EVOL, V123, P113, DOI 10.1016/j.ympev.2018.02.015; Fan WW, 2019, MITOCHONDRIAL DNA B, V4, P538, DOI 10.1080/23802359.2018.1553514; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Govaerts R, 2016, WORLD CHECKLIST RUBI; Greiner S, 2019, NUCLEIC ACIDS RES, V47, pW59, DOI 10.1093/nar/gkz238; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Guyeux C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216347; Guyot R, 2016, MOL GENET GENOMICS, V291, P1979, DOI 10.1007/s00438-016-1235-7; Hamon P, 2017, MOL PHYLOGENET EVOL, V109, P351, DOI 10.1016/j.ympev.2017.02.009; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Kainulainen K, 2013, BOT J LINN SOC, V173, P387, DOI 10.1111/boj.12038; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Khan SA, 2008, TAXON, V57, P7, DOI 10.2307/25065944; Kim JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186788; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li JJ, 2018, BIOTECHNOL BIOTEC EQ, V32, P1087, DOI 10.1080/13102818.2018.1496034; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Lu SH, 2016, MITOCHONDRIAL DNA A, V27, P2802, DOI 10.3109/19401736.2015.1053074; Maurin O, 2007, ANN BOT-LONDON, V100, P1565, DOI 10.1093/aob/mcm257; McFadden GI, 2001, PLANT PHYSIOL, V125, P50, DOI 10.1104/pp.125.1.50; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Mouly A, 2014, TAXON, V63, P801, DOI 10.12705/634.4; Mouly A, 2009, ANN MO BOT GARD, V96, P146, DOI 10.3417/2006194; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Persson C, 2000, NORD J BOT, V20, P257, DOI 10.1111/j.1756-1051.2000.tb00742.x; Rambaut A., 2007, FIGTREE; RoBBRECHT E., 1988, OPERA BOT BELG, V1, P13, DOI DOI 10.2307/4110534; Robbrecht Elmar, 2006, Systematics and Geography of Plants, V76, P85; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; Rydin C, 2017, AM J BOT, V104, P1522, DOI 10.3732/ajb.1700255; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Sanderson MJ, 2015, AM J BOT, V102, P1115, DOI 10.3732/ajb.1500184; Shrestha B, 2019, MOL PHYLOGENET EVOL, V138, P53, DOI 10.1016/j.ympev.2019.05.030; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Staats M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069189; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Tosh J, 2009, ANN MO BOT GARD, V96, P194, DOI 10.3417/2006202; Weng ML, 2017, NEW PHYTOL, V214, P842, DOI 10.1111/nph.14375; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wikstrom N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126690; Yang YC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00959; Zhai W, 2019, MOL PHYLOGENET EVOL, V135, P12, DOI 10.1016/j.ympev.2019.02.024; Zhang N, 2017, PLANTA MED, V83, P1420, DOI 10.1055/s-0043-113449; Zhang XF, 2019, MITOCHONDRIAL DNA B, V4, P675, DOI 10.1080/23802359.2019.1572467; Zhang Y, 2019, FORESTS, V10, DOI 10.3390/f10111000; Zheng XM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01518-5; Zhu ZX, 2019, MITOCHONDRIAL DNA B, V4, P742, DOI 10.1080/23802359.2019.1565931	74	6	6	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232295	10.1371/journal.pone.0232295	http://dx.doi.org/10.1371/journal.pone.0232295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353023	Green Published, gold			2022-12-26	WOS:000536673200071
J	Mercado-Uribe, H; Andrade-Medina, M; Espinoza-Rodriguez, JH; Carrillo-Tripp, M; Scheckhuber, CQ				Mercado-Uribe, Hilda; Andrade-Medina, Mariana; Horacio Espinoza-Rodriguez, Juan; Carrillo-Tripp, Mauricio; Quintus Scheckhuber, Christian			Analyzing structural alterations of mitochondrial intermembrane space superoxide scavengers cytochrome-c and SOD1 after methylglyoxal treatment	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; GLYCATION END-PRODUCTS; GLYOXALASE-I; CELL; ACETYLATION; STABILITY	Mitochondria are quantitatively the most important sources of reactive oxygen species (ROS) which are formed as by-products during cellular respiration. ROS generation occurs when single electrons are transferred to molecular oxygen. This leads to a number of different ROS types, among them superoxide. Although most studies focus on ROS generation in the mitochondrial matrix, the intermembrane space (IMS) is also important in this regard. The main scavengers for the detoxification of superoxide in the IMS are Cu, Zn superoxide dismutase (SOD1) and cytochrome-c. Similar to ROS, certain reactive carbonyl species are known for their high reactivity. The consequences are deleterious modifications to essential components compromising cellular functions and contributing to the etiology of severe pathological conditions like cancer, diabetes and neurodegeneration. In this study, we investigated the susceptibility of SOD1 and cytochrome-c to in vitro glycation by the dicarbonyl methylglyoxal (MGO) and the resulting effects on their structure. We utilized experimental techniques like immunodetection of the MGO-mediated modification 5-hydro-5-methylimidazolone, differential scanning calorimetry, fluorescence emission and circular dichroism measurements. We found that glycation of cytochrome-c leads to monomer aggregation, an altered secondary structure (increase in alpha helical content) and slightly more compact folding. In addition to structural changes, glycated cytochrome-c displays an altered thermal unfolding behavior. Subjecting SOD1 to MGO does not influence its secondary structure. However, similar to cytochrome-c, subunit aggregation is observed under denaturating conditions. Furthermore, the appearance of a second peak in the calorimetry diagram indirectly suggests de-metallation of SOD1 when high MGO levels are used. In conclusion, our data demonstrate that MGO has the potential to alter several structural parameters in important proteins of energy metabolism (cytochrome-c) and antioxidant defense (cytochrome-c, SOD1).	[Mercado-Uribe, Hilda; Andrade-Medina, Mariana; Carrillo-Tripp, Mauricio; Quintus Scheckhuber, Christian] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Monterrey, Parque PIIT, Apodaca, Nuevo Leon, Mexico; [Horacio Espinoza-Rodriguez, Juan] Univ Americas Puebla, Escuela Ingn, Cholula, Mexico; [Quintus Scheckhuber, Christian] Tecnol Monterrey, Bioengn Dept, Sch Engn & Sci, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Americas Puebla (UDLAP); Tecnologico de Monterrey	Scheckhuber, CQ (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Monterrey, Parque PIIT, Apodaca, Nuevo Leon, Mexico.	christian.scheckhube@cinvestav.mx	Scheckhuber, Christian Q./A-6462-2012; Espinoza-Rodriguez, J. Horacio/GPK-6313-2022; Espinoza-Rodríguez, J. Horacio/AHI-8357-2022	Scheckhuber, Christian Q./0000-0002-2924-7547; Espinoza-Rodriguez, J. Horacio/0000-0002-2602-660X; 	 [236505]		Received award: HMU Grant number: 236505 Full name: Consejo Nacional de Ciencia y Tecnologia Website: https://www.conacyt.gob.mx/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Abidi M, 2018, ARCH BIOCHEM BIOPHYS, V645, P87, DOI 10.1016/j.abb.2018.02.019; Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Ahmed N, 2003, INVEST OPHTH VIS SCI, V44, P5287, DOI 10.1167/iovs.03-0573; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Bhat SA, 2018, ARCH BIOCHEM BIOPHYS, V650, P103, DOI 10.1016/j.abb.2018.05.015; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Chaplen FWR, 1998, P NATL ACAD SCI USA, V95, P5533, DOI 10.1073/pnas.95.10.5533; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Groener JB, 2019, EXP CLIN ENDOCR DIAB, V127, P497, DOI 10.1055/s-0043-106443; Jyoti, 2016, INT J BIOL MACROMOL, V86, P799, DOI 10.1016/j.ijbiomac.2016.02.019; Kang JH, 2003, MOL CELLS, V15, P194; KUWAJIMA K, 1987, FEBS LETT, V221, P115, DOI 10.1016/0014-5793(87)80363-0; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Mannervik Bengt, 2008, Drug Metabolism and Drug Interactions, V23, P13; Marin EP, 2012, CIRC RES, V110, P1336, DOI 10.1161/CIRCRESAHA.112.269514; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; NALL BT, 1988, BIOCHEMISTRY-US, V27, P7310, DOI 10.1021/bi00419a020; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Oliveira LMA, 2013, BBA-PROTEINS PROTEOM, V1834, P1010, DOI 10.1016/j.bbapap.2012.12.001; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Pasupulati Anil Kumar, 2016, BioMolecular Concepts, V7, P293, DOI 10.1515/bmc-2016-0021; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Rabbani N, 2016, GLYCOCONJUGATE J, V33, P513, DOI 10.1007/s10719-016-9705-z; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rabbani N, 2014, NAT PROTOC, V9, P1969, DOI 10.1038/nprot.2014.129; Rasouli S, 2017, J BIOL CHEM, V292, P19366, DOI 10.1074/jbc.M117.805283; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; Schalkwijk CG, 2020, PHYSIOL REV, V100, P407, DOI 10.1152/physrev.00001.2019; Scheckhuber CQ, 2019, INT J BIOL MACROMOL, V127, P85, DOI 10.1016/j.ijbiomac.2019.01.032; Scheckhuber Christian Q, 2015, BMC Res Notes, V8, P830, DOI 10.1186/s13104-015-1793-5; Scheckhuber CQ, 2010, AGING-US, V2, P969, DOI 10.18632/aging.100251; Sharma GS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41282-2; Shaw BF, 2008, PROTEIN SCI, V17, P1446, DOI 10.1110/ps.035154.108; Shibata N, 1999, ACTA NEUROPATHOL, V97, P240, DOI 10.1007/s004010050980; Sirangelo V, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00055; Sjoblom NM, 2018, ANGEW CHEM INT EDIT, V57, P16077, DOI 10.1002/anie.201810037; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561; Zhang QB, 2007, J PROTEOME RES, V6, P2323, DOI 10.1021/pr070112q	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232408	10.1371/journal.pone.0232408	http://dx.doi.org/10.1371/journal.pone.0232408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353034	Green Published, gold			2022-12-26	WOS:000536673200089
J	Messan, KS; Jones, RM; Doherty, SJ; Foley, K; Douglas, TA; Barbato, RA				Messan, Komi S.; Jones, Robert M.; Doherty, Stacey J.; Foley, Karen; Douglas, Thomas A.; Barbato, Robyn A.			The role of changing temperature in microbial metabolic processes during permafrost thaw	PLOS ONE			English	Article							SOIL BIODIVERSITY; ACTIVE LAYER; BACTERIAL; COMMUNITIES; CARBON; THERMOKARST; PSEUDOMONAS; BIOCONTROL; STRATEGIES; INSIGHTS	Approximately one fourth of the Earth's Northern Hemisphere is underlain by permafrost, earth materials (soil, organic matter, or bedrock), that has been continuously frozen for at least two consecutive years. Numerous studies point to evidence of accelerated climate warming in the Arctic and sub-Arctic where permafrost is located. Changes to permafrost biochemical processes may critically impact ecosystem processes at the landscape scale. Here, we sought to understand how the permafrost metabolome responds to thaw and how this response differs based on location (i.e. chronosequence of permafrost formation constituting diverse permafrost types). We analyzed metabolites from microbial cells originating from Alaskan permafrost. Overall, permafrost thaw induced a shift in microbial metabolic processes. Of note were the dissimilarities in biochemical structure between frozen and thawed samples. The thawed permafrost metabolomes from different locations were highly similar. In the intact permafrost, several metabolites with antagonist properties were identified, illustrating the competitive survival strategy required to survive a frozen state. Interestingly, the intensity of these antagonistic metabolites decreased with warmer temperature, indicating a shift in ecological strategies in thawed permafrost. These findings illustrate the impact of change in temperature and spatial variability as permafrost undergoes thaw, knowledge that will become crucial for predicting permafrost biogeochemical dynamics as the Arctic and Antarctic landscapes continue to warm.	[Messan, Komi S.; Jones, Robert M.; Doherty, Stacey J.; Foley, Karen; Barbato, Robyn A.] US Army Engineer Res & Dev Ctr, Cold Reg Res & Engn Lab, Hanover, NH 03755 USA; [Douglas, Thomas A.] US Army Engineer Res & Dev Ctr, Cold Reg Res & Engn Lab, Fairbanks, AK USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL)	Messan, KS; Barbato, RA (corresponding author), US Army Engineer Res & Dev Ctr, Cold Reg Res & Engn Lab, Hanover, NH 03755 USA.	komi.messan@nih.gov; Robyn.A.Barbato@erdc.dren.mil		Messan, Komi/0000-0001-6176-9591	United States Army Engineer Research and Development Center, Basic Research Program Office and Applied Research Program Office, Environmental Quality and Installations; U.S. Army Basic Research (6.1) Program; Department of Defense's Strategic Environmental Research and Development Program [RC18-C2-1170]	United States Army Engineer Research and Development Center, Basic Research Program Office and Applied Research Program Office, Environmental Quality and Installations; U.S. Army Basic Research (6.1) Program; Department of Defense's Strategic Environmental Research and Development Program	Funding support was provided from the United States Army Engineer Research and Development Center, Basic Research Program Office and Applied Research Program Office, Environmental Quality and Installations. T.A.D. acknowledges the U.S. Army Basic Research (6.1) Program and the Department of Defense's Strategic Environmental Research and Development Program (project RC18-C2-1170).	Akerman HJ, 2008, PERMAFROST PERIGLAC, V19, P279, DOI 10.1002/ppp.626; Barbato RA, 2016, JOVE-J VIS EXP, DOI 10.3791/54091; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Basu S, 2017, BIOINFORMATICS, V33, P1545, DOI 10.1093/bioinformatics/btx012; Beale DJ, 2016, MICROBIAL METABOLOMI, P289, DOI DOI 10.1007/978-3-319-46326-1_10; Bockheim J, 2013, GLOBAL PLANET CHANGE, V100, P215, DOI 10.1016/j.gloplacha.2012.10.018; Brutemark A, 2015, PHYCOL RES, V63, P56, DOI 10.1111/pre.12075; Burkert A, 2019, APPL ENVIRON MICROB, V85, DOI [10.1128/AEM.02646-18, 10.1128/aem.02646-18]; Chen YL, 2017, MOL ECOL, V26, P6608, DOI 10.1111/mec.14396; DeConto RM, 2012, NATURE, V484, P87, DOI 10.1038/nature10929; Deng J, 2015, MOL ECOL, V24, P222, DOI 10.1111/mec.13015; Douglas TA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09410-8; Douglas TA, 2011, PERMAFROST PERIGLAC, V22, P120, DOI 10.1002/ppp.709; DOWLING DN, 1994, TRENDS BIOTECHNOL, V12, P133, DOI 10.1016/0167-7799(94)90091-4; Ernakovich JG, 2017, BIOGEOCHEMISTRY, V134, P183, DOI 10.1007/s10533-017-0354-5; Farres M, 2015, J CHEMOMETR, V29, P528, DOI 10.1002/cem.2736; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Fine A M, 2000, Altern Med Rev, V5, P144; Frey KE, 2009, HYDROL PROCESS, V23, P169, DOI 10.1002/hyp.7196; GHISALBERTI EL, 1991, SOIL BIOL BIOCHEM, V23, P1011, DOI 10.1016/0038-0717(91)90036-J; Gilichinsky DA, 1995, PERMAFROST PERIGLAC, V6, P281, DOI 10.1002/ppp.3430060402; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Griffith AW, 2020, HARMFUL ALGAE, V91, DOI 10.1016/j.hal.2019.03.008; Grubbs K. J., 2019, BIORXIV PREPRINT, DOI [10.1101/511493, DOI 10.1101/511493]; Gunther F, 2015, CRYOSPHERE, V9, P151, DOI 10.5194/tc-9-151-2015; Guyonnet JP, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix022; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Heggie DT, 1999, MAR FRESHWATER RES, V50, P589, DOI 10.1071/MF98054; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hultman J, 2015, NATURE, V521, P208, DOI 10.1038/nature14238; Isaksen K, 2001, PERMAFROST PERIGLAC, V12, P13, DOI 10.1002/ppp.380; Jiang HY, 2011, FOOD CHEM, V129, P830, DOI 10.1016/j.foodchem.2011.05.031; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Karamizadeh S., 2013, JSIP, V4, P173, DOI [10.4236/jsip.2013.43B031, DOI 10.4236/JSIP.2013.43B031]; Krivushin KV, 2010, INT J SYST EVOL MICR, V60, P455, DOI 10.1099/ijs.0.011205-0; LACHENBRUCH AH, 1986, SCIENCE, V234, P689, DOI 10.1126/science.234.4777.689; Lachniet MS, 2016, WATER RESOUR RES, V52, P6575, DOI 10.1002/2016WR019436; Lau MCY, 2015, ISME J, V9, P1880, DOI 10.1038/ismej.2015.13; Liigand P, 2017, ANAL CHEM, V89, P5666, DOI 10.1021/acs.analchem.7b00096; Loranty MM, 2018, BIOGEOSCIENCES, V15, P5287, DOI 10.5194/bg-15-5287-2018; Lurling M, 2017, TOXINS, V9, DOI 10.3390/toxins9020064; Mackelprang R, 2017, ISME J, V11, P2305, DOI 10.1038/ismej.2017.93; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Margesin R, 2019, APPL MICROBIOL BIOT, V103, P1, DOI [10.1007/s00253-018-9435-1, DOI 10.1007/S00253-018-9435-1]; Miao GP, 2019, SYMBIOSIS, V77, P83, DOI [10.1007/s13199-018-0565-0, 10.10]; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Mishra P, 2017, CHEMOSPHERE, V188, P157, DOI 10.1016/j.chemosphere.2017.08.149; Mondav R, 2017, ENVIRON MICROBIOL, V19, P3201, DOI 10.1111/1462-2920.13809; MORLEY CR, 1983, MICROB ECOL, V9, P329, DOI 10.1007/BF02019022; Nagano H, 2018, SOIL SCI PLANT NUTR, V64, P793, DOI 10.1080/00380768.2018.1525267; Nelson FE, 2001, NATURE, V410, P889, DOI 10.1038/35073746; Osterkamp TE, 1999, PERMAFROST PERIGLAC, V10, P17, DOI 10.1002/(SICI)1099-1530(199901/03)10:1&lt;17::AID-PPP303&gt;3.0.CO;2-4; Ozerskaya Svetlana, 2009, V16, P85; Prasain P., 2016, METABOLOMICS FUNDAME, P63; RCore Team, 2020, R LANG ENV STAT COMP; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Romanovsky VE, 2010, PERMAFROST PERIGLAC, V21, P106, DOI 10.1002/ppp.689; Rowland J., 2010, EOS T AGU, V91, P229, DOI DOI 10.1029/2010EO260001; Schuur EAG, 2007, ECOSYSTEMS, V10, P280, DOI 10.1007/s10021-007-9024-0; Sellmann PV, 1967, GEOLOGY US CRREL PER; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Shi T, 1997, MICROB ECOL, V33, P169, DOI 10.1007/s002489900019; Spaans SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00742; Spiegler V, 2015, MOLECULES, V20, P14810, DOI 10.3390/molecules200814810; Stackhouse BT, 2015, J GEOPHYS RES-BIOGEO, V120, P1764, DOI 10.1002/2015JG003004; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Tripathi BM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18777-x; Turetsky MR, 2019, NATURE, V569, P32, DOI 10.1038/d41586-019-01313-4; Tyc O, 2017, TRENDS MICROBIOL, V25, P280, DOI 10.1016/j.tim.2016.12.002; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vishnivetskaya T, 2000, EXTREMOPHILES, V4, P165, DOI 10.1007/s007920070031; Vorobyova E, 1997, FEMS MICROBIOL REV, V20, P277, DOI 10.1016/S0168-6445(97)00047-8; Waldrop MP, 2010, GLOBAL CHANGE BIOL, V16, P2543, DOI 10.1111/j.1365-2486.2009.02141.x; Wall DH, 1999, APPL SOIL ECOL, V13, P137, DOI 10.1016/S0929-1393(99)00029-3; Wall DH, 1999, BIOSCIENCE, V49, P109, DOI 10.2307/1313536; Wallenstein MD, 2010, SOIL BIOL BIOCHEM, V42, P484, DOI 10.1016/j.soilbio.2009.12.001; Walls JT, 2018, SCI TOTAL ENVIRON, V610, P786, DOI 10.1016/j.scitotenv.2017.08.149; Walsh UF, 2001, CURR OPIN BIOTECH, V12, P289, DOI 10.1016/S0958-1669(00)00212-3; Wang JL, 1999, PROCESS BIOCHEM, V34, P745; Wang YN, 2019, J CLEAN PROD, V226, P540, DOI 10.1016/j.jclepro.2019.04.128; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wold S, CHEMOMETRICS INTELLI, V58, P109; Woodcroft BJ, 2018, NATURE, V560, P49, DOI 10.1038/s41586-018-0338-1; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang T.J., 2000, POLAR GEOGR, V24, P126, DOI [10.1080/10889370009377692, DOI 10.1080/10889370009377692]; Zhang X, 2020, SCI TOTAL ENVIRON, V710, DOI 10.1016/j.scitotenv.2019.136314; Zucconi L, 2012, POLAR BIOL, V35, P749, DOI 10.1007/s00300-011-1119-6	90	11	11	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232169	10.1371/journal.pone.0232169	http://dx.doi.org/10.1371/journal.pone.0232169			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353013	Green Published, gold			2022-12-26	WOS:000536673200047
J	Paudel, R; Fedorova, L; Fedorov, A				Paudel, Rajan; Fedorova, Larisa; Fedorov, Alexei			Adapting Biased Gene Conversion theory to account for intensive GC-content deterioration in the human genome by novel mutations	PLOS ONE			English	Article							MAMMALIAN GENOMES; BASE COMPOSITION; EVOLUTION; ISOCHORES; RECOMBINATION; NUCLEOTIDE; SIGNATURES; DIVERSITY; SELECTION; FIXATION	We examined seventy million well-characterized human mutations, and their impact on G +C-compositional dynamics, in order to understand the formation and maintenance of major genomic nucleotide sequence patterns. Among novel mutations, those that change a strong (S) base pair G:C/C:G to a weak (W) pair A:T/T:A occur at nearly twice the frequency of the opposite mutations. Such imbalance puts strong downward pressure on overall GC-content. However, along protracted paths to fixation, S -> W mutations are much less likely to propagate than W -> S mutations. The magnitude of relative propagation disadvantages for S -> W mutations is inexplicable by any currently-accepted model. This fact forced us to re-examine the quantitative features of Biased Gene Conversion (BGC) theory. Revised parameters of BGC that, per average individual, convert 7-14 W base pairs into S pairs, would account for the S-content turnover differences between new and old mutations, and make BGC an instrumental force for nucleotide dynamics and evolution. BGC should thus be considered seriously in both theories and biomedical practice. In particular, BGC should be taken into account during allele imputations, where missing SNP alleles are computationally predicted based on the information about several neighboring alleles. Finally, we analyzed the effect of neighboring nucleotide context on the mutation frequencies, dynamics, and GC-composition turnover. For this purpose, we examined genomic regions having extremely biased nucleotide compositions (enriched for S-, W-, purine/pyrimidine strand asymmetry, or AC/GT-strand asymmetry). It was found that point mutations in these regions preferentially degrade the nucleotide inhomogeneities, decreasing the sequence biases. Degradation of sequence bias is highest for novel mutations, and considerably lower for older mutations (those widespread across populations). Besides BGC, there may be additional, still uncharacterized molecular mechanisms that either preserve genomic regions with biased nucleotide compositions from mutational degradation or fail to degrade such inhomogeneities in specific chromosomal regions.	[Paudel, Rajan; Fedorov, Alexei] Univ Toledo, Program Bioinformat & Prote Genom, 2801 W Bancroft St, Toledo, OH 43606 USA; [Fedorova, Larisa; Fedorov, Alexei] CRI Genet LLC, Santa Monica, CA 90404 USA; [Fedorov, Alexei] Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Fedorov, A (corresponding author), Univ Toledo, Program Bioinformat & Prote Genom, 2801 W Bancroft St, Toledo, OH 43606 USA.; Fedorov, A (corresponding author), CRI Genet LLC, Santa Monica, CA 90404 USA.; Fedorov, A (corresponding author), Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	Alexei.fedorov@utoledo.edu			CRI Genetics	CRI Genetics	The funder (CRI Genetics) provided support in the form of salaries for the author [LF] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agashe D, 2014, J EXP ZOOL PART B, V322, P517, DOI 10.1002/jez.b.22565; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Aslam S, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1365-8; Bechtel JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-284; BERNARDI G, 1993, MOL BIOL EVOL, V10, P186; Bernardi G, 2012, ANN NY ACAD SCI, V1267, P31, DOI 10.1111/j.1749-6632.2012.06591.x; Bohlin J, 2019, COMPUT STRUCT BIOTEC, V17, P362, DOI 10.1016/j.csbj.2019.03.001; Cole F, 2014, NAT GENET, V46, P1072, DOI 10.1038/ng.3068; Costantini M, 2017, J MOL EVOL, V84, P93, DOI 10.1007/s00239-017-9785-9; Dutta R, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4593-1; Eyre-Walker A, 1999, GENETICS, V152, P675; Fedorova L, 2011, THESCIENTIFICWORLDJO, V11, P842, DOI 10.1100/tsw.2011.82; Galtier N, 2001, GENETICS, V159, P907; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Gay J, 2007, GENETICS, V177, P881, DOI 10.1534/genetics.107.078907; Jabbari K, 1998, GENE, V224, P123, DOI 10.1016/S0378-1119(98)00474-0; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; KIMURA M, 1969, GENETICS, V61, P763; Kimura M., 1983, NEUTRAL THEORY MOL E; Lee ES., 2006, ANAL COMPLEX SURVEY, P50, DOI 10.4135/9781412983341.n6; Lesecque Y, 2013, MOL BIOL EVOLUTION; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; McCandlish DM, 2014, Q REV BIOL, V89, P225, DOI 10.1086/677571; Melamed-Bessudo C, 2016, CURR OPIN PLANT BIOL, V30, P82, DOI 10.1016/j.pbi.2016.02.003; Messer PW, 2016, TRENDS GENET, V32, P408, DOI 10.1016/j.tig.2016.04.005; Mugal CF, 2013, MOL BIOL EVOL, V30, P1700, DOI 10.1093/molbev/mst067; Odenthal-Hesse L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004106; Ohno M, 2019, GENES GENET SYST, V94, P13, DOI 10.1266/ggs.18-00015; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Park L, 2011, GENET RES, V93, P105, DOI 10.1017/S0016672310000558; Park L, 2009, GENET RES, V91, P293, DOI 10.1017/S0016672309990164; Paudel R., 2019, THESIS; Prakash A, 2011, THESIS; Prakash A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-513; Qiu SH, 2014, GENOME BIOL EVOL, V6, P988, DOI 10.1093/gbe/evu075; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Segovia R, 2015, TRENDS GENET, V31, P465, DOI 10.1016/j.tig.2015.04.001; Vinogradov AE, 2005, TRENDS GENET, V21, P639, DOI 10.1016/j.tig.2005.09.002; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Williams AL, 2015, ELIFE, V4, DOI 10.7554/eLife.04637; Yu N, 2003, GENETICS, V164, P1511	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232167	10.1371/journal.pone.0232167	http://dx.doi.org/10.1371/journal.pone.0232167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353016	Green Published, gold			2022-12-26	WOS:000536673200046
J	Priest, ND; Dauer, LT; Hoel, DG				Priest, Nicholas D.; Dauer, Lawrence T.; Hoel, David G.			Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment	PLOS ONE			English	Article							THERAPY; RISK	The use of low doses of radium-224 (Ra-224) chloride for the treatment of ankylosing spondylitis was stopped following the discovery that patients treated with it had a higher than control incidence of leukaemia and other cancers. This was so even though the treatment resulted in decreased pain and increased mobility-both of which are associated with decreased mortality. It was decided to re-analyze the epidemiological data looking at all causes of death. The risk of leukaemia, solid cancer, death from non-cancer causes and from all causes in a study populations of men that received either the typical dose of 5.6 to 11.1 MBq of Ra-224, any dose of Ra-224 or no radium were compared using the Cox proportional hazard model. For patients that received the typical dose of Ra-224 agreed with the excess cancer was similar to that reported in previous studies. In contrast, these patients were less likely to die from non-cancer diseases and from all causes of death than the control patients. No excess mortality was also found in the population of all males that received the radionuclide. It is concluded that Ra-224 treatment administered at low doses to patients with ankylosing spondylitis did not impact mortality from all causes. The study demonstrates the need to consider all causes of death and longevity when assessing health impacts following irradiation.	[Priest, Nicholas D.] Canadian Nucl Labs, Radiobiol & Hlth, Chalk River, ON, Canada; [Dauer, Lawrence T.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, 1275 York Ave, New York, NY 10021 USA; [Hoel, David G.] Med Univ South Carolina, Charleston, SC 29425 USA	Atomic Energy of Canada Limited; Memorial Sloan Kettering Cancer Center; Medical University of South Carolina	Hoel, DG (corresponding author), Med Univ South Carolina, Charleston, SC 29425 USA.	dghoel@gmail.com		Dauer, Lawrence/0000-0002-5629-8462; Hoel, David/0000-0002-1178-1610	NCI NIH HHS [P30 CA008748] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERTRAND A, 1978, HEALTH PHYS, V35, P57, DOI 10.1097/00004032-197807000-00005; Bickel A., 1913, BERL KLIN WSCHR, V50, P346; ICRP. International Commission on Radiological Protection, 1993, ICRP PUBL, V65; JIMENEZBALDERAS EJ, 1993, J RHEUMATOL, V20, P2069; KOCH W, 1978, Z ORTHOP GRENZGEB, V116, P608; Landesmann B., 2018, PROTEIN ALKYLATION L; Lassmann M, 2002, RADIAT ENVIRON BIOPH, V41, P173, DOI 10.1007/s00411-002-0164-5; LLOYD EL, 1983, HEALTH PHYS, V44, P135, DOI 10.1097/00004032-198306001-00011; Mathias D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157616; Miller SC, 2005, STATUS TABLES RADIOB; Nekolla EA, 2010, RADIAT RES, V174, P377, DOI 10.1667/RR1955.1; PRIEST ND, 1995, HEALTH PHYS, V69, P330, DOI 10.1097/00004032-199509000-00004; Priest ND, DOSE RESPONSE; RADFORD EP, 1977, NEW ENGL J MED, V297, P572, DOI 10.1056/NEJM197709152971103; Rutherford E, 1902, PHILOS MAG, V4, P370; SCHALES F, 1978, HEALTH PHYS, V35, P25, DOI 10.1097/00004032-197807000-00003; Speiss H, 1971, CORRIGENDUM HLTH PHY, V20, P543; Speiss H, 1970, HEALTH PHYS, V19, P71329; Spiess H, 2010, HEALTH PHYS, V99, P286, DOI 10.1097/HP.0b013e3181cb857f; Spiess H, 2002, RADIAT ENVIRON BIOPH, V41, P163, DOI 10.1007/s00411-002-0165-4; Troch P., 1949, PETOSTHOR NEUE WEGE; Wick RR, 2009, RADIAT ENVIRON BIOPH, V48, P287, DOI 10.1007/s00411-009-0227-y; WICK RR, 1999, RADIAT RES, V152, pS	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232597	10.1371/journal.pone.0232597	http://dx.doi.org/10.1371/journal.pone.0232597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353063	Green Published, gold			2022-12-26	WOS:000536673200107
J	Sehovic, E; Spahic, L; Smajlovic-Skenderagic, L; Pistoljevic, N; Dzanko, E; Hajdarpasic, A				Sehovic, Emir; Spahic, Lemana; Smajlovic-Skenderagic, Lejla; Pistoljevic, Nirvana; Dzanko, Eldin; Hajdarpasic, Aida			Identification of developmental disorders including autism spectrum disorder using salivary miRNAs in children from Bosnia and Herzegovina	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; MENTAL-RETARDATION; SEX-DIFFERENCES; YOUNG-CHILDREN; MICRORNAS; GENE; DYSREGULATION; PREVALENCE; BLOOD; CELLS	Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by major social, communication and behavioural challenges. The cause of ASD is still unclear and it is assumed that environmental, genetic and epigenetic factors influence the risk of ASD occurrence. MicroRNAs (miRNAs) are short 21-25 nucleotide long RNA molecules which post-transcriptionally regulate gene expression. MiRNAs play an important role in central nervous system development; therefore, dysregulation of miRNAs is connected to changes in behaviour and cognition observed in many disorders including ASD. Based on previously published work, on diagnosing ASD using miRNAs, we hypothesized that miRNAs can be used as biomarkers in children with suspected developmental disorders (DD) including ASD within Bosnian-Herzegovinian (B&H) population. 14 selected miRNAs were tested on saliva of children with suspected developmental disorders including ASD. The method of choice was qRT-PCR as a relatively cheap method available in most diagnostic laboratories in low to mid-income countries (LMIC). Out of 14 analysed miRNAs, 6 were differentially expressed between typically developing children and children with some type of developmental disorder including autism spectrum disorder. Using the most optimal logistic regression, we were able to distinguish between ASD and typically developing (TD) children. We have found 5 miRNAs as potential biomarkers. From those, 3 were differentially expressed within the ASD cohort. All 5 miRNAs had shown good chi-square statistics within the logistic regression performed on all 14 analysed miRNAs. The accuracy of 5-miRNAs model training set was 90.2%, while the validation set had a 90% accuracy. This study has shown that miRNAs may be considered as biomarkers for ASD detection and may be used to identify children with ASD along with standard developmental screening tests. By combining these methods we may be able to reach a reliable and accessible diagnostic model for children with ASD in LMIC such as B&H.	[Sehovic, Emir; Spahic, Lemana; Smajlovic-Skenderagic, Lejla] Int Burch Univ, Genet & Bioengn, Sarajevo, Bosnia & Herceg; [Pistoljevic, Nirvana; Dzanko, Eldin] Educ All EDUS, Sarajevo, Bosnia & Herceg; [Hajdarpasic, Aida] Sarajevo Sch Sci & Technol, Sarajevo Med Sch, Dept Med Biol, Sarajevo, Bosnia & Herceg	University of Sarajevo	Hajdarpasic, A (corresponding author), Sarajevo Sch Sci & Technol, Sarajevo Med Sch, Dept Med Biol, Sarajevo, Bosnia & Herceg.	aida.saracevic@ssst.edu.ba	Smajlovic, Lejla/AAV-5124-2020; Pistoljevic, Nirvana/HCI-1825-2022; , WaNgtJ/AAR-7045-2020	Smajlovic, Lejla/0000-0003-2638-1713; Pistoljevic, Nirvana/0000-0001-5909-8805; Spahic, Lemana/0000-0002-0922-6335; Sehovic, Emir/0000-0003-3375-0441; Hajdarpasic, Aida/0000-0001-8131-4084	United States Agency for International Development (USAID) through the Marginalized Populations Support Activity in Bosnia and Herzegovina (USAID/PPMG)	United States Agency for International Development (USAID) through the Marginalized Populations Support Activity in Bosnia and Herzegovina (USAID/PPMG)(United States Agency for International Development (USAID))	The research and development of this publication was supported by the United States Agency for International Development (USAID) through the Marginalized Populations Support Activity in Bosnia and Herzegovina (USAID/PPMG) to NP. The views expressed in this publication do not necessarily reflect those of USAID or the United States Government, and are the exclusive responsibility of the author and the research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ander BP, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0029-9; Bachmann CJ, 2018, AUTISM, V22, P283, DOI 10.1177/1362361316673977; Bahlo M, 2010, CANCER EPIDEM BIOMAR, V19, P794, DOI 10.1158/1055-9965.EPI-09-0812; Brown TT, 2012, NEUROPSYCHOL REV, V22, P313, DOI 10.1007/s11065-012-9214-1; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Christensen Deborah L, 2018, MMWR Surveill Summ, V65, P1, DOI [10.15585/mmwr.ss6503a1, 10.15585/mmwr.ss6513a1]; Collins PY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002393; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Elder JH, 2017, PSYCHOL RES BEHAV MA, V10, P283, DOI 10.2147/PRBM.S117499; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Frazier TW, 2014, J AM ACAD CHILD PSY, V53, P329, DOI 10.1016/j.jaac.2013.12.004; Gallo A., 2012, PLOS ONE, V7; Greer R.D., 1997, BEHAV SOCIAL ISSUES, V7, P59, DOI [DOI 10.5210/BSI.V7I1.300, 10.5210/bsi.v7i1.300]; Greer R.D., 2002, BEHAV ANAL TODAY, V3, P120, DOI DOI 10.1037/H0099977; Greer RD., 2008, VERBAL BEHAV ANAL IN; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hicks SD, 2019, J AM ACAD CHILD ADOL; Hicks SD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00534; Hicks SD, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00176; Hicks SD, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0586-x; Huang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129000; Hulusic V, 2016, LECT NOTES COMPUT SC, V9599, P255, DOI 10.1007/978-3-319-40216-1_27; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Jung C. R, 2013, PLOS ONE, V8, pe755, DOI [10.10.1371/journal.pone.0075510, DOI 10.HTTPS://D0I.0RG/10.1371/J0URNAL.P0NE]; Karam R, 2012, RNA BIOL, V9, P22, DOI 10.4161/rna.9.1.18010; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Kos A, 2016, CELL MOL LIFE SCI, V73, P3555, DOI 10.1007/s00018-016-2179-0; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Kubota T, 2002, CYTOGENET GENOME RES, V99, P276, DOI 10.1159/000071604; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Lamm N., 1991, J BEHAV EDUC, V1, P427, DOI 10.1007/BF00946776; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lintas C, 2009, J MED GENET, V46, P1, DOI 10.1136/jmg.2008.060871; Masi A, 2017, NEUROSCI BULL, V33, P183, DOI 10.1007/s12264-017-0100-y; Mor M, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0040-1; Nguyen LS, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-015-0064-6; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Onaolapo A. Y., 2017, UNIVERSAL J CLIN MED, V5, P14, DOI [10.13189/ujcm.2017.050202, DOI 10.13189/UJCM.2017.050202]; Pistoljevic N, 2016, DEV BEHAV SCREENING; Popov NT, 2012, BIOTECHNOL BIOTEC EQ, V26, P3385, DOI 10.5504/BBEQ.2012.0093; Rai Shesh N, 2012, Open Access Med Stat, V2012, P21; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Schopler E., 2010, CHILDHOOD AUTISM RAT; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; SELINSKE JE, 1991, J APPL BEHAV ANAL, V24, P107, DOI 10.1901/jaba.1991.24-107; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P691, DOI 10.1001/jama.2016.0018; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Suren Pal, 2013, Tidsskr Nor Laegeforen, V133, P1929, DOI 10.4045/tidsskr.13.0050; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Tierney Adrienne L, 2009, Zero Three, V30, P9; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Toriello HV, 2012, PEDIATR CLIN N AM, V59, P113, DOI 10.1016/j.pcl.2011.10.014; Vaccaro TD, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8080075; Vasu MM, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-40; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; World Bank, 2015, BOSN HERZ COUNTR PAR; Wu YE, 2016, NAT NEUROSCI, V19, P1463, DOI 10.1038/nn.4373; Xu GF, 2018, JAMA-J AM MED ASSOC, V319, P81, DOI 10.1001/jama.2017.17812; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Zubakov D, 2008, INT J LEGAL MED, V122, P135, DOI 10.1007/s00414-007-0182-6	81	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232351	10.1371/journal.pone.0232351	http://dx.doi.org/10.1371/journal.pone.0232351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353026	gold, Green Published			2022-12-26	WOS:000536673200080
J	Itokawa, K; Hu, JP; Sukehiro, N; Tsuda, Y; Komagata, O; Kasai, S; Tomita, T; Minakawa, N; Sawabe, K				Itokawa, Kentaro; Hu, Jinping; Sukehiro, Nayu; Tsuda, Yoshio; Komagata, Osamu; Kasai, Shinji; Tomita, Takashi; Minakawa, Noboru; Sawabe, Kyoko			Genetic analysis of Aedes aegypti captured at two international airports serving to the Greater Tokyo Area during 2012-2015	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; DENGUE-FEVER; POPULATION; VECTOR; CULICIDAE; INFERENCE; ALIGNMENT; SEQUENCE; PROGRAM; DIPTERA	The introduction of exotic disease vectors into a new habitat can drastically change the local epidemiological situation. During 2012-2015, larvae and an adult of the yellow-fever mosquito, Aedes aegypti, were captured alive at two international airports serving the Greater Tokyo Area, Japan. Because this species does not naturally distribute in this country, those mosquitoes were considered to be introduced from overseas via air-transportation. To infer the places of origin of those mosquitoes, we genotyped the 12 microsatellite loci for which the most comprehensive population genetic reference is currently available. Although clustering by Bayesian and multivariate methods both suggested that all those mosquitoes captured at the airports in Japan belonged to the Asia/Pacific populations, they were not clustered into a single cluster. Moreover, there was variation in mitochondrial cytochrome oxidase I gene (CoxI) haplotypes among mosquitoes collected in different incidents of discovery which indicated the existence of multiple maternal origins. We conclude there is little evidence to support the overwintering of Ae. aegypti at the airports; nevertheless, special attention is still needed to prevent the invasion of this prominent arbovirus vector.	[Itokawa, Kentaro] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Hu, Jinping; Minakawa, Noboru] Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki, Japan; [Sukehiro, Nayu] Fukuoka Quarantine Stn, Fukuoka, Japan; [Tsuda, Yoshio; Komagata, Osamu; Kasai, Shinji; Tomita, Takashi; Sawabe, Kyoko] Natl Inst Infect Dis, Dept Med Entomol, Tokyo, Japan; [Komagata, Osamu] Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Nagasaki University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Itokawa, K (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	itokawa@nih.go.jp		, Noboru/0000-0003-3664-9605; Itokawa, Kentaro/0000-0003-1300-9883	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development (AMED); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sports, Science and Technology in Japan; AMED	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sports, Science and Technology in Japan; AMED	This research was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development (AMED) and by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sports, Science and Technology in Japan and AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196; Falush D, 2003, GENETICS, V164, P1567; Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226; Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866; Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029; Gratz NG, 2000, B WORLD HEALTH ORGAN, V78, P995; Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0; Jaimes-Duenez J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003553; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]; Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351; Mitchell A, INSECT SYST EVOL; Morlais I, 2002, DNA SEQUENCE, V13, P123, DOI 10.1080/10425170290030051; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Powell JR, 2018, BIOSCIENCE, V68, P854, DOI 10.1093/biosci/biy119; Pritchard JK, 2000, GENETICS, V155, P945; Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rudbeck L, 1998, BIOTECHNIQUES, V25, P588, DOI 10.2144/98254bm09; Schmidt TL, 2019, EVOL APPL; Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386; Sukehiro N, 2016, J JAPAN QUAR MED ASS, V18, P52; Sukehiro N, 2013, JPN J INFECT DIS, V66, P189, DOI 10.7883/yoken.66.189; Tanaka K, 1979, CONTRIB AM ENTOMOL I, V16, P98; Vadivalagan C, 2016, PARASITOL RES, V115, P1149, DOI 10.1007/s00436-015-4847-7	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232192	10.1371/journal.pone.0232192	http://dx.doi.org/10.1371/journal.pone.0232192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343725	Green Published, gold, Green Submitted			2022-12-26	WOS:000536661300040
J	Makumire, S; Zininga, T; Vahokoski, J; Kursula, I; Shonhai, A				Makumire, Stanley; Zininga, Tawanda; Vahokoski, Juha; Kursula, Inari; Shonhai, Addmore			Biophysical analysis of Plasmodium falciparum Hsp70-Hsp90 organising protein (PfHop) reveals a monomer that is characterised by folded segments connected by flexible linkers	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SMALL-ANGLE SCATTERING; SECONDARY STRUCTURE; CHAPERONE ACTIVITY; ATPASE ACTIVITY; HSP90; HOP; COMPLEXES; BINDING; PREDICTION	Plasmodium falciparum causes the most lethal form of malaria. The cooperation of heat shock protein (Hsp) 70 and 90 is thought to facilitate folding of select group of cellular proteins that are crucial for cyto-protection and development of the parasites. Hsp70 and Hsp90 are brought into a functional complex that allows substrate exchange by stress inducible protein 1 (STI1), also known as Hsp70-Hsp90 organising protein (Hop). P. falciparum Hop (PfHop) co-localises and occurs in complex with the parasite cytosolic chaperones, PfHsp70-1 and PfHsp90. Here, we characterised the structure of recombinant PfHop using synchrotron radiation circular dichroism (SRCD) and small-angle X-ray scattering. Structurally, PfHop is a monomeric, elongated but folded protein, in agreement with its predicted TPR domain structure. Using SRCD, we established that PfHop is unstable at temperatures higher than 40 degrees C. This suggests that PfHop is less stable at elevated temperatures compared to its functional partner, PfHsp70-1, that is reportedly stable at temperatures as high as 80 degrees C. These findings contribute towards our understanding of the role of the Hop-mediated functional partnership between Hsp70 and Hsp90.	[Makumire, Stanley; Zininga, Tawanda; Shonhai, Addmore] Univ Venda, Dept Biochem, Sch Math & Nat Sci, Thohoyandou, South Africa; [Zininga, Tawanda] Stellenbosch Univ, Dept Biochem, Stellenbosch, South Africa; [Vahokoski, Juha; Kursula, Inari] Univ Bergen, Dept Biomed, Bergen, Norway; [Kursula, Inari] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kursula, Inari] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland	University of Venda; Stellenbosch University; University of Bergen; University of Oulu; University of Oulu	Shonhai, A (corresponding author), Univ Venda, Dept Biochem, Sch Math & Nat Sci, Thohoyandou, South Africa.	addmore.shonhai@univen.ac.za	Zininga, Tawanda/AAY-1428-2021; Kursula, Inari/AHB-9980-2022; Shonhai, Addmore/AAS-4506-2021	Kursula, Inari/0000-0001-5236-7056; Makumire, Stanley/0000-0003-4355-1382	Sigrid Juselius Foundation [L1/402/14-1]; Deutsche Forchungsgemeinshaft [75464, 92598]; National Research Foundation/Department of Science & Innovation of South Africa [111989]; National Research Foundation of South Africa	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Deutsche Forchungsgemeinshaft(German Research Foundation (DFG)); National Research Foundation/Department of Science & Innovation of South Africa; National Research Foundation of South Africa(National Research Foundation - South Africa)	1. IK, Sigrid Juse ' lius Foundation; https://sigridjuselius.fi/en/2.AS, L1/402/14-1; Deutsche Forchungsgemeinshaft; https://www.validatenetwork.org/event/german-african-cooperation-projects-in-infectiology-dfg 3. AS; 75464; 92598; National Research Foundation/Department of Science & Innovation of South Africa; https://www.nrf.ac.za/3.TZ; 111989; National Research Foundation of South Africa; www.nrf.ac.za	Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Batista FAH, 2016, ARCH BIOCHEM BIOPHYS, V600, P12, DOI 10.1016/j.abb.2016.04.008; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carrigan PE, 2005, J BIOL CHEM, V280, P8906, DOI 10.1074/jbc.M414245200; Charnaud SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181656; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Genest O, 2015, J MOL BIOL, V427, P3877, DOI 10.1016/j.jmb.2015.10.010; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; Hildenbrand ZL, 2011, ONCOTARGET, V2, P43; Hombach A, 2014, PARASITOLOGY, V141, P1156, DOI 10.1017/S0031182013002151; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kravats AN, 2018, P NATL ACAD SCI USA, V115, pE2210, DOI 10.1073/pnas.1719969115; Kravats AN, 2017, J MOL BIOL, V429, P858, DOI 10.1016/j.jmb.2016.12.014; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Misra G, 2009, BIOPHYS CHEM, V142, P55, DOI 10.1016/j.bpc.2009.03.006; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Pallavi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-236; Posfai D, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01799-17; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Reidy M, 2018, GENETICS, V209, P1139, DOI 10.1534/genetics.118.301178; Rohl A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7655; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schmidt JC, 2018, PARASITOL INT, V67, P131, DOI 10.1016/j.parint.2017.10.009; Shahinas D, 2013, PATHOGENS, V2, P33, DOI 10.3390/pathogens2010033; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A., 2014, HEAT SHOCK PROTEINS, P47, DOI [10.1007/978-94-007-7438-4_3, DOI 10.1007/978-94-007-7438-4_3]; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Silva NSM, 2020, BBA-PROTEINS PROTEOM, V1868, DOI [10.1016/j.bbapap.2019.140282, 10.1016/j.]; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sun M, 2019, J BIOL CHEM, V294, P6387, DOI 10.1074/jbc.RA118.007050; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Wang T, 2014, J MED CHEM, V57, P2524, DOI 10.1021/jm401801t; Yamamoto S, 2014, J BIOL CHEM, V289, P9880, DOI 10.1074/jbc.M114.553255; Yi F, 2010, PROTEIN SCI, V19, P19, DOI 10.1002/pro.278; Zininga T, 2018, MOLECULES, V23, DOI 10.3390/molecules23112846; Zininga T, 2017, MOLECULES, V22, DOI 10.3390/molecules22122139; Zininga T, 2017, CELL STRESS CHAPERON, V22, P707, DOI 10.1007/s12192-017-0797-6; Zininga T, 2016, CELL STRESS CHAPERON, V21, P499, DOI 10.1007/s12192-016-0678-4; Zininga T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135326; Zininga T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129445	53	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0226657	10.1371/journal.pone.0226657	http://dx.doi.org/10.1371/journal.pone.0226657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343703	Green Submitted, gold, Green Published			2022-12-26	WOS:000536661300002
J	Sun, JH; Yang, L; Wei, J; Quan, JN; Yang, XT				Sun, Jinhua; Yang, Liu; Wei, Jie; Quan, Jine; Yang, Xitian			The responses of soil bacterial communities and enzyme activities to the edaphic properties of coal mining areas in Central China	PLOS ONE			English	Article							MICROBIAL DIVERSITY; LAND SUBSIDENCE; CARBON; AFFORESTATION; AMENDMENTS; GROWTH; MANURE	Soil physicochemical properties, bacterial communities and enzyme activities change with land subsidence resulting from coal mining. However, research on the responses of bacterial communities and enzyme activities to the soil properties in different degree of subsidence areas is limited. As such, we collected soil samples from a control area (C area), a moderate mining subsidence area (M area) and a severe mining subsidence area (S area) in Central China. Soil properties, such as the pH, total nitrogen (TN) content, total phosphorus (TP) content, available phosphorus (AP) content, organic matter (OM) content, and soil enzyme (urease, invertase, catalase and alkaline phosphatase) activities were measured in each sampling area at depths of 0-20 cm, 20-40 cm, and 40-60 cm. The results indicated that the soil physiochemical properties, soil urease activity, soil alkaline phosphatase activity and soil bacterial richness and diversity in the topsoil (0-20 cm) of the mining subsidence area were significantly lower than those in the C area. However, the soil enzyme activities within the deepest layer of the subsidence area were significantly greater than those of the C area. The bacterial communities within the depth of 0-20 cm were dominated by RB41, Pseudomonas, MND1, Nitrospira, Trichococcus, Sphingomonas and Dongia, whereas RB41 and Pseudomonas were the dominant species in the C area and subsidence area, respectively. Using correlation analysis, we found that the soil pH value, soil AP content and activities of the four enzymes were the main factors affecting the soil bacterial community structure. In addition, the soil nutrient contents, enzyme activities and bacterial richness and evenness decreased with increasing subsidence degree (classified by geological hazards, groundwater and landscape damage degree of coal mining subsidence). These results provide a reliable basis for environmental management of mining areas.	[Sun, Jinhua; Yang, Liu; Quan, Jine; Yang, Xitian] Henan Agr Univ, Coll Forestry, Zhengzhou, Peoples R China; [Wei, Jie] Henan Ecol & Environm Monitoring Ctr, Zhengzhou, Peoples R China	Henan Agricultural University	Yang, XT (corresponding author), Henan Agr Univ, Coll Forestry, Zhengzhou, Peoples R China.	xitianyang@aliyun.com	SUN, JIN/GPX-9641-2022		School-level Doctoral Start-up Fund [30500650]; National Natural Fund Project [31700549]	School-level Doctoral Start-up Fund; National Natural Fund Project	The funding sources that supported this work are the School-level Doctoral Start-up Fund (No.30500650) and National Natural Fund Project (No.31700549).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No conflict of interest exists in the submission of this manuscript	Aislabie JM, 2006, SOIL BIOL BIOCHEM, V38, P3041, DOI 10.1016/j.soilbio.2006.02.018; Albiach R, 2000, BIORESOURCE TECHNOL, V75, P43, DOI 10.1016/S0960-8524(00)00030-4; Alef K., 1995, METHODS APPL SOIL MI, P350; [Anonymous], FAO UNESCO SOIL B; Bao S.D., 1999, ANAL SOIL AGR CHEM, V3rd Edn; Bastida F, 2018, SCI TOTAL ENVIRON, V640, P18, DOI 10.1016/j.scitotenv.2018.05.288; Boerner REJ, 2005, SOIL BIOL BIOCHEM, V37, P1419, DOI 10.1016/j.soilbio.2004.12.012; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Dallaire K, 2019, FORESTS, V10, DOI 10.3390/f10070549; Delgado-Baquerizo M, 2018, ECOLOGY, V99, P583, DOI 10.1002/ecy.2137; Fungo B, 2017, FIELD CROP RES, V209, P179, DOI 10.1016/j.fcr.2017.05.013; Gao YC, 2015, APPL SOIL ECOL, V86, P165, DOI 10.1016/j.apsoil.2014.10.011; Guan Y. M, 1986, SOIL ENZYMES RES MET; Jing X, 2017, SCI TOTAL ENVIRON, V607, P806, DOI 10.1016/j.scitotenv.2017.07.060; Jing ZR, 2018, J CLEAN PROD, V177, P350, DOI 10.1016/j.jclepro.2017.12.191; Jurburg SD, 2015, BIODIVERSITY IN ECOSYSTEMS - LINKING STRUCTURE AND FUNCTION, P29, DOI 10.5772/58981; Khan S, 2017, J SOIL SCI PLANT NUT, V17, P240; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Landesman WJ, 2014, SOIL BIOL BIOCHEM, V76, P201, DOI 10.1016/j.soilbio.2014.05.025; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li YY, 2014, J MICROBIOL BIOTECHN, V24, P313, DOI 10.4014/jmb.1309.09001; Liang YC, 2005, SOIL BIOL BIOCHEM, V37, P1185, DOI 10.1016/j.soilbio.2004.11.017; Mander C, 2012, SOIL BIOL BIOCHEM, V44, P93, DOI 10.1016/j.soilbio.2011.09.009; Nannipieri P, 2012, BIOL FERT SOILS, V48, P743, DOI 10.1007/s00374-012-0723-0; Pagaling E, 2014, ISME J, V8, P19, DOI 10.1038/ismej.2013.150; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ren CJ, 2016, FOREST ECOL MANAG, V376, P59, DOI 10.1016/j.foreco.2016.06.004; Saleem M, 2019, ANNU REV ECOL EVOL S, V50, P145, DOI 10.1146/annurev-ecolsys-110617-062605; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Shi PL, 2017, APPL SOIL ECOL, V121, P1, DOI 10.1016/j.apsoil.2017.09.020; Sollins P, 2017, GEODERMA, V301, P60, DOI 10.1016/j.geoderma.2017.04.013; Surriya O, 2015, SOIL REMEDIATION AND PLANTS: PROSPECTS AND CHALLENGES, P1; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Topp W, 2010, ECOL ENG, V36, P751, DOI 10.1016/j.ecoleng.2009.12.011; Osorio NW, 2013, BIOL FERT SOILS, V49, P481, DOI 10.1007/s00374-012-0763-5; Wan WJ, 2020, SCI TOTAL ENVIRON, V700, P1; Wang JM, 2017, CATENA, V159, P51, DOI 10.1016/j.catena.2017.08.001; Xu HY, 2018, ECOL INDIC, V85, P585, DOI 10.1016/j.ecolind.2017.11.013; Yang F, 2018, APPL SOIL ECOL, V128, P43, DOI 10.1016/j.apsoil.2018.04.001; Yang Y, 2018, SCI TOTAL ENVIRON, V626, P48, DOI 10.1016/j.scitotenv.2018.01.081; Zeng Q., 2016, PLOS ONE, V11, P1	43	20	21	15	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231198	10.1371/journal.pone.0231198	http://dx.doi.org/10.1371/journal.pone.0231198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343698	Green Published, gold			2022-12-26	WOS:000536661300009
J	Shawon, MAA; Yousuf, MA; Raheem, E; Ahmed, S; Dipti, TT; Hoque, MR; Taniguchi, H; Karim, MR				Shawon, M. Al-Amin; Yousuf, M. Abul Khair; Raheem, Enayetur; Ahmed, Sium; Dipti, Tyeaba Tasnim; Hoque, Mohammad Razuanul; Taniguchi, Hiroaki; Karim, M. Rezaul			Epidemiology, clinical features, and impact of food habits on the risk of hepatocellular carcinoma: A case-control study in Bangladesh	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LIVER-CANCER; HEPATITIS-B; GLOBAL EPIDEMIOLOGY; CIGARETTE-SMOKING; REDUCES RISK; MEAT INTAKE; CONSUMPTION; FRUIT; MULTICENTER	Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most common cause of cancer mortality worldwide. Infection with hepatitis B virus (HBV) and/or hepatitis C virus (HCV) is the most predominant cause of HCC. Concerns arise for the presence of additional risk factors, as there is still a large proportion of patients without HBV or HCV infection. Previous studies have reported that higher intake of fruits and vegetables and reduced consumption of red/processed meat might play a protective role in HCC etiology, though the nationwide proof is limited. Hence, we studied multiple risk factors including food habit, lifestyle, and clinical implications of HCC patients in Bangladeshi. Demographic, clinical, and biochemical data, as well as data on food habits, were collected in this study. Our results indicated that a high intake of rice (AOR 4.28, 95% CI 1.48 to 14.07, p = 0.011), low intake of fruits (AOR = 4.41 95% CI 1.48-15.46; p = 0.012), leafy vegetables (AOR = 2.80, 95% CI 1.32-6.08; p = 0.008), and fish (AOR = 4.64 95% CI 2.18-10.23; p< 0.001) increased the HCC risk. Moreover, a high intake of eggs (AOR = 2.07 95% CI 0.98-4.43; p = 0.058) also showed an increased risk. Roti, non-leafy vegetables, red meat, and tea were found to have no association with HCC risk. This study revealed that food habit patterns and lifestyle may have a profound effect on HCC development among Bangladeshi patients in addition to well established risk factors.	[Shawon, M. Al-Amin; Ahmed, Sium; Dipti, Tyeaba Tasnim; Karim, M. Rezaul] Jahangirnagar Univ, Dept Biotechnol & Genet Engn, Lab Canc Biol, Dhaka, Bangladesh; [Yousuf, M. Abul Khair] Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka, Bangladesh; [Raheem, Enayetur] Biomed Res Fdn, Dhaka, Bangladesh; [Hoque, Mohammad Razuanul] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh; [Taniguchi, Hiroaki] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Magdalenka, Poland	Jahangirnagar University; Bangabandhu Sheikh Mujib Medical University (BSMMU); University of Chittagong; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Karim, MR (corresponding author), Jahangirnagar Univ, Dept Biotechnol & Genet Engn, Lab Canc Biol, Dhaka, Bangladesh.	mrkarimcu@gmail.com	Ahmed, Sium/GOJ-9759-2022	Ahmed, Sium/0000-0002-9643-3091; Raheem, Enayetur/0000-0001-8880-3649; Karim, M. Rezaul/0000-0001-5440-0315	University Grant Commission (UGC) of Bangladesh [4308]; Polish National Science Center [2017/25/B/NZ5/02762]	University Grant Commission (UGC) of Bangladesh(University Grants Commission, India); Polish National Science Center	M. Rezaul Karim Grant no. 4308 University Grant Commission (UGC) of Bangladesh http://www.ugc.gov.bd/, and Dr. Hiroaki Taniguchi Grant no. OPUS 13 (2017/25/B/NZ5/02762) The Polish National Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelino D, 2019, INT J FOOD SCI NUTR, V70, P652, DOI 10.1080/09637486.2019.1571021; Bamia C, 2015, BRIT J CANCER, V112, P1273, DOI 10.1038/bjc.2014.654; Bamia C, 2015, INT J CANCER, V136, P1899, DOI 10.1002/ijc.29214; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; De Maria N, 2002, MOL CELL ENDOCRINOL, V193, P59; Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323; Donato F, 1997, HEPATOLOGY, V26, P579, DOI 10.1002/hep.510260308; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-serag HB, 2001, ROLE DIABETES HEPATO, P96, DOI [10.1111/j.1572-0241, DOI 10.1111/J.1572-0241]; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Fedirko V, 2013, ANN ONCOL, V24, P2166, DOI 10.1093/annonc/mdt168; Fedirko V, 2013, ANN ONCOL, V24, P543, DOI 10.1093/annonc/mds434; Freedman ND, 2010, J NATL CANCER I, V102, P1354, DOI 10.1093/jnci/djq301; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Gao M, 2015, CANCER CAUSE CONTROL, V26, P367, DOI 10.1007/s10552-014-0512-1; Godos J, 2020, INT J FOOD SCI NUTR, V71, P138, DOI 10.1080/09637486.2019.1625035; Hossain MA, 2017, J SCI FOUND, V14, P36, DOI [10.3329/jsf.v14i2.33442, DOI 10.3329/JSF.V14I2.33442]; Huang YS, 2003, AM J GASTROENTEROL, V98, P1417, DOI 10.1016/S0002-9270(03)00226-0; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Kanazir M, 2010, TUMORI J, V96, P911, DOI 10.1177/548.6508; Kar P, 2014, J CLIN EXP HEPATOL, V4, pS34, DOI 10.1016/j.jceh.2014.02.155; Karim MF, 2012, J ACUTE DIS, V1, P35, DOI 10.1016/S2221-6189(13)60008-6; Keng VW, 2012, J HEPATOL, V57, P453, DOI 10.1016/j.jhep.2012.03.004; Khan M., 2002, INT HEPATOL COMMUN, V1, P27; Koh WP, 2011, BRIT J CANCER, V105, P1430, DOI 10.1038/bjc.2011.360; Kohi MP, 2016, J VASC INTERV RADIOL, V27, P1338, DOI 10.1016/j.jvir.2016.06.035; Koumbi L, 2017, WORLD J HEPATOL, V9, P119, DOI 10.4254/wjh.v9.i3.119; Kuper H, 2009, DIET HEPATOCELLULAR, P37, DOI [10.1207/S15327914NC381, DOI 10.1207/S15327914NC381]; Kurahashi N, 2009, BRIT J CANCER, V100, P181, DOI 10.1038/sj.bjc.6604843; Kurozawa Youichi, 2004, Kurume Medical Journal, V51, P141, DOI 10.2739/kurumemedj.51.141; LAVECCHIA C, 1988, INT J CANCER, V42, P872, DOI 10.1002/ijc.2910420614; Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280; Liu PA, 2017, ONCOTARGET, V8, P68131, DOI 10.18632/oncotarget.19245; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Luo J, 2014, ALIMENT PHARM THER, V39, P913, DOI 10.1111/apt.12678; Ma YN, 2019, INT J EPIDEMIOL, V48, P1863, DOI 10.1093/ije/dyz146; Magnussen A, 2013, WORLD J GASTROENTERO, V19, P1508, DOI 10.3748/wjg.v19.i10.1508; Marventano S, 2020, INT J FOOD SCI NUTR, V71, P325, DOI 10.1080/09637486.2019.1648388; Maucort-Boulch D, 2018, INT J CANCER, V142, P2471, DOI 10.1002/ijc.31280; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Miele L, 2015, GASTROENT RES PRACT, V2015, P2921, DOI [10.1002/ijc.22267, DOI 10.1002/IJC.22267]; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Nahar Q., 2013, DIETARY GUIDELINES B; Nazir RT, 2010, JCPSP-J COLL PHYSICI, V20, P373, DOI 06.2010/JCPSP.373376; Polesel J, 2007, EUR J CANCER, V43, P2381, DOI 10.1016/j.ejca.2007.07.012; Rahman Salimur, 2014, Euroasian J Hepatogastroenterol, V4, P25, DOI 10.5005/jp-journals-10018-1092; Sauvaget C, 2003, BRIT J CANCER, V88, P689, DOI 10.1038/sj.bjc.6600775; Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018; Stevenson M, 2016, PACKAGE EPIR TITLE T; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Talamini R, 2006, INT J CANCER, V119, P2916, DOI 10.1002/ijc.22267; Tieri M, 2020, INT J FOOD SCI NUTR, V71, P668, DOI 10.1080/09637486.2020.1715354; Tsou MH, 1998, ACTA CYTOL, V42, P1359, DOI 10.1159/000332168; Valery PC, 2018, HEPATOLOGY, V67, P600, DOI 10.1002/hep.29498; Yang Y, 2014, GASTROENTEROLOGY, V147, P1031, DOI 10.1053/j.gastro.2014.08.005; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang W, 2013, CANCER SCI, V104, P1353, DOI 10.1111/cas.12231	62	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232121	10.1371/journal.pone.0232121	http://dx.doi.org/10.1371/journal.pone.0232121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339207	gold, Green Published, Green Submitted			2022-12-26	WOS:000536657400029
J	Mine, D; Ogawa, N; Narumi, T; Yokosawa, K				Mine, Daisuke; Ogawa, Nami; Narumi, Takuji; Yokosawa, Kazuhiko			The relationship between the body and the environment in the virtual world: The interpupillary distance affects the body size perception	PLOS ONE			English	Article							EYE HEIGHT; REPRESENTATION; OWNERSHIP	Previous research suggests that the size of one's body is used as a metric to scale the external world. On the other hand, the influence of information from the external world on the perception of body size is unclear. It has been suggested that increased inter-pupillary distance (IPD) leads people to perceive the external world as smaller than it actually is. The present study investigated the effect of the IPD on body size perception, and the relationship between the perceived scale of the body and the external world when the IPD is manipulated. To this end, in a virtual environment, we manipulated the IPD as well as the size and presence of participants' hands, while participant's eye height was increased vertically. Results showed that, when participants' eye height was increased and their hands were enlarged, people with a fixed IPD perceived the size of their body to be large (like a giant) while the external world was perceived to be changed minimally. Alternatively, people with increased IPD perceived that the external world as having shrank, whereas their perception of their body size changed little. However, when a viewers' virtual hands were not shown, the IPD did not affect the individual's percept of body size, although the IPD did affect one's perception of the external world. These results suggest that, when the ratio of the size between one's body and the external world are explicit, the perceived size of one's body is affected by the IPD or perceived scale of the external world that is affected by the IPD.	[Mine, Daisuke; Yokosawa, Kazuhiko] Univ Tokyo, Dept Psychol, Tokyo, Japan; [Ogawa, Nami] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Narumi, Takuji] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Narumi, Takuji] JST PRESTO, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Mine, D (corresponding author), Univ Tokyo, Dept Psychol, Tokyo, Japan.	mine@l.u-tokyo.ac.jp	Narumi, Takuji/K-3925-2014	Narumi, Takuji/0000-0002-9010-1491; Mine, Daisuke/0000-0002-4564-6310	JSPS KAKENHI [19H01490]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 19H01490 to KY (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT19H01490/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi P, 2019, CHI C HUM FACT COMP, P1; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Bennett S, 1999, EXP BRAIN RES, V129, P362, DOI 10.1007/s002210050904; Charbonneau P, 2017, INT C VIRT REH, DOI [10.1109/ICVR.2017.8007481, DOI 10.1109/ICVR.2017.8007481]; Dixon MW, 2000, J EXP PSYCHOL HUMAN, V26, P582, DOI 10.1037/0096-1523.26.2.582; GOGEL WC, 1987, PERCEPT PSYCHOPHYS, V41, P318, DOI 10.3758/BF03208233; Gonzalez-Franco M, 2019, 2019 26TH IEEE CONFERENCE ON VIRTUAL REALITY AND 3D USER INTERFACES (VR), P941, DOI 10.1109/VR.2019.8798348; Harrar SW, 2019, J APPL STAT, V46, P1649, DOI 10.1080/02664763.2018.1555575; JUDGE SJ, 1988, PERCEPTION, V17, P783, DOI 10.1068/p170783; Jun E, 2015, ACM T APPL PERCEPT, V12, DOI 10.1145/2811266; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Kim J., 2017, PROC 27 INT C ARTIF, P153; Kim NG, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00988; Langbehn E, 2016, 2016 IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI), P211, DOI 10.1109/3DUI.2016.7460054; Leyrer Markus, 2011, P ACM SIGGRAPH S APP, P67, DOI [DOI 10.1145/2077451.2077464, DOI 10.1145/2077451]; Li Z, 2011, ATTEN PERCEPT PSYCHO, V73, P2205, DOI 10.3758/s13414-011-0170-2; Linkenauger SA, 2014, PSYCHOL SCI, V25, P2086, DOI 10.1177/0956797614548875; Linkenauger SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068594; Ogawa N., 2017, P 8 AUGMENTED HUMAN, DOI [10.1145/3041164.3041204, DOI 10.1145/3041164.3041204]; Piumsomboon T, 2018, IEEE T VIS COMPUT GR, V24, P2974, DOI 10.1109/TVCG.2018.2868594; Ponto K, 2013, IEEE T VIS COMPUT GR, V19, P691, DOI 10.1109/TVCG.2013.36; PREDEBON J, 1994, PERCEPT PSYCHOPHYS, V56, P238, DOI 10.3758/BF03213902; Proffitt DR, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P171; Renner RS, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2543581.2543590; Shahnewaz S, 2016, 2016 IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI), P265, DOI 10.1109/3DUI.2016.7460072; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Stefanucci JK, 2005, PERCEPT PSYCHOPHYS, V67, P1052, DOI 10.3758/BF03193631; van der Hoort B, 2014, ATTEN PERCEPT PSYCHO, V76, P1414, DOI 10.3758/s13414-014-0664-9; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Vorderer P, 2004, SHORT DOCUMENTATION; Witt JK, 2011, CURR DIR PSYCHOL SCI, V20, P201, DOI 10.1177/0963721411408770; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; Wraga M, 1999, PERCEPT PSYCHOPHYS, V61, P490, DOI 10.3758/BF03211968; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x	36	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232290	10.1371/journal.pone.0232290	http://dx.doi.org/10.1371/journal.pone.0232290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8RF	32330199	gold, Green Published			2022-12-26	WOS:000536647300069
J	Tagawa, M; Tambo, N; Maezawa, M; Tomihari, M; Watanabe, K; Inokuma, H; Miyahara, K				Tagawa, Michihito; Tambo, Naomi; Maezawa, Masaki; Tomihari, Mizuki; Watanabe, Ken-ichi; Inokuma, Hisashi; Miyahara, Kazuro			Quantitative analysis of the BRAF V595E mutation in plasma cell-free DNA from dogs with urothelial carcinoma	PLOS ONE			English	Article							CIRCULATING-TUMOR DNA; CANCER; BLADDER; EGFR	Circulating tumor DNA (ctDNA), which carries tumor-specific mutations, is an emerging candidate biomarker for malignancies and for monitoring disease status in various human tumors. Recently, BRAF V595E mutation has been reported in 80% of dogs with urothelial carcinoma. This study investigates the BRAF V595E allele concentration in circulating cell-free DNA (cfDNA) and assesses the clinical significance of BRAF-mutated ctDNA levels in canines with urothelial carcinoma. A total of 15 dogs with urothelial carcinoma were included. cfDNA concentration was measured using a real-time polymerase chain reaction (PCR) of the LINE-1 gene. To measure the concentration of the mutated BRAF gene in cfDNA, allele-specific real-time PCR with a locked nucleic acid probe was performed. BRAF mutations were detected in 11 (73%) of the 15 tested tumor samples. BRAF-mutated ctDNA concentrations were significantly higher in dogs with the BRAF mutation (14.05 +/- 13.51 ng/ml) than in wild-type dogs (0.21 +/- 0.41 ng/ml) (p = 0.031). The amount of BRAF-mutated ctDNA in plasma increased with disease progression and responded to treatment. Our results show that BRAF-mutated ctDNA can be detected using allele-specific real-time PCR in plasma samples of canines with urothelial carcinoma with the BRAF V595E mutation. This ctDNA analysis may be a potentially useful tool for monitoring the progression of urothelial carcinoma and its response to treatment.	[Tagawa, Michihito; Tambo, Naomi; Miyahara, Kazuro] Obihiro Univ Agr & Vet Med, Ctr Vet Med, Obihiro, Hokkaido, Japan; [Maezawa, Masaki; Tomihari, Mizuki; Inokuma, Hisashi] Obihiro Univ Agr & Vet Med, Div Clin Vet Med, Obihiro, Hokkaido, Japan; [Watanabe, Ken-ichi] Obihiro Univ Agr & Vet Med, Res Ctr Global Agromed, Obihiro, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine	Tagawa, M (corresponding author), Obihiro Univ Agr & Vet Med, Ctr Vet Med, Obihiro, Hokkaido, Japan.	mtagawa@obihiro.ac.jp						Ahlborn Lise Barlebo, 2018, Oncotarget, V9, P32570, DOI 10.18632/oncotarget.25948; [Anonymous], GASTROENTEROLOGY; Ashida A, 2016, INT J CLIN ONCOL, V21, P981, DOI 10.1007/s10147-016-0976-y; Beffagna G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169454; Butler TM, 2017, CURR OPIN GENET DEV, V42, P14, DOI 10.1016/j.gde.2016.12.003; Decker B, 2015, MOL CANCER RES, V13, P993, DOI 10.1158/1541-7786.MCR-14-0689; Fan GW, 2017, ONCOTARGET, V8, P33922, DOI 10.18632/oncotarget.15412; Fulkerson CM, 2015, VET J, V205, P217, DOI 10.1016/j.tvjl.2015.01.017; Griffin MA, 2018, VET SCI, V5, DOI 10.3390/vetsci5040096; Hamakawa T, 2015, BRIT J CANCER, V112, P352, DOI 10.1038/bjc.2014.609; Jahr S, 2001, CANCER RES, V61, P1659; Rodriguez BJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081183; Kunnath AP, 2019, CUREUS, V11, DOI 10.7759/cureus.4907; Lee B, 2019, ANN ONCOL, V30, P1472, DOI 10.1093/annonc/mdz200; Lee JS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53271-6; Leffler AJ, 2018, VET RADIOL ULTRASOUN, V59, P767, DOI 10.1111/vru.12652; Mochizuki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144170; Mochizuki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129534; Nguyen SM, 2015, VET COMP ONCOL, V13, P176, DOI 10.1111/vco.12032; Ossandon MR, 2018, JNCI-J NATL CANCER I, V110, P929, DOI 10.1093/jnci/djy105; Owen L.N., 1980, TNM CLASSIFICATION T, pp46; Phallen J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2415; Pinzani P, 2010, CLIN CHIM ACTA, V411, P1319, DOI 10.1016/j.cca.2010.05.024; Schreuer M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0852-6; Tagawa M, 2019, J VET DIAGN INVEST, V31, P836, DOI 10.1177/1040638719880245; Zhou YD, 2019, MOL ONCOL, V13, P1033, DOI 10.1002/1878-0261.12456; Zhu YJ, 2017, LUNG CANCER, V109, P124, DOI 10.1016/j.lungcan.2017.05.005	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232365	10.1371/journal.pone.0232365	http://dx.doi.org/10.1371/journal.pone.0232365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330187	gold, Green Published			2022-12-26	WOS:000536647300072
J	Rouaud, F; Tessaro, F; Aimaretti, L; Scapozza, L; Citi, S				Rouaud, Florian; Tessaro, Francesca; Aimaretti, Laura; Scapozza, Leonardo; Citi, Sandra			Cooperative binding of the tandem WW domains of PLEKHA7 to PDZD11 promotes conformation-dependent interaction with tetraspanin 33	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pleckstrin homology domain containing A7 (PLEKHA7); PDZ domain containing 11 (PDZD11); tetraspanin 33; WW domain; polyproline; cooperativity; cell-cell junction; ?-toxin; ADAM metallopeptidase domain 10 (ADAM10); adherens junction; membrane protein; molecular docking; protein complex; PDZD11; PLEKHA7; polyproline; tetraspanin33	GENOME-WIDE ASSOCIATION; ADHERENS JUNCTIONS; PROTEIN; SUSCEPTIBILITY; MOTIF	Pleckstrin homology domain?containing A7 (PLEKHA7) is a cytoplasmic protein at adherens junctions that has been implicated in hypertension, glaucoma, and responses toStaphylococcus aureus?-toxin. Complex formation between PLEKHA7, PDZ domain?containing 11 (PDZD11), tetraspanin 33, and the ?-toxin receptor ADAM metallopeptidase domain 10 (ADAM10) promotes junctional clustering of ADAM10 and ?-toxin?mediated pore formation. However, how the N-terminal region of PDZD11 interacts with the N-terminal tandem WW domains of PLEKHA7 and how this interaction promotes tetraspanin 33 binding to the WW1 domain is unclear. Here, we used site-directed mutagenesis, glutathioneS-transferase pulldown experiments, immunofluorescence, molecular modeling, and docking experiments to characterize the mechanisms driving these interactions. We found that Asp-30 of WW1 and His-75 of WW2 interact through a hydrogen bond and, together with Thr-35 of WW1, form a binding pocket that accommodates a polyproline stretch within the N-terminal PDZD11 region. By strengthening the interactions of the ternary complex, the WW2 domain stabilized the WW1 domain and cooperatively promoted the interaction with PDZD11. Modeling results indicated that, in turn, PDZD11 binding induces a conformational rearrangement, which strengthens the ternary complex, and contributes to enlarging a ?hydrophobic hot spot? region on the WW1 domain. The last two lipophilic residues of tetraspanin 33, Trp-283 and Tyr-282, were required for its interaction with PLEKHA7. Docking of the tetraspanin 33 C terminus revealed that it fits into the hydrophobic hot spot region of the accessible surface of WW1. We conclude that communication between the two tandem WW domains of PLEKHA7 and the PLEKHA7?PDZD11 interaction modulate the ligand-binding properties of PLEKHA7.	[Rouaud, Florian; Citi, Sandra] Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland; [Rouaud, Florian; Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Tessaro, Francesca; Aimaretti, Laura; Scapozza, Leonardo] Univ Geneva, Sch Pharmaceut Sci, Pharmaceut Biochem Grp, Geneva, Switzerland; [Tessaro, Francesca; Aimaretti, Laura; Scapozza, Leonardo] Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland.; Citi, S (corresponding author), Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland.	sandra.citi@unige.ch	Tessaro, Francesca/AAQ-9441-2020	Tessaro, Francesca/0000-0001-8672-885X; Scapozza, Leonardo/0000-0003-1079-648X	Swiss National Fund [31003A_172809]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Fund Grant 31003A_172809 (to S. C.).	Bhattacharya S, 2008, INT J BIOCHEM CELL B, V40, P147, DOI 10.1016/j.biocel.2007.07.007; Case D. A., 2016, AMBER 2016; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Dodson EJ, 2015, EXP BIOL MED, V240, P351, DOI 10.1177/1535370214566558; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Fedoroff OY, 2004, J BIOL CHEM, V279, P34991, DOI 10.1074/jbc.M404987200; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Guerrera D, 2016, J BIOL CHEM, V291, P11016, DOI 10.1074/jbc.M115.712935; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kourtidis A, 2016, CELL CYCLE, V15, P498, DOI 10.1080/15384101.2016.1141840; Kourtidis A, 2015, NAT CELL BIOL, V17, P1145, DOI 10.1038/ncb3227; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Lee MC, 2017, HUM MOL GENET, V26, P4011, DOI 10.1093/hmg/ddx292; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Nabokina SM, 2011, AM J PHYSIOL-GASTR L, V301, pG808, DOI 10.1152/ajpgi.00269.2011; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Popov LM, 2015, P NATL ACAD SCI USA, V112, P14337, DOI 10.1073/pnas.1510265112; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Ramirez-Espain X, 2007, J MOL BIOL, V373, P1255, DOI 10.1016/j.jmb.2007.08.052; Shah J, 2018, CELL REP, V25, P2132, DOI 10.1016/j.celrep.2018.10.088; Stephenson SEM, 2005, J BIOL CHEM, V280, P33270, DOI 10.1074/jbc.M505889200; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tavano S, 2018, NEURON, V97, P1299, DOI 10.1016/j.neuron.2018.01.052; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wythe JD, 2011, DIS MODEL MECH, V4, P607, DOI 10.1242/dmm.002204; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zweifel ME, 2005, STRUCTURE, V13, P1599, DOI 10.1016/j.str.2005.07.015	38	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9299	9312		10.1074/jbc.RA120.012987	http://dx.doi.org/10.1074/jbc.RA120.012987			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32371390	hybrid, Green Published			2022-12-26	WOS:000552758600004
J	Esmaili, M; Tancowny, BP; Wang, XY; Moses, A; Cortez, LM; Sim, VL; Wille, H; Overduin, M				Esmaili, Mansoore; Tancowny, Brian P.; Wang, Xiongyao; Moses, Audric; Cortez, Leonardo M.; Sim, Valerie L.; Wille, Holger; Overduin, Michael			Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; nanotechnology; prion; lipid; lipid binding protein; neurodegenerative disease; lipid-protein interaction; protein misfolding; native nanodisc; SMALP; styrene maleic acid copolymer; styrene?maleic acid lipid particle (SMALP)	BRANCHED POLYAMINES; PROTEIN; SMA; EXTRACTION; RAFTS	Prions are lipidated proteins that interact with endogenous lipids and metal ions. They also assemble into multimers and propagate into the infectious scrapie form known as PrPSc. The high-resolution structure of the infectious PrP(Sc)state remains unknown, and its analysis largely relies on detergent-based preparations devoid of endogenous ligands. Here we designed polymers that allow isolation of endogenous membrane:protein assemblies in native nanodiscs without exposure to conventional detergents that destabilize protein structures and induce fibrillization. A set of styrene?maleic acid (SMA) polymers including a methylamine derivative facilitated gentle release of the infectious complexes for resolution of multimers, and a thiol-containing version promoted crystallization. Polymer extraction from brain homogenates from Syrian hamsters infected with Hyper prions and WT mice infected with Rocky Mountain Laboratories prions yielded infectious prion nanoparticles including oligomers and microfilaments bound to lipid vesicles. Lipid analysis revealed the brain phospholipids that associate with prion protofilaments, as well as those that are specifically enriched in prion assemblies captured by the methylamine-modified copolymer. A comparison of the infectivity of PrP(Sc)attached to SMA lipid particles in mice and hamsters indicated that these amphipathic polymers offer a valuable tool for high-yield production of intact, detergent-free prions that retainin vivoactivity. This native prion isolation method provides an avenue for producing relevant prion:lipid targets and potentially other proteins that form multimeric assemblies and fibrils on membranes.	[Esmaili, Mansoore; Tancowny, Brian P.; Wang, Xiongyao; Wille, Holger; Overduin, Michael] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada; [Tancowny, Brian P.; Wang, Xiongyao; Cortez, Leonardo M.; Sim, Valerie L.; Wille, Holger] Univ Alberta, Ctr Prions & Prot Folding Dis, Fac Med & Dent, Edmonton, AB, Canada; [Moses, Audric] Univ Alberta, Fac Med & Dent, Lipid Core Facil, Edmonton, AB, Canada; [Cortez, Leonardo M.; Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Med, Div Neurol, Edmonton, AB, Canada; [Cortez, Leonardo M.; Sim, Valerie L.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wille, H; Overduin, M (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada.; Wille, H (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Fac Med & Dent, Edmonton, AB, Canada.	overduin@ualberta.ca; wille@ualberta.ca	Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706; Overduin, Michael/0000-0002-3114-6585; Cortez, Leonardo/0000-0003-4080-8728	Alberta Prion Research Institute Exploration Grant [201600018]; NSERC [RGPIN-2018-04994]; Campus Alberta Innovates Program Grant [RCP-12-002C]; Alberta Prion Research Institute Team Program Award [201600029]	Alberta Prion Research Institute Exploration Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Campus Alberta Innovates Program Grant; Alberta Prion Research Institute Team Program Award	This work was supported by Alberta Prion Research Institute Exploration Grant 201600018 (to M. O.), NSERC Discovery Grant RGPIN-2018-04994 (to M. O.), Campus Alberta Innovates Program Grant RCP-12-002C (to M. O.), and Alberta Prion Research Institute Team Program Award 201600029 (to H. W.).	Angelisova P, 2019, BBA-BIOMEMBRANES, V1861, P130, DOI 10.1016/j.bbamem.2018.08.006; Bode DC, 2019, J BIOL CHEM, V294, P7566, DOI 10.1074/jbc.AC118.007195; Botsios S, 2015, VIRULENCE, V6, P787, DOI 10.1080/21505594.2015.1098804; Breyer J, 2012, VET MICROBIOL, V157, P23, DOI 10.1016/j.vetmic.2011.12.008; Camargo M, 2013, HUM REPROD, V28, P33, DOI 10.1093/humrep/des357; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Dorr JM, 2016, EUR BIOPHYS J BIOPHY, V45, P3, DOI 10.1007/s00249-015-1093-y; Dorr JM, 2014, P NATL ACAD SCI USA, V111, P18607, DOI 10.1073/pnas.1416205112; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fischer M, 2010, BIOMACROMOLECULES, V11, P1314, DOI 10.1021/bm100101s; Giles K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023499; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Graeve M, 2009, J CHROMATOGR B, V877, P1815, DOI 10.1016/j.jchromb.2009.05.004; Grethen A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11616-z; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Gursky O, 2015, ADV EXP MED BIOL, V855, pV; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Korotych O, 2019, EUR POLYM J, V114, P485, DOI 10.1016/j.eurpolymj.2018.10.035; Korshavn KJ, 2017, J BIOL CHEM, V292, P4638, DOI 10.1074/jbc.M116.764092; Lee SC, 2016, NAT PROTOC, V11, P1149, DOI 10.1038/nprot.2016.070; Levine DJ, 2015, ACS CHEM BIOL, V10, P1269, DOI 10.1021/cb5006239; Lim YB, 2010, BIOMATERIALS, V31, P2025, DOI 10.1016/j.biomaterials.2009.11.085; Lindhoud S, 2016, BIOMACROMOLECULES, V17, P1516, DOI 10.1021/acs.biomac.6b00140; McCarthy JM, 2013, BIOMACROMOLECULES, V14, P27, DOI 10.1021/bm301165u; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Morrison KA, 2016, BIOCHEM J, V473, P4349, DOI 10.1042/BCJ20160723; Overduin M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061230; Overduin M, 2019, CHEM PHYS LIPIDS, V218, P73, DOI 10.1016/j.chemphyslip.2018.11.008; Priola SA, 2009, PRION, V3, P134, DOI 10.4161/pri.3.3.9771; Qiu WH, 2018, P NATL ACAD SCI USA, V115, P12985, DOI 10.1073/pnas.1812526115; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Sciacca MFM, 2018, BBA-BIOMEMBRANES, V1860, P1625, DOI 10.1016/j.bbamem.2018.02.022; Shaked Y, 2002, J NEUROCHEM, V82, P1, DOI 10.1046/j.1471-4159.2002.00995.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun C, 2018, NATURE, V557, P123, DOI 10.1038/s41586-018-0061-y; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Terry C, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160035; Teruya K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006045; Thody SA, 2018, BBA-BIOMEMBRANES, V1860, P1927, DOI 10.1016/j.bbamem.2018.02.031; Tonge SR, 2001, ADV DRUG DELIVER REV, V53, P109, DOI 10.1016/S0169-409X(01)00223-X; Tsukigawa K, 2015, CANCER SCI, V106, P270, DOI 10.1111/cas.12592; Wang F, 2013, ACTA BIOCH BIOPH SIN, V45, P485, DOI 10.1093/abbs/gmt038; Wenborn A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10062; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X; Wille H, 2009, P NATL ACAD SCI USA, V106, P3740, DOI 10.1073/pnas.0812770106	52	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8460	8469		10.1074/jbc.RA119.012348	http://dx.doi.org/10.1074/jbc.RA119.012348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358064	hybrid, Green Published			2022-12-26	WOS:000546986500010
J	Garcia, PAA; Lovejoy, CM; Nagarajan, P; Park, D; Popova, LV; Freitas, MA; Parthun, MR				Garcia, Paula A. Agudelo; Lovejoy, Callie M.; Nagarajan, Prabakaran; Park, Dongju; Popova, Liudmila V.; Freitas, Michael A.; Parthun, Mark R.			Histone acetyltransferase 1 is required for DNA replication fork function and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyltransferase; acetylation; DNA replication; histone acetylase; chromatin; chromatin assembly; HAT1; replication fork; replication fork stalling; replication stress	CHAPERONE ASF1; NASCENT DNA; CHROMATIN; H3; ACETYLATION; LYSINE-56; H3-H4; BINDING; H4; INHERITANCE	The replisome is a protein complex on the DNA replication fork and functions in a dynamic environment at the intersection of parental and nascent chromatin. Parental nucleosomes are disrupted in front of the replication fork. The daughter DNA duplexes are packaged with an equal amount of parental and newly synthesized histones in the wake of the replication fork through the activity of the replication-coupled chromatin assembly pathway. Histone acetyltransferase 1 (HAT1) is responsible for the cytosolic diacetylation of newly synthesized histone H4 on lysines 5 and 12, which accompanies replication-coupled chromatin assembly. Here, using proximity ligation assay-based chromatin assembly assays and DNA fiber analysis, we analyzed the role of murine HAT1 in replication-coupled chromatin assembly. We demonstrate that HAT1 physically associates with chromatin near DNA replication sites. We found that the association of HAT1 with newly replicated DNA is transient, but can be stabilized by replication fork stalling. The association of HAT1 with nascent chromatin may be functionally relevant, as HAT1 loss decreased replication fork progression and increased replication fork stalling. Moreover, in the absence of HAT1, stalled replication forks were unstable, and newly synthesized DNA became susceptible to MRE11-dependent degradation. These results suggest that HAT1 links replication fork function to the proper processing and assembly of newly synthesized histones.	[Garcia, Paula A. Agudelo; Lovejoy, Callie M.; Nagarajan, Prabakaran; Popova, Liudmila V.; Parthun, Mark R.] Ohio State Univ, Dept Biol Chem, Columbus, OH 43210 USA; [Park, Dongju] Ohio State Univ, Dept Pharmacol, Columbus, OH 43210 USA; [Freitas, Michael A.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Parthun, MR (corresponding author), Ohio State Univ, Dept Biol Chem, Columbus, OH 43210 USA.	parthun.1@osu.edu	NAGARAJAN, PRABAKARAN/AAA-2881-2020	NAGARAJAN, PRABAKARAN/0000-0001-6124-3274	National Institutes of Health NINDS [P30 NS104177]	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Microscopy was supported by a grant from the National Institutes of Health NINDS Grant P30 NS104177.	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Alvarez F, 2011, J BIOL CHEM, V286, P17714, DOI 10.1074/jbc.M111.223453; Annunziato AT, 2012, BBA-GENE REGUL MECH, V1819, P196, DOI 10.1016/j.bbagrm.2011.07.005; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Bellelli R, 2018, MOL CELL, V72, P112, DOI 10.1016/j.molcel.2018.08.043; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Chang L, 1997, BIOCHEMISTRY-US, V36, P469, DOI 10.1021/bi962069i; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Clement C, 2015, NAT STRUCT MOL BIOL, V22, P587, DOI 10.1038/nsmb.3067; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; Clemente-Ruiz M, 2009, EMBO REP, V10, P790, DOI 10.1038/embor.2009.67; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ejlassi-Lassallette A, 2011, MOL BIOL CELL, V22, P245, DOI 10.1091/mbc.E10-07-0633; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Foltman M, 2013, CELL REP, V3, P892, DOI 10.1016/j.celrep.2013.02.028; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Garcia PAA, 2020, J PROTEOME RES, V19, P1663, DOI 10.1021/acs.jproteome.9b00843; Garcia PAA, 2017, NUCLEIC ACIDS RES, V45, P9319, DOI 10.1093/nar/gkx545; Ge ZQ, 2013, MOL CELL BIOL, V33, P3286, DOI 10.1128/MCB.00460-13; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jasencakova Z, 2010, SEMIN CELL DEV BIOL, V21, P231, DOI 10.1016/j.semcdb.2009.09.018; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kehrli K, 2016, J BIOL CHEM, V291, P24487, DOI 10.1074/jbc.M115.708594; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Kolinjivadi AM, 2017, MOL CELL, V67, P867, DOI 10.1016/j.molcel.2017.07.001; Lazarchuk P, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00421-19; Lazarchuk P, 2019, METHODS MOL BIOL, V1983, P29, DOI 10.1007/978-1-4939-9434-2_3; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu SF, 2017, SCIENCE, V355, P415, DOI 10.1126/science.aah4712; Liu WH, 2012, NUCLEIC ACIDS RES, V40, P11229, DOI 10.1093/nar/gks906; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Mejlvang J, 2014, J CELL BIOL, V204, P29, DOI 10.1083/jcb.201305017; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Nagarajan P, 2019, AGING CELL, V18, DOI 10.1111/acel.12992; Nagarajan P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003518; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Petruk S, 2017, MOL CELL, V66, P247, DOI 10.1016/j.molcel.2017.03.006; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Qin S, 2006, MOL CELL BIOL, V26, P3649, DOI 10.1128/MCB.26.9.3649-3658.2006; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Richet N, 2015, NUCLEIC ACIDS RES, V43, P1905, DOI 10.1093/nar/gkv021; Ridgway P, 2000, J CELL SCI, V113, P2647; Rivera C, 2015, NUCLEIC ACIDS RES, V43, P9097, DOI 10.1093/nar/gkv929; Roy S, 2018, J CELL BIOL, V217, P1553, DOI 10.1083/JCB.20170912103212018c; Saade E, 2009, PROTEOMICS, V9, P4934, DOI 10.1002/pmic.200900206; SEALE RL, 1975, J MOL BIOL, V94, P479, DOI 10.1016/0022-2836(75)90216-8; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang H, 2015, PROTEIN CELL, V6, P693, DOI 10.1007/s13238-015-0190-0; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574; Wang HY, 2012, NUCLEIC ACIDS RES, V40, P660, DOI 10.1093/nar/gkr781; WEINTRAU.H, 1972, NATURE, V240, P449, DOI 10.1038/240449a0; WEINTRAUB H, 1972, J MOL BIOL, V66, P13, DOI 10.1016/S0022-2836(72)80003-2; Wessel SR, 2019, CELL REP, V28, P3497, DOI 10.1016/j.celrep.2019.08.051; Yang JY, 2016, CELL REP, V16, P3414, DOI 10.1016/j.celrep.2016.08.070; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199	80	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8363	8373		10.1074/jbc.RA120.013496	http://dx.doi.org/10.1074/jbc.RA120.013496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32366460	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000546986500002
J	Khan, MA; Srivastava, SK; Zubair, H; Patel, GK; Arora, S; Khushman, M; Carter, JE; Gorman, GS; Singh, S; Singh, AP				Khan, Mohammad Aslam; Srivastava, Sanjeev Kumar; Zubair, Haseeb; Patel, Girijesh Kumar; Arora, Sumit; Khushman, Moh'd; Carter, James Elliot; Gorman, Gregory Stephen; Singh, Seema; Singh, Ajay Pratap			Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic cancer; chemoresistance; sonic hedgehog (SHH); C-X-C chemokine receptor type 4 (CXCR-4); stromal cell; cancer stemness; chemotherapy; pancreatic stellate cell (PSC); paracrine signaling; cancer stemness	GEMCITABINE-METABOLIZING ENZYME; SONIC HEDGEHOG; MOUSE MODEL; PROMOTES DESMOPLASIA; CELLS; EXPRESSION; CHEMORESISTANCE; RESISTANCE; SURVIVAL; ADENOCARCINOMA	Pancreatic cancer (PC) remains a therapeutic challenge because of its intrinsic and extrinsic chemoresistance mechanisms. Here, we report that C-X-C motif chemokine receptor 4 (CXCR4) and hedgehog pathways cooperate in PC chemoresistance via bidirectional tumor-stromal crosstalk. We show that when PC cells are co-cultured with pancreatic stellate cells (PSCs) they are significantly more resistant to gemcitabine toxicity than those grown in monoculture. We also demonstrate that this co-culture?induced chemoresistance is abrogated by inhibition of the CXCR4 and hedgehog pathways. Similarly, the co-culture?induced altered expression of genes in PC cells associated with gemcitabine metabolism, antioxidant defense, and cancer stemness is also reversed upon CXCR4 and hedgehog inhibition. We have confirmed the functional impact of these genetic alterations by measuring gemcitabine metabolites, reactive oxygen species production, and sphere formation in vehicle- or gemcitabine-treated monocultures and co-cultured PC cells. Treatment of orthotopic pancreatic tumor?bearing mice with gemcitabine alone or in combination with a CXCR4 antagonist (AMD3100) or hedgehog inhibitor (GDC-0449) displays reduced tumor growth. Notably, we show that the triple combination treatment is the most effective, resulting in nearly complete suppression of tumor growth. Immunohistochemical analysis of Ki67 and cleaved caspase-3 confirm these findings fromin vivoimaging and tumor measurements. Our findings provide preclinical and mechanistic evidence that a combination of gemcitabine treatment with targeted inhibition of both the CXCR4 and hedgehog pathways improves outcomes in a PC mouse model.	[Khan, Mohammad Aslam; Srivastava, Sanjeev Kumar; Zubair, Haseeb; Carter, James Elliot; Singh, Seema; Singh, Ajay Pratap] Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA; [Khan, Mohammad Aslam; Srivastava, Sanjeev Kumar; Zubair, Haseeb; Patel, Girijesh Kumar; Arora, Sumit; Singh, Seema; Singh, Ajay Pratap] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA; [Khushman, Moh'd] Univ S Alabama, Mitchell Canc Inst, Dept Med Oncol, Mobile, AL USA; [Gorman, Gregory Stephen] Samford Univ, Pharmaceut Sci Res Inst, Birmingham, AL USA; [Singh, Seema; Singh, Ajay Pratap] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; Samford University; University of South Alabama	Singh, AP (corresponding author), Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA.; Singh, AP (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA.; Singh, AP (corresponding author), Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.	asingh@health.southalabama.edu		Singh, Ajay/0000-0003-3492-6330	NCI, National Institutes of Health [R01CA175772, R01CA224306]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grants R01CA175772 and R01CA224306 (to A. P. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiello Nicole M, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot078360; Aier I, 2019, CANCER EPIDEMIOL, V58, P104, DOI 10.1016/j.canep.2018.12.001; Allison Malorye, 2012, Nat Biotechnol, V30, P203, DOI 10.1038/nbt0312-203; Amrutkar M, 2017, CANCERS, V9, DOI 10.3390/cancers9110157; Ansari D, 2019, ANTICANCER RES, V39, P3317, DOI 10.21873/anticanres.13474; Arora S, 2013, J BIOL CHEM, V288, P21197, DOI 10.1074/jbc.M113.484576; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bhardwaj A, 2016, J BIOL CHEM, V291, P16263, DOI 10.1074/jbc.M116.732651; Chen F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06860-4; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Deshmukh SK, 2017, CANCER LETT, V396, P21, DOI 10.1016/j.canlet.2017.03.010; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P549, DOI 10.1016/j.bbamcr.2014.12.016; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P89, DOI 10.1016/j.bbamcr.2014.10.003; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; Fu JS, 2013, CANCER LETT, V330, P22, DOI 10.1016/j.canlet.2012.11.018; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Herreros-Villanueva M, 2014, WORLD J GASTROENTERO, V20, P2247, DOI 10.3748/wjg.v20.i9.2247; Hu QS, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12456; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Ju HQ, 2015, MOL CANCER THER, V14, P788, DOI 10.1158/1535-7163.MCT-14-0420; Khan MA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040779; Khan MA, 2015, ONCOTARGET, V6, P39140, DOI 10.18632/oncotarget.3784; Khan MA, 2012, MOL CANCER THER, V11, P1873, DOI 10.1158/1535-7163.MCT-12-0141; Kumari S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918755391; Li XQ, 2014, CLIN CANCER RES, V20, P4326, DOI 10.1158/1078-0432.CCR-13-3426; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Meng QC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1244-z; Meng QC, 2018, ONCOGENE, V37, P5843, DOI 10.1038/s41388-018-0392-z; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Neesse A, 2019, GUT, V68, P159, DOI 10.1136/gutjnl-2018-316451; Nikitovic D, 2013, FOOD CHEM TOXICOL, V61, P178, DOI 10.1016/j.fct.2013.06.013; Nunes T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124036; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Patel GK, 2017, BRIT J CANCER, V116, P609, DOI 10.1038/bjc.2017.18; Patzak MS, 2019, EBIOMEDICINE, V40, P394, DOI 10.1016/j.ebiom.2019.01.037; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Saiki Y, 2012, BIOCHEM BIOPH RES CO, V421, P98, DOI 10.1016/j.bbrc.2012.03.122; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Singh A. P., 2016, STEM CELLS TOXICOLOG, P375; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Soini Y, 2014, PATHOL RES PRACT, V210, P35, DOI 10.1016/j.prp.2013.10.001; Thomas D, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0927-5; Tu YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42630; von Ahrens D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0448-5; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang Z, 2013, ANTICANCER RES, V33, P4103; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Xiao GF, 2017, CELL PHYSIOL BIOCHEM, V43, P840, DOI 10.1159/000481610; Xiong JJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002936; Zhang JB, 2018, ONCOL LETT, V15, P1771, DOI 10.3892/ol.2017.7512; Zubair H, 2016, CANCER RES, V76, P7254, DOI 10.1158/0008-5472.CAN-16-1666	62	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8413	8424		10.1074/jbc.RA119.011748	http://dx.doi.org/10.1074/jbc.RA119.011748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358063	Green Published, hybrid			2022-12-26	WOS:000546986500006
J	Zoltner, M; Campagnaro, GD; Taleva, G; Burrell, A; Cerone, M; Leung, KF; Achcar, F; Horn, D; Vaughan, S; Gadelha, C; Zikova, A; Barrett, MP; de Koning, HP; Field, MC				Zoltner, Martin; Campagnaro, Gustavo D.; Taleva, Gergana; Burrell, Alana; Cerone, Michela; Leung, Ka-Fai; Achcar, Fiona; Horn, David; Vaughan, Sue; Gadelha, Catarina; Zikova, Alena; Barrett, Michael P.; de Koning, Harry P.; Field, Mark C.			Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug action; trypanosome; Trypanosoma brucei; parasite metabolism; metabolomics; suramin; glycosomes; polypharmacology; proteomics; differentiation; drug mechanisms; energy homeostasis; sleeping sickness	TRYPANOCIDAL DRUG SURAMIN; WEB-BASED TOOL; PROLINE METABOLISM; MASS-SPECTROMETRY; BRUCEI; IDENTIFICATION; MEMBRANE; RESISTANCE; INHIBITORS; EXPRESSION	Introduced about a century ago, suramin remains a frontline drug for the management of early-stage East African trypanosomiasis (sleeping sickness). Cellular entry into the causative agent, the protozoan parasiteTrypanosoma brucei, occurs through receptor-mediated endocytosis involving the parasite's invariant surface glycoprotein 75 (ISG75), followed by transport into the cytosol via a lysosomal transporter. The molecular basis of the trypanocidal activity of suramin remains unclear, but some evidence suggests broad, but specific, impacts on trypanosome metabolism (i.e.polypharmacology). Here we observed that suramin is rapidly accumulated in trypanosome cells proportionally to ISG75 abundance. Although we found little evidence that suramin disrupts glycolytic or glycosomal pathways, we noted increased mitochondrial ATP production, but a net decrease in cellular ATP levels. Metabolomics highlighted additional impacts on mitochondrial metabolism, including partial Krebs' cycle activation and significant accumulation of pyruvate, corroborated by increased expression of mitochondrial enzymes and transporters. Significantly, the vast majority of suramin-induced proteins were normally more abundant in the insect forms compared with the blood stage of the parasite, including several proteins associated with differentiation. We conclude that suramin has multiple and complex effects on trypanosomes, but unexpectedly partially activates mitochondrial ATP-generating activity. We propose that despite apparent compensatory mechanisms in drug-challenged cells, the suramin-induced collapse of cellular ATP ultimately leads to trypanosome cell death.	[Zoltner, Martin; Horn, David; Field, Mark C.] Univ Dundee, Sch Life Sci, Dundee, Scotland; [Campagnaro, Gustavo D.; Cerone, Michela; de Koning, Harry P.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Achcar, Fiona; Barrett, Michael P.] Univ Glasgow, Wellcome Ctr Integrat Parasitol & Glasgow Poly, Glasgow, Lanark, Scotland; [Taleva, Gergana; Zikova, Alena; Field, Mark C.] Univ South Bohemia, Czech Acad Sci, Inst Parasitol, Fac Sci,Biol Ctr, Ceske Budejovice, Czech Republic; [Burrell, Alana; Vaughan, Sue] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford, England; [Leung, Ka-Fai] Univ Cambridge, Dept Pathol, Cambridge, England; [Gadelha, Catarina] Univ Nottingham, Sch Life Sci, Nottingham, England; [Zoltner, Martin] Charles Univ Prague, Fac Sci, Dept Parasitol, BIOCEV, Vestec, Czech Republic	University of Dundee; University of Glasgow; University of Glasgow; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Oxford Brookes University; University of Cambridge; University of Nottingham; Charles University Prague	Field, MC (corresponding author), Univ Dundee, Sch Life Sci, Dundee, Scotland.; Field, MC (corresponding author), Univ South Bohemia, Czech Acad Sci, Inst Parasitol, Fac Sci,Biol Ctr, Ceske Budejovice, Czech Republic.	mfield@mac.com	Gadelha, Catarina/ABD-5623-2021; Zikova, Alena/G-7855-2014; Field, Mark/AAD-6455-2021	Gadelha, Catarina/0000-0001-5016-3682; Zikova, Alena/0000-0002-8686-0225; Horn, David/0000-0001-5173-9284; Campagnaro, Gustavo/0000-0001-6542-0485; Cerone, Michela/0000-0003-0535-3983; Burrell, Alana/0000-0002-6067-5160; De Koning, Harry/0000-0002-9963-1827; Achcar, Fiona/0000-0001-8792-7615	Wellcome Trust [104111/Z/14/Z, 204697/Z/16/Z]; Medical Research Council [MR/P009018/1]; Leverhulme Trust Early Career Fellowship [ECF-2015-392]; University of Bologna, Italy; Science Without Borders (CNPq, Brazil) [206385/2014-5]; Czech Academy of Science [CZ.02.1.01/0.0/0.0/16_019/0000759];  [17-22248S]; MRC [MR/N010558/1, MR/N01037X/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust Early Career Fellowship(Leverhulme Trust); University of Bologna, Italy; Science Without Borders (CNPq, Brazil); Czech Academy of Science(Czech Academy of Sciences); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 204697/Z/16/Z (to M. C. F.) and Medical Research Council Grant MR/P009018/1 (to M. C. F.). M. C. F. and D. H. are Wellcome Trust investigators. F. A. was supported by Leverhulme Trust Early Career Fellowship ECF-2015-392. M. P. B. was supported by Wellcome Trust Grant 104111/Z/14/Z. M. C. was supported by a post-lauream fellowship from the University of Bologna, Italy. G. D. C. received a Ph.D. scholarship from Science Without Borders (206385/2014-5, CNPq, Brazil). A. Z. was supported by Grant 17-22248S and ERD Fund Grant CZ.02.1.01/0.0/0.0/16_019/0000759 Czech Academy of Science.	ABEBE G, 1983, TROP ANIM HEALTH PRO, V15, P151, DOI 10.1007/BF02239924; Akama T, 2018, BIOORG MED CHEM LETT, V28, P6, DOI 10.1016/j.bmcl.2017.11.028; Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016; Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Alsford S, 2013, TRENDS PARASITOL, V29, P207, DOI 10.1016/j.pt.2013.03.004; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barrett MP, 2011, FUTURE MICROBIOL, V6, P1037, DOI [10.2217/FMB.11.88, 10.2217/fmb.11.88]; Begolo D, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007315; BRINGAUD F, 1993, MOL CELL BIOL, V13, P1146, DOI 10.1128/MCB.13.2.1146; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Chokkathukalam A, 2013, BIOINFORMATICS, V29, P281, DOI 10.1093/bioinformatics/bts674; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; Colasante C, 2018, MOL BIOCHEM PARASIT, V221, P36, DOI 10.1016/j.molbiopara.2018.03.003; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; COLLINS JM, 1986, J CLIN PHARMACOL, V26, P22; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croci R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091765; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; Deramchia K, 2014, J BIOL CHEM, V289, P17365, DOI 10.1074/jbc.M114.567230; Fairlamb AH, 2018, TRENDS PARASITOL, V34, P481, DOI 10.1016/j.pt.2018.04.002; FANG Y, 1994, ACTA TROP, V58, P79, DOI 10.1016/0001-706X(94)90123-6; Field MC, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.193; Gadelha C, 2009, P NATL ACAD SCI USA, V106, P17425, DOI 10.1073/pnas.0909289106; Giordani F, 2016, PARASITOLOGY, V143, P1862, DOI 10.1017/S0031182016001268; Gloaguen Y, 2017, BIOINFORMATICS, V33, P4007, DOI 10.1093/bioinformatics/btx499; Haanstra JR, 2016, BBA-MOL CELL RES, V1863, P1038, DOI 10.1016/j.bbamcr.2015.09.015; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Kerkhoven EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003371; Koeller CM, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12980; Kovarova J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006953; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Leung KF, 2011, EUKARYOT CELL, V10, P916, DOI 10.1128/EC.05012-11; Lingnau A, 1999, J CELL SCI, V112, P3061; Mantilla BS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006158; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; McCain DF, 2004, J BIOL CHEM, V279, P14713, DOI 10.1074/jbc.M312488200; Mesu VKBK, 2018, LANCET, V391, P144, DOI 10.1016/S0140-6736(17)32758-7; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Mony BM, 2015, MOL MICROBIOL, V96, P220, DOI 10.1111/mmi.12949; Mony BM, 2014, NATURE, V505, P681, DOI 10.1038/nature12864; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Natesan Senthil Ka, 2010, BMC Res Notes, V3, P63, DOI 10.1186/1756-0500-3-63; Naviaux RK, 2017, ANN CLIN TRANSL NEUR, V4, P491, DOI 10.1002/acn3.424; Ong HB, 2015, MOL MICROBIOL, V95, P143, DOI 10.1111/mmi.12853; Opoku-Temeng C, 2016, CHEM COMMUN, V52, P3754, DOI 10.1039/c5cc10446g; Pal A, 2002, MOL BIOCHEM PARASIT, V122, P217, DOI 10.1016/S0166-6851(02)00096-8; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rattigan KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194126; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Rico E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00078; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Rotureau B, 2011, CELL MICROBIOL, V13, P705, DOI 10.1111/j.1462-5822.2010.01566.x; Saldivia M, 2016, CELL REP, V17, P660, DOI 10.1016/j.celrep.2016.09.041; Salvador GHM, 2015, ACTA CRYSTALLOGR D, V71, P2066, DOI 10.1107/S1399004715014443; Sanchez MA, 2013, J BIOL CHEM, V288, P14428, DOI 10.1074/jbc.M113.473157; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Scott AG, 1996, ACTA TROP, V60, P251, DOI 10.1016/0001-706X(96)00131-3; Seed John Richard, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-3; Silvester E, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030029; Sonoiki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14574; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Stafkova J, 2016, MOL MICROBIOL, V100, P442, DOI 10.1111/mmi.13325; STEIN CA, 1989, J CLIN ONCOL, V7, P499, DOI 10.1200/JCO.1989.7.4.499; Stoffel SA, 2011, MOL BIOCHEM PARASIT, V179, P1, DOI 10.1016/j.molbiopara.2011.04.006; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017; Thomas J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006980; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; VANSTERKENBURG ELM, 1993, ACTA TROP, V54, P237, DOI 10.1016/0001-706X(93)90096-T; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; VICKERMAN K, 1989, PARASITOLOGY, V99, pS37, DOI 10.1017/S0031182000083402; Wall RJ, 2018, P NATL ACAD SCI USA, V115, P9616, DOI 10.1073/pnas.1807915115; Wallace LJM, 2002, J BIOL CHEM, V277, P26149, DOI 10.1074/jbc.M202835200; Wenzler T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22451; Wiedemar N, 2019, FASEB BIOADV, V1, P595, DOI 10.1096/fba.2019-00033; Wiedemar N, 2018, MOL MICROBIOL, V107, P57, DOI 10.1111/mmi.13854; WIEMER EAC, 1995, BIOCHEM J, V312, P479, DOI 10.1042/bj3120479; WILLSON M, 1993, MOL BIOCHEM PARASIT, V59, P201, DOI 10.1016/0166-6851(93)90218-M; Wu K, 2016, P NATL ACAD SCI USA, V113, pE2011, DOI 10.1073/pnas.1601089113; Zhang N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006850; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; Zoltner M, 2016, CURR OPIN MICROBIOL, V34, P97, DOI 10.1016/j.mib.2016.08.005; Zoltner M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005236	96	16	16	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8331	8347		10.1074/jbc.RA120.012355	http://dx.doi.org/10.1074/jbc.RA120.012355			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32354742	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000542965700019
J	Martins, VCA; Cunha, IW; Figliuolo, G; Rondon, HHDF; de Souza, PM; Silva, FLT; Silva, GLT; Bastos, MD; de Castro, DB; Santana, MF; Ramasawmy, R; Levi, JE; Torres, KL				Alves Martins, Valquiria Carmo; Cunha, Isabela Werneck; Figliuolo, Giuseppe; de Melo Farah Rondon, Heidy Halanna; de Souza, Paloma Menezes; Torres Silva, Felipe Luz; Torres Silva, Guilherme Luz; Bastos, Michele de Souza; de Castro, Daniel Barros; Santana, Monique Freire; Ramasawmy, Rajendranath; Levi, Jose Eduardo; Torres, Katia Luz			Presence of HPV with overexpression of p16(INK4a) protein and EBV infection in penile cancer-A series of cases from Brazil Amazon	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN-PAPILLOMAVIRUS DNA; SQUAMOUS-CELL CARCINOMA; IN-SITU; PREVALENCE; CLASSIFICATION; EXPRESSION; TUMORS; P53; AMPLIFICATION	Background In Brazil, penile cancer (PC) is not uncommon. The highest incidence of PC is in the North and Northeast of the country. In addition to phimosis, the Human Papillomavirus (HPV) and Epstein-Baar Virus (EBV) infections are also related as risk factors for PC. The overexpression of p16(INK4a) is a surrogate sensitive marker of HPV infection in PC. Objectives To correlate p16(INK4a) overexpression and HPV infection status with EBV infection in a series of PC patients from the Amazon region. Methods Tumor tissues from 47 PC cases were analyzed for the presence of HPV and EBV DNA by PCR. All PC patients were diagnosed between 2013 and 2018 at a public reference cancer center hospital in Manaus, Amazonas-Brazil. HPV was genotyped using E7 HPV16/HPV18 type-specific real-time PCR and the PapilloCheck (R) HPV-Screening assay. p16INK4a expression was evaluated by immunohistochemistry using the automated Ventana (R) BenchMark Ultra. Results The mean age of patients at the time of diagnosis was 57.4 years +/- SD 17.8 ranging from 20 to 90 years old. Most of the patients (64%) came from rural areas of the Amazonas State. Thirty patients had phimosis (64%). Among the patients with phimosis, 43% (13/30) underwent circumcision, three during childhood and 10 in adulthood. 60% of the patients were smokers or ex-smokers. HPV infection was observed in 45% (21/47) of cases. HPV16 was detected in 13 patients (61%). Other HPV types detected were HPV 6, 11, 42, 51, 53, 68 and 44/55. EBV infection was observed in 30% (14/47) of the patients with PC. Co-infection with HPV and EBV was observed in 28% (6/21) cases. p16(INK4a) was only investigated in 26 samples. The p16(INK4a) overexpression was observed exclusively in HPV 16 positive cases and four HPV negative cases. In the survival analysis, the follow-up time was 35.4 months/patient. The mortality rate during the follow up time was 38%. Conclusions p16(INK4a) positivity presented a high correlation to HPV 16 DNA detection, reinforcing its use as a surrogate marker for HPV-driven cancers. Infection with EBV was quite frequent and its role in epithelial penile oncogenesis needs to be demonstrated.	[Alves Martins, Valquiria Carmo; Figliuolo, Giuseppe; Santana, Monique Freire; Torres, Katia Luz] Fundacao Ctr Controle Oncol Estado Amazonas, Dept Educ & Res, Manaus, Amazonas, Brazil; [Alves Martins, Valquiria Carmo; de Melo Farah Rondon, Heidy Halanna; Torres Silva, Felipe Luz; Torres, Katia Luz] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Alves Martins, Valquiria Carmo; de Castro, Daniel Barros; Ramasawmy, Rajendranath; Torres, Katia Luz] Genom Hlth Surveillance Network Optimizat Assista, Manaus, Amazonas, Brazil; [Cunha, Isabela Werneck] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil; [Cunha, Isabela Werneck] Rede DOR Sao Luiz, Dept Pathol, Sao Paulo, Brazil; [Figliuolo, Giuseppe; de Souza, Paloma Menezes; Torres Silva, Guilherme Luz] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Bastos, Michele de Souza; Santana, Monique Freire; Ramasawmy, Rajendranath] Fundacao Med Trop Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil; [de Castro, Daniel Barros] Fundacao Vigilancia Saude Amazonas, Tech Advisory, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Univ Nilton Lins, Fac Med, Manaus, Amazonas, Brazil; [Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil	Universidade Federal de Amazonas; A.C.Camargo Cancer Center; Universidade do Estado do Amazonas; Centro Universitario Nilton Lins; Universidade de Sao Paulo	Martins, VCA (corresponding author), Fundacao Ctr Controle Oncol Estado Amazonas, Dept Educ & Res, Manaus, Amazonas, Brazil.; Martins, VCA (corresponding author), Univ Fed Amazonas, Manaus, Amazonas, Brazil.; Martins, VCA (corresponding author), Genom Hlth Surveillance Network Optimizat Assista, Manaus, Amazonas, Brazil.	alvesvalquiria@yahoo.com.br	Torres, K. L./AGN-0021-2022; Bastos, Michele/AAS-7386-2020; Barros de Castro, Daniel/J-9358-2016	Torres, K. L./0000-0003-0922-5866; Bastos, Michele/0000-0003-3450-666X; Barros de Castro, Daniel/0000-0001-5969-544X; Martins, Valquiria/0000-0003-1259-9738	Fundacao de Amparo a Pesquisa do Estado do Amazonas-FAPEAM [021/2011-FAPEAM, 020/2013 FAPEAM, 05/2019 FAPEAM, 002./2008-FAPEAM]	Fundacao de Amparo a Pesquisa do Estado do Amazonas-FAPEAM	This work was supported by The Fundacao de Amparo a Pesquisa do Estado do Amazonas-FAPEAM for financial support (PROGRAMA UNIVERSAL AMAZONAS N.021/2011-FAPEAM; PROGRAMA PAPAC N.020/2013 FAPEAM; PROGRAMA PAPAC N.05/2019 FAPEAM and PROGRAMA PRo ' ESTADO N.002./2008-FAPEAM). The Rede D'OR-Sao Luiz provided support in the form of a salary for author Isabela Werneck Cunha IW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the `author contributions' section. The Genomic Health Surveillance Network: Optimization of Assistance and Research in the State of Amazonas -REGESAM is not a funder but a network of researchers in the Genomic field on the State of Amazonas.	Afonso LA, 2017, J MED VIROLOGY; Afonso LA, 2012, MEM I OSWALDO CRUZ, V107, P18, DOI 10.1590/S0074-02762012000100003; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Alves G, 2004, CANCER LETT, V215, P79, DOI 10.1016/j.canlet.2004.04.025; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; BARBOSA AD, 1984, REV SAUDE PUBL, V18, P429; Bethune G, 2012, UROLOGY, V79, P1092, DOI 10.1016/j.urology.2011.12.048; Bezerra ALR, 2001, CANCER, V91, P2315, DOI 10.1002/1097-0142(20010615)91:12<2315::AID-CNCR1263>3.0.CO;2-C; Bezerra SM, 2015, HUM PATHOL, V46, P532, DOI 10.1016/j.humpath.2014.12.004; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; de Sousa IDB, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0007-8; Calmon MF, 2011, THESCIENTIFICWORLDJO, V11, P269, DOI 10.1100/tsw.2011.24; Chalya PL, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0482-0; Chipollini J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081777; Christodoulidou M, 2015, CURR PROB CANCER, V39, P126, DOI 10.1016/j.currproblcancer.2015.03.010; Cubilla AL, 2011, AM J SURG PATHOL, V35, P253, DOI 10.1097/PAS.0b013e318203cdba; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; de Araujo LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199557; de Lima MAP, 2006, REV BRASILEIRA CANCE, V52, P87; Djajadiningrat RS, 2015, J UROLOGY, V193, P1245, DOI 10.1016/j.juro.2014.11.057; do Couto TC, 2014, INT BRAZ J UROL, V40, P738, DOI 10.1590/S1677-5538.IBJU.2014.06.04; Dorfman S, 2006, TROP DOCT, V36, P232, DOI 10.1258/004947506778604896; Favorito LA, 2008, INT BRAZ J UROL, V34, P587, DOI 10.1590/S1677-55382008000500007; Ferrandiz-Pulido C, 2015, GENE CHROMOSOME CANC, V54, P629, DOI 10.1002/gcc.22274; Ferreux E, 2003, J PATHOL, V201, P109, DOI 10.1002/path.1394; FIGLIUOLO G, 2015, REV BRASILEIRA ONCOL, V11; Fonseca AGD, 2010, REV PAN-AMAZ SAUDE, V1, P85, DOI [10.5123/S2176-62232010000200010, DOI 10.5123/S2176-62232010000200010]; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guidry JT, 2017, VIRUS RES, V231, P139, DOI 10.1016/j.virusres.2016.11.002; Heard I, 2016, J CLIN VIROL, V81, P6, DOI 10.1016/j.jcv.2016.05.004; Hernandez BY, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00009; LAM KY, 1995, CANCER-AM CANCER SOC, V76, P658, DOI 10.1002/1097-0142(19950815)76:4<658::AID-CNCR2820760418>3.0.CO;2-B; Larke NL, 2011, CANCER CAUSE CONTROL, V22, P1097, DOI 10.1007/s10552-011-9785-9; Levi JE, 1998, INT J CANCER, V76, P779, DOI 10.1002/(SICI)1097-0215(19980610)76:6<779::AID-IJC1>3.3.CO;2-9; Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001; Martinez-Bailon C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4696-6; Martins VD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205350; Micali G, 2006, J AM ACAD DERMATOL, V54, P369, DOI 10.1016/j.jaad.2005.05.007; Michels KB, 2009, LANCET, V374, P268, DOI 10.1016/S0140-6736(09)61247-2; Miralles-Guri C, 2009, J CLIN PATHOL; Moch H, 2016, EUR UROL, V70, P93, DOI 10.1016/j.eururo.2016.02.029; Cardona CEM, 2017, REV PANAM SALUD PUBL, V41, DOI [10.26633/rpsp.2017.117, 10.26633/RPSP.2017.117]; Mosconi AM, 2005, CRIT REV ONCOL HEMAT, V53, P165, DOI 10.1016/j.critrevonc.2004.09.006; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nd Melo MCBd, 2009, REV SBPH, V12, P99; Olesen TB, 2019, LANCET ONCOL, V20, P145, DOI 10.1016/S1470-2045(18)30682-X; Paner GP, 2018, EUR UROL, V73, P560, DOI 10.1016/j.eururo.2017.12.018; Parkin DM, 2010, INT J CANCER, V127, P2918, DOI 10.1002/ijc.25517; Pow-Sang Mariela R, 2002, Cancer Control, V9, P305; Prue G, 2017, ORAL DIS, V23, P726, DOI 10.1111/odi.12562; Reddy JP, 2017, BJU INT, V119, P591, DOI 10.1111/bju.13686; Rubin MA, 2001, AM J PATHOL, V159, P1211, DOI 10.1016/S0002-9440(10)62506-0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Salvioni R, 2009, PENILE CANC, P677; Schabath MB, 2011, CANC EPIDEMIOLOGY PR; Scheiner MA, 2008, INT BRAZ J UROL, V34, P467, DOI 10.1590/S1677-55382008000400009; Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86; Senba M, 2006, J MED VIROL, V78, P1341, DOI 10.1002/jmv.20703; Soufir N, 2007, BRIT J DERMATOL, V156, P448, DOI 10.1111/j.1365-2133.2006.07604.x; Spiess PE, 2016, CA-CANCER J CLIN, V66, P482, DOI 10.3322/caac.21354; Stratton KL, 2016, ONCOLOGY-NY, V30, P245; Szostek S, 2009, ACTA BIOCHIM POL, V56, P337; Tang DH, 2015, J UROLOGY, V193, P519, DOI 10.1016/j.juro.2014.08.120; Torres KL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201262; Veo CAR, 2015, TUMOR BIOL, V36, P5399, DOI 10.1007/s13277-015-3205-9; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Zargar-Shoshtari K, 2016, CLIN GENITOURIN CANC, V14, P346, DOI 10.1016/j.clgc.2015.12.019	67	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232474	10.1371/journal.pone.0232474	http://dx.doi.org/10.1371/journal.pone.0232474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374757	Green Published, gold			2022-12-26	WOS:000537283500037
J	Saldanha, V; de Araujo, IB; Lima, SIVC; Martins, RR; Oliveira, AG				Saldanha, Valdjane; de Araujo, Ivonete Batista; Vieira Cunha Lima, Sara Iasmin; Martins, Rand Randall; Oliveira, Antonio Gouveia			Risk factors for drug-related problems in a general hospital: A large prospective cohort	PLOS ONE			English	Article							EXPERT SUPPORT-SYSTEM; EMERGENCY-DEPARTMENT; CLINICAL-OUTCOMES; SCORE; EPIDEMIOLOGY; VALIDATION; KINGDOM; EVENTS	Objective To identify risk factors for potential Drug-Related Problems (DRP) at admission in hospitalized patients. Methodology Prospective cohort study conducted in adults patients hospitalized (May 2016 to May 2018) in a general tertiary care hospital in Brazil. Potential DRP were detected by daily review of 100% of electronic medication orders by hospital pharmacists and classified by the Pharmaceutical Care Network Europe classification system (PCNE version 6.2). For the identification of risk factors of potential DRP, backward stepwise logistic regression was used to identify the set of independent predictors among over 120 variables collected in the initial 48 hours after admission in a training set consisting of 2/3 of the study population. The model was validated in the remaining sample. Results The study population consisted of 1686 patients aged 52.0+/-18.3 years-old, 51.4% females, with a median length of stay of 3.24 days, and 4.5% in-hospital mortality. The cumulative incidence of potential DRP was 14.5%. Admission for elective surgery and main diagnosis of disease of the circulatory system were associated with reduced risk of DRP (OR 0.41 and 0.57, respectively, p< 0.05). The independent risk factors of DRP are heart rate. 80 bpm (OR 1.41, p = 0.05), prescription of more than seven drugs in day 2 (OR 1.63, p = 0.05), prescription in day 1 of drugs of the Anatomical Therapeutic Chemical Code (ATC) class A (alimentary tract and metabolism, OR 2.24, p = 0.003), prescription in day 2 of two or more ATC class A drugs (OR = 3.52, p < 0.001), and in day 1 of ATC class J drugs (antiinfectives for systemic use, OR 1.97, p = 0.001). In the validation set, the c-statistic of the predictive model was 0.65, the sensitivity was 56.1% and the specificity was 65.2%. Conclusion This study identified seven independent risk factors of potential DRP in patients hospitalized in a general hospital that have fair predictive performance for utilization in clinical practice.	[Saldanha, Valdjane; Vieira Cunha Lima, Sara Iasmin; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Grad Program Pharmaceut Sci, Natal, RN, Brazil; [de Araujo, Ivonete Batista; Martins, Rand Randall; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Pharm Dept, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Martins, RR (corresponding author), Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Pharm Dept, Natal, RN, Brazil.	randrandall@gmail.com	Martins, Rand Randall/X-8188-2019	Martins, Rand Randall/0000-0001-9668-0482; Lima, Sara/0000-0002-4127-7909				Abdela OA, 2016, J PHARM BIOALLIED SC, V8, P289, DOI 10.4103/0975-7406.199335; Al Hamid A, 2014, BRIT J CLIN PHARMACO, V78, P202, DOI 10.1111/bcp.12293; Alghamdy MS, 2015, J FAM COMMUNITY MED, V22, P44, DOI 10.4103/2230-8229.149590; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; Bedouch P, 2009, J CLIN PHARM THER, V34, P187, DOI 10.1111/j.1365-2710.2008.00990.x; Birarra MK, 2017, INT J CLIN PHARM-NET, V39, P1039, DOI 10.1007/s11096-017-0504-9; Blix HS, 2004, EUR J CLIN PHARMACOL, V60, P651, DOI 10.1007/s00228-004-0830-4; Ensor J., 2018, STAT SOFTWARE COMPON; Ferrandez O, 2018, SAUDI PHARM J, V26, P703, DOI 10.1016/j.jsps.2018.02.020; Finazzi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016110; Gastelurrutia P, 2011, J CARD FAIL, V17, P217, DOI 10.1016/j.cardfail.2010.10.009; Hammar T, 2015, INT J CLIN PHARM-NET, V37, P941, DOI 10.1007/s11096-015-0146-8; Baena MI, 2014, EUR J CLIN PHARMACOL, V70, P79, DOI 10.1007/s00228-013-1562-0; Kaufmann CP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006376; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Lampert ML, 2008, PHARM WORLD SCI, V30, P768, DOI 10.1007/s11096-008-9213-8; Liang SY, 2016, EMERG MED CLIN N AM, V34, P501, DOI 10.1016/j.emc.2016.04.005; Ma SN, 2019, THER CLIN RISK MANAG, V15, P505, DOI 10.2147/TCRM.S194921; Menditto E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210701; Meyer-Massetti C, 2018, INT J CLIN PHARM-NET, V40, P325, DOI 10.1007/s11096-017-0581-9; Nebeker JR, 2004, ANN INTERN MED, V140, P795, DOI 10.7326/0003-4819-140-10-200405180-00009; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Pharmaceutical Care Network Europe (PCNE), 2009, DEF DRUG REL PROBL 6; Qu C, 2019, INT J CLIN PHARM-NET, V41, P13, DOI 10.1007/s11096-018-0777-7; Rashed AN, 2014, BRIT J CLIN PHARMACO, V77, P873, DOI 10.1111/bcp.12270; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P1657, DOI 10.1007/s00228-012-1302-x; Roten I, 2010, PHARM WORLD SCI, V32, P103, DOI 10.1007/s11096-009-9352-6; Saokaew Surasak, 2009, Pharmacy Pract (Granada), V7, P81; Silva C, 2015, INT J CLIN PHARM-NET, V37, P327, DOI 10.1007/s11096-014-0063-2; Sinvani L, 2019, J HEALTHC QUAL, V41, P146, DOI 10.1097/JHQ.0000000000000153; Stampfli D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021284; Szilvay A, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4114-1; Tasaka Y, 2018, J PHARM HEALTH CARE, V4, DOI 10.1186/s40780-018-0125-z; Tora H, 2014, INT J CLIN PHARM-NET, V36, P943, DOI 10.1007/s11096-014-9976-z; Urbina O, 2015, THER CLIN RISK MANAG, V11, P9, DOI 10.2147/TCRM.S71749; Urbina O, 2014, PHARMACOEPIDEM DR S, V23, P923, DOI 10.1002/pds.3634; Rodrigues JPV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210779; Zopf Y, 2008, DRUG SAFETY, V31, P789, DOI 10.2165/00002018-200831090-00007	38	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0230215	10.1371/journal.pone.0230215	http://dx.doi.org/10.1371/journal.pone.0230215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369489	Green Published, gold			2022-12-26	WOS:000537280000003
J	Zhang, J; Fu, B; Lin, QT; Riley, IT; Ding, SL; Chen, LL; Cui, JK; Yang, LR; Li, HL				Zhang, Jie; Fu, Bo; Lin, Qitong; Riley, Ian T.; Ding, Shengli; Chen, Linlin; Cui, Jiangkuan; Yang, Lirong; Li, Honglian			Colonization of Beauveria bassiana 08F04 in root-zone soil and its biocontrol of cereal cyst nematode (Heterodera filipjevi)	PLOS ONE			English	Article							REAL-TIME PCR; TUMEFACIENS-MEDIATED TRANSFORMATION; PLANT-PARASITIC NEMATODES; AGROBACTERIUM-TUMEFACIENS; PSEUDOMONAS-FLUORESCENS; BIOLOGICAL-CONTROL; T-DNA; GENE; QUANTIFICATION; RESISTANCE	Cereal cyst nematodes cause serious yield losses of wheat in Hunaghuai winter wheat growing region in China. Beauveria bassiana 08F04 isolated from the surface of cysts is a promising biological control agent for cereal cyst nematodes. As the colonization capacity is a crucial criteria to assess biocontrol effectiveness for a microbial agent candidate, we aimed to label B. bassiana 08F04 for efficient monitoring of colonization in the soil. The binary pCAM-gfp plasmid containing sgfp and hph was integrated into B. bassiana 08F04 using the Agrobacterium tumefaciens-mediated transformation. The transformation caused a significant change in mycelial and conidial yields, and in extracellular chitinase activity in some transformants. The cultural filtrates of some transformants also decreased acetylcholinesterase activity and the survival of Heterodera filipjevi second-stage juveniles relative to the wild-type strain. One transformant (G10) had a growth rate and biocontrol efficacy similar to the wild-type strain, so it was used for a pilot study of B. bassiana colonization conducted over 13 weeks. Real-time PCR results and CFU counts revealed that the population of G10 increased quickly over the first 3 weeks, then decreased slowly over the following 4 weeks before stabilizing. In addition, the application of wild-type B. bassiana 08F04 and transformant G10 significantly reduced the number of H. filipjevi females in roots by 64.4% and 60.2%, respectively. The results of this study have practical applications for ecological, biological and functional studies of B. bassiana 08F04 and for bionematicide registration.	[Zhang, Jie; Yang, Lirong] Henan Acad Agr Sci, Inst Plant Protect Res, Zhengzhou, Peoples R China; [Fu, Bo] Henan Agr Univ, Coll Tobacco Sci, Zhengzhou, Peoples R China; [Lin, Qitong; Ding, Shengli; Chen, Linlin; Cui, Jiangkuan; Li, Honglian] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China; [Riley, Ian T.] Nigde Omer Halisdemir Univ, Fac Agr Sci & Technol, Dept Plant Prod & Technol, Nigde, Turkey	Henan Academy of Agricultural Sciences; Henan Agricultural University; Henan Agricultural University; Nigde Omer Halisdemir University	Yang, LR (corresponding author), Henan Acad Agr Sci, Inst Plant Protect Res, Zhengzhou, Peoples R China.; Li, HL (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China.	luck_ylr@126.com; honglianli@sina.com	Qitong, Lin/GXG-4089-2022; Riley, Ian Timothy/AAD-2764-2020	Riley, Ian Timothy/0000-0002-3592-0785	National Special Fund for Agro-scientific Research in the Public Interest of China [201503112]; Scientific and Technological Project of Henan Province [182102110272]; Special Funds for Research and Development of Henan Academy of Agricultural Sciences [2019CY02]	National Special Fund for Agro-scientific Research in the Public Interest of China; Scientific and Technological Project of Henan Province; Special Funds for Research and Development of Henan Academy of Agricultural Sciences	This research was financially supported by National Special Fund for Agro-scientific Research in the Public Interest of China (201503112), Scientific and Technological Project of Henan Province (182102110272) and Special Funds for Research and Development of Henan Academy of Agricultural Sciences (2019CY02).	Aggarwal R, 2014, J PLANT PATHOL, V96, P477; Ali MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020432; Binod P, 2005, ENZYME MICROB TECH, V36, P880, DOI 10.1016/j.enzmictec.2004.12.031; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BLAND JM, 1990, COMPUT BIOL MED, V20, P337, DOI 10.1016/0010-4825(90)90013-F; Bonaldi M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00025; Bordin AI, 2012, VET IMMUNOL IMMUNOP, V145, P290, DOI 10.1016/j.vetimm.2011.11.012; Bowyer P., 2001, DNA MEDIATED TRANSFO; Bundock P, 1999, MOL GEN GENET, V261, P115, DOI 10.1007/s004380050948; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; CASWELL EP, 1985, J NEMATOL, V17, P337; Chen SY, 2000, J NEMATOL, V32, P117; Chen SY, 1996, J NEMATOL, V28, P148; Cheng RB, 2012, MICROBIOL RES, V167, P179, DOI 10.1016/j.micres.2011.05.003; Chiarini L, 1998, APPL SOIL ECOL, V8, P11, DOI 10.1016/S0929-1393(97)00071-1; Crowder DW, 2014, BIOL CONTROL, V75, P8, DOI 10.1016/j.biocontrol.2013.10.010; Dababat AA, 2015, EUPHYTICA, V202, P173, DOI 10.1007/s10681-014-1269-z; Ding Y, 2011, MICROBIOL RES, V166, P314, DOI 10.1016/j.micres.2010.07.001; dos Reis MC, 2004, J MICROBIOL METH, V58, P197, DOI 10.1016/j.mimet.2004.03.012; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Escudero N, 2012, SYMBIOSIS, V57, P33, DOI 10.1007/s13199-012-0173-3; Fang WG, 2004, J INVERTEBR PATHOL, V85, P18, DOI 10.1016/j.jip.2003.12.003; Gotz M, 2006, FEMS MICROBIOL ECOL, V56, P207, DOI 10.1111/j.1574-6941.2006.00093.x; Hajihasani A., 2010, Nematologia Mediterranea, V38, P53; Hajihasani A, 2010, NEMATOLOGY, V12, P357, DOI 10.1163/138855409X12548945788321; Hashem M, 2011, CROP PROT, V30, P285, DOI 10.1016/j.cropro.2010.12.009; Hyun SH, 2013, J MICROBIOL BIOTECHN, V23, P47, DOI 10.4014/jmb.1208.08058; Islam MN, 2012, MICROBIOL RES, V167, P332, DOI 10.1016/j.micres.2012.02.001; Kang JS, 2011, MOL BIOCHEM PARASIT, V175, P154, DOI 10.1016/j.molbiopara.2010.11.005; Kerry BR, 1996, PESTIC SCI, V47, P69, DOI 10.1002/(SICI)1096-9063(199605)47:1&lt;69::AID-PS386&gt;3.0.CO;2-6; Krehenwinkel H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189188; Kumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096311; Landi L, 2012, PHYTOPATHOLOGY, V102, P290, DOI 10.1094/PHYTO-06-11-0165; Li HL, 2010, PLANT DIS, V94, P1505, DOI 10.1094/PDIS-04-10-0301; Lima IGP, 2006, LETT APPL MICROBIOL, V42, P631, DOI 10.1111/j.1472-765X.2006.01861.x; Liu T, 2008, WORLD J MICROB BIOT, V24, P113, DOI 10.1007/s11274-007-9446-z; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macia-Vicente JG, 2009, NEW PHYTOL, V182, P213, DOI 10.1111/j.1469-8137.2008.02743.x; Mascarin GM, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2131-3; McKinnon AC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01161; Mendis HC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193119; Morton CO, 2004, NEMATOLOGY, V6, P161, DOI 10.1163/1568541041218004; Nai YS, 2015, J ASIA-PAC ENTOMOL, V18, P677, DOI 10.1016/j.aspen.2015.07.013; Nicol J M, 2007, Commun Agric Appl Biol Sci, V72, P677; Ohmine Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00895; Pariyar Shree R, 2016, Phytopathology, V106, P1128, DOI 10.1094/PHYTO-02-16-0054-FI; Pujol M, 2006, APPL ENVIRON MICROB, V72, P2421, DOI 10.1128/AEM.72.4.2421-2427.2006; R Core Team, 2013, R LANG ENV STAT COMP; Riley IT, 2010, AUSTRALAS PLANT PATH, V39, P424, DOI 10.1071/AP10084; Ruano-Rosa D, 2016, BIOCONTROL, V61, P269, DOI 10.1007/s10526-015-9706-z; Sarrocco S, 2006, MYCOL RES, V110, P179, DOI 10.1016/j.mycres.2005.08.005; Savazzini F, 2008, J MICROBIOL METH, V73, P185, DOI 10.1016/j.mimet.2008.02.004; Schena L, 2003, J PLANT PATHOL, V85, P15; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Shi YW, 2017, J MICROBIOL, V55, P267, DOI 10.1007/s12275-017-6371-1; Siddiqui ZA, 1999, BIORESOURCE TECHNOL, V69, P167, DOI 10.1016/S0960-8524(98)00122-9; Toumi F, 2018, EUR J PLANT PATHOL, V150, P1, DOI 10.1007/s10658-017-1263-0; Valero-Jimenez CA, 2016, J INVERTEBR PATHOL, V133, P41, DOI 10.1016/j.jip.2015.11.011; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; Villacieros M, 2003, PLANT SOIL, V251, P47, DOI 10.1023/A:1022943708794; Wang HL, 1999, MYCOL RES, V103, P77, DOI 10.1017/S0953756298006698; Wang J, 2017, APPL MICROBIOL BIOT, V101, P185, DOI 10.1007/s00253-016-7757-4; Wickham H., 2015, GGPLOT2 ELEGANT GRAP; Zhang J, 2016, AUSTRALAS PLANT PATH, V45, P57, DOI 10.1007/s13313-015-0385-0; Zhang J, 2016, BIOL CONTROL, V92, P1, DOI 10.1016/j.biocontrol.2015.08.004; Zhang Jie, 2013, Chinese Journal of Biological Control, V29, P509	66	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232770	10.1371/journal.pone.0232770	http://dx.doi.org/10.1371/journal.pone.0232770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369513	Green Published, gold			2022-12-26	WOS:000537280000046
J	Lukacsi, S; Gerecsei, T; Balazs, K; Francz, B; Szabo, B; Erdei, A; Bajtay, Z				Lukacsi, Szilvia; Gerecsei, Tamas; Balazs, Katalin; Francz, Barbara; Szabo, Balint; Erdei, Anna; Bajtay, Zsuzsa			The differential role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in the adherence, migration and podosome formation of human macrophages and dendritic cells under inflammatory conditions	PLOS ONE			English	Article							COMPLEMENT RECEPTOR; RHEUMATOID-ARTHRITIS; ANTIGEN PRESENTATION; LEUKOCYTE INTEGRINS; ADHESION; EXPRESSION; ENDOTOXIN; BINDING; LIPOPOLYSACCHARIDE; NEUTROPHILS	CR3 and CR4, the leukocyte specific beta(2)-integrins, involved in cellular adherence, migration and phagocytosis, are often assumed to have similar functions. Previously however, we proved that under physiological conditions CR4 is dominant in the adhesion to fibrinogen of human monocyte-derived macrophages (MDMs) and dendritic cells (MDDCs). Here, using inflammatory conditions, we provide further evidence that the expression and function of CR3 and CR4 are not identical in these cell types. We found that LPS treatment changes their expression differently on MDMs and MDDCs, suggesting a cell type specific regulation. Using mAb24, specific for the high affinity conformation of CD18, we proved that the activation and recycling of beta(2)-integrins is significantly enhanced upon LPS treatment. Adherence to fibrinogen was assessed by two fundamentally different approaches: a classical adhesion assay and a computer-controlled micropipette, capable of measuring adhesion strength. While both receptors participated in adhesion, we demonstrated that CR4 exerts a dominant role in the strong attachment of MDDCs. Studying the formation of podosomes we found that MDMs retain podosome formation after LPS activation, whereas MDDCs lose this ability, resulting in a significantly reduced adhesion force and an altered cellular distribution of CR3 and CR4. Our results suggest that inflammatory conditions reshape differentially the expression and role of CR3 and CR4 in macrophages and dendritic cells.	[Lukacsi, Szilvia; Erdei, Anna; Bajtay, Zsuzsa] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary; [Gerecsei, Tamas; Szabo, Balint] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Gerecsei, Tamas] Hungarian Acad Sci, Ctr Energy Res, Nanobiosensor Lendulet Grp, Inst Tech Phys & Mat Sci, Budapest, Hungary; [Balazs, Katalin; Erdei, Anna; Bajtay, Zsuzsa] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Francz, Barbara; Szabo, Balint] CellSorter Co Innovat, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University	Bajtay, Z (corresponding author), Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary.; Bajtay, Z (corresponding author), Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary.	bajtay@elte.hu		Lukacsi, Szilvia/0000-0003-3499-8422	Hungarian National Science Fund (OTKA) [K112011]; Hungarian Academy of Sciences; CellSorter Company for Innovations	Hungarian National Science Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); CellSorter Company for Innovations	This study was funded by the Hungarian National Science Fund (OTKA) [grant K112011 for AE] and by the Hungarian Academy of Sciences for AE and ZB. CellSorter Company for Innovations (https://www.singlecellpicker.com/) provided its technology, including hardware and software, and funding in the form of salaries for authors BS and BF. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DC, 1986, J IMMUNOL, V137, P15; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; ARNAOUT MA, 1988, J CELL PHYSIOL, V137, P305, DOI 10.1002/jcp.1041370214; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Cervero P, 2013, METHODS MOL BIOL, V1046, P97, DOI 10.1007/978-1-62703-538-5_6; Chang YW, 2018, AM J PHYSIOL-LUNG C, V314, P1654, DOI 10.1152/ajplung.00501.2016; CORBI AL, 1988, J BIOL CHEM, V263, P12403; Cougoule C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00846; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Erdei A, 2019, SEMIN CELL DEV BIOL, V85, P110, DOI 10.1016/j.semcdb.2017.11.025; Fagerholm SC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00254; Flaherty SF, 1997, J SURG RES, V73, P85, DOI 10.1006/jsre.1997.5195; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; GALANOS C, 1993, IMMUNOBIOLOGY, V187, P346, DOI 10.1016/S0171-2985(11)80349-9; Gawden-Bone C, 2014, J CELL SCI, V127, P4213, DOI 10.1242/jcs.151167; Georgakopoulos T, 2008, MOL IMMUNOL, V45, P3671, DOI 10.1016/j.molimm.2008.04.021; Gildea LA, 2001, J IMMUNOL, V166, P1049, DOI 10.4049/jimmunol.166.2.1049; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Halvorsen B, 2014, CARDIOVASC RES, V102, P148, DOI 10.1093/cvr/cvu036; He GD, 2017, BIOMED PHARMACOTHER, V90, P598, DOI 10.1016/j.biopha.2017.03.095; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Ingalls RR, 1997, J IMMUNOL, V159, P433; Kornyei Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01088; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2015, CELL MOL LIFE SCI, V72, P121, DOI 10.1007/s00018-014-1731-z; Liote F, 1996, CLIN EXP IMMUNOL, V106, P13, DOI 10.1046/j.1365-2249.1996.d01-820.x; Lishko VK, 2001, BLOOD, V98, P2448, DOI 10.1182/blood.V98.8.2448; LO SK, 1989, J EXP MED, V169, P1779, DOI 10.1084/jem.169.5.1779; LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044; Lukacsi S, 2017, IMMUNOL LETT, V189, P64, DOI 10.1016/j.imlet.2017.05.014; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; ROSEN H, 1990, CURR TOP MICROBIOL, V153, P99; ROSS GD, 1992, J LEUKOCYTE BIOL, V51, P109, DOI 10.1002/jlb.51.2.109; Salanki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111450; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sandor N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163120; Sandor N, 2013, IMMUNOBIOLOGY, V218, P652, DOI 10.1016/j.imbio.2012.07.031; SANDSTROM T, 1992, EUR RESPIR J, V5, P992; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schittenhelm L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01866; SCHWARTZ DA, 1995, AM J RESP CRIT CARE, V152, P603, DOI 10.1164/ajrccm.152.2.7633714; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Ungai-Salanki R, 2019, ADV COLLOID INTERFAC, V269, P309, DOI 10.1016/j.cis.2019.05.005; Ungai-Salanki R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20375; Uzonyi B, 2017, IMMUNOL LETT, V189, P73, DOI 10.1016/j.imlet.2017.05.016; van den Dries K, 2014, CELL ADHES MIGR, V8, P268, DOI 10.4161/cam.28182; van den Dries K, 2012, CELL MOL LIFE SCI, V69, P1889, DOI 10.1007/s00018-011-0908-y; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; van Helden SFG, 2010, J IMMUNOL, V184, P1280, DOI 10.4049/jimmunol.0900764; Vorup-Jensen T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02716; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; West MA, 2008, J CELL BIOL, V182, P993, DOI 10.1083/jcb.200801022; Wilder RL, 2002, ANN RHEUM DIS, V61, P96, DOI 10.1136/ard.61.suppl_2.ii96; Wong KF, 2007, FASEB J, V21, P3231, DOI 10.1096/fj.06-7579com; WRIGHT SD, 1989, J EXP MED, V169, P175, DOI 10.1084/jem.169.1.175; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; WRIGHT SD, 1991, J EXP MED, V173, P1281, DOI 10.1084/jem.173.5.1281; Xuan WJ, 2015, J LEUKOCYTE BIOL, V97, P61, DOI 10.1189/jlb.1A0314-170R; Zarewych DM, 1996, J IMMUNOL, V156, P430	78	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232432	10.1371/journal.pone.0232432	http://dx.doi.org/10.1371/journal.pone.0232432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365067	Green Published, Green Accepted, gold			2022-12-26	WOS:000536959700032
J	Melanda, GCS; Accioly, T; Ferreira, RJ; Rodrigues, ACM; Cabral, TS; Coelho, G; Sulzbacher, MA; Cortez, VG; Grebenc, T; Martin, MP; Baseia, IG				Melanda, Gislaine C. S.; Accioly, Thiago; Ferreira, Renato J.; Rodrigues, Ana C. M.; Cabral, Tiara S.; Coelho, Gilberto; Sulzbacher, Marcelo A.; Cortez, Vagner G.; Grebenc, Tine; Martin, Maria P.; Baseia, Iuri G.			Diversity trapped in cages: Revision of Blumenavia Moller (Clathraceae, Basidiomycota) reveals three hidden species	PLOS ONE			English	Article							ANCESTRAL POPULATION SIZES; BAYES ESTIMATION; RIBOSOMAL DNA; DELIMITATION	Basidiomata of Phallales have a diversified morphology with adhesive gleba that exudes an odor, usually unpleasant that attracts mainly insects, which disperse the basidiospores. The genus Blumenavia belongs to the family Clathraceae and, based on morphological features, only two species are currently recognized: B. rhacodes and B. angolensis. However, the morphological characters adopted in species delimitations within this genus are inconsistent, and molecular data are scarce. The present study aimed to review and identify informative characters that contribute to the delimitation of Blumenavia species. Exsiccates from America and Africa were analyzed morphologically, and molecularly, using ITS, LSU, ATP6, RPB2 and TEF-1a markers for Maximum Parsimony, Bayesian and Maximum likelihood analyses, and also for coalescent based species delimitations (BP&P), as well as for bPTP, PhyloMap, Topo-phylogenetic and Geophylogenetic reconstructions. According to our studies, seven species can be considered in the genus: B. rhacodes and B. angolensis are maintained, B. usambarensis and B. toribiotalpaensis are reassessed, and three new species are proposed, B. baturitensis Melanda, M.P. Martin & Baseia, sp. nov., B. crucis-hellenicae G. Coelho, Sulzbacher, Grebenc & Cortez, sp. nov., and B. heroica Melanda, Baseia & M.P. Marti'n, sp. nov. Blumenavia rhacodes is typified by selecting a lectotype and an epitype. Macromorphological characters considered informative to segregate and delimit the species through integrative taxonomy include length of the basidiomata, color, width and presence of grooves on each arm as well as the glebifer position and shape. These must be clearly observed while the basidiomata are still fresh. Since most materials are usually analyzed after dehydration and deposit in collections, field techniques and protocols to describe fugacious characters from fresh specimen are demanded, as well as the use of molecular analysis, in order to better assess recognition and delimitation of species in Blumenavia.	[Melanda, Gislaine C. S.; Accioly, Thiago; Baseia, Iuri G.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Programa Posgrad Sistemat & Evolucao, Natal, RN, Brazil; [Ferreira, Renato J.; Rodrigues, Ana C. M.; Baseia, Iuri G.] Univ Fed Pernambuco, Programa Posgrad Biol Fungos, Dept Micol, Recife, PE, Brazil; [Cabral, Tiara S.] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Genet Conservacao & Biol Evolut, Manaus, Amazonas, Brazil; [Coelho, Gilberto; Sulzbacher, Marcelo A.] Univ Fed Santa Maria, Santa Maria, RS, Brazil; [Cortez, Vagner G.] Univ Fed Parana, Dept Biodiversidade, Setor Palotina, Palotina, Parana, Brazil; [Grebenc, Tine] Slovenian Forestry Inst, Ljubljana, Slovenia; [Martin, Maria P.] Real Jardin Bot CSIC, Dept Micol, Madrid, Spain	Universidade Federal do Rio Grande do Norte; Universidade Federal de Pernambuco; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Santa Maria (UFSM); Universidade Federal do Parana; Slovenian Forestry Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Melanda, GCS (corresponding author), Univ Fed Rio Grande do Norte, Dept Bot & Zool, Programa Posgrad Sistemat & Evolucao, Natal, RN, Brazil.	gsmelanda@gmail.com	; Ferreira, Renato Juciano/P-6887-2017; Melanda, Gislaine Cristina de Souza/T-7046-2017	Cortez, Vagner/0000-0002-1467-8723; Grebenc, Tine/0000-0003-4035-8587; Ferreira, Renato Juciano/0000-0002-9786-2226; Melanda, Gislaine Cristina de Souza/0000-0001-5667-2824	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Plan Nacional I+D+i project [CGL2015-67459-P]; Brazil-Slovenia bilateral project [BI-BR/11-13-005(SRA)/490648/2010-0]; Research Program in Forest Biology, Ecology and Technology of the Slovenian Research Agency [P4-0107]; CAPES; RJF; Special Visiting Researcher - PVE/CNPq [407474/2013-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Plan Nacional I+D+i project; Brazil-Slovenia bilateral project; Research Program in Forest Biology, Ecology and Technology of the Slovenian Research Agency; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); RJF; Special Visiting Researcher - PVE/CNPq	This work was supported by: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for ACMR, GCSM, TA and TSC scholarships, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for RJF scholarship; Special Visiting Researcher - PVE/CNPq (Process 407474/2013-7) given to IGB and MPM; Plan Nacional I+D+i project CGL2015-67459-P given to MPM; Brazil-Slovenia bilateral project (BI-BR/11-13-005(SRA)/490648/2010-0 (CNPq) and the Research Program in Forest Biology, Ecology and Technology (P4-0107) of the Slovenian Research Agency support TG and MS work.; ACMR, GCSM, TA and TSC thank the funding agency CAPES, and RJF to CNPq, for the scholarships. Acknowledgments are also due to the herbarium curators (B, BPI, HBG, IBUG, ICN, XAL, MBM, PACA, SMDB) by the loan of exsiccates, and for sending photographs of exsiccates; and the collectors for sending pictures of some specimens. Thanks to Association des amis des cryptogames (A.D.A.C.), Claire Margerie (Administration for Publications Scientifiques, Museum national dHistoire natural), and Jerome Degreef for permission to reproduce the image of B. angolensis from Degreef et al. [8]; to Gina Fullerlove (Head of Publishing of Royal Botanic Gardens, Kew) for permission to reproduce the image of B. angolensis from Dring [4]; to Dennis Desjardin for permission to reproduce the image of B. angolensis from Desjardin and Perry [11]; to Yalma L. Vargas-Rodriguez and J. Antonio Vazquez-Garcia for permission to reproduce the images of B. toribiotalpaensis from Vargas-Rodriguez and Vazquez-Garcia [7]. The authors give sincere thanks to Marian Glenn for English revision.	[Anonymous], 1842, SECRET MARRIAGE, piii; [Anonymous], 2002, ATLAS DE LOS COLORES; Arrigoni R, 2016, MOL PHYLOGENET EVOL, V105, P146, DOI 10.1016/j.ympev.2016.08.023; Bas C, 1969, PERSOONIA, V5, P285, DOI DOI 10.3852/09-288; Calonge FD, 2007, B SOC MICOLOGICA MAD, V31, P151; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Degreef J, 2013, CRYPTOGAMIE MYCOL, V34, P3, DOI 10.7872/crym.v34.iss1.2013.3; Dennis R.W.G., 1953, KEW BULL, V8, P307; Desjardin DE, 2015, MYCOSPHERE, V6, P515, DOI 10.5943/mycosphere/6/5/2; Dominguez deToledo LS., 1995, DARWINIANA, V33, P195; DRING D. M., 1967, J EAST AFR NATUR HIST SOC NAT MUS, V26, P5; DRING D M, 1980, Kew Bulletin, V35, P1, DOI 10.2307/4117008; Fischer E, 1886, JB KONIGLICHEN BOT G, V4, P1; Fischer E., 1900, SERIE ANHANG VERWAND; Hennings P, 1902, VERGL BOT JB, V28, P318; Hibbett DS, 1997, P NATL ACAD SCI USA, V94, P12002, DOI 10.1073/pnas.94.22.12002; Kretzer AM, 1999, MOL PHYLOGENET EVOL, V13, P483, DOI 10.1006/mpev.1999.0680; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lloyd CG, 1905, MYCOLOGICAL WRITINGS, VII; Lopez A, 2012, FUNGA VERACRUZANA, V134, P1; Lopez A, 2001, FUNGA VERACRUZANA, V33, P1; Luo A, 2018, SYST BIOL, V67, P830, DOI 10.1093/sysbio/syy011; Martin MP, 2000, LICHENOLOGIST, V32, P189, DOI 10.1006/lich.1999.0254; Miller OKJr., 1988, GASTEROMYCETES MORPH; Moller A, 1895, BOT MITTHEILUNGEN TR, V7, P1, DOI DOI 10.5962/BHL.TITLE.2748; de Oca ANM, 2017, MOL PHYLOGENET EVOL, V106, P241, DOI 10.1016/j.ympev.2016.09.001; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Rannala B, 2003, GENETICS, V164, P1645; Rick J., 1929, EGATEA, V14, P299; Rodrigues ACM, 2013, MYCOSPHERE, V4, P1066, DOI 10.5943/mycosphere/4/6/4; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sousa JO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177873; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stielow JB, 2015, PERSOONIA, V35, P242, DOI 10.3767/003158515X689135; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Trierveiler-Pereira L, 2014, MYCOSPHERE, V5, P496, DOI 10.5943/mycosphere/5/3/12; Vargas-Rodriguez YL, 2005, MYCOTAXON, V94, P7; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Waese J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175895; Welwitsch F, 1870, T LINN SOC LOND, V26, P279; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang ZH, 2002, GENETICS, V162, P1811; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	45	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232467	10.1371/journal.pone.0232467	http://dx.doi.org/10.1371/journal.pone.0232467			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357194	gold, Green Published			2022-12-26	WOS:000536957700031
J	Ruff, TM; Marston, EJ; Eagle, JD; Sthapit, SR; Hooker, MA; Skinner, DZ; See, DR				Ruff, Travis M.; Marston, Elliott J.; Eagle, Jonathan D.; Sthapit, Sajal R.; Hooker, Marcus A.; Skinner, Daniel Z.; See, Deven R.			Genotyping by multiplexed sequencing (GMS): A customizable platform for genomic selection	PLOS ONE			English	Article							ALIGNMENT; DIVERSITY; ACCURACY; PCR	As genotyping technologies continue to evolve, so have their throughput and multiplexing capabilities. In this study, we demonstrate a new PCR-based genotyping technology that multiplexes thousands of single nucleotide polymorphism (SNP) markers with high-throughput capabilities in a simple protocol using a two-step PCR approach. The bioinformatic pipeline is user friendly and yields results that are intuitive to interpret. This method was tested on two recombinant inbred line (RIL) populations that had previous genotyping data from the Illumina Infinium assay for Triticum aestivum L. and the two data sets were found to be 100% in agreement. The genotyping by multiplexed sequencing (GMS) protocol multiplexes 1,656 wheat SNP markers, 207 syntenic barley SNP markers, and 49 known informative markers, which generate a possible 2,433 data points (including homoeoalleles and paralogs). This genotyping approach has the flexibility of being sequenced on either the Ion Torrent or Illumina next generation sequencing (NGS) platforms. Products are the result of direct sequencing and are therefore more reliable than scatter plot analysis which is the output of other genotyping methods such as the Illumina Infinium assay, komeptitive allele specific PCR and other like technologies.	[Ruff, Travis M.; Hooker, Marcus A.; Skinner, Daniel Z.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Ruff, Travis M.; Skinner, Daniel Z.; See, Deven R.] USDA ARS, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA; [Marston, Elliott J.; Eagle, Jonathan D.; Sthapit, Sajal R.; See, Deven R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University	Ruff, TM (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.; Ruff, TM (corresponding author), USDA ARS, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA.	truff@wsu.edu		Sthapit, Sajal/0000-0003-4759-8639	United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The United States Department of Agriculture, Agricultural Research Service provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Bernardo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143890; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Campbell NR, 2015, MOL ECOL RESOUR, V15, P855, DOI 10.1111/1755-0998.12357; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Chan EY, 2009, METHODS MOL BIOL, V578, P95, DOI 10.1007/978-1-60327-411-1_5; Chen K, 2016, ANAL BIOANAL CHEM, V408, P4371, DOI 10.1007/s00216-016-9536-6; DeFaveri J, 2013, MOL ECOL RESOUR, V13, P377, DOI 10.1111/1755-0998.12071; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gordon A.H., 2010, FASTX TOOLKIT; Himi E, 2011, THEOR APPL GENET, V122, P1561, DOI 10.1007/s00122-011-1555-2; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Leonard JM, 2008, THEOR APPL GENET, V116, P261, DOI 10.1007/s00122-007-0664-4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JY, 2017, J CEREAL SCI, V77, P211, DOI 10.1016/j.jcs.2017.08.016; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu S., 2015, GENOTYPING MULTIPLEX, P10; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Oliphant A., 2002, BIOTECHNIQUES, V32, pS56, DOI DOI 10.2144/JUN0207; Onda Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00201; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rasheed A, 2016, THEOR APPL GENET, V129, P1843, DOI 10.1007/s00122-016-2743-x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sears E. R., 1954, RES B, V572; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thomson M. J., 2014, Plant Breeding and Biotechnology, V2, P195, DOI 10.9787/PBB.2014.2.3.195; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; Voss-Fels K, 2016, PLANT BIOTECHNOL J, V14, P1086, DOI 10.1111/pbi.12456; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0229207	10.1371/journal.pone.0229207	http://dx.doi.org/10.1371/journal.pone.0229207			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357171	gold, Green Published			2022-12-26	WOS:000536957700002
J	Bae, IS; Kim, JM; Cheong, JH; Ryu, JI; Choi, KS; Han, MH				Bae, In-Suk; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Choi, Kyu-Sun; Han, Myung-Hoon			Does the skull Hounsfield unit predict shunt dependent hydrocephalus after decompressive craniectomy for traumatic acute subdural hematoma?	PLOS ONE			English	Article							BONE-MINERAL DENSITY; INTRACRANIAL HYPERTENSION; RISK-FACTORS; CRANIOPLASTY; CT; EVACUATION	Background and purpose Posttraumatic hydrocephalus affects 11.9%-36% of patients undergoing decompressive craniectomy (DC) after traumatic brain injury and necessitates a ventriculo-peritoneal shunt placement. As bone and arachnoid trabeculae share the same collagen type, we investigated possible connections between the skull Hounsfield unit (HU) values and shunt-dependent hydrocephalus (SDHC) in patients that received cranioplasty after DC for traumatic acute subdural hematoma (SDH). Methods We measured HU values in the frontal bone and internal occipital protuberance from admission brain CT. Receiver operating characteristic curve analysis was performed to identify the optimal cut-off skull HU values for predicting SDHC in patients receiving cranioplasty after DC due to traumatic acute SDH. We investigated independent predictive factors for SDHC occurrence using multivariable logistic regression analysis. Results A total of 162 patients (>15 years of age) were enrolled in the study over an 11-year period from two university hospitals. Multivariable logistic analysis revealed that the group with simultaneous frontal skull HU.797.4 and internal occipital protuberance HU.586.5 (odds ratio, 8.57; 95% CI, 3.05 to 24.10; P<0.001) was the only independent predictive factor for SDHC in patients who received cranioplasty after DC for traumatic acute SDH. Conclusions Our study reveals a potential relationship between possible low bone mineral density and development of SDHC in traumatic acute SDH patients who had undergone DC. Our findings provide deeper insight into the association between low bone mineral density and hydrocephalus after DC for traumatic acute SDH.	[Bae, In-Suk] Eulji Univ, Dept Neurosurg, Eulji Hosp, Seoul, South Korea; [Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon] Hanyang Univ, Dept Neurosurg, Guri Hosp, Gyonggi Do, South Korea; [Choi, Kyu-Sun] Hanyang Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea	Eulji University; Hanyang University; Hanyang University	Han, MH (corresponding author), Hanyang Univ, Dept Neurosurg, Guri Hosp, Gyonggi Do, South Korea.	gksmh80@gmail.com			Hanyang University [HY-201900000003370]	Hanyang University	This work was supported by the research fund of Hanyang University (HY-201900000003370).	Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; Bratton S.L., 2007, J NEUROTRAUMA S, V24, pS37, DOI DOI 10.1089/NEU.2007.9999; CHARNAS LR, 1993, NEUROLOGY, V43, P2603, DOI 10.1212/WNL.43.12.2603; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Choi MK, 2016, ACTA NEUROCHIR, V158, P1421, DOI 10.1007/s00701-016-2821-5; Chrastina J, 2020, EUR J TRAUMA EMERG S, V46, P347, DOI 10.1007/s00068-019-01077-6; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Han MH, 2018, STROKE, V49, P1850, DOI 10.1161/STROKEAHA.118.021063; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Johnson CC, 2016, J HAND SURG-AM, V41, P767, DOI 10.1016/j.jhsa.2016.04.016; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Lee J, 2013, ENDOCRINOL METAB, V28, P180, DOI 10.3803/EnM.2013.28.3.180; Lee R, 2020, IMPLEMENT SCI, V15; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Mann V, 2003, BONE, V32, P711, DOI 10.1016/S8756-3282(03)00087-5; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mortazavi MM, 2018, WORLD NEUROSURG, V111, P279, DOI 10.1016/j.wneu.2017.12.041; Na MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197336; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Saboori Parisa, 2015, Anat Res Int, V2015, P279814, DOI 10.1155/2015/279814; Schreiber JJ, 2011, J BONE JOINT SURG AM, V93A, P1057, DOI 10.2106/JBJS.J.00160; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Scott GG, 2015, IEEE T MED IMAGING, V34, P1452, DOI 10.1109/TMI.2015.2396527; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Won YD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28471-1; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI 10.1080/10255840903064897	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232631	10.1371/journal.pone.0232631	http://dx.doi.org/10.1371/journal.pone.0232631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353054	Green Published, gold			2022-12-26	WOS:000536673200112
J	Gomez-Garcia, FJ; Lopez, AL; Guerrero-Sanchez, Y; Siles, MS; Diaz, FM; Alonso, FC				Jose Gomez-Garcia, Francisco; Lopez Lopez, Antonia; Guerrero-Sanchez, Yolanda; Sanchez Siles, Mariano; Martinez Diaz, Francisco; Camacho Alonso, Fabio			Chemopreventive effect of pomegranate and cocoa extracts on ultraviolet radiation-induced photocarcinogenesis in SKH-1 mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; INDUCED DNA-DAMAGE; SKIN; UVA; PREVENTION; IMPACT; P53	Non-melanoma skin cancer (NMSC) has a high and increasing incidence all over the world. Solar radiation is the main aetiology for humans. Although most research into photocarcinogenesis uses UVB as a source of radiation, UVA is also carcinogenic in long term. Pomegranate (PGE) and cocoa (CE) extracts have been used for medicinal purposes for time immemorial. Recently, it has been claimed that some of their properties may be an effective preventative measure against photocarcinogenesis and photoaging, but to date in vivo models have not been tested using RUVA, the objective of the present work. A lower incidence of lesions was observed in SKH-1 mice treated with PGE (p<0.001), and lower incidence of invasive squamous carcinoma in both treatment groups (p<0.001 for PGE and p<0.05 for CE); the PGE group also showed a lower level of cell proliferation than the control group (p<0.001). Significantly greater p53 alteration was observed in the control group than the treatment groups (p<0.001 for PGE and p = 0.05 for CE). No significant differences were found in relation to TIMP-1 and MMP-9. Taken together, the results suggest that oral feeding of PGE and CE to SKH-1 mice affords substantial protection against the adverse effects of RUVA, especially PGE.	[Jose Gomez-Garcia, Francisco; Lopez Lopez, Antonia; Guerrero-Sanchez, Yolanda; Sanchez Siles, Mariano; Camacho Alonso, Fabio] Univ Murcia, Dept Dermatol Stomatol Radiol & Phys Med, Fac Med, Campus Excellence Mare Nostrum, Murcia, Spain; [Martinez Diaz, Francisco] Hosp Gen Univ Reina Sofia, Dept Pathol, Murcia, Spain	University of Murcia; Hospital Universitario Reina Sofia - Cordoba	Guerrero-Sanchez, Y (corresponding author), Univ Murcia, Dept Dermatol Stomatol Radiol & Phys Med, Fac Med, Campus Excellence Mare Nostrum, Murcia, Spain.	yolanda.guerreros@um.es	Gómez García, Francisco José/ABE-5240-2021	Gómez García, Francisco José/0000-0001-6795-1028; Camacho-Alonso, Fabio/0000-0002-3739-1792; Guerrero Sanchez, Yolanda/0000-0002-4228-2355	Ministerio de Ciencia, Innovacion y Universidades [PGC2018-097198-BI00]; Fundacion Seneca de la Region de Murcia [20783/PI/18]	Ministerio de Ciencia, Innovacion y Universidades; Fundacion Seneca de la Region de Murcia(Fundacion Seneca)	Yolanda Guerrero-Sanchez is partially supported by Ministerio de Ciencia, Innovacion y Universidades grant number PGC2018-097198-BI00 and Fundacion Seneca de la Region de Murcia grant number 20783/PI/18.	Afaq F, 2005, PHOTOCHEM PHOTOBIOL, V81, P38, DOI 10.1562/2004-08-06-RA-264.1; Afaq F, 2010, PHOTOCHEM PHOTOBIOL, V86, P1318, DOI 10.1111/j.1751-1097.2010.00815.x; Andisheh-Tadbir A, 2016, J CLIN EXP DENT, V8, P130; Bachelor MA, 2004, SEMIN CANCER BIOL, V14, P131, DOI 10.1016/j.semcancer.2003.09.017; Bassiri-Jahromi S, 2018, ONCOL REV, V12, P1, DOI 10.4081/oncol.2018.345; Benjamin CL, 2007, TOXICOL APPL PHARM, V224, P241, DOI 10.1016/j.taap.2006.12.006; Bosch R, 2015, ANTIOXIDANTS-BASEL, V4, P248, DOI 10.3390/antiox4020248; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; de Anda-Jauregui G, 2019, APPL MATH NONLIN SCI, V4, P223, DOI 10.2478/AMNS.2019.1.00020; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; deLaat A, 1997, CARCINOGENESIS, V18, P1013, DOI 10.1093/carcin/18.5.1013; Duarte AF, 2018, CANCER EPIDEMIOL, V56, P154, DOI 10.1016/j.canep.2018.08.004; Eisemann N, 2014, J INVEST DERMATOL, V134, P43, DOI 10.1038/jid.2013.304; Fisher GJ, 2001, J INVEST DERMATOL, V117, P219, DOI 10.1046/j.0022-202x.2001.01432.x; FORBES PD, 1981, J INVEST DERMATOL, V77, P139, DOI 10.1111/1523-1747.ep12479351; Fu X.R., CMAJ, V34, P369; Gupta A, 2014, AGEING RES REV, V13, P65, DOI 10.1016/j.arr.2013.12.001; Ibrahim MAA, 2017, ANN ANAT, V211, P78, DOI 10.1016/j.aanat.2017.01.007; Justin J.H., 2004, J MED FOOD, V6, P157; Kim JE, 2016, J INVEST DERMATOL, V136, P1012, DOI 10.1016/j.jid.2015.11.032; Lopez AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157689; Moller P, 2002, FASEB J, V16, P45, DOI 10.1096/fj.01-0386com; Park HM, 2010, INT J DERMATOL, V49, P276, DOI 10.1111/j.1365-4632.2009.04269.x; Poswar FO, 2013, PATHOL RES PRACT, V209, P705, DOI 10.1016/j.prp.2013.08.002; Preidl RHM, 2019, STRAHLENTHER ONKOL, V195, P52, DOI 10.1007/s00066-018-1382-3; Rigby CM, 2017, CARCINOGENESIS, V38, P40, DOI 10.1093/carcin/bgw106; Rojas C, 2018, APPL MATH NONLIN SCI, V3, P375, DOI DOI 10.21042/AMNS.2018.2.00029; Ruksha TG, 2007, B EXP BIOL MED+, V144, P77, DOI 10.1007/s10517-007-0259-8; Scapagnini G, 2014, NUTRIENTS, V6, P3202, DOI 10.3390/nu6083202; Seebode C, 2016, ANTICANCER RES, V36, P1371; Shaygannia E., 2015, J EVID BASED COMPLEM, V21, P221; Silva ES, 2019, PHOTOCHEM PHOTOBIOL, V95, P644, DOI 10.1111/php.13026; Singh RP, 2002, CARCINOGENESIS, V23, P499, DOI 10.1093/carcin/23.3.499; Smolarek AK, 2013, MOL CARCINOGEN, V52, P514, DOI 10.1002/mc.21886; Urpi-Sarda M, 2009, ANAL BIOANAL CHEM, V394, P1545, DOI 10.1007/s00216-009-2676-1; Vlachojannis C., SAFETY HERBAL MED PR; Waldman A, 2019, HEMATOL ONCOL CLIN N, V33, P1, DOI 10.1016/j.hoc.2018.08.001; Weinstock MA, 2008, AM J PREV MED, V34, P171, DOI 10.1016/j.amepre.2007.11.002	38	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232009	10.1371/journal.pone.0232009	http://dx.doi.org/10.1371/journal.pone.0232009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353018	Green Published, gold			2022-12-26	WOS:000536673200033
J	Khan, MA; Asaf, S; Khan, AL; Jan, R; Kang, SM; Kim, KM; Lee, IJ				Khan, Muhammad Aaqil; Asaf, Sajjad; Khan, Abdul Latif; Jan, Rahmatullah; Kang, Sang-Mo; Kim, Kyung-Min; Lee, In-Jung			Extending thermotolerance to tomato seedlings by inoculation with SA1 isolate of Bacillus cereus and comparison with exogenous humic acid application	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIUM; SALINITY STRESS TOLERANCE; HIGH-TEMPERATURE STRESS; SPHINGOMONAS SP LK11; PLANT-GROWTH; HEAT-STRESS; SALICYLIC-ACID; MOLECULAR-MECHANISMS; ANTIOXIDANT SYSTEMS; OXIDATIVE STRESS	Heat stress is one of the major abiotic stresses that impair plant growth and crop productivity. Plant growth-promoting endophytic bacteria (PGPEB) and humic acid (HA) are used as bio-stimulants and ecofriendly approaches to improve agriculture crop production and counteract the negative effects of heat stress. Current study aimed to analyze the effect of thermotolerant SA1 an isolate of Bacillus cereus and HA on tomato seedlings. The results showed that combine application of SA1+HA significantly improved the biomass and chlorophyll fluorescence of tomato plants under normal and heat stress conditions. Heat stress increased abscisic acid (ABA) and reduced salicylic acid (SA) content; however, combined application of SA1+HA markedly reduced ABA and increased SA. Antioxidant enzymes activities revealed that SA1 and HA treated plants exhibited increased levels of ascorbate peroxidase (APX), superoxide dismutase (SOD), and reduced glutathione (GSH). In addition, heat stress markedly reduced the amino acid contents; however, the amino acids were increased with co-application of SA1 +HA. Similarly, inductively-coupled plasma mass-spectrometry results showed that plants treated with SA1+HA exhibited significantly higher iron (Fe+), phosphorus (P), and potassium (K+) uptake during heat stress. Heat stress increased the relative expression of SlWRKY33b and autophagy-related (SlATG5) genes, whereas co-application of SA1+HA augmented the heat stress response and reduced SlWRKY33b and SlATG5 expression. The heat stress-responsive transcription factor (SlHsfA1a) and high-affinity potassium transporter (SlHKT1) were upregulated in SA1+HA-treated plants. In conclusion, current findings suggest that co-application with SA1+HA can be used for the mitigation of heat stress damage in tomato plants and can be commercialized as a biofertilizer.	[Khan, Muhammad Aaqil; Jan, Rahmatullah; Kang, Sang-Mo; Kim, Kyung-Min; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Asaf, Sajjad; Khan, Abdul Latif] Univ Nizwa, Nat & Med Plants Res Ctr, Nizwa, Oman	Kyungpook National University; University of Nizwa	Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	ijlee@knu.ac.kr	Asaf, Sajjad/ABA-3647-2021; Khan, Muhammad Aqil/ABB-9797-2021; Khan, Muhammad Aaqil/ABG-9777-2021; Lee, In-Jung/GLS-0432-2022	Lee, In-Jung/0000-0001-7154-4820; Khan, Muhammad Aaqil/0000-0002-9556-2350	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B04035601]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B04035601) to IJL.	Abd El-Daim IA, 2014, PLANT SOIL, V379, P337, DOI 10.1007/s11104-014-2063-3; Abdellatif Islam Mohamed Yassin, 2017, Journal of Horticultural Research, V25, P59, DOI 10.1515/johr-2017-0022; Aggarwal PK, 2008, INDIAN J AGR SCI, V78, P911; Ahammed GJ, 2016, PLANT HORMONES CHALL, P1, DOI [10.1007/978-94-017-7758-2_1, DOI 10.1007/978-94-017-7758-2_1]; Ahammed GJ, 2018, FRONTIERS PLANT SCI, V9; Cura JA, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030041; Ali A, 2018, FRONTIERS PLANT SCI, V9; Ali SZ, 2011, J PLANT INTERACT, V6, P239, DOI 10.1080/17429145.2010.545147; Ali SZ, 2009, BIOL FERT SOILS, V46, P45, DOI 10.1007/s00374-009-0404-9; Almeida DM, 2017, GENET MOL BIOL, V40, P326, DOI [10.1590/1678-4685-gmb-2016-0106, 10.1590/1678-4685-GMB-2016-0106]; Alonso-Ramirez A, 2009, PLANT PHYSIOL, V150, P1335, DOI 10.1104/pp.109.139352; Arora A, 2002, CURR SCI INDIA, V82, P1227; Asaf S, 2017, MICROBIOL RES, V205, P135, DOI 10.1016/j.micres.2017.08.009; Asaf S, 2017, J PLANT INTERACT, V12, P31, DOI 10.1080/17429145.2016.1274060; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Atiyeh RM, 2002, BIORESOURCE TECHNOL, V84, P7, DOI 10.1016/S0960-8524(02)00017-2; Bacilio M, 2016, APPL SOIL ECOL, V107, P394, DOI 10.1016/j.apsoil.2016.04.012; Barbosa M. A. M., 2013, Australian Journal of Crop Science, V7, P1983; Bashar KK, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020043; Beecher GR, 1998, P SOC EXP BIOL MED, V218, P98, DOI 10.3181/00379727-218-44282a; Benbella M, 1998, AGRON J, V90, P332, DOI 10.2134/agronj1998.00021962009000030004x; Bensalim S, 1998, AM J POTATO RES, V75, P145, DOI 10.1007/BF02895849; Bhise KK, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0739-0; Bilal S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00870; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Baldotto LEB, 2010, REV BRAS CIENC SOLO, V34, P1593, DOI 10.1590/S0100-06832010000500012; Bottini R, 2004, APPL MICROBIOL BIOT, V65, P497, DOI 10.1007/s00253-004-1696-1; Busato JG, 2012, BIORESOURCE TECHNOL, V110, P390, DOI 10.1016/j.biortech.2012.01.126; Camejo D, 2005, J PLANT PHYSIOL, V162, P281, DOI 10.1016/j.jplph.2004.07.014; Canellas LP, 2014, CHEM BIOL TECHNOL AG, V1, DOI 10.1186/2196-5641-1-3; Canellas LP, 2013, PLANT SOIL, V366, P119, DOI 10.1007/s11104-012-1382-5; Carneiro Jr JB, 2000, FITOPATOL BRAS, V29, P614; Chan CX, 2004, J APPL PHYCOL, V16, P297, DOI 10.1023/B:JAPH.0000047782.20940.de; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Cortina J, 2013, NEW FOREST, V44, P719, DOI 10.1007/s11056-013-9379-3; da Silva SF, 2017, CHEM BIOL TECHNOL AG, V4, DOI 10.1186/s40538-017-0106-8; de Ollas C, 2016, PLANT MOL BIOL, V91, P641, DOI 10.1007/s11103-016-0503-6; de Ronde JA, 2004, EUPHYTICA, V138, P123, DOI 10.1023/B:EUPH.0000046806.68554.5b; Dobra J, 2015, PLANT SCI, V231, P52, DOI 10.1016/j.plantsci.2014.11.005; Driedonks N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00999; Egamberdieva D, 2017, FRONTIERS MICROBIOLO, V8; Esringu A, 2016, COMMUN SOIL SCI PLAN, V47, P602, DOI 10.1080/00103624.2016.1141922; Fairbairn DJ, 2000, PLANT MOL BIOL, V43, P515, DOI 10.1023/A:1006496402463; Firon N, 2006, SCI HORTIC-AMSTERDAM, V109, P212, DOI 10.1016/j.scienta.2006.03.007; Fragkostefanakis S, 2016, PLANT PHYSIOL, V170, P2461, DOI 10.1104/pp.15.01913; Gagne-Bourque F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00584; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Georgieva K, 2003, FUNCT PLANT BIOL, V30, P515, DOI 10.1071/FP03024; Glick BR, 1997, SOIL BIOL BIOCHEM, V29, P1233, DOI 10.1016/S0038-0717(97)00026-6; Gururani MA, 2015, INT J MOL SCI, V16, P19055, DOI 10.3390/ijms160819055; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; He YL, 2005, CROP SCI, V45, P988, DOI 10.2135/cropsci2003.0678; Hemmati H., 2015, ELUCIDATION ABIOTIC, P109, DOI [10.1007/978-1-4939-2540-7_5, DOI 10.1007/978-1-4939-2540-7_5]; Hildebrandt TM, 2018, PLANT MOL BIOL, V98, P121, DOI 10.1007/s11103-018-0767-0; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hong SW, 2003, PLANT PHYSIOL, V132, P757, DOI 10.1104/pp.102.017145; Ihsan MZ, 2019, ACTA AGR SCAND B-S P, V69, P332, DOI 10.1080/09064710.2019.1569715; Issa A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01397; Jan N., 2018, BIOTECHNOLOGIES CROP, V1, P327, DOI [10.1007/978-3-319-78283-6, DOI 10.1007/978-3-319-78283-6]; Jan R, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100363; Jin J, 2015, ANN BOT-LONDON, V116, P975, DOI 10.1093/aob/mcu209; Kang SM, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1450-6; Kang SM, 2012, PAK J BOT, V44, P365; KATZNELSON H, 1959, CAN J MICROBIOL, V5, P79, DOI 10.1139/m59-010; Kaushal Neeru, 2011, Physiology and Molecular Biology of Plants, V17, P203, DOI 10.1007/s12298-011-0078-2; Khaleda L, 2017, MOL CELLS, V40, P966, DOI 10.14348/molcells.2017.0229; Khan AL, 2016, ELECTRON J BIOTECHN, V21, P58, DOI 10.1016/j.ejbt.2016.02.001; Khan AL, 2014, J MICROBIOL, V52, P689, DOI 10.1007/s12275-014-4002-7; Khan MA, 2019, BIOCH J BCJ; Khan MA, 2019, ANN MICROBIOLOGY; Khan MA, 2018, BIOCH J BCJ; Khan MA, 2019, PEERJ, V7, DOI 10.7717/peerj.7741; Khan MA, 2019, SYMBIOSIS, V77, P9, DOI 10.1007/s13199-018-0562-3; Khan N, 2018, FRONTIERS MICROBIOLO, V9; Khan N, 2019, ARCH MICROBIOL, V201, P769, DOI 10.1007/s00203-019-01644-w; Khan N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38702-8; Kim Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192650; Kumar P, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq002; Kumar S, 2013, ARCH AGRON SOIL SCI, V59, P823, DOI 10.1080/03650340.2012.683424; Lamaoui M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00026; Lee KE, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9030144; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lopez-Delgado H, 1998, J EXP BOT, V49, P713, DOI 10.1093/jexbot/49.321.713; Lv WT, 2011, PLANT PHYSIOL, V156, P1921, DOI 10.1104/pp.111.175810; Moraditochaee M., 2012, Journal of Agricultural and Biological Science, V7, P289; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Nahar K, 2015, ENVIRON EXP BOT, V112, P44, DOI 10.1016/j.envexpbot.2014.12.001; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Nazar R, 2011, ENVIRON EXP BOT, V70, P80, DOI 10.1016/j.envexpbot.2010.09.011; Nikbakht A, 2008, J PLANT NUTR, V31, P2155, DOI 10.1080/01904160802462819; Olivares FL, 2017, CHEM BIOL TECHNOL AG, V4, DOI 10.1186/s40538-017-0112-x; Olivares FL, 2015, SCI HORTIC-AMSTERDAM, V183, P100, DOI 10.1016/j.scienta.2014.11.012; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; Park YG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173203; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Pishchik VN, 2018, IJPSS, V22, P1, DOI [10.9734/IJPSS/2018/41148, DOI 10.9734/IJPSS/2018/41148]; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P190, DOI 10.1071/FP11245; Puglisi E, 2013, J GEOCHEM EXPLOR, V129, P82, DOI 10.1016/j.gexplo.2012.10.006; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Roomi S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01812; Sambrook J., 2001, MOL CLONING LAB MANU; Santos AD, 2018, BRAZ J MICROBIOL, V49, P685, DOI 10.1016/j.bjm.2018.01.007; Sato S, 2006, ANN BOT-LONDON, V97, P731, DOI 10.1093/aob/mcl037; Schoebitz M, 2013, AGRON SUSTAIN DEV, V33, P751, DOI 10.1007/s13593-013-0142-0; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Shah ZH, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00263; Shahzad R, 2017, ENVIRON EXP BOT, V136, P68, DOI 10.1016/j.envexpbot.2017.01.010; Shahzad R, 2016, PLANT PHYSIOL BIOCH, V106, P236, DOI 10.1016/j.plaphy.2016.05.006; Shao HB, 2005, COLLOID SURFACE B, V45, P7, DOI 10.1016/j.colsurfb.2005.06.016; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Sharma SS, 2004, PLANT SCI, V166, P1287, DOI 10.1016/j.plantsci.2004.01.006; Siddiqui MH, 2017, J PLANT INTERACT, V12, P177, DOI 10.1080/17429145.2017.1310941; Singh S, 2015, BIOCATAL AGRIC BIOTE, V4, P286, DOI 10.1016/j.bcab.2015.03.004; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Srivastava S, 2008, CURR MICROBIOL, V56, P453, DOI 10.1007/s00284-008-9105-0; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tariq A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01561; Tiwari S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01510; Tuna AL, 2008, ENVIRON EXP BOT, V62, P1, DOI 10.1016/j.envexpbot.2007.06.007; Vaculik M, 2012, ANN BOT-LONDON, V110, P433, DOI 10.1093/aob/mcs039; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Vettakkorumakankav NN, 1999, PLANT CELL PHYSIOL, V40, P542, DOI 10.1093/oxfordjournals.pcp.a029575; Vilchez JI, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00284; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Vollenweider P, 2005, ENVIRON POLLUT, V137, P455, DOI 10.1016/j.envpol.2005.01.032; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-34; Wang LJ, 2006, PLANT SCI, V170, P685, DOI 10.1016/j.plantsci.2005.09.005; Wang QJ, 2016, PLANT BIOTECHNOL J, V14, P1986, DOI 10.1111/pbi.12556; Wang QL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030849; Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408; Xu ZS, 2012, INT J MOL SCI, V13, P15706, DOI 10.3390/ijms131215706; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yildiz M, 2008, BIOLOGIA, V63, P521, DOI 10.2478/s11756-008-0089-9; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; Young CC, 2006, BIOTECHNOL BIOENG, V95, P76, DOI 10.1002/bit.20957; Yuan L, 2017, ACTA SOC BOT POL, V86, P1; Zhang HJ, 2014, J PINEAL RES, V57, P269, DOI 10.1111/jpi.12167; Zhang LX, 2009, J PLANT NUTR, V32, P1861, DOI 10.1080/01904160903242367; Zhang LX, 2009, PLANT GROWTH REGUL, V58, P297, DOI 10.1007/s10725-009-9379-7; Zhang SA, 2002, BIOL CONTROL, V25, P288, DOI 10.1016/S1049-9644(02)00108-1; Zhou J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00174	145	39	39	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232228	10.1371/journal.pone.0232228	http://dx.doi.org/10.1371/journal.pone.0232228			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353077	gold, Green Published			2022-12-26	WOS:000536673200056
J	Odiachi, A; Sam-Agudu, NA; Erekaha, S; Isah, C; Ramadhani, HO; Swomen, HE; Charurat, M; Cornelius, LJ				Odiachi, Angela; Sam-Agudu, Nadia A.; Erekaha, Salome; Isah, Christopher; Ramadhani, Habib O.; Swomen, Homsuk E.; Charurat, Manhattan; Cornelius, Llewellyn J.			A mixed-methods assessment of disclosure of HIV status among expert mothers living with HIV in rural Nigeria	PLOS ONE			English	Article							POSTPARTUM RETENTION; SERVICE UPTAKE; PREVENTION; PROGRAMS; IMPACT; WOMEN; PMTCT; MALAWI; TRIAL; CARE	Background Peer support provided by experienced and/or trained "expert" women living with HIV has been adopted by prevention of mother-to-child transmission of HIV (PMTCT) programs across sub-Saharan Africa. While there is ample data on HIV status disclosure among nonexpert women, there is little data on disclosure among such expert women, who support other women living with HIV. Objective This study compared HIV disclosure rates between expert and non-expert mothers living with HIV, and contextualized quantitative findings with qualitative data from expert women. Methods We compared survey data on HIV disclosure to male partners and family/friends from 37 expert and 100 non-expert mothers living with HIV in rural North-Central Nigeria. Four focus group discussions with expert mothers provided further context on disclosure to male partners, extended family and peers. Chi square and Fisher's exact tests were applied to quantitative data. Qualitative data were manually analyzed using a Grounded Theory approach. Results Two-thirds of the 137 participants were 21-30 years old; 89.8% were married, and 52.3% had secondary-level education. Disclosure to male partners was higher among expert (100.0%) versus non-expert mothers (85.0%), p = 0.035. Disclosure to anyone (93.1% vs 80.8%, p = 0.156), and knowledge of male partners' HIV status were similar (75.7% versus 66.7%, p = 0.324) between expert and non-expert mothers, respectively. With respect to male partners, HIV serodiscordance rates were also similar (46.4% vs 55.6%, p = 0.433). Group discussions indicated that expert mothers did not consistently disclose to their mentored clients, with community-level stigma and discrimination stated as major reasons for this non-disclosure. Conclusions Expert mothers experience similar disclosure barriers as their non-expert peers, especially regarding disclosure outside of intimate relationships. Thus, attention to expert mothers' coping skills and disclosure status, particularly to mentored clients is important to maximize the impact of peer support in PMTCT.	[Odiachi, Angela] Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria; [Sam-Agudu, Nadia A.; Erekaha, Salome; Isah, Christopher] Univ Maryland, Sch Med, Div Epidemiol & Prevent, Inst Human Virol, Baltimore, MD 21201 USA; [Sam-Agudu, Nadia A.; Ramadhani, Habib O.; Charurat, Manhattan] United Nations Populat Fund, Sexual Reprod Hlth & Gender Unit, Abuja, Nigeria; [Swomen, Homsuk E.] Univ Georgia Athens, Sch Social Work, Athens, GA USA; [Cornelius, Llewellyn J.] Univ Georgia Athens, Coll Publ Hlth, Athens, GA USA	University System of Maryland; University of Maryland Baltimore; United Nations Population Fund; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sam-Agudu, NA (corresponding author), Univ Maryland, Sch Med, Div Epidemiol & Prevent, Inst Human Virol, Baltimore, MD 21201 USA.; Sam-Agudu, NA (corresponding author), United Nations Populat Fund, Sexual Reprod Hlth & Gender Unit, Abuja, Nigeria.	nsamagudu@ihvnigeria.org	Odiachi, Angela/AAP-7547-2021		World Health Organization [WHO RPC 531]; Fogarty International AIDS Training and Research Program [5D43TW001041]	World Health Organization(World Health Organization); Fogarty International AIDS Training and Research Program	The MoMent Nigeria study was funded by the World Health Organization through an award to Dr. NA Sam-Agudu (WHO RPC 531) for the INtegrating and Scaling up PMTCT through Implementation REsearch (INSPIRE) initiative from Global Affairs Canada. http://www.who.int/hiv/pub/journal_articles/inspire-intro/en/.Additional funding for this work was provided by a training fellowship to Ms. Salome Erekaha through the Fogarty International AIDS Training and Research Program (5D43TW001041, PI Dr. M. Charurat). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1965; Ambia J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20309; Batte A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1420-3; Cataldo F, 2017, JAIDS-J ACQ IMM DEF, V75, pS224, DOI [10.1097/QAI.0000000000001375, 10.1097/qai.0000000000001375]; Dhlamini L, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17391; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Glaser B. G., 2009, DISCOVERY GROUNDED T; Hardon A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-589; Madiba Sphiwe, 2013, Glob J Health Sci, V5, P1, DOI 10.5539/gjhs.v5n4p1; Maeri I, 2016, AIDS CARE, V28, P59, DOI 10.1080/09540121.2016.1168917; Matthews LT, 2015, AIDS BEHAV, V19, P2291, DOI 10.1007/s10461-015-1050-x; McGrath CJ, 2018, AIDS CARE, V30, P765, DOI 10.1080/09540121.2017.1400642; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; National AIDS Control Agency, 2016, FACT SHEET PREV MOTH; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; National Population Commission (NPC) [Nigeria] ICF, 2019, NIG DEM HLTH SURV 20; Ngonzi J, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.200.12541; Nyandat J, 2017, NONDISCLOSURE HIV PO, V18, P691; Odiachi A, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0474-y; Onono MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-390; Onovo AA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2155-x; Phiri S, 2017, JAIDS-J ACQ IMM DEF, V75, pS140, DOI 10.1097/qai.0000000000001357; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Sam-Agudu NA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1417-2; Sam-Agudu NA, 2017, JAIDS-J ACQ IMM DEF, V75, pS173, DOI [10.1097/QAI.0000000000001346, 10.1097/qai.0000000000001346]; Sam-Agudu NA, 2017, JAIDS-J ACQ IMM DEF, V75, pS182, DOI [10.1097/QAI.0000000000001345, 10.1097/qai.0000000000001345]; Sam-Agudu NA, 2014, JAIDS-J ACQ IMM DEF, V67, pS132, DOI 10.1097/QAI.0000000000000331; Sarko KA, 2017, INT HEALTH, V9, P243, DOI 10.1093/inthealth/ihx023; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Spangler SA, 2014, JAIDS-J ACQ IMM DEF, V67, pS235, DOI 10.1097/QAI.0000000000000376; Tam M, 2015, AIDS CARE, V27, P436, DOI 10.1080/09540121.2014.997662; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2018, UNAIDS DAT 2018; Vrazo AC, 2018, TROP MED INT HEALTH, V23, P136, DOI 10.1111/tmi.13014	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232423	10.1371/journal.pone.0232423	http://dx.doi.org/10.1371/journal.pone.0232423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353036	Green Published, gold			2022-12-26	WOS:000536673200090
J	Chambers, LM; Esakov, E; Braley, C; AlHilli, M; Michener, C; Reizes, O				Chambers, Laura M.; Esakov, Emily; Braley, Chad; AlHilli, Mariam; Michener, Chad; Reizes, Ofer			Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer	PLOS ONE			English	Article							CELL-LINES; OPEN-LABEL; MODEL; CHEMOTHERAPY; SURGERY	Objective To evaluate intraperitoneal (IP) tumor engraftment, metastasis and growth in a pre-clinical murine epithelial ovarian cancer (EOC) model using both transabdominal ultrasound (TAUS) and bioluminescence in vivo imaging system (IVIS). Methods Ten female C57Bl/6J mice at six weeks of age were included in this study. Five mice underwent IP injection of 5x10(6) ID8-luc cells (+ D- luciferin) and the remaining five mice underwent IP injection of ID8-VEGF cells. Monitoring of tumor growth and ascites was performed weekly starting at seven days post-injection until study endpoint. ID8-luc mice were monitored using both TAUS and IVIS, and ID8-VEGF mice underwent TAUS monitoring only. Individual tumor implant dimension and total tumor volume were calculated. Average luminescent intensity was calculated and reported per mouse abdomen. Tumor detection was confirmed by gross evaluation and histopathology. All data are presented as mean +/- standard deviation. Results Overall, tumors were successfully detected in all ten mice using TAUS and IVIS, and tumor detection correlated with terminal endpoint histology/ H&E staining. For TAUS, the smallest confirmed tumor measurements were at seven days post-injection with mean long axis of 2.23mm and mean tumor volume of 4.17mm(3). However, IVIS imaging was able to detect tumor growth at 14 days post-injection. Ascites formation was detected in mice at 21 days post-injection. Conclusions TAUS is highly discriminatory for monitoring EOC in pre-clinical murine model, allowing for detection of tumor dimension as small as 2 mm and as early as seven days post-injection compared to IVIS. In addition, TAUS provides relevant information for ascites development and detection of multiple small metastatic tumor implants. TAUS provides an accurate and reliable method to detect and monitor IP EOC growth in mouse xenografts.	[Chambers, Laura M.; AlHilli, Mariam; Michener, Chad] Cleveland Clin, Obstet Gynecol & Womens Hlth Inst, Div Gynecol Oncol, Cleveland, OH 44106 USA; [Esakov, Emily; Braley, Chad; Reizes, Ofer] Cleveland Clin, Dept Cardiovasc & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Reizes, O (corresponding author), Cleveland Clin, Dept Cardiovasc & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA.	reizeso@ccf.org	Reizes, Ofer/ABA-4179-2021	Reizes, Ofer/0000-0003-0075-6871; Braley, Chad/0000-0002-0629-3508	VeloSano Bike to Cure	VeloSano Bike to Cure	This work was supported by VeloSano Bike to Cure to OR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baert T, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0102-0; Baklaushev VP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07851-z; Baun MLL, 2019, ACTA OBSTET GYN SCAN, V98, P1540, DOI 10.1111/aogs.13693; Bian C, 2016, ARCH GYNECOL OBSTET, V293, P163, DOI 10.1007/s00404-015-3813-z; Brown DL, 1998, RADIOLOGY, V208, P103, DOI 10.1148/radiology.208.1.9646799; Elias KM, 2015, GYNECOL ONCOL, V139, P97, DOI 10.1016/j.ygyno.2015.08.017; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hernandez L, 2016, GYNECOL ONCOL, V142, P332, DOI 10.1016/j.ygyno.2016.05.028; Janat-Amsbury MM, 2006, ANTICANCER RES, V26, P2785; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Liao JB, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0060-6; Mitra AK, 2015, GYNECOL ONCOL, V138, P372, DOI 10.1016/j.ygyno.2015.05.040; Morrison J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005343.pub3; NERI A, 1981, INT J CANCER, V28, P731, DOI 10.1002/ijc.2910280612; Patel AR, 2010, UROLOGY, V75, P799, DOI 10.1016/j.urology.2009.06.047; Pignata S, 2014, LANCET ONCOL, V15, P396, DOI 10.1016/S1470-2045(14)70049-X; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Snyder CS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-106; Toyoshima M, 2009, LUMINESCENCE, V24, P324, DOI 10.1002/bio.1112; Weroha SJ, 2014, CLIN CANCER RES, V20, P1288, DOI 10.1158/1078-0432.CCR-13-2611; Wilson AL, 2019, CANCERS, V11, DOI 10.3390/cancers11010032; Ziske C, 2008, PANCREAS, V36, P146, DOI 10.1097/MPA.0b013e3181586cd9	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0228511	10.1371/journal.pone.0228511	http://dx.doi.org/10.1371/journal.pone.0228511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348309	gold, Green Published, Green Submitted			2022-12-26	WOS:000536668200004
J	Cvitas, I; Oberhansli, S; Leeb, T; Dettwiler, M; Mueller, E; Bruggman, R; Marti, EI				Cvitas, Iva; Oberhansli, Simone; Leeb, Tosso; Dettwiler, Martina; Mueller, Eliane; Bruggman, Remy; Marti, Eliane Isabelle			Investigating the epithelial barrier and immune signatures in the pathogenesis of equine insect bite hypersensitivity	PLOS ONE			English	Article							ATOPIC-DERMATITIS; EPIDERMAL BARRIER; LANGERHANS CELLS; SKIN; HYPOXIA; TYPE-2; DIFFERENTIATION; IDENTIFICATION; KERATINOCYTES; MODULATION	Insect bite hypersensitivity (IBH) is a Th-2, IgE-mediated dermatitis of horses caused by bites of insects of the genus Culicoides that has common features with human atopic dermatitis. Together with Th-2 cells, the epithelial barrier plays an important role in development of type I hypersensitivities. In order to elucidate the role of the epithelial barrier and of the skin immune response in IBH we studied the transcriptome of lesional whole skin of IBH-horses (IBH-LE; n = 9) in comparison to non-lesional skin (IBH-NL; n = 8) as well as to skin of healthy control horses (H; n = 9). To study the "baseline state" of the epithelial barrier, we investigated the transcriptome of non-lesional epidermis in IBH-horses (EPI-IBH-NL; n = 10) in comparison with healthy epidermis from controls (EPI-H; n = 9). IBH-LE skin displayed substantial transcriptomic difference compared to H. IBH-LE was characterized by a downregulation of genes involved in tight junction formation, alterations in keratins and substantial immune signature of both Th-1 and Th-2 types with particular upregulation of IL13, as well as involvement of the hypoxic pathway. IBH-NL shared a number of differentially expressed genes (DEGs) with IBH-LE, but was overall more similar to H skin. In the epidermis, genes involved in metabolism of epidermal lipids, pruritus development, as well as IL25, were significantly differentially expressed between EPI-IBH-NL and EPI-H. Taken together, our data suggests an impairment of the epithelial barrier in IBH-affected horses that may act as a predisposing factor for IBH development. Moreover, these new mechanisms could potentially be used as future therapeutic targets. Importantly, many transcriptional features of equine IBH skin are shared with human atopic dermatitis, confirming equine IBH as a natural model of skin allergy.	[Cvitas, Iva; Marti, Eliane Isabelle] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Div Expt Clin Res, Bern, Switzerland; [Cvitas, Iva] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Cvitas, Iva; Leeb, Tosso; Dettwiler, Martina; Mueller, Eliane; Marti, Eliane Isabelle] Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland; [Oberhansli, Simone; Bruggman, Remy] Univ Bern, Interfac Bioinformat Unit, Bern, Switzerland; [Oberhansli, Simone; Bruggman, Remy] Univ Bern, SIB Swiss Inst Bioinformat, Bern, Switzerland; [Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [Dettwiler, Martina; Mueller, Eliane] Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland; [Mueller, Eliane] Univ Bern, Dept Biomed Res Mol Dermatol & Stem Cell Res, Bern, Switzerland; [Mueller, Eliane] Univ Hosp Bern, Dept Dermatol, Inselspital, Bern, Switzerland	University of Bern; University of Bern; University of Bern; University of Bern; Swiss Institute of Bioinformatics; University of Bern; University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern	Cvitas, I (corresponding author), Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Div Expt Clin Res, Bern, Switzerland.; Cvitas, I (corresponding author), Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.; Cvitas, I (corresponding author), Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland.	iva.cvitas@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014	Leeb, Tosso/0000-0003-0553-4880; Cvitas, Iva/0000-0002-1791-6643; Dettwiler, Martina/0000-0001-9404-7122	Swiss National Science Foundation [310030160196/1]; SNF	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNF	This work was supported by the Swiss National Science Foundation grant no. 310030160196/1. This SNF grant was awarded to E.M. http://www.snf.ch/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieber T, 2020, ALLERGY, V75, P54, DOI 10.1111/all.13954; Bogiatzi SI, 2007, J IMMUNOL, V178, P3373, DOI 10.4049/jimmunol.178.6.3373; Bosco MC, 2012, IMMUNOBIOLOGY, V217, P1241, DOI 10.1016/j.imbio.2012.07.023; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Cvitas I, 2020, VET DERMATOL, V31, P154, DOI 10.1111/vde.12813; Dijkstra D, 2008, J INVEST DERMATOL, V128, P1696, DOI 10.1038/sj.jid.5701250; Dyjack N, 2018, J ALLERGY CLIN IMMUN, V141, P1298, DOI 10.1016/j.jaci.2017.10.046; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Esaki H, 2015, J ALLERGY CLIN IMMUN, V135, P153, DOI 10.1016/j.jaci.2014.10.037; Fabregat A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1559-2; FADOK VA, 1990, EQUINE VET J, V22, P236, DOI 10.1111/j.2042-3306.1990.tb04259.x; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; Ghosh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144316; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hammami A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004938; Hamza E, 2007, INT ARCH ALLERGY IMM, V144, P325, DOI 10.1159/000106459; Han HW, 2017, IMMUNOL REV, V278, P116, DOI 10.1111/imr.12546; Harper JI, 2010, BRIT J DERMATOL, V162, P397, DOI 10.1111/j.1365-2133.2009.09467.x; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Heimann M, 2011, VET IMMUNOL IMMUNOP, V140, P63, DOI 10.1016/j.vetimm.2010.11.016; Janda J, 2012, VET IMMUNOL IMMUNOP, V147, P180, DOI 10.1016/j.vetimm.2012.04.013; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jensen JM, 2004, J INVEST DERMATOL, V122, P1423, DOI 10.1111/j.0022-202X.2004.22621.x; Khawar MB, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8413768; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Kohler T, 2012, EUR J IMMUNOL, V42, P1226, DOI 10.1002/eji.201142053; Koeppen M, 2011, ADV PHARMACOL, V61, P145, DOI 10.1016/B978-0-12-385526-8.00006-0; Koppes SA, 2016, INT ARCH ALLERGY IMM, V170, P187, DOI 10.1159/000448400; KRZYWINSKA E, 2018, BIOMEDICINES, V6, DOI DOI 10.1016/J.CELL.2016.08.064; KUROTAKI T, 1994, J COMP PATHOL, V110, P145, DOI 10.1016/S0021-9975(08)80186-7; Kurotaki T, 2002, J VET MED SCI, V64, P539, DOI 10.1292/jvms.64.539; Kurotaki T, 2000, J VET MED SCI, V62, P561, DOI 10.1292/jvms.62.561; Li Q, 2018, IMMUNITY, V48, P258, DOI 10.1016/j.immuni.2017.12.013; Manresa MC, 2019, ALLERGY, V74, P753, DOI 10.1111/all.13655; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Morita T, 2015, NEURON, V87, P124, DOI 10.1016/j.neuron.2015.05.044; Naldini A, 2012, J CELL PHYSIOL, V227, P587, DOI 10.1002/jcp.22761; Nobs SP, 2019, J ALLERGY CLIN IMMUN, V143, P1513, DOI 10.1016/j.jaci.2018.08.044; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Olomski F, ALLERGY; Pali-Scholl I, 2019, ALLERGY, V74, P874, DOI 10.1111/all.13722; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Purwar R, 2008, J INVEST DERMATOL, V128, P59, DOI 10.1038/sj.jid.5700940; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Szegedi K, 2015, J EUR ACAD DERMATOL, V29, P2136, DOI 10.1111/jdv.13160; Tazawa T, 2004, ARCH DERMATOL RES, V295, P459, DOI 10.1007/s00403-004-0455-6; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Velie BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152966; Wagner B, 2006, VET RES, V37, P813, DOI 10.1051/vetres:2006039; Wobben R, 2013, BIOL CHEM, V394, P495, DOI 10.1515/hsz-2012-0320; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126	57	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232189	10.1371/journal.pone.0232189	http://dx.doi.org/10.1371/journal.pone.0232189			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343720	Green Published, gold			2022-12-26	WOS:000536661300039
J	Imai, A; Hagiwara, Y; Niimi, Y; Tokumoto, T; Saga, Y; Suzuki, A				Imai, Atsuki; Hagiwara, Yoshihiko; Niimi, Yuki; Tokumoto, Toshinobu; Saga, Yumiko; Suzuki, Atsushi			Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence	PLOS ONE			English	Article							GERM-CELL DEFICIENCY; TER MUTATION; BINDING; MAINTAINS; FATE	Spontaneous testicular teratomas (STTs) derived from primordial germ cells (PGCs) in the mouse embryonic testes predominantly develop in the 129 family inbred strain. Ter (spontaneous mutation) is a single nucleotide polymorphism that generates a premature stop codon of Dead end1 (Dnd1) and increases the incidence of STTs in the 129 genetic background. We previously found that DND1 interacts with NANOS2 or NANOS3 and that these complexes play a vital role in male embryonic germ cells and adult spermatogonia. However, the following are unclear: (a) whether DND1 works with NANOS2 or NANOS3 to regulate teratoma incidence, and (b) whether Ter simply causes Dnd1 loss or produces a short mutant DND1 protein. In the current study, we newly established a conventional Dnd1-knockout mouse line and found that these mice showed phenotypes similar to those of Ter mutant mice in spermatogenesis, oogenesis, and teratoma incidence, with a slight difference in spermiogenesis. In addition, we found that the amount of DND1 in Dnd1(+/Ter) embryos decreased to half of that in wild-type embryos, while the expression of the short mutant DND1 was not detected. We also found that double mutants for Dnd1 and Nanos2 or Nanos3 showed synergistic increase in the incidence of STTs. These data support the idea that Ter causes Dnd1 loss, leading to an increase in STT incidence, and that DND1 acts with NANOS2 and NANOS3 to regulate the development of teratoma from PGCs in the 129 genetic background. Thus, our results clarify the role of Dnd1 in the development of STTs and provide a novel insight into its pathogenic mechanism.	[Imai, Atsuki; Hagiwara, Yoshihiko; Niimi, Yuki; Suzuki, Atsushi] Yokohama Natl Univ, Grad Sch Engn, Div Mat Sci & Chem Engn, Yokohama, Kanagawa, Japan; [Tokumoto, Toshinobu] Shizuoka Univ, Natl Univ Corp, Grad Sch Sci, Biol Sci Course, Shizuoka, Japan; [Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka, Japan; [Suzuki, Atsushi] Yokohama Natl Univ, Div Mat Sci & Chem Engn, Fac Engn, Yokohama, Kanagawa, Japan; [Niimi, Yuki] Hitachi Ltd, Res & Dev Grp, Ctr Exploratory Res, Kobe, Hyogo, Japan	Yokohama National University; Shizuoka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Yokohama National University; Hitachi Limited	Suzuki, A (corresponding author), Yokohama Natl Univ, Grad Sch Engn, Div Mat Sci & Chem Engn, Yokohama, Kanagawa, Japan.; Suzuki, A (corresponding author), Yokohama Natl Univ, Div Mat Sci & Chem Engn, Fac Engn, Yokohama, Kanagawa, Japan.	suzuki-atsushi-gz@ynu.ac.jp		Suzuki, Atsushi/0000-0002-8413-6436	Japan Society for the Promotion of Science (KAKENHI) [16H01252, 17H05046]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (KAKENHI) grants 16H01252 and 17H05046 to AS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; Dawson EP, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156612; Gross-Thebing T, 2017, DEV CELL, V43, P704, DOI 10.1016/j.devcel.2017.11.019; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Lam MYJ, 2007, HUM MOL GENET, V16, P2233, DOI 10.1093/hmg/ddm175; Liu SM, 2017, MOL CELL, V67, P853, DOI 10.1016/j.molcel.2017.07.011; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Lyndaker AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003320; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Niimi Y, 2019, DEV BIOL, V445, P103, DOI 10.1016/j.ydbio.2018.11.003; Nishiyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035000; Noguchi M, 1996, DEV GROWTH DIFFER, V38, P59, DOI 10.1046/j.1440-169X.1996.00008.x; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Ruthig VA, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.175950; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; Schemmer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071113; Stevens L C, 1975, Symp Soc Dev Biol, P93; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; STEVENS LC, 1957, J NATL CANCER I, V18, P719; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki A, 2016, EMBO REP, V17, P37, DOI 10.15252/embr.201540828; Suzuki A, 2014, BIOL OPEN, V3, P1207, DOI 10.1242/bio.20149308; Suzuki H, 2008, DEV BIOL, V318, P133, DOI 10.1016/j.ydbio.2008.03.020; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Yu X, 2004, J ANDROL, P77; Zechel JL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-54	32	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232047	10.1371/journal.pone.0232047	http://dx.doi.org/10.1371/journal.pone.0232047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339196	Green Published, gold, Green Submitted			2022-12-26	WOS:000536657400024
J	Takenaga, K; Akimoto, M; Koshikawa, N; Nagase, H				Takenaga, Keizo; Akimoto, Miho; Koshikawa, Nobuko; Nagase, Hiroki			Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model	PLOS ONE			English	Article							CXC-CHEMOKINES; ST2 GENE; CD8(+) T; IL-33; EXPRESSION; FAMILY; MICROENVIRONMENT; INFLAMMATION; CARCINOMA; CYTOKINE	Background Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth. Methods ST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO+, F4/80(+) and CD20(+) cells in tumor tissues were detected using immunohistochemistry. Results Some but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects. Conclusions Cancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.	[Takenaga, Keizo; Koshikawa, Nobuko; Nagase, Hiroki] Chiba Canc Ctr Res Inst, Lab Canc Genet, Chuoh Ku, Chiba, Japan; [Akimoto, Miho] Teikyo Univ, Sch Med, Dept Biochem, Itabashi Ku, Tokyo, Japan	Chiba Cancer Center; Teikyo University	Takenaga, K (corresponding author), Chiba Canc Ctr Res Inst, Lab Canc Genet, Chuoh Ku, Chiba, Japan.	ktakenaga@chiba-cc.jp		Nagase, Hiroki/0000-0002-3992-5399	JSPS KAKENHI [24791422, 25430110]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI (https://www.jsps.go.jp/) Grant Number 25430110 and by JSPS KAKENHI Grant Number 24791422 to M.A. The funding bodies had no role in the design of the study and data collection, analysis, and interpretation of data and in preparing the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Akimoto M, 2019, CELL IMMUNOL, V343, DOI 10.1016/j.cellimm.2017.12.014; Akimoto M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13589; Akimoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126605; Andersson P, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122375; Ben-Josef E, 2012, NAT REV CLIN ONCOL, V9, P9, DOI 10.1038/nrclinonc.2011.182; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Bonecchi R, 2010, CURR TOP MICROBIOL, V341, P15, DOI 10.1007/82_2010_19; Brabcova E, 2014, FOLIA BIOL-PRAGUE, V60, P180; CORBETT TH, 1984, CANCER RES, V44, P717; Erkan M, 2016, EXPERT REV GASTROENT, V10, P301, DOI 10.1586/17474124.2016.1117386; Fang YJ, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0880-3; Gao K, 2013, CANCER LETT, V335, P463, DOI 10.1016/j.canlet.2013.03.002; Gao X, 2015, J IMMUNOL, V194, P438, DOI 10.4049/jimmunol.1401344; Hoover M, 2017, ONCOTARGET, V8, P5885, DOI 10.18632/oncotarget.11809; Hu LA, 2013, ASIAN PAC J CANCER P, V14, P2563, DOI 10.7314/APJCP.2013.14.4.2563; Janakiram NB, 2014, ADV EXP MED BIOL, V816, P25, DOI 10.1007/978-3-0348-0837-8_2; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; Koltsova EK, 2010, IMMUNITY, V33, P7, DOI 10.1016/j.immuni.2010.07.012; Liew FY, 2012, ANN RHEUM DIS, V71, P101, DOI 10.1136/annrheumdis-2011-200589; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Loc WS, 2014, WORLD J GASTROENTERO, V20, P14717, DOI 10.3748/wjg.v20.i40.14717; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ocana A, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0707-7; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Partensky C, 2013, PANCREAS, V42, P729, DOI 10.1097/MPA.0b013e318288107a; Reich N, 2011, J CELL MOL MED, V15, P756, DOI 10.1111/j.1582-4934.2010.01051.x; Schmieder A, 2012, CYTOKINE, V60, P514, DOI 10.1016/j.cyto.2012.06.286; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Smith DF, 2005, AM J PHYSIOL-HEART C, V289, pH1976, DOI 10.1152/ajpheart.00153.2005; Steinmetz Oliver M, 2009, Front Biosci (Schol Ed), V1, P13, DOI 10.2741/s2; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Sun PH, 2011, DIGEST DIS SCI, V56, P3596, DOI 10.1007/s10620-011-1760-5; Tago K, 2001, BIOCHEM BIOPH RES CO, V285, P1377, DOI 10.1006/bbrc.2001.5306; Takahashi K, 2018, ONCOGENE, V37, P2757, DOI 10.1038/s41388-018-0144-0; Templeton AJ, 2016, EUR UROL, V70, P358, DOI 10.1016/j.eururo.2016.02.033; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Werner J, 2013, NAT REV CLIN ONCOL, V10, P323, DOI 10.1038/nrclinonc.2013.66; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Zhang P, 2012, J INT MED RES, V40, P1654, DOI 10.1177/030006051204000504	49	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232230	10.1371/journal.pone.0232230	http://dx.doi.org/10.1371/journal.pone.0232230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32340025	gold, Green Published			2022-12-26	WOS:000536657400034
J	Tesfay, F; Ziersch, A; Mwanri, L; Javanparast, S				Tesfay, Fisaha; Ziersch, Anna; Mwanri, Lillian; Javanparast, Sara			Contextual and individual level factors influencing nutritional program effectiveness in HIV care setting in Tigray region, northern Ethiopia: Mixed methods study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HEALTH; FOOD; HIV/AIDS; ADULTS; MALNUTRITION; EDUCATION; BEHAVIOR	Introduction Addressing malnutrition is one of the key components of HIV care among people living with HIV. Since 2010, a nutritional program has been implemented to address malnutrition amongst HIV patients in Ethiopia, with patients enrolled in the program for 3 months (for mild acute malnutrition) and 6 months (for severe acute malnutrition). However, utilisation and effectiveness of the nutritional programs remain unexplored. This study aimed to examine individual level determinants and contextual factors influencing the effectiveness of the nutritional program in the Tigray region of Ethiopia. Methods and setting The study employed a mixed-methods approach involving quantitative and qualitative research methods. In the quantitative phase of the study, records from 1757 adult patients, including socio-demographic characteristics, clinical and nutritional program outcomes were retrieved from three selected hospitals in the Tigray region, Ethiopia. Logistic regression analysis was used to identify the individual demographic and socioeconomic, clinical and immunological, and anthropometric and nutritional determinants of nutritional outcomes. The qualitative study included 33 individual interviews with adult patients, health providers, and program managers. Interview data were analysed using a framework analysis approach. Results Amongst study participants, 55.3% (95% CI = 53.2-57.4) recovered from malnutrition, 19% (95% CI, 17.3-20.7) did not complete the program, and 21% (95% CI = 19.7-23.4) completed the program but failed to recover from malnutrition. In the multivariable logistic regression analysis, those who were: living in urban areas (AOR = 1.44, 95% CI = 1.05-1.97), employed (AOR = 1.39, 95% CI = 1.01-1.93), attending Shul (AOR = 4.6, 95% CI = 3.15-6.71) and Lemlem Karl (AOR = 2.5, 95% CI = 1.69-3.71) hospitals, in clinical stages II (AOR = 2.49, 95% CI = 1.59-3.91) and III (AOR = 1.46(1.02-2.07), on ART for less than six months (AOR = 1.61, 95% CI = 1.09-2.39), anaemic (AOR = 1.77, 95% = 1.29-2.41), and diagnosed with severe acute malnutrition at enrolment (AOR = 6.43, 95% CI = 4.69-8.3); were less likely to complete the program. Results for those who completed the program indicated that urban residence, (AOR = 1.46, 95% CI = 1.4-2.91), attending Shul (AOR = 2.92, 95% CI = 2.04-4.19) and Lemlem Karl (AOR = 1.49, 95% CI 1.05-2.11) hospitals, having bedridden functional status (AOR = 0.36, 95% CI = 0.15-0.83), advanced WHO clinical stage (WHO clinical stage IV) (AOR = 0.52, 95% CI = 0.28-0.98) and severe malnutrition at enrolment (AOR = 4.25, 95% CI = 3.02-5.98)) predicted non-response to the nutritional program. Qualitative interviews revealed that the taste and perceived side effects of the nutritional supplement provided as part of the nutritional program, sharing/selling practices, religious and sociocultural issues, distance and poor access to the health services were barriers to program utilisation. Nutritional counselling and health service-related factors such as a previous enrolment in the program and positive experience in the health service were enablers of program utilisation. Conclusion There was a clear nexus between contextual factors such as distance, quality of health service and sociocultural factors, and individual patient characteristics with the effectiveness of the nutritional program. Taking individual and contextual factors into consideration in program design, planning and implementation is essential if the nutritional program in HIV care services is to achieve its goal in addressing malnutrition amongst people living with HIV.	[Tesfay, Fisaha; Ziersch, Anna] Flinders Univ Australia, Southgate Inst Hlth Soc & Equ, Bedford Pk, SA, Australia; [Tesfay, Fisaha] Mekelle Univ Ethiopia, Sch Publ Hlth, Addis Ababa, Ethiopia; [Mwanri, Lillian; Javanparast, Sara] Flinders Univ Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia	Flinders University South Australia; Flinders University South Australia	Tesfay, F (corresponding author), Flinders Univ Australia, Southgate Inst Hlth Soc & Equ, Bedford Pk, SA, Australia.; Tesfay, F (corresponding author), Mekelle Univ Ethiopia, Sch Publ Hlth, Addis Ababa, Ethiopia.	fisaha.1999@gmail.com	Mwanri, Lillian/AGG-3711-2022	Mwanri, Lillian/0000-0002-5792-7785; Ziersch, Anna/0000-0001-6600-2568; Tesfay (PhD), Fisaha Haile/0000-0003-0399-1711	Australian Government Research Training Scholarship	Australian Government Research Training Scholarship(Australian Government)	This work is taken from PhD thesis of the first author and I (the first author) would like to express my gratitude to Flinders University for providing me with covering my tuition fee and stipend through the Australian Government Research Training Scholarship during my study. However, Flinders University had no role in the design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-2; Anabwani G, 2005, NUTRITION, V21, P96, DOI 10.1016/j.nut.2004.09.013; Andrade CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048717; Anema A, 2012, PUBLIC HEALTH NUTR, V15, P938, DOI 10.1017/S136898001100125X; Anthony D, 2009, SUPPLY CHAIN ANAL RE; Bahwere P., 2011, WORLD J AIDS, V1, P169, DOI [10.4236/wja.2011.14025, DOI 10.4236/WJA.2011.14025]; Bahwere P, 2011, WORLD J AIDS, V01, P13, DOI [10.4236/wja.2011.14020, DOI 10.4236/WJA.2011.14020]; Bahwere P, 2009, PATIENT PREFER ADHER, V3, P67; Barnabas G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-628; Bitew BD., 2014, AM J HLTH RES, V2, P234, DOI [10.11648/j.ajhr.20140205.13, DOI 10.11648/J.AJHR.20140205.13]; Bontrager E, 2010, EARLY STAGES FOOD PR; Brazeley P., 2013, QUALITATIVE DATA ANA; Bronfenbrenner U., 1996, ECOLOGY HUMAN DEV EX; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Catholic Relief Services, 2011, 101614920478 CATH RE; Coyne-Meyers Kristen, 2004, Nutr Clin Pract, V19, P340, DOI 10.1177/0115426504019004340; Creswell J. W., 2012, ED RES PLANNING COND, V4th; Dawson-Rose C, 2016, J ASSOC NURSE AIDS C, V27, P574, DOI 10.1016/j.jana.2016.03.001; Dibari F, 2012, PUBLIC HEALTH NUTR, V15, P316, DOI 10.1017/S1368980010003435; Ethiopian Federal Ministry of Health, 2008, ETH GUID CLIN NUTR C; Ethiopian Public Health Institute Federal Ministry of Health, 2017, HIV REL EST PROJ ETH; Fisaha Haile B.M., 2014, J AIDS CLIN RES, V5, DOI [10.4172/2155-6113.1000268, DOI 10.4172/2155-6113.1000268]; Food and Nutrition Technical Assistance II Project (FANTA-2), 2009, 360 FHI; Gedrich K, 2003, APPETITE, V41, P231, DOI 10.1016/j.appet.2003.08.005; Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634; Gombachika BChimphamba, 2012, ISRN PUBLIC HLTH, V2012, P1, DOI [10.5402/2012/825459, DOI 10.5402/2012/825459]; Government of the Federal Democratic Republic of Ethiopia, 2013, NAT NUTR PROGR 2013, P22; Hussien S., 2015, INT J NUTR FOOD SCI, V4, P518, DOI 10.11648/j.ijnfs.20150405.12; Ivers LC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-33; Juma R. J., 2016, J FOOD AGR NUTR DEV, V16, P10809, DOI [10.18697/ajfnd.74.12470, DOI 10.18697/AJFND.74.12470]; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kaye HL, 2010, AJAR-AFR J AIDS RES, V9, P271, DOI 10.2989/16085906.2010.530183; Kebede MA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-20; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Kuria EN, 2010, PUBLIC HEALTH NUTR, V13, P475, DOI 10.1017/S1368980009990826; Lategan R, 2010, S AFR J CLIN NUTR, V22, P89; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Mageda K, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/843598; Mbonu NC, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/145891; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Mulu H, 2016, ETHIOP J HEALTH SCI, V26, P217, DOI 10.4314/ejhs.v26i3.4; Musumari PM., 2015, HLTH HIV INFECTED PE, P181; Ndekha MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1867; Nnyepi MS, 2009, S AFR J CLIN NUTR, V22, P89, DOI 10.1080/16070658.2009.11734224; Rakesh B., 2010, AFRICAN J MARKETING, V2, P10; Reifsnider E, 2005, J PROF NURS, V21, P216, DOI 10.1016/j.profnurs.2005.05.006; Robinson T, 2008, J COMMUN HEALTH, V33, P395, DOI 10.1007/s10900-008-9109-5; Sadler K, 2012, MEASURING IMPACT COS, P29; Sicotte M, 2015, J HEALTH POPUL NUTR, V34, DOI 10.1186/s41043-015-0001-5; Srivastava P., 2009, INT J QUAL METH, V8, P76, DOI [10.1177/160940690900800107, DOI 10.1177/160940690900800107]; Stokols D, 1996, AM J HEALTH PROMOT, V10, P282, DOI 10.4278/0890-1171-10.4.282; Tigray Regional Health Bureau, 2015, TIGR REG HLTH BUR 20; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Tirivayi N, 2011, SOC SCI MED, V73, P685, DOI 10.1016/j.socscimed.2011.06.056; van Oosterhout JJ, 2010, AIDS CARE, V22, P737, DOI 10.1080/09540120903373581; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; WFP WHO UNAIDs, 2008, HIV FOOD SEC NUTR; WHO, 2005, CONS NUTR CONS NUTR; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; World Health Organization (WHO), 2004, NUTR COUNS CAR SUPP; Zellelew TB, 2014, CRIT RES RELIG, V2, P134, DOI 10.1177/2050303214535002	63	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231859	10.1371/journal.pone.0231859	http://dx.doi.org/10.1371/journal.pone.0231859			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8VC	32339181	Green Published, gold			2022-12-26	WOS:000536657400015
J	Jones, ST; Asher, JM; Boland, RC; Kanenaka, BK; Weng, KC				Jones, Stuart T.; Asher, Jacob M.; Boland, Raymond C.; Kanenaka, Brian K.; Weng, Kevin C.			Fish biodiversity patterns of a mesophotic-to-subphotic artificial reef complex and comparisons with natural substrates	PLOS ONE			English	Article							ECOLOGY; ASSEMBLAGE; ZOOGEOGRAPHY; COMMUNITIES; ABUNDANCE; SNAPPER; SYSTEM	Artificial reefs act as high-rugosity habitats and are often deployed to enhance fishing; however, the effects of man-made features on fish communities can be unpredictable and are poorly understood in deeper waters. In this study, we used a submersible to describe a deep-water artificial reef complex (93-245 m) off of Ewa Beach, Oahu, Hawaii, USA, and evaluated possible conservation and/or fisheries-related contributions. Sixty-eight species were recorded, with larger features supporting greater diversity of species. Species composition changed strongly with depth and a faunal break was detected from 113-137 m. While the features supported diverse fish communities, they were not similar to those on natural substrates, and were numerically dominated by only two species, Lutjanis kasmira and Chromis verater. Depth-generalist and endemic species were present at levels comparable to natural substrates, but were less abundant and species-rich than at biogenic Leptoseris reefs at similar depths. While the non-native L. kasmira was highly abundant, its presence and abundance were not associated with discernable changes in the fish community, and was not present deeper than 120 m. Finally, five species of commercially- and recreationally-important 'Deep 7' fisheries species were also observed, but the artificial reef complex was mostly too shallow to provide meaningful benefits.	[Jones, Stuart T.] Coll William & Mary, Williamsburg, VA 23185 USA; [Asher, Jacob M.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Asher, Jacob M.; Boland, Raymond C.] NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Kanenaka, Brian K.] Dept Land & Nat Resources, Honolulu, HI USA; [Weng, Kevin C.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	William & Mary; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; William & Mary; Virginia Institute of Marine Science	Jones, ST (corresponding author), Coll William & Mary, Williamsburg, VA 23185 USA.	stjones@email.wm.edu	Weng, Kevin Chi-Ming/C-4709-2013	Weng, Kevin Chi-Ming/0000-0002-7069-7152	Hawaii Undersea Research Laboratory (HURL) at the School of Ocean and Earth Science and Technology (SOEST) at the University of Hawaii; Pelagic Fisheries Research Program (PFRP) at the Joint Institute for Marine and Atmospheric Science (JIMAR) at the University of Hawaii; College of William Mary (WM); School of Marine and Environmental Affairs at the University of Washington; WM; VIMS; Virginia Institute of Marine Science (VIMS)	Hawaii Undersea Research Laboratory (HURL) at the School of Ocean and Earth Science and Technology (SOEST) at the University of Hawaii; Pelagic Fisheries Research Program (PFRP) at the Joint Institute for Marine and Atmospheric Science (JIMAR) at the University of Hawaii; College of William Mary (WM); School of Marine and Environmental Affairs at the University of Washington; WM; VIMS; Virginia Institute of Marine Science (VIMS)	Research was funded by the Hawaii Undersea Research Laboratory (HURL) at the School of Ocean and Earth Science and Technology (SOEST) at the University of Hawaii. Additional support for K Weng was also provided by the Pelagic Fisheries Research Program (PFRP) at the Joint Institute for Marine and Atmospheric Science (JIMAR) at the University of Hawaii, and the College of William & Mary (WM) and Virginia Institute of Marine Science (VIMS). Additional support for S Jones was provided by WM, VIMS and the School of Marine and Environmental Affairs at the University of Washington.	AMBROSE RF, 1989, B MAR SCI, V44, P718; Andradi-Brown D., 2016, MESOPHOTIC CORAL ECO; Asher J, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00098; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Baldwin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23067-1; BOHNSACK JA, 1994, B MAR SCI, V55, P796; Boland R., B MARINE SCI; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bridge TCL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2332; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Cappo M, AUSTR SOC FISH BIOL; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Feitoza BM, 2005, B MAR SCI, V76, P725; Friedlander AM, 2002, J FISH BIOL, V60, P28, DOI 10.1006/jfbi.2001.1808; FROESE R, 2008, FISHBASE; Kahng S, 2017, MARINE ANIMAL FOREST, P185, DOI [10.1007/978-3-319-17001-5_4-., DOI 10.1007/978-3-319-21012-4]; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; Komyakova V, 2019, MAR ENVIRON RES, V143, P71, DOI 10.1016/j.marenvres.2018.11.005; Kosaki RK, 2017, MAR BIODIVERS, V47, P783, DOI 10.1007/s12526-016-0510-5; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; LUKENS RR, 1981, GULF RES REP, V7, P79; Merritt D, 2011, FISH B-NOAA, V109, P56; MOFFITT RB, 1989, B MAR SCI, V44, P616; Nelson WR, 1985, SUBMERSIBLE SURVEY C; Parrish JD, 2000, INTERACTIONS NONINDI; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Pyle RL, 2016, PEERJ, V4, DOI 10.7717/peerj.2475; Randall JE, 1998, ZOOL STUD, V37, P227; Randall JE, 2007, REEF SHORE FISHES HA; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Schumacher BD, 2011, HABITAT USE TROPHIC, V73; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Smith TB, 2014, ECOLOGY, V95, P1663, DOI 10.1890/13-0468.1; Stender S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023184; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Swerdloff SN, 1970, THESIS; Tenggardjaja KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115493; THRESHER RE, 1986, B MAR SCI, V38, P253; Wagner D, 2014, MARINE BIODIVERSITY, P7; Weijerman M, 2019, MAR ECOL PROG SER, V630, P161, DOI 10.3354/meps13135; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010	47	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231668	10.1371/journal.pone.0231668	http://dx.doi.org/10.1371/journal.pone.0231668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330931	Green Published, gold			2022-12-26	WOS:000536647300018
J	Lange, MJP; Szperlinski, M; Kalix, L; Lange, T				Lange, Maria Joao Pimenta; Szperlinski, Manuela; Kalix, Leon; Lange, Theo			Cucumber gibberellin 1-oxidase/desaturase initiates novel gibberellin catabolic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; recombinant protein expression; development; dioxygenase; enzyme; metabolism; oxidase; plant physiology; plant molecular biology; phytohormone; anabolism; catabolism; cucumber; gibberellins; seed development	EXPRESSION; BIOSYNTHESIS; 20-OXIDASE; OXIDASES; IDENTIFICATION; SATIVUS; EMBRYOS; CLONING; GENES	Bioactive gibberellins (GAs) are central regulators of plant growth and development, including seed development. GA homeostasis is achieved via complex biosynthetic and catabolic pathways, whose exact activities remain to be elucidated. Here, we isolated two cDNAs from mature or imbibed cucumber seeds with high sequence similarity to known GA 3-oxidases. We found that one enzyme (designated here CsGA3ox5) has GA 3-oxidation activity. However, the second enzyme (designated CsGA1ox/ds) performed multiple reactions, including 1?-oxidation and 9,11-desaturation of GAs, but was lacking the 3-oxidation activity. CsGA1ox/ds overexpression inArabidopsisplants resulted in severely dwarfed plants that could be rescued by the exogenous application of bioactive GA(4), confirming that CsGA1ox/ds catabolizes GAs. Substitution of three amino acids in CsGA1ox/ds, Phe(93), Pro(106), and Ser(202), with those typically conserved among GA 3-oxidases, Tyr(93), Met(106), and Thr(202), respectively, conferred GA 3-oxidase activity to CsGA1ox/ds and thereby augmented its potential to form bioactive GAs in addition to catabolic products. Accordingly, overexpression of this amino acid?modified GA1ox/ds variant inArabidopsisaccelerated plant growth and development, indicating that this enzyme variant can produce bioactive GAsin planta. Furthermore, a genetically modified GA3ox5 variant in which these three canonical GA 3-oxidase amino acids were changed to the ones present in CsGA1ox/ds was unable to convert GA(9)to GA(4), highlighting the importance of these three conserved amino acids for GA 3-oxidase activity.	[Lange, Maria Joao Pimenta; Szperlinski, Manuela; Kalix, Leon; Lange, Theo] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pflanzenbiol, Braunschweig, Germany	Braunschweig University of Technology	Lange, MJP; Lange, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pflanzenbiol, Braunschweig, Germany.	m.pimenta@tu-bs.de; theo.lange@tu-bs.de	Lange, Theo/H-6148-2018	Lange, Theo/0000-0003-1294-2647	Volkswagen Foundation [Az. 95475]	Volkswagen Foundation(Volkswagen)	This work was supported in part by the Volkswagen Foundation Az. 95475 (to M. J. P. L.).	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Curtis IS, 2000, PLANT J, V23, P329, DOI 10.1046/j.1365-313x.2000.00784.x; Frisse A, 2003, PLANT PHYSIOL, V131, P1220, DOI 10.1104/pp.015206; Gaskin P., 1992, GC MS GIBBERELLINS R; He J, 2019, NAT PLANTS, V5, P1057, DOI 10.1038/s41477-019-0511-z; Hedden P, 2016, ANNU PLANT REV, V49, P37, DOI 10.1002/9781119210436.ch2; HEMPHILL DD, 1972, PLANTA, V103, P241, DOI 10.1007/BF00386846; Hu YL, 2018, NAT PLANTS, V4, P289, DOI 10.1038/s41477-018-0143-8; Huang Y, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0490-2; Lange MJP, 2006, PLANT BIOLOGY, V8, P281, DOI 10.1055/s-2006-923882; Lange MJP, 2016, DEVELOPMENT, V143, P4425, DOI 10.1242/dev.135947; Lange MJP, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.25, 10.1038/NPLANTS.2014.25]; Lange MJP, 2013, PHYTOCHEMISTRY, V90, P62, DOI 10.1016/j.phytochem.2013.02.006; Lange T, 1997, P NATL ACAD SCI USA, V94, P6553, DOI 10.1073/pnas.94.12.6553; Lange T, 2005, PLANT PHYSIOL, V139, P213, DOI 10.1104/pp.105.064162; LANGE T, 1994, P NATL ACAD SCI USA, V91, P8552, DOI 10.1073/pnas.91.18.8552; LANGE T, 1993, PLANTA, V189, P350, DOI 10.1007/BF00194431; Magome H, 2016, ANNU PLANT REV, V49, P73, DOI 10.1002/9781119210436.ch3; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Niki T, 2001, PLANT PHYSIOL, V126, P965, DOI 10.1104/pp.126.3.965; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0520-7; Radi A, 2006, PLANT PHYSIOL, V140, P528, DOI 10.1104/pp.105.073668; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Ward DA, 2010, PHYTOCHEMISTRY, V71, P2010, DOI 10.1016/j.phytochem.2010.09.015; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	30	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8442	8448		10.1074/jbc.RA120.013708	http://dx.doi.org/10.1074/jbc.RA120.013708			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32345611	hybrid, Green Published			2022-12-26	WOS:000546986500008
J	Cattley, RT; Lee, M; Boggess, WC; Hawse, WF				Cattley, Richard T.; Lee, Mijoon; Boggess, William C.; Hawse, William F.			Transforming growth factor ? (TGF-?) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell receptor (TCR); phosphatidylinositide 3-kinase (PI 3-kinase); computer modeling; phosphatidylinositol; phosphatidylinositol kinase (PI kinase); T cell; T-cell biology; phosphatase and tensin homolog (PTEN); protein kinase A (PKA); phosphatidylinositol signaling; C-terminal Src kinase (CSK); immunity; transforming growth factor ? (TGF-?); cytokine; phosphoinositide 3-kinase (PI3K); phospholipid signaling	FOCAL ADHESION KINASE; FACTOR-BETA; PROTEIN-KINASE; PHOSPHORYLATION; TYROSINE; 3-KINASE; BINDING; INHIBITION; DOMAIN; PTEN	The cytokine content in tissue microenvironments shapes the functional capacity of a T cell. This capacity depends on the integration of extracellular signaling through multiple receptors, including the T-cell receptor (TCR), co-receptors, and cytokine receptors. Transforming growth factor ? (TGF-?) signals through its cognate receptor, TGF?R, to SMAD family member proteins and contributes to the generation of a transcriptional program that promotes regulatory T-cell differentiation. In addition to transcription, here we identified specific signaling networks that are regulated by TGF?R. Using an array of biochemical approaches, including immunoblotting, kinase assays, immunoprecipitation, and flow cytometry, we found that TGF?R signaling promotes the formation of a SMAD3/4-protein kinase A (PKA) complex that activates C-terminal Src kinase (CSK) and thereby down-regulates kinases involved in proximal TCR activation. Additionally, TGF?R signaling potentiated CSK phosphorylation of the P85 subunit in the P85?P110 phosphoinositide 3-kinase (PI3K) heterodimer, which reduced PI3K activity and down-regulated the activation of proteins that require phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) for their activation. Moreover, TGF?R-mediated disruption of the P85?P110 interaction enabled P85 binding to a lipid phosphatase, phosphatase and tensin homolog (PTEN), aiding in the maintenance of PTEN abundance and thereby promoting elevated PtdIns(4,5)P2 levels in response to TGF?R signaling. Taken together, these results highlight that TGF-? influences the trajectory of early T-cell activation by altering PI3K activity and PtdIns levels.	[Cattley, Richard T.; Hawse, William F.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Lee, Mijoon; Boggess, William C.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Notre Dame	Hawse, WF (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	whawse@pitt.edu	Lee, Mijoon/AFK-1543-2022	Lee, Mijoon/0000-0001-7432-0427	Competitive Medical Research Fund Grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology; National Institutes of Health [1R21AI144558-01A1]	Competitive Medical Research Fund Grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Competitive Medical Research Fund Grant from the University of Pittsburgh Medical Center (to W. F. H.), startup funds generously provided by the University of Pittsburgh Department of Immunology (to W. F. H.) and by the National Institutes of Health Grant 1R21AI144558-01A1 (to W. F. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Ching KA, 2000, J IMMUNOL, V165, P256, DOI 10.4049/jimmunol.165.1.256; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Dimeloe S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3334; Girod A, 1996, FEBS LETT, V391, P121, DOI 10.1016/0014-5793(96)00717-X; Gokhale NA, 2013, BIOCHEM J, V453, P413, DOI 10.1042/BJ20121528; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hawse WF, 2019, J IMMUNOL, V203, P2771, DOI 10.4049/jimmunol.1900749; Hawse WF, 2019, J BIOL CHEM, V294, P4793, DOI 10.1074/jbc.RA118.006524; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Hawse WF, 2015, J IMMUNOL, V194, P4615, DOI 10.4049/jimmunol.1402554; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horwitz DA, 2003, J LEUKOCYTE BIOL, V74, P471, DOI 10.1189/jlb.0503228; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Luo W, 2019, NAT IMMUNOL, V20, P736, DOI 10.1038/s41590-019-0376-3; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oudart JB, 2016, ONCOTARGET, V7, P1516, DOI 10.18632/oncotarget.6399; Pages F, 1996, J BIOL CHEM, V271, P9403, DOI 10.1074/jbc.271.16.9403; Piccirillo AR, 2019, J BIOL CHEM, V294, P2397, DOI 10.1074/jbc.RA118.006977; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; Yaqub S, 2003, BIOCHEM J, V372, P271, DOI 10.1042/BJ20030021; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	52	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8236	8251		10.1074/jbc.RA120.012572	http://dx.doi.org/10.1074/jbc.RA120.012572			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358062	Green Published, hybrid			2022-12-26	WOS:000542965700012
J	Jones, CS; Sychantha, D; Howell, PL; Clarke, AJ				Jones, Carys S.; Sychantha, David; Howell, P. Lynne; Clarke, Anthony J.			Structural basis for theO-acetyltransferase function of the extracytoplasmic domain of OatA fromStaphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptidoglycan; virulence factor; Staphylococcus aureus (S; aureus); methicillin-resistant Staphylococcus aureus (MRSA); cell wall; bacterial cell wall; O-acetylation; O-acetyltransferase; OatA; X-ray crystal structure	PEPTIDOGLYCAN O-ACETYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; LYSOZYME RESISTANCE; NEISSERIA-GONORRHOEAE; ENTEROCOCCUS-FAECALIS; MUREIN BIOSYNTHESIS; PROTEUS-MIRABILIS; ACETYLATION; MODEL; PATHOGENESIS	Many bacteria possess enzymes that modify the essential cell-wall polymer peptidoglycan byO-acetylation. This modification occurs in numerous Gram-positive pathogens, including methicillin-resistantStaphylococcus aureus, a common cause of human infections.O-Acetylation of peptidoglycan protects bacteria from the lytic activity of lysozyme, a mammalian innate immune enzyme, and as such is important for bacterial virulence. TheO-acetylating enzyme in Gram-positive bacteria,O-acetyltransferase A (OatA), is a two-domain protein consisting of an N-terminal integral membrane domain and a C-terminal extracytoplasmic domain. Here, we present the X-ray crystal structure at 1.71 ? resolution and the biochemical characterization of the C-terminal domain ofS. aureusOatA. The structure revealed that this OatA domain adopts an SGNH-hydrolase fold and possesses a canonical catalytic triad. Site-specific replacement of active-site amino acids revealed the presence of a water-coordinating aspartate residue that limits esterase activity. This residue, although conserved in staphyloccocal OatA and most other homologs, is not present in the previously characterized streptococcal OatA. These results provide insights into the mechanism of acetyl transfer in the SGNH/GDSL hydrolase family and highlight important evolutionary differences between homologous OatA enzymes. Furthermore, this study enhances our understanding of PGO-acetyltransferases, which could guide the development of novel antibacterial drugs to combat infections with multidrug-resistant bacterial pathogens.	[Jones, Carys S.; Sychantha, David; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Howell, P. Lynne] Hosp Sick Children, Program Mol Med, Toronto, ON, Canada; [Howell, P. Lynne] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON, Canada; [Clarke, Anthony J.] Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON, Canada; [Sychantha, David] McMaster Univ, David Braley Ctr Antibiot Discovery, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	University of Guelph; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Wilfrid Laurier University; McMaster University	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.; Clarke, AJ (corresponding author), Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON, Canada.	ajclarke@wlu.ca		Jones, Carys/0000-0003-0591-0815	Canadian Institutes of Health Research Operating Grant [PJT156353]; Canadian Glycomics Network; National Centre of Excellence; Natural Sciences and Engineering Research Council; Province of Ontario; Canadian Research Chair	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Canadian Glycomics Network; National Centre of Excellence; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Province of Ontario; Canadian Research Chair(Canada Research Chairs)	This work was supported by Canadian Institutes of Health Research Operating Grant PJT156353 (to A. J. C.); an operating grant from the Canadian Glycomics Network, a National Centre of Excellence (to A. J. C.); postgraduate scholarships from the Natural Sciences and Engineering Research Council and the Province of Ontario (to C. S. J.); and a Canadian Research Chair (to P. L. H.).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; Baranwal G, 2017, INT J MED MICROBIOL, V307, P388, DOI 10.1016/j.ijmm.2017.08.002; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Bernard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047893; BLUNDELL JK, 1980, FEMS MICROBIOL LETT, V9, P259, DOI 10.1111/j.1574-6968.1980.tb05648.x; Brott AS, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8020065; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLEMING TJ, 1986, INFECT IMMUN, V52, P600, DOI 10.1128/IAI.52.2.600-608.1986; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; GMEINER J, 1987, EUR J BIOCHEM, V163, P389, DOI 10.1111/j.1432-1033.1987.tb10811.x; GMEINER J, 1981, EUR J BIOCHEM, V117, P171; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; JOHANNSEN L, 1983, FEMS MICROBIOL LETT, V16, P313; Kell L. F., 2015, THESIS; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAR AL, 1986, J GEN MICROBIOL, V132, P2413; Moynihan PJ, 2014, BIOCHEMISTRY-US, V53, P6243, DOI 10.1021/bi501002d; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Pushkaran AC, 2015, J CHEM INF MODEL, V55, P760, DOI 10.1021/ci500734k; Review on Antimicrobial Resistance, 2014, ANTIMICROBIAL RESIST; Rex JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11303-9; Sanchez M, 2017, CELL HOST MICROBE, V22, P543, DOI 10.1016/j.chom.2017.08.008; Schallenberger MA, 2012, J BACTERIOL, V194, P2677, DOI 10.1128/JB.00064-12; SNOWDEN MA, 1989, J GEN MICROBIOL, V135, P3015; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; SWIM SC, 1983, INFECT IMMUN, V42, P446, DOI 10.1128/IAI.42.2.446-452.1983; Sychantha D, 2018, BIOCHEMISTRY-US, V57, P2394, DOI 10.1021/acs.biochem.8b00301; Sychantha D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006667; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veyrier FJ, 2013, MOL MICROBIOL, V87, P1100, DOI 10.1111/mmi.12153; Wang G, 2012, MBIO, V3, DOI 10.1128/mBio.00409-12; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Williams AH, 2014, ACTA CRYSTALLOGR D, V70, P2631, DOI 10.1107/S1399004714016770	48	10	10	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8204	8213		10.1074/jbc.RA120.013108	http://dx.doi.org/10.1074/jbc.RA120.013108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350117	hybrid, Green Published			2022-12-26	WOS:000542965700009
J	Torii, S; Orba, Y; Sasaki, M; Tabata, K; Wada, Y; Carr, M; Hobson-Peters, J; Hall, RA; Takada, A; Fukuhara, T; Matsuura, Y; Hall, WW; Sawa, H				Torii, Shiho; Orba, Yasuko; Sasaki, Michihito; Tabata, Koshiro; Wada, Yuji; Carr, Michael; Hobson-Peters, Jody; Hall, Roy A.; Takada, Ayato; Fukuhara, Takasuke; Matsuura, Yoshiharu; Hall, William W.; Sawa, Hirofumi			Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chikungunya virus; endosomal sorting complexes required for transport (ESCRT); alphavirus; trafficking; viral replication; hepatocyte growth factor-regulated tyrosine kinase substrate (HGS); viral release; host factor; siRNA screen; particle release; host-pathogen interaction	MONOCLONAL-ANTIBODIES; CYTOPLASMIC SURFACE; PROTEIN; MEMBRANE; ASSOCIATION; DISSECTION; TRANSPORT; OUTBREAK; BINDING; TSG101	Chikungunya fever is a re-emerging zoonotic disease caused by chikungunya virus (CHIKV), a member of the Alphavirus genus in the Togaviridae family. Only a few studies have reported on the host factors required for intracellular CHIKV trafficking. Here, we conducted an imaging-based siRNA screen to identify human host factors for intracellular trafficking that are involved in CHIKV infection, examined their interactions with CHIKV proteins, and investigated the contributions of these proteins to CHIKV infection. The results of the siRNA screen revealed that host endosomal sorting complexes required for transport (ESCRT) proteins are recruited during CHIKV infection. Co-immunoprecipitation analyses revealed that both structural and nonstructural CHIKV proteins interact with hepatocyte growth factor?regulated tyrosine kinase substrate (HGS), a component of the ESCRT-0 complex. We also observed that HGS co-localizes with the E2 protein of CHIKV and with dsRNA, a marker of the replicated CHIKV genome. Results from gene knockdown analyses indicated that, along with other ESCRT factors, HGS facilitates both genome replication and post-translational steps during CHIKV infection. Moreover, we show that ESCRT factors are also required for infections with other alphaviruses. We conclude that during CHIKV infection, several ESCRT factors are recruited via HGS and are involved in viral genome replication and post-translational processing of viral proteins.	[Torii, Shiho; Orba, Yasuko; Sasaki, Michihito; Tabata, Koshiro; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan; [Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan; [Carr, Michael; Takada, Ayato; Hall, William W.; Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan; [Wada, Yuji] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Carr, Michael; Hall, William W.] Univ Coll Dublin, Sch Med, Natl Virus Reference Lab, Dublin, Ireland; [Hall, William W.] Univ Coll Dublin, Sch Med, Ctr Res Infect Dis, Dublin, Ireland; [Hobson-Peters, Jody; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Fukuhara, Takasuke; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Suita, Osaka, Japan; [Hall, William W.; Sawa, Hirofumi] Global Virus Network, Baltimore, MD 21201 USA	Hokkaido University; Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); University College Dublin; University College Dublin; University of Queensland; Osaka University	Sawa, H (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan.; Sawa, H (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan.; Sawa, H (corresponding author), Global Virus Network, Baltimore, MD 21201 USA.	h-sawa@czc.hokudai.ac.jp	Sawa, Hirofumi/F-6954-2012; Sawa, Hirofumi/AAW-8816-2021; Sasaki, Michihito/AAY-1900-2021	Sawa, Hirofumi/0000-0003-2569-2755; Sasaki, Michihito/0000-0003-1607-2175; Carr, Michael/0000-0003-0011-6209; Torii, Shiho/0000-0003-4584-1199	MEXT/JSPS KAKENHI [JP16H06431, JP16H06429, JP16K21723]; Japan Initiative for Global Research Network on Infectious Diseases, from the Japan Agency for Medical Research and Development [JP19fm0108008]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Initiative for Global Research Network on Infectious Diseases, from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by grants for Scientific Research on Innovative Areas and International Group from the MEXT/JSPS KAKENHI (JP16H06431, JP16H06429, JP16K21723), and the Japan Initiative for Global Research Network on Infectious Diseases, from the Japan Agency for Medical Research and Development (JP19fm0108008).	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Andriamandimby SF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002339; Arii J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05889-9; Barajas D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004087; Barajas D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000705; Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16; Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479; Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169; Chen RB, 2018, J GEN VIROL, V99, P761, DOI 10.1099/jgv.0.001072; Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0; Chou SF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005123; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002; Crump CA, 2007, J VIROL, V81, P7380, DOI 10.1128/JVI.00222-07; DECURTIS I, 1988, P NATL ACAD SCI USA, V85, P8052, DOI 10.1073/pnas.85.21.8052; Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013; Diaz A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004742; FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; GEIGENMULLERGNIRKE U, 1993, J VIROL, V67, P1620; Goh LYH, 2015, J GEN VIROL, V96, P507, DOI 10.1099/jgv.0.000002; Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004; Gordon TB, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010025; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Howley PM., 2013, FIELDS VIROLOGY, V6, P651; Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Kumar S, 2019, CELL REP, V26, P1800, DOI 10.1016/j.celrep.2019.01.075; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lim CK, 2009, AM J TROP MED HYG, V81, P865, DOI 10.4269/ajtmh.2009.09-0009; Liu Y, 2010, FUTURE VIROL, V5, P481, DOI 10.2217/FVL.10.33; Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nobori H, 2018, ANTIVIR RES, V155, P60, DOI 10.1016/j.antiviral.2018.05.003; Pattanakitsakul SN, 2010, J PROTEOME RES, V9, P4640, DOI 10.1021/pr100357f; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; Perera R, 2001, J VIROL, V75, P1, DOI 10.1128/JVI.75.1.1-10.2001; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Remenyi R, 2018, J VIROL, V92, DOI [10.1128/JVI.00477-18, 10.1128/jvi.00477-18]; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249; Sasaki M, 2011, GENES CELLS, V16, P343, DOI 10.1111/j.1365-2443.2011.01491.x; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068; Taylor GM, 2007, J VIROL, V81, P13631, DOI 10.1128/JVI.01688-07; Thomas S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-269; van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wada Y, 2017, VIROLOGY, V505, P102, DOI 10.1016/j.virol.2017.02.014; Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016; Zhang N, 2017, BIOCHEM BIOPH RES CO, V493, P1190, DOI 10.1016/j.bbrc.2017.09.142; Zhang R, 2018, NATURE, V557, P570, DOI 10.1038/s41586-018-0121-3	63	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7941	7957		10.1074/jbc.RA119.012303	http://dx.doi.org/10.1074/jbc.RA119.012303			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341071	Green Published, hybrid			2022-12-26	WOS:000540935400010
J	Di Dio, C; Longobardi, V; Zullo, G; Parma, P; Pauciullo, A; Perucatti, A; Higgins, J; Iannuzzi, A				Di Dio, Chiara; Longobardi, Valentina; Zullo, Gianluigi; Parma, Pietro; Pauciullo, Alfredo; Perucatti, Angela; Higgins, James; Iannuzzi, Alessandra			Analysis of meiotic segregation by triple-color fish on both total and motile sperm fractions in a t(1p;18) river buffalo bull	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; X-Y ANEUPLOIDY; BUBALUS-BUBALIS; CHROMOSOME-ABNORMALITIES; MULTICOLOR-FISH; FERTILITY; SEMEN; COWS; PREGNANCY; INTEGRITY	Chromosomal aberrations are relatively frequent pathologies in both humans and animals. Among them, translocations present a specific meiotic segregation pattern able to give a higher percentage of unbalanced gametes that can induce fertility problems. In this study, the meiotic segregation patterns of 1p, 1q and 18 Bubalus bubalis chromosomes were analyzed in both total sperm fraction and motile sperm fraction of a t(1p;18) carrier and a control bulls by triple-color FISH analysis with a pool of specific BAC probes. The frequencies of each total sperm fraction products in the carrier resulting from alternate, adjacent I, adjacent II and 3:1 segregation were 39%, 20%, 1% and 38%, respectively. On the other hand, the frequencies of each motile sperm fraction products in the carrier resulting from alternate, adjacent I, adjacent II and 3:1 segregation were 93%, 5%, 0% and 2%, respectively. The frequencies of normal sperms in the carrier were 27% and 69% in total sperm fraction and motile sperm fraction, respectively. The frequencies detected in motile sperm fraction were also validated by comparison with bull's progeny. To our knowledge, this is the first report on the meiotic segregation patterns in motile sperm fractions of B. bubalis bull carrying a chromosomal translocation. These data suggest that translocation has a very limited effect on aneuploidy in the gametes, and therefore, on the reproductive abilities of the bull.	[Di Dio, Chiara; Higgins, James] Univ Leicester, Genet & Genome Biol, Leicester, Leics, England; [Longobardi, Valentina; Zullo, Gianluigi] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Parma, Pietro] Milan Univ, Dept Agr & Environm Sci, Milan, Italy; [Pauciullo, Alfredo] Univ Torino, Dept Agr Forest & Food Sci, Grugliasco, TO, Italy; [Perucatti, Angela; Iannuzzi, Alessandra] Natl Res Council CNR ISPAAM, Lab Anim Cytogenet & Genom, Naples, Italy	University of Leicester; University of Naples Federico II; University of Milan; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Iannuzzi, A (corresponding author), Natl Res Council CNR ISPAAM, Lab Anim Cytogenet & Genom, Naples, Italy.	alessandra.iannuzzi@cnr.it	Perucatti, Angela/B-7743-2015; Longobardi, Valentina/GWM-4218-2022; Iannuzzi, Alessandra/B-8085-2015; Pauciullo, Alfredo/AAF-7713-2020	Perucatti, Angela/0000-0003-4642-9921; Pauciullo, Alfredo/0000-0002-3140-9373; longobardi, valentina/0000-0001-6560-3572	Marie Curie Horizon 2020 grant	Marie Curie Horizon 2020 grant	This work was supported by Marie Curie Horizon 2020 grant to CDD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarella S, 2013, CYTOGENET GENOME RES, V139, P17, DOI 10.1159/000342360; [Anonymous], 2007, R LANG ENV STAT COMP; Barth A.D., 2006, CURR THER LARGE ANIM, DOI [10.1016/B978-072169323-1.50034-9, DOI 10.1016/B978-072169323-1.50034-9]; Berry DP, 2016, ANNU REV ANIM BIOSCI, V4, P269, DOI 10.1146/annurev-animal-021815-111406; Boccia L, 2007, ITAL J ANIM SCI, V6, P739; Bonnet-Garnier A, 2008, CYTOGENET GENOME RES, V120, P91, DOI 10.1159/000118744; Bonnet-Garnier A, 2007, CHROMOSOME RES, V15, P148; Bonnet-Garnier A, 2006, CYTOGENET GENOME RES, V112, P241, DOI 10.1159/000089877; Cremer T, 2004, BIOL CELL, V96, P555, DOI 10.1016/j.biolcel.2004.07.002; De Lorenzi L, 2012, CHROMOSOME RES, V20, P815, DOI [10.1007/s10577-012-9315-y, 10.1007/s1057]; Di Meo GP, 2006, CHROMOSOME RES, V14, P649, DOI 10.1007/s10577-006-1074-1; Di Meo GP, 2011, CYTOGENET GENOME RES, V132, P26, DOI 10.1159/000318011; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Eggen A, 2001, GENET SEL EVOL, V33, P543, DOI 10.1051/gse:2001132; Evans G., 1987, SALAMONS ARTIFICIAL; GUSTAVSSON I, 1964, NATURE, V201, P950, DOI 10.1038/201950a0; HAAF T, 1995, EXP CELL RES, V219, P604, DOI 10.1006/excr.1995.1270; Iannuzzi A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227117; Iannuzzi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180158; Iannuzzi L, 2004, VET REC, V154, P823, DOI 10.1136/vr.154.26.823; Iannuzzi L, 1998, CYTOGENET CELL GENET, V81, P137; JACOBS PA, 1990, REPROD NUTR DEV, pS63; Jakab A, 2003, HUM REPROD, V18, P1481, DOI 10.1093/humrep/deg288; Jelinski M, 2002, UNDERSTANDING B BREE, P7; KING WA, 1991, CAN VET J, V32, P99; Koonjaenak S, 2007, ITAL J ANIM SCI, V6, P701; Larkin DM, 2015, GENETICS OF CATTLE, 2ND EDITION, P103, DOI 10.1079/9781780642215.0103; Nordin W, 1990, BUFFALO J, V6, P6; O'Hara EA, 2020, PREV VET MED, V175, DOI 10.1016/j.prevetmed.2019.104876; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Pauciullo A, 2012, THERIOGENOLOGY, V78, P688, DOI 10.1016/j.theriogenology.2012.03.017; Pauciullo A, 2011, THERIOGENOLOGY, V76, P328, DOI 10.1016/j.theriogenology.2011.02.010; Pauciullo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110297; Pauciullo A, 2014, J APPL GENET, V55, P397, DOI 10.1007/s13353-014-0207-z; Rubes J, 1999, CYTOGENET CELL GENET, V85, P200, DOI 10.1159/000015293; Rybar R, 2010, INT J ANDROL, V33, P613, DOI 10.1111/j.1365-2605.2009.00989.x; Serafini R, 2016, ANIM REPROD SCI, V172, P26, DOI 10.1016/j.anireprosci.2016.06.010; Spriggs EL, 1996, AM J HUM GENET, V58, P356; TATENO H, 1994, HEREDITAS, V120, P7, DOI 10.1111/j.1601-5223.1994.00007.x; Templado C, 2005, CYTOGENET GENOME RES, V111, P199, DOI 10.1159/000086890; Yan LY, 2016, THERIOGENOLOGY, V85, P1390, DOI 10.1016/j.theriogenology.2015.12.027; Zalenskaya IA, 2004, CHROMOSOME RES, V12, P163, DOI 10.1023/B:CHRO.0000013166.04629.97	42	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232592	10.1371/journal.pone.0232592	http://dx.doi.org/10.1371/journal.pone.0232592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365118	gold, Green Published			2022-12-26	WOS:000536959700043
J	Klink, T; Rankin, DA; Piya, B; Spieker, AJ; Faouri, S; Shehabi, A; Williams, JV; Khuri-Bulos, N; Halasa, NB				Klink, Thomas; Rankin, Danielle A.; Piya, Bhinnata; Spieker, Andrew J.; Faouri, Samir; Shehabi, Asem; Williams, John V.; Khuri-Bulos, Najwa; Halasa, Natasha B.			Evaluating the diagnostic accuracy of the WHO Severe Acute Respiratory Infection (SARI) criteria in Middle Eastern children under two years over three respiratory seasons	PLOS ONE			English	Article							CASE DEFINITIONS; INFLUENZA SURVEILLANCE; HUMAN-METAPNEUMOVIRUS; HOSPITALIZED-PATIENTS; WESTERN KENYA; ILLNESS; EPIDEMIOLOGY	Objective The World Health Organization created the Severe Acute Respiratory Infection (SARI) criteria in 2011 to monitor influenza (flu)-related hospitalization. Many studies have since used the SARI case definition as inclusion criteria for surveillance studies. We sought to determine the sensitivity, specificity, positive predictive value, and negative predictive value of the SARI criteria for detecting ten different respiratory viruses in a Middle Eastern pediatric cohort. Materials and methods The data for this study comes from a prospective acute respiratory surveillance study of hospitalized children < 2 years in Amman, Jordan from March 16, 2010 to March 31, 2013. Participants were recruited if they had a fever and/or respiratory symptoms. Nasal and throat swabs were obtained and tested by real-time RT-PCR for eleven viruses. Subjects meeting SARI criteria were determined post-hoc. Sensitivity, specificity, positive predictive value, and negative predictive value of the SARI case definition for detecting ten different viruses were calculated and results were stratified by age. Results Of the 3,175 patients enrolled, 3,164 were eligible for this study, with a median age of 3.5 months, 60.4% male, and 82% virus-positive (44% RSV and 3.8% flu). The sensitivity and specificity of the SARI criteria for detecting virus-positive patients were 44% and 77.9%, respectively. Sensitivity of SARI criteria for any virus was lowest in children < 3 months at 22.4%. Removing fever as a criterion improved the sensitivity by 65.3% for detecting RSV in children <3 months; whereas when cough was removed, the sensitivity improved by 45.5% for detecting flu in same age group. Conclusions The SARI criteria have poor sensitivity for detecting RSV, flu, and other respiratory viruses -particularly in children < 3 months. Researchers and policy makers should use caution if using the criteria to estimate burden of disease in children.	[Klink, Thomas] Univ Minnesota, Med & Pediat Residency Program, Minneapolis, MN USA; [Rankin, Danielle A.] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol PhD Program, Nashville, TN 37212 USA; [Rankin, Danielle A.; Halasa, Natasha B.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Piya, Bhinnata] Vanderbilt Inst Clin & Translat Res, Nashville, TN USA; [Spieker, Andrew J.] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Faouri, Samir] Al Bashir Hosp, Dept Pediat, Amman, Jordan; [Shehabi, Asem; Khuri-Bulos, Najwa] Jordan Univ, Dept Pediat, Amman, Jordan; [Williams, John V.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15261 USA	University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Jordan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Halasa, NB (corresponding author), Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA.	Natasha.halasa@vumc.org	Williams, John/ABE-3227-2020; Rankin, Danielle A/AAT-8589-2021	Williams, John/0000-0001-8377-5175; Rankin, Danielle A/0000-0003-3018-3373	UBS Optimus Foundation; National Institutes of Health [R01AI085062]; CTSA award from the National Center for Advancing Translational Sciences [UL1TR000445]	UBS Optimus Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA award from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	N.H. received grants from Sanofi and Quidel and consulting fees for Moderna, and Karius outside the submitted work. J.V.W. reports personal fees from Quidel, personal fees from GlaxoSmithKline outside the submitted work. For the remaining authors, none were declared. This work was supported by the UBS Optimus Foundation; National Institutes of Health: R01AI085062, and the CTSA award UL1TR000445 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Al-Awaidy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144186; Ali SA, 2010, J MED VIROL, V82, P1012, DOI 10.1002/jmv.21768; Amini R, 2017, J PEDIATR INFECT DIS, V6, P297, DOI 10.1093/jpids/piw044; Bimouhen A, 2016, E MEDITERR HEALTH J, V22, P482, DOI 10.26719/2016.22.7.482; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Gouya M, 2016, E MEDITERR HEALTH J, V22, P432, DOI 10.26719/2016.22.7.432; Groome MJ, 2015, J CLIN VIROL, V69, P125, DOI 10.1016/j.jcv.2015.06.089; Halasa N, 2015, VACCINE, V33, P6479, DOI 10.1016/j.vaccine.2015.08.048; Hirve S, 2012, B WORLD HEALTH ORGAN, V90, P804, DOI 10.2471/BLT.12.108837; Horton KC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180954; Kadjo Herve A, 2018, Afr J Infect Dis, V12, P78, DOI 10.21010/ajid.v12i2.13; Kandeel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161301; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Makokha C, 2016, INFLUENZA OTHER RESP, V10, P333, DOI 10.1111/irv.12382; Mohamed GA, 2015, AM J TROP MED HYG, V93, P1371, DOI 10.4269/ajtmh.15-0141; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Murray EL, 2013, EPIDEMIOL INFECT, V141, P212, DOI 10.1017/S095026881200043X; Nyawanda BO, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1532-0; Refaey S, 2016, East Mediterr Health J, V22, P503; Rha B, 2018, J PEDIAT INFECT DIS, DOI [10.1017/S095026881200043X, DOI 10.1017/S095026881200043X]; Saha S, 2015, J GLOB HEALTH, V5, P233, DOI 10.7189/jogh.05.020419; Saleh M, 2018, INFLUENZA OTHER RESP, V12, P331, DOI 10.1111/irv.12527; Thabet AAK, 2016, E MEDITERR HEALTH J, V22, P440, DOI 10.26719/2016.22.7.440; World Health Organization, 2014, GLOB EP SURV STAND F	25	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232188	10.1371/journal.pone.0232188	http://dx.doi.org/10.1371/journal.pone.0232188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353012	Green Published, gold			2022-12-26	WOS:000536673200050
J	Sarker, AR; Islam, Z; Sultana, M; Sheikh, N; Mahumud, RA; Islam, MT; Van der Meer, R; Morton, A; Khan, AI; Clemens, JD; Qadri, F; Khan, JAM				Sarker, Abdur Razzaque; Islam, Ziaul; Sultana, Marufa; Sheikh, Nurnabi; Mahumud, Rashidul Alam; Islam, Md. Taufiqul; Van der Meer, Robert; Morton, Alec; Khan, Ashraful Islam; Clemens, John David; Qadri, Firdausi; Khan, Jahangir A. M.			Willingness to pay for oral cholera vaccines in urban Bangladesh	PLOS ONE			English	Article							CONTINGENT VALUATION METHOD; PRIVATE DEMAND; ECONOMIC-BENEFITS; RISK ATTITUDES; DENGUE VACCINE; WHOLE-CELL; IMMUNOGENICITY; IMMUNIZATION; DECADE; SAFETY	Introduction Cholera is a highly infectious disease and remains a serious public health burden in Bangladesh. The objective of the study was to measure the private demand for oral cholera vaccines (OCV) in Bangladesh and to investigate the key determinants of this demand, reflected in the household's willingness to pay (WTP) for oral cholera vaccine. Methods A contingent valuation method was employed in an urban setting of Bangladesh during December 2015 to January 2016. All respondents (N = 1051) received a description of World Health Organization (WHO) prequalified OCV, Shanchol (TM). Interviews were conducted with either the head of households or their spouse or a major economic contributor of the households. Respondents were asked about how much at maximum they were willing to pay for OCV for their own and their household members' protection. Results are presented as the average and median of the reported maximum WTP of the respondents with standard deviations and 95% confidence interval. Natural log-linear regression model was employed to examine the factors influencing participants' WTP for OCV. Results About 99% of the respondents expressed WTP for OCV with a maximum mean and median WTP per vaccination (2 doses) of US$ 2.23 and US$ 1.92 respectively. On the household level with an average number of 4.62 members, the estimated mean WTP was US$ 10 (median: US$ 7.69) which represents the perceived demand for OCV of a household to vaccinate against cholera. Conclusions The demand of vaccination further indicates that there is a potential scope for recovering a certain portion of the expenditure of immunization program by introducing direct user fees for future cholera vaccination in Bangladesh. Findings from this study will be useful for the policy-makers to make decision on cost-recovery in future oral cholera vaccination programs in Bangladesh and in similar countries.	[Sarker, Abdur Razzaque; Islam, Ziaul; Sultana, Marufa; Sheikh, Nurnabi; Islam, Md. Taufiqul; Khan, Ashraful Islam; Clemens, John David; Qadri, Firdausi] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Sarker, Abdur Razzaque; Van der Meer, Robert; Morton, Alec] Univ Strathclyde, Glasgow, Lanark, Scotland; [Sarker, Abdur Razzaque] Bangladesh Inst Dev Studies, Dhaka, Bangladesh; [Mahumud, Rashidul Alam] Univ Southern Queensland, Toowoomba, Qld, Australia; [Khan, Jahangir A. M.] Karolinska Inst, Stockholm, Sweden; [Khan, Jahangir A. M.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	International Centre for Diarrhoeal Disease Research (ICDDR); University of Strathclyde; Bangladesh Institute of Development Studies (BIDS); University of Southern Queensland; Karolinska Institutet; Liverpool School of Tropical Medicine	Sarker, AR (corresponding author), Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.; Sarker, AR (corresponding author), Univ Strathclyde, Glasgow, Lanark, Scotland.; Sarker, AR (corresponding author), Bangladesh Inst Dev Studies, Dhaka, Bangladesh.	razzaque@bids.org.bd	Qadri, Firdausi/AAF-4583-2019; Mahumud, Rashidul Alam/O-2477-2018; Islam, Taufiqul/AAT-9613-2021; Van Der Meer, Robert B/O-1731-2016	Mahumud, Rashidul Alam/0000-0001-9788-1868; Van Der Meer, Robert B/0000-0002-9442-1628; Sheikh, Nurnabi/0000-0002-5185-9996; Sarker, Abdur Razzaque/0000-0002-2022-7590; Morton, Alec/0000-0003-3803-8517	Gavi, The Vaccine Alliance; Government of Australia; Government of Canada; Government of Sweden; Government of UK; Bangladesh Institute of Development Studies (BIDS); University of Strathclyde; Government of Bangladesh	Gavi, The Vaccine Alliance; Government of Australia; Government of Canada(CGIAR); Government of Sweden; Government of UK; Bangladesh Institute of Development Studies (BIDS); University of Strathclyde; Government of Bangladesh	This research study was funded by Gavi, The Vaccine Alliance. Additionally, the Governments of Australia, Bangladesh, Canada, Sweden, and the UK for providing core or unrestricted support. The Bangladesh Institute of Development Studies (BIDS) and University of Strathclyde also provided research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2006, APPL ENVIRON MICROB, V72, P4096, DOI 10.1128/AEM.00066-06; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Anh DD, 2007, VACCINE, V25, P1149, DOI 10.1016/j.vaccine.2006.09.049; Barnighausen T, 2014, P NATL ACAD SCI USA, V111, P12313, DOI 10.1073/pnas.1400475111; Beyer H., 1981, S BIOMETRICAL J, V23, P414; Birhane M. G., 2016, PLOS NEGLECTED TROP, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004486; Botzen WJW, 2012, J ECON BEHAV ORGAN, V82, P151, DOI 10.1016/j.jebo.2012.01.005; Cai LM, 2017, APPL MATH COMPUT, V299, P127, DOI 10.1016/j.amc.2016.11.013; Canh DG, 2006, HEALTH POLICY PLANN, V21, P241, DOI 10.1093/heapol/czl009; Carson RT, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.4.27; Chowdhury F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000999; Dickinson KL, 2016, AM J TROP MED HYG, V94, P775, DOI 10.4269/ajtmh.15-0666; Drummond MF., 2005, METHODS EC EVALUATIO, P55; GoB, 2015, BANGL EC REV 2015; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; Harapan H, 2019, VACCINE, V37, P1398, DOI 10.1016/j.vaccine.2019.01.062; Harapan H, 2017, ACTA TROP, V166, P249, DOI 10.1016/j.actatropica.2016.11.035; Harrison GW, 2007, SCAND J ECON, V109, P341, DOI 10.1111/j.1467-9442.2007.00496.x; Heinzen RR, 2008, INT J TECHNOL ASSESS, V24, P481, DOI 10.1017/S026646230808063X; Hoevenagel R., 1994, CONTINGENT VALUATION; Incepta, 2017, STEER COMM M OR CHOL; Islam Z, 2008, HEALTH POLICY, V85, P184, DOI 10.1016/j.healthpol.2007.07.009; IVI, 2013, COUNTR INV CAS STUD; Jeuland M, 2010, J DEV ECON, V91, P310, DOI 10.1016/j.jdeveco.2009.06.007; JOHANNESSON M, 1991, HEALTH POLICY, V17, P1, DOI 10.1016/0168-8510(91)90114-D; Kairu-Wanyoike SW, 2014, PREV VET MED, V115, P130, DOI 10.1016/j.prevetmed.2014.03.028; Kartman B, 1996, HEALTH ECON, V5, P531, DOI 10.1002/(SICI)1099-1050(199611)5:6<531::AID-HEC235>3.3.CO;2-A; Khan AI, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006652; Kim D, 2008, VALUE HEALTH, V11, P119, DOI 10.1111/j.1524-4733.2007.00220.x; Klose T, 1999, HEALTH POLICY, V47, P97, DOI 10.1016/S0168-8510(99)00010-X; Kobelt G., 2013, HLTH EC INTRO EC EVA; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; LICHTENSTEIN DR, 1989, J CONSUM RES, V16, P55, DOI 10.1086/209193; Lucas MES, 2007, VACCINE, V25, P2599, DOI 10.1016/j.vaccine.2006.12.027; Mahalanabis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002323; MoHFW, 2015, BANGL NAT HLTH ACC 1, DOI [10.13140/RG.2.1.3951.6247, DOI 10.13140/RG.2.1.3951.6247]; NOAA, 1993, FED REGISTER, V58, P4607; O'Brien BJ, 1998, MED CARE, V36, P370, DOI 10.1097/00005650-199803000-00013; OBRIEN B, 1994, MED DECIS MAKING, V14, P289, DOI 10.1177/0272989X9401400311; Ozawa S, 2012, VACCINE, V31, P96, DOI 10.1016/j.vaccine.2012.10.103; Pachico D, 2004, Consumer Acceptance of Genetically Modified Foods, P155, DOI 10.1079/9780851997476.0155; Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011; Park SH, 2014, FASH TEXT, V1, DOI 10.1186/s40691-014-0001-x; RANDALL A, 1974, J ENVIRON ECON MANAG, V1, P132, DOI 10.1016/0095-0696(74)90010-2; Saha A, 2011, VACCINE, V29, P8285, DOI 10.1016/j.vaccine.2011.08.108; Sarker AR, 2015, VACCINE, V33, P4916, DOI 10.1016/j.vaccine.2015.07.042; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Sauerborn R, 2005, SCAND J PUBLIC HEALT, V33, P146, DOI 10.1080/14034940510005743; Shen AK, 2016, HEALTH AFFAIR, V35, P272, DOI 10.1377/hlthaff.2015.1418; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; Suraratdecha C, 2005, HEALTH POLICY, V73, P272, DOI [10.1016/j.healthpol.2004.11.019, 10.1016/j.healthpol.2004.05.005]; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; Whittington D, 2002, VACCINE, V20, P2585, DOI 10.1016/S0264-410X(02)00152-4; Whittington D, 2002, ENVIRON RESOUR ECON, V22, P323, DOI 10.1023/A:1015575517927; WHO, 2004, WHO M 10 11 DEC 2002; World Health Organization, 2016, CHOL FACT SHEET; Yeung RYT, 2005, APPL HEALTH ECON HEA, V4, P165, DOI 10.2165/00148365-200504030-00005	58	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232600	10.1371/journal.pone.0232600	http://dx.doi.org/10.1371/journal.pone.0232600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353086	Green Published, gold, Green Accepted			2022-12-26	WOS:000536673200108
J	Yin, L; Mou, HM; Shao, J; Zhu, Y; Pang, XH; Yang, JJ; Zhang, JM; Shi, W; Yu, SM; Wang, HL				Yin, Li; Mou, Huaming; Shao, Jiang; Zhu, Ye; Pang, Xiaohua; Yang, Jianjun; Zhang, Jianming; Shi, Wei; Yu, Shimei; Wang, Hailong			Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control study	PLOS ONE			English	Article							INFLAMMATORY CYTOKINES; CORONAVIRUS; PLASMA; SARS	Background Heart-fatty acid binding protein (HFABP) has been recognized as a highly heart-specific marker. However, it is currently unknown that its HFABP is also closely related to the severity of COVID-19. Methods We retrospectively screened 46 patients who met our inclusion criteria within 4 weeks. They were tested for HFABP after the diagnosis of COVID-19, and monitored for HFABP during their hospital stay. We tracked the patients during their hospital stay to determine if they had severe COVID-19 or mild-to-severe transition features. We calculated the chi-square test values found for HFABP to predict the correlation between HFABP levels and the severity of the COVID-19. Results Of these 46 cases, 16 cases with confirmed COVID-19 were tested for HFABP> 7 ng / mL upon admission; among them, 14 cases were diagnosed with severe COVID-19 within the hospitalization. The Odds ratio of the measured HFABP elevation was 6.81(95% confidence interval [CI] 5.23-8.40), and 3 patients with severe COVID-19 progressed in 5 patients with mild HFABP> 7 ng/mL. Conclusion These data indicate that the elevation of HFABP is closely related to the severity of COVID-19 in the patients, and the elevated HFABP may cause rapid development of patients with mild COVID-19 into severe COVID-19. But serum HFABP negative maybe make patients with mild COVID-19 safer, the current data show no effect on the all-cause mortality.	[Yin, Li; Mou, Huaming; Shao, Jiang; Pang, Xiaohua; Yang, Jianjun; Zhang, Jianming; Shi, Wei; Wang, Hailong] Chongqing Univ, Dept Cardiol, Chongqing Three Gorges Cent Hosp, Heart Ctr,Affiliated Three Gorges Hosp, Chongqing, Peoples R China; [Zhu, Ye] Sichuan Univ, Dept Cardiol, West China Hosp, Chengdu, Peoples R China; [Yu, Shimei] Wanzhou First People Hosp, Dept Otorhinolaryngol, Chongqing, Peoples R China	Chongqing University; Sichuan University	Wang, HL (corresponding author), Chongqing Univ, Dept Cardiol, Chongqing Three Gorges Cent Hosp, Heart Ctr,Affiliated Three Gorges Hosp, Chongqing, Peoples R China.	wangjinlong2007666@163.com		Wang, Hailong/0000-0002-8565-6599				[Anonymous], 2020, NOV COR THAIL EXCH; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Centers for Disease Control and Prevention, 2020, 1 TRAV REL CAS 2019; China National Health Commission, 2020, UPD NOV COR PENUM OU; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Faure E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088716; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; GLATZ JFC, 1994, BRIT HEART J, V71, P135; He L, 2006, J PATHOL, V210, P288, DOI 10.1002/path.2067; KLEINE AH, 1992, MOL CELL BIOCHEM, V116, P155, DOI 10.1007/BF01270583; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025; Richman D., 2016, CLIN VIROLOGY, V4th, DOI DOI 10.1128/9781555819439; Wang HL, 2018, JCPSP-J COLL PHYSICI, V28, P56, DOI 10.29271/jcpsp.2018.01.56; Wang Manli, 2013, Virologica Sinica, V28, P315, DOI 10.1007/s12250-013-3402-x; WHO, 2020, NOV COR REP KOR EXCH; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; World Health Organization, 2020, NOV COR JAP EXCH; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	22	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231687	10.1371/journal.pone.0231687	http://dx.doi.org/10.1371/journal.pone.0231687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348339	Green Published, gold			2022-12-26	WOS:000536668200022
J	Chovatiya, R; Silverberg, JI				Chovatiya, Raj; Silverberg, Jonathan I.			Inpatient morbidity and mortality of measles in the United States	PLOS ONE			English	Article							PUBLIC-HEALTH; CHILDHOOD BLINDNESS; CORNEAL ULCERATION; ECONOMIC BURDEN; COMPLICATIONS; EPIDEMIC; OUTBREAK; HOSPITALIZATIONS; ELIMINATION; CHILDREN	Background Measles is an extremely contagious, vaccine-preventable infection that was officially declared eradicated in the US in 2000. However, measles outbreaks are increasingly occurring in the US. Measles cases have considerable morbidity requiring hospitalization, yet little is known about hospitalization and complications from measles in recent years. Objectives To analyze the frequency, predictors, costs and other outcomes of hospitalization for measles in the US. Methods The 2002-2016 Nationwide Inpatient Sample, containing a 20% sample of US hospitalizations (n = 96,568,625), was analyzed. Measles and comorbidities were defined by International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) or ICD-10-CM codes. Multivariable survey logistic regression and linear regression models controlling for sociodemographic demographic factors were constructed to understand associations with organ-specific complications, and cost of care and length of stay, respectively. Results Overall, 1,018 measles hospitalizations occurred in 2002-2016, and hospitalizations increased over time. In multivariable logistic regression models, measles was associated with higher odds of gastrointestinal, hematologic, infectious, neurologic, ophthalmologic, pulmonary, and renal complications, with the strongest association observed with encephalitis (39.84 [16.51-96.12], P < 0.0001). Increased length of stay (LOS) and similar cost of care (mean [95% CI]; 4.8 [4.4-5.4]; $7,438 [$6,446-$8,582]) were observed versus (vs.) all other admissions (4.5 [4.4-4.5]; P < 0.01; $7,854 [$7,774-$7,935], P > 0.05). There were 34 deaths in hospitalized measles patients; inpatient mortality was numerically higher in those with vs. without measles (proportion +/- SEM: 3.3 +/- 1.2% vs. 2.3 +/- 0.01%, P = 0.333). Limitations Lack of outpatient or prescription data. Conclusions Measles continues to pose a substantial and preventable health care burden, with serious complications, hospitalization and inpatient mortality. Further studies are needed to improve the prevention and management of measles.	[Chovatiya, Raj] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Silverberg, Jonathan I.] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC 20052 USA	Northwestern University; Feinberg School of Medicine; George Washington University	Silverberg, JI (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC 20052 USA.	JonathanISilverberg@Gmail.com	silverberg, jonathan/ABH-2765-2021	silverberg, jonathan/0000-0003-3686-7805	Agency for Healthcare Research and Quality (AHRQ); Dermatology Foundation; NIH [K12 HS023011, T32 AR060710]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Dermatology Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This publication was made possible with support from the Agency for Healthcare Research and Quality (AHRQ) (JIS), the Dermatology Foundation (JIS), NIH K12 HS023011 (JIS), and NIH T32 AR060710 (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICARDI J, 1977, PEDIATRICS, V59, P232; BARKIN RM, 1975, AM J EPIDEMIOL, V102, P341, DOI 10.1093/oxfordjournals.aje.a112170; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUTLER JC, 1993, PEDIATRICS, V91, P1176; Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373; Clemmons NS, 2017, JAMA-J AM MED ASSOC, V318, P1279, DOI 10.1001/jama.2017.9984; DAVIS SF, 1993, AM J PUBLIC HEALTH, V83, P1011, DOI 10.2105/AJPH.83.7.1011; Dayan GH, 2004, PEDIATRICS, V2005, P116; DETELS R, 1973, LANCET, V2, P11; Fiebelkorn AP, 2017, J PEDIATR INFECT DIS, V6, P40, DOI 10.1093/jpids/piv080; FOSTER A, 1986, B WORLD HEALTH ORGAN, V64, P619; FOSTER A, 1987, BRIT J OPHTHALMOL, V71, P331, DOI 10.1136/bjo.71.5.331; GAVISH D, 1983, ARCH INTERN MED, V143, P674, DOI 10.1001/archinte.143.4.674; Ghebrehewet S, 2016, VACCINE, V34, P1823, DOI 10.1016/j.vaccine.2016.02.029; Gindler J, 2004, J INFECT DIS, V189, pS69, DOI 10.1086/378565; Goodson JL, 2015, INFECT DIS CLIN N AM, V29, P725, DOI 10.1016/j.idc.2015.08.001; HALSEY NA, 1980, AM J EPIDEMIOL, V111, P415, DOI 10.1093/oxfordjournals.aje.a112916; HENNEMAN PL, 1995, ANN EMERG MED, V26, P278, DOI 10.1016/S0196-0644(95)70072-2; Hester G, 2019, PEDIATR INFECT DIS J, V38, P547, DOI 10.1097/INF.0000000000002221; HUDSON JB, 1956, J PEDIATR-US, V48, P48, DOI 10.1016/S0022-3476(56)80116-9; Hussey GD, 1996, ANN TROP PAEDIATR, V16, P307, DOI 10.1080/02724936.1996.11747843; KAMBARAMI RA, 1991, B WORLD HEALTH ORGAN, V69, P213; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Lee B, 2004, J INFECT DIS, V189, pS210, DOI 10.1086/381555; MAKHENE MK, 1993, PEDIATR INFECT DIS J, V12, P836, DOI 10.1097/00006454-199310000-00008; MARKOWITZ LE, 1987, AM J PUBLIC HEALTH, V77, P866, DOI 10.2105/AJPH.77.7.866; MARKOWITZ LE, 1991, REV INFECT DIS, V13, pS555; Marx GE, 2017, MMWR-MORBID MORTAL W, V66, P1272, DOI 10.15585/mmwr.mm6646a3; MASON WH, 1993, PEDIATR INFECT DIS J, V12, P42, DOI 10.1097/00006454-199301000-00010; MILLER DL, 1964, BRIT MED J, V2, P75, DOI 10.1136/bmj.2.5401.75; MILLER HG, 1956, Q J MED, V25, P427; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Ortega-Sanchez IR, 2014, VACCINE, V32, P1311, DOI 10.1016/j.vaccine.2013.10.012; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Paules CI, 2019, NEW ENGLAND J MED NE; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; SOMMER A, 1990, INT OPHTHALMOL, V14, P195, DOI 10.1007/BF00158318; Stuart R. L., 2010, Healthcare Infection, V15, P43; Van Den Hof S, 2002, PEDIATR INFECT DIS J, V21, P1146, DOI 10.1097/00006454-200212000-00012; Varavithya W, 1989, J Med Assoc Thai, V72 Suppl 1, P151; Wairagkar NS, 1999, LANCET, V354, P992, DOI 10.1016/S0140-6736(98)10101-0; Walker Allison T, 2014, MMWR Suppl, V63, P7; Watzlaf Valerie J M, 2007, Perspect Health Inf Manag, V4, P6; Wendorf KA, 2015, PEDIATR INFECT DIS J, V34, P589, DOI 10.1097/INF.0000000000000682; WONG RD, 1993, AM J MED, V95, P377, DOI 10.1016/0002-9343(93)90306-A; World Health Organization, 2007, ADDR SEX GEND EP PRO; Zhou FJ, 2004, J INFECT DIS, V189, pS131, DOI 10.1086/378987	49	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231329	10.1371/journal.pone.0231329	http://dx.doi.org/10.1371/journal.pone.0231329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343688	Green Published, gold			2022-12-26	WOS:000536661300011
J	James, BS; Shetty, RS; Kamath, A; Shetty, A				James, Beulah Sarah; Shetty, Ranjitha S.; Kamath, Asha; Shetty, Avinash			Household cooking fuel use and its health effects among rural women in southern India-A cross-sectional study	PLOS ONE			English	Article							AIR-POLLUTION; BIOMASS FUEL; DISEASE; SMOKE; COMMUNITY; MORTALITY; BURDEN; RISK	The use of biomass fuel is associated with the deterioration of human health and women are more likely to develop health conditions due to their exposure to indoor air pollution during cooking. This study was conducted to assess the pattern of fuel used for cooking in households as well as to determine the association between the types of fuel used with respect to socio-demographic characteristics and health status of women. A community based cross-sectional survey was conducted between August 2016 and September 2018 in four rural areas and one semi-urban area of Udupi district, Karnataka, India. The study comprised 587 families including 632 women. A pre-tested semi-structured questionnaire was used to collect data on the type of fuel as well as self-reported health conditions. Overall, 72.5% of the families used biomass, where 67.2% families were currently using both biomass and liquefied petroleum gas while only biomass was used in 5.3% of the families for cooking. Among women, being ever exposed to biomass fuel was significantly associated with their age, literacy level, occupation and socio-economic status (p < 0.001). Those who were exposed to biomass fuel showed a significant association with self-reported ophthalmic (AOR = 3.85; 95% CI: 1.79-8.29), respiratory (OR = 5.04; 95% CI: 2.52-10.07), cardiovascular (OR = 6.07; 95% CI: 1.88-19.67), dermatological symptoms /conditions (AOR = 3.67; 95% CI: 1.07-12.55) and history of adverse obstetric outcomes (AOR = 2.45; 95% CI: 1.08-5.57). A positive trend was observed between cumulative exposure to biomass in hour-years and various self-reported health symptoms/conditions (p < 0.001). It was observed that more than two-thirds of women using biomass fuel for cooking were positively associated with self-reported health symptoms. Further longitudinal studies are essential to determine the level of harmful air pollutants in household environment and its association with various health conditions among women in this region.	[James, Beulah Sarah] Epidem Dis Hosp, Mysuru, Karnataka, India; [Shetty, Ranjitha S.; Shetty, Avinash] Manipal Acad Higher Educ, Kasturba Med Coll Manipal, Dept Community Med, Manipal, Karnataka, India; [Kamath, Asha] Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Dept Data Sci, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE)	Shetty, RS (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll Manipal, Dept Community Med, Manipal, Karnataka, India.	ranjitha.shetty@manipal.edu			Department of Community Medicine, KMC, Manipal	Department of Community Medicine, KMC, Manipal	Authors are grateful to all the ANMs of the Department of Community Medicine, KMC, Manipal for their support in conducting the survey and authors would like to thank all the study participants.	Agrawal S, 2012, J ASTHMA, V49, P355, DOI 10.3109/02770903.2012.663030; Alexander D. A., 2017, NIGERIA ENV INT, V111, P152, DOI DOI 10.1016/j.envint.2017.11.021; Amegah AK, 2016, B WORLD HEALTH ORGAN, V94, P215, DOI 10.2471/BLT.15.155812; [Anonymous], 2018, IS WORLD TRACK DEL E; [Anonymous], 2018, HOUS AIR POLL POL PR; [Anonymous], 2018, IND AIR POLL; [Anonymous], 2018, HOUS AIR POLL HLTH; Balakrishnan K., 2013, EXAMINING HLTH EFFEC; Balakrishnan K., 2004, INDOOR AIR POLLUTION; Chandramouli C., 2011, HOUSEHOLD AMENITIES; Choi Jin Young, 2014, OPT QUANT ELECTRON, P1; Directorate of Census Operations, 2011, HOUS HOUS AM ASS KAR; Directorate of Census Operations, 2011, DISTR CENS HDB UD; Dutta A, 2014, AIR QUAL ATMOS HLTH, V7, P229, DOI 10.1007/s11869-013-0228-5; Haider Mohammad Rifat, 2016, J Health Pollut, V6, P18, DOI 10.5696/2156-9614-6-11.18; Isara AR, 2014, EURASIAN J MED, V46, P203, DOI 10.5152/eajm.2014.0051; Janjua NZ, 2012, PUBLIC HEALTH, V126, P855, DOI 10.1016/j.puhe.2012.06.012; Johnson P, 2011, GLOB HLTH ACTION, V4, P1; Kazi A., 2018, SM WOMENS HLTH ISSUE, V1, P1001; Lahiri T, 2007, HLTH EFFECTS CHRONIC; Lakshmi PVM, 2013, ENVIRON RES, V121, P17, DOI 10.1016/j.envres.2012.12.004; Lee MS, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-18; Mehta, 2006, INDOOR AIR POLLUTION; Ministry of Health and Family Welfare, 2016, NAT FAM HLTH SURV 4, V4, P2015; Mohapatra Ipsa, 2018, J Family Med Prim Care, V7, P11, DOI 10.4103/jfmpc.jfmpc_21_17; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ndwiga T., 2014, OPEN J AIR POLLUT, V3, P61, DOI [10.4236/ojap.2014.33007, DOI 10.4236/OJAP.2014.33007]; Ofori SN, 2018, ENVIRON POLLUT, V242, P390, DOI 10.1016/j.envpol.2018.06.102; Parikh J. K., 2016, PROVIDING CLEAN COOK; Piddock Katy C, 2014, Ann Am Thorac Soc, V11, P915, DOI 10.1513/AnnalsATS.201311-413OC; Pokhrel AK, 2015, OPTOMETRY VISION SCI, V90, P257; Ramirez-Venegas A, 2018, INT J CHRONIC OBSTR, V13, P1727, DOI 10.2147/COPD.S156409; Ravilla TD, 2016, ENVIRON HEALTH PERSP, V124, P1857, DOI 10.1289/EHP193; Saha A, 2017, ENV DIS, P255; Samaraweera Y, 2010, AUST NZ J OBSTET GYN, V50, P352, DOI 10.1111/j.1479-828X.2010.01190.x; Sana A, 2018, BMJ OPEN RESPIR RES, V5, DOI 10.1136/bmjresp-2017-000246; Sharma Rahul, 2013, South Asian J Cancer, V2, P157, DOI 10.4103/2278-330X.114142; Sinha B, 2015, J POSTGRAD MED, V61, P169, DOI 10.4103/0022-3859.159418; Smith KR, 2000, P NATL ACAD SCI USA, V97, P13286, DOI 10.1073/pnas.97.24.13286; Tamire M, 2018, INT J ENV RES PUB HE, V15, P1; Tielsch JM, 2009, INT J EPIDEMIOL, V38, P1351, DOI 10.1093/ije/dyp286; Tipre M., 2019, PRENATAL EXPOSURE PA, DOI [DOI 10.1101/461632, 10.1101/461632]; Unosson J, 2013, PART FIBRE TOXICOL, V10, P1; Wylie BJ, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-1	44	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231757	10.1371/journal.pone.0231757	http://dx.doi.org/10.1371/journal.pone.0231757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339177	Green Published, Green Submitted, gold			2022-12-26	WOS:000536657400013
J	Justilien, V; Lewis, KC; Meneses, KM; Jamieson, L; Murray, NR; Fields, AP				Justilien, Verline; Lewis, Kayla C.; Meneses, Kayleah M.; Jamieson, Lee; Murray, Nicole R.; Fields, Alan P.			Protein kinase C? promotes UBF1?ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell proliferation; protein-protein interaction; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); tumor cell biology; epithelial cell transforming protein 2 (ECT2); non-small cell lung cancer; protein kinase C ? (PKC?); ribosomal DNA transcription; upstream binding factor 1 (UBF1); gene regulation; ribosome biogenesis	POLYMERASE-I TRANSCRIPTION; CYTOKINESIS REGULATOR ECT2; RDNA TRANSCRIPTION; GENE-EXPRESSION; BRCT DOMAINS; PHOSPHORYLATION; ACTIVATION; PRKCI; PROTOONCOGENE; ONCOGENES	Epithelial cell?transforming sequence 2 (ECT2) is a guanine nucleotide exchange factor for Rho GTPases that is overexpressed in many cancers and involved in signal transduction pathways that promote cancer cell proliferation, invasion, and tumorigenesis. Recently, we demonstrated that a significant pool of ECT2 localizes to the nucleolus of non-small-cell lung cancer (NSCLC) cells, where it binds the transcription factor upstream binding factor 1 (UBF1) on the promoter regions of ribosomal DNA (rDNA) and activates rDNA transcription, transformed cell growth, and tumor formation. Here, we investigated the mechanism by which ECT2 engages UBF1 on rDNA promoters. Results from ECT2 mutagenesis indicated that the tandem BRCT domain of ECT2 mediates binding to UBF1. Biochemical and MS-based analyses revealed that protein kinase C? (PKC?) directly phosphorylates UBF1 at Ser-412, thereby generating a phosphopeptide-binding epitope that binds the ECT2 BRCT domain. Lentiviral shRNA knockdown and reconstitution experiments revealed that both a functional ECT2 BRCT domain and the UBF1 Ser-412 phosphorylation site are required for UBF1-mediated ECT2 recruitment to rDNA, elevated rRNA synthesis, and transformed growth. Our findings provide critical molecular insight into ECT2-mediated regulation of rDNA transcription in cancer cells and offer a rationale for therapeutic targeting of UBF1- and ECT2-stimulated rDNA transcription for the management of NSCLC.	[Justilien, Verline; Lewis, Kayla C.; Meneses, Kayleah M.; Jamieson, Lee; Murray, Nicole R.; Fields, Alan P.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Justilien, V; Fields, AP (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA.	justilien.verline@mayo.edu; fields.alan@mayo.edu			NCI, National Institutes of Health [R01 CA081436-22, R01 CA206267-04, R01 CA140290-05, R21 CA204938]; Mayo Clinic Center for Biomedical Discovery Career Development Award; American Cancer Society Research Scholar Award [RSG-18-201-01]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Center for Biomedical Discovery Career Development Award; American Cancer Society Research Scholar Award(American Cancer Society)	This work was supported by NCI, National Institutes of Health, Grants R01 CA081436-22 and R01 CA206267-04 (to A. P. F.), R01 CA140290-05 (to N. R. M.), and R21 CA204938 (to V. J.). A. P. F. is the Monica Flynn Jacoby Professor of Cancer Research, an endowment fund that provides partial support for the investigator's research program. V. J. was supported in part by a Mayo Clinic Center for Biomedical Discovery Career Development Award and an American Cancer Society Research Scholar Award (RSG-18-201-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali SA, 2016, CANCER CELL, V29, P367, DOI 10.1016/j.ccell.2016.02.012; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Chen JX, 2015, J HEPATOL, V62, P1287, DOI 10.1016/j.jhep.2015.01.014; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fields Alan P, 2017, Small GTPases, V8, P58, DOI 10.1080/21541248.2016.1194953; Fields Alan P., 2015, Advances in Biological Regulation, V60, P47, DOI 10.1016/j.jbior.2015.10.009; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hannan R, 1999, NUCLEIC ACIDS RES, V27, P1205, DOI 10.1093/nar/27.4.1205; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien Verline, 2019, Small GTPases, V10, P388, DOI 10.1080/21541248.2017.1335274; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370; Khot A, 2019, CANCER DISCOV, V9, P1036, DOI 10.1158/2159-8290.CD-18-1455; Kim H, 2014, CELL CYCLE, V13, P2952, DOI 10.4161/15384101.2014.947201; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Nguyen LXT, 2015, J CELL PHYSIOL, V230, P1181, DOI 10.1002/jcp.24854; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Liu Y, 2020, CELL REP, V30, P771, DOI 10.1016/j.celrep.2019.12.071; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Parker PJ, 2014, BIOCHEM PHARMACOL, V88, P1, DOI 10.1016/j.bcp.2013.10.023; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Reina-Campos M, 2019, CANCER CELL, V36, P218, DOI 10.1016/j.ccell.2019.07.010; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; TAKAI S, 1995, GENOMICS, V27, P220, DOI 10.1006/geno.1995.1033; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Tokinaga-Uchiyama A, 2019, INT J GYNECOL PATHOL, V38, P301, DOI 10.1097/PGP.0000000000000539; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yin N, 2019, CANCER CELL, V36, P156, DOI 10.1016/j.ccell.2019.07.002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005; Zhang ML, 2008, HEPATOB PANCREAT DIS, V7, P533; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k; Zou Y, 2014, FEBS LETT, V588, P2911, DOI 10.1016/j.febslet.2014.07.019	62	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8214	8226		10.1074/jbc.RA120.013175	http://dx.doi.org/10.1074/jbc.RA120.013175			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350115	Green Published, hybrid			2022-12-26	WOS:000542965700010
J	Verma, M; Zhu, JH; Wang, KZQ; Chu, CT				Verma, Manish; Zhu, Jianhui; Wang, Kent Z. Q.; Chu, Charleen T.			Chronic treatment with the complex I inhibitor MPP+ depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2?associated athanogene 6 (BAG6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PTEN-induced putative kinase 1 (PINK1); mitochondria; Parkinson disease; neurodegeneration; protein degradation; BAG6; mitochondrial complex I inhibition; mitochondrial dysfunction; MPP+; neuron injury	OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; DENDRITIC MITOCHONDRIA; PARKINSONS-DISEASE; MITOFUSIN 2; APOPTOSIS; 1-METHYL-4-PHENYLPYRIDINIUM; MITOPHAGY; MUTATIONS; AUTOPHAGY	Mitochondrial dysfunction is implicated in sporadic and familial Parkinson's disease (PD). However, the mechanisms that impair homeostatic responses to mitochondrial dysfunction remain unclear. Previously, we found that chronic, low-dose administration of the mitochondrial complex I inhibitor 1-methyl-4-phenylpyridinium (MPP+) dysregulates mitochondrial fission?fusion, mitophagy, and mitochondrial biogenesis. Given that PTEN-induced kinase 1 (PINK1) regulates mitochondrial function, dynamics, and turnover, we hypothesized that alterations in endogenous PINK1 levels contribute to depletion of mitochondria during chronic complex I injury. Here we found that chronic MPP+ treatment of differentiated SH-SY5Y neuronal cells significantly decreases PINK1 expression prior to reductions in other mitochondrial components. Furthermore, Bcl2-associated athanogene 6 (BAG6, BAT3, or Scythe), a protein involved in protein quality control and degradation, was highly up-regulated during the chronic MPP+ treatment. BAG6 interacted with PINK1, and BAG6 overexpression decreased the half-life of PINK1. Conversely, siRNA-mediated BAG6 knockdown prevented chronic MPP+ stress-induced loss of PINK1, reversed MPP+-provoked mitochondrial changes, increased cell viability, and prevented MPP+-induced dendrite shrinkage in primary neurons. These results indicate that BAG6 up-regulation during chronic complex I inhibition contributes to mitochondrial pathology by decreasing the levels of endogenous PINK1. Given that recessive mutations in PINK1 cause familial PD, the finding of accelerated PINK1 degradation in the chronic MPP+ model suggests that PINK1 loss of function represents a point of convergence between the neurotoxic and genetic causes of PD.	[Verma, Manish; Zhu, Jianhui; Wang, Kent Z. Q.; Chu, Charleen T.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Ctr Prot Conformat Dis, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chu, CT (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, Ctr Prot Conformat Dis, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA.	ctc4@pitt.edu	Chu, Charleen/B-1601-2008	Chu, Charleen/0000-0002-5052-8271	National Institutes of Health [R01-AG026389, R01-NS065789, R01-NS101628]; (NINDS/NIA)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); (NINDS/NIA)	This work was supported in part by National Institutes of Health Grants R01-AG026389, R01-NS065789, and R01-NS101628 (co-funded by NINDS/NIA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0174-z; BATES TE, 1994, J NEUROCHEM, V63, P640; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Bogaerts V, 2008, GENES BRAIN BEHAV, V7, P129, DOI 10.1111/j.1601-183X.2007.00342.x; Cao YL, 2017, NEUROBIOL AGING, V60, P104, DOI 10.1016/j.neurobiolaging.2017.08.023; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Chien WL, 2013, FREE RADICAL BIO MED, V58, P160, DOI 10.1016/j.freeradbiomed.2012.12.008; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Choi JW, 2014, MOL BIOSYST, V10, P1940, DOI 10.1039/c4mb00026a; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Fall CP, 1999, J NEUROSCI RES, V55, P620, DOI 10.1002/(SICI)1097-4547(19990301)55:5<620::AID-JNR9>3.0.CO;2-S; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Guo JF, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0103-7; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hayashishita M, 2019, FEBS OPEN BIO, V9, P1281, DOI 10.1002/2211-5463.12677; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kermer P, 2015, J MOL NEUROSCI, V55, P587, DOI 10.1007/s12031-014-0396-2; Kostic M, 2015, CELL REP, V13, P376, DOI 10.1016/j.celrep.2015.08.079; Krug AK, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.166; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Qu DB, 2015, J BIOL CHEM, V290, P30441, DOI 10.1074/jbc.M115.677815; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Stephans SE, 2002, NEUROTOXICOLOGY, V23, P569, DOI 10.1016/S0161-813X(02)00060-8; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; TORTOSA A, 1994, J NEUROCHEM, V62, P1913; Trancikova A, 2012, ANTIOXID REDOX SIGN, V16, P896, DOI 10.1089/ars.2011.4200; Um JW, 2010, BIOCHEM BIOPH RES CO, V393, P824, DOI 10.1016/j.bbrc.2010.02.090; Verma M, 2017, J NEUROSCI, V37, P11151, DOI 10.1523/JNEUROSCI.3791-16.2017; Vives-Bauza C, 2010, AUTOPHAGY, V6, P674, DOI 10.4161/auto.6.5.12068; Wang KJ, 2018, J MANUF SYST, V47, P1, DOI 10.1016/j.jmsy.2018.01.009; WANG XX, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/journal.pone.0086276; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524; Zhu JH, 2010, J ALZHEIMERS DIS, V20, pS325, DOI 10.3233/JAD-2010-100363	74	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7865	7876		10.1074/jbc.RA119.010474	http://dx.doi.org/10.1074/jbc.RA119.010474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32332095	hybrid, Green Published			2022-12-26	WOS:000540935400005
J	Adu, MO; Asare, PA; Yawson, DO; Nyarko, MA; Razak, AA; Kusi, AK; Tachie-Menson, JW; Afutu, E; Andoh, DA; Ackah, FK; Vanderpuije, GC; Taah, KJ; Asare-Bediako, E; Amenorpe, G				Adu, Michael O.; Asare, Paul A.; Yawson, David O.; Nyarko, Mishael A.; Razak, Ahmed Abdul; Kusi, Amoah K.; Tachie-Menson, Josiah W.; Afutu, Emmanuel; Andoh, Dick A.; Ackah, Frank K.; Vanderpuije, Grace C.; Taah, Kingsley J.; Asare-Bediako, Elvis; Amenorpe, Godwin			The search for yield predictors for mature field-grown plants from juvenile pot-grown cassava (Manihot esculenta Crantz)	PLOS ONE			English	Article							ROOT ARCHITECTURAL TRAITS; GENOTYPIC VARIATION; DROUGHT-TOLERANCE; SYSTEM TRAITS; MAIZE; SEEDLINGS; QTL; RESPONSES; SELECTION	Cassava is the 6th most important source of dietary energy in the world but its root system architecture (RSA) had seldom been quantified. Ability to select superior genotypes at juvenile stages can significantly reduce the cost and time for breeding to bridge the large yield gap. This study adopted a simple approach to phenotyping RSA traits of juvenile and mature cassava plants to identify genotypic differences and the relationships between juvenile traits and harvest index of mature plants. Root classes were categorised and root and shoot traits of eight (8) juvenile pot-grown cassava genotypes, were measured at 30 and 45 days after planting (DAP). The same or related traits were measured at 7 months after planting of the same genotypes grown in the field while yield and yield components were measured in 12-months old field-grown plants. The field experiment was done in 2017 and repeated in 2018. Differences between genotypes for the measured traits were explored using analysis of variance (ANOVA) while traits in juvenile plants were correlated or regressed onto traits measured in 7- and 12-months old plants. The results show significant genotypic variations for most of the traits measured in both juvenile and 7-months old plants. In the 12-months old plants, differences between genotypes were consistent for both 2017 and 2018. Broad-sense heritability was highest for the number of commercial roots (0.87) and shoot fresh weight (0.78) and intermediate for the total number of roots (0.60), harvest index (0.58), fresh weight of roots (0.45). For all the sampling time points or growth stages, there were greater correlations between traits measured at a particular growth stage than between the same traits at different growth stages. However, some juvenile-mature plant trait relationships were significant, positive and consistent for both 2017 and 2018. For example, total root length and the total number of roots in 30 DAP, and branching density of upper nodal roots in 45 DAP, positively correlated with harvest index of 12-months old plants in both 2017 and 2018. Similarly, the diameter of nodal roots, for example, had a negative, significant correlation with fresh shoot biomass of mature plants in both 2017 and 2018. Regression of traits measured in 30 DAP explained up to 22% and 36% of the variation in HI of mature plants in 2017 and 2018, respectively. It is concluded that the simple, rapid, inexpensive phenotyping approach adopted in this study is robust for identifying genotypic variations in juvenile cassava using root system traits. Also, the results provide seminal evidence for the existence of useful relationships between traits of juvenile and mature cassava plants that can be explored to predict yield and yield components.	[Adu, Michael O.; Asare, Paul A.; Nyarko, Mishael A.; Razak, Ahmed Abdul; Kusi, Amoah K.; Tachie-Menson, Josiah W.; Afutu, Emmanuel; Andoh, Dick A.; Ackah, Frank K.; Vanderpuije, Grace C.; Taah, Kingsley J.; Asare-Bediako, Elvis] Univ Cape Coast, Coll Agr & Nat Sci, Sch Agr, Dept Crop Sci, Cape Coast, Ghana; [Yawson, David O.] Univ West Indies, Ctr Resource Management & Environm Studies CERMES, Bridgetown, Barbados; [Amenorpe, Godwin] Ghana Atom Energy Commiss, Nucl Agr Res Biotechnol & Nucl Agr Res Inst, Legon, Accra, Ghana	University of Cape Coast; University West Indies Mona Jamaica; University of the West Indies Open Campus	Adu, MO; Asare, PA (corresponding author), Univ Cape Coast, Coll Agr & Nat Sci, Sch Agr, Dept Crop Sci, Cape Coast, Ghana.	michael.adu@ucc.edu.gh; pasare@ucc.edu.gh	Adu, Michael O./H-9699-2019; Ackah, Frank/AAE-4413-2021	Adu, Michael O./0000-0001-5243-7472; Afutu, Emmanuel/0000-0002-9182-3939; Yawson, David/0000-0002-5771-4042				Adams JP, 2007, SILVAE GENET, V56, P80, DOI 10.1515/sg-2007-0012; Adu MO, 2019, FIELD CROP RES, V232, P106, DOI 10.1016/j.fcr.2018.12.015; Adu MO, 2017, RHIZOSPHERE-NETH, V3, P29, DOI 10.1016/j.rhisph.2016.12.004; Adu MO, 2014, J EXP BOT, V65, P2039, DOI 10.1093/jxb/eru048; Adu MO, 2018, HELIYON, V4, P1, DOI DOI 10.1016/J.HELIY0N.2018.E00665; An DG, 2006, PLANT SOIL, V284, P73, DOI 10.1007/s11104-006-0030-3; ARIHARA J, 1982, CROP SCI, V22, P1197, DOI 10.2135/cropsci1982.0011183X002200060026x; Arraouadi S, 2012, GENOMICS, V99, P118, DOI 10.1016/j.ygeno.2011.11.005; Atkinson JA, 2015, J EXP BOT, V66, P2283, DOI 10.1093/jxb/erv006; Bouteille M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032319; Cane MA, 2014, MOL BREEDING, V34, P1629, DOI 10.1007/s11032-014-0177-1; Cao P, 2014, MOL BREEDING, V33, P975, DOI 10.1007/s11032-013-0013-z; Carvalho LJ, 2017, INCASSAVA; de Oliveira EJ, 2015, PESQUI AGROPECU BRAS, V50, P233, DOI 10.1590/S0100-204X2015000300007; Delgado A, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0216-0; Duque LO, 2019, FRONT PLANT SCI, P10, DOI [10.3389/fpls.2019.00010, DOI 10.3389/FPLS.2019.00010]; El-Sharkawy MA, 2005, PHOTOSYNTHETICA, V43, P161, DOI 10.1007/s11099-005-0030-1; El-Sharkawy MA, 2003, PLANT MOL BIOL, V53, P621, DOI 10.1023/B:PLAN.0000019109.01740.c6; ELSHARKAWY MA, 1987, PLANT SOIL, V100, P345, DOI 10.1007/BF02370950; Farshadfar E., 2014, Australian Journal of Crop Science, V8, P133; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Izumi Yasuhiro, 1999, Plant Production Science, V2, P267; Ju CL, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1383-5; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kassambara A., 2017, PRACTICAL GUIDE PRIN, V1; Kengkanna J, 2019, APPL PLANT SCI, V7, DOI 10.1002/aps3.1238; Khan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043991; Kumar B, 2012, PLANT BREEDING, V131, P465, DOI 10.1111/j.1439-0523.2012.01980.x; Li PC, 2015, J EXP BOT, V66, P3175, DOI 10.1093/jxb/erv127; Liu XL, 2013, EUPHYTICA, V189, P51, DOI 10.1007/s10681-012-0690-4; LOWE SB, 1982, CAN J BOT, V60, P3040, DOI 10.1139/b82-359; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2005, PLANT SOIL, V269, P45, DOI 10.1007/s11104-004-1096-4; Ministry of Food and Agriculture, 2019, AGR GHAN FACTS FIG 2; MoFA, 2001, ROOT TUB REP CASS PR, P15; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Pardales Jose R. Jr., 1999, Plant Production Science, V2, P247; Pardales JR, 1996, JPN J CROP SCI, V65, P93, DOI 10.1626/jcs.65.93; Pardales JR, ROOTS DYNAMIC INTERF, P201; Parkes EY, 2012, INT J AGR SCI, V2; R Core Team, 2021, R LANGUAGE ENV STAT; SAFOKANTANKA O, 1992, J SCI FOOD AGR, V60, P99, DOI 10.1002/jsfa.2740600116; SIMONS RG, 1990, CAN J PLANT SCI, V70, P209, DOI 10.4141/cjps90-023; Spencer D.S., 2017, ACHIEVING SUSTAINABL, P141; Strock CF, 2019, FIELD CROP RES, V237, P53, DOI 10.1016/j.fcr.2019.04.012; Subere JOQ, 2009, PLANT PROD SCI, V12, P462; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Thomas CL, 2016, ANN BOT-LONDON, V118, P655, DOI 10.1093/aob/mcw046; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; Villordon AQ, 2014, TRENDS PLANT SCI, V19, P419, DOI 10.1016/j.tplants.2014.02.002; Wei T, 2017, J ROY STAT SOC D-STA, V56, P24; Wishart J, 2013, PLANT SOIL, V368, P231, DOI 10.1007/s11104-012-1483-1; Wricke G., 2010, QUANTITATIVE GENETIC; de Freitas JPX, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2209-0; XIE C, 1995, THEOR APPL GENET, V91, P1032, DOI 10.1007/BF00223916; Xie Q, 2017, ANN BOT-LONDON, V119, P1115, DOI 10.1093/aob/mcx001; Zhan A, 2015, PLANT PHYSIOL, V168, P1603, DOI 10.1104/pp.15.00187; Zhan A, 2015, J EXP BOT, V66, P2055, DOI 10.1093/jxb/erv007; Zhu JM, 2006, THEOR APPL GENET, V113, P1, DOI 10.1007/s00122-006-0260-z; Zhu JM, 2011, CURR OPIN PLANT BIOL, V14, P310, DOI 10.1016/j.pbi.2011.03.020	62	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232595	10.1371/journal.pone.0232595	http://dx.doi.org/10.1371/journal.pone.0232595			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374747	Green Published, gold			2022-12-26	WOS:000537283500046
J	Aubanel, V; Nguyen, N				Aubanel, Vincent; Nguyen, Noel			Speaking to a common tune: Between-speaker convergence in voice fundamental frequency in a joint speech production task	PLOS ONE			English	Article							PHONETIC CONVERGENCE; VOCAL ACCOMMODATION; COMMUNICATION; ALIGNMENT; ADAPTATION; IMITATION; PITCH	Recent research on speech communication has revealed a tendency for speakers to imitate at least some of the characteristics of their interlocutor's speech sound shape. This phenomenon, referred to as phonetic convergence, entails a moment-to-moment adaptation of the speaker's speech targets to the perceived interlocutor's speech. It is thought to contribute to setting up a conversational common ground between speakers and to facilitate mutual understanding. However, it remains uncertain to what extent phonetic convergence occurs in voice fundamental frequency (F-0), in spite of the major role played by pitch, F-0's perceptual correlate, as a conveyor of both linguistic information and communicative cues associated with the speaker's social/individual identity and emotional state. In the present work, we investigated to what extent two speakers converge towards each other with respect to variations in F-0 in a scripted dialogue. Pairs of speakers jointly performed a speech production task, in which they were asked to alternately read aloud a written story divided into a sequence of short reading turns. We devised an experimental set-up that allowed us to manipulate the speakers' F-0 in real time across turns. We found that speakers tended to imitate each other's changes in F-0 across turns that were both limited in amplitude and spread over large temporal intervals. This shows that, at the perceptual level, speakers monitor slow-varying movements in their partner's F-0 with high accuracy and, at the production level, that speakers exert a very fine-tuned control on their laryngeal vibrator in order to imitate these F-0 variations. Remarkably, F-0 convergence across turns was found to occur in spite of the large melodic variations typically associated with reading turns. Our study sheds new light on speakers' perceptual tracking of F-0 in speech processing, and the impact of this perceptual tracking on speech production.	[Aubanel, Vincent] Univ Grenoble Alpes, GIPSA Lab, CNRS, Grenoble, France; [Nguyen, Noel] Aix Marseille Univ, CNRS, LPL, Aix En Provence, France; [Nguyen, Noel] Aix Marseille Univ, Inst Language Commun & Brain, Marseille, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Aubanel, V (corresponding author), Univ Grenoble Alpes, GIPSA Lab, CNRS, Grenoble, France.	vincent.aubanel@gipsa-lab.fr	Nguyen, Noel/R-5231-2017	Nguyen, Noel/0000-0003-3424-5340	French National Research Agency; Excellence Initiative of Aix-Marseille University (A* MIDEX) [ANR-08-BLAN-0276-01, ANR-16-CONV-0002, ANR-11-LABX0036]; European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013 Grant) [339152]	French National Research Agency(French National Research Agency (ANR)); Excellence Initiative of Aix-Marseille University (A* MIDEX); European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013 Grant)	This work has been conducted with the financial support of the French National Research Agency (anr.fr) and the Excellence Initiative of Aix-Marseille University (A*MIDEX, amidex.univ-amu. fr) (Grant Agreements no. ANR-08-BLAN-0276-01, ANR-16-CONV-0002 (ILCB) and ANR-11-LABX0036 (BLRI)), and of the European Research Council (erc.europa.eu) under the European Community's Seventh Framework Program (FP7/2007-2013 Grant Agreement no. 339152, "Speech Unit(e)s", J.-L. Schwartz PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2017, LANG SPEECH, V60, P479, DOI 10.1177/0023830916665652; Aguilar L, 2016, J PERS, V84, P165, DOI 10.1111/jopy.12149; [Anonymous], 2019, R LANG ENV STAT COMP; Babel M, 2014, LAB PHONOL, V5, P123, DOI 10.1515/lp-2014-0006; Babel M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00653; Babel M, 2012, LANG SPEECH, V55, P231, DOI 10.1177/0023830911417695; Babel M, 2012, J PHONETICS, V40, P177, DOI 10.1016/j.wocn.2011.09.001; Boersma P., 2019, PRAAT DOING PHONETIC; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Cummins F, 2009, J PHONETICS, V37, P16, DOI 10.1016/j.wocn.2008.08.003; De Looze C., 2010, ANAL INTERPRETATION; De Looze C, 2014, SPEECH COMMUN, V58, P11, DOI 10.1016/j.specom.2013.10.002; Delvaux V, 2007, PHONETICA, V64, P145, DOI 10.1159/000107914; Dias JW, 2016, ATTEN PERCEPT PSYCHO, V78, P317, DOI 10.3758/s13414-015-0982-6; Dias JW, 2011, PERCEPTION, V40, P1457, DOI 10.1068/p7071; Franken MK, 2018, PSYCHON B REV, V25, P1458, DOI 10.3758/s13423-018-1494-x; Garnier M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00600; Gentilucci M, 2007, NEUROPSYCHOLOGIA, V45, P608, DOI 10.1016/j.neuropsychologia.2006.04.004; Gijssels T, 2016, DISCOURSE PROCESS, V53, P233, DOI 10.1080/0163853X.2015.1023965; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Goldinger Stephen D., 1997, TALKER VARIABILITY S, P33; GREGORY S, 1993, LANG COMMUN, V13, P195, DOI 10.1016/0271-5309(93)90026-J; Gregory SW, 1997, J NONVERBAL BEHAV, V21, P23; GREGORY SW, 1990, J NONVERBAL BEHAV, V14, P237, DOI 10.1007/BF00989318; Gregory SW, 2001, LANG COMMUN, V21, P37, DOI 10.1016/S0271-5309(00)00011-2; Gregory SW, 1996, J PERS SOC PSYCHOL, V70, P1231, DOI 10.1037/0022-3514.70.6.1231; GREGORY SW, 1982, J PSYCHOLINGUIST RES, V11, P35, DOI 10.1007/BF01067500; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Kappes J, 2009, BRAIN LANG, V111, P140, DOI 10.1016/j.bandl.2009.08.008; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Levitan R, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P3088; Lewandowski EM, 2018, J ACOUST SOC AM, V144, P620, DOI 10.1121/1.5038567; Mantell JT, 2013, COGNITION, V127, P177, DOI 10.1016/j.cognition.2012.12.008; Miller RM, 2013, ATTEN PERCEPT PSYCHO, V75, P1817, DOI 10.3758/s13414-013-0517-y; Miller RM, 2010, ATTEN PERCEPT PSYCHO, V72, P1614, DOI 10.3758/APP.72.6.1614; Mukherjee S, 2017, INTERSPEECH, P2341, DOI 10.21437/Interspeech.2017-795; Namy LL, 2002, J LANG SOC PSYCHOL, V21, P422, DOI 10.1177/026192702237958; NATALE M, 1975, J PERS SOC PSYCHOL, V32, P790, DOI 10.1037/0022-3514.32.5.790; Pardo JS, 2018, J PHONETICS, V69, P1, DOI 10.1016/j.wocn.2018.04.001; Pardo JS, 2017, ATTEN PERCEPT PSYCHO, V79, P637, DOI 10.3758/s13414-016-1226-0; Pardo JS, 2013, J MEM LANG, V69, P183, DOI 10.1016/j.jml.2013.06.002; Pardo JS, 2013, DISCOURSE PROCESS, V50, P276, DOI 10.1080/0163853X.2013.778168; Pardo JS, 2012, J PHONETICS, V40, P190, DOI 10.1016/j.wocn.2011.10.001; Pardo JS, 2010, ATTEN PERCEPT PSYCHO, V72, P2254, DOI 10.3758/APP.72.8.2254; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Postma-Nilsenova M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00826; Priva UC, 2017, J ACOUST SOC AM, V141, P2989, DOI 10.1121/1.4982199; Robel A, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2146; Sato M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00422; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Walker A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00546; Wisniewski M.G., 2013, PSYCHOMUSICOL MUSIC, V23, P82, DOI [10.1037/A0033299, DOI 10.1037/A0033299, 10.1037/a0033299]	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232209	10.1371/journal.pone.0232209	http://dx.doi.org/10.1371/journal.pone.0232209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365075	Green Published, gold			2022-12-26	WOS:000536959700019
J	Tan, HH; Thomas, NF; Inayat-Hussain, SH; Chan, KM				Tan, Huan Huan; Thomas, Noel Francis; Inayat-Hussain, Salmaan Hussain; Chan, Kok Meng			Cytoprotective effects of (E)-N-(2-(3, 5-dimethoxystyryl) phenyl) furan-2-carboxamide (BK3C231) against 4-nitroquinoline 1-oxide-induced damage in CCD-18Co human colon fibroblast cells	PLOS ONE			English	Article							CANCER CHEMOPREVENTIVE ACTIVITY; OXIDATIVE STRESS; NITRIC-OXIDE; REACTIVE OXYGEN; IN-VITRO; RESVERATROL; ACTIVATION; CARCINOGEN; STILBENES; APOPTOSIS	Stilbenes are a group of chemicals characterized with the presence of 1,2-diphenylethylene. Previously, our group has demonstrated that synthesized (E)-N-(2-(3, 5-dimethoxystyryl) phenyl) furan-2-carboxamide (BK3C231) possesses potential chemopreventive activity specifically inducing NAD(P)H:quinone oxidoreductase 1 (NQO1) protein expression and activity. In this study, the cytoprotective effects of BK3C231 on cellular DNA and mitochondria were investigated in normal human colon fibroblast, CCD-18Co cells. The cells were pretreated with BK3C231 prior to exposure to the carcinogen 4-nitroquinoline 1-oxide (4NQO). BK3C231 was able to inhibit 4NQO-induced cytotoxicity. Cells treated with 4NQO alone caused high level of DNA and mitochondrial damages. However, pretreatment with BK3C231 protected against these damages by reducing DNA strand breaks and micronucleus formation as well as decreasing losses of mitochondrial membrane potential (Delta psi m) and cardiolipin. Interestingly, our study has demonstrated that nitrosative stress instead of oxidative stress was involved in 4NQO-induced DNA and mitochondrial damages. Inhibition of 4NQO-induced nitrosative stress by BK3C231 was observed through a decrease in nitric oxide (NO) level and an increase in glutathione (GSH) level. These new findings elucidate the cytoprotective potential of BK3C231 in human colon fibroblast CCD-18Co cell model which warrants further investigation into its chemopreventive role.	[Tan, Huan Huan; Chan, Kok Meng] Univ Kebangsaan Malaysia, Fac Hlth Sci, Ctr Toxicol & Hlth Risk Studies, Kuala Lumpur, Malaysia; [Thomas, Noel Francis] Methodist Coll Kuala Lumpur, Kuala Lumpur, Malaysia; [Inayat-Hussain, Salmaan Hussain] Petr Nas Berhad PETRONAS, Prod Stewardship & Toxicol, Grp Hlth Safety Secur & Environm, Kuala Lumpur, Malaysia; [Inayat-Hussain, Salmaan Hussain] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA	Universiti Kebangsaan Malaysia; Petronas; Yale University	Chan, KM (corresponding author), Univ Kebangsaan Malaysia, Fac Hlth Sci, Ctr Toxicol & Hlth Risk Studies, Kuala Lumpur, Malaysia.	chan@ukm.edu.my	Chan, Kok Meng/AAG-2296-2019	Chan, Kok Meng/0000-0001-8837-125X	Exploratory Research Grant Scheme (ERGS) from Kementerian Pendidikan Malaysia [ERGS/1/2013/SKK03/UKM/02/1]; Dana Impak Perdana (DIP) from Universiti Kebangsaan Malaysia [DIP-2012-024]	Exploratory Research Grant Scheme (ERGS) from Kementerian Pendidikan Malaysia; Dana Impak Perdana (DIP) from Universiti Kebangsaan Malaysia	This research was financially supported by Exploratory Research Grant Scheme (ERGS) from Kementerian Pendidikan Malaysia (Grant number: ERGS/1/2013/SKK03/UKM/02/1, URL: http://jpt.mohe.gov.my/portal/penyelidikan/mygrants) and Dana Impak Perdana (DIP) from Universiti Kebangsaan Malaysia (Grant number: DIP-2012-024, URL: http://research.ukm.my/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Arima Y, 2006, TOXICOL SCI, V91, P382, DOI 10.1093/toxsci/kfj161; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bhat KPL, 2002, ANN NY ACAD SCI, V957, P210, DOI 10.1111/j.1749-6632.2002.tb02918.x; Ferreira PEB, 2018, BIOMED PHARMACOTHER, V105, P724, DOI 10.1016/j.biopha.2018.06.030; Brusehafer K, 2016, MUTAGENESIS, V31, P171, DOI 10.1093/mutage/gev069; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Chan KM, 2012, FOOD CHEM TOXICOL, V50, P2916, DOI 10.1016/j.fct.2012.04.048; Chen RS, 2002, J AGR FOOD CHEM, V50, P1665, DOI 10.1021/jf011134e; Chen WJ, 2017, PHYSIOL BEHAV, V182, P54, DOI 10.1016/j.physbeh.2017.09.024; Clancy S, 2008, NAT ED, V1, P1, DOI DOI https://doi.org/10.1038/nrm2351.pdf; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dunlap T, 2007, CHEM RES TOXICOL, V20, P1903, DOI 10.1021/tx7002257; Gomez-Zorita S, 2013, J PHYSIOL BIOCHEM, V69, P585, DOI 10.1007/s13105-012-0229-0; Han HB, 2007, TOXICOLOGY, V230, P151, DOI 10.1016/j.tox.2006.11.045; Han JH, 1996, PORTL PR P, V10, P114; HART JH, 1979, PHYTOPATHOLOGY, V69, P1138, DOI 10.1094/Phyto-69-1138; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Inayat-Hussain SH, 2004, EXPERT OPIN THER PAT, V14, P819, DOI 10.1517/13543776.14.6.819; Ionescu Mirela E, 2011, Maedica (Bucur), V6, P173; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kapse-Mistry S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00159; Kee CH, 2010, ORG BIOMOL CHEM, V8, P5646, DOI 10.1039/c0ob00296h; Kimbrough CW, 2015, SURGERY, V158, P1095, DOI 10.1016/j.surg.2015.07.012; King RE, 2006, COMPR REV FOOD SCI F, V5, P65, DOI 10.1111/j.1541-4337.2006.00001.x; Kitano M, 2000, PATHOL INT, V50, P353, DOI 10.1046/j.1440-1827.2000.01058.x; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; KOHDA K, 1991, CARCINOGENESIS, V12, P1523, DOI 10.1093/carcin/12.8.1523; Kotecha R, 2016, ONCOTARGET, V7, P52517, DOI 10.18632/oncotarget.9593; Kruk J, 2017, MINI-REV MED CHEM, V17, P904, DOI 10.2174/1389557517666170228115324; Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65; Kuipers EJ, 2013, NAT REV CLIN ONCOL, V10, P130, DOI 10.1038/nrclinonc.2013.12; Kurutas EB, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0186-5; Lan AX, 2016, ONCOTARGET, V7, P53502, DOI 10.18632/oncotarget.10609; LANGCAKE P, 1977, EXPERIENTIA, V33, P151, DOI 10.1007/BF02124034; Leong LM, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2091085; Li CQ, 2002, P NATL ACAD SCI USA, V99, P10364, DOI 10.1073/pnas.162356399; Li XN, 2018, EXP THER MED, V16, P4339, DOI 10.3892/etm.2018.6747; Lu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170418; Mahady GB, 2003, AM J GASTROENTEROL, V98, P1440; Manan A.A., 2016, MALAYSIAN NATL CANC, P1; Marra M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-171; McKenna DJ, 2008, MUTAGENESIS, V23, P183, DOI 10.1093/mutage/gem054; Nagao M, 1976, Adv Cancer Res, V23, P131, DOI 10.1016/S0065-230X(08)60545-X; Namasivayam N, 2011, ANN NY ACAD SCI, V1215, P60, DOI 10.1111/j.1749-6632.2010.05873.x; NUNOSHIBA T, 1993, CANCER RES, V53, P3250; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Ooi TC, 2017, IMMUNOPHARM IMMUNOT, V39, P259, DOI 10.1080/08923973.2017.1344987; Parage C, 2012, PLANT PHYSIOL, V160, P1407, DOI 10.1104/pp.112.202705; Penny LK, 2015, CHEM SOC REV, V44, P8836, DOI 10.1039/c5cs00705d; Rimando AM, 2008, PLANTA MED, V74, P1635, DOI 10.1055/s-0028-1088301; Saracci R, 2015, INT AGENCY RES CANC; Sawicka E, 2015, POSTEP HIG MED DOSW, V69, P744, DOI 10.5604/17322693.1160361; Shrotriya S, 2015, ADV EXP MED BIOL, V815, P333, DOI 10.1007/978-3-319-09614-8_19; Sporn MB, 2002, NAT REV CANCER, V2, P537, DOI 10.1038/nrc844; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; STANLEY JS, 1988, BIOCHEM J, V256, P303, DOI 10.1042/bj2560303; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; TADA M, 1975, NATURE, V255, P510, DOI 10.1038/255510a0; Thiel G, 2017, PHARMACOL RES, V117, P166, DOI 10.1016/j.phrs.2016.12.029; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tokarz P, 2014, ACTA BIOCHIM POL, V61, P671; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Watts KT, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-22; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Yokozawa T, 2007, BIOL PHARM BULL, V30, P2007, DOI 10.1248/bpb.30.2007; Zhao J, 2007, PLANT SIGNAL BEHAV, V2, P544, DOI 10.4161/psb.2.6.4802; Zhou ZX, 2018, MOL MED REP, V17, P1269, DOI 10.3892/mmr.2017.7933	74	3	3	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0223344	10.1371/journal.pone.0223344	http://dx.doi.org/10.1371/journal.pone.0223344			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365104	Green Published, gold, Green Submitted			2022-12-26	WOS:000536959700002
J	Hui, SC; Huang, L; Wang, XL; Zhu, XH; Zhou, M; Chen, MT; Yi, L; Mi, MT				Hui, Suocheng; Huang, Li; Wang, Xiaolan; Zhu, Xiaohui; Zhou, Min; Chen, Mengting; Yi, Long; Mi, Mantian			Capsaicin improves glucose homeostasis by enhancing glucagon-like peptide-1 secretion through the regulation of bile acid metabolism via the remodeling of the gut microbiota in male mice	FASEB JOURNAL			English	Article						bile acids; capsaicin; GLP-1; gut microbiota; type 2 diabetes	SEX-DIFFERENCES; IMPACT; ENERGY; GLP-1	Mounting evidence has linked dietary capsaicin (CAP) consumption to the improvement of glucose homeostasis; however, the underlying mechanisms still need to be further elucidated. Male mice were fed a high-fat diet (HFD) with CAP administration for 8 weeks, gut microbiota, bile acid (BA) profiles and markers for BA, and glucose metabolism were investigated. CAP improved glucose homeostasis partially by enhancing the secretion of glucagon-like peptide 1 (GLP-1). The gut microbiota was remodeled by CAP and was characterized by the increased abundance of Bacteroides genera, which is related with lithocholic acid (LCA) production. LCA is an endogenous agonist of Takeda G-protein coupled receptor 5 (TGR5); it may enhance GLP-1 secretion in intestinal L cells. Meanwhile, antibiotics experiment abolished the effects of CAP on glucose homeostasis and microbiota transplantation experiments demonstrated that the CAP-induced beneficial effects were transferable, indicating that the effects of CAP on glucose homeostasis were largely dependent on the gut microbiota. Additionally, we further identified that the improvements induced by CAP were attenuated by the antagonist of GLP-1 receptor, indicating that the activation of GLP-1 signaling contributes to the CAP-induced improvement in glucose homeostasis.	[Hui, Suocheng; Huang, Li; Wang, Xiaolan; Zhu, Xiaohui; Zhou, Min; Chen, Mengting; Yi, Long; Mi, Mantian] Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing 400038, Peoples R China	Army Medical University	Mi, MT (corresponding author), Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing 400038, Peoples R China.	mi_mt2009@hotmail.com		Mi, Mantian/0000-0002-7213-2155	National Natural Science Foundation of China [81673157]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81673157	Albaugh VL, 2019, GASTROENTEROLOGY, V156, P1041, DOI 10.1053/j.gastro.2018.11.017; Anhe FF, 2019, GUT, V68, P453, DOI 10.1136/gutjnl-2017-315565; Baggio LL, 2008, GASTROENTEROLOGY, V134, P1137, DOI 10.1053/j.gastro.2008.01.017; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Beli E, 2018, DIABETES, V67, P1867, DOI 10.2337/db18-0158; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen MT, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800612; Chen MT, 2020, CLIN NUTR, V39, P1264, DOI 10.1016/j.clnu.2019.05.020; Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; DeMars MD, 2018, FASEB J, V32; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; FISHER MM, 1973, CAN MED ASSOC J, V109, P190; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Fuchs CD, 2018, GUT, V67, P1683, DOI 10.1136/gutjnl-2017-314553; Galman C, 2011, J INTERN MED, V270, P580, DOI 10.1111/j.1365-2796.2011.02466.x; Grasset E, 2017, CELL METAB, V26, P278, DOI 10.1016/j.cmet.2017.06.003; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gupta R, 2009, CURR DRUG TARGETS, V10, P71, DOI 10.2174/138945009787122860; HIRANO S, 1982, J LIPID RES, V23, P1152; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hui SC, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900608; Kang C, 2017, MBIO, V8, DOI [10.1128/mBio.00470-17, 10.1128/mbio.00470-17, 10.1128/mBio.00900-17]; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Lan K, 2016, ANAL CHEM, V88, P7041, DOI 10.1021/acs.analchem.6b00573; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857; Patriti A, 2004, OBES SURG, V14, P840, DOI 10.1381/0960892041590818; Phelps T, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0265-3; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Sharma SK, 2013, EUR J PHARMACOL, V720, P55, DOI 10.1016/j.ejphar.2013.10.053; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q; Yasir M, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.3; Zeng XL, 2019, ANTIOXID REDOX SIGN, V30, P163, DOI 10.1089/ars.2017.7172; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	51	16	17	0	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8558	8573		10.1096/fj.201902618RR	http://dx.doi.org/10.1096/fj.201902618RR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359008				2022-12-26	WOS:000530046700001
J	Zhu, ZW; Peng, XF; Li, XP; Tu, T; Yang, H; Teng, S; Zhang, W; Xing, ZH; Tang, JJ; Hu, XQ; Fang, ZF; Zhou, SH				Zhu, Zhaowei; Peng, Xiaofan; Li, Xuping; Tu, Tao; Yang, Hui; Teng, Shuai; Zhang, Wei; Xing, Zhenhua; Tang, Jianjun; Hu, Xinqun; Fang, Zhenfei; Zhou, Shenghua			HMGB1 impairs endothelium-dependent relaxation in diabetes through TLR4/eNOS pathway	FASEB JOURNAL			English	Article						diabetes; endothelium-dependent relaxation; glycyrrhizin acid; HMGB1	NITRIC-OXIDE SYNTHASE; RECEPTOR 4; MURINE MODEL; DYSFUNCTION; ACTIVATION; INJURY; CONTRIBUTES; MICE	Endothelium-dependent relaxation (EDR) is an initial key step leading to various vascular complications in patients with diabetes. However, the underlying mechanism of EDR impairment in diabetes is not fully understood. Present study defined the role of high-mobility group protein (HMGB1) in EDR related to diabetes. Serum level of HMGB1 was increased in diabetic patients and in db/db mice. Serum HMGB1 level was also positively correlated with HbA1c and negatively correlated with nitric oxide (NO) in diabetic patients. Results from wire myograph showed that recombinant HMGB1 (rHMGB1) was capable of impairing EDR of aortas from wild-type (WT) mice by an eNOS-dependent mechanism. Consistently, HMGB1 inhibitor glycyrrhizin acid (GA) decreased the serum level of HMGB1 and rescued EDR impairment partly in db/db mice. Furthermore, rHMGB1 mediated EDR impairment was abolished in aortas of TLR4(-/-) mice. In addition, high-glucose-induced HMGB1 upregulation and secretion in endothelial cells. In conclusion, HMGB1 contributes to the EDR impairment through TLR4/eNOS pathway in the setting of diabetes. GA as the HMGB1 inhibitor could attenuate EDR impairment in an animal model of diabetes.	[Zhu, Zhaowei; Peng, Xiaofan; Li, Xuping; Tu, Tao; Yang, Hui; Teng, Shuai; Xing, Zhenhua; Tang, Jianjun; Hu, Xinqun; Fang, Zhenfei; Zhou, Shenghua] Cent South Univ, Xiangya Hosp 2, Cardiovasc Dept, Middle Ren Min Rd 139, Changsha 410011, Hunan, Peoples R China; [Zhang, Wei] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27101 USA	Central South University; Wake Forest University	Zhou, SH (corresponding author), Cent South Univ, Xiangya Hosp 2, Cardiovasc Dept, Middle Ren Min Rd 139, Changsha 410011, Hunan, Peoples R China.	zhoushenghua@csu.edu.cn	zhou, sheng/GYJ-6012-2022		National Natural Science Foundation of China (NSFC) [81600248, 81670269]; Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation) [2018JJ3744, 2018JJ2563]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81600248 and 81670269; Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation), Grant/Award Number: 2018JJ3744 and 2018JJ2563	Andersson U, 2018, SEMIN IMMUNOL, V38, P40, DOI 10.1016/j.smim.2018.02.011; Arrigo T, 2013, EUR J ENDOCRINOL, V168, P631, DOI 10.1530/EJE-13-0037; Bauer EM, 2013, J BIOL CHEM, V288, P1365, DOI 10.1074/jbc.M112.434142; Benhamou Y, 2014, ARTHRITIS RHEUMATOL, V66, P3210, DOI 10.1002/art.38785; Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Chen J, 2012, ATHEROSCLEROSIS, V224, P332, DOI 10.1016/j.atherosclerosis.2012.07.020; Chiesa ST, 2019, EUR HEART J, V40, P3559, DOI 10.1093/eurheartj/ehz114; Donath MY, 2019, NAT REV IMMUNOL, V19, P734, DOI 10.1038/s41577-019-0213-9; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Hernanz R, 2015, BRIT J PHARMACOL, V172, P3159, DOI 10.1111/bph.13117; Idelman G, 2015, REDOX BIOL, V5, P398, DOI 10.1016/j.redox.2015.06.008; Jiang RZ, 2014, J IMMUNOL, V193, P5000, DOI 10.4049/jimmunol.1303445; Kang R, 2017, CELL RES, V27, P916, DOI 10.1038/cr.2017.51; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kraehling JR, 2016, CIRC RES, V118, P48, DOI 10.1161/CIRCRESAHA.115.307767; Lee JH, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0260-0; Li H, 2019, THERANOSTICS, V9, P1909, DOI 10.7150/thno.30578; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Pellegrini L, 2019, PHARMACOL THERAPEUT, V196, P160, DOI 10.1016/j.pharmthera.2018.12.005; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Sachdev U, 2013, J VASC SURG, V58, P460, DOI 10.1016/j.jvs.2012.11.071; Szasz T, 2016, DIABETES, V65, P3754, DOI 10.2337/db16-0480; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Vellecco V, 2016, DIABETES OBES METAB, V18, P1236, DOI 10.1111/dom.12750; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136564; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang S, 2014, J LEUKOCYTE BIOL, V95, P563, DOI 10.1189/jlb.0713412; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Zhao DD, 2013, INT J CARDIOL, V168, P1559, DOI 10.1016/j.ijcard.2012.12.073; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zhu ZW, 2020, J VASC INTERV RADIOL, V31, P42, DOI 10.1016/j.jvir.2019.09.017	36	13	13	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8641	8652		10.1096/fj.202000242R	http://dx.doi.org/10.1096/fj.202000242R		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359123				2022-12-26	WOS:000530046500001
J	Griffiths, JR; Lehtinen, S; Suikkanen, S; Winder, M				Griffiths, Jennifer R.; Lehtinen, Sirpa; Suikkanen, Sanna; Winder, Monika			Limited evidence for common interannual trends in Baltic Sea summer phytoplankton biomass	PLOS ONE			English	Article							SAN-FRANCISCO BAY; LONG-TERM CHANGES; TIME-SERIES; NITROGEN-FIXATION; MARINE ECOSYSTEM; VARIABILITY; COMMUNITIES; RESPONSES; DYNAMICS; PATTERNS	The Baltic Sea summer phytoplankton community plays an important role in biogeochemical cycling and in the transfer of energy through the food web via zooplankton. We aimed to improve the understanding of the degree to which large-scale versus local environmental dynamics regulate phytoplankton dynamics by analyzing time series at the Baltic Sea scale. We used dynamic factor analysis to study if there are common patterns of interannual variation that are shared ("common trends") among summer phytoplankton total and class-level biomass time series observed across Baltic Sea latitudinal gradients in salinity and temperature. We evaluated alternative hypotheses regarding common trends among summer phytoplankton biomass: Baltic Sea-wide common trends; common trends by geography (latitude and basin); common trends differing among functional groups (phytoplankton classes); or common trends driven by both geography and functional group. Our results indicated little support for a common trend in total summer phytoplankton biomass. At a finer resolution, classes had common trends that were most closely associated with the cryptophyte and cyanobacteria time series with patterns that differed between northern and southern sampling stations. These common trends were also very sensitive to two anomalous years (1990, 2008) of cryptophyte biomass. The Baltic Sea Index, a regional climate index, was correlated with two common class trends that shifted in mean state around the mid-1990s. The limited coherence in phytoplankton biomass variation over time despite known, large-scale, ecosystem shifts suggests that stochastic dynamics at local scales limits the ability to observe common trends at the scale of monitoring data collection.	[Griffiths, Jennifer R.; Winder, Monika] Stockholm Univ, Dept Ecol, Environm, Plant Sci, Stockholm, Sweden; [Lehtinen, Sirpa; Suikkanen, Sanna] Marine Res Ctr, Finnish Environm Inst, Helsinki, Finland	Stockholm University; Finnish Environment Institute	Winder, M (corresponding author), Stockholm Univ, Dept Ecol, Environm, Plant Sci, Stockholm, Sweden.	monika.winder@su.se		Winder, Monika/0000-0001-9467-3035; Suikkanen, Sanna/0000-0002-0768-8149; Lehtinen, Sirpa/0000-0001-7784-8497	Stockholm University Postdoctoral Fellowship; BONUS (Art 185) - EU; BONUS (Art 185) - Swedish Research Council FORMAS	Stockholm University Postdoctoral Fellowship; BONUS (Art 185) - EU; BONUS (Art 185) - Swedish Research Council FORMAS(Swedish Research Council Formas)	JRG received funding from a Stockholm University Postdoctoral Fellowship. This is a contribution to the BONUS BIO-C3 project and was supported by BONUS (Art 185), funded jointly by the EU and the Swedish Research Council FORMAS to MW.	Adam B, 2016, ISME J, V10, P450, DOI 10.1038/ismej.2015.126; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; Angeler DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146053; Bollens GCR, 2003, MAR ECOL PROG SER, V257, P139; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; DIEKMANN R, 2010, 302 ICES COOP RES; Edwards KF, 2013, ECOLOGY, V94, P1626, DOI 10.1890/12-1459.1; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Elmgren R, 2001, AMBIO, V30, P222, DOI 10.1639/0044-7447(2001)030[0222:UHIOTB]2.0.CO;2; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Forsblom L, 2019, HYDROBIOLOGIA, V828, P301, DOI 10.1007/s10750-018-3826-2; Galloway AWE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130053; Gorokhova E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158326; Griffiths JR, 2017, GLOBAL CHANGE BIOL, V23, P2179, DOI 10.1111/gcb.13642; Griffiths JR, 2016, OIKOS, V125, P1134, DOI 10.1111/oik.02405; Hampton SE, 2006, LIMNOL OCEANOGR, V51, P2042, DOI 10.4319/lo.2006.51.5.2042; Harris V, 2014, J MARINE SYST, V133, P55, DOI 10.1016/j.jmarsys.2013.07.001; HELCOM, 1980, HELCOM GUIDELINES AN; HELCOM, 1988, BALT SEA ENV P, V27; HELCOM, 2014, HELCOM MON MAN INTR; Holmes EE, 2014, ANAL MULTIVARIATE TI; Holmes EE, 2012, R J, V4, P11; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; Hurrell J., CLIMATE DATA GUIDE H; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Jaanus A, 2017, J MARINE SYST, V171, P65, DOI 10.1016/j.jmarsys.2016.10.009; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; Kahru M, 2014, BIOGEOSCIENCES, V11, P3619, DOI 10.5194/bg-11-3619-2014; Kahru M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24829-7; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karlson AML, 2015, AMBIO, V44, pS413, DOI 10.1007/s13280-015-0660-x; Kristensen K, 2016, J STAT SOFTW, V70, P1; Kuosa H, 2017, J MARINE SYST, V167, P78, DOI 10.1016/j.jmarsys.2016.11.020; Larsson U, 2001, LIMNOL OCEANOGR, V46, P811, DOI 10.4319/lo.2001.46.4.0811; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Litchman E, 2012, MAR ECOL PROG SER, V470, P235, DOI 10.3354/meps09912; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Ohlberger J, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1333; Olenina I, 2006, HELCOM BALTIC SEA EN; Olli K, 2013, MAR ECOL PROG SER, V473, P53, DOI 10.3354/meps10065; Olli K, 2011, BOREAL ENVIRON RES, V16, P3; Planque B, 2018, ICES J MAR SCI, V75, P1021, DOI 10.1093/icesjms/fsx223; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; R Development Core Team, 2012, R LANG ENV STAT COMP; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Reusch TBH, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8195; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Smayda TJ, 1998, ICES J MAR SCI, V55, P562, DOI 10.1006/jmsc.1998.0385; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; The BACC II Team Author, 2015, 2 ASSESSMENT CLIMATE; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Wickham H, 2007, J STAT SOFTW, V21, P1; Wills K., 2013, R PACKAGE VERSION, V3, P9; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zuur AF, 2003, CAN J FISH AQUAT SCI, V60, P542, DOI 10.1139/F03-030; Zuur AF, 2003, ENVIRONMETRICS, V14, P665, DOI 10.1002/env.611	66	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231690	10.1371/journal.pone.0231690	http://dx.doi.org/10.1371/journal.pone.0231690			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353002	gold, Green Published			2022-12-26	WOS:000536673200020
J	Huang, Y				Huang, Ying			Grandparents' wealth and the body mass index trajectories of grandchildren	PLOS ONE			English	Article							CATCH-UP GROWTH; PHYSICAL-ACTIVITY; CHILDHOOD OVERWEIGHT; INTERGENERATIONAL TRANSFERS; OBESITY PREVENTION; HEALTH; CHILDREN; CONSEQUENCES; ADIPOSITY; POVERTY	Background The aims of this study are to (i) examine associations between grandparents' wealth and grandchild's initial body mass index (BMI) in early childhood and its subsequent growth patterns, and to (ii) assess whether the associations are similar for white and black children. Methods Data are from the U.S. Panel Study of Income Dynamics (PSID) and its supplemental studies of Child Development Supplement (CDS) and Transition to Adulthood (TA) (N = 2,128). Three-level growth curve models are used to analyze the association between exposure to grandparental wealth in early childhood and grandchildren's BMI growth trajectories, accounting for parental sociodemographic characteristics and maternal BMI levels. Results Children with less grandparental wealth in early childhood have higher initial BMI than children with more grandparental wealth. Further, increases in grandparental wealth in childhood are associated with a slower BMI growth rate. The wealth-body mass index associations are more evident among white children than black children. Conclusions The study reveals a multigenerational social gradient to body mass index. Elevating the wealth levels of the grandparent generation could potentially reduce their grandchildren's obesity risk. The protective role of grandparental wealth seems to be more evident among white families than black families.	[Huang, Ying] Univ Texas San Antonio, Coll Publ Policy, Dept Demog, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA)	Huang, Y (corresponding author), Univ Texas San Antonio, Coll Publ Policy, Dept Demog, San Antonio, TX 78249 USA.	ying.huang@utsa.edu		Huang, Ying/0000-0003-3569-7576				Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bayer O, 2011, OBESITY, V19, P1069, DOI 10.1038/oby.2010.250; Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Brophy S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-467; Cherlin AJ, 1998, J COMP FAM STUD, V29, P147; Dashiff C, 2009, J CHILD ADOL PS NURS, V22, P23, DOI 10.1111/j.1744-6171.2008.00166.x; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Estabrooks PA, 2003, ANN BEHAV MED, V25, P100, DOI 10.1207/S15324796ABM2502_05; Evensen E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0599-5; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Gordon-Larsen P, 2002, OBES RES, V10, P141, DOI 10.1038/oby.2002.23; GOTTFREDSON DC, 1981, AM SOCIOL REV, V46, P542, DOI 10.2307/2094937; Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018; Hajat A, 2011, AM J EPIDEMIOL, V173, P192, DOI 10.1093/aje/kwq348; Hearn MD, 1998, J HLTH ED, V29, P26, DOI DOI 10.1080/10556699.1998.10603294; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150; Jones-Smith JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100181; Kemper HCG, 1999, INT J OBESITY, V23, pS34, DOI 10.1038/sj.ijo.0800881; KLESGES RC, 1995, PEDIATRICS, V95, P126; Knigge A, 2016, DEMOGRAPHY, V53, P1219, DOI 10.1007/s13524-016-0486-6; Kohl Karl-Heinz, 2004, CARGO CULT CULTURE C, P79, DOI 10.1515/9780824840440-006; KOTLIKOFF LJ, 1981, J POLIT ECON, V89, P706, DOI 10.1086/260999; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Li B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0251-z; Li M, 2015, AM J EPIDEMIOL, V181, P163, DOI 10.1093/aje/kwu259; McFarland MJ, 2017, J MARRIAGE FAM, V79, P784, DOI 10.1111/jomf.12383; McGonagle KA, 2012, LONGITUD LIFE COURSE, P3; Milteer RM, 2011, PEDIATRICS; MODIGLIANI F, 1988, J ECON PERSPECT, V2, P15, DOI 10.1257/jep.2.2.15; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Nevill AM, 2006, AM J PHYS ANTHROPOL, V129, P151, DOI 10.1002/ajpa.20262; Newman LA, 2009, POPUL RES POLICY REV, V28, P661, DOI 10.1007/s11113-008-9124-3; Niclasen BVL, 2007, EUR J PUBLIC HEALTH, V17, P17, DOI 10.1093/eurpub/ckl246; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Oliver M. L., 2006, BLACK WEALTH WHITE W; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Pettit B, 2004, AM SOCIOL REV, V69, P151, DOI 10.1177/000312240406900201; Pinquart M, 2014, J PEDIATR PSYCHOL, V39, P381, DOI 10.1093/jpepsy/jst144; Popkin BM, 2005, PHYSIOL BEHAV, V86, P603, DOI 10.1016/j.physbeh.2005.08.051; PORTES A, 1976, AM SOCIOL REV, V41, P414, DOI 10.2307/2094251; PSID, 2017, CHILD DEV SUPPL 2014; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rankin BH, 2002, SOC PROBL, V49, P79, DOI 10.1525/sp.2002.49.1.79; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1207, DOI 10.1136/bmj.39048.503750.BE; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Sallis JF, 2009, MILBANK Q, V87, P123, DOI 10.1111/j.1468-0009.2009.00550.x; Sallis JF, 2006, FUTURE CHILD, V16, P89, DOI 10.1353/foc.2006.0009; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; Sarkisian N, 2004, AM SOCIOL REV, V69, P812, DOI 10.1177/000312240406900604; Schneider Mark., 2002, CHOOSING SCH CONSUME; Shapiro Thomas M., 2004, HIDDEN COST BEING AF; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Singh GK, 2008, ANN EPIDEMIOL, V18, P682, DOI 10.1016/j.annepidem.2008.05.001; Skinner AC, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1916, 10.1542/peds.2017-3459, 10.1542/peds.2018-0725]; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; South SJ, 2016, AM SOCIOL REV, V81, P1276, DOI 10.1177/0003122416673029; Spence JC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-192; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Swinburn B, 2013, OBES REV, V14, P60, DOI 10.1111/obr.12103; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Vogels N, 2006, AM J CLIN NUTR, V84, P717, DOI 10.1093/ajcn/84.4.717; WHITAKER RC, 1998, PEDIATRICS, V101; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	78	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232491	10.1371/journal.pone.0232491	http://dx.doi.org/10.1371/journal.pone.0232491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353081	Green Published, gold			2022-12-26	WOS:000536673200103
J	Fernandez, IS; Yang, E; Calvachi, P; Amengual-Gual, M; Wu, JY; Krueger, D; Northrup, H; Bebin, ME; Sahin, M; Yu, KH; Peters, JM				Fernandez, Ivan Sanchez; Yang, Edward; Calvachi, Paola; Amengual-Gual, Marta; Wu, Joyce Y.; Krueger, Darcy; Northrup, Hope; Bebin, Martina E.; Sahin, Mustafa; Yu, Kun-Hsing; Peters, Jurriaan M.		TACERN Study Grp	Deep learning in rare disease. Detection of tubers in tuberous sclerosis complex	PLOS ONE			English	Article								Objective To develop and test a deep learning algorithm to automatically detect cortical tubers in magnetic resonance imaging (MRI), to explore the utility of deep learning in rare disorders with limited data, and to generate an open-access deep learning standalone application. Methods T2 and FLAIR axial images with and without tubers were extracted from MRIs of patients with tuberous sclerosis complex (TSC) and controls, respectively. We trained three different convolutional neural network (CNN) architectures on a training dataset and selected the one with the lowest binary cross-entropy loss in the validation dataset, which was evaluated on the testing dataset. We visualized image regions most relevant for classification with gradient-weighted class activation maps (Grad-CAM) and saliency maps. Results 114 patients with TSC and 114 controls were divided into a training set, a validation set, and a testing set. The InceptionV3 CNN architecture performed best in the validation set and was evaluated in the testing set with the following results: sensitivity: 0.95, specificity: 0.95, positive predictive value: 0.94, negative predictive value: 0.95, F1-score: 0.95, accuracy: 0.95, and area under the curve: 0.99. Grad-CAM and saliency maps showed that tubers resided in regions most relevant for image classification within each image. A stand-alone trained deep learning App was able to classify images using local computers with various operating systems. Conclusion This study shows that deep learning algorithms are able to detect tubers in selected MRI images, and deep learning can be prudently applied clinically to manually selected data in a rare neurological disorder.	[Fernandez, Ivan Sanchez; Yang, Edward; Amengual-Gual, Marta; Sahin, Mustafa; Peters, Jurriaan M.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Calvachi, Paola] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Wu, Joyce Y.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Krueger, Darcy] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Northrup, Hope] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Bebin, Martina E.] Univ Alabama Birmingham, Birmingham, AL USA; [Yu, Kun-Hsing] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cincinnati Children's Hospital Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard Medical School	Fernandez, IS (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.	ivan.fernandez@childrens.harvard.edu		SAHIN, MUSTAFA/0000-0001-7044-2953; Krueger, Darcy/0000-0002-7250-7391	National Institute of Neurological Disorders And Stroke of the National Institutes of Health (NINDS); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01NS082320]; TACERN collaborative	National Institute of Neurological Disorders And Stroke of the National Institutes of Health (NINDS); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); TACERN collaborative	JMP, MS, HN, JYW, DK and MEB were supported by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health (NINDS) and Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) under Award Number U01NS082320. ISF has received an Amazon Web Services Cloud Credits for Research support in the form of computational credits for his project on "Identification and localization of tubers in Tuberous Sclerosis Complex with deep learning convolutional neural networks". JYW, DK, HN, MEB, MS, and JP received funding to collect the data as a part of the TACERN collaborative. The funders had no additional role in study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aarti Bagul, 2017, Arxiv, DOI arXiv:1711.05225; Abadi M., 2016, TENSORFLOW LARGE SCA; [Anonymous], 2019, TUBEROUS SCLEROSIS C; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Chollet F., 2015, KERAS; Crino PB, 1999, NEUROLOGY, V53, P1384, DOI 10.1212/WNL.53.7.1384; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; He K., 2016, CVPR, P770; Kassiri J, 2011, PEDIATR NEUROL, V44, P328, DOI 10.1016/j.pediatrneurol.2011.01.001; Kingma DP., 2014, ADAM METHOD STOCHAST; Kingswood JC, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-016-0553-5; Kluyver T, 2014, JUPYTER NOTEBOOKS PU; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lehman CD, 2019, RADIOLOGY, V290, P52, DOI 10.1148/radiol.2018180694; Lindsey R, 2018, P NATL ACAD SCI USA, V115, P11591, DOI 10.1073/pnas.1806905115; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lyons K.R., 2019, J OPEN SOURCE SOFTW, V4, DOI [10.21105/joss.01745, DOI 10.21105/JOSS.01745]; McKinney W., 2010, C POTTPIS; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; O'Callaghan FJK, 1998, LANCET, V351, P1490, DOI 10.1016/S0140-6736(05)78872-3; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peters JM, 2013, FUTUR NEUROL, V8, P583, DOI 10.2217/FNL.13.37; Python Software Foundation, 2018, PYTH LANG REF VERS 3; Rajpurkar P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002686; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Simonyan K., 2013, 13126034 ARXIV, DOI DOI 10.1038/S41591-018-0335-9; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Torrey L., 2010, HDB RES MACHINE LEAR; Veit A., 2016, ADV NEURAL INFORM PR, P550; Wang J., 2017, CONVOLUTIONAL NEURAL; Xie S., 2017, AGGREGATED RESIDUAL; Zech J., 2018, WHAT ARE RADIOLOGICA; Zhang J, 2018, CIRCULATION, V138, P1623, DOI 10.1161/CIRCULATIONAHA.118.034338	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232376	10.1371/journal.pone.0232376	http://dx.doi.org/10.1371/journal.pone.0232376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348367	gold, Green Published			2022-12-26	WOS:000536668200062
J	Oveisgharan, S; Dawe, RJ; Leurgans, SE; Yu, L; Schneider, JA; Bennett, DA; Buchman, AS				Oveisgharan, Shahram; Dawe, Robert J.; Leurgans, Sue E.; Yu, Lei; Schneider, Julie A.; Bennett, David A.; Buchman, Aron S.			Total daily physical activity, brain pathologies, and parkinsonism in older adults	PLOS ONE			English	Article							COGNITIVE FUNCTION; DISEASE PATHOLOGY; MOTOR FUNCTION; AD PATHOLOGY; SIGNS; EDUCATION; EXERCISE; DECLINE; POPULATION; PREVALENCE	Objective We examined the association of physical activity, postmortem brain pathologies, and parkinsonism proximate to death in older adults. Methods We studied the brains of 447 older decedents participating in a clinical-autopsy cohort study. We deployed a wrist worn activity monitor to record total daily physical activity during everyday living in the community-setting. Parkinsonism was assessed with 26 items of a modified motor portion of Unified Parkinson's Disease Rating Scale ( UPDRS). We used linear regression models, controlling for age and sex, to examine the association of physical activity with parkinsonism with and without indices of Alzheimer's disease and related disorders (ADRD) pathologies. In separate models, we added interaction terms to examine if physical activity modified the associations of brain pathologies with parkinsonism. Results Mean age at death was 90.9 (SD, 6.2), mean severity of parkinsonism was 14.1 (SD, 9.2, Range 0-59.4), and 350 (77%) had evidence of more than one ADRD pathologies. Higher total daily physical activity was associated with less severe parkinsonism (Estimate, -0.315, S.E., 0.052, p<0.001). The association of more physical activity with less severe parkinsonism persisted after adding terms for ten brain pathologies (Estimate, -0.283, S.E., 0.052, p<0.001). The associations of brain pathologies with more severe parkinsonism did not vary with the level of physical activity. Conclusion The association of higher physical activity with less severe parkinsonism may be independent of the presence of ADRD brain pathologies. Further work is needed to identify mechanisms through which physical activity may maintain motor function in older adults.	[Oveisgharan, Shahram; Dawe, Robert J.; Leurgans, Sue E.; Yu, Lei; Schneider, Julie A.; Bennett, David A.; Buchman, Aron S.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Oveisgharan, Shahram; Leurgans, Sue E.; Yu, Lei; Schneider, Julie A.; Bennett, David A.; Buchman, Aron S.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Dawe, Robert J.] Rush Univ, Med Ctr, Dept Radiol & Nucl Med, Chicago, IL 60612 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University	Oveisgharan, S (corresponding author), Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.; Oveisgharan, S (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	shahram_oveisgharan@rush.edu	Yu, Lei/AAT-3685-2020; Oveisgharan, Shahram/AAI-5971-2021	oveisgharan, shahram/0000-0001-6841-4830	National Institute of Health [R01AG47679, R01AG056352, R01AG059732, P30AG10161, R01AG017917, R01AG15819, R01AG043379]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health grants: A.S.B.: R01AG47679; R01AG056352; R01AG059732 D.A.B.: P30AG10161; R01AG017917; R01AG15819; R01AG043379 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bennett DA, 1997, NEUROLOGY, V49, P1580, DOI 10.1212/WNL.49.6.1580; Bennett DA, 1999, J GERONTOL A-BIOL, V54, pM191, DOI 10.1093/gerona/54.4.M191; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Boyle PA, 2012, ARCH GEN PSYCHIAT, V69, P499, DOI 10.1001/archgenpsychiatry.2011.1487; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Buchman AS, 2019, NEUROLOGY, V92, pE1821, DOI 10.1212/WNL.0000000000007315; Buchman AS, 2019, NEUROLOGY, V92, pE811, DOI 10.1212/WNL.0000000000006954; Buchman AS, 2018, NEUROLOGY, V90, pE1911, DOI 10.1212/WNL.0000000000005552; Buchman AS, 2017, STROKE, V48, P2792, DOI 10.1161/STROKEAHA.117.017643; Buchman AS, 2016, NEUROLOGY, V87, P1036, DOI 10.1212/WNL.0000000000003059; Buchman AS, 2016, NEUROLOGY, V86, P735, DOI 10.1212/WNL.0000000000002387; Buchman AS, 2014, J GERONTOL A-BIOL, V69, P1536, DOI 10.1093/gerona/glu117; Buchman AS, 2012, ANN NEUROL, V71, P258, DOI 10.1002/ana.22588; Buchman AS, 2011, STROKE, V42, P3183, DOI 10.1161/STROKEAHA.111.623462; Buchman AS, 2019, PLOS ONE, P14; De Souto Barreto P, 2015, J PREV ALZHEIEMRS DI, V2, P56, DOI DOI 10.14283/JPAD.2015.34; Del Ser T, 1999, BRAIN, V122, P2309, DOI 10.1093/brain/122.12.2309; Delezie J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00698; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elbaz A, 2013, NEUROLOGY, V81, P417, DOI 10.1212/WNL.0b013e31829d8761; Farfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b; Fleischman DA, 2015, NEUROLOGY, V84, P1294, DOI 10.1212/WNL.0000000000001417; Intlekofer KA, 2013, NEUROBIOL DIS, V57, P47, DOI 10.1016/j.nbd.2012.06.011; Lim ASP, 2011, SLEEP, V34, P1569, DOI 10.5665/sleep.1400; Louis ED, 2005, ARCH NEUROL-CHICAGO, V62, P297, DOI 10.1001/archneur.62.2.297; Louis ED, 2003, NEUROLOGY, V61, P24, DOI 10.1212/01.WNL.0000072330.07328.D6; Louis ED, 2005, NEUROLOGY, V64, P1157, DOI 10.1212/01.WNL.0000156157.97411.5E; Louis ED, 2010, MOVEMENT DISORD, V25, P172, DOI 10.1002/mds.22943; Maass A, 2016, NEUROIMAGE, V131, P142, DOI 10.1016/j.neuroimage.2015.10.084; Maliszewska-Cyna E, 2016, J ALZHEIMERS DIS, V53, P243, DOI 10.3233/JAD-150660; Mostafavi S, 2018, NAT NEUROSCI, V21, P811, DOI 10.1038/s41593-018-0154-9; Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388; Oveisgharan S, 2019, J GERONTOL BIOL SCI, P30, DOI [10.1212/WNL.0000000000007315, DOI 10.1212/WNL.0000000000007315]; Oveisgharan S, 2018, ACTA NEUROPATHOL, V136, P887, DOI 10.1007/s00401-018-1920-1; Rahimi J, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0082-1; Schneider JA, 2003, NEUROLOGY, V60, P1082, DOI 10.1212/01.WNL.0000055863.87435.B2; Tapia-Rojas C, 2016, BRAIN PATHOL, V26, P62, DOI 10.1111/bpa.12255; Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001; Wilson RS, 2013, NEUROLOGY, V81, P314, DOI 10.1212/WNL.0b013e31829c5e8a; Yu L, 2018, ANN NEUROL, V84, P78, DOI 10.1002/ana.25266; Zhang Jing, 2016, BioMolecular Concepts, V7, P253, DOI 10.1515/bmc-2016-0012	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232404	10.1371/journal.pone.0232404	http://dx.doi.org/10.1371/journal.pone.0232404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348372	gold, Green Published			2022-12-26	WOS:000536668200064
J	Patt, JM; Moreno, AMT; Niedz, RP				Patt, Joseph M.; Moreno, Aleena M. Tarshis; Niedz, Randall P.			Response surface methodology reveals proportionality effects of plant species in conservation plantings on occurrence of generalist predatory arthropods	PLOS ONE			English	Article							RADIATA HYMENOPTERA EULOPHIDAE; CITRI HEMIPTERA LIVIIDAE; ASIAN CITRUS; BIOLOGICAL-CONTROL; DIAPHORINA-CITRI; WILDFLOWER STRIPS; NATURAL ENEMIES; AGRICULTURAL LANDSCAPES; INSECTICIDE RESISTANCE; FAGOPYRUM-ESCULENTUM	Multivariate geometric designs for mixture experiments and response surface methodology (RSM) were tested as a means of optimizing plant mixtures to support generalist predatory arthropods. The mixture design included 14 treatment groups, each comprised of six planters and having a proportion of 0.00, 0.17, 0.33, 0.66, or 1.00 of each plant species. The response variable was the frequency of predators trapped on sticky card traps placed in each group and replaced 2 times per week. The following plant species were used: Spring 2017: Euphorbia milii, E. heterophylla, and Phaseolus lunatus; Summer 2017: E. milii, Fagopyrum esculentum, and Chamaecrista fasciculata; and, Summer 2018: E. milii, F. esculentum, and Portulaca umbraticola. Predator occurrence was influenced by: 1) Linear mixture effects, which indicated that predator occurrence was driven by the amount of a single plant species in the mixture; or, 2) Nonlinear blending effects, which indicated that the plant mixture itself had emergent properties that contributed to predator occurrence. Predator abundance was highest in the Spring 2017 experiment and both linear mixture effects and nonlinear blending effects were observed. Predator occurrence decreased in subsequent experiments, which were conducted in the warmer summer months. In both Summer experiments, only linear mixture effects were observed, indicating that predator occurrence was driven by the amount of a single plant species in the test mixtures: Euphorbia milii in 2017 and Portulaca umbraticola in 2018. The results showed that not only did the species composition of a plant mixture drive predator occurrence but that proportionality of species contributed to the outcome as well. This suggests that, when formulating a plant mixture to aid in conservation biological control consideration should be given to the proportion of each plant species included in the mixture. RSM can be an important tool for achieving the goal of optimizing mixtures of plants for conservation biological control.	[Patt, Joseph M.; Moreno, Aleena M. Tarshis; Niedz, Randall P.] USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Patt, JM (corresponding author), USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA.	joseph.patt@usda.gov	Patt, Joseph/V-1113-2018	Patt, Joseph/0000-0001-9105-8520	USDA Agricultural Research Service	USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the USDA Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their sincere gratitude to Diane Kimes, Executive Director of Heathcote Botanical Gardens, for providing access, encouragement, and logistical support, Nichol Gaza and Frank Manthey for their assistance with the fieldwork studies and sticky card trap analysis, Paul Robbins and William Meikle for reviewing an early draft of the manuscript, and three anonymous reviewers whose critical comments greatly improved the manuscript. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation of endorsement by the USDA for its use.	Adair R., 2018, METALIZED REFLECTIVE; Ambrosino MD, 2006, ENVIRON ENTOMOL, V35, P394, DOI 10.1603/0046-225X-35.2.394; Balzan MV, 2017, ARTHROPOD-PLANT INTE, V11, P743, DOI 10.1007/s11829-017-9544-2; Balzan MV, 2016, ENTOMOL EXP APPL, V158, P304, DOI 10.1111/eea.12403; Balzan MV, 2014, J INSECT CONSERV, V18, P713, DOI 10.1007/s10841-014-9680-2; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blaauw BR, 2012, ECOL ENTOMOL, V37, P386, DOI 10.1111/j.1365-2311.2012.01376.x; Boina DR, 2015, PEST MANAG SCI, V71, P808, DOI 10.1002/ps.3957; Bouvet JPR, 2019, J ANIM ECOL, V88, P915, DOI 10.1111/1365-2656.12982; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brennan EB, 2016, BIOL CONTROL, V97, P109, DOI 10.1016/j.biocontrol.2016.02.015; Brennan EB, 2013, BIOL CONTROL, V65, P302, DOI 10.1016/j.biocontrol.2013.03.017; BRENNER RJ, 1988, ANN ENTOMOL SOC AM, V81, P432, DOI 10.1093/aesa/81.3.432; Campbell AJ, 2012, BASIC APPL ECOL, V13, P363, DOI 10.1016/j.baae.2012.04.003; Campbell JW, 2016, FLA ENTOMOL, V99, P264, DOI 10.1653/024.099.0216; Chen XD, 2018, APPL ENTOMOL ZOOL, V53, P453, DOI 10.1007/s13355-018-0574-8; Cornell J. A., 2002, EXPT MIXTURES; Cottrell TE, 1998, ENVIRON ENTOMOL, V27, P1402, DOI 10.1093/ee/27.6.1402; FAEGRI K, 1979, P244; Farnsworth D., 2014, CHOICES, V29, P1; Frank SD, 2010, BIOL CONTROL, V52, P8, DOI 10.1016/j.biocontrol.2009.09.011; Gardarin A, 2018, J PEST SCI, V91, P943, DOI 10.1007/s10340-018-0958-0; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Grossman J., 1993, IPM Practitioner, V15, P1; Gurr G. M., 2005, P326, DOI 10.1017/CBO9780511542220.012; Gurr GM, 2017, ANNU REV ENTOMOL, V62, P91, DOI 10.1146/annurev-ento-031616-035050; Haaland C, 2011, INSECT CONSERV DIVER, V4, P60, DOI 10.1111/j.1752-4598.2010.00098.x; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2015, J ECON ENTOMOL, V108, P1198, DOI 10.1093/jee/tov052; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hatt S, 2019, ARTHROPOD-PLANT INTE, V13, P127, DOI 10.1007/s11829-018-9652-7; Hatt S, 2017, EUR J ENTOMOL, V114, P66, DOI 10.14411/eje.2017.010; Hatt S, 2017, ECOL ENG, V98, P240, DOI 10.1016/j.ecoleng.2016.10.080; Holland JM, 2016, PEST MANAG SCI, V72, P1638, DOI 10.1002/ps.4318; Jervis M. A., 1996, P375; Kistner EJ, 2016, J ECON ENTOMOL, V109, P1047, DOI 10.1093/jee/tow021; Kondo Takumasa, 2015, Insecta Mundi, V457, P1; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Lapointe SL, 2016, J CHEM ECOL, V42, P941, DOI 10.1007/s10886-016-0745-4; Lapointe SL, 2009, J CHEM ECOL, V35, P896, DOI 10.1007/s10886-009-9674-9; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Lewis-Rosenblum H, 2015, J ECON ENTOMOL, V108, P3, DOI 10.1093/jee/tou008; Lundgren, 2009, RELATIONSHIPS NATURA, V7; Lundgren JG, 2009, BIOL CONTROL, V51, P294, DOI 10.1016/j.biocontrol.2009.05.016; Martini X, 2015, AGR ECOSYST ENVIRON, V212, P168, DOI 10.1016/j.agee.2015.06.027; Michaud JP, 2004, BIOL CONTROL, V29, P260, DOI 10.1016/S1049-9644(03)00161-0; Monzo C, 2014, B ENTOMOL RES, V104, P576, DOI 10.1017/S0007485314000315; Monzo C, 2020, PEST MANAG SCI, DOI [10.1002/ps, DOI 10.1002/PS]; Monzo C, 2015, ACTA HORTIC, V1065, P1137; Nicholls CI, 2001, LANDSCAPE ECOL, V16, P133, DOI 10.1023/A:1011128222867; Niedz RP, 2018, IN VITRO CELL DEV-PL, V54, P658, DOI 10.1007/s11627-018-9940-z; Niedz RP, 2016, IN VITRO CELL DEV-PL, V52, P547, DOI 10.1007/s11627-016-9786-1; Olson MD, 2005, PLANT PROVIDED FOOD, P137; Pardo S, 2018, PEST MANAG SCI, V74, P135, DOI 10.1002/ps.4669; Pascacio-Villafan C, 2014, J CHEM ECOL, V40, P297, DOI 10.1007/s10886-014-0404-6; Patt J. M., 1997, Advances in Horticultural Science, V11, P175; Patt JM, 1997, ENTOMOL EXP APPL, V83, P21, DOI 10.1023/A:1002936210051; Patt JM, 2003, ECOL ENTOMOL, V28, P717, DOI 10.1111/j.1365-2311.2003.00556.x; Patt JM, 2018, FLA ENTOMOL, V101, P131, DOI 10.1653/024.101.0124; Patt JM, 2017, FLA ENTOMOL, V100, P149, DOI 10.1653/024.100.0121; Patt JM, 2012, BIOL CONTROL, V63, P237, DOI 10.1016/j.biocontrol.2011.02.004; Perovic DJ, 2018, BIOL REV, V93, P306, DOI 10.1111/brv.12346; Pfannenstiel RS, 2012, BIOL CONTROL, V63, P231, DOI 10.1016/j.biocontrol.2012.07.013; Pfannenstiel RS, 2008, ANN ENTOMOL SOC AM, V101, P763, DOI 10.1603/0013-8746(2008)101[763:BADBAN]2.0.CO;2; PROCTOR M., 1972, POLLINATION FLOWERS; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Qureshi JA, 2009, J ECON ENTOMOL, V102, P247, DOI 10.1603/029.102.0134; Schellhorn NA, 2014, ANNU REV ENTOMOL, V59, P559, DOI 10.1146/annurev-ento-011613-161952; Setamou M, 2010, J ECON ENTOMOL, V103, P1711, DOI 10.1603/EC09371; Singerman A., 2019, CITRUS IND NEWS; SMITH D, 1991, EXP APPL ACAROL, V12, P195, DOI 10.1007/BF01193467; Stelinski LL, 2019, INSECTS, V10, DOI 10.3390/insects10070208; Stephens MJ, 1998, BIOCONTROL SCI TECHN, V8, P547, DOI 10.1080/09583159830063; Tian F, 2018, SCI REPORTS, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Tiwari S, 2010, J ECON ENTOMOL, V103, P1972, DOI 10.1603/EC10149; Toivonen M, 2018, BIOL CONTROL, V121, P109, DOI 10.1016/j.biocontrol.2018.02.015; Tomaseto AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38597-5; Tschumi M, 2016, J APPL ECOL, V53, P1169, DOI 10.1111/1365-2664.12653; Tschumi M, 2015, P ROY SOC B-BIOL SCI, V282, P189, DOI 10.1098/rspb.2015.1369; Uyttenbroeck R, 2015, AGRIC AGRIC SCI PROC, V6, P95, DOI 10.1016/j.aaspro.2015.08.044; Van Rijn PCJ, 1999, EXP APPL ACAROL, V23, P785, DOI 10.1023/A:1006227704122; Wackers Felix L., 2012, P139; Wackers FL, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P17, DOI 10.1017/CBO9780511542220.003; Wackers FL, 2004, BIOL CONTROL, V29, P307, DOI 10.1016/j.biocontrol.2003.08.005; Walton NJ, 2011, ENVIRON ENTOMOL, V40, P697, DOI 10.1603/EN10288; Zhang MQ, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01890; Zhu PY, 2018, J PEST SCI, V91, P575, DOI 10.1007/s10340-017-0946-9	91	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231471	10.1371/journal.pone.0231471	http://dx.doi.org/10.1371/journal.pone.0231471			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348341	gold, Green Published			2022-12-26	WOS:000536668200019
J	Chen, H; Shi, ZN; Guo, JJ; Chang, KJ; Chen, QQ; Yao, CH; Haigis, MC; Shi, Y				Chen, Hao; Shi, Zhennan; Guo, Jiaojiao; Chang, Kao-jung; Chen, Qianqian; Yao, Cong-Hui; Haigis, Marcia C.; Shi, Yang			The human mitochondrial 12S rRNA m(4)C methyltransferase METTL15 is required for mitochondrial function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						m4C methylation; 12S mt-rRNA; mitochondrial translation; mitoribosome biogenesis; methyltransferase-like 15 (METTL15); rsmH; post-transcriptional modification; RNA methylation; RNA methyltransferase; RNA modification; mitochondria; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); m4C methylation; mitochondrial translation	GENE-EXPRESSION; METHYLATION; TRANSCRIPTION; TRANSLATION; GENOME	Mitochondrial DNA gene expression is coordinately regulated both pre- and post-transcriptionally, and its perturbation can lead to human pathologies. Mitochondrial rRNAs (mt-rRNAs) undergo a series of nucleotide modifications after release from polycistronic mitochondrial RNA precursors, which is essential for mitochondrial ribosomal biogenesis. CytosineN(4)-methylation (m(4)C) at position 839 (m(4)C839) of the 12S small subunit mt-rRNA was identified decades ago; however, its biogenesis and function have not been elucidated in detail. Here, using several approaches, including immunofluorescence, RNA immunoprecipitation and methylation assays, and bisulfite mapping, we demonstrate that human methyltransferase-like 15 (METTL15), encoded by a nuclear gene, is responsible for 12S mt-rRNA methylation at m(4)C839 bothin vivoandin vitro. We tracked the evolutionary history of RNA m(4)C methyltransferases and identified a difference in substrate preference between METTL15 and its bacterial ortholog rsmH. Additionally, unlike the very modest impact of a loss of m(4)C methylation in bacterial small subunit rRNA on the ribosome, we found that METTL15 depletion results in impaired translation of mitochondrial protein-coding mRNAs and decreases mitochondrial respiration capacity. Our findings reveal that human METTL15 is required for mitochondrial function, delineate the evolution of methyltransferase substrate specificities and modification patterns in rRNA, and highlight a differential impact of m(4)C methylation on prokaryotic ribosomes and eukaryotic mitochondrial ribosomes.	[Chen, Hao; Shi, Zhennan; Chang, Kao-jung; Chen, Qianqian; Shi, Yang] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Chen, Hao; Shi, Zhennan; Chang, Kao-jung; Chen, Qianqian; Shi, Yang] Boston Childrens Hosp, Dept Med, Epigenet Program, Boston, MA 02115 USA; [Chen, Hao; Shi, Zhennan; Chang, Kao-jung; Chen, Qianqian; Yao, Cong-Hui; Haigis, Marcia C.; Shi, Yang] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Guo, Jiaojiao] Northeastern Univ, Coll Sci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Northeastern University	Shi, Y (corresponding author), Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.; Shi, Y (corresponding author), Boston Childrens Hosp, Dept Med, Epigenet Program, Boston, MA 02115 USA.; Shi, Y (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	Yang.Shi@childrens.harvard.edu		Chang, Kao-Jung/0000-0002-2238-7387; CHEN, HAO/0000-0002-2534-9650; Yao, Conghui/0000-0003-3922-1874	Boston Children's Hospital funds	Boston Children's Hospital funds	This work was supported by Boston Children's Hospital funds. Y. S. is an American Cancer Society Research Professor.	Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Bradfield JP, 2019, HUM MOL GENET, V28, P3327, DOI 10.1093/hmg/ddz161; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DUBIN DT, 1974, J MOL BIOL, V84, P257, DOI 10.1016/0022-2836(74)90584-1; DUBIN DT, 1978, NUCLEIC ACIDS RES, V5, P4385, DOI 10.1093/nar/5.11.4385; Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Ma HH, 2019, NAT CHEM BIOL, V15, P88, DOI 10.1038/s41589-018-0184-3; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Popova AM, 2014, J AM CHEM SOC, V136, P2058, DOI 10.1021/ja412084b; Rieder D, 2016, BIOINFORMATICS, V32, P782, DOI 10.1093/bioinformatics/btv647; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Sergiev PV, 2018, NAT CHEM BIOL, V14, P226, DOI [10.1038/nchembio.2569, 10.1038/NCHEMBIO.2569]; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharoyko VV, 2014, HUM MOL GENET, V23, P5733, DOI 10.1093/hmg/ddu288; Shi ZN, 2019, FASEB J, V33, P13040, DOI 10.1096/fj.201901331R; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Van Haute L, 2019, NUCLEIC ACIDS RES, V47, P10267, DOI 10.1093/nar/gkz735; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wei Y, 2012, J STRUCT BIOL, V179, P29, DOI 10.1016/j.jsb.2012.04.011	37	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8505	8513		10.1074/jbc.RA119.012127	http://dx.doi.org/10.1074/jbc.RA119.012127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371392	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000546986500015
J	Koshizuka, T; Inoue, N				Koshizuka, Tetsuo; Inoue, Naoki			Activation of c-Jun by human cytomegalovirus UL42 through JNK activation	PLOS ONE			English	Article							IE1 PROTEIN; PHOSPHORYLATION; EXPRESSION; NUCLEAR; KINASE; AP-1	c-Jun is a major component of the AP-1 transactivator complex. In this report, we demonstrated that AP-1 was activated by the expression of UL42, a human cytomegalovirus-encoded membrane protein that has two PPXY (PY) motifs and a C-terminal transmembrane domain (TMD). Although UL42 interacts with Itch, an ubiquitin E3 ligase, through the PY motifs, UL42 phosphorylated c-Jun and c-Jun N-terminal kinase (JNK) in the absence of any interaction with Itch. Experiments using mutated versions of UL42 suggest the importance of the carboxyl half (a.a. 52-124) of UL42 for the activation of the JNK signaling, while C-terminal TMD alone is not sufficient. Thus, we hypothesize that UL42 plays a role in the activation of JNK signaling in HCMV-infected cells. (118 words).	[Koshizuka, Tetsuo; Inoue, Naoki] Gifu Pharmaceut Univ, Microbiol & Immunol, Gifu, Japan	Gifu Pharmaceutical University	Koshizuka, T (corresponding author), Gifu Pharmaceut Univ, Microbiol & Immunol, Gifu, Japan.	koshizuka-te@gifu-pu.ac.jp		Koshizuka, Tetsuo/0000-0003-2783-2520; Inoue, Naoki/0000-0002-9245-4979	Japan Society for the Promotion of Science (JSPS KAKENHI) [17K10185]; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was partly supported by the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI 17K10185) to T.K. and a grant from the Takeda Science Foundation to T.K.	Ahn YH, 2009, J BIOL CHEM, V284, P29399, DOI 10.1074/jbc.M109.044958; An H, 2014, MOL BIOSYST, V10, P1643, DOI 10.1039/c3mb70572b; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Fu YZ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007691; Kim S, 1999, J GEN VIROL, V80, P961, DOI 10.1099/0022-1317-80-4-961; Koshizuka T, 2002, J VIROL, V76, P6718, DOI 10.1128/JVI.76.13.6718-6728.2002; Koshizuka T, 2018, MICROBIOL IMMUNOL, V62, P651, DOI 10.1111/1348-0421.12645; Koshizuka T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22682-2; Koshizuka T, 2016, J GEN VIROL, V97, P196, DOI 10.1099/jgv.0.000336; Koshizuka T, 2010, VIROLOGY, V405, P280, DOI 10.1016/j.virol.2010.06.016; Kurapati S, 2017, J VIROL, V91, DOI 10.1128/JVI.00640-17; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Schreck I, 2011, BIOCHEM BIOPH RES CO, V407, P735, DOI 10.1016/j.bbrc.2011.03.092; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; TENNEY DJ, 1991, J VIROL, V65, P6724, DOI 10.1128/JVI.65.12.6724-6734.1991; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Wang XB, 2005, J VIROL, V79, P95, DOI 10.1128/JVI.79.1.95-105.2005; Xuan BQ, 2009, J VIROL, V83, P3463, DOI 10.1128/JVI.02307-08; Zeke A, 2016, MICROBIOL MOL BIOL R, V80, P793, DOI 10.1128/MMBR.00043-14; Zhang HP, 2015, J MED VIROL, V87, P2135, DOI 10.1002/jmv.24286	23	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232635	10.1371/journal.pone.0232635	http://dx.doi.org/10.1371/journal.pone.0232635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369499	Green Published, gold			2022-12-26	WOS:000537280000037
J	Liu, T; Woo, JAA; Bukhari, MZ; LePochat, P; Chacko, A; Selenica, MLB; Yan, Y; Kotsiviras, P; Buosi, SC; Zhao, XY; Kang, DVE				Liu, Tian; Woo, Jung-A A.; Bukhari, Mohammed Zaheen; LePochat, Patrick; Chacko, Ann; Selenica, Maj-Linda B.; Yan, Yan; Kotsiviras, Peter; Buosi, Sara Cazzaro; Zhao, Xingyu; Kang, David E.			CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia	FASEB JOURNAL			English	Article						CHCHD10; frontotemporal dementia; mitofilin; OPA1; TDP-43	AMYOTROPHIC-LATERAL-SCLEROSIS; CHCHD10 MUTATIONS; CONTACT SITE; TAU PATHOLOGY; MICOS COMPLEX; IN-VIVO; TDP-43; DISEASE; ALS; GENE	Mutations in CHCHD10, a gene coding for a mitochondrial protein, are implicated in ALS-FTD spectrum disorders, which are pathologically characterized by transactive response DNA binding protein 43 kDa (TDP-43) accumulation. While both TDP-43 and CHCHD10 mutations drive mitochondrial pathogenesis, mechanisms underlying such phenotypes are unclear. Moreover, despite the disruption of the mitochondrial mitofilin protein complex at cristae junctions in patient fibroblasts bearing the CHCHD10(S59L) mutation, the role of CHCHD10 variants in mitofilin-associated protein complexes in brain has not been examined. Here, we utilized novel CHCHD10 transgenic mouse variants (WT, R15L, & S59L), TDP-43 transgenic mice, FTLD-TDP patient brains, and transfected cells to assess the interplay between CHCHD10 and TDP-43 on mitochondrial phenotypes. We show that CHCHD10 mutations disrupt mitochondrial OPA1-mitofilin complexes in brain, associated with impaired mitochondrial fusion and respiration. Likewise, CHCHD10 levels and OPA1-mitofilin complexes are significantly reduced in brains of FTLD-TDP patients and TDP-43 transgenic mice. In cultured cells, CHCHD10 knockdown results in OPA1-mitofilin complex disassembly, while TDP-43 overexpression also reduces CHCHD10, promotes OPA1-mitofilin complex disassembly via CHCHD10, and impairs mitochondrial fusion and respiration, phenotypes that are rescued by wild type (WT) CHCHD10. These results indicate that disruption of CHCHD10-regulated OPA1-mitofilin complex contributes to mitochondrial abnormalities in FTLD-TDP and suggest that CHCHD10 restoration could ameliorate mitochondrial dysfunction in FTLD-TDP.	[Liu, Tian; Woo, Jung-A A.; Bukhari, Mohammed Zaheen; LePochat, Patrick; Chacko, Ann; Yan, Yan; Kotsiviras, Peter; Buosi, Sara Cazzaro; Zhao, Xingyu; Kang, David E.] USF Hlth Morsani Coll Med, Byrd Alzheimers Ctr & Res Inst, Tampa, FL 33613 USA; [Liu, Tian; Bukhari, Mohammed Zaheen; LePochat, Patrick; Chacko, Ann; Yan, Yan; Kotsiviras, Peter; Buosi, Sara Cazzaro; Zhao, Xingyu; Kang, David E.] USF Hlth Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [Woo, Jung-A A.] USF Hlth Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Selenica, Maj-Linda B.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY USA; [Kang, David E.] James A Haley Vet Adm Hosp, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Liu, T; Kang, DVE (corresponding author), USF Hlth Morsani Coll Med, Byrd Alzheimers Ctr & Res Inst, Tampa, FL 33613 USA.	tianliu@usf.edu; dkang@usf.edu		Woo, Jung A/0000-0002-9194-1361; Kang, David E./0000-0002-7132-821X	Foundation for the National Institutes of Health (FNIH) [1RF1AG053060-01A1, 5R01NS073899]; U.S. Department of Veterans Affairs (VA) [1 I01 BX002478-01A1]; Florida Department of Health [8AZ29]	Foundation for the National Institutes of Health (FNIH); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Florida Department of Health	Foundation for the National Institutes of Health (FNIH), Grant/Award Number: 1RF1AG053060-01A1 and 5R01NS073899; U.S. Department of Veterans Affairs (VA), Grant/Award Number: 1 I01 BX002478-01A1; Florida Department of Health, Grant/Award Number: 8AZ29	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Anderson CJ, 2019, ACTA NEUROPATHOL, V138, P103, DOI 10.1007/s00401-019-01989-y; Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454; Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Brockmann SJ, 2018, HUM MOL GENET, V27, P706, DOI 10.1093/hmg/ddx436; Burstein SR, 2018, HUM MOL GENET, V27, P160, DOI 10.1093/hmg/ddx397; Callegari S, 2019, J MOL BIOL, V431, P2835, DOI 10.1016/j.jmb.2019.05.015; Cho B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15754; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Davis SA, 2018, NEUROSCI LETT, V678, P8, DOI 10.1016/j.neulet.2018.04.053; Del Dotto V, 2017, CELL REP, V19, P2557, DOI 10.1016/j.celrep.2017.05.073; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Feneberg E, 2018, MOL NEUROBIOL, V55, P7789, DOI 10.1007/s12035-018-0947-6; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z; Genin EC, 2018, NEUROBIOL DIS, V119, P159, DOI 10.1016/j.nbd.2018.07.027; Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496; Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049; Guarani V, 2015, ELIFE, V4, DOI 10.7554/eLife.06265; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Huang HP, 2019, HUM MOL GENET, V28, P3880, DOI 10.1093/hmg/ddz218; Huynen MA, 2016, BBA-MOL CELL RES, V1863, P91, DOI 10.1016/j.bbamcr.2015.10.009; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiang TC, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.038109; Johnson JO, 2014, BRAIN, V137, DOI 10.1093/brain/awu265; Joshi AU, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708166; Kaurov I, 2018, CURR BIOL, V28, P3393, DOI 10.1016/j.cub.2018.09.008; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li H, 2016, CELL DEATH DIFFER, V23, P380, DOI 10.1038/cdd.2015.102; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Liu W, 2020, CELL DEATH DIFFER, V10, P1038; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Lu JS, 2012, BRAIN RES BULL, V89, P185, DOI 10.1016/j.brainresbull.2012.09.005; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Meng H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15500; Muller K, 2014, BRAIN, V137, DOI 10.1093/brain/awu227; Muyderman H, 2014, BRIT J PHARMACOL, V171, P2191, DOI 10.1111/bph.12476; Penttila S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Purandare N, 2018, J BIOL CHEM, V293, P6517, DOI 10.1074/jbc.RA117.001073; Rampelt H, 2017, BBA-MOL CELL RES, V1864, P737, DOI 10.1016/j.bbamcr.2016.05.020; Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393; SU C, 1994, ANAL BIOCHEM, V223, P93, DOI 10.1006/abio.1994.1552; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Wang P, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007947; Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Woo JA, 2017, HUM MOL GENET, V26, P3973, DOI 10.1093/hmg/ddx284; Woo JAA, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0359-9; Woo JAA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15558; Wu X, 2018, J CELL BIOL, V217, P139, DOI 10.1083/jcb.201702125; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082	66	9	9	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8493	8509		10.1096/fj.201903133RR	http://dx.doi.org/10.1096/fj.201903133RR		MAY 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32369233	Green Accepted			2022-12-26	WOS:000530303800001
J	Yaqoob, A; Li, WM; Liu, V; Wang, CY; Mackedenski, S; Tackaberry, LE; Massicotte, HB; Egger, KN; Reimer, K; Lee, CH				Yaqoob, Almas; Li, Wai Ming; Liu, Victor; Wang, Chuyi; Mackedenski, Sebastian; Tackaberry, Linda E.; Massicotte, Hugues B.; Egger, Keith N.; Reimer, Kerry; Lee, Chow H.			Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells	PLOS ONE			English	Article							ANTITUMOR NATURAL-PRODUCT; MEROTERPENOID PIGMENTS; CYCLE ARREST; RNA; DERIVATIVES; INHIBITORS; GROWTH; APOPTOSIS; POTENT; MUSHROOMS	In our search for bioactive mushrooms native to British Columbia, we determined that the ethanol extracts from fruiting bodies of the terrestrial polypore Albatrellus flettii had potent anti-cell viability activity. Using bioassay-guided fractionation, mass spectrometry and nuclear magnetic resonance, we successfully isolated three known compounds (grifolin, neogrifolin and confluentin). These compounds represent the major anti-cell viability components from the ethanol extracts of A. flettii. We also identified a novel biological activity for these compounds, specifically in down-regulating KRAS expression in two human colon cancer cell lines. Relatively little is known about the anti-cell viability activity and mechanism of action of confluentin. For the first time, we show the ability of confluentin to induce apoptosis and arrest the cell cycle at the G2/M phase in SW480 human colon cancer cells. The oncogenic insulin-like growth factor 2 mRNA-binding protein 1 (IMP1) has been previously shown to regulate KRAS mRNA expression in colon cancer cells, possibly through its ability to bind to the KRAS transcript. Using a fluorescence polarization assay, we show that confluentin dose-dependently inhibits the physical interaction between KRAS RNA and full-length IMP1. The inhibition also occurs with truncated IMP1 containing the KH1 to KH4 domain (KH1to4 IMP1), but not with the di-domain KH3 and KH4 (KH3&4 IMP1). In addition, unlike the control antibiotic neomycin, grifolin, neogrifolin and confluentin do not bind to KRAS RNA. These results suggest that confluentin inhibits IMP1-KRAS RNA interaction by binding to the KH1&2 di-domains of IMP1. Since the molecular interaction between IMP1 and its target RNAs is a pre-requisite for the oncogenic function of IMP1, confluentin should be further explored as a potential inhibitor of IMP1 in vivo.	[Yaqoob, Almas; Li, Wai Ming; Liu, Victor; Wang, Chuyi; Mackedenski, Sebastian; Reimer, Kerry; Lee, Chow H.] Univ Northern British Columbia, Chem & Biochem Program, Prince George, BC, Canada; [Tackaberry, Linda E.; Massicotte, Hugues B.; Egger, Keith N.] Univ Northern British Columbia, Ecosyst Sci & Management Program, Prince George, BC, Canada	University of Northern British Columbia; University of Northern British Columbia	Lee, CH (corresponding author), Univ Northern British Columbia, Chem & Biochem Program, Prince George, BC, Canada.	chow.lee@unbc.ca		Liu, Victor/0000-0002-2453-1418	Natural Sciences & Engineering Research Council [227158]; Canada Foundation for Innovation [34711]; UNBC Research Project Award	Natural Sciences & Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); UNBC Research Project Award	This work was supported by Natural Sciences & Engineering Research Council Discovery grant number 227158 (CHL), Canada Foundation for Innovation grant number 34711 (CHL) and UNBC Research Project Award (AY).	Barad A, 2018, CARBOHYD POLYM, V181, P923, DOI 10.1016/j.carbpol.2017.11.058; Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bates SE, 2015, CLIN CANCER RES, V21, P1796, DOI 10.1158/1078-0432.CCR-14-2664; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bryant R, 2013, ENGL STUD CAN, V39, P91, DOI 10.1353/esc.2013.0047; Che XX, 2016, ONCOL REP, V36, P1041, DOI 10.3892/or.2016.4840; Chen Y, 2015, INT J CLIN EXP PATHO, V8, P1154; Dagil R, 2019, NUCLEIC ACIDS RES, V47, P4334, DOI 10.1093/nar/gkz136; Deo GS, 2019, INT J MED MUSHROOMS, V21, P629, DOI 10.1615/IntJMedMushrooms.2019031193; Downward J, 2013, NAT REV CANCER, V3, P11; Ginns J, 1997, CAN J BOT, V75, P261, DOI 10.1139/b97-028; Hall MD, 2016, METHODS APPL FLUORES, V4, DOI 10.1088/2050-6120/4/2/022001; Hellwig V, 2003, ARCH PHARM, V336, P119, DOI 10.1002/ardp.200390008; Hocker HJ, 2013, P NATL ACAD SCI USA, V110, P10201, DOI 10.1073/pnas.1300016110; Kawagishi H, 1996, PHYTOCHEMISTRY, V42, P547, DOI 10.1016/0031-9422(95)00881-0; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; King DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091585; Koch B, 2007, EUR J ORG CHEM, V2007, P1631, DOI 10.1002/ejoc.200601022; Leung ELH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0065-9; Liu LY, 2014, NAT PRODUCT BIOPROSP, V4, P119, DOI 10.1007/s13659-014-0015-5; Liu LY, 2013, J NAT PROD, V76, P79, DOI 10.1021/np300751m; Liu XT, 2010, PLANTA MED, V76, P182, DOI 10.1055/s-0029-1186001; Luo XJ, 2011, EUR J CANCER, V47, P316, DOI 10.1016/j.ejca.2010.09.021; Mackedenski S, 2018, BIOCHEM J, V475, P2749, DOI 10.1042/BCJ20180575; Mahapatra L, 2017, TRANSL ONCOL, V10, P818, DOI 10.1016/j.tranon.2017.07.008; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; Mehmood K, 2016, MOL PHARMACOL, V89, P695, DOI 10.1124/mol.115.102434; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Nukata M, 2002, PHYTOCHEMISTRY, V59, P731, DOI 10.1016/S0031-9422(02)00050-X; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Quang DN, 2006, BIOORGAN MED CHEM, V14, P164, DOI 10.1016/j.bmc.2005.08.005; Ross SJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5253; Smith A, 2017, INT J MED MUSHROOMS, V19, P485, DOI 10.1615/IntJMedMushrooms.v19.i6.10; Tor Y, 2003, CHEMBIOCHEM, V4, P998, DOI 10.1002/cbic.200300680; van Rensburg G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171196; Wu ZJ, 2017, ONCOTARGET, V8, P21454, DOI 10.18632/oncotarget.15250; Xi HJ, 2009, FEBS LETT, V583, P2269, DOI 10.1016/j.febslet.2009.06.007; Xue W, 2014, P NATL ACAD SCI USA, V111, pE3553, DOI 10.1073/pnas.1412686111; Yan H, 2017, ONCOL LETT, V13, P4806, DOI 10.3892/ol.2017.6092; Yang SM, 2016, INT J CLIN EXP MED, V9, P12659; Ye M, 2005, FEBS LETT, V579, P3437, DOI 10.1016/j.febslet.2005.05.013; Ye M, 2007, CANCER LETT, V258, P199, DOI 10.1016/j.canlet.2007.09.001; Yuan TL, 2014, CANCER DISCOV, V4, P1182, DOI 10.1158/2159-8290.CD-13-0900; Zeng M, 2017, CELL CHEM BIOL, V24, P1005, DOI 10.1016/j.chembiol.2017.06.017	46	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0231948	10.1371/journal.pone.0231948	http://dx.doi.org/10.1371/journal.pone.0231948			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369483	Green Published, gold			2022-12-26	WOS:000537280000013
J	Cai, LR; Tong, JJ; Zhang, ZN; Zhang, YH; Jiang, LS; Hou, XL; Zhang, H				Cai, Lirong; Tong, Jinjin; Zhang, Zhaonan; Zhang, Yonghong; Jiang, Linshu; Hou, Xiaolin; Zhang, Hua			Staphylococcus aureus-induced proteomic changes in the mammary tissue of rats: A TMT-based study	PLOS ONE			English	Article							HEAVY-CHAIN 4; MASTITIS; MILK; INFECTION; SUSCEPTIBILITY; INTEGRIN; LENGTH	Staphylococcus aureus is one of the most important pathogens causing mastitis in dairy cows. The objective of this study was to establish a rat model of mastitis induced by S. aureus infection and to explore changes in the proteomes of mammary tissue in different udder states, providing a better understanding of the host immune response to S. aureus mastitis. On day 3 post-partum, 6 rats were randomly divided into two groups (n = 3), with either 100 mu L of PBS (blank group) or a S. aureus suspension containing 2x10(7) CFU.mL(-1) (challenge group) infused into the mammary gland duct. After 24 h of infection, the rats were sacrificed, and mammary gland tissue was collected. Tandem mass tag (TMT)-based technology was applied to compare the proteomes of healthy and mastitic mammary tissues. Compared with the control group, the challenge group had 555 proteins with significant differences in expression, of which 428 were significantly upregulated (FC>1.2 and p<0.05) and 127 were downregulated (FC>0.83 and p<0.05 or p<0.01). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses revealed that upregulated differentially significant expressed proteins (DSEPs) were associated with mainly immune responses, including integrin alpha M, inter-alpha-trypsin inhibitor heavy chain 4, and alpha-2-macroglobulin. This study is the first in which a rat model of S. aureusinduced mastitis was used to explore the proteins related to mastitis in dairy cows by TMT technology, providing a model for replication of dairy cow S. aureus-induced mastitis experiments.	[Cai, Lirong; Tong, Jinjin; Zhang, Zhaonan; Jiang, Linshu; Zhang, Hua] Beijing Univ Agr, Anim Sci & Technol Coll, Beijing Key Lab Dairy Cow Nutr, Beijing, Peoples R China; [Zhang, Yonghong; Hou, Xiaolin] Beijing Univ Agr, Anim Sci & Technol Coll, Beijing Key Lab Tradit Chinese Vet Med, Beijing, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture	Zhang, H (corresponding author), Beijing Univ Agr, Anim Sci & Technol Coll, Beijing Key Lab Dairy Cow Nutr, Beijing, Peoples R China.	huazhang0914@163.com	tong, jinjin/GVU-2372-2022	Jiang, Linshu/0000-0002-9076-5749	National Natural Science Foundation of China [31702302, 31802091, 31472245]; Beijing Education Commission Science and Technology Project [SQKM201710020011]; Young Teacher Research Fund of BUA [SXQN2016105]; Da Bei Nong Foundation for Young Teachers [15ZK006]; Research Fund for Academic Degree & Graduate Education of BUA; Beijing Innovation Consortium of Swine Research System [BAIC02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Education Commission Science and Technology Project; Young Teacher Research Fund of BUA; Da Bei Nong Foundation for Young Teachers; Research Fund for Academic Degree & Graduate Education of BUA; Beijing Innovation Consortium of Swine Research System	This work was financially supported by the National Natural Science Foundation of China (Grant no. 31702302, 31802091,HZ), Beijing Education Commission Science and Technology Project (SQKM201710020011,HZ), Young Teacher Research Fund of BUA (SXQN2016105,HZ) and Da Bei Nong Foundation for Young Teachers (15ZK006.HZ). The funds were used to purchase rat and related test reagents and consumables, and the collection, detection, data analysis of mammary gland samples, and preparation of the manuscript. Open Project of Beijing Key Laboratory of Dairy Cow Nutrition, Beijing University of Agriculture provides an experimental place for this experiment.; This study was supported by the National Natural Science Foundation of China (grant no. 31702302, 31472245), Young Teacher Research Fund of BUA (SXQN2016105), Beijing Education Commission Science and Technology Project (SQKM201710020011), Research Fund for Academic Degree & Graduate Education of BUA and Beijing Innovation Consortium of Swine Research System (BAIC02).	Boras M, 2017, J EXP MED, V214, P851, DOI 10.1084/jem.20160647; Bouchard D, 2012, J BACTERIOL, V194, P6292, DOI 10.1128/JB.01188-12; Breyne K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02348; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; BROOKS BW, 1984, CAN J COMP MED, V48, P146; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Guimares JLB, 2017, PREV VET MED, V142, P46, DOI 10.1016/j.prevetmed.2017.04.011; Huang JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-839; Jagielski T, 2014, J DAIRY SCI, V97, P6122, DOI 10.3168/jds.2014-8321; Jeng David, 2011, Recent Pat DNA Gene Seq, V5, P97; Keragala CB, 2018, BRIT J HAEMATOL, V180, P782, DOI 10.1111/bjh.15062; Laban H, 2018, J CELL BIOL, V217, P1503, DOI 10.1083/jcb.201702048; Lee HY, 2000, INFECT IMMUN, V68, P4274, DOI 10.1128/IAI.68.7.4274-4281.2000; Lee KY, 2015, INT J CHRONIC OBSTR, V10, P831, DOI 10.2147/COPD.S81611; Li ZH, 2019, CHIN J NAT MEDICINES, V17, P241, DOI 10.1016/S1875-5364(19)30028-7; Lu J, 2013, J PROTEOME RES, V12, P3288, DOI 10.1021/pr4001306; Luoreng ZM, 2018, INT J BIOL SCI, V14, P87, DOI 10.7150/ijbs.22498; Mudaliar M, 2016, MOL BIOSYST, V12, P2748, DOI 10.1039/c6mb00290k; Murphy-Ullrich JE, 2019, J HISTOCHEM CYTOCHEM, V67, P683, DOI 10.1369/0022155419851103; Nancey S, 2008, DIGEST DIS SCI, V53, P242, DOI 10.1007/s10620-007-9849-6; PANKEY JW, 1985, J DAIRY SCI, V68, P726, DOI 10.3168/jds.S0022-0302(85)80879-1; Pineiro M, 2004, INFECT IMMUN, V72, P3777, DOI 10.1128/IAI.72.7.3777-3782.2004; PRASAD LBM, 1968, CANADIAN VET J, V9, P107; Rocha LS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220804; Ruegg PL, 2017, J DAIRY SCI, V100, P10381, DOI 10.3168/jds.2017-13023; Schmidt T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00511; Soler L, 2019, VET IMMUNOL IMMUNOP, V217, DOI 10.1016/j.vetimm.2019.109922; Soler L, 2019, J DAIRY SCI, V102, P539, DOI 10.3168/jds.2018-14953; Suzuki-Hatano S, 2019, MOL THER-METH CLIN D, V13, P167, DOI 10.1016/j.omtm.2019.01.007; Vrieling M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37759; Wang H, 2019, J DAIRY SCI, V102, P8264, DOI [10.3168/jds.2019-16414, 10.316]; Wang H, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0116-0; Yang M, 2017, INT J FOOD SCI NUTR, V68, P671, DOI 10.1080/09637486.2017.1279129; Zhang HM, 2018, J AGR FOOD CHEM, V66, P11188, DOI 10.1021/acs.jafc.8b02386; Zhang XC, 2019, MOLECULES, V24, DOI 10.3390/molecules24142641; Zhou KX, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11100524; Zhu YM, 2007, INT IMMUNOPHARMACOL, V7, P435, DOI 10.1016/j.intimp.2006.10.008	37	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0231168	10.1371/journal.pone.0231168	http://dx.doi.org/10.1371/journal.pone.0231168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365127	Green Published, gold			2022-12-26	WOS:000536959700009
J	Falero-Perez, J; Sheibani, N; Sorenson, CM				Falero-Perez, Juliana; Sheibani, Nader; Sorenson, Christine M.			Bim expression modulates the pro-inflammatory phenotype of retinal astroglial cells	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; BCL-2 FAMILY-MEMBERS; VASCULAR DEVELOPMENT; SOLUBLE RECEPTOR; IL-6; THROMBOSPONDIN-1; ANGIOGENESIS; RECRUITMENT; ASTROCYTES; MIGRATION	Apoptosis of neurovascular cells, including astroglial cells, contributes to the pathogenesis of diseases in which neurovascular disruption plays a central role. Bim is a pro-apoptotic protein that modulates not only apoptosis but also various cellular functions such as migration and extracellular matrix protein expression. Astroglial cells act as an intermediary between neural and vascular cells facilitating retinal vascular development and remodeling while maintaining normal vascular function and neuronal integrity. We previously showed that Bim deficient (Bim -/-) mice were protected from hyperoxia mediated vessel obliteration and ischemia-mediated retinal neovascularization. However, the underlying mechanisms and more specifically the role Bim expression in astroglial cells play remains elusive. Here, using retinal astroglial cells prepared from wild-type and Bim -/- mice, we determined the impact of Bim expression in retinal astroglial cell function. We showed that astroglial cells lacking Bim expression demonstrate increased VEGF expression and altered matricellular protein production including increased expression of thrombospondin-2 (TSP2), osteopontin and SPARC. Bim deficient astroglial cells also exhibited altered proliferation, migration, adhesion to various extracellular matrix proteins and increased expression of inflammatory mediators. Thus, our data emphasizes the importance of Bim expression in retinal astroglia cell autonomous regulatory mechanisms, which could influence neurovascular function.	[Falero-Perez, Juliana; Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA; [Falero-Perez, Juliana; Sheibani, Nader; Sorenson, Christine M.] Univ Wisconsin, McPherson Eye Res Inst, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Sheibani, Nader] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Sorenson, Christine M.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sorenson, CM (corresponding author), Univ Wisconsin, McPherson Eye Res Inst, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Sorenson, CM (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	cmsorenson@pediatrics.wisc.edu		Sorenson, Christine/0000-0001-8461-6619	Research to Prevent Blindness [P30 EY016665, P30 CA014520, EPA 83573701, R24 EY022883, R01 EY026078]; RRF/Daniel M. Albert Chair, Villas Life Cycle Professorship [R01 EY030076]; RPB Stein Innovation Award; T32 training grant [T32 ES007015]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RRF/Daniel M. Albert Chair, Villas Life Cycle Professorship; RPB Stein Innovation Award; T32 training grant	This work was supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation, P30 EY016665, P30 CA014520, EPA 83573701, R24 EY022883, and R01 EY026078. CMS is supported by the RRF/Daniel M. Albert Chair, Villas Life Cycle Professorship and R01 EY030076. NS is a recipient of RPB Stein Innovation Award. JFP is supported by a T32 training grant T32 ES007015.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848; Bouillet P, 2002, J CELL SCI, V115, P1567; Bouillet P, 2000, ANN NY ACAD SCI, V926, P83; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dharmarajan S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0855-0; Dharmarajan S, 2014, MOL VIS, V20, P1085; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Grutzmacher C, 2010, AM J PHYSIOL-LUNG C, V299, pL607, DOI 10.1152/ajplung.00390.2009; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; JIANG B, 1995, GLIA, V15, P1, DOI 10.1002/glia.440150102; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kondo S, 2008, AM J PHYSIOL-CELL PH, V294, pC1521, DOI 10.1152/ajpcell.90633.2007; Kondo S, 2007, AM J PHYSIOL-CELL PH, V292, pC2070, DOI 10.1152/ajpcell.00489.2006; KORSMEYER SJ, 1992, CANCER SURV, V15, P105; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Morrison Margaret E, 2013, Int J Cell Biol, V2013, P297537, DOI 10.1155/2013/297537; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Rattner A, 2019, J CLIN INVEST, V129, P3807, DOI 10.1172/JCI126655; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rust R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40135-2; Scatizzi JC, 2006, ARTHRITIS RHEUM, V54, P3182, DOI 10.1002/art.22133; Scatizzi JC, 2010, ARTHRITIS RHEUM-US, V62, P441, DOI 10.1002/art.27198; Scheef E, 2005, MOL VIS, V11, P613; Scheef EA, 2007, MOL VIS, V13, P1483; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sheibani N, 2012, AM J PHYSIOL-RENAL, V302, pF809, DOI 10.1152/ajprenal.00498.2011; Shim MS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0171-8; Tao CQ, 2016, CELL REP, V17, P1832, DOI 10.1016/j.celrep.2016.10.035; Tsai F, 2017, J EXP MED, V214, P3753, DOI 10.1084/jem.20170479; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; Wang SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178198; Wang SJ, 2011, DEV BIOL, V349, P296, DOI 10.1016/j.ydbio.2010.10.034; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Zhang X, 1997, LAND DEGRAD DEV, V8, P1, DOI 10.1002/(SICI)1099-145X(199703)8:1<1::AID-LDR240>3.0.CO;2-X; Ziehr J, 2004, AM J PHYSIOL-RENAL, V287, pF1154, DOI 10.1152/ajprenal.00129.2004	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232779	10.1371/journal.pone.0232779	http://dx.doi.org/10.1371/journal.pone.0232779			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365083	Green Published, gold			2022-12-26	WOS:000536959700061
J	Moseson, H; Lunn, MR; Katz, A; Fix, L; Durden, M; Stoeffler, A; Hastings, J; Cudlitz, L; Goldberg, E; Lesser-Lee, B; Letcher, L; Reyes, A; Flentje, A; Capriotti, MR; Lubensky, ME; Obedin-Maliver, J				Moseson, Heidi; Lunn, Mitchell R.; Katz, Anna; Fix, Laura; Durden, Mary; Stoeffler, Ari; Hastings, Jen; Cudlitz, Lyndon; Goldberg, Eli; Lesser-Lee, Bori; Letcher, Laz; Reyes, Aneidys; Flentje, Annesa; Capriotti, Matthew R.; Lubensky, Micah E.; Obedin-Maliver, Juno			Development of an affirming and customizable electronic survey of sexual and reproductive health experiences for transgender and gender nonbinary people	PLOS ONE			English	Article							ORIENTATION; IDENTITY; CARE	To address pervasive measurement biases in sexual and reproductive health (SRH) research, our interdisciplinary team created an affirming, customizable electronic survey to measure experiences with contraceptive use, pregnancy, and abortion for transgender and gender nonbinary people assigned female or intersex at birth and cisgender sexual minority women. Between May 2018 and April 2019, we developed a questionnaire with 328 items across 10 domains including gender identity; language used for sexual and reproductive anatomy and events; gender affirmation process history; sexual orientation and sexual activity; contraceptive use and preferences; pregnancy history and desires; abortion history and preferences; priorities for sexual and reproductive health care; family building experiences; and sociodemographic characteristics. Recognizing that the words people use for their sexual and reproductive anatomy can vary, we programmed the survey to allow participants to input the words they use to describe their bodies, and then used those customized words to replace traditional medical terms throughout the survey. This process-oriented paper aims to describe the rationale for and collaborative development of an affirming, customizable survey of the SRH needs and experiences of sexual and gender minorities, and to present summary demographic characteristics of 3,110 people who completed the survey. We also present data on usage of customizable words, and offer the full text of the survey, as well as code for programming the survey and cleaning the data, for others to use directly or as guidelines for how to measure SRH outcomes with greater sensitivity to gender diversity and a range of sexual orientations.	[Moseson, Heidi; Katz, Anna; Durden, Mary] Ibis Reprod Hlth, Oakland, CA 94612 USA; [Lunn, Mitchell R.; Flentje, Annesa; Capriotti, Matthew R.; Lubensky, Micah E.; Obedin-Maliver, Juno] Stanford Univ, PRIDE Study PRIDEnet, Sch Med, Stanford, CA USA; [Lunn, Mitchell R.] Stanford Univ, Dept Med, Div Nephrol, Sch Med, Stanford, CA 94305 USA; [Fix, Laura] Ibis Reprod Hlth, Cambridge, MA USA; [Stoeffler, Ari] Planned Parenthood League Massachusetts, Boston, MA USA; [Hastings, Jen] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA USA; [Cudlitz, Lyndon] Lyndon Cudlitz Consulting Educ & Training, Albany, NY USA; [Goldberg, Eli] Univ Vermont, Robert Lamer MD Coll Med, Burlington, VT USA; [Letcher, Laz] Univ New Mexico, Albuquerque, NM 87131 USA; [Reyes, Aneidys] Edgewood Coll, Madison, WI USA; [Flentje, Annesa] Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA USA; [Flentje, Annesa] Univ Calif San Francisco, Dept Psychiat, Alliance Hlth Project, San Francisco, CA USA; [Capriotti, Matthew R.] San Jose State Univ, Dept Psychol, San Jose, CA 95192 USA; [Obedin-Maliver, Juno] Stanford Univ, Dept Obstet & Gynecol, Sch Med, Stanford, CA USA	Stanford University; Stanford University; University of California System; University of California San Francisco; University of Vermont; University of New Mexico; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Jose State University; Stanford University	Moseson, H (corresponding author), Ibis Reprod Hlth, Oakland, CA 94612 USA.	hmoseson@ibisreproductivehealth.org		Fix, Laura/0000-0001-5655-086X; Lunn, Mitchell/0000-0002-0068-0814	Society of Family Planning [SFPRF11-II1]; Society of Family Planning grant; National Institute of Diabetes, Digestive, and Kidney Disorders [K12DK111028]; Stanford University School of Medicine; Clinical Research Training Fellowship from the American Academy of Neurology and Tourette Association of America; National Institute on Drug Abuse [K23DA039800]	Society of Family Planning; Society of Family Planning grant; National Institute of Diabetes, Digestive, and Kidney Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanford University School of Medicine; Clinical Research Training Fellowship from the American Academy of Neurology and Tourette Association of America; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Society of Family Planning (SFPRF11-II1) to HM; AK, AR, AS, BLL, EG, HM, JH, JOM, LC, LF, LL, and MD received partial support in the form of salaries, stipends or consulting fees from funds provided by the Society of Family Planning grant, but the Society of Family Planning did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. JOM was partially supported by grant K12DK111028 from the National Institute of Diabetes, Digestive, and Kidney Disorders. MRL and JOM were partially supported by Stanford University School of Medicine. MRC was supported by a Clinical Research Training Fellowship from the American Academy of Neurology and Tourette Association of America. AF was supported by National Institute on Drug Abuse K23DA039800. None of the funders had a role in the study design, nor in the collection, analysis, or interpretation of data, nor in the writing of this manuscript, nor the decision to submit the article for publication. The specific roles of funded authors are articulated in the `author contributions' section.	[Anonymous], 2019, AD LGBT POP US UCLA; [Anonymous], 2016, EV SEX OR GEND ID SU; [Anonymous], 2016, NURS HLTH STUD QUEST; Arluck JC, 2018, CLIN OBSTET GYNECOL, V61, P62, DOI 10.1097/GRF.0000000000000338; Austin S Bryn, 2007, J LGBT Health Res, V3, P55; Bauer G., 2012, WHAT DIFFERENCE SEX; Bauer GR, 2009, J ASSOC NURSE AIDS C, V20, P348, DOI 10.1016/j.jana.2009.07.004; Carrotte ER, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0193-4; Centers for Disease Control and Prevention, 2012, PREGN RISK ASS MON S; Centers for Disease Control and Prevention, 2016, 2017 BEH RISK FACT S; Conron Kerith Jane, 2008, J LGBT Health Res, V4, P1, DOI 10.1080/15574090802412572; Dean E., 2007, INT J SOC RES METHOD, V10, P227, DOI [DOI 10.1080/13645570701401032, https://doi.org/10.1080/13645570701401032]; Deutsch MB, 2015, J GEN INTERN MED, V30, P843, DOI 10.1007/s11606-014-3148-7; Fix L, 2020, ARCH SEX BEHAV, V49, P2683, DOI 10.1007/s10508-020-01707-w; Flores AR, 2016, RACE ETHNICITY ADULT; Harris J., 2018, DICT SOCIAL WORK SOC; Hart CG, 2019, J HEALTH SOC BEHAV, V60, P101, DOI 10.1177/0022146519825749; Ingraham N, 2018, BMJ SEX REPROD HLTH; James S. E., 2016, REPORT US TRANSGENDE; Krempasky C, 2019, AM J OBSTET GYNECOL; Moseson H, 2020, OBSTET GYNECOL; Moseson H, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0812-4; Moseson H, 2015, INT J EPIDEMIOL, V44, P1951, DOI 10.1093/ije/dyv174; Patterson JG, 2017, LGBT HEALTH, V4, P82, DOI 10.1089/lgbt.2016.0026; Potter J, 2015, J GEN INTERN MED, V30, P1857, DOI 10.1007/s11606-015-3462-8; Reisner SL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1224; Riley NC, 2017, AM J PUBLIC HEALTH, V107, P1290, DOI 10.2105/AJPH.2017.303834; SGMRO, 2020, NAT I HLTH SEX GEND; Tate CC, 2013, J SEX RES, V50, P767, DOI 10.1080/00224499.2012.690110; Tordoff D, 2019, EPIDEMIOLOGY, V30, P669, DOI 10.1097/EDE.0000000000001046; Truman JL, 2019, J OFF STAT, V35, P835, DOI 10.2478/JOS-2019-0035; VanKim NA, 2010, AM J PUBLIC HEALTH, V100, P2392, DOI 10.2105/AJPH.2009.186270	32	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232154	10.1371/journal.pone.0232154	http://dx.doi.org/10.1371/journal.pone.0232154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3GS	32365110	Green Published, gold			2022-12-26	WOS:000536959700017
J	Shin, NR; Bose, S; Wang, JH; Nam, YD; Song, EJ; Lim, DW; Kim, HB; Lim, YS; Choi, HS; Kim, H				Shin, Na Rae; Bose, Shambhunath; Wang, Jing-Hua; Nam, Young-Do; Song, Eun-Ji; Lim, Dong-Woo; Kim, Hee-Bok; Lim, Yun-Sung; Choi, Han Seok; Kim, Hojun			Chemically or surgically induced thyroid dysfunction altered gut microbiota in rat models	FASEB JOURNAL			English	Article						gut microbiota; hyperthyroidism; hypothyroidism; thyroid function; thyroidectomy	YERSINIA-ENTEROCOLITICA; OBESITY; AUTOIMMUNITY; ASSOCIATION	Thyroid hormones are essential for the regulation of energy homeostasis and metabolic processes. However, the relationship between thyroid function and host gut microbial communities is not properly understood. To determine whether and how gut microbiota is associated with thyroid function, metagenomics analysis of the bacterial population in fecal samples of rat models of hyperthyroidism (induced by levothyroxine) and hypothyroidism (induced by propylthiouracil or thyroidectomy) was conducted through 16S rRNA gene sequencing. Our results revealed that all thyroid dysfunction models were definitely established and gut microbial composition varied according to different thyroid functional status. The relative abundance of Ruminococcus was significantly higher in the hyperthyroidism group (HE) vs both the normal and hypothyroidism groups (HO) while S24-7 was significantly higher in the HO group. The population of Prevotellaceae and Prevotella were significantly lower in the HO group vs the normal. Firmicutes and Oscillospira were significantly higher in the SHO (surgery-induced hypothyroidism) group, while Prevotellaceae and Prevotella showed lower abundance in the SHO group than the SHAM group. Present results suggest that thyroid functions may have the potential to influence the profile of gut microbiota and could be used as foundation to investigate interaction mechanism between thyroid and gut microbiome.	[Shin, Na Rae; Wang, Jing-Hua; Kim, Hojun] Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea; [Bose, Shambhunath] NosQuest, Seongnam Si, South Korea; [Nam, Young-Do; Song, Eun-Ji] Korea Food Res Inst, Res Grp Gut Microbiome, Wanju Gun, South Korea; [Nam, Young-Do; Song, Eun-Ji] Korea Univ Sci & Technol, Dept Food Biotechnol, Wonju, South Korea; [Lim, Dong-Woo] Dongguk Univ, Coll Korean Med, Dept Pathol, Goyang, South Korea; [Kim, Hee-Bok; Lim, Yun-Sung] Dongguk Univ, Dept Otorhinolaryngol Head & Neck Surg, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea; [Choi, Han Seok] Dongguk Univ, Dept Endocrinol, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea	Dongguk University; Korea Food Research Institute (KFRI); Dongguk University; Dongguk University; Dongguk University	Kim, H (corresponding author), Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea.; Lim, YS (corresponding author), Dongguk Univ, Dept Otorhinolaryngol Head & Neck Surg, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea.; Choi, HS (corresponding author), Dongguk Univ, Dept Endocrinol, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea.	splash1@hanmail.net; hschoi402@dumc.or.kr; kimklar@dongguk.ac.kr	Song, Eun-Ji/HDO-8376-2022; Wang, Jing-hua/AAO-2350-2020; Lim, Dongwoo/GLU-0640-2022	Wang, Jing-hua/0000-0002-2034-7429; 	National Research Foundation (NRF) [NRF2019R1A2B5B01070365]; Main Research Program of the Korea Food Research Institute (KFRI) [E0170602-02]	National Research Foundation (NRF); Main Research Program of the Korea Food Research Institute (KFRI)	National Research Foundation (NRF), Grant/Award Number: NRF2019R1A2B5B01070365; Main Research Program of the Korea Food Research Institute (KFRI), Grant/Award Number: E0170602-02	ARSCOTT P, 1992, J CLIN ENDOCR METAB, V75, P295, DOI 10.1210/jc.75.1.295; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; BYFIELD PGH, 1989, J ENDOCRINOL, V121, P571, DOI 10.1677/joe.0.1210571; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Conley MN, 2016, PEERJ, V4, DOI 10.7717/peerj.1854; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Corapcioglu D, 2002, THYROID, V12, P613, DOI 10.1089/105072502320288483; Hage MP, 2012, J THROID RES, V2012, DOI 10.1155/2012/590648; Hoshi N, 2007, ENDOCRINOLOGY, V148, P4251, DOI 10.1210/en.2006-0490; Ishaq HM, 2018, INT J BIOL SCI, V14, P1558, DOI 10.7150/ijbs.24151; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Johnson BM, 2020, J AUTOIMMUN, V108, DOI 10.1016/j.jaut.2020.102420; Kim Seong-Mo, 2012, Evid Based Complement Alternat Med, V2012, P578497, DOI 10.1155/2012/578497; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Kohling HL, 2017, CLIN IMMUNOL, V183, P63, DOI 10.1016/j.clim.2017.07.001; Lauritano EC, 2007, J CLIN ENDOCR METAB, V92, P4180, DOI 10.1210/jc.2007-0606; Limonard EJ, 2012, SCI WORLD J, P1, DOI 10.1100/2012/548796; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; MKGarg NM, 2017, PRINC PRACT THYROID, V22, P3; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nilsson M, 2017, DEVELOPMENT, V144, P2123, DOI 10.1242/dev.145615; Okamoto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080801; Pearson K, 1909, Science, V30, P23, DOI 10.1126/science.30.757.23; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005; Salam MH A, 2015, BASIC SCI MED, V4, P12; Sari R, 2003, CLIN ENDOCRINOL, V59, P258, DOI 10.1046/j.1365-2265.2003.01836.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHENKMAN L, 1976, ANN INTERN MED, V85, P735, DOI 10.7326/0003-4819-85-6-735; Shin NR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02271; Taylor PN, 2013, J CLIN ENDOCR METAB, V98, P3562, DOI 10.1210/jc.2013-1315; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Varian B, 2014, J OBES WEIGHT LOSS T, V4; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086117, 10.1371/journal.pone.0101358]; WENZEL BE, 1988, LANCET, V1, P56; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44; Zhou L, 2014, CURR MICROBIOL, V69, P675, DOI 10.1007/s00284-014-0640-6	47	7	7	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8686	8701		10.1096/fj.201903091RR	http://dx.doi.org/10.1096/fj.201903091RR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32356337				2022-12-26	WOS:000530007100001
J	Bardon, VF; Peytavin, G; Le, MP; Guilleminot, T; Elefant, E; Stirnemann, J; Leruez-Ville, M; Ville, Y				Bardon, Valentine Faure; Peytavin, Gilles; Le, Minh Patrick; Guilleminot, Tiffany; Elefant, Elisabeth; Stirnemann, Julien; Leruez-Ville, Marianne; Ville, Yves			Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection	PLOS ONE			English	Article							ANTIPYRINE; PREGNANCY; 1263W94; SAFETY; DRUG	Background Congenital cytomegalovirus infection can lead to severe sequelae. When fetal infection is confirmed, we hypothesize that fetal treatment could improve the outcome. Maternal oral administration of an effective drug crossing the placenta could allow fetal treatment. Letermovir (LMV) and Maribavir (MBV) are new CMV antivirals, and potential candidates for fetal treatment. Methods The objective was to investigate the placental transfer of LMV and MBV in the ex vivo method of the human perfused cotyledon. Term placentas were perfused, in an open-circuit model, with LMV or MBV at concentrations in the range of clinical peak plasma concentrations. Concentrations were measured using ultraperformance liquid chromatography coupled with tandem mass spectrometry. Mean fetal transfer rate (FTR) (fetal (FC) /maternal concentration), clearance index (CLI), accumulation index (AI) (retention of each drug in the cotyledon tissue) were measured. Mean FC were compared with half maximal effective concentrations of the drugs (EC50(LMV) and EC50(MBV)). Results For LMV, the mean FC was (+/- standard deviation) 1.1 +/- 0.2 mg/L, 1,000-fold above the EC50(LMV). Mean FTR, CLI and AI were 9 +/- 1%, 35 +/- 6% and 4 +/- 2% respectively. For MBV, the mean FC was 1.4 +/- 0.2 mg/L, 28-fold above the EC50(MBV). Mean FTR, CLI and AI were 10 +/- 1%, 50 +/- 7% and 2 +/- 1% respectively. Conclusions Drugs' concentrations in the fetal side should be in the range for in utero treatment of fetuses infected with CMV as the mean FC was superior to the EC50 for both molecules.	[Bardon, Valentine Faure; Stirnemann, Julien; Ville, Yves] Necker Enfants Malades Hosp, APHP, Fetal Med & Obstet Dept, Paris, France; [Bardon, Valentine Faure; Guilleminot, Tiffany; Stirnemann, Julien; Leruez-Ville, Marianne; Ville, Yves] Univ Paris 05, IMAGINE Inst, EHU7328, Paris, France; [Peytavin, Gilles; Le, Minh Patrick] Univ Paris, APHP, Pharmacol & Toxicol Lab, Paris, France; [Peytavin, Gilles; Le, Minh Patrick] Univ Paris, IAME, Inserm UMR 1137, Paris, France; [Guilleminot, Tiffany; Leruez-Ville, Marianne] Necker Enfants Malades Hosp, APHP, Virol Lab, Natl Reference Lab Congenital CMV, Paris, France; [Elefant, Elisabeth] Trousseau Hosp, APHP, Reference Ctr Teratogen Agents, CRAT, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Ville, Y (corresponding author), Necker Enfants Malades Hosp, APHP, Fetal Med & Obstet Dept, Paris, France.; Ville, Y (corresponding author), Univ Paris 05, IMAGINE Inst, EHU7328, Paris, France.	yves.ville@aphp.fr		Faure Bardon, Valentine/0000-0002-7510-9364	University Paris Descartes	University Paris Descartes	This work was supported by the University Paris Descartes.	Bapat P, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.065; Berveiller P, 2017, J MATERN-FETAL NEO M, V30, P1347, DOI 10.1080/14767058.2016.1213807; Berveiller P, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.023; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; Ceccaldi PF, 2010, J GYNECOL OBST BIO R, V39, P601, DOI 10.1016/j.jgyn.2010.06.010; Challier J C, 1985, Contrib Gynecol Obstet, V13, P32; CHALLIER JC, 1983, REPROD NUTR DEV, V23, P41, DOI 10.1051/rnd:19830104; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Dropulic LK, 2010, CLIN PHARMACOL THER, V88, P610, DOI 10.1038/clpt.2010.178; Evain-Brion D, 2014, THERAPIE, V69, P3, DOI 10.2515/therapie/2014002; Faure-Bardon V, 2018, AIDS, V32, P321, DOI 10.1097/QAD.0000000000001681; Gavard L, 2006, AM J OBSTET GYNECOL, V195, P296, DOI 10.1016/j.ajog.2006.01.017; Koren G, 2002, DRUGS, V62, P757, DOI 10.2165/00003495-200262050-00004; Koszalka GW, 2002, ANTIMICROB AGENTS CH, V46, P2373, DOI 10.1128/AAC.46.8.2373-2380.2002; KRAUER B, 1984, BRIT J OBSTET GYNAEC, V91, P875, DOI 10.1111/j.1471-0528.1984.tb03700.x; Kropeit D, 2017, BRIT J CLIN PHARMACO, V83, P1944, DOI 10.1111/bcp.13292; Leruez-Ville M, 2017, BEST PRACT RES CL OB, V38, P97, DOI 10.1016/j.bpobgyn.2016.10.005; Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.003; Lischka P, 2010, ANTIMICROB AGENTS CH, V54, P1290, DOI 10.1128/AAC.01596-09; Mandelbrot L, 2015, ANTIMICROB AGENTS CH, V59, P2901, DOI 10.1128/AAC.00075-15; Mandelbrot L, 2014, ANTIMICROB AGENTS CH, V58, P5617, DOI 10.1128/AAC.03184-14; Marty FM, 2017, NEW ENGL J MED, V377, P2433, DOI 10.1056/NEJMoa1706640; Mathiesen L, 2010, REPROD TOXICOL, V30, P138, DOI 10.1016/j.reprotox.2010.01.006; Melendez DP, 2015, INFECT DRUG RESISTAN; Myllynen P, 2013, TOXICOL IN VITRO, V27, P507, DOI 10.1016/j.tiv.2012.08.027; Ring JA, 1999, PHARMACOL THERAPEUT, V84, P429, DOI 10.1016/S0163-7258(99)00046-7; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Stone KM, 2004, BIRTH DEFECTS RES A, V70, P201, DOI 10.1002/bdra.20013; Vinot C, 2016, ANTIMICROB AGENTS CH, V60, P3112, DOI 10.1128/AAC.00007-16; Wang LH, 2003, ANTIMICROB AGENTS CH, V47, P1334, DOI 10.1128/AAC.47.4.1334-1342.2003	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232140	10.1371/journal.pone.0232140	http://dx.doi.org/10.1371/journal.pone.0232140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353010	Green Published, gold			2022-12-26	WOS:000536673200043
J	Cumbane, V; Imbach, M; Chissumba, RM; Macicame, I; Eller, LA; Lawlor, J; Milazzo, M; Li, Q; Crowell, T; Mutombene, M; Guiliche, O; Viegas, E; Nwoga, C; Yates, A; Michael, N; Robb, M; Polyak, CS; Jani, IV; Bhatt, N				Cumbane, Victoria; Imbach, Michelle; Chissumba, Raquel Matavele; Macicame, Ivalda; Eller, Leigh Anne; Lawlor, John; Milazzo, Mark; Li, Qun; Crowell, Trevor; Mutombene, Mirna; Guiliche, Onelia; Viegas, Edna; Nwoga, Chiaka; Yates, Adam; Michael, Nelson; Robb, Merlin; Polyak, Christina S.; Jani, Ilesh V.; Bhatt, Nilesh			Determining hematological, biochemical and immunological reference values in healthy adults with high-risk for HIV acquisition in Mozambique	PLOS ONE			English	Article							REFERENCE RANGES; POPULATION	Introduction In many African countries, laboratory reference values are not established for the local healthy adult population. In Mozambique, reference values are known for young adults (18-24yo) but not yet established for a wider age range. Our study aimed to establish hematological, biochemical and immunological reference values for vaccine trials in Mozambican healthy adults with high-risk for HIV acquisition. Methods A longitudinal cohort and site development study in Mozambique between November 2013 and 2014 enrolled 505 participants between 18 to 35 years old. Samples from these healthy participants, were analyzed to determine reference values. All volunteers included in the analysis were clinically healthy and human immunodeficiency virus (HIV), hepatitis B and C virus, and syphilis negative. Median and reference ranges were calculated for the hematological, biochemical and immunological parameters. Ranges were compared with other African countries, the USA and the US National Institute of Health (NIH) Division of AIDS (DAIDS) toxicity tables. Results A total of 505 participant samples were analyzed. Of these, 419 participants were HIV, hepatitis B and C virus and syphilis negative including 203 (48.5%) females and 216 (51.5%) males, with a mean age of 21 years. In the hematological parameters, we found significant differences between sex for erythrocytes, hemoglobin, hematocrit, MCV, MCH and MCHC as well as white blood cells, neutrophils and platelets: males had higher values than females. There were also significant differences in CD4(+)T cell values, 803 cells/mu L in men versus 926 cells/mu L in women. In biochemical parameters, men presented higher values than women for the metabolic, enzymatic and renal parameters: total and direct bilirubin, ALT and creatinine. Conclusion This study has established reference values for healthy adults with high-risk for HIV acquisition in Mozambique. These data are helpful in the context of future clinical research and patient care and treatment for the general adult population in the Mozambique and underline the importance of region-specific clinical reference ranges.	[Cumbane, Victoria; Chissumba, Raquel Matavele; Macicame, Ivalda; Mutombene, Mirna; Guiliche, Onelia; Viegas, Edna; Jani, Ilesh V.; Bhatt, Nilesh] Minist Saude MISAU, Inst Nacl Saude INS, Ctr Invest & Treino Saude Polana Canico CISPOC, Maputo, Mozambique; [Imbach, Michelle; Eller, Leigh Anne; Lawlor, John; Milazzo, Mark; Li, Qun; Crowell, Trevor; Nwoga, Chiaka; Yates, Adam; Michael, Nelson; Polyak, Christina S.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA; [Imbach, Michelle; Eller, Leigh Anne; Lawlor, John; Milazzo, Mark; Li, Qun; Crowell, Trevor; Nwoga, Chiaka; Yates, Adam; Robb, Merlin; Polyak, Christina S.] Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Polyak, CS (corresponding author), Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA.; Polyak, CS (corresponding author), Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	cpolyak@hivresearch.org	Crowell, Trevor A./W-3904-2019	Crowell, Trevor A./0000-0001-5947-265X; Matavele Chissumba, Raquel/0000-0003-1957-340X; Nwoga, Chiaka/0000-0002-4514-330X	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067, 3167]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; U.S. National Institute of Allergy and Infectious Diseases	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). This research was funded, in part, by the U.S. National Institute of Allergy and Infectious Diseases. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army, the Department of Defense, or the National Institutes of Health. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. Financial assistance was provided by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to the Instituto Nacional de Sau ' de (INS) under the terms of the Clinical Services Agreement No. 3167. The funders had no role in the study, data collection, analysis, decision to publish or preparation of the manuscript.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; Division of AIDS (DAIDS),, 2014, TABL GRAD SEV AD PED; Dogan E, 2005, RENAL FAILURE, V27, P421, DOI 10.1081/JDI-200065342; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Inquerito de Indicadores de Imunizacao, 2015, MAL HIV SIDA MOC; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kueviakoe Irenee Messanh, 2011, ISRN Hematol, V2011, P736062, DOI 10.5402/2011/736062; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; Mulu W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181268; Odhiambo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123140; Palacpac NMQ, 2014, INT J ENV RES PUB HE, V11, P4870, DOI 10.3390/ijerph110504870; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; Tembe N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097391; Tukey JW, 1977, EXPLORATORY DATA ANA; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232018	10.1371/journal.pone.0232018	http://dx.doi.org/10.1371/journal.pone.0232018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352972	gold, Green Published			2022-12-26	WOS:000536673200035
J	Miyazawa, M; Takatori, H; Kawaguchi, K; Kitamura, K; Arai, K; Matsuda, K; Urabe, T; Inamura, K; Komura, T; Mizuno, H; Fuchizaki, U; Yamashita, T; Sakai, Y; Yamashita, T; Mizukoshi, E; Honda, M; Kaneko, S				Miyazawa, Masaki; Takatori, Hajime; Kawaguchi, Kazunori; Kitamura, Kazuya; Arai, Kuniaki; Matsuda, Koichiro; Urabe, Takeshi; Inamura, Katsuhisa; Komura, Takuya; Mizuno, Hideki; Fuchizaki, Uichiro; Yamashita, Taro; Sakai, Yoshio; Yamashita, Tatsuya; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi			Management of biliary stricture in patients with IgG4-related sclerosing cholangitis	PLOS ONE			English	Article							AUTOIMMUNE PANCREATITIS; BILE-DUCT; CONSENSUS; OUTCOMES; CANCER; RISK	Background We aimed to determine the optimal approach with endoscopic biliary drainage (EBD) and corticosteroid (CS) for the treatment of IgG4-related sclerosing cholangitis (ISC). Methods To evaluate the safety of EBD for treatment of biliary stricture caused by ISC, we assessed the risk of stent dislodgement and sought to determine the most appropriate time for stent removal. We also assessed the safety of treatment with CS alone for patients with obstructive jaundice, and the rate of and risk factors for biliary tract complications. Results Sixty-nine patients with ISC treated with CS were enrolled. Twenty-eight patients (40.6%) were treated with EBD for biliary stricture before CS initiation. Intentional stent removal was performed in thirteen (46.4%) after confirming CS-induced improvement. Eleven of thirteen patients (84.6%) underwent stent removal within 1 month after CS initiation and all their stent removals were safely carried out without early (within two weeks) recurrence of obstructive jaundice. Ten of twenty-eight patients (35.7%) experienced spontaneous stent dislodgement after CS initiation, and seven (70%) of them developed stent dislodgement two weeks to two months after CS initiation. Among forty-one patients treated with CS alone without EBD, 10 patients had obstructive jaundice at the time of CS initiation and all of them achieved clinical improvement without biliary tract infection. During the follow-up, three patients (4.3%), all of whom had undergone EBD, developed bile-duct stones, while none of those treated with CS alone developed bile-duct stones (p = 0.032). Long-term biliary stenting was a risk factor for bile-duct stones. Conclusions Biliary stent removal should be carried out within 2 weeks after CS initiation if biliary stricture improves to prevent stent dislodgement. Obstructive jaundice can be treated safely with CS alone in patients without infection. Clinicians should be aware of the possibility of bile-duct stones in patients treated with EBD.	[Miyazawa, Masaki; Takatori, Hajime; Kawaguchi, Kazunori; Kitamura, Kazuya; Arai, Kuniaki; Yamashita, Taro; Sakai, Yoshio; Yamashita, Tatsuya; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Matsuda, Koichiro] Toyama Prefectural Cent Hosp, Dept Internal Med, Toyama, Japan; [Urabe, Takeshi] Publ Cent Hosp Matto Ishikawa, Dept Gastroenterol, Haku San, Japan; [Inamura, Katsuhisa] Tonami Gen Hosp, Dept Internal Med, Tonami, Toyama, Japan; [Komura, Takuya] Natl Hosp Org Kanazawa Med Ctr, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Mizuno, Hideki] Toyama City Hosp, Dept Gastroenterol, Toyama, Japan; [Fuchizaki, Uichiro] Keiju Med Ctr, Dept Gastroenterol, Nanao, Japan	Kanazawa University	Miyazawa, M (corresponding author), Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.	miyacchi_1985@yahoo.co.jp	Yamashita, Tatsuya/K-8648-2015; Miyazawa, Masaki/AAD-4425-2021	Yamashita, Tatsuya/0000-0002-3602-8086; Miyazawa, Masaki/0000-0003-0341-1123; Kawaguchi, Kazunori/0000-0002-4927-1704				Bi Y, 2016, PANCREATOLOGY, V16, P391, DOI 10.1016/j.pan.2016.03.017; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; Hirano K, 2016, J CLIN GASTROENTEROL, V50, P331, DOI 10.1097/MCG.0000000000000440; Hirano K, 2014, INTERNAL MED, V53, P171, DOI 10.2169/internalmedicine.53.1342; Huggett MT, 2014, AM J GASTROENTEROL, V109, P1675, DOI 10.1038/ajg.2014.223; Hyoung-Chul O, 2008, INTERNAL MED, V47, P2025, DOI 10.2169/internalmedicine.47.1347; Iwasaki S, 2015, ADV MED SCI-POLAND, V60, P211, DOI 10.1016/j.advms.2015.02.006; Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Kamisawa T, 2019, J HEPATO-BIL-PAN SCI, V26, P9, DOI 10.1002/jhbp.596; Kamisawa T, 2014, J GASTROENTEROL, V49, P961, DOI 10.1007/s00535-014-0945-z; Kamisawa T, 2009, PANCREAS, V38, P890, DOI 10.1097/MPA.0b013e3181b65a1c; Mady RF, 2015, CASE REPORTS, V2015; Miyazawa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188549; Nakanuma Y, 2014, HISTOL HISTOPATHOL; Nakazawa T, 2005, PANCREAS, V30, P20; Nakazawa T, 2012, J GASTROENTEROL, V47, P79, DOI 10.1007/s00535-011-0465-z; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Okazaki K, 2017, PANCREATOLOGY, V17, P1, DOI 10.1016/j.pan.2016.12.003; Park DH, 2000, ROM J GASTROENTEROL, V9, P269; Shiokawa M, 2013, AM J GASTROENTEROL, V108, P610, DOI 10.1038/ajg.2012.465; Straub BK, 2011, VIRCHOWS ARCH, V458, P761, DOI 10.1007/s00428-011-1073-2; Tanaka A, 2017, CLIN GASTROENTEROL H, V15, P920, DOI 10.1016/j.cgh.2016.12.038; Watanabe T, 2014, PANCREAS, V43, P255, DOI 10.1097/01.mpa.0000437323.52598.20; You MW, 2014, EUR RADIOL, V24, P1039, DOI 10.1007/s00330-014-3127-8; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c	26	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232089	10.1371/journal.pone.0232089	http://dx.doi.org/10.1371/journal.pone.0232089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353060	Green Published, gold			2022-12-26	WOS:000536673200040
J	Ramkissoon, S; MacArthur, I; Ibrahim, M; de Graaf, H; Read, RC; Preston, A				Ramkissoon, Stacy; MacArthur, Iain; Ibrahim, Muktar; de Graaf, Hans; Read, Robert C.; Preston, Andrew			A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE; NETHERLANDS; SEQUENCES; DISEASE; GENOME; PCR	Bordetella pertussis is the causative agent of whooping cough, commonly referred to as pertussis. Although the incidence of pertussis was reduced through vaccination, during the last thirty years it has returned to high levels in a number of countries. This resurgence has been linked to the switch from the use of whole-cell to acellular vaccines. Protection afforded by acellular vaccines appears to be short-lived compared to that afforded by whole cell vaccines. In order to inform future vaccine improvement by identifying immune correlates of protection, a human challenge model of B. pertussis colonisation has been developed. Accurate measurement of colonisation status in this model has required development of a qPCR-based assay to enumerate B. pertussis in samples that distinguishes between viable and dead bacteria. Here we report the development of this assay and its performance in the quantification of B. pertussis from human challenge model samples. This assay has future utility in diagnostic labs and in research where a quantitative measure of both B. pertussis number and viability is required.	[Ramkissoon, Stacy; MacArthur, Iain; Preston, Andrew] Univ Bath, Milner Ctr Evolut, Bath, Avon, England; [Ramkissoon, Stacy; MacArthur, Iain; Preston, Andrew] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Ibrahim, Muktar; de Graaf, Hans; Read, Robert C.] Univ Southampton, Fac Med, Southampton, Hants, England; [Ibrahim, Muktar; de Graaf, Hans; Read, Robert C.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Ibrahim, Muktar; de Graaf, Hans; Read, Robert C.] Univ Southampton, Southampton Gen Hosp, Univ Hosp Southampton NHS Fdn Trust, Sch Clin Expt Sci, Southampton, Hants, England; [Ibrahim, Muktar; de Graaf, Hans; Read, Robert C.] Univ Southampton, Southampton Gen Hosp, Univ Hosp Southampton NHS Fdn Trust, NIHR Clin Res Facil, Southampton, Hants, England; [Ibrahim, Muktar; de Graaf, Hans; Read, Robert C.] Univ Southampton, Southampton Gen Hosp, Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England	University of Bath; University of Bath; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust	Preston, A (corresponding author), Univ Bath, Milner Ctr Evolut, Bath, Avon, England.; Preston, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	a.preston@bath.ac.uk	de Graaf, Hans/J-3381-2017	Read, Robert/0000-0002-4297-6728; Ramkissoon, Stacy/0000-0002-9829-4531; Preston, Andrew/0000-0002-1489-280X; Ibrahim, Muktar/0000-0002-2027-3095	Innovative Medicines Initiative 2 Joint Undertaking [115910]; European Union; EFPIA; BMGF; MRC [MR/N013204/1, MR/N026993/1] Funding Source: UKRI	Innovative Medicines Initiative 2 Joint Undertaking; European Union(European Commission); EFPIA; BMGF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding to the PERISCOPE Consortium (AP, HDG, RR). PERISCOPE has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115910. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and BMGF. https://www.imi.europa.eu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AM, 2015, PEDIATRICS, V135, P981, DOI [10.1542/peds.2014-3358, 10.1542/peds.2014-4118]; Althouse BM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0382-8; Bart M. J., 2014, GENOME ANNOUNC, V2, P2; Bodilis H, 2013, EMERG INFECT DIS, V19, P471, DOI 10.3201/1903.121475; de Graaf H, 2020, CLIN INFECT DIS, V71, P403, DOI 10.1093/cid/ciz840; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; Diavatopoulos DA, 2019, LANCET INFECT DIS, V19, pE179, DOI 10.1016/S1473-3099(18)30646-7; HPA, 2012, HEAL PROT REP, V6; Kanojia G, 2018, J CONTROL RELEASE, V286, P167, DOI 10.1016/j.jconrel.2018.07.035; Kilgore PE, 2016, CLIN MICROBIOL REV, V29, P449, DOI 10.1128/CMR.00083-15; Lam C, 2014, EMERG INFECT DIS, V20, P626, DOI 10.3201/eid2004.131478; Martini H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175587; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Nkuipou-Kenfack E, 2013, J MICROBIOL METH, V93, P20, DOI 10.1016/j.mimet.2013.01.018; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pawloski LC, 2014, CLIN VACCINE IMMUNOL, V21, P119, DOI 10.1128/CVI.00717-13; Probert WS, 2008, J CLIN MICROBIOL, V46, P3228, DOI 10.1128/JCM.00386-08; Ring N, 2019, ADV EXP MED BIOL, V1183, P1, DOI 10.1007/5584_2019_401; Ring N, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000234; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Ruike W, 2016, WATER SCI TECHNOL, V74, P1243, DOI 10.2166/wst.2016.327; Safarchi A, 2015, VACCINE, V33, P6277, DOI 10.1016/j.vaccine.2015.09.064; Schuh G, 2015, CIRP J MANUF SCI TEC, V10, P1, DOI 10.1016/j.cirpj.2015.05.007; Spokes Paula J, 2010, N S W Public Health Bull, V21, P167, DOI 10.1071/NB10031; Taylor Michael J, 2014, Microbiol Insights, V7, P15, DOI 10.4137/MBI.S17723; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; Warfel JM, 2013, MUCOSAL IMMUNOL, V6, P787, DOI 10.1038/mi.2012.117; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Wu B, 2015, J MICROBIOL METH, V115, P147, DOI 10.1016/j.mimet.2015.05.016; Zeddeman A, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.33.20881	32	2	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232334	10.1371/journal.pone.0232334	http://dx.doi.org/10.1371/journal.pone.0232334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353041	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000536673200079
J	Vlacil, AK; Vollmeister, E; Bertrams, W; Schoesser, F; Oberoi, R; Schuett, J; Schuett, H; Huehn, S; Bedenbender, K; Schmeck, BT; Schieffer, B; Grote, K				Vlacil, Ann-Kathrin; Vollmeister, Evelyn; Bertrams, Wilhelm; Schoesser, Florian; Oberoi, Raghav; Schuett, Jutta; Schuett, Harald; Huehn, Sonja; Bedenbender, Katrin; Schmeck, Bernd T.; Schieffer, Bernhard; Grote, Karsten			Identification of microRNAs involved in NOD-dependent induction of pro-inflammatory genes in pulmonary endothelial cells	PLOS ONE			English	Article							IMMUNE-RESPONSES; FAMILY-MEMBER; ACTIVATION; EXPRESSION; MIR-147; PROTEIN	The nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 are mammalian cytosolic pattern recognition receptors sensing bacterial peptidoglycan fragments in order to initiate cytokine expression and pathogen host defense. Since endothelial cells are relevant cells for pathogen recognition at the blood/tissue interface, we here analyzed the role of NOD1- and NOD2-dependently expressed microRNAs (miRNAs, miR) for cytokine regulation in murine pulmonary endothelial cells. The induction of inflammatory cytokines in response to NOD1 and NOD2 was confirmed by increased expression of tumour necrosis factor (Tnf)-alpha and interleukin (Il)-6. MiRNA expression profiling revealed NOD1- and NOD2-dependently regulated miRNA candidates, of which miR-147-3p, miR-200a-3p, and miR-298-5p were subsequently validated in pulmonary endothelial cells isolated from Nod1/2-deficient mice. Analysis of the two down-regulated candidates miR-147-3p and miR-298-5p revealed predicted binding sites in the 3' untranslated region (UTR) of the murine Tnf-alpha and Il-6 mRNA. Consequently, transfection of endothelial cells with miRNA mimics decreased Tnf-alpha and Il-6 mRNA levels. Finally, a novel direct interaction of miR-298-5p with the 3' UTR of the Il-6 mRNA was uncovered by luciferase reporter assays. We here identified a mechanism of miRNA-down-regulation by NOD stimulation thereby enabling the induction of inflammatory gene expression in endothelial cells.	[Vlacil, Ann-Kathrin; Schoesser, Florian; Oberoi, Raghav; Schuett, Jutta; Schuett, Harald; Schieffer, Bernhard; Grote, Karsten] Philipps Univ Marburg, Cardiol & Angiol, Marburg, Germany; [Vollmeister, Evelyn; Bertrams, Wilhelm; Bedenbender, Katrin; Schmeck, Bernd T.] Philipps Univ Marburg, Inst Lung Res iLung, German Ctr Lung Res, Univ Giessen & Marburg Lung Ctr, Marburg, Germany; [Huehn, Sonja] Philipps Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany; [Schmeck, Bernd T.] Philipps Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Marburg, Marburg, Germany; [Schmeck, Bernd T.] Philipps Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Schmeck, Bernd T.] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; German Center for Infection Research	Grote, K (corresponding author), Philipps Univ Marburg, Cardiol & Angiol, Marburg, Germany.	karsten.grote@staff.uni-marburg.de	Vollmeister, Evelyn/ABA-7940-2021	Schmeck, Bernd/0000-0002-2767-3606; Vollmeister, Evelyn/0000-0002-0539-7874; Vlacil, Ann-Kathrin/0000-0001-9743-0290	German Federal Ministry of Education and Research (BMBF, ERACoSysMed) [031L0140]; Behring Rontgen foundation [62-0002]	German Federal Ministry of Education and Research (BMBF, ERACoSysMed)(Federal Ministry of Education & Research (BMBF)); Behring Rontgen foundation	B.T.S. (031L0140) German Federal Ministry of Education and Research (BMBF, ERACoSysMed) -https://www.bmbf.de/en/index.html B.S. and K.G. (62-0002) Behring Rontgen foundation -https://www.br-stiftung.de/The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbagallo D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-62; Bedenbender K, 2019, FASEB J, V33, P9017, DOI 10.1096/fj.201900451R; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Chistiakov DA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00365; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473; Kang L, 2018, PROGNOST SYST HEALT, P1, DOI 10.1109/PHM-Chongqing.2018.00008; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liuba P, 2000, CIRCULATION, V102, P1039, DOI 10.1161/01.CIR.102.9.1039; Lv QS, 2012, MOLECULES, V17, P3599, DOI 10.3390/molecules17043599; Mallat RK, 2017, CRIT REV CL LAB SCI, V54, P458, DOI 10.1080/10408363.2017.1394267; Minasyan H, 2017, J CRIT CARE, V40, P229, DOI 10.1016/j.jcrc.2017.04.015; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Nagyoszi P, 2015, J NEUROCHEM, V135, P551, DOI 10.1111/jnc.13197; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh HM, 2005, CELL IMMUNOL, V237, P37, DOI 10.1016/j.cellimm.2005.09.006; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pashenkov MV, 2018, INT IMMUNOPHARMACOL, V54, P385, DOI 10.1016/j.intimp.2017.11.036; Pierdomenico M, 2016, INFLAMM BOWEL DIS, V22, P315, DOI 10.1097/MIB.0000000000000659; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schmolka N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1392; Spinosa M, 2018, FASEB J, V32, P6038, DOI 10.1096/fj.201701138RR; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Wang XW, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0089-x; Wu W, 2015, GUT, V64, P1755, DOI 10.1136/gutjnl-2014-307980; Xu R, 2016, BIOMED PHARMACOTHER, V83, P892, DOI 10.1016/j.biopha.2016.07.030	33	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0228764	10.1371/journal.pone.0228764	http://dx.doi.org/10.1371/journal.pone.0228764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353008	Green Published, Green Submitted, gold			2022-12-26	WOS:000536673200009
J	Piccolo, G; Zanghi, A; Di Vita, M; Bisagni, P; Lecchi, F; Cavallaro, A; Cardi, F; Lo Menzo, E; Cappellani, A				Piccolo, Gaetano; Zanghi, Antonio; Di Vita, Maria; Bisagni, Pietro; Lecchi, Francesca; Cavallaro, Andrea; Cardi, Francesco; Lo Menzo, Emanuele; Cappellani, Alessandro			The role of E-cadherin expression in the treatment of western undifferentiated early gastric cancer: Can a biological factor predict lymph node metastasis?	PLOS ONE			English	Article							ENDOSCOPIC MUCOSAL RESECTION; ADHESION MOLECULES; CELL-ADHESION; ADENOCARCINOMA; MUTATIONS; SNAIL	The use of endoscopic techniques to cure small sized, well differentiated early gastric cancer has been adopted worldwide. In the Eastern world, endoscopic resection is being increasingly utilized to treat small undifferentiated early gastric cancer according to the extended criteria proposed by the Japanese Gastric Cancer Associations. However, studies in the Western world reported in these tumors a rate of nodal metastasis ranging between 5% and 20%, that is higher of those observed in Eastern counterparts. A tool to predict the risk of nodal dissemination would be of great use to guide treatment toward endoscopic resection. In our study, we propose E-cadherin expression as a biological factor to predict lymph node involvement. We retrospectively reviewed the E-cadherin (E-cad) expression profile of all histological specimens of undifferentiated early gastric cancer from two Oncologic Departments and compared it with several tumor characteristics. A total of 39 patients with early gastric cancer met the inclusion criteria, of which 16 (41%) pT1a, and 23 (58.9%) pT1b SM1. Thirty-two patients (82%) underwent subtotal gastrectomy, whereas total gastrectomy was performed in only seven cases (17.9%). Patients were divided into two groups: low E-cad expression (E-cad 0/1+, 10 patients) and high E-cad expression (E-cad 2+/3+, 29 patients) according to the immunohistochemical assay (ICH). On univariate analysis, we found an association between low E-cad expression and low grading tumor (p = 0.019), pure undifferentiated histotype (PU-type) (p = 0.014), and lymph node involvement (N+) (p < 0.001). The association between low E-cad expression and lymph node metastasis was confirmed by multivariate analysis (OR = 14.5, 95% CI 3.46-60.76, p < 0.001). The loss of expression of E-cad may be a simple biological factor to predict lymph nodes metastasis in patients with undifferentiated early gastric cancer. Additional larger prospective studies are necessary to confirm these findings.	[Piccolo, Gaetano; Zanghi, Antonio; Di Vita, Maria; Cavallaro, Andrea; Cardi, Francesco; Cappellani, Alessandro] Univ Catania, Dept Gen Surg & Med Surg Specialty, Catania, Italy; [Bisagni, Pietro] ASST Lodi, Osped Maggiore Lodi, Dept Surg, Lodi, Italy; [Lecchi, Francesca] Univ Milan, Gen Surg Residency Program, Milan, Italy; [Lo Menzo, Emanuele] Cleveland Clin Florida, Sect Minimally Invas & Endoscop Surg, Weston, FL USA	University of Catania; Ospedale Maggiore di Lodi; University of Milan; Cleveland Clinic Foundation	Piccolo, G (corresponding author), Univ Catania, Dept Gen Surg & Med Surg Specialty, Catania, Italy.	gpiccolo1983@gmail.com	Bisagni, pietro/AAZ-6053-2020	Bisagni, pietro/0000-0001-6680-4253; Cavallaro, Andrea Sebastiano/0000-0002-0311-5191				Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; [Anonymous], 2020, CLIN PRACT GUID ONC; Becker KF, 2007, CELLS TISSUES ORGANS, V185, P204, DOI 10.1159/000101321; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Blair V, 2006, CLIN GASTROENTEROL H, V4, P262, DOI 10.1016/j.cgh.2005.12.003; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Cai J, 2001, Gastric Cancer, V4, P66, DOI 10.1007/PL00011726; Carneiro F, 2008, J CLIN PATHOL, V61, P25, DOI 10.1136/jcp.2006.043679; Chen XY, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0070-6; Chu YQ, 2008, WORLD J GASTROENTERO, V14, P1990, DOI 10.3748/wjg.14.1990; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Goodwin M, 2004, J MOL HISTOL, V35, P839, DOI 10.1007/s10735-004-1833-2; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jee YS, 2012, J KOREAN MED SCI, V27, P987, DOI 10.3346/jkms.2012.27.9.987; Li T, 2014, EUR REV MED PHARMACO, V18, P2693; Liu YC, 2006, WORLD J GASTROENTERO, V12, P2168, DOI 10.3748/wjg.v12.i14.2161; Nasu J, 2010, GASTRIC CANCER, V13, P264, DOI 10.1007/s10120-010-0562-3; Odagaki T, 2013, WORLD J GASTROENTERO, V19, P3157, DOI 10.3748/wjg.v19.i20.3157; Ohashi S, 2007, GASTRIC CANCER, V10, P241, DOI 10.1007/s10120-007-0442-7; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Park YD, 2008, ENDOSCOPY, V40, P7, DOI 10.1055/s-2007-966750; Pokala SK, 2018, ENDOSCOPY, V50, P479, DOI 10.1055/s-0043-122379; Rossi T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184452; Shun CT, 2001, ONCOLOGY-BASEL, V60, P339, DOI 10.1159/000058530; Wang YW, 2016, TUMOR BIOL, V37, P8567, DOI 10.1007/s13277-015-4721-3; Wu CY, 2002, HEPATO-GASTROENTEROL, V49, P1465	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232429	10.1371/journal.pone.0232429	http://dx.doi.org/10.1371/journal.pone.0232429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348353	Green Published, gold			2022-12-26	WOS:000536668200066
J	Cruzado, RK; Rashidi, M; Olsen, N; Novy, RG; Wenninger, EJ; Bosque-Perez, NA; Karasev, AV; Price, WJ; Rashed, A				Cruzado, Regina K.; Rashidi, Mahnaz; Olsen, Nora; Novy, Richard G.; Wenninger, Erik J.; Bosque-Perez, Nilsa A.; Karasev, Alexander V.; Price, William J.; Rashed, Arash			Effect of the level of "Candidatus Liberibacter solanacearum" infection on the development of zebra chip disease in different potato genotypes at harvest and post storage	PLOS ONE			English	Article							COCKERELLI HEMIPTERA TRIOZIDAE; BACTERICERA-COCKERELLI; RESISTANCE; TIME; HAPLOTYPES; MANAGEMENT; PCR; SUSCEPTIBILITY; TRANSMISSION; INSECTICIDES	Potato psyllid (Bactericera cockerelli Sulc)-transmitted "Candidatus Liberibacter solanacearum" (Lso) has been negatively impacting the potato industry in the United States as well as other potato-producing countries. Lso has been linked to a condition known as zebra chip (ZC) that affects yield and quality of potato tubers. Efforts to find sources of resistance to ZC have primarily focused on greenhouse evaluations based on a single inoculation time prior to harvest. Plant response to infection, however, could be influenced by the developmental stage of the host plant, and ZC may continue to develop after harvest. The objectives of this study were to quantify Lso inoculation success, Lso titer, ZC severity and Lso development during storage in eight potato genotypes. These evaluations were conducted on plants infested with Lso-positive psyllids at 77, 12, and 4 days before vine removal (DBVR). The evaluated genotypes were categorized according to their relative resistance to Lso and tolerance to ZC symptoms. Lso inoculation success in the genotype family A07781, derived from Solanum chacoense, was lower than that of the susceptible control ('Russet Burbank'). A07781-4LB and A07781-3LB genotypes were characterized relatively resistant to the pathogen and highly tolerant to ZC symptoms, while A07781-10LB was categorized as susceptible to Lso but relatively tolerant to symptom expression. In stored potatoes, increase in Lso concentrations was observed for all infestation times. However, significantly higher Lso titer was detected in tubers infested 12 DBVR and the effect was similar across genotypes. Overall, the A07781 family can be considered as a promising source of resistance or tolerance to ZC.	[Cruzado, Regina K.; Rashidi, Mahnaz; Rashed, Arash] Univ Idaho, Aberdeen R&E Ctr, Dept Entomol Plant Pathol & Nematol, Aberdeen, ID 83210 USA; [Rashidi, Mahnaz] Univ Florida, Dept Plant Pathol, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Olsen, Nora] Univ Idaho, Dept Plant Sci, Kimberly Res & Extens Ctr, Kimberly, ID USA; [Novy, Richard G.] ARS, Small Grains & Potato Germplasm Res Unit, USDA, Aberdeen, ID USA; [Wenninger, Erik J.] Univ Idaho, Kimberly Res & Extens Ctr, Dept Entomol Plant Pathol & Nematol, Kimberly, ID USA; [Bosque-Perez, Nilsa A.; Karasev, Alexander V.; Rashed, Arash] Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA; [Price, William J.] Univ Idaho, Stat Programs, Coll Agr & Life Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; State University System of Florida; University of Florida; Idaho; University of Idaho; United States Department of Agriculture (USDA); Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Rashed, A (corresponding author), Univ Idaho, Aberdeen R&E Ctr, Dept Entomol Plant Pathol & Nematol, Aberdeen, ID 83210 USA.; Rashed, A (corresponding author), Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA.	arashed@uidaho.edu		Karasev, Alexander/0000-0001-8197-0639; , Regina/0000-0001-9972-5121	United States Department of Agriculture-Agriculture and Food Research Initiative [2014-67014-22408]; United States Department of Agriculture [IDA01506]	United States Department of Agriculture-Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); United States Department of Agriculture(United States Department of Agriculture (USDA))	AR, RGN, EJW, NO: United States Department of Agriculture-Agriculture and Food Research Initiative Grant no. 2014-67014-22408 AR: United States Department of Agriculture hatch IDA01506 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios NG, 2005, PLANT PATHOLOGY GENE; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2003, PLANT SCI, V164, P421, DOI 10.1016/S0168-9452(03)00033-5; Butler Casey D., 2012, Terrestrial Arthropod Reviews, V5, P87, DOI 10.1163/187498312X634266; Butler CD, 2011, CROP PROT, V30, P1233, DOI 10.1016/j.cropro.2011.05.006; Cooper WR, 2016, AM J POTATO RES, V93, P386, DOI 10.1007/s12230-016-9512-x; Cooper WR, 2015, AM J POTATO RES, V92, P91, DOI 10.1007/s12230-014-9416-6; Cooper WR, 2014, AM J POTATO RES, V91, P532, DOI 10.1007/s12230-014-9384-x; Crosslin JM, 2011, SOUTHWEST ENTOMOL, V36, P125, DOI 10.3958/059.036.0202; Dahan J, 2019, PLANT DIS, V103, P2587, DOI 10.1094/PDIS-11-18-2113-RE; Dahan J, 2017, PLANT DIS, V101, P822, DOI 10.1094/PDIS-05-16-0668-RE; Diaz-Montano J, 2014, AM J POTATO RES, V91, P363, DOI 10.1007/s12230-013-9356-6; Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s; Greenway G, 2014, AM J POTATO RES, V91, P714, DOI 10.1007/s12230-014-9404-x; Greenway GA, 2018, AM J POTATO RES, V95, P362, DOI 10.1007/s12230-018-9636-2; Grimm KDS, 2018, AM J POTATO RES, V95, P709, DOI 10.1007/s12230-018-9678-5; Guenthner J, 2012, SOUTHWEST ENTOMOL, V37, P263, DOI 10.3958/059.037.0302; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Hove AH, 2008, ANNU REV PLANT BIOL, V59, P41, DOI [10.1146/annurev.arplant.59.032607.092825, DOI 10.1146/ANNUREV.ARPLANT.59.032607.092825]; Levy J, 2014, J ECON ENTOMOL, V107, P1187, DOI 10.1603/EC13295; Levy J, 2011, PHYTOPATHOLOGY, V101, P1285, DOI 10.1094/PHYTO-04-11-0121; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, J MICROBIOL METH, V78, P59, DOI 10.1016/j.mimet.2009.04.009; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Liu D, 2007, ENTOMOL EXP APPL, V123, P35, DOI 10.1111/j.1570-7458.2007.00521.x; Marzachi C, 1998, ANN APPL BIOL, V133, P45, DOI 10.1111/j.1744-7348.1998.tb05801.x; Miles GP, 2010, AM J POTATO RES, V87, P337, DOI 10.1007/s12230-010-9140-9; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2012, PLANT DIS, V96, P18, DOI 10.1094/PDIS-03-11-0185; Munyaneza JE, 2011, AM J POTATO RES, V88, P435, DOI 10.1007/s12230-011-9209-0; Poiatti VAD, 2009, BIOL RES, V42, P205, DOI [/S0716-97602009000200009, 10.4067/S0716-97602009000200009]; Prager SM, 2016, CALIF AGR, V70, P89, DOI 10.3733/ca.v070n02p89; Prager SM, 2013, CROP PROT, V54, P84, DOI 10.1016/j.cropro.2013.08.001; Rashed A, 2014, PLANT DIS, V98, P24, DOI 10.1094/PDIS-04-13-0366-RE; Rashed A, 2013, PHYTOPATHOLOGY, V103, P419, DOI 10.1094/PHYTO-09-12-0244-R; Rashed A, 2012, PHYTOPATHOLOGY, V102, P1079, DOI 10.1094/PHYTO-04-12-0094-R; Rashed A, 2018, PLANT DIS, V102, P561, DOI [10.1094/PDIS-05-17-0619-RE, 10.1094/pdis-05-17-0619-re]; Rashed A, 2015, PLANT DIS, V99, P274, DOI 10.1094/PDIS-04-14-0421-RE; Rashed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055326; Rashidi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183283; Rubio-Covarrubias OA, 2017, AM J POTATO RES, V94, P342, DOI 10.1007/s12230-017-9570-8; Rush CM, 2015, PHYTOPATHOLOGY, V105, P929, DOI 10.1094/PHYTO-12-14-0365-FI; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Secor GA, 2004, REV LATINOAMER PAP S, V1, P1; Stroup W. W, 2014, AGRON J, V106, P1; Swisher KD, 2014, SOUTHWEST ENTOMOL, V39, P49, DOI 10.3958/059.039.0106; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Szczepaniec A, 2019, CROP PROT, V116, P188, DOI 10.1016/j.cropro.2018.11.001; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Vereijssen J, 2018, J INTEGR PEST MANAG, V9, P1; Wallis CM, 2017, AM J POTATO RES, V94, P334, DOI 10.1007/s12230-017-9569-1; Wallis CM, 2015, PHYTOPATHOLOGY, V105, P1573, DOI 10.1094/PHYTO-02-15-0040-R; Wallis CM, 2014, PHYTOPATHOLOGY, V104, P126, DOI 10.1094/PHYTO-05-13-0125-R; Wallis CM, 2012, PHYSIOL MOL PLANT P, V78, P66, DOI 10.1016/j.pmpp.2012.02.001; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Wenninger EJ, 2017, ENVIRON ENTOMOL, V46, P1; Wenninger EJ, 2020, AM J POTATO RES, V97, P278, DOI 10.1007/s12230-020-09772-6; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231973	10.1371/journal.pone.0231973	http://dx.doi.org/10.1371/journal.pone.0231973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343710	gold, Green Published			2022-12-26	WOS:000536661300024
J	Shin, JM; Ko, JW; Choi, CW; Lee, Y; Seo, YJ; Lee, JH; Kim, CD				Shin, Jung-Min; Ko, Jung-Woo; Choi, Chong-Won; Lee, Young; Seo, Young-Joon; Lee, Jeung-Hoon; Kim, Chang-Deok			Deficiency of Crif1 in hair follicle stem cells retards hair growth cycle in adult mice	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; METABOLISM	Hair growth is the cyclically regulated process that is characterized by growing phase (anagen), regression phase (catagen) and resting phase (telogen). Hair follicle stem cells (HFSCs) play pivotal role in the control of hair growth cycle. It has been notified that stem cells have the distinguished metabolic signature compared to differentiated cells, such as the preference to glycolysis rather than mitochondrial respiration. Crif1 is a mitochondrial protein that regulates the synthesis and insertion of oxidative phosphorylation (OXPHOS) polypeptides to inner membrane of mitochondria. Several studies demonstrate that tissue-specific knockout of Crif1 leads to mitochondrial dysfunction. In this study, we investigated the effect of mitochondrial dysfunction in terms of Crif1 deficiency on the hair growth cycle of adult mice. We created two kinds of inducible conditional knockout (icKO) mice. In epidermal specific icKO mice (Crif1 K14icKO), hair growth cycle was significantly retarded compared to wild type mice. Similarly, HFSC specific icKO mice (Crif1 K15icKO) showed significant retardation of hair growth cycle in depilation-induced anagen model. Interestingly, flow cytometry revealed that HFSC populations were maintained in Crif1 K15icKO mice. These results suggest that mitochondrial function in HFSCs is important for the progression of hair growth cycle, but not for maintenance of HFSCs.	[Shin, Jung-Min; Ko, Jung-Woo; Choi, Chong-Won; Lee, Young; Seo, Young-Joon; Lee, Jeung-Hoon; Kim, Chang-Deok] Chungnam Natl Univ, Sch Med, Dept Dermatol, Daejeon, South Korea; [Lee, Young; Seo, Young-Joon; Lee, Jeung-Hoon; Kim, Chang-Deok] Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon, South Korea	Chungnam National University; Chungnam National University	Kim, CD (corresponding author), Chungnam Natl Univ, Sch Med, Dept Dermatol, Daejeon, South Korea.; Kim, CD (corresponding author), Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon, South Korea.	cdkimd@cnu.ac.kr		Kim, Chang Deok/0000-0001-9341-6491	National Research Foundation of Korea [NRF-2017R1A2B4008810]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF-2017R1A2B4008810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chovatiya GL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11830-9; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; De Miguel MP, 2015, CURR MOL MED, V15, P343; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kloepper JE, 2015, J INVEST DERMATOL, V135, P679, DOI 10.1038/jid.2014.475; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Lopes C, 2017, MOL NEUROBIOL, V54, P1858, DOI 10.1007/s12035-016-9714-8; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Ryu MJ, 2013, MOL CELLS, V35, P134, DOI 10.1007/s10059-012-2257-1; Shin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053577; Shin JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44828; Tang Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1821; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Velarde MC, 2015, P NATL ACAD SCI USA, V112, P10407, DOI 10.1073/pnas.1505675112; Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232206	10.1371/journal.pone.0232206	http://dx.doi.org/10.1371/journal.pone.0232206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330194	gold, Green Published			2022-12-26	WOS:000536647300061
J	Lockhart, DEA; Stanley, M; Raimi, OG; Robinson, DA; Boldovjakova, D; Squair, DR; Ferenbach, AT; Fang, WX; van Aalten, DMF				Lockhart, Deborah E. A.; Stanley, Mathew; Raimi, Olawale G.; Robinson, David A.; Boldovjakova, Dominika; Squair, Daniel R.; Ferenbach, Andrew T.; Fang, Wenxia; van Aalten, Daan M. F.			Targeting a critical step in fungal hexosamine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; cell wall; protein-protein interaction; X-ray crystallography; virulence factor; chitin; antifungal drug development; fragment; glucosamine 6-phosphate N-acetyltransferase (Gna1); resistance; Aspergillus fumigatus	INFECTIOUS-DISEASES SOCIETY; GALLERIA-MELLONELLA LARVAE; ASPERGILLUS-FUMIGATUS; CELL-WALL; STRUCTURAL VALIDATION; PRACTICE GUIDELINES; STRESS-RESPONSE; MURINE MODEL; NIKKOMYCIN-Z; INHIBITORS	Aspergillus fumigatusis a human opportunistic fungal pathogen whose cell wall protects it from the extracellular environment including host defenses. Chitin, an essential component of the fungal cell wall, is synthesized from UDP-GlcNAc produced in the hexosamine biosynthetic pathway. As this pathway is critical for fungal cell wall integrity, the hexosamine biosynthesis enzymes represent potential targets of antifungal drugs. Here, we provide genetic and chemical evidence that glucosamine 6-phosphateN-acetyltransferase (Gna1), a key enzyme in this pathway, is an exploitable antifungal drug target.GNA1deletion resulted in loss of fungal viability and disruption of the cell wall, phenotypes that could be rescued by exogenous GlcNAc, the product of the Gna1 enzyme. In a murine model of aspergillosis, the ?gna1mutant strain exhibited attenuated virulence. Using a fragment-based approach, we discovered a small heterocyclic scaffold that binds proximal to the Gna1 active site and can be optimized to a selective submicromolar binder. Taken together, we have provided genetic, structural, and chemical evidence that Gna1 is an antifungal target inA. fumigatus.	[Lockhart, Deborah E. A.; Stanley, Mathew; Raimi, Olawale G.; Squair, Daniel R.; Ferenbach, Andrew T.; Fang, Wenxia; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Dundee, Scotland; [Lockhart, Deborah E. A.; Boldovjakova, Dominika] Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland; [Robinson, David A.] Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Drug Discovery Unit, Dundee, Scotland	University of Dundee; University of Aberdeen; University of Dundee	Lockhart, DEA; van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Dundee, Scotland.; Lockhart, DEA (corresponding author), Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland.	deborah.lockhart@abdn.ac.uk; dmfvanaalten@dundee.ac.uk		Fang, Wenxia/0000-0001-8055-2072; Robinson, David/0000-0003-1979-5918; Ferenbach, Andrew/0000-0002-1562-7987; Raimi, Olawale G./0000-0003-2782-7318; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust [WT105772/A/14/Z, WT105772/Z/14/Z]; MRC Programme Grant [MR/M004139/1]; University of Aberdeen; MRC [MR/M004139/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aberdeen; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Postdoctoral Research Training Fellowship for Clinicians WT105772/A/14/Z and WT105772/Z/14/Z (to D. L.) and MRC Programme Grant MR/M004139/1 (to D. M. F. v. A). This work was also supported by a University of Aberdeen Summer Research Scholarship (to D. B).	Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Allen D, 2015, EXPERT REV ANTI-INFE, V13, P787, DOI 10.1586/14787210.2015.1032939; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boehmelt G, 2000, J BIOL CHEM, V275, P12821, DOI 10.1074/jbc.275.17.12821; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Buil JB, 2018, J ANTIMICROB CHEMOTH, V73, P134, DOI [10.1093/jac/dkx354, 10.1093/jac/dkx425]; Campitelli Marco, 2017, J Clin Med Res, V9, P451, DOI 10.14740/jocmr2992w; Cardinale D, 2010, CURR MED CHEM, V17, P826, DOI 10.2174/092986710790712156; Centers for Disease Control and Prevention, 2019, ICML; Chowdhary A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003633; Cova M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22441-3; Da Silva F, 2019, J MED CHEM, V62, P9732, DOI 10.1021/acs.jmedchem.9b01184; dEnfert C, 1996, CURR GENET, V30, P76, DOI 10.1007/s002940050103; DEnfert C, 1996, INFECT IMMUN, V64, P4401, DOI 10.1128/IAI.64.10.4401-4405.1996; Denning DW, 2013, MYCOSES, V56, P13; Drwal MN, 2018, J MED CHEM, V61, P5963, DOI 10.1021/acs.jmedchem.8b00256; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Falci Diego R, 2013, Infect Drug Resist, V6, P163, DOI 10.2147/IDR.S51340; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Fang WX, 2013, BIOSCIENCE REP, V33, P689, DOI 10.1042/BSR20130053; Fang WX, 2013, MOL MICROBIOL, V89, P479, DOI 10.1111/mmi.12290; Feher VA, 1996, NAT STRUCT BIOL, V3, P516, DOI 10.1038/nsb0696-516; Fisher MC, 2018, SCIENCE, V360, P739, DOI 10.1126/science.aap7999; Gao CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04712; Gao F, 2006, J MED CHEM, V49, P5273, DOI 10.1021/jm060732n; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Golus J, 2016, J APPL MICROBIOL, V121, P1291, DOI 10.1111/jam.13253; Haiduven D, 2009, MED MYCOL, V47, pS210, DOI 10.1080/13693780802247694; Hamill R, 2013, DRUGS, V73, P919, DOI 10.1007/s40265-013-0069-4; Head MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004129; Holt SL, 2011, AM J HEALTH-SYST PH, V68, P1207, DOI 10.2146/ajhp100456; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Huang MY, 2019, EUR J MED CHEM, V178, P259, DOI 10.1016/j.ejmech.2019.05.078; Hurtado-Guerrero R., 2008, STRUCTURAL COMP ASPE; Hurtado-Guerrero R., 2009, AFGNA1 CRYSTAL STRUC; Hurtado-Guerrero R, 2008, BIOCHEM J, V415, P217, DOI 10.1042/BJ20081000; Hurtado-Guerrero R, 2007, FEBS LETT, V581, P5597, DOI 10.1016/j.febslet.2007.10.065; Ichihara O, 2011, MOL INFORM, V30, P298, DOI 10.1002/minf.201000174; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Jiang HC, 2014, FUNGAL GENET BIOL, V62, P62, DOI 10.1016/j.fgb.2013.11.003; Kovalevsky AY, 2008, J MOL BIOL, V384, P178, DOI 10.1016/j.jmb.2008.09.031; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Lopata A, 2016, J BIOL CHEM, V291, P26320, DOI 10.1074/jbc.M116.734012; Maertens JA, 2016, LANCET, V387, P760, DOI 10.1016/S0140-6736(15)01159-9; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Min J, 2006, CRYSTAL STRUCTURE GN; Mio T, 1999, J BIOL CHEM, V274, P424, DOI 10.1074/jbc.274.1.424; Mio T, 2000, MICROBIOL-SGM, V146, P1753, DOI 10.1099/00221287-146-7-1753; Mondal J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006180; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Ngo L, 2019, CHEM BIOL DRUG DES, V93, P865, DOI 10.1111/cbdd.13476; NIAID, NIHNIAIDN01AI30041; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Perfect JR, 2017, NAT REV DRUG DISCOV, V16, P603, DOI 10.1038/nrd.2017.46; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Prakash O, 2019, MOLECULES, V24, DOI 10.3390/molecules24050996; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Renwick J, 2006, MYCOPATHOLOGIA, V161, P377, DOI 10.1007/s11046-006-0021-1; Roemer T, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019703; Schauwvlieghe AFAD, 2018, LANCET RESP MED, V6, P782, DOI 10.1016/S2213-2600(18)30274-1; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; SELITRENNIKOFF CP, 1976, P NATL ACAD SCI USA, V73, P534, DOI 10.1073/pnas.73.2.534; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Steinbach WJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003642; Tada R, 2013, CURR PHARM DESIGN, V19, P3738, DOI 10.2174/1381612811319200012; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wang J, 2008, FEBS LETT, V582, P2973, DOI 10.1016/j.febslet.2008.07.040; Wang Y, 2016, ELIFE, V5, DOI [10.7554/elife.17505, 10.7554/eLife.17505]; Wapenaar H, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0225-2; Wartchow CA, 2011, J COMPUT AID MOL DES, V25, P669, DOI 10.1007/s10822-011-9439-8; Williams V, 2011, EUKARYOT CELL, V10, P293, DOI 10.1128/EC.00252-10; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wyatt PG, 2011, CURR TOP MED CHEM, V11, P1275; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zhang D, 1999, CURR PHARM DESIGN, V5, P73; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188	91	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8678	8691		10.1074/jbc.RA120.012985	http://dx.doi.org/10.1074/jbc.RA120.012985			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32341126	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000546296800005
J	Archer, CR; Enslow, BT; Carver, CM; Stockand, JD				Archer, Crystal R.; Enslow, Benjamin T.; Carver, Chase M.; Stockand, James D.			Phosphatidylinositol 4,5-bisphosphate directly interacts with the ? and ? subunits of the sodium channel ENaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypertension; phosphoinositide; epithelial sodium channel (ENaC); ion channel; transport; epithelial ion transport; microscale thermophoresis; phospholipid signaling; sodium excretion; steady state intrinsic spectroscopy	K+ CHANNEL; POTASSIUM CHANNELS; PIP2 ACTIVATION; PROTEINS; SEGREGATION; PI(4,5)P-2; CALMODULIN	The plasma membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) regulates the activity of diverse ion channels to include the epithelial Na+ channel ENaC. Whether PIP2 regulation of ENaC is due to a direct phospholipid-protein interaction, remains obscure. To date, possible interaction of PIP2 with ENaC primarily has been tested indirectly through assays of channel function. A fragment-based biochemical analysis approach is used here to directly quantify possible PIP2-ENaC interactions. We find using the CIBN-CRY2 optogenetic dimerization system that the phosphoryl group positioned at carbon 5 of PIP2 is necessary for interaction with ENaC. Previous studies have implicated conserved basic residues in the cytosolic portions of ?- and ?-ENaC subunits as being important for PIP2-ENaC interactions. To test this, we used synthetic peptides of these regions of ?- and ?-ENaC. Steady-state intrinsic fluorescence spectroscopy demonstrated that phosphoinositides change the local conformation of the N terminus of ?-ENaC, and two sites of ?-ENaC adjacent to the plasma membrane, suggesting direct interactions of PIP2 with these three regions. Microscale thermophoresis elaborated PIP2 interactions with the N termini of ?- (K-d ?5.2 ?m) and ?-ENaC (K-d ?13 ?m). A weaker interaction site within the carboxyl terminus of ?-ENaC (K-d ?800 ?m) was also observed. These results support that PIP2 regulates ENaC activity by directly interacting with at least three distinct regions within the cytoplasmic domains of the channel that contain conserved basic residues. These interactions are probably electrostatic in nature, and are likely to bear a key structural role in support of channel activity.	[Archer, Crystal R.; Carver, Chase M.; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Enslow, Benjamin T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Archer, CR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA.	ArcherC@uthscsa.edu		Archer, Crystal/0000-0002-2377-643X	American Heart Association [20POST35210746]; National Institutes of Health, NHLBI Grant [T32 HL007446]; NCATS Grant [TL1 TR002647]; NIGMS Grant [K12 GM11726]; NIDDK Grant [R01 DK113816]	American Heart Association(American Heart Association); National Institutes of Health, NHLBI Grant; NCATS Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIGMS Grant; NIDDK Grant	This work was supported by American Heart Association Grant 20POST35210746 and National Institutes of Health, NHLBI Grant T32 HL007446 (to C. R. A.), NCATS Grant TL1 TR002647 and NIGMS Grant K12 GM11726 (to B. T. E.), and NIDDK Grant R01 DK113816 (to J. D. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Heart Association or National Institutes of Health.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; CHU A, 1991, J BIOL CHEM, V266, P7699; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Everett J.K., 2008, SPARSE CONSTRAINT SO; Feng SJ, 2019, CELL REP, V28, P567, DOI 10.1016/j.celrep.2019.06.023; Furukawa T, 1996, PFLUG ARCH EUR J PHY, V431, P504, DOI 10.1007/s004240050028; Han B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23417; Hansen SB, 2015, BBA-MOL CELL BIOL L, V1851, P620, DOI 10.1016/j.bbalip.2015.01.011; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kasuya G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00887-9; Klemens CA, 2017, J BIOL CHEM, V292, P375, DOI 10.1074/jbc.M116.753616; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Mahon MJ, 2011, CELL SIGNAL, V23, P1659, DOI 10.1016/j.cellsig.2011.05.020; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mironova E, 2015, ACTA PHYSIOL, V213, P213, DOI 10.1111/apha.12372; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Pavlov TS, 2017, AM J PHYSIOL-RENAL, V313, pF135, DOI 10.1152/ajprenal.00427.2016; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Shei RJ, 2018, CURR OPIN PHARMACOL, V43, P152, DOI 10.1016/j.coph.2018.09.007; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tong QS, 2006, AM J PHYSIOL-RENAL, V290, pF821, DOI 10.1152/ajprenal.00312.2005; Tu P, 2009, J NEUROCHEM, V108, P126, DOI 10.1111/j.1471-4159.2008.05752.x; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Yin Y, 2019, SCIENCE, V363, P945, DOI 10.1126/science.aav9334; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhou-Suckow Z, 2017, CELL TISSUE RES, V367, P537, DOI 10.1007/s00441-016-2562-z	48	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7958	7969		10.1074/jbc.RA120.012606	http://dx.doi.org/10.1074/jbc.RA120.012606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341072	Green Published, hybrid			2022-12-26	WOS:000540935400011
J	Li, T; Zhang, YM; Liu, Y; Li, XD; Hao, GL; Han, QH; Dirk, LMA; Downie, AB; Ruan, YL; Wang, JM; Wang, GY; Zhao, TY				Li, Tao; Zhang, Yumin; Liu, Ying; Li, Xudong; Hao, Guanglong; Han, Qinghui; Dirk, Lynnette M. A.; Downie, A. Bruce; Ruan, Yong-Ling; Wang, Jianmin; Wang, Guoying; Zhao, Tianyong			Raffinose synthase enhances drought tolerance through raffinose synthesis or galactinol hydrolysis in maize and Arabidopsis plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; carbohydrate metabolism; carbohydrate biosynthesis; carbohydrate function; galactosyltransferase; drought stress; galactinol hydrolysis; maize; raffinose synthase; raffinose synthesis	INOSITOL 1-PHOSPHATE SYNTHASE; COARCTATA ROXB. TATEOKA; FAMILY OLIGOSACCHARIDES; MOLECULAR-CLONING; STRESS TOLERANCE; ABIOTIC STRESS; EXPRESSION; SEEDS; GENE; OVEREXPRESSION	Raffinose and its precursor galactinol accumulate in plant leaves during abiotic stress. RAFFINOSE SYNTHASE (RAFS) catalyzes raffinose formation by transferring a galactosyl group of galactinol to sucrose. However, whether RAFS contributes to plant drought tolerance and, if so, by what mechanism remains unclear. In this study, we report that expression of RAFS from maize (or corn, Zea mays) (ZmRAFS) is induced by drought, heat, cold, and salinity stresses. We found that zmrafs mutant maize plants completely lack raffinose and hyper-accumulate galactinol and are more sensitive to drought stress than the corresponding null-segregant (NS) plants. This indicated that ZmRAFS and its product raffinose contribute to plant drought tolerance. ZmRAFS overexpression in Arabidopsis enhanced drought stress tolerance by increasing myo-inositol levels via ZmRAFS-mediated galactinol hydrolysis in the leaves due to sucrose insufficiency in leaf cells and also enhanced raffinose synthesis in the seeds. Supplementation of sucrose to detached leaves converted ZmRAFS from hydrolyzing galactinol to synthesizing raffinose. Taken together, we demonstrate that ZmRAFS enhances plant drought tolerance through either raffinose synthesis or galactinol hydrolysis, depending on sucrose availability in plant cells. These results provide new avenues to improve plant drought stress tolerance through manipulation of the raffinose anabolic pathway.	[Li, Tao; Zhang, Yumin; Liu, Ying; Li, Xudong; Hao, Guanglong; Han, Qinghui; Zhao, Tianyong] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Li, Tao; Zhang, Yumin; Liu, Ying; Li, Xudong; Hao, Guanglong; Han, Qinghui; Zhao, Tianyong] Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China; [Li, Tao] Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Coll Life Sci, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China; [Dirk, Lynnette M. A.; Downie, A. Bruce] Univ Kentucky, Dept Hort, Coll Agr Food & Environm, Seed Biol, Lexington, KY USA; [Ruan, Yong-Ling] Univ Newcastle, Australia China Res Ctr Crop Improvement, Callaghan, NSW, Australia; [Ruan, Yong-Ling] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Wang, Jianmin; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Henan Agricultural University; University of Kentucky; University of Newcastle; University of Newcastle; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhao, TY (corresponding author), Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Zhao, TY (corresponding author), Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China.; Wang, GY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	wangguoying@caas.cn; tzhao2@nwafu.edu.cn	wang, jian/GVS-0711-2022; Ruan, Yong-Ling/AAU-7244-2021	Ruan, Yong-Ling/0000-0002-8394-4474; li, tao/0000-0002-6422-608X	NSFC (National Science Foundation in China) [31671776]; Ministry of Agriculture in China [2014ZX0800920B]	NSFC (National Science Foundation in China); Ministry of Agriculture in China(Ministry of Agriculture & Rural Affairs)	This work was supported by NSFC (National Science Foundation in China) Grant 31671776 and the Special fund for transgenic research from Ministry of Agriculture in China Grant 2014ZX0800920B (to T. Z.).	BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; Cacela C, 2006, BBA-BIOMEMBRANES, V1758, P680, DOI 10.1016/j.bbamem.2006.04.005; Cao T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00263; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Dos Santos TB, 2015, GENET MOL BIOL, V38, P182, DOI 10.1590/S1415-475738220140171; Downie B, 2003, PLANT PHYSIOL, V131, P1347, DOI 10.1104/pp.016386; Egert A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00206; Egert A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-218; Gangl R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01115; Gangl R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00789; Gangola MP, 2016, PHYTOCHEMISTRY, V125, P88, DOI 10.1016/j.phytochem.2016.02.009; Selvaraj MG, 2017, PLANT BIOTECHNOL J, V15, P1465, DOI 10.1111/pbi.12731; Goswami L, 2014, J PLANT BIOCHEM BIOT, V23, P316, DOI 10.1007/s13562-013-0217-7; Gu L, 2016, PLANT MOL BIOL, V90, P157, DOI 10.1007/s11103-015-0403-1; Gu L, 2013, PLANT SCI, V213, P38, DOI 10.1016/j.plantsci.2013.09.002; Himuro Y, 2014, J PLANT PHYSIOL, V171, P1127, DOI 10.1016/j.jplph.2014.04.007; Joshi R, 2013, PLANT PHYSIOL BIOCH, V65, P61, DOI 10.1016/j.plaphy.2013.01.009; Kaur H, 2013, PLANTA, V237, P321, DOI 10.1007/s00425-012-1781-0; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lahuta LB, 2014, J PLANT PHYSIOL, V171, P1306, DOI 10.1016/j.jplph.2014.04.012; Lahuta LB, 2011, ACTA PHYSIOL PLANT, V33, P725, DOI 10.1007/s11738-010-0597-4; Li SH, 2007, BIOTECHNOL LETT, V29, P635, DOI 10.1007/s10529-006-9268-3; Li T, 2017, MOL PLANT, V10, P1540, DOI 10.1016/j.molp.2017.10.014; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; LINEBERGER RD, 1980, PLANT PHYSIOL, V65, P298, DOI 10.1104/pp.65.2.298; Majee M, 2004, J BIOL CHEM, V279, P28539, DOI 10.1074/jbc.M310138200; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Peterbauer T, 2002, PLANTA, V215, P839, DOI 10.1007/s00425-002-0804-7; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; Shimosaka E, 2015, BREEDING SCI, V65, P363, DOI 10.1270/jsbbs.65.363; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; Sui XL, 2012, J PLANT PHYSIOL, V169, P1883, DOI 10.1016/j.jplph.2012.07.019; Sun ZB, 2013, PLANT PHYSIOL BIOCH, V69, P82, DOI 10.1016/j.plaphy.2013.04.009; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tan JL, 2013, PLANT CELL ENVIRON, V36, P288, DOI 10.1111/j.1365-3040.2012.02573.x; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhao TY, 2006, SEED SCI RES, V16, P107, DOI 10.1079/SSR2006243; Zhou ML, 2012, GLYCOBIOLOGY, V22, P1775, DOI 10.1093/glycob/cws121; Zhou Y, 2017, J AGR FOOD CHEM, V65, P2751, DOI 10.1021/acs.jafc.7b00377	41	28	30	13	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8064	8077		10.1074/jbc.RA120.013948	http://dx.doi.org/10.1074/jbc.RA120.013948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32366461	Green Published, hybrid			2022-12-26	WOS:000540935400019
J	Nasir, BB; Fentie, AM; Adisu, MK				Nasir, Beshir Bedru; Fentie, Atalay Mulu; Adisu, Mistr Kindu			Adherence to iron and folic acid supplementation and prevalence of anemia mong pregnant women attending antenatal care clinic at Tikur Anbessa Specialized Hospital, Ethiopia	PLOS ONE			English	Article							INCOME	Introduction Anemia during pregnancy has a significant adverse effect on both the mother and fetus. Iron and folic acid supplementation (IFAS) is the feasible and cost effective strategy to control and prevent anemia in pregnancy. However, the success of this strategy is suboptimal due to poor maternal adherences to the regimen. The aim of this study was to assess prevalence of anemia, rate of adherence to IFAS and associated factors among pregnant women at Tikur Anbessa Specialized Hospital (TASH), Ethiopia. Method Institution based cross sectional study was conducted among 250 pregnant women who were selected using systematic random sampling from antenatal care clinic (ANC) attendants of TASH. Data was collected through interview and medical chart review by using structured questionnaire. The data was analyzed by SPSS v.24. Binary logistic regression was used to identify the associated factors for IFAS and P < 0.05 was used to declare the association. Results The prevalence of anemia was 4.8% and half of the study participants were knowledgeable about anemia. The rate of adherence to IFAS was 63.6%. Forgetfulness and fear of side effect were the commonest reasons for poor adherence to IFAS. Gestational age at first ANC visit and educational level were significantly associated with adherence to IFAS. Thus, pregnant women who started their ANC follow up at first trimester (AOR = 1.87, 95% CI (1.18-3.36)) and education level of college and above (AOR = 4.236, 95% CI (1.35-13.25)) and completed secondary education (AOR = 4.09, 95% CI (1.39-12.02)) were more likely to be adherent to IFAS compared with their comparators. Conclusion Even though anemia prevalence was very low among the study participants, adherence to IFAS was still a challenge during pregnancy. Therefore, counseling about IFAS and anemia prevention and promoting the benefits of early ANC visit are recommended to improve adherence to IFAS.	[Nasir, Beshir Bedru; Fentie, Atalay Mulu; Adisu, Mistr Kindu] Addis Ababa Univ AAU, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia		Nasir, BB (corresponding author), Addis Ababa Univ AAU, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia.	beshir.bedru@aau.edu.et		, Beshir/0000-0002-8246-9640; Fentie, Atalay Mulu/0000-0001-6065-0695				Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Begum S., 2012, INDIAN J MATERN CHIL, V14, P8; Birhanu Tesfaye Molla, 2018, BMC Res Notes, V11, P345, DOI 10.1186/s13104-018-3433-3; Boti N., 2018, INT J REPROD MED, V2018; Fiedler J, 2014, RAPID INITIAL ASSESS; Gebre A., 2015, INT J NUTR FOOD SCI, V4, P161, DOI [10.11648/j.ijnfs.20150402.16, DOI 10.11648/J.IJNFS.20150402.16]; Gebremariam AD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210086; Getachew M, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1716-2; Haidar Jemal A, 2009, BMC Blood Disord, V9, P7, DOI 10.1186/1471-2326-9-7; Harvey T, 2016, WOMENS HEALTH, V12, P95, DOI 10.2217/whe.15.91; Ibrahim Zm, 2011, MED J CAIRO U, V79; Karaoglu L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-329; Kassa Getachew Mullu, 2017, BMC Hematol, V17, P17, DOI 10.1186/s12878-017-0090-z; Lacerte P, 2011, ASIA-PAC J PUBLIC HE, V23, P315, DOI 10.1177/1010539511403133; Lakew Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-52; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Melku M, 2014, ANEMIA, V2014, DOI 10.1155/2014/108593; Mithra P, 2013, Afr Health Sci, V13, P880, DOI 10.4314/ahs.v13i4.3; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Organization WH, 2018, MED MAN AB 2018; Rahman MM, 2016, AM J CLIN NUTR, V103, P495, DOI 10.3945/ajcn.115.107896; Salhan S, 2012, ANEMIA, V2012, DOI 10.1155/2012/608658; Stephen G, 2018, ANEMIA, V2018, DOI 10.1155/2018/1846280; Taye B, 2015, J ENV PUBLIC HLTH, V20, P1; Tegegne M, 2017, GLOBAL J MED RES, V7; WHO, 2016, WORLD HLTH STAT 2016; WHO, 2012, DAIL IR FOL AC SUPPL, P27; Yusrawati Yusrawati, 2019, Open Access Maced J Med Sci, V7, P1114, DOI 10.3889/oamjms.2019.202	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232625	10.1371/journal.pone.0232625	http://dx.doi.org/10.1371/journal.pone.0232625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365114	Green Published, gold			2022-12-26	WOS:000536959700046
J	Rasch-Halvorsen, O; Hassel, E; Brumpton, B; Jenssen, H; Spruit, MA; Langhammer, A; Steinshamn, S				Rasch-Halvorsen, Oystein; Hassel, Erlend; Brumpton, Ben M.; Jenssen, Haldor; Spruit, Martijn A.; Langhammer, Arnulf; Steinshamn, Sigurd			The association between normal lung function and peak oxygen uptake in patients with exercise intolerance and coronary artery disease	PLOS ONE			English	Article							HEART-FAILURE; CAPACITY; ABNORMALITIES; SPIROMETRY	In coronary artery disease (CAD), exercise intolerance with reduced oxygen uptake at peak exercise (VO2peak) is assumed to primarily reflect cardiovascular limitation. However, oxygen transport and utilization depends on an integrated organ response, to which the normal pulmonary system may influence overall capacity. This study aimed to investigate the associations between normal values of lung function measures and VO2peak in patients with exercise intolerance and CAD. We hypothesized that forced expiratory lung volume in one second (FEV1), transfer factor of the lung for carbon monoxide (TLCO) and TLCO/alveolar volume (TLCO/VA) above lower limits of normal (LLN) are associated with VO2peak in these patients. We assessed patients with established CAD (n = 93; 21 women) referred for evaluation due to exercise intolerance from primary care to a private specialist clinic in Norway. Lung function tests and cardiopulmonary exercise testing (CPET) were performed. Z-scores of FEV1, FEV1/forced vital capacity (FVC), TLCO and TLCO/VA were calculated using the Global Lung Function Initiative (GLI) software and LLN was defined as the fifth percentile (z = -1.645). Non-obstructive patients, defined by both FEV1 and FEV1/FVC above LLN, were assessed. The associations of FEV1Z-score, TLCOZ-score and TLCO/VA(Z-score) above LLN with VO2peak were investigated using linear regression models. Mean VO2peak +/- standard deviation (SD) was 23.8 +/- 6.4 ml/kg/min in men and 19.7 +/- 4.4 ml/kg/min in women. On average, one SD increase in FEV1, TLCO and TLCO/VA were associated with 1.4 (95% CI 0.2, 2.6), 2.6 (95% CI 1.2, 4.0) and 1.3 (95% CI 0.2, 2.5) ml/kg/min higher VO2peak, respectively. In non-obstructive patients with exercise intolerance and CAD, FEV1, TLCO and TLCO/VA above LLN are positively associated with VO2peak. This may imply a clinically significant influence of normal lung function on exercise capacity in these patients.	[Rasch-Halvorsen, Oystein; Hassel, Erlend; Steinshamn, Sigurd] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, NTNU, Trondheim, Norway; [Rasch-Halvorsen, Oystein; Hassel, Erlend; Brumpton, Ben M.; Steinshamn, Sigurd] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Thorac & Occupat Med, Trondheim, Norway; [Brumpton, Ben M.] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Nursing, Trondheim, Norway; [Brumpton, Ben M.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Jenssen, Haldor] Telemark Heart Lung & Blood Inst, Skien, Norway; [Spruit, Martijn A.] CIRO, Deptartment Res & Educ, Horn, Netherlands; [Spruit, Martijn A.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Resp Med, Med Ctr, Maastricht, Netherlands; [Spruit, Martijn A.] Hasselt Univ, Fac Rehabil Sci, REVAL Rehabil Res Ctr, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Langhammer, Arnulf] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, NTNU, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bristol; Maastricht University; Maastricht University Medical Centre (MUMC); Hasselt University; Norwegian University of Science & Technology (NTNU)	Rasch-Halvorsen, O (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, NTNU, Trondheim, Norway.; Rasch-Halvorsen, O (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Thorac & Occupat Med, Trondheim, Norway.	oystein.rasch-halvorsen@ntnu.no		Hassel, Erlend/0000-0003-3282-8921	Norwegian ExtraFoundation for Health and Rehabilitation [2015/FO5150]	Norwegian ExtraFoundation for Health and Rehabilitation	OR-H received a Ph.D. -grant from the Norwegian ExtraFoundation for Health and Rehabilitation (https://www.dam.no).Grant number 2015/FO5150. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2012, EXP PHYSIOL, V97, P311, DOI 10.1113/expphysiol.2011.058800; Andrea R, 2014, HEART LUNG CIRC, V23, P273, DOI 10.1016/j.hlc.2013.08.003; Arena R, 2011, CIRCULATION, V123, P668, DOI 10.1161/CIRCULATIONAHA.109.914788; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BABB TG, 1991, J APPL PHYSIOL, V70, P223, DOI 10.1152/jappl.1991.70.1.223; Belardinelli R, 2003, EUR HEART J, V24, P1304, DOI 10.1016/S0195-668X(03)00210-0; BYE PTP, 1983, ANNU REV PHYSIOL, V45, P439, DOI 10.1146/annurev.ph.45.030183.002255; CAMPBELL SC, 1982, J OCCUP ENVIRON MED, V24, P531; Chaudhry S, 2009, AM J CARDIOL, V103, P615, DOI 10.1016/j.amjcard.2008.10.034; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; DEMPSEY JA, 1984, J PHYSIOL-LONDON, V355, P161, DOI 10.1113/jphysiol.1984.sp015412; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Ferrazza A M, 2009, Respiration, V77, P3, DOI 10.1159/000186694; Guazzi M, 2008, J CARD FAIL, V14, P695, DOI 10.1016/j.cardfail.2008.06.004; Guazzi M, 2010, AM HEART J, V160, P900, DOI 10.1016/j.ahj.2010.07.014; Hassel E, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0317-0; Hiraga T, 2003, CLIN PHYSIOL FUNCT I, V23, P324, DOI 10.1046/j.1475-0961.2003.00514.x; Ketcyian SJ, 2008, AM HEART J, V156, P292, DOI 10.1016/j.ahj.2008.03.017; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Langhammer A, 2016, EUR RESPIR J, V48, P1602, DOI 10.1183/13993003.00443-2016; MANCINI DM, 1995, PROG CARDIOVASC DIS, V37, P347, DOI 10.1016/S0033-0620(05)80018-0; Miller MR, 2011, CHEST, V139, P52, DOI 10.1378/chest.10-0189; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Myers J, 2015, CURR PROB CARDIOLOGY, V40, P322, DOI 10.1016/j.cpcardiol.2015.01.009; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; Paoletti P, 2011, RESP PHYSIOL NEUROBI, V179, P167, DOI 10.1016/j.resp.2011.07.013; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Poole DC, 2017, J APPL PHYSIOL, V122, P997, DOI 10.1152/japplphysiol.01063.2016; PURI S, 1995, CIRCULATION, V91, P2769, DOI 10.1161/01.CIR.91.11.2769; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rasch-Halvorsen O, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-018-0762-x; Stanojevic S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00010-2017; Stickland MK, 2012, PULM MED, V2012, DOI 10.1155/2012/824091; Wagner PD, 1996, ANNU REV PHYSIOL, V58, P21, DOI 10.1146/annurev.physiol.58.1.21	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232693	10.1371/journal.pone.0232693	http://dx.doi.org/10.1371/journal.pone.0232693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365098	Green Published, gold			2022-12-26	WOS:000536959700053
J	Zhang, CZ; Huang, SZ; Zhuang, HK; Ruan, SY; Zhou, ZX; Huang, KJ; Ji, F; Ma, ZY; Hou, BH; He, XS				Zhang, Chuanzhao; Huang, Shanzhou; Zhuang, Hongkai; Ruan, Shiye; Zhou, Zixuan; Huang, Kaijun; Ji, Fei; Ma, Zuyi; Hou, Baohua; He, Xiaoshun			YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation	ONCOGENE			English	Article							MICRORNAS	N-6-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell (CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown to be associated with hepatocellular carcinoma (HCC) patient prognosis. However, the effect of YTHDF2 on liver CSC and cancer metastasis and the molecular mechanism of this effect have not been documented. Here, we show that YTHDF2 expression is negatively correlated with HCC patient survival in both data from the Cancer Genome Atlas (TCGA) database and clinical data from our center. By detecting CD133(+) cells and carrying out sphere culture assays, we found that knockdown of YTHDF2 led to impaired stemness in Hep3B and Huh7 cells. In contrast, overexpression of YTHDF2 increased the CSC phenotype. Mechanistically, the knockdown and overexpression of YTHDF2 in liver cancer cells resulted in decreased and increased m6A levels in the 5 '-untranslated region (UTR) of OCT4 mRNA, respectively, leading to decreased and increased OCT4 protein expression, respectively. A luciferase activity assay showed that mutation of the corresponding m6A methylation sequence in the 5 '-UTR of OCT4 mRNA caused significantly decreased gene expression, suggesting a role for YTHDF2-dependent m6A methylation in protein translation. Polysome profiling results also indicated the knockdown and overexpression of YTHDF2 could decrease and increase OCT4 translation, respectively. In particular, overexpression of OCT4 rescued the impaired stemness caused by YTHDF2 depletion, which confirmed the effect of YTHDF2 on CSC phenotype is dependent on OCT4. In vivo, the loss of YTHDF2 reduced tumor burden and inhibited lung metastasis following orthotopic transplantation in nude mice. Last, we demonstrated that YTHDF2 expression is positively correlated with OCT4 expression and m6A levels in the 5 '-UTR of OCT4 mRNA in clinical HCC specimens. In conclusion, YTHDF2 promotes the CSC liver phenotype and cancer metastasis by modulating the m6A methylation of OCT4 mRNA.	[Zhang, Chuanzhao; Huang, Shanzhou; Zhuang, Hongkai; Ruan, Shiye; Zhou, Zixuan; Huang, Kaijun; Ji, Fei; Ma, Zuyi; Hou, Baohua] South China Univ Technol, Sch Med, Guangdong Acad Med Sci, Dept Gen Surg,Guangdong Prov Peoples Hosp, Guangzhou 510080, Peoples R China; [Zhuang, Hongkai; Ma, Zuyi] Shantou Univ Med Coll, Shantou 515000, Guangdong, Peoples R China; [He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510080, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; South China University of Technology; Sun Yat Sen University	Zhang, CZ; Hou, BH (corresponding author), South China Univ Technol, Sch Med, Guangdong Acad Med Sci, Dept Gen Surg,Guangdong Prov Peoples Hosp, Guangzhou 510080, Peoples R China.; He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510080, Peoples R China.	641703837@qq.com; 15917919681@163.com; 13922171191@163.com	zhang, chuanzhao/K-8624-2019		National Natural Science Foundation of China [81702783, 81672475]; Natural Science Foundation of Guangdong Province [2017A030310574]; Guangdong Medical Science and Technology Research Fund [A2019494, A2019252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Medical Science and Technology Research Fund	This study was supported by the National Natural Science Foundation of China (project Nos.: 81702783 and 81672475), the Natural Science Foundation of Guangdong Province (project No.: 2017A030310574), and Guangdong Medical Science and Technology Research Fund (A2019494 and A2019252).	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016; Faye MD, 2014, JOVE-J VIS EXP, DOI 10.3791/52295; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x; Li MM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1436-y; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Song YY, 2015, GASTROENTEROLOGY, V149, P1068, DOI 10.1053/j.gastro.2015.06.010; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Yang Z, 2017, J BIOL CHEM, V292, P3614, DOI 10.1074/jbc.M116.749689; Zhang CZ, 2016, ONCOTARGET, V7, P64527, DOI 10.18632/oncotarget.11743; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhao BS, 2018, RNA, V24, P268, DOI 10.1261/rna.064295.117; Zhong L, 2019, CANCER LETT, V442, P252, DOI 10.1016/j.canlet.2018.11.006; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhu PP, 2015, J CLIN INVEST, V125, P3795, DOI 10.1172/JCI81979	24	148	155	11	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4507	4518		10.1038/s41388-020-1303-7	http://dx.doi.org/10.1038/s41388-020-1303-7		MAY 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32366907				2022-12-26	WOS:000530271400004
J	Asali, A; Miller, N; Pasternak, Y; Freger, V; Belenky, M; Berkovitz, A				Asali, Aula; Miller, Netanella; Pasternak, Yael; Freger, Vita; Belenky, Michael; Berkovitz, Arie			The possibility of integrating motile sperm organelle morphology examination (MSOME) with intracytoplasmic morphologically-selected sperm injection (IMSI) when treating couples with unexplained infertility	PLOS ONE			English	Article							PREGNANCY RATE; SPERMATOZOA; VACUOLES; OUTCOMES	Purpose To examine the efficacy of motile sperm organelle morphology examination (MSOME) and intracytoplasmic morphologically-selected sperm injection (IMSI) for unexplained infertility. Methods This historical study, included 271 couples with primary, unexplained infertility/male subfertility, treated at an outpatient, IVF clinic, 2015-2018. These couples underwent MSOME after >= 3 failed intrauterine insemination (IUI) cycles and >= 1 failed IVF-ICSI cycle. They proceeded to intracytoplasmic morphologically-selected sperm injection (IMSI) within 6 months of MSOME. IMSI is conducted on the day of oocyte pick-up with a fresh semen sample. Pregnancy and delivery rates were analyzed. Results The cohort was divided based on percentage of normal cells at MSOME: Group A included 55 with no normal cells, Group B, 184 with 0.5% <= normal cells <= 1.5% and Group C, 32 with >= 2% normal cells. Normal spermatozoa were found in 49 (89%) of Group A after extensive search. Group A had higher pregnancy rate (62.7%) compared to B (47.2%, P = 0.05) and C (28.1%, P = 0.002). Group B had higher pregnancy rate than C (p = 0.045). Delivery rate was higher in Group A (52.1%) compared to B (34.1%, p = 0.023) and C (21.9%, p = 0.007). Pregnancy and delivery rates were higher in A compared to B+C (p = 0.018, p = 0.01, respectively). Conclusions MSOME may be useful for evaluating unexplained infertility. IMSI can be recommended for men with < 2% normal spermatozoa at MSOME.	[Asali, Aula; Miller, Netanella; Pasternak, Yael; Berkovitz, Arie] Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel; [Freger, Vita; Belenky, Michael] Male Fertil Ctr, Rishon Leziyyon, Israel; [Berkovitz, Arie] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Berkovitz, Arie] Assuta Med Ctr, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Asali, A (corresponding author), Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel.	aula_atamna@yahoo.com						[Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Bartoov B, 2003, FERTIL STERIL, V80, P1413, DOI 10.1016/j.fertnstert.2003.05.016; Bartoov B, 2002, J ANDROL, V23, P1; Bartoov B, 2001, NEW ENGL J MED, V345, P1067, DOI 10.1056/NEJM200110043451416; Berkovitz A, 2005, HUM REPROD, V20, P185, DOI 10.1093/humrep/deh545; Berkovitz A, 2018, HUM REPROD, V33, P563, DOI 10.1093/humrep/dey019; Gunn DD, 2016, FERTIL STERIL, V105, DOI 10.1016/j.fertnstert.2016.02.001; Klatsky PC, 2008, AM J OBSTET GYNECOL, V198, P357, DOI 10.1016/j.ajog.2007.12.039; Klement AH, 2013, FERTIL STERIL, V99, P1290, DOI 10.1016/j.fertnstert.2012.12.020; Malvezzi H, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-121; MOGHISSI KS, 1983, FERTIL STERIL, V39, P5; O'Neill CL, 2018, J ASSIST REPROD GEN, V35, P1911, DOI 10.1007/s10815-018-1270-x; Perdrix A, 2013, HUM REPROD UPDATE, V19, P527, DOI 10.1093/humupd/dmt021; Setti AS, 2014, EUR J OBSTET GYN R B, V183, P96, DOI 10.1016/j.ejogrb.2014.10.008; Soullier N, 2011, REPROD BIOMED ONLINE, V22, P496, DOI 10.1016/j.rbmo.2011.01.013; van Eekelen R, 2019, HUM REPROD, V34, P84, DOI 10.1093/humrep/dey329; Vanderzwalmen P, 2008, REPROD BIOMED ONLINE, V17, P617, DOI 10.1016/S1472-6483(10)60308-2; Wang SS, 2014, YONSEI MED J, V55, P815, DOI 10.3349/ymj.2014.55.3.815	18	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232156	10.1371/journal.pone.0232156	http://dx.doi.org/10.1371/journal.pone.0232156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357155	Green Published, gold			2022-12-26	WOS:000536957700017
J	Ata-abadi, NS; Mowla, SJ; Aboutalebi, F; Dormiani, K; Kiani-Esfahani, A; Tavalaee, M; Nasr-Esfahani, MH				Ata-abadi, Nafiseh Sanei; Mowla, Seyed Javad; Aboutalebi, Fatemeh; Dormiani, Kianoush; Kiani-Esfahani, Abbas; Tavalaee, Marziyeh; Nasr-Esfahani, Mohammad Hossein			Hypoxia-related long noncoding RNAs are associated with varicocele-related male infertility	PLOS ONE			English	Article							INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTOME ANALYSIS; DNA-DAMAGE; EXPRESSION; LNCRNAS; PCR	One of the main molecular causes that contributes to varicocele-related male infertility is excess production of reactive oxygen species (ROS). It is believed that hypoxia is an important stimulator of ROS in this condition. Recently, the significant roles of long non-coding RNAs (lncRNAs) in hypoxia response have emerged. Despite the investigation of hypoxia, there is scant information about the role of hypoxia-responding lncRNAs in varicocele-related male infertility. In the present study, we deduced eight hypoxia-responding lncRNAs based on high-throughput RNA sequencing data from two Gene Expression Omnibus (GEO) datasets. We used qRT-PCR to assess the expression levels of some of these lncRNAs in 42 ejaculated spermatozoa samples from 25 infertile men with varicocele and 17 fertile men as controls. We identified significant increases in expression levels of hypoxia-related lncRNAs, MIR210HG and MLLT4-AS1 in ejaculated spermatozoa of infertile men with varicocele. These lncRNAs also showed significant positive correlations with ROS levels and meaningful negative correlations with sperm parameters (count and motility). Besides, in silico studies identified several hypoxia response elements (HREs) within selected lncRNAs promoters. Delineation of hypoxia-related lncRNAs in varicocele-related infertility provides a valuable insight into male infertility.	[Ata-abadi, Nafiseh Sanei; Mowla, Seyed Javad] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran; [Aboutalebi, Fatemeh; Dormiani, Kianoush] ACECR, Dept Mol Biotechnol, Cell Sci Res Ctr, Royan Inst Biotechnol, Esfahan, Iran; [Kiani-Esfahani, Abbas] ACECR, Dept Cellular Biotechnol, Cell Sci Res Ctr, Royan Inst Biotechnol, Esfahan, Iran; [Tavalaee, Marziyeh; Nasr-Esfahani, Mohammad Hossein] ACECR, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, Royan Inst Biotechnol, Esfahan, Iran; [Nasr-Esfahani, Mohammad Hossein] Isfahan Fertil & Infertil Ctr, Esfahan, Iran	Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Mowla, SJ (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran.; Nasr-Esfahani, MH (corresponding author), ACECR, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, Royan Inst Biotechnol, Esfahan, Iran.; Nasr-Esfahani, MH (corresponding author), Isfahan Fertil & Infertil Ctr, Esfahan, Iran.	sjmowla@modares.ac.ir; mh.nasr-esfahani@royaninstitute.org	, Nasr-Esfahani/AAR-2434-2021; Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020; Tavalaee, Marziyeh/AAM-7801-2020	Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435; Tavalaee, Marziyeh/0000-0001-9954-964X; Dormiani, Kianoush/0000-0002-6383-3099; Mowla, Seyed Javad/0000-0002-3300-6332	Tarbiat Modares University; Royan Institute [96000239]	Tarbiat Modares University; Royan Institute	This study was partially funded by grants from Tarbiat Modares University and Royan Institute (Grant no. 96000239) in support of NSA for obtaining his PhD degree from Tarbiat Modares University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the Isfahan Fertility and Infertility Center only helps for obtaining semen samples and had no finical contribution to this study. This center, did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal A, 2012, NAT REV UROL, V9, P678, DOI 10.1038/nrurol.2012.197; Bansal SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127007; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chu CL, 2017, INT J CLIN EXP PATHO, V10, P10009; Esfahani MHN, 2012, INT J FERTIL STERIL, V6, P141; Feng L, 2017, ONCOTARGET, V8, P31521, DOI 10.18632/oncotarget.16358; Ghandehari-Alavijeh R, 2019, ANDROLOGIA, V51, DOI 10.1111/and.13189; He ZY, 2019, J CELL PHYSIOL, V234, P6769, DOI 10.1002/jcp.27424; Kilinc F, 2004, J UROLOGY, V172, P1188, DOI 10.1097/01.ju.0000135455.97627.15; Lai YX, 2017, ONCOL LETT, V14, P2629, DOI 10.3892/ol.2017.6478; Li DG, 2018, DNA CELL BIOL, V37, P839, DOI 10.1089/dna.2018.4312; Li J, 2017, DNA CELL BIOL, V36, P1117, DOI 10.1089/dna.2017.3888; Lin J, 2015, AM J PHYSIOL-RENAL, V309, pF901, DOI 10.1152/ajprenal.00290.2015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luk ACS, 2014, REPRODUCTION, V147, pR131, DOI 10.1530/REP-13-0594; Min WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160451; Nohata N, 2016, ORAL ONCOL, V59, P58, DOI 10.1016/j.oraloncology.2016.05.014; Paick JS, 2012, ACTAS UROL ESP, V36, P282, DOI [10.1016/j.acuroe.2012.08.005, 10.1016/j.acuro.2011.07.022]; Reyes JG, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/929285; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; Shih JW, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0358-4; Vaerman JL, 2004, J BIOL REG HOMEOS AG, V18, P212; Verratti V, 2008, ASIAN J ANDROL, V10, P602, DOI 10.1111/j.1745-7262.2008.00346.x; Voellenkle C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24141; Wang YJ, 2012, REPROD BIOMED ONLINE, V25, P307, DOI 10.1016/j.rbmo.2012.05.002; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Zhao J, 2018, ONCOTARGET, V9, P5105, DOI 10.18632/oncotarget.23696	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232357	10.1371/journal.pone.0232357	http://dx.doi.org/10.1371/journal.pone.0232357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353040	Green Published, gold			2022-12-26	WOS:000536673200082
J	Azarakhsh, M; Rumyantsev, AM; Lebedeva, MA; Lutova, LA				Azarakhsh, Mahboobeh; Rumyantsev, Andrey M.; Lebedeva, Maria A.; Lutova, Lyudmila A.			Cytokinin biosynthesis genes expressed during nodule organogenesis are directly regulated by the KNOX3 protein in Medicago truncatula	PLOS ONE			English	Article							HOMEODOMAIN PROTEIN; KNOTTED CLASS; ARABIDOPSIS; RNA; RESPONSES; PLANT; MAP	Cytokinin is an important regulator of symbiotic nodule development. Recently, KNOT-TED1-LIKE HOMEOBOX 3 transcription factor (TF) was shown to regulate symbiotic nodule development possibly via the activation of cytokinin biosynthesis genes. However, the direct interaction between the KNOX3 TF and its target genes has not been investigated up to date. Here, using EMSA analysis and SPR-based assay, we found that MtKNOX3 homeodomain directly binds to the regulatory sequences of the MtLOG1, MtLOG2, and MtIPT3 genes involved in nodulation in Medicago truncatula. Moreover, we showed that MtLOG2 and MtIPT3 expression patterns partially overlap with MtKNOX3 expression in developing nodules as it was shown by promoter:GUS analysis. Our data suggest that MtKNOX3 TF may directly activate the MtLOG1, MtLOG2, and MtIPT3 genes during nodulation thereby increasing cytokinin biosynthesis in developing nodules.	[Azarakhsh, Mahboobeh; Rumyantsev, Andrey M.; Lebedeva, Maria A.; Lutova, Lyudmila A.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia; [Azarakhsh, Mahboobeh] Kosar Univ Bojnord, Cell & Mol Biol Dept, Bojnord, North Khorasan, Iran	Saint Petersburg State University	Lebedeva, MA (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia.	m.a.lebedeva@spbu.ru	Lebedeva, Maria/C-6386-2013; Azarakhsh, Mahboobeh/AAV-3540-2020; Maria, Lebedeva/ABC-4550-2021	Lebedeva, Maria/0000-0002-6412-7401; Maria, Lebedeva/0000-0002-6412-7401	Russian Scientific Foundation [16-16-10011]; SaintPetersburg State University [IAS 1.42.710.2017]; Russian Science Foundation [19-16-13001] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); SaintPetersburg State University; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Scientific Foundation project no. 16-16-10011 (http://rscf.ru/en/) and by the grant from SaintPetersburg State University (http://english.spbu.ru/) IAS 1.42.710.2017 to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Azarakhsh M, 2015, J EXP BOT, V66, P7181, DOI 10.1093/jxb/erv414; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Chen H, 2004, PLANT J, V38, P276, DOI 10.1111/j.1365-313X.2004.02048.x; Coudert Y, 2019, CURR BIOL, V29, P2743, DOI 10.1016/j.cub.2019.06.083; Di Giacomo E, 2017, NEW PHYTOL, V213, P822, DOI 10.1111/nph.14146; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Furumizu C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004980; Gaudioso-Pedraza R, 2018, CURR BIOL, V28, P3562, DOI 10.1016/j.cub.2018.09.031; Held M, 2014, PLANT CELL, V26, P678, DOI 10.1105/tpc.113.119362; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; KERSTETTER R, 1994, PLANT CELL, V6, P1877, DOI 10.1105/tpc.6.12.1877; Kim D, 2013, PLANT J, V75, P755, DOI 10.1111/tpj.12236; Krusell L, 1997, FEBS LETT, V408, P25, DOI 10.1016/S0014-5793(97)00382-7; Langmuir I., 1916, RES LAB GEN ELECT CO, P2221; Langmuir I., 1918, RES LAB GEN ELECT 2, P1848; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Limpens E, 2004, J EXP BOT, V55, P983, DOI 10.1093/jxb/erh122; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mortier V, 2014, NEW PHYTOL, V202, P582, DOI 10.1111/nph.12681; Moyroud E, 2009, PLANT J, V59, P851, DOI 10.1111/j.1365-313X.2009.03903.x; Reid D, 2017, PLANT PHYSIOL, V175, P361, DOI 10.1104/pp.17.00832; Roux B, 2014, PLANT J, V77, P817, DOI 10.1111/tpj.12442; Sasaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5983; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smith HMS, 2002, P NATL ACAD SCI USA, V99, P9579, DOI 10.1073/pnas.092271599; Truernit E, 2006, PLANT MOL BIOL, V60, P1, DOI 10.1007/s11103-005-1673-9; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232352	10.1371/journal.pone.0232352	http://dx.doi.org/10.1371/journal.pone.0232352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353031	gold, Green Published			2022-12-26	WOS:000536673200081
J	Ghozayel, M; Ghaddar, A; Farhat, G; Nasreddine, L; Kara, J; Jomaa, L				Ghozayel, Malake; Ghaddar, Ali; Farhat, Ghada; Nasreddine, Lara; Kara, Janine; Jomaa, Lamis			Energy drinks consumption and perceptions among University Students in Beirut, Lebanon: A mixed methods approach	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; ADOLESCENT; HEALTH; ASSOCIATIONS; MODEL; INTERVENTIONS; PERFORMANCE; BEHAVIORS; BEVERAGES; PATTERNS	Background Energy drinks (ED) are caffeine- and sugar-rich beverages with other ingredients that are marketed for their energy-boosting and performance-enhancing effects. The consumption of these drinks, with and without alcohol, is dramatically increasing worldwide, despite the reported side effects and potential harms to consumers. Few studies, to date, have explored the perceptions and experiences of young adults towards these beverages. Objective The present study aimed to explore the consumption patterns and correlates of ED consumption, as well as the perceptions and experiences of university students in Lebanon towards these beverages. Methods A sequential explanatory mixed-methods approach was adopted. Data collection was conducted in two private universities in Beirut, Lebanon. A self-administered 36-item quantitative survey was first used to explore the prevalence and correlates of ED consumption among a convenience sample of university students (n = 226). The survey included questions related to socio-demographic characteristics, anthropometric measurements, and other lifestyle behaviors, including physical activity of university students. The subsequent qualitative phase consisted of focus group discussions (FGD) conducted to further examine the perceptions and experiences of university students towards ED. Descriptive statistics and logistic regression analyses were conducted using survey data, whereas the transcribed FGD were analyzed thematically. Results A total of 226 university students completed the survey. Results showed that 45% of survey respondents consumed ED at least once in their life (ever consumers), among which 30% reported consumption of ED mixed with alcohol (AmED). Adjusting for socio-demographic and anthropometric characteristics, coffee and sports drinks consumption were significantly associated with ED (OR = 2.45, 95% CI = 1.20, 5.00, and OR = 4.88, 95%CI = 2.41, 9.88, respectively). In addition, physically active participants were 1.89 times (95%CI = 1.01, 3.51) more likely to consume ED compared to their inactive counterparts. During the qualitative phase, a total of six FGD were conducted with 29 university students, who reported consuming ED at least once per month. Three main themes were derived reflecting individual-, interpersonal/social- and environmental-level factors affecting ED consumption among university students. These themes were further supported by eight subthemes, including: perceived benefits of ED, experienced side effects, misinformation about content of ED, peer pressure and social image, as well as affordability and accessibility of ED. Conclusion Findings highlight the need for public health policies and programs to curb the growing public health phenomenon of ED consumption amongst university students. Such programs should consider the multi-level factors affecting ED consumption at the individual, interpersonal/social, and environmental levels, including educational campaigns on ED potential harms, regulating ED content and labeling, as well as restricting sales and marketing of these beverages, especially among young consumers.	[Ghozayel, Malake; Nasreddine, Lara; Jomaa, Lamis] Amer Univ Beirut, Dept Nutr & Food Sci, Fac Agr & Food Sci, Beirut, Lebanon; [Ghaddar, Ali] Lebanese Int Univ, Dept Biomed Sci, Beirut, Lebanon; [Farhat, Ghada] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA; [Kara, Janine] Yale Univ, Yale Sch Publ Hlth, Social & Behav Sci Dept, New Haven, CT USA	American University of Beirut; Emory University; Rollins School Public Health; Yale University	Jomaa, L (corresponding author), Amer Univ Beirut, Dept Nutr & Food Sci, Fac Agr & Food Sci, Beirut, Lebanon.	lj18@aub.edu.lb		Nasreddine, Lara/0000-0003-3707-8218; Ghaddar, Ali/0000-0001-7261-347X; Jomaa, Lamis/0000-0002-3046-4581	Department of Nutrition and Food Sciences at the American University of Beirut	Department of Nutrition and Food Sciences at the American University of Beirut	This study received funding from the Department of Nutrition and Food Sciences at the American University of Beirut in support of graduate student thesis. There was no additional external funding received for this study.	Al-Shaar L, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00225; AlcoholPolicyMD, 2019, EFF ENV FACT ALC US; Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021; Alsunni AA, 2015, INT J HEALTH SCI-IJH, V9, P468, DOI 10.12816/0031237; Anderson L., 2008, REFLEXIVITY; [Anonymous], J SCI RES REP; Asaad YA, 2017, ZANCO J MED SCI, V21, P1680; Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008; Ayob AH, 2016, INT REV MANAGEMENT M, V6, P688; Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019; Ballistreri MC, 2008, REV LAT-AM ENFERM, V16, P558, DOI 10.1590/S0104-11692008000700009; Bawazeer NA, 2013, INT J MED STUDENTS, V1, P104, DOI DOI 10.5195/ijms.2013.215; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bunting H, 2013, APPETITE, V65, P132, DOI 10.1016/j.appet.2013.02.011; Costa BM, 2016, APPETITE, V105, P638, DOI 10.1016/j.appet.2016.07.001; de Bruijn GJ, 2007, HEALTH EDUC RES, V22, P227, DOI 10.1093/her/cyl066; Del Coso J, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-21; Duchan E, 2010, PHYSICIAN SPORTSMED, V38, P171, DOI 10.3810/psm.2010.06.1796; Dwaidy J, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-018-0056-y; Fletcher Ea LCSAMKMOASSA, 2017, EN DRINKS LINK MOR H; Francis J, 2017, J NUTR EDUC BEHAV, V49, P724, DOI 10.1016/j.jneb.2017.06.007; FROMME K, 1992, ADDICT BEHAV, V17, P167, DOI 10.1016/0306-4603(92)90021-M; Gallimberti L, 2013, EUR J PEDIATR, V172, P1335, DOI 10.1007/s00431-013-2036-1; Grimm GC, 2004, J AM DIET ASSOC, V104, P1244, DOI 10.1016/j.jada.2004.05.206; Gruenewald PJ, 2014, ADDICTION, V109, P736, DOI 10.1111/add.12438; Ibrahim NKR, 2014, J FOOD NUTR RES, V2, P174, DOI DOI 10.12691/JFNR-2-4-7; IPAQ Research Committee, 2005, IPAQ, P1; IstiZada, 2019, MIDDL E AR CONS PROF; Itany Manal, 2014, Int J High Risk Behav Addict, V3, pe18857, DOI 10.5812/ijhrba.18857; Jackson DAE, 2013, CLIN TOXICOL, V51, P557, DOI 10.3109/15563650.2013.820311; Jacob S., 2013, Gulf Medical Journal, V2, P22; James JE, 2015, SUBST USE MISUSE, V50, P257, DOI 10.3109/10826084.2014.977394; Jay M., 2014, ENERGY DRINKS SPARK; Jiang H, 2015, ALCOHOL ALCOHOLISM, V50, P631, DOI 10.1093/alcalc/agv064; Jones SC, 2011, AUSTRALAS MARK J, V19, P189, DOI 10.1016/j.ausmj.2011.05.005; Jones SC, 2012, DRUG ALCOHOL REV, V31, P281, DOI 10.1111/j.1465-3362.2011.00319.x; Khazan O., 2015, WHY BROS LOVE ENERGY; Kodl MM, 2004, ADDICT BEHAV, V29, P17, DOI 10.1016/S0306-4603(03)00087-X; Kumar G, 2015, AM J HEALTH PROMOT, V29, P238, DOI 10.4278/ajhp.130820-QUAN-435; Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008; Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35; Matthee R, 2014, PAST PRESENT, P100; McLellan TM, 2012, NUTR REV, V70, P730, DOI 10.1111/j.1753-4887.2012.00525.x; Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003; Moore L, 2013, PUBLIC HEALTH NUTR, V16, P1000, DOI 10.1017/S1368980012005605; National Institutes of Health, 2018, EN DRINKS US DEP HLT; O'Dea JA, 2003, HEALTH EDUC RES, V18, P98, DOI 10.1093/her/18.1.98; Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x; Polak Kathryn, 2016, Prev Med Rep, V4, P381, DOI 10.1016/j.pmedr.2016.06.019; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Riemer AR, 2019, SEX ROLES, V80, P617, DOI 10.1007/s11199-018-0958-9; Robinson T, 2008, J COMMUN HEALTH, V33, P395, DOI 10.1007/s10900-008-9109-5; Scully M, 2012, APPETITE, V58, P1, DOI 10.1016/j.appet.2011.09.020; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Smit HJ, 2004, NUTR NEUROSCI, V7, P127, DOI 10.1080/10284150400003041; Sondhi A., 2011, INFLUENCE FAMILY FRI; Steinke L, 2009, ANN PHARMACOTHER, V43, P596, DOI 10.1345/aph.1L614; Sudhinaraset M, 2016, ALCOHOL RES-CURR REV, V38, P35; Trapp GSA, 2014, DRUG ALCOHOL DEPEN, V134, P30, DOI 10.1016/j.drugalcdep.2013.09.006; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; US Department of Health Human Services, 1999, PROM PHYS ACT GUID C, P67; Vargas-Garcia EJ, 2017, OBES REV, V18, P1350, DOI 10.1111/obr.12580; Verster JC, 2012, INT J GEN MED, V5, P187, DOI 10.2147/IJGM.S29313; Visram S, 2016, WORKING PAPER; Visram S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188668; Visram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010380; von Philipsborn P, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012292.pub2; Waterlander WE, 2014, APPETITE, V78, P32, DOI 10.1016/j.appet.2014.03.012; Willett WC, 2017, AM J EPIDEMIOL, V185, P1109, DOI 10.1093/aje/kwx107; Young EM, 2004, J NUTR EDUC BEHAV, V36, P2, DOI 10.1016/S1499-4046(06)60122-X	71	7	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232199	10.1371/journal.pone.0232199	http://dx.doi.org/10.1371/journal.pone.0232199			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353017	gold, Green Published			2022-12-26	WOS:000536673200051
J	Angebault, C; Payen, M; Woerther, PL; Rodriguez, C; Botterel, F				Angebault, Cecile; Payen, Mathilde; Woerther, Paul-Louis; Rodriguez, Christophe; Botterel, Francoise			Combined bacterial and fungal targeted amplicon sequencing of respiratory samples: Does the DNA extraction method matter?	PLOS ONE			English	Article							DIVERSITY; ITS2; BARCODE	Background High-throughput sequencing techniques are used to analyse the diversity of the respiratory microbiota in health and disease. Although extensive data are available regarding bacterial respiratory microbiota, its fungal component remains poorly studied. This is partly due to the technical issues associated with fungal metagenomics analyses. In this study, we compared two DNA extraction protocols and two fungal amplification targets for combined bacterial and fungal targeted amplicon sequencing analyses of the respiratory microbiota. Methods Six sputa, randomly selected from routine samples in Mondor Hospital (Creteil, France) and treated anonymously, were tested after bacterial and fungal routine culture. Two of which were spiked with Aspergillus Fumigati and Aspergillus Nigri (10(5) conidia/mL). After mechanical lysis, DNA was extracted using automated QIAsymphony (R) extraction (AQE) or manual PowerSoil (R) MoBio extraction (MPE). DNA yield and purity were compared. DNA extracted from spiked sputa was subjected to (i) real-time PCR for Aspergillus DNA detection and (ii) combined metagenomic analyses targeting barcoded primers for fungal ITS1 and ITS2, and bacterial V1-V2 and V3-V4 16S regions. Amplicon libraries were prepared using MiSeq Reagent V3 kit on Illumina platform. Data were analysed using PyroMIC (c) and SHAMAN software, and compared with culture results. Results AQE extraction provided a higher yield of DNA (AQE/MPE DNA ratio = 4.5 [1.3-11]) in a shorter time. The yield of Aspergillus DNA detected by qPCR was similar for spiked sputa regardless of extraction protocol. The extraction moderately impacted the diversity or relative abundances of bacterial communities using targeted amplicon sequencing (2/43 taxa impacted). For fungi, the relative abundances of 4/11 major taxa were impacted and AQE results were closer to culture results. The V1-V2 or V3-V4 and ITS1 or ITS2 targets assessed similarly the diversity of bacterial and fungal major taxa, but ITS2 and V3-V4 detected more minor taxa. Conclusion Our results showed the importance of DNA extraction for combined bacterial and fungal targeted metagenomics of respiratory samples. The extraction protocol can affect DNA yield and the relative abundances of few bacterial but more fungal taxa. For fungal analysis, ITS2 allowed the detection of a greater number of minor taxa compared with ITS1.	[Angebault, Cecile; Payen, Mathilde; Botterel, Francoise] CHU Henri Mondor, Assistance Publ Hop Paris APHP, Unite Parasitol Mycol, Dept Prevent Diagnost & Traitement Infect, Creteil, France; [Angebault, Cecile; Woerther, Paul-Louis; Botterel, Francoise] Univ Paris Est Creteil, EA DYNAMiC 7380, Fac Sante, Creteil, France; [Angebault, Cecile; Botterel, Francoise] USC Anses, Ecole Natl Vet Alfo, EA DYNAMiC 7380, Maisons Alfort, France; [Woerther, Paul-Louis] CHU Henri Mondor, APHP, Unite Bacteriol Hyg, Dept Prevent Diagnost & Traitement Infect, Creteil, France; [Rodriguez, Christophe] IMRB Creteil, APHP, INSERM U955, Next Generat Sequencing Platform Genom, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ecole Nationale Veterinaire d'Alfort (ENVA); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Angebault, C (corresponding author), CHU Henri Mondor, Assistance Publ Hop Paris APHP, Unite Parasitol Mycol, Dept Prevent Diagnost & Traitement Infect, Creteil, France.; Angebault, C (corresponding author), Univ Paris Est Creteil, EA DYNAMiC 7380, Fac Sante, Creteil, France.; Angebault, C (corresponding author), USC Anses, Ecole Natl Vet Alfo, EA DYNAMiC 7380, Maisons Alfort, France.	cecile.angebault@aphp.fr	WOERTHER, Paul-Louis/AAC-4637-2019; rodriguez, christophe/B-8024-2012; Woerther, Paul-Louis/ABD-9084-2020; Rodriguez, Christophe/AAG-5900-2021	rodriguez, christophe/0000-0001-8128-4030; Woerther, Paul-Louis/0000-0002-6957-9482; Rodriguez, Christophe/0000-0002-9817-5006; Payen, Mathilde/0000-0002-4310-1624	Vaincre La Mucoviscidose" Fondation [2013/2013-047/03]	Vaincre La Mucoviscidose" Fondation	This work is an ancillary project of a larger study entitled "Ecologie et dynamique des communautes bacteriennes et fongiques des voies aeriennes superieures des patients atteints de mucoviscidose: Exploration prospective des discordances clinico-biologiques lors des traitements anti-infectieux par pyrosequencage a haut debit", which received a grant from "Vaincre La Mucoviscidose" Fondation (Grant Number attributed to FB: 2013/2013-047/03, https://www.vaincrelamuco.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.`	Ali NABM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20204991; Angebault C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201174; [Anonymous], 2015, INFECT BRONCHO PULMO; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Botterel F, 2018, MYCOPATHOLOGIA, V183, P171, DOI 10.1007/s11046-017-0185-x; BRETAGNE S, 1995, J CLIN MICROBIOL, V33, P1164, DOI 10.1128/JCM.33.5.1164-1168.1995; Challier S, 2004, J CLIN MICROBIOL, V42, P844, DOI 10.1128/JCM.42.2.844-846.2004; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960; Cui LJ, 2013, GENOME MED, V5, DOI 10.1186/gm467; De Filippis F, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00905-17; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Dupuy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090899; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Huseyin CE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01432; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Illumina, 2014, 16S MET SEQ LIB PREP; Karakousis A, 2006, J MICROBIOL METH, V65, P38, DOI 10.1016/j.mimet.2005.06.008; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lazarevic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067699; Lim MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23745; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; MURRAY PR, 1975, MAYO CLIN PROC, V50, P339; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quereda JJ, 2016, P NATL ACAD SCI USA, V113, P5706, DOI 10.1073/pnas.1523899113; Rosenbaum J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38049-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sohrabi M, 2016, J MICROBIOL METH, V122, P64, DOI 10.1016/j.mimet.2016.01.013; Tipton L, 2017, VIRULENCE, V8, P334, DOI 10.1080/21505594.2016.1235671; Usyk M, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00488-17; Vesty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169877; Wang XC, 2015, MOL ECOL RESOUR, V15, P573, DOI 10.1111/1755-0998.12325; Wen Y, 2016, AM J TRANSL RES, V8, P1412; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	49	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232215	10.1371/journal.pone.0232215	http://dx.doi.org/10.1371/journal.pone.0232215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343737	Green Published, gold			2022-12-26	WOS:000536661300042
J	Cho, Y; Jung, B; Lee, YJ; Kim, MR; Kim, EJ; Sung, WS; Ha, IH				Cho, Yongkyu; Jung, Boyoung; Lee, Yoon Jae; Kim, Me-riong; Kim, Eun-Jung; Sung, Won-Suk; Ha, In-Hyuk			Association between sleep duration and osteoarthritis and their prevalence in Koreans: A cross-sectional study	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; METABOLIC SYNDROME; CHRONIC DISEASES; NATIONAL-HEALTH; PAIN; ADULTS; DISTURBANCE; RECOMMENDATIONS; DISABILITY; SEVERITY	Objective To determine the association of radiological and symptomatic osteoarthritis with sleep duration in a representative sample of the Korean population. Methods Using data from the national cross-sectional fifth Korea National Health and Nutrition Examination Survey 2010-2012. Of the 16,528 participants in KNHANES-V, 8,918 were adults aged >= 50 years who had completed the survey questions on sleep duration and osteoarthritis, and had diagnostic X-ray results. We evaluated the association between sleep duration as the primary predictor for osteoarthritis involving the hip, knee, and spinal joints. A complex sample logistic regression analysis was performed to adjust for the covariates. Results Proportions of participants with total daily sleep duration of <= 6 hours, 7-8 hours, and >= 9 hours were 47.1%, 45.2, and 7.7%, respectively. The rate of osteoarthritis diagnoses in the <= 6 hours, 7-8 hours, and >= 9 hours of sleep duration groups was 24.1%, 17.6%, and 21.8%, respectively (p < 0.0001). The odds ratios (OR) were significantly higher in the <= 6 hours of sleep group than in the 7-8 hours of sleep group (OR, 1.20; 95% confidence interval [CI], 1.03-1.39; p = 0.02), but no significant difference in the >= 9 hours of sleep group was found after adjusting the confounding variables. When we compared knee joint pain (Numeric Rating Scale 0 versus 1-10) in participants with grade 2-4 Kellgren-Lawrence (KL) classification after adjusting these same confounding variables, the <= 6 hours of sleep group (OR, 1.32; 95% CI, 1.10-1.58) and the >= 9 hours of sleep group (OR, 1.41; 95% CI, 1.03-1.95) showed significantly higher ORs. Conclusion This study confirmed the significant association between sleep duration and osteoarthritis in adults aged >= 50 years. Participants' positive for both radiological (KL grade >= 2) and symptomatic osteoarthritis showed a strong association between knee joint pain and not enough sleep duration.	[Cho, Yongkyu; Kim, Me-riong] Jaseng Hosp Korean Med, Seoul, South Korea; [Jung, Boyoung] Hanyang Womens Univ, Dept Hlth Adm, Seoul, South Korea; [Lee, Yoon Jae; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Kim, Eun-Jung; Sung, Won-Suk] Dongguk Univ, Dept Acupuncture & Moxibust, Bundang Oriental Hosp, Seongnam Si, South Korea	Dongguk University	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; HA, IN-HYUK/0000-0002-5020-6723				Allen KD, 2008, J RHEUMATOL, V35, P1102; Baldwin CM, 2011, SLEEP DISORDERS AND SLEEP PROMOTION IN NURSING PRACTICE, P243; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Chiang JK, 2014, J CLIN SLEEP MED, V10, P743, DOI 10.5664/jcsm.3862; Cho KO, 2014, IRAN J PUBLIC HEALTH, V43, P590; Choi KM, 2008, INT J OBESITY, V32, P1091, DOI 10.1038/ijo.2008.62; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Fang J, 2012, AM J HYPERTENS, V25, P335, DOI 10.1038/ajh.2011.201; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Hall MH, 2008, SLEEP, V31, P635, DOI 10.1093/sleep/31.5.635; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Kim Hye-Ryoung, 2013, [Journal of Korean Public Health Nursing, 한국보건간호학회지], V27, P27; Kim MY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021491; Kim Y, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014002; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee MS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2542-3; Lerman SF, 2017, PAIN, V158, P2189, DOI 10.1097/j.pain.0000000000001023; Lian Y, 2019, PSYCHIAT RES, V274, P66, DOI 10.1016/j.psychres.2019.01.096; Lima MG, 2012, SLEEP MED, V13, P139, DOI 10.1016/j.sleep.2011.07.011; Montero A, 2016, CLIN RHEUMATOL, V35, P2293, DOI 10.1007/s10067-016-3248-3; Murase K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140058; Nagarajan MB, 2013, IEEE T BIO-MED ENG, V60, P2896, DOI 10.1109/TBME.2013.2266325; Nakazaki C, 2012, AM J HYPERTENS, V25, P1149, DOI 10.1038/ajh.2012.107; Nieves-Plaza M, 2013, JCR-J CLIN RHEUMATOL, V19, P1, DOI 10.1097/RHU.0b013e31827cd578; Ohayon MM, 2005, J PSYCHIAT RES, V39, P151, DOI 10.1016/j.jpsychires.2004.07.001; Park HM, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030356; Parmelee PA, 2015, ARTHRIT CARE RES, V67, P358, DOI 10.1002/acr.22459; Rahman MM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002624; Sasaki E, 2014, ARTHRIT CARE RES, V66, P1027, DOI 10.1002/acr.22258; Shakespeare W., SLEEP DISORDERS, P243; Shin DW, 2013, J KOREAN MED ASSOC, V56, P431, DOI 10.5124/jkma.2013.56.5.431; Smith MT, 2009, CURR PAIN HEADACHE R, V13, P447, DOI 10.1007/s11916-009-0073-2; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Wang SB, 2017, J CLIN SLEEP MED, V13, P377, DOI 10.5664/jcsm.6484; Wilcox S, 2000, J AM GERIATR SOC, V48, P1241, DOI 10.1111/j.1532-5415.2000.tb02597.x; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Wu QQ, 2010, ANN NY ACAD SCI, V1192, P344, DOI 10.1111/j.1749-6632.2009.05212.x	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0230481	10.1371/journal.pone.0230481	http://dx.doi.org/10.1371/journal.pone.0230481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339178	Green Published, gold			2022-12-26	WOS:000536657400004
J	Jo, KW; Park, YE; Chong, YP; Shim, TS				Jo, Kyung-Wook; Park, Yea Eun; Chong, Yong Pil; Shim, Tae Sun			Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung disease	PLOS ONE			English	Article							PULMONARY-DISEASE; NONTUBERCULOUS MYCOBACTERIA; TREATMENT OUTCOMES; MASSILIENSE; INFECTION; IDENTIFICATION	Background We aim to investigate the rate of spontaneous sputum conversion and reversion in patients with Mycobacterium abscessus complex (MABC) lung disease. Methods Among 241 patients diagnosed with MABC lung disease between July 2012 and December 2018, 126 patients with persistent sputum positivity for. 6 months without treatment were enrolled at a tertiary referral center in South Korea. Patients were subdivided into two groups, depending on whether or not treatment was initiated within 2 years of diagnosis. The rates of spontaneous sputum culture conversion and reversion was investigated in patients who did not receive treatment within 2 years. Results The mean age of 126 patients was 62.9 years. During a mean follow-up duration of 3.2 years, 33 (26.2%) patients received treatment within 2 years of diagnosis. Among the remaining 93 patients not receiving treatment within 2 years, spontaneous sputum conversion occurred in 24 (25.8%) patients during a mean follow-up duration of 3.7 years after diagnosis. No significant differences were observed in time to conversion between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. The Cox regression analysis showed that malignancy as a comorbid disease and the lower number of lobes involved were independent predictors of spontaneous sputum conversion. After spontaneous sputum conversion, reversion occurred in 27.8% patients at a median of 18.2 months after conversion. Conclusions Among patients with MABC lung disease who did not receive treatment for at least 2 years after diagnosis, approximately one-fourth experienced spontaneous conversion. However, not a few patients experienced reversion after spontaneous conversion.	[Jo, Kyung-Wook; Park, Yea Eun; Shim, Tae Sun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulmonol & Crit Care Med,Dept Internal Med, Seoul, South Korea; [Chong, Yong Pil] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Jo, KW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulmonol & Crit Care Med,Dept Internal Med, Seoul, South Korea.; Chong, YP (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	heathcliff6800@hanmail.net; drchong@amc.seoul.kr	Chong, Yong Pil/AAB-2623-2021		National Research Foundation of Korea - Korea government (Ministry of Science and ICT) [2019R1F1A1059190]	National Research Foundation of Korea - Korea government (Ministry of Science and ICT)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (Ministry of Science and ICT) (No. 2019R1F1A1059190) for Kyung-Wook Jo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant JM, 2016, SCIENCE, V354, P751, DOI 10.1126/science.aaf8156; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Caverly LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117657; Choi GE, 2012, AM J RESP CRIT CARE, V186, P917, DOI 10.1164/rccm.201111-2005OC; Diel R, 2017, CHEST, V152, P120, DOI 10.1016/j.chest.2017.04.166; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Griffith DE, 2015, ANN AM THORAC SOC, V12, P436, DOI 10.1513/AnnalsATS.201501-015OI; Hamilton LA, 2018, J MED MICROBIOL, V67, P1491, DOI 10.1099/jmm.0.000822; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Hwang JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00537-2016; Jarand J, 2011, CLIN INFECT DIS, V52, P565, DOI 10.1093/cid/ciq237; Jeon K, 2009, AM J RESP CRIT CARE, V180, P896, DOI 10.1164/rccm.200905-0704OC; Jeong BH, 2014, TUBERC RESPIR DIS, V76, P30, DOI 10.4046/trd.2014.76.1.30; Koh WJ, 2014, INT J TUBERC LUNG D, V18, P1141, DOI 10.5588/ijtld.14.0134; Koh WJ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02503-2016; Koh WJ, 2017, CLIN INFECT DIS, V64, P309, DOI 10.1093/cid/ciw724; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Kwon BS, 2019, RESP MED, V150, P45, DOI 10.1016/j.rmed.2019.02.007; Kwon YS, 2019, TUBERC RESPIR DIS, V82, P15, DOI 10.4046/trd.2018.0060; Lyu J, 2014, RESP MED, V108, P1706, DOI 10.1016/j.rmed.2014.09.002; Moon SM, 2019, RESP MED, V151, P1, DOI 10.1016/j.rmed.2019.03.014; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Novosad SA, 2016, EMERG INFECT DIS, V22, P511, DOI 10.3201/eid2203.150828; Orme IM, 2014, INFECT IMMUN, V82, P3516, DOI 10.1128/IAI.01606-13; Park J, 2017, CLIN INFECT DIS, V64, P301, DOI 10.1093/cid/ciw723; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Simmon KE, 2007, J CLIN MICROBIOL, V45, P1978, DOI 10.1128/JCM.00563-07; Stout JE, 2016, INT J INFECT DIS, V45, P123, DOI 10.1016/j.ijid.2016.03.006; van Ingen J, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00170-2018; Vento S, 2011, LANCET ONCOL, V12, P520, DOI 10.1016/S1470-2045(11)70105-X; Wang HY, 2014, INT J TUBERC LUNG D, V18, P1114, DOI 10.5588/ijtld.14.0140; Woods GL, 2011, SUSCEPTIBILITY TESTI, V2nd	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232161	10.1371/journal.pone.0232161	http://dx.doi.org/10.1371/journal.pone.0232161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339194	gold, Green Published			2022-12-26	WOS:000536657400032
J	Daftarian, N; Zandi, S; Piryaie, G; Zarif, MN; Pirmardan, ER; Yamaguchi, M; Nejad, QB; Hasanpour, H; Samiei, S; Pfister, IB; Soheili, ZS; Nakao, S; Barakat, A; Garweg, JG; Ahmadieh, H; Hafezi-Moghadam, A				Daftarian, Narsis; Zandi, Souska; Piryaie, Golbarg; Zarif, Mahin Nikougoftar; Pirmardan, Ehsan Ranaei; Yamaguchi, Muneo; Nejad, Qurban Behzadian; Hasanpour, Hossein; Samiei, Shahram; Pfister, Isabel B.; Soheili, Zahra-Soheila; Nakao, Shintaro; Barakat, Aliaa; Garweg, Justus G.; Ahmadieh, Hamid; Hafezi-Moghadam, Ali			Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration	FASEB JOURNAL			English	Article						AMD pathogenesis; CD206; choroidal neovascularization (CNV); M1; M2 differentiation; macrophage polarization	COMPLEMENT FACTOR-H; BRUCHS MEMBRANE; MACROPHAGES; VARIANT; SUSCEPTIBILITY; IDENTIFICATION; POLARIZATION; POLYMORPHISM; EXPRESSION; BIOMARKERS	Macrophages are the main infiltrating immune cells in choroidal neovascularization (CNV), a hallmark of the human wet, or neovascular age-related macular degeneration (AMD). Due to their plasticity and ability to adapt to the local microenvironment in a tissue-dependent manner, macrophages display polar functional phenotypes characterized by their cell surface markers and their cytokine profiles. We found accumulation of hemoglobin-scavenging cluster of differentiation 163 (CD163)(+) macrophages in laser-induced CNV lesions and higher expression of CD163(+) monocytes in the peripheral blood on day 7 post injury in mice. In comparison, CD80(+) macrophages did not differ with laser-injury in young or aged mice and did not significantly change in the peripheral blood of CNV mice. We examined the percentages of CD163(+), CD206(+), and CD80(+) monocytes in the peripheral blood of patients with wet AMD, patients with dry AMD, and in age-matched individuals without AMD as controls. Percentages of peripheral blood CD163(+) monocytes in both dry AMD (P < .001) and wet AMD (P < .05) were higher than in age-matched non-AMD controls, while there was no difference between the groups in the percentages of peripheral CD206(+) and CD80(+) monocytes. Further, serum level of soluble CD163 (sCD163) was elevated only in patients with wet AMD (P < .05). An examination of 40 cytokine levels across the study groups revealed that anti-VEGF treated patients with wet AMD, who showed no exudative signs on the day of blood drawing had a cytokine profile that was similar to that of non-AMD individuals. These results indicate that CD163 could be further evaluated for its potential as a useful marker of disease activity in patients with neovascular AMD. Future studies will address the origin and potential mechanistic role of CD163(+) macrophages in wet AMD pathologies of angiogenesis and leakage of blood components.	[Daftarian, Narsis; Zandi, Souska; Pirmardan, Ehsan Ranaei; Barakat, Aliaa; Ahmadieh, Hamid; Hafezi-Moghadam, Ali] Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Daftarian, Narsis; Pirmardan, Ehsan Ranaei; Barakat, Aliaa; Ahmadieh, Hamid; Hafezi-Moghadam, Ali] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Daftarian, Narsis] Shahid Beheshti Univ Med Sci, Ocular Tissue Engn Res Ctr, Tehran, Iran; [Zandi, Souska; Pfister, Isabel B.; Garweg, Justus G.] Lindenhofspital, Rotkreuz & Berner Augenklin, Swiss Eye Inst, Bern, Switzerland; [Zandi, Souska; Garweg, Justus G.] Univ Bern, Bern Univ Hosp, Dept Ophthalmol, Inselspital, Bern, Switzerland; [Piryaie, Golbarg; Ahmadieh, Hamid] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran; [Zarif, Mahin Nikougoftar; Samiei, Shahram] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran; [Yamaguchi, Muneo; Nakao, Shintaro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Nejad, Qurban Behzadian; Hasanpour, Hossein] Shahid Beheshti Univ Med Sci, Negah Specialty Ophthalm Res Ctr, Tehran, Iran; [Soheili, Zahra-Soheila] Natl Inst Genet Engn & Biotechnol, Inst Med Biotechnol, Dept Mol Med, Tehran, Iran	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Shahid Beheshti University Medical Sciences; University of Bern; University Hospital of Bern; Shahid Beheshti University Medical Sciences; Kyushu University; Shahid Beheshti University Medical Sciences	Hafezi-Moghadam, A (corresponding author), Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab MBNI, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA.	ahm@bwh.harvard.edu	Hasanpour, Hossein/HGF-0571-2022; Pirmardan, Ehsan Ranaei/AAG-3914-2021; Daftarian, Narsis/AAW-5803-2020; Soheili, Zahra-Soheila/W-8316-2018; Ahmadieh, Hamid/M-4853-2017	Daftarian, Narsis/0000-0001-5846-8739; Soheili, Zahra-Soheila/0000-0003-1292-465X; Ahmadieh, Hamid/0000-0002-8139-2661; Hasanpour, Hossein/0000-0002-1090-1166; Zandi, Souska/0000-0001-9351-4278; Ranaei Pirmardan, Ehsan/0000-0002-6848-5839	Juvenile Diabetes Research Foundation (JDRF) Innovation award; Malaysian Palm Oil Board (MPOB)	Juvenile Diabetes Research Foundation (JDRF) Innovation award; Malaysian Palm Oil Board (MPOB)	This work was supported by Juvenile Diabetes Research Foundation (JDRF) Innovation award (AHM) and the Malaysian Palm Oil Board (MPOB).	Bronkhorst IHG, 2011, INVEST OPHTH VIS SCI, V52, P643, DOI 10.1167/iovs.10-5979; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Costantini A, 2018, AGING-US, V10, P1268, DOI 10.18632/aging.101465; Droste A, 1999, BIOCHEM BIOPH RES CO, V256, P110, DOI 10.1006/bbrc.1999.0294; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Garweg JG, 2019, ACTA OPHTHALMOL, V97, pE580, DOI 10.1111/aos.13998; Garweg JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182571; Grunin M, 2012, INVEST OPHTH VIS SCI, V53, P5292, DOI 10.1167/iovs.11-9165; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Ikram MK, 2013, DIABETES CARE, V36, P750, DOI 10.2337/dc12-1554; ISHIBASHI T, 1987, INVEST OPHTH VIS SCI, V28, P1116; Jabs DA, 2019, AM J OPHTHALMOL, V199, P230, DOI 10.1016/j.ajo.2018.12.002; Jones K, 2013, CLIN CANCER RES, V19, P731, DOI 10.1158/1078-0432.CCR-12-2693; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; Kim S, 2019, MOL VIS, V25, P129; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Krohne TU, 2010, INVEST OPHTH VIS SCI, V51, P553, DOI 10.1167/iovs.09-3755; Lad EM, 2015, GRAEF ARCH CLIN EXP, V253, P1941, DOI 10.1007/s00417-015-3094-z; Lechner J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16754; Liu F, 2016, MOL VIS, V22, P352; Mettu PS, 2012, MOL ASPECTS MED, V33, P376, DOI 10.1016/j.mam.2012.04.006; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Peng XN, 2018, EXP EYE RES, V176, P88, DOI 10.1016/j.exer.2018.06.030; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Singh A, 2013, OPHTHALMOLOGY, V120, P1029, DOI 10.1016/j.ophtha.2012.11.002; Skeie JM, 2009, EYE, V23, P747, DOI 10.1038/eye.2008.206; Spindler J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203337; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zandi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214674; Zandi S, 2016, INVEST OPHTH VIS SCI, V57, P6320, DOI 10.1167/iovs.16-20657; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	43	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8001	8011		10.1096/fj.201901902RR	http://dx.doi.org/10.1096/fj.201901902RR		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333612	Bronze			2022-12-26	WOS:000529448100001
J	Kosciuch, K; Riser-Espinoza, D; Gerringer, M; Erickson, W				Kosciuch, Karl; Riser-Espinoza, Daniel; Gerringer, Michael; Erickson, Wallace			A summary of bird mortality at photovoltaic utility scale solar facilities in the Southwestern US	PLOS ONE			English	Article							GREBES PODICEPS-NIGRICOLLIS; COMMUNICATION TOWERS; AVIAN MORTALITY; UNITED-STATES; WEATHER; MIGRATION	Recent trends in renewable energy development in the United States (U.S.) show that new installed capacity of utility-scale solar energy has exceeded 30% of total installed capacity of all sources per year since 2013. Photovoltaic solar energy provides benefits in that no emissions are produced; however, there are potential impacts from photovoltaic solar development on birds that include habitat loss and potential for collision mortality. Only 2 papers in the peer-reviewed literature present fatality information from fatality monitoring studies at a photovoltaic utility-scale solar energy facility; however, more data exists in unpublished reports. To provide a more comprehensive overview of bird mortality patterns, we synthesized results from fatality monitoring studies at 10 photovoltaic solar facilities across 13 site-years in California and Nevada. We found variability in the distribution of avian orders and species among and within Bird Conservation Regions, and found that water-obligate birds, which rely on water for take-off and landing, occurred at 90% (9/10) of site-years in the Sonoran and Mojave Deserts Bird Conservation Region. We found that a cause of mortality could not be determined for approximately 61% of intact carcasses, and that approximately 54% of all carcasses were feather spots, introducing uncertainty into the interpretation of the fatality estimates. The average annual fatality estimate we calculated for photovoltaic solar (high-end estimate of 2.49 birds per megawatt per year) is lower than that reported by another study (9.9 birds per megawatt per year) that included one photovoltaic facility. Our results provide a summary of fatalities in bird conservation regions where the facilities are located, but expanding our conclusions to new regions is limited by the location of facilities with fatality monitoring data.	[Kosciuch, Karl; Riser-Espinoza, Daniel; Gerringer, Michael; Erickson, Wallace] Western EcoSyst Technol Inc, Cheyenne, WY 82001 USA		Kosciuch, K (corresponding author), Western EcoSyst Technol Inc, Cheyenne, WY 82001 USA.	kkosciuch@west-inc.com			NextEra Energy, Inc.; Clearway Energy Group, LLC; First Solar; Duke Energy	NextEra Energy, Inc.; Clearway Energy Group, LLC; First Solar; Duke Energy	Funding for this research was provided by First Solar; NextEra Energy, Inc.; Duke Energy, and Clearway Energy Group, LLC, and the funders provided support in the form of salaries for KK, DR-E, MG, and WE, who all work for Western EcoSystems Technology, Inc. The specific roles of these authors are articulated in the `author contributions' section. The funders did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Ornithological Society, 2019, CHECKL N MIDDL AM BI; [Anonymous], [No title captured]; [Anonymous], 2019, SEARCH SOL EN; California Energy Commission and California Department of Fish and Game, 2007, CAL GUID RED IMP BIR; Cornell Lab of Ornithology, 2018, BIRD GUIDE; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; EDF Renewable Energy, 2017, CACA48810 EDF REN EN; Erickson WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107491; Erickson WP, 2001, AVIAN COLLISIONS WIN; Frank MG, 2017, WILSON J ORNITHOL, V129, P98, DOI 10.1676/1559-4491-129.1.98; Gehring J, 2009, ECOL APPL, V19, P505, DOI 10.1890/07-1708.1; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Kagan RA, 2014, AVIAN MORTALITY SOLA, P28; Larkin R., 1999, P WORKSH AV MORT COM, V11; Longcore T, 2013, BIOL CONSERV, V158, P410, DOI 10.1016/j.biocon.2012.09.019; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Partners in Flight, 2019, POP EST DAT VERS 3 0; Roberts AJ, 2014, WILSON J ORNITHOL, V126, P584, DOI 10.1676/13-192.1; Roberts AJ, 2013, CAN J ZOOL, V91, P906, DOI 10.1139/cjz-2013-0181; Schmidt P, 1988, PROPOSED FRAMEWORK D; Schummer ML, 2010, J WILDLIFE MANAGE, V74, P94, DOI 10.2193/2008-524; Shire G. G., 2000, COMMUNICATION TOWERS; Shuford WD, 2000, R826552010 EPA; Sinha P, 2018, CASE STUD ENVIRON, V2, DOI 10.1525/cse.2018.001123; Smith JA, 2016, CONDOR, V118, P411, DOI 10.1650/CONDOR-15-61.1; U.S. Energy Information Administration, 2018, ANN EN OUTL 2018 PRO; U.S. FISH & WILDLIFE SERV, 2012, LAND BAS WIND EN GUI; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Visser E, 2019, RENEW ENERG, V133, P1285, DOI 10.1016/j.renene.2018.08.106; Walston LJ, 2018, ENVIRON SCI TECHNOL, V52, P7566, DOI 10.1021/acs.est.8b00020; Walston LJ, 2016, RENEW ENERG, V92, P405, DOI 10.1016/j.renene.2016.02.041; Warren-Hicks W., 2013, IMPROVING METHODS ES; Western EcoSystems Technology Inc., 2017, IV SOL EL GEN SYST A; Williams AA, 2018, INT J BIOMETEOROL, V62, P433, DOI 10.1007/s00484-017-1452-8; Wood Mackenzie Limited, 2018, US SOL MARK INS 2018	36	9	9	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232034	10.1371/journal.pone.0232034	http://dx.doi.org/10.1371/journal.pone.0232034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330207	gold, Green Published			2022-12-26	WOS:000536647300042
J	Macavei, LI; Benassi, G; Stoian, V; Maistrello, L				Macavei, Laura I.; Benassi, Giacomo; Stoian, Vlad; Maistrello, Lara			Optimization of Hermetia illucens (L.) egg laying under different nutrition and light conditions	PLOS ONE			English	Article							BLACK SOLDIER FLY; LIFE-HISTORY TRAITS; DIPTERA STRATIOMYIDAE; FLIES DIPTERA; LARVAE; OVIPOSITION; CONVERSION; BEHAVIOR; LIPIDS; ADULT	The black soldier fly Hermetia illucens is gaining growing interest as a tool for the valorisation of bio-waste in a circular economy perspective. Although a wide variety of studies are available for larvae rearing, the indoor breeding of adults still presents a great challenge for industrial purposes. This study was designed to assess the simultaneous influence of 3 different light sources (the Mix of LED UV:blue:green 1:1:3, White LED, Neon light) and 3 types of nutrition (sugar and water, only water, no sugar no water) on adult performances, obtaining different egg production parameters that included the number and weight of the egg masses and single eggs laid by the females, the duration of pre-oviposition and oviposition period, the adult life span, the hatchability of the eggs. Our results showed that production parameters are influenced mainly by nutrition rather than light factor, although light plays an important secondary role. Moreover, the presence of sugar positively affects the egg production (12,93-27,10 mg eggs/female) and increases oviposition period (18,2-31,8 days) and adult lifespan (20,79-27,11 days). Light sources also affect egg production parameters, with the exposure to the Mix of LEDs resulting in the best performance of flies. Results obtained from this study are very useful for the design and management of an efficient industrial black soldier fly mass rearing process.	[Macavei, Laura I.; Benassi, Giacomo; Maistrello, Lara] Univ Modena & Reggio Emilia, Dept Life Sci, Emilia Romagna, Italy; [Stoian, Vlad] Univ Agr Sci & Vet Med Cluj Napoca, Dept Microbiol, Fac Agr, Cluj Napoca, Cluj, Romania; [Benassi, Giacomo] Kour Energy SRL, Reggio Emilia, Emilia Romagna, Italy	Universita di Modena e Reggio Emilia; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Macavei, LI (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Emilia Romagna, Italy.	lmacavei@unimore.it	, Lara/AAK-3036-2021; Stoian, Vlad/O-4311-2014	, Lara/0000-0002-2996-8993; Stoian, Vlad/0000-0003-1518-8037; Macavei, Laura/0000-0003-1260-8390	project VALORIBIO -ERDF Emilia-Romagna Regional Operational Program 2014-2020 [PG/2015/737518]; Emilia Romagna region within the Rural Development Plan 2014-2020 Op. 16.1.01 -GO EIP-Agri -FA 5C, Pr. "BIOECO-FLIES"	project VALORIBIO -ERDF Emilia-Romagna Regional Operational Program 2014-2020; Emilia Romagna region within the Rural Development Plan 2014-2020 Op. 16.1.01 -GO EIP-Agri -FA 5C, Pr. "BIOECO-FLIES"	This work was partially supported by the project VALORIBIO -ERDF Emilia-Romagna Regional Operational Program 2014-2020 [grant number PG/2015/737518] and by the Emilia Romagna region within the Rural Development Plan 2014-2020 Op. 16.1.01 -GO EIP-Agri -FA 5C, Pr. "BIOECO-FLIES". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and that there was no additional external funding received for this study.	Barbi S, BIOPOLYMERS; Barragan-Fonseca KB, 2017, J INSECTS FOOD FEED, V3, P105, DOI 10.3920/JIFF2016.0055; Bertinetti C, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez001; BOOTH DC, 1984, ENVIRON ENTOMOL, V13, P421, DOI 10.1093/ee/13.2.421; Borgogno M, 2017, J SCI FOOD AGR, V97, P3402, DOI 10.1002/jsfa.8191; Caligiani A, 2018, FOOD RES INT, V105, P812, DOI 10.1016/j.foodres.2017.12.012; Cickova H, 2015, WASTE MANAGE, V35, P68, DOI 10.1016/j.wasman.2014.09.026; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Feng WL, 2018, RENEW ENERG, V119, P12, DOI 10.1016/j.renene.2017.11.076; Giunti G, 2018, ENTOMOL GEN, V38, P29, DOI 10.1127/entomologia/2018/0657; Gobbi P, 2013, EUR J ENTOMOL, V110, P461, DOI 10.14411/eje.2013.061; Heussler CD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197896; Hoc B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216160; HOGSETTE JA, 1992, J ECON ENTOMOL, V85, P2291, DOI 10.1093/jee/85.6.2291; Holmes LA, 2012, ENVIRON ENTOMOL, V41, P971, DOI 10.1603/EN12054; Kim JongGill, 2008, Korean Journal of Applied Entomology, V47, P337; Lalander C, 2019, J CLEAN PROD, V208, P211, DOI 10.1016/j.jclepro.2018.10.017; Lupi D., 2019, Journal of Entomological and Acarological Research, V51, P27, DOI 10.4081/jear.2019.8046; Nakayama S, 2015, ADV CO NUCL ENGR, P1, DOI 10.1007/978-4-431-55417-2_1; Nguyen TTX, 2015, ENVIRON ENTOMOL, V44, P406, DOI 10.1093/ee/nvv002; Nyakeri EM, 2017, J INSECTS FOOD FEED, V3, P193, DOI 10.3920/JIFF2017.0004; Oonincx DGAB, 2016, J INSECT PHYSIOL, V95, P133, DOI 10.1016/j.jinsphys.2016.10.006; Park Kwanho, 2010, International Journal of Industrial Entomology, V21, P189; Pastor B, 2015, J INSECTS FOOD FEED, V1, P179, DOI 10.3920/JIFF2014.0024; Samayoa AC, 2016, J ECON ENTOMOL; Schiepatti A, 2019, BRIT J NUTR, V121, P576, DOI 10.1017/S0007114518003616; Setti L, 2019, WASTE MANAGE, V95, P278, DOI 10.1016/j.wasman.2019.06.017; Sheppard DC, 2002, J MED ENTOMOL, V39, P695, DOI 10.1603/0022-2585-39.4.695; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; Tomberlin JK, 2002, J ENTOMOL SCI, V37, P345, DOI 10.18474/0749-8004-37.4.345; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; Tomberlin JK, 2001, FLA ENTOMOL, V84, P729, DOI 10.2307/3496413; Wang YS, 2017, FOODS, V6, DOI 10.3390/foods6100091; Zhang JB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20201	34	14	14	43	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232144	10.1371/journal.pone.0232144	http://dx.doi.org/10.1371/journal.pone.0232144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330204	Green Published, gold			2022-12-26	WOS:000536647300055
J	Morin, KA; Prevost, CR; Eibl, JK; Franklyn, MT; Moise, AR; Marsh, DC				Morin, Kristen A.; Prevost, Chad R.; Eibl, Joseph K.; Franklyn, Michael T.; Moise, Alexander R.; Marsh, David C.			A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada	PLOS ONE			English	Article							INJECTION-DRUG USERS; SEPTIC ARTHRITIS; VERTEBRAL OSTEOMYELITIS; SOCIOECONOMIC-STATUS; SUBSTITUTION TREATMENT; JOINT INFECTIONS; UNITED-STATES; ENDOCARDITIS; THERAPY; PRESCRIPTION	Objective The objective of this study was to evaluate the relationship between individual characteristics and deep tissue infections in patients enrolled in opioid agonist treatment in Ontario, Canada. Methods A retrospective cohort study was conducted on patients in opioid agonist treatment between January 1, 2011, and December 31, 2015 in Ontario, Canada. Patients were identified using data from the Ontario Health Insurance Plan Database, and the Ontario Drug Benefit Plan Database. We identified other study variables including all-cause mortality using data from the Registered Persons Database. Encrypted patient identifiers were used to link across databases. Logistic regression models were used to measure potential correlates of deep tissue infections. Results An increase in the incidence of deep tissue infections was observed between 2011 and 2016 for patients on opioid agonist treatment. Additionally, age, sex, positive HIV diagnosis, and all-cause mortality was correlated with deep tissue infection in our study population. Conclusion The study indicates factors that are associated with deep tissue infections in the opioid use disorder population and can be used to identify opportunities to reduce the incidence of new infections.	[Morin, Kristen A.; Prevost, Chad R.; Eibl, Joseph K.; Franklyn, Michael T.; Moise, Alexander R.; Marsh, David C.] Northern Ontario Sch Med, Sudbury, ON, Canada; [Morin, Kristen A.] Laurentian Univ, Sudbury, ON, Canada; [Marsh, David C.] Canadian Addict Treatment Ctr, Richmond Hill, ON, Canada	Northern Ontario School of Medicine; Laurentian University	Marsh, DC (corresponding author), Northern Ontario Sch Med, Sudbury, ON, Canada.; Marsh, DC (corresponding author), Canadian Addict Treatment Ctr, Richmond Hill, ON, Canada.	dmarsh@nosm.ca	Moise, Alexander R/C-9498-2009; Marsh, David C./AAU-7184-2020	Moise, Alexander R/0000-0003-2307-6035; Marsh, David C./0000-0002-8769-1785	Clinical Innovation Grant from the Northern Ontario Academic Medicine Association; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long Term Care	Clinical Innovation Grant from the Northern Ontario Academic Medicine Association; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by a Clinical Innovation Grant from the Northern Ontario Academic Medicine Association. It was also supported by the Institute for Clinical Evaluative Sciences (ICES), a non-profit research institute sponsored by the Ontario Ministry of Health and Long Term Care. The design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation and review of the manuscript were conducted by the authors independently from the funding sources.; We thank IC/ES Data Analytic Services, more specifically, Ryan Ng for his assistance with data extraction and database set up. We also thank members of the Patient and Family Advisory Committee for sharing their stories and helping to guide the research project. Lastly, we would like to thank Brittany A Loney for editing the final draft of the paper.	Ali AM, 2013, CASE REP INFECT DIS, V2013, DOI 10.1155/2013/729812; Amato L, 2018, SOC SOC MED ANN SCI; [Anonymous], 2018, PRINCIPLES PRACTICE, V2nd; [Anonymous], 1999, AM DRUG OVERDOSE DEA; Antoniou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021748; Bachmeyer C, 2005, J AM ACAD DERMATOL, V52, P704, DOI 10.1016/j.jaad.2004.11.045; Ball C, 1991, EFFECTIVENESS METHAD; Barbosa TR, 2013, JBJS CASE CONNECT, V3, pe1011; Bawor Monica, 2015, CMAJ Open, V3, pE344, DOI 10.9778/cmajo.20140089; Bekele T, 2018, AIDS BEHAV, V22, P2214, DOI 10.1007/s10461-018-2040-6; Blecher CDM, 2007, INFECT DIS EMERGENCI; Bohnert KM, 2017, ADDICTION, V112, P1193, DOI 10.1111/add.13774; Brien S., 2015, TAKING STOCK REPORT; Bukten A, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4382-9; Centers for Disease Control and Prevention, 2017, HIV SURV REP, P28; CHANDRASEKAR PH, 1986, REV INFECT DIS, V8, P904; Chang KC, 2015, DRUG ALCOHOL DEPEN, V153, P152, DOI 10.1016/j.drugalcdep.2015.05.033; Chen TC, 2019, INT J DRUG POLICY, V64, P87, DOI 10.1016/j.drugpo.2018.10.013; Cleary MLB, 2005, EUROPEAN J ORTHOPAED, V15, P159; Colville T, 2016, POSTGRAD MED J, V92, P105, DOI 10.1136/postgradmedj-2015-133648; Conlon Michael S C, 2019, CMAJ Open, V7, pE197, DOI 10.9778/cmajo.20180148; Conway B, 2004, CLIN INFECT DIS, V38, pS402, DOI 10.1086/421404; Coughlin PA, 2006, EUR J VASC ENDOVASC, V32, P389, DOI 10.1016/j.ejvs.2006.03.003; Crawfort MH, 2017, INFECTIVE ENDOCARDIT; del Giudice P, 2004, BRIT J DERMATOL, V150, P1, DOI 10.1111/j.1365-2133.2004.05607.x; Deo SV, 2018, J AM COLL CARDIOL, V71, P1596, DOI 10.1016/j.jacc.2018.02.011; Doherty MC, 2000, J URBAN HEALTH, V77, P396, DOI 10.1007/BF02386749; Eibl JK, 2017, DRUG ALCOHOL DEPEN, V176, P133, DOI 10.1016/j.drugalcdep.2017.01.048; Eibl JK, 2015, J ADDICT MED, V9, P440, DOI 10.1097/ADM.0000000000000156; Elkbuli A, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-018-0189-7; Fischer B, 2018, PREV MED, V107, P109, DOI 10.1016/j.ypmed.2017.11.001; Franklyn AM, 2017, INT J DRUG POLICY, V48, P1, DOI 10.1016/j.drugpo.2017.05.044; Franklyn AM, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0134-5; Gebauer S, 2017, J AM BOARD FAM MED, V30, P775, DOI 10.3122/jabfm.2017.06.170061; Geirsson AJ, 2008, ANN RHEUM DIS, V67, P638, DOI 10.1136/ard.2007.077131; Gomes T, 2017, LATEST TRENDS OPIOID; Gomes Tara, 2016, Healthc Q, V18, P8; Gomes T, 2014, CAN FAM PHYSICIAN, V60, P826; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Gomes Tara, 2011, Healthc Q, V14, P22; Gowing L., 2004, COCHRANE DB SYST REV; Harron K, 2018, Int J Popul Data Sci, V3, P2, DOI 10.23889/ijpds.v3i1.419; Hartman L, 2016, AM J MED SCI, V352, P603, DOI 10.1016/j.amjms.2016.08.010; Hayashi K, 2016, AM J EPIDEMIOL, V183, P544, DOI 10.1093/aje/kwv207; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Jones CM, 2017, DRUG ALCOHOL DEPEN, V176, P89, DOI 10.1016/j.drugalcdep.2017.03.011; Kak V, 2002, INFECT DIS CLIN N AM, V16, P681, DOI 10.1016/S0891-5520(02)00016-8; Keller K, 2017, AM J CARDIOL, V119, P317, DOI 10.1016/j.amjcard.2016.09.035; KRAKOWSKI M, 1974, CAN PSYCHIAT ASSOC J, V19, P41, DOI 10.1177/070674377401900108; Larney S, 2017, DRUG ALCOHOL DEPEN, V171, P39, DOI [10.1016/j.drugalcdep.2016.11.029, 10.1016/j.drugalcdep.2016.08.320]; Leece P, 2015, CAN MED ASSOC J, V187, P717, DOI 10.1503/cmaj.150329; Longardner K, 2013, BMJ CASE REP, V2013; Luo C, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0283-9; MAGARIAN GJ, 1985, WESTERN J MED, V142, P691; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Meyers SA, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0270-6; Ministry of Health and Long-Term Care, 2012, IMP NOTIC REG CHANG; Morin KA, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-019-0213-6; Murillo O, 2018, INFECTION, V46, P245, DOI 10.1007/s15010-018-1121-9; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Nicholls SG, 2016, CLIN EPIDEMIOL, V8, P389, DOI 10.2147/CLEP.S110528; Nosyk B, 2010, J SUBST ABUSE TREAT, V39, P22, DOI 10.1016/j.jsat.2010.03.008; Nosyk B, 2009, AM J EPIDEMIOL, V170, P783, DOI 10.1093/aje/kwp186; Pea F, 2014, INFECTION, V42, P207, DOI 10.1007/s15010-013-0511-2; Peles E, 2008, J ADDICT DIS, V27, P11, DOI 10.1080/10550880802324382; Peles E, 2014, PSYCHIAT RES, V219, P191, DOI 10.1016/j.psychres.2014.05.003; Pigrau C, 2005, AM J MED, V118, DOI 10.1016/j.amjmed.2005.02.027; Probst C, 2018, CAN MED ASSOC J, V190, pE1294, DOI 10.1503/cmaj.180806; Rosenthal ES, 2016, AM J MED, V129, P481, DOI 10.1016/j.amjmed.2015.09.024; Rutherford AI, 2016, RHEUMATOLOGY, V55, P2176, DOI 10.1093/rheumatology/kew323; Salloum A, 2004, AM J MED, V116, P208, DOI 10.1016/j.amjmed.2003.05.006; SAPICO FL, 1980, REV INFECT DIS, V2, P196; Staak M., 1993, Versicherungsmedizin, V45, P10; Stone DM, 2017, AM J PUBLIC HEALTH, V107, P1233, DOI [10.2105/AJPH.2017.303863, 10.2105/ajph.2017.303863]; Sullivan LE, 2005, ADDICTION, V100, P150, DOI 10.1111/j.1360-0443.2004.00963.x; Suzuki J, 2016, AM J ADDICTION, V25, P191, DOI 10.1111/ajad.12349; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; Vanichseni S, 2015, AM J PUBLIC HEALTH, V105, P1136, DOI 10.2105/AJPH.2014.302473; Volkow ND., AM ADDICTION OPIOIDS; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Wright A, 2018, HEART LUNG CIRC, V27, P484, DOI 10.1016/j.hlc.2017.03.166; Wurcel AG, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw157; Yanagawa B, 2018, CURR OPIN CARDIOL, V33, P140, DOI 10.1097/HCO.0000000000000493	86	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232191	10.1371/journal.pone.0232191	http://dx.doi.org/10.1371/journal.pone.0232191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8RF	32330184	gold, Green Published			2022-12-26	WOS:000536647300060
J	Huang, WJ; Tian, XP; Bi, SX; Zhang, SR; He, TS; Song, LY; Yun, JP; Zhou, ZG; Yu, RM; Li, M				Huang, Wei-Juan; Tian, Xiao-Peng; Bi, Si-Xue; Zhang, Si-Rui; He, Ting-Sha; Song, Li-Yan; Yun, Jing-Ping; Zhou, Zhong-Guo; Yu, Rong-Min; Li, Mei			The beta-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; WNT/BETA-CATENIN PATHWAY; LONG NONCODING RNAS; CELL-PROLIFERATION; ACTIVATION; CROSSTALK; NETWORKS; CERNA	Hepatocellular carcinoma (HCC) metastasis is largely responsible for HCC-associated recurrence and mortality. We aimed to identify metastasis-related long non-coding RNAs (lncRNAs) to understand the molecular mechanism of HCC metastasis. We first identified that miR-1258 was downregulated in HCC tissues both in The Cancer Genome Atlas (TCGA) and Sun Yat-sen University Cancer Center (SYSUCC) dataset. MiR-1258 expression negatively correlated with recurrence-free survival and overall survival of HCC patients. MiR-1258 overexpression inhibited migration and invasion of HCC cells both in vitro and in vivo, whereas miR-1258 downregulation promoted cell metastasis. Luciferase assays verified direct binding of miR-1258 to Smad2 and Smad3, thereby attenuating TGF-beta/Smad signaling. We further established that lncRNA LINC01278 was a negative regulator of miR-1258. In vivo and in vitro assays demonstrated that LINC01278-mediated HCC metastasis was dependent on miR-1258 expression. Furthermore, miR-1258 downregulation in turn increased LINC01278 expression. We also observed that TCF-4 could bind to the LINC01278 promoter site. In addition, LINC01278 downregulation decreased migration and invasion of HCC cells induced by beta-catenin and TGF-beta 1 both in vitro and in vivo. We uncovered a novel mechanism for beta-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 feedback loop activation in HCC metastasis, and the study indicated that LINC01278 could serve as a therapeutic target for HCC metastasis.	[Huang, Wei-Juan; Bi, Si-Xue; Zhang, Si-Rui; He, Ting-Sha; Song, Li-Yan; Yu, Rong-Min] Jinan Univ, Coll Pharm, Dept Pharmacol, Guangzhou, Peoples R China; [Huang, Wei-Juan; Yu, Rong-Min] Jinan Univ, Integrated Chinese & Western Med Postdoctoral Res, Guangzhou, Peoples R China; [Huang, Wei-Juan; Yu, Rong-Min] Jinan Univ, Biotechnol Inst Chinese Mat Med, Guangzhou, Peoples R China; [Tian, Xiao-Peng; Yun, Jing-Ping; Li, Mei] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou, Peoples R China; [Yun, Jing-Ping; Li, Mei] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Peoples R China; [Zhou, Zhong-Guo] Sun Yat Sen Univ, Ctr Canc, Dept Hepatol, Guangzhou, Peoples R China	Jinan University; Jinan University; Jinan University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, M (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou, Peoples R China.; Li, M (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Peoples R China.	limei@sysucc.org.cn			National Natural Science Foundation of China [81973384]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (81973384).	Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Arun G, 2018, TRENDS MOL MED, V24, P257, DOI 10.1016/j.molmed.2018.01.001; Chen DL, 2017, THERANOSTICS, V7, P4836, DOI 10.7150/thno.20942; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; DiRenzo DM, 2016, CELL SIGNAL, V28, P498, DOI 10.1016/j.cellsig.2016.02.011; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Gagliardi M, 2016, METHODS MOL BIOL, V1480, P73, DOI 10.1007/978-1-4939-6380-5_7; Joliat GR, 2018, EUR J GASTROEN HEPAT, V30, P792, DOI 10.1097/MEG.0000000000001115; Li GY, 2018, THERANOSTICS, V8, P2846, DOI 10.7150/thno.23463; Lin SJ, 2019, CANCER MANAG RES, V11, P8557, DOI 10.2147/CMAR.S217886; Liu W, 2019, BIOCHEM BIOPH RES CO, V510, P479, DOI 10.1016/j.bbrc.2019.01.139; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Paraskevopoulou MD, 2016, NUCLEIC ACIDS RES, V44, pD231, DOI 10.1093/nar/gkv1270; Ceballos MP, 2011, BIOCHEM PHARMACOL, V82, P1682, DOI 10.1016/j.bcp.2011.08.001; Qiu JL, 2017, J CLIN ONCOL, V35, P734, DOI [10.1200/JCO.2016.68.2153, 10.1200/jco.2016.68.2153]; Song YX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00304-1; Su XQ, 2013, CHINESE J CANCER RES, V25, P235, DOI 10.3978/j.issn.1000-9604.2013.03.08; Taiyab A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092078; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tian XP, 2019, THERANOSTICS, V9, P1965, DOI 10.7150/thno.30958; Ueno M, 2015, J HEPATOL, V63, P1352, DOI 10.1016/j.jhep.2015.07.013; Vilchez V, 2016, WORLD J GASTROENTERO, V22, P823, DOI 10.3748/wjg.v22.i2.823; Wallace MC, 2015, EXPERT REV GASTROENT, V9, P765, DOI 10.1586/17474124.2015.1028363; Wang LQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0889-7; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu L, 2017, J CELL MOL MED, V21, P1545, DOI 10.1111/jcmm.13085; Yang Y, 2018, CARCINOGENESIS, V39, P900, DOI 10.1093/carcin/bgy010; Yeh HW, 2018, NAT CELL BIOL, V20, P479, DOI 10.1038/s41556-018-0062-y; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhang ZY, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12505	34	26	26	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4538	4550		10.1038/s41388-020-1307-3	http://dx.doi.org/10.1038/s41388-020-1307-3		MAY 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32372060	Green Published, hybrid			2022-12-26	WOS:000530617200001
J	Fernando, BNTW; Sudeshika, TSH; Hettiarachchi, TW; Badurdeen, Z; Abeysekara, TDJ; Abeysundara, HTK; Jayasinghe, S; Ranasighe, S; Nanayakkara, N				Fernando, Buddhi N. T. W.; Sudeshika, Thilini S. H.; Hettiarachchi, Thilini W.; Badurdeen, Zeid; Abeysekara, Thilak D. J.; Abeysundara, Hemalika T. K.; Jayasinghe, Sakunthala; Ranasighe, Shirani; Nanayakkara, Nishantha			Evaluation of biochemical profile of Chronic Kidney Disease of uncertain etiology in Sri Lanka	PLOS ONE			English	Article							NORTH CENTRAL REGION; UNKNOWN ETIOLOGY; RENAL-FAILURE; PREVALENCE; ORIGIN; ADULTS	Chronic Kidney Disease of uncertain etiology ( CKDu) is an endemic, disease that mostly affects young agricultural workers in the rural dry zone of Sri Lanka. This study was designed to identify specific biochemical manifestations of CKDu cases. All ( 119) nondialysis definite CKDu patients in Girandurukotte and Wilgamuwa were selected. Blood and urine samples were collected and measured biochemical parameters. All analyses were performed in IBM SPSS statistics version 23 (IBM Corp, USA). The median blood pressure was normal though nearly half of the patients (45.4%) who were in the advanced stages (Stage 3b, 4 and 5) of CKDu. Patients without a history of hypertension before the diagnosis of CKDu (100%) and minimal proteinuria (26%) are similar to the previous findings. Patients without a history of diabetes before the CKDu diagnosis had high percentages of diabetes (15.7%) and pre-diabetes (59.8%) and hence indicated the possibility of uremia induced impaired glucose intolerance in the rural areas of the country. There were 62.2% patients who had low vitamin D and only a minority had evidence of bone mineral diseases. Out of liver disease markers serum glutamic pyruvic transaminases (SGPT), serum glutamic oxaloacetic transaminases ( SGOT), gamma-glutamyl transferase (GGT), and Lactic acid degydrogenase (LDH) had an inverse correlation with the advancement of the disease indicating subclinical liver disease. Osmolality in serum and urine showed a discrepancy despite > 50% of CKDu patients had increased their serum osmolality. The current study supports most of the previously described manifestations of CKDu. Moreover, some specific patterns have been identified which need to be validated in a larger group.	[Fernando, Buddhi N. T. W.] Univ Ruhuna, Fac Allied Hlth Sci, Dept Med Lab Sci, Matara, Sri Lanka; [Sudeshika, Thilini S. H.] Univ Peradeniya, Fac Allied Hlth Sci, Dept Pharm, Peradeniya, Sri Lanka; [Hettiarachchi, Thilini W.; Badurdeen, Zeid; Abeysekara, Thilak D. J.] Univ Peradeniya, Fac Med, Ctr Educ Res & Training Kidney Dis CERTKiD, Peradeniya, Sri Lanka; [Abeysundara, Hemalika T. K.] Univ Peradeniya, Fac Sci, Dept Stat & Comp Sci, Peradeniya, Sri Lanka; [Jayasinghe, Sakunthala] Univ Peradeniya, Fac Med, Dept Pathol, Peradeniya, Sri Lanka; [Ranasighe, Shirani] Univ Peradeniya, Fac Med, Dept Biochem, Peradeniya, Sri Lanka; [Nanayakkara, Nishantha] Teaching Hosp, Transplant & Dialysis Unit, Kandy, Sri Lanka	University Ruhuna; University of Peradeniya; University of Peradeniya; University of Peradeniya; University of Peradeniya; University of Peradeniya	Fernando, BNTW (corresponding author), Univ Ruhuna, Fac Allied Hlth Sci, Dept Med Lab Sci, Matara, Sri Lanka.	buddhifernando08@gmail.com	Salpahewage, Thilini Sudeshika/AAC-1196-2019	Salpahewage, Thilini Sudeshika/0000-0002-5500-0353; Fernando, Buddhi/0000-0002-5063-8649	National Research Council [TO 14-05]	National Research Council	This study was funded by the National Research Council (Grant Number TO 14-05), Sri Lanka The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguer M, 2014, MEDICC REV, V16, P9, DOI 10.37757/MR2014.V16.N2.3; Anand S, 2019, CLIN J AM SOC NEPHRO, V14, P224, DOI 10.2215/CJN.07430618; Arnaiz Quintana A, 2008, TIERRAS PAGADAS PREC; Athuraliya NTC, 2011, KIDNEY INT, V80, P1212, DOI 10.1038/ki.2011.258; Athuraliya T N C, 2009, Ceylon Med J, V54, P23; Bindu C.M., 2013, INT J CURR RES REV, V17, P10; Dasgupta A., 2015, ALCOHOL ITS BIOMARKE, P121; De Silva P, 2016, PLOS NEGLECT TROP D, V10, P17; Deighan CJ, 2000, AM J KIDNEY DIS, V35, P852, DOI 10.1016/S0272-6386(00)70255-1; Devuyst O, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-28; Fabrizi F, 2001, AM J KIDNEY DIS, V38, P1009, DOI 10.1053/ajkd.2001.28590; Harthy MN, 2016, TROP MED INT HEALTH, V21, P41, DOI [10.1111/tmi.12622, DOI 10.1111/TMI.12622]; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Jayasekara JMKB, 2013, CEYLON MED J, V58, P6, DOI 10.4038/cmj.v58i1.5356; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Katulanda P, 2018, J CLIN LIPIDOL, V12, P447, DOI 10.1016/j.jacl.2018.01.006; Lebeau C, 2001, KIDNEY INT, V60, P1332, DOI 10.1046/j.1523-1755.2001.00938.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mohammed E, 2018, SAUDI J KIDNEY DIS T, V29, P1290, DOI 10.4103/1319-2442.248287; MohammedJumaah IA, 2013, J BASRAH RESEARCHES, V39; Mountokalakis T D, 1990, Magnes Res, V3, P121; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Nanayakkara Shanika, 2012, Environmental Health and Preventive Medicine, V17, P109, DOI 10.1007/s12199-011-0224-z; Nanayakkara S, 2014, J OCCUP HEALTH, V56, P28, DOI 10.1539/joh.13-0172-OA; Nielsen JDJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065764; Nitzsche D, 2013, ENVIRON TOXICOL PHAR, V35, P325, DOI 10.1016/j.etap.2013.01.007; Orantes CM, 2011, MEDICC REV, V13, P14, DOI 10.37757/MR2011V13.N4.5; Orr SE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051039; Perkovic V, 2008, KIDNEY INT, V73, P473, DOI 10.1038/sj.ki.5002701; Popat R., 2011, CLIN PHARMACIST, V3, P15; Ratnayake C, 2017, HYPOKALEMIA DISTAL R; Ray Lopamudra, 2015, Int J Appl Basic Med Res, V5, P31, DOI 10.4103/2229-516X.149232; Sayanthooran S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0440-x; Singh AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-114; Takahashi S, 2010, KIDNEY INT, V77, pS17, DOI 10.1038/ki.2009.539; Vervaet BA, 2020, KIDNEY INT, V97, P350, DOI 10.1016/j.kint.2019.11.009; Walimaki VV, 2004, J CLIN ENDOCR METAB, V89, P3785, DOI 10.1210/jc.2003-032187; Wanigasuriya K, 2017, CEYLON MED J, V62, P210, DOI 10.4038/cmj.v62i4.8568; Weaver VM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0105-6; Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611; Wijkstrom J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193056; Wiso VK, 1953, LANCET, V2, P66; WROBLEWSKI F, 1961, ANN NY ACAD SCI, V94, P912, DOI 10.1111/j.1749-6632.1961.tb35584.x; YASUDA M, 1995, NEPHRON, V69, P14, DOI 10.1159/000188354	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232522	10.1371/journal.pone.0232522	http://dx.doi.org/10.1371/journal.pone.0232522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365131	Green Published, gold			2022-12-26	WOS:000536959700037
J	Dalhaus, T; Barnett, BJ; Finger, R				Dalhaus, Tobias; Barnett, Barry J.; Finger, Robert			Behavioral weather insurance: Applying cumulative prospect theory to agricultural insurance design under narrow framing	PLOS ONE			English	Article							EXPECTED UTILITY; CROP INSURANCE; RISK PREFERENCES; DEMAND; FARMERS; CHOICE; DECISIONS; AVERSION	Experience across many countries shows that, without large premium subsidies, crop insurance uptake rates are generally low. In this article, we propose to use the cumulative prospect theory to design weather insurance products for situations in which farmers frame insurance narrowly as a stand-alone investment. To this end, we introduce what we call "behavioral weather insurance" whereby insurance contract parameters are adjusted to correspond more closely with farmers' preferences. Depending on farmers' preferences, we find that a stochastic multiyear premium increases the prospect value of weather insurance, while a zero deductible design does not. We suggest that insurance contracts should be tailored precisely to serve farmers' needs. This offers potential benefits for both the insurer and the insured.	[Dalhaus, Tobias; Finger, Robert] Swiss Fed Inst Technol, Agr Econ & Policy Grp, Zurich, Switzerland; [Barnett, Barry J.] Univ Kentucky, Dept Agr Econ, Lexington, KY USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kentucky	Dalhaus, T (corresponding author), Swiss Fed Inst Technol, Agr Econ & Policy Grp, Zurich, Switzerland.	tdalhaus@ethz.ch	Finger, Robert/A-6248-2011; Dalhaus, Tobias/I-2446-2017	Finger, Robert/0000-0002-0634-5742; Dalhaus, Tobias/0000-0001-5853-0942				[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], [No title captured]; Babcock BA, 2015, AM J AGR ECON, V97, P1371, DOI 10.1093/ajae/aav032; Barberis N, 2006, AM ECON REV, V96, P1069, DOI 10.1257/aer.96.4.1069; Barberis NC, 2013, J ECON PERSPECT, V27, P173, DOI 10.1257/jep.27.1.173; Barseghyan L, 2011, AM ECON REV, V101, P591, DOI 10.1257/aer.101.2.591; Bocqueho G, 2014, EUR REV AGRIC ECON, V41, P135, DOI 10.1093/erae/jbt006; Bordalo P, 2012, Q J ECON, V127, P1243, DOI 10.1093/qje/qjs018; Botzen WJW, 2013, J ECON PSYCHOL, V39, P357, DOI 10.1016/j.joep.2013.05.007; Bougherara D, 2017, EUR REV AGRIC ECON, V44, P782, DOI 10.1093/erae/jbx011; Brown JR, 2016, J RISK INSUR, V83, P139, DOI 10.1111/j.1539-6975.2013.12004.x; Cao Y. J., 2019, AGRIC RESOUR ECON RE, P1, DOI DOI 10.1080/00102202.2019.1565497; Carter MR, 2016, AGR ECON-BLACKWELL, V47, P85, DOI 10.1111/agec.12312; Chantarat S, 2013, J RISK INSUR, V80, P205, DOI 10.1111/j.1539-6975.2012.01463.x; Chen YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145384; Clarke DJ, 2016, AM ECON J-MICROECON, V8, P283, DOI 10.1257/mic.20140103; Coble KH, 2013, AM J AGR ECON, V95, P498, DOI 10.1093/ajae/aas093; Cole S, 2014, AM ECON REV, V104, P284, DOI 10.1257/aer.104.5.284; Conradt S, 2015, AGR ECON-BLACKWELL, V46, P537, DOI 10.1111/agec.12180; Dalhaus T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18656-5; Dalhaus T, 2016, WEATHER CLIM SOC, V8, P409, DOI 10.1175/WCAS-D-16-0020.1; Dalhaus Tobias, 2018, THESIS; Di Falco S, 2006, EUR REV AGRIC ECON, V33, P289, DOI 10.1093/eurrag/jbl016; Di Falco S, 2014, J AGR ECON, V65, P485, DOI 10.1111/1477-9552.12053; DOHERTY NA, 1990, Q J ECON, V105, P243, DOI 10.2307/2937829; DOHERTY NA, 1995, J RISK UNCERTAINTY, V10, P157, DOI 10.1007/BF01083558; Du XD, 2017, AM J AGR ECON, V99, P732, DOI 10.1093/ajae/aaw035; Elabed G, 2013, AGR ECON-BLACKWELL, V44, P419, DOI 10.1111/agec.12025; Elahed G, 2015, J ECON BEHAV ORGAN, V118, P150, DOI 10.1016/j.jebo.2015.03.002; Enjolras G, 2011, AGR ECON-BLACKWELL, V42, P475, DOI 10.1111/j.1574-0862.2011.00535.x; Feng H., 2020, AGR EC; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Finger R, 2013, AGR ECON-BLACKWELL, V44, P217, DOI 10.1111/agec.12005; Finger R, 2012, AGR ECON-BLACKWELL, V43, P343, DOI 10.1111/j.1574-0862.2012.00587.x; Glauber J. W., 2004, American Journal of Agricultural Economics, V86, P1179, DOI 10.1111/j.0002-9092.2004.00663.x; Harrison GW, 2009, EXP ECON, V12, P133, DOI 10.1007/s10683-008-9203-7; Hill RV, 2016, AM J AGR ECON, V98, P1250, DOI 10.1093/ajae/aaw031; Holden ST, 2017, EUR REV AGRIC ECON, V44, P285, DOI 10.1093/erae/jbw016; Jantti M, 2014, REV INCOME WEALTH, V60, P182, DOI 10.1111/roiw.12095; Jaspersen JG, 2017, J RISK INSUR, V84, P239, DOI 10.1111/jori.12088; Jaspersen JG, 2016, J RISK INSUR, V83, P217, DOI 10.1111/jori.12100; Kim K, 2014, EUR REV AGRIC ECON, V41, P775, DOI 10.1093/erae/jbt041; Koszegi B, 2006, Q J ECON, V121, P1133, DOI 10.1093/qje/121.4.1133; Lampe I., 2019, J EC BEHAV ORG; Liu EM, 2013, REV ECON STAT, V95, P1386, DOI 10.1162/REST_a_00295; Luckstead J, 2019, J AGRIC APPL ECON, V51, P267, DOI 10.1017/aae.2018.32; Luttger A. B, 2017, THEORETICAL APPL CLI; Mahul O, 2003, AM J AGR ECON, V85, P580, DOI 10.1111/1467-8276.00457; Mahul O, 2001, AM J AGR ECON, V83, P593, DOI 10.1111/0002-9092.00180; Markowitz H, 1952, J POLIT ECON, V60, P151, DOI 10.1086/257177; Mera M, 2017, ROUTLEDGE COMPANION TO SCREEN MUSIC AND SOUND, P1; Musshoff O, 2013, EUR REV AGRIC ECON, V40, P463, DOI 10.1093/erae/jbs032; Odening M, 2007, AGRIC FINANCE REV, V67, P135, DOI 10.1108/00214660780001202; Petraud J, 2015, COMPETING THEORIES R; Platteau JP, 2017, WORLD DEV, V94, P139, DOI 10.1016/j.worlddev.2017.01.010; Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573; QUIGGIN J, 1991, J RISK UNCERTAINTY, V4, P339, DOI 10.1007/BF00056160; Rauthe M, 2013, METEOROL Z, V22, P235, DOI 10.1127/0941-2948/2013/0436; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmidt U, 2008, J RISK UNCERTAINTY, V36, P203, DOI 10.1007/s11166-008-9040-2; Schmidt U, 2016, J RISK INSUR, V83, P77, DOI 10.1111/jori.12098; Scholten M, 2014, J RISK UNCERTAINTY, V48, P67, DOI 10.1007/s11166-014-9183-2; Sproul T, 2017, AGRIC FINANCE REV, V77, P196, DOI 10.1108/AFR-05-2016-0045; Starmer C, 2000, J ECON LIT, V38, P332, DOI 10.1257/jel.38.2.332; Sung KCJ, 2011, INSUR MATH ECON, V49, P418, DOI 10.1016/j.insmatheco.2011.04.008; Sydnor J, 2010, AM ECON J-APPL ECON, V2, P177, DOI 10.1257/app.2.4.177; Szocs E., 2017, ESMISC MISC FUNCTION; THALER RH, 1990, MANAGE SCI, V36, P643, DOI 10.1287/mnsc.36.6.643; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956	71	12	12	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232267	10.1371/journal.pone.0232267	http://dx.doi.org/10.1371/journal.pone.0232267			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT3FY	32357184	Green Published, gold			2022-12-26	WOS:000536957700022
J	Harezlak, J; Sarwat, S; Wools-Kaloustian, K; Schomaker, M; Balestre, E; Law, M; Kiertiburanakul, S; Fox, M; Veld, DHI; Musick, BS; Yiannoutsos, CT				Harezlak, Jaroslaw; Sarwat, Samiha; Wools-Kaloustian, Kara; Schomaker, Michael; Balestre, Eric; Law, Matthew; Kiertiburanakul, Sasisopin; Fox, Matthew; Veld, Diana Huis in't; Musick, Beverly Sue; Yiannoutsos, Constantin Theodore			PS-SiZer map to investigate significant features of body-weight profile changes in HIV infected patients in the IeDEA Collaboration	PLOS ONE			English	Article							SPLINES; SERIES	Objectives We extend the method of Significant Zero Crossings of Derivatives (SiZer) to address within-subject correlations of repeatedly collected longitudinal biomarker data and the computational aspects of the methodology when analyzing massive biomarker databases. SiZer is a powerful visualization tool for exploring structures in curves by mapping areas where the first derivative is increasing, decreasing or does not change (plateau) thus exploring changes and normalization of biomarkers in the presence of therapy. Methods We propose a penalized spline SiZer (PS-SiZer) which can be expressed as a linear mixed model of the longitudinal biomarker process to account for irregularly collected data and within-subject correlations. Through simulations we show how sensitive PS-SiZer is in detecting existing features in longitudinal data versus existing versions of SiZer. In a real-world data analysis PS-SiZer maps are used to map areas where the first derivative of weight change after antiretroviral therapy (ART) start is significantly increasing, decreasing or does not change, thus exploring the durability of weight increase after the start of therapy. We use weight data repeatedly collected from persons living with HIV initiating ART in five regions in the International Epidemiologic Databases to Evaluate AIDS (IeDEA) worldwide collaboration and compare the durability of weight gain between ART regimens containing and not containing the drug stavudine (d4T), which has been associated with shorter durability of weight gain. Results Through simulations we show that the PS-SiZer is more accurate in detecting relevant features in longitudinal data than existing SiZer variants such as the local linear smoother (LL) SiZer and the SiZer with smoothing splines (SS-SiZer). In the illustration we include data from 185,010 persons living with HIV who started ART with a d4T (53.1%) versus non-d4T (46.9%) containing regimen. The largest difference in durability of weight gain identified by the SiZer maps was observed in Southern Africa where weight gain in patients treated with d4T-containing regimens lasted 59.9 weeks compared to 133.8 weeks for those with nond4T-containing regimens. In the other regions, persons receiving d4T-containing regimens experienced weight gains lasting 38-62 weeks versus 55-93 weeks in those receiving nond4T-based regimens. Discussion PS-SiZer, a SiZer variant, can handle irregularly collected longitudinal data and within-subject correlations and is sensitive in detecting even subtle features in biomarker curves.	[Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Bloomington, IN USA; [Sarwat, Samiha] Bayer US LLC, Whippany, NJ USA; [Wools-Kaloustian, Kara] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Schomaker, Michael] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Balestre, Eric] INSERM, Inst Sante Publ Epidemiol & Dev, Bordeaux, France; [Law, Matthew] Univ New South Wales, Kirby Inst, Biostat & Databases Program, Sydney, NSW, Australia; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok, Thailand; [Fox, Matthew] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Fox, Matthew] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Veld, Diana Huis in't] Univ Hosp, Dept Internal Med & Infect Dis, Ghent, Belgium; [Musick, Beverly Sue] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Yiannoutsos, Constantin Theodore] Indiana Univ, Dept Biostat, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Cape Town; Institut National de la Sante et de la Recherche Medicale (Inserm); University of New South Wales Sydney; Kirby Institute; Mahidol University; Boston University; Boston University; Ghent University; Ghent University Hospital; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Yiannoutsos, CT (corresponding author), Indiana Univ, Dept Biostat, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA.	cyiannou@iu.edu	Harezlak, Jaroslaw/P-8557-2014	Harezlak, Jaroslaw/0000-0002-3070-7686; Law, Matthew/0000-0002-3540-8837	National Institute of Allergy and Infectious Diseases [AI069911, AI069924, AI069907, AI069927, AI069923, AI069919]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases AI069911 Dr. Kara Wools-Kaloustian, Indianapolis, IN, USA National Institute of Allergy and Infectious Diseases AI069924 Dr. Matthias Egger, Bern Switzerland National Institute of Allergy and Infectious Diseases AI069907 Matthew Law, Foundation of AIDS Research, NY, USA National Institute of Allergy and Infectious Diseases AI069927 Tyler Hartwell, Research Triangle Park, NC, USA National Institute of Allergy and Infectious Diseases AI069923 Catherine McGowan, Nashville, TN, USA National Institute of Allergy and Infectious Diseases AI069919 Francois Dabis, Bordeaux, France.	Bourgi K, 2019, CLIN INFECT DIS; Bowman AW, 1997, APPL SMOOTHING TECHN; Brumback BA, 1999, J AM STAT ASSOC, V94, P794, DOI 10.2307/2669991; Chaudhuri P, 1999, J AM STAT ASSOC, V94, P807, DOI 10.2307/2669996; Chen HH, 2011, BIOMETRICS, V67, P861, DOI 10.1111/j.1541-0420.2010.01524.x; Currie ID, 2002, STAT MODEL, V2, P333, DOI 10.1191/1471082x02st039ob; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fan J., 1996, LOCAL POLYNOMIAL MOD; Gallant JE, 2016, LANCET HIV, V3, pE158, DOI 10.1016/S2352-3018(16)00024-2; Hannig J, 2006, J AM STAT ASSOC, V101, P484, DOI 10.1198/016214505000001294; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Huis in 't Veld D, 2015, JAIDS-J ACQ IMM DEF, V70, P146, DOI 10.1097/QAI.0000000000000691; Joly V, 2002, AIDS, V16, P2447, DOI 10.1097/00002030-200212060-00010; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Marron JS, 2005, COMPUTATION STAT, V20, P481, DOI 10.1007/BF02741310; Menard A, 2017, AIDS, V31, P1499, DOI 10.1097/QAD.0000000000001495; Ojeda Cabrera JL, 2012, IOCPOL KERNEL LOCAL; Park C, 2008, COMPUT STAT DATA AN, V52, P3954, DOI 10.1016/j.csda.2008.01.006; Park C, 2009, STAT SINICA, V19, P1511; Park CW, 2004, J APPL STAT, V31, P999, DOI 10.1080/0266476042000270554; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Rondonotti V, 2007, ELECTRON J STAT, V1, P268, DOI 10.1214/07-EJS006; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Verbeke G, 2000, LINEAR MIXED MODELS; Willig JH, 2008, AIDS, V22, P1951, DOI 10.1097/QAD.0b013e32830efd79; Wood BR, 2019, CLIN INFECT DIS; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2010, MGCV MIXED GAM COMPU	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0220165	10.1371/journal.pone.0220165	http://dx.doi.org/10.1371/journal.pone.0220165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357149	Green Submitted, gold, Green Published			2022-12-26	WOS:000536957700001
J	Yoshimatsu, Y; Kimuro, S; Pauty, J; Takagaki, K; Nomiyama, S; Inagawa, A; Maeda, K; Podyma-Inoue, KA; Kajiya, K; Matsunaga, YT; Watabe, T				Yoshimatsu, Yasuhiro; Kimuro, Shiori; Pauty, Joris; Takagaki, Kazuki; Nomiyama, Sanae; Inagawa, Akihiko; Maeda, Kentaro; Podyma-Inoue, Katarzyna A.; Kajiya, Kentaro; Matsunaga, Yukiko T.; Watabe, Tetsuro			TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of Activin signals	PLOS ONE			English	Article							NF-KAPPA-B; LYMPHANGIOGENESIS; PERMEABILITY; REGENERATION; MAINTENANCE; IDENTITY; PATHWAY; MODEL; ADULT; FLOW	Lymphatic systems play important roles in the maintenance of fluid homeostasis and undergo anatomical and physiological changes during inflammation and aging. While lymphatic endothelial cells (LECs) undergo mesenchymal transition in response to transforming growth factor-beta (TGF-beta), the molecular mechanisms underlying endothelial-to-mesenchymal transition (EndMT) of LECs remain largely unknown. In this study, we examined the effect of TGF-beta 2 and tumor necrosis factor-alpha (TNF-alpha), an inflammatory cytokine, on EndMT using human skin-derived lymphatic endothelial cells (HDLECs). TGF-beta 2-treated HDLECs showed increased expression of SM22 alpha, a mesenchymal cell marker accompanied by increased cell motility and vascular permeability, suggesting HDLECs to undergo EndMT. Our data also revealed that TNF-alpha could enhance TGF-beta 2-induced EndMT of HDLECs. Furthermore, both cytokines induced the production of Activin A while decreasing the expression of its inhibitory molecule Follistatin, and thus enhancing EndMT. Finally, we demonstrated that human dermal lymphatic vessels underwent EndMT during aging, characterized by double immunostaining for LYVE1 and SM22 alpha. These results suggest that both TGF-beta and TNF-alpha signals play a central role in EndMT of LECs and could be potential targets for senile edema.	[Yoshimatsu, Yasuhiro; Kimuro, Shiori; Inagawa, Akihiko; Podyma-Inoue, Katarzyna A.; Watabe, Tetsuro] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Biochem, Tokyo, Japan; [Yoshimatsu, Yasuhiro; Maeda, Kentaro; Watabe, Tetsuro] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Oncol, Tokyo, Japan; [Yoshimatsu, Yasuhiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Pharmacol, Niigata, Japan; [Pauty, Joris; Matsunaga, Yukiko T.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Takagaki, Kazuki; Nomiyama, Sanae; Kajiya, Kentaro] Shiseido Global Innovat Ctr, Yokohama, Kanagawa, Japan	Tokyo Medical & Dental University (TMDU); Tokyo University of Pharmacy & Life Sciences; Niigata University; University of Tokyo; Shiseido Company, Limited	Watabe, T (corresponding author), Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Biochem, Tokyo, Japan.; Watabe, T (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Oncol, Tokyo, Japan.	t-watabe@umin.ac.jp	Yoshimatsu, Yasuhiro/AAY-2259-2020; Inoue, Katarzyna A./ABD-9622-2020	Kajiya, Kentaro/0000-0002-5224-7051	Japan Science and Technology Agency [PRESTO: JPMJPR12M3]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [23122504]; Japan Society for the Promotion of Science (JSPS) [15K21394, 17K07157]; Uehara Memorial Foundation; Japan Foundation for Applied Enzymology; Project for Promoting Leading-edge Research in Oral Science at Tokyo Medical and Dental University (TMDU); Japan Agency for Medical Research and Development (AMED) [JP18cm0106239, 17cm0106613h0001]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Foundation for Applied Enzymology; Project for Promoting Leading-edge Research in Oral Science at Tokyo Medical and Dental University (TMDU); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by a grant for the Precursory Research for Embryonic Science and Technology (PRESTO: JPMJPR12M3) (to TW) from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research on Innovative Areas, Cellular, and Molecular Basis for Neuro-vascular Wiring (23122504) (to TW) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Grant-in-Aid for Young Scientists (B) (15K21394 to YY) and Scientific Research (C) (17K07157 to YY) from the Japan Society for the Promotion of Science (JSPS); grants from Uehara Memorial Foundation (to TW); the Japan Foundation for Applied Enzymology (to YY); and Project for Promoting Leading-edge Research in Oral Science at Tokyo Medical and Dental University (TMDU) (to YY and TW). This study was also conducted as part of a research program of the Project for Cancer Research and Therapeutic Evolution (P-CREATE), the Japan Agency for Medical Research and Development (AMED) (JP18cm0106239 to YTM; 17cm0106613h0001 to TW). The funder provided support in the form of salaries for authors KT, SN and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akl TJ, 2011, AM J PHYSIOL-HEART C, V301, pH1828, DOI 10.1152/ajpheart.00538.2011; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; Bridenbaugh EA, 2013, LYMPHAT RES BIOL, V11, P35, DOI 10.1089/lrb.2012.0025; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Derynck Rik, 2008, P29; Dufton NP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01169-0; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Hopper RK, 2016, CIRCULATION, V133, P1783, DOI 10.1161/CIRCULATIONAHA.115.020617; Ichise T, 2014, J CELL SCI, V127, P845, DOI 10.1242/jcs.137836; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kajiya K, 2011, J DERMATOL SCI, V61, P206, DOI 10.1016/j.jdermsci.2010.12.005; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Katsura A, 2016, GENES CELLS, V21, P99, DOI 10.1111/gtc.12323; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Kim H, 2014, J CLIN INVEST, V124, P936, DOI 10.1172/JCI71607; Kokudo T, 2008, J CELL SCI, V121, P3317, DOI 10.1242/jcs.028282; Li ZY, 2016, AGING-US, V8, P2337, DOI 10.18632/aging.101050; Mahler GJ, 2013, ARTERIOSCL THROM VAS, V33, P121, DOI 10.1161/ATVBAHA.112.300504; Maleszewska M, 2013, IMMUNOBIOLOGY, V218, P443, DOI 10.1016/j.imbio.2012.05.026; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Moskowitz IP, 2011, P NATL ACAD SCI USA, V108, P4006, DOI 10.1073/pnas.1019025108; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Nagai T, 2011, MICROCIRCULATION, V18, P463, DOI 10.1111/j.1549-8719.2011.00107.x; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Overby DR, 2014, P NATL ACAD SCI USA, V111, P13876, DOI 10.1073/pnas.1410602111; Park DY, 2014, J CLIN INVEST, V124, P3960, DOI 10.1172/JCI75392; Pauty J, 2018, EBIOMEDICINE, V27, P225, DOI 10.1016/j.ebiom.2017.12.014; Pauty Joris, 2017, Nanotheranostics, V1, P103, DOI 10.7150/ntno.18303; Petrova T. Ye., 2009, Toksikologicheskii Vestnik, P35; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; Sanchez-Duffhues G, 2019, J PATHOL, V247, P333, DOI 10.1002/path.5193; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Wu KQ, 2017, AM J PATHOL, V187, P2102, DOI 10.1016/j.ajpath.2017.05.014; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xiao L, 2017, J PATHOL, V241, P25, DOI 10.1002/path.4814; Yang Y, 2017, INT J MOL MED, V40, P558, DOI 10.3892/ijmm.2017.3034; Yoshimatsu Y, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/724080; Yoshimatsu Y, 2013, P NATL ACAD SCI USA, V110, P18940, DOI 10.1073/pnas.1310479110; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zolla V, 2015, AGING CELL, V14, P582, DOI 10.1111/acel.12330	47	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232356	10.1371/journal.pone.0232356	http://dx.doi.org/10.1371/journal.pone.0232356			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357159	gold, Green Published			2022-12-26	WOS:000536957700027
J	Fernandez, JRE; Eckhardt, BL; Lee, J; Lim, B; Pearson, T; Seitz, RS; Hout, DR; Schweitzer, BL; Nielsen, TJ; Lawrence, OR; Wang, Y; Rao, A; Ueno, NT				Fernandez, Jose Rodrigo Espinosa; Eckhardt, Bedrich L.; Lee, Jangsoon; Lim, Bora; Pearson, Troy; Seitz, Rob S.; Hout, David R.; Schweitzer, Brock L.; Nielsen, Tyler J.; Lawrence, O. Rayne; Wang, Ying; Rao, Arvind; Ueno, Naoto T.			Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research	PLOS ONE			English	Article								The original algorithm that classified triple-negative breast cancer (TNBC) into six subtypes has recently been revised. The revised algorithm (TNBCtype-IM) classifies TNBC into five subtypes and a modifier based on immunological (IM) signatures. The molecular signature may differ between cancer cells in vitro and their respective tumor xenografts. We identified cell lines with concordant molecular subtypes regardless of classification algorithm or analysis of cells in vitro or in vivo, to establish a panel of clinically relevant molecularly stable TNBC models for translational research. Gene expression data were used to classify TNBC cell lines using the original and the revised algorithms. Tumor xenografts were established from 17 cell lines and subjected to gene expression profiling with the original 2188-gene algorithm TNBCtype and the revised 101-gene algorithm TNBCtype-IM. A total of six cell lines (SUM149PT (BL2), HCC1806 (BL2), SUM149PT (BL2), BT549 (M), MDA-MB-453 (LAR), and HCC2157 (BL1)) maintained their subtype classification between in vitro and tumor xenograft analyses across both algorithms. For TNBC molecular classification-guided translational research, we recommend using these TNBC cell lines with stable molecular subtypes.	[Fernandez, Jose Rodrigo Espinosa; Eckhardt, Bedrich L.; Lee, Jangsoon; Lim, Bora; Pearson, Troy; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Seitz, Rob S.; Hout, David R.; Schweitzer, Brock L.; Nielsen, Tyler J.; Lawrence, O. Rayne] Insight Genet Inc, Nashville, TN USA; [Wang, Ying; Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Eckhardt, Bedrich L.] La Trobe Univ, Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Eckhardt, Bedrich L.] La Trobe Univ, Sch Canc Med, Heidelberg, Vic, Australia; [Rao, Arvind] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; University of Michigan System; University of Michigan	Ueno, NT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.	nueno@mdanderson.org	, 0000-0002-4182-6058/F-9978-2014; Nielsen, Tyler/AAD-7515-2022	, 0000-0002-4182-6058/0000-0002-4182-6058; Nielsen, Tyler/0000-0002-9576-2838; Seitz, Rob/0000-0002-5806-2840; Schweitzer, Brock/0000-0003-0178-5594; Eckhardt, Bedrich/0000-0002-3402-3900	Morgan Welch Inflammatory Breast Cancer Research Program, a State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson's Cancer Center Support Grant [P30CA016672]; Insight Genetics Inc.	Morgan Welch Inflammatory Breast Cancer Research Program, a State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson's Cancer Center Support Grant; Insight Genetics Inc.	This study was supported by: This study was supported by the Morgan Welch Inflammatory Breast Cancer Research Program, a State of Texas Rare and Aggressive Breast Cancer Research Program grant (N.T. Ueno), and MD Anderson's Cancer Center Support Grant (P30CA016672, used the Animal Core Facility). Insight Genetics Inc. provided support for this study in the form of salaries for RSS, DRH, BLS, TJN, ORL. The specific roles of these authors are articulated in the 'author contributions' section. All funders in this study provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatti S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00032; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Mota AD, 2017, ONCOL LETT, V13, P4708, DOI 10.3892/ol.2017.6093; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ring BZ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2198-0; Smith SE, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0855-0	10	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231953	10.1371/journal.pone.0231953	http://dx.doi.org/10.1371/journal.pone.0231953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353087	Green Published, gold			2022-12-26	WOS:000536673200029
J	Herrig, I; Fleischmann, S; Regnery, J; Wesp, J; Reifferscheid, G; Manz, W				Herrig, Ilona; Fleischmann, Susanne; Regnery, Julia; Wesp, Jessica; Reifferscheid, Georg; Manz, Werner			Prevalence and seasonal dynamics of bla(CTX-M) antibiotic resistance genes and fecal indicator organisms in the lower Lahn River, Germany	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; RISK-ASSESSMENT; WATER; TRANSMISSION; ENVIRONMENT; BACTERIA; ENTEROBACTERIACEAE; DISSEMINATION; HUMANS	Antibiotic-resistant bacteria represent an emerging global health problem and are frequently detected in riverine environments. Analyzing the occurrence of corresponding antibiotic-resistant genes in rivers is of public interest as it contributes towards understanding the origin and dissemination of these emerging microbial contaminants via surface water. This is critical for devising strategies to mitigate the spread of resistances in the environment. Concentrations of bla(CTX-M) antibiotic resistance genes were quantified weekly over a 12-month period in Lahn River surface water at two sampling sites using quantitative real-time PCR. Gene abundances were statistically assessed with regard to previously determined concentrations of fecal indicator organisms Escherichia coli, intestinal enterococci and somatic coliphages, as well as influential environmental factors. Similar seasonal patterns and strong positive correlations between fecal indicators and bla(CTX-M) genes indicated identical sources. Accordingly, linear regression analyses showed that bla(CTX-M) concentrations could largely be explained by fecal pollution. E. coli provided the best estimates (75% explained variance) at the upstream site, where proportions of bla(CTX-M) genes in relation to fecal indicator organisms were highest. At this site, rainfall proved to be more influential, hinting at surface runoff as an emission source. The level of agricultural impact increased from downstream to upstream, linking increasing bla(CTX-M) concentrations after rainfall events to the degree of agricultural land use. Exposure assessment revealed that even participants in non-swimming recreational activities were at risk of incidentally ingesting bla(CTX-M) genes and thus potentially antibiotic resistant bacteria. Considering that bla(CTX-M) genes are ubiquitous in Lahn River and participants in bathing and non-bathing water sports are at risk of exposure, results highlight the importance of microbial water quality monitoring with an emphasis on antibiotic resistance not only in designated bathing waters. Moreover, E. coli might serve as a suitable estimate for the presence of respective antibiotic resistant strains.	[Herrig, Ilona; Fleischmann, Susanne; Regnery, Julia; Wesp, Jessica; Reifferscheid, Georg] Fed Inst Hydrol, Dept G3 Biochem, Ecotoxicol, Koblenz, Germany; [Herrig, Ilona; Manz, Werner] Univ Koblenz Landau, Inst Integrated Nat Sci, Dept Biol, Koblenz, Germany; [Fleischmann, Susanne] FU Berlin, Inst Food Safety & Food Hyg, Dept Vet Med, Berlin, Germany	University of Koblenz & Landau; Free University of Berlin	Herrig, I (corresponding author), Fed Inst Hydrol, Dept G3 Biochem, Ecotoxicol, Koblenz, Germany.; Herrig, I (corresponding author), Univ Koblenz Landau, Inst Integrated Nat Sci, Dept Biol, Koblenz, Germany.	iherrig@uni-koblenz.de			Federal Ministry of Transport and Digital Infrastructure within the research program KLIWAS ("Impacts of climate change on waterways and navigation Searching for options of adaptation")	Federal Ministry of Transport and Digital Infrastructure within the research program KLIWAS ("Impacts of climate change on waterways and navigation Searching for options of adaptation")	This study was supported by the Federal Ministry of Transport and Digital Infrastructure within the research program KLIWAS ("Impacts of climate change on waterways and navigation Searching for options of adaptation"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2004, SOIL BIOL BIOCHEM, V36, P859, DOI 10.1016/j.soilbio.2004.02.004; Amos GCA, 2014, VET MICROBIOL, V171, P441, DOI 10.1016/j.vetmic.2014.02.017; Ashbolt NJ, 2013, ENVIRON HEALTH PERSP, V121, P993, DOI 10.1289/ehp.1206316; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bassetti M, 2009, CURR MED CHEM, V16, P564, DOI 10.2174/092986709787458498; Beattie RE, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy131; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Bevan ER, 2017, J ANTIMICROB CHEMOTH, V72, P2145, DOI 10.1093/jac/dkx146; BfG, 2011, GEW JB RHEING 3; Biedenkapp A, 2004, NATURSCHUTZ WASSERSP; Blaak, 2011, 7037190712011 RIVM N; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; BMWi, 2016, WIRTSCH POT WASS DEU; Buchter B., 2011, THESIS, DOI [10.17169/refubium-5158, DOI 10.17169/REFUBIUM-5158]; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Ceecherini MT, 2007, SOIL BIOL BIOCHEM, V39, P158, DOI 10.1016/j.soilbio.2006.07.006; Chen BW, 2013, WATER RES, V47, P2811, DOI 10.1016/j.watres.2013.02.042; Coque TM, 2002, ANTIMICROB AGENTS CH, V46, P500, DOI 10.1128/AAC.46.2.500-510.2002; Dorevitch S, 2011, WATER RES, V45, P2020, DOI 10.1016/j.watres.2010.12.006; Dufour Alfred P., 2006, Journal of Water and Health, V4, P425; DUPONT HL, 1971, NEW ENGL J MED, V285, P1, DOI 10.1056/NEJM197107012850101; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Franz E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14372; Gekenidis MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207857; Gothwal R, 2015, CLEAN-SOIL AIR WATER, V43, P479, DOI 10.1002/clen.201300989; H?bner U., 2018, DYNAMIK KLARWASSERAN; Haas C.N., 1999, QUANTITATIVE MICROBI; HAAS CN, 1983, AM J EPIDEMIOL, V118, P573, DOI 10.1093/oxfordjournals.aje.a113662; Haberecht HB, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/3862949; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Herrig I, 2019, ENVIRON SCI EUR, V31, DOI 10.1186/s12302-019-0250-9; Herrig IM, 2015, WATER RES, V85, P148, DOI 10.1016/j.watres.2015.08.006; ISO, 2000, 78992 ISO, DOI [10.31030/8974114, DOI 10.31030/8974114]; ISO, 2000, 107052 ISO, DOI [10.31030/9224349, DOI 10.31030/9224349]; ISO, 1998, 93083 ISO, DOI [10.31030/8106465, DOI 10.31030/8106465]; Iversen A, 2004, ENVIRON MICROBIOL, V6, P55, DOI 10.1046/j.1462-2920.2003.00534.x; Jorgensen SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186576; Karkman A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07992-3; Khan FA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00688; Kim J, 2005, ANTIMICROB AGENTS CH, V49, P1572, DOI 10.1128/AAC.49.4.1572-1575.2005; Knapp CW, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00396; Knudsen PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18659-2; Larsson DGJ, 2018, ENVIRON INT, V117, P132, DOI 10.1016/j.envint.2018.04.041; Laurens C, 2018, J GLOB ANTIMICROB RE, V15, P88, DOI 10.1016/j.jgar.2018.06.022; Leonard AFC, 2018, ENVIRON INT, V114, P326, DOI 10.1016/j.envint.2017.11.003; Leonard AFC, 2015, ENVIRON INT, V82, P92, DOI 10.1016/j.envint.2015.02.013; Li AD, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fix189; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Manaia CM, 2017, TRENDS MICROBIOL, V25, P173, DOI 10.1016/j.tim.2016.11.014; Mao DQ, 2014, ENVIRON SCI TECHNOL, V48, P71, DOI 10.1021/es404280v; Marti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078906; McConnell MM, 2018, J ENVIRON QUAL, V47, P997, DOI 10.2134/jeq2017.12.0477; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; NCBI, 2019, ESCH COL WELL STUD E; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Okeke IN, 2001, CLIN INFECT DIS, V33, P364, DOI 10.1086/321877; ONeill J., 2016, TACKLING DRUG RESIST; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Pfeifer Y., 2013, Hygiene & Medizin, V38, P294; PIETRAMELLARA G, 2009, BIOL FERT SOILS, V45, P219, DOI DOI 10.1007/s00374-008-0345-8; Pote J, 2003, EUR J SOIL BIOL, V39, P65, DOI 10.1016/S1164-5563(03)00003-7; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; R Core Team, 2018, R LANG ENV STAT COMP; Rath S, 2018, J WATER POLLUT CONTR, V1, P1; Rijal G, 2011, J WATER HEALTH, V9, P169, DOI 10.2166/wh.2010.020; Robin F, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01911-16, 10.1128/aac.01911-16]; Sabri NA, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2018.03.004; Schets FM, 2011, WATER RES, V45, P2392, DOI 10.1016/j.watres.2011.01.025; Seis W, 2018, WATER RES, V143, P301, DOI 10.1016/j.watres.2018.06.057; Servais P, 2009, SCI TOTAL ENVIRON, V408, P365, DOI 10.1016/j.scitotenv.2009.09.042; Statistisches Bundesamt, 2020, ONL FLACH; Tacao M, 2012, APPL ENVIRON MICROB, V78, P4134, DOI 10.1128/AEM.00359-12; von Wintersdorff CJH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00173; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zurfluh K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095864	78	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232289	10.1371/journal.pone.0232289	http://dx.doi.org/10.1371/journal.pone.0232289			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353007	Green Published, gold			2022-12-26	WOS:000536673200068
J	Nobert, BR; Larsen, TA; Pigeon, KE; Finnegan, L				Nobert, Barry R.; Larsen, Terrence A.; Pigeon, Karine E.; Finnegan, Laura			Caribou in the cross-fire? Considering terrestrial lichen forage in the face of mountain pine beetle (Dendroctonus ponderosae) expansion	PLOS ONE			English	Article							INVASIVE SPECIES REMOVAL; WOODLAND CARIBOU; HABITAT SELECTION; BETA REGRESSION; DISTURBANCE; LANDSCAPE; FORESTS; MODEL; VEGETATION; GROWTH	Mountain pine beetle (MPB) has become an invasive forest pest of mature pine in western North America as it spreads beyond its former endemic range. Management actions such as timber harvest can reduce the spread of MPB but may affect species of conservation concern like woodland caribou. Our goal was to inform MPB management within caribou ranges by exploring the impacts of MPB on caribou habitat-focusing on terrestrial lichens, an important winter food for caribou. We evaluated differences in lichen cover among four MPB management actions: timber harvest, wildfires, leaving MPB killed trees as-is, and single-tree cut-and-burn control. We found little evidence that leaving MPB killed trees as-is or controlling MPB using single-tree cut-and-burn impacted lichen cover. However, we found that lichen cover was lower in timber harvested and burned areas compared to intact undisturbed forest but only 10 to 20 years post-disturbance, respectively. Our results suggest that despite short-term reductions in lichen cover, using timber harvesting and prescribed burns to control MPB may balance management needs for MPB while maintaining lichen cover over time. However, using timber harvesting and prescribed burns to manage MPB is likely to have detrimental population-level effects on caribou by increasing the proportion of disturbed habitat and thus predators within caribou ranges. Among the four management actions that we evaluated, the cut-and-burn control program balances the need to limit the spread of MPB while also limiting negative impacts on caribou food. Our work addresses some of the challenges of managing competing forest and ecosystem values by evaluating the consequence of forest pest management actions on an important food resource for a species-at-risk.	[Nobert, Barry R.; Pigeon, Karine E.; Finnegan, Laura] FRI Res, Caribou Program, Hinton, AB, Canada; [Nobert, Barry R.] Alberta Environm & Pk, Grande Prairie, AB, Canada; [Larsen, Terrence A.] FRI Res, Grizzly Bear Program, Hinton, AB, Canada; [Pigeon, Karine E.] Carleton Univ, Geomat & Landscape Ecol Res Lab, Ottawa, ON, Canada	Carleton University	Finnegan, L (corresponding author), FRI Res, Caribou Program, Hinton, AB, Canada.	lfinnegan@friresearch.ca		Finnegan, Laura/0000-0002-4797-6284	Forest Resource Improvement Association of Alberta Mountain Pine Beetle Rehabilitation Funds [MPB-FRP-14-06]; Alberta Agriculture and Forestry; fRI Research; fRI Research Mountain Pine Beetle Ecology Program	Forest Resource Improvement Association of Alberta Mountain Pine Beetle Rehabilitation Funds; Alberta Agriculture and Forestry; fRI Research; fRI Research Mountain Pine Beetle Ecology Program	Funding for this project was provided by Alberta Agriculture and Forestry, the Forest Resource Improvement Association of Alberta Mountain Pine Beetle Rehabilitation Funds (MPB-FRP-14-06), fRI Research and partners, and the fRI Research Mountain Pine Beetle Ecology Program. Any opinions, findings and conclusions, or recommendations expressed herein do not necessarily reflect the views of funding entities, and funding entities had no involvement in the design of the study or in interpretation of results. These funding sources did not alter our adherence to PLOS ONE policies on sharing data and materials.	Alberta Environment and Parks, 2017, RES DAT PROD CAT HYD; Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 30 ALB SUST RES DEV; Amalesh Dhar, 2011, BC Journal of Ecosystems and Management, V12, P1; Amoroso MM, 2013, FOREST ECOL MANAG, V310, P300, DOI 10.1016/j.foreco.2013.08.037; Andison DW, 2000, LANDSCAPE LEVEL FIRE; [Anonymous], 2007, MOUNT PIN BEETL ACT; [Anonymous], 2016, INFERENTIAL FORWARD, V26, P2548, DOI [10.1002/eap.1415, DOI 10.1002/EAP.1415]; [Anonymous], 2017, DRAFT PROV WOODL CAR; ASRD [Alberta Sustainable Resource Development], 2007, MOUNT PIN BEETL MAN; Avgar T, 2017, ECOL EVOL, V7, P5322, DOI 10.1002/ece3.3122; Avgar T, 2015, J ANIM ECOL, V84, P1059, DOI 10.1111/1365-2656.12357; Avgar T, 2013, J ANIM ECOL, V82, P96, DOI 10.1111/j.1365-2656.2012.02035.x; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BENEDICT JB, 1990, BRYOLOGIST, V93, P319, DOI 10.2307/3243520; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Bleiker K.P., 2019, RISK ASSESSMENT THRE; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; BRADSHAW CJA, 1995, CAN J ZOOL, V73, P1567, DOI 10.1139/z95-185; Brown GS, 2007, OECOLOGIA, V154, P485, DOI 10.1007/s00442-007-0855-3; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Canadian Council on Animal Care, 2017, GUIDE CARE USE EXPT; Chan-McLeod Ann C. Allaye, 2006, British Columbia Journal of Ecosystems and Management, V7, P119; Cichowski D, 2013, RESPONSE CARIBOU TER; Cichowski DB, 2013, ANN REPORT 2012 13 Y; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cooke BJ, 2017, FOREST ECOL MANAG, V396, P11, DOI 10.1016/j.foreco.2017.04.008; Coxson DS, 2001, CAN J BOT, V79, P1449, DOI 10.1139/cjb-79-12-1449; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; DeCesare NJ, 2010, ANIM CONSERV, V13, P353, DOI 10.1111/j.1469-1795.2009.00328.x; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; DeCesare NJN, 2012, THESIS; Denryter KA, 2017, CAN J ZOOL, V95, P81, DOI 10.1139/cjz-2016-0114; Dettki H, 2000, ECOSCIENCE, V7, P317, DOI 10.1080/11956860.2000.11682601; Dhar A, 2016, FORESTS, V7, DOI 10.3390/f7080171; Dhar A, 2016, CAN J FOREST RES, V46, P987, DOI 10.1139/cjfr-2016-0137; Dzus EH, 2001, STATUS WOODLAND CARI; Environment and Climate Change Canada, 2021, REC STR BARN OWL TYT; Environment Canada, 2011, SCI ASS INF ID CRIT; Environment Canada, 2014, OTT SPEC RISK ACT RE; Eskelson BNI, 2011, FOREST SCI, V57, P212; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finnegan L, 2018, NATURAL REGENERATION; Finnegan L, 2018, FOREST ECOL MANAG, V409, P634, DOI 10.1016/j.foreco.2017.12.010; Fornwalt PJ, 2018, FOREST ECOL MANAG, V409, P84, DOI 10.1016/j.foreco.2017.10.056; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Gessler PE, 2000, SOIL SCI SOC AM J, V64, P2046, DOI 10.2136/sssaj2000.6462046x; Graham L, 2006, WILLMORE WILDERNESS; Hebert I, 2013, FOREST ECOL MANAG, V291, P318, DOI 10.1016/j.foreco.2012.11.011; Hervieux D, 2013, CAN J ZOOL, V91, P872, DOI 10.1139/cjz-2013-0123; Hicke JA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000101; Hosmer DW, 2008, WILEY SERIES PROBABI; Hui FKC, 2013, ECOLOGY, V94, P1913, DOI 10.1890/12-1322.1; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson Chris J., 2000, Rangifer, V20, P159; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; Joly K, 2010, ECOSCIENCE, V17, P321, DOI 10.2980/17-3-3337; Keim JL, 2017, ECOL EVOL, V7, P486, DOI 10.1002/ece3.2625; Kohavi R., 1995, P 1995 INT JOINT C A; Kopf RK, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0172; Kuhn M., 2021, CARET CLASSIFICATION; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lafleur B, 2016, FOREST ECOL MANAG, V372, P44, DOI 10.1016/j.foreco.2016.04.007; Lamont BG, 2019, J WILDLIFE MANAGE, V83, P679, DOI 10.1002/jwmg.21631; Lance AN, 2000, GUIDE EVALUATING FOR; Lance Art N., 1996, Rangifer, V16, P355; Larsen TA, 2012, THESIS; Latifi H, 2017, FORESTRY, V90, P496, DOI 10.1093/forestry/cpw066; Liu F, 2015, R J, V7, P34; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; MacNearney D, 2016, ECOL EVOL, V6, P6484, DOI 10.1002/ece3.2362; Matsuoka SM, 2001, CAN J ZOOL, V79, P1678, DOI 10.1139/cjz-79-9-1678; Mbogga MS, 2009, AGR FOREST METEOROL, V149, P881, DOI 10.1016/j.agrformet.2008.11.009; McDonald J.H., 2014, HDB BIOL STAT; McFarlane BL, 2006, BIOL CONSERV, V130, P340, DOI 10.1016/j.biocon.2005.12.029; Mikkelson KM, 2013, ECOHYDROLOGY, V6, P64, DOI 10.1002/eco.278; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Natural Regions Committee, 2006, NAT REG SUBR ALB; Natural Resources Canada, 2015, CAN DIG EL MOD; Nealis VG, 2014, FO79142014EPDF CAN C; Nijland W, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083572; Nobert BR, 2016, CAN J ZOOL; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Pec GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124691; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Plummer M., 2012, ASCL1209002; R Development Core Team, 2017, R LANG ENV STAT COMP; Rejmanek M., 2002, TURNING TIDE ERADICA, P249; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rich P.M., 1994, AM SOC PHOTOGRAMM RE; Rstudio Team, 2019, RSTUDIO INTEGRATED D; Saab VA, 2014, FOREST SCI, V60, P539, DOI 10.5849/forsci.13-022; Sachs L., 1997, ANGEW STAT, P11, DOI [10.1007/978-3-662-05746-9_2, DOI 10.1007/978-3-662-05746-9_2, 10.1007/978-3-662-05746-9]; Safranyik L, 2001, BCX391; Safranyik L., 2006, MOUNTAIN PINE BEETLE; Saher D. Joanne, 2005, Rangifer, P143; Sancho LG, 2007, FLORA, V202, P667, DOI 10.1016/j.flora.2007.05.005; Sasketchewan Ministry of the Environment, 2019, STAT ENV 2019 FOC FO; Schindler DE, 2015, SCIENCE, V347, P953, DOI 10.1126/science.1261824; SEIP DR, 1992, CAN J ZOOL, V70, P1494, DOI 10.1139/z92-206; Serrouya R, 2019, P NATL ACAD SCI USA, V116, P6181, DOI 10.1073/pnas.1816923116; Serrouya R, 2017, PEERJ, V5, DOI 10.7717/peerj.3736; Silva JA, 2019, MODELLING LICHEN ABU; Smith KG, 2000, CAN J ZOOL, V78, P1433, DOI 10.1139/cjz-78-8-1433; Snyder J, 1992, LICHEN REGENERATION; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Strong DR, 2000, SCIENCE, V288, P1969, DOI 10.1126/science.288.5473.1969; Thomas D.C., 1996, METHODS, V9, P1; Thompson ID, 2015, CAN J ZOOL, V93, P87, DOI 10.1139/cjz-2014-0140; Tigner J, 2014, J WILDLIFE MANAGE, V78, P282, DOI 10.1002/jwmg.664; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Waterhouse Michaela J., 2011, Rangifer, V31, P119; Webb Elizabeth T., 1998, Rangifer, V18, P41; White B, 2012, CAN WATER RESOUR J, V37, P333, DOI 10.4296/cwrj2011-909; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y; Woodard PM, 1995, EFFECTS HARVESTING L; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	125	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232248	10.1371/journal.pone.0232248	http://dx.doi.org/10.1371/journal.pone.0232248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353088	gold, Green Published			2022-12-26	WOS:000536673200060
J	Rasmussen, J; Ewald, J; Sterner, T				Rasmussen, Joel; Ewald, Jens; Sterner, Thomas			Gender and life-stage dependent reactions to the risk of radioactive contamination: A survey experiment in Sweden	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; HEALTH; PERCEPTION; FUKUSHIMA; RADIATION; JAPAN; MASCULINITY; RESIDENTS; CHERNOBYL; ALTRUISM	This article proposes and examines gender and life-stage factors as determinants of public worry and risk avoidance in a nuclear fallout scenario. Drawing on a survey (N 2,291) conducted in Sweden, the article demonstrates statistically significant results that women as well as parents with children at home are more likely to express high levels of worry for radiation exposure and have a preference to move away from a fallout area despite assurance of successful remediation. Moreover, a negative relationship is shown between age and both worry for radiation exposure and preference to move. These novel results from Northern Europe thus support a life-stage framing of public risk attitudes. As radiation physicists develop new methods showing that women and children are at higher risk of cancer than other groups at the same radiation exposure, we may actually see the precaution among women and parents as a regulating mechanism for the higher objective risk they face. The results are moreover in agreement with studies of public risk reactions in Japan, creating a strong knowledge base that human-induced radiation pollution is largely an intolerable risk to the public. Considering the public opinion, managing an intolerable risk through risk mitigation by remediation alone is likely insufficient in many cases. A viable strategy would offer a range of social support options that enable individual decision-making and the protection of risk groups.	[Rasmussen, Joel] Orebro Univ, Sch Humanities Educ & Social Sci, Media & Commun Studies, Orebro, Sweden; [Ewald, Jens; Sterner, Thomas] Gothenburg Univ, Sch Business Econ & Law, Dept Econ, Gothenburg, Sweden	Orebro University; University of Gothenburg	Rasmussen, J (corresponding author), Orebro Univ, Sch Humanities Educ & Social Sci, Media & Commun Studies, Orebro, Sweden.	joel.rasmussen@oru.se	Sterner, Thomas/AGZ-2537-2022	Rasmussen, Joel/0000-0001-6407-6037; Ewald, Jens/0000-0001-7438-9184	Swedish Civil Contingencies Agency	Swedish Civil Contingencies Agency	JR, TS (fellow applicants) Dnr 2017-7043 The Swedish Civil Contingencies Agency https://www.msb.se/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DICT GENDER STUDIES; Aven T, 2010, RISK GOV SOC, V16, P1, DOI 10.1007/978-3-642-13926-0; BORKOVEC TD, 1983, BEHAV RES THER, V21, P9, DOI 10.1016/0005-7967(83)90121-3; Cameron TA, 2010, J HEALTH ECON, V29, P364, DOI 10.1016/j.jhealeco.2010.02.005; Commar A., 2018, WHO global report on trends in prevalence of tobacco smoking 2000-2025; Dahlin J, 2013, SOC SCI MED, V98, P24, DOI 10.1016/j.socscimed.2013.08.028; Dickie M, 2004, J ENVIRON ECON MANAG, V48, P1146, DOI 10.1016/j.jeem.2003.12.005; Dickie M, 2007, J ENVIRON ECON MANAG, V53, P323, DOI 10.1016/j.jeem.2006.09.005; DROTTZSJOBERG BM, 1990, J ENVIRON PSYCHOL, V10, P135, DOI 10.1016/S0272-4944(05)80124-0; Dupont DP, 2004, ECOL ECON, V49, P273, DOI 10.1016/j.ecolecon.2004.01.013; Eibach RP, 2011, J EXP SOC PSYCHOL, V47, P694, DOI 10.1016/j.jesp.2010.12.009; Fukasawa M, 2017, SSM-POPUL HLTH, V3, P740, DOI 10.1016/j.ssmph.2017.09.002; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Hammitt JK, 2010, J RISK UNCERTAINTY, V40, P57, DOI 10.1007/s11166-009-9086-9; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hawkes S, 2013, LANCET, V381, P1783, DOI 10.1016/S0140-6736(13)60253-6; Henwood Karen L., 2008, Equal Opportunities International, V27, P662, DOI 10.1108/02610150810916730; Hidaka T, 2016, INVEST OPHTH VIS SCI, V57; Hinote BP, 2012, MEN MASC, V15, P292, DOI 10.1177/1097184X12448466; IAEA, 2013, IAEA REP DOC REM NUC; Jewett A, 2015, MMWR-MORBID MORTAL W, V64, P814, DOI 10.15585/mmwr.mm6430a2; Kim Y, 2018, CENT EUR J PUBL HEAL, V26, P54, DOI 10.21101/cejph.a4920; Kimura Aya Hirata, 2016, RAD BRAIN MOMS CITIZ; Kunreuther H, 1996, ANN AM ACAD POLIT SS, V545, P116, DOI 10.1177/0002716296545001012; Lienard P, 2011, NEUROSCI BIOBEHAV R, V35, P1067, DOI 10.1016/j.neubiorev.2010.09.007; Liu JT, 2000, HEALTH ECON, V9, P319, DOI 10.1002/1099-1050(200006)9:4<319::AID-HEC521>3.0.CO;2-3; Lund IO, 2012, J RISK RES, V15, P1171, DOI 10.1080/13669877.2012.705317; Morioka R, 2014, SOC SCI MED, V107, P105, DOI 10.1016/j.socscimed.2014.02.014; Morita T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194134; Murakami M, 2015, ENVIRON SCI-TOKYO, V28, P193; Normile D, 2013, SCIENCE, V340, P678, DOI 10.1126/science.340.6133.678; Oe M, 2016, PSYCHIAT CLIN NEUROS, V70, P245, DOI 10.1111/pcn.12387; Ohto H, 2017, ASIA-PAC J PUBLIC HE, V29, p10S, DOI 10.1177/1010539516675700; Olofsson A, 2015, J RISK RES, V18, P2, DOI 10.1080/13669877.2013.879485; Olofsson A, 2011, RISK ANAL, V31, P1016, DOI 10.1111/j.1539-6924.2010.01566.x; Raaf C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228549; Rolison JJ, 2014, J GERONTOL B-PSYCHOL, V69, P870, DOI 10.1093/geronb/gbt081; Rushton Lesley, 2017, Curr Environ Health Rep, V4, P340, DOI 10.1007/s40572-017-0151-2; Slovic P, 2012, B ATOM SCI, V68, P67, DOI 10.1177/0096340212444870; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Stergiou-Kita M, 2015, SAFETY SCI, V80, P213, DOI 10.1016/j.ssci.2015.07.029; Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498; United Nations Human Rights Office of the High Commissioner, JAP MUST HALT RET FU; Waddington I, 2017, PROCESS SAF ENVIRON, V112, P16, DOI 10.1016/j.psep.2017.03.012; Wang XT, 2009, EVOL HUM BEHAV, V30, P77, DOI 10.1016/j.evolhumbehav.2008.09.006; Zhang H, 2014, INT J ENV RES PUB HE, V11, P9286, DOI 10.3390/ijerph110909286	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232259	10.1371/journal.pone.0232259	http://dx.doi.org/10.1371/journal.pone.0232259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS9BE	32353020	Green Published, gold			2022-12-26	WOS:000536673200062
J	Wang, Y; Bailey, DC; Yin, SK; Dong, XH				Wang, Yue; Bailey, Donovan C.; Yin, Shikai; Dong, Xuehui			Characterizing rhizome bud dormancy in Polygonatum kingianum: Development of novel chill models and determination of dormancy release mechanisms by weighted correlation network analysis	PLOS ONE			English	Article							UNIT MODELS; TRANSCRIPTION FACTORS; PREDICTION MODEL; WINTER CHILL; APPLE; GERMINATION; GENE; REQUIREMENTS; COMPLETION; BREAKING	This study was conducted to explore specific chill models and the mechanisms underlying rhizome bud dormancy break in Polygonatum kingianum. Rhizome buds were subjected to various chilling temperatures for different duration and then transferred to warm conditions for germination and subsequent evaluation of their response to temperature and chilling requirements. A CUkingianum model was constructed to describe the contribution of low temperature to the chill unit, and it was suggested that 2.97 degrees C was the optimum temperature and that 11.54 degrees C was the upper limit for bud release. The CAS(kingianum) model showed the relationship between chilling accumulation and sprouting percentage; therefore, rhizome bud development could be predicted through the model. Weighted correlation network analysis (WGCNA) of transcriptomic data of endo-, eco- and nondormant rhizome buds generated 33 gene modules, 6 of which were significantly related to bud sprouting percentage. In addition, 7 significantly matched transcription factors (TFs) were identified from the promoters of 17 "real" hub genes, and DAG2 was the best matched TF that bound to AAAG element to regulate gene expression. The current study is valuable for developing a highly efficient strategy for seedling cultivation and provides strong candidates for key genes related to rhizome bud dormancy in P. kingianum.	[Wang, Yue; Yin, Shikai; Dong, Xuehui] China Agr Univ, Dept Agron & Biotechnol, Beijing, Peoples R China; [Bailey, Donovan C.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	China Agricultural University; New Mexico State University	Dong, XH (corresponding author), China Agr Univ, Dept Agron & Biotechnol, Beijing, Peoples R China.	xuehuidong@cau.edu.cn		Wang, Yue/0000-0002-3480-3544	Chinese Agricultural University	Chinese Agricultural University	The work was supported by Chinese Agricultural University. The author thanks Professor Dong for providing guidance on the research idea and experimental facilities. We also thank Professor Bailey of New Mexico State University for language editing.	Bai Y, 2015, MOL GENET GENOMICS, V290, P1247, DOI 10.1007/s00438-014-0986-2; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bailey TL, 2009, NUCL ACIDS RES S2; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Campoy JA, 2013, PLANT BIOLOGY, V15, P28, DOI 10.1111/j.1438-8677.2012.00636.x; Chen YC, 2016, J BONE MINER RES, V31, P1041, DOI 10.1002/jbmr.2781; Commission CP, 2015, PHARM PEOPL REP; Coville FV, 1920, P NATL ACAD SCI USA, V6, P434, DOI 10.1073/pnas.6.7.434; EREZ A, 1979, J AM SOC HORTIC SCI, V104, P536; FISHMAN S, 1987, J THEOR BIOL, V126, P309, DOI 10.1016/S0022-5193(87)80237-0; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Fulton TA, 2001, SCI HORTIC-AMSTERDAM, V89, P237, DOI 10.1016/S0304-4238(00)00237-5; Gao DongSheng, 2001, Acta Horticulturae Sinica, V28, P283; GILREATH PR, 1981, J AM SOC HORTIC SCI, V106, P426; Guak S, 2013, HORTIC ENVIRON BIOTE, V54, P29, DOI 10.1007/s13580-013-0140-9; Gualberti G, 2002, PLANT CELL, V14, P1253, DOI 10.1105/tpc.010491; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Jones HG, 2013, PLANT BIOLOGY, V15, P18, DOI 10.1111/j.1438-8677.2012.00590.x; LANG GA, 1987, HORTSCIENCE, V22, P371; Langfelder P., 2016, TUTORIAL WGCNA PACKA; Lattoo SK, 2001, CURR SCI INDIA, V81, P1414; LAVARENNE S, 1975, PHYSIOL VEG, V13, P215; Linsley-Noakes G, 1995, J SO AFRICAN SOC HOR; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmood K, 2000, J HORTIC SCI BIOTECH, V75, P602, DOI 10.1080/14620316.2000.11511293; Mo XH, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1611-1; Ren Yiran, 2016, Horticultural Plant Journal, V2, P61, DOI 10.1016/j.hpj.2016.06.007; RICHARDSON E A, 1974, Hortscience, V9, P331; Rose GA, 2009, SCI HORTIC-AMSTERDAM, V122, P654, DOI 10.1016/j.scienta.2009.06.029; Santopolo S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0453-1; SHALTOUT AD, 1983, J AM SOC HORTIC SCI, V108, P957; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sunley RJ, 2006, J HORTIC SCI BIOTECH, V81, P949, DOI 10.1080/14620316.2006.11512181; THOMPSON WK, 1975, AUST J AGR RES, V26, P989, DOI 10.1071/AR9750989; Wang Y, 2019, PLANT MOL BIOL, V99, P205, DOI 10.1007/s11103-018-0812-z; Weinberger JH, 1950, P AM SOC HORTICULTUR; Wu WC., 1995, J CHIN MED MAT, V18, P597; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yang LW, 2020, NEW PHYTOL, V225, P1593, DOI 10.1111/nph.16236; Yeo SM, 2012, HORTIC ENVIRON BIOTE, V53, P263, DOI 10.1007/s13580-012-0037-z; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	44	4	4	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0231867	10.1371/journal.pone.0231867	http://dx.doi.org/10.1371/journal.pone.0231867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32353065	Green Published, gold			2022-12-26	WOS:000536673200025
J	Baldanza, VE; Rogic, A; Yan, WW; Levine, CB; Levine, RA; Miller, AD; McCleary-Wheeler, AL				Baldanza, Vincent E.; Rogic, Anita; Yan, Weiwei; Levine, Corri B.; Levine, Roy A.; Miller, Andrew D.; McCleary-Wheeler, Angela L.			Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma	PLOS ONE			English	Article							DOXORUBICIN COMBINATION CHEMOTHERAPY; APPENDICULAR OSTEOSARCOMA; AMPUTATION; CARBOPLATIN; METASTASIS; CISPLATIN; TARGET; GROWTH; DOGS	Canine osteosarcoma (OSA), the most common canine primary bone malignancy, has a highly aggressive biologic behavior. Despite current standard of care therapies, including amputation and adjuvant chemotherapy, most dogs still succumb to metastatic disease. Further investigations into molecular mechanisms and pathways driving OSA are needed to improve therapeutic options. The Hedgehog (HH) cell-signaling pathway has demonstrated involvement in human OSA. Several studies in canine OSA have found changes in expression of some HH pathway genes and demonstrated a role for HH transcription factors. However, the role of this pathway as well as the translational value of its targeting in canine OSA are still undefined. The objectives of this study were to determine the expression of HH components directly in canine OSA tissues and to evaluate the biologic impact of HH signaling inhibition in canine OSA cells. In situ hybridization was used to detect HH family mRNA expression in archived canine OSA tissues and revealed variable expression levels of these mRNAs in canine OSA tissues. The effect of a commercially available Smoothened inhibitor, vismodegib, was studied in established canine OSA cell lines. Alterations in cellular growth as well as assessment of downstream HH targets were evaluated. Although changes in cell growth were noted following Smoothened inhibition, inconsistent decreases in target gene expression were found. While treatment with vismodegib had a negative impact on canine OSA cell growth and viability, the mechanism remains unclear. Further studies are warranted to evaluate the clinical significance of canonical HH signaling in canine OSA.	[Baldanza, Vincent E.; Yan, Weiwei; Levine, Corri B.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Rogic, Anita; McCleary-Wheeler, Angela L.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Levine, Roy A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Miller, Andrew D.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Sect Anat Pathol, Ithaca, NY 14853 USA; [Baldanza, Vincent E.] Vet Canc Grp, Culver City, CA USA	Cornell University; University of Missouri System; University of Missouri Columbia; Cornell University; Cornell University	McCleary-Wheeler, AL (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.	mcclearywheelera@missouri.edu		Levine, Corri/0000-0003-0405-5191; McCleary-Wheeler, Angela/0000-0002-2638-6736	American Kennel Club Canine Health Foundation Clinician Scientist Fellowship [26084]	American Kennel Club Canine Health Foundation Clinician Scientist Fellowship	This work was partially supported by the American Kennel Club Canine Health Foundation Clinician Scientist Fellowship, Grant #26084 (VEB). The sponsor did not play any role in the study design, data collection, analysis, decision to publish, or the preparation of the manuscript.; The authors thank Greg Vitone and Erica Sloma for their assistance with the experiments utilizing canine OSA tumor tissue samples. The authors thank Allison Byrne for assistance with colony formation assay preparation. The authors also thank the Cornell Statistical Consulting Unit (CSCU) for assistance with statistical analysis. We also thank Karen Clifford, Strategic Communications Associate at the University of Missouri College of Veterinary Medicine, for her assistance with figure formatting.	Bailey D, 2003, J VET INTERN MED, V17, P199, DOI 10.1892/0891-6640(2003)017&lt;0199:CADCCF&gt;2.3.CO;2; Barroga EF, 1999, J VET MED SCI, V61, P361; Bergman PJ, 1996, J VET INTERN MED, V10, P76, DOI 10.1111/j.1939-1676.1996.tb02031.x; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; BRODEY RS, 1969, CLIN ORTHOP RELAT R, P54; Chan LH, 2014, ONCOGENE, V33, P4857, DOI 10.1038/onc.2013.433; Chun R, 2000, J VET INTERN MED, V14, P495, DOI 10.1892/0891-6640(2000)014&lt;0495:CADCCF&gt;2.3.CO;2; Frimberger AE, 2016, J AM ANIM HOSP ASSOC, V52, P149, DOI 10.5326/JAAHA-MS-6315; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; HEYMAN SJ, 1992, VET SURG, V21, P304, DOI 10.1111/j.1532-950X.1992.tb00069.x; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Horvai AE, 2012, MODERN PATHOL, V25, P1452, DOI 10.1038/modpathol.2012.110; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kent MS, 2004, J VET INTERN MED, V18, P540, DOI 10.1892/0891-6640(2004)18&lt;540:ACADAA&gt;2.0.CO;2; Legare ME, 2011, J CANCER, V2, P262, DOI 10.7150/jca.2.262; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lo Winnie W., 2014, Sarcoma, V2014, P261804, DOI 10.1155/2014/261804; Lo WW, 2014, CANCER-AM CANCER SOC, V120, P537, DOI 10.1002/cncr.28439; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; Mohseny AB, 2012, EUR J CANCER, V48, P3429, DOI 10.1016/j.ejca.2012.06.018; Mueller F, 2007, ANTICANCER RES, V27, P155; Murakami S, 1997, ENDOCRINOLOGY, V138, P1972, DOI 10.1210/en.138.5.1972; Nagao H, 2011, J PATHOL, V224, P169, DOI 10.1002/path.2880; Nagao-Kitamoto H, 2015, INT J CANCER, V136, P1276, DOI 10.1002/ijc.29107; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069466; Nam A, 2019, J VET MED SCI, V81, P1722, DOI 10.1292/jvms.19-0043; O'Donoghue LE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-506; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philips B, 2009, J AM ANIM HOSP ASSOC, V45, P33, DOI 10.5326/0450033; Raju GP, 2011, J CLIN INVEST, V121, P14, DOI 10.1172/JCI45692; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Shahi MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131006; Shahi MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096593; Shen AD, 2012, J SURG ONCOL, V105, P830, DOI 10.1002/jso.23012; Skorupski KA, 2016, VET COMP ONCOL, V14, P81, DOI 10.1111/vco.12069; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; STRAW RC, 1991, J VET INTERN MED, V5, P205, DOI 10.1111/j.1939-1676.1991.tb00950.x; Vail DM, 2013, WITHROW MACEWENS SMA, V5th, P463; Warzecha J, 2007, J CHEMOTHERAPY, V19, P554, DOI 10.1179/joc.2007.19.5.554; Warzecha J, 2012, INT J MOL MED, V29, P423, DOI 10.3892/ijmm.2011.851; Yang HG, 2014, ONCOL LETT, V8, P193, DOI 10.3892/ol.2014.2079; Yang W, 2013, J ORTHOP RES, V31, P502, DOI 10.1002/jor.22230	45	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231762	10.1371/journal.pone.0231762	http://dx.doi.org/10.1371/journal.pone.0231762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348319	Green Published, gold			2022-12-26	WOS:000536668200025
J	Chen, CD; Rudy, MA; Zeldich, E; Abraham, CR				Chen, Ci-Di; Rudy, Melissa A.; Zeldich, Ella; Abraham, Carmela R.			A method to specifically activate the Klotho promoter by using zinc finger proteins constructed from modular building blocks and from naturally engineered Egr1 transcription factor backbone	FASEB JOURNAL			English	Article						aging; Alzheimer's disease; cancer; kidney disease; neurodegeneration; transcription factor	GENE-EXPRESSION; COGNITION; KIDNEY; MODEL; MICE; RNA; METHYLATION; REPRESSION; MORTALITY; COMPLEX	There is an unmet need for treatments for diseases associated with aging. The antiaging, life-extending, and cognition-enhancing protein Klotho is neuroprotective due to its anti-inflammatory, antioxidative, and pro-myelinating effects. In addition, Klotho is also a tumor suppressor and has beneficial roles in multiple organs. Klotho is downregulated as part of the aging process. Thus, upregulating Klotho in the brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis, and demyelinating diseases such as multiple sclerosis. We attempted to upregulate Klotho for its beneficial effects in the brain and elsewhere. Here, we describe a method to specifically activate Klotho gene expression. To accomplish this task, we designed zinc finger proteins (ZFPs) targeting within -300 bps of the human Klotho promoter. We designed the ZPF constructs either de novo from modular building blocks, or modified sequences from the natural endogenous Egr1 transcription factor backbone structure. Egr1 is known to upregulate Klotho expression. We tested the transcriptional activation effects of these ZFPs in a dual luciferase coincidence reporter system under the control of 4-kb promoter of human Klotho in stable HEK293 cells and in HK-2 cells that express Klotho protein endogenously. We found that the best ZFPs are the de novo designed ones targeting -250 bps of Klotho promoter and one of the Egr1-binding sites. We further enhanced Klotho's activation using p65-Rta transcriptional activation domains in addition to VP64. These upregulation approaches could be useful for studying Klotho's protective effects and designing Klotho boosting therapeutics for future in vivo experiments.	[Chen, Ci-Di; Rudy, Melissa A.; Zeldich, Ella; Abraham, Carmela R.] Klogene Therapeut Inc, Boston, MA 02118 USA		Chen, CD (corresponding author), Klogene Therapeut Inc, Boston, MA 02118 USA.	cidichen@bu.edu		Rudy, Melissa/0000-0003-0165-5669	small business innovation research (SBIR) [1R44 AG053084]; NIH-NIA	small business innovation research (SBIR)(United States Department of Agriculture (USDA)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a small business innovation research (SBIR) grant 1R44 AG053084 from NIH-NIA to Klogene Therapeutics, Inc.	Abraham CR, 2016, VITAM HORM, V101, P215, DOI 10.1016/bs.vh.2016.02.004; Anamizu Y, 2005, ACTA NEUROPATHOL, V109, P457, DOI 10.1007/s00401-004-0971-7; Beerli RR, 2000, J BIOL CHEM, V275, P32617, DOI 10.1074/jbc.M005108200; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Brobey RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139914; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2018, J MOL NEUROSCI, V64, P175, DOI 10.1007/s12031-017-1011-0; Cheng MF, 2015, ACTA NEUROBIOL EXP, V75, P60; Choi BH, 2010, GENE, V450, P121, DOI 10.1016/j.gene.2009.11.004; Chtarto A, 2007, EXP NEUROL, V204, P387, DOI 10.1016/j.expneurol.2006.11.014; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Haussler MR, 2016, VITAM HORM, V100, P165, DOI 10.1016/bs.vh.2015.11.005; Haussler MR, 2012, REV ENDOCR METAB DIS, V13, P57, DOI 10.1007/s11154-011-9199-8; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Marcais C, 2017, J CLIN ENDOCR METAB, V102, P3154, DOI 10.1210/jc.2017-00104; Masso A, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.211; Masso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143623; Masuda H, 2005, MECH AGEING DEV, V126, P1274, DOI 10.1016/j.mad.2005.07.007; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perveez M, 2015, MOL BIOL RES COMMUN, V4, P217; Pollock R, 2002, NAT BIOTECHNOL, V20, P729, DOI 10.1038/nbt0702-729; Polstein LR, 2014, METHODS MOL BIOL, V1148, P89, DOI 10.1007/978-1-4939-0470-9_7; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Rubinek T, 2012, BREAST CANCER RES TR, V133, P649, DOI 10.1007/s10549-011-1824-4; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; Seibert E, 2017, CLIN NEPHROL, V87, P173, DOI 10.5414/CN108970; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Wehling-Henricks M, 2016, HUM MOL GENET, V25, P2465, DOI 10.1093/hmg/ddw111; Yamagishi T, 2001, HYPERTENS RES, V24, P705, DOI 10.1291/hypres.24.705; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Zeldich E, 2019, J MOL NEUROSCI, V69, P264, DOI 10.1007/s12031-019-01356-2; Zeldich E, 2015, J MOL NEUROSCI, V57, P185, DOI 10.1007/s12031-015-0598-2; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang Q, 2017, KIDNEY INT, V91, P144, DOI 10.1016/j.kint.2016.07.040	52	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7234	7246		10.1096/fj.202000171R	http://dx.doi.org/10.1096/fj.202000171R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32347987	Bronze, Green Accepted			2022-12-26	WOS:000529968700001
J	Devaux, M; Lerouge, A; Giuffre, G; Giesecke, S; Baiocco, S; Ricci, A; Reyes, F; Cantarero, D; Ventelou, B; Cecchini, M				Devaux, Marion; Lerouge, Alienor; Giuffre, Giovanna; Giesecke, Susanne; Baiocco, Sara; Ricci, Andrea; Reyes, Francisco; Cantarero, David; Ventelou, Bruno; Cecchini, Michele			How will the main risk factors contribute to the burden of non-communicable diseases under different scenarios by 2050? A modelling study	PLOS ONE			English	Article							HEALTH; MORTALITY	Background The future burden of non-communicable diseases (NCDs) depends on numerous factors such as population ageing, evolution of societal trends, behavioural and physiological risk factors of individuals (e.g. smoking, alcohol use, obesity, physical inactivity, and hypertension). This study aims to assess the burden of NCDs in Europe by 2050 under alternative scenarios. Methods This study combines qualitative and quantitative forecasting techniques to examine how population health in Europe may evolve from 2015 to 2050, taking into account future societal trends. Four scenarios were developed (one business-as-usual scenario, two response scenarios and one pessimistic scenario) and assessed against 'best' and 'worst'-case scenarios. This study provides quantitative estimates of both diseases and mortality outcomes, using a microsimulation model incorporating international survey data. Findings Each scenario is associated with a different risk factor prevalence rate across Europe during the period 2015-2050. The prevalence and incidence of NCDs consistently increase during the analysed time period, mainly driven by population ageing. In more optimistic scenarios, diseases will appear in later ages, while in the pessimistic scenarios, NCDs will impair working-age people. Life expectancy is expected to grow in all scenarios, but with differences by up to 4 years across scenarios and population groups. Premature mortality from NCDs will be reduced in more optimistic scenarios but stagnate in the worst-case scenario. Interpretation Population ageing will have a greater impact on the spread of NCDs by 2050 compared to risk factors. Nevertheless, risk factors, which are influenced by living environments, are an important factor for determining future life expectancy in Europe.	[Devaux, Marion; Lerouge, Alienor; Cecchini, Michele] Org Econ Cooperat & Dev, Paris, France; [Giuffre, Giovanna; Baiocco, Sara; Ricci, Andrea] Inst Studies Integrat Syst, ISINNOVA, Rome, Italy; [Giesecke, Susanne] Austrian Inst Technol, Seibersdorf, Austria; [Baiocco, Sara] Ctr European Policy Studies, Brussels, Belgium; [Reyes, Francisco] Univ Vigo, Vigo, Spain; [Cantarero, David] Univ Cantabria, Cantabria, Spain; [Ventelou, Bruno] Aix Marseille Univ, CNRS, Cent Marseille, EHESS,IRD,AMSE, Marseille, France	Organisation for Economic Co-operation & Development (OECD); Austrian Institute of Technology (AIT); Universidade de Vigo; Universidad de Cantabria; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Devaux, M (corresponding author), Org Econ Cooperat & Dev, Paris, France.	marion.devaux@oecd.org		Giesecke, Susanne/0000-0003-4668-7904	European Union [643576]; Ministries of Health; European Commission (DG Sante)	European Union(European Commission); Ministries of Health; European Commission (DG Sante)(European CommissionEuropean Commission Joint Research Centre)	FRESHER ("FoResight and Modelling for European Health policy and Regulation") is an interdisciplinary research project funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No 643576 for a duration of 36 months (2015-2018). The European Commission provided support in the form of salaries for GG, SB, SG, AR, FR, DC, and BV. The Austrian Institute of Technology provided support in the form of salaries for SG. The OECD programme of work on the economics of public health is supported by a number of voluntary contributions by Ministries of Health or other national government institutions of OECD member countries or key partners, including grants from the European Commission (DG Sante '). The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. The specific roles of these authors are articulated in the `author contributions' section. The opinions expressed herein are solely those of the authors and do not necessarily reflect the official views of the OECD or its member countries.	[Anonymous], 2005, PREV CHRON DIS VIT I; Cagnin C, 2015, TECHNOL FORECAST SOC, V101, P182, DOI 10.1016/j.techfore.2015.11.020; Cecchini, 2015, 80 OECD; Cecchini M, 2017, SCI PAPER METHODOLOG; Cobiac LJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012805; Devaux M, 2019, PUBLIC HEALTH, V169, P173, DOI 10.1016/j.puhe.2019.02.009; Evans D, 2011, 3 WHO; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Giesecke S, 2012, ROLE FORWARD LOOKING; Gonzalez-Pier E, 2016, LANCET GLOB HEALTH, V4, pE714, DOI 10.1016/S2214-109X(16)30181-4; Kontis V, 2015, LANCET GLOB HEALTH, V3, pE746, DOI 10.1016/S2214-109X(15)00179-5; LI YC, 2017, BMC MED, V15, DOI DOI 10.1186/812916-017-0894-5; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; United Nations, 2015, 2030 AG SUST DEV; United Nations, WORLD POP PROSP POP; United Nations General Assembly, 2012, POL DECL HIGH LEV M; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Waverley Consultants,, 2017, FUT TOOLK WAS ASS UK; Webber L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004787; World Health Organization, 2000, WHAA5314; World Health Organization, 2010, EQUI HLTH; World Health Organization (WHO), 2013, NATL ACTION PLAN PRE	23	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231725	10.1371/journal.pone.0231725	http://dx.doi.org/10.1371/journal.pone.0231725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348352	Green Published, gold			2022-12-26	WOS:000536668200023
J	Matsuda, T; Sugita, M; Ichinose, M				Matsuda, Takuya; Sugita, Mamoru; Ichinose, Mizuho			The L motifs of two moss pentatricopeptide repeat proteins are involved in RNA editing but predominantly not in RNA recognition	PLOS ONE			English	Article							PPR-DYW PROTEINS; PHYSCOMITRELLA-PATENS; BINDING SPECIFICITY; SITES; DOMAIN	Pentatricopeptide repeat (PPR) proteins, composed of PPR motifs repeated in tandem, are sequence-specific RNA binding proteins. Recent bioinformatic studies have shown that the combination of polar amino acids at positions 5 and last in each PPR motif recognizes RNA bases, and an RNA recognition code for PPR proteins has been proposed. Subsequent studies confirmed that the P (canonical length) and S (short) motifs bind to specific nucleotides according to this code. However, the contribution of L (long) motifs to RNA recognition is mostly controversial, owing to the presence of a nonpolar amino acid at position 5. The PLS-class PPR protein PpPPR_56 is a mitochondrial RNA editing factor in the moss Physcomitrella patens. Here, we performed in vitro RNA binding and in vivo complementation assays with PpPPR_56 and its variants containing mutated L motifs to investigate their contributions to RNA recognition. In vitro RNA binding assay showed that the original combination of amino acids at positions 5 and last in the L motifs of PpPPR_56 is not required for RNA recognition. In addition, an in vivo complementation assay with RNA editing factors PpPPR_56 and PpPPR_78 revealed the importance of nonpolar amino acids at position 5 of C-terminal L motifs for efficient RNA editing. Our findings suggest that L motifs function as non-binding spacers, not as RNA-binding motifs, to facilitate the formation of a complex between PLS-class PPR protein and RNA. As a result, the DYW domain, a putative catalytic deaminase responsible for C-to-U RNA editing, is correctly placed in proximity to C, which is to be edited.	[Matsuda, Takuya; Sugita, Mamoru; Ichinose, Mizuho] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi, Japan; [Ichinose, Mizuho] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Sugita, M; Ichinose, M (corresponding author), Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi, Japan.; Ichinose, M (corresponding author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi, Japan.	sugita@gene.nagoya-u.ac.jp; ichinose@gene.nagoya-u.ac.jp			JSPS KAKENHI [17K08195, 18K14435]; Hori Science and Arts Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hori Science and Arts Foundation	This work was supported by JSPS KAKENHI [grant Nos 17K08195 (to MS) and 18K14435 (to MI)]; the Hori Science and Arts Foundation (to MI); the Association of Fordays Self-Reliance Support (to MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; Choudhury R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2154; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Ebihara T, 2019, PLANT J, V97, P1120, DOI 10.1111/tpj.14187; Goto S, 2016, PLANT J, V86, P493, DOI 10.1111/tpj.13184; Hayes ML, 2020, J BIOL CHEM, V295, P3497, DOI 10.1074/jbc.RA119.011790; Ichinose M, 2018, PLANT CELL PHYSIOL, V59, P1652, DOI 10.1093/pcp/pcy086; Ichinose M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010005; Ichinose M, 2012, PLANT J, V70, P271, DOI 10.1111/j.1365-313X.2011.04869.x; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Kindgren P, 2015, PLANT CELL, V27, P403, DOI 10.1105/tpc.114.134189; Kobayashi T, 2019, PLANT CELL PHYSIOL, V60, P862, DOI 10.1093/pcp/pcy251; Lu G, 2009, CURR OPIN STRUC BIOL, V19, P110, DOI 10.1016/j.sbi.2008.12.009; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Miranda RG, 2018, NUCLEIC ACIDS RES, V46, P2613, DOI 10.1093/nar/gkx1288; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; Okuda K, 2014, PLANT J, V80, P870, DOI 10.1111/tpj.12687; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Oldenkott B, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0328-3; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rojas M, 2019, NAT PLANTS, V5, P505, DOI 10.1038/s41477-019-0412-1; Rudinger M, 2011, PLANT J, V67, P370, DOI 10.1111/j.1365-313X.2011.04600.x; Ruwe H, 2019, NEW PHYTOL, V222, P218, DOI 10.1111/nph.15578; Schallenberg-Rudinger M, 2016, ADV BOT RES, V78, P37, DOI 10.1016/bs.abr.2016.01.002; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Small ID, 2020, PLANT J, V101, P1040, DOI 10.1111/tpj.14578; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; Uchida M, 2011, FEBS LETT, V585, P2367, DOI 10.1016/j.febslet.2011.06.009; Yagi Y, 2014, PLANT J, V78, P772, DOI 10.1111/tpj.12377; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yan JJ, 2019, NUCLEIC ACIDS RES, V47, P3728, DOI 10.1093/nar/gkz075; Yan JJ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.37; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049	41	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232366	10.1371/journal.pone.0232366	http://dx.doi.org/10.1371/journal.pone.0232366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348368	gold, Green Published			2022-12-26	WOS:000536668200060
J	Park, YG; Park, YH				Park, Young Gun; Park, Young-Hoon			Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography	PLOS ONE			English	Article							OCT ANGIOGRAPHY; CELLS; 2A; PROGRESSION; PIGMENT	Purpose To evaluate retinal vascular changes on optical coherence tomography angiography (OCTA) in patients with macular telangiectasia type 2 (MacTel 2) and to assess their correlation with visual acuity. Methods Twenty-six patients (52 eyes) with MacTel 2 and 20 age-matched controls (40 eyes) were included. Fundus examinations, including fundus autofluorescence, swept-source optical coherence tomography, and OCTA, were performed. Differences in the vascular density in the fovea and parafovea, the area of the foveal avascular zone, and the diameter of the ellipsoid zone defect of the two groups were analyzed. Results The foveal vascular density of the superficial capillary plexus was significantly lower in the MacTel 2 group than in the control group (p = 0.027). The vascular density in the entire deep capillary plexus was also significantly less in the MacTel 2 group than in the control group (all p < 0.05). The mean diameter of ellipsoid-zone disruption on OCT in the MacTel 2 group was 634.6 +/- 104.3 mu m. The foveal avascular zone areas of the superficial and deep capillary plexuses were significantly enlarged in the MacTel 2 group compared to those in the control group (0.45 +/- 0.12 mm(2) vs. 0.27 +/- 0.08 mm(2), p < 0.001; 0.56 +/- 0.15 mm(2) vs. 0.40 +/- 0.14 mm(2), p = 0.001). In addition, the enlarged foveal avascular zone of the superficial and deep plexus was negatively correlated with best corrected visual acuity (logMAR) in MacTel 2 patients (p = 0.013, r = -0.642 and p = 0.042, and r = -0.511, respectively). Conclusions Retinal vascular density changes occur in the superficial fovea and in the entire deep capillary plexus of patients with MacTel 2. The enlarged foveal avascular zone areas of the superficial and deep plexuses were prominent in the MacTel 2 group, and this enlargement correlates with worsened visual acuity.	[Park, Young Gun] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Park, Young-Hoon] Catholic Univ Korea, Catholic Inst Visual Sci, Collage Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, YH (corresponding author), Catholic Univ Korea, Catholic Inst Visual Sci, Collage Med, Seoul, South Korea.	parkyh@catholic.ac.kr			Catholic University of Korea, Research foundation 2019	Catholic University of Korea, Research foundation 2019	This work was supported by the Catholic University of Korea, Research foundation 2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Chidambara L, 2016, BRIT J OPHTHALMOL, V100, P1482, DOI 10.1136/bjophthalmol-2015-307941; Cohen SM, 2007, RETINA-J RET VIT DIS, V27, P59, DOI 10.1097/01.iae.0000256663.94734.e1; Coscas G, 2013, EUR J OPHTHALMOL, V23, P917, DOI 10.5301/ejo.5000363; GASS JD, 1982, ARCH OPHTHALMOL-CHIC, V100, P769; GASS JDM, 1993, OPHTHALMOLOGY, V100, P1536; Heeren TFC, 2018, RETINA-J RET VIT DIS, V38, pS20, DOI 10.1097/IAE.0000000000001715; Heeren TFC, 2015, INVEST OPHTH VIS SCI, V56, P3905, DOI 10.1167/iovs.15-16915; Issa PC, 2013, PROG RETIN EYE RES, V34, P49, DOI 10.1016/j.preteyeres.2012.11.002; Maruko I, 2008, BRIT J OPHTHALMOL, V92, P1488, DOI 10.1136/bjo.2007.131409; Narayanan R, 2013, GRAEF ARCH CLIN EXP, V251, P1311, DOI 10.1007/s00417-012-2191-5; Ooto S, 2013, AM J OPHTHALMOL, V155, P1045, DOI 10.1016/j.ajo.2013.01.006; Paunescu LA, 2006, OPHTHALMOLOGY, V113, P48, DOI 10.1016/j.ophtha.2005.08.016; Peto T, 2018, RETINA-J RET VIT DIS, V38, pS8, DOI 10.1097/IAE.0000000000001697; Powner MB, 2013, OPHTHALMOLOGY, V120, P2344, DOI 10.1016/j.ophtha.2013.04.013; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P7889, DOI 10.1167/iovs.12-10765; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P66, DOI 10.1001/jamaophthalmol.2014.3950; Thorell MR, 2014, OSLI RETINA, V45, P369, DOI 10.3928/23258160-20140909-06; Toto L, 2016, INVEST OPHTH VIS SCI, V57, pOCT268, DOI 10.1167/iovs.15-18872; Unterlauft JD, 2012, NEUROCHEM RES, V37, P1524, DOI 10.1007/s11064-012-0747-8; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Wu L, 2015, INDIAN J OPHTHALMOL, V63, P394, DOI 10.4103/0301-4738.159864; Wu L, 2013, SURV OPHTHALMOL, V58, P536, DOI 10.1016/j.survophthal.2012.11.007; Yannuzzi LA, 2006, ARCH OPHTHALMOL-CHIC, V124, P450, DOI 10.1001/archopht.124.4.450; Zeimer M, 2015, RETINA-J RET VIT DIS, V35, P2307, DOI 10.1097/IAE.0000000000000868; Zheng F, 2018, OSLI RETINA, V49, P303, DOI 10.3928/23258160-20180501-03; Zhu MD, 2013, RETINA-J RET VIT DIS, V33, P1547, DOI 10.1097/IAE.0b013e318285cb9c	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232255	10.1371/journal.pone.0232255	http://dx.doi.org/10.1371/journal.pone.0232255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348375	Green Published, gold			2022-12-26	WOS:000536668200050
J	Hoppe, MW; Barnics, V; Freiwald, J; Baumgart, C				Hoppe, Matthias W.; Barnics, Vadim; Freiwald, Juergen; Baumgart, Christian			Contrary to endurance, power associated capacities differ between different aged and starting-nonstarting elite junior soccer players	PLOS ONE			English	Article							MATCH RUNNING PERFORMANCE; SPRINT PERFORMANCE; 1ST TEAM; FOOTBALL; STRENGTH; RELIABILITY; PARAMETERS; SPEED; PHYSIOLOGY; MATURITY	This study aimed to investigate differences in anthropometric characteristics and physical capacities (1) between under (U) 17, 19, and 21 years old elite junior soccer players, and also (2) between starting and nonstarting players within each age group. Ninety-two male elite German junior field players were tested for height, mass, fat, and fat-free mass as well as aerobic endurance, squat (SJ) and counter movement jump (CMJ), linear sprint, core strength-endurance, and one repetition maximum (1RM) bench press performance. According to their age and competitive match playing times, the players were divided into the mentioned different groups. Magnitude-based inferences and effect sizes (ES) were computed for statistical analyses. The fat-free mass, SJ and CMJ, 1RM bench press, and linear sprinting performances increased likely to most likely from U17 to U21 players (ES: moderate to large), whereas the body fat, core strength-endurance, and aerobic endurance performances remain constant. The fat-free mass, 1RM bench press, and linear sprinting performances were likely to most likely higher in U21 starting compared to nonstarting players (ES: moderate to large). Our study shows that contrary to endurance, power associated capacities differ between different aged and starting-nonstarting elite junior soccer players. This outcome should be considered for training, testing, and talent selection procedures in elite junior soccer players.	[Hoppe, Matthias W.] Univ Leipzig, Inst Movement & Training Sci 1, Leipzig, Germany; [Barnics, Vadim; Freiwald, Juergen; Baumgart, Christian] Univ Wuppertal, Dept Movement & Training Sci, Wuppertal, Germany	Leipzig University; University of Wuppertal	Hoppe, MW (corresponding author), Univ Leipzig, Inst Movement & Training Sci 1, Leipzig, Germany.	matthias.hoppe@uni-leipzig.de	Hoppe, Matthias W./AAT-1168-2021		German Research Foundation (DFG); University of Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig	The publication fees were funded by the German Research Foundation (DFG) and University of Leipzig within the Program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2016, INT J SPORT PHYSIOL, V11, P1038, DOI 10.1123/ijspp.2015-0672; Bangsbo J, 2014, INDIVIDUAL TRAINING; Barnes C, 2014, INT J SPORTS MED, V35, P1095, DOI 10.1055/s-0034-1375695; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Baumgart C, 2018, SPORTS, V6, DOI 10.3390/sports6040161; Bidaurrazaga-Letona I, 2019, J STRENGTH COND RES, V33, P2548, DOI 10.1519/JSC.0000000000001924; Bradley PS, 2018, INT J SPORT PHYSIOL, V13, P656, DOI 10.1123/ijspp.2017-0433; Buchheit M, 2010, INT J SPORTS MED, V31, P818, DOI 10.1055/s-0030-1262838; Buchheit M, 2010, INT J SPORTS MED, V31, P709, DOI 10.1055/s-0030-1261897; Buchheit M, 2017, ASPETAR SPORTS MED J, V6, P36; Buchheit M, 2014, J SPORT SCI, V32, P1271, DOI 10.1080/02640414.2014.884721; Rebelo ANC, 2016, J SPORT SCI, V34, P2246, DOI 10.1080/02640414.2016.1194527; Canhadas Ive Luz, 2010, Rev. bras. cineantropom. desempenho hum., V12, P239, DOI 10.5007/1980-0037.2010V12N4P239; Cardoso de Araujo M, 2018, J SPORT MED PHYS FIT, V58, P1204, DOI 10.23736/S0022-4707.17.07116-X; Castillo D, 2018, J SPORT MED PHYS FIT, V58, P392, DOI 10.23736/S0022-4707.16.06436-7; Deprez D, 2015, J SPORT SCI, V33, P243, DOI 10.1080/02640414.2014.934707; Da Silva CD, 2008, J SPORT SCI MED, V7, P309; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Gravina L, 2008, J STRENGTH COND RES, V22, P1308, DOI 10.1519/JSC.0b013e31816a5c8e; Haugen T, 2015, SPORT SCI, V19, P10; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; Haugen TA, 2013, INT J SPORT PHYSIOL, V8, P148, DOI 10.1123/ijspp.8.2.148; Herrera E, 2015, REV INT MED CIENS AC, V15, P1; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hoppe MW, 2015, SPORTVERLETZ SPORTSC, V29, P173, DOI 10.1055/s-0034-1399096; Hoppe MW, 2015, J SPORT MED PHYS FIT, V55, P150; Hoppe MW, 2013, J STRENGTH COND RES, V27, P31, DOI 10.1519/JSC.0b013e31824e1711; Hoppe MW, 2017, ASIAN J SPORTS MED, V8, P1; Kenney W. L., 2015, PHYSL SPORT EXERCISE, V6th; Linthorne NP, 2001, AM J PHYS, V69, P1198, DOI 10.1119/1.1397460; Mallo J., 2014, PERIODIZATION FITNES; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; Martinez-Santos R, 2016, J SPORT SCI, V34, P2279, DOI 10.1080/02640414.2016.1190460; Mendez-Villanueva A, 2011, J SPORT SCI, V29, P477, DOI 10.1080/02640414.2010.536248; Milsom J, 2015, J SPORT SCI, V33, P1799, DOI 10.1080/02640414.2015.1012101; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Morgans R, 2018, INT J SPORT PHYSIOL, V13, P665, DOI 10.1123/ijspp.2016-0412; Nesser TW, 2008, J STRENGTH COND RES, V22, P1750, DOI 10.1519/JSC.0b013e3181874564; Owen AL, 2012, J STRENGTH COND RES, V26, P2748, DOI 10.1519/JSC.0b013e318242d2d1; Vieira LHP, 2019, SPORTS MED, V49, P289, DOI 10.1007/s40279-018-01048-8; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Roth R, 2016, J APPL BIOMECH, V32, P241, DOI 10.1123/jab.2014-0303; Sannicandro I, 2015, MED SPORT, V68, P19; Schubert MM, 2019, CLIN PHYSIOL FUNCT I, V39, P150, DOI 10.1111/cpf.12550; Selmi MA, 2020, J STRENGTH COND RES, V34, P506, DOI 10.1519/JSC.0000000000002810; Seo DI, 2012, J SPORT SCI MED, V11, P221; Silva JR, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0006-z; Sporis G, 2011, J SPORT MED PHYS FIT, V51, P374; Stolen T, 2005, SPORTS MED, V35, P501; Thomann R, 2014, FUSSBALL FORSCHUNG L, P99; Tonnessen E, 2013, INT J SPORT PHYSIOL, V8, P323, DOI 10.1123/ijspp.8.3.323; Vaeyens R, 2005, J SPORT SCI, V23, P1003, DOI 10.1080/02640410400023266; [No title captured]	54	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232118	10.1371/journal.pone.0232118	http://dx.doi.org/10.1371/journal.pone.0232118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343716	Green Published, gold			2022-12-26	WOS:000536661300035
J	Lozada, DN; Ward, BP; Carter, AH				Lozada, Dennis N.; Ward, Brian P.; Carter, Arron H.			Gains through selection for grain yield in a winter wheat breeding program	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; GENOMIC SELECTION; REGISTRATION; ACCURACY; ASSOCIATION; QTL	Increased genetic gain for complex traits in plant breeding programs can be achieved through different selection strategies. The objective of this study was to compare potential gains for grain yield in a winter wheat breeding program through estimating response to selection R values across several selection approaches including phenotypic (PS), marker-based (MS), genomic (GS), and a combination of PS and GS (PS+GS). Ten populations of Washington State University (WSU) winter wheat breeding lines including a diversity panel and F5 and double haploid lines evaluated from 2015 to 2019 growing seasons for grain yield in Lind and Pullman, WA, USA were used in the study. Selection was conducted by selecting the top 20% of lines based on observed yield (PS strategy), genomic estimated breeding values (GS), presence of yield "enhancing" alleles of the most significant single nucleotide polymorphism (SNP) markers identified from genome-wide association mapping (MS), and high observed yield and estimated breeding values (PS+GS). Overall, PS compared to other individual selection strategies (MS and GS) showed the highest mean response (R = 0.61) within the same environment. When combined with GS, a 23% improvement in R for yield was observed, indicating that gains could be improved by complementing traditional PS with GS within the same environment. Validating selection strategies in different environments resulted in low to negative R values indicating the effects of genotype-by-environment interactions for grain yield. MS was not successful in terms of R relative to the other selection approaches; using this strategy resulted in a significant (P < 0.05) decrease in response to selection compared with the other approaches. An integrated PS+GS approach could result in optimal genetic gain within the same environment, whereas a PS strategy might be a viable option for grain yield validated in different environments. Altogether, we demonstrated that gains through increased response to selection for yield could be achieved in the WSU winter wheat breeding program by implementing different selection strategies either exclusively or in combination.	[Lozada, Dennis N.; Carter, Arron H.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Ward, Brian P.] USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA	Washington State University; United States Department of Agriculture (USDA)	Lozada, DN (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	den.lozada@wsu.edu		Ward, Brian/0000-0002-4129-7934	Washington State University [1014919]; US Department of Agriculture National Institute of Food and Agriculture [2016-6800424770]	Washington State University; US Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	AHC-Washington State University Hatch Project 1014919 (http://fs.cahnrs.wsu.edu/home/research-and-grant-unit/grant-preparation/hatchmulti-state/) and US Department of Agriculture National Institute of Food and Agriculture (https://nifa.usda.gov/grants) award number 2016-6800424770. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN RE, 1989, CROP SCI, V29, P1575, DOI 10.2135/cropsci1989.0011183X002900060068x; Anderson JA, 2007, CROP SCI, V47, pS112, DOI 10.2135/cropsci2007.04.0006IPBS; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Arruda MP, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0508-5; Belamkar V, 2018, G3-GENES GENOM GENET, V8, P2735, DOI 10.1534/g3.118.200415; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo R, 2014, CROP SCI, V54, P68, DOI 10.2135/cropsci2013.05.0315; Bhatta M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103011; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Carter AH, 2017, J PLANT REGIST, V11, P263, DOI 10.3198/jpr2016.09.0051crc; Carter AH, 2014, J PLANT REGIST, V8, P273, DOI 10.3198/jpr2013.12.0074crc; Carter AH, 2013, J PLANT REGIST, V7, P195, DOI 10.3198/jpr2012.07.0013crc; Cericola F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169606; Chen CPJ, 2018, BIOINFORMATICS, V34, P1925, DOI 10.1093/bioinformatics/bty015; Cobb JN, 2019, THEOR APPL GENET, V132, P627, DOI 10.1007/s00122-019-03317-0; Crain J, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.05.0043; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D. S., 1989, Introduction to quantitative genetics.; Galiano-Carneiro AL, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-018-2327-8; Garcia M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211730; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Green AJ, 2012, CROP SCI, V52, P2097, DOI 10.2135/cropsci2012.01.0026; Gupta PK, 2010, MOL BREEDING, V26, P145, DOI 10.1007/s11032-009-9359-7; Herter CP, 2019, THEOR APPL GENET, V132, P2425, DOI 10.1007/s00122-019-03364-7; Hickey JM, 2017, NAT GENET, V49, P1297, DOI 10.1038/ng.3920; Hickey LT, 2019, NAT BIOTECHNOL, V37, P744, DOI 10.1038/s41587-019-0152-9; Hospital F, 2009, GENETICA, V136, P303, DOI 10.1007/s10709-008-9307-1; Huang M, 2018, CROP SCI, V58, P2274, DOI 10.2135/cropsci2017.10.0638; Institute SAS, 2015, SAS SYST OPT REF; Jafarzadeh J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162860; Jamil M, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1754-6; Jones SS, 2010, J PLANT REGIST, V4, P137, DOI 10.3198/jpr2009.06.0306crc; Jones SS, 2001, CROP SCI, V41, P2006, DOI 10.2135/cropsci2001.2006; Larkin DL, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9090479; Li FJ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1781-3; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HH, 2018, TRENDS PLANT SCI, V23, P184, DOI 10.1016/j.tplants.2018.01.007; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005767; Lorenz AJ, 2013, G3-GENES GENOM GENET, V3, P481, DOI 10.1534/g3.112.004911; Lozada D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01337; Lozada DN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010165; Lozada DN, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0785-1; Lozada DN, 2018, CROP SCI, V58, P1964, DOI 10.2135/cropsci2018.04.0232; Michel S, 2018, THEOR APPL GENET, V131, P477, DOI 10.1007/s00122-017-2998-x; Miedaner T, 2009, EUPHYTICA, V166, P219, DOI 10.1007/s10681-008-9832-0; Money D, 2015, G3-GENES GENOM GENET, V5, P2383, DOI 10.1534/g3.115.021667; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; PETERSON CJ, 1991, CROP SCI, V31, P1704, DOI DOI 10.2135/CR0PSCI1991.0011183X003100060075X; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez F, 2018, ACBD R AUGMENTED COM ACBD R AUGMENTED COM; Rutkoski J, 2015, PLANT GENOME-US, V8, DOI [10.3835/plantgenome2014.09.0046, 10.3835/plantgenome2014.10.0074]; Rutkoski JE, 2019, PRACTICAL GUIDE GENE, P217, DOI [10.1016/bs.agron.2019.05.001, DOI 10.1016/BS.AGRON.2019.05.001]; Rutkoski J, 2016, G3-GENES GENOM GENET, V6, P2799, DOI 10.1534/g3.116.032888; Santos Aladir Horacio, 2002, Sci. agric. (Piracicaba, Braz.), V59, P483, DOI 10.1590/S0103-90162002000300012; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Sun J, 2019, THEOR APPL GENET, V132, P1705, DOI 10.1007/s00122-019-03309-0; Venske E, 2019, HEREDITAS, V156, DOI 10.1186/s41065-019-0093-9; Vivek BS, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.07.0070; Ward BP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208217; Wilde F, 2007, MOL BREEDING, V19, P357, DOI 10.1007/s11032-006-9067-5; Zemetra RS, 1998, CROP SCI, V38, P1404, DOI 10.2135/cropsci1998.0011183X003800050056x; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	69	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0221603	10.1371/journal.pone.0221603	http://dx.doi.org/10.1371/journal.pone.0221603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343696	Green Published, gold, Green Submitted			2022-12-26	WOS:000536661300001
J	Wu, WW; Sung, CC; Yu, PC; Li, JH; Chung, KKK				Wu, Weiwei; Sung, Chun Chau; Yu, Peichun; Li, Jiahua; Chung, Kenny K. K.			S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MEDIATED PHOSPHORYLATION; UP-REGULATION; SERINE 129; NEURODEGENERATION; SER129; OLIGOMERIZATION; INCLUSIONS; NITRATION; INSIGHTS	Parkinson's disease (PD) is a common neurodegenerative disorder which is mostly sporadic but familial-linked PD (FPD) cases have also been found. The first reported gene mutation that linked to PD is alpha-synuclein (alpha-syn). Studies have shown that mutations, increased expression or abnormal processing of alpha-syn can contribute to PD, but it is believed that multiple mechanisms are involved. One of the contributing factors is post-translational modification (PTM), such as phosphorylation of alpha-syn at serine 129 by G-protein-coupled receptor kinases (GRKs) and casein kinase 2 alpha (CK2 alpha). Another known important contributing factor to PD pathogenesis is oxidative and nitrosative stress. In this study, we found that GRK6 and CK2 alpha can be S-nitrosylated by nitric oxide (NO) both in vitro and in vivo. S-nitrosylation of GRK6 and CK2 alpha enhanced their kinase activity towards the phosphorylation of alpha-syn at S129. In an A53T alpha-syn transgenic mouse model of PD, we found that increased GRK6 and CK2 alpha S-nitrosylation were observed in an age dependent manner and it was associated with an increased level of pSer129 alpha-syn. Treatment of A53T alpha-syn transgenic mice with N.-Nitro-L-arginine (L-NNA) significantly reduced the S-nitrosylation of GRK6 and CK2 alpha in the brain. Finally, deletion of neuronal nitric oxide synthase (nNOS) in A53T alpha-syn transgenic mice reduced the levels of pSer129 alpha-syn and alpha-syn in an age dependent manner. Our results provide a novel mechanism of how NO through S-nitrosylation of GRK6 and CK2 alpha can enhance the phosphorylation of pSer129 alpha-syn in an animal model of PD.	[Wu, Weiwei; Sung, Chun Chau; Yu, Peichun; Li, Jiahua; Chung, Kenny K. K.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Chung, KKK (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Hong Kong, Peoples R China.	bckchung@ust.hk		Sung, Chun Chau/0000-0002-6980-0431	Hong Kong Research Grants Council [DAG12SC03S, ITCPD/17-9, GRF16100214]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	KKC received supported from the Hong Kong Research Grants Council DAG12SC03S, ITCPD/17-9, and GRF16100214. No, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arimoto T, 2003, NEUROBIOL DIS, V12, P35, DOI 10.1016/S0969-9961(02)00017-7; Bellou V, 2016, PARKINSONISM RELAT D, V23, P1, DOI 10.1016/j.parkreldis.2015.12.008; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Chung KKK, 2010, NITRIC OXIDE-BIOL CH, V22, P290, DOI 10.1016/j.niox.2010.02.002; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Dzamko N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00057; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hara S, 2013, MOL BIOL CELL, V24, P1649, DOI 10.1091/mbc.E12-12-0903; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kalia LV, 2015, CURR OPIN NEUROL, V28, P375, DOI 10.1097/WCO.0000000000000215; KIM HS, 1995, J PHARMACOL EXP THER, V275, P551; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Liberatore GT, 1999, NAT MED, V5, P1403; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Nakamura T, 2015, NEUROBIOL DIS, V84, P99, DOI 10.1016/j.nbd.2015.03.017; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Tagliafierro L, 2016, NEUROGENETICS, V17, P145, DOI 10.1007/s10048-016-0478-0; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x; Xie WL, 2010, BBA-MOL BASIS DIS, V1802, P935, DOI 10.1016/j.bbadis.2010.07.014; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zhang P, 2010, J NEUROSCI, V30, P14366, DOI 10.1523/JNEUROSCI.3899-10.2010	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232019	10.1371/journal.pone.0232019	http://dx.doi.org/10.1371/journal.pone.0232019			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343709	gold, Green Published			2022-12-26	WOS:000536661300027
J	van den Bos, E; Ambrosy, B; Horsthemke, M; Walbaum, S; Bachg, AC; Wettschureck, N; Innamorati, G; Wilkie, TM; Hanley, PJ				van den Bos, Esther; Ambrosy, Benjamin; Horsthemke, Markus; Walbaum, Stefan; Bachg, Anne C.; Wettschureck, Nina; Innamorati, Giulio; Wilkie, Thomas M.; Hanley, Peter J.			Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor?mediated chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; cell motility; chemotaxis; complement system; G protein-coupled receptor (GPCR); G protein; gene knockout; complement C5a; immune system; macrophage	MACROPHAGE-MIGRATION; BLOOD-PRESSURE; CELL; INHIBITION; MOTILITY; RELEASE; G-ALPHA(I2); DEFECTS; P2Y(2)	G protein?coupled receptor signaling is required for the navigation of immune cells along chemoattractant gradients. However, chemoattractant receptors may couple to more than one type of heterotrimeric G protein, each of which consists of a G?, G?, and G? subunit, making it difficult to delineate the critical signaling pathways. Here, we used knockout mouse models and time-lapse microscopy to elucidate G? and G? subunits contributing to complement C5a receptor-mediated chemotaxis. Complement C5a-mediated chemokinesis and chemotaxis were almost completely abolished in macrophages lacking Gnai2 (encoding G?(i2)), consistent with a reduced leukocyte recruitment previously observed in Gnai2(?/?) mice, whereas cells lacking Gnai3 (G?(i3)) exhibited only a slight decrease in cell velocity. Surprisingly, C5a-induced Ca2+ transients and lamellipodial membrane spreading were persistent in Gnai2(?/?) macrophages. Macrophages lacking both Gnaq (G?(q)) and Gna11 (G?(11)) or both Gna12 (G?(12)) and Gna13 (G?(13)) had essentially normal chemotaxis, Ca2+ signaling, and cell spreading, except Gna12/Gna13-deficient macrophages had increased cell velocity and elongated trailing ends. Moreover, Gnaq/Gna11-deficient cells did not respond to purinergic receptor P2Y(2) stimulation. Genetic deletion of Gna15 (G?(15)) virtually abolished C5a-induced Ca2+ transients, but chemotaxis and cell spreading were preserved. Homozygous Gnb1 (G?(1)) deletion was lethal, but mice lacking Gnb2 (G?(2)) were viable. Gnb2(?/?) macrophages exhibited robust Ca2+ transients and cell spreading, albeit decreased cell velocity and impaired chemotaxis. In summary, complement C5a-mediated chemotaxis requires G?(i2) and G?(2), but not Ca2+ signaling, and membrane protrusive activity is promoted by G proteins that deplete phosphatidylinositol 4,5-bisphosphate.	[van den Bos, Esther; Ambrosy, Benjamin; Horsthemke, Markus; Walbaum, Stefan; Bachg, Anne C.; Hanley, Peter J.] Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, Munster, Germany; [Wettschureck, Nina] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Innamorati, Giulio] Univ Verona, Dept Surg Sci Dent Gynecol & Pediat, Verona, Italy; [Wilkie, Thomas M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, Dallas, TX 75390 USA	University of Munster; Max Planck Society; University of Verona; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hanley, PJ (corresponding author), Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, Munster, Germany.	hanley@uni-muenster.de	Innamorati, Giulio/AAR-6314-2020; Innamorati, Giulio/GVU-1941-2022	Innamorati, Giulio/0000-0003-0123-8777; 	Deutsche Forschungsgemeinschaft (DFG) [HA 3271/3-2]; NCI, National Institutes of Health [CA192381]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant HA 3271/3-2 (to P. J. H.). T. M. W. is supported by NCI, National Institutes of Health, Grant CA192381. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Artemenko Y, 2014, CELL MOL LIFE SCI, V71, P3711, DOI 10.1007/s00018-014-1638-8; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Bzymek R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25016; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins SR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156027; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; Davignon I, 2000, MOL CELL BIOL, V20, P797, DOI 10.1128/MCB.20.3.797-804.2000; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Grimm M, 2016, ARTERIOSCL THROM VAS, V36, P37, DOI 10.1161/ATVBAHA.115.306066; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Horsthemke M, 2018, JOVE-J VIS EXP, DOI 10.3791/57566; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Hwang JI, 2004, P NATL ACAD SCI USA, V101, P488, DOI 10.1073/pnas.0307549100; Hwang JI, 2005, P NATL ACAD SCI USA, V102, P9493, DOI 10.1073/pnas.0503503102; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Jiang MS, 2002, METHOD ENZYMOL, V344, P277; Kehrl JH, 2016, BIOCHEM PHARMACOL, V114, P40, DOI 10.1016/j.bcp.2016.04.005; Konigs V, 2014, J BIOL CHEM, V289, P30772, DOI 10.1074/jbc.M114.563270; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Kuang YN, 1996, J BIOL CHEM, V271, P3975; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Leber T., 1888, FORTSCHR MED, V6, P460; Li XX, 2019, J IMMUNOL, V202, P3339, DOI 10.4049/jimmunol.1900371; Li XG, 2018, P NATL ACAD SCI USA, V115, pE9125, DOI 10.1073/pnas.1809039115; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Meade B D, 1985, Dev Biol Stand, V61, P63; MEADE BD, 1984, INFECT IMMUN, V45, P718, DOI 10.1128/IAI.45.3.718-725.1984; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; van den Bos E, 2020, JOVE-J VIS EXP, DOI 10.3791/60750; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Wang SP, 2015, J CLIN INVEST, V125, P3077, DOI 10.1172/JCI81067; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wiege K, 2012, J IMMUNOL, V189, P980, DOI 10.4049/jimmunol.1200891; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565; Zengel P, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-21	47	6	6	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7726	7742		10.1074/jbc.RA119.011984	http://dx.doi.org/10.1074/jbc.RA119.011984			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32332099	hybrid, Green Published			2022-12-26	WOS:000538038900013
J	Banach, AM; Kuzniar, A; Grzadziel, J; Wolinska, A				Banach, Artur M.; Kuzniar, Agnieszka; Grzadziel, Jaroslaw; Wolinska, Agnieszka			Azolla filiculoides L. as a source of metal-tolerant microorganisms	PLOS ONE			English	Article							PLANT-GROWTH PROMOTION; BACTERIAL COMMUNITIES; HEAVY-METALS; WASTE-WATER; MICROBIAL-COMMUNITY; BIOREMEDIATION; PHYTOREMEDIATION; CONTAMINATION; RHIZOSPHERE; TOXICITY	The metal hyperaccumulator Azolla filiculoides is accompanied by a microbiome potentially supporting plant during exposition to heavy metals. We hypothesized that the microbiome exposition to selected heavy metals will reveal metal tolerant strains. We used Next Generation Sequencing technique to identify possible metal tolerant strains isolated from the metaltreated plant (Pb, Cd, Cr(VI), Ni, Au, Ag). The main dominants were Cyanobacteria and Proteobacteria constituting together more than 97% of all reads. Metal treatment led to changes in the composition of the microbiome and showed significantly higher richness in the Pb-, Cd- and Cr-treated plant in comparison with other (95-105 versus 36-44). In these treatments the share of subdominant Actinobacteria (0.4-0.8%), Firmicutes (0.5-0.9%) and Bacteroidetes (0.2-0.9%) were higher than in non-treated plant (respectively: 0.02, 0.2 and 0.001%) and Ni-, Au- and Ag-treatments (respectively: < 0.4%, < 0.2% and up to 0.2%). The exception was Au-treatment displaying the abundance 1.86% of Bacteroidetes. In addition, possible metal tolerant genera, namely: Acinetobacter, Asticcacaulis, Anabaena, Bacillus, Brevundimonas, Burkholderia, Dyella, Methyloversatilis, Rhizobium and Staphylococcus, which form the core microbiome, were recognized by combining their abundance in all samples with literature data. Additionally, the presence of known metal tolerant genera was confirmed: Mucilaginibacter, Pseudomonas, Mycobacterium, Corynebacterium, Stenotrophomonas, Clostridium, Micrococcus, Achromobacter, Geobacter, Flavobacterium, Arthrobacter and Delftia. We have evidenced that A. filiculoides possess a microbiome whose representatives belong to metal-resistant species which makes the fern the source of biotechnologically useful microorganisms for remediation processes.	[Banach, Artur M.; Kuzniar, Agnieszka; Wolinska, Agnieszka] John Paul II Catholic Univ Lublin, Dept Biol & Biotechnol Microorganisms, Lublin, Poland; [Grzadziel, Jaroslaw] INCBR Ctr, Inst Soil Sci & Plant Cultivat, State Res Inst, Dept Agr Microbiol, Pulawy, Poland	Catholic University of Lublin; Institute of Soil Science & Plant Cultivation	Banach, AM (corresponding author), John Paul II Catholic Univ Lublin, Dept Biol & Biotechnol Microorganisms, Lublin, Poland.	abanach@kul.pl	Grządziel, Jarosław/J-4610-2019; Kuźniar, Agnieszka/ABC-5316-2021; Grządziel, Jarosław JG/K-2784-2017; Banach, Artur/G-9748-2012	Grządziel, Jarosław/0000-0003-3028-1256; Grządziel, Jarosław JG/0000-0003-3028-1256; Banach, Artur/0000-0002-3166-9669; Kuzniar, Agnieszka/0000-0001-6767-370X; Wolinska, Agnieszka/0000-0001-5734-7169				Adekanmbi AO, 2019, J TAIBAH UNIV SCI, V13, P266, DOI 10.1080/16583655.2018.1561968; Ali B, 2014, ECOTOX ENVIRON SAFE, V102, P25, DOI 10.1016/j.ecoenv.2014.01.013; Ali B, 2014, BIOL PLANTARUM, V58, P131, DOI 10.1007/s10535-013-0358-5; Alquethamy SF, 2020, ACS INFECT DIS, V6, P150, DOI 10.1021/acsinfecdis.9b00351; [Anonymous], 2013, R PACKAGE VERSION 2; Antunes APM, 2001, BIOTECHNOL LETT, V23, P249, DOI 10.1023/A:1005633608727; Arora Anju, 2004, Indian Journal of Plant Physiology, V9, P302; BABICH H, 1983, ADV APPL MICROBIOL, V29, P195, DOI 10.1016/S0065-2164(08)70358-7; Babu AG, 2013, J HAZARD MATER, V250, P477, DOI 10.1016/j.jhazmat.2013.02.014; Banach A.M., 2012, ACTA AGROPHYS, V19, P241; Banach A, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9102143; Benaroya RO, 2004, PLANT PHYSIOL BIOCH, V42, P639, DOI 10.1016/j.plaphy.2004.03.010; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bhat SA, 2020, CHEMOSPHERE, V241, DOI 10.1016/j.chemosphere.2019.125035; Biswas JK, 2018, BIODEGRADATION, V29, P323, DOI 10.1007/s10532-018-9835-z; Brovedan M., 2019, BIORXIV710913, DOI [10.1101/710913, DOI 10.1101/710913]; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Burat F, 2020, J MATER CYCLES WASTE, V22, P907, DOI 10.1007/s10163-020-00982-y; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cardoso P, 2018, ECOTOX ENVIRON SAFE, V150, P260, DOI 10.1016/j.ecoenv.2017.12.002; Dijkhuizen LW, 2018, NEW PHYTOL, V217, P453, DOI 10.1111/nph.14843; Dixit R, 2015, SUSTAINABILITY-BASEL, V7, P2189, DOI 10.3390/su7022189; El-Sheekh MM, 2005, ENVIRON TOXICOL PHAR, V19, P357, DOI 10.1016/j.etap.2004.09.005; Elmachliy S, 2011, WATER AIR SOIL POLL, V218, P365, DOI 10.1007/s11270-010-0650-3; Fernandes VC, 2009, BIODEGRADATION, V20, P375, DOI 10.1007/s10532-008-9228-9; Figueira EMDP, 2005, CAN J MICROBIOL, V51, P7, DOI [10.1139/w04-101, 10.1139/W04-101]; Fosso-Kankeu E, 2011, J ENVIRON MANAGE, V92, P2786, DOI 10.1016/j.jenvman.2011.06.025; FRANCIS AJ, 1994, ENVIRON SCI TECHNOL, V28, P636, DOI 10.1021/es00053a016; Gremion F, 2004, FEMS MICROBIOL ECOL, V48, P273, DOI 10.1016/j.femsec.2004.02.004; Guo HJ, 2010, BIORESOURCE TECHNOL, V101, P8599, DOI 10.1016/j.biortech.2010.06.085; Gupta S, 2015, INT J PHARM PHARM SC, V7, P9; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; He W, 2020, CRIT REV BIOTECHNOL, V40, P31, DOI 10.1080/07388551.2019.1675582; Helal M., 2016, AM J MICROBIOLOGICAL, V4, P26, DOI DOI 10.12691/AJMR-4-1-3; Pham HN, 2018, APPL SOIL ECOL, V125, P240, DOI 10.1016/j.apsoil.2018.01.004; Huang XW, 2018, J RADIOANAL NUCL CH, V317, P739, DOI 10.1007/s10967-018-5934-x; Idris R, 2004, APPL ENVIRON MICROB, V70, P2667, DOI 10.1128/AEM.70.5.2667-2677.2004; Khanna K, 2019, PLANT SOIL, V436, P325, DOI 10.1007/s11104-019-03932-2; Kuzniar A, 2020, SYST APPL MICROBIOL, V43, DOI 10.1016/j.syapm.2019.126025; Lee TK, 2010, APPL MICROBIOL BIOT, V87, P2335, DOI 10.1007/s00253-010-2680-6; Li DF, 2016, GCB BIOENERGY, V8, P183, DOI 10.1111/gcbb.12252; Li YP, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120573; Liu X., 2019, EFFECT ENTREPRENEURI, V10, P1, DOI DOI 10.1038/s41467-018-07882-8; Luo JP, 2017, APPL MICROBIOL BIOT, V101, P7961, DOI 10.1007/s00253-017-8469-0; Manna A, 2019, GOVERNANCE-LED CORPORATE PERFORMANCE: THEORY AND PRACTICE, P69, DOI 10.1108/978-1-78973-847-620191006; Mateos LM, 2006, INT MICROBIOL, V9, P207; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mihdhir A. A., 2016, Journal of Microbial and Biochemical Technology, V8, P226; Mindlin S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3970831; Mondal M, 2019, CHEMOSPHERE, V232, P439, DOI 10.1016/j.chemosphere.2019.05.156; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Oyewole OA, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1015-1; Qu YY, 2016, ENVIRON SCI POLLUT R, V23, P2864, DOI 10.1007/s11356-015-5532-1; R Core Team, 2018, R LANG ENV STAT COMP; Rahman Z, 2019, J BASIC MICROB, V59, P477, DOI 10.1002/jobm.201900024; Rajbanshi A, 2008, OUR NATURE, V6, P52, DOI DOI 10.3126/0N.V6I1.1655; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Ramirez V, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01833; Rossmann M, 2017, BRAZILIAN MICROBIOME: CURRENT STATUS AND PERSPECTIVES, P7, DOI 10.1007/978-3-319-59997-7_2; Rout ME, 2014, ADV BOT RES, V69, P279, DOI 10.1016/B978-0-12-417163-3.00011-1; Furlan JPR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02151; Santoyo G, 2016, MICROBIOL RES, V183, P92, DOI 10.1016/j.micres.2015.11.008; SELA M, 1990, PHYSIOL PLANTARUM, V79, P547, DOI 10.1111/j.1399-3054.1990.tb02116.x; Selvi A, 2019, FRONT ENV SCI-SWITZ, V7, DOI 10.3389/fenvs.2019.00066; Seneviratne M, 2016, S AFR J BOT, V105, P19, DOI 10.1016/j.sajb.2016.02.206; Sheng XF, 2008, CAN J MICROBIOL, V54, P417, DOI [10.1139/W08-020, 10.1139/w08-020]; Singh N, 2016, ECOTOX ENVIRON SAFE, V125, P25, DOI 10.1016/j.ecoenv.2015.11.020; Siposova N. S., 2017, Nova Biotechnologica et Chimica, V16, P42; Soares JC, 2019, PLANT SOIL, V443, P1, DOI 10.1007/s11104-019-04229-0; Soliman T, 2017, PEERJ, V5, DOI 10.7717/peerj.4178; Song HP, 2008, CHEMOSPHERE, V72, P616, DOI 10.1016/j.chemosphere.2008.02.064; Sood A, 2012, AMBIO, V41, P122, DOI 10.1007/s13280-011-0159-z; Sun LN, 2010, BIORESOURCE TECHNOL, V101, P501, DOI 10.1016/j.biortech.2009.08.011; Surosz W, 2004, ARCH ENVIRON CON TOX, V48, P40, DOI 10.1007/s00244-004-0163-4; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Ugur A, 2003, ARCH MED RES, V34, P130, DOI 10.1016/S0188-4409(03)00006-7; Ulhassan Z, 2019, PLANT PHYSIOL BIOCH, V145, P142, DOI 10.1016/j.plaphy.2019.10.035; Visioli G, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00752; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang X, 2019, METALLOMICS, V11, P1252, DOI 10.1039/c9mt00054b; Watanabe I, 1992, BIOFERTILIZER GERMPL; Wood JL, 2016, AIMS BIOENG, V3, P211, DOI 10.3934/bioeng.2016.2.211; Yasmin H., 2019, FIELD CROPS SUSTAINA, P279, DOI DOI 10.1007/978-3-030-30926-8_11; Yu ZS, 2016, ECOTOXICOLOGY, V25, P1759, DOI 10.1007/s10646-016-1719-6; Zadel U, 2020, SCI TOTAL ENVIRON, V711, DOI 10.1016/j.scitotenv.2019.134433; Zazouli MA, 2015, HMJ, V19, P127; Zhang WH, 2012, CHEMOSPHERE, V87, P1171, DOI 10.1016/j.chemosphere.2012.02.036; Zhao LJ, 2010, J HAZARD MATER, V181, P602, DOI 10.1016/j.jhazmat.2010.05.055	89	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232699	10.1371/journal.pone.0232699	http://dx.doi.org/10.1371/journal.pone.0232699			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374760	gold, Green Published			2022-12-26	WOS:000537283500052
J	Lee, KN; Torres, MA; Troeschel, AN; He, J; Gogineni, K; McCullough, LE				Lee, Kyung Na; Torres, Mylin A.; Troeschel, Alyssa N.; He, Jiabei; Gogineni, Keerthi; McCullough, Lauren E.			Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status	PLOS ONE			English	Article							SURVIVAL OUTCOMES; INCIDENT CANCER; MELLITUS; IMPACT; RISK; OBESITY; WOMEN; COHORT; INDEX; COMPLICATIONS	Introduction While type 2 diabetes (T2D) has been associated with increased all-cause mortality among women diagnosed with breast cancer (BC), the association between T2D and breast cancer-specific (BCS) mortality is unresolved. The goal of this study was to examine the association between T2D and BCS mortality and examine the influence of metformin treatment on mortality rates. Methods A retrospective cohort study was conducted between 2002 and 2008 at Emory University Hospitals among non-Hispanic black and white women who had confirmed diagnosis of stage I-III BC and known diabetes status (T2D: n = 73; non-T2D: n = 514). Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Results Compared to non-T2D patients, T2D women had almost a 2-fold increase in BCS mortality after adjusting for covariates (HR = 2.01; 95%CI = 1.02-3.98). Though attenuated, the increased hazard of death was also observed for all-cause mortality (HR = 1.74; 95%CI = 1.06-2.87). T2D patients who were not on metformin had substantially higher hazard of BCS mortality compared to non-diabetic patients (HR = 4.54; 95%CI = 1.98-10.44), whereas the association among T2D patients treated with metformin was weak (HR = 1.20; 95%CI = 0.36-3.97) and included the null. Conclusions Among women with BC, T2D is associated with increased BCS mortality. Metformin treatment for T2D during the initial diagnosis of BC may improve outcomes.	[Lee, Kyung Na; Troeschel, Alyssa N.; McCullough, Lauren E.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Torres, Mylin A.; He, Jiabei] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Torres, Mylin A.; He, Jiabei; Gogineni, Keerthi; McCullough, Lauren E.] Emory Univ, Winship Canc Inst, Glenn Family Breast Ctr, Atlanta, GA 30322 USA; [Gogineni, Keerthi] Emory Univ, Dept Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	McCullough, LE (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.; McCullough, LE (corresponding author), Emory Univ, Winship Canc Inst, Glenn Family Breast Ctr, Atlanta, GA 30322 USA.	lauren.mccullough@emory.edu						Ahmadieh Hala, 2013, ISRN Endocrinol, V2013, P181240, DOI 10.1155/2013/181240; AJCC-American Joint Committee on Cancer, AJCC WHAT IS CANC ST; Aksoy S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0590-z; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bayraktar S, 2012, CANCER-AM CANCER SOC, V118, P1202, DOI 10.1002/cncr.26439; Bronsveld HK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170084; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042; Charlot M, 2017, CANCER CAUSE CONTROL, V28, P61, DOI 10.1007/s10552-016-0837-z; Chen WW, 2012, ONCOLOGIST, V17, P485, DOI 10.1634/theoncologist.2011-0412; Cleveland RJ, 2012, CANCER CAUSE CONTROL, V23, P1193, DOI 10.1007/s10552-012-9989-7; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; de Bruijn KMJ, 2013, BRIT J SURG, V100, P1421, DOI 10.1002/bjs.9229; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Du W, 2005, BREAST CANCER RES TR, V91, P243, DOI 10.1007/s10549-005-0324-9; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Fleming ST, 1999, MED CARE, V37, P601, DOI 10.1097/00005650-199906000-00009; Gegechkori N, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.5_suppl.116; Gillespie EF, 2010, ANN SURG ONCOL, V17, P752, DOI 10.1245/s10434-009-0797-6; Hatoum D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/548436; He X, 2012, ANN ONCOL, V23, P1771, DOI 10.1093/annonc/mdr534; Hou GF, 2013, BREAST CANCER RES TR, V137, P807, DOI 10.1007/s10549-012-2404-y; Jiralerspong S, 2013, ANN ONCOL, V24, P2506, DOI 10.1093/annonc/mdt224; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kiderlen M, 2013, ANN ONCOL, V24, P3011, DOI 10.1093/annonc/mdt367; Kim HJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0574-3; KOHLER BA, 2015, JNCI J NATL CANCER I, V107, DOI DOI 10.1093/JNCI/DJV048; Kowall B, 2015, PHARMACOEPIDEM DR S, V24, P865, DOI 10.1002/pds.3823; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; Liu XD, 2012, CANCER-AM CANCER SOC, V118, P1353, DOI 10.1002/cncr.26420; Luo JH, 2014, BREAST CANCER RES TR, V148, P153, DOI 10.1007/s10549-014-3146-9; Maruthur NM, 2009, J GEN INTERN MED, V24, P665, DOI 10.1007/s11606-009-0939-3; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Nechuta S, 2013, BREAST CANCER RES TR, V139, P227, DOI 10.1007/s10549-013-2521-2; Oppong BA, 2014, CANCER MED-US, V3, P1025, DOI 10.1002/cam4.259; Palmer JR, 2017, CANCER RES, V77, P6462, DOI 10.1158/0008-5472.CAN-17-1903; Peeters PJHL, 2013, CURR DRUG SAF, V8, P357, DOI 10.2174/15680266113136660069; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schott S, 2011, CANCER IMMUNOL IMMUN, V60, P1221, DOI 10.1007/s00262-011-1062-y; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sonnenblick A, 2017, J CLIN ONCOL, V35, P1421, DOI 10.1200/JCO.2016.69.7722; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Tsilidis KK, 2014, DIABETES CARE, V37, P2522, DOI 10.2337/dc14-0584; van de Poll-Franse LV, 2007, INT J CANCER, V120, P1986, DOI 10.1002/ijc.22532; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; Vissers PAJ, 2015, BREAST CANCER RES TR, V150, P427, DOI 10.1007/s10549-015-3331-5; Xiao YT, 2014, TUMOR BIOL, V35, P2035, DOI 10.1007/s13277-013-1270-5; Xu H, 2015, J AM MED INFORM ASSN, V22, P179, DOI 10.1136/amiajnl-2014-002649; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885; Yeh HC, 2012, DIABETES CARE, V35, P113, DOI 10.2337/dc11-0255; Zhang ZJ, 2014, DIABETES OBES METAB, V16, P707, DOI 10.1111/dom.12267; Zhao XB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005602; Zhou YH, 2015, ANZ J SURG, V85, P972, DOI 10.1111/ans.12877	57	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0232581	10.1371/journal.pone.0232581	http://dx.doi.org/10.1371/journal.pone.0232581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369516	Green Published, gold			2022-12-26	WOS:000537280000035
J	Wohlford, EM; Borrell, LN; Elhawary, JR; Plotkin, B; Oh, SS; Nuckton, TJ; Eng, C; Salazar, S; LeNoir, MA; Meade, K; Farber, HJ; Serebrisky, D; Brigino-Buenaventura, E; Rodriguez-Cintron, W; Kumar, R; Thyne, S; Seibold, MA; Rodriguez-Santana, JR; Burchard, EG				Wohlford, Eric M.; Borrell, Luisa N.; Elhawary, Jennifer R.; Plotkin, Brian; Oh, Sam S.; Nuckton, Thomas J.; Eng, Celeste; Salazar, Sandra; LeNoir, Michael A.; Meade, Kelley; Farber, Harold J.; Serebrisky, Denise; Brigino-Buenaventura, Emerita; Rodriguez-Cintron, William; Kumar, Rajesh; Thyne, Shannon; Seibold, Max A.; Rodriguez-Santana, Jose R.; Burchard, Esteban G.			Differential asthma odds following respiratory infection in children from three minority populations	PLOS ONE			English	Article							SYNCYTIAL-VIRUS BRONCHIOLITIS; GALA II; RHINOVIRUS ILLNESSES; CHILDHOOD ASTHMA; LUNG-FUNCTION; RISK; INFANCY; AGE; DISEASE; ALLERGY	Rationale Severe early-life respiratory illnesses, particularly those caused by respiratory syncytial virus (RSV) and human rhinovirus (HRV), are strongly associated with the development of asthma in children. Puerto Rican children in particular have a strikingly high asthma burden. However, prior studies of the potential associations between early-life respiratory illnesses and asthma in Puerto Rican and other minority populations have been limited. Objectives We sought to determine whether early-life respiratory illness was associated with asthma in Puerto Rican, Mexican American, and African American children. Methods Using a logistic regression analysis, we examined the association between early-life respiratory illnesses (report of upper respiratory infection (URI), pneumonia, bronchitis, and bronchiolitis/RSV) within the first two years of life and physician-diagnosed asthma after the age of two in a large cohort of Puerto Rican, Mexican American, and African American children. Measurements and main results While early-life respiratory illnesses were associated with greater asthma odds in Puerto Ricans, Mexican Americans, and African Americans, these associations were stronger among Puerto Rican children. Specifically, in Puerto Ricans, the odds was 6.15 (95% CI: 4.21-9.05) if the child reported at least one of the following respiratory illness: URI, pneumonia, bronchitis or bronchiolitis. The odds were also higher in Puerto Ricans when considering these conditions separately. Conclusions We observed population-specific associations between early-life respiratory illnesses and asthma, which were especially significant and stronger in Puerto Ricans. Taken together with the known high burden of RSV in Puerto Rico, our results may help explain the high burden of asthma in Puerto Ricans.	[Wohlford, Eric M.; Elhawary, Jennifer R.; Plotkin, Brian; Oh, Sam S.; Nuckton, Thomas J.; Eng, Celeste; Salazar, Sandra; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Borrell, Luisa N.] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [LeNoir, Michael A.] Bay Area Pediat, Oakland, CA USA; [Meade, Kelley] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Farber, Harold J.] Baylor Coll Med, Dept Pediat, Sect Pulmonol, Houston, TX 77030 USA; [Farber, Harold J.] Texas Childrens Hosp, Houston, TX 77030 USA; [Serebrisky, Denise] Jacobi Med Ctr, Pediat Pulm Div, Bronx, NY USA; [Brigino-Buenaventura, Emerita] Kaiser Permanente, Vallejo Med Ctr, Dept Allergy & Immunol, Vallejo, CA USA; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; [Kumar, Rajesh] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Thyne, Shannon] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Seibold, Max A.] Natl Jewish Hlth, Denver, CO USA; [Rodriguez-Santana, Jose R.] Ctr Neumol Pediat, Caguas, PR USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; City University of New York (CUNY) System; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Baylor College of Medicine; Baylor College of Medicine; Jacobi Medical Center; Kaiser Permanente; Ann & Robert H. Lurie Children's Hospital of Chicago; University of California System; University of California Los Angeles; National Jewish Health; University of California System; University of California San Francisco	Borrell, LN (corresponding author), CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.	Luisa.Borrell@sph.cuny.edu	Borrell, Luisa N./G-8753-2018	Borrell, Luisa N./0000-0002-0560-4853; Oh, Sam/0000-0002-2815-6037; Meade, Kelley/0000-0001-5225-4713; Kumar, Rajesh/0000-0002-1962-7108; Elhawary, Jennifer/0000-0003-3326-1680	Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; National Institutes of Health [R01HL117004, R01HL128439, R01HL135156, 1X01HL134589, R01HL141992, 5T32GM007546, 1U01HL138626-01A1]; National Institute of Health and Environmental Health Sciences [R01ES015794, R21ES24844]; National Institute on Minority Health and Health Disparities [P60MD006902 RL5GM118984, R01MD010443]; TobaccoRelated Disease Research Program [24RT-0025, 27IR-0030]; Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II	Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health and Environmental Health Sciences; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); TobaccoRelated Disease Research Program(University of California System); Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II	This work was supported in part by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II, National Institutes of Health R01HL117004, R01HL128439, R01HL135156, 1X01HL134589, R01HL141992, 5T32GM007546, 1U01HL138626-01A1, National Institute of Health and Environmental Health Sciences R01ES015794, R21ES24844, the National Institute on Minority Health and Health Disparities P60MD006902 RL5GM118984, R01MD010443 and the TobaccoRelated Disease Research Program under Award Number 24RT-0025, 27IR-0030.	Akinbami LJ, 2010, ASTHMA PREVALENCE HL; Aligne CA, 2000, AM J RESP CRIT CARE, V162, P873; [Anonymous], 2017, GLOB STRAT ASTHM MAN; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Bai JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118286; Barr RG, 2016, AM J RESP CRIT CARE, V193, P386, DOI 10.1164/rccm.201506-1211OC; Bloom Barbara, 2010, Vital Health Stat 10, P1; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2016, J ALLER CL IMM-PRACT, V4, P1111, DOI 10.1016/j.jaip.2016.05.003; Escobar GJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-97; Genome Toolbox, 2014, TEST DIFF 2 ODDS RAT; Gillman MW, 2007, PEDIATR RES, V61, P625, DOI 10.1203/pdr.0b013e3180459fcd; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2011, CURR RESPIR MED REV, V7, P160, DOI 10.2174/157339811795589423; Jartti T, 2011, PEDIAT ALLERG IMM-UK, V22, P350, DOI 10.1111/j.1399-3038.2011.01170.x; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Matias I, 2015, P R HEALTH SCI J, V34, P98; McGuiness CB, 2014, PEDIATR INFECT DIS J, V33, P589, DOI 10.1097/INF.0000000000000257; Molinari Such Maria, 2005, P R Health Sci J, V24, P137; Munywoki PK, 2015, J INFECT DIS, V212, P1711, DOI 10.1093/infdis/jiv263; Neophytou Andreas M, 2019, Environ Epidemiol, V3, pe048, DOI 10.1097/EE9.0000000000000048; Neophytou AM, 2016, AM J RESP CRIT CARE, V193, P1271, DOI 10.1164/rccm.201508-1706OC; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Oh SS, 2016, AM J RESP CRIT CARE, V193, P348, DOI 10.1164/rccm.201510-2045ED; Oh SS, 2012, J ALLERGY CLIN IMMUN, V129, P1478, DOI 10.1016/j.jaci.2012.03.017; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; SIGURS N, 1995, PEDIATRICS, V95, P500; Sigurs N, 2001, AM J RESP CRIT CARE, V163, pS2, DOI 10.1164/ajrccm.163.supplement_1.2011109; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Szentpetery SE, 2016, J ALLERGY CLIN IMMUN, V138, P1556, DOI 10.1016/j.jaci.2016.08.047; Thakur N, 2017, CHEST, V151, P804, DOI 10.1016/j.chest.2016.11.027; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Voraphani N, 2014, AM J RESP CRIT CARE, V190, P392, DOI 10.1164/rccm.201311-2095OC; Wennergren G, 2001, EUR RESPIR J, V18, P1044, DOI 10.1183/09031936.01.00254101; World Health Organization (WHO), ASTHMA	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2020	15	5							e0231782	10.1371/journal.pone.0231782	http://dx.doi.org/10.1371/journal.pone.0231782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7XS	32369487	Green Submitted, Green Published, gold			2022-12-26	WOS:000537280000010
J	Yoneda, A; Minomi, K; Tamura, Y				Yoneda, Akihiro; Minomi, Kenjiro; Tamura, Yasuaki			HSP47 promotes metastasis of breast cancer by interacting with myosin IIA via the unfolded protein response transducer IRE1 alpha	ONCOGENE			English	Article							MATRIX METALLOPROTEINASES; CHAPERONE HSP47; ENDOPLASMIC-RETICULUM; IV COLLAGEN; EXPRESSION; INHIBITORS; INDUCTION; PROGNOSIS; PODOSOMES; APOPTOSIS	Breast cancer (BC) is an aggressive cancer that is a leading cause of cancer-associated death in women worldwide. Although increased expression of heat shock protein 47 (HSP47), a collagen-specific chaperone, is associated with the high malignancy of BC, its role in BC remains largely unclear. Here we show that a small population of high-invasive BC cells expresses HSP47 and that HSP47-positive high-invasive BC cells have a high metastatic potential that is completely abolished by disruption of HSP47. HSP47 interacts with non-muscle myosin IIA (NMIIA) via the unfolded protein response transducer IRE1 alpha, resulting in enhancement of the metastatic potential of high-invasive BC cells by augmenting the contractile force of actin filaments. Ablation of NMIIA abrogates the metastatic potential of HSP47-positive high-invasive BC cells. We further show that forced expression of NMIIA confers a high metastatic potential on low-invasive BC cells in which HSP47 but not NMIIA is expressed. Overall, our study indicates that HSP47 acts as a stimulator for metastasis of BC cells and suggest that HSP47 may be a candidate for a therapeutic target against BC.	[Yoneda, Akihiro; Minomi, Kenjiro; Tamura, Yasuaki] Hokkaido Univ, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat, Dept Mol Therapeut, Sapporo, Hokkaido 0010021, Japan; [Minomi, Kenjiro] Nitto Denko Corp, Nucle Acid Med Business Div, Res & Dev Dept, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Nitto Denko Corporation	Yoneda, A (corresponding author), Hokkaido Univ, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat, Dept Mol Therapeut, Sapporo, Hokkaido 0010021, Japan.	ayoneda@fmi.hokuida.ac.jp						Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Bachmeier BE, 2001, ANTICANCER RES, V21, P3821; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Derycke L, 2011, INT J DEV BIOL, V55, P835, DOI 10.1387/ijdb.113336ld; Duarte BD, 2018, J CANCER RES CLIN, V144, P2319, DOI 10.1007/s00432-018-2739-9; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; He Y, 2012, DEV CELL, V23, P1141, DOI 10.1016/j.devcel.2012.11.006; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishiwata-Kimata Y, 2013, CELL STRUCT FUNCT, V38, P135, DOI 10.1247/csf.12033; Ito S, 2019, J BIOL CHEM, V294, P2133, DOI 10.1074/jbc.TM118.002812; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Kawasaki K, 2015, J BIOL CHEM, V290, P3639, DOI 10.1074/jbc.M114.592139; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; Kumar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10740-0; Kumar A, 2015, PEERJ, V3, DOI 10.7717/peerj.1026; Li XX, 2017, ONCOGENE, V36, P6738, DOI 10.1038/onc.2017.284; Liu RG, 2017, INT J CLIN EXP PATHO, V10, P5498; Logue SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05763-8; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Mori K, 2017, INT J CANCER, V140, P1425, DOI 10.1002/ijc.30557; Newell-Litwa KA, 2015, DIS MODEL MECH, V8, P1495, DOI 10.1242/dmm.022103; Parveen A, 2019, GENOMICS, VS0888-7543, P30671; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Sasaki H, 2002, J IMMUNOL, V168, P5178, DOI 10.4049/jimmunol.168.10.5178; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Winer A, 2018, MOL CANCER THER, V17, P1147, DOI 10.1158/1535-7163.MCT-17-0646; Xiong GF, 2020, P NATL ACAD SCI USA, V117, P3748, DOI 10.1073/pnas.1911951117; Yeo SK, 2017, TRENDS CANCER, V3, P753, DOI 10.1016/j.trecan.2017.09.001; Zhang X, 2010, INT J ONCOL, V36, P405, DOI 10.3892/ijo_00000513; Zhao D, 2014, J NEURO-ONCOL, V118, P39, DOI 10.1007/s11060-014-1412-7; Zhou PT, 2019, ONCOGENE, V38, P5500, DOI 10.1038/s41388-019-0806-6; Zhu JQ, 2015, CANCER RES, V75, P1580, DOI 10.1158/0008-5472.CAN-14-1027	47	7	7	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4519	4537		10.1038/s41388-020-1311-7	http://dx.doi.org/10.1038/s41388-020-1311-7		MAY 2020	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32366908				2022-12-26	WOS:000530271400002
J	Lederer, S; Heskes, T; van Heeringen, SJ; Albers, CA				Lederer, Simone; Heskes, Tom; van Heeringen, Simon J.; Albers, Cornelis A.			Investigating the effect of dependence between conditions with Bayesian Linear Mixed Models for motif activity analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; PYTHON	Motivation Cellular identity and behavior is controlled by complex gene regulatory networks. Transcription factors (TFs) bind to specific DNA sequences to regulate the transcription of their target genes. On the basis of these TF motifs in cis-regulatory elements we can model the influence of TFs on gene expression. In such models of TF motif activity the data is usually modeled assuming a linear relationship between the motif activity and the gene expression level. A commonly used method to model motif influence is based on Ridge Regression. One important assumption of linear regression is the independence between samples. However, if samples are generated from the same cell line, tissue, or other biological source, this assumption may be invalid. This same assumption of independence is also applied to different yet similar experimental conditions, which may also be inappropriate. In theory, the independence assumption between samples could lead to loss in signal detection. Here we investigate whether a Bayesian model that allows for correlations results in more accurate inference of motif activities. Results We extend the Ridge Regression to a Bayesian Linear Mixed Model, which allows us to model dependence between different samples. In a simulation study, we investigate the differences between the two model assumptions. We show that our Bayesian Linear Mixed Model implementation outperforms Ridge Regression in a simulation scenario where the noise, which is the signal that can not be explained by TF motifs, is uncorrelated. However, we demonstrate that there is no such gain in performance if the noise has a similar covariance structure over samples as the signal that can be explained by motifs. We give a mathematical explanation to why this is the case. Using four representative real datasets we show that at most similar to(a) over cap 40% of the signal is explained by motifs using the linear model. With these data there is no advantage to using the Bayesian Linear Mixed Model, due to the similarity of the covariance structure.	[Lederer, Simone; Heskes, Tom] Radboud Univ Nijmegen, Inst Comp & Informat Sci, Data Sci, Nijmegen, Netherlands; [Lederer, Simone; van Heeringen, Simon J.; Albers, Cornelis A.] Radboud Univ Nijmegen, Res Inst Mol Life Sci, Mol Dev Biol, Nijmegen, Netherlands; [Albers, Cornelis A.] Euretos, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Lederer, S (corresponding author), Radboud Univ Nijmegen, Inst Comp & Informat Sci, Data Sci, Nijmegen, Netherlands.; Lederer, S; van Heeringen, SJ (corresponding author), Radboud Univ Nijmegen, Res Inst Mol Life Sci, Mol Dev Biol, Nijmegen, Netherlands.	slederer@cs.ru.nl; s.vanheeringen@science.ru.nl	Heskes, Tom/A-1443-2010	Heskes, Tom/0000-0002-3398-5235; Lederer, Simone/0000-0002-0180-4540	Radboud University; Netherlands Organization for Scientific research (NWO) [016.Vidi.189.081]; FP7-PEOPLE-2013-CIG program [631716]	Radboud University; Netherlands Organization for Scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); FP7-PEOPLE-2013-CIG program	This work has been supported by the Radboud University. SJvH was additionally supported by the Netherlands Organization for Scientific research (NWO grant 016.Vidi.189.081, https://www.nwo.nl/en).CAA was supported by the FP7-PEOPLE-2013-CIG program (project nr. 631716).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Bollag WB, 2011, J INVEST DERMATOL, V131, P11, DOI 10.1038/jid.2010.322; Bruse N, 2018, GIMMEMOTIFS ANAL FRA; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Collado-Torres Leonardo, 2017, F1000Res, V6, P1558, DOI 10.12688/f1000research.12223.1; Collado-Torres L, 2017, NAT BIOTECHNOL, V35, P319, DOI 10.1038/nbt.3838; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Ellis SE, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky102; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109; Gunnell A, 2016, NUCLEIC ACIDS RES, V44, P4636, DOI 10.1093/nar/gkw085; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Janich P, 2013, CELL STEM CELL, V13, P745, DOI 10.1016/j.stem.2013.09.004; Koleti A, 2018, NUCLEIC ACIDS RES, V46, pD558, DOI 10.1093/nar/gkx1063; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lippert C, 2015, LIMIX LINEAR MIXED M; Lippert C., 2014, BIORXIV, P003905, DOI [10.1101/003905, DOI 10.1101/003905]; Lippert C, 2014, NFORMATION MULTIVA S; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Madsen JGS, 2018, GENOME RES, V28, P243, DOI 10.1101/gr.227231.117; Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Meuleman W, 2019, INDEX BIOL SPECTRUM; Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36; National Center for Biotechnology Information (US) EntrezGene, 2019, ENTR GEN YY1 TRANSCR; Ng A. Y., 2004, P 21 INT C MACH LEAR, DOI [10.1145/1015330.1015435, DOI 10.1145/1015330.1015435]; Okuda T, 2001, INT J HEMATOL, V74, P252, DOI 10.1007/BF02982057; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Osmanbeyoglu HU, 2014, GENOME RES, V24, P1869, DOI 10.1101/gr.173039.114; Pearson K., 1895, P R SOC LOND, V58, P240, DOI [10.1098/rspl.1895.0041, DOI 10.1098/RSPL.1895.0041]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakitsch B., 2013, PROC 26 INT C NEURAL, V26, P1466; Schmidt C, 2017, NATURE, V552, P567, DOI 10.1038/d41586-017-08702-7; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sood R, 2017, BLOOD, V129, P2070, DOI 10.1182/blood-2016-10-687830; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Spender LC, 2002, J VIROL, V76, P4919, DOI 10.1128/JVI.76.10.4919-4927.2002; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Taguchi S, 2011, J INVEST DERMATOL, V131, P37, DOI 10.1038/jid.2010.229; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TIBSHIRANI R, 1988, J AM STAT ASSOC, V83, P394, DOI 10.2307/2288855; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Toufighi K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004256; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; van Heeringen SJ, 2011, BIOINFORMATICS, V27, P270, DOI 10.1093/bioinformatics/btq636; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wilke C.O., 2018, COWPLOT STREAMLINED	61	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0231824	10.1371/journal.pone.0231824	http://dx.doi.org/10.1371/journal.pone.0231824			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357166	Green Published, gold			2022-12-26	WOS:000536957700009
J	Reis, RD; Gatta, G; de Camargo, B				Reis, Rejane de Souza; Gatta, Gemma; de Camargo, Beatriz			Thyroid carcinoma in children, adolescents, and young adults in Brazil: A report from 11 population-based cancer registries	PLOS ONE			English	Article							UNITED-STATES; CHILDHOOD; TRENDS; RADIATION; MUTATIONS; PATTERNS; EXPOSURE; OBESITY	Background The increasing incidence of thyroid cancer has been described worldwide. Overdiagnosis, improved imaging, and increased environmental risk factors have contributed to the rising incidence. The objective of this study was to analyze the population incidence rate and trends during the period of 2000-2013 in children, adolescents and young adults (AYAs) in Brazil. Methods Data were extracted from 11 population-based cancer registries (PBCRs) encompassing the five geographic regions of Brazil. Incidence rates per million in children (0-14) and AYAs (15-39) according to world population were analyzed according to sex, age, and type of carcinoma. Incidence trends were evaluated using joinpoint regression. Results During 2000 to 2013, we identified 11,081 children and AYAs (0-39 years) with thyroid carcinoma in 11 PBCRs, with an age-adjusted incidence rate (AAIR) of 42 cases per million. Females had a higher AAIR of 66 cases per million versus 14 cases per million in males. Age-specific incidence rate (ASR) increased with age. Geographic variation was also observed; the Midwest and Southeast regions had the highest ASR in all age groups. The lowest ASR in all age groups was seen in the North region. Papillary subtype was the most common. Overall, the incidence rates in children and AYAs significantly increased from 0.2 in 2000 to 2.8 in 2013 and from 47.1 to 115.3, respectively, with an annual average percent change of 18.8 [8.1; 30.6] for children and 7.9 [CI 5.6; 10.3] for AYAs. Conclusions Rates of thyroid cancer, particularly the papillary subtype, are steadily increasing in children and AYAs, especially among females. There are variations among geographic areas. This increased incidence is unlikely to be explained by screening, as children less than 14 years of age do not typically undergo medical surveillance. Environmental risk factors must be investigated.	[Reis, Rejane de Souza] Hosp Fundacao Canc, Rio De Janeiro, RJ, Brazil; [Gatta, Gemma] Fdn IRCCS, Ist Nazl Tumori, Milan, Italy; [de Camargo, Beatriz] Inst Nacl Canc, Res Ctr, Rio De Janeiro, RJ, Brazil	Fondazione IRCCS Istituto Nazionale Tumori Milan; National Cancer Institute (Inca)	de Camargo, B (corresponding author), Inst Nacl Canc, Res Ctr, Rio De Janeiro, RJ, Brazil.	bdecamar@terra.com.br	Reis, Rejane/B-1513-2015; de Camargo, Beatriz/I-8414-2014	Reis, Rejane/0000-0003-3067-0526; de Camargo, Beatriz/0000-0002-5794-1042				Aarestrup J, 2019, CANCER EPIDEMIOL, V62, DOI 10.1016/j.canep.2019.07.003; Avula S, 2010, PEDIATR RADIOL, V40, P1774, DOI 10.1007/s00247-010-1684-9; Balmant NV, 2019, CANCER-AM CANCER SOC, V125, P2638, DOI 10.1002/cncr.32121; Bernier MO, 2019, CANCER-AM CANCER SOC, V125, P2497, DOI 10.1002/cncr.32125; Burgess JR, 2000, J CLIN ENDOCR METAB, V85, P1513, DOI 10.1210/jc.85.4.1513; Chow SM, 2004, PEDIATR BLOOD CANCER, V42, P176, DOI 10.1002/pbc.10410; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Francis GL, 2015, THYROID, V25, P716, DOI 10.1089/thy.2014.0460; Fritz A, 2000, INT CLASSIFICATION D; Han MA, 2018, THYROID, V28, P220, DOI 10.1089/thy.2017.0159; International Agency for Research on Cancer, CANC INCIDENCE 5 CON, VXI; James BC, 2018, CANCER CAUSE CONTROL, V29, P465, DOI 10.1007/s10552-018-1023-2; Kaatsch P, 2006, EUR J CANCER, V42, P1961, DOI 10.1016/j.ejca.2006.05.014; Kang HW, 2004, THYROID, V14, P29, DOI 10.1089/105072504322783812; Keegan THM, 2015, THYROID, V25, P635, DOI 10.1089/thy.2015.0021; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Marcello MA, 2014, ENDOCR-RELAT CANCER, V21, pT255, DOI 10.1530/ERC-14-0070; Morris LGT, 2008, ANN SURG ONCOL, V15, P1169, DOI 10.1245/s10434-008-9812-6; Nikiforov YE, 1997, CANCER RES, V57, P1690; Nomellini PF, 2018, J ADOLESC YOUNG ADUL, V7, P164, DOI 10.1089/jayao.2017.0088; Pappa T, 2014, THYROID, V24, P190, DOI 10.1089/thy.2013.0232; Penko K, 2005, THYROID, V15, P320, DOI 10.1089/thy.2005.15.320; Percy C., 1990, INT CLASSIFICATION D; PETTERSSON B, 1991, INT J CANCER, V48, P28; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Schonfeld SJ, 2011, CLIN ONCOL-UK, V23, P244, DOI 10.1016/j.clon.2011.01.159; Siegel DA, 2014, PEDIATRICS, V134, pE945, DOI 10.1542/peds.2013-3926; Sigurdson AJ, 2005, LANCET, V365, P2014, DOI 10.1016/S0140-6736(05)66695-0; Silva ND, 2017, REV PANAM SALUD PUBL, V41; Sobrinho-Simoes M, 2008, ENDOCRIN METAB CLIN, V37, P333, DOI 10.1016/j.ecl.2008.02.004; STSJAZHKO VA, 1995, BMJ-BRIT MED J, V310, P801, DOI 10.1136/bmj.310.6982.801; Taniguchi N, 2013, J MED ULTRASON, V40, P219, DOI 10.1007/s10396-013-0456-1; Veiga LHS, 2013, THYROID, V23, P748, DOI 10.1089/thy.2012.0532; Vergamini LB, 2014, J PEDIATR-US, V164, P1481, DOI 10.1016/j.jpeds.2014.01.059; Cordioli MICV, 2017, THYROID, V27, P182, DOI 10.1089/thy.2016.0387; Vriens MR, 2011, CANCER-AM CANCER SOC, V117, P259, DOI 10.1002/cncr.25369; Yamamoto H, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017165; ZIMMERMAN D, 1988, SURGERY, V104, P1157	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232416	10.1371/journal.pone.0232416	http://dx.doi.org/10.1371/journal.pone.0232416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357198	Green Published, gold			2022-12-26	WOS:000536957700030
J	Vo, BV; Siddiki, MAB; Chaklader, MR; Fotedar, R; Nahar, A; Foysal, MJ; Bui, DP; Nguyen, HQ				Binh Van Vo; Siddiki, Muhammad A. B.; Chaklader, Md. Reaz; Fotedar, Ravi; Nahar, Ashfaqun; Foysal, Md. Javed; Bui, Dien Phan; Huy Quang Nguyen			Growth and health of juvenile barramundi (Lates calcarifer) challenged with DO hypoxia after feeding various inclusions of germinated, fermented and untreated peanut meals	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; ATLANTIC SALMON; RAINBOW-TROUT; VITAMIN-C; FISH-MEAL; INTESTINAL MORPHOLOGY; ONCORHYNCHUS-MYKISS; SKELETAL MYOPATHY; SPARUS-AURATA; SOYBEAN-MEAL	Peanut (Arachis hypogaea) is mainly grown for oil extraction and the remaining oil-free seed referred as peanut meal (PM) leaves with high protein content which can be a possible substitute for fishmeal in aqua-diets. This study evaluates the suitability of three types of processed peanut seeds, namely untreated PM (UPM), fermented PM (FPM), and germinated PM (GPM) from peanut seeds to replace fishmeal in barramundi (Lates calcarifer) diets cultured under a commercial production environment. Nine formulated diets having 3 inclusion levels from the 3 different peanuts (15%, 30% and 60% fishmeal replacement) were evaluated against a control without PM. The performance of various types and levels of PMs was assessed by examining the growth, gut and liver condition and survival of fish after eight weeks of feeding the test diets. The immunological responses of juvenile barramundi were assessed by exposing the fish to the hypoxic conditions for 4 hours. The results showed that fermentation and germination significantly (P<0.05) reduced the tannins and alkaloid contents in the PMs. The fish fed 15% GPM diet grew faster and had higher survival than fish fed control diet, while fish fed diet including 60% GPM showed a significant reduction in growth and survival, and an increase in food conversion rate (FCR). FPM and UPM at any inclusion levels did not alter the growth, survival and FCR. Histology analysis revealed that fish fed 60% GPM and UPM showed higher amount of lipid droplets in liver, myodigeneration in fish muscle and a decrease number of acidic mucins in distal gut compare to all other test diets. Stress caused by reduced dissolved oxygen did not change the sodium, potassium, chlorides and alanine aminotransferase concentrations of plasma of fish fed any diet. However, the stress did increase plasma cortisol significantly (P<0.05) in fish fed 60% GPM, 30% and 60% UPM diets. These results suggest that the PMs can partly replace the fishmeal in juvenile barramundi diet and the processing further improves the PMs quality by reducing its antinutritional factors which in turn can increase either its inclusion level in the barramundi diets or improved growth and health status of the species.	[Binh Van Vo; Bui, Dien Phan; Huy Quang Nguyen] Res Inst Aquaculture 1, Hanoi, Vietnam; [Siddiki, Muhammad A. B.] Patuakhali Sci & Technol Univ, Dept Fisheries Biol & Genet, Patuakhali, Bangladesh; [Chaklader, Md. Reaz; Fotedar, Ravi; Foysal, Md. Javed] Curtin Univ, Sch Mol & Life Sci, Bentley, WA, Australia; [Nahar, Ashfaqun] Patuakhali Sci & Technol Univ, Dept Marine Fisheries & Oceanog, Patuakhali, Bangladesh; [Foysal, Md. Javed] Shahjalal Univ Sci & Technol, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh	Curtin University; Shahjalal University of Science & Technology (SUST)	Siddiki, MAB (corresponding author), Patuakhali Sci & Technol Univ, Dept Fisheries Biol & Genet, Patuakhali, Bangladesh.	siddik@pstu.ac.bd	Foysal, Javed/S-9971-2019; Siddik, Muhammad A.B./ABB-1947-2021; Fotedar, Ravi/L-2810-2013	Foysal, Javed/0000-0002-2064-8897; Siddik, Muhammad A.B./0000-0002-3636-1639; Fotedar, Ravi/0000-0002-4548-3064	PhD program of Curtin International Postgraduate Research Scholarships (CIPRS); Ministry of Education and Training Vietnam (MoET) Award	PhD program of Curtin International Postgraduate Research Scholarships (CIPRS); Ministry of Education and Training Vietnam (MoET) Award	The research was financially supported by PhD program of Curtin International Postgraduate Research Scholarships (CIPRS) in conjunction with Ministry of Education and Training Vietnam (MoET) Award.	[Anonymous], 2009, THESIS; Ashida T, 2005, FISHERIES SCI, V71, P257, DOI 10.1111/j.1444-2906.2005.00958.x; BARTON BA, 1988, PROG FISH CULT, V50, P16, DOI 10.1577/1548-8640(1988)050&lt;0016:FADCAS&gt;2.3.CO;2; Becker K, 1999, AQUACULTURE, V175, P327, DOI 10.1016/S0044-8486(99)00106-4; Bian F, 2017, AQUACULT NUTR, V23, P1429, DOI 10.1111/anu.12518; Van Vo B, 2015, AQUACULTURE, V444, P62, DOI 10.1016/j.aquaculture.2015.03.019; BOLAND ARD, 1975, J AGR FOOD CHEM, V23, P1186, DOI 10.1021/jf60202a038; Buttle LG, 2001, VET IMMUNOL IMMUNOP, V80, P237, DOI 10.1016/S0165-2427(01)00269-0; Cai CF, 2013, AQUACULTURE, V410, P203, DOI 10.1016/j.aquaculture.2013.07.006; Carter CG, 2000, AQUACULTURE, V185, P299, DOI 10.1016/S0044-8486(99)00353-1; Chaklader MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53018-3; Connelly P, 2011, J AUST TRADIT-MED SO, V17, P21; Diaz AO, 2003, ANAT HISTOL EMBRYOL, V32, P341, DOI 10.1111/j.1439-0264.2003.00490.x; Duenas M, 2009, FOOD CHEM, V117, P599, DOI 10.1016/j.foodchem.2009.04.051; Duong DN, 2016, AQUACULTURE, V464, P364, DOI 10.1016/j.aquaculture.2016.07.011; Ejigui J., 2005, Journal of Biological Sciences, V5, P597; Estevez A, 2011, AQUACULT NUTR, V17, pE572, DOI 10.1111/j.1365-2095.2010.00798.x; Fernandez-Orozco R, 2006, EUR FOOD RES TECHNOL, V223, P495, DOI 10.1007/s00217-005-0229-1; Francis G, 2001, AQUACULTURE; Garcia F, 2007, AQUACULTURE, V271, P39, DOI 10.1016/j.aquaculture.2007.06.021; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Glencross B, 2005, AQUACULTURE, V245, P211, DOI 10.1016/j.aquaculture.2004.11.033; Glencross B, 2011, AQUACULT NUTR, V17, pE722, DOI 10.1111/j.1365-2095.2010.00834.x; Gonzalez JD, 2012, BRIT J NUTR, V107, P1747, DOI 10.1017/S000711451100496X; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; He YH, 2010, J HENAN I SCI TECHNO, V38, P56; Hedemann MS, 2006, J ANIM SCI, V84, P1375, DOI 10.2527/2006.8461375x; HENDRICKS JD, 1981, EXP MOL PATHOL, V35, P170, DOI 10.1016/0014-4800(81)90057-5; Hung Duc Pham, 2016, Modern Applied Science, V10, P180, DOI 10.5539/mas.v10n10p180; Ilham, 2016, AQUACULTURE, V457, P15, DOI 10.1016/j.aquaculture.2016.02.003; Ilham I, 2016, BIOL TRACE ELEM RES, V174, P436, DOI 10.1007/s12011-016-0708-1; Katersky RS, 2009, COMP BIOCHEM PHYS A, V152, P513, DOI 10.1016/j.cbpa.2008.12.017; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Liang JF, 2008, FOOD CHEM, V110, P821, DOI 10.1016/j.foodchem.2008.02.064; Lopez-Amoros ML, 2006, J FOOD COMPOS ANAL, V19, P277, DOI 10.1016/j.jfca.2004.06.012; Luo Lin, 2009, Current Zoology, V55, P416; Mandal S, 2010, FISH PHYSIOL BIOCHEM, V36, P1171, DOI 10.1007/s10695-010-9395-6; Marklinder I, 1996, FOOD QUAL PREFER, V7, P285, DOI 10.1016/S0950-3293(96)00027-4; Martinez-Llorens S, 2012, AQUACULTURE, V338, P124, DOI 10.1016/j.aquaculture.2012.01.029; McMeniman N., 2003, DIGESTIBILITY UTILIZ; Mukhopadhyay N, 1999, AQUACULT NUTR, V5, P229; Narra MR, 2015, CHEMOSPHERE, V132, P172, DOI 10.1016/j.chemosphere.2015.03.006; Nnam NM, 2003, ECOL FOOD NUTR, V42, P265, DOI [10.1080/03670240390229634, 10.1080/03670244.2003.9657684]; Padra JT, 2014, INFECT IMMUN, V82, P5235, DOI 10.1128/IAI.01931-14; Partridge GJ, 2008, AQUACULTURE, V278, P164, DOI 10.1016/j.aquaculture.2008.03.042; Partridge GJ, 2004, J FISH DIS, V27, P523, DOI 10.1111/j.1365-2761.2004.00567.x; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Pirarat N, 2011, RES VET SCI, V91, pE92, DOI 10.1016/j.rvsc.2011.02.014; RODGER HD, 1991, DIS AQUAT ORGAN, V12, P17, DOI 10.3354/dao012017; Ronnestad I, 2013, FEEDING BEHAV DIGEST, pS59; Mariya Sewaka, 2019, FISH SHELLFISH IMMUN, V86, P260, DOI 10.1016/j.fsi.2018.11.026; Siddik MAB, 2019, FISH SHELLFISH IMMUN, V89, P61, DOI 10.1016/j.fsi.2019.03.042; Sklan D, 2004, AQUAC RES, V35, P350, DOI 10.1111/j.1365-2109.2004.01020.x; Skrede G, 2002, AQUACULTURE, V210, P305, DOI 10.1016/S0044-8486(01)00851-1; Suski CD, 2003, N AM J FISH MANAGE, V23, P760, DOI 10.1577/M02-042; Tocher DR, 2002, AQUACULT NUTR, V8, P195, DOI 10.1046/j.1365-2095.2002.00205.x; Tsantilas H, 2006, AQUACULTURE, V253, P64, DOI 10.1016/j.aquaculture.2005.07.034; van Barneveld RJ, 1999, NUTR RES REV, V12, P203, DOI 10.1079/095442299108728938; VERMA SR, 1981, TOXICOL LETT, V9, P327, DOI 10.1016/0378-4274(81)90005-9; WAAGBO R, 1994, J FISH DIS, V17, P245, DOI 10.1111/j.1365-2761.1994.tb00220.x; Williams KC, 2003, AQUAC RES, V34, P33, DOI 10.1046/j.1365-2109.2003.00786.x; WILSON RW, 1992, FISH PHYSIOL BIOCHEM, V10, P149, DOI 10.1007/BF00004526; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; Yang F, 2001, INT J FOOD SCI NUTR, V52, P319, DOI 10.1080/09637480120057567; Ye HQ, 2019, AQUACULTURE, V506, P437, DOI 10.1016/j.aquaculture.2019.03.075; Yin B, 2018, FISH SHELLFISH IMMUN, V81, P318, DOI 10.1016/j.fsi.2018.07.038; Yu JM, 2006, J FOOD COMPOS ANAL, V19, P364, DOI 10.1016/j.jfca.2005.08.003; Zhao XY, 2012, J FOOD SCI TECH MYS, V49, P521, DOI 10.1007/s13197-011-0449-2; Zhou QC, 2012, FISH SHELLFISH IMMUN, V32, P969, DOI 10.1016/j.fsi.2012.01.024	69	13	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2020	15	4							e0232278	10.1371/journal.pone.0232278	http://dx.doi.org/10.1371/journal.pone.0232278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS9BE	32352997	Green Published, gold			2022-12-26	WOS:000536673200066
J	Gou, YP; Quandahor, P; Zhang, YX; Coulter, JA; Liu, CZ				Gou, Yuping; Quandahor, Peter; Zhang, Yanxia; Coulter, Jeffrey A.; Liu, Changzhong			Host plant nutrient contents influence nutrient contents in Bradysia cellarum and Bradysia impatiens	PLOS ONE			English	Article							DIFFORMIS DIPTERA SCIARIDAE; BUCHNERA-APHIDICOLA; 1ST REPORT; ODORIPHAGA; ENDOSYMBIONT; APHIDS; HEAT	The chive maggot Bradysia cellarum and the fungus gnat B. impatiens are two primary root pests of plants, which can coexist on the same host plants and are the devastating pests on liliaceous crops and edible fungi. Their growth and development are affected by the nutrient contents of their host plants. In this study, we assessed the effects of different host plant nutrients on the nutrient contents of these two Bradysia species. The nutrients of the chive (Allium tuberosum Rottl. ex Spreng.), board bean (Vicia faba L.), lettuce (Lactuca sativa L. var. ramosa Hort.), cabbage (Brassica oleracea L.), wild cabbage (Brassica oleracea var. capitata rubra) and pepper (Capsicum annuum L.) roots were determined, and their effect on nutrient content of the two Bradysia species after feeding on the host plant for three continuous generations were evaluated. The results show that chive and B-bean contained higher levels of protein, free amino acid, soluble sugar and starch than others. As a result, the soluble sugar, fat and protein contents were significantly higher in both Bradysia species reared on chive and B-bean than on cabbage, lettuce, W-cabbage and pepper, suggesting nutritional preference of these insects. Based on our results, we concluded that the two Bradysia species displayed nutrient preference toward chive and B-bean, which provides a reference for understanding their host plant range and for control of the insect species via field crop rotations.	[Gou, Yuping; Quandahor, Peter; Zhang, Yanxia; Liu, Changzhong] Gansu Agr Univ, Coll Plant Protect, Lanzhou, Gansu, Peoples R China; [Gou, Yuping; Quandahor, Peter; Zhang, Yanxia; Liu, Changzhong] Biocontrol Engn Lab Crop Dis & Pests Gansu Prov, Lanzhou, Gansu, Peoples R China; [Coulter, Jeffrey A.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	Gansu Agricultural University; University of Minnesota System; University of Minnesota Twin Cities	Liu, CZ (corresponding author), Gansu Agr Univ, Coll Plant Protect, Lanzhou, Gansu, Peoples R China.; Liu, CZ (corresponding author), Biocontrol Engn Lab Crop Dis & Pests Gansu Prov, Lanzhou, Gansu, Peoples R China.	liuchzh@gsau.edu.cn		Liu, Changzhong/0000-0003-0546-3680; Gou, Yuping/0000-0001-7001-5978	Discipline Construction Fund Project of Gansu Agricultural University [GAU-XKJS-2018-149]; International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology [201303027]	Discipline Construction Fund Project of Gansu Agricultural University; International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology	This study was supported by the Discipline Construction Fund Project of Gansu Agricultural University (GAU-XKJS-2018-149), and International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology (201303027).	An LN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210379; Dang Zhi-Hong, 2000, Entomological Knowledge, V37, P308; Gou YP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217867; [苟玉萍 Gou Yuping], 2015, [植物保护, Plant Protection], V41, P28; Han QX, 2015, J ASIA-PAC ENTOMOL, V18, P77, DOI 10.1016/j.aspen.2014.12.005; HOUSE H. L., 1949, Canadian Entomologist, V81, P133; Jiang ChangMu, 2006, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V35, P24; KOLIBACHUK D, 1995, CURR MICROBIOL, V30, P313, DOI 10.1007/BF00295507; Li Hong, 2007, Chinese Bulletin of Entomology, V44, P834; [李进步 Li Jinbu], 2008, [植物保护, Plant Protection], V34, P26; Li Run-Hong, 2016, Acta Entomologica Sinica, V59, P1298, DOI 10.16380/j.kcxb.2016.12.002; [李子玲 LI Ziling], 2006, [西南农业大学学报, Journal of Southwest Agricultural University], V28, P986; [刘倩 Liu Qian], 2015, [植物保护, Plant Protection], V41, P85; Lu W, 2006, ANN M CHIN PLANT PRO; Lu Zhong-xian, 2006, Chinese Journal of Rice Science, V20, P649; Luo JY, 2011, J NW AGR FORESTY U N, V39; Lv N, 2018, INSECTS, V9, DOI 10.3390/insects9040161; Mei Zeng-Xia, 2003, Entomological Knowledge, V40, P396; Mohrig Werner, 2012, Studia Dipterologica, V19, P141; Mu W., 2003, ENTOMOLOGICAL J E CH, V12, P87; MUNSON MA, 1993, GENE, V137, P171, DOI 10.1016/0378-1119(93)90003-L; Santos A, 2012, FLA ENTOMOL, V95, P569, DOI 10.1653/024.095.0305; Shen Deng-Rong, 2009, Acta Entomologica Sinica, V52, P934; Sheng C F, 2000, ACTA ENTOMOL SINICA, V43, P168; Shi Cai-Hua, 2016, Chinese Journal of Applied Entomology, V53, P1225, DOI 10.7679/j.issn.2095-1353.2016.152; Tang QY, 2001, PLANT PROTECTION TEC, V21, P43; Tang QY, 2001, PLANT PROTECTION TEC, V21, P41; THOMPSON SN, 1976, ANN ENTOMOL SOC AM, V69, P835, DOI 10.1093/aesa/69.5.835; THOMPSON SN, 1974, J INSECT PHYSIOL, V20, P1515, DOI 10.1016/0022-1910(74)90083-3; Xu Lei, 2016, Chinese Journal of Applied Entomology, V53, P1190, DOI 10.7679/j.issn.2095-1353.2016.147; [杨玉婷 Yang Yuting], 2017, [植物保护, Plant Protection], V43, P119; Ye L, 2017, J ASIA-PAC ENTOMOL, V20, P179, DOI 10.1016/j.aspen.2016.12.012; Zhang HR, 2008, EDIBLE FUNGI CHINA, P54; Zhang S., 2014, ELEMENTARY STUDIES B; Zhang Yan-Xia, 2016, Chinese Journal of Applied Entomology, V53, P1184, DOI 10.7679/j.issn.2095-1353.2016.146; Zhou FuCai, 1999, Jiangsu Agricultural Research, V20, P60; Zhou Xian-Hong, 2019, Huanjing Kunchong Xuebao, V41, P465; Zhu GD, 2018, J ASIA-PAC ENTOMOL, V21, P106, DOI 10.1016/j.aspen.2017.11.001; Zhu GD, 2017, J ECON ENTOMOL, V110, P2371, DOI 10.1093/jee/tox242	39	5	6	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0226471	10.1371/journal.pone.0226471	http://dx.doi.org/10.1371/journal.pone.0226471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348333	gold, Green Submitted, Green Published			2022-12-26	WOS:000536668200003
J	Hosokawa, S; Shukuya, K; Sogabe, K; Ejima, Y; Morinishi, T; Hirakawa, E; Ohsaki, H; Shimosawa, T; Tokuhara, Y				Hosokawa, Sho; Shukuya, Kenichi; Sogabe, Keisuke; Ejima, Yasukazu; Morinishi, Tatsuya; Hirakawa, Eiichiro; Ohsaki, Hiroyuki; Shimosawa, Tatsuo; Tokuhara, Yasunori			Novel absorbance peak of gentisic acid following the oxidation reaction	PLOS ONE			English	Article							SALICYLIC-ACID; METABOLITES; ASPIRIN; PHARMACOKINETICS; KINETICS	Gentisic acid (GA), a metabolite of acetylsalicylic acid (ASA), and homogentisic acid (HGA), which is excreted at high levels in alkaptonuria, are divalent phenolic acids with very similar structures. Urine containing HGA is dark brown in color due to its oxidation. We recently reported a new oxidation method of HGA involving the addition of sodium hydroxide (NaOH) with sodium hypochlorite pentahydrate (NaOCl center dot 5H(2)O), which is a strong oxidant. In the present study, we attempted to oxidize GA, which has a similar structure to HGA, using our method. We herein observed color changes in GA solution and analyzed the absorption spectra of GA after the addition of NaOH with NaOCl center dot 5H(2)O. We also examined the oxidation reaction of GA using a liquid chromatography time-of-flight mass spectrometer (LC/TOF-MS). The results obtained indicated that GA solution had a unique absorption spectrum with a peak at approximately 500 nm through an oxidation reaction following the addition of NaOH with NaOCl center dot 5H(2)O. This spectrophotometric method enables GA to be detected in sample solutions without expensive analytical instruments or a complex method.	[Hosokawa, Sho; Tokuhara, Yasunori] Ehime Prefectural Univ Hlth Sci, Dept Med Technol, Tobe, Ehime, Japan; [Shukuya, Kenichi] Int Univ Hlth & Welf, Sch Hlth Sci Fukuoka, Dept Med Technol & Sci, Fukuoka, Japan; [Sogabe, Keisuke] Kaneka Techno Res Corp, Takasago, Hyogo, Japan; [Ejima, Yasukazu] Kaneka Corp, Vinyls & Chlor Alkali Solut Vehicle, Osaka, Japan; [Morinishi, Tatsuya; Hirakawa, Eiichiro] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Mure, Kagawa, Japan; [Ohsaki, Hiroyuki] Kobe Univ, Grad Sch Hlth Sci, Dept Med Biophys, Kobe, Hyogo, Japan; [Shimosawa, Tatsuo] Int Univ Hlth & Welf, Sch Med, Clin Lab Med, Chiba, Japan	International University of Health & Welfare; Kaneka Corporation; Kobe University; International University of Health & Welfare	Tokuhara, Y (corresponding author), Ehime Prefectural Univ Hlth Sci, Dept Med Technol, Tobe, Ehime, Japan.	ytokuhara@epu.ac.jp		Tokuhara, Yasunori/0000-0002-8322-2543	Kaneka Corporation, Japan; JSPS KAKENHI [JP19K16957]	Kaneka Corporation, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly funded by Kaneka Corporation, Japan. Y. Ejima and K. Sogabe have an employment position to disclose. Y. Ejima is the Assistant Manager of Kaneka Corporation, which paid measurement expenses (LC/TOF-MS) to Kaneka Techno Research Corporation. K. Sogabe is the General Manager of Kaneka Techno Research Corporation. Y.T. -This work was supported by JSPS KAKENHI Grant Number JP19K16957. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka S, 1983, Sangyo Igaku, V25, P399; Bojic M, 2015, EUR J PHARM SCI, V73, P49, DOI 10.1016/j.ejps.2015.03.015; BOREHAM DR, 1969, BRIT J PHARMACOL, V37, P294, DOI 10.1111/j.1476-5381.1969.tb09546.x; CHAM BE, 1980, THER DRUG MONIT, V2, P365; CHAM BE, 1980, CLIN CHEM, V26, P111; CONSDEN R, 1951, BIOCHEM J, V48, pR14; Fernandez IS, 2010, J BIOL CHEM, V285, P11714, DOI 10.1074/jbc.M109.064618; FROHLICH J, 1973, CLIN CHEM, V19, P770; HOLMES TJ, 1984, J ORG CHEM, V49, P4736, DOI 10.1021/jo00198a035; Hotta H, 2002, BBA-GEN SUBJECTS, V1572, P123, DOI 10.1016/S0304-4165(02)00285-4; Kapp EM, 1942, J BIOL CHEM, V145, P549; Khadem S, 2010, MOLECULES, V15, P7985, DOI 10.3390/molecules15117985; Kivrak S, 2017, INT J FOOD PROP, V20, P864, DOI 10.1080/10942912.2016.1188307; Lares-Asseff I, 2004, BIOL PHARM BULL, V27, P706, DOI 10.1248/bpb.27.706; Li JP, 2017, J PHARMACEUT BIOMED, V138, P109, DOI 10.1016/j.jpba.2016.12.038; MARTIN JP, 1987, FREE RADICAL BIO MED, V3, P241, DOI 10.1016/S0891-5849(87)80031-X; MEYER K, 1948, SCIENCE, V108, P281, DOI 10.1126/science.108.2802.281; MILCH RA, 1960, ARCH BIOCHEM BIOPHYS, V89, P27, DOI 10.1016/0003-9861(60)90006-0; Nematollahi D, 2008, CHEM PHARM BULL, V56, P513, DOI 10.1248/cpb.56.513; Phornphutkul C, 2002, NEW ENGL J MED, V347, P2111, DOI 10.1056/NEJMoa021736; ROSEMAN S, 1951, J BIOL CHEM, V192, P105; SHAHIDI NT, 1970, J CLIN INVEST, V49, P1334, DOI 10.1172/JCI106349; Sharma S, 2004, EUR J CANCER PREV, V13, P53, DOI 10.1097/00008469-200402000-00009; Tokuhara Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29769-w; Tokuhara Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086606; Yaffe SJ, 1968, CLIN TOXICOL, V1, P409, DOI [10.3109/15563656808990591, DOI 10.3109/15563656808990591]; Yen TA, 2018, MICROCHEM J, V137, P85, DOI 10.1016/j.microc.2017.09.024	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232263	10.1371/journal.pone.0232263	http://dx.doi.org/10.1371/journal.pone.0232263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348369	Green Published, gold			2022-12-26	WOS:000536668200052
J	Boon, GJAM; van Rein, N; Bogaard, HJ; Ende-Verhaar, YM; Huisman, MV; Kroft, LJM; van der Meer, FJM; Meijboom, LJ; Symersky, P; Noordegraaf, AV; Klok, FA				Boon, Gudula J. A. M.; van Rein, Nienke; Bogaard, Harm Jan; Ende-Verhaar, Yvonne M.; Huisman, Menno V.; Kroft, Lucia J. M.; van der Meer, Felix J. M.; Meijboom, Lilian J.; Symersky, Petr; Noordegraaf, Anton Vonk; Klok, Frederikus A.			Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; HYPERTENSION; THERAPY	Background The pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk of CTEPH after acute pulmonary embolism (PE), partly explaining the transition from acute PE to CTEPH. We assessed the association between the time in therapeutic range (TTR) of vitamin-K antagonist (VKA) treatment and incidence of CTEPH after a PE diagnosis. Methods Case-control study in which the time spent in, under and above therapeutic range was calculated in 44 PE patients who were subsequently diagnosed with CTEPH (cases). Controls comprised 150 consecutive PE patients in whom echocardiograms two years later did not show pulmonary hypertension. All patients were treated with VKA for at least 6 months after the PE diagnosis. Time in (TTR), under and above range were calculated. Mean differences between cases and controls were estimated by linear regression. Results Mean TTR during the initial 6-month treatment period was 72% in cases versus 78% in controls (mean difference -6%, 95%CI -12 to -0.1), mainly explained by more time above the therapeutic range in the cases. Mean difference of time under range was 0% (95%CI -6 to 7) and 2% (95CI% -3 to 7) during the first 3 and 6 months, respectively. In a multivariable model, adjusted odds ratios (ORs) for CTEPH were around unity considering different thresholds for 'poor anticoagulation', i.e. TTR <50%, <60% and <70%. Conclusion Subtherapeutic initial anticoagulation was not more prevalent among PE patients diagnosed with CTEPH than in those who did not develop CTEPH.	[Boon, Gudula J. A. M.; Ende-Verhaar, Yvonne M.; Huisman, Menno V.; van der Meer, Felix J. M.; Klok, Frederikus A.] Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands; [van Rein, Nienke] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands; [Bogaard, Harm Jan; Noordegraaf, Anton Vonk] Amsterdam Univ Med Ctr, Dept Pulm Med, Amsterdam, Netherlands; [Kroft, Lucia J. M.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Meijboom, Lilian J.] Amsterdam Univ Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Symersky, Petr] Vrije Univ Amsterdam Med Ctr, Dept Cardiac Surg, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Klok, FA (corresponding author), Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands.	f.a.klok@LUMC.nl	Klok, Erik/U-4870-2019	Klok, Erik/0000-0001-9961-0754; Boon, Duliette/0000-0003-4532-436X; Symersky, Petr/0000-0002-5181-881X; vonk noordegraaf, anton/0000-0002-4057-758X; Bogaard, Harm Jan/0000-0001-5371-0346				Abdou JK, 2016, BRIT J HAEMATOL, V174, P30, DOI 10.1111/bjh.14134; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Caldeira D, 2015, BLOOD COAGUL FIBRIN, V26, P972, DOI 10.1097/MBC.0000000000000312; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Dronkers CEA, 2018, THROMB RES, V167, P135, DOI 10.1016/j.thromres.2018.05.013; Dutt Tiyas Sen, 2013, Indian J Chest Dis Allied Sci, V55, P205; Egermayer P, 2000, EUR RESPIR J, V15, P440, DOI 10.1034/j.1399-3003.2000.15.03.x; Ende-Verhaar YM, 2018, J THROMB HAEMOST, V16, P2168, DOI 10.1111/jth.14266; Ende-Verhaar YM, 2019, J HEART LUNG TRANSPL; Ende-Verhaar YM, 2017, THROMB RES, V151, P1, DOI 10.1016/j.thromres.2016.12.026; Ende-Verhaar YM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01792-2016; Galie N, 2016, REV ESP CARDIOL, V69, P177, DOI 10.1016/j.rec.2016.01.002; Guerin L, 2014, THROMB HAEMOSTASIS, V112, P598, DOI 10.1160/TH13-07-0538; Huisman MV, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.28; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Klok FA, 2010, J THROMB HAEMOST, V8, P853, DOI 10.1111/j.1538-7836.2010.03780.x; Klok FA, 2010, HAEMATOL-HEMATOL J, V95, P970, DOI 10.3324/haematol.2009.018960; NIV, RICHTL ANT BEL NED I; Palareti G, 2005, J THROMB HAEMOST, V3, P955, DOI 10.1111/j.1538-7836.2005.01330.x; Pepke-Zaba J, 2013, EUR RESPIR J, V41, P985, DOI 10.1183/09031936.00201612; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Simonneau G, 2017, EUR RESPIR REV, V26, P143; van der Bijl N, 2011, CHEST, V140, P1008, DOI 10.1378/chest.10-3174; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485; Van Dongen CJJ, 2005, J THROMB HAEMOST, V3, P939; van Rein N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164485; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239	28	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232354	10.1371/journal.pone.0232354	http://dx.doi.org/10.1371/journal.pone.0232354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343741	gold, Green Published			2022-12-26	WOS:000536661300053
J	Kumar, M; Moptom, SE; Sen, P; Khetan, V; Bhende, M; Sivaprasad, S; Raman, R				Kumar, Meenakshi; Moptom, Sangeetha E.; Sen, Parveen; Khetan, Vikas; Bhende, Muna; Sivaprasad, Sobha; Raman, Rajiv		Sankara Nethralaya Vitreore	Prevalence of polypoidal choroidal vasculopathy in Indian population: Risk factors, clinical and imaging characteristics	PLOS ONE			English	Article							MACULAR DEGENERATION; CHINESE; FEATURES	Aim To assess prevalence, clinical presentation and multimodal imaging characteristics of polypoidal choroidal vasculopathy (PCV) in a hospital-based setting in South India. Methods Electronic medical records (EMR) of new patients presenting with suspected clinical signs of wet age-related macular degeneration (AMD) in a tertiary hospital from January to December 2016 were retrospectively analyzed using keywords and filtered for patient who underwent multimodal imaging. Clinical presentations were categorized into predominantly hemorrhagic, exudative or mixed pattern. The imaging features were compared in these clinical groups. The multimodal images were graded by two masked graders and discrepancies between them were settled by a senior arbitrator. Results Of the 147 clinically suspicious cases of PCV out of 785 patients with clinical presentation of AMD as recorded in the EMR, 73 (49.7%) patients had a multimodal imaging diagnosis of PCV. There was no difference in the demography, distribution of polyps, ICGA and OCT characteristics in eyes presenting with hemorrhagic, exudative or mixed clinical features. Conclusion Approximately half of South Asian patients presenting with clinical features of neovascular AMD harbor PCV irrespective of their clinical presentation and so we recommend that multimodal imaging is done in all cases of suspicious neovascular AMD in Indian population.	[Kumar, Meenakshi; Sen, Parveen; Khetan, Vikas; Bhende, Muna; Raman, Rajiv] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Chennai, Tamil Nadu, India; [Moptom, Sangeetha E.] Sankara Nethralaya, Diabet Retinopathy Project, Chennai, Tamil Nadu, India; [Sivaprasad, Sobha] NIHR Moorfields Biomed Res Ctr, London, England		Raman, R (corresponding author), Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Chennai, Tamil Nadu, India.	rajivpgraman@gmail.com	Sivaprasad, S./D-6876-2015	Sivaprasad, S./0000-0001-8952-0659; Bhende, Muna/0000-0002-9251-170X; Khetan, Vikas/0000-0003-4396-9877				Ahuja RM, 2000, BRIT J OPHTHALMOL, V84, P479, DOI 10.1136/bjo.84.5.479; Anantharaman G, 2018, INDIAN J OPHTHALMOL, V66, P896, DOI 10.4103/ijo.IJO_1136_17; Bhoomibunchoo C, 2017, CLIN OPHTHALMOL, V11, P317, DOI 10.2147/OPTH.S126226; Byeon SH, 2008, JPN J OPHTHALMOL, V52, P57, DOI 10.1007/s10384-007-0498-2; Cackett P, 2009, RETINA-J RET VIT DIS, V29, P187, DOI 10.1097/IAE.0b013e318188c839; Honda S, 2014, OPHTHALMOLOGICA, V231, P59, DOI 10.1159/000355488; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Kwok AKH, 2002, BRIT J OPHTHALMOL, V86, P892, DOI 10.1136/bjo.86.8.892; Ladas ID, 2004, EYE, V18, P455, DOI 10.1038/sj.eye.6700706; Lafaut BA, 2000, GRAEF ARCH CLIN EXP, V238, P752, DOI 10.1007/s004170000180; Li Y, 2014, OPHTHALMOLOGY, V121, P2290, DOI 10.1016/j.ophtha.2014.06.016; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Raman R, 2016, EYE, V30, P688, DOI 10.1038/eye.2016.14; Scassellati-Sforzolini B, 2001, RETINA-J RET VIT DIS, V21, P121, DOI 10.1097/00006982-200104000-00004; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Song SJ, 2009, OPHTHAL EPIDEMIOL, V16, P304, DOI 10.3109/09286580902999413; Tan CS, 2015, BRIT J OPHTHALMOL, V99, P624, DOI 10.1136/bjophthalmol-2014-305674; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Wen F, 2004, GRAEF ARCH CLIN EXP, V242, P625, DOI 10.1007/s00417-003-0667-z; Wong CW, 2015, J CLIN MED, V4, P782, DOI 10.3390/jcm4050782; Yadav S, 2017, BRIT J OPHTHALMOL, V101, P1377, DOI 10.1136/bjophthalmol-2016-310074; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Yannuzzi LA, 1982, MAC SOC M MIAM 5 FEB; Yannuzzi Lawrence A, 2012, Retina, V32 Suppl 1, P416	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231901	10.1371/journal.pone.0231901	http://dx.doi.org/10.1371/journal.pone.0231901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343707	Green Published, gold			2022-12-26	WOS:000536661300018
J	Leu, C; Richardson, TG; Kaufmann, T; van der Meer, D; Andreassen, OA; Westlye, LT; Busch, RM; Smith, GD; Lal, D				Leu, Costin; Richardson, Tom G.; Kaufmann, Tobias; van der Meer, Dennis; Andreassen, Ole A.; Westlye, Lars T.; Busch, Robyn M.; Smith, George Davey; Lal, Dennis			Pleiotropy of polygenic factors associated with focal and generalized epilepsy in the general population	PLOS ONE			English	Article							ACCURACY; HEALTH	Epilepsy is clinically heterogeneous, and neurological or psychiatric comorbidities are frequently observed in patients. It has not been tested whether common risk variants for generalized or focal epilepsy are enriched in people with other disorders or traits related to brain or cognitive function. Here, we perform two brain-focused phenome association studies of polygenic risk scores (PRS) for generalized epilepsy (GE-PRS) or focal epilepsy (FE-PRS) with all binary brain or cognitive function-related traits available for 334,310 European-ancestry individuals of the UK Biobank. Higher GE-PRS were associated with not having a college or university degree (P = 3.00x10(-4)), five neuroticism-related personality traits (P<2.51x10(-4)), and having ever smoked (P = 1.27x10(-6)). Higher FE-PRS were associated with several measures of low educational attainment (P<4.87x10(-5)), one neuroticism-related personality trait (P = 2.33x10(-4)), having ever smoked (P = 1.71x10(-4)), and having experienced events of anxiety or depression (P = 2.83x10(-4)). GE- and FE-PRS had the same direction of effect for each of the associated traits. Genetic factors associated with GE or FE showed similar patterns of correlation with genetic factors associated with cortical morphology in a subset of the UKB with 16,612 individuals and T1 magnetic resonance imaging data. In summary, our results suggest that genetic factors associated with epilepsies may confer risk for other neurological and psychiatric disorders in a population sample not enriched for epilepsy.	[Leu, Costin; Lal, Dennis] Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44106 USA; [Leu, Costin; Lal, Dennis] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Leu, Costin] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London, England; [Richardson, Tom G.; Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Populat Hlth Sci, Bristol Med Sch, Oakfield House, Bristol, Avon, England; [Kaufmann, Tobias] Univ Oslo, Div Mental Hlth & Addict, NORMENT, KG Jebsen Ctr Psychosis Res,Oslo Univ Hosp, Oslo, Norway; [Kaufmann, Tobias] Univ Oslo, Inst Clin Med, Oslo, Norway; [van der Meer, Dennis; Andreassen, Ole A.; Westlye, Lars T.] Univ Oslo, Norwegian Ctr Mental Disorders Res, Oslo, Norway; [van der Meer, Dennis; Andreassen, Ole A.; Westlye, Lars T.] Oslo Univ Hosp, Oslo, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Busch, Robyn M.; Lal, Dennis] Cleveland Clin, Epilepsy Ctr, Neurol Inst, Cleveland, OH 44106 USA; [Busch, Robyn M.] Cleveland Clin, Dept Psychiat & Psychol, Neurol Inst, Cleveland, OH 44106 USA; [Busch, Robyn M.] Cleveland Clin, Dept Neurol, Neurol Inst, Cleveland, OH 44106 USA; [Lal, Dennis] Univ Cologne, Cologne Ctr Genom CCG, Cologne, Germany	Cleveland Clinic Foundation; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; University College London; University of Bristol; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; German Sport University Cologne; University of Cologne	Leu, C; Lal, D (corresponding author), Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44106 USA.; Leu, C; Lal, D (corresponding author), Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Leu, C (corresponding author), UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London, England.; Lal, D (corresponding author), Cleveland Clin, Epilepsy Ctr, Neurol Inst, Cleveland, OH 44106 USA.; Lal, D (corresponding author), Univ Cologne, Cologne Ctr Genom CCG, Cologne, Germany.	leuc@ccf.org; lald@ccf.org	Kaufmann, Tobias/M-8972-2017; van der Meer, Dennis/H-6663-2019; Andreassen, Ole A./AAY-7531-2020; Davey Smith, George/A-7407-2013	Kaufmann, Tobias/0000-0002-4003-1018; van der Meer, Dennis/0000-0002-0466-386X; Davey Smith, George/0000-0002-1407-8314; Westlye, Lars T./0000-0001-8644-956X; Leu, Costin/0000-0003-0598-3301; Richardson, Tom/0000-0002-7918-2040	Integrative Epidemiology Unit from the UK Medical Research Council; University of Bristol [MC_UU_00011/1]; NIH/NCATS, CTSA, Cleveland, Ohio [UL1TR000439]; UKRI Innovation Research [MR/S003886/1]; MRC [MC_UU_00011/1] Funding Source: UKRI	Integrative Epidemiology Unit from the UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; NIH/NCATS, CTSA, Cleveland, Ohio; UKRI Innovation Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Integrative Epidemiology Unit, which receives funding from the UK Medical Research Council and the University of Bristol (MC_UU_00011/1). TGR is a UKRI Innovation Research Fellow (MR/S003886/1). RMB received support from the NIH/NCATS, CTSA UL1TR000439, Cleveland, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Abou-Khalil B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07524-z; Alexander-Bloch AF, 2018, NEUROIMAGE, V178, P540, DOI 10.1016/j.neuroimage.2018.05.070; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clary HMM, 2018, EPILEPSY BEHAV, V85, P64, DOI 10.1016/j.yebeh.2018.05.024; Dudbridge F, 2015, HUM HERED, V80, P178, DOI 10.1159/000446581; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gormley P, 2018, NEURON, V99, P1098, DOI [10.1016/j.neuron.2018.08.029, 10.1016/j.neuron.2018.04.014]; Jonas KG, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0612-5; Kaufmann T, 2018, BIORXIV, DOI [10.1101/487173, DOI 10.1101/487173]; Keezer MR, 2016, LANCET NEUROL, V15, P106, DOI 10.1016/S1474-4422(15)00225-2; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kim M, 2018, EPILEPSY BEHAV, V84, P56, DOI 10.1016/j.yebeh.2018.04.015; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Krapohl E, 2016, MOL PSYCHIATR, V21, P1188, DOI 10.1038/mp.2015.126; Lakhani CM, 2019, NAT GENET, V51, P327, DOI 10.1038/s41588-018-0313-7; Lee S, 2011, BIOMETRICS, V67, P967, DOI 10.1111/j.1541-0420.2010.01520.x; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maxwell J, 2019, BIORXIV; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Mottus R, 2017, PSYCHOL SCI, V28, P1631, DOI 10.1177/0956797617719083; Nagel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03242-8; O'Connor LJ, 2019, AM J HUM GENET, V105, P456, DOI 10.1016/j.ajhg.2019.07.003; Peterson RE, 2017, AM J ADDICTION, V26, P494, DOI 10.1111/ajad.12586; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Richardson TG, 2019, ELIFE, V8, DOI 10.7554/eLife.43657; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Scott AJ, 2017, EPILEPSIA, V58, P973, DOI 10.1111/epi.13769; Srinivas H V, 2017, Neurol India, V65, pS18, DOI 10.4103/neuroindia.NI_922_16; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; van Rheenen W, 2019, NAT REV GENET, V20, P567, DOI 10.1038/s41576-019-0137-z; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Whelan CD, 2018, BRAIN, V141, P391, DOI 10.1093/brain/awx341	40	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232292	10.1371/journal.pone.0232292	http://dx.doi.org/10.1371/journal.pone.0232292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343744	Green Published, gold			2022-12-26	WOS:000536661300051
J	Broady, TR; Brener, L; Cama, E; Hopwood, M; Treloar, C				Broady, Timothy R.; Brener, Loren; Cama, Elena; Hopwood, Max; Treloar, Carla			Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population	PLOS ONE			English	Article							HEALTH-RELATED STIGMA; HEPATITIS-C; EFFECTIVE INTERVENTIONS; POSITIVE SPEAKERS; SOCIAL DISTANCE; USERS; CARE; PREJUDICE; DISCRIMINATION; PROFESSIONALS	Stigma has significant detrimental health outcomes for those affected. This study examined socio-demographic characteristics that were associated with stigmatising attitudes among the general population towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections. Questions were included in the Australian Survey of Social Attitudes (total sample = 1,001). Attitudes towards each of the target populations were measured by 5-item stigma scales. Bivariate analyses and multiple regression analyses were conducted to identify socio-demographic characteristics associated with stigmatising attitudes. Knowing a person affected by a stigmatised attribute was associated with reduced stigmatising attitudes, while voting for a conservative political party was associated with increased stigmatising attitudes. Age, gender, education, income, and marital status were each related to some stigmatising attitudes. Results also highlight differences between attitudes towards a stigmatised behaviour (i.e., injecting drug use) and stigmatised conditions (i.e., blood borne viruses and sexually transmissible infections). Identifying socio-demographic characteristics that are associated with stigmatising attitudes may have global implications for informing stigma reduction interventions, in order to promote positive health outcomes for affected communities.	[Broady, Timothy R.; Brener, Loren; Cama, Elena; Hopwood, Max; Treloar, Carla] UNSW Sydney, Ctr Social Res Hlth, Sydney, NSW, Australia	University of New South Wales Sydney	Broady, TR (corresponding author), UNSW Sydney, Ctr Social Res Hlth, Sydney, NSW, Australia.	t.broady@unsw.edu.au	Broady, Timothy/J-7362-2017	Broady, Timothy/0000-0002-4341-1868	Australian Government Department of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	The Centre for Social Research in Health receives funding from the Australian Government Department of Health.	Allport G. W., 1954, NATURE PREJUDICE; Brandt MJ, 2014, CURR DIR PSYCHOL SCI, V23, P27, DOI 10.1177/0963721413510932; Brener L, AIDS CARE; Brener L, 2008, SUBST USE MISUSE, V43, P295, DOI 10.1080/10826080701202627; Brener L, 2007, INT J DRUG POLICY, V18, P381, DOI 10.1016/j.drugpo.2007.01.006; Brener L, 2019, PSYCHOL HEALTH MED, V24, P439, DOI 10.1080/13548506.2018.1546018; Brener L, 2013, J NERV MENT DIS, V201, P460, DOI 10.1097/NMD.0b013e318294744a; Brener L, 2013, PSYCHOL HEALTH MED, V18, P242, DOI 10.1080/13548506.2012.701753; Brener L, 2010, SUBST USE MISUSE, V45, P1007, DOI 10.3109/10826081003659543; Cama EJ, 2015, J COMMUNITY APPL SOC, V25, P418, DOI 10.1002/casp.2222; Corrigan Patrick W, 2002, World Psychiatry, V1, P16; Corrigan PW, 2001, SCHIZOPHRENIA BULL, V27, P219, DOI 10.1093/oxfordjournals.schbul.a006868; Crocker J., 1998, HDB SOCIAL PSYCHOL, V4th ed, P504, DOI DOI 10.1002/9780470561119; Crowson HM, 2009, J PSYCHOL, V143, P449, DOI 10.3200/JRL.143.5.449-463; Elliott AJ, 2000, DRUG ALCOHOL REV, V19, P191, DOI 10.1080/713659328; Farwell L, 2000, PERS SOC PSYCHOL B, V26, P845, DOI 10.1177/0146167200269009; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Grimmer M, 2019, PARTY POLIT, V25, P268, DOI 10.1177/1354068817710585; Gronholm PC, 2017, SOC PSYCH PSYCH EPID, V52, P249, DOI 10.1007/s00127-017-1341-9; Harris AHS, 2006, DRUG ALCOHOL DEPEN, V84, P93, DOI 10.1016/j.drugalcdep.2005.12.010; Hebl MR, 2002, J APPL SOC PSYCHOL, V32, P223, DOI 10.1111/j.1559-1816.2002.tb00214.x; Hopwood M, 2004, INTERN MED J, V34, P526, DOI 10.1111/j.1445-5994.2004.00639.x; Hopwood M, 2010, DRUG ALCOHOL REV, V29, P385, DOI 10.1111/j.1465-3362.2009.00151.x; Hughes CE, 2011, INT J DRUG POLICY, V22, P285, DOI 10.1016/j.drugpo.2011.05.008; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kingori C, 2017, INT J STD AIDS, V28, P910, DOI 10.1177/0956462416680764; Korner H., 2004, International Journal of Drug Policy, V15, P46, DOI 10.1016/S0955-3959(03)00089-6; Lauber C, 2004, COMMUNITY MENT HLT J, V40, P265, DOI 10.1023/B:COMH.0000026999.87728.2d; Lenton S, 1997, INT J DRUG POLICY, V8, P101; Lim T, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18637; Major B, 2018, OXFORD HDB STIGMA DI; Malka A, 2014, J PERS SOC PSYCHOL, V106, P1031, DOI 10.1037/a0036170; Mehta N, 2015, BRIT J PSYCHIAT, V207, P377, DOI 10.1192/bjp.bp.114.151944; Pachankis JE, 2018, PERS SOC PSYCHOL B, V44, P451, DOI 10.1177/0146167217741313; Paxton S, 2002, AIDS EDUC PREV, V14, P282, DOI 10.1521/aeap.14.5.282.23874; Richmond JA, 2007, J VIRAL HEPATITIS, V14, P624, DOI 10.1111/j.1365-2893.2007.00849.x; Schmitt MT, 2014, PSYCHOL BULL, V140, P921, DOI 10.1037/a0035754; Shodimu M. A., 2017, J AIDS HIV RES, V9, P139; Sibley CG, 2008, PERS SOC PSYCHOL REV, V12, P248, DOI 10.1177/1088868308319226; Thornicroft G, 2016, LANCET, V387, P1123, DOI 10.1016/S0140-6736(15)00298-6; Tindal C, 2010, AUST J PRIM HEALTH, V16, P119, DOI 10.1071/PY09026; Turan B, 2017, AIDS BEHAV, V21, P283, DOI 10.1007/s10461-016-1451-5; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018; von Hippel W, 2008, PSYCHOL SCI, V19, P7, DOI 10.1111/j.1467-9280.2008.02037.x; Yuan Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167297	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232218	10.1371/journal.pone.0232218	http://dx.doi.org/10.1371/journal.pone.0232218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8VC	32339212	Green Published, gold			2022-12-26	WOS:000536657400033
J	Dirisu, O; Eluwa, G; Adams, E; Torpey, K; Shittu, O; Adebajo, S				Dirisu, Osasuyi; Eluwa, George; Adams, Eseoghene; Torpey, Kwasi; Shittu, Oladapo; Adebajo, Sylvia			"I think this is the only challenge ... the stigma" Stakeholder perceptions about barriers to Antenatal care (ANC) and Prevention of mother-to-child transmission (PMTCT) uptake in Kano state, Nigeria	PLOS ONE			English	Article							FOLLOW-UP; HIV; IMPLEMENTATION; PROGRAM; CASCADE	Background Despite the progress made so far in reducing mother-to-child transmission (MTCT), Nigeria still contributes significantly to the global burden of new pediatric HIV infections. The elimination target for MTCT has not been reached and the decline in new infections among all Global Plan countries from 2009 to 2015 was lowest in Nigeria. This qualitative study explores the barriers to uptake of prevention of mother-to-child transmission (PMTCT) intervention in Kano, the second most populous state in Nigeria. Methods Key informant interviews (KIIs) were conducted among twelve stakeholders who were purposively selected based on their knowledge and involvement in PMTCT program activities in the state. The KII guide explored the status and challenges of PMTCT uptake in Kano state. Qualitative data analysis was managed using NVIVO 11 software and themes were analyzed using thematic analysis. Results We found that the key barriers to uptake of PMTCT identified by stakeholders cut across the domains of the socio-ecological model. These include-fear of stigma associated with being seen accessing HIV related services, low male partner involvement, socio-cultural beliefs about the dangers of hospital-based delivery, poor attitude of health workers, distance/cost to facilities, issues with availability of HIV test kits and poor organization of health services. Conclusion The implementation of effective PMTCT programs would require innovative strategies that leverage improvement of Antenatal care (ANC) uptake as an entry point for PMTCT. In addition, sustaining engagement in care requires creating a supportive stigma-free environment in the community as well as spousal support to ensure women can navigate the socio-cultural barriers that limit access to health services.	[Dirisu, Osasuyi; Eluwa, George; Adebajo, Sylvia] Populat Council, HIV & AIDS Program, Abuja, Nigeria; [Adams, Eseoghene] LEEDx Africa, Abuja, Nigeria; [Torpey, Kwasi] Univ Ghana, Coll Hlth Sci, Accra, Ghana; [Shittu, Oladapo] Ahmadu Bello Univ, Teaching Hosp, Dept Obstet & Gynaecol, Zaria, Kaduna, Nigeria	University of Ghana; Ahmadu Bello University	Dirisu, O (corresponding author), Populat Council, HIV & AIDS Program, Abuja, Nigeria.	osasuyidirisu@gmail.com			United States Presidential Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [AID-620-A-00002]	United States Presidential Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was carried out as part of Strengthening Integrated Delivery of HIV/AIDS Services (SIDSHAS) project, funded by the United States Presidential Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) under the Cooperative Agreement AID-620-A-00002, managed by an FHI 360-led consortium. The funders played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Aizire J, 2013, CURR HIV RES, V11, P144, DOI 10.2174/1570162X11311020007; Al-Mujtaba M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3645415; Avert, 2019, HIV AIDS NIG; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Ezeanolue EE, 2016, JAIDS-J ACQ IMM DEF, V72, pS161, DOI 10.1097/QAI.0000000000001066; Fagbamigbe AF, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0527-y; Ginsburg AS, 2007, AIDS, V21, P2529, DOI 10.1097/QAD.0b013e3282f155f4; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Gulaid LA, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17390; Hampanda K., 2013, ISRN INFECT DIS, V2012; Haroz D, 2017, JAIDS-J ACQ IMM DEF, V75, pS2, DOI 10.1097/QAI.0000000000001318; HIarlaithe MO, 2014, AIDS BEHAV, V18, pS516, DOI 10.1007/s10461-014-0756-5; Igwegbe A., 2010, J MED MED SCI, V1, P296; Iwelunmor J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-771; Kalembo FW, 2012, ISRN AIDS, V2012; Liu JX, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2172-3; Lumbantoruan C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198329; National Population Commission (NPC), 2012, KAN STAT POP PROJ 20; National Population Commission (NPC) [Nigeria] ICF, 2019, NIG DEM HLTH SURV 20; Nyasulu J. Y., 2011, Journal of Rural and Tropical Public Health, V10, P48; Okoli JC, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.154.4225; Olugbenga-Bello AI, 2013, INT J WOMENS HEALTH, V5, P399, DOI 10.2147/IJWH.S45815; Onono M., 2015, J AIDS CLIN RES, V6; Rawizza HE, 2015, CURR HIV RES, V13, P201, DOI 10.2174/1570162X1303150506183256; Rollins N, 2014, JAIDS-J ACQ IMM DEF, P67; Sam-Agudu NA, 2014, JAIDS-J ACQ IMM DEF, P67; Sam-Agudu NA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1417-2; Sloan NL, 2018, MATERN CHILD HLTH J, P1; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Turan JM, 2015, JAIDS-J ACQ IMM DEF, V69, pe172, DOI 10.1097/QAI.0000000000000678; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2019, EXP DAT COLL AN PROV; UNAIDS, 2020, GLOB HIV AIDS STAT F; UNAIDS, 2011, COUNTD ZER GLOB PLAN; WHO, MOTH TO CHILD TRANSM; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Bank, 2019, TRENDS MAT MORT 2000; World Health Organization, 2010, PMTCT STRAT VIS 2010; Youngleson MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013891	39	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232028	10.1371/journal.pone.0232028	http://dx.doi.org/10.1371/journal.pone.0232028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339180	Green Published, gold			2022-12-26	WOS:000536657400022
J	Rimal, S; Ojha, KC; Chaisowwong, W; Shah, Y; Pant, DK; Sirimalaisuwan, A				Rimal, Shikha; Ojha, Krishna Chandra; Chaisowwong, Warangkhana; Shah, Yogendra; Pant, Dhan Kumar; Sirimalaisuwan, Anucha			Detection of virus-neutralising antibodies and associated factors against rabies in the vaccinated household dogs of Kathmandu Valley, Nepal	PLOS ONE			English	Article								Background Rabies is a vaccine-preventable neglected tropical viral zoonosis. It occurs worldwide, creating a very heavy burden in many developing countries, including Nepal. Dogs are the principle vector for the transmission of this disease in urban areas. Vaccination is the most important preventive measure in areas where dogs are the principle source of infection. This study was conducted with the aim of detecting virus-neutralising antibodies and associated factors against rabies in vaccinated household dogs of Kathmandu valley. Methods Blood samples were collected from 110 vaccinated pet dogs in Kathmandu, Bhaktapur, and Lalitpur districts of Nepal. The samples were taken to the laboratory of the National Zoonosis and Food Hygiene Research Center where serum was separated. An indirect immune-enzymatic assay (Platelia (TM) Rabies II kit ad usum Veterinarium, Biorad, China) was used for the detection of rabies virus anti-glycoprotein antibodies in the dog serum samples following the manufacturer's recommendations and instructions. Optical density values for unknown samples were compared with the positive sera titers in quantification tests obtained after a direct reading on the standard curve. Results were expressed as equivalent units per ml (EU/ml). Findings Of the total samples, 89.09% exceeded the required seroconversion level (>= 0.5 EU/ml); another 9.09% did not reach the seroconversion level (0.125-0.5 EU/ml); and 1.81% had undetectable seroconversion levels (< 0.125 EU/ml) suggesting that the animal had not seroconverted according to the PLATELIA (TM) RABIES II test. Only one factor, the condition under which the dog was kept, was significantly associated with the antibody titer level. No association was found for any of the other factors included in the study. Interpretation Vaccination is the most effective measure for prevention and control of rabies. The locally manufactured brand of vaccine, which is available in Nepal, is potent enough to generate a sufficient amount of protective antibodies, equal to international brands.	[Rimal, Shikha; Ojha, Krishna Chandra; Shah, Yogendra; Pant, Dhan Kumar] Natl Zoonoses & Food Hyg Res Ctr, Kalimati, Nepal; [Rimal, Shikha; Chaisowwong, Warangkhana; Sirimalaisuwan, Anucha] Chiang Mai Univ, Fac Vet Med, Vet Publ Hlth & Food Safety Ctr Asia Pacific, Chiang Mai, Thailand; [Rimal, Shikha; Chaisowwong, Warangkhana; Sirimalaisuwan, Anucha] Chiang Mai Univ, Fac Vet Med, Excellent Ctr Vet Publ Hlth, Chiang Mai, Thailand; [Chaisowwong, Warangkhana; Sirimalaisuwan, Anucha] Chiang Mai Univ, Dept Vet Biosci & Vet Publ Hlth, Fac Vet Med, Chiang Mai, Thailand; [Pant, Dhan Kumar] Tribhuwan Univ, Teaching Hosp, Inst Med, Kathmandu, Nepal; [Pant, Dhan Kumar] Natl Acad Med Sci, Kathmandu, Nepal	Chiang Mai University; Chiang Mai University; Chiang Mai University; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Sirimalaisuwan, A (corresponding author), Chiang Mai Univ, Fac Vet Med, Vet Publ Hlth & Food Safety Ctr Asia Pacific, Chiang Mai, Thailand.; Sirimalaisuwan, A (corresponding author), Chiang Mai Univ, Fac Vet Med, Excellent Ctr Vet Publ Hlth, Chiang Mai, Thailand.; Sirimalaisuwan, A (corresponding author), Chiang Mai Univ, Dept Vet Biosci & Vet Publ Hlth, Fac Vet Med, Chiang Mai, Thailand.	anucha.siri@gmail.com	Pant, Dhan/HHN-2817-2022; Shah, Yogendra/AAU-7395-2020	Shah, Yogendra/0000-0002-0820-4556; Chaisowwong, Warangkhana/0000-0002-9609-1087	Veterinary Public Health and Food Safety Centre for Asia Pacific and Excellent Center of Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, Thailand [R000016652]	Veterinary Public Health and Food Safety Centre for Asia Pacific and Excellent Center of Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, Thailand	This study was supported by the Veterinary Public Health and Food Safety Centre for Asia Pacific and Excellent Center of Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, Thailand to Anucha Sirimalaisuwan (A.S) with Grant award no: R000016652.; The authors would like to acknowledge the staffs of National Zoonoses and Food Hygiene Research Center for their kind support during the research period.	Aspinall R, 2000, BIOGERONTOLOGY, V1, P273, DOI 10.1023/A:1010046532657; Berndtsson LT, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-22; Bourhy H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000839; Clark KA, 1996, J AM VET MED ASSOC, V208, P1827; Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; Devleesschauwer B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004461; Gongal Gyanendra, 2011, Adv Prev Med, V2011, P383870, DOI 10.4061/2011/383870; Goyal K, 2011, PREVALENCE RABIES AN, P111; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hu RL, 2008, EPIDEMIOL INFECT, V136, P1556, DOI 10.1017/S0950268807000131; Jakel V, 2008, DEV BIOLOGICALS, V131, P431; Kennedy LJ, 2007, VACCINE, V25, P8500, DOI 10.1016/j.vaccine.2007.10.015; Kitala P, 2001, ACTA TROP, V78, P217, DOI 10.1016/S0001-706X(01)00082-1; Mansfield KL, 2004, VET REC, V154, P423, DOI 10.1136/vr.154.14.423; Mauti S, 2017, ACTA TROP, V165, P194, DOI 10.1016/j.actatropica.2015.10.016; Mihaela Anca D, 2016, DETECTION ANTIBODIES; Millan J, 2013, EMERG INFECT DIS, V19, P680, DOI 10.3201/eid1904.121143; Minke JM, 2009, VET MICROBIOL, V133, P283, DOI 10.1016/j.vetmic.2008.06.024; Moore SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000595; Pant GR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002560; Tenzin, 2012, ZOONOSES PUBLIC HLTH, V59, P451, DOI 10.1111/j.1863-2378.2012.01489.x; Wang XW, 2008, J BIOL SYST, V16, P519, DOI 10.1142/S0218339008002666; World Health Organization, 2013, WHO EXP CONS RAB 2 R	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0231967	10.1371/journal.pone.0231967	http://dx.doi.org/10.1371/journal.pone.0231967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339182	Green Published, gold			2022-12-26	WOS:000536657400021
J	Yeh, YT; Lu, TJ; Lian, GT; Lung, MC; Lee, YL; Chiang, AN; Hsieh, SC				Yeh, Yu-Te; Lu, Ting-Jang; Lian, Guan-Ting; Lung, Meng-Chuan; Lee, Yu-Lin; Chiang, An-Na; Hsieh, Shu-Chen			Chinese olive (Canarium album L.) fruit regulates glucose utilization by activating AMP-activated protein kinase	FASEB JOURNAL			English	Article						AMPK; Chinese olive (Canarium album L; ); high-fat diet; glucose uptake; mitochondrial	INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLYCOGEN-SYNTHASE; MOLECULAR-MECHANISMS; GLUT4 TRANSLOCATION; IN-VIVO; INHIBITION; METFORMIN; POLYPHENOLS; EXERCISE	A growing body of evidence demonstrates obesity-induced insulin resistance is associated with the development of metabolic diseases. This study was designed to investigate ethyl acetate fraction of Chinese olive fruit extract (CO-EtOAc)-mediated attenuation of obesity and hyperglycemia in a mouse model. About 60% HFD-fed mice were treated intragastrically with CO-EtOAc for last 6 weeks, and body weight, blood biochemical parameters as well as hepatic inflammation response were investigated. Our results showed that CO-EtOAc treatment significantly reduced the formation of hepatic lipid droplets, body weight gain, blood glucose, and improved serum biochemical parameters in HFD-induced obese and insulin resistant mice. We further explored the molecular mechanism underlying the blood glucose modulating effect of CO-EtOAc using L6 myotubes model. We conclude that CO-EtOAc effectively increases the glycogen content and glucose uptake by stimulating the membrane translocation of glucose transporter 4. In addition, CO-EtOAc depolarizes the mitochondrial membrane and decreases the mitochondrial oxygen consumption, which may result in AMPK activation and the consequent mitochondrial fission. This study shows that CO-EtOAc prevents the development of obesity in mice fed with HFD and is also capable of stimulating glucose uptake. The possible mechanism might be due to the effects of CO-EtOAc on activation of AMPK and promotion of mitochondrial fission.	[Yeh, Yu-Te; Lu, Ting-Jang; Lian, Guan-Ting; Lung, Meng-Chuan; Hsieh, Shu-Chen] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 106, Taiwan; [Yeh, Yu-Te] Johns Hopkins Univ, Johns Hopkins All Childrens Hosp, Inst Fundamental Biomed Res, Dept Med,Div Endocrinol Diabet & Metab,Sch Med, St Petersburg, FL USA; [Lee, Yu-Lin; Chiang, An-Na] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan	National Taiwan University; Johns Hopkins University; Johns Hopkins Medicine; National Yang Ming Chiao Tung University	Hsieh, SC (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 106, Taiwan.	schsieh@ntu.edu.tw		LU, TING-JANG/0000-0002-3956-8272	Ministry of Science and Technology, Taiwan (MOST) [104&-3011&-B&-010-001-1-4-2, 104&-2320-B-002-039]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 104&-3011&-B&-010&-001&-1&-4&-2 and 104&-2320&-B&-002&-039	Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Bahadoran Z, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-43; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; Calmettes G, 2015, J MOL CELL CARDIOL, V78, P107, DOI 10.1016/j.yjmcc.2014.09.020; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dali-Youcef N, 2013, ANN MED, V45, P242, DOI 10.3109/07853890.2012.705015; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Doan KV, 2015, ENDOCRINOLOGY, V156, P157, DOI 10.1210/en.2014-1354; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Gupta RN, 2009, INT J DIABETES DEV C, V29, P170, DOI 10.4103/0973-3930.57349; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hsieh SC, 2016, FOOD FUNCT, V7, P4797, DOI [10.1039/c6fo01202g, 10.1039/C6FO01202G]; Hu RK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00925-y; Hur KY, 2015, J DIABETES INVEST, V6, P600, DOI 10.1111/jdi.12328; Jeon M, 2016, BIOCHEM BIOPH RES CO, V479, P22, DOI 10.1016/j.bbrc.2016.08.178; Kanamaru Yusuke, 2012, J Signal Transduct, V2012, P931215, DOI 10.1155/2012/931215; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee EY, 2017, YONSEI MED J, V58, P312, DOI 10.3349/ymj.2017.58.2.312; Liew YF, 2005, J NUTR, V135, P2151, DOI 10.1093/jn/135.9.2151; LILLIOJA S, 1986, J CLIN ENDOCR METAB, V62, P922, DOI 10.1210/jcem-62-5-922; Liu HY, 2008, FOOD RES INT, V41, P363, DOI 10.1016/j.foodres.2007.12.012; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Manchester J, 1996, P NATL ACAD SCI USA, V93, P10707, DOI 10.1073/pnas.93.20.10707; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; Nagano T, 2015, FOOD SCI TECHNOL RES, V21, P489, DOI 10.3136/fstr.21.489; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Polce SA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050531; Poulose N, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000149; Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Solini A, 2001, HYPERTENSION, V37, P1492, DOI 10.1161/01.HYP.37.6.1492; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Thornton C, 2017, NEURONAL SIGNALING, V1, P1; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Xiao JB, 2015, CURR MED CHEM, V22, P23; Yamada E, 2010, FUTURE MED CHEM, V2, P1785, DOI 10.4155/FMC.10.264; Yang JZ, 2014, PROG MOL BIOL TRANSL, V121, P133, DOI 10.1016/B978-0-12-800101-1.00005-3; Yeh YT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19553-1; Yeh YT, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101123; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang CS, 2016, CELL METAB, V23, P399, DOI 10.1016/j.cmet.2016.02.017; Zhang JD, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4353510	57	4	6	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7866	7884		10.1096/fj.201902494RR	http://dx.doi.org/10.1096/fj.201902494RR		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333610				2022-12-26	WOS:000529447300001
J	Ware, M; Garfield, EN; Nedimyer, K; Levy, J; Kaufman, L; Precht, W; Winters, RS; Miller, SL				Ware, Matthew; Garfield, Eliza N.; Nedimyer, Ken; Levy, Jessica; Kaufman, Les; Precht, William; Winters, R. Scott; Miller, Steven L.			Survivorship and growth in staghorn coral (Acropora cervicornis) outplanting projects in the Florida Keys National Marine Sanctuary	PLOS ONE			English	Article							REGION-WIDE DECLINES; POPULATION-STRUCTURE; GENETIC DIVERSITY; REEF RESTORATION; SPECIES COMPOSITION; DIADEMA-ANTILLARUM; BUILDING CORAL; TISSUE LOSS; TRANSPLANTATION; COMMUNITY	Significant population declines in Acropora cervicornis and A. palmata began in the 1970s and now exceed over 90%. The losses were caused by a combination of coral disease and bleaching, with possible contributions from other stressors, including pollution and predation. Reproduction in the wild by fragment regeneration and sexual recruitment is inadequate to offset population declines. Starting in 2007, the Coral Restoration Foundation (TM) evaluated the feasibility of outplanting A. cervicornis colonies to reefs in the Florida Keys to restore populations at sites where the species was previously abundant. Reported here are the results of 20 coral outplanting projects with each project defined as a cohort of colonies outplanted at the same time and location. Photogrammetric analysis and in situ monitoring (2007 to 2015) measured survivorship, growth, and condition of 2419 colonies. Survivorship was initially high but generally decreased after two years. Survivorship among projects based on colony counts ranged from 4% to 89% for seven cohorts monitored at least five years. Weibull survival models were used to estimate survivorship beyond the duration of the projects and ranged from approximately 0% to over 35% after five years and 0% to 10% after seven years. Growth rate averaged 10 cm/year during the first two years then plateaued in subsequent years. After four years, approximately one-third of surviving colonies were >= 50 cm in maximum diameter. Projects used three to sixteen different genotypes and significant differences did not occur in survivorship, condition, or growth. Restoration times for three reefs were calculated based on NOAA Recovery Plan (NRP) metrics (colony abundance and size) and the findings from projects reported here. Results support NRP conclusions that reducing stressors is required before significant population growth and recovery will occur. Until then, outplanting protects against local extinction and helps to maintain genetic diversity in the wild.	[Ware, Matthew] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Garfield, Eliza N.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Nedimyer, Ken] Reef Renewal LLC, Tavernier, FL USA; [Levy, Jessica; Winters, R. Scott] Coral Restorat Fdn, Key Largo, FL USA; [Kaufman, Les] Boston Univ, Marine Program, Boston, MA 02215 USA; [Kaufman, Les] Boston Univ, Pardee Ctr Study Longer Range Future, Boston, MA 02215 USA; [Precht, William] Dial Cordy & Associates, Marine & Coastal Programs, Miami, FL USA; [Miller, Steven L.] Nova Southeastern Univ, Halmos Coll Nat Sci & Oceanog, Dania, FL 33064 USA	State University System of Florida; Florida State University; University of Hawaii System; University of Hawaii Manoa; Boston University; Boston University; Nova Southeastern University	Miller, SL (corresponding author), Nova Southeastern Univ, Halmos Coll Nat Sci & Oceanog, Dania, FL 33064 USA.	smiller@nova.edu	Ware, Matt/R-3860-2019	Ware, Matt/0000-0002-3251-1759; Miller, Steven/0000-0003-3399-6660	American Recovery and Reinvestment Act; Nature Conservancy; NOAA's Coral Reef Conservation Program [NA13NMF4630144]; NOAA's Restoration Center; Coral Restoration FoundationT; A Brian Keller Memorial Fellowship at Nova Southeastern University	American Recovery and Reinvestment Act; Nature Conservancy; NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's Restoration Center(National Oceanic Atmospheric Admin (NOAA) - USA); Coral Restoration FoundationT; A Brian Keller Memorial Fellowship at Nova Southeastern University	An award by the American Recovery and Reinvestment Act to the Coral Restoration Foundation (TM) (to CRF and KN, with financial administration by the Nature Conservancy) funded outplant work in 2012. A partnership with the Nature Conservancy supported work in 2013. NOAA's Coral Reef Conservation Program (NA13NMF4630144: https://coralreef.noaa.gov), NOAA's Restoration Center (www.fisheries.noaa.gov/grant/coastal-and-marine-habitat-restoration-grants), and the Coral Restoration FoundationT (www.coralrestoration.org) provided additional funding for this project. A Brian Keller Memorial Fellowship at Nova Southeastern University (cnso. nova.edu/tools-resources/brian-keller-memorial-fellowship.html#loan) toMWsupported his Master's thesis. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Adey W., 1977, P 3 INT COR REEF S M, V2, P11; Afiq-Rosli L, 2019, CONSERV GENET, V20, P629, DOI 10.1007/s10592-019-01164-6; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2005, CANVAS X GIS VERSION; [Anonymous], 2008, 11 INT COR REEF S; Aronson R., 2008, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008.RLTS.T133381A3716457.en, DOI 10.2305/IUCN.UK.2008.RLTS.T133381A3716457.EN]; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; Barton AD, 2005, CORAL REEFS, V24, P536, DOI 10.1007/s00338-005-0017-1; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2019, ECOL APPL, V29, DOI 10.1002/eap.1978; Benjamin CS, 2017, RESTOR ECOL, V25, P112, DOI 10.1111/rec.12395; Bostrom-Einarsson L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226631; BOTTJER DJ, 1980, J PALEONTOL, V54, P1102; Bowden-Kerby A, 2001, B MAR SCI, V69, P915; Bruckner Andrew W., 2006, P257; Bruno JF, 1998, J EXP MAR BIOL ECOL, V229, P187, DOI 10.1016/S0022-0981(98)00050-1; Burman SG, 2012, MAR ECOL PROG SER, V467, P89, DOI 10.3354/meps09950; Busch J, 2016, B MAR SCI, V92, P265, DOI 10.5343/bms.2015.1038; Cabaitan PC, 2008, J EXP MAR BIOL ECOL, V357, P85, DOI 10.1016/j.jembe.2008.01.001; Carpenter R.C., 1985, P 5 INT COR REEF S, V4, P53; Causey B, 2002, STATUS CORAL REEFS W, P251; Challenger Greg E., 2006, P205; Colella MA, 2012, CORAL REEFS, V31, P621, DOI 10.1007/s00338-012-0880-5; D'Angelo C, 2014, CURR OPIN ENV SUST, V7, P82, DOI 10.1016/j.cosust.2013.11.029; D'Antonio NL, 2016, PEERJ, V4, DOI 10.7717/peerj.2473; DAVIS GE, 1982, B MAR SCI, V32, P608; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Drury C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2583-8; Drury C, 2019, ECOL EVOL, V9, P4518, DOI 10.1002/ece3.5035; Drury C, 2018, CORAL REEFS, V37, P585, DOI 10.1007/s00338-018-1683-0; Drury C, 2017, ECOL EVOL, V7, P6188, DOI 10.1002/ece3.3184; DUSTAN P, 1987, CORAL REEFS, V6, P91, DOI 10.1007/BF00301378; Dustan P., 1985, SMITHSONIAN I ATOLL, V288, P1, DOI DOI 10.5479/SI.00775630.288.1; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edmunds PJ, 2020, MAR ECOL PROG SER, V635, P233, DOI 10.3354/meps13205; Edwards AJ, 1998, MAR POLLUT BULL, V37, P474; Edwards CB, 2017, CORAL REEFS, V36, P1291, DOI 10.1007/s00338-017-1624-3; Epstein N, 2003, AQUAT CONSERV, V13, P387, DOI 10.1002/aqc.558; FFWRI, 2016, UN FLOR COR REEF TRA; FORCUCCI D, 1994, B MAR SCI, V54, P917; Franklin E, 2006, NMSP0609 US DEP COMM; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garrison V, 2008, BIOL CONSERV, V141, P3089, DOI 10.1016/j.biocon.2008.09.020; Garrison VH, 2012, REV BIOL TROP, V60, P59; Ginsberg R, 1964, AM ASS PETROLIUM GEO, P310; Gintert B, 2012, P 12 INT COR REEF MA, P9; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Goergen EA, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00036; Goergen EA, 2018, PEERJ, V6, DOI 10.7717/peerj.4433; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Grablow K, 2010, C WORKSH FLOR KEYS M; Griffin S, 2012, P 12 INT COR REEF S; Hemond EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008652; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hogarth W.T., 2006, FED REGISTER, V71, P26852; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hunt J, 2014, R32R1169 STAT WILDL; Huntington BE, 2017, OECOLOGIA, V184, P247, DOI 10.1007/s00442-017-3859-7; JAAP WC, 1984, FWSOBS8208; JACKSON JBC, 1992, AM ZOOL, V32, P719; Johnson M, 2011, CAN MATH BULL, V54, P297, DOI 10.4153/CMB-2011-014-x; Jones TA, 2011, PROG BOT, V72, P249, DOI 10.1007/978-3-642-13145-5_10; Kaufman L., 1977, Proceedings int Coral Reef Symp, V3, P559; Keck J, 2005, CORAL REEFS, V24, P509, DOI 10.1007/s00338-005-0502-6; Keefer J., 2016, THESIS; Kemp DW, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1373; Kissling DL, 2014, B MAR SCI, V90, P665, DOI 10.5343/bms.2013.1022; Kleinbaum D.G.D., 2011, SURVIVAL ANAL SELF L, V3rd ed.; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuffner IB, 2017, CORAL REEFS, V36, P679, DOI 10.1007/s00338-017-1560-2; Ladd MC, 2019, RESTOR ECOL, V27, P1166, DOI 10.1111/rec.12939; Ladd MC, 2018, FRONT ECOL ENVIRON, V16, P239, DOI 10.1002/fee.1792; Ladd MC, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00261; Ladd MC, 2017, MAR ECOL PROG SER, V572, P129, DOI 10.3354/meps12169; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; Lenihan HS, 2015, ECOLOGY, V96, P1540, DOI 10.1890/14-1115.1; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; Lewis J, 1968, NONR4934 US OFF NAV; Lidz BH, 2013, J COASTAL RES, V29, P256, DOI 10.2112/JCOASTRES-D-12-00078.1; Lirman D, 2010, AQUAT CONSERV, V20, P773, DOI 10.1002/aqc.1146; Lirman D, 2010, CORAL REEFS, V29, P729, DOI 10.1007/s00338-010-0621-6; Lirman D, 2007, ENVIRON MONIT ASSESS, V125, P59, DOI 10.1007/s10661-006-9239-0; Lirman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107253; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Lohr KE, 2017, REG STUD MAR SCI, V9, P1, DOI 10.1016/j.rsma.2016.11.003; Maynard J, 2015, NAT CLIM CHANGE, V5, P688, DOI 10.1038/nclimate2625; MEESTERS H.W.G., 2015, CORAL RESTORATION BO; Mercado-Molina AE, 2018, MAR ECOL PROG SER, V597, P147, DOI 10.3354/meps12578; Mercado-Molina AE, 2015, CORAL REEFS, V34, P1113, DOI 10.1007/s00338-015-1341-8; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; Miller S, 2013, TECHNICAL SERIES, P1; Miller S, 2011, NOVA SE U TECHNICAL; Monty JA, 2006, P 10 INT COR REEF S, P1665; Moulding AL., 2020, NOAA TECHNICAL MEMOR, DOI [10.25923/N4TX-1A30, DOI 10.25923/N4TX-1A30, 10.25923/n4tx-1a30]; Nedimyer Kenneth, 2011, AACL Bioflux, V4, P442; NEIGEL JE, 1983, EVOLUTION, V37, P437, DOI 10.1111/j.1558-5646.1983.tb05561.x; NMFS, 2015, FED REG; NOAA Fisheries, REST 7 ICON REEFS MI; O'Donnell KE, 2018, CORAL REEFS, V37, P1109, DOI 10.1007/s00338-018-01743-y; Pachauri R.K., CLIMATE CHANGE 2014; Page CA, 2018, ECOL ENG, V123, P86, DOI 10.1016/j.ecoleng.2018.08.017; PERKINS RD, 1968, J GEOL, V76, P710, DOI 10.1086/627394; PORTER JW, 1982, P NATL ACAD SCI-BIOL, V79, P1678, DOI 10.1073/pnas.79.5.1678; Precht W, 2012, TROPICAL CONNECTIONS, P434; Precht William F., 2006, P1, DOI 10.1201/9781420003796.ch1; Precht WF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31374; Precht William F., 2007, V192, P237, DOI 10.1007/978-0-387-33537-7_9; Precht William F., 2005, Ecological Restoration, V23, P24, DOI 10.3368/er.23.1.24; Riegl B, 2009, MAR POLLUT BULL, V58, P24, DOI 10.1016/j.marpolbul.2008.10.019; Rinkevich B, 1995, RESTOR ECOL, V3, P241, DOI 10.1111/j.1526-100X.1995.tb00091.x; Rinkevich Baruch, 2006, P291, DOI 10.1201/9781420003796.ch16; ROBERTS HH, 1982, J SEDIMENT PETROL, V52, P145; Schmahl George P., 2006, P235, DOI 10.1201/9781420003796.ch13; Schopmeyer SA, 2017, CORAL REEFS, V36, P1047, DOI 10.1007/s00338-017-1596-3; Schopmeyer SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141302; Schopmeyer SA, 2012, RESTOR ECOL, V20, P696, DOI 10.1111/j.1526-100X.2011.00836.x; Schutter M, 2010, CORAL REEFS, V29, P737, DOI 10.1007/s00338-010-0617-2; Shafir S., 2008, AQUACULTURE RES TREN, P279; Shearer TL, 2009, CORAL REEFS, V28, P727, DOI 10.1007/s00338-009-0520-x; SHINN E. A., 1966, J PALEONTOL, V40, P233; SHINN EA, 1976, ENVIRON GEOL, V1, P241, DOI 10.1007/BF02407510; Smith SG, 2011, ENVIRON MONIT ASSESS, V183, P121, DOI 10.1007/s10661-011-1912-2; Steiner KC, 2017, NEW FOREST, V48, P317, DOI 10.1007/s11056-016-9561-5; Team RC, 2014, R LANG ENV STAT COMP; Toth LT, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2781; van Hooidonk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39666; Van Oppen MJH, 2017, GLOBAL CHANGE BIOL, V23, P3437, DOI 10.1111/gcb.13647; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112; van Woesik R, 2018, RESTOR ECOL, V26, P563, DOI 10.1111/rec.12590; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Walker BK, 2012, CORAL REEFS, V31, P885, DOI 10.1007/s00338-012-0910-3; Walton CJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00323; Wapnick Cheryl, 2006, P339; Weil E, 2020, PEERJ, V8, DOI 10.7717/peerj.8435; White M. W., 1985, P 5 INT COR REEF C T, V5, P531; Williams D.E., 2006, PROC 10 INT CORAL RE, V1, P1096; Williams DE, 2010, RESTOR ECOL, V18, P446, DOI 10.1111/j.1526-100X.2009.00579.x; Yap HT, 2009, MAR ECOL PROG SER, V374, P33, DOI 10.3354/meps07650; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143; Zhao MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep33324	144	29	28	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0231817	10.1371/journal.pone.0231817	http://dx.doi.org/10.1371/journal.pone.0231817			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374734	gold, Green Published			2022-12-26	WOS:000537283500011
J	Ben Ahmed, Y; Coulaud, J; Ken, S; Parent, L				Ben Ahmed, Yassir; Coulaud, Jeremy; Ken, Soleakhena; Parent, Laure			Determination of paramagnetic ferrous gel sensitivity in low energy x-ray beam produced by a miniature accelerator	PLOS ONE			English	Article							ABSORBED DOSE DISTRIBUTIONS; INTRAOPERATIVE RADIOTHERAPY TARGIT; PROTON RELAXATION-TIMES; POLYMER GEL; DOSIMETRY; MRI; BRACHYTHERAPY; VERIFICATION; DEPENDENCE; SYSTEM	The INTRABEAM Carl Zeiss Surgical system (Oberkochen, Germany) is a miniature accelerator producing low energy photons (50 keV maximum). The published dosimetric characterization of the INTRABEAM was based on detectors (radiochromic films or ionization chambers) not allowing measuring the absorbed dose in the first millimeters of the irradiated medium, where the dose is actually prescribed. This study aims at determining with Magnetic Resonance Imaging (MRI) the sensitivity of a paramagnetic gel in order to measure the dose deposit produced with the INTRABEAM from 0 to 20 mm. Although spherical applicators are mostly used with the INTRABEAM system for breast applications, this study focuses on surface applicators that are of interest for cutaneous carcinomas. The irradiations at 12 different dose levels (between 2 Gy and 50 Gy at the gel surface) were performed with the INTRABEAM and a 4 cm surface applicator. The gel used in this study is a new "sensitive" material. In order to compare gel sensitivity at low energy with high energy, gels were irradiated by an 18 MV photon beam produced by a Varian Clinac 2100 CD. T-2 weighted multi echo MRI sequences were performed with 16 echo times. The T-2 signal versus echo times was fitted with a mono-exponential function with 95% confidence interval. The calibration curve determined at low energy is a linear function (r2 = 0.9893) with a sensitivity of 0.0381 s(-1).Gy(-1), a similar linear function was obtained at high energy (0.0372 s(-1).Gy(-1) with r(2) = 0.9662). The calibration curve at low energy was used to draw isodose maps from the MR images. The PDD (Percent Depth Dose) determined in the gel is within 5%-1mm of the ionization chamber PDD except for one point. The dosimetric sensitivity of this new paramagnetic ferrous gel was determined with MRI measurements. It allowed measuring the dose distribution specifically in the first millimeters for an irradiation with the INTRABEAM miniature accelerator equipped with a surface applicator.	[Ben Ahmed, Yassir; Ken, Soleakhena; Parent, Laure] Inst Univ Canc Toulouse Oncopole IUCT O, Dept Ingn & Phys Med, Inst Claudius Regaud ICR, Toulouse, France; [Coulaud, Jeremy] Univ Paul Sabatier Toulouse III, SIMAD LU50, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ben Ahmed, Y (corresponding author), Inst Univ Canc Toulouse Oncopole IUCT O, Dept Ingn & Phys Med, Inst Claudius Regaud ICR, Toulouse, France.	yassir.benahmed@yahoo.fr	Ken, Soleakhena/AAC-1260-2021; Parent, Laure/AAG-3973-2021	Ken, Soleakhena/0000-0001-7904-5882; COULAUD, Jeremy/0000-0001-9674-727X				Andreo P, 2000, TECHNICAL REPORTS SE, V398; Antoniou Panagiotis E., 2008, Recent Patents on Biomedical Engineering, V1, P203, DOI 10.2174/1874764710801030203; Baldock C., 2004, Journal of Physics: Conference Series, V3, P1, DOI 10.1088/1742-6596/3/1/001; Baldock C, 1998, PHYS MED BIOL, V43, P695, DOI 10.1088/0031-9155/43/3/019; Baldock C, 2010, PHYS MED BIOL, V55, pR1, DOI 10.1088/0031-9155/55/5/R01; BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684; Campbell WG, 2013, MED PHYS, V40, DOI 10.1118/1.4805111; Coulaud J, 2019, BIOMED PHYS ENG EXPR, V5, DOI 10.1088/2057-1976/ab50ce; Coulaud J, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aaac68; Coulaud J, 2019, SPECTROCHIM ACTA A, V220, DOI 10.1016/j.saa.2019.05.029; De Deene Y, 1998, RADIOTHER ONCOL, V48, P283, DOI 10.1016/S0167-8140(98)00087-5; De Deene Y, 2002, PHYS MED BIOL, V47, P2459, DOI 10.1088/0031-9155/47/14/307; De Deene Y, 1998, SIGNAL PROCESS, V70, P85, DOI 10.1016/S0165-1684(98)00115-7; Dedieu V, 2000, MAGN RESON IMAGING, V18, P1221, DOI 10.1016/S0730-725X(00)00222-8; Dedieu V, 2015, PHYS MEDICA, V31, pe50, DOI DOI 10.1016/J.EJMP.2015.10.076; Ebert MA, 2009, J APPL CLIN MED PHYS, V10, P232, DOI 10.1120/jacmp.v10i4.2957; Fletcher CL, 2008, PHYS MED BIOL, V53, pN209, DOI 10.1088/0031-9155/53/11/N02; GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002; Gore JC, 1996, PHYS MED BIOL, V41, P2695, DOI 10.1088/0031-9155/41/12/009; Goubert M, 2015, PHYS MEDICA, V31, P224, DOI 10.1016/j.ejmp.2015.01.009; HAZLE JD, 1991, PHYS MED BIOL, V36, P1117, DOI 10.1088/0031-9155/36/8/007; Knutsen BH, 1997, RADIOTHER ONCOL, V43, P219, DOI 10.1016/S0167-8140(97)01925-7; KRON T, 1994, PHYS MED BIOL, V39, P1337, DOI 10.1088/0031-9155/39/9/003; Lam SCP, 2014, TRANSL CANCER RES, V3, P106, DOI 10.3978/j.issn.2218-676X.2014.02.02; Ma CM, 2001, MED PHYS, V28, P868, DOI 10.1118/1.1374247; MacDougall N, 2002, PHYS MED BIOL, V47, pR107, DOI 10.1088/0031-9155/47/20/201; NELSON TR, 1987, MAGN RESON IMAGING, V5, P189, DOI 10.1016/0730-725X(87)90020-8; Oldham M, 1998, PHYS MED BIOL, V43, P1113, DOI 10.1088/0031-9155/43/5/005; OLSEN DR, 1994, BRIT J RADIOL, V67, P1121, DOI 10.1259/0007-1285-67-803-1121; OLSSON LE, 1989, PHYS MED BIOL, V34, P43, DOI 10.1088/0031-9155/34/1/004; OLSSON LE, 1990, PHYS MED BIOL, V35, P1623, DOI 10.1088/0031-9155/35/12/003; Pantelis E, 2004, PHYS MED BIOL, V49, P3495, DOI 10.1088/0031-9155/49/15/013; PODGORSAK MB, 1992, MED PHYS, V19, P87, DOI 10.1118/1.596901; Saur S, 2005, PHYS MED BIOL, V50, P5251, DOI 10.1088/0031-9155/50/22/003; Schneider F, 2014, J APPL CLIN MED PHYS, V15, P167, DOI 10.1120/jacmp.v15i1.4502; SCHREINER LJ, 1994, MAGN RESON IMAGING, V12, P901, DOI 10.1016/0730-725X(94)92031-1; Shih TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151300; Solc J, 2015, PHYS MEDICA, V31, pe51, DOI [10.1016/j.ejmp.2015.10.079, DOI 10.1016/J.EJMP.2015.10.079]; Solc J, 2012, METROLOGIA, V49, pS231, DOI 10.1088/0026-1394/49/5/S231; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Steenbeke F, 2016, TECHNOL CANCER RES T, V15, P163, DOI 10.1177/1533034614565910; Stien C., 2015, PHYS MEDICA, V31, pe52, DOI DOI 10.1016/J.EJMP.2015.10.080; Suchowerska N, 2001, PHYS MED BIOL, V46, P1391, DOI 10.1088/0031-9155/46/5/305; Vaidya JS, 2005, SEMIN RADIAT ONCOL, V15, P84, DOI 10.1016/j.semradonc.2004.10.007; Vaidya JS, 2002, EUR J SURG ONCOL, V28, P447, DOI 10.1053/ejso.2002.1275; Watson PGF, 2018, MED PHYS, V45, P4274, DOI 10.1002/mp.13059; Yang YJ, 2015, J RADIOANAL NUCL CH, V304, P481, DOI 10.1007/s10967-014-3890-7	47	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232315	10.1371/journal.pone.0232315	http://dx.doi.org/10.1371/journal.pone.0232315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365071	Green Published, gold			2022-12-26	WOS:000536959700024
J	Janzen-Senn, I; Schuon, RA; Tavassol, F; Lenarz, T; Paasche, G				Janzen-Senn, Ida; Schuon, Robert A.; Tavassol, Frank; Lenarz, Thomas; Paasche, Gerrit			Dimensions and position of the Eustachian tube in Humans	PLOS ONE			English	Article							ANATOMY; AGE; DYSFUNCTION	Eustachian tube (ET) dysfunction is one of the causes for chronic otitis media. To develop new therapies such as stents to facilitate middle ear ventilation, a better knowledge on dimensions and positions of the ET in individual patients is necessary. Cone beam CT scans of 143 patients were retrospectively investigated. Parameters such as lengths of the ET and its cartilaginous and bony parts, diameters, angles as well as distance of the ostium from the nasal conchae were determined and evaluated for side, gender and age specific differences. The average length of the cartilaginous and bony tubes was smaller in women than men. The average deviation from the horizontal plane was 1.7 degrees larger on the left side (35.4 degrees) compared to the right side (33.7 degrees). Tools to manipulate the ET or to insert stents into the ET should cover angles from at least 42 degrees to 64 degrees. The distance of the pharyngeal orifices from the conchae nasalis inferior increased with age, becoming most prominent above 70 years of age. This investigation provides necessary information to develop stents for human application and tools for safe positioning of the stents.	[Janzen-Senn, Ida; Schuon, Robert A.; Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Tavassol, Frank] Hannover Med Sch, Clin Craniomaxillofacial Surg, Hannover, Germany; [Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Hearing4all Cluster Excellence, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Paasche, G (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.; Paasche, G (corresponding author), Hannover Med Sch, Hearing4all Cluster Excellence, Hannover, Germany.	Paasche.Gerrit@mh.hannover.de			BMBF RESPONSE - partnership for innovation in implant technology [FKZ 03ZZ0902E]	BMBF RESPONSE - partnership for innovation in implant technology	This study was supported by BMBF RESPONSE - partnership for innovation in implant technology, FKZ 03ZZ0902E, granted to Thomas Lenarz. The study was part of a publicly funded research Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Moraissi EA, 2015, INT J ORAL MAX SURG, V44, P1110, DOI 10.1016/j.ijom.2015.05.006; Alper CM, 2012, ARCH OTOLARYNGOL, V138, P741, DOI 10.1001/archoto.2012.1293; Berger G, 2003, LARYNGOSCOPE, V113, P1192, DOI 10.1097/00005537-200307000-00015; Bezold F, 1882, CORROSIONS ANATOMIE, P24; BROWNING GG, 1992, CLIN OTOLARYNGOL, V17, P317, DOI 10.1111/j.1365-2273.1992.tb01004.x; Brullmann D, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140204; Buytaert J, 2014, MICROSC MICROANAL, V20, P1208, DOI 10.1017/S1431927614001329; Chau ACM, 2009, ORAL SURG ORAL MED O, V107, P559, DOI 10.1016/j.tripleo.2008.11.009; Kujawski OB, 2004, OTOL NEUROTOL, V25, P1, DOI 10.1097/00129492-200401000-00001; LANG J, 1981, ARCH OTO-RHINO-LARYN, V231, P1, DOI 10.1007/BF00465556; Lang J., 1992, KLIN ANATOMIE OHRES; Llewellyn A, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18460; Loftus PA, 2016, LARYNGOSCOPE, V126, P2212, DOI 10.1002/lary.26064; Loubele M, 2009, EUR J RADIOL, V71, P461, DOI 10.1016/j.ejrad.2008.06.002; Miller F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113906; Norman G, 2014, CLIN OTOLARYNGOL, V39, P6, DOI 10.1111/coa.12220; Ockermann T, 2010, LARYNGOSCOPE, V120, P1411, DOI 10.1002/lary.20950; Pahnke J., 2000, LARYNGORHINOOTOLOGIE, V79, pS1; Pau HW, 2011, HNO, V59, P953, DOI 10.1007/s00106-011-2368-y; Pohl F, 2018, HEAD FACE MED, V14, DOI 10.1186/s13005-018-0165-5; Prades JM, 1998, SURG RADIOL ANAT, V20, P335, DOI 10.1007/BF01630616; PROCTOR B, 1967, ARCHIV OTOLARYNGOL, V86, P503; PROCTOR B, 1973, ARCH OTOLARYNGOL, V97, P2; Rajion ZA, 2012, INT J PEDIATR OTORHI, V76, P227, DOI 10.1016/j.ijporl.2011.11.008; Renteria AE, 2017, OTOLARYNG HEAD NECK, V156, P598, DOI 10.1177/0194599817691258; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Schrodter S, 2003, ANAT EMBRYOL, V207, P19, DOI 10.1007/s00429-003-0326-5; Schroder S, 2018, HNO, V66, P155, DOI 10.1007/s00106-017-0465-2; Silvola J, 2014, OTOLARYNG HEAD NECK, V151, P125, DOI 10.1177/0194599814529538; Smith ME, 2016, NEURORADIOLOGY, V58, P543, DOI 10.1007/s00234-016-1663-4; Steinbach E, 1988, Adv Otorhinolaryngol, V39, P94; Sudhoff HH, 2018, AURIS NASUS LARYNX, V45, P207, DOI 10.1016/j.anl.2017.07.001; Takasaki K, 2007, LARYNGOSCOPE, V117, P1251, DOI 10.1097/MLG.0b013e318058a09f; Tarabichi M, 2016, OTOLARYNG CLIN N AM, V49, P1135, DOI 10.1016/j.otc.2016.05.004; TOMODA K, 1981, ACTA OTO-LARYNGOL, V92, P463, DOI 10.3109/00016488109133285	35	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232655	10.1371/journal.pone.0232655	http://dx.doi.org/10.1371/journal.pone.0232655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365086	Green Published, gold			2022-12-26	WOS:000536959700051
J	Umek, N; Hodzovic, I; Damjanovska, M; Cvetko, E; Zel, J; Seliskar, A; Pintaric, TS				Umek, Nejc; Hodzovic, Iljaz; Damjanovska, Marija; Cvetko, Erika; Zel, Jurij; Seliskar, Alenka; Pintaric, Tatjana Stopar			Rescue oxygenation success by cannula or scalpel-bougie emergency front-of-neck access in an anaesthetised porcine model	PLOS ONE			English	Article							DIFFICULT INTUBATION; AIRWAY MANAGEMENT; SURGICAL CRICOTHYROIDOTOMY; CANNOT VENTILATE; JET VENTILATION; GUIDELINES	In the obese, the evidence for the choice of the optimal emergency front-of-neck access technique is very limited and conflicting. We compared cannula and scalpel-bougie emergency front-of-neck access techniques in an anaesthetised porcine model with thick pretracheal tissue. Cannula and scalpel-bougie cricothyroidotomy techniques were performed in 11 and 12 anaesthetised pigs, respectively. Following successful tracheal access, oxygenation was commenced and continued for 5 min using Rapid-O2 device for cannula and circle breathing system for scalpel-bougie study groups. The primary outcome was a successful rescue oxygenation determined by maintenance of arterial oxygen saturation > 90% 5 min after the beginning of oxygenation. Secondary outcomes included success rate of airway device placement, time to successful airway device placement, and trauma to the neck and airway. The success rate of rescue oxygenation was 18% after cannula, and 83% after scalpel-bougie technique (P = 0.003). The success rate of airway device placement was 73% with cannula and 92% with scalpel-bougie technique (P = 0.317). Median (inter-quartilerange) times to successful airway device placement were 108 (30-256) and 90 (63-188) seconds (P = 0.762) for cannula and scalpel-bougie emergency front-of-neck access, respectively. Proportion of animals with iatrogenic trauma additional to the procedure itself was 27% for cannula and 75% for scalpel-bougie technique (P = 0.039). Thus, in the porcine model of obesity, the scalpel-bougie technique was more successful in establishing and maintaining rescue oxygenation than cannula-based technique; however, it was associated with a higher risk of severe trauma.	[Umek, Nejc; Cvetko, Erika; Pintaric, Tatjana Stopar] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana, Slovenia; [Hodzovic, Iljaz] Cardiff Univ, Univ Hosp Wales, Dept Anaesthet Intens Care & Pain Med, Cardiff, Wales; [Damjanovska, Marija; Pintaric, Tatjana Stopar] Univ Med Ctr Ljubljana, Dept Anaesthesiol & Surg Intens Therapy, Ljubljana, Slovenia; [Zel, Jurij; Seliskar, Alenka] Univ Ljubljana, Vet Fac, Small Anim Clin, Ljubljana, Slovenia	University of Ljubljana; Cardiff University; University Medical Centre Ljubljana; University of Ljubljana	Umek, N (corresponding author), Univ Ljubljana, Fac Med, Inst Anat, Ljubljana, Slovenia.	nejc.umek@mf.uni-lj.si	Umek, Nejc/AAX-8299-2020	Umek, Nejc/0000-0001-5831-2216	Slovenian Research Agency [P30043, P4-0053]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	NU, EC, and TSP received grant No. P30043 from Slovenian Research Agency, and JZ and AS received grant No. P4-0053 from Slovenian Research Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PA, 2016, BRIT J ANAESTH, V117, P17, DOI 10.1093/bja/aew219; Berry M, 2014, BRIT J ANAESTH, V113, P1039, DOI 10.1093/bja/aeu188; Cho J, 2008, EMERG MED J, V25, P732, DOI 10.1136/emj.2008.059014; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; DeVore EK, 2019, LARYNGOSCOPE INVEST, V4, P602, DOI 10.1002/lio2.314; Ezri T, 2003, CAN J ANAESTH, V50, P179, DOI 10.1007/BF03017853; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Frova G, 2009, MINERVA ANESTESIOL, V75, P201; Habib CA, 2013, J MAGN RESON IMAGING, V38, P641, DOI 10.1002/jmri.24003; Heard A, 2016, BRIT J ANAESTH, V117, P533, DOI 10.1093/bja/aew286; Heard A, 2013, 02 SCALPEL BOUGI; Heard A., 2013, PERCUTANEOUS EMERGEN; Heard A, 2013, 01 CANNULA INSERTION; Heard AMB, 2009, ANAESTHESIA, V64, P601, DOI 10.1111/j.1365-2044.2009.05888.x; Hill C, 2010, ACAD EMERG MED, V17, P666, DOI 10.1111/j.1553-2712.2010.00753.x; Howes TE, 2015, BRIT J ANAESTH, V114, P136, DOI 10.1093/bja/aeu336; Kristensen MS, 2015, BRIT J ANAESTH, V114, P357, DOI 10.1093/bja/aev029; Kristensenh MS, 2016, BRIT J ANAESTH, V117, P39, DOI 10.1093/bja/aew176; Kumar SP, 2014, INDIAN J OTOLARYNGOL, V66, pS261, DOI 10.1007/s12070-012-0477-x; Langvad S, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-43; Manoach S, 2004, RESUSCITATION, V62, P79, DOI 10.1016/j.resuscitation.2004.02.005; Onrubia X, 2018, TRENDS ANAESTH CRIT, V22, P45, DOI 10.1016/j.tacc.2018.06.001; Pairaudeau CF, 2018, ANAESTHESIA, V73, P579, DOI 10.1111/anae.14218; Patel RG, 1999, CHEST, V116, P1689, DOI 10.1378/chest.116.6.1689; Pintaric TS, 2013, ZDR VESTN, V82, P791; Rees KA, 2019, ANAESTHESIA, V74, P1153, DOI 10.1111/anae.14706; ROMITA MC, 1977, SURG FORUM, V28, P174; Schaumann N, 2005, ANESTHESIOLOGY, V102, P7, DOI 10.1097/00000542-200501000-00005; Sorbello M, 2018, EUR J ANAESTH, V35, P811, DOI 10.1097/EJA.0000000000000893; Szeto C, 2010, OTOLARYNG HEAD NECK, V143, P223, DOI 10.1016/j.otohns.2010.03.007; Timmermann A, 2016, BRIT J ANAESTH, V117, P5, DOI 10.1093/bja/aew107; Watterson L, 2014, TRANSITION SUPRAGLOT; Weightman WM, 2018, BRIT J ANAESTH, V121, P1166, DOI 10.1016/j.bja.2018.07.013; Wong DT, 2014, CAN J ANESTH, V61, P717, DOI 10.1007/s12630-014-0183-0; Wong DT, 2005, ANESTH ANALG, V100, P1439, DOI 10.1213/01.ANE.0000148695.37190.34; Yeow C, 2018, ANAESTHESIA, V73, P1235, DOI 10.1111/anae.14321; Zel J, 2019, BRIT J ANAESTH, V122, P379, DOI 10.1016/j.bja.2018.10.025; ZRUNEK M, 1988, ACTA OTO-LARYNGOL, V105, P155, DOI 10.3109/00016488809119460	38	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2020	15	5							e0232510	10.1371/journal.pone.0232510	http://dx.doi.org/10.1371/journal.pone.0232510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3GS	32365136	Green Published, gold			2022-12-26	WOS:000536959700035
J	Puig-Castellvi, F; Cardona, L; Bouveresse, DJR; Cordella, CBY; Mazeas, L; Rutledge, DN; Chapleur, O				Puig-Castellvi, Francesc; Cardona, Laetitia; Bouveresse, Delphine Jouan-Rimbaud; Cordella, Christophe B. Y.; Mazeas, Laurent; Rutledge, Douglas N.; Chapleur, Olivier			Assessment of the microbial interplay during anaerobic co-digestion of wastewater sludge using common components analysis	PLOS ONE			English	Article							COMMUNITY STRUCTURE; METHANE PRODUCTION; RIBOSOMAL-RNA; FERMENTATION; CELLULOSE; GREASE; ACID; FATS; PULP	Anaerobic digestion (AD) is used to minimize solid waste while producing biogas by the action of microorganisms. To give an insight into the underlying microbial dynamics in anaerobic digesters, we investigated two different AD systems (wastewater sludge mixed with either fish or grass waste). The microbial activity was characterized by 16S RNA sequencing. 16S data is sparse and dispersed, and existent data analysis methods do not take into account this complexity nor the potential microbial interactions. In this line, we proposed a data pre-processing pipeline addressing these issues while not restricting only to the most abundant microorganisms. The data were analyzed by Common Components Analysis (CCA) to decipher the effect of substrate composition on the microorganisms. CCA results hinted the relationships between the microorganisms responding similarly to the AD physicochemical parameters. Thus, in overall, CCA allowed a better understanding of the inter-species interactions within microbial communities.	[Puig-Castellvi, Francesc; Rutledge, Douglas N.] Univ Paris Saclay, UMR SayFood, AgroParisTech, INRAE, Paris, France; [Puig-Castellvi, Francesc; Cardona, Laetitia; Mazeas, Laurent; Chapleur, Olivier] Univ Paris Saclay, PRoc BiOtechnol Serv Environm, INRAE, Antony, France; [Bouveresse, Delphine Jouan-Rimbaud; Cordella, Christophe B. Y.] Univ Paris Saclay, Grp Chimiornetrie Caracterisat Biomarqueurs C2B, AgroParisTech, UMR Physiol Nutr & Comportement Alimentaire,INRAE, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chapleur, O (corresponding author), Univ Paris Saclay, PRoc BiOtechnol Serv Environm, INRAE, Antony, France.	Olivier.chapleur@inrae.fr	Puig-Castellví, Francesc/ABA-2909-2020; Puig-Castellví, Francesc/AAB-7108-2019; Rutledge, Douglas/AAY-5362-2021	Puig-Castellví, Francesc/0000-0003-1064-9586; CORDELLA, Christophe B.Y./0000-0001-6907-5252; Bouveresse, Delphine/0000-0003-0639-0911; Rutledge, Douglas/0000-0001-5634-0766; Cardona, Laetitia/0000-0003-3360-3468	National Research Agency [ANR-16-CE05-0014]	National Research Agency(French National Research Agency (ANR))	LM is holder of a grant from the National Research Agency (https://anr.fr/) with grant number ANR-16-CE05-0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0271-6; Amha YM, 2017, WATER RES, V123, P277, DOI 10.1016/j.watres.2017.06.065; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Bouhlel J, 2018, TALANTA, V178, P854, DOI 10.1016/j.talanta.2017.10.025; Calusinska M, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1195-8; Cardona L, 2019, WASTE MANAGE, V87, P772, DOI 10.1016/j.wasman.2019.03.016; Duan S, 2016, J AGR FOOD CHEM, V64, P2591, DOI 10.1021/acs.jafc.5b05826; Eldem NO, 2004, J ENVIRON SCI HEAL A, V39, P2405, DOI [10.1081/lesa-200026297, 10.1081/ESE-200026297]; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Fermoso FG, 2018, J AGR FOOD CHEM, V66, P8451, DOI 10.1021/acs.jafc.8b02667; Gagliano MC, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv018; Garcia-Pena EI, 2011, BIORESOURCE TECHNOL, V102, P9447, DOI 10.1016/j.biortech.2011.07.068; Godon JJ, 2005, ENVIRON MICROBIOL, V7, P213, DOI 10.1111/j.1462-2920.2004.00693.x; Hartemink R, 1997, J APPL MICROBIOL, V83, P367, DOI 10.1046/j.1365-2672.1997.00239.x; HARWOOD CS, 1981, J BACTERIOL, V148, P109, DOI 10.1128/JB.148.1.109-116.1981; ISO, 1995, 117341995 ISO; Kirkegaard RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09303-0; KITTS WD, 1954, J AGR FOOD CHEM, V2, P639, DOI 10.1021/jf60032a007; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Kurade MB, 2019, BIORESOURCE TECHNOL, V272, P351, DOI 10.1016/j.biortech.2018.10.047; Li HZ, 2015, ANNU REV STAT APPL, V2, P73, DOI 10.1146/annurev-statistics-010814-020351; Li WW, 2018, APPL ENERG, V226, P1219, DOI 10.1016/j.apenergy.2018.05.055; Li YB, 2011, RENEW SUST ENERG REV, V15, P821, DOI 10.1016/j.rser.2010.07.042; Madigou C, 2019, CHEM ENG J, V361, P266, DOI 10.1016/j.cej.2018.12.003; Mata-Alvarez J, 2014, RENEW SUST ENERG REV, V36, P412, DOI 10.1016/j.rser.2014.04.039; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nobu MK, 2015, ISME J, V9, P1710, DOI 10.1038/ismej.2014.256; Ntemiri A, 2019, J AGR FOOD CHEM, V67, P2098, DOI 10.1021/acs.jafc.8b06414; Panichnumsin P, 2012, WATER SCI TECHNOL, V66, P1590, DOI 10.2166/wst.2012.358; PAVLOSTATHIS SG, 1988, APPL ENVIRON MICROB, V54, P2655, DOI 10.1128/AEM.54.11.2655-2659.1988; Qu X, 2009, FEMS MICROBIOL ECOL, V68, P236, DOI 10.1111/j.1574-6941.2009.00661.x; Ransom-Jones E, 2012, MICROB ECOL, V63, P267, DOI 10.1007/s00248-011-9998-1; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Rui JP, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0339-3; Rutledge DN, 2018, J ANAL TEST, V2, P235, DOI 10.1007/s41664-018-0065-5; Saini A, 2015, ENZYME RES, V2015, P1, DOI DOI 10.1155/2015/279381; Thomas S, 2000, APPL BIOCHEM BIOTECH, V84-6, P455, DOI 10.1385/ABAB:84-86:1-9:455; Treu L, 2016, BIORESOURCE TECHNOL, V216, P260, DOI 10.1016/j.biortech.2016.05.081; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Wang NX, 2019, J SCI FOOD AGR, V99, P507, DOI 10.1002/jsfa.9315	40	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232324	10.1371/journal.pone.0232324	http://dx.doi.org/10.1371/journal.pone.0232324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357180	Green Published, gold			2022-12-26	WOS:000536957700024
J	Rauber, F; Steele, EM; Louzada, MLC; Millett, C; Monteiro, CA; Levy, RB				Rauber, Fernanda; Steele, Euridice Martinez; Louzada, Maria Laura Costa; Millett, Christopher; Monteiro, Carlos Augusto; Levy, Renata Bertazzi			Ultra-processed food consumption and indicators of obesity in the United Kingdom population (2008-2016)	PLOS ONE			English	Article							ARTIFICIAL SWEETENERS; NUTRITIONAL QUALITY; DIETARY; SHARE	We examined the association between the consumption of ultra-processed foods and adiposity in a nationally representative sample of the UK adult population. We studied 6,143 participants ( 19 to 96 years, 51.6% female) sampled by the UK National Diet and Nutrition Survey (2008-16). Food items reported in four-day food diary were classified according to the NOVA system. Multiple linear and logistic regressions were used to evaluate associations between the dietary contribution of ultra-processed foods (sex-specific quartile and continuous) and Body Mass Index ( BMI), Waist Circumference (WC) and obesity (BMI> 30kg/m(2)) and abdominal obesity (men: WC >= 102cm, women: WC >= 88cm) status. Models were adjusted for sociodemographic and lifestyle characteristics. In multivariable analyses, the highest consumption of ultra-processed food was associated with 1.66 kg/m(2) higher BMI ( 95%CI 0.96-2.36), 3.56 cm greater WC (95% CI 1.79-5.33) and 90% higher odds for being obese (OR = 1.90, 95%CI 1.39-2.61), compared with the lowest consumption. A 10% increase in the consumption of ultra-processed foods was associated with an increase of 0.38 kg/m(2) in BMI (95%CI 0.20-0.55), 0.87 cm in WC (95%CI 0.40-1.33) and 18% higher odds of being obese (OR = 1.18, 95%CI 1.08-1.28). The consumption of ultra-processed food was associated with an increase in BMI, WC and prevalence of obesity in both sexes. A dose response relationship was observed in both sexes, with a 10% increase in the consumption of ultra-processed foods being associated with a 18% increase in the prevalence of obesity in men and a 17% increase in women. Higher consumption of ultra-processed food is associated with greater adiposity in the UK adult population. Policy makers should consider actions that promote consumption of unprocessed or minimally processed foods and reduce consumption of ultra-processed foods.	[Rauber, Fernanda; Steele, Euridice Martinez; Louzada, Maria Laura Costa; Millett, Christopher; Monteiro, Carlos Augusto; Levy, Renata Bertazzi] Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, Sao Paulo, Brazil; [Rauber, Fernanda; Steele, Euridice Martinez; Louzada, Maria Laura Costa; Monteiro, Carlos Augusto] Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, Brazil; [Millett, Christopher] Imperial Coll London, Sch Publ Hlth, Publ Hlth Policy Evaluat Unit, London, England; [Levy, Renata Bertazzi] Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Imperial College London; Universidade de Sao Paulo	Rauber, F (corresponding author), Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, Sao Paulo, Brazil.; Rauber, F (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, Brazil.	rauber.fernanda@gmail.com	Levy, Renata Bertazzi/F-8931-2012; Rauber, Fernanda/H-6162-2016; Monteiro, Carlos Augusto/F-9892-2012; Steele, Eurídice Martinez/AAP-9903-2021	Levy, Renata Bertazzi/0000-0001-5388-7002; Rauber, Fernanda/0000-0001-9693-7954; Monteiro, Carlos Augusto/0000-0002-3777-1533; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/14900-9, 2016/14302-7, 2018/19820-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers 2015/14900-9, 2016/14302-7 and 2018/19820-1 (FR is a beneficiary of a postdoctoral fellowship). FAPESP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0317-y; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; [Anonymous], 2016, GUIA AL POBL UR AL S; [Anonymous], 2015, MCCANCE WIDD COMP FO; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057; Bingham S, 2007, CANCER EPIDEM BIOMAR, V16, P1651, DOI 10.1158/1055-9965.EPI-06-1050; Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752; Canhada SL, 2020, PUBLIC HEALTH NUTR, V23, P1076, DOI 10.1017/S1368980019002854; Louzada MLD, 2018, PUBLIC HEALTH NUTR, V21, P94, DOI 10.1017/S1368980017001434; Louzada MLD, 2015, PREV MED, V81, P9, DOI 10.1016/j.ypmed.2015.07.018; Mendonca RD, 2017, AM J HYPERTENS, V30, P358, DOI 10.1093/ajh/hpw137; Mendonca RD, 2016, AM J CLIN NUTR, V104, P1433, DOI 10.3945/ajcn.116.135004; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052182; Fiolet T, 2018, QUOI MON ASSIETTE OB; Fiolet T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k322; Fitt E, 2010, EUR J CLIN NUTR, V64, pS32, DOI 10.1038/ejcn.2010.207; Fitt E, 2015, PUBLIC HEALTH NUTR, V18, P234, DOI 10.1017/S1368980014000342; Food Agriculture Organization of the United Nations,, 2015, GUID COLL INF FOOD P; Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X; Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008; Heindel JJ, 2015, NAT REV ENDOCRINOL, V11, P653, DOI 10.1038/nrendo.2015.163; Juul F, 2018, BRIT J NUTR, V120, P90, DOI [10.1017/S0007114518001046, 10.1017/s0007114518001046]; Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; Mckee M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001209; Minister of Health. Government of Canada, 2019, CAN FOOD GUID; Mirrahimi A, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0381-1; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P18, DOI 10.1017/S1368980017001379; Monteiro CA, 2015, PUBLIC HEALTH NUTR, V18, P2311, DOI 10.1017/S1368980015002165; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006; Nardocci M, 2019, CAN J PUBLIC HEALTH, V110, P4, DOI 10.17269/s41997-018-0130-x; National Health Service, 2017, STAT OB PHYS ACT DIE; Nielsen SJ, 2007, J AM DIET ASSOC, V107, P792, DOI 10.1016/j.jada.2007.02.003; PAHO, 2015, ULTRA PROCESSED FOOD; Payne AN, 2012, OBES REV, V13, P799, DOI 10.1111/j.1467-789X.2012.01009.x; Pearlman Michelle, 2017, Curr Gastroenterol Rep, V19, P64, DOI 10.1007/s11894-017-0602-9; Pryer JA, 1997, INT J EPIDEMIOL, V26, P146, DOI 10.1093/ije/26.1.146; Public Health England, 2014, NAT DIET NUTR SURV R; Rauber F, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027546; Srour B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1451; Steele EM, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0119-3; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860; Wahlqvist ML, 2016, FOOD FUNCT, V7, P1245, DOI [10.1039/C5FO01285F, 10.1039/c5fo01285f]; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, BOD MASS IND BMI CLA; Youn S, 2012, NUTR RES, V32, P153, DOI 10.1016/j.nutres.2011.12.009; Zinocker MK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030365	55	66	67	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2020	15	5							e0232676	10.1371/journal.pone.0232676	http://dx.doi.org/10.1371/journal.pone.0232676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT3FY	32357191	Green Published, gold			2022-12-26	WOS:000536957700044
J	Bath, E; Biscocho, ER; Easton-Calabria, A; Wigby, S				Bath, Eleanor; Biscocho, Edmund Ryan; Easton-Calabria, August; Wigby, Stuart			Temporal and genetic variation in female aggression after mating	PLOS ONE			English	Article							SEMINAL FLUID PROTEIN; DROSOPHILA-MELANOGASTER; SEX-PEPTIDE; MORPHOLOGICAL TRAITS; FRUIT-FLIES; BEHAVIOR; SPERM; COMPETITION; RELEASE; CONSEQUENCES	Aggression between individuals of the same sex is almost ubiquitous across the animal kingdom. Winners of intrasexual contests often garner considerable fitness benefits, through greater access to mates, food, or social dominance. In females, aggression is often tightly linked to reproduction, with females displaying increases in aggressive behavior when mated, gestating or lactating, or when protecting dependent offspring. In the fruit fly, Drosophila melanogaster, females spend twice as long fighting over food after mating as when they are virgins. However, it is unknown when this increase in aggression begins or whether it is consistent across genotypes. Here we show that aggression in females increases between 2 to 4 hours after mating and remains elevated for at least a week after a single mating. In addition, this increase in aggression 24 hours after mating is consistent across three diverse genotypes, suggesting this may be a universal response to mating in the species. We also report here the first use of automated tracking and classification software to study female aggression in Drosophila and assess its accuracy for this behavior. Dissecting the genetic diversity and temporal patterns of female aggression assists us in better understanding its generality and adaptive function, and will facilitate the identification of its underlying mechanisms.	[Bath, Eleanor; Biscocho, Edmund Ryan; Wigby, Stuart] Univ Oxford, Dept Zool, Oxford, England; [Easton-Calabria, August] Harvard Univ, Organism & Evolutionary Biol Dept, Cambridge, MA 02138 USA	University of Oxford; Harvard University	Bath, E (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	eleanor.bath@zoo.ox.ac.uk	Wigby, Stuart/A-3916-2017	Wigby, Stuart/0000-0002-2260-2948	Christ Church college, University of Oxford; John Fell Fund grant; BBSRC fellowship [BB/K014544/1]; BBSRC [BB/K014544/1] Funding Source: UKRI	Christ Church college, University of Oxford; John Fell Fund grant; BBSRC fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by a Junior Research Fellowship from Christ Church college, University of Oxford, and a John Fell Fund grant to E.B., as well as a BBSRC fellowship to S.W. (BB/K014544/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila FW, 2015, GENETICS, V200, P1171, DOI 10.1534/genetics.115.176669; Avila FW, 2010, GENETICS, V186, P595, DOI 10.1534/genetics.110.119735; Bath E, 2018, FUNCT ECOL, V32, P2542, DOI 10.1111/1365-2435.13214; Bath E, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0154; Billeter JC, 2018, J CHEM ECOL, V44, P750, DOI 10.1007/s10886-018-0947-z; Bretman A, 2013, J INSECT PHYSIOL, V59, P824, DOI 10.1016/j.jinsphys.2013.05.011; Bretman A, 2010, BEHAV ECOL, V21, P317, DOI 10.1093/beheco/arp189; Buitenhuis AJ, 2008, WORLD POULTRY SCI J, V64, P477, DOI 10.1017/S0043933908000159; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Clancy David J., 2001, Drosophila Information Service, V84, P168; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; de Almeida RMM, 2005, EUR J PHARMACOL, V526, P51, DOI 10.1016/j.ejphar.2005.10.004; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; DUNGAN SZ, 2017, P ROY SOC B-BIOL SCI, V284, DOI DOI 10.1098/RSPB.2017.1658; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Eyjolfsdottir E, 2014, LECT NOTES COMPUT SC, V8690, P772, DOI 10.1007/978-3-319-10605-2_50; Fitzgerald EA, 2015, IEEE C ELEC DEVICES, P1, DOI 10.1109/EDSSC.2015.7285034; Gilchrist AS, 1999, GENETICS, V153, P1775; Hallsson LR, 2012, ECOL EVOL, V2, P128, DOI 10.1002/ece3.56; Haussmann IU, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1938; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Heyne HO, 2014, GENETICS, V198, P1277, DOI 10.1534/genetics.114.168948; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Huchard E, 2011, BEHAV ECOL, V22, P1003, DOI 10.1093/beheco/arr083; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Ferreiro MJ, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00732; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Krstic D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077904; Kubli E, 2012, CURR BIOL, V22, pR520, DOI 10.1016/j.cub.2012.04.058; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Mattei AL, 2015, P NATL ACAD SCI USA, V112, P8475, DOI 10.1073/pnas.1505797112; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; MONSMA SA, 1990, DEV BIOL, V142, P465, DOI 10.1016/0012-1606(90)90368-S; Murphy TG, 2009, BEHAV ECOL, V20, P1000, DOI 10.1093/beheco/arp089; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Palanza P, 1996, BEHAVIOUR, V133, P863, DOI 10.1163/156853996X00288; Papadopoulos NT, 2009, PHYSIOL ENTOMOL, V34, P238, DOI 10.1111/j.1365-3032.2009.00680.x; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034; Pilpel N, 2008, INSECT BIOCHEM MOLEC, V38, P320, DOI 10.1016/j.ibmb.2007.11.010; Qazi MCB, 2003, J EXP BIOL, V206, P3521, DOI 10.1242/jeb.00585; Qiu S, 2017, COMP BIOCHEM PHYS A, V206, P17, DOI 10.1016/j.cbpa.2017.01.003; R Core Team, 2012, R LANG ENV STAT COMP; REED SC, 1950, EVOLUTION, V4, P34, DOI 10.2307/2405532; Rezaval C, 2012, CURR BIOL, V22, P1155, DOI 10.1016/j.cub.2012.04.062; Rosvall KA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0083; Rubinstein C, 2013, P NATL ACAD SCI, V110; Seebacher F, 2013, J EXP BIOL, V216, P771, DOI 10.1242/jeb.079756; Shorter J, 2015, P NATL ACAD SCI USA, V112, pE3555, DOI 10.1073/pnas.1510104112; SLUYTER F, 1995, BEHAV GENET, V25, P247, DOI 10.1007/BF02197183; Stockley P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0073; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Tibbetts EA, 2014, ANIM BEHAV, V92, P281, DOI 10.1016/j.anbehav.2014.02.015; Ueda A, 2002, PHYSIOL ENTOMOL, DOI [10.1046/j.1365-3032.2002.00262.x/full, DOI 10.1046/J.1365-3032.2002.00262.X/FULL]; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wensing KU, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1563; Wigby S, 2016, FUNCT ECOL, V30, P410, DOI 10.1111/1365-2435.12515	63	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0229633	10.1371/journal.pone.0229633	http://dx.doi.org/10.1371/journal.pone.0229633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348317	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000536668200008
J	Konig, KS; Verhaar, N; Hopster, K; Pfarrer, C; Neudeck, S; Rohn, K; Kastner, SBR				Koenig, Kathrin S.; Verhaar, Nicole; Hopster, Klaus; Pfarrer, Christiane; Neudeck, Stephan; Rohn, Karl; Kaestner, Sabine B. R.			Ischaemic preconditioning and pharmacological preconditioning with dexmedetomidine in an equine model of small intestinal ischaemia-reperfusion	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; 2ND WINDOW; PROTECTS; PHARMACOKINETICS; CALPROTECTIN; NEUTROPHILS; ISOFLURANE; APOPTOSIS; JEJUNUM; HORSES	Small intestinal strangulation associated with ischaemia-reperfusion injury (IRI) is common in horses. In laboratory animals IRI can be ameliorated by ischaemic preconditioning (IPC) and pharmacological preconditioning (PPC) with dexmedetomidine. The aim of this study was to determine the effect of PPC with dexmedetomidine or IPC in an equine model of small intestinal ischaemia-reperfusion (IR). In a randomized controlled experimental trial, 15 horses were assigned to three groups: control (C), IPC, and PPC with dexmedetomidine (DEX). All horses were placed under general anaesthesia and 90% jejunal ischaemia was induced for 90 minutes, followed 30 minutes of reperfusion. In group IPC, three short bouts of ischaemia and reperfusion were implemented, and group DEX received a continuous rate infusion of dexmedetomidine prior to the main ischaemia. Jejunal biopsies were collected before ischaemia (P), and at the end of ischaemia (I) and reperfusion (R). Mucosal injury was assessed by the Chiu-Score, inflammatory cells were stained by cytosolic calprotectin. The degree of apoptosis and cell necrosis was assessed by cleaved-caspase-3 and TUNEL. Parametric data were analyzed by two-way ANOVA for repeated measurements followed by Dunnetts t-test. Non parametric data were compared between groups at the different time points by a Kruskal-Wallis-Test and a Wilcoxon-2-Sample-test. The mucosal injury score increased during I in all groups. After reperfusion, IRI further progressed in group C, but not in IPC and DEX. In all groups the number of cleaved caspase-3 and TUNEL positive cells increased from P to I. The number of TUNEL positive cells were lower in group DEX compared to group C after I and R. Infiltration with calprotectin positive cells was less pronounced in group DEX compared to group C, whereas in group IPC more calprotectin positive cells were seen. In conclusion, IPC and DEX exert protective effects in experimental small intestinal ischaemia in horses.	[Koenig, Kathrin S.; Verhaar, Nicole; Hopster, Klaus; Neudeck, Stephan; Kaestner, Sabine B. R.] Univ Vet Med Hannover, Clin Horses, Hannover, Germany; [Pfarrer, Christiane] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Rohn, Karl] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany; [Kaestner, Sabine B. R.] Univ Vet Med Hannover, Clin Small Anim, Hannover, Germany; [Hopster, Klaus] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Pennsylvania	Kastner, SBR (corresponding author), Univ Vet Med Hannover, Clin Horses, Hannover, Germany.; Kastner, SBR (corresponding author), Univ Vet Med Hannover, Clin Small Anim, Hannover, Germany.	sabine.kaestner@tiho-hannover.de	Kästner, Sabine/ABC-9884-2020; Kästner, Sabine Beate Rita/T-7864-2019	Kästner, Sabine/0000-0001-6430-6154; 	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aantaa R, 1997, ANESTHESIOLOGY, V86, P1055, DOI 10.1097/00000542-199705000-00008; Aksoyek S, 2002, SHOCK, V18, P476; Arslan M, 2012, LIBYAN J MED, V7, DOI 10.3402/ljm.v7i0.18185; Aufricht C, 2002, PEDIATR RES, V51, P722, DOI 10.1203/01.PDR.0000015128.65800.28; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; DABAREINER RM, 1995, AM J VET RES, V56, P639; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Dong X, 2014, J SURG RES, V186, P240, DOI 10.1016/j.jss.2013.07.052; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Erling N, 2013, CLINICS, V68, P1548, DOI 10.6061/clinics/2013(12)12; FREEMAN DE, 1988, AM J VET RES, V49, P810; Gonullu E, 2014, REV BRAS ANESTESIOL, V64, P152, DOI 10.1016/j.bjane.2013.06.002; Gozalo-Marcilla M, 2018, J VET PHARMACOL THER, V41, P205, DOI 10.1111/jvp.12474; Grosche A, 2008, EQUINE VET J, V40, P393, DOI 10.2746/042516408X302500; Hanci V, 2010, UROL INT, V84, P105, DOI 10.1159/000273476; Hausenloy DJ, 2010, CARDIOVASC DRUG THER, V24, P235, DOI 10.1007/s10557-010-6237-9; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hopster-Iversen CCS, 2014, AM J VET RES, V75, P385, DOI 10.2460/ajvr.75.4.385; Hotter G, 1996, BIOCHEM BIOPH RES CO, V222, P27, DOI 10.1006/bbrc.1996.0692; Kageyama S, 2015, LIVER TRANSPLANT, V21, P112, DOI 10.1002/lt.24006; Kaneene JB, 1997, PREV VET MED, V29, P277, DOI 10.1016/S0167-5877(96)01080-X; Kocoglu H, 2008, CURR THER RES CLIN E, V69, P150, DOI 10.1016/j.curtheres.2008.04.003; Krenz M, MORGAN CLAYPOOL LIFE, P1, DOI [10.1001/archsurg.1970.01340280030009, DOI 10.1001/ARCHSURG.1970.01340280030009]; Kucuk A, 2014, BRATISL MED J, V115, P680, DOI 10.4149/BLL_2014_132; Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409; dos Santos CHM, 2008, ACTA CIR BRAS, V23, P22, DOI 10.1590/S0102-86502008000100005; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Okada H, 2007, RESUSCITATION, V74, P538, DOI 10.1016/j.resuscitation.2007.01.032; Panzer O, 2009, CRIT CARE CLIN, V25, P451, DOI 10.1016/j.ccc.2009.04.004; Ranheim B, 2015, J VET PHARMACOL THER, V38, P93, DOI 10.1111/jvp.12157; Reichert C, 2014, AM J VET RES, V75, P990, DOI 10.2460/ajvr.75.11.990; Rezende ML, 2015, J VET PHARMACOL THER, V38, P15, DOI 10.1111/jvp.12138; Sahin T, 2013, J SURG RES, V183, P385, DOI 10.1016/j.jss.2012.11.034; Sun Y, 2015, EXP THER MED, V10, P647, DOI 10.3892/etm.2015.2561; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; Tomai F, 1999, CIRCULATION, V100, P559, DOI 10.1161/01.CIR.100.5.559; Varga J, 2012, ANN TRANSPL, V17, P11; Vente C, 2011, INTESTINALE ENTZUNDU; Wagner A, 2018, VET IMMUNOL IMMUNOP, V197, P49, DOI 10.1016/j.vetimm.2018.01.011; Wang YQ, 2018, J CELL BIOCHEM, DOI [10.1007/s00540-016-2214-1, DOI 10.1007/S00540-016-2214-1]; Wang ZD, 2015, INFLAMMATION, V38, P424, DOI 10.1007/s10753-014-0047-3; WHITE NA, 1980, AM J VET RES, V41, P193; Wittenberg-Voges L, 2018, VET ANAESTH ANALG, V45, P165, DOI 10.1016/j.vaa.2017.08.010; Yui S, 2003, BIOL PHARM BULL, V26, P753; Zhang L, 2011, LIFE SCI, V88, P1102, DOI 10.1016/j.lfs.2011.04.004; Zhang W, 2016, J ANESTH, V30, P826, DOI 10.1007/s00540-016-2214-1	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0224720	10.1371/journal.pone.0224720	http://dx.doi.org/10.1371/journal.pone.0224720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348301	Green Published, Green Submitted, gold			2022-12-26	WOS:000536668200002
J	Wang, B; Li, YR; Hu, HY; Shu, WH; Yang, LQ; Zhang, JH				Wang, Bo; Li, Yiru; Hu, Huaying; Shu, Wenhao; Yang, Lianqiao; Zhang, Jianhua			Acetylcholinesterase electrochemical biosensors with graphene-transition metal carbides nanocomposites modified for detection of organophosphate pesticides	PLOS ONE			English	Article							CARBON NANOTUBES; IMMOBILIZATION; TEMPERATURE; ELECTRODE	An acetylcholinesterase biosensor modified with graphene and transition metal carbides was prepared to detect organophosphorus pesticides. Cyclic voltammetry, differential pulse voltammetry, and electrochemical impedance spectroscopy were used to characterize the electrochemical catalysis of the biosensor: acetylcholinesterase/chitosan-transition metal carbides/graphene/glassy carbon electrode. With the joint modification of graphene and transition metal carbides, the biosensor has a good performance in detecting dichlorvos with a linear relationship from 11.31 mu M to 22.6 nM and the limit of detection was 14.45 nM. Under the premise of parameter optimization, the biosensor showed a good catalytic performance for acetylcholine. Compared to the biosensors without modification, it expressed a better catalytic performance due to the excellent electrical properties, biocompatibility and high specific surface area of graphene, transition metal carbides. Finally, the biosensor exhibits good stability, which can be stored at room temperature for one month without significant performance degradation, and has practical potential for sample testing.	[Wang, Bo] Shanghai Univ, Microelect Res & Develop Ctr, Shanghai, Peoples R China; [Wang, Bo; Li, Yiru; Hu, Huaying; Shu, Wenhao; Yang, Lianqiao; Zhang, Jianhua] Shanghai Univ, Key Lab Adv Display & Syst Applicat, Minist Educ, Shanghai, Peoples R China	Shanghai University; Shanghai University	Yang, LQ (corresponding author), Shanghai Univ, Key Lab Adv Display & Syst Applicat, Minist Educ, Shanghai, Peoples R China.	yanglianqiao@i.shu.edu.cn			National Natural Science Foundation of China [51505270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (51505270).	Aghoutane Y, 2020, BIOELECTROCHEMISTRY, V132, DOI 10.1016/j.bioelechem.2019.107404; Anasori B, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.98; Aragay G, 2012, CHEM REV, V112, P5317, DOI 10.1021/cr300020c; Boulanouar S, 2018, ANAL CHIM ACTA, V1018, P35, DOI 10.1016/j.aca.2018.02.069; Cui HF, 2019, BIOSENS BIOELECTRON, V141, DOI 10.1016/j.bios.2019.111452; Cui HF, 2013, BIOSENS BIOELECTRON, V46, P113, DOI 10.1016/j.bios.2013.02.029; da Silva W, 2019, SENSOR ACTUAT B-CHEM, V298, DOI 10.1016/j.snb.2019.126862; Ding MM, 2020, J MEMBRANE SCI, V600, DOI 10.1016/j.memsci.2020.117871; Durak D, 2009, ENVIRON TOXICOL, V24, P235, DOI 10.1002/tox.20423; Fu JY, 2020, MICROCHIM ACTA, V187, DOI 10.1007/s00604-019-4022-4; Fu JY, 2020, SCI TOTAL ENVIRON, V712, DOI 10.1016/j.scitotenv.2019.136410; Gu H, 2019, ACS APPL NANO MATER, V2, P6537, DOI 10.1021/acsanm.9b01465; Hamann CH, 2003, J SOLID STATE ELECTR, V7, P525, DOI 10.1007/s10008-003-0361-4; Jiang YJ, 2018, CHEM ENG J, V339, P547, DOI 10.1016/j.cej.2018.01.111; KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010; Kim KW, 2015, ELECTROCHIM ACTA, V170, P146, DOI 10.1016/j.electacta.2015.04.132; Li TK, 2019, J MATER CHEM C, V7, P1022, DOI 10.1039/c8tc04893b; Long Q, 2015, BIOSENS BIOELECTRON, V68, P168, DOI 10.1016/j.bios.2014.12.046; Lukatskaya MR, 2014, ANGEW CHEM INT EDIT, V53, P4877, DOI 10.1002/anie.201402513; Ma X, 2020, SENSOR ACTUAT B-CHEM, V309, DOI 10.1016/j.snb.2020.127815; Mahmoudi E, 2019, BIOELECTROCHEMISTRY, V130, DOI 10.1016/j.bioelechem.2019.107348; Naguib M, 2011, ADV MATER, V23, P4248, DOI 10.1002/adma.201102306; Prokhorov E, 2016, ELECTROCHIM ACTA, V215, P600, DOI 10.1016/j.electacta.2016.08.148; Qian SH, 2015, ANAL CHEM, V87, P5395, DOI 10.1021/acs.analchem.5b00738; Salehi E, 2016, CARBOHYD POLYM, V152, P419, DOI 10.1016/j.carbpol.2016.07.033; Shah SA, 2017, CHEM COMMUN, V53, P400, DOI 10.1039/c6cc07733a; Shimada H, 2019, SENSOR ACTUAT B-CHEM, V298, DOI 10.1016/j.snb.2019.126893; Song DD, 2019, J HAZARD MATER, V373, P367, DOI 10.1016/j.jhazmat.2019.03.083; Stoytcheva M, 2009, ELECTROCHIM ACTA, V54, P1721, DOI 10.1016/j.electacta.2008.09.063; Su XH, 2018, J ALLOY COMPD, V752, P32, DOI 10.1016/j.jallcom.2018.04.152; Sun X, 2010, BIOSENS BIOELECTRON, V25, P2611, DOI 10.1016/j.bios.2010.04.028; Tian Y, 2020, J ELECTROCHEMICAL SO, V167, DOI [10.1021/acsanm.9b01465, DOI 10.1021/ACSANM.9B01465]; Vondrak J., 1983, SURF TECHNOL, V20, P91; Wang HY, 2020, ANAL CHIM ACTA, V1094, P18, DOI 10.1016/j.aca.2019.10.003; Wang H, 2019, BIOSENS BIOELECTRON, V142, DOI 10.1016/j.bios.2019.111531; Wei M, 2015, SENSOR ACTUAT B-CHEM, V211, P290, DOI 10.1016/j.snb.2015.01.112; Xu Q, 2020, J ELECTROANAL CHEM, V860, DOI 10.1016/j.jelechem.2020.113869; Yu GX, 2015, BIOSENS BIOELECTRON, V68, P288, DOI 10.1016/j.bios.2015.01.005; Zhang JH, 2019, RSC ADV, V9, P25248, DOI 10.1039/c9ra02140j; Zheng D, 2012, ANALYST, V137, P3800, DOI 10.1039/c2an35128e; Zhou LY, 2017, BIOCHEM ENG J, V128, P243, DOI 10.1016/j.bej.2017.10.008	41	24	24	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0231981	10.1371/journal.pone.0231981	http://dx.doi.org/10.1371/journal.pone.0231981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	32348360	gold, Green Published			2022-12-26	WOS:000536668200034
J	Webber, E; Dunbar, R				Webber, Emily; Dunbar, Robin			The fractal structure of communities of practice: Implications for business organization	PLOS ONE			English	Article							SOCIAL NETWORK SIZE; INDIVIDUAL-DIFFERENCES; PREFRONTAL VOLUME; BRAIN; CORTEX; CONSTRAINTS; AMYGDALA; COMPLEX	Communities of practice (COP) are informal (sometimes formal) groupings of professionals with shared interests that form to facilitate the exchange of expertise and shared learning or to function as professional support networks. We analyse a dataset on the size of COPs and show that their distribution has a fractal structure similar to that found in huntergatherer social organisation and the structure of human personal social networks. Small communities up to about 40 in size can be managed democratically, but all larger communities require a leadership team structure. We show that frequency of interaction declines as size increases, as is the case in personal social networks. This suggests that professional work-oriented organisations may be subject to the same kinds of constraint imposed on human social organisation by the social brain. We discuss the implications for business management structure.	[Webber, Emily] Tacit London Ltd, Loughton, England; [Dunbar, Robin] Univ Oxford Magdalen Coll, Oxford, England	University of Oxford	Dunbar, R (corresponding author), Univ Oxford Magdalen Coll, Oxford, England.	robin.dunbar@magd.ox.ac.uk		dunbar, robin/0000-0002-9982-9702				Arnaboldi Valerio, 2016, Advances in Network Science. 12th International Conference and School, NetSci-X 2016. Proceedings: LNCS 9564, P82, DOI 10.1007/978-3-319-28361-6_7; Arnaboldi V., 2015, ONLINE SOCIAL NETWOR; Bickart KC, 2012, J NEUROSCI, V32, P14729, DOI 10.1523/JNEUROSCI.1599-12.2012; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Burt RS, 2000, SOC NETWORKS, V22, P1, DOI 10.1016/S0378-8733(99)00015-5; Burton-Chellew MN, 2015, BEHAV ECOL, V26, P130, DOI 10.1093/beheco/aru165; Casari M, 2018, P NATL ACAD SCI USA, V115, P2728, DOI 10.1073/pnas.1713496115; Coulsen M.R.C., 1987, CARTOGRAPHICA, V24, P16, DOI DOI 10.3138/U7X0-1836-5715-3546; David-Barrett T, 2014, BEHAV ECOL, V25, P58, DOI 10.1093/beheco/art085; Devaine M, 2017, PLOS COMPUTATIONAL B, V13, pe1005; Dube L, 2005, J ORGAN CHANGE MANAG, V18, P145, DOI 10.1108/09534810510589570; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Dunbar RIM, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0490; Dunbar RIM, 2017, ADAPT HUM BEHAV PHYS, V3, P198, DOI 10.1007/s40750-017-0061-4; Dunbar RIM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0244; Dunbar RIM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150292; Dunbar RIM, 2015, SOC NETWORKS, V43, P39, DOI 10.1016/j.socnet.2015.04.005; Dunbar RIM, 2011, J I ECON, V7, P345, DOI 10.1017/S1744137410000366; Dunbar RIM, 2009, BIOL REV, V84, P413, DOI 10.1111/j.1469-185X.2009.00080.x; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Dunbar RIM, 2014, LUCY LANGUAGE BENCHM; Dunbar RIM, 2018, EVOL HUM BEHAV, V39, P106, DOI 10.1016/j.evolhumbehav.2017.11.001; Fuchs B, 2014, SCI REP-UK, V4, DOI 10.1038/srep06526; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Haerter JO, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168701; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Hampton WH, 2016, SOC COGN AFFECT NEUR, V11, P721, DOI 10.1093/scan/nsv153; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hill RA, 2019, DUNBARS NUMBER, P21; Hill RA, 2008, BIOL LETTERS, V4, P748, DOI 10.1098/rsbl.2008.0393; Johnson G. A., 1982, THEORY EXPLANATION A, P389; Kamenetz A., 2012, 4 YEAR CAREER; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Kordsmeyer T, 2017, CURR ANTHROPOL, V58, P289, DOI 10.1086/690731; Krol SA, 2018, ADAPT HUM BEHAV PHYS, V4, P387, DOI 10.1007/s40750-018-0100-9; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Kwak S, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2708; Lave J, 1991, STRUCTURED LEARNING; Layton RA, 2010, SOCIAL BRAIN DISTRIB, P84; Lehmann J., 2014, LUCY LANGUAGE BENCHM, P245, DOI DOI 10.1093/ACPROF:OSOBL/9780199652594.003.0011; Lewis PA, 2017, SOC COGN AFFECT NEUR, V12, P1063, DOI 10.1093/scan/nsx034; Lewis PA, 2011, NEUROIMAGE, V57, P1624, DOI 10.1016/j.neuroimage.2011.05.030; Mac Carron P, 2016, SOC NETWORKS, V47, P151, DOI 10.1016/j.socnet.2016.06.003; Mars RB, 2016, BRAIN STRUCT FUNCT, V221, P4059, DOI 10.1007/s00429-015-1146-0; McDermott R, 2010, HARVARD BUS REV, V88, P82; Meguerditchian A, EVOLUTION HUMAN BEHA; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Noonan MP, 2018, BEHAV BRAIN RES, V355, P12, DOI 10.1016/j.bbr.2018.02.019; Powell J, 2012, P ROY SOC B-BIOL SCI, V279, P2157, DOI 10.1098/rspb.2011.2574; Powell JL, 2014, CORTEX, V54, P63, DOI 10.1016/j.cortex.2014.02.010; Powell JL, 2010, NEUROPSYCHOLOGIA, V48, P3554, DOI 10.1016/j.neuropsychologia.2010.08.004; Powers KE, 2016, SOC COGN AFFECT NEUR, V11, P121, DOI 10.1093/scan/nsv096; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; Spagna A, 2018, J COMP NEUROL, V526, P1183, DOI 10.1002/cne.24402; Sutcliffe AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158605; Sutcliffe A, 2012, BRIT J PSYCHOL, V103, P149, DOI 10.1111/j.2044-8295.2011.02061.x; Tamarit I, 2018, P NATL ACAD SCI USA, V115, P8316, DOI 10.1073/pnas.1719233115; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Von Der Heide R, 2014, SOC COGN AFFECT NEUR, V9, P1962, DOI 10.1093/scan/nsu009; Wenger E., 2002, GUIDE MANAGING KNOWL, P284; Wenger E., 1998, COMMUNITIES PRACTICE; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970	66	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0232204	10.1371/journal.pone.0232204	http://dx.doi.org/10.1371/journal.pone.0232204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8ZG	32348329	Green Published, gold			2022-12-26	WOS:000536668200045
J	Becker, N; Cordeiro, LS; Poudel, KC; Sibiya, TE; Sayer, AG; Sibeko, LN				Becker, Nozipho; Cordeiro, Lorraine S.; Poudel, Krishna C.; Sibiya, Thokozile E.; Sayer, Aline G.; Sibeko, Lindiwe N.			Individual, household, and community level barriers to ART adherence among women in rural Eswatini	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; FOOD INSECURITY; IMPROVE ADHERENCE; HIV; CARE; INTERRUPTION; OUTCOMES; ADULTS	Background Despite access to free antiretroviral therapy (ART) for all people living with human immunodeficiency virus (HIV), noncompliance to treatment continues to be a significant challenge in Eswatini. Yet studies investigating barriers to ART adherence in Eswatini are scarce. Most notably, there is a lack of research regarding rural women in Eswatini, who are currently the country's most vulnerable to HIV infection. Therefore, the objective of the study is to investigate individual, household, and community level barriers to ART adherence among rural women living with HIV. Methods We conducted a qualitative study to investigate individual, household, and community level barriers to ART adherence. We conducted focus group discussions with HIV-infected women (n = 4) from rural villages in Eswatini, and in-depth interviews with healthcare workers (n = 8) serving the area clinics. Open and axial coding techniques were used for data analysis and interpreted within a social ecological framework. Results Our findings revealed several individual level barriers including hunger, side effects of ART, personal stress, lack of disclosure of HIV status, alcohol use, and forgetting to take ART. Lack of food, unemployment and scarcity of financial resources were identified as critical barriers at the household level. Community and institutional barriers encompassed factors related to health delivery such as lack of privacy, travel time, transportation costs, excessive alcohol use by healthcare workers, maltreatment, public and self-stigma, gossip, and long waits at clinics. Conclusions Rural women living with HIV face multilevel barriers to ART adherence. Support programs aimed at increasing ART adherence among this vulnerable population need to develop targeted polices to alleviate challenges rural women face, beginning with expanding qualifications for food assistance programs.	[Becker, Nozipho; Cordeiro, Lorraine S.; Sibeko, Lindiwe N.] Univ Massachusetts, Dept Nutr, Amherst, MA 01003 USA; [Becker, Nozipho; Sibiya, Thokozile E.] Univ Eswatini, Dept Food & Nutr Sci, Luyengo, Eswatini; [Poudel, Krishna C.] Univ Massachusetts, Dept Hlth Promot & Policy, Amherst, MA 01003 USA; [Sayer, Aline G.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Becker, N (corresponding author), Univ Massachusetts, Dept Nutr, Amherst, MA 01003 USA.; Becker, N (corresponding author), Univ Eswatini, Dept Food & Nutr Sci, Luyengo, Eswatini.	nmaziya@nutrition.umass.edu		Cordeiro, Lorraine/0000-0002-7400-5483; Becker, Nozipho/0000-0002-1780-7682				Ahmed CV, 2017, AJAR-AFR J AIDS RES, V16, P321, DOI 10.2989/16085906.2017.1380677; Axelsson JM, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0026-9; Azia IN, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.476; Barnett W, 2013, S AFR J HIV MED, V14, P170, DOI 10.7196/SAJHIVMED.981; Benator DA, 2015, AIDS BEHAV, V19, P594, DOI 10.1007/s10461-014-0917-6; Bhat VG, 2010, EUR J CLIN MICROBIOL, V29, P947, DOI 10.1007/s10096-010-0949-4; Campbell C, 2011, INT J NURS STUD, V48, P175, DOI 10.1016/j.ijnurstu.2010.07.019; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Central Statistical Office and UNICEF, SWAZ MULT IND CLUST; Creswell J. W., 2011, CONDUCTING DESIGNING; Czaicki NL, 2017, AIDS CARE, V29, P876, DOI 10.1080/09540121.2017.1287340; Gary FA, 2015, FACTORS INFLUENCING, V5; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Gugsa S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179838; Haberer JE, 2015, JAIDS-J ACQ IMM DEF, V70, P386, DOI 10.1097/QAI.0000000000000737; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hong SY, 2014, JAIDS-J ACQ IMM DEF, V67, pE115, DOI 10.1097/QAI.0000000000000308; Horter S, 2019, AJAR-AFR J AIDS RES, V18, P27, DOI 10.2989/16085906.2018.1552163; Kamiru HN, 2009, AIDS CARE, V21, P1463, DOI 10.1080/09540120902883093; Kolb S. M., 2012, J EMERGING TRENDS ED, V3, P83, DOI DOI 10.10520/EJC135409; Koole O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147309; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McLafferty SL, 2003, ANNU REV PUBL HEALTH, V24, P25, DOI 10.1146/annurev.publhealth.24.012902.141012; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Ministry of Health, ART PROGR ANN REP; Ministry of Health, SWAZ INT HIV MAN GUI; Ministry of Health: Swaziland National AIDS Programme, 2016, STAND OP PROC IMPL C; Mukherjee JS, 2016, CURR HIV-AIDS REP, V13, P359, DOI 10.1007/s11904-016-0335-7; Mukora R, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-205; Mukumbang FC, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/7356362; Onwuegbuzie AJ, 2007, QUAL REP, V12, P281; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Punch K., 2014, INTRO RES METHODS ED, V2; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Reza A, 2009, LANCET, V373, P1966, DOI 10.1016/S0140-6736(09)60247-6; Root R, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17978; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Senkomago V, 2011, AIDS CARE, V23, P1246, DOI 10.1080/09540121.2011.564112; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; Stricker SM, 2014, AIDS BEHAV, V18, pS465, DOI 10.1007/s10461-013-0598-6; Swaziland Vulnerability and Assessment Committee, SWAZ ANN VULN ASS AN; Tabatabai J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24795; The Ministry of Health, 2017, SWAZ HIV INC MEAS SU; The National Emergency Response on HIV and AIDS, EXTENDED NATL MULTIS; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; WFP, FOOD PRESCR STAND PR; Whiteside A, WHAT IS DRIVING HIV; WHO, GLOB UPD HIV TREATM; World Health Organization, NUMB PEOPL ALL AG LI	57	17	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0231952	10.1371/journal.pone.0231952	http://dx.doi.org/10.1371/journal.pone.0231952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8WP	32343742	Green Published, gold			2022-12-26	WOS:000536661300021
J	Gisler, S; Maia, ARR; Chandrasekaran, G; Kopparam, J; van Lohuizen, M				Gisler, Santiago; Maia, Ana Rita R.; Chandrasekaran, Gayathri; Kopparam, Jawahar; van Lohuizen, Maarten			A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition	PLOS ONE			English	Article								BMI1 is a core protein of the polycomb repressive complex 1 (PRC1) that is overexpressed in several cancer types, making it a promising target for cancer therapies. However, the underlying mechanisms and interactions associated with BMI1-induced tumorigenesis are often context-dependent and complex. Here, we performed a drug resistance screen on mutagenized human haploid HAP1 cells treated with BMI1 inhibitor PTC-318 to find new genetic and mechanistic features associated with BMI1-dependent cancer cell proliferation. Our screen identified NUMA1-mutations as the most significant inducer of PTC-318 cell death resistance. Independent validations on NUMA1-proficient HAP1 and non-small cell lung cancer cell lines exposed to BMI1 inhibition by PTC-318 or BMI1 knockdown resulted in cell death following mitotic arrest. Interestingly, cells with CRISPR-Cas9 derived NUMA1 knockout also showed a mitotic arrest phenotype following BMI1 inhibition but, contrary to cells with wildtype NUMA1, these cells were resistant to BMI1-dependent cell death. The current study brings new insights to BMI1 inhibition-induced mitotic lethality in cancer cells and presents a previously unknown role of NUMA1 in this process.	[Gisler, Santiago; Chandrasekaran, Gayathri; Kopparam, Jawahar; van Lohuizen, Maarten] Oncode, Div Mol Genet, Amsterdam, Netherlands; [Gisler, Santiago; Chandrasekaran, Gayathri; Kopparam, Jawahar; van Lohuizen, Maarten] Netherlands Canc Inst, Amsterdam, Netherlands; [Maia, Ana Rita R.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	van Lohuizen, M (corresponding author), Oncode, Div Mol Genet, Amsterdam, Netherlands.; van Lohuizen, M (corresponding author), Netherlands Canc Inst, Amsterdam, Netherlands.	m.v.lohuizen@nki.nl		van Lohuizen, Maarten/0000-0001-6877-2873	Netherlands Institute of regenerative medicine (NIRM) [58473]; Netherlands organization for scientific research (NWO) [823.02.007]	Netherlands Institute of regenerative medicine (NIRM); Netherlands organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO))	MVL and SGB: Netherlands Institute of regenerative medicine (NIRM) 58473. MVL and SGB: Netherlands organization for scientific research (NWO) 823.02.007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad PC, 2007, MOL BIOL CELL; Abdouh M, 2009, J NEUROSCI; An SJ, 2009, CANCER RES, V69; [Anonymous], 2017, BLOOD; Ban KH, 2007, DEV CELL; Bhattacharyya S, 2009, CANCER RES, V69; Biehs B, 2013, NAT CELL BIOL; Bruggeman SWM, 2005, GENES DEV; Carette JE, 2010, BLOOD; Carette JE, 2009, SCIENCE; Carette JE, 2011, NATURE; Compton DA, 1995, J CELL SCI; Du Q, 2001, NAT CELL BIOL; Gascoigne KE, 2009, J CELL SCI; Gehmlich K, 2004, EMBO REP; Godlewski J, 2008, CANC RES; Griffith DA, 2017, ADV GEOGR INFORM SCI, P1, DOI 10.1007/978-3-319-22786-3_1; Haupt Y, 1991, CELL; Herold MJ, 2008, P NATL ACAD SCI US; Jacobs JJL, 1999, GENES DEV; Jacobs JL, 1999, NATURE; Jae LT, 2013, SCIENCE; Jae LT, 2014, SCIENCE; Kreso A, 2014, NAT MED; Lechler T, 2005, NATURE; Lee CC, 2013, PLOS ONE; Liu L, 2006, ONCOGENE; Lukacs RU, 2010, CELL STEM CELL; Maeda A, 2018, ONCOTARGET; Maia ARR, 2015, ANN ONCOL; Mezzadra R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212053; Michalak EM, 2013, STEM CELLS; Ohata H, 2013, MOL CELL BIOL; Ojo D, 2018, CANC LETT; Paranjape AN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-785; Pietersen AM, 2008, CURR BIOL; Planells-Cases R, 2015, EMBO J; Radulescu AE, 2010, TRENDS CELL BIOL; Siller KH, 2009, NATURE CELL BIOL; Staring J, 2017, NATURE; van Lohuizen M, 1991, CELL; Vidi PA, 2014, NUCL ACIDS RES; Vrzalikova K, 2008, J CANC RES CLIN ONCO; Wang Q, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0481-z; Wei F, 2015, ONCOGENE; Wilson BG, 2010, CANC CELL; Wu Z, 2011, PLOS ONE; Wu Z, 2011, CELL DEATH DIFFER; Xiong D, 2015, CANC BIOL THER; Yin T, 2012, CHEMOTHERAPY; Yin T, 2016, 2016 FIRST IEEE INTERNATIONAL CONFERENCE ON COMPUTER COMMUNICATION AND THE INTERNET (ICCCI 2016), P1, DOI 10.1109/CCI.2016.7778865; Yin XM, 1994, NATURE; Zhang DS, 2017, 2017 UNITED STATES NATIONAL COMMITTEE OF URSI NATIONAL RADIO SCIENCE MEETING (USNC-URSI NRSM); Zhou L, 2014, CELL BIOL INT	54	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0227592	10.1371/journal.pone.0227592	http://dx.doi.org/10.1371/journal.pone.0227592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8WP	32343689	Green Published, Green Submitted, gold			2022-12-26	WOS:000536661300004
J	Rizvi, SMH; Schopf, T; Sangha, A; Ulvin, K; Gjersvik, P				Rizvi, Syed Mohammad Husain; Schopf, Thomas; Sangha, Amandip; Ulvin, Kim; Gjersvik, Petter			Teledermatology in Norway using a mobile phone app	PLOS ONE			English	Article							FORWARD TELEDERMATOLOGY; TRIAGE; CARE	Rashes, ulcers and skin lesions are well suited for telemedicine. We have developed a smartphone app, the first of its kind in Norway, where a referring physician can write a short medical history and take clinical and dermatoscopic photographs with a smartphone, which is then sent to and evaluated by a dermatologist. In the period from June 1st, 2017, to September 1st, 2019, clinical information and photographs of rash and skin lesions from 171 patients were sent by 40 primary care and nursing home physicians via the smartphone app to four dermatologists for diagnosis and therapeutic advice. A wide range of dermatological conditions were diagnosed, most commonly chronic ulcers (17%), eczema (15%) and pigmented lesions (13%). Assessed later by a dermatologist, referral for regular consultations with a specialist was avoided in 119 patients (70%). Sixteen patients (9%) were recommended a regular consultation with a dermatologist; information for prioritization in the specialist healthcare service was then provided. In 36 patients (21%), further measures by the referring physician were recommended. Our experience indicates that many ordinary consultations on rash, ulcers and skin lesions in the specialist healthcare services can be avoided when using the smartphone app.	[Rizvi, Syed Mohammad Husain] Oslo Univ Hosp, Dept Dermatol, Oslo, Norway; [Rizvi, Syed Mohammad Husain; Sangha, Amandip; Ulvin, Kim] Askin AS, Oslo, Norway; [Schopf, Thomas] Univ Hosp Northern Norway, Natl Ctr E Hlth Res, Tromso, Norway; [Gjersvik, Petter] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo	Rizvi, SMH (corresponding author), Oslo Univ Hosp, Dept Dermatol, Oslo, Norway.; Rizvi, SMH (corresponding author), Askin AS, Oslo, Norway.	mohammad.rizvi@askin.no		Sangha, Amandip/0000-0002-8058-1751	Research Council of Norway; Innovation Norway	Research Council of Norway(Research Council of Norway); Innovation Norway	SMHR, AS and KU founded and are shareholders in Askin AS (www.askin.no), of which TS is a partner. The funder provided support in the form of salaries for authors [SMHR, AS and KU], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section; We thank the Oslo Board for Nursing Homes, the primary care and nursing home physicians who used the smartphone app, the dermatologists who performed the teledermatological consultations, and the Research Council of Norway and Innovation Norway for financial support.	Borve A, 2015, ACTA DERM-VENEREOL, V95, P186, DOI 10.2340/00015555-1906; Brinker TJ, 2018, J MED INTERNET RES, V20, DOI 10.2196/11871; Chanussot-Deprez C, 2013, ADV SKIN WOUND CARE, V26, P78, DOI 10.1097/01.ASW.0000426717.59326.5f; Coates SJ, 2015, J AM ACAD DERMATOL, V72, P563, DOI 10.1016/j.jaad.2014.07.061; Kips J, 2019, ACTA CLIN BELG, V8, P1; Lee JJ, 2018, AM J CLIN DERMATOL, V19, P253, DOI 10.1007/s40257-017-0317-6; Levin YS, 2009, DERMATOL CLIN, V27, P163, DOI 10.1016/j.det.2008.11.012; Moreno-Ramirez D, 2007, ARCH DERMATOL, V143, P479, DOI 10.1001/archderm.143.4.479; Norwegian Directorate for e-health, NORM INF SEC PRIV HL; Norwegian Directorate of Health, WAIT TIM ASS TREATM; Snoswell C, 2016, JAMA DERMATOL, V152, P702, DOI 10.1001/jamadermatol.2016.0525; van der Heijden JP, 2011, BRIT J DERMATOL, V165, P1058, DOI 10.1111/j.1365-2133.2011.10509.x	12	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2020	15	4							e0232131	10.1371/journal.pone.0232131	http://dx.doi.org/10.1371/journal.pone.0232131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8VC	32339203	Green Published, gold			2022-12-26	WOS:000536657400030
J	Chao, HH; Karagounis, IV; Thomas, C; Francois, NB; Facciabene, A; Koumenis, C; Maity, A				Chao, Hann-Hsiang; Karagounis, Ilias, V; Thomas, Christoforos; Francois, Noeulle B.; Facciabene, Andrea; Koumenis, Constantinos; Maity, Amit			Combination of CHEK1/2 inhibition and ionizing radiation results in abscopal tumor response through increased micronuclei formation	ONCOGENE			English	Article							INTERFERON REGULATORY FACTOR-3; CYTOSOLIC DNA SENSOR; KINASE INHIBITOR; MITOTIC ENTRY; STING PATHWAY; S-PHASE; CHECKPOINT; CELLS; PEMBROLIZUMAB; CANCER	We explore a novel strategy of activating immune signaling through increased micronuclei formation utilizing a cell cycle checkpoint inhibitor to drive cell cycle progression following ionizing radiation. The Chk1/2 inhibitor AZD7762 is used to abrogate radiation therapy (RT)-induced G2/M cell cycle arrest in multiple cell lines and, we find that this therapeutic combination promotes increased micronuclei formation in vitro and subsequently drives increased type I interferon signaling and cytotoxic T-cell activation. In vivo studies using B16-F10 melanoma cancer cells implanted in C57/BL6 mice demonstrate improved rates of tumor control at the abscopal (unirradiated) site, located outside of the radiation field, only in the AZD7762 + RT group, with a corresponding reduction in mean tumor volume, increase in the CD8 T-cell population, and immune activated gene signaling. Our results demonstrate that targeted inhibition of cell cycle checkpoint activation following ionizing radiation drives increased production of immunogenic micronuclei, leading to systemic tumor response with potential future clinical benefit.	[Chao, Hann-Hsiang; Karagounis, Ilias, V; Thomas, Christoforos; Francois, Noeulle B.; Facciabene, Andrea; Koumenis, Constantinos; Maity, Amit] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Chao, Hann-Hsiang] McGuire VA Med Ctr, Dept Radiat Oncol, Richmond, VA USA	University of Pennsylvania; Hunter Holmes McGuire Veterinary Affairs Medical Center	Maity, A (corresponding author), Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	Amit.Maity@uphs.upenn.edu	Karagounis, Ilias V/A-6497-2013	Karagounis, Ilias V/0000-0003-1642-1996; Koumenis, Costas/0000-0001-5945-4726; Maity, Amit/0000-0001-7151-2845	NIH/NCI grant [1R01CA182747]; University of Pennsylvania Radiation Oncology Resident Research Award	NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Radiation Oncology Resident Research Award	This study was supported by NIH/NCI grant (1R01CA182747 (PI: AM, CK) and the University of Pennsylvania Radiation Oncology Resident Research Award (to H-HC). The authors thank Roger Greenberg group for contribution of cGAS constructs.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Cuneo KC, 2019, J CLIN ONCOL, V37, P2643, DOI 10.1200/JCO.19.00730; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Dillon MT, 2017, MOL CANCER THER, V16, P25, DOI 10.1158/1535-7163.MCT-16-0239; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Guzi TJ, 2011, MOL CANCER THER, V10, P591, DOI 10.1158/1535-7163.MCT-10-0928; Hamilton DH, 2014, CANCER RES, V74, P2510, DOI 10.1158/0008-5472.CAN-13-1894; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; KASTAN MB, 1991, CANCER RES, V51, P6304; Lu Hsu-Fung, 2007, Cancer Genomics & Proteomics, V4, P93; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Maity A, 2018, BRIT J CANCER, V119, P1200, DOI 10.1038/s41416-018-0281-9; Melms JC, 2020, CANCER RES, V80, P798, DOI 10.1158/0008-5472.CAN-19-2330; Moran DM, 2008, ONCOGENE, V27, P5567, DOI 10.1038/onc.2008.172; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Reck M, 2018, IMMUNOTHERAPY-UK, V10, P93, DOI 10.2217/imt-2017-0121; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Schoonen PM, 2019, MOL ONCOL, V13, P2422, DOI 10.1002/1878-0261.12573; Shaverdian N, 2017, LANCET ONCOL, V18, P895, DOI 10.1016/S1470-2045(17)30380-7; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Thomas C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3358; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Vendetti FP, 2018, J CLIN INVEST, V128, P3926, DOI 10.1172/JCI96519; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Woo SR, 2015, TRENDS IMMUNOL, V36, P250, DOI 10.1016/j.it.2015.02.003; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zeng L, 2017, MOL CANCER THER, V16, P591, DOI 10.1158/1535-7163.MCT-16-0352; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	45	12	13	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4344	4357		10.1038/s41388-020-1300-x	http://dx.doi.org/10.1038/s41388-020-1300-x		APR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32335582	Green Accepted			2022-12-26	WOS:000528824400001
J	Kimera, E; Vindevogel, S; Reynaert, D; Justice, KM; Rubaihayo, J; De Maeyer, J; Engelen, AM; Musanje, K; Bilsen, J				Kimera, Emmanuel; Vindevogel, Sofie; Reynaert, Didier; Justice, Kintu Mugenyi; Rubaihayo, John; De Maeyer, Jessica; Engelen, Anne-Mie; Musanje, Khamisi; Bilsen, Johan			Experiences and effects of HIV-related stigma among youth living with HIV/AIDS in Western Uganda: A photovoice study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-RELATED STIGMA; MEDICATION ADHERENCE; HEALTH; ADOLESCENTS; PEOPLE; CARE; MECHANISMS; DISCLOSURE	HIV-related stigma has been identified as a significant stressor affecting Quality of Life of Youth Living With HIV/AIDS (YLWHA). Gaining a contextualized understanding of how this stigma is experienced by YLWHA in Western Uganda is crucial in addressing it in this group and setting. In this study, we explored the lived experiences of YLWHA with HIV-related stigma. Photovoice was used to gain insight into the lived experiences of HIV-related stigma in 11 YLWHA (15-19 years), purposively selected from a hospital-based peer support group. Group interview transcripts, notes and photographs were subjected to phenomenological hermeneutic analysis. Encounters with enacted, anticipated and internalized stigmas and their myriad sequels were prevalent in the photos and narratives of participants. Our findings were categorized and presented in 5 main themes that were identified through the analysis: being devalued, experiencing fear, experiencing injustices, feeling lonely, and lacking future perspectives. HIV-related stigmas were experienced in various socio-ecological domains but predominantly in homes and schools that ought to be supportive surroundings for youths. A multilevel approach, targeting the entire society where the root causes of stigma can be found and specific contexts like schools and homes where youth are confronted with stigma on a daily basis is proposed for a wholistic intervention.	[Kimera, Emmanuel; Justice, Kintu Mugenyi; Rubaihayo, John] Mt Moon Univ, Dept Publ Hlth, Ft Portal, Uganda; [Kimera, Emmanuel; Vindevogel, Sofie; Reynaert, Didier; De Maeyer, Jessica; Engelen, Anne-Mie] Univ Appl Sci & Arts, Social Work & E QUAL, Fac Educ, Hlth, Ghent, Belgium; [Kimera, Emmanuel; Bilsen, Johan] Vrije Univ Brussel, Dept Publ Hlth, Mental Hlth & Wellbeing Res Grp, Brussels, Belgium; [Musanje, Khamisi] Makerere Univ, Sch Psychol, Kampala, Uganda	Vrije Universiteit Brussel; Makerere University	Kimera, E (corresponding author), Mt Moon Univ, Dept Publ Hlth, Ft Portal, Uganda.; Kimera, E (corresponding author), Univ Appl Sci & Arts, Social Work & E QUAL, Fac Educ, Hlth, Ghent, Belgium.; Kimera, E (corresponding author), Vrije Univ Brussel, Dept Publ Hlth, Mental Hlth & Wellbeing Res Grp, Brussels, Belgium.	kimeraemma@yahoo.co.uk	Rubaihayo, John/HDO-2747-2022; kimera, emmanuel/K-4479-2015	Rubaihayo, Prof. John/0000-0002-3421-2242; kimera, emmanuel/0000-0003-0836-8814	Fund for Applied Research of the University College Gent (HoGent)	Fund for Applied Research of the University College Gent (HoGent)	This work was supported by the Fund for Applied Research of the University College Gent (HoGent). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors acknowledge the support of the study participants and Fort Portal regional referral hospital.	Abubakar A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2854-y; Aguwa EN, 2016, W INDIAN MED J, V65, P98, DOI 10.7727/wimj.2014.228; Alesina A, 2010, J ECON GROWTH, V15, P93, DOI 10.1007/s10887-010-9052-z; Ambati BK, 1997, AIDS CARE, V9, P319, DOI 10.1080/09540129750125118; Anderson KL, 2010, J MARRIAGE FAM, V72, P726, DOI 10.1111/j.1741-3737.2010.00727.x; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bernays S, 2017, MED ANTHROPOL, V36, P485, DOI 10.1080/01459740.2017.1306856; Birungi H, 2009, J ADOLESCENT HEALTH, V44, P184, DOI 10.1016/j.jadohealth.2008.06.004; Bogart LM, 2008, AIDS BEHAV, V12, P244, DOI 10.1007/s10461-007-9231-x; Booth T, 2003, DISABIL SOC, V18, P431, DOI 10.1080/0968759032000080986; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Bruton P. J., 2017, P4 18 NOT SO NORMALI; Busza J, 2014, CHILD YOUTH SERV REV, V45, P137, DOI 10.1016/j.childyouth.2014.03.030; Carter-Black J, 2007, J SOC WORK EDUC, V43, P31, DOI 10.5175/JSWE.2007.200400471; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; Crivello G, 2012, DEV PRACT, V22, P536, DOI 10.1080/09614524.2012.673556; Crocker J, 1999, J EXP SOC PSYCHOL, V35, P89, DOI 10.1006/jesp.1998.1369; Deacon H., 2005, UNDERSTANDING HIV AI; Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900; DeMatteo D, 2002, AIDS CARE, V14, P261, DOI 10.1080/09540120120076940; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Drolet M., 2013, INT ED STUDIES, V6, P29, DOI [10.5539/ies.v6n4p29, DOI 10.5539/IES.V6N4P29]; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Erving Goffman, 1963, STIGMA NOTES MANAGEM; Fielden SJ, 2011, CULT HEALTH SEX, V13, P267, DOI 10.1080/13691058.2010.525665; Freeman M, 2006, AIDS CARE, V18, P302, DOI 10.1080/09540120500359009; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Harper GW, 2014, AIDS PATIENT CARE ST, V28, P543, DOI 10.1089/apc.2013.0331; Helms CB, 2017, AIDS BEHAV, V21, P238, DOI 10.1007/s10461-016-1320-2; Herek GM, 1998, BASIC APPL SOC PSYCH, V20, P230, DOI 10.1207/15324839851036705; Kahana SY, 2015, JAIDS-J ACQ IMM DEF, V68, P169, DOI 10.1097/QAI.0000000000000408; Kalichman SC, 2013, ANN BEHAV MED, V46, P256, DOI 10.1007/s12160-013-9529-z; Kelly M, 2000, CURRENT ISSUES COMP, V3, P28; Kimera E, 2019, SAHARA J-J SOC ASP H, V16, P51, DOI 10.1080/17290376.2019.1626760; Kurth AE, 2015, J INT AIDS SOC, V18, P23, DOI 10.7448/IAS.18.2.19433; Lall P, 2015, J INT AIDS SOC, V18, P41, DOI 10.7448/IAS.18.2.19393; Landefeld CC, 2018, AIDS CARE, V30, P116, DOI 10.1080/09540121.2017.1390540; Laverty S.M., 2003, INT J QUAL METH, V21-35, P21, DOI [10.1177/160940690300200303, DOI 10.1177/160940690300200303]; Leary MR, 2017, CURR ISS SOC PSYCHOL, P50; Lee S, 2015, J ADOLESCENT HEALTH, V57, P73, DOI 10.1016/j.jadohealth.2015.03.002; Lindseth A, 2004, SCAND J CARING SCI, V18, P145, DOI 10.1111/j.1471-6712.2004.00258.x; Marco B. B., 2011, DOMESTIC VIOLENCE RE; Martinez J, 2012, AIDS PATIENT CARE ST, V26, P281, DOI 10.1089/apc.2011.0317; Martinez J, 2012, AIDS PATIENT CARE ST, V26, P108, DOI 10.1089/apc.2011.0178; Mukolo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075744; Mutumba M, 2015, AIDS PATIENT CARE ST, V29, P86, DOI 10.1089/apc.2014.0222; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Nglazi MD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1275-3; Orban LA, 2010, AIDS CARE, V22, P420, DOI 10.1080/09540120903193724; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Ramos JV, 2018, AIDS PATIENT CARE ST, V32, P31, DOI 10.1089/apc.2017.0196; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Ricoeur Paul, 1976, INTERPRETATION THEOR; Rutakumwa R, 2015, INT J ENV RES PUB HE, V12, P2120, DOI 10.3390/ijerph120202120; Singh V., 2018, PLOS ONE, V15, pe0232359; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Stutterheim SE, 2009, AIDS, V23, P2353, DOI 10.1097/QAD.0b013e3283320dce; Swendeman D, 2006, HEALTH PSYCHOL, V25, P501, DOI 10.1037/0278-6133.25.4.501; Teti M, 2013, J ASSOC NURSE AIDS C, V24, P539, DOI 10.1016/j.jana.2013.05.001; Turan B, 2016, JAIDS-J ACQ IMM DEF, V72, P198, DOI 10.1097/QAI.0000000000000948; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; van Manen M., 1990, RES LIVED EXPERIENCE; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Wang CC, 1999, J WOMENS HEALTH, V8, P185, DOI 10.1089/jwh.1999.8.185; Winchester MS, 2013, AIDS CARE, V25, P1253, DOI 10.1080/09540121.2013.764386; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345	68	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232359	10.1371/journal.pone.0232359	http://dx.doi.org/10.1371/journal.pone.0232359			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8RF	32330206	Green Published, gold			2022-12-26	WOS:000536647300071
